<SEC-DOCUMENT>0001641172-25-001861.txt : 20250331
<SEC-HEADER>0001641172-25-001861.hdr.sgml : 20250331
<ACCEPTANCE-DATETIME>20250331172010
ACCESSION NUMBER:		0001641172-25-001861
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		92
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250331
DATE AS OF CHANGE:		20250331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Glucotrack, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41141
		FILM NUMBER:		25795060

	BUSINESS ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GlucoTrack, Inc.
		DATE OF NAME CHANGE:	20220328

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integrity Applications, Inc.
		DATE OF NAME CHANGE:	20101203
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:GCTK="http://glucotrack.com/20241231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2024%2D(with%2DECD%2Dand%2DCYD) -->
<!-- Field: Set; Name: xdx; ID: xdx_039_GCTK_glucotrack.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001506983 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06F_Israel_0_iso4217%2D%2DILS -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000006" name="dei:EntityCentralIndexKey">0001506983</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-12-31" id="xdx2ixbrl0092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0113" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0128" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0131" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-12-31" id="xdx2ixbrl0139" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0150" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0165" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0201" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0204" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:GainLossOnEquityIssuance" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0207" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0210" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0243" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0252" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0253" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0259" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0261" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0263" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0269" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0275" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0277" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0278" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0285" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0289" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0293" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0298" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0307" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0323" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0325" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0332" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0334" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0337" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0340" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0372" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0380" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0390" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0410" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0419" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:EquityIssuanceCosts" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:GainLossOnEquityIssuance" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:NetProceedsReceivedFromUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0518" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:DeemedDividendUponTriggerOfDownRoundProtection" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:SettlementOfLiabilitiesWithEquity" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0557" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:NonCashDerivativeLiability" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0647" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-12-31_custom_PrefundedWarrantsMember" id="xdx2ixbrl0661" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-12-31_custom_PrefundedWarrantsMember" id="xdx2ixbrl0663" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-12-31_custom_PerformanceMilestoneMember" id="xdx2ixbrl0669" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-12-31_custom_PerformanceMilestoneMember" id="xdx2ixbrl0671" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-12-31_custom_JuneTwentySevenWarrantsMember" id="xdx2ixbrl0777" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31_custom_JulyMember" id="xdx2ixbrl0992" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_custom_JulyWarrantsMember" id="xdx2ixbrl0994" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:DiscountAmortizationAndInterestExpensesOne" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1088" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1091" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl1146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1154" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1162" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl1170" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1178" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1180" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1182" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1184" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1186" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl1194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1202" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1219" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1220" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2023-12-31" id="xdx2ixbrl1248" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl1250" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl1252" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1260" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1262" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1264" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1266" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextRef="AsOf2024-12-31" id="xdx2ixbrl1274" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl1282" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-12-31" id="xdx2ixbrl1370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-12-31" id="xdx2ixbrl1371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gctk-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReceiptsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReceiptsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ReceiptsOnAccountOfSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-03-28_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">GCTK:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">GCTK:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_PerformanceMilestoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PerformanceMilestoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PerformanceMilestoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PerformanceMilestoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-13_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-142024-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-14</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-01-012004-12-31_custom_FourSeparateLendersMember_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">GCTK:FourSeparateLendersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-01-01</xbrli:startDate>
        <xbrli:endDate>2004-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_FourSeparateLendersMember_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">GCTK:FourSeparateLendersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-032024-01-03_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-03</xbrli:startDate>
        <xbrli:endDate>2024-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-15_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-132024-02-13_custom_ExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:ExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-13</xbrli:startDate>
        <xbrli:endDate>2024-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-13_custom_ExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:ExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-222024-04-22_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-22</xbrli:startDate>
        <xbrli:endDate>2024-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-22_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-302024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-30</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-27_custom_UnsecuredPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GCTK:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-272024-06-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-27</xbrli:startDate>
        <xbrli:endDate>2024-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-18_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-182024-07-18_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-18</xbrli:startDate>
        <xbrli:endDate>2024-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-05_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-30_custom_SeriesACommonWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesACommonWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-30_custom_SeriesBCommonWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesBCommonWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_SeriesACommonWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesACommonWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_SeriesBCommonWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesBCommonWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-30_custom_ConvertiblePromissoryNotesMember_custom_WarrantsAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:WarrantsAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-302024-07-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-30</xbrli:startDate>
        <xbrli:endDate>2024-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-302024-07-30_custom_FirstWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:FirstWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-30</xbrli:startDate>
        <xbrli:endDate>2024-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-30_custom_FirstWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:FirstWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-302024-07-30_custom_SecondWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SecondWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-30</xbrli:startDate>
        <xbrli:endDate>2024-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-30_custom_SecondWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SecondWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-302024-07-30_custom_ThirdWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ThirdWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-30</xbrli:startDate>
        <xbrli:endDate>2024-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-30_custom_ThirdWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ThirdWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-122024-11-12_custom_JuneThirtyNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-12</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_JuneThirtyNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-12</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-12</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-122024-11-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-12</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-232024-08-23_custom_JuneTwentySevenNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-23</xbrli:startDate>
        <xbrli:endDate>2024-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-23_custom_JuneTwentySevenNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-152024-10-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-15</xbrli:startDate>
        <xbrli:endDate>2024-10-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-232024-08-23_custom_AugustTwentyThreeWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-23</xbrli:startDate>
        <xbrli:endDate>2024-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-232024-08-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-23</xbrli:startDate>
        <xbrli:endDate>2024-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05_custom_JuneTwentySevenNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05_custom_JulyEighteenNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JulyEighteenNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-05_custom_JulyTwentySevenNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JulyTwentySevenNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-152024-10-15_custom_JuneTwentySevenNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-15</xbrli:startDate>
        <xbrli:endDate>2024-10-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05_custom_SeptemberFiveWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsThirdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsThirdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-122024-11-12_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-12</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_SeriesACommonWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesACommonWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_SeriesBCommonWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBCommonWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_PrefundedWarrantsMember28421031">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-122024-11-12_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-12</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-122024-11-12_custom_SeriesBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-12</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-12_custom_SeriesBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_JuneTwentySevenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_JuneTwentySevenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_JulyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_JulyWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_JulyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyEighteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyEighteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyEighteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyEighteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_JulyEighteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyEighteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember28421750">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SeriesBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-03-03</xbrli:startDate>
        <xbrli:endDate>2004-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-03-03</xbrli:startDate>
        <xbrli:endDate>2004-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember28422109">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_IsraeliInnovationAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-07</xbrli:startDate>
        <xbrli:endDate>2022-10-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-07</xbrli:startDate>
        <xbrli:endDate>2022-10-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember_custom_TrueupSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:TrueupSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-202024-11-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-20</xbrli:startDate>
        <xbrli:endDate>2024-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-192024-02-19_us-gaap_LeaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-19</xbrli:startDate>
        <xbrli:endDate>2024-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-19_us-gaap_LeaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LessThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">GCTK:LessThanOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_BetweenOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">GCTK:BetweenOneYearToTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_MoreThanTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">GCTK:MoreThanTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-132023-04-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-13</xbrli:startDate>
        <xbrli:endDate>2023-04-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-132023-04-13_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-13</xbrli:startDate>
        <xbrli:endDate>2023-04-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-132023-04-13_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-13</xbrli:startDate>
        <xbrli:endDate>2023-04-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-13_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-172023-04-17_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-17</xbrli:startDate>
        <xbrli:endDate>2023-04-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-01-102010-01-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-01-10</xbrli:startDate>
        <xbrli:endDate>2010-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_custom_DrindaBenjaminMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:DrindaBenjaminMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_custom_MarkTapsakMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_custom_MarkTapsakMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-142024-06-14_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-14</xbrli:startDate>
        <xbrli:endDate>2024-06-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_DrindaBenjaminMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:DrindaBenjaminMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DrindaBenjaminMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:DrindaBenjaminMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-13_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-13_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SalariesAndRelatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:SalariesAndRelatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SalariesAndRelatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:SalariesAndRelatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ProfessionalFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:ProfessionalFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ProfessionalFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:ProfessionalFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:DepreciationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_OtherExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_OtherExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:TapsakEnterprisesLLCAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:TapsakEnterprisesLLCAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-032025-02-03_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-03</xbrli:startDate>
        <xbrli:endDate>2025-02-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03_srt_MinimumMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03_srt_MaximumMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-03_srt_MinimumMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-03_srt_MaximumMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-172024-12-17_custom_SalesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SalesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-17</xbrli:startDate>
        <xbrli:endDate>2024-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-03-212025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-21</xbrli:startDate>
        <xbrli:endDate>2025-03-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-03-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-042025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-04</xbrli:startDate>
        <xbrli:endDate>2025-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-06</xbrli:startDate>
        <xbrli:endDate>2025-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-06</xbrli:startDate>
        <xbrli:endDate>2025-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Israel">
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="xdx2ixbrl0289" toRefs="Footnote000440"/>
  <ix:relationship fromRefs="Fact000653" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact000655" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact000657" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact000659" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="xdx2ixbrl0661" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="xdx2ixbrl0663" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact000665" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact000667" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="xdx2ixbrl0669" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="xdx2ixbrl0671" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact000673" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact000675" toRefs="Footnote001203"/>
  <ix:relationship fromRefs="Fact001198" toRefs="Footnote001203"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_906_edei--DocumentType_c20240101__20241231_z8Uwclcy55Gg"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000013" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Mark
One)</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--DocumentAnnualReport_c20240101__20241231_zBq1l2ytcyUk"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the fiscal year ended <span id="xdx_901_edei--DocumentPeriodEndDate_c20240101__20241231_zRp1VZouJKZh"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate"><span id="xdx_90F_edei--CurrentFiscalYearEndDate_c20240101__20241231_zbc83Xn4UVWj"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:datemonthdayen" id="Fact000016" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_903_edei--DocumentFiscalYearFocus_c20240101__20241231_zu5Kra9vRhC5"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000017" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric></span></ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_906_edei--DocumentTransitionReport_c20240101__20241231_zhrejvoi7P8b"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from _______ to ______</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number <span id="xdx_90C_edei--EntityFileNumber_c20240101__20241231_zMiqqk3o9Nk7"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000019" name="dei:EntityFileNumber">001-42374</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_908_edei--EntityRegistrantName_c20240101__20241231_zdNzVUxOaMF"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000020" name="dei:EntityRegistrantName">GLUCOTRACK,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20240101__20241231_zePLxWsMMI7e"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:stateprovnameen" id="Fact000021" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20240101__20241231_zaZZkXZ36fk9"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000022" name="dei:EntityTaxIdentificationNumber">98-0668934</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of incorporation or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer Identification No.)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20240101__20241231_zLOKUgnpufF6"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000023" name="dei:EntityAddressAddressLine1">301
                                            Route 17 North</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20240101__20241231_z7F9wic7HkNi"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000024" name="dei:EntityAddressAddressLine2">Suite 800</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20240101__20241231_ze9ylDPt3eX7"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000025" name="dei:EntityAddressCityOrTown">Rutherford</ix:nonNumeric></span>,
    <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20240101__20241231_zA8vi2J8eMe3"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000026" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressPostalZipCode_c20240101__20241231_ziy9Z2xLHLIg"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000027" name="dei:EntityAddressPostalZipCode">07070</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Principal Executive Offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--CityAreaCode_c20240101__20241231_zRENtLuVifZk"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000028" name="dei:CityAreaCode">(201)</ix:nonNumeric></span>
<span id="xdx_90C_edei--LocalPhoneNumber_c20240101__20241231_zPWcvIozkOz"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000029" name="dei:LocalPhoneNumber">842-7715</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20240101__20241231_zW3f5B1fwxJf"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000030" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20240101__20241231_zFu1I8HQ5UJa"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000031" name="dei:TradingSymbol">GCTK</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--SecurityExchangeName_c20240101__20241231_zR50DXvuYew8"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to section 12(g) of the Act: None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_902_edei--EntityWellKnownSeasonedIssuer_c20240101__20241231_z6rm2SwOvMIb"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000033" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span id="xdx_908_edei--EntityVoluntaryFilers_c20240101__20241231_z9In9U6Na8Gf"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000034" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90C_edei--EntityCurrentReportingStatus_c20240101__20241231_zBQXv2Q4YYoj"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000035" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <span id="xdx_906_edei--EntityInteractiveDataCurrent_c20240101__20241231_zWkrJC2N2wVg"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000036" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746; No &#9744; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityFilerCategory_c20240101__20241231_zUF2x2IUc219"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:entityfilercategoryen" id="Fact000037" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&#9746;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span id="xdx_901_edei--EntitySmallBusiness_c20240101__20241231_z0qtUJEbsixh"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000038" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20240101__20241231_zjCNrB737x8g"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000039" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <span id="xdx_90B_edei--IcfrAuditorAttestationFlag_c20240101__20241231_zEyBYlqM6PU"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000040" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_90E_edei--DocumentFinStmtErrorCorrectionFlag_c20240101__20241231_zV5CuQxktDVi"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000041" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes &#9744; No <span id="xdx_909_edei--EntityShellCompany_dbF_c20240101__20241231_ze6zwRTMM1B4"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000042" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 28, 2024, the last business day of the registrant&#8217;s last completed second quarter, the aggregate market value of the
common stock held by non-affiliates of the registrant was approximately $<span id="xdx_900_edei--EntityPublicFloat_iI_pn5n6_c20240628_z67aBc90XYgi"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2024-06-28" id="Fact000043" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">8.6</ix:nonFraction></span> million based on the closing price per share of the
registrant&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), on June 28, 2024, as reported by the
Nasdaq Stock Market. For the purposes of this disclosure, shares of Common Stock held by each executive officer, director and
affiliate based on public filings and other information known to the registrant have been excluded since such persons may be deemed
affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2025, there were <span id="xdx_902_edei--EntityCommonStockSharesOutstanding_iI_pid_c20250331_zxJZWtE8iLJ7"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-03-31" id="Fact000044" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,585,853</ix:nonFraction></span> shares of Common Stock, par value $<span id="xdx_904_edei--EntityListingParValuePerShare_c20240101__20241231_zpfljOmVUkr2"><ix:nonFraction name="dei:EntityListingParValuePerShare" contextRef="From2024-01-01to2024-12-31" id="Fact000045" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share, of the registrant issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
<span id="xdx_904_edei--DocumentsIncorporatedByReferenceTextBlock_c20240101__20241231_zDLg6jEPo2yk"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000046" name="dei:DocumentsIncorporatedByReferenceTextBlock">None</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
of Contents</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#sk_001">PART I</a></b></span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_002">Item 1. Business</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right">4<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_003">Item 1A. Risk Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SS_001">Item 1B. Unresolved Staff Comments</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">29<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_004">Item 1C. Cybersecurity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">29<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_005">Item 2. Properties</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_006">Item 3. Legal Proceedings</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_007">Item 4. Mine Safety Disclosures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>30</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#sk_008">PART II</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_009">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right">31<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_010">Item 6. [Reserved]</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">35<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_011">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>35</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_012">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_013">Item 8. Financial Statements and Supplementary Data</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_014">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_015">Item 9A. Controls and Procedures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_016">Item 9B. Other Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">46<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_017">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>46</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#sk_018">PART III</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_019">Item 10. Directors, Executive Officers and Corporate Governance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">47<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_020">Item 11 Executive Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_021">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>52</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_022">Item 13. Certain Relationships and Related Transactions, and Director Independence</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>58</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_023">Item 14. Principal Accountant Fees and Services</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span>61</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#sk_024">PART IV</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_025">Item 15. Exhibits and Financial Statement Schedules</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_027">Item 16. Form 10-K Summary</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">63<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_026">Signatures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">64<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cautionary
Note Regarding Forward-Looking Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K (the &#8220;Annual Report&#8221;) includes statements that express our opinions, expectations, beliefs, plans,
objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, &#8220;forward-looking
statements.&#8221; All statements other than statements of historical facts contained in this Annual Report may be forward-looking statements.
These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms &#8220;believes,&#8221;
&#8220;estimates,&#8221; &#8220;continues,&#8221; &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;seeks,&#8221; &#8220;projects,&#8221;
&#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or &#8220;should&#8221; or, in
each case, their negative or other variations or comparable terminology. They appear in a number of places throughout this Annual Report,
and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations,
financial condition, liquidity, prospects, growth, strategies, future acquisitions and the industry in which we operate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that
may or may not occur in the future. We believe that these risks and uncertainties include, but are not limited to, those described in
the &#8220;<i>Risk Factors</i>&#8221; section of this Annual Report, which include, but are not limited to, risks related
to the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to manufacture, market and sell our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to launch and penetrate markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependency upon effective operation with operating systems, devices, networks and standards that we do not control and on our continued
    relationships with mobile operating system providers, device manufacturers and mobile software application stores on commercially
    reasonable terms or at all;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to hire and retain key personnel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the possibility of security and privacy breaches in our systems and in the third-party software and/or systems that we use, damaging client relations and inhibiting our ability to grow;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">our ability to internally develop new inventions and intellectual property;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the existence of undetected software defects in our products and our failure to resolve detected defects in a timely manner;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to remain a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to raise additional capital and the risk of such capital not being available to us at commercially reasonable terms or at
    all;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">our ability to be profitable;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">interpretations of current laws and the passages of future laws;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">acceptance of our business model by investors;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">intense
    competition in our industry and the markets in which we operate, and our ability to successfully compete;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the risks inherent with international operations;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of evolving information security and data privacy laws on our business and industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the impact of governmental regulations on our business and industry;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to protect our intellectual property and our ability to operate our business without infringing on the rights of others;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk of being delisted from Nasdaq Capital Market (&#8220;Nasdaq&#8221;) if we fail to meet any of its applicable listing requirements; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    difficulty of predicting our revenues and operating results and the chance of such revenues and results falling below analyst or
    investor expectations, which could cause the price of our Common Stock to fall</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    other factors described in the &#8220;<i>Risk Factors</i>&#8221; section of this Annual Report.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
factors should not be construed as exhaustive and should be read with the other cautionary statements in this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Readers
are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this report is filed with
the Securities and Exchange Commission (&#8220;SEC&#8221;). We cannot guarantee the accuracy of any such forward-looking statements contained
in this Annual Report, and we do not intend to publicly update or revise any forward-looking statements, whether as a result of new information,
future events, or otherwise. For further information regarding risks and uncertainties associated with our business, and important factors
that could cause our actual results to vary materially from those expressed or implied in such forward-looking statements, please refer
to the factors listed and described in this Annual Report and in our other SEC filings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_001"></span>PART
I</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_002"></span>Item
1. Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
the context otherwise requires, the terms &#8220;we&#8221;, &#8220;our&#8221;, &#8220;ours&#8221; &#8220;us&#8221;,
&#8220;Company&#8221; and &#8220;Glucotrack&#8221; refer to Glucotrack, Inc., a Delaware corporation.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was incorporated on May 18, 2010 under the laws of the State of Delaware. We are a medical device company focused on the
development of an implantable continuous blood glucose monitor (&#8220;CBGM&#8221;) for persons with Type 1 diabetes and insulin-dependent Type 2
diabetes (the &#8220;Glucotrack CBGM&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was founded with a mission to develop Glucotrack&#174;, a non-invasive glucose monitoring device designed to help people with diabetes
and pre-diabetics obtain glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot
finger stick devices. The first generation Glucotrack, which successfully received CE Mark approval, obtained glucose measurements via
a small sensor clipped onto one&#8217;s earlobe. A limited release beta test in Europe and the Middle East demonstrated the need for
an updated product with improved accuracy and human factors. As the glucose monitoring landscape has since rapidly moved away from point-in-time
measurement to continuous measurement, the Company recently determined that it would focus its efforts on developing the Glucotrack
CBGM. As such, we have since withdrawn our CE Mark for Glucotrack and are no longer pursuing commercialization of this product
or development of any further iterations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2022, the Company acquired certain intellectual property related to the Glucotrack CBGM from Paul V. Goode, the
Company&#8217;s Chief Executive Officer and intends to develop the technology to address the growing Type 1 and insulin-dependent
Type 2 diabetes market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is currently developing the Glucotrack CBGM for use by Type 1 diabetes patients as well as insulin-dependent Type 2
patients. Implant longevity is key to the success of such a device. We have continued to evolve our sensor chemistry following our successful
in-vitro feasibility study demonstrating that a minimum two-year implant life is highly probable with the current sensor design. Recently
we announced that a 3-year longevity is feasible leveraging both in-vitro and in-silico test results. We have also completed multiple
animal studies with initial prototype systems which demonstrated a simple implant procedure with good safety and functionality. The results
of both were presented in poster form at the 2024 American Diabetes Association annual conference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
to the above progress on the Glucotrack CBGM, we have also successfully demonstrated continuous glucose sensing in the epidural space. This
latter approach is of importance for patients with diabetes already contemplating spinal cord stimulation therapy for their condition.
We believe our technology, if successful, has the potential to be more accurate, more convenient and have a longer duration than other
implantable glucose monitors that are either in the market or currently under development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has recently completed a first in human study. This study was an acute study intended to demonstrate device performance and safety,
as well as safety of the implant and removal procedures. The study used the planned commercial version of the implantable sensor connected
to an externalized prototype electronics device. Patients were monitored in hospital for 4 days. Results of the study were positive,
meeting the endpoints of no serious safety events while demonstrating similar performance and accuracy as observed in longer-term animal
studies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
regulatory submission has recently been made for a first in human study of the planned commercial version of the Glucotrack CBGM
system: fully implantable sensor and electronics with no on-body wearable. This will be a long-term study intended to demonstrate
device performance and safety over a period of at least one year. Most of the preparatory clinical activities are complete and the
study is expected to initiate late in the second quarter of 2025, pending regulatory approval. In parallel, the Company is also
preparing for pre-submission discussions with the U.S. Food and Drug Administration (FDA) regarding our planned multi-center United
States (&#8220;U.S.&#8221;) clinical trial we hope to launch before the end of 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of this effort, the Company has recently obtained ISO13485 certification, an internationally agreed-upon standard of quality
system requirements for the design, production, distribution, and sale of medical devices. The Company has successfully completed
all necessary audits without any major nonconformities. Certification of compliance to the standard is recognized and accepted by
the FDA, the European Medicines Agency (EMA), and many other regulatory authorities worldwide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive management team consists of our Chief Executive Officer and President, Paul V. Goode PhD, an experienced executive with a
25+ year career developing innovative medical technologies, including at Dexcom, Inc. (&#8220;Dexcom&#8221;) and MiniMed (now
Medtronic Diabetes) and Chief Financial Officer, Peter C. Wulff, who has over 35 years of experience as a chief financial officer
and chief operating officer in both public and private entities. Our senior management team consists of: Mark Tapsak PhD, Chief
Scientific Officer, a medical research scientist who brings over 25 years of experience in the diabetes industry, including previous
senior roles at Dexcom and Medtronic; James P. Thrower PhD, Vice President of Advanced Technologies, a seasoned engineering
executive with 20 years&#8217; experience formerly of Sterling Medical Devices, Mindray DS USA and Dexcom.; Drinda Benjamin, Vice
President of Marketing, a medical device professional with over 20 years of experience in the medical device and diabetes industry
with senior roles at Intuity Medical, Senseonics, Incorporated, Abbott Diabetes, and Medtronic Diabetes; Vincent Wong, Vice
President of Operations, a medical device professional with 15 years of experience in quality system for implantable medical device
manufacturing with senior roles at Cirtec Medical and TOMZ Corporation (&#8220;TOMZ&#8221;); Sandie Martha, Vice President Clinical Operations, a medical device
professional with over 20 years of experience in the medical device and diabetes industry with senior roles at Dexcom and GlySens Incorporated (&#8220;GlySens&#8221;);
and Ted Williams, Vice President Regulatory, a medical device professional with over 20 years of experience in the biotech and
diabetes industry with a senior role at GlySens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors (the &#8220;Board&#8221; or &#8220;Board of Directors&#8221;) includes the Chairman Luis J. Malav&#233;, formerly
of Insulet Corp, Medtronic and MiniMed (now Medtronic Diabetes); Andy Balo, formerly of Dexcom and St Jude Medical (now Abbott), Erin
Carter, formerly of Medtronic and Boston Scientific; John Ballantyne, formerly of Aldeveron; Robert Fischell, formerly of Pacesetter
(now Abbott), NeuroPace, and IsoStent, Inc.; and Allen Danzig, formerly of L3-Harris Technologies and Celanese.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Opportunity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Diabetes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diabetes
is a chronic, life-threatening disease for which there is no known cure. Diabetes is caused by the body&#8217;s inability to produce
or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. Glucose,
the primary source of energy for cells, must be maintained at certain concentrations in the blood in order to permit optimal cell function
and health. Normally, the pancreas provides control of blood glucose levels by secreting the hormone insulin to decrease blood glucose
levels when concentrations are too high. In people with diabetes, blood glucose levels fluctuate between very high levels, a condition
known as hyperglycemia, and very low levels, a condition known as hypoglycemia. Hyperglycemia can lead to serious long-term complications,
such as blindness, kidney disease, nervous system disease, amputations, stroke and cardiovascular disease. Hypoglycemia can lead to confusion,
loss of consciousness or death.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diabetes
is typically classified into two major groups: Type 1 and Type 2. Type 1 diabetes is characterized by the body&#8217;s inability to produce
insulin, resulting from destruction of the insulin producing cells of the pancreas. Individuals with Type 1 diabetes must rely on frequent
insulin injections in order to regulate and maintain blood glucose levels. Type 1 diabetes is frequently diagnosed during childhood or
adolescence, although disease onset can occur at any age. Type 2 diabetes, the more common form of diabetes, is a metabolic disorder
that is characterized by the body&#8217;s inability to either properly utilize insulin or produce enough insulin. Type 2 diabetes is
associated with older age, obesity, family history of diabetes, history of gestational diabetes, impaired glucose metabolism, physical
inactivity and race or ethnicity. Depending on the severity of Type 2 diabetes, individuals may require diet and nutrition management,
exercise, oral medications or insulin injections to regulate blood glucose levels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Diabetes Atlas (Ninth Edition) published by the International Diabetes Federation in 2021, approximately 537 million adults
worldwide, between the ages of 20 and 79, or approximately 10% of the world&#8217;s adult population, were estimated to suffer from
diabetes in 2021 (not including those persons who suffer from impaired glucose tolerance or gestational diabetes, diabetic
conditions first arising during pregnancy). The International Diabetes Federation estimates that this number will grow to
approximately 784 million adults worldwide by 2045. The Centers for Disease Control and Prevention in its 2023 National Diabetes
Statistics Report provided crude estimates for 2021 that there are approximately 38 million people with diabetes in the U.S.,
of which 29.7 million have diagnosed diabetes. Among US adults ages 18 years or older, there were 1.2 million new cases of diabetes
diagnosed in 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Glucose
Monitoring</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blood
glucose levels can be affected by many factors, including the carbohydrate and fat content of meals, exercise, stress, illness or impending
illness, hormonal releases, medications, variability in insulin absorption and changes in the effects of insulin in the body. Given the
many factors that affect blood glucose levels, maintaining glucose within a normal range can be difficult. People with diabetes generally
manage their blood glucose levels by administering insulin or ingesting carbohydrates throughout the day to maintain blood glucose within
normal ranges. Normal ranges vary from person to person. In order to maintain blood glucose levels within normal ranges, people with
diabetes must first measure their blood glucose levels so that they can make the proper therapeutic adjustments. As adjustments are made,
additional blood glucose measurements may be necessary to gauge the individual&#8217;s response to the adjustments. More frequent testing
of blood glucose levels provides these individuals with information that can be used to better understand and manage their diabetes.
Testing of blood glucose levels should be performed (at a minimum) before meals, after meals and before going to sleep. People with diabetes
who take insulin usually need to test more often than those who do not take insulin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
recently, spot finger stick devices known as blood glucose monitors (&#8220;BGM&#8221;) have been the most prevalent devices for blood
glucose monitoring. These devices require users to insert a strip into a glucose meter, take a blood sample with a finger stick and place
a drop of blood on a test strip that yields a single point in time blood glucose measurement. Despite continued developments in the field
of BGMs, the routine measurement of glucose levels remains invasive, painful, inconvenient, difficult and costly. Moreover, the American
Diabetes Association updated guidelines (released 2023) indicated there is no clinical evidence of benefit for non-insulin dependent
Type 2 diabetes patients; and recommended CGM as the standard of care for those patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuous glucose monitor (&#8220;CGM&#8221;)
systems involve the insertion of sensors into the body to measure glucose levels in the interstitial fluid throughout the day and night,
providing real-time data that shows trends in glucose measurements. Many published clinical studies demonstrate that CGMs improve glycemic
control in people with Type 1 diabetes or people with insulin-requiring Type 2 diabetes. As a result, CGM use is rapidly increasing and
has become the clinically recommended standard of care for these patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the benefits in glycemic control and significant insurance coverage, almost half of the people with diabetes still have not adopted CGM.
We believe that a significant market opportunity exists for an innovative CGM device that addresses the remaining barriers to adoption.
According to a 2017&#160;Diabetes Care&#160;study, these barriers include the inconvenience of wearing devices all the time, discomfort
and inconvenience of bi-weekly device replacement, dislike for having diabetes devices on the body, and dislike for how diabetes devices
look on the body. Additionally, the study reported that reasons that people discontinued using a CGM included the device being uncomfortable
or painful and the belief that the device is not accurate.<sup>1</sup> The Company conducted its own market research study in 2024 to
validate these findings as still being relevant. The results on over 750 patients demonstrated that patients with diabetes still have
the same issues as expressed in 2017.<sup>2</sup> We believe that improved CGM devices that address these barriers could provide significant
benefits to patients, healthcare providers and payors, thereby increasing overall CGM adoption and ongoing satisfaction. The Company
is developing a long-term implantable blood-based CGM that will allow continuous monitoring of blood glucose levels, which the Company
believes is a significant improvement in quality compared to spot finger stick devices and CGM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1&#160;</sup>Tanenbaum
ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential
intervention targets.&#160;<i>Diabetes Care </i><b>2017 </b>Feb 1;40(2):181-7.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<sup>2
</sup>&#8220;Evaluating Acceptance of a Continuous Blood Glucose Monitor for People with Insulin Requiring Diabetes&#8221;, Presented
at 2024 ADCES annual conference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Product</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is currently developing a long-term implantable CBGM with no requirement for an additional
wearable component with maintained calibration status (the &#8220;Glucotrack CBGM&#8221;). The Glucotrack CBGM utilizes
an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood
vessel. This facilitates continuous blood glucose measurements with zero lag time. In comparison, all other CGM systems of which we are
aware measure glucose in the interstitial fluid, which lags behind blood glucose. Our approach is based on design elements, implant techniques,
and implant tools commonly used for active implantable devices in the cardiovascular space. As a result, it employs a recognized, established,
and widely utilized implant procedure and device form factor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the second quarter of 2023, we completed the laboratory-based feasibility study demonstrating that the CBGM sensor is capable of measuring
glucose for at least two years post-implant. By the end of 2023 we completed our initial preclinical in vivo animal study. This initial
preclinical study produced very strong results, demonstrating at least three months of well-sustained sensor life while also demonstrating
that the sensor is safe for animals. The study also indicated the CBGM is capable of a high level of measurement accuracy as compared
with conventional CGM technologies on the market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the fourth quarter of 2023, we initiated a human clinical device/system design and development program. The objective was to complete
this effort in time to initiate regulatory filings for a first-in-human acute (&#8220;FIH-A&#8221;) study in the second quarter of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2024, we advanced the program of the commercial device/system design and development program with our contract manufacturing
partner, Cirtec Medical. The objective was to complete this effort in time to initiate regulatory filings for a first-in-human chronic
(&#8220;FIH-C&#8221;) study in the fourth quarter of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the second quarter of 2024, we announced that the Glucotrack CBGM successfully completed 30 days of a 60-day long-term preclinical
study on measuring glucose in the epidural space.&#160;The Glucotrack CBGM sensor, implanted in the epidural space of animals,
closely tracked both blood glucose and a commercially available subcutaneous CGM throughout the 30-day period. The implantation
procedure took approximately 20 minutes, and the animals recovered without complications. No abnormal clinical signs or findings in
the spinal cord or surrounding tissues were observed at the 30-day mark. We subsequently announced that the 60-day long-term study
was completed, demonstrating the feasibility of glucose monitoring in the epidural space. No abnormal clinical signs were observed
throughout the study period, and no abnormal findings were observed in the spinal cord or surrounding tissues during post-explant
analysis. The study also confirmed that the implanted sensor did not cause any delayed latent effects over the long-term period,
which is particularly important as a complete healing process in animal studies with implanted devices may take several weeks. With
the completion of this study, the durability of the epidural approach for continuous glucose monitoring has now been confirmed over
the 60-day period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in the second quarter of 2024, a regulatory submission was prepared and eventually submitted for the FIH-A study to be performed in Sao
Paulo, Brazil. This study was a small cohort of up to 10 patients evaluated in-hospital for 4 days. The goals of the study were to prove
the implant and removal procedures were safe and reasonable, the device was safe and functional, and the overall experience was well-tolerated.
The trial began in December 2024 and was completed in late January 2025. The study successfully met all objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the third quarter of 2024, we presented data at the Diabetes Technology Society annual meeting that demonstrated a sensor longevity of
3 years. Using in silico modeling to iterate membrane parameter design changes and further validated by in vitro bench testing, we were
able to improve our projected sensor longevity from 2 years to 3 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fourth quarter of 2024, a regulatory submission was prepared and eventually submitted for the FIH-C study to be performed in Melbourne,
Australia. This study is to be up to 30 patients across up to 3 centers evaluated in daily life for one year, with the option to extend
the study longer. The goals of the study are to collect data for sensor characterization and algorithm development, along with implant
procedure characterization and refinement. These results will drive any necessary refinements to the system. Upon incorporation of any
required refinements, we intend to conduct a U.S. Pilot Study. Initial regulatory feedback from the Australian regulatory body is expected
in first quarter 2025 with trial start expected in second quarter 2025.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to clinical trials, we are targeting the second quarter of 2025 for initiation of the FIH-C trial. This trial is expected to
use the commercial version of the implantable system products (device and sensor), along with the scaled mobile app and cloud. Throughout
2025, we will identify potential clinical sites, obtain regulatory approval, and prepare the sites for trial initiation. We will also
be working with key physician partners to refine the implant, explant, and replacement procedures and associated tool set. We will also
request our first pre-submission meeting with the FDA. The goal of this is to initiate
discussions culminating in an Investigational Device Exemption (&#8220;IDE&#8221;) submission in the third quarter of 2025. The IDE submission
will be for a U.S. Pilot Study targeting up to 40 patients across up to 3 U.S. clinical centers; however, the FDA may limit number of patients
and/or clinical centers. The primary goal of this study is to be a &#8216;dry run&#8217; for the eventual FDA pivotal trial for FDA approval. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2025, we received ISO 13485:2016 certification from the British Standards Institute (&#8220;BSI&#8221;). We successfully
completed Stage I and Stage II Assessments performed by the notified body, BSI, to verify the Company has established, and is maintaining,
a quality management system that meets all requirements of the ISO 13485:2016 standard for design and development of our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have commercial manufacturing facilities and do not intend to build commercial manufacturing facilities of our own in the foreseeable
future. Our strategy has been to select leaders in the manufacturing of similar or complementary products. We recently announced a development
and manufacturing agreement with Cirtec Medical (Brooklyn Park, MN), one of the leading medical device solutions providers of implantable
therapies. We require our critical suppliers and their manufacturing facilities to comply with applicable regulations in the jurisdictions
in which our devices are to be marketed (including ISO 13485 in the European Union (&#8220;EU&#8221;)), current quality system regulations,
which include current good manufacturing practices, and to the extent laboratory analysis is involved, current good laboratory practices.
There can be no assurance that our manufacturing partners will perform as expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research
and Development</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;<i>Item 7 &#8211; Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation &#8211; Results
of Operation</i>&#8221; below for a discussion of the research and development expenses for the fiscal years ended December 31, 2024 and
2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
is heavily regulated by federal, state and local governments in the United States, and by similar authorities in other countries. Any
product that we develop must receive all relevant regulatory approvals or clearances, as the case may be, before it may be marketed in
a particular country. The laws and regulations affecting healthcare change regularly, thereby increasing the uncertainty and risk associated
with any healthcare related venture. The United States government has in the past considered, is currently considering and may in the
future consider healthcare policies and proposals intended to curb rising healthcare costs, including those that could significantly
and adversely affect reimbursement for healthcare products such as our devices. These policies have included and may in the future include:
basing reimbursement policies and rates on clinical outcomes, the comparative effectiveness and costs of different treatment technologies
and modalities; imposing price controls and taxes on medical device providers; and other measures. Future significant changes in the
healthcare systems in any jurisdiction in which our devices, may be cleared for sale could also have a negative impact on the demand
for our devices. These include changes that may reduce reimbursement or payment rates for such products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, the federal government regulates healthcare through various agencies, including but not limited to the following:
(i) the FDA, which administers the Food, Drug, and Cosmetic Act (the &#8220;FDCA&#8221;) as well as other relevant laws; (ii) the Centers
for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), which administers the Medicare and Medicaid programs; (iii) the Office of Inspector
General, which enforces various laws aimed at curtailing fraudulent or abusive practices including, by way of example, the Anti-Kickback
Law, the Anti-Physician Referral Law, commonly referred to as the Stark Law, the Anti-Inducement Law, the Civil Money Penalty Law, and
the laws that authorize the Office of Inspector General to exclude health care providers and others from participating in federal healthcare
programs; and (iv) the Office of Civil Rights which administers the privacy and security aspects of the Health Insurance Portability
and Accountability Act of 1996 (&#8220;HIPAA&#8221;). All of the aforementioned are agencies within the Department of Health and Human
Services. Healthcare is also provided or regulated, as the case may be, by the Department of Defense through its TriCare program, the
Department of Veterans Affairs under, among other laws, the Veterans Health Care Act of 1992, the Public Health Service within the Department
of Health and Human Services under the Public Health Service Act, the Department of Justice through the federal False Claims Act (the
&#8220;FCA&#8221;) and various criminal statutes, and state governments under the Medicaid program and their internal laws regulating
all healthcare activities. If and when we receive FDA approval to market our devices in the United States, we will be subject to regulation
by some or all of the foregoing agencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
applicable regulatory schemes in the EU are significantly more diverse than those in the United States and do not lend themselves to
similar summary. Although the CE Mark system and the Medical Device Regulation (&#8220;MDR&#8221;) require a minimum level of harmonization
in the EU, each EU member country may impose additional regulatory requirements. Because there are numerous EU member countries with
distinct legal systems, the scope of potential regulatory requirements in each of the EU countries (additional to the harmonized EU requirements)
is difficult to summarize or predict.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regulation
of the Design, Manufacture and Distribution of Medical Devices</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
product that we develop must receive all relevant regulatory clearances or approvals, as the case may be, before it may be marketed in
a particular country.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of medical devices outside the United States are subject to foreign regulatory requirements that vary widely from country to country.
These laws and regulations range from simple product registration requirements in some countries to complex clearance and production
controls in others. As a result, the processes and time periods required to obtain foreign marketing approval may be longer or shorter
than those necessary to obtain FDA approval (as described below). These differences may affect the efficiency and timeliness of international
market introduction of our devices. For countries in the EU, medical devices must display a CE Mark before they may be imported or sold
and must comply with the requirements of the MDR. However, although the MDR is applicable throughout the EU, in practice it does not
ensure uniform regulation throughout the EU. Rather, the MDR requires only a minimum level of harmonization in the EU. Accordingly, member
countries may apply and enforce the MDR&#8217;s terms differently, and certain EU member countries may request or require performance
and/or safety data in addition to the MDR&#8217;s requirements from time to time, on a case-by-case basis. The CE Mark also permits the
sale in countries that have an MDR Mutual Recognition Agreement with the EU.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, under Section 201(h) of the FDCA, a medical device is an article which, among other things, is intended for use in
the diagnosis of disease or other conditions or in the cure, mitigation, treatment or prevention of disease in man or other animals.
We believe that our devices will be classified as medical devices and subject to regulation by numerous agencies and legislative bodies,
including the FDA and its foreign counterparts. Devices are subject to varying levels of regulatory control, the most comprehensive of
which requires that a clinical evaluation be conducted before a device receives approval for commercial distribution. The FDA classifies
medical devices into one of three classes. Class I devices are relatively simple and can be manufactured and distributed with general
controls. Class II devices are somewhat more complex and require greater scrutiny. Class III devices are new and frequently help sustain
life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, a company generally can obtain permission to distribute a new device in two ways &#8211; through a so-called
&#8220;510(k)&#8221; premarket notification application or through a Section 515 premarket approval (&#8220;PMA&#8221;) application.
The 510(k) submission applies to any device that is substantially equivalent to a device first marketed prior to May 28, 1976 or to
another device marketed after that date, but which was substantially equivalent to a pre-May 28, 1976 device. These devices are
either Class I or Class II devices. Under the 510(k) submission process, the FDA will issue an order finding substantial equivalence
to a predicate device (pre-May 28, 1976 or post-May 28, 1976 device that was substantially equivalent to a pre- May 28, 1976 device)
and permitting commercial distribution of that device for its intended use. A 510(k) submission must provide information supporting
its claim of substantial equivalence to the predicate device. The FDA permits certain low risk medical devices to be marketed
without requiring the manufacturer to submit a premarket notification. In other instances, the FDA may require that a premarket
notification not only be submitted, but also be accompanied by clinical data. If clinical data from human experiments are required
to support the 510(k) submissions, these data must be gathered in compliance with investigational device exemption regulations for
investigations performed in the United States. The FDA review process for premarket notifications submitted pursuant to section
510(k) should take about 90 days, but it can take substantially longer if the FDA has concerns, and there is no guarantee that the
FDA will clear the device for marketing, in which case the device cannot be lawfully distributed in the United States. If the FDA
finds that the device subject to the premarket notification is substantially equivalent to a proper predicate device, then the FDA
may &#8220;clear&#8221; that device for marketing. These devices are not &#8220;approved&#8221; by the FDA. It is very unlikely,
however, that the FDA will deem our Glucotrack CBGM subject to the 510(k) process, as opposed to the more time-consuming, resource
intensive and problematic PMA application process described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
more comprehensive PMA process applies to a new device that either is not substantially equivalent to a pre-May 28, 1976 product or is
to be used in supporting or sustaining life or preventing impairment. These devices are normally Class III devices and can only be marketed
following approval of a PMA application. For example, most implantable devices are subject to the PMA approval process. Two steps of
FDA approval generally are required before a company can market a product in the U.S. that is subject to Section 515 PMA approval, as
compared to a Section 510(k) clearance. First, a company must comply with investigational device exemption regulations in connection
with any human clinical investigation of the device; however, those regulations permit a company to undertake a clinical study of a &#8220;non-significant
risk&#8221; device without formal FDA approval. Prior express FDA approval is required if the device is a significant risk device. If
there is any doubt as to whether a device is a &#8220;non-significant risk&#8221; device, companies normally seek prior approval from
the FDA. Normally, clinical studies of new diagnostic products are conducted in tandem with a cleared or approved device and treatment
decisions are based on the results from the existing diagnostic device. In such a setting, the FDA may consider the clinical trial as
one not posing a significant risk. However, FDA action is always uncertain and dependent on the contours of the design of the clinical
trial and the device and there is no assurance that the FDA would consider any proposed clinical trial as one posing a non-significant
risk. Moreover, before undertaking any clinical trial, the company sponsoring the trial and the investigator conducting the trial are
required by federal law to seek and obtain the approval of institutional review boards (&#8220;IRB&#8221;). An IRB weighs the risks and
benefits of a proposed trial to ensure that the human subjects are not exposed to unnecessary risk and reviews the informed consent form
to ensure that it meets federal requirements and accurately describes the risks and benefits, if any, of the clinical trial. IRB review
occurs annually, and annual re-approval is required. University medical centers as well as other entities maintain and operate IRB. Second,
the FDA must review a company&#8217;s PMA, which contains, among other things, clinical information acquired under the investigational
device exemption. The FDA will approve the PMA if it finds there is reasonable assurance that the device is safe and effective for its
intended use. The premarket approval process takes substantially longer than the 510(k) process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Glucotrack CBGM is still under development and has not yet been approved for commercial sale in or outside the United States. Given
the implantable nature of our CBGM, it is most likely that the device will be assigned a Class III designation and need to follow
the PMA process for regulatory approval. We are preparing for this approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
when a clinical study has been approved or cleared by the FDA or a notified body or deemed approved, the study is subject to factors
beyond a manufacturer&#8217;s control, including, but not limited to the fact that the IRB at a given clinical site might not approve
the study, might decline to renew approval which is required annually, or might suspend or terminate the study before the study has been
completed. Also, the interim results of a study may not be satisfactory, in which case the sponsor may terminate or suspend the study
on its own initiative or the FDA or a notified body may terminate or suspend the study. There is no assurance that a clinical study at
any given site will progress as anticipated; there may be an insufficient number of patients who qualify for the study or who agree to
participate in the study, or the investigator at the site may have priorities other than the study. Also, there can be no assurance that
the clinical study will provide sufficient evidence to assure the FDA or a notified body that the product is safe and effective, a prerequisite
for FDA approval of a PMA. Even if the FDA or a notified body approves or clears a device, it may limit its intended uses in such a way
that manufacturing and distributing the device may not be commercially feasible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
approval to market is given, the FDA and foreign regulatory agencies, upon the occurrence of certain events, are authorized under various
circumstances to withdraw the clearance or approval or require changes to a device, its manufacturing process or its labeling or additional
proof that regulatory requirements have been met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
manufacturer of a device approved through the PMA process is not permitted to make changes to the device which affects its safety or
effectiveness without first submitting a supplement application to its PMA and obtaining FDA approval for that supplement. In some instances,
the FDA may require clinical trials to support a supplement application. Any change in the intended uses of a PMA device or a 510(k)
device requires an approval supplement. Exported devices are subject to the regulatory requirements of each country to which the device
is exported, as well as certain FDA export requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to leverage the De Novo/PMA clinical trial data, if successful, along with the associated development and manufacturing information,
for CE Mark certification. The Company will choose a notified body and submit via the MDR regulations to obtain this necessary clearance
for marketing in EU member states. Upon approval, if granted, the Company may consider alternative markets that can leverage both the
FDA and CE Mark approvals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reimbursement
Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S. market, coverage and reimbursement from Medicare, Medicaid or other governmental healthcare programs or systems, and private
third-party healthcare payors is critical to the success of a medical device company. CGM systems have been broadly accepted by Medicare
and commercial third-party payors. Currently, Medicare covers CGM systems, which includes supplies necessary for the use of the device
under the Durable Medical Equipment (DME), benefit category. Previously, Medicare coverage for CGM was only available to Medicare patients
who take at least three doses of insulin a day. The Local Coverage Determination (LCD), that the Medicare Administrative Contractors
(MACs) released in April 2023 extended Medicare CGM coverage to all patients using insulin. The LCD also allows coverage for patients
not taking insulin if the patient has a history of problematic hypoglycemia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently one commercially available implantable CGM product and the current reimbursement landscape includes coverage for the product
itself, coverage for the implantation process and coverage for the removal and reinsertion process. Additionally, an LCD was recently
released (NGS ICGM LCD - Effective 4/1/2024) allowing for expanded access of this product to include all people with diabetes using insulin,
removing the previous requirement for at least three doses of insulin a day. Like non-implantable CGM, the LCD also allows coverage for
patients not taking insulin if the patient has a history of problematic hypoglycemia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though CGM coverage is broad, we anticipate that sales volumes and prices of the Glucotrack CBGM will depend in large part on
the availability of adequate reimbursement from Medicare and third-party payors. Medicare reimburses medical devices in a variety of
ways depending on where and how the device is used. However, Medicare only provides reimbursement if CMS determines that the device should
be covered and that the use of the device is consistent with the coverage criteria. A coverage determination can be made at the national
level by CMS or at the local level by the Medicare administrative contractor (formerly called carriers and fiscal intermediaries) or
a private contractor that processes and pays claims on behalf of CMS for the geographic area where the services were rendered. Obtaining
a coverage determination, whether local or national, is a time-consuming, expensive and highly uncertain proposition, especially for
a new technology, and inconsistent local determinations are possible. Our inability to obtain a favorable coverage determination for
our CBGM product may adversely affect our ability to market the product and thus, the commercial viability of the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we believe that the overall escalating cost of medical products and services has led to and will continue to lead to increased pressures
on the healthcare industry to reduce the costs of products and services. There can be no assurance that third-party reimbursement and
coverage will be available or adequate, or that future legislation, regulation, or reimbursement policies of third-party payors will
not adversely affect the demand for our products or our ability to sell these products on a profitable basis. The unavailability or inadequacy
of third-party payor coverage or reimbursement could have a material adverse effect on our business, operating results, and financial
condition. Until adequate reimbursement or insurance coverage is established, patients may have to bear the financial cost of our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
mitigate these risks, we are starting our reimbursement planning process early, well in advance of obtaining regulatory approval. We
have engaged a leading reimbursement consultancy to complete an analysis of the current landscape for CGM technologies.
Additionally, since our product is an implantable device and very similar in form factor and procedure to commercially available
cardiovascular devices, we are also assessing the current reimbursement landscape for those technologies. This will enable us to
craft a reimbursement strategy that is best suited to our Glucotrack CBGM and reflects the different healthcare providers
that may be involved in utilizing the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
reimbursement strategy also incorporates coverage for the product, the implantation procedure, and the removal and reinsertion procedures.
While we are proactively preparing our reimbursement strategy, some activities such as coding applications, if needed, are not able to
be executed until FDA approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
the United States, availability of reimbursement from third parties varies widely from country to country. Within the EU member countries,
healthcare reimbursement, coverage regulations, and systems differ significantly. An EU reimbursement analysis and strategy may begin
if and when we decide to enter the EU market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Anti-Fraud
and Abuse Rule </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are extensive United States federal and state laws and regulations prohibiting fraud and abuse in the healthcare industry that can result
in significant criminal and civil penalties that can materially affect us, if and when we receive FDA approval to market our products
in the United States. These federal laws include, by way of example, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    anti-kickback statute (Section 1128B(b) of the Social Security Act), which prohibits certain business practices and relationships
    that might affect the provision and cost of healthcare services reimbursable under Medicare, Medicaid and other federal healthcare
    programs, including the payment or receipt of remuneration for the referral of patients whose care will be paid by Medicare or other
    governmental programs;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    physician self-referral prohibition (Ethics in Patient Referral Act of 1989, as amended, commonly referred to as the Stark Law, Section
    1877 of the Social Security Act), which prohibits referrals by physicians of Medicare or Medicaid patients to providers of a broad
    range of designated healthcare services in which the physicians (or their immediate family members) have ownership interests or with
    which they have certain other financial arrangements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    anti-inducement provisions of the Civil Monetary Penalties Law (Section 1128A(a)(5) of the Social Security Act), which prohibit providers
    from offering anything to a Medicare or Medicaid beneficiary to induce that beneficiary to use items or services covered by either
    program;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    FCA (31 U.S.C. &#167; 3729 et seq.), which prohibits any person from knowingly presenting or causing to be presented false or fraudulent
    claims for payment to the federal government (including the Medicare and Medicaid programs); and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Civil Monetary Penalties Law (Section 1128A of the Social Security Act), which authorizes the United States Department of Health
    and Human Services to impose civil penalties administratively for fraudulent or abusive acts.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanctions
for violating these federal laws include criminal and civil penalties that range from punitive sanctions, damage assessments, monetary
penalties, imprisonment and/or denial of Medicare and Medicaid payments or exclusion from the Medicare and Medicaid programs, or both.
These laws also impose an affirmative duty on those receiving Medicare or Medicaid funding to ensure that they do not employ or contract
with persons excluded from the Medicare and other government programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
states have adopted or are considering legislative proposals similar to the federal fraud and abuse laws, some of which extend beyond
the Medicare and Medicaid programs, to prohibit the payment or receipt of remuneration for the referral of patients and physician self-referrals
regardless of whether the service was reimbursed by Medicare or Medicaid. Many states have also adopted or are considering legislative
proposals to increase patient protections, such as limiting the use and disclosure of patient specific health information. These state
laws also impose criminal and civil penalties similar to the federal laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similarly,
the EU and EU member countries may have similar fraud and abuse laws which would regulate our business in those jurisdictions. However,
given the diversity of legal systems within the EU, it is difficult to predict with specificity what anti-fraud legislation and regulations
may be implemented and the penalties that they impose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of their business, medical device manufacturers and suppliers have been and are subject regularly to inquiries, investigations
and audits by federal and state agencies that oversee these laws and regulations. Recent federal and state legislation has greatly increased
funding for investigations and enforcement actions, which have increased dramatically over the past several years. This trend is expected
to continue. Private enforcement of healthcare fraud also has increased due in large part to amendments to the civil FCA that were designed
to encourage private persons to sue on behalf of the government. These whistleblower suits by private persons, known as qui tam relators,
may be filed by almost anyone, including present and former patients or nurses and other employees, as well as competitors. HIPAA, in
addition to its privacy provisions, created a series of new healthcare-related crimes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
federal and state budget pressures continue, federal and state administrative agencies may also continue to escalate investigation and
enforcement efforts to root out waste and to control fraud and abuse in governmental healthcare programs. A violation of any of these
federal and state fraud and abuse laws and regulations could have a material adverse effect on a supplier&#8217;s liquidity and financial
condition. An investigation into the use of a device by physicians may dissuade physicians from recommending that their patients use
the device. This could have a material adverse effect on our ability to commercialize our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Privacy Provisions of HIPAA</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, HIPAA, among other things, protects the privacy and security of individually identifiable health information by
limiting its use and disclosure. HIPAA directly regulates &#8220;covered entities,&#8221; such as healthcare providers, insurers and
clearinghouses, and regulates &#8220;business associates,&#8221; with respect to the privacy of patients&#8217; medical information.
All entities that receive and process protected health information are required to adopt certain procedures to safeguard the
security of that information. It is uncertain whether we would be deemed to be a covered entity under HIPAA and, owing to changes in
the law, it is uncertain, based on our current business model, whether we would be a business associate. Nevertheless, we will
likely be contractually required to physically safeguard the integrity and security of any patient information that we receive,
store, create or transmit in the United States. If we fail to adhere to our contractual commitments, then our physician, hospital or
insurance customers may be subject to civil monetary penalties, which could adversely affect our ability to market our devices.
Changes in the law wrought by the provisions of Health Information Technology for Economic and Clinical Health
(&#8220;HITECH&#8221;) Act, enacted as part of the American Recovery and Reinvestment Act of 2009 (&#8220;ARRA&#8221;), increase the
duties of business associates and covered entities with respect to protected health information that thereby subject them to direct
government regulation, increasing its compliance costs and exposure to civil monetary penalties and other government sanctions.
While HITECH does not alter the definition of a business associate, it makes it more likely that covered entities with whom we are
likely to do business in the United States, if and when we receive FDA approval to market the Glucotrack CBGM in the United States,
will require us to enter into business associate agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pursuing a proactive intellectual property strategy, which includes patent filings in multiple jurisdictions, including the United
States and other commercially significant markets. We understand the importance of obtaining patent and trade secret protection for new
technologies, products and processes. Our success will depend in large part on our ability to file for and obtain patent protection of
our principal products and procedures, to defend existing or future patents, to maintain trade secrets and to operate without infringing
upon the proprietary rights of others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s U.S. patent application, US20230079720A1, titled &#8216;Methods and Systems for Continuously Monitoring the Glucose Level
of a Patient,&#8217; is currently under review. Two related international applications, EP4401635A1 and WO2023044347A1, have been published
and are also pending review. Additionally, the Company has filed during 2024 four new provisional patent applications: US63/563,880,
&#8216;Systems and Methods for Integrated Spinal Cord Stimulation and Glucose Monitoring&#8217;; US63/633,647, &#8216;Methods and Systems
for Continuously Monitoring the Glucose Level of a Patient&#8217;; US63/661,648, &#8216;Methods and Systems for Continuously Monitoring
the Glucose Level of a Patient&#8217; ; and US63/661,526, &#8216;Amperometric Electrochemical Enzyme Oxidase Sensor&#8217;. We have trademark
registrations for Glucotrack&#174; in the U.S. and Europe and various other jurisdictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our intellectual property and products do not and will not infringe patents or violate proprietary rights of others, although
it is possible that our existing patent rights may not be valid or that infringement of existing or future patents or proprietary rights
may occur. Litigation may be necessary to defend or enforce our patent rights or to determine the scope and validity of the proprietary
rights of others. Defense and enforcement of patent claims can be expensive and time consuming, even in those instances in which the
outcome is favorable and could result in the diversion of substantial resources and management time and attention from our other activities.
An adverse outcome could subject us to significant liability to third parties, require us to obtain licenses from third parties, require
us to alter our products or processes, or require that we cease altogether any related research and development activities or product
sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
protection is highly uncertain and involves complex legal and factual questions and issues. The patent application and issuance process
can be expected to take several years and entails considerable expense. There can be no assurance that patents will be issued as a result
of any applications or that any patents resulting from such applications, or our existing patents will be sufficiently broad to afford
protection against competitors with similar or competing technology. Patents that we obtain may be challenged, invalidated or circumvented,
or the rights granted under such patents may not provide us with any competitive advantages.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for CGM devices is intensely competitive, subject to rapid change and significantly affected by new product introductions. Three
companies, Abbott Laboratories (&#8220;Abbott&#8221;), DexCom and Medtronic currently account for substantially all of the worldwide
sales of CGM systems. These products are all transcutaneous systems with sensor longevities of 7-15 days. These systems have a sensor
that is worn on the back of the upper arm or the abdomen, depending on the system. The sensor measures glucose in the interstitial fluid,
which lags glucose in the blood, so the CGM readings may lag about 15-20 minutes behind blood glucose readings. Depending on the system,
the sensor provides glucose readings every one to five minutes and streams directly to the users&#8217; compatible smartphone. Following
the insertion of a new Abbott FreeStyle Libre 3 or DexCom G7 sensor, there is a warm-up period of 30-60 minutes, depending on the system,
during which time no readings are available. After that period, both systems are factory-calibrated, which means that no fingersticks
(blood glucose measurements using a glucometer) are required for calibration. For the Medtronic Guardian 4 system, there is a 2-hour
warm-up period; after that period, no fingersticks are required for calibration when using as a part of the MiniMed 780G insulin pump
system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently one implantable CGM that is commercially available in the US and Europe: Senseonics Holdings, Inc. The sensor is inserted
by a doctor under the skin of the upper arm and lasts up to 365 days. The wearable smart transmitter provides on-body vibe alerts and
is worn over the sensor using a daily adhesive. There is a 24-hour warm up period with this system and, after that period, fingersticks
are required for calibration twice a day for the 1st 21 days and then once daily. Similar to the transcutaneous systems, this system
also measures glucose in the interstitial fluid. All four competitors are either publicly traded or are divisions of publicly traded
companies, and they enjoy several competitive advantages, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significantly
    greater name recognition;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">established
    relations with healthcare professionals, customers and third-party payors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">established
    distribution networks;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional
    lines of products, and the ability to offer rebates or bundle products to offer higher discounts or incentives to gain a competitive
    advantage;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">greater
    experience in conducting research and development, manufacturing, clinical trials, obtaining regulatory approval for products and
    marketing approved products; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">greater
    financial and human resources for product development, sales and marketing, and patent litigation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, we cannot ensure that we will be able to compete effectively against these companies or their products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are several new and smaller players that have obtained clearance to market in EU or Asia. Their systems are transcutaneous systems with
similar form factors and longevity as the Abbott, DexCom and Medtronic systems. None of these companies has yet achieved a significant
user base.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
Medtronic and other companies have developed or are developing, insulin pumps integrated with CGM systems that provide, among other things,
the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal or bolus insulin dosing.
Both Abbott and DexCom have received FDA clearance to integrate certain versions of their sensors into automated insulin delivery systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we face potential competition from many different sources, we believe that our technology, experience and scientific knowledge provide
us with competitive advantages of accuracy, longevity, discretion and usability, though our technology is not in any way integrated with
an automatic insulin delivery system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal offices are located at 301 17 North, Suite 800, Rutherford NJ 07070, and our telephone number is 201-842-7715. Our website
address is http://www.glucotrack.com; the reference to such website address does not constitute incorporation by reference of the information
contained on the website and such information should not be considered part of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
and Committees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have seven members on our Board, five of whom are independent. The Board has an audit committee (the &#8220;Audit Committee&#8221;),
a compensation committee and a nominating and corporate governance committee. Each of our committees consist solely of independent
directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, we had eleven full-time employees. None of our employees are represented by a collective bargaining agreement.
In addition, as of December 31, 2024, we had three significant consultants.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_003"></span>Item
1A. Risk Factors </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>An
investment in our Common Stock involves a high degree of risk. You should carefully consider the following risks and all of the other
information contained in this Annual Report before deciding whether to invest in our Common Stock. If any of the following risks are
realized, our business, financial condition and results of operations could be materially and adversely affected. In that event, the
trading price of our Common Stock could decline, and you could lose all or part of your investment in our Common Stock. Additional risks
of which we are not presently aware or that we currently believe are immaterial may also harm our business and results of operations.
Some statements in this Annual Report, including such statements in the following risk factors, constitute forward-looking statements.
See the section entitled &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Business and Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have a history of operating losses, and there is no assurance that we will generate material revenues or become profitable in the near
future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a medical device company with a limited operating history. We are not profitable and have incurred losses since our inception. To
date we have not generated material revenue from the sale of products, and we do not anticipate that we will report operating income
in the foreseeable future. Our initial product, Glucotrack CBGM, has not been approved for marketing in the United States and is currently
under preclinical development. We continue to incur research and development and selling, marketing and general and administrative expenses
related to our operations, development and commercialization of our first product. Our operating losses for the years ended December
31, 2024 and 2023 were approximately $22.6 million and $7.1 million, respectively, and we had an accumulated deficit of approximately
$132.0 million as of December 31, 2024. We expect to continue to incur losses for the foreseeable future, and these losses will likely
increase as we develop and prepare to commercialize Glucotrack CBGM. If we are not successful in developing, manufacturing and distributing
Glucotrack CBGM, or if Glucotrack CBGM does not achieve market acceptance, we may never become profitable. Even if we achieve profitability
in the future, we may not be able to sustain profitability in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
we continue to evolve from a company primarily involved in development to a company also involved in commercialization, we may encounter
difficulties in managing our growth and expanding our operations successfully.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that, as our operations expand and, assuming that our development, testing, studies and trials are successful, we will need
to expand our manufacturing, marketing and sales capabilities by contracting with third parties. Maintaining these relationships and
managing our future growth will impose significant added responsibilities on members of our management team. We must be able to manage
our development efforts effectively; manage our clinical trials effectively; hire, train and integrate additional management, development,
administrative and sales and marketing personnel; improve managerial, development, operational and finance systems; and expand our facilities,
all of which may impose a strain on our administrative and operational infrastructure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may have future capital needs and may not be able to obtain additional financing on acceptable terms.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Economic
and credit market conditions, the performance of our industry and our financial performance, as well as other factors, may constrain
our financing abilities. Our ability to secure additional financing, if available, and to satisfy our financial obligations under indebtedness
outstanding from time to time will depend upon our future operating performance, the availability of credit, economic conditions and
financial, business and other factors, many of which are beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may require additional financing to fund our operations and growth. The failure to secure additional financing could have an adverse
effect on our continued development or growth. None of our officers, directors or stockholders is required to provide any financing to
us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Raising
additional capital may cause dilution to our existing stockholders and investors, restrict our operations, or require us to relinquish
rights to our products and/or product candidates on unfavorable terms to us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will seek additional capital through a variety of means, including through private and public equity offerings and debt financings, collaborations,
strategic alliances and marketing, distribution or licensing arrangements. To the extent that we raise additional capital through the
sale of equity or convertible debt securities, or through the issuance of shares under other types of contracts, or upon the exercise
or conversion of outstanding options, warrants, convertible debt or other similar securities, the ownership interests of our stockholders
will be diluted, and the terms of such financings may include liquidation or other preferences, anti-dilution rights, conversion and
exercise price adjustments and other provisions that adversely affect the rights of our stockholders, including rights, preferences and
privileges that are senior to those of our holders of Common Stock in terms of the payment of dividends or in the event of a liquidation.
In addition, debt financing, if available, could include covenants limiting or restricting our ability to take certain actions, such
as incurring additional debt, making capital expenditures, entering into licensing arrangements or declaring dividends and may require
us to grant security interests in our assets. If we raise additional funds through collaborations, strategic alliances or marketing,
distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue
streams, product or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional
funds through equity or debt financing when needed, we may need to curtail or cease our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
independent registered public accounting firm&#8217;s report contains an explanatory paragraph that expresses substantial doubt about
our ability to continue as a &#8220;going concern.&#8221;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not have sufficient liquidity to meet our anticipated obligations over the next year from the issuance of the financial
statements contained in this Annual Report. We have incurred net losses and negative cash flows from our operations and
comprehensive loss since our inception and as of December 31, 2024, we had an accumulated deficit of $132.5 million. These
conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Economic
crises and market instability may materially and adversely affect the demand for our products, as well as our ability to obtain credit
or secure funds through sales of our stock, which may materially and adversely affect our business, financial condition and ability to
fund our operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Economic
crises may reduce the demand for new and innovative medical devices, resulting in delayed market acceptance of our products, if and
when they are approved. Such a delay could have a material adverse impact on our business, expected cash flows, results of
operations and financial condition. Additionally, we have funded our operations to date primarily through public and private sales
of securities, including Common Stock and other securities convertible into or exercisable for shares of our Common Stock. Economic
turmoil and instability in the world&#8217;s equity and credit markets may materially adversely affect our ability to sell
additional securities and/or borrow cash. There can be no assurance that we will be able to raise additional working capital on
acceptable terms or at all, and any failure to do so may materially adversely affect our ability to continue operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Glucotrack
CBGM is not approved for sale in the United States or other jurisdictions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will likely be required to undertake significant clinical trials to demonstrate to the FDA that Glucotrack CBGM is safe and
effective for its intended use (refer to &#8220;<i>Business</i> &#8211; <i>Regulatory Considerations</i>&#8221;). We may also be required to
undertake similar clinical trials by non-U.S. regulatory agencies, particularly for the European Union (CE Mark). Clinical trials
for implantable medical devices are expensive and uncertain processes that take years to complete. Failure can occur at any point in
the process and early positive results do not ensure that the entire clinical trial will be successful. Product candidates in
clinical trials may fail to show desired efficacy and safety traits despite early promising results. A number of companies in the
medical device industry have suffered significant setbacks in advanced clinical trials, even after their product candidates
demonstrated promising results at earlier points.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Positive
results from the limited safety and performance pre-clinical trials and first-in-human acute clinical studies that we have conducted
should not be relied upon as evidence that early-stage or large-scale clinical trials will succeed. Despite efforts to choose the
proper animal model reflecting our intended use, our pre-clinical animal trials and first-in-human acute clinical studies cannot be
a guarantee of clinical trial success because human physiology and anatomy are different. Because of the sample size, possible
variation in methodology or differences in physiology, the results of these pre-clinical trials may not be indicative of future
results. We will be required to demonstrate through well-controlled clinical trials that Glucotrack CBGM or future product
candidates, if any, are safe and effective for their intended uses.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the Glucotrack CBGM or our future product candidates, if any, may not be cleared or approved, as the case may be, even if the clinical
data are satisfactory and support, in our view, its or their clearance or approval. The FDA or other non-U.S. regulatory authorities
may disagree with our trial design or interpretation of the clinical data. In addition, any of these regulatory authorities may change
requirements for the clearance or approval of a product candidate even after reviewing and providing comment on a protocol for a pivotal
clinical trial that has the potential to result in FDA approval. In addition, any of these regulatory authorities may also clear or approve
a product candidate for fewer or more limited uses than we request or may grant clearance or approval contingent on the performance of
costly post-marketing clinical trials. In addition, the FDA or other non-regulatory authorities may not approve the labeling claims necessary
or desirable for the successful commercialization of Glucotrack CBGM or our future product candidates, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are highly dependent on the success of our product candidate, Glucotrack CBGM, and cannot give any assurance that it will receive regulatory
approval or clearance or be successfully commercialized.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are highly dependent on the success of our product candidate, Glucotrack CBGM. We cannot give any assurance that the FDA will permit
us to clinically test the device, nor can we give any assurance that the clinical trials will be successful or that Glucotrack CBGM will
receive regulatory clearance or approval or be successfully commercialized, for a number of reasons, including, without limitation, the
potential introduction by our competitors of more clinically-effective or cost-effective alternatives, failure in our sales and marketing
efforts, or the failure to obtain positive coverage determinations or reimbursement.&#160; Any failure to obtain approval to conduct
clinical trials, favorable clinical data, clearance or approval of or to successfully commercialize Glucotrack CBGM would have a material
adverse effect on our business. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our competitors develop and market products that are more effective, safer or less expensive than Glucotrack CBGM or our future product
candidates, if any, our commercial opportunities will be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
life sciences industry is highly competitive, and we face significant competition from many medical device companies that are researching
and marketing products designed to address the needs of people suffering from diabetes. We are currently developing medical devices that
will compete with other medical devices that currently exist or are being developed. Some of our competitors have significantly greater
financial, manufacturing, marketing and product development resources than we do. Large medical device companies, in particular, have
extensive experience in clinical testing and in obtaining regulatory clearances or approvals for medical devices. These companies also
have significantly greater research and marketing capabilities than us. Some of the medical device companies that we expect to compete
with include Abbott Laboratories, DexCom, Medtronic, and Senseonics. In addition, many universities and private and public research institutions
are or may become active in research involving blood glucose measurement devices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our ability to successfully compete will depend on, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to have partners manufacture and sell commercial quantities of any approved products to the market; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
    of product candidates by physicians and other health care providers; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the results of our clinical trials;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to recruit and enroll patients for our clinical trials; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    efficacy, safety, performance and reliability of our product candidates; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the speed at which we develop product candidates;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain prompt and favorable IRB review and approval at each of our clinical sites; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">our ability to commercialize and market any of our product candidates that may receive regulatory clearance or approval;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">our ability to design and successfully execute appropriate clinical trials;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing and scope of regulatory clearances or approvals; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">appropriate coverage and adequate levels of reimbursement under private and governmental health insurance plans, including Medicare; and</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to protect intellectual property rights related to our products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our competitors market products that are more effective, safer, easier to use or less expensive than Glucotrack CBGM or our future product
candidates, if any, or that reach the market sooner than Glucotrack CBGM or our future product candidates, if any, we may not achieve
commercial success. In addition, the medical device industry is characterized by rapid technological change. It may be difficult for
us to stay abreast of the rapid changes in each technology. If we fail to stay at the forefront of technological change, we may be unable
to compete effectively. Technological advances or products developed by our competitors may render our technologies or product candidates
obsolete or less competitive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of medical device companies, medical researchers and pharmaceutical companies are also pursuing new delivery technologies, procedures,
drugs and other therapies for the monitoring, treatment and prevention of diabetes. If successful, these technologies could render glucose
monitoring devices, like the Glucotrack CBGM, obsolete. Technological breakthroughs in diabetes treatment or prevention could reduce
the potential market for Glucotrack CBGM, making it less competitive or obsolete altogether.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diabetes market is currently seeing increasing use of GLP-1 drugs for the treatment of obesity and Type 2 diabetes. While we believe
that GLP-1s are a companion product and can be used in conjunction with CGM systems, such drugs could potentially compete with the Glucotrack
CBGM and impact successful commercialization.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
product development activities could be delayed or stopped.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not know whether our future clinical trials will begin on time, or at all, and whether ongoing and/or future clinical trials will
be completed on schedule, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
commencement of future clinical trials could be substantially delayed or prevented by several factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the failure to obtain sufficient funding to pay for all necessary clinical trials;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    number of, and competition for, suitable patients that meet the protocol&#8217;s inclusion criteria and do not meet any of the exclusion
    criteria; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">limited number of, and competition for, suitable sites to conduct the clinical trials, and delay or failure to obtain FDA approval, if necessary, to commence a clinical trial;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
    or failure to obtain sufficient supplies of the product candidate for clinical trials; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">requirements to provide the medical device required in clinical trials at cost, which may require significant expenditures that we are unable or unwilling to make;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">delay or failure to reach agreement on acceptable clinical trial agreement terms or clinical trial protocols with prospective sites or investigators; and</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
    or failure to obtain IRB approval or renewal of such approval to conduct a clinical trial at a prospective or accruing site, respectively.
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
completion of clinical trials in connection with our application for FDA approval could also be substantially delayed or prevented by
several factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">slower
    than expected rates of patient recruitment and enrollment; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">failure of patients to complete the clinical trial;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">unforeseen safety issues;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
    of efficacy evidenced during clinical trials; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">termination of clinical trials by one or more clinical trial sites;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    or unwillingness of patients or medical investigators to follow clinical trial protocols; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">inability to monitor patients adequately during or after treatment.</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
clinical trials may be suspended or terminated at any time by the FDA, other regulatory authorities, the IRB for any given site or us.
Any failure or significant delay in completing clinical trials for Glucotrack&#174; or future product candidates, if any, could
materially harm our financial results and the commercial prospects for our product candidates. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
regulatory approval process is expensive, time-consuming and uncertain and may prevent us from obtaining approvals for the commercialization
of Glucotrack CBGM or our future product candidates, if any.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
research, testing, manufacturing, labeling, approval, selling, marketing and distribution of medical devices are subject to
extensive regulation by the FDA and other non-U.S. regulatory authorities, with regulations that differ from country to country. We
are not permitted to market our product candidates in the United States until we receive a clearance letter under Section 515
premarket approval from the FDA. We have not submitted an application or premarket notification for or received marketing clearance
or approval for our current product candidate. Obtaining approval of any premarket approval can be a lengthy, expensive and
uncertain process, particularly for Class III devices under which our product candidate falls. In lieu of acting on a premarket
notification, the FDA may seek additional information or additional data which would further delay our ability to market the
product candidate. In addition, failure to comply with FDA, non-U.S. regulatory authorities or other applicable U.S. and non-U.S. regulatory
requirements may, either before or after product clearance or approval, if any, subject us to administrative or judicially imposed
sanctions, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the products, manufacturers or manufacturing process; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    inspectional observations (Form 483), warning letters or non-warning letters incorporating inspectional observations, i.e., so-called
    &#8220;untitled letter&#8221;; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">civil
    and criminal penalties; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">injunctions;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
    or withdrawal of regulatory clearances or approvals; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizures, detentions or import bans; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">voluntary
    or mandatory product recalls and publicity requirements; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">total or partial suspension of production;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">imposition
    of restrictions on operations, including costly new manufacturing requirements; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">refusal to clear or approve pending applications or premarket notifications.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
approval of a PMA or PMA supplement is not guaranteed, and the approval will take several years when factoring in clinical trial timelines.
The FDA also has substantial discretion in the medical device clearance or approval processes. Despite the time and expense exerted,
failure can occur at any stage, and we could encounter problems that cause us to abandon clinical trials or to repeat or perform additional
pre-clinical studies and clinical trials. The number of pre-clinical studies and clinical trials that will be required for FDA clearance
or approval varies depending on the medical device candidate, the disease or condition that the medical device candidate is designed
to address and the regulations applicable to any particular medical device candidate. The FDA can delay, limit or deny clearance or approval
of a medical device candidate for many reasons, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;a
    medical device candidate may not be deemed safe or effective; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
    officials may not find the data from the clinical trials sufficient;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA might not approve our third-party manufacturer&#8217;s processes or facilities; or </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
FDA may change its clearance or approval policies or adopt new regulations. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to recruit and enroll patients for clinical trials may cause the development of our product candidates to be delayed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may encounter delays if we are unable to recruit, enroll and retain enough patients to complete clinical trials. Patient enrollment depends
on many factors, including the size of the patient population, the nature of the protocol, the proximity of patients to clinical sites
and the eligibility criteria for the trial. Delays in patient enrollment are not unusual. Any such delays in planned patient enrollment
may result in increased costs, which could harm our ability to develop products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
terms of clearances or approvals and ongoing regulation of our products may limit how we manufacture and market our product candidates,
which could materially impair our ability to generate anticipated revenues.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
regulatory clearance or approval has been granted, the cleared or approved product and its manufacturer are subject to continual review.
Any cleared or approved product may only be promoted for its indicated uses. In addition, if the FDA or other non-U.S. regulatory authorities
clear or approve Glucotrack CBGM or our future product candidates, if any, the labeling, packaging, adverse event reporting, storage,
advertising and promotion for the product will be subject to extensive regulatory requirements. We, and the manufacturers of our products
also will be required to comply with the FDA&#8217;s Quality System Regulation, which includes requirements relating to quality control
and quality assurance, as well as the corresponding maintenance of records and documentation. Moreover, device manufacturers are required
to report adverse events by filing Medical Device Reports with the FDA, which are publicly available. Further, regulatory agencies must
approve our manufacturing facilities before they can be used to manufacture products, and these facilities are subject to ongoing regulatory
inspection. If we fail to comply with the regulatory requirements of the FDA and other non-U.S. regulatory authorities, or if previously
unknown problems with our products, manufacturers or manufacturing processes are discovered, we could be subject to administrative or
judicially imposed sanctions, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">restrictions on the products, manufacturers or manufacturing process;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    inspectional observations (Form 483), warning letters, or non-warning letters incorporating inspectional observations; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">civil
    or criminal penalties or fines; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">injunctions;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizures, detentions or import bans; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">voluntary or mandatory product recalls and publicity requirements;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">suspension or withdrawal of regulatory clearances or approvals;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">total or partial suspension of production; </td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">imposition of restrictions on operations, including costly new manufacturing requirements; and</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    to clear or approve pending applications or premarket notifications. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the FDA and other non-U.S. regulatory authorities, including the EU and each of the EU member countries individually, may change
their policies and enact additional regulations that could prevent or delay regulatory clearance or approval of our product candidates.
We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative
action, either in the United States or abroad. If we are not able to maintain regulatory compliance, we will likely not be permitted
to market future product candidates and may not achieve or sustain profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Even
if we receive regulatory clearance or approval to market Glucotrack CBGM or our future product candidates, if any, the market may not
be receptive to our products.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if Glucotrack CBGM or our future product candidates, if any, obtain regulatory clearance or approval, resulting products may not gain
market acceptance among physicians, patients, health care payors or the medical community. We believe that the degree of market acceptance
will depend on a number of factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">timing of market introduction of competitive products; </td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">safety
    and efficacy of our product; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prevalence
    and severity of any side effects; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    advantages or disadvantages over alternative treatments; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">strength of marketing and distribution support;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">price of our product candidates, both in absolute terms and relative to alternative treatments; and</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">availability
    of coverage and reimbursement from government and other third-party payors. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the Glucotrack CBGM or our future product candidates, if any, fail to achieve market acceptance, we may not be able to generate significant
revenue or achieve or sustain profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
coverage and reimbursement status of newly cleared or approved medical devices is uncertain, and failure to obtain adequate coverage
and adequate reimbursement could limit our ability to market Glucotrack CBGM or future product candidates, if any, and may inhibit our
ability to generate revenue from Glucotrack CBGM or our future product candidates, if any, that may be cleared or approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is significant uncertainty related to the third-party coverage and reimbursement of newly cleared or approved medical devices. The commercial
success of Glucotrack CBGM or our future product candidates, if any, in both domestic and international markets will depend in part on
the availability of coverage and adequate reimbursement from third-party payors, including government payors, such as the Medicare and
Medicaid programs, managed care organizations and other third-party payors. Government and other third-party payors are increasingly
attempting to contain health care costs by limiting both coverage and the level of reimbursement for new products and, as a result, they
may not cover or provide adequate payment for Glucotrack CBGM or our future product candidates, if any. These payors may conclude that
our products are not as safe or effective as existing devices or that the overall cost of using one of our devices exceeds the overall
cost of the competing device, and third-party payors may not approve Glucotrack CBGM or our future product candidates, if any, for coverage
and adequate reimbursement. Furthermore, deficit reduction and austerity measures in the United States and abroad may put further pressure
on governments to limit coverage of, and reimbursement for, our products. The failure to obtain coverage and adequate reimbursement for
Glucotrack CBGM or our future product candidates, if any, or health care cost containment initiatives that limit or restrict reimbursement
for such products, may reduce any future product revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not obtain insurance coverage to adequately cover all significant risk exposures.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be exposed to liabilities that are unique to the products we provide. We currently maintain commercial general liability and property insurance, but there can be
no assurance that we will acquire or maintain insurance for certain risks, that the amount of our insurance coverage will be adequate
to cover all claims or liabilities or that we will not be forced to bear substantial costs resulting from risks and uncertainties of
business. It is also not possible to obtain insurance to protect against all operational risks and liabilities. The failure
to obtain adequate insurance coverage on terms favorable to us, or at all, could have a material adverse effect on our business, financial
condition and results of operations. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
product liability lawsuits are brought against us, we may incur substantial liabilities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face a potential risk of product liability as a result of any of the products that we offer for sale. For example, we may be sued if
any product we sell allegedly causes injury or is found to be otherwise unsuitable during product testing, manufacturing, marketing or
sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of
dangers inherent in the product, negligence, strict liability and a breach of warranties. Claims could also be asserted under state or
federal consumer protection laws or regulations. If we cannot successfully defend ourselves against product liability claims, we may
incur substantial liabilities. Even successful defense would require significant financial and managerial resources. Regardless of the
merits or eventual outcome, liability claims may result in:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">decreased demand for products that we may offer for sale;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury
    to our reputation; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    to defend the related litigation; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    diversion of management&#8217;s time and our resources; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
    monetary awards to trial participants or patients; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">product recalls, withdrawals or labeling, marketing or promotional restrictions; and</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decline in our stock price. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
inability to obtain and retain sufficient product liability insurance at an acceptable cost to protect against potential product liability
claims could prevent or inhibit the commercialization of products we develop. We currently maintain product liability insurance up to
$5,000 per claim and in the aggregate. Although we have product liability coverage, we may have to pay amounts awarded by a court or
negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be
able to obtain, sufficient capital to pay such amounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to attract and retain key management and scientific personnel, we may be unable to successfully develop or commercialize Glucotrack
CBGM or our future product candidates, if any.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will need to expand and effectively manage our managerial, operational, financial, development and other resources in order to
successfully pursue our research, development and commercialization efforts for Glucotrack CBGM or our future product candidates, if
any. Our success depends on our continued ability to attract, retain and motivate highly qualified management and pre-clinical and
clinical personnel. The loss of the services of any of our executive and senior management could delay or prevent the development or
commercialization of Glucotrack CBGM or our future product candidates, if any. At present, we do not have executive insurance
policies with respect to any of our employees. We will need to hire additional personnel as we continue to expand our research and
development activities and build a sales and marketing function.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to attract or retain qualified management and scientific personnel in the future due to the intense competition for
qualified personnel among medical device and other businesses. If we are not able to attract and retain the necessary personnel to
accomplish our business objectives, we may experience constraints that will significantly impede the achievement of our research and
development objectives, our ability to raise additional capital and our ability to implement our business strategy. In particular,
if we lose any members of our executive or senior management teams, we may not be able to find suitable replacements in a timely
fashion or at all and our business may be harmed as a result.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on third parties to manufacture and supply our product.</i></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not own or operate manufacturing facilities for clinical or commercial production of Glucotrack CBGM, other than a prototype lab.
We have no experience in medical device manufacturing and lack the resources and the capability to manufacture the Glucotrack CBGM on
a commercial scale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our manufacturing partners are unable to produce our products in the amounts, timing or pricing that we require, we may not be able to
establish a contract and obtain a sufficient alternative supply from another supplier on a timely basis and in the quantities or pricing
we require. We expect to depend on third-party contract manufacturers for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucotrack
CBGM does, and our future product candidates, if any, likely will require precise, high quality manufacturing. Any of our contract manufacturers
will be subject to ongoing periodic unannounced inspections by the FDA and other non-U.S. regulatory authorities to ensure strict compliance
with quality system regulations, including current good manufacturing practices and other applicable government regulations and corresponding
standards. If our contract manufacturers fail to achieve and maintain high manufacturing standards in compliance with quality system
regulations, we may experience manufacturing errors resulting in patient injury or death, product recalls or withdrawals, delays or interruptions
of production or failures in product testing or delivery, delay or prevention of filing or approval of marketing applications for our
products, cost overruns or other problems that could seriously harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
performance failure on the part of our third-party manufacturers could delay clinical development or regulatory clearance or
approval of our product candidates or commercialization of our future product candidates, if any, depriving us of potential product
revenue and resulting in additional losses. In addition, our dependence on a third-party for manufacturing may adversely affect our
future profit margins. Our ability to replace an existing manufacturer may be difficult because the number of potential
manufacturers is limited and the FDA must approve any replacement manufacturer before it can begin manufacturing our product
candidates. Such approval would require additional non-clinical testing and compliance inspections. It may be difficult or
impossible for us to identify and engage a replacement manufacturer on acceptable terms in a timely manner, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Independent
clinical investigators and contract research organizations that we may engage to conduct our clinical trials may not be diligent, careful
or timely.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will depend on independent clinical investigators to conduct our clinical trials. Contract research organizations may also assist us
in the collection and analysis of data. These investigators and contract research organizations will not be our employees and we will
not be able to control, other than by contract, the amount of resources spent on our endeavors, including time that they devote to products
that we develop. If independent investigators fail to devote sufficient resources to the clinical trials, or if their performance is
substandard, it will delay the approval or clearance and commercialization of any products that we develop. Further, the FDA requires
that we comply with standards, commonly referred to as good clinical practice, for conducting, recording and reporting clinical trials
to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial subjects
are protected. If our independent clinical investigators and contract research organizations fail to comply with good clinical practice,
the results of our clinical trials could be called into question and the clinical development of our product candidates could be delayed.
Failure of clinical investigators or contract research organizations to meet their obligations to us or comply with federal regulations
could adversely affect the clinical development of our product candidates and harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business may become subject to economic, political, regulatory and other risks associated with international operations, which could
harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to risks associated with conducting business internationally. Accordingly, our future results could be harmed by
a variety of factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in compliance with non-U.S. laws and regulations; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in non-U.S. regulations and customs;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">changes in non-U.S. currency exchange rates and currency controls;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">changes in a specific country or region&#8217;s political or economic environment;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">trade
    protection measures, import or export licensing requirements or other restrictive actions by U.S. or non-U.S. governments; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">negative consequences from changes in tax laws; and</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    associated with staffing and managing foreign operations, including differing labor relations. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
funding that we received through the Israeli Innovation Authority (&#8220;IIA&#8221;) for research and development activities restricts
our ability to manufacture products or to transfer technology outside of Israel.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 4, 2004, the IIA agreed to provide us with a grant of 420 New Israeli Shekels (&#8220;NIS&#8221;), or approximately $93 at an
exchange rate of 4.502 NIS/dollar (the exchange rate in effect on such date), for our plan to develop a non-invasive blood glucose
monitor (the &#8220;development plan&#8221;). This grant constituted 60% of our research and development budget for the development
plan at that time. Due to our acceptance of this grant, we are subject to the provisions of the Israeli Law for the Encouragement of
Industrial Research and Development, 1984 (the &#8220;R&amp;D Law&#8221;). Among other things, the R&amp;D Law restricts the ability
to sell or transfer rights in technology or know-how developed with IIA funding or transfer any Means of Control (as defined in the
R&amp;D Law) of us to non-Israeli entities. The Industrial Research and Development Committee at the IIA (the &#8220;research
committee&#8221;) may, under special circumstances, approve the transfer outside of Israel of rights in technology or know-how
developed with IIA funding subject to certain conditions, including the condition that certain payments be made to the IIA.
Additionally, products developed with IIA funding outside of Israel cannot be manufactured without the approval of a research
committee. The restrictions regarding the sale or transfer of technology or manufacturing rights out of Israel could have a material
adverse effect on the ability to enter into strategic alliances or enter into merger or acquisition transactions in the future that
provide for the sale or transfer of technology or manufacturing rights.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
late 2023, the Company abandoned pursuit of its Israeli originated first generation product development programs top focus solely on
its next generation CBGM product development efforts for FDA market approval.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Owning our Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have never declared or paid any cash dividends on our Common Stock and do not anticipate paying any dividends on our Common Stock in
the foreseeable future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our Common Stock and do not anticipate paying any dividends on our Common Stock in
the foreseeable future. Any cash that might be available for payment of dividends will be used to expand our business. Payments of any
cash dividends in the future will depend on our financial condition, results of operation and capital requirements, as well as other
factors deemed relevant to our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to continue to satisfy the applicable continued listing requirements of Nasdaq, our Common Stock could be delisted, and
we and our stockholders could face significant material adverse consequences.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to remain listed on Nasdaq, we must satisfy minimum financial and other continued listing requirements and standards, including
those regarding director independence and independent committee requirements, minimum stockholders&#8217; equity, minimum share price,
and certain corporate governance requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, Nasdaq Listing Rule 5550(b)(1) requires companies listed on Nasdaq to maintain a minimum of $2,500,000 in stockholders&#8217;
equity for continued listing (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). On May 21, 2024, the Nasdaq Qualifications Listing Staff (the &#8220;Staff&#8221;)
notified us that our Form 10-Q for the period ended March 31, 2024, indicated that we no longer met the Minimum Stockholders&#8217; Equity
Requirement. Failure to meet the Minimum Stockholders&#8217; Equity Requirement is a basis for delisting our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we were not in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq as
set forth in Nasdaq Listing Rule 5550(a)(2) (the &#8220;Bid Price Rule&#8221;), at the time we were notified about the
non-compliance with the Minimum Stockholders&#8217; Equity Requirement, we were not eligible to submit a plan to regain compliance
with the Staff. However, we timely requested a hearing before the Nasdaq Hearings Panel (the &#8220;Panel&#8221;) and paid the fee,
which resulted in a stay of any suspension or delisting action pending the hearing. The hearing took place on July 9, 2024, and on
August 5, 2024, we received the decision of the Panel, and they granted us an extension until November 18, 2024 to regain compliance
with the Minimum Stockholders&#8217; Equity Requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 19, 2024, the Company received a compliance letter (the &#8220;Compliance Letter&#8221;) from Nasdaq, informing the Company
that it had regained compliance with the Minimum Stockholders&#8217; Equity Requirement. The Compliance Letter noted, that because
the Company&#8217;s bid price has closed below the minimum required by the Bid Price Rule following the November Offering (defined blow), the
Panel has determined to impose on the Company a Discretionary Panel Monitor, pursuant to Listing Rule 5815(d)(4)(B), for a period of
one year from the date of the Compliance Letter, to ensure that the Company maintains long-term compliance with the Minimum
Stockholders&#8217; Equity Requirement, the Bid Price Rule, and all of Nasdaq&#8217;s continued listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that we will be able to continue to maintain compliance with Nasdaq&#8217;s continued listing requirements, the Bid
Price Rule, or other Nasdaq listing requirements. If we are not able to comply with applicable listing standards, our shares of Common
Stock will be subject to delisting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Nasdaq delists our Common Stock from trading on its exchange for failure to meet comply with the Bid Price Rule, or any other listing
standards, we and our stockholders could face significant material adverse consequences including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">a limited availability of market quotations for our securities;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">a reduction in liquidity and market price of our Common Stock;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">a reduction in the number of investors willing to hold or acquire our Common Stock, which could negatively impact our ability to raise equity financing;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">a determination that our Common Stock is a &#8220;penny stock,&#8221; which will require brokers trading in our Common Stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our Common Stock;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">a limited amount of analyst coverage; and</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">a decreased ability to issue additional securities or obtain additional financing in the future.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
had identified a material weakness in our internal control over financial reporting, and we may not be able to successfully implement
remedial measures.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified material weaknesses related to our internal control over financial reporting as of December 31, 2024 and concluded that internal
control over financial reporting as at December 31, 2024 were not effective. The ineffectiveness of the Company&#8217;s internal control
over financial reporting was due to identification of material weaknesses related to lack of sufficient internal accounting personnel,
segregation of duties, and lack of sufficient internal controls (including IT general controls) that encompass the Company as a whole
with respect to entity and transaction level controls in order to ensure complete documentation of complex and non-routine transactions
and adequate financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
there can be no assurance that we will not suffer from other material weaknesses or significant deficiencies in the future. If we fail
to remediate these material weaknesses or fail to otherwise maintain effective internal controls over financial reporting in the future,
such failure could result in a material misstatement of our annual or quarterly financial statements that would not be prevented or detected
on a timely basis and which could cause investors and other users to lose confidence in our financial statements, limit our ability to
raise capital and have a negative effect on the trading price of our Common Stock. Additionally, failure to remediate the material weakness
or otherwise maintain effective internal controls over financial reporting may also negatively impact our operating results and financial
condition, impair our ability to timely file our periodic and other reports with the SEC, subject us to additional litigation and regulatory
actions and cause us to incur substantial additional costs in future periods relating to the implementation of remedial measures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market price of our Common Stock has been volatile and may continue to be volatile due to numerous circumstances beyond our control,
and stockholders could lose all or part of their investment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our Common Stock has been and may continue to be highly volatile. Our stock price could be subject to wide fluctuations
in response to a variety of factors, including, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">results of trials or studies;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the announcement of new products or product enhancements by us or our competitors;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    concerning intellectual property rights and regulatory approvals; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
    in our and our competitors&#8217; results of operations; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in earnings estimates or recommendations by securities analysts, if the Common Stock is covered by analysts; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    in the medical device industry; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the results of product liability or intellectual property lawsuits;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales,
    or the perception that future sales may occur, of equity securities or issuance of debt; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
    issuances of Common Stock or other securities; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    addition or departure of key personnel; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in state, provincial, or federal regulations affecting us and our industry; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic,
    political, and other external factors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of acquisitions, investments or strategic alliances; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    market conditions and other factors, including factors unrelated to our operating performance. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock market in general, and the market for medical device companies in particular, have experienced extreme price and
volume fluctuations. Continued or renewed market fluctuations could result in extreme volatility in the price of our Common Stock, which
could cause a decline in the value of the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Intellectual Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to obtain and enforce patent protection for our products, our business could be materially harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends, among other things, on our ability to protect proprietary methods and technologies that we develop under the patent
and other intellectual property laws of the United States and other countries, so that we can prevent others from unlawfully using our
inventions and proprietary information. However, we may not hold proprietary rights to some patents required for us to commercialize
proposed products. For this and other reasons, we may be unable to secure desired patent rights, thereby losing desired exclusivity.
Although we do not believe that we need any licenses for Glucotrack CBGM, we may need to obtain licenses in the future for other products
or in certain circumstances, such as if one of our patents were declared invalid in the future. If such licenses are not available to
us on acceptable terms, we will not be able to market the affected products or conduct the desired activities, unless we successfully
challenge the validity, enforceability or infringement of the third-party patent or otherwise circumvent the third-party patent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy depends on our ability to rapidly identify and seek patent protection for our discoveries. The process of obtaining patent protection
is expensive and time-consuming. Despite our efforts to protect our proprietary rights, unauthorized parties may be able to obtain and
use information that we regard as proprietary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of a patent does not guarantee that it is valid or enforceable. Any patents we have obtained, or which we may obtain in the
future, may be challenged, invalidated, unenforceable or circumvented. Moreover, the United States Patent and Trademark Office (the &#8220;USPTO&#8221;)
may commence interference proceedings involving our patents or patent applications. Any challenge to, finding of unenforceability or
invalidation or circumvention of our patents or patent applications would be costly, would require significant time and attention of
our management and could have a material adverse effect on our business. In addition, court decisions may introduce uncertainty in the
enforceability or scope of patents owned by medical device companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pending patent applications may not result in issued patents. The patent position of medical device companies, including us, is
generally uncertain and involves complex legal and factual considerations. The standards that the USPTO and its foreign counterparts
use to grant patents are not always applied predictably or uniformly and can change. There is also no uniform, worldwide policy regarding
the subject matter and scope of claims granted or allowable in medical device patents. Accordingly, we do not know the degree of future
protection for our proprietary rights or the breadth of claims that will be allowed in any patents issued to us or to others. The legal
systems of certain countries do not favor the aggressive enforcement of patents, and the laws of foreign countries may not protect our
rights to the same extent as the laws of the United States. Therefore, the enforceability or scope of our patents in the United States
or in foreign countries cannot be predicted with certainty, and, as a result, any patents that we own may not provide sufficient protection
against competitors. We may not be able to obtain or maintain patent protection for our pending patent applications or those we may file
in the future.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that any patents that will issue, that may issue or that may be licensed to us will be enforceable or valid or will
not expire prior to the commercialization of our product candidates, thus allowing others to more effectively compete with us. Therefore,
any patents that we own may not adequately protect our product candidates or our future products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to protect the confidentiality of our proprietary information and know-how, the value of our technology and products could
be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to patent protection, we also rely on other proprietary rights, including protection of trade secrets, know-how and confidential
and proprietary information. To maintain the confidentiality of trade secrets and proprietary information, we will seek to enter into
confidentiality and non-disclosure agreements with our employees, consultants and collaborators upon the commencement of their relationships
with us. These agreements generally require that all confidential information developed by the individual or made known to the individual
by us during the course of the individual&#8217;s relationship with us be kept confidential and not disclosed to third parties. Our agreements
with employees also generally provide and will generally provide that any inventions conceived by the individual in the course of rendering
services to us shall be our exclusive property. However, we may not obtain these agreements in all circumstances, and individuals with
whom we have these agreements may not comply with their terms. In the event of unauthorized use or disclosure of our trade secrets or
proprietary information, these agreements, even if obtained, may not provide meaningful protection, particularly for trade secrets or
other confidential information. To the extent that our employees, consultants or contractors use technology or know-how owned by third
parties in their work for us, disputes may arise between us and those third parties as to the rights in related inventions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adequate
remedies may not exist in the event of unauthorized use or disclosure of our confidential information. The disclosure of trade secrets
would impair our competitive position and may materially harm our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
commercial success depends significantly on our ability to operate without infringing the patents and other proprietary rights of third
parties.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
entities may have or obtain patents or proprietary rights that could limit our ability to manufacture, use, sell, offer for sale or import
products or impair our competitive position. In addition, to the extent that a third party develops new technology that covers our products,
we may be required to obtain licenses to that technology, which licenses may not be available on commercially reasonable terms, if at
all. If licenses are not available on acceptable terms, we will not be able to market the affected products or conduct the desired activities
unless we successfully challenge the validity, enforceability or infringement of the third-party patent or circumvent the third-party
patent, which would be costly and would require significant time and attention of our management. Third parties may have or obtain valid
and enforceable patents or proprietary rights that could block us from developing products using our technology. Our failure to obtain
a license to any technology that we require may materially harm our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we become involved in patent litigation or other proceedings related to a determination of rights, we could incur substantial costs and
expenses, substantial liability for damages or be required to stop our product development and commercialization efforts.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties may sue us for infringing their patent rights. Likewise, we may need to resort to litigation to enforce a patent issued or licensed
to us or to determine the scope and validity of proprietary rights of others. In addition, a third party may claim that we have improperly
obtained or used our confidential or proprietary information. The cost to us of any litigation or other proceeding relating to intellectual
property rights, even if resolved in our favor, could be substantial, and the litigation would divert management&#8217;s efforts. Some
of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially
greater resources. Uncertainties resulting from the initiation and continuation of any litigation could limit our ability to continue
our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any parties successfully claim that our creation or use of proprietary technologies infringes upon their intellectual property rights,
we might be forced to pay damages, potentially including treble damages, if we are found to have willfully infringed on such parties&#8217;
patent rights. In addition to any damages we might have to pay, a court could require us to stop the infringing activity or obtain a
license. Any license required under any patent may not be made available on commercially acceptable terms, if at all. In addition, such
licenses are likely to be non-exclusive and, therefore, our competitors may have access to the same technology. If we fail to obtain
a required license and are unable to design technology that does not infringe upon a patent belonging to a third party, we may be unable
to effectively market some of our technology and products, which could limit our ability to generate revenues or achieve profitability
and possibly prevent us from generating revenue sufficient to sustain operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Security
threats to our information technology infrastructure could expose us to liability and damage our reputation and business.</i></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is essential to our business strategy that our technology and network infrastructure remain secure and are perceived by our customers
and corporate partners to be secure. Despite security measures, however, any network infrastructure may be vulnerable to cyber-attacks
by hackers and other security threats. We may face cyber-attacks that attempt to penetrate our network security, sabotage or otherwise
disable our research, products and services, misappropriate our or our customers&#8217; and partners&#8217; proprietary information,
which may include personally identifiable information, or cause interruptions of our internal systems and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
there are a number of state, federal and international laws protecting the privacy and security of health information and personal data.
For example, HIPAA imposes limitations on the use and disclosure of an individual&#8217;s healthcare information by healthcare providers,
healthcare clearinghouses and health insurance plans, or, collectively, covered entities, and also grants individuals rights with respect
to their health information. HIPAA also imposes compliance obligations and corresponding penalties for non-compliance on individuals
and entities that provide services to healthcare providers and other covered entities. As part of the ARRA, the privacy and security
provisions of HIPAA were amended. ARRA also made significant increases in the penalties for improper use or disclosure of an individual&#8217;s
health information under HIPAA and extended enforcement authority to state attorneys general. As amended by ARRA and subsequently by
the final omnibus rule adopted in 2013, HIPAA also imposes notification requirements on covered entities in the event that certain health
information has been inappropriately accessed or disclosed as well as notification requirements to individuals, federal regulators and
in some cases, notification to local and national media. Notification is not required under HIPAA if the health information that is improperly
used or disclosed is deemed secured in accordance with encryption or other standards developed by the U.S. Department of Health and Human
Services. Most states have laws requiring notification of affected individuals and/or state regulators in the event of a breach of personal
information, which is a broader class of information than the health information protected by HIPAA. Many state laws impose significant
data security requirements, such as encryption or mandatory contractual terms, to ensure ongoing protection of personal information.
Activities outside of the United States implicate local and national data protection standards, impose additional compliance requirements,
and generate additional risks of enforcement for non-compliance. We may be required to expend significant capital and other resources
to ensure ongoing compliance with applicable privacy and data security laws, to protect against security breaches and hackers or to alleviate
problems caused by such breaches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are not able to adequately prevent disclosure of trade secrets and other proprietary information, the value of our technology and
product could be significantly diminished.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely on trade secrets to protect our proprietary technologies, especially where we do not believe patent protection is appropriate
or obtainable. However, trade secrets are difficult to protect. We rely in part on confidentiality agreements with our employees, consultants,
outside scientific collaborators, sponsored researchers and other advisors to protect our trade secrets and other proprietary information.
These agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event
of unauthorized disclosure of confidential information. In addition, others may independently discover our trade secrets and proprietary
information. For example, the FDA, as part of its transparency initiative, is currently considering whether to make additional information
publicly available on a routine basis, including information that we may consider to be trade secrets or other proprietary information,
and it is not clear at the present time how the FDA&#8217;s disclosure policies may change in the future, if at all. Costly and time-consuming
litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret
protection could adversely affect our competitive business position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to claims that our employees or consultants have wrongfully used or disclosed alleged trade secrets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
is common in the biotechnology and pharmaceutical industries, we employ individuals who were previously employed at other biotechnology
or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants
do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees
or consultants have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers.
Litigation may be necessary to defend against these claims. If we fail to defend any such claims, in addition to paying monetary damages,
we could lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful
in defending against these claims, litigation could result in substantial costs and be a distraction to management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SS_001"></span>Item
1B. Unresolved Staff Comments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sk_004"></span><b>Item
1C. Cybersecurity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_988_ecyd--CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_iB_c20240101__20241231_gBFCRMPFAIAMT-VOAJS_zKd1DMd3QFA4" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" continuedAt="ConU000053-01" escape="true" id="Fact000053" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risk
Management and Strategy</i></b></span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C08_gBFCRMPFAIAMT-VOAJS_zvxvh0Xegxqa"><ix:continuation continuedAt="ConU000053-02" id="ConU000053-01">&#160;</ix:continuation></span></span></p>

<div id="xdx_C01_gBFCRMPFAIAMT-VOAJS_z7Dsh95htTee"><ix:continuation continuedAt="ConU000053-03" id="ConU000053-02"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information
systems and protect the confidentiality, integrity, and availability of our data. The Company considers its primary cybersecurity risks
to be theft of intellectual property, theft of other business data, fraud or extortion, lack of access to its information systems, harm
to employees, harm to business partners, violation of privacy laws, potential reputational risk, and litigation or other legal risk if
a cybersecurity incident were to occur. It is difficult to assign a monetary materiality assessment to these risks or to the impact if
the Company were to sustain a breach of its systems. The Company&#8217;s approach to cybersecurity is based on the premise that any cybersecurity
incident could result in material harm to the Company. We have a cybersecurity and risk management processes in place to oversee risks
associated with cybersecurity and respond to emerging threats in a timely and effective manner. We monitor our systems to assess cybersecurity risks and threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Managing
Material Risks &amp; Integrated Overall Risk Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zr85dhfOxlq" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000054" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock">We
have <span id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zB6t3xTQfVR9" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000055" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag">integrated</ix:nonNumeric></span> cybersecurity risk management into our broader risk management framework. This integration ensures that cybersecurity
considerations are an integral part of our decision-making process. We conduct annual risk assessments and quarterly vulnerability scans
of risks posed by cybersecurity threats in conjunction with our insurance renewal cycles. As a result of these assessments, we have implemented
technical, administrative, and, where appropriate, physical controls and practices to proactively monitor our systems and user accounts
including, but not limited to, deploying solutions to constantly monitor users accessing systems, implementation of two factor authentication
for logins, and improved rules for password maintenance</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Like
many companies, we make use of cloud-based solutions provided by several large service providers for critical information technology
infrastructure such as email and file storage. We do not maintain stand-alone servers for our email, file storage or other business applications.
In the normal course of our relationships with the providers of these services, we regularly monitor their message boards and other formal
and informal communications channels for signs of breaches of their systems. We also survey available public information for indications
that they have suffered a breach of their systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Engage
Third Parties on Risk Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has been designated with oversight responsibility for cybersecurity risks and our Chief Financial Officer is responsible
for managing our efforts in this area. Neither the Chief Financial Officer nor any member of the Audit Committee has relevant expertise
in cybersecurity. Recognizing the complexity and evolving nature of cybersecurity threats, the Company has retained an <span id="xdx_90D_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zj75rM3MZCdh" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000056" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag">third-party technical
expert</ix:nonNumeric> </span>to support its information technology systems including addressing cybersecurity risks. This relationship enables us to leverage
specialized knowledge and insights, to ensure our cybersecurity strategies and processes are aligned with industry best practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Oversee
Third Party Risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240101__20241231_zrtDYO8CHBgh" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000057" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">We
utilize various third-party software applications in the functioning of our core business. We conduct assessments of all third-party
providers and maintain ongoing reviews to ensure compliance with our cybersecurity standards. Our assessment of risks associated with
the use of third-party providers is part of our overall cybersecurity framework</ix:nonNumeric></span>. In addition, some of our business partners also
maintain data related to our trials and ongoing product development on servers they maintain. We require these partners to comply with
all HIPAA standards for maintaining security of their systems where this data resides.</span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0C_gBFCRMPFAIAMT-VOAJS_zoT1VU8A3iQh"><ix:continuation continuedAt="ConU000053-04" id="ConU000053-03">&#160;</ix:continuation></span></span></p>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0B_gBFCRMPFAIAMT-VOAJS_zSER5WClP138"><ix:continuation continuedAt="ConU000053-05" id="ConU000053-04"><i>&#160;</i></ix:continuation></span></span></p>

<div id="xdx_C0D_gBFCRMPFAIAMT-VOAJS_zi3L2WnlNBL4"><ix:continuation continuedAt="ConU000053-06" id="ConU000053-05"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
from Cybersecurity Threats</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face risk from cybersecurity threats that could have a material adverse effect on our business, financial condition, results of operations,
cash flows or reputation. For more information about the cybersecurity risks we face, see the risk factor entitled &#8220;<i>Security
threats to our information technology infrastructure could expose us to liability and damage our reputation and business</i>.&#8221;
in <i>Item 1A., Risk Factors</i>. </span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0E_gBFCRMPFAIAMT-VOAJS_zjcata6wjYi9"><ix:continuation id="ConU000053-06">&#160;</ix:continuation></span></span></p>

<p id="xdx_98F_ecyd--CybersecurityRiskBoardOfDirectorsOversightTextBlock_c20240101__20241231_gBFCRBODOTB-AAZNQL_zv3Uqk2sEVTd" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" continuedAt="ConU000061-01" escape="true" id="Fact000061" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governance</i></b></span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C01_gBFCRBODOTB-AAZNQL_zta7SvXxpZY6"><ix:continuation continuedAt="ConU000061-02" id="ConU000061-01">&#160;</ix:continuation></span></span></p>

<div id="xdx_C02_gBFCRBODOTB-AAZNQL_zPKuoEB5Ugbl"><ix:continuation continuedAt="ConU000061-03" id="ConU000061-02"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes the
significance of these threats to our operational integrity and stockholder confidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk
Management Personnel</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
utilize an out-sourced information technology (IT) network and cybersecurity compliance service provider, Windstar Technologies,
Inc. (&#8220;Windstar&#8221;) Windstar, under the supervision of our Chief Financial Officer, is responsible for developing and
implementing our information security program. Windstar provides managed IT network and cloud services, network, cyber and web
security services, cyber risk audits and compliance and penetration testing assessments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
of Directors Oversight</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240101__20241231_zE5Z9F8KMYXf" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000062" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">Our Board is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes
the significance of these threats to our operational integrity and stockholder confidence</ix:nonNumeric></span>. <span id="xdx_903_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20240101__20241231_zwJfGL7z4pGj" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000063" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">The
<span id="xdx_902_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zNn16VnzcPwj" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000064" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">Audit Committee</ix:nonNumeric></span> is central to the Board&#8217;s oversight of cybersecurity risks and bears the primary responsibility for this domain</ix:nonNumeric></span>. </span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0C_gBFCRBODOTB-AAZNQL_z8YqNTubHwuf"><ix:continuation id="ConU000061-03">&#160;</ix:continuation></span></span></p>

<p id="xdx_989_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20240101__20241231_gBFCRROMTB-NYJ_zlcDKodeA50a" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" continuedAt="ConU000068-01" escape="true" id="Fact000068" name="cyd:CybersecurityRiskRoleOfManagementTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Management&#8217;s
Role Managing Risk and Reporting to the Board</i></span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C07_gBFCRROMTB-NYJ_zS5GBo0JmJJ1"><ix:continuation continuedAt="ConU000068-02" id="ConU000068-01">&#160;</ix:continuation></span></span></p>

<div id="xdx_C09_gBFCRROMTB-NYJ_zfTOSbDLgj6"><ix:continuation continuedAt="ConU000068-03" id="ConU000068-02"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not currently have an employee who has significant and demonstrated professional IT management experience.
Presently, <span id="xdx_905_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20240101__20241231_zJ4QFgMhK2m7" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000069" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">our Chief Financial Officer with assistance from our third-party IT services provider, Windstar,
are primarily responsible for informing the Audit Committee regarding cybersecurity risks. They provide briefings to the Audit Committee
on a regular basis, with a minimum frequency of once per year</ix:nonNumeric></span>. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to scheduled meetings, the Audit Committee and the Chief Financial Officer maintain an ongoing
dialogue regarding emerging or potential cybersecurity risks. Together, they receive updates on any significant developments in the
cybersecurity domain, ensuring the Board&#8217;s oversight is proactive and responsive. This involvement ensures that cybersecurity
considerations are integrated into the Company&#8217;s broader strategic objectives and helps in identify areas for improvement,
ensuring the alignment of cybersecurity efforts with the overall risk management framework.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have <span id="xdx_903_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zQJf2UDLuSg6" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleanfalse" id="Fact000070" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">not</ix:nonNumeric></span> experienced any previous cybersecurity incidents that have materially affected or are reasonably likely to materially
affect our business strategy, results of operations, or financial condition.&#160;</span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C01_gBFCRROMTB-NYJ_zDno1oA8fGDf"><ix:continuation id="ConU000068-03">&#160;</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_005"></span>Item
2. Properties</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table describes our principal property leased as of the date of this Annual Report. We believe the facility described below is adequate for our current needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purpose</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Square
    Footage</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    and Research Laboratory<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    Front Royal, Virginia</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,700</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
    rental payments of $2,500 per month on a month-to-month basis. The lease expires on March 31, 2027.</span></td></tr>

  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_006"></span>Item
3. Legal Proceedings </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not presently a party to any material litigation. From time to time, may however, become involved in litigation matters arising in
the ordinary course of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_007"></span>Item
4. Mine Safety Disclosures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_008"></span>PART
II </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_009"></span>Item
5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Market
Information </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on the Nasdaq Capital Market under the symbol &#8220;GCTK.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders
</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2025, there were 313 holders of record of our Common Stock. A substantially greater number of holders are &#8220;street
name&#8221; or beneficial holders, whose shares of record are held by banks, brokers, and other financial institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends
</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have not paid any dividends on our Common Stock, and we currently expect that, for the foreseeable future, all earnings,
if any, will be retained for use in the development and operation of our business. In the future, our Board may decide, at its discretion,
whether dividends may be declared and paid to holders of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Authorized for Issuance under Equity Compensation Plans </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to Item 12 of Part
III of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unregistered
Sales of Equity Securities </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance
Under Intellectual Property Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2022, the Company entered into the Intellectual Property Purchase Agreement (the &#8220;IP Purchase Agreement&#8221;)
with Paul Goode, which is the Company&#8217;s Chief Executive Officer, pursuant to which Dr. Goode sold, assigned, transferred, conveyed
and delivered to the Company, all of his right, title and interest in and to the following assets, properties and rights
(collectively, the &#8220;Purchased Assets&#8221;): (a) all rights, title, interests in all current and future intellectual
property, including, but not limited to patents, trademarks, trade secrets, industry know-how and other IP rights relating to an
implantable continuous glucose sensor (collectively, the &#8220;Conveyed Intellectual Property&#8221;); and (b) all the goodwill
relating to the Purchased Assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the sale by Dr. Goode of the Purchased Assets to the Company, the Company paid to Dr. Goode cash in the amount of
one dollar and became obligated to issue up to 10,000 shares of Common Stock based upon specified performance milestones as set
forth in the IP Purchase Agreement (the &#8220;Purchase Price&#8221;). In addition, if upon the final issuance of Common Stock under the IP Purchase Agreement, the aggregate
10,000 shares represent less than 1.5% of the then outstanding Common Stock of the Company, the final issuance will include such
number of additional shares so that the total aggregate issuance equals 1.5% of the outstanding shares (the &#8220;True-Up
Shares&#8221;) of Common Stock of the Company. All shares of Common Stock to be issued under the IP Purchase Agreement shall be (i) restricted over a limited
period as defined in the IP Purchase Agreement and issued in transactions exempt from registration under Section 4(a)(2) of the
Securities Act of 1933, as amended and (ii) subject to the lockup provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, 1,000 shares of Common Stock were earned under the terms of the IP Purchase Agreement and were issued to Dr. Goode on
February 6, 2024. On May 1, 2024, 1,500 shares of Common Stock were earned under the terms of the IP Purchase Agreement. On March 26, 2025, the Board determined that the third milestone was met
and that an additional 2,500 shares of Common Stock have been earned under the terms of the IP Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>February
2024 Exchange</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 13, 2024, the Company entered into an exchange agreement (the &#8220;February Exchange Agreement&#8221;) with certain
shareholders (the &#8220;February Holders&#8221;), pursuant to which the Company and the February Holders agreed to exchange (the
&#8220;February Exchange&#8221;) Common Stock purchase warrants (the &#8220;February Warrants&#8221;) owned by the Holders for
shares of Common Stock to be issued by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 13, 2024, the Company closed the Exchange and issued to the February Holders an aggregate of 35,932 shares of Common Stock in exchange for 43,820 February Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the Common Stock to the February Holders was made pursuant to the exemption from registration contained in Section
3(a)(9) of the Securities Act and Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>April
Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2024, the Company entered into a private placement agreement under which the Company issued 3,968 shares of its Common Stock
at a price of $126.0 per share for aggregate gross proceeds of $500. The Offering included participation of certain members of the Company&#8217;s
executive management, Board of Directors and existing shareholders. The shares were issued in reliance on the exemption from registration
requirements thereof provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated under the Securities Act. The Company
relied on this exemption from registration based in part on representations made by the investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 27 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2024, the Company entered into note and warrant purchase agreements with certain officers,
directors, and existing investors (the &#8220;June 27 Investors&#8221;), providing for the private placement of unsecured promissory notes
in the aggregate principal amount of $100,000 (the &#8220;June 27 Notes&#8221;) and warrants (the &#8220;June 27 Warrants&#8221;) to purchase
up to an aggregate of 15,000 shares of Common Stock. The closing of the private placement occurred on July
1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 27 Notes bore simple interest at the rate of three percent (3%) per annum and were due and payable in cash on the earlier of:
(a) twelve (12) months from the date of the June 27 Note; or (b) the date the Company raised third-party equity capital in an amount
equal to or in excess of $1,000,000 (the &#8220;June 27 Maturity Date&#8221;). The Company could prepay the June 27 Notes at any time
prior to the June 27 Maturity Date without penalty. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
June 27 Warrant has an exercise price of $99.0 per share. The June 27 Warrants are immediately exercisable and have a five-year term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 27 Notes and the June 27 Warrants were issued in reliance on the exemption from registration requirements thereof provided by Section
4(a)(2) of the Securities Act and Regulation D promulgated thereunder. The Company relied on this exemption from registration
based in part on representations made by the June 27 Investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
18 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2024, the Company entered into a series of convertible promissory notes with certain officers and directors (the
&#8220;July 18 Investors&#8221;), providing for the private placement of unsecured convertible promissory notes in the aggregate
principal amount of $360,000 (the &#8220;July 18 Notes&#8221; and each a &#8220;July 18 Note&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
July 18 Notes bore simple interest at the rate of eight percent (8%) per annum and were due and payable in cash on the earlier of:
(a) the twelve (12) month anniversary of the July 18 Note, or (b) the date of closing of a Qualified Financing (defined below) (the
&#8220;July 18 Maturity Date&#8221;). </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
with regard to conversion of the July 18 Notes as discussed below, the Company could not prepay the July 18 Notes without the
written consent of the holder. If not sooner repaid, all outstanding principal and accrued but unpaid interest on the July 18 Notes
(the &#8220;Note Balance&#8221;), as of the close of business on the day immediately preceding the date of the closing of the next
issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting
in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a &#8220;Qualified
Financing&#8221;), would automatically be converted into that number of shares of equity securities of the Company sold in the
Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price
per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security
issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the &#8220;Floor Price&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
July 18 Notes were issued in reliance on the exemption from registration requirements thereof provided by Section 4(a)(2) of the Securities
Act and Regulation D promulgated thereunder. The Company relied on this exemption from registration based in part on representations
made by the July 18 Investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
30 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company entered into a convertible promissory note and
three warrant agreements (the &#8220;July 30 Warrants&#8221;) with an existing investor (the &#8220;July 30 Holder&#8221;), providing
for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the &#8220;July 30
Note&#8221;). The July 30 Note was not convertible until and unless approved at a meeting of the Company&#8217;s stockholders (&#8220;Stockholder
Approval&#8221;). Stockholder Approval was obtained on September 26, 2024. The July 30 Note bore simple interest at the rate of eight
percent (8%) per annum and was due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of July 30 Note, or (b)
the date of closing of a Sale Transaction (defined below) (the &#8220;July 30 Maturity Date&#8221;). The July 30 Note was secured by a
first-priority security interest on all Company assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
with regard to conversion of the July 30 Note or a Sale Transaction as discussed below, the Company could not prepay the July 30 Notes
without the written consent of the July 30 Holder. The July 30 Note (i) was convertible at the discretion of the July 30 Holder at a
price equal to the closing price of the Common Stock on the date of conversion and, (ii) if the closing price of the Common Stock exceeds
$100.00 per share for a period of five (5) consecutive trading days, would automatically convert at a price equal to the five-day (5)
VWAP (subject to adjustment for any stock split, stock dividend, reverse stock split, combination or similar transaction). &#8220;VWAP&#8221;
means the daily volume weighted average price of the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a Sale Transaction on or prior to the Maturity Date, the Company would repay the July 30 Holder, at the July 30 Holder&#8217;s
election, as follows: (a) cash equal to 200% of the Note balance, or (b) transaction consideration in the amount to be received by the
July 30 Holder in such Sale Transaction if the July 30 Note was converted pursuant to an optional conversion. &#8220;Sale Transaction&#8221;
means a merger or consolidation of the Company with or into any other entity, or a sale of all or substantially all of the assets of
the Company, or any other transaction or series of related transactions in which the Company&#8217;s stockholders immediately prior to
such transaction(s) receive cash, securities or other property in exchange for their shares and, immediately after such transaction(s),
own less than 50% of the equity securities of the surviving corporation or its parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
July 30 Warrant becomes exercisable 12 months after its issuance and has term of 10 years. The July 30 Warrants are exercisable for cash
only and have no price-based antidilution. The first July 30 Warrant is for 106,667 shares at $37.50 per share. The second July 30 Warrant
is for 76,191 shares at $52.50 per share. The third July 30 Warrant is for 59,260 shares at $67.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
July 30 Note and the July 30 Warrants were issued in reliance on the exemption from registration requirements thereof provided by Section
4(a)(2) of the Securities Act and Regulation D promulgated under the Securities Act. The Company relied on this exemption from registration
based in part on representations made by the July 30 Holder</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August
23 Conversion</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2024, two of the June 27 Investors entered into conversion agreements (each an &#8220;August Conversion Agreements&#8221;)
with the Company, pursuant to which the Company agreed to convert the principal amount, plus any accrued but unpaid interest
pursuant to each of the June 27 Notes, totaling $20,076 each (the &#8220;August Conversion Debt&#8221;), held by the Investors to
Common Stock at a conversion price of $20.40 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in satisfaction of the August Conversion Debt and pursuant to the August Conversion Agreements, the Company issued to each of the two
June 27 Investors three warrants (each an &#8220;August 23 Warrant&#8221;). Each August 23 Warrant becomes exercisable on August 16,
2025 and has term of 10 years. The August 23 Warrants are exercisable for cash only and have no price-based antidilution. The first
August 23 Warrant is for 535 shares of Common Stock and is exercisable at $37.50 per share. The second August 23 Warrant is for 382
shares of Common Stock, exercisable at $52.50 per share. The third August 23 Warrant is for 297 shares of Common Stock, exercisable
at $67.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
August 23 Warrants and the shares issued in satisfaction of the Debt were issued in reliance on the exemption from registration requirements
thereof provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder. The Company relied on
this exemption from registration based in part on representations made by the investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>September
5 Conversion</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 5, 2024, another June 27 Investor entered into a Conversion Agreement with the Company (the September Conversion
Agreement&#8221;), pursuant to which the Company agreed to convert the principal amount, plus any accrued but unpaid interest
pursuant to the June 27 Investor&#8217;s June 27 Note, totaling $259,310.67 (the &#8220;September Conversion Debt&#8221;), held by the
June 27 Investor to Common Stock at a conversion price of $20.40 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in satisfaction of the September Conversion Debt and pursuant to the September Conversion Agreement, the Company issued to the June 27 Investor three warrants (each an &#8220;September 5 Warrant&#8221;). Each September 5 Warrant becomes exercisable on August 16,
2025 and has term of 10 years. The September 5 Warrants are exercisable for cash only and have no price-based antidilution. The
first September 5 Warrant is for 6,915 shares of Common Stock and is exercisable at $37.50 per share. The second September 5 Warrant
is for 4,940 shares of Common Stock, exercisable at $52.50 per share. The third September 5 Warrant is for 3,842 shares of Common
Stock, exercisable at $67.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
September 5 Warrants and the shares issued in satisfaction of the Debt were issued in reliance on the exemption from registration requirements
thereof provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder. The Company relied on
this exemption from registration based in part on representations made by the investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concurrent
Private Offering</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a private placement offering completed concurrently with the November 2024 Offering (the &#8220;Concurrent Private Offering&#8221;),
the July 30 Holder, which is an existing investor controlled by a director of the Company, converted approximately $4,093,112 of
debt, which represented the then outstanding principal and accrued interest under the July 30 Note (the &#8220;July 30 Note
Debt&#8221;). The July 30 Note Debt was converted to Common Stock and Common Warrants on substantially the same terms as the
November 2024 Offering, resulting in the issuance of 132,036 shares of Common Stock, 132,036 accompanying Series A common warrants to purchase Common Stock (the &#8220;Series A Common
Warrants&#8221;), and 132,036 accompanying Series B common warrants to purchase Common Stock (the &#8220;Series A Common Warrants&#8221;,
and together with the Series A Common Warrants, the &#8220;Common Warrants&#8221;), based on a conversion price of $31.0 per share, which
is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
18 Note Conversion</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, concurrently with the November 2024 Offering, the Company converted on substantially the same terms as the November
Offering, the three outstanding July 18 Notes, with an aggregate outstanding principal and accrued interest in the amount
of $304,494. As previously disclosed in the Form 8-K filed by the Company with the SEC on July 22, 2024, that disclosed the entry
into the July 18 Notes, the July 18 Notes were to automatically convert upon a Qualified Financing, into a number of equity
securities of the Company sold in the Qualified Financing, equal to a number of shares calculated by dividing (X) the Note Balance
by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise
on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower
than the Floor Price. The three outstanding July 18 Notes automatically converted in connection with the closing of the
November 2024 Offering at a conversion price of $31.20, which is equal to the Floor Price as defined in the July 18 Notes, for an
aggregate of 9,760 shares of Common Stock, 9,760 Series A Common Warrants, and 9,760 Series B Common Warrants (the &#8220;July 18
Note Conversion&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock and the Common Warrants issued in connection with the Concurrent Private Offering and the July 18 Note Conversion were not
registered under the Securities Act and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the
Securities Act and Rule 506(b) promulgated thereunder. The Company relied on this exemption from registration based in part on representations made by the investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_010"></span>Item
6. [Reserved] </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_011"></span>Item
7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
discussion in this section contains forward-looking statements. These statements relate to future events, our future operations or our
future financial performance. We have attempted to identify forward-looking statements by terminology such as &#8220;anticipate,&#8221;
&#8220;believe,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;would&#8221;
or &#8220;will&#8221; or the negative of these terms or other comparable terminology, but their absence does not mean that a statement
is not forward-looking. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which
could cause our actual results to differ from those projected in any forward-looking statements we make. Several risks and uncertainties
we face are discussed in more detail under &#8220;Risk Factors&#8221; in Part I, Item 1A of this Annual Report or in the discussion and
analysis below. You should, however, understand that it is not possible to predict or identify all risks and uncertainties and you should
not consider the risks and uncertainties identified by us to be a complete set of all potential risks or uncertainties that could materially
affect us. You should not place undue reliance on the forward-looking statements we make herein because some or all of them may turn
out to be wrong. We undertake no obligation to update any of the forward-looking statements contained herein to reflect future events
and developments, except as required by law. The following discussion should be read in conjunction with the consolidated financial statements
and the notes to those statements included elsewhere in this Annual Report.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise noted, all information in this Item 7 regarding share amounts of our Common Stock and prices per share of our Common Stock
has been adjusted to reflect the application of the one-for-five reverse stock split of our Common Stock that we effected on May 27,
2024 and the one-for-twenty reverse stock split of our Common Stock that we effected on February 3, 2025, as further described below,
on a retroactive basis.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was incorporated on May 18, 2010 under the laws of the State of Delaware. We are currently developing an implantable CBGM,
the Glucotrack CBGM, for persons with Type 1 diabetes and insulin-dependent Type 2 diabetes.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was founded with a mission to develop Glucotrack&#174;, a non-invasive glucose monitoring device designed to help people with
diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive)
spot finger stick devices. The first generation Glucotrack, which successfully received CE Mark approval, obtained glucose measurements
via a small sensor clipped onto one&#8217;s earlobe. A limited release beta test in Europe and the Middle East demonstrated the need
for an updated product with improved accuracy and human factors. As the glucose monitoring landscape rapidly moved away from point-in-time
measurement to continuous measurement since then, the Company recently determined that it would focus its efforts on developing its Glucotrack
CBGM. As such, we have since withdrawn our CE Mark for Glucotrack and are no longer pursuing commercialization of this product or development
of any further iterations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is currently developing the Glucotrack CBGM for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients.
Implant longevity is key to the success of such a device. We have continued to evolve our sensor chemistry following our successful in-vitro
feasibility study demonstrating that a minimum two-year implant life is highly probable with the current sensor design. Recently we announced
a 3-year longevity is feasible leveraging both in-vitro and in-silico test results. We have also completed four animal studies with evolving
prototype systems, all four of which consistently demonstrated a simple implant procedure, good functionality, and safety. The Company
has also successfully demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated
a simple implant procedure, good functionality, and safety. This latter approach is of importance for patients with painful diabetic
neuropathy contemplating spinal cord stimulation therapy for their condition. The results of these animal trials were recently presented
in poster form at the American Diabetes Association, the Diabetes Technology Society, and the DiabetesMine annual conferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
regulatory submission has been made for a first in human study outside of the United States. This will be an acute study intended to
demonstrate device performance and safety. All preparatory clinical activities and applicable regulatory approvals are complete. In parallel,
the Company is also preparing for a long-term clinical trial outside the United States that is expected to begin in the second quarter of 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our technology, if successful, has the potential to be more accurate, more convenient and have a longer duration than other implantable
glucose monitors that are either in the market or currently under development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive management team consists of our Chief Executive Officer and President, Paul V. Goode PhD, an experienced executive with a 25+
year career developing innovative medical technologies, including at Dexcom and MiniMed (now Medtronic Diabetes) and Chief Financial
Officer, Peter C. Wulff, who has over 35 years of experience as a chief financial officer and chief operating officer in both public
and private entities. Our senior management team consists of: Mark Tapsak PhD, Chief Scientific Officer, a medical research scientist
who brings over 25 years of experience in the diabetes industry, including previous senior roles at Dexcom and Medtronic&#160;; James
P. Thrower PhD, Vice President of Advanced Technologies, a seasoned engineering executive with 20 years&#8217; experience formerly of
Sterling Medical Devices, Mindray DS USA and Dexcom; Drinda Benjamin, Vice President of Marketing, a medical device professional
with over 20 years of experience in the medical device and diabetes industry with senior roles at Intuity Medical, Senseonics, Abbott
Diabetes, and Medtronic Diabetes; Vincent Wong, Vice President of Operations, a medical device professional with 15 years of experience
in quality system for implantable medical device manufacturing with senior roles at Cirtec Medical and TOMZ; Sandie Martha, Vice President
Clinical Operations, a medical device professional with over 20 years of experience in the medical device and diabetes industry with
senior roles at Dexcom and GlySens; and Ted Williams, Vice President Regulatory, a medical device professional with over 20 years of
experience in the biotech and diabetes industry with a senior role at GlySens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Completion
of Preclinical Study</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 16, 2024, we announced that our implantable continuous glucose monitor successfully completed 30 days of a 60-day long-term preclinical
study on measuring glucose in the epidural space. The Glucotrack sensor, implanted in the epidural space of animals, closely tracked
both blood glucose and a commercially available subcutaneous CGM throughout the 30-day period. The implantation procedure took approximately
20 minutes, and the animals recovered without complications. No abnormal clinical signs or findings in the spinal cord or surrounding
tissues were observed at the 30-day mark. On June 13, 2024, we announced that the 60-day long-term study was completed, demonstrating
the feasibility of glucose monitoring in the epidural space. No abnormal clinical signs were observed throughout the study period, and
no abnormal findings were observed in the spinal cord or surrounding tissues during post-explant analysis. The study also confirmed that
the implanted sensor did not cause any delayed latent effects over the long-term period, which is particularly important as a complete
healing process in animal studies with implanted devices may take several weeks. With the completion of this study, the durability of
the epidural approach for continuous glucose monitoring has now been confirmed over the 60-day period. These developments mark another
potential use of the Glucotrack technology by combining the technology with a conventional spinal cord stimulator for treating patients
who have chronic lower back and lower limb pain, a significant proportion of which have diabetes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 4, 2025, we announced the successful completion of our first in-human clinical study, marking a significant milestone in continuous
glucose monitoring. This study represents the first real-time CBGM placed in the subclavian vein,
offering the potential for direct blood glucose measurement without the limitations often seen with traditional continuous glucose monitors
that measure glucose levels in interstitial fluid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
prospective single arm study was a short-term in-hospital study over a period of four days, focusing on the safety and procedural
aspects of the Glucotrack CBGM sensor lead placement, use, and removal. The sensor lead was placed intravascularly via a
percutaneous procedure and connected to a prototype sensor electronics component that was placed on the skin. The six study
participants had been previously diagnosed with diabetes mellitus requiring glucose monitoring and intensive insulin
therapy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results established safety of the placement, usage and removal of the CBGM sensor lead. While neither the study nor prototype system
was designed to evaluate sensor accuracy, the system performed as expected with similar accuracy results as previously seen in our animal
studies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
study met its primary endpoint with no procedure or device related serious adverse events reported from implant through seven days post-removal
of the CBGM sensor lead. The study also confirmed the function of the CBGM sensor lead in the subclavian vein. Placement and removal
procedures were successfully performed by interventional cardiologists.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ISO
13485:2016 Certification</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 21, 2025, we announced that we received ISO 13485:2016 certification from the British Standards Institute
(&#8220;BSI&#8221;). We successfully completed Stage I and Stage II Assessments performed by the notified body, BSI, to verify the
Company has established, and is maintaining, a quality management system that meets all requirements of the ISO 13485:2016 standard
for design and development of its products. ISO 13485 is an internationally recognized standard for quality management systems,
created by the International Organization for Standardization to ensure the safety and effectiveness of medical devices. It builds
on the ISO 9001 standard with additional regulatory requirements specific to medical devices. In 2024, the FDA issued the Quality Management System Regulation Final Rule, which harmonizes U.S. requirements with global standards
through the adoption of ISO 13485 for medical devices. ISO 13485 is also strongly recommended and widely used in the European
Union.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate
and Regulatory</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nasdaq
Listing Status</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
Listing Rule 5550(b)(1) requires companies listed on Nasdaq to maintain a minimum of $2,500,000 in stockholders&#8217; equity for continued
listing. On May 21, 2024, Nasdaq notified us that our Quarterly Report
on Form 10-Q for the period ended March 31, 2024, indicated that we no longer met the Minimum Stockholders&#8217; Equity Requirement.
Failure to meet the Minimum Stockholders&#8217; Equity Requirement was a basis for delisting our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we were not in compliance with the Bid Price Rule at the time we were notified about the non-compliance with the Minimum
Stockholders&#8217; Equity Requirement, we were not eligible to submit a plan to regain compliance with the Staff. However, we timely
requested a hearing before the Nasdaq Hearings Panel and paid the fee, which resulted in a stay of any suspension or delisting action
pending the hearing. The hearing took place on July 9, 2024, and on August 5, 2024, we received the decision of the Panel, and they granted
us an extension until November 18, 2024 to regain compliance with the Minimum Stockholders&#8217; Equity Requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 19, 2024, the Company received a Compliance Letter from Nasdaq, informing the Company that it had regained compliance with
the Minimum Stockholders&#8217; Equity Requirement. The Compliance Letter noted, that because the Company&#8217;s bid price has
closed below the minimum required by the Bid Price Rule following the 2024 November Offering (defined below), the Panel had
determined to impose on the Company a Discretionary Panel Monitor, pursuant to Listing Rule 5815(d)(4)(B), for a period of one year
from the date of the Compliance Letter, to ensure that the Company maintains long-term compliance with the Minimum
Stockholders&#8217; Equity Requirement, the Bid Price Rule, and all of Nasdaq&#8217;s continued listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, we received a notification from Nasdaq that for at least the last 30 consecutive business days, the Company was not
in compliance with the Bid Price Rule and, in accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have a compliance period of 180 calendar
days, or until June 30, 2025, to regain compliance with the Bid Price Rule. If at any time before June 30, 2025, the bid price of our
Common Stock closes at $1.00 per share or more for a minimum of ten consecutive business days, Nasdaq will provide us with a written
confirmation of compliance with the Bid Price Rule and the matter will be deemed closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we do not regain compliance with the Bid Price Rule by June 30, 2025, we may be eligible for an additional 180-day compliance period.
To qualify, we would be required to meet the continued listing requirement for market value of publicly held shares and all other initial
listing standards for the Nasdaq Capital Market, with the exception of the Bid Price Rule, and would need to provide written notice of
our intention to cure the bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that we will be able to continue to maintain compliance with Nasdaq&#8217;s continued listing requirements, the Bid
Price Rule, or other Nasdaq listing requirements. See &#8220;<i>Risk Factors &#8212; Our failure to maintain compliance with Nasdaq&#8217;s
continued listing requirements could result in the delisting of our Common Stock</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reverse
Stock Splits</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">2024
Reverse Stock Split</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
filed with the Delaware Secretary of State a Certificate of Amendment (the &#8220;May Certificate of Amendment&#8221;), to our
Certificate of Incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;), which became effective at 4:30 p.m. on
May 17, 2024 (the &#8220;First Effective Time&#8221;) to implement a one-for-five (1:5) reverse stock split (the &#8220;2024 Reverse
Stock Split&#8221;) of the shares of our Common Stock. The 2024 Reverse Stock Split was approved by our stockholders at the 2024
annual meeting of the stockholders on April 26, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the 2024 Reverse Stock Split, every five (5) shares of issued and outstanding Common Stock were automatically combined into
one (1) issued and outstanding share of Common Stock, without any change in the par value per share. No fractional shares were issued
as a result of the 2024 Reverse Stock Split, and any person who would otherwise be entitled to a fractional share of Common Stock as
a result of the 2024 Reverse Stock Split was entitled to receive a cash payment equal to the fraction of a share of Common Stock to which
such holder would otherwise be entitled, multiplied by the closing price per share of the Common Stock on Nasdaq at the close of business
on the date prior to the First Effective Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the 2024 Reverse Stock Split, the number of shares of Common Stock outstanding was proportionally reduced. The shares of Common Stock
underlying the outstanding stock options and warrants were similarly adjusted along with corresponding adjustments to their exercise
prices. The 2024 Reverse Stock Split also proportionally reduced the total number of authorized shares of Common Stock from 500,000,000
shares to 100,000,000 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">2025
Reverse Stock Split</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
filed with the Delaware Secretary of State a Certificate of Amendment to our Certificate of Incorporation (the &#8220;2025
Certificate of Amendment&#8221;) which became effective at 4:30 p.m. on February 3, 2025 (the &#8220;Second Effective Time&#8221;),
to implement a reverse stock split at a ratio of 1-for-20 (the &#8220;2025 Reverse Stock Split&#8221;) of the shares of our Common
Stock. The 2025 Reverse Stock Split was approved by our stockholders at the special meeting of our stockholders held on January 3,
2025 (the &#8220;Special Meeting&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As a result of the 2025 Reverse Stock Split, every twenty (20) shares of issued and outstanding Common Stock were
automatically combined into one (1) issued and outstanding share of Common Stock, without any change in the par value per share. No fractional
shares were issued as a result of the 20254 Reverse Stock Split, and instead, stockholders who otherwise would have been entitled to receive
fractional shares because they held a number of shares not evenly divisible by the Reverse Stock Split ratio were entitled to receive
an additional fraction of a share of Common Stock to round up to the next whole share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stockholders approved at the Special Meeting an increase in our authorized shares of Common Stock from 100,000,000 to 250,000,000,
as well as the full issuance of shares of Common Stock issuable by us upon the exercise of Series A Warrants and Series B Warrants (further
described below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Increase
in Authorized Common Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed an amendment to the Company&#8217;s Certificate of Incorporation, as to increase the Company&#8217;s
authorized shares of Common Stock from 100,000,000 to 250,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>February
2024 Exchange</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 13, 2024, we entered into the February Exchange Agreement with the February Holders, pursuant to which the Company and the
February Holders agreed to exchange the February
Warrants owned by the February Holders for shares of Common Stock to be issued by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 13, 2024, the Company closed the February Exchange and issued to the February Holders an aggregate of 35,932 shares of Common Stock in exchange for 43,820 February Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>April
Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2024, we entered into a private placement agreement under which the Company issued 3,968 shares of its Common Stock at a price
of $126.0 per share for aggregate gross proceeds of $500,000. The Offering included participation of certain members of the Company&#8217;s executive management, Board
of Directors and existing shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June
27 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2024, we entered into note and warrant purchase agreements with the June 27 Investors, providing for the private placement of unsecured promissory notes in the
aggregate principal amount of $100,000 and to purchase
up to an aggregate of 15,000 shares of Common Stock. The closing occurred on June 27, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
18 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2024, we entered into a series of convertible promissory notes with the July 18 Investors, providing for the private placement of unsecured convertible promissory notes in the aggregate
principal amount of $360,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2024, two of the June 27 Investors entered into conversion agreements with the Company, pursuant to which the Company agreed
to convert the principal amount, plus any accrued but unpaid interest, of each of the June 27 Notes, totaling $20,076 each, held by the
investors into Common Stock at a conversion price of $20.40 per share. On September 5, 2024, another June 27 Investor entered into a separate
conversion agreement with the Company, under which the Company agreed to convert
the principal amount, plus any accrued but unpaid interest, of the June 27 Note held by the investor, totaling $259,310, into Common
Stock at the same conversion price of $20.40 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in satisfaction of the debt and pursuant to the August Conversion Agreement, the Company issued to each of the two June 27 Investors
that converted their notes in August, three August 23 Warrants. Each August 23 Warrant becomes
exercisable on August 16, 2025 and has term of 10 years. The August 23 Warrants are exercisable for cash only and have no
price-based antidilution. The first August 23 Warrant is for 535 shares of Common Stock and is exercisable at $37.50 per share. The
second August 23 Warrant is for 382 shares of Common Stock, exercisable at $52.50 per share. The third August 23 Warrant is for 297
shares of Common Stock, exercisable at $67.50 per share. The June 27 Investor that converted his note in September was issued three September 5 Warrants on the same terms as the August 23 Warrants. The first September 5 Warrant is
for 6,915 shares of Common Stock and is exercisable at $37.50 per share. The second September 5 Warrant is for 4,940 shares of
Common Stock, exercisable at $52.50 per share. The third September 5 Warrant is for 3,842 shares of Common Stock, exercisable at
$67.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
30 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, we entered into the July 30 Note and three July 30 Warrants with the July 30 Holder, providing for the private placement
of a secured convertible promissory note in the aggregate principal amount of $4,000,000. The July 30
Note bore simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve
(12) month anniversary of July 30 Note, or (b) the date of closing of a Sale Transaction. The July 30 Note was secured by a first-priority security interest on all Company assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>$10.0
Million Public Offering and Concurrent Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 13, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain
purchasers identified on the signature pages therein, pursuant to which the Company sold in a &#8220;best efforts&#8221; public
offering (the &#8220;2024 November Offering&#8221;), pursuant to an effective registration statement on Form S-1 (File No. 333-
282158) under the Securities Act, an aggregate of (i) 121,867 shares of its
Common Stock (the &#8220;Shares&#8221;), (ii) 237,845 pre-funded warrants to purchase up to an aggregate of 237,845 shares of Common
Stock in lieu of Shares (the &#8220;Pre-Funded Warrants&#8221;), (iii) 359,712 Series A Common Warrants, and (iv) 359,712 Series B
Common Warrants. The public offering price for each Share and accompanying Common Warrants was $27.80, and the public offering price
for each Pre-Funded Warrant and accompanying Common Warrants was $27.78 (the &#8220;Offering Price&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a private placement offering completed concurrently with the Offering (the &#8220;Concurrent Private Offering&#8221;), the July 30
Holder, converted approximately $4,093,112 of debt, which represented the then outstanding principal and accrued interest under a
convertible promissory note dated July 30, 2024 (the &#8220;July 30 Note Debt&#8221;). The July 30 Note Debt was converted to Common
Stock and Series A Common Warrants and Series B Common Warrants on substantially the same terms as the November 2024 Offering,
resulting in the issuance of 132,036 shares of Common Stock, 132,036 accompanying Series A Common Warrants, and 132,036 accompanying
Series B Common Warrants, based on a conversion price of $31.00 per share, which is equal to the consolidated closing bid price of
the Common Stock on the Nasdaq Capital Market on November 12, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, concurrently with the November 2024 Offering, the Company completed the July 18 Note Conversion of the outstanding July 18
Notes. The July 18 Notes, which represented an aggregate outstanding principal and accrued interest in the amount of $304,494 were converted
at a conversion price of $31.20, which is equal to the Floor Price as defined in the July 18 Notes, for an aggregate of 9,760 shares
of Common Stock, 9,760 Series A Common Warrants, and 9,760 Series B Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ATM
Sales Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 17, 2024, we entered into an ATM sales agreement (the &#8220;Sales Agreement&#8221;) with Dawson James Securities, Inc. (&#8220;Dawson
James&#8221;), pursuant to which we have agreed to issue and sell shares of Common Stock, having an aggregate offering price of up to
$8.23 million, from time to time, through an &#8220;at-the-market&#8221; equity offering program under which Dawson James will act as
sales agent (the &#8220;Agent&#8221;). As of December 31, 2024, no sales of Common Stock had been made pursuant to the Sales Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">On March 21, 2025, we sold
12,377,967 shares of Common Stock at an average offering price of $0.304 per share pursuant to the Sales Agreement (the &#8220;March
ATM Sale&#8221;). We received net proceeds of approximately $3,643,000, after deducting fees owed to the placement agent from such
sale.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>February
2025 Registered Direct Offering</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 4, 2025, we entered into a securities purchase agreement with certain institutional investors, relating to the registered direct
offering and sale of an aggregate of 2,638,042 shares of Common Stock at an offering price of $1.15 per share. The shares of Common Stock
were offered by the Company pursuant to a prospectus supplement dated February 4, 2025, and accompanying prospectus dated October 3,
2024, in connection with a takedown from the Company&#8217;s shelf registration statement on Form S-3 (Registration No. 333-282297),
which was declared effective by the SEC, on October 3, 2024 (the &#8220;February 2025 Offering&#8221; and, together with the March ATM Sale, the &#8220;2025 Offerings&#8221;). Dawson James acted as
the placement agent for the offering pursuant to a placement agency agreement, dated February 4, 2025, by and between the Company and
Dawson James. The net proceeds to the Company from the offering were approximately $2,706,000, after deducting fees owed to Dawson
James and other offering expenses. The February 2025 Offering closed on February
5, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant
Exchange</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
on January 6, 2025, through March 13, 2025, the Company received exchange notices from certain holders of the Series B Warrants, with
respect to an aggregate of 359,612 of the Series B Warrants, requiring the delivery of 9,721,782 shares of Common Stock. The remaining
100 Series B Warrants are exchangeable for an aggregate of approximately 1,940 shares of Common Stock (subject to adjustment in the event
of any stock dividend and split, reverse stock split, recapitalization, reorganization or similar transaction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span style="text-decoration: underline">Pro Forma Impact of Registered Direct Offerings,
Warrant Exchange, and Series A Warrant Revaluation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following financial information
has been developed by application of pro forma adjustments to the historical financial statements of the Company appearing elsewhere in
this Annual Report. The unaudited pro forma information gives effect to the 2025 Offerings, the exchange of Series B Warrants to common
stock, and the revaluation of Series A Warrants.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The unaudited pro forma
financial information is presented for informational purposes only and does not purport to represent what the results of operations or
financial position of the Company would have been had the transactions described above actually occurred on the dates indicated, nor do
they purport to project the financial condition of the Company for any future period or as of any future date. The unaudited pro forma
financial information should be read in conjunction with the Company&#8217;s financial statements and notes thereto included elsewhere in this
Annual Report.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited
Pro Forma Balance Sheet</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; text-align: center"><b>Year Ended December 31, 2024</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Series B Warrant Exercise</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025 Offerings</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Revaluation of Series A Warrants</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Pro Forma as Adjusted</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 35%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,617</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,917</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">151</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">151</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,768</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,068</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease right-of-use asset, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Restricted cash</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,932</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,232</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">992</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">992</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">252</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">252</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,275</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,275</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="margin: 0pt 0pt 0pt 10pt">Derivative financial liabilities</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,421</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(14,877</p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,452</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability, non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Loans from stockholders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">203</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">203</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,932</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,603</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commitments and contingent liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholders&#8217; (Deficit) Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Common Stock of $0.001 par value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">100,000,000 shares authorized as of December 31, 2024 and 2023; 791,609 and 208,914 shares issued and outstanding as of December 31, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,877</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,858</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Receipts on account of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(132,450</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(132,450</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; (deficit) equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(13,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,629</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,932</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,232</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 164.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 164.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Research
and Development</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses consist primarily of salaries and other personnel-related expenses, including stock-based compensation expenses,
materials, travel expenses, clinical trials and other expenses. We expect research and development expenses to increase in 2025 and beyond,
primarily due to expanding clinical trial activities, hiring additional personnel, as well the development of Glucotrack CBGM; however,
we may adjust or allocate the level of our research and development expenses based on available financial resources and based on our
commercial needs, including the FDA registration process, specific requirements from customers, development of new Glucotrack CBGM models
and other product candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">General
and Administrative</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of professional services, salaries, travel expenses and other related expenses for executive,
finance and administrative personnel, including stock-based compensation expenses. Other general and administrative costs and expenses
include facility-related costs not otherwise included in research and development costs and expenses, and professional fees for legal
and accounting services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Other
(Income) Expense</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income expense, consist primarily of the change in fair value of derivatives liabilities, loss on the issuance of equity, loss on settlement
of debt to equity and finance income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations &#8211; Comparison of the Years Ended December 31, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All information below is stated in thousands of US dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion of our operating results explains material changes in our results of operations for the years ended December 31,
2024 and December 31, 2023. The discussion should be read in conjunction with the financial statements and related notes included elsewhere
in this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses were $9,499 for the year ended December 31, 2024, as compared to $4,704 for the prior-year period. The increase
of $4,795 was primarily attributable to increased expenses related to product design, development and manufacturing activities and pre-clinical
animal studies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses were $4,655 for the year ended December 31, 2024, as compared to $2,278 for the prior-year period. The increase
of $2,377 is primarily attributable to increased legal and professional fees, personnel costs and placement agent fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
compensation expense included in research and development and general and administrative expense, for the fiscal years ended December
31, 2024 and 2023, was comprised as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Research and development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">176</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">364</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">159</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">671</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">335</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in share-based compensation expense is attributable to the current year vesting of equity awards granted to employees, directors
and consultants supporting our research and development and general and administrative functions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
(Income) Expense, net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense was $8,050 for the year ended December 31, 2024, as compared to other income $7 for the prior-year period. The increase in other
expense is primarily attributed to recognized losses on the settlement of debt and the issuance of warrants containing derivative features.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss was $22,597 for the year ended December 31, 2024, as compared to a net loss of $7,097 for the prior-year period. The increase in
net loss is attributable primarily to the expense classifications discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, we had $5,617 in cash and cash equivalents compared with $4,492 in cash and cash equivalents as of December 31,
2023. The net increase in cash and cash equivalents was attributable to the $13,743 received from financing activities offset by cash
used in operating and investing activities of $12,594.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a history of recurring losses, and as of December 31, 2024, we have a stockholders&#8217; deficiency of $13,000. During the fiscal
year ended December 31, 2024, we recorded a net loss of $22,597. Our primary requirements for liquidity have been to fund product and
clinical development activities and to satisfy our general corporate and working capital needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to December 31, 2024, we received approximately $6,349 through the February 2025 Offering and the March ATM Sale. In addition,
as noted above, the impact of the subsequent financings, the exercise of Series B Warrants and the revaluation of Series A warrants
has resulted in Stockholders&#8217; Equity of $10,629 as of December 31, 2024, on a pro forma basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on our operating plans, we do not expect that our current cash and cash equivalents as of December 31, 2024, will be sufficient to fund
our operating, investing, and financing cash flow needs for at least the next twelve months, assuming our programs advance as currently
contemplated. Based upon this review and our current financial condition, the Company has concluded that substantial doubt exists as
to our ability to continue as a going concern. We have raised and believe we will continue to be able to raise additional capital through
debt financing, private or public equity financings, license agreements, collaborative agreements or other arrangements with other companies,
or other sources of financing. However, there can be no assurances that such financing will be available or will be at terms acceptable
to us, or at all. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce, or eliminate
our clinical trials or other operations. If any of these events occur, our ability to achieve our operational goals would be adversely
affected. Our future capital requirements and the adequacy of available funds will depend on many factors, including those described
in the section titled &#8220;<i>Risk Factors</i>.&#8221; Depending on the severity and direct impact of these factors on us, we may be
unable to secure additional financing to meet our operating requirements on commercially acceptable terms favorable to us, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern Uncertainty</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have not yet commercialized the Glucotrack CBGM. Further development and commercialization efforts are expected to
require substantial additional expenditure. Therefore, we are dependent upon external sources for financing our operations. As of December
31, 2024, we have incurred a stockholders&#8217; deficiency of $13,000, which includes an accumulated deficit of $132,450. In addition,
we have generated operating losses and negative operating cash flow for all reported periods. As of December 31, 2024, the balance of
cash and cash equivalents amounted to $5,617.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2024, we received approximately $13,734 through public offerings and debt issuances which were
subsequently converted to equity. In addition, subsequent to the balance sheet date, we received $6,349 through the sale of
shares of Common Stock. We plan to finance our operations through the sale of debt or equity securities (including the shelf
registration statement on Form S-3 that was declared effective on October 3, 2024 by the SEC which allows us to register up to
$30,000 of certain equity and/or debt securities of the Company through prospectus supplement). There can be no assurance that we
will succeed in obtaining the necessary financing or generating sufficient revenue from sale of the Glucotrack CBGM in order to
continue our operations as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has considered the significance of such conditions in relation to our ability to meet current obligations and to achieve our business
targets and determined that these conditions raise substantial doubt about our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion and analysis of our financial condition and results of operations are based on our audited consolidated financial statements,
which have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP. The preparation of
these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues,
expenses, and related disclosures. We evaluate our estimates on an ongoing basis. We base our estimates on historical experience and
on other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments
about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from
these estimates under different assumptions or conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the following accounting policies and estimates are critical to aid you in understanding and evaluating our reported financial
results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share-Based
Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
grant equity-based awards under share-based compensation plans. We estimate the fair value of share-based payment awards using the Black-Scholes
option valuation model. This fair value is then amortized over the requisite service periods of the awards. The Black-Scholes option
valuation model requires the input of subjective assumptions, including price volatility of the underlying stock, risk-free interest
rate, dividend yield, and expected life of the option. Share-based compensation expense is based on awards ultimately expected to vest
and therefore is reduced by expected forfeitures. Changes in assumptions used under the Black-Scholes option valuation model could materially
affect our net loss and net loss per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review the terms of the Common Stock, warrants and convertible debt we issue to determine whether there are derivative instruments, including
embedded conversion options that are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances
where the host instrument contains more than one embedded derivative instrument, including a conversion option, that is required to be
bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivatives
are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating
income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated
and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative
instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments
being recorded at a discount from their face value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Accounting Pronouncements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
regarding recent accounting pronouncements is contained in Note 2 to the Consolidated
Financial Statements, included elsewhere in this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off
Balance Sheet Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any off-balance sheet arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_012"></span>Item
7A. Quantitative and Qualitative Disclosure About Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a smaller reporting company, we have elected not to provide the disclosure required by this item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_013"></span>Item
8. Financial Statements and Supplementary Data </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to pages F-1 through F-31 comprising a portion of this Annual Report on Form 10-K, which are incorporated by reference
under this Item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_014"></span>Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_015"></span>Item
9A. Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evaluation
of Disclosure Controls and Procedures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management,
under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, have conducted an evaluation
of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)
under the Exchange Act). Disclosure controls and procedures are designed to ensure that information required to be disclosed by a company
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange
Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate
to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and our Chief Financial
Officer, concluded that as of the end of the period covered by this Annual Report, (i) the Company&#8217;s disclosure controls and procedures
were not effective to ensure that material information relating to the Company is recorded, processed, summarized, and reported within
the time periods specified in the rules and forms of the SEC, and (ii) the Company&#8217;s controls and procedures have not been designed
to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is
accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, or
persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management&#8217;s
Report on Internal Controls Over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange
Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of management including our Chief Executive Officer
and our Chief Financial Officer, the Company conducted an evaluation of the effectiveness of its internal control over financial reporting
based principally on the framework and criteria established in Internal Control - Integrated Framework (2013) issued by the Committee
of Sponsoring Organizations of the Treadway Commission as of the end of the period covered by this Annual Report. Based on the
foregoing evaluation, management concluded that the Company&#8217;s internal controls over financial reporting were not effective because
of the material weaknesses discussed below. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report does not include an attestation report of the Company&#8217;s registered public accounting firm regarding internal control
over financial reporting because the attestation report requirement has been removed for &#8220;smaller reporting companies&#8221; under
the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified material weaknesses in its internal control over financial reporting. As defined in Regulation 12b-2 under the
Exchange Act, a &#8220;material weakness&#8221; is a deficiency, or combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented,
or detected on a timely basis. The Company identified material weaknesses in its internal controls in the following areas: general IT
controls; lack of sufficient accounting personnel and inadequate segregation of duties consistent with control objectives. None of these
deficiencies resulted in a material misstatement to the Company&#8217;s annual or interim Consolidated Financial Statements for the year
ended December 31, 2024.&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management&#8217;s
Remediation Measures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has identified corrective actions to remediate such material weaknesses, which includes the implementation of proper IT system access
controls and the proper backup of the Company&#8217;s IT architecture. In addition, the Company has outsourced certain accounting functions
to ensure proper segregation of duties over financial reporting and hired additional accounting personnel. Management intends to continue
the implementation of procedures to remediate such material weaknesses during the fiscal year 2025; however, the implementation of these
initiatives may not fully address any material weaknesses that we may have in our internal control over financial reporting.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will continue to review and improve its internal controls over financial reporting to address the underlying causes of the material
weaknesses and control deficiencies. Such material weaknesses and control deficiencies will not be remediated until the Company&#8217;s
remediation plan has been fully implemented, and it has concluded that its internal controls are operating effectively for a sufficient
period of time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the material weaknesses and the remediation efforts described above, no other change in our internal control over financial reporting
(as defined by Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended December 31, 2024, that has materially
affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_016"></span>Item
9B. Other Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--NoInsiderTradingFlag_dbT_c20240101__20241231_z1LfFZ8xTMvi" title="No insider trading flag" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000072" name="GCTK:NoInsiderTradingFlag">None</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_017"></span>Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_018"></span>PART
III </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_019"></span>Item
10. Directors, Executive Officers and Corporate Governance </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Information
Regarding Directors and Executive Officers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following table sets forth
information regarding our executive officers and non-employee directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-size: 9pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><span style="font-size: 9pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: center"><span style="font-size: 9pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Paul V. Goode</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Chief Executive Officer, President, and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Peter C. Wulff</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Luis Malave</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Erin Carter</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">55</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Dr. Robert Fischell</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">96</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Andrew K. Balo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">77</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Allen Danzig</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">69</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">John Ballantyne</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">55</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Paul V. Goode, PhD &#8211; Chief Executive Officer,
President and Director</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Dr. Goode
has served as the Company&#8217;s Chief Executive Officer since November 2021. He most recently served as Vice President of Product Development
at Orchestra Biomed where he oversaw development of its implantable cardiac stimulator system for hypertension. Prior to Orchestra, from
2010 until July 2019 Dr. Goode served in several executive roles at EndoStim, including Senior Vice President of R&amp;D, Chief Technology
Officer, and Interim Chief Executive Officer. From 2006 through 2010 he served as Vice President of Research and Development at Metacure
and from 2004 through 2006 Mr. Goode served as Director of Engineering at Impulse Dynamics. Prior to that, Mr. Goode was employed as Director
of Engineering at DexCom and as Senior Engineer at MiniMed. Dr. Goode received his BS, MS and PhD degrees from North Carolina State University.
Dr. Goode&#8217;s extensive experience in the medical device space qualifies him to serve on our Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Peter C. Wulff &#8211; Chief Financial Officer,
Treasurer and Corporate Secretary</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Mr. Wulff has served as the Company&#8217;s
Chief Financial Officer since January 2025. Mr. Wulff has over 40 years&#8217; experience in financial and operating management in the
emerging growth life sciences industry, having served most recently as Chief Financial Officer of Biological Dynamics, Inc., a life science
research organization focused on early cancer detection, from January 2023 to June 2024. Prior to his time at Biological Dynamics, Inc.,
he served as the Chief Financial Officer at JenaValve Technology, Inc., a heart valve technology medical device company, from August 2015
to April 2022. Mr. Wulff has served as the executive financial officer of various other medical technology companies, including PURE Bioscience,
Inc. from November 2012 to July 2015, Alphatec Spine Holdings from June 2008 to April 2011, Artes Medical Inc. from January 2005 to May
2008, and CryoCor, Inc. from May 2001 to May 2004. In these roles, he directed and managed accounting and finance and investor relations.
Mr. Wulff earned his MBA in Finance and his bachelor&#8217;s degree in Economics and Germanic Languages from Indiana University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Luis Malav&#233; &#8211; Director</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Mr. Malav&#233; has served
as a director of the Company since June 22, 2021 and serves on our Audit Committee and Nominating, Governance and Compensation Committee.
Mr. Malav&#233; brings more than 30 years of leadership experience in the MedTech industry, primarily in diabetes management, spanning
all company stages, from private startups to large-cap publicly listed companies. He has extensive expertise in product development, operations,
marketing, strategic partnerships, and US FDA regulatory strategy. Since October 2017, Mr. Malav&#233; has served as President of EOFLOW
CO. Ltd., a company listed on the Korea Stock Exchange that has developed a wearable disposable insulin pump. From October 2014 to June
2016, he was COO of Mikroscan Technologies. Prior to that, Mr. Malav&#233; was the President and CEO of Palyon Medical, maker of an
implantable drug-delivery system that spun out from German medical-technology giant Fresenius SE. Prior to Palyon, he spent nearly a decade
at insulin pump maker Insulet Corp., including as its Senior Vice President of Research, Development and Engineering, and as Chief Operating
Officer. He also held various senior positions at Medtronic and MiniMed, overseeing product development of various diabetes management
devices. Mr. Malav&#233; earned his Bachelor&#8217;s degree in Mathematics and Computer Science from the University of Minnesota, a
Master&#8217;s degree in Software Engineering from the University of St. Thomas, and an MBA from the University of Maryland. Mr. Malav&#233;&#8217;s
extensive experience in the medical device space and public company experience qualify him to serve on our Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Erin Carter &#8211; Director </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Ms. Carter has served as a director
of the Company since August 25, 2023, and is the Chair of its Audit Committee. Ms. Carter brings 30 years of executive level finance experience
in the medical device industry. Ms. Carter (since July of 2024) currently serves as the Chief Financial Officer for the Mayo Collaborative Services,
at the Mayo Clinic. Mayo Collaborative Services facilitates access to the Mayo Clinic diagnostic expertise and services with revenues
exceeding $1B. From 2012 until March of 2023, she held various senior roles with Medtronic, most recently serving as
Chief Financial Officer and Vice President of Finance for their $9B Neuroscience division. In addition, during her tenure at Medtronic
she grew the Gastrointestinal Solutions division from early tech start-up acquisition of $36M to revenue of $450M in 5 years through organic
growth and multiple acquisitions. Prior to Medtronic, Ms. Carter served as Director of Finance at Boston Scientific and as VP of Accounting
and Reporting at UnitedHealth Group. Prior to that, she served as Assistant Controller for Arterial Vascular Engineering, where she was
instrumental in guiding the rapid growth of the company from 200 employees to over 4,000 in under five years. During this time, she managed
the integration of two acquisitions and subsequently that company&#8217;s sale to Medtronic. Ms. Carter holds a B.S. in Business Administration
from California Polytech State University and is a Certified Public Accountant (inactive) in the State of California. Ms. Carter&#8217;s extensive
executive finance experience, including leadership roles in the medical device space, makes her qualified to serve on our Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Dr. Robert Fischell &#8211;Director</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Dr. Fischell
has served as a director of the Company since 2010. He also serves on the Company&#8217;s Nominating, Governance and Compensation Committee
and on the Audit Committee. Dr. Fischell is an inventor and serial entrepreneur with over 160 issued U.S. patents. Starting in 1959, Dr.
Fischell spent over 30 years with the Johns Hopkins University Applied Physics Laboratory, which resulted in 53 patents in both aerospace
and biomedical technology. His interests at Johns Hopkins then turned to the invention of new medical devices such as pacemakers and implantable
heart defibrillators. Starting in 1969, Dr. Fischell began the formation of 14 private companies that licensed his patents on medical
devices. These companies include Pacesetter Systems, Inc. (purchased by Siemens and now part of St. Jude Medical, Inc.), IsoStent, Inc.
(merged with Cordis Company, a Johnson and Johnson Company), NeuroPace, Inc., Neuralieve, Inc., Angel Medical Systems, Inc., and Svelte
Medical Systems, Inc. As it relates to diabetes management devices, he was the inventor of the first implantable insulin pump (which became
Minimed, which was sold to Medtronic). Dr. Fischell&#8217;s honors include Inventor of the Year for the USA in 1984, election to the National
Academy of Engineering in 1989, the Distinguished Physics Alumnus Award of the University of Maryland, and several medals for distinguished
accomplishments in science, engineering and innovation. In 2004, Discover magazine gave Dr. Fischell their annual Technology for Humanity
award. In 2008, Dr. Fischell received the honorary degree of Doctor of Humane Letters from the Johns Hopkins University in recognition
of his many lifesaving inventions. From June 2009 until March 2011, Dr. Fischell was a director of InspireMD, Inc. (OTCBB: NSPR), a medical
device company focusing on the development and commercialization of its proprietary stent system, MGuard. Dr. Fischell received his BSME
degree from Duke University and MS and Sc.D. degrees from the University of Maryland. At the White House on May 16, 2016, President Obama
presented to Dr. Fischell the National Medical of Technology and Innovation, the highest award in the USA for achievements in innovative
technology. Dr. Fischell is suited to serve as a member of the Board of Directors due to his extensive diabetes and medical device experience.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Andrew K. Balo &#8211; Director</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt"><span style="font-size: 10pt">Mr.
Balo has served as a director of the Company since June 2024. Mr. Balo joined DexCom International, Ltd. as part of the original executive
team in 2002 and played a critical role in shaping the company&#8217;s future. During his tenure, he was responsible for numerous glucose
monitoring regulatory submissions and clinical trials worldwide and coordinated quality activities across multiple manufacturing facilities.
From February 2022 until his retirement on March 24, 2024, Mr. Balo served as Executive Vice President of Clinical, Global Access, and
Medical Affairs. Prior to joining Dexcom, Mr. Balo held several leadership positions at St. Jude Medical, including Corporate Vice President
of Regulatory, Clinical, and Quality, and also served in executive roles at Baxter, Pacesetter and Endocardial Solutions.</span><span style="font-size: 8pt">&#160;</span>
<span style="font-size: 10pt">Mr. Balo&#8217;s extensive leadership experience in clinical and regulatory affairs makes him qualified
to serve on the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Allen Danzig &#8211; Director</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Mr. Danzig has served on our
Board since October 31, 2019 and is the Chair of our Nominating, Governance and Compensation Committee. Mr. Danzig most recently served
as Vice President, Assistant General Counsel and Assistant Secretary of L3Harris Technologies, Inc., a global aerospace and defense technology
contractor, with $17 billion in annual revenue. Prior to its merger with Harris Corporation in June 2019, Mr. Danzig served as Vice President,
Assistant General Counsel and Assistant Secretary at L3 Technologies, Inc. where he had been employed since 2006. Prior to his employment
at L3, Mr. Danzig served in management positions with Celanese Corporation, a global chemical and specialty materials company, and The
Hertz Corporation, one of the world&#8217;s largest vehicle and equipment rental companies. He received his undergraduate degree from
Adelphi University and law degree from Pace University School of Law and is a member of the New York State Bar. Mr. Danzig&#8217;s extensive
legal and corporate governance experience makes him qualified to serve on the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>John Ballantyne &#8211; Director</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">Mr. Ballantyne has served on our Board since September 2024. Mr. Ballantyne
brings over 20 years of experience on the executive team at the global biotechnology contract development and manufacturing organization,
Aldevron. He co-founded the company in 1998 and served as its Chief Science Officer through its acquisition by Danaher, and until December
2021. A leader in advancing biological science, Aldevron&#8217;s custom development and manufacturing services have provided scientists
around the world with the essential components to accelerate research within their laboratories for groundbreaking science and breakthrough
discoveries. Due to Aldevron&#8217;s significant presence in the biotechnology sector, Mr. Ballantyne has developed relationships across
a continuum of focus areas maintained through investments, Board and Scientific Advisory Board roles and co-founding of multiple companies.
Mr. Ballantyne holds undergraduate degrees in Pharmacy from the Central Institute of Technology (Heretaunga, NZ) and University of Otago
(Dunedin, NZ) and his Doctorate in Pharmaceutical Sciences from North Dakota State University (Fargo, ND). Mr. Ballantyne&#8217;s extensive
experience in healthcare research and innovation, strategic growth, and other key business functions makes him a valuable addition to
the Board.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compliance
with Section 16(a) of the Exchange Act</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 16(a) of the Securities Exchange Act of 1934, requires our directors,
executive officers and persons who own more than 10% of our common stock to file with the SEC initial reports of ownership and reports
of changes in ownership of common stock and other of our equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely upon a review of those reports and written representations provided to us by all of our directors and executive officers, we believe
that during the year ended December&#160;31, 2024, our directors, executive officers and greater than 10% stockholders did not report
the following transactions on a timely basis: a Form 3 filing for Luis Malave that was due on June 22, 2021, which was filed on March
28, 2025; a Form 3 filing for Andrew Balo that was due on June 14, 2024, which was filed on March 28, 2025; a Form 3 filing for the John
A. Ballantyne Revocable Trust 08/01/2017 (the &#8220;Ballantyne Trust&#8221;) that was due on July 30, 2024, which was filed on March
28, 2025; Forms 4 for Allen Danzig reporting the acquisition of Common Stock on each of October 4, 2022 and April 8, 2024, both of which
were not filed (both of the aforementioned acquisitions by Allen Danzig were subsequently reported on a Form 4 filed on March 28, 2025);
Forms 4 for Robert Fischell reporting the acquisition of Common Stock on each of August 24, 2021 and April 8, 2024, each of which were
not filed (both of the aforementioned acquisitions by Robert Fischell were subsequently reported on a Form 4 filed on March 28, 2025);
a Form 4 for Paul Goode disclosing an option grant that was made on June 14, 2024, was not filed; a Form 4 for Paul Goode disclosing
the purchase of a warrant on July 1, 2024, was not filed; a Form 4 for Paul Goode reporting the purchase of a convertible promissory
note on July 18, 2024, was not filed; a Form 4 for Paul Goode reporting the conversion of a promissory note on November 14, 2024, was
not filed; a Form 4 for Paul Goode reporting the acquisition of Series A Common Warrants and Series B Common Warrants on November 14,
2024, was not filed; a Form 4 for Paul Goode reporting the acquisition of Common Stock pursuant to the IP Purchase Agreement, was not
filed (each of the aforementioned transactions by Paul Goode were subsequently reported on a Form 4 filed on March 28, 2025); Forms 4
for Erin Carter reporting the acquisition of Common Stock on each of December 31, 2023 and April 8, 2024, both of which were not filed;
a Form 4 for Erin Carter reporting the purchase of a convertible promissory note on July 18, 2024, was not filed; a Form 4 for Erin Carter
reporting the conversion of a promissory note on November 14, 2024, was not filed; a Form 4 for Erin Carter reporting the acquisition
of Series A Common Warrants and Series B Common Warrants on November 14, 2024, was not filed (each of the aforementioned transactions
by Erin Carter were subsequently reported on a Form 4 filed on March 28, 2025); a Form 4 for John Ballantyne reporting the purchase of
three warrants on July 30, 2024, was not filed; a Form 4 for John Ballantyne reporting the conversion of a promissory note on November
14, 2024, was not filed; a Form 4 for John Ballantyne reporting the acquisition of Series A Common Warrants and Series B Common Warrants
on November 14, 2024, was not filed; (each of the aforementioned transactions by John Ballantyne were subsequently reported on a Form
4 filed on March 31, 2025); a Form 4 for the Ballantyne Trust reporting the purchase of three warrants on July 30, 2024, was not filed;
a Form 4 for the Ballantyne Trust reporting the conversion of a promissory note on November 14, 2024, was not filed; a Form 4 for the
Ballantyne Trust reporting the acquisition of Series A Common Warrants and Series B Common Warrants on November 14, 2024, was not filed
(each of the aforementioned transactions by the Ballantyne Trust were subsequently reported on a Form 4 filed on March 31, 2025); Forms
4 for Luis Malave reporting the acquisition of Common Stock on each of August 31, 2021, December 31, 2021, March 31, 2022, June 30, 2022,
October 4, 2022, January 9, 2023, August 20, 2023, December 31, 2024 and April 8, 2024, each of which were not filed; a Form 4 for Luis
Malave reporting the purchase of a convertible promissory note on July 18, 2024, was not filed; a Form 4 for Luis Malave reporting the
conversion of a promissory note on November 14, 2024, was not filed; and a Form 4 for Luis Malave reporting the acquisition of Series
A Common Warrants and Series B Common Warrants on November 14, 2024, was not filed; (each of the aforementioned transactions by Luis
Malave were subsequently reported on a Form 4 filed on March 31, 2025).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Code
of Ethics and Business Conduct</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the information required by this Item 10 relating to the code of ethics required by Item 406 of Regulation S-K, the
Company has a Code of Ethics and Business Ethics (the &#8220;Code of Ethics&#8221;), which applies to its directors, officers, and
employees, including its principal executive officer, principal financial officer, principal accounting officer or controller, or
persons performing similar functions (collectively, the &#8220;Covered Persons&#8221; and each a &#8220;Covered Person&#8221;). The
full text of the Code of Ethics is available on the &#8220;Investors&#8221; section of our website, which is located at <i>www.glucotrack.com</i>.
The Company intends to satisfy the SEC&#8217;s requirements regarding amendments to, or waivers from, the Code of Ethics by posting
such information on its website or by filing a Current Report on Form 8-K to disclose such information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Procedures
for Stockholders to Recommend Director Nominees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no material changes to the procedures by which security holders may recommend nominees to our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee Information</i></b><i> </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Board has a standing Audit Committee. Our Audit Committee
is chaired by Erin Carter and its other members are Luis Malave and Dr. Robert Fischell. Our Board has determined that each of these directors
is &#8220;independent&#8221; as defined by the rules of the SEC and the Nasdaq Listing Rules. The Board has determined that Ms. Carter
is an &#8220;audit committee financial expert&#8221; as that term is defined in Item 407(d)(5)(ii) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insider
Trading Policy</i></b><i> </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company <span id="xdx_905_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20240101__20241231_zfDrwAn5pf05" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000073" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">has an insider trading policy (the &#8220;Insider Trading Policy&#8221;)</ix:nonNumeric></span> which prohibits Covered Persons from buying or selling the Company&#8217;s securities while the
Covered Person is aware of material nonpublic information about the Company. The Company believes that its Insider Trading Policy is
reasonably designed to promote compliance with insider trading laws, rules and regulations, and any applicable listing standards. A copy
of the Insider Trading Policy is filed as Exhibit 19.1 to this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_020"></span>Item
11. Executive Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following discussion contains
forward-looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation
programs. The actual amount and form of compensation and the compensation policies and practices that we adopt in the future may differ
materially from currently planned programs as summarized in this discussion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">We are
currently considered a &#8220;smaller reporting company&#8221; within the meaning of the Securities Act for purposes of the SEC&#8217;s
executive compensation disclosure rules. Accordingly, we are required to provide a Summary Compensation Table, as well as limited narrative
disclosures regarding executive compensation for our last two completed fiscal years and an Outstanding Equity Awards at Fiscal Year End
Table for our last completed fiscal year. These reporting obligations extend only to &#8220;named executive officers.&#8221; Individuals
we refer to as our &#8220;named executive officers&#8221; include (i) all individuals serving as our Chief Executive Officer during the
fiscal year ended December 31, 2024 and (ii) our two most highly compensated executive officers, as defined in Exchange Act Rule 3b-7,
other than our Chief Executive Officer, who were serving as executive officers at the end of the fiscal year ended December 31, 2024,
whose salary and bonus for services rendered in all capacities exceeded $100,000 during the fiscal year ended December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">This section
discusses material components of the executive compensation programs for the Company&#8217;s &#8220;named executive officers&#8221; who
area named in the &#8220;Summary Compensation Table&#8221; below. In 2024, the Company&#8217;s &#8220;named executive officer&#8221; was
Paul V. Goode, the Company&#8217;s Chief Executive Officer. No other executive officer of the Company received total compensation during
the fiscal year ended December 31, 2024 in excess of $100,000, and thus disclosure is not required for any other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Summary Compensation Table</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following table sets forth
total compensation paid to our named executive officer for the years ended December 31, 2024, and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Name and Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Year </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Salary ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Bonus ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Stock Awards&#160; ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Option Awards ($)<sup>(1)</sup> &#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Non-Equity Incentive Plan Compensation ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Non-qualified Deferred Compensation Earnings ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>All Other Compensation ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Total ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 37%"><span style="font-size: 10pt">Paul V Goode</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">350,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">2,096</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-size: 10pt">352,096</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><i>Chief Executive Officer</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">225,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">258,243</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-size: 10pt">356,237</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Narrative to the Summary Compensation Table</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Annual Base Salary</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">We pay
our named executive officer a base salary to compensate him for services rendered to our company. The base salary payable to our named
executive officers is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role
and responsibilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Equity Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">We have
granted stock options to our employees, including our named executive officer, in order to attract and retain them, as well as to align
their interests with the interests of our shareholders. In order to provide a long-term incentive, these stock options vest over three
years subject to continued service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Executive Compensation Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Employment Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Set forth
below is a summary of the material terms of the employment agreement of our current named executive officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Paul Goode</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">On October
19, 2021, Paul V. Goode was appointed as President and Chief Operating Officer of the Company, effective November 1, 2021 (the &#8220;Goode
Effective Date&#8221;) and currently serves as the Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">In this
role, Goode leads the Company&#8217;s operations, overseeing strategy, design, manufacturing, business and product development and helps
to build the U.S. infrastructure in preparation for the U.S. clinical trials of the Company. He devotes such time as necessary to perform
his duties but is able to pursue other professional opportunities at the same time. His base salary shall be $175,000 per year, and he
is entitled to a cash bonus of up to 20% of his annual base salary as determined by the Company&#8217;s Compensation Committee and was
granted options to purchase up to one-and-a-half percent (1.5%) of the fully diluted Common Stock as of the Goode Effective Date, with
a per share exercise price equal to $49.00 per share, which vests in equal monthly installments over a three-year period following the
Goode Effective Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The bonus
and equity incentives are subject to clawback rights if there is a misstatement of financials which changes any metrics upon which a bonus
or incentives are based and the clawback will be pro rata based upon the changes in the financials with respect to the effect on any underlying
metrics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Outstanding Equity Awards as of December 31, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The following
table sets forth for the Company&#8217;s named executive officer certain information regarding unexercised options as of December 31,
2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Number of Securities Underlying Unexercised Options</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Number of Securities Underlying Unexercised Options</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Option</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Exercise</b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Option</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Expiration</b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>(#) Exercisable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>(#) Unexercisable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Price</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b>Date</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-size: 10pt">Paul V. Goode</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-size: 10pt">3,277</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-size: 10pt">49.00</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-size: 10pt">10/31/31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Director Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Decisions regarding the compensation
to be paid to the members of our Board of Directors, if any, are determined and/or ratified by the Board with recommendations given by
the Compensation Committee. Non-employee directors are compensated with a combination of cash and shares. Additionally, we provide reimbursement
to our non-employee directors for their reasonable expenses incurred in attending meetings of our Board of Directors and its committees.
Directors may also receive equity awards from time to time. The directors who also serve as an employee of the Company do not receive
additional compensation for their service as a director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The following
table sets forth information with respect to the compensation of our directors as of December 31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees Earned or Paid in Cash</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock Awards ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Awards ($)</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other Compensation ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left">Allen Danzig</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">70,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Luis Malave</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">64,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">55,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">120,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dr. Robert Fischell</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Erin Carter</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">45,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">55,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">John Ballantyne</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">34,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">34,783</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Andrew Balo</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">53,022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">53,022</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Shimon Rapps<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">58,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">Andrew Sycoff<sup>(1)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">58,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">58,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">293,083</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">331,388</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">624,471</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">On July 29, 2024, the director resigned from the board of directors.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_021"></span>Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Authorized for Issuance under Share-Based Compensation Plans</i></b><i> </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Equity Compensation Plan Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The following
table sets forth, as of December 31, 2024, information regarding awards previously granted and outstanding, and securities authorized
for future issuance, under the Company&#8217;s equity compensation plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Plan Category</b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Number of Securities
to be Issued Upon Exercise of Outstanding Options, Warrants or Rights</b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Weighted-Average
Exercise Price of Outstanding Options, Warrants or Rights</b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Outstanding Options, Warrants, or Rights)</b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Equity compensation plans approved by shareholders</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 14%"><p style="margin: 0">16,436</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 14%"><p style="margin: 0">49.72</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 14%"><p style="margin: 0">10,321</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Equity compensation plans not approved by
shareholders</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">-</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><b><i>Summary of Material Terms
of the 2024 Equity Incentive Plan</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The following
is a summary of the material features of the Glucotrack, Inc. 2024 Equity Incentive Plan (the &#8220;2024 Plan&#8221;), which was adopted
by the stockholders on April 26, 2024. This summary is qualified in its entirety by the full text of the 2024 Plan, a copy of which is
filed as an exhibit to this Annual Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Purpose</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The purpose
of the 2024 Plan is to provide employees, directors, and consultants with opportunities to acquire the Company&#8217;s shares, or to receive
monetary payments based on the value of such shares. Equity awards and equity-linked compensatory opportunities are intended to assist
in further aligning the interests of directors, employees, and consultants with those of our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Eligibility</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt"><span style="font-size: 10pt">Persons
eligible to participate in the 2024 Plan will be employees, directors, and consultants of the Company and its subsidiaries as selected
from time to time by the plan administrator in its discretion, including prospective officers, employees, non-employee directors and
consultants. Any awards granted to such a prospect before the individual&#8217;s start date may not become vested or exercisable, and
no shares may be issued to such individual, before the date the individual first commences performance of services with the Company.
As of the date of this Annual Report, approximately 13 individuals are eligible to participate in the 2024 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Administration</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The 2024
Plan will be administered by the Compensation Committee of our Board of Directors, our Board of Directors, or such other similar committee
pursuant to the terms of the 2024 Plan. The plan administrator, which initially will be the Compensation Committee of our Board of Directors,
will have full power to select, from among the individuals eligible for awards, the individuals to whom awards will be granted, to make
any combination of awards to participants, and to determine the specific terms and conditions of each award, subject to the provisions
of the 2024 Plan. The plan administrator may delegate to one or more officers of the Company, the authority to grant awards to individuals
who are not subject to the reporting and other provisions of Section 16 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Share Reserve</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">Up
to 26,756 shares of our Common Stock may be issued under the 2024 Plan. Following stockholder approval of the 2024 Plan, no new awards
will be made under the 2010 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Shares
issuable under the 2024 Plan may be authorized, but unissued, or reacquired shares of Common Stock. Shares underlying any awards under
the 2024 Plan that are forfeited, cancelled, held back upon exercise of an option or settlement of an award to cover the exercise price
or tax withholding satisfied without the issuance of stock or otherwise terminated (other than by exercise) will be added back to the
shares available for issuance under the 2024 Plan, although shares shall not again become available for issuance as incentive stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Annual Limitation on Awards to Non-Employee Directors</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The 2024
Plan contains a limitation whereby the value of all awards under the 2024 Plan and all other cash compensation paid by the Company to
any non-employee director may not exceed $750,000 for the first calendar year a non-employee director is initially appointed to the Company&#8217;s
Board of Directors, and $500,000 in any other calendar year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Types of Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The 2024
Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-based
awards (collectively, &#8220;awards&#8221;). Unless otherwise set forth in an individual award agreement, each award shall vest over a
three (3) year period, with one-third (1/3) of the award vesting on the first annual anniversary of the date of grant and the remaining
portion of the award vesting monthly thereafter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="text-decoration: underline">Stock Options</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The 2024 Plan permits the granting
of both options intended to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (the
&#8220;Code&#8221;) and options that do not so qualify. Options granted under the 2024 Plan will be nonqualified options if they fail
to qualify as incentive stock options or exceed the annual limit on incentive stock options. Incentive stock options may only be granted
to employees of the Company and its subsidiaries. Nonqualified options may be granted to any persons eligible to receive awards under
the 2024 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The exercise price of each option
will be determined by the plan administrator, but such exercise price may not be less than 100% of the fair market value of one share
of Common Stock on the date of grant or, in the case of an incentive stock option granted to a 10% or greater stockholder, 110% of such
share&#8217;s fair market value. The term of each option will be fixed by the plan administrator and may not exceed ten (10) years from
the date of grant (or five years for an incentive stock option granted to a 10% or greater stockholder). The plan administrator will determine
at what time or times each option may be exercised, including the ability to accelerate the vesting of such options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Upon exercise
of an option, the exercise price must be paid in full either in cash, check or, with approval of the plan administrator, by delivery (or
attestation to the ownership) of the shares of Company Common Stock that are beneficially owned by the optionee free of restrictions or
were purchased in the open market. Subject to applicable law and approval of the plan administrator, the exercise price may also be made
by means of a broker-assisted cashless exercise. In addition, the plan administrator may permit nonqualified options to be exercised using
a &#8220;net exercise&#8221; arrangement that reduces the number of shares issued to the optionee by the largest whole number of shares
with fair market value that does not exceed the aggregate exercise price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Stock Appreciation Rights. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The plan
administrator may award stock appreciation rights subject to such conditions and restrictions as it may determine. Stock appreciation
rights entitle the recipient to shares of Common Stock or cash, equal to the value of the appreciation in the Company&#8217;s stock price
over the exercise price, as set by the plan administrator. The term of each stock appreciation right will be set by the plan administrator
and may not exceed ten years from the date of grant. The plan administrator will determine at what time or times each stock appreciation
right may be exercised, including the ability to accelerate the vesting of such stock appreciation rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Restricted Stock. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">A restricted
stock award is an award of shares of Common Stock that vests in accordance with the terms and conditions established by the plan administrator.
The plan administrator will determine the persons to whom grants of restricted stock awards are made, the number of restricted shares
to be awarded, the price (if any) to be paid for the restricted shares, the time or times within which awards of restricted stock may
be subject to forfeiture, the vesting schedule and rights to acceleration thereof, and all other terms and conditions of restricted stock
awards. Unless otherwise provided in the applicable award agreement, a participant generally will have the rights and privileges of a
stockholder as to such restricted shares, including without limitation the right to vote such restricted shares and the right to receive
dividends, if applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Restricted Stock Units</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Restricted stock units are the
right to receive shares of Common Stock at a future date in accordance with the terms of such grant upon the attainment of certain conditions
specified by the plan administrator. Restrictions or conditions could include, but are not limited to, the attainment of performance goals,
continuous service with the Company or its subsidiaries, the passage of time or other restrictions or conditions. The plan administrator
determines the persons to whom grants of restricted stock units are made, the number of restricted stock units to be awarded, the time
or times within which awards of restricted stock units may be subject to forfeiture, the vesting schedule, and rights to acceleration
thereof, and all other terms and conditions of the restricted stock unit awards. The value of the restricted stock units may be paid in
shares of Common Stock, cash, other securities, other property, or a combination of the foregoing, as determined by the plan administrator.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The holders
of restricted stock units will have no voting rights. Prior to settlement or forfeiture, restricted stock units awarded under the 2024
Plan may, at the plan administrator&#8217;s discretion, provide for a right to dividend equivalents. Such right entitles the holder to
be credited with an amount equal to all dividends paid on one share of Common Stock while each restricted stock unit is outstanding. Dividend
equivalents may be converted into additional restricted stock units. Settlement of dividend equivalents may be made in the form of cash,
shares of Common Stock, other securities, other property, or a combination of the foregoing. Prior to distribution, any dividend equivalents
shall be subject to the same conditions and restrictions as the restricted stock units to which they are payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Other Stock-Based Awards</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Other stock-based
awards may be granted either alone, in addition to, or in tandem with, other awards granted under the 2024 Plan and/or cash awards made
outside of the 2024 Plan. The plan administrator shall have authority to determine the persons to whom and the time or times at which
other stock-based awards will be made, the amount of such other stock-based awards, and all other conditions, including any dividend and/or
voting rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Repricing</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The 2024
Plan authorizes the plan administrator to take the following repricing actions without stockholder approval: (i) modify the purchase price
or the exercise price of any outstanding award or (ii) cancel any award in exchange for cash or another award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Tax Withholding</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Participants
in the 2024 Plan are responsible for the payment of any federal, state, or local taxes that the Company or its subsidiaries are required
by law to withhold upon the exercise of options or stock appreciation rights or vesting of other awards. The plan administrator may cause
any tax withholding obligation of the Company or its subsidiaries to be satisfied, in whole or in part, by the applicable entity withholding
from the shares of Common Stock to be issued pursuant to an award a number of shares with an aggregate fair market value that would satisfy
the withholding amount due. The plan administrator may also require any tax withholding obligation of the Company or its subsidiaries
to be satisfied, in whole or in part, by an arrangement whereby a certain number of shares issued pursuant to any award are immediately
sold and proceeds from such sale are remitted to the Company or its subsidiaries in an amount that would satisfy the withholding amount
due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Equitable Adjustments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">In the
event of a merger, consolidation, recapitalization, stock split, reverse stock split, reorganization, split-up, spin-off, combination,
repurchase or other change in corporate structure affecting shares of Common Stock, the maximum number and kind of shares reserved for
issuance or with respect to which awards may be granted under the 2024 Plan will be adjusted to reflect such event, and the plan administrator
will make such adjustments as it deems appropriate and equitable in the number, kind, and exercise price of shares of Common Stock covered
by outstanding awards made under the 2024 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Change in Control</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">In the
event of any proposed change in control (as defined in the 2024 Plan), the plan administrator will take any action as it deems appropriate,
which action may include, without limitation, the following: (i) the continuation of any award, if the Company is the surviving corporation;
(ii) the assumption of any award by the surviving corporation or its parent or subsidiary; (iii) the substitution by the surviving corporation
or its parent or subsidiary of equivalent awards; (iv) accelerated vesting of the award, with all performance objectives and other vesting
criteria deemed achieved at targeted levels, and a limited period during which to exercise the award prior to closing of the change in
control, or (v) settlement of any award for the change in control price (less, to the extent applicable, the per share exercise price).
Unless determined otherwise by the plan administrator, in the event that the successor corporation refuses to assume or substitute for
the award, a participant shall fully vest in and have the right to exercise the award as to all shares of Common Stock, including those
that would not otherwise be vested or exercisable, all applicable restrictions will lapse, and all performance objectives and other vesting
criteria will be deemed achieved at targeted levels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Transferability of Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Unless
determined otherwise by the plan administrator, an award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of
in any manner, except to a participant&#8217;s estate or legal representative, and may be exercised, during the lifetime of the participant,
only by the participant. If the plan administrator makes an award transferable, such award will contain such additional terms and conditions
as the plan administrator deems appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Term</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The 2024
Plan became effective when approved by our shareholders, and, unless terminated earlier, the 2024 Plan will continue in effect for a term
of ten (10) years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Amendment and Termination</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Our Board
may amend or terminate the 2024 Plan at any time. Any such termination will not affect outstanding awards. No amendment or termination
of the 2024 Plan will materially impair the rights of any participant, unless mutually agreed otherwise between the participant and the
Company. Approval of the stockholders shall be required for any amendment, where required by applicable law, as well as (i) to increase
the number of shares available for issuance under the 2024 Plan and (ii) to change the persons or class of persons eligible to receive
awards under the 2024 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Recoupment Policy</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">All awards
granted under the 2024 Plan, all amounts paid under the 2024 Plan, and all shares of Common Stock issued under the 2024 Plan shall be
subject to reduction, recoupment, clawback, or recovery by the Company in accordance with applicable laws and with Company policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Form S-8</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The Company
intends to file with the SEC a registration statement on Form S-8 covering the shares of Common Stock issuable under the 2024 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Material United States Federal Income Tax Considerations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The following
is a general summary under current law of the material U.S. federal income tax considerations related to awards and certain transactions
under the 2024 Plan, based upon the current provisions of the Code and regulations promulgated thereunder. This summary deals with the
general federal income tax principles that apply and is provided only for general information. It does not describe all federal tax consequences
under the 2024 Plan, nor does it describe state, local, or foreign income tax consequences or federal employment tax consequences. The
rules governing the tax treatment of such awards are quite technical, so the following discussion of tax consequences is necessarily general
in nature and is not complete. In addition, statutory provisions are subject to change, as are their interpretations, and their application
may vary in individual circumstances. This summary is not intended as tax advice to participants, who should consult their own tax advisors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The 2024
Plan is not qualified under the provisions of Section 401(a) of the Code and is not subject to any of the provisions of the Employee Retirement
Income Security Act of 1974, as amended. The Company&#8217;s ability to realize the benefit of any tax deductions described below depends
on the Company&#8217;s generation of taxable income as well as the requirement of reasonableness and the satisfaction of the Company&#8217;s
tax reporting obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Incentive Stock Options</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">No taxable
income is generally realized by the optionee upon the grant or exercise of an incentive stock option. If shares of Common Stock issued
to an optionee pursuant to the exercise of an incentive stock option are sold or transferred after two years from the date of grant and
after one year from the date of exercise, then generally (i) upon sale of such shares, any amount realized in excess of the option exercise
price (the amount paid for the shares) will be taxed to the optionee as a long-term capital gain, and any loss sustained will be a long-term
capital loss, and (ii) neither the Company nor its subsidiaries will be entitled to any deduction for federal income tax purposes; provided
that such incentive stock option otherwise meets all of the technical requirements of an incentive stock option. The exercise of an incentive
stock option will give rise to an item of tax preference that may result in alternative minimum tax liability for the optionee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">If the
shares of Common Stock acquired upon the exercise of an incentive stock option are disposed of prior to the expiration of the two-year
and one-year holding periods described above (a &#8220;disqualifying disposition&#8221;), generally (i) the optionee will realize ordinary
income in the year of disposition in an amount equal to the excess (if any) of the fair market value of the shares of Common Stock at
exercise (or, if less, the amount realized on a sale of such shares of Common Stock) over the option exercise price thereof, and (ii)
the Company or its subsidiaries will be entitled to deduct such amount. Special rules will apply where all or a portion of the exercise
price of the incentive stock option is paid by tendering shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">If an incentive
stock option is exercised at a time when it no longer qualifies for the tax treatment described above, the option is treated as a nonqualified
option. Generally, an incentive stock option will not be eligible for the tax treatment described above if it is exercised more than three
months following termination of employment (or one year in the case of termination of employment by reason of disability). In the case
of termination of employment by reason of death, the three-month rule does not apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Nonqualified Options</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">No income
is generally realized by the optionee at the time a nonqualified option is granted. Generally, (i) at exercise, ordinary income is realized
by the optionee in an amount equal to the difference between the option exercise price and the fair market value of the shares of Common
Stock issued on the date of exercise, and the Company or its subsidiaries receive a tax deduction for the same amount, and (ii) at disposition,
appreciation or depreciation after the date of exercise is treated as either short-term or long-term capital gain or loss depending on
how long the shares of Common Stock have been held. Special rules will apply where all or a portion of the exercise price of the nonqualified
option is paid by tendering shares of Common Stock. Upon exercise, the optionee will also be subject to Social Security taxes on the excess
of the fair market value of the shares of Common Stock over the exercise price of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="text-decoration: underline">Stock Appreciation Rights,
Restricted Stock, Restricted Stock Units, and Other Stock-Based Awards</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The current
federal income tax consequences of other awards authorized under the 2024 Plan generally follow certain basic patterns: (i) stock appreciation
rights are taxed and deductible in substantially the same manner as nonqualified options; (ii) nontransferable restricted stock subject
to a substantial risk of forfeiture results in income recognition equal to the excess of the fair market value of the shares of Common
Stock over the price paid, if any, only at the time the restrictions lapse (unless the recipient elects to accelerate recognition as of
the date of grant through a Section 83(b) election); and (iii) restricted stock units, dividend equivalents, and other stock or cash based
awards are generally subject to tax at the time of payment. The Company or its subsidiaries generally should be entitled to a federal
income tax deduction in an amount equal to the ordinary income recognized by the participant at the time the participant recognizes such
income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The participant&#8217;s
basis for the determination of gain or loss upon the subsequent disposition of shares of Common Stock acquired from a stock appreciation
right, restricted stock, restricted stock unit, or other stock-based award will be the amount paid for such shares plus any ordinary income
recognized when the shares were originally delivered, and the participant&#8217;s capital gain holding period for those shares will begin
on the day after they are transferred to the participant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Parachute Payments</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">The vesting
of any portion of an award that is accelerated due to the occurrence of a change in control (such as a sale event) may cause all or a
portion of the payments with respect to such accelerated awards to be treated as &#8220;parachute payments&#8221; as defined in the Code.
Any such parachute payments may be non-deductible to either the Company or its subsidiaries, in whole or in part, and may subject the
recipient to a non-deductible 20% federal excise tax on all or a portion of such payment (in addition to other taxes ordinarily payable).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="text-decoration: underline">Section 409A</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The foregoing description assumes that Section 409A of the Code does not
apply to an award under the 2024 Plan. In general, stock options and stock appreciation rights are exempt from Section 409A if the exercise
price per share is at least equal to the fair market value per share of the underlying stock at the time the option or stock appreciation
right was granted. Restricted stock awards are not generally subject to Section 409A. Restricted stock units are subject to Section 409A
unless they are settled within two and one-half months after the end of the later of (1) the end of the Company&#8217;s fiscal year in
which vesting occurs or (2) the end of the calendar year in which vesting occurs. If an award is subject to Section 409A and the provisions
for the exercise or settlement of that award do not comply with Section 409A, then the participant would be required to recognize ordinary
income whenever a portion of the award vested (regardless of whether it had been exercised or settled). This amount would also be subject
to a 20% federal tax and premium interest in addition to the federal income tax at the participant&#8217;s usual marginal rate for ordinary
income.</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Security
Ownership of Certain Beneficial Owners and Management </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding the beneficial ownership of our common stock as of March 31, 2025, or the Evaluation Date,
by: (i) each of our current directors, (ii) each of our named executive officers as set forth in Item 11 of this Annual Report, (iii)
all such directors and executive officers as a group and (iv) our five percent or greater stockholders. The table is based upon information
supplied by our officers, directors and principal stockholders and a review of Schedules 13D and 13G, if any, filed with the SEC. Unless
otherwise indicated in the footnotes to the table and subject to community property laws where applicable, we believe that each of the
stockholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
percentages are based on 25,585,853 shares outstanding as of the Evaluation Date, adjusted as required by rules promulgated by the SEC.
These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power
with respect to those securities. In addition, the rules include shares of our common stock issuable pursuant to the exercise of stock
options or warrants or settlement of shares issued for services that are either immediately exercisable or exercisable within 60 days
of the Evaluation Date. These shares are deemed to be outstanding and beneficially owned by the person holding those securities for the
purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the
percentage ownership of any other person. Unless otherwise noted, the business address of each of the following entities or individuals
is 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name of Beneficial Owner</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficially</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Named Executive Officers</i> <span style="font-style: normal">and Directors</span></b></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Paul V. Goode</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">27,662</td><td style="width: 1%; text-align: left">(1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Peter C. Wulff</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">* </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Luis Malave</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,502</td><td style="text-align: left">(2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Erin Carter</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,710</td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dr. Robert Fischell</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,077</td><td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">* </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Andrew K. Balo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,490</td><td style="text-align: left">(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">* </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Allen Danzig</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,922</td><td style="text-align: left">(6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">John A. Ballantyne</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,121,871</td><td style="text-align: left">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.02</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">All of our named executive officers and directors as a group (8 individuals)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,356,234</td><td style="text-align: left">(8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.91</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">5% or Greater Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">John A. Ballantyne Rev Trust 08/01/2017</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,117,745</td><td style="text-align: left">(9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.82</td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates less than one
    percent of the outstanding shares of the Company&#8217;s common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 3,277 shares
    of common stock subject to options currently exercisable or exercisable within 60 days of the Evaluation Date, (ii) 2,896 warrants
    currently exercisable, (iii) 2,500 shares earned under the IP Purchase Agreement and issuable within 60 days of the Evaluation Date
    and (iv) 18,989 shares of common stock held directly by Mr. Goode.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 6,886 warrants
    currently exercisable, (ii) 2,076 unissued shares earned in connection with Board service and issuable within 60 days of the Evaluation
    Date and (iii) 141,540 shares of common stock held directly by Mr. Malave.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 2,078 warrants
    currently exercisable, (ii) 1,896 unissued shares earned in connection with Board service and issuable within 60 days of the Evaluation
    Date and (iii) 43,736 shares of common stock held directly by Ms. Carter.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 32 shares
    of common stock subject to options currently exercisable or exercisable within 60 days of the Evaluation Date, (ii) 1,498 unissued
    shares earned in connection with Board service and issuable within 60 days of the Evaluation Date and (iii) 547 shares of common
    stock held directly by Dr. Fischell.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 4,490 unissued
    shares earned in connection with Board service and issuable within 60 days of the Evaluation Date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 1,498 unissued
    shares earned in connection with Board service and issuable within 60 days of the Evaluation Date and (ii) 424 shares of common stock
    held directly by Mr. Danzig.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 4,126 unissued
    shares earned in connection with Board service and issuable within 60 days of the Evaluation Date, (ii) 2,743,591 shares owned by
    the John A. Ballantyne Revocable Trust 08/01/2017, and (iii) 374,154 warrants currently exercisable and owned by John A. Ballantyne
    Revocable Trust 08/01/2017. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) an aggregate
    of 3,309 shares of common stock subject to options currently exercisable or exercisable within 60 days of the Evaluation Date, (ii)
    386,014 warrants currently exercisable, (iii) 15,584 unissued shares earned in connection with Board service and issuable within
    60 days of the Evaluation Date, (iv) 2,500 shares earned under the IP Purchase Agreement and issuable within 60 days of the Evaluation
    Date and (v) 2,948,827 shares of common stock, held by all directors and executive officers as a group.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    2,743,591 shares owned by the John A. Ballantyne Revocable Trust 08/01/2017 and 374,154 warrants currently exercisable and
    owned by John A. Ballantyne Revocable Trust 08/01/2017. The address of John A. Ballantyne Rev Trust 08/01/2017 is 7410 Claire Drive
    South, Fargo ND 58104. John A. Ballantyne has voting and investment control over the shares held by John A. Ballantyne Rev Trust
    08/01/2017.</span></p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Changes in Control</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Management of the Company knows of no arrangements, including any pledge
by any person or securities of the Company, the operation of which may at a subsequent date result in a change in control of the registrant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_022"></span>Item
13. Certain Relationships and Related Transactions, and Director Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as listed below, during 2024 and 2023, we were not a participant in any transaction or series of transactions in which the amount
involved did exceed or may exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for 2024 and 2023 in which
any directors, director nominees, executive officers, greater than 5% beneficial owners and their respective immediate family members
(each, a &#8220;Related Person&#8221;) had or will have a direct or indirect material interest, other than the compensation arrangements
(including with respect to equity compensation) described in &#8220;<i>Executive Compensation</i>&#8221; beginning on page 50
and &#8220;<i>Director Compensation</i>&#8221; on page 51.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to ensure that in accordance with the Audit Committee charter, that the Audit Committee shall conduct reasonable prior review
and oversight of all related party transaction for potential conflicts of interest, except for transactions involving the compensation
of executive officers or directors, which shall be overseen by the compensation committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance
Under IP Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2022, the Company entered into the IP Purchase Agreement with
Paul Goode, which is the Company&#8217;s Chief Executive Officer, pursuant to which Dr. Goode sold, assigned, transferred, conveyed and
delivered to the Company the
Purchased Assets: (a) the Conveyed Intellectual Property and (b) all the goodwill relating to the Purchased Assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the sale by Dr. Goode of the Purchased Assets to the Company, the Company paid to Dr. Goode cash in the amount of one
dollar and became obligated to issue up to 10,000 shares of Common Stock based upon specified performance milestones as set forth in
the IP Purchase Agreement. In addition, if upon the final issuance of Common Stock under the IP Purchase
Agreement, the aggregate 10,000 shares represent less than 1.5% of the then outstanding Common Stock of the Company, the final issuance
will include such number of additional shares so that the total aggregate issuance equals 1.5% of the outstanding shares (the &#8220;True-Up
Shares&#8221;) of Common Stock of the Company. All shares of Common Stock to be issued under the IP Purchase Agreement shall be (i) restricted
over a limited period as defined in the IP Purchase Agreement and issued in transactions exempt from registration under Section 4(a)(2)
of the Securities Act of 1933, as amended and (ii) subject to the lockup provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, 1,000 shares of Common Stock were earned under the terms of the IP Purchase Agreement and were issued to Dr.
Goode on February 6, 2024. On May 1, 2024, 1,500 shares of Common Stock were earned under the terms of the IP Purchase Agreement. On March 26, 2025, the Board determined that the third milestone was met and that an additional 2,500 shares of Common
Stock have been earned under the terms of the IP Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>April
Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2024, the Company entered into a private placement agreement under which the Company issued 3,969 shares of its Common Stock
at a price of $126.0 per share for aggregate gross proceeds of $500. The Offering included participation of certain members of the Company&#8217;s
executive management, Board of Directors and existing shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 27 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2024, the Company entered into note and warrant purchase agreements with certain officers, directors, and existing investors
(the &#8220;June 27 Investors&#8221;), providing for the private placement of unsecured promissory notes in the aggregate principal amount
of $100,000 (the &#8220;June 27 Notes&#8221;) and warrants (the &#8220;June 27 Warrants&#8221;) to purchase up to an aggregate of 15,000
shares of Common Stock. The closing of the private placement occurred on June 27, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 27 Notes bore simple interest at the rate of three percent (3%) per annum and were due and payable in cash on the earlier of: (a)
twelve (12) months from the date of the June 27 Note; or (b) the date the Company raised third-party equity capital in an amount equal
to or in excess of $1,000,000 (the &#8220;June 27 Maturity Date&#8221;). The Company could prepay the June 27 Notes at any time prior to
the June 27 Maturity Date without penalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
June 27 Warrant has an exercise price of $99.0 per share. The June 27 Warrants are immediately exercisable and have a five-year term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
18 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2024, the Company entered into a series of convertible promissory notes with the July
18 Investors, providing for the private placement of unsecured convertible promissory notes in the aggregate principal amount
of $360,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
July 18 Notes bore simple interest at the rate of eight percent (8%) per annum and were due and payable in cash on the earlier of: (a)
the twelve (12) month anniversary of the July 18 Note, or (b) the date of closing of a Qualified Financing (defined below) (the &#8220;July
18 Maturity Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
with regard to conversion of the July 18 Notes as discussed below, the Company could not prepay the July 18 Notes without the written
consent of the holder. If not sooner repaid, all outstanding principal and accrued but unpaid interest on the July 18 Notes (the &#8220;Note
Balance&#8221;), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of
capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to
the Company of at least $500,000 (excluding indebtedness converted in such financing) (a &#8220;Qualified Financing&#8221;), would automatically
be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares
calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in
such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion
price per share shall not be lower than $31.20 (the &#8220;Floor Price&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
30 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, the Company entered into the July 30 Notes and the July
30 Warrants with the July 30 Holder, providing for the private placement of a secured convertible promissory note in the aggregate principal
amount of 4,000,000. The July 30 Note was not convertible until and Stockholder Approval was obtained, which occurred on  September
26, 2024. The July 30 Note bore simple interest at the rate of eight percent (8%) per annum and was due and payable in cash on the July
30 Maturity Date. The July 30 Note was secured by a first-priority security interest on all Company assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
with regard to conversion of the July 30 Note or a Sale Transaction as discussed below, the Company could not prepay the July 30 Notes
without the written consent of the July 30 Holder. The July 30 Note (i) was convertible at the discretion of the July 30 Holder at a
price equal to the closing price of the Common Stock on the date of conversion and, (ii) if the closing price of the Common Stock exceeds
$100.00 per share for a period of five (5) consecutive trading days, would automatically convert at a price equal to the five-day (5)
VWAP (subject to adjustment for any stock split, stock dividend, reverse stock split, combination or similar transaction). &#8220;VWAP&#8221;
means the daily volume weighted average price of the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a Sale Transaction on or prior to the Maturity Date, the Company would repay the July 30 Holder, at the July 30 Holder&#8217;s
election, as follows: (a) cash equal to 200% of the Note balance, or (b) transaction consideration in the amount to be received by the
July 30 Holder in such Sale Transaction if the July 30 Note was converted pursuant to an optional conversion. &#8220;Sale Transaction&#8221;
means a merger or consolidation of the Company with or into any other entity, or a sale of all or substantially all of the assets of
the Company, or any other transaction or series of related transactions in which the Company&#8217;s stockholders immediately prior to
such transaction(s) receive cash, securities or other property in exchange for their shares and, immediately after such transaction(s),
own less than 50% of the equity securities of the surviving corporation or its parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
July 30 Warrant becomes exercisable 12 months after its issuance and has term of 10 years. The July 30 Warrants are exercisable for cash
only and have no price-based antidilution. The first July 30 Warrant is for 106,667 shares at $37.50 per share. The second July 30 Warrant
is for 76,191 shares at $52.50 per share. The third July 30 Warrant is for 59,260 shares at $67.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concurrent
Private Offering</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the Concurrent Private Offering,
the July 30 Holder, which is an existing investor controlled by a director of the Company, converted the July 30 Note Debt, equaling approximately $4,093,112 of debt, which represented the then outstanding principal and accrued interest
under the July 30 Note. The
July 30 Note Debt was converted to Common Stock and Common Warrants on substantially the same terms as the November 2024 Offering, resulting
in the issuance of 132,036 shares of Common Stock, 132,036 accompanying Series A Common Warrants, and 132,036 accompanying Series B Common
Warrants, based on a conversion price of $31.0 per share, which is equal to the consolidated closing bid price of the Common Stock on
the Nasdaq Capital Market on November 12, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
18 Note Conversion</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, concurrently with the November 2024 Offering, the Company converted on substantially the same terms as the November Offering,
the three outstanding July 18 Notes, with an aggregate outstanding principal and accrued interest in the amount of $304,494. As previously
disclosed in the Form 8-K filed by the Company with the SEC on July 22, 2024, that disclosed the entry into the July 18 Notes, the July
18 Notes were to automatically convert upon a Qualified Financing, into a number of equity securities of the Company sold in the Qualified
Financing, equal to a number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other
unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified
Financing, provided that the conversion price per share shall not be lower than the Floor Price. The three outstanding July 18 Notes
automatically converted in connection with the closing of the November 2024 Offering at a conversion price of $31.20, which is equal
to the Floor Price as defined in the July 18 Notes, for an aggregate of 9,760 shares of Common Stock, 9,760 Series A Common Warrants,
and 9,760 Series B Common Warrants (the &#8220;July 18 Note Conversion&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_023"></span>Item
14. Principal Accountant Fees and Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.25in; margin-bottom: 0pt">Fahn Kanne
&amp; Co. Grant Thornton Israel has served as the independent registered public accounting firm for the Company for 2024 and 2023. The
following table sets forth the fees billed to the Company by Fahn Kanne &amp; Co. Grant Thornton Israel for 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>(in thousands)</i></p></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Audit Fees (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><p style="margin: 0">113,152</p></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><p style="margin: 0">145,000</p></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">71,000</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">All Other Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0">184,152</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">145,000</p></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">(1) Represents,
for each year, fees for services related to the Company&#8217;s annual financial statement audit and quarterly reviews.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Under its charter, the Company&#8217;s Audit Committee must review and
pre-approve both audit and permitted non-audit services provided by the Company&#8217;s independent registered public accounting firm
and shall not engage the independent registered public accounting firm to perform any non-audit services prohibited by law or regulation.
The independent registered public accounting firm&#8217;s retention to audit the Company&#8217;s financial statements, including the associated
fee, is subject to approval each year by the Audit Committee. The Audit Committee does not regularly evaluate potential engagements of
the independent registered public accounting firm and approve or reject such potential engagements. At each Audit Committee meeting, the
Audit Committee receives updates on the services actually provided by the independent registered public accounting firm, and management
may present additional services for pre-approval.</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_024"></span>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_025"></span>Item
15. Exhibits and Financial Statement Schedules </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Documents filed as part of this Annual Report</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
All financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 95%"><a href="#ar_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report of Independent Registered Public Accounting Firm*</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#ar_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#ar_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations for the Years Ended December 31, 2024, 2023, and 2022</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#ar_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Changes in Stockholders&#8217; Equity for the Years Ended December 31, 2024, 2023, and 2022</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#ar_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023, and 2022</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#ar_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Fahn Kanne &amp; Co., PCAOB Firm ID No. 1375<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Financial Statement Schedules</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial statement schedules are omitted because they are either inapplicable or not required, or because the required information is
included in the Consolidated Financial Statements or notes thereto contained in this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Exhibits required by Item 601 of Regulation S-K</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are filed as exhibits to this registration statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    of Exhibit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex2-1.htm" style="-sec-extract: exhibit">Merger Agreement and Plan of Reorganization, dated as of May 25, 2010, by and among Integrity Applications, Inc., Integrity Acquisition Ltd. and A.D. Integrity Applications Ltd. (incorporated by reference to Exhibit 2.1 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-1.htm" style="-sec-extract: exhibit">Certificate of Incorporation of Integrity Applications, Inc. (incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-2.htm" style="-sec-extract: exhibit">Certificate of Amendment to Certificate of Incorporation of Integrity Applications, Inc. (incorporated by reference to Exhibit 3.2 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-3.htm" style="-sec-extract: exhibit">Bylaws of Integrity Applications, Inc. (incorporated by reference to Exhibit 3.3 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315220006997/ex99-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to Certificate of Incorporation of Integrity Applications, Inc. (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K filed by Integrity Applications, Inc. on April 23, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315222008417/ex3-7.htm" style="-sec-extract: exhibit">Amendments to The Company&#8217;s Certificate of Incorporation (incorporated by reference to Exhibit 3.5 to the Annual Report on Form 10-K filed by Glucotrack, Inc. on March 28, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224024427/ex3-01.htm" style="-sec-extract: exhibit">First Amendment to Bylaws dated June 14, 2024 (incorporated by reference to Exhibit 3.01 to the Current Report on Form 8-K filed by Glucotrack, Inc. on June 20, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224020548/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on May 17, 2024 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on May 20, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315225001222/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment of Certificate of Incorporation of Glucotrack, Inc., dated January 3, 2025 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on January 7, 2025)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315225004793/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on February 3, 2025 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on February 4, 2025)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Description of Registrant&#8217;s Securities</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex4-1.htm" style="-sec-extract: exhibit">Specimen Certificate Evidencing Shares of Common Stock (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224025858/ex4-1.htm" style="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on July 1, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224029775/ex10-2.htm" style="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by Glucotrack, Inc. on July 31, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224045979/ex4-3.htm" style="-sec-extract: exhibit">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.3 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 14, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224045979/ex4-1.htm" style="-sec-extract: exhibit">Form of Series A Common Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 14, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224045979/ex4-2.htm" style="-sec-extract: exhibit">Form of Series B Common Warrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 14, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex10-1.htm" style="-sec-extract: exhibit">Integrity Applications, Inc. 2010 Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000117891316004823/exhibit_10-3.htm" style="-sec-extract: exhibit">Amendment No. 1 to Integrity Applications, Inc. 2010 Incentive Compensation Plan (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed by Integrity Applications, Inc. on March 23, 2016)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000117891317001119/exhibit_10-4.htm" style="-sec-extract: exhibit">Amendment No. 2 to Integrity Applications, Inc. 2010 Incentive Compensation Plan (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed by Integrity Applications, Inc. on April 13, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex10-14.htm" style="-sec-extract: exhibit">Form of Stock Option Agreement (incorporated by reference to Exhibit 10.14 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex10-15.htm" style="-sec-extract: exhibit">Form of Stock Option Agreement (ESOP) (incorporated by reference to Exhibit 10.15 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on August 22, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411062924/v240011_ex10-16.htm" style="-sec-extract: exhibit">Letter of Approval, addressed to Integrity Applications Ltd. from the Ministry of Industry, Trade and Employment of the State of Israel (incorporated by reference to Exhibit 10.16 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on November 10, 2011)</a></span></td></tr>
</table>

<p style="margin: 0">&#160;&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000114420411056920/v236650_ex10-17.htm" style="-sec-extract: exhibit">Letter of Undertaking, addressed to the Ministry of Industry, Trade and Employment of the State of Israel - Office of the Chief Scientist from Integrity Applications Ltd. (incorporated by reference to Exhibit 10.17 to the Registration Statement on Form S-1 filed by Integrity Applications, Inc. on November 10, 2011)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315223037074/ex10-1.htm" style="-sec-extract: exhibit">Consulting Agreement, dated October 11, 2023, by and between GlucoTrack, Inc. and James S. Cardwell (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on October 12, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224007006/ex10-1.htm" style="-sec-extract: exhibit">Form of Exchange Agreement, dated February 13, 2024, by and among GlucoTrack, Inc. and certain holders thereof (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on February 16, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement, dated October 19, 2021, by and between Integrity Applications, Inc. and Paul V. Goode (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Integrity Applications, Inc. on October 25, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement, dated January 29, 2025, by and between Glucotrack, Inc. and Peter Wulff (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on January 29, 2025)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224025858/ex10-1.htm" style="-sec-extract: exhibit">Form of Note and Warrant Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on July 1, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224025858/ex10-2.htm" style="-sec-extract: exhibit">Form of Promissory Note (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by Glucotrack, Inc. on July 1, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224028635/ex10-1.htm" style="-sec-extract: exhibit">Form of Convertible Promissory Note (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on July 22, 2024)</a></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224029775/ex10-1.htm" style="-sec-extract: exhibit">Form of Convertible Promissory Note (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on July 31, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224045979/ex10-1.htm" style="-sec-extract: exhibit">Placement Agent Agreement, dated November 13, 2024, between the Company and Dawson James Securities, Inc. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 14, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224045979/ex10-2.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 14, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224012324/formdef14a.htm" style="-sec-extract: exhibit">Glucotrack, Inc. 2024 Equity Incentive Plan (incorporated by reference to Appendix A of Glucotrack, Inc.&#8217;s DEF 14A filed with the Commission on April 1, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224045979/ex10-3.htm" style="-sec-extract: exhibit">Form of Lock-up Agreement (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 14, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224045979/ex10-4.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated November 13, 2024, by and between the Company and John A. Ballantyne Revocable Trust DTD 8/1/2017 (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 14, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224046564/ex10-1.htm" style="-sec-extract: exhibit">Form of Support Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on November 18, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224050462/ex1-1.htm" style="-sec-extract: exhibit">At-the-Market Sales Agreement, dated December 17, 2024, by and between Glucotrack, Inc. and Dawson James Securities, Inc. (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed by Glucotrack, Inc. on December 17, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224011765/ex19.htm" style="-sec-extract: exhibit">Insider Trading Policies and Procedures, adopted March 22, 2024 (incorporated by reference to Exhibit 19 to the Annual Report on Form 10-K filed by Glucotrack, Inc. on March 28, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex21-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries of the Registrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex23-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Fahn Kanne &amp; Co., an Independent Public Accounting Firm</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506983/000149315224011765/ex97-1.htm" style="-sec-extract: exhibit">Policy Related to Recovery of Erroneously Awarded Compensation, adopted November 30, 2023 (incorporated by reference to Exhibit 97.1 to the Annual Report on Form 10-K filed by Glucotrack, Inc. on March 28, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Certification of Principal Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-2.htm">Certification of Principal Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-2.htm">Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Ethics</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document - the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded
    within the Inline XBRL document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+
Denotes a management contract or compensatory plan or arrangement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Filed or furnished herewith</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;
Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant
agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_027"></span>Item
16. Form 10-K Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contents
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt"><a href="#ar_006">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Fahn Kanne &amp; Co., PCAOB Firm ID No. <span id="xdx_904_edei--AuditorFirmId_c20240101__20241231_zmsFh85Xvmka"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000074" name="dei:AuditorFirmId">1375</ix:nonNumeric></span>)</a></span></td>
    <td style="width: 0.5in"><span style="font-size: 10pt">F-2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt"><b>Consolidated Financial Statements</b></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt"><a href="#ar_001">Consolidated Balance Sheets as of December 31, 2024 and 2023</a></span></td>
    <td><span style="font-size: 10pt">F-4</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt"><a href="#ar_002">Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023</a></span></td>
    <td><span style="font-size: 10pt">F-5 </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt"><a href="#ar_003">Consolidated Statements of Changes in Stockholders&#8217; Equity for the Years Ended December 31, 2024 and 2023</a></span></td>
    <td><span style="font-size: 10pt">F-6 </span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt"><a href="#ar_004">Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023</a></span></td>
    <td><span style="font-size: 10pt">F-7 </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt"><a href="#ar_005">Notes to Consolidated Financial Statements</a></span></td>
    <td><span style="font-size: 10pt">F-8 </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 64; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_006"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fahn
    Kanne &amp; Co.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
    Office</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32
    Hamasger Street</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel-Aviv
    6721118, ISRAEL</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PO
    Box 36172, 6136101</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T
    +972 3 7106666</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F
    +972 3 7106660</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.gtfk.co.il</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of Directors and the Stockholders of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLUCOTRACK
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the financial statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--AuditorOpinionTextBlock_c20240101__20241231_zOlMTUkqQq1h"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000075" name="dei:AuditorOpinionTextBlock">We
have audited the accompanying consolidated balance sheets of Glucotrack Inc. a Delaware corporation (the &#8220;Company&#8221;) as
of December 31, 2024, and 2023, the related consolidated statements of operations and comprehensive loss, changes in
stockholders&#8217; equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes
(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023, and
the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with
accounting principles generally accepted in the United States of America</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As
discussed in Note 1B to the consolidated financial statements, the Company has incurred operating losses and negative cash flows from its
operations and comprehensive loss since its inception and as of December 31, 2024, there is an accumulated deficit of $132,450.
These conditions, along with other matters as set forth in Note 1B, raise substantial doubt about the Company&#8217;s ability to
continue as a going concern. Management&#8217;s plans regarding these matters are also described in Note 1B. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an
opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered
with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that
were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material
to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication
of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are
not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or
disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>The accounting and valuation of warrant derivative
liability</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As described further in Notes 4F, 4G and 4J to the
consolidated financial statements, the Series A warrants, and Series B warrants issued by the Company in November 2024, as part of a package
issuance (hereinafter &#8211; &#8220;the Warrants&#8221;), include certain features that management has determined to preclude such financial
instruments from being considered as indexed to the company&#8217;s own stock and accordingly, the Warrants are accounted for as warrant
derivative liability. In evaluating whether the Warrants are deemed indexed to the company&#8217;s own equity, the management used the
assistance of a third-party accounting expert. The Warrants were recognized upon initial recognition and on each reporting date at fair
value with changes in fair value reported in earnings. As the Warrants are not traded on a public exchange, the Company is required to
estimate their fair value based on a valuation technique.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Upon initial recognition and at each reporting date,
management, with the assistance of a third-party appraiser, performs a fair value measurement using option pricing model with inputs that
include the exercise price, share prices risk-free interest rates, term to expiration and volatility. Because certain inputs used to determine
the fair value of option contracts are unobservable (principally implied volatility) and require the management to use Judgments and assumptions,
the Company has categorized the warrant derivative liability as Level 3 fair value measure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On December 31, 2024, the fair value of the Company&#8217;s warrant derivative liability was $17,421 thousands and, in the year, ended
December 31, 2024, the company recognized loss from changes in fair value in earnings in the amount of $798 thousands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We identified the accounting and the valuation of the Warrants as a critical audit matter. The principal considerations for our determination
that the accounting and the valuation of the Warrants is a critical audit matter are due to the high degree of auditor judgment, effort
and subjectivity in performing procedures and evaluating management&#8217;s accounting analysis and the estimates and assumptions. Given
the complexity of the accounting of financial instruments involved, the subjective nature and judgment applied by management, auditing
these accounting treatment and estimates required a high degree of auditor judgment and an increased extent of effort including the use
of specialists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Our audit procedures related to the accounting
and the valuation of the warrant derivative liability included the following, among others. We evaluated the appropriateness of the option
pricing model; tested the completeness, accuracy and relevance of underlying data used in the model; and evaluated the reasonableness
of significant assumptions used by management, including mainly implied volatility. Our evaluation involved evaluating whether the assumptions
used by management were reasonable. We utilized a valuation specialist and an accounting expert to assess the accounting analysis and
the appropriateness of the option pricing model used by the company and to assist us with testing the assumptions in the model.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described further in Note 1B to the consolidated financial statements, the Company has not yet generated significant revenues from
its previous product and the development and commercialization of its current product is expected to require substantial additional
expenditures. Thus, it was determined by Company&#8217;s management that the Company is dependent upon external sources for
financing its operations. As of December 31, 2024, the Company has incurred an accumulated deficit of $132,450. Furthermore, the
Company has generated recurring operating losses and negative operating cash flow. As of December 31, 2024, the remaining balance of
cash was determined by the Company&#8217;s management as insufficient for the Company to realize its business
plans for the twelve-month period subsequent to the reporting period. Accordingly, the Company&#8217;s management has determined
that these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to finance its operations through the sale of equity and/or debt securities. However, Company&#8217;s management has concluded
that such plans do not alleviate the substantial doubt regarding to the Company&#8217;s ability to continue as a going concern as it
was determined by management that there can be no assurance that the Company will succeed in obtaining the necessary financing or generating
sufficient revenues from sales of its current product in order to continue its operations as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified the assessment of the Company&#8217;s ability to continue as a going concern as a critical audit matter. The principal considerations
for our determination are due to significant judgment required by management when assessing the Company&#8217;s ability to continue as
a going concern, taking into consideration management plans, the Company&#8217;s available funds, the ability of the Company to generate
revenues from sales of its current product and the risk of bias in management&#8217;s judgments and assumptions in their determination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit procedures related to this matter included the following, among others. We reviewed and evaluated management&#8217;s plans for
dealing with the adverse effect of these conditions and events. We inquired Company management and reviewed the company records to assess
whether there are additional factors that might contribute to the uncertainties disclosed. We evaluated the reasonableness of significant
assumptions used by management in its determination. We assessed whether the Company&#8217;s determination that there is substantial
doubt about its ability to continue as a going concern was adequately disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>/s/
    <span id="xdx_908_edei--AuditorName_c20240101__20241231_zXl86RPpPpgc"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000076" name="dei:AuditorName">FAHN KANNE &amp; CO. GRANT THORNTON ISRAEL</ix:nonNumeric></span></i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified
    Public Accountants (Isr.)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have served as the Company&#8217;s auditor since 2010.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--AuditorLocation_c20240101__20241231_zYtFT1XLheW4"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000077" name="dei:AuditorLocation">Tel-Aviv,
    Israel</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_001"></span>GLUCOTRACK
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_pn3n3_zi80MNKJ8An3" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20241231_zrHfRF1P6LTc" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20231231_ziLNaPwMNhQ4" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In
                                            thousands of US dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(except
                                            stock data)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrentAbstract_iB_zhsbmrlvy5Ic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_pn3n3_maACzjly_zbgmd4xD4Mu2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash
    equivalents (Note 2D)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-12-31" id="Fact000082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,617</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,492</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherAssetsCurrent_i01I_maACzjly_zDtUkEVslYTa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other
    current assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2024-12-31" id="Fact000085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">376</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AssetsCurrent_i01TI_mtACzjly_maAznEQ_zOeA25NBY1jb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-12-31" id="Fact000088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,768</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,868</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_maAznEQ_zygCyU8SDoKe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right-of-use asset, net (Note
    6)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-12-31" id="Fact000091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0092">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAznEQ_zAhRug7keFPd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-12-31" id="Fact000094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact000095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--RestrictedCashNoncurrent_iI_pn3n3_maAznEQ_zJJaiQTfZc99" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Restricted cash (Note
    2D)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RestrictedCashNoncurrent" contextRef="AsOf2024-12-31" id="Fact000097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RestrictedCashNoncurrent" contextRef="AsOf2023-12-31" id="Fact000098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Assets_iTI_mtAznEQ_zt8xTz6YixU4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-12-31" id="Fact000100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,932</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact000101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,905</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND STOCKHOLDERS&#8217;
    (DEFICIT) EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrentAbstract_i01B_zmg8pbb2lWgk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_i02I_maLCzADQ_z19A9YXL3Cz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-12-31" id="Fact000109" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">992</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31" id="Fact000110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_pn3n3_maLCzADQ_zcFHxDzlLin5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability,
    current (Note 6)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-12-31" id="Fact000112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0113">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ConvertibleNotesPayableCurrent_i02I_pn3n3_maLCzADQ_z8cq3BbN6Qj8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible promissory
    notes (Note 4E)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2024-12-31" id="Fact000115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0116">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_i02I_maLCzADQ_zMn0m3zbuoSh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other
    current liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">252</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">673</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzADQ_maLzHRu_zQP95R3QTJb3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,275</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,512</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_z846Oawa37N" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Current Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DerivativeLiabilitiesNoncurrent_i02I_maLzHRu_znkscMI0nySb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivative financial liabilities
    (Note 4F, 4G and Note 4J)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31" id="Fact000127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,421</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0128">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_pn3n3_maLzHRu_zvGVdxC4fhq1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability,
    non-current (Note 6)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-12-31" id="Fact000130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0131">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesNoncurrent_i02I_pn3n3_maLzHRu_zZ3d7BcNGtni" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Loans
    from stockholders (Note 3)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2024-12-31" id="Fact000133" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">203</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">196</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Liabilities_i01TI_mtLzHRu_maLASEzST0_zs6LGP67mNLc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-12-31" id="Fact000136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,932</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact000137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,708</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzST0_zvTlHVLzjpl9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commitments and contingent liabilities (Note
    5)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0139">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stockholders&#8217; (Deficit) Equity (Note
    8)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Common Stock of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20241231_z4bujItD66B3" title="Common stock, par value"><span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zovDzZP6HtI3" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" id="Fact000145" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000147" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value (&#8220;Common
    Stock&#8221;):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzQML_zXLqLvYOuQ91" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20241231_z8dC7uSx3794" title="Common stock, shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zcNomrv6UYF2" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-12-31" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000154" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized as of December
    31, 2024 and 2023; <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20241231_zUdt4cTpQ3Ef" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20241231_zDZBTg7jAwp" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-12-31" id="Fact000156" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000158" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">791,609</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zs5ssDEluae4" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zWQ1FsP3dlwa" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000160" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000162" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">208,914</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2024 and 2023, respectively</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31" id="Fact000149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0150">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzQML_z1LivT26NQRf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Common Stock of $0.001 par value (&#8220;Common
    Stock&#8221;): 100,000,000 shares authorized as of December
    31, 2024 and 2023; 802,609 and 208,914 shares issued and outstanding as of December 31, 2024 and 2023, respectively</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31" id="Fact000164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0165">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--AdditionalPaidInCapitalCommonStock_i02I_maSEzQML_zP0sCyxJHNG4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2024-12-31" id="Fact000167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,229</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2023-12-31" id="Fact000168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112,986</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ReceiptsOnAccountOfShares_i02I_maSEzQML_zO90N6prVMfh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Receipts on account of shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:ReceiptsOnAccountOfShares" contextRef="AsOf2024-12-31" id="Fact000170" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:ReceiptsOnAccountOfShares" contextRef="AsOf2023-12-31" id="Fact000171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzQML_zvBz6LZiK8db" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive
    income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-12-31" id="Fact000173" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-12-31" id="Fact000174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzQML_z2v0MpmPPlB7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-12-31" id="Fact000176" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">132,450</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact000177" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">109,853</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzQML_maLASEzST0_z8Z5CdfmC6Yg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    stockholders&#8217; (deficit) equity</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000179" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,197</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzST0_z6dt1XRFLkfl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL LIABILITIES AND
    STOCKHOLDERS&#8217; (DEFICIT) EQUITY</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,932</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,905</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_002"></span>GLUCOTRACK
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_113_pn3n3_zo3Fq2POrdZ9" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20240101__20241231_z9n0isAbjoIe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20230101__20231231_zER8FXS5vwCi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In
                                            thousands of US dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(except
                                            stock and per stock amounts)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ResearchAndDevelopmentExpense_maOEz8jw_zeFVxr95OrRj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses
    (Note 9)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,499</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31" id="Fact000186" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,704</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--MarketingExpense_maOEz8jw_zyQeIPMPZWHa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">393</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2023-01-012023-12-31" id="Fact000189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--GeneralAndAdministrativeExpense_maOEz8jw_zAcp6z4utCu3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative
    expenses (Note 10)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,655</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31" id="Fact000192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,278</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingExpenses_iT_mtOEz8jw_msOILzcJl_zA2Ez9q03oga" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-01-01to2024-12-31" id="Fact000194" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,547</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31" id="Fact000195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,104</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_iNT_pn3n3_di_mtOILzcJl_maFINzkPq_zDrS01shBs31" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating loss</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000197" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,547</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000198" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,104</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherNonoperatingIncomeExpense_iN_di_maFINzkPq_zTm0VWru69Hk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other (income) expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-01-01to2024-12-31" id="Fact000200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0201">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_maFINzkPq_zyCP2n5HlcL6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2024-01-01to2024-12-31" id="Fact000203" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">798</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0204">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--GainLossOnEquityIssuance_iN_di_maFINzkPq_z0delDw8ZKs7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on equity issuance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:GainLossOnEquityIssuance" contextRef="From2024-01-01to2024-12-31" id="Fact000206" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,925</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0207">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--GainLossRelatedToLitigationSettlement_iN_di_maFINzkPq_zIvSeIdH07th" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on settlement of liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2024-01-01to2024-12-31" id="Fact000209" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0210">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--FinanceExpenseIncomeNet_iN_di_maFINzkPq_zjLFfDRP32Oa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Finance expense (income), net (Note
    7)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:FinanceExpenseIncomeNet" contextRef="From2024-01-01to2024-12-31" id="Fact000212" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">583</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GCTK:FinanceExpenseIncomeNet" contextRef="From2023-01-012023-12-31" id="Fact000213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_iNT_pn3n3_di_mtFINzkPq_maCINOTz4Ng_z5BOv0ztwLej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Loss for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000215" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,597</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000216" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,097</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive loss:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_i01N_pn3n3_di_maCINOTz4Ng_zLa4psBJ6z37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation
    adjustment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2024-01-01to2024-12-31" id="Fact000221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-01-012023-12-31" id="Fact000222" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ComprehensiveIncomeNetOfTax_i01NT_pn3n3_di_mtCINOTz4Ng_z9mEyhIPzMC8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Comprehensive
    loss for the year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2024-01-01to2024-12-31" id="Fact000224" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,573</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-12-31" id="Fact000225" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,098</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted loss per
    share (Note 2O)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zQyKRdqf4oyi" title="Basic net loss per common stock" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_ziMD7BbeB4j9" title="Diluted net loss per common stock" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-01to2024-12-31" id="Fact000227" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-12-31" id="Fact000229" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">68.44</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zZu5qUF9MQ27" title="Basic loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zkiZB904DKTg" title="Diluted loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31" id="Fact000231" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31" id="Fact000233" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.18</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zhHyNBdVWnP6" title="Weighted average number of common stock outstanding used in computing basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zPEvwSX72Ee9" title="Weighted average number of common stock outstanding used in computing diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-01to2024-12-31" id="Fact000235" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-12-31" id="Fact000237" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,171</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zzBi7a3I8Rob" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_z3Bq9ZgPuJi" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31" id="Fact000239" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31" id="Fact000241" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">207,603</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_003"></span>GLUCOTRACK
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; (DEFICIT) EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_114_pn3n3_zGjZxvA4NGue" summary="xdx: Statement - Consolidated Statements of Changes in Stockholders' (Deficit) Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zttTjJ1X3Av8" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zyEo3IZWVinl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_custom--ReceiptsOnAccountOfSharesMember_zvtgF2XyQoKd" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zaC7ex55NHgh" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zKRZQkZKJPxl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_4BF_zHU9BLq1HDW4" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="26" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US Dollars (except share data)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">Receipts
    <br/> on<span style="font-family: Times New Roman, Times, Serif"></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">Accumulated<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">Total<span style="font-family: Times New Roman, Times, Serif"></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Numbers
    of <br/> Shares</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional<br/>
    Paid-in <br/> Capital</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> account of <br/> shares</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> Other<br/> Comprehensive <br/> Income</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    <br/> Deficit</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><br/>
    Stockholders&#8217; <br/> (Deficit) Equity</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43B_c20230101__20231231_eus-gaap--StockholdersEquity_iS_z7ewoFNmZxh5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 23%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance as of January 1, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhyK2GWNesjh" title="Balance, shares" style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000250" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">154,999</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0243">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000244" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103,110</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000247" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">101,901</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000248" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,230</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_zeom8hKcoHj1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0252">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0253">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0254">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0255">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact000256" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,097</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000257" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,097</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_zrZGQNaecgO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive loss</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0259">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0260">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0261">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000262" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0263">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2023-01-012023-12-31" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_ecustom--StockIssuedDuringPeriodValueUnderwrittenPublicOffering_zPINmTi7QiN3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net proceeds received from underwritten U.S.
    public offering</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesUnderwrittenPublicOffering_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBNXEjAr6em7" title="Net proceeds received from underwritten U.S. public offering, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000273" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">53,765</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0266">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,730</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0268">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0269">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0270">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31" id="Fact000271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,730</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted_zsUvwB2gcdj9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deemed dividend resulted from trigger of down
    round protection feature of certain warrants granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0275">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">855</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0277">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0278">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact000279" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">855</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0280">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zXQH3gZ9Yzh3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0284">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0285">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0286">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-01-012023-12-31" id="Fact000287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_zu53vEPYnpm9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Issuance of restricted
    shares as compensation to directors</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTjVKkUmR44b" title="Issuance of restricted shares as compensation to directors, shares" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000296" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0289">-</span></span><span id="xdx_F2A_zljOiN7cJpvl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0292">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0293">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-12-31" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43C_c20240101__20241231_eus-gaap--StockholdersEquity_iS_zU6TQ5o9pMI7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance as of December
    31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYHiX3Iv6eY3" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000305" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">208,914</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0298">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112,986</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000302" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">109,853</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,197</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20240101__20241231_eus-gaap--StockholdersEquity_iS_zlsk1EUWZuXa" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOBJUGEEqhO5" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000314" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">208,914</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0307">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112,986</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000311" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">109,853</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,197</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_zqO7HFxHzZ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0316">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0318">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember" id="Fact000320" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,597</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000321" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,597</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_zl8BzAxb9Kml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive loss</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0323">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0324">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0325">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000326" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0327">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="From2024-01-01to2024-12-31" id="Fact000328" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zewS5WT7Xn5f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0330">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0332">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0334">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-01-01to2024-12-31" id="Fact000335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_zhS2ZtJrNslj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of restricted shares as compensation
    to directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLcFEBJ8eEo9" title="Issuance of restricted shares as compensation to directors, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000344" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,343</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0337">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000339" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">48</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0340">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0341">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2024-01-01to2024-12-31" id="Fact000342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross_zmZby0A4s818" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restricted shares to be issued as compensation
    towards directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0346">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0347">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0349">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-01-01to2024-12-31" id="Fact000351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone_zpQCfnyYYaHa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of restricted shares as payment for
    achievement of milestone pursuant to purchase agreement (Note 5B)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zweGfh5Ibbma" title="Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B), shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000360" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0353">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">192</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0356">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0357">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" contextRef="From2024-01-01to2024-12-31" id="Fact000358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">192</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueOther_zWpCo1E4wOi9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of Common Stock upon private placement
    transaction (Note 4C)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znG9znMrTIug" title="Issuance of Common Stock upon private placement transaction (Note 4C), shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000369" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,968</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0362">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0364">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0365">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-01-01to2024-12-31" id="Fact000367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares_ztCLjrEOh5b6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercise of prefunded warrants into shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXuSLL7sBcyf" title="Exercise of prefunded warrants into shares, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000378" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">19,765</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0372">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0375">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zoEcm2I9hv8f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of Ordinary Shares upon completion
    of public offering, net of offering expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAfk22wqF4xl" title="Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">121,867</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0380">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0381">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions_zIlzHEW6Ujhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of detachable warrants through private
    placement transactions</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKCVOxn8e906" title="Issuance of detachable warrants through private placement transactions, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000396" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,845</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0389">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zhCknMgD7Sye" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Exchange of warrants into shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrUZS2yokJ97" title="Exchange of warrants into shares, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000405" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,932</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000398" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000399" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0402">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities_zWcuvKqArqXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of shares and warrants as settlement
    of financial liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4RyfPlvX9Hc" title="Issuance of shares and warrants as settlement of financial liabilities, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000414" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,475</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0407">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,618</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0410">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" contextRef="From2024-01-01to2024-12-31" id="Fact000412" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,618</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_zDm6JeKWVnUe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Issuance of detachable
    warrants through private placement transactions</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0416">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000417" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,635</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0418">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0419">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2024-01-01to2024-12-31" id="Fact000421" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,635</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_438_c20240101__20241231_eus-gaap--StockholdersEquity_iE_znRGFIczcIxd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Balance as of December
    31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn5Nh3YMtIok" title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000430" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">791,609</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000423" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000424" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,229</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000425" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000426" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" id="Fact000427" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">132,450</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000428" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_43F_c20240101__20241231_eus-gaap--StockholdersEquity_iE_zfSWiQPtYXZa" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Balance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9hqw2LwweRh" title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000439" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">791,609</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000433" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,229</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_custom_ReceiptsOnAccountOfSharesMember" id="Fact000434" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000435" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" id="Fact000436" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">132,450</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000437" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F03_z6a8zUmR4Yeh" style="width: 15pt; text-align: right">(*)</td><td style="width: 5pt"/><td id="xdx_F14_zRIfLXQL4xk8" style="text-align: justify"><ix:footnote id="Footnote000440" xml:lang="en-US">Less than 1.</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_004"></span>GLUCOTRACK
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_112_pn3n3_z4kL6otz9iV7" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20240101__20241231_zpDhrsNZZicj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20230101__20231231_zQ2Kg460Cvc7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash flows from operating
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGtO_zWlPyV5AZUXk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss for the
    year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000445" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,597</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000446" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,097</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments to reconcile
    loss for the year to net cash used in operating activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Depreciation_i02_pn3n3_maNCPBUzGtO_zlelt2xbja4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-01-01to2024-12-31" id="Fact000451" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-012023-12-31" id="Fact000452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--EquityIssuanceCosts_i02_pn3n3_maNCPBUzGtO_ztJNXSj9hhM6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:EquityIssuanceCosts" contextRef="From2024-01-01to2024-12-31" id="Fact000454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,217</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0455">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--ShareBasedCompensation_i02_pn3n3_maNCPBUzGtO_z9LrZenw48Wi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-12-31" id="Fact000457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31" id="Fact000458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors_i02_pn3n3_maNCPBUzGtO_z3zc0szr74U2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of restricted
    shares as compensation to directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" contextRef="From2024-01-01to2024-12-31" id="Fact000460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">306</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" contextRef="From2023-01-012023-12-31" id="Fact000461" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_pn3n3_maNCPBUzGtO_zl5kcjExD0Uc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Shares issued to CEO for
    achieving of IP Agreement milestones</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2024-01-01to2024-12-31" id="Fact000463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">192</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0464">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--GainLossRelatedToLitigationSettlement_i02N_pn3n3_di_msNCPBUzGtO_z0DugOsXwCLh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on settlement of liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2024-01-01to2024-12-31" id="Fact000466" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--GainLossOnEquityIssuance_i02N_pn3n3_di_msNCPBUzGtO_zBqiecWVp0C7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on equity issuance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:GainLossOnEquityIssuance" contextRef="From2024-01-01to2024-12-31" id="Fact000469" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,925</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0470">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_pn3n3_di_msNCPBUzGtO_zrsn6GKQ4Xnd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of
    derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2024-01-01to2024-12-31" id="Fact000472" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">798</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0473">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_i02_pn3n3_maNCPBUzGtO_zFP04bgvURQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount amortization and interest expenses related to promissory notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2024-01-01to2024-12-31" id="Fact000475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">628</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0476">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--LinkageDifferenceOnPrincipalOfLoansFromStockholders_i02_pn3n3_maNCPBUzGtO_zTDFBXq33Yr4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Linkage difference on principal
    of loans from stockholders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:LinkageDifferenceOnPrincipalOfLoansFromStockholders" contextRef="From2024-01-01to2024-12-31" id="Fact000478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:LinkageDifferenceOnPrincipalOfLoansFromStockholders" contextRef="From2023-01-012023-12-31" id="Fact000479" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zoRKaMm5bRAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Changes
    in assets and liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherCurrentAssets_i03N_pn3n3_di_msNCPBUzGtO_zemBgaQyZ4Vi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Decrease (increase) in other current
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2024-01-01to2024-12-31" id="Fact000484" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">225</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2023-01-012023-12-31" id="Fact000485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">309</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_pn3n3_maNCPBUzGtO_zj4JzS5OXhua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase in accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2024-01-01to2024-12-31" id="Fact000487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-01-012023-12-31" id="Fact000488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">167</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i03_pn3n3_maNCPBUzGtO_zEEEWmpFXtR1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Increase
    (decrease) in other current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2024-01-01to2024-12-31" id="Fact000490" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">421</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2023-01-012023-12-31" id="Fact000491" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">332</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pn3n3_mtNCPBUzGtO_maCCERCzAaH_zQiFUhkLUOM" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash used in operating
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-12-31" id="Fact000493" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,490</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact000494" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,558</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash flows from investment
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_pn3n3_di_msNCPBUzqTH_zol6kfy3guY3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Purchase
    of property and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-01-01to2024-12-31" id="Fact000499" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0500">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pn3n3_mtNCPBUzqTH_maCCERCzAaH_z4WYZGtVweZ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash used in investment
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-01to2024-12-31" id="Fact000502" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">104</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash flows from financing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromIssuanceOfWarrants_i01_pn3n3_maNCPBUzB4f_ziIJgDbsJWL8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of promissory
    notes and detachable warrants through private placement Transaction (Note 4E)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2024-01-01to2024-12-31" id="Fact000508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--NetProceedsReceivedFromUnderwrittenPublicOffering_i01_pn3n3_maNCPBUzB4f_zHYoZFyIzcr9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net proceeds received from
    underwritten U.S. public offering (Note 4J)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:NetProceedsReceivedFromUnderwrittenPublicOffering" contextRef="From2024-01-01to2024-12-31" id="Fact000511" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,783</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0512">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromRelatedPartyDebt_i01_pn3n3_maNCPBUzB4f_zB7QWws3hIJh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of convertible
    promissory notes - related parties (Note 4G)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-01-01to2024-12-31" id="Fact000514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ProceedsFromConvertibleDebt_i01_pn3n3_maNCPBUzB4f_zhmfZNhxzgHc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of convertible
    promissory notes and bifurcated conversion feature through <br/>private placement transaction (Note 4F)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-01-01to2024-12-31" id="Fact000517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">360</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0518">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--ProceedsReceivedFromUnderwrittenPublicOffering_i01_pn3n3_maNCPBUzB4f_zo3GdT6GmSJ7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    proceeds received from underwritten U.S. public offering (Note 4C)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:ProceedsReceivedFromUnderwrittenPublicOffering" contextRef="From2024-01-01to2024-12-31" id="Fact000520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:ProceedsReceivedFromUnderwrittenPublicOffering" contextRef="From2023-01-012023-12-31" id="Fact000521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,730</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pn3n3_maCCERCzAaH_mtNCPBUzB4f_zBRPrrFXT6ml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash provided by financing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-12-31" id="Fact000523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,743</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,730</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCCERCzAaH_zdKtpRYmrvH3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect of exchange rate
    changes on cash and cash equivalents</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2024-01-01to2024-12-31" id="Fact000526" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2023-01-012023-12-31" id="Fact000527" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pn3n3_mtCCERCzAaH_zohMFI1Z0PYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in cash, cash equivalents, and restricted
    cash</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-01-01to2024-12-31" id="Fact000529" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,125</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-12-31" id="Fact000530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,171</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Cash, cash equivalents,
    and restricted cash at beginning of the year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,502</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,331</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash, cash equivalents,
    and restricted cash at end of the year</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-12-31" id="Fact000535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,627</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,502</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SupplementalCashFlowInformationAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental
    disclosure of cash flow activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--InterestPaidAbstract_i01B_z0vD2F21JaC4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">(a) Net cash (received) paid during the year
    for:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InterestPaidNet_i02N_pn3n3_di_zC2nw2QtGPC2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-01-01to2024-12-31" id="Fact000544" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_i01B_zRyR40p7nk23" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">(b) Non-cash investment and financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--DeemedDividendUponTriggerOfDownRoundProtection_i02_pn3n3_ziZF6VtRF635" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deemed dividend upon
    trigger of down round protection</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0550">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:DeemedDividendUponTriggerOfDownRoundProtection" contextRef="From2023-01-012023-12-31" id="Fact000551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">855</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_i02_pn3n3_zRCzro12PHeg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Recognition of right
    for use asset against a lease liability (Note 6)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2024-01-01to2024-12-31" id="Fact000553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0554">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--SettlementOfLiabilitiesWithEquity_i02_pn3n3_zk133tLun4x3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Settlement of liabilities
    with equity (Note 4H and 4I)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:SettlementOfLiabilitiesWithEquity" contextRef="From2024-01-01to2024-12-31" id="Fact000556" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,743</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0557">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--NonCashDerivativeLiability_i02_pn3n3_zXVRG48MD82" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Derivative liability
    (Note 4G)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:NonCashDerivativeLiability" contextRef="From2024-01-01to2024-12-31" id="Fact000559" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0560">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DebtConversionConvertedInstrumentAmount1_i02_pn3n3_znvAxqKIDib5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Conversion of debt into
    equity (Note 4F and 4G)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2024-01-01to2024-12-31" id="Fact000562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,284</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ar_005"></span>GLUCOTRACK
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000565" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z0lfR6pHfO5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; <span id="xdx_822_zKts6pKaDwxb">GENERAL</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was incorporated on May 18, 2010 under the laws of the State of Delaware. The Company is currently developing an implantable
CBGM, the Glucotrack CBGM, for persons with Type 1 diabetes and insulin-dependent Type 2 diabetes.</span></p>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Glucotrack CBGM is being developed for use by Type 1 diabetes patients as
                                            well as insulin-dependent Type 2 patients. Implant longevity is key to the success of such
                                            a device. The Company has continued to evolve its sensor chemistry following the successful
                                            in-vitro feasibility study demonstrating that a minimum two-year implant life is highly probable
                                            with the current sensor design. Recently the Company announced that a 3-year longevity is
                                            feasible leveraging both in-vitro and in-silico test results. The Company has also completed
                                            multiple animal studies with initial prototype systems which demonstrated a simple implant
                                            procedure with good safety and functionality. The results of both were presented in poster
                                            form at the 2024 American Diabetes Association annual conference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
to the above progress on the Glucotrack CBGM, the Company has also successfully demonstrated continuous glucose sensing in the epidural
space. This latter approach is of importance for patients with diabetes already contemplating spinal cord stimulation therapy for their
condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
regulatory submission has been made for a first in human study outside of the United States. This will be an acute study intended to
demonstrate device performance and safety. All preparatory clinical activities and applicable regulatory approvals are complete. In parallel,
the Company is also preparing for a long-term clinical trial outside the United States that is expected to begin in the second quarter
of 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The
Company believes its technology, if successful, has the potential to be more accurate, more convenient and have a longer duration than
other implantable glucose monitors that are either in the market or currently under development.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
    and capital resources</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            date, the Company has not yet commercialized the Glucotrack CBGM Product. Further development
                                            and commercialization efforts are expected to require substantial additional expenditure.
                                            Therefore, the Company is dependent upon external sources for financing its operations. As
                                            of December 31, 2024, the Company has incurred an accumulated deficit of $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20241231_zGL5wqlPBts4" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-12-31" id="Fact000567" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">132,450</ix:nonFraction></span>. In addition,
                                            the Company has generated operating losses and negative cash flow from operations since inception.
                                            As of December 31, 2024, the balance of cash and cash equivalents amounted to $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20241231_z7xelKLAfS54" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-12-31" id="Fact000569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,617</ix:nonFraction></span>.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended December 31, 2024, the Company raised approximately $<span id="xdx_903_ecustom--ProceedsFromPublicOfferingsAndDebtIssuances_pn6n6_c20240101__20241231_zkKyt77U0Hz5" title="Proceeds from public offerings and debt issuances"><ix:nonFraction name="GCTK:ProceedsFromPublicOfferingsAndDebtIssuances" contextRef="From2024-01-01to2024-12-31" id="Fact000571" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">15</ix:nonFraction></span> million through public offerings and debt issuances which
    were subsequently converted to equity. In addition, subsequent to the balance sheet date, the Company raised $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20250101__20250328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zE8QizcG9CTf" title="Proceeds from sale of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2025-01-012025-03-28_us-gaap_SubsequentEventMember" id="Fact000573" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">6.3</ix:nonFraction></span> million through the
    sale of shares of Common Stock. See Note 4 and 14. The Company plans to finance its operations through the sale of equity
    securities (and/or debt securities). There can be no assurance that the Company will succeed in obtaining the necessary financing
    or generating sufficient revenue from sale of its Glucotrack CBGM Product in order to continue its operations as a going concern.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    has considered the significance of such conditions in relation to the Company&#8217;s ability to meet its current obligations and
    to achieve its business targets and determined that these conditions raise substantial doubt about the Company&#8217;s ability to
    continue as a going concern.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000575" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zpPV7MwXNhhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 - <span id="xdx_823_zBoHat5hP5yc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America
(US GAAP).</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000577" name="us-gaap:UseOfEstimates"><p id="xdx_84E_eus-gaap--UseOfEstimates_zjDx5ZhV6Yt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zEznVgam0Iz4">Use
    of estimates in the preparation of financial statements</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions
    that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of
    the financial statements, and the reported amounts of expenses during the reported periods. Actual results could differ from those
    estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to evaluation of going
    concern, the classification of financial instruments as equity or liability, share based compensation and the determination of the fair value of derivative
    liabilities.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000579" name="GCTK:FunctionalCurrencyPolicyTextBlock"><p id="xdx_84D_ecustom--FunctionalCurrencyPolicyTextBlock_zcMGwwBuz3Z3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zsfOrdVScWMf">Functional
    currency</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    functional currency of the Company is the US dollar, which is the currency of the primary economic environment in which it operates.
    In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to foreign currency
    are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions
    included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses
    arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.
    The functional currency of the Israeli subsidiary is the New Israeli Shekel (&#8220;NIS&#8221;) and its financial statements are
    included in consolidation, based on translation into US dollars. Accordingly, assets and liabilities were translated from NIS to
    US dollars using year-end exchange rates, and expense items were translated at average exchange rates during the year. Gains or losses
    resulting from translation adjustments are reflected in stockholders&#8217; equity, under &#8220;accumulated other comprehensive
    income&#8221;.</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000581" name="us-gaap:ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zZ9rfSF7hGXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B8_zTTl2xrLE2B8" style="display: none">SCHEDULE OF OFFICIAL EXCHANGE RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Official exchange rate of NIS
    1 to US dollar</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20241231_z3HXiJacJyz9" title="Official exchange rate of NIS 1 to US dollar"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateRemeasurement1" contextRef="AsOf2024-12-31" id="Fact000583" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.274</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231_zvIwJW1INYW9" title="Official exchange rate of NIS 1 to US dollar"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateRemeasurement1" contextRef="AsOf2023-12-31" id="Fact000585" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.272</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Increase (Decrease) of the official exchange
    rate of NIS 1 to US dollar during the year:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20241231_z2itxYshtO72" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2024-12-31" id="Fact000587" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.74</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_di_uPure_c20231231_z76cwanQoTr2" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:">(<ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2023-12-31" id="Fact000589" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">8.86</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zoMrBAn5EBze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000591" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zid9BrgUl8zf" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_ze3PW2OpjFOe">Principles
    of consolidation</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
    have been eliminated in consolidation.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000593" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zvmJcRej0eh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zTEQrxYW2h43">Cash
    and cash equivalents and restricted cash</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company considers all short-term investments, which are highly liquid investments with original
                                            maturities of three months or less at the date of purchase, to be cash equivalents.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash is invested in certificates of deposit, which are used to secure Integrity Israel&#8217;s obligations in respect of its credit
    card.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    presentation of statement of cash flows purposes, restricted cash balances are included with cash and cash equivalents, when reconciling
    the reported period total amounts.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s cash is held with financial institutions in the United States and Israel. Management believes that the financial
    institutions that hold the Company&#8217;s cash are financially sound and, accordingly, minimal credit risk exists with respect to
    these investments. Account balances held in the Unites States may, at times, exceed the Federal Deposit Insurance Corporation (FDIC)
    insurance limit. As of December 31, 2024 and 2023, the Company had $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20241231_zEPeadpMAweg" title="FDIC insurance limit"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2024-12-31" id="Fact000595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,968</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20231231_zvIRQSvWJPFf" title="FDIC insurance limit"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2023-12-31" id="Fact000597" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,942</ix:nonFraction></span>, respectively, in excess of the FDIC insurance
    limit.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000599" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zouO1GTW9Lbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zJV2l25V0qPi" style="display: none">SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20241231_z3WoxWo2yNN3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20231231_zfkg4c0VGFR9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzao3_z4E5ARni6Iuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-12-31" id="Fact000601" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,617</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,492</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCash_iI_pn3n3_maCCERCzao3_zOrcs6hmU6U4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Restricted cash</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2024-12-31" id="Fact000604" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2023-12-31" id="Fact000605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzao3_zvgHrUD5n5v" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total cash, cash equivalents,
    and restricted cash shown in the statement of cash flows</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-12-31" id="Fact000607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,627</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,502</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zTJK59TQNx7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000610" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWgRKuvXVJP8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zpuB5HHvNqCk">Property
    and equipment, net</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over
    the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated
    depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected
    in the statements of operations and comprehensive loss.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rates
    of depreciation:</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000612" name="GCTK:ScheduleOfPropertyRatesOfDepreciationTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfPropertyRatesOfDepreciationTableTextBlock_zw0g56Tqghwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zFW86EHUW8dj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Computers and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zVRpfYDp41N7" title="Property and equipment rates of depreciation"><ix:nonNumeric contextRef="AsOf2024-12-31_us-gaap_ComputerEquipmentMember" format="ixt-sec:duryear" id="Fact000614" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and office equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zOYuSeCsE90d" title="Property and equipment rates of depreciation"><ix:nonNumeric contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000616" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaKkwjrOhRdg" title="Property and equipment rates of depreciation"><ix:nonNumeric contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000618" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">15</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zTJTnyrhRK9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000620" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zOIbb9kzGgK1" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_ziWv8giK7N0f">Impairment
    of long-lived assets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Group&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;,
    whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
    of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows
    expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by
    the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment
    losses related to long lived assets.</span></td></tr>
</table>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000622" name="GCTK:ModificationOfEquityClassifiedContractsPolicyTextBlock"><p id="xdx_84D_ecustom--ModificationOfEquityClassifiedContractsPolicyTextBlock_ziZE3MIk5rr" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z56evVdHSr88">Modification
    of equity-classified contracts</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    modification or exchange of equity-classified contracts, such as warrants that were classified as equity before the modification or
    exchange and remained eligible for equity classification after the modification, was accounted for in a similar manner to a
    modification of stock-based compensation. Accordingly, the incremental fair value from the modification or exchange (the change in
    the fair value of the instrument before and after the modification or exchange), due to the characteristics of the modification, was recognized as a reduction of retained earnings (or an increase of
    accumulated deficit) as a deemed dividend. Modifications or exchanges that result in a decrease in the fair value of an
    equity-classified share-based payment awards are not recognized. In addition, the amount of the deemed dividend is also recognized
    as an adjustment to earnings available to common shareholders for purposes of calculating earnings per share.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000624" name="GCTK:ConvertiblePromissoryNotesPolicyTextBlock"><p id="xdx_84A_ecustom--ConvertiblePromissoryNotesPolicyTextBlock_zrN5WIV4goI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zPLmBcF6oOKe">Convertible
    Promissory Notes</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition of convertible promissory notes and similar instruments, the Company considers the provisions of ASC 815-40,
    &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;) in order to determine whether
    the conversion features embedded within the convertible instrument should be separated from the host instrument.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            it is determined that an embedded derivative required to be bifurcated (such as embedded
                                            conversion feature that does not qualify for equity classification), the Company recognizes
                                            the embedded derivative bifurcated as a separate derivative liability upon initial recognition
                                            and on subsequent periods at fair value. The remaining consideration amount received or allocated
                                            to the entire convertible instrument is allocated to the host debt instrument. The difference
                                            between the face value of the host and the allocated amount represents a discount which is
                                            amortized as finance expense to profit or loss using the effective interest method over the
                                            term of the note until its stated maturity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    it is determined that the embedded conversion feature qualifies for equity classification (such when the embedded conversion option,
    if it were freestanding, is not qualified as a derivative in accordance with the provisions of ASC 815-10, &#8220;Derivatives and
    Hedging&#8221; since its terms did not require or permit net settlement or when the embedded conversion option is indexed to the
    entity&#8217;s own stock), the conversion option is not bifurcated. When bifurcation is not required, the Company considers whether
    the debt instrument involves a significant premium (i.e. when the proceeds received or allocated upon issuance exceed the principal
    amount that will be paid at maturity). When it is determined that a substantial premium exists, the entire premium is allocated to
    paid-in capital and when it is determined, otherwise no additional accounting is required and the convertible promissory note is
    accounted for at amortized cost using the effective interest method over the term of the note until its stated maturity.</span></p></td></tr>
</table>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000626" name="GCTK:AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock"><p id="xdx_847_ecustom--AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_z5sd7NFjOR4a" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zx0GcQuIiITa">Allocation
    of proceeds and related issuance costs</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            multiple instruments are issued in a single transaction (package issuance), the total gross
                                            proceeds from the transaction are allocated among the individual freestanding instruments
                                            identified. The allocation occurs after identifying all freestanding instruments and the
                                            subsequent measurement basis for those instruments.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    instruments that are required to be subsequently measured at fair value (such as derivative liabilities) are measured at fair value
    and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at
    fair value (such as liabilities measured at amortized cost, common shares and warrants eligible for equity classification), based
    on the relative fair value basis for such instruments.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    costs allocated to financial instruments that are required to be subsequently measured at fair value are immediately expensed.
    Issuance costs allocated to shares and warrants classified as equity components and are recorded as a reduction of additional
    paid-in capital. Issuance costs allocated to financial liabilities measured at amortized cost are recorded as a discount and
    accreted over the contractual term of the financial instrument using the effective interest method.</span></p></td></tr>
</table>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000628" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_840_eus-gaap--DerivativesPolicyTextBlock_zzaf9EzAzAJ8" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>J.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zwRtdmypMikh">Warrants</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
                                            classified warrants</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    warrants that were determined to be freestanding financial instruments that are legally detachable and separately exercisable, do
    not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary
    Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company&#8217;s own shares, were classified
    as equity instruments. As such warrants were issued together with financial instruments that are not subsequently measured at fair
    value, the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair
    value basis. Direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
                                            classified as derivative liabilities</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition of Series A Warrants and Series B Warrants that were issued in November 2024 as part of an equity issuance and
    debt conversions, management considered the provisions of ASC 815-40, Derivatives and Hedging &#8212; Contracts in Entity&#8217;s
    Own Equity and determined that the settlement amount of Series A Warrants and Series B Warrants might not be based on an exchange
    of a fixed number of shares for a fixed amount of consideration and thus such Warrants are not eligible to be considered as indexed
    to the Company&#8217;s own shares. Accordingly, the Series A Warrants and Series B Warrants were accounted for as warrant derivative
    liability at fair value and the changes in fair values are carried to profit or loss. In accordance with ASC 210-10-20, the warrant
    derivative liability is presented as a noncurrent liability since its settlement will require the issuance of shares and not the
    use of any resources that are properly classified as current assets.</span></p></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000630" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_840_eus-gaap--LesseeLeasesPolicyTextBlock_zAFnE1nB1bz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>K.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zSqGXDVPbGRf">Leases</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company applies ASC Topic 842, &#8220;Leases&#8221; (&#8220;ASC 842&#8221;) under which the
                                            Company determines if an arrangement is a lease at inception.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases
    are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following
    criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option
    to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful
    life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset,
    or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end
    of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company&#8217;s
    lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be
    classified as operating leases.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of Use (&#8220;ROU&#8221;) assets and liabilities are recognized on the commencement date based on the present value of remaining
    lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the
    time of commencement. As most of the Company&#8217;s leases do not provide an implicit rate, the Company uses its Incremental Borrowing
    Rate (&#8220;IBR&#8221;) based on the information available on the commencement date in determining the present value of lease payments.
    The Company&#8217;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
    and in economic environments where the leased asset is located. The ROU asset also includes any lease payments made prior to commencement
    and is recorded net of any lease incentives received. Moreover, the ROU asset may also include initial direct costs, which are incremental
    costs of a lease that would not have been incurred if the lease had not been obtained. The Company uses the long-lived assets impairment
    guidance in ASC 360-10, &#8220;Property, Plant, and Equipment - Overall&#8221;, to determine whether a ROU asset is impaired, and
    if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option
    to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain
    that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company
    will not exercise the option.</span></p></td></tr>
</table>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000632" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8Ckl0y83uBd" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>L.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_znRym6lSYEtf">Income
    tax</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are
    determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial
    accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the
    enacted tax rates expected to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets
    are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial
    statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements.
    According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting
    policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not
    recognize such items in its fiscal 2024 and 2023 financial statements and did not recognize any liability with respect to unrecognized
    tax position in its balance sheet.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000634" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zaqMHPXIf17k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zKvC4MV0qI9f">Research
    and development expenses</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development expenses are charged to operations and comprehensive loss, as incurred.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000636" name="GCTK:RoyaltyBearingGrantsPolicyTextBlock"><p id="xdx_846_ecustom--RoyaltyBearingGrantsPolicyTextBlock_z8mdfwVJt0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWOO3CIF9uye">Royalty-bearing
    grants</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalty-bearing
    grants from the Israeli Innovation Authority (IIA) to fund approved research and development projects are recognized at the time
    Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs. To date,
    the cumulative research and development grants received by Integrity Israel from IIA amounted to $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zxQ1tqmmUSfh" title="Cumulative research and development"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-012024-12-31_us-gaap_IsraelTaxAuthorityMember" id="Fact000638" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span>. See also Note 5A below.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000640" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_z9o48b788pJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>O.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zHt8cvBHACei">Basic
    and diluted loss per share</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share for the year ended December 31, 2024 is computed by dividing the loss for the period applicable for Common Stockholders
and the holders of the pre-funded warrants divided by the weighted average number of shares of Common Stock outstanding and shares of
Common Stock to be issued upon the exercise of prefunded warrants during the period. Basic loss per share for December 31, 2023 is computed
by dividing the loss for the period applicable (after considering the effect of deemed dividend related to trigger of down round protection
feature) for Common Stockholders and the holders of the pre-funded warrants divided by the weighted average number of shares of Common
Stock outstanding and shares of Common Stock to be issued upon achievement of first performance milestone <span style="background-color: white">(see
Note </span>5B <span style="background-color: white">below) and upon </span>exercise of pre-funded warrants (see Note 8B below) during
the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing, diluted loss per share, basic earnings per share are adjusted to reflect the potential dilution that could occur upon the
exercise of options or warrants issued or granted using the &#8220;treasury stock method&#8221;, and using the if-converted method for
other financial instruments such as convertible liabilities and other share settled derivative liabilities, if the effect of each of
such financial instruments is dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing diluted loss per share, the average stock price for the period is used in determining the number of Common Stock assumed to
be purchased from the proceeds to be received from the exercise of stock options or stock warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
that will be issued upon exercise of all stock options and stock warrants, have been excluded from the calculation of the diluted net
loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result
of the exercise or conversion of these instruments was anti-dilutive</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000642" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zBj6J9PKDyHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zcK24H5JdCR2" style="display: none">SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240101__20241231_z6Ym4uflSN3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20230101__20231231_z5zzqKUWHrA7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In thousands
    of US dollars</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(except
    share data)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_iN_pn3n3_di_maNILATzfsR_zmwax6xVGU0l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000644" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,597</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000645" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,097</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_iN_pn3n3_di_maNILATzfsR_zpbcLJeGQ6R8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Deemed
    dividend related to trigger of down round protection feature (see Note 8C3 below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" contextRef="From2023-01-012023-12-31" id="Fact000648" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">855</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iNT_pn3n3_di_mtNILATzfsR_z3nyCkEPqS75" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable
    to common stockholders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-01-01to2024-12-31" id="Fact000650" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,597</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-01-012023-12-31" id="Fact000651" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,952</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    used in computing basic and diluted net loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zUwaJqH5hLqc" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj6bGPKWH3na" title="Ordinary shares used in computing diluted net loss per common stock"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000653" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact000655" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,171</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQoV8c1SBjS1" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_ztuK22onwYV6" title="Ordinary shares used in computing diluted net loss per common stock"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000657" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000659" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">193,131</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    to be issued upon exercise of pre-funded warrants (see Note 8B1 below)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zXDAwwEkUIN2" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zskmRws7TrWj" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0661"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zX4Xg66JJtuk" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zjBrCIsx5YDh" title="Ordinary shares used in computing diluted net loss per common stock"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31_custom_PrefundedWarrantsMember" id="Fact000665" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31_custom_PrefundedWarrantsMember" id="Fact000667" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,971</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Shares
    of Common Stock to be issued upon achievement of first performance milestone (see Note 5B below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_z4WPaA8G3I53" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zS2qa5cwJH8b" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0669"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></span></span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zbbEBgBnhxD7" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zXNs6HF7bgu" title="Ordinary shares used in computing diluted net loss per common stock"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31_custom_PerformanceMilestoneMember" id="Fact000673" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31_custom_PerformanceMilestoneMember" id="Fact000675" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">501</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zKqCY5joreQ7" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zxOBS8n14FZ" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-01to2024-12-31" id="Fact000677" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-12-31" id="Fact000679" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,171</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zmHxTTLjbWWc" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zpCU3cJC3yI7" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31" id="Fact000681" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31" id="Fact000683" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">207,603</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss
    per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zeDTjIp7toZ1" title="Basic net loss per common stock"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zOWA1Kng7Vz7" title="Diluted net loss per common stock"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-01to2024-12-31" id="Fact000685" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-12-31" id="Fact000687" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">68.44</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zwlwpLprfKLb" title="Basic net loss per common stock"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_z4hc6XluP3Na" title="Diluted net loss per common stock"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31" id="Fact000689" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31" id="Fact000691" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.18</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zG6bWZc6ZMle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Note 14 regarding a significant issuance of shares as part of the exercise of the Series B Warrants subsequent to the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000693" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLF7bBtd6dQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>P.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zbIkTHzb4Xl4">Stock-based
    compensation</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair
    values in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments including grants of stock
    options are recognized in the consolidated statement of operations and comprehensive loss as an operating expense based on the fair
    value of the award at the date of grant. The fair value of stock options granted is estimated using the Black-Scholes option-pricing
    model. The Company has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the
    requisite service period or over the implicit service period when a performance condition affects the vesting, and it is considered
    probable that the performance condition will be achieved. Share-based payments to non-employees are accounted for in accordance with
    ASC 718.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000695" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zw3K0lUr9aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zUIeoiC4EIgl">Fair
    value of financial instruments</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
    Topic 825-10, &#8220;Financial Instruments&#8221; defines financial instruments and requires disclosure of the fair value of financial
    instruments held by the Company. The Company considers the carrying amount of cash and cash equivalents, restricted cash, accounts
    receivable, other current assets, accounts payable and other current liabilities balances, to approximate their fair values due to
    the short-term maturities of such financial instruments. ASC Topic 825-10, establishes the following fair value hierarchy, which
    prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair
    value hierarchy gives the highest priority to Level 1 inputs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 - Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 - Unobservable inputs are used when little or no market data is available. Level 3 inputs are considered as the lowest priority
    under the fair value hierarchy.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    fair value of the financial instruments included in the working capital of the Company (cash and cash equivalents, accounts payable
    and other current assets and liabilities) approximates their carrying value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not estimate the fair value of the loans received from stockholders since their repayment schedule has not yet been determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000697" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjxuB5pAO6r8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no Level 3 assets or liabilities for the year ended December 31, 2023. The following table presents changes in Level 3 assets and
liabilities measured at fair value for the year ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_z5O5I8YYPGZi" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20241114__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGGSdi8tCfHi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zYHWiGgSwBAc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; November 14, 2024
    &#8211; Warrant issuance date</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-11-13_us-gaap_FairValueInputsLevel3Member" id="Fact000699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,626</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FairValueAdjustmentOfWarrants_z7jXuJroSoDi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value adjustments &#8211; Derivative financial liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-11-142024-12-31_us-gaap_FairValueInputsLevel3Member" id="Fact000701" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">795</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_z7DlHWtDQvw4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member" id="Fact000703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,421</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_za73EkdSN8C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000705" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zFilp6g8Nc6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the Company&#8217;s assets and liabilities which are measured at fair value on a recurring basis by level
within the fair value hierarchy:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zGEafnPJxhX3" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair
    Value Measurements as of December 31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    I</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    II</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    III</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Liability:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant derivative
    liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWoUjctiPq35" title="Warrant derivative liability" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8XKvtuCOA69" title="Warrant derivative liability" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsrWFm7aZ6Qg" title="Warrant derivative liability" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="Fact000711" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,421</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_zfoypcLOJi29" title="Warrant derivative liability" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31" id="Fact000713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,421</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_z5lTH7oIToS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000715" name="us-gaap:SegmentReportingPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zzdcZwraGoa8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zNHFGJM5Nsc4">Segment
    reporting</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation
    by the chief operating decision maker, or (&#8220;CODM&#8221;). The Company has identified its Chief Executive Officer, Paul V. Goode, as the CODM who is responsible for making decisions regarding resource allocation and assessing performance. The Company views
    its operations and manages its business as one operating segment. The Company&#8217;s long-lived assets consist primarily of property
    and equipment, net, which are all held in the United States.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000717" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z2FGCZ6IAGlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_z1EHr4i96mI3">Concentrations
    of credit risk</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents,
    and restricted cash. Cash and cash equivalents and restricted cash are deposited with a major bank in the United States. Management
    believes that such financial institutions are financially sound, accordingly, minimal credit risk exists with respect to these financial
    instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts,
    option contracts or other foreign hedging arrangements.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000719" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_841_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zAlGHH2E7KW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>T.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z5Yi9ZOFIsFf">Contingencies</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
    has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
    information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000721" name="GCTK:WarrantsWithDownRoundProtectionPolicyTextBlock"><p id="xdx_847_ecustom--WarrantsWithDownRoundProtectionPolicyTextBlock_zn4f45ay0S6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zqEHhM9QsPOi">Warrants
    with down-round protection</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company disregards the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining
    liability or equity classification in accordance with the provisions of ASU 2017-11, &#8220;Earnings Per Share&#8221; (ASU 2017-11).
    Based on its evaluation, management has determined that such warrants with down-round protection feature are eligible for equity
    classification.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordantly,
upon the occurrence of an event that triggers a down round protection feature (i.e., when the exercise price of the warrants is adjusted
downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available
to common shareholders for purposes of basic earnings per share calculation. See also Note 2P above.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000723" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ziEK3LmjD6qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>V.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zqfiCRG2Y698">Recently
    adopted accounting pronouncements</span> </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU
    2023-07&#8221;). This standard requires a public entity to disclose significant segment expenses and other segment items on an interim
    and annual basis. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker.
    ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after
    December 15, 2024, with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all
    prior periods presented in the financial statements. The Company adopted ASU 2023-07 for the fiscal year ended December 31, 2024
    and interim financial statements thereafter, on a retrospective basis for all prior periods presented in the financial statements.
    The adoption of ASU 2023-07 did not change the way that the Company identifies its reportable segments and, as a result, did not
    have a material impact on the Company&#8217;s financial position or results of operations. See (Note 13) - Segment Reporting for
    further information.</span></td></tr>
  </table>
</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000725" name="GCTK:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"><p id="xdx_846_ecustom--NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_zHjYSoLTljei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>W.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zXFMCpsDTK0f">Recently
    issued accounting pronouncements, not yet adopted</span> </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    November 2024, the FASB issued ASU 2024-03, &#8220;Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation
    Disclosures&#8221; to require more detailed information about specified categories of expenses (purchases of inventory, employee
    compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the income
    statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and for interim periods within fiscal years
    beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial
    statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented
    in the financial statements. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial
    statements and related disclosures. The adoption of this pronouncement is not expected to have a material impact on the Company&#8217;s
    consolidated financial statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures related to improvements
    to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for
    the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning
    after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</span></td></tr>
  </table>
<!-- Field: Split-Segment; Name: 001 -->
</ix:nonNumeric><p id="xdx_85A_zh2CGAkErrJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000727" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_z5f1aSH53Oy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3</b> &#8211; <b><span id="xdx_827_zOfH3zoHyk4h">LOANS FROM STOCKHOLDERS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the years 2003-2004, Integrity Israel received loans from stockholders (four separate lenders) in a total amount of approximately
    $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfLongTermDebt_pn3n3_c20030101__20041231__us-gaap--LineOfCreditFacilityAxis__custom--FourSeparateLendersMember__srt--StatementGeographicalAxis__country--IL_zr9dQFodh7xe" title="Total loan amount"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2003-01-012004-12-31_custom_FourSeparateLendersMember_country_IL" id="Fact000729" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">400</ix:nonFraction></span>. However, following the repayment of the entire balance to certain lender in 2015, the remaining balance as of December 31,
    2024 is approximately $<span id="xdx_903_eus-gaap--RepaymentsOfLongTermDebt_pn3n3_c20240101__20241231__us-gaap--LineOfCreditFacilityAxis__custom--FourSeparateLendersMember__srt--StatementGeographicalAxis__country--IL_zsZWIq7gVNub" title="Repayment of loan"><ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2024-01-012024-12-31_custom_FourSeparateLendersMember_country_IL" id="Fact000731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">203</ix:nonFraction></span>. The loans are indexed to the Israeli consumer price index from their origination date and bear no interest.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company will be required to pay the loans, in quarterly installments, commencing on the first quarter following the first fiscal
    year in which the Company reports net profit in its annual report. At such time, the Company will be required to make quarterly payments
    equal to <span id="xdx_90E_ecustom--QuarterlyPaymentsEqualsToSalesPercentage_pid_dp_uPure_c20240101__20241231_zfmt4Ik4MBL3" title="Sales percent"><ix:nonFraction name="GCTK:QuarterlyPaymentsEqualsToSalesPercentage" contextRef="From2024-01-01to2024-12-31" id="Fact000733" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% of its total sales for each quarter until the loans have been repaid in full. Notwithstanding the repayment mechanism,
    the Company will not be required to repay the loans during any period in which such payment would cause a deficit in the Company&#8217;s
    working capital.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, the Company does not expect to make any material repayments during the following 12-month period, if any, and
    accordingly the entire remaining balance of the loans from stockholders have been presented as non-current liability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000735" name="GCTK:SignificantTransactionsTextBlock"><p id="xdx_80B_ecustom--SignificantTransactionsTextBlock_zlR8CmcYuYhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8211; <span id="xdx_82A_zdHYqqQx9lwg">SIGNIFICANT TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    of pre-funded warrants</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 3, 2024, <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240103__20240103__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGN0l6NFO3O1" title="Pre-funded warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-01-032024-01-03_custom_PrefundedWarrantsMember" id="Fact000737" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,765</ix:nonFraction></span> pre-funded warrants granted through underwritten public offering in April 2023 have been fully exercised
    into the same number of shares of Common Stock of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange
    Agreement</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 13, 2024, the Company entered into an Exchange Agreement with certain warrant holders (the &#8220;Holders&#8221;), pursuant
    to which the Company and the Holders agreed to exchange (the &#8220;Exchange&#8221;) warrants with down round protection feature
    exercisable to common shares (the &#8220;Warrants&#8221;) owned by the Holders for shares of Common Stock to be issued by the Company.
    On February 15, 2024, <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20240215_z6TLVGLUwzbc" title="Shares of Common Stock"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-02-15" id="Fact000739" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,932</ix:nonFraction> </span>shares of Common Stock have been issued in exchange for <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20240215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNBITjKu9TU5" title="Shares of Common Stock"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-02-15_us-gaap_WarrantMember" id="Fact000741" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,820</ix:nonFraction></span> Warrants (the &#8220;Shares&#8221;).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            was also agreed that the Holders will not, during the period (&#8220;Lock-Up Period&#8221;)
                                            (i) offer, pledge, announce the intention to sell, contract to sell, sell any option or contract
                                            to purchase, purchase any option or contract to sell, grant any option, right or warrant
                                            to purchase, or otherwise transfer or dispose of, directly or indirectly, any Shares, (ii)
                                            enter into any swap or other agreement that transfers, in whole or in part, any of the economic
                                            consequences of ownership of the Shares of, whether any such transaction described in clause
                                            (i) or (ii) above is to be settled by delivery of Shares or such other securities, in cash
                                            or otherwise, (iii) make any demand for or exercise any right with respect to, the registration
                                            of any Shares or any security convertible into or exercisable or exchangeable for shares
                                            of common stock, or (iv) publicly announce an intention to effect any transaction specific
                                            in clause (i), (ii) or (iii) above, provided that the Holder, during the Lock-Up Period,
                                            may <span id="xdx_900_ecustom--LockUpPeriodDescription_c20240213__20240213__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zTyrs3D4LGHg" title="Lock-up period conditions"><ix:nonNumeric contextRef="From2024-02-132024-02-13_custom_ExchangeAgreementMember" id="Fact000743" name="GCTK:LockUpPeriodDescription">(a) sell or contract to sell Shares at a price higher than $0.5 per Share on any trading
                                            day up to 10% of the daily volume of Shares or (b) sell or contract to sell Shares at a price
                                            higher than $0.8 per Share on any trading day with no volume limitation.</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Lock-Up Period shall expire at the earliest of (i) 365 days after the date hereof or (ii) until the Shares traded above $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20240213__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zBrTVdgo8hKl" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-02-13_custom_ExchangeAgreementMember" id="Fact000745" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">100.00</ix:nonFraction></span> per
    Share for five consecutive trading days.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounted for the Exchange of the aforesaid warrants with shares in a similar manner of a modification of shares-based payment as a deemed dividend which was calculated at the closing
    date by the management using the assistance of external appraiser as the excess of fair value of the shares to be issued after taking
    into consideration a discount for lack of marketability at a rate of 16.81% over the Lock-Up Period over the fair value of the original
    equity instrument (i.e. warrants which included down round protection feature). However, since the fair value of the shares was estimated
    as less than the fair value of the replaced equity instrument, deemed dividend was not recorded.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
    Placement Agreement</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 22, 2024, the Company entered into a private placement agreement under which the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240422__20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbdezgYJDnM6" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-04-222024-04-22_us-gaap_PrivatePlacementMember" id="Fact000747" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,968</ix:nonFraction></span> shares of its common
    stock at a price of $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrwSVH7pwn68" title="Common stock share price"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-04-22_us-gaap_PrivatePlacementMember" id="Fact000749" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">126</ix:nonFraction></span> per share for aggregate gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20240422__20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzEu8KMDeaXe" title="Aggregate gross proceeds offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2024-04-222024-04-22_us-gaap_PrivatePlacementMember" id="Fact000751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></span> (the &#8220;Offering&#8221;). The Offering included participation
    of certain members of the Company&#8217;s executive management, Board of Directors and existing shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adoption
    of 2024 Equity Incentive Plan and Reverse Share Split</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            April 26, 2024, the Company held its Annual Meeting of Shareholders (the &#8220;Annual Meeting&#8221;)
                                            under which the Company&#8217;s stockholders approved, inter alia, the following proposals:
                                            (i) adoption of the Company&#8217;s 2024 Equity Incentive Plan and (ii) an amendment to Article
                                            IV of the Company&#8217;s Certificate of Incorporation, to effect a reverse stock split of
                                            the Company&#8217;s Common Stock at a ratio of between one-for-five and one-for-thirty, with
                                            such ratio to be determined at the sole discretion of the Board of Directors. Following the
                                            Annual Meeting, on April 30, 2024, the Company&#8217;s Board of Directors approved a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240430__20240430_zCGY9Uuxwkea" title="Reverse stock split"><ix:nonNumeric contextRef="From2024-04-302024-04-30" id="Fact000753" name="us-gaap:StockholdersEquityReverseStockSplit">one-for-five</ix:nonNumeric></span>
                                            reverse stock split of the Company&#8217;s issued and outstanding shares of common stock.
                                            On May 17, 2024, the Company filed a Certificate of Amendment to the Company&#8217;s Certificate
                                            of Incorporation with the Secretary of State of the State of Delaware which effected the
                                            reverse stock split.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 3, 2025, subsequent to the balance sheet date on December 31, 2024, the Company approved to effect an additional reverse
    stock split of twenty-for-one (20 to 1). The reverse split did not impact the total number of authorized shares of common stock or
    the par value per share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    accounting purposes, all shares, options and warrants to purchase shares of common stock and loss per share amounts have been adjusted
    to give retroactive effect to both of the reverse splits for all periods presented in these consolidated financial statements. Any
    fractional shares resulting from the reverse splits were rounded up to the nearest whole share.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    and Warrant Purchase Agreements</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            June 27, 2024, the Company entered into note and warrant purchase agreements (the &#8220;Purchase
                                            Agreement&#8221;) with certain investors (the &#8220;June 27 Investors&#8221;), providing
                                            for the private placement of unsecured promissory notes in the aggregate principal amount
                                            of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240627__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNotesMember_zRv9SM97kIZb" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-06-27_custom_UnsecuredPromissoryNotesMember" id="Fact000755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span> (the &#8220;June 27 Notes&#8221; and each a &#8220;June 27 Note&#8221;) and warrants
                                            to purchase up to an aggregate of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240627_ztkGGeX4DbRc" title="Aggregate of shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-06-27" id="Fact000757" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></span> shares of the Company&#8217;s Common Stock (the
                                            &#8220;June 27 Warrants&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShortTermDebtDescription_c20240627__20240627_zieJexGNEwv9" title="Notes payable description"><ix:nonNumeric contextRef="From2024-06-272024-06-27" id="Fact000759" name="us-gaap:ShortTermDebtDescription">The
    June 27 Notes bear simple interest at a rate of 3% per annum and are due and payable in cash on the earlier of: (a) 12 months from
    the date of the June 27 Note; or (b) the date the Company raises third-party equity capital in an amount equal to or in excess of
    $1,000 (the &#8220;Maturity Date&#8221;). The Company may prepay the June 27 Notes at any time prior to the Maturity Date without
    penalty. If an event of default occurs, the then-outstanding principal amount of the June 27 Notes plus any unpaid accrued interest
    will accelerate and become immediately payable in cash.</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of June 27 Warrants has a fixed exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240627_ztRn2iQS7MY9" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-27" id="Fact000761" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">99</ix:nonFraction></span> per share. The June 27 Warrants are immediately exercisable and have a <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240627_zbTJcsbZj1Fi" title="Warrants term"><ix:nonNumeric contextRef="AsOf2024-06-27" format="ixt-sec:duryear" id="Fact000763" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span>-year
    term.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition, the management allocated the gross cash proceeds received based on the relative fair value of the June 27 Notes
    and the detachable June 27 Warrants in total amount of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240627__20240627_zmtZee7eSgq2" title="Proceeds from notes"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-06-272024-06-27" id="Fact000765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240627__20240627_z9moFUDsLI2h" title="Fair value of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-06-272024-06-27" id="Fact000767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></span>, respectively. The fair value of the June 27 Note was determined
    based on a rating model using a debt discount rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240627_zfFYEaz45n3" title="Debt discount rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-06-27" id="Fact000769" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28.65</ix:nonFraction></span>% which represented the Company&#8217;s applicable rate of risk. The fair
    value of the June 27 Warrants was determined by using Black-Scholes pricing model taking into account, inter alia, expected stock
    price volatility of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20240627__20240627_zu3fi8rRqQJ2" title="Price volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-06-272024-06-27" id="Fact000771" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">245</ix:nonFraction></span>% and risk-free interest rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20240627__20240627_zNbNEZZm8Gz9" title="Risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-06-272024-06-27" id="Fact000773" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.52</ix:nonFraction></span>%. The amount allocated to June 27 Warrants was classified as a component
    of equity (as their terms permit the holders to receive a fixed number of shares of common stock upon exercise for a fixed exercise
    price).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    June 27 Notes were accounted for as a financial liability measured at amortized cost. In subsequent periods, the Company recognized
    a discount and interest expense over the economic life of the June 27 Notes based on the effective interest rate method.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tabular presentation reflects the reconciliation of the carrying amount of the June 27 Notes during the period of years ended
December 31, 2024:</span></p>

<ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember" escape="true" id="Fact000775" name="GCTK:ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zxSka9mHzdi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zID20Ar4xsO6" style="display: none">SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zQzBG2rGhi89" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended<br/> December 31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--WarrantsAndRightsOutstanding_iS_pn3n3_zBqCZcYjxCba" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_zNAWB0oWRiXf" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total proceeds received</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember" id="Fact000779" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromAllocatedWarrantsAtInitialRecognition_pn3n3_zl0W3dNDg9Md" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total proceeds allocated to June 27 Warrants
    at initial recognition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GCTK:ProceedsFromAllocatedWarrantsAtInitialRecognition" contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember" id="Fact000781" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">85</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--DiscountAmortizationAndInterestExpenses_pn3n3_zjUlikiL6W5f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount amortization and interest expenses
    related to June 27 Notes (Note 7 below)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:DiscountAmortizationAndInterestExpenses" contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember" id="Fact000783" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--PartialConversionNotesAndAccruedInterest_pn3n3_zblcEzG7AGM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Partial conversion June
    27 Notes and accrued Interest (Note 4H and Note 4I below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GCTK:PartialConversionNotesAndAccruedInterest" contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember" id="Fact000785" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstanding_iE_pn3n3_z7iEpCvk4pL" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance December</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31_custom_JuneTwentySevenWarrantsMember" id="Fact000787" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_ztXZHekuZg23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period commencing the issuance date through December 31, 2024, none of the June 27 Warrants have been exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
    Promissory Notes</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            July 18, 2024, the Company entered into a series of convertible promissory notes with three
                                            directors, and one member of the Company&#8217;s executive management (the &#8220;July 18
                                            Investors&#8221;), providing for the private placement of unsecured convertible promissory
                                            notes in the aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zGIEAjUhfCd4" title="Debt instrument face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-07-18_us-gaap_ConvertibleNotesPayableMember" id="Fact000789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">360</ix:nonFraction></span> (the &#8220;July 18 Notes&#8221; and each
                                            a &#8220;July 18 Note&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    July 18 Notes bore simple interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zmxR4IGaVL76" title="Debt instrument interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-07-18_us-gaap_ConvertibleNotesPayableMember" id="Fact000791" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum. Upon initial date, the management measured the fair value of the embedded
    conversion feature which is accounted for as embedded derivative liability. The difference between the total gross cash proceeds
    received and the fair value of the embedded conversion feature is allocated to the host component of the July 18 Notes that are measured
    at amortized cost under which in subsequent periods the Company recognizes a discount expense over the economic life of the July
    18 Notes based on the effective interest rate method. However, the fair value of the embedded derivative liability related to the
    conversion feature was determined by the management at an insignificant amount since upon closing of a Qualified Financing, the loan
    will convert based on market conditions (i.e. conversion price will be equal to the fair value of the share upon conversion) and
    thus all proceeds received of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_pn3n3_c20240718__20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z352712MHZhd" title="Conversion price"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2024-07-182024-07-18_us-gaap_ConvertibleNotesPayableMember" id="Fact000793" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">360</ix:nonFraction></span> were allocated to the July 18 Notes.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 5, 2024, the Company and one of July 18 noteholders entered into a conversion agreement, under which the Company agreed
    to convert his portion of the outstanding principal nominal amount plus any accrued but unpaid interest pursuant to the July 18 Note,
    totaling $<span id="xdx_904_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFGdte93rCyg" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-09-052024-09-05_us-gaap_ConvertibleNotesPayableMember" id="Fact000795" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></span> into <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240905__20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z7AIvJgbwjh6" title="Stock issued during period shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-09-052024-09-05_us-gaap_ConvertibleNotesPayableMember" id="Fact000797" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,955</ix:nonFraction></span> shares of Common Stock at a conversion price of $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjyKAXhkdBSd" title="Conversion price per share"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-09-05_us-gaap_ConvertibleNotesPayableMember" id="Fact000799" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.4</ix:nonFraction></span> per share. Please see note 4I.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In
    November 2024, the Company and the remaining July 18 noteholders entered into a conversion agreement under which the Company agreed
    to convert their portion of the outstanding principal nominal amount plus any accrued but unpaid interest pursuant to the July 18
    Note, totaling $<span id="xdx_90E_eus-gaap--InterestExpense_pn3n3_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO1wVwsBdW87" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-11-012024-11-30_us-gaap_CommonStockMember" id="Fact000801" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">305</ix:nonFraction></span>
    to Common Stock and warrants at a conversion price of $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZ6V3R04nNxe" title="Conversion price per share"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-11-30_us-gaap_WarrantMember" id="Fact000803" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">31.2</ix:nonFraction></span>
    per share. The July 18 noteholders received <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOm3FLVIkE5d" title="Stock issued during period shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-11-012024-11-30_us-gaap_CommonStockMember" id="Fact000805" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">9,760</ix:nonFraction></span>
    shares of Common Stock, <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesACommonWarrantMember_zrF4T0nv00Dl" title="Stock issued during period shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-11-012024-11-30_custom_SeriesACommonWarrantMember" id="Fact000807" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,760</ix:nonFraction></span>
    Series A Warrants and <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesBCommonWarrantMember_zE7t1kVmD8r9" title="Stock issued during period shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-11-012024-11-30_custom_SeriesBCommonWarrantMember" id="Fact000809" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,760</ix:nonFraction></span>
    Series B Warrants. The fair value of the shares of Common Stock received was $<span id="xdx_905_eus-gaap--CommonStockSharesSubscriptions_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpW3GebmbFoi" title="Fair value of common stock"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2024-11-30_us-gaap_CommonStockMember" id="Fact000811" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span>.
    The Series A and Series B Warrants are treated as derivative liabilities and at grant date were valued at $<span id="xdx_909_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesACommonWarrantMember_zbghkfmRsmCh" title="Derivative financial liabilities"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-11-30_custom_SeriesACommonWarrantMember" id="Fact000813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></span>
    and $<span id="xdx_907_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesBCommonWarrantMember_z6A3HYYa6s56" title="Derivative financial liabilities"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-11-30_custom_SeriesBCommonWarrantMember" id="Fact000815" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">279</ix:nonFraction></span>,
    respectively. As a result, the Company recorded a loss on the settlement of debt in the amount of $<span id="xdx_902_eus-gaap--LitigationSettlementLoss_pn3n3_c20241101__20241130_z5O0Y6dxo2c4" title="Settlement of debt loss"><ix:nonFraction name="us-gaap:LitigationSettlementLoss" contextRef="From2024-11-012024-11-30" id="Fact000817" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span>
    in the Statement of Operations. Please see Note 4J for the terms and valuation methodology of the Series A and Series B
    Warrants.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
    Promissory Note and Warrant Agreements</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    July 30, 2024, the Company entered into a convertible promissory note and three warrant agreements (the &#8220;July 30 Warrants&#8221;)
    with an existing investor (the &#8220;July 30 Holder&#8221;), providing for the private placement of a secured convertible promissory
    note in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240730__us-gaap--ShortTermDebtTypeAxis__custom--ConvertiblePromissoryNotesMember__us-gaap--TypeOfArrangementAxis__custom--WarrantsAgreementMember_ztUekVUIZXOf" title="Debt instrument face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-07-30_custom_ConvertiblePromissoryNotesMember_custom_WarrantsAgreementMember" id="Fact000819" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></span> (the &#8220;July 30 Note&#8221;). The July 30 Note bore simple interest at a rate
    of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240730__us-gaap--ShortTermDebtTypeAxis__custom--ConvertiblePromissoryNotesMember__us-gaap--TypeOfArrangementAxis__custom--WarrantsAgreementMember_zW3TEMO4BSmh" title="Debt instrument interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-07-30_custom_ConvertiblePromissoryNotesMember_custom_WarrantsAgreementMember" id="Fact000821" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum and is due and payable in cash on earlier of: (i) 12 months anniversary of July 30 Note, or (ii) closing date of
    a Sale Transaction (defined below) (the &#8220;Maturity Date&#8221;). The July 30 Note is secured by a first-priority security interest
    on all Company&#8217;s assets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
July 30 Warrant becomes exercisable 12 months after its issuance and has term of <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20240730__20240730_z24iw094gAl8"><ix:nonNumeric contextRef="From2024-07-302024-07-30" format="ixt-sec:duryear" id="Fact000822" name="us-gaap:DebtInstrumentTerm">10</ix:nonNumeric></span> years. The July 30 Warrants are exercisable for cash
only and have no price-based antidilution. The first July 30 Warrant is for <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_z4Q0Cs9LY69h"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-302024-07-30_custom_FirstWarrantMember" id="Fact000823" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">106,667</ix:nonFraction></span> shares at $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zWwO0eENRtW6" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-07-30_custom_FirstWarrantMember" id="Fact000825" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.50</ix:nonFraction></span> per share. The second July 30 Warrant
is for <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zU1Ku3QGllpl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-302024-07-30_custom_SecondWarrantMember" id="Fact000826" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,191</ix:nonFraction></span> shares at $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_z3Ugdsmakn4" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-07-30_custom_SecondWarrantMember" id="Fact000828" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.50</ix:nonFraction></span> per share. The third July 30 Warrant is for <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_z1kbIallstY3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-302024-07-30_custom_ThirdWarrantMember" id="Fact000829" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,259</ix:nonFraction></span> shares at $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zgZYmHg1fRp1" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-07-30_custom_ThirdWarrantMember" id="Fact000831" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">67.50</ix:nonFraction></span> per share. Management has determined
that the warrants are eligible to be classified as a component of equity as their terms permit the holders to receive a fixed number
of shares of common stock upon exercise for a fixed exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the initial date, the Company has issued four freestanding instruments that include (i) a financial instrument that is considered as
&#8220;host&#8221; which comprised of July 30 Note and two embedded derivative financial instruments (i.e. an embedded conversion feature
and an embedded redemption feature to receive cash equals to <span id="xdx_90F_ecustom--EmbeddedConversionFeaturePercentage_iI_pid_dp_c20240730_zIsEmfYfef7g" title="Embedded conversion feature percentage"><ix:nonFraction name="GCTK:EmbeddedConversionFeaturePercentage" contextRef="AsOf2024-07-30" id="Fact000833" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">200</ix:nonFraction></span>% of July 30 Note balance upon the occurrence of a Sale Transaction)
and (ii) three series of detachable warrants. At the initial date, the Company is required to estimate the fair value of the freestanding
instruments and allocate the total gross proceeds received between them based on that relative fair value identified. The fair value
of the embedded derivative financial instruments (i.e. the conversion right and the redemption right) should be bifurcated from the host
instrument and remeasured on recurring basis at each reporting period under marked to market approach, the July 30 Note was accounted
for at amortized cost whereby discount and interest expenses are recorded over the economic life of the July 30 Note based on the effective
interest rate method and the July 30 Warrants are classified into equity without any further subsequent measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            initial recognition, the management by using the assistance of an external appraiser allocated
                                            the gross cash proceeds received based on the relative fair value of the July 30 Note and
                                            the detachable July 30 Warrants in total amount of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240730__20240730_zqSo9tsVZMv" title="Proceeds from notes"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-07-302024-07-30" id="Fact000835" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,450</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240730__20240730_zdMQ41uT4G04" title="Fair value of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-302024-07-30" id="Fact000837" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,550</ix:nonFraction></span>, respectively. The fair
                                            value of the convertible note was determined by using hybrid method that includes conversion
                                            scenario and liquidation scenario taking into account, inter alia, a debt discount rate of
                                            <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240730_zwJGQesNW7Je" title="Debt discount rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-07-30" id="Fact000839" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28.65</ix:nonFraction></span>%. The fair value of the July 30 Warrants was determined by using Black-Scholes pricing
                                            model taking into account, inter alia, expected stock price volatility of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240730__20240730_zqVH78shgyHi" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-302024-07-30" id="Fact000841" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">122.8</ix:nonFraction></span>% and risk-free
                                            interest rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240730__20240730_zmgCmHyq9079" title="Risk- free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-07-302024-07-30" id="Fact000843" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.78</ix:nonFraction></span>%. The amount allocated to July 30 Warrants was classified as a component
                                            of equity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
    it was determined that the embedded conversion feature and embedded redemption feature are required to be bifurcated from the host
    loan instrument. The fair value of the bifurcated derivatives was determined by the management using the assistance of an external
    appraiser in a total amount of $<span id="xdx_903_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_c20240730_zWIAD82R0aM3" title="Fair value of embedded derivative liability"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2024-07-30" id="Fact000845" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></span> upon initial recognition and in subsequent periods as derivative liability at fair value through
    profit and loss. The remaining amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240730_z7woT8PnKIq4"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-07-30" id="Fact000846" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,415</ix:nonFraction></span> was allocated to the host loan instrument which in subsequent periods was accounted
    for using the effective interest method over the term of the loan, until its stated maturity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 24, 2024, the Company held a special meeting of its stockholders under which shares of common stock issuable by the Company
upon conversion of the July 30 Note and exercise of the July 30 Warrants was approved. The July 30 Holder has not elected to trigger
the exercise of the July 30 Warrants into shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 12, 2024, the Company and the July 30 Holder entered into an agreement for the settlement of the July 30 Note plus any accrued
but unpaid interest totaling $<span id="xdx_902_eus-gaap--InterestExpense_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zX0cijeriv81" title="Unpaid interest"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember" id="Fact000848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,093</ix:nonFraction></span> to Common Stock and warrants at a conversion price of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zsV6MmZsmKD5" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember" id="Fact000850" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">31.0</ix:nonFraction></span> per share. The July 30 Holder received
<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zsTiE8jZpGi" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember" id="Fact000852" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">132,036</ix:nonFraction></span> shares of Common Stock, <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zM5mUwXLFugi" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember" id="Fact000854" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">132,036</ix:nonFraction></span> Series A Warrants and <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zTeq0VCiAZ6f" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember" id="Fact000856" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">132,036</ix:nonFraction></span> Series B Warrants. The fair value of the shares of Common Stock
received was $<span id="xdx_908_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zQjXYDtMfBma" title="Fair value"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember" id="Fact000858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">813</ix:nonFraction></span>. The Series A and Series B Warrants are treated as derivative liabilities and at grant date were valued at $<span id="xdx_905_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zJ36WYzAnv99" title="Derivative liabilities"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember" id="Fact000860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">609</ix:nonFraction></span> and
$<span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zIQyIiV0gD68" title="Derivative liabilities"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember" id="Fact000862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,768</ix:nonFraction></span>, respectively. As of the settlement date, the carrying amount of the July 30 Note under the effective interest method was $<span id="xdx_90D_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zJmXQPChHK3c" title="Fair value of the derivative liability"><ix:nonFraction name="us-gaap:DerivativeLiabilityFairValueOfCollateral" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember" id="Fact000864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,978</ix:nonFraction></span>
and the fair value of the derivative liability relating to the conversion feature was $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zcNAy2fNwUEe" title="Conversion amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember" id="Fact000866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></span>. Upon settlement, the total fair value of
the warrant related derivatives of $<span id="xdx_908_ecustom--FairValueOfWarrantRelatedDerivatives_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zVrWQQeFlpF2" title="Fair value of the warrant related derivatives"><ix:nonFraction name="GCTK:FairValueOfWarrantRelatedDerivatives" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember" id="Fact000868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,377</ix:nonFraction></span> and the equity received of $<span id="xdx_900_ecustom--FairValueOfWarrantRelatedDerivativesValue_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zeVJKt7GYZu9" title="Fair value of the warrant related derivatives book value"><ix:nonFraction name="GCTK:FairValueOfWarrantRelatedDerivativesValue" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember" id="Fact000870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">813</ix:nonFraction></span> exceeded the net book value of the July 30 Note of $<span id="xdx_90F_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zIfR0Di3BRqd" title="Fair value of the derivative liability"><ix:nonFraction name="us-gaap:DerivativeLiabilityFairValueOfCollateral" contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember" id="Fact000872" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,978</ix:nonFraction></span> and
the value of the debt conversion derivative that was settled of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zxci8mtEqcGc" title="Conversion amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember" id="Fact000874" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></span>. As a result, the Company recorded a loss on  extinguishment of debt
in the amount of $<span id="xdx_900_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20241112__20241112_zCYwIZucXBB" title="Loss on settlement debt"><ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2024-11-122024-11-12" id="Fact000876" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,175</ix:nonFraction></span> in the Statement of Operations. Please see Note 4J for the terms and valuation methodology of the Series A and
Series B Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
    23 Conversion</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 23, 2024 (the &#8220;Commitment Date&#8221;), the Company and two of June 27 Investors entered into conversion agreement,
    under which the Company agreed to convert the principal nominal amount plus any accrued but unpaid interest pursuant to each of June
    27 Notes, with a face value of $<span id="xdx_90F_eus-gaap--InterestExpense_pn3n3_c20240823__20240823__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zbMIAdMndhwg" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-08-232024-08-23_custom_JuneTwentySevenNotesMember" id="Fact000878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span> each (the &#8220;Debt&#8221;), held by the Investors to Common Stock at a conversion price of
    $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zySWPQaJNg5h" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-08-23_custom_JuneTwentySevenNotesMember" id="Fact000880" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.4</ix:nonFraction></span> per share. On October 15, 2024, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241015__20241015_zkNOk5IwPrRg" title="Stock issued during period shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-10-152024-10-15" id="Fact000882" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">985</ix:nonFraction></span> shares of common stock for each of the two of the June 27 Investors
    in respect of each respective Debt converted.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            satisfaction of the Debt, the Company also issued to each of the two June 27 Investors three
                                            warrants (each an &#8220;August 23 Warrant&#8221;). Each August 23 Warrant becomes exercisable
                                            on <span id="xdx_906_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20240823__20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantMember_z17UjLLG5V18" title="Warrants exercisable"><ix:nonNumeric contextRef="From2024-08-232024-08-23_custom_AugustTwentyThreeWarrantMember" format="ixt:datemonthdayyearen" id="Fact000884" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">August 16, 2025</ix:nonNumeric></span> and has term of <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantMember_zox6rZrPFCMa" title="Warrants and rights outstanding term"><ix:nonNumeric contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantMember" format="ixt-sec:durwordsen" id="Fact000886" name="us-gaap:WarrantsAndRightsOutstandingTerm">10 years</ix:nonNumeric></span>. The August 23 Warrants are exercisable for cash
                                            only and have no price-based antidilution. The first August 23 Warrant is for <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantOneMember_zBTOw9onf0lc" title="Class of warrant or right number of securities called by warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantOneMember" id="Fact000888" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">535</ix:nonFraction></span> shares
                                            of Common Stock and is exercisable at $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantOneMember_zl5Zo0nipCH5" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantOneMember" id="Fact000890" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.5</ix:nonFraction></span> per share. The second August 23 Warrant is for
                                            <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantTwoMember_zFSd0H8KkNk4" title="Class of warrant or right number of securities called by warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantTwoMember" id="Fact000892" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382</ix:nonFraction></span> shares of Common Stock, exercisable at $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantTwoMember_zVpQ5VfNf7Fg" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantTwoMember" id="Fact000894" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.5</ix:nonFraction></span> per share. The third August 23 Warrant is
                                            for <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantThreeMember_zmqSh3JPAbhg" title="Class of warrant or right number of securities called by warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantThreeMember" id="Fact000896" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">297</ix:nonFraction></span> shares of Common Stock, exercisable at $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantThreeMember_zJiZ1aa04Xi2" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantThreeMember" id="Fact000898" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">67.5</ix:nonFraction></span> per share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    above transaction was accounted for as a settlement of financial liabilities under which the instruments issued or to be issued to
    the June 27 Investors (i.e. shares of common stock and August 23 Warrants) are eligible for equity classification and thus both have
    been recorded as part of equity based on the total fair value of $<span id="xdx_904_eus-gaap--EquityFairValueDisclosure_iI_pn3n3_c20240823_z09wiISPCquk" title="Equity fair value disclosure"><ix:nonFraction name="us-gaap:EquityFairValueDisclosure" contextRef="AsOf2024-08-23" id="Fact000900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">238</ix:nonFraction></span> at the Commitment Date. The difference between the fair value
    of these equity instruments and the carrying amount of each of the respective Debt at the Commitment Date amounted to $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240823_zVWWZ50izxml" title="Debt instrument face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-08-23" id="Fact000902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span> was charged
    immediately to the finance expenses (see also Note 7 below). Due to the above settlement, the Company recorded a loss on the settlement
    on the amount of $<span id="xdx_90E_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20240823__20240823_zABvb7YnA8A3" title="Loss on settlement debt"><ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2024-08-232024-08-23" id="Fact000904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span>.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the period commencing the issuance date through December 31, 2024, none of the August 23 Warrants have been exercised.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
    5 Conversion</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            September 5, 2024 (the &#8220;Commitment Date&#8221;), the Company and one of June 27 Investors
                                            and July 18 Investors entered into a conversion agreement, under which the Company agreed
                                            to convert outstanding board fees amounted $<span id="xdx_90F_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_z9pzxzE6iHB9" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-09-052024-09-05_custom_JuneTwentySevenNotesMember" id="Fact000906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113</ix:nonFraction></span> and the principal nominal amount plus any
                                            accrued but unpaid interest pursuant to June 27 Note and July 18 Note, totaling $<span id="xdx_909_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--JulyEighteenNotesMember_zEH9y3uBrvh4" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-09-052024-09-05_custom_JulyEighteenNotesMember" id="Fact000908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">146</ix:nonFraction></span> (referring
                                            together as a &#8220;Debt&#8221;), held by the Investor to Common Stock at a conversion price
                                            of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--JulyTwentySevenNotesMember_zO03f1MMbfPa" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-09-05_custom_JulyTwentySevenNotesMember" id="Fact000910" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.4</ix:nonFraction></span> per share. On October 15, 2024, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241015__20241015__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zKAXvRUgXwKc" title="Stock issued during period shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-10-152024-10-15_custom_JuneTwentySevenNotesMember" id="Fact000912" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,712</ix:nonFraction></span> shares of common stock
                                            for the June 27 Investor in respect of the Debt converted.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    satisfaction of the Debt, the Company also issued to June 27 Investor and July 18 Investor three warrants (each an &#8220;September
    5 Warrant&#8221;). Each September 5 Warrant becomes exercisable on <span id="xdx_904_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsMember_zrJHLMPfYbN1" title="Warrants exercisable"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_SeptemberFiveWarrantsMember" format="ixt:datemonthdayyearen" id="Fact000914" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">August 16, 2025</ix:nonNumeric></span> and has term of <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsMember_zYMEHkoOBh22" title="Warrants and rights outstanding term"><ix:nonNumeric contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsMember" format="ixt-sec:durwordsen" id="Fact000916" name="us-gaap:WarrantsAndRightsOutstandingTerm">10 years</ix:nonNumeric></span>. The September 5 Warrants
    are exercisable for cash only and have no price-based antidilution. The first September 5 Warrant is for <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsOneMember_zzRItV2Z0FV1" title="Class of warrant or right number of securities called by warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsOneMember" id="Fact000918" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,915</ix:nonFraction></span> shares of Common Stock
    and is exercisable at $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsOneMember_zNOlSfhqkr7" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsOneMember" id="Fact000920" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.5</ix:nonFraction></span> per share. The second September 5 Warrant is for <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsTwoMember_zuiLyxiXgVBc" title="Class of warrant or right number of securities called by warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsTwoMember" id="Fact000922" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,940</ix:nonFraction></span> shares of Common Stock, exercisable at $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsTwoMember_zCw1Ee4GHrzg" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsTwoMember" id="Fact000924" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.5</ix:nonFraction></span> per
    share. The third September 5 Warrant is for <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsThirdMember_zxa637LkjBKi" title="Class of warrant or right number of securities called by warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsThirdMember" id="Fact000926" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,842</ix:nonFraction></span> shares of Common Stock, exercisable at $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsThirdMember_zCZWpWrxNCj6" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsThirdMember" id="Fact000928" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">67.5</ix:nonFraction></span> per share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    above transaction was accounted for as settlements of financial liabilities under which the instruments issued or to be issued to
    the July 18 Investor (i.e. shares of common stock and September 5 Warrants) are eligible for equity classification and thus both
    have been recorded as part of equity based on the total fair value of $<span id="xdx_901_eus-gaap--EquityFairValueDisclosure_iI_pn3n3_c20240905_zOmw3OhEbMwa" title="Equity fair value disclosure"><ix:nonFraction name="us-gaap:EquityFairValueDisclosure" contextRef="AsOf2024-09-05" id="Fact000930" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,505</ix:nonFraction></span> at the Commitment Date. The carrying amount of the Debt
    at the Commitment Date amounted to $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240905_zRgoLrr0GsIl" title="Debt instrument face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-09-05" id="Fact000932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">227</ix:nonFraction></span> and the difference was recorded as loss on settlement of debt in the Statement of Operations
    in the amount of $<span id="xdx_905_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20240905__20240905_zGqVLk76fea9" title="Loss on settlement debt"><ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2024-09-052024-09-05" id="Fact000934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,278</ix:nonFraction></span> (see also Note 7 below).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the period commencing the issuance date through December 31, 2024, none of the September 5 Warrants have been exercised.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>November
    12 Issuance</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 12, 2024, the Company completed a public offering (the &#8220;Offering&#8221;) under
                                            which the Company received gross proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20241112__20241112_zWMSviPQXNsj" title="Gross proceeds from public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2024-11-122024-11-12" id="Fact000936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,000</ix:nonFraction></span> in exchange for issuance of an aggregate
                                            of (i) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSJlQiH5QPG5" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-11-122024-11-12_us-gaap_CommonStockMember" id="Fact000938" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">121,867</ix:nonFraction></span> shares (the &#8220;Shares&#8221;) of its Common Stock, (ii) <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zBmn4GDkNb6e" title="Warrants to purchase shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember" id="Fact000940" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,845</ix:nonFraction></span> pre-funded
                                            warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to an aggregate of <span id="xdx_905_eus-gaap--SharesIssued_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zRv3svNccvHe" title="Shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember" id="Fact000942" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,845</ix:nonFraction></span>
                                            shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;) in lieu of Shares, (iii)
                                            Series A Warrants (the &#8220;Series A Warrants&#8221;) to purchase up to <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonWarrantMember_zm5NzMxZQNA7" title="Warrants to purchase shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-11-12_custom_SeriesACommonWarrantMember" id="Fact000944" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">359,712</ix:nonFraction></span> shares
                                            of Common Stock (the &#8220;Series A Warrant Shares&#8221;) and (iv) Series B Warrants (the
                                            &#8220;Series B Warrants&#8221; and, together with the Series A Warrants, the &#8220;Common
                                            Warrants&#8221;) to purchase up to <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBCommonWarrantMember_zdTkdbD1EI43" title="Warrants to purchase shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-11-12_custom_SeriesBCommonWarrantMember" id="Fact000946" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">359,712</ix:nonFraction></span> shares of Common Stock (&#8220;the &#8220;Series
                                            B Warrant Shares&#8221; together with the Series A Warrant Shares, the &#8220;Warrant Shares&#8221;).
                                            Each Share or Pre-Funded Warrant, as applicable, was sold together with one Series A Warrant
                                            to purchase one share of Common Stock and one Series B Warrant to purchase one Common Share.
                                            The public offering price for each Share and accompanying Common Warrants was $<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_zKl7wgiBIuCc" title="Shares issued, per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember28421031" id="Fact000948" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">27.80</ix:nonFraction></span>, and
                                            the public offering price for each Pre-Funded Warrant and accompanying Common Warrants was
                                            $<span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1EMHM1vM2we" title="Shares issued, per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-12_us-gaap_IPOMember" id="Fact000950" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">27.78</ix:nonFraction></span> (the &#8220;Offering Price&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Pre-Funded Warrants have an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zZvYu8Vi9P68" title="Warrant, exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember" id="Fact000952" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></span> per share, are exercisable immediately and expire when exercised in full. Each
    Series A Common Warrant will have an exercise price per share of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonWarrantMember_zKpeGoJL24Pi" title="Warrant, exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-11-12_custom_SeriesACommonWarrantMember" id="Fact000954" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">36.2</ix:nonFraction></span> and will be exercisable beginning on the date on which Stockholder
    Approval (as defined below) is received and deemed effective (the &#8220;Initial Exercise Date&#8221; or the &#8220;Stockholder Approval
    Date&#8221;). The Series A Warrants will expire on the five-year anniversary of the Initial Exercise Date. The Series B Warrants
    will have an exercise price per share of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBCommonWarrantMember_zjlVZPq8QtB8" title="Warrant, exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-11-12_custom_SeriesBCommonWarrantMember" id="Fact000956" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">36.2</ix:nonFraction></span> and will be exercisable beginning on the Initial Exercise Date. The Series B Warrants
    will expire on the two and one-half year anniversary of the Initial Exercise Date. The issuance of Common Warrant Shares upon exercise
    of the Common Warrants is subject to stockholder approval under applicable rules and regulations of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
    (&#8220;Stockholder Approval&#8221; and the date on which Stockholder Approval is received and deemed effective, the &#8220;Stockholder
    Approval Date&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    exercise price of Series A Warrants and Series B Warrants is subject to certain adjustments. If at the time of exercise there is
    no effective registration statement registering, or the prospectus is not available for the issuance of the Series A Warrants Shares
    and Series B Warrant Shares to the holders, then the Series A Warrants and Series B Warrants may also be exercised, in whole or in
    part, at such time by means of a &#8220;cashless exercise&#8221;. In addition, the holders are entitled to an option to require the
    Company to purchase the Series A Warrants and Series B Warrants for cash in an amount equal to their Black-Scholes Option Pricing
    Model value, in the event that certain fundamental transactions (which some of them are not considered solely within the control
    of the Company) as defined in the Series B Warrants agreement, occur. Additionally, holders of Series B Warrants may also effect
    an &#8220;alternative cashless exercise&#8221; at any time while the Series B Warrants are outstanding following the Initial Exercise
    Date. Under the alternate cashless exercise option, the holder of the Series B Warrant has the right to receive an aggregate number
    of shares equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cashless exercise
    of the Series B Warrant and (ii) 3.0. The Company analyzed the terms of the warrants in accordance with Accounting Standards Codification
    No. 480, <i>Distinguishing Liabilities from Equity</i> (&#8220;ASC 480&#8221;) and determined that the Series A and Series B Warrants
    are not eligible for equity classification and thus would be classified as derivative liabilities and recorded at fair value, with
    changes in fair value recorded through profit or loss. The Company used the Monte Carlo Simulation method for determining the fair
    value of the warrants. The Series A Warrant assumptions used in the Monte Carlo simulations are an expected term of <span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z9949G0KyME5" title="Expected term years"><ix:nonNumeric contextRef="From2024-11-122024-11-12_custom_SeriesAWarrantMember" format="ixt-sec:duryear" id="Fact000958" name="us-gaap:DebtInstrumentTerm">5</ix:nonNumeric></span> years, exercise
    price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zapUGoyJRTH2" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember" id="Fact000960" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">36.2</ix:nonFraction></span>, comparable company volatility of <span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zfbhkTyUAOkj" title="Volatility rate"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember" id="Fact000962" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">96.3</ix:nonFraction></span>%, risk-free interest rate of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zdUvutBgIIG1" title="Interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-11-122024-11-12_custom_SeriesAWarrantMember" id="Fact000964" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.32</ix:nonFraction></span>% and share price of $<span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zG3cqmPoSnke" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember" id="Fact000966" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.17</ix:nonFraction></span>. The Series B Warrant
    assumptions used in the Monte Carlo simulations are an expected term of <span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z5PN0aZYYAta" title="Expected term years"><ix:nonNumeric contextRef="From2024-11-122024-11-12_custom_SeriesBWarrantMember" format="ixt-sec:duryear" id="Fact000968" name="us-gaap:DebtInstrumentTerm">2.5</ix:nonNumeric></span> years, exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdp6iUyw1Rkd" title="exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember" id="Fact000970" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">36.2</ix:nonFraction></span>, company historical volatility
    of <span id="xdx_903_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zTOC484c1zv6" title="volatility"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember" id="Fact000972" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">378.6</ix:nonFraction></span>%, risk-free interest rate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zH1czuAkJ01d" title="Risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-11-122024-11-12_custom_SeriesBWarrantMember" id="Fact000974" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.30</ix:nonFraction></span>% and share price of $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zFDs7PjQaQr4" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember" id="Fact000976" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.17</ix:nonFraction></span>.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition, the management allocated the gross cash proceeds to the detachable instruments included in the issuance, firstly
    to Series A Warrants and Series B Warrants which were classified as financial instruments that are required to be subsequently measured
    at fair value. The fair value at the issuance date of the Series A and Series B Warrants received was $<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zuLbq51y5WQ7" title="Fair value issuance"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember" id="Fact000978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,659</ix:nonFraction></span> and <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zFrPrcpYpKd6" title="Fair value issuance"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember" id="Fact000980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,266</ix:nonFraction></span>, respectively.
    Accordingly, there were no remaining proceeds to allocate to the equity instruments (the Shares and the Pre-Funded Warrants). Issuance
    costs in the amount of $<span id="xdx_903_ecustom--EquityIssuanceCosts_pn3n3_c20240101__20241231_zw0w21SCrWjg" title="Equity issuance costs"><ix:nonFraction name="GCTK:EquityIssuanceCosts" contextRef="From2024-01-01to2024-12-31" id="Fact000982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,217</ix:nonFraction></span> were recorded as expenses in the Statement of Operations.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition, as the total fair value of the derivative liabilities amounting to $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241231_zmNPvMQPCwh7" title="Fair value issuance"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31" id="Fact000984" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,925</ix:nonFraction></span> exceeded the $<span id="xdx_90B_ecustom--ClassOfWarrantOrRightReasonForCashRaised_pn3n3_c20240101__20241231_z0mpSHsOPeug" title="Fair value cash raised"><ix:nonFraction name="GCTK:ClassOfWarrantOrRightReasonForCashRaised" contextRef="From2024-01-01to2024-12-31" id="Fact000986" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,000</ix:nonFraction></span> of cash raised in the issuance,
    the Company recorded an immediate loss from the issuance of equity in the amount of $<span id="xdx_901_ecustom--GainLossOnEquityIssuance_iN_pn3n3_di_c20240101__20241231_z4w4LImdwUVb" title="Loss on equity issuance"><ix:nonFraction name="GCTK:GainLossOnEquityIssuance" contextRef="From2024-01-01to2024-12-31" id="Fact000988" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,925</ix:nonFraction></span> in the Statement of Operations.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Note 14 regarding a significant issuance of shares as a settlement of Series B Warrants subsequent to the balance sheet date.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tabular presentation reflects the reconciliation of the fair value of the Warrants during the period from their issuance through
December 31, 2024:</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000990" name="GCTK:ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_zHPTjgCmnKH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zrEEX7hZhYze" style="display: none">SCHEDULE OF RECONCILIATION OF THE
FAIR VALUE OF THE WARRANTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Common Warrants</b></td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    A Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    B Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">July issuance</td>
    <td>&#160;</td>
    <td>$</td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zothQHk05qo5" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyMember" id="Fact000991" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34</ix:nonFraction></td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zyjzotPs6cZk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Settlement of July warrants</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_98D_eus-gaap--DerivativeLiabilities_iNI_di_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zM5WrZeLqBHa" style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyWarrantsMember" id="Fact000993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></td>
    <td>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zSEgNfU2s6Q6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">November issuance</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 12%">-</td>
    <td style="width: 1%">&#160;</td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zAHJKYckqqI" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember" id="Fact000995" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,659</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z2SDXoaKDPl4" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember" id="Fact000996" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,266</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231_zEoAAEQdhnG6" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31" id="Fact000997" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,925</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Settlement of July 30 Convertible Promissory
    Note</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zKji4VH4AQU9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyThirtyMember" id="Fact000998" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">609</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_z8ojZdUDHMI1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyThirtyMember" id="Fact000999" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,768</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zdfnem8pASHg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_custom_JulyThirtyMember" id="Fact001000" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,377</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Settlement of July 18 Convertible Promissory
    Note</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_z4eCCdZQksGh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyEighteenMember" id="Fact001001" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zYXCzt00Le54" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyEighteenMember" id="Fact001002" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">279</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zVSbUt2Vord9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-12-31_custom_JulyEighteenMember" id="Fact001003" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">324</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zm6qh7wfSiLg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember28421750" id="Fact001004" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zIrMNUIrn8Mi" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-12-31_custom_SeriesAWarrantMember" id="Fact001005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">230</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zyr94jq70tQ2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-12-31_custom_SeriesBWarrantMember" id="Fact001006" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">565</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231_zrbSjxmjjQ8e" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-01to2024-12-31" id="Fact001007" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">798</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2024</span></td>
    <td>&#160;</td>
    <td><b>$</b></td>
    <td style="text-align: right"><b>-</b></td>
    <td>&#160;</td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z2TXbwpfsUo9" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember" id="Fact001008" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,544</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdqXFV0gyFfi" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember" id="Fact001009" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,877</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_znRu6gwQIiKe" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2024-12-31" id="Fact001010" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,421</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001012" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zEHqyKYrVkde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_822_zi4zQGR3fTw">COMMITMENTS AND CONTINGENT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    2004, the Israeli Innovation Authority (IIA) provided Integrity Israel with a grant of approximately $<span id="xdx_908_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember_zetCAtf0Hq11"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember" id="Fact001013" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span> (NIS <span id="xdx_902_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_uIsrael_c20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember_zuBzhv6IbkT1" title="Contingent consideration liability"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember" id="Fact001015" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Israel">420,000</ix:nonFraction></span>), for develop
    a non-invasive blood glucose monitor (the &#8220;Development Plan&#8221;). Integrity Israel is required to pay royalties to IIA at
    a rate ranging between <span id="xdx_90B_ecustom--RoyaltyPercentage_pid_dp_uPure_c20040303__20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember__srt--RangeAxis__srt--MinimumMember_z5RtbXBJvz0l" title="Royalty percentage minimum"><ix:nonFraction name="GCTK:RoyaltyPercentage" contextRef="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MinimumMember" id="Fact001017" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3</ix:nonFraction></span>-<span id="xdx_903_ecustom--RoyaltyPercentage_pid_dp_uPure_c20040303__20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember__srt--RangeAxis__srt--MaximumMember_z10Fcv8efBy9" title="Royalty percentage maximum"><ix:nonFraction name="GCTK:RoyaltyPercentage" contextRef="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MaximumMember" id="Fact001019" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% of the proceeds from sale of the Company&#8217;s products arising from the Development Plan up to an
    amount equal to $<span id="xdx_90A_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20040304__dei--LegalEntityAxis__custom--IsraeliInnovationAuthorityMember_zwWDitPsIrN5" title="Business combination contingent consideration liability"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember28422109" id="Fact001021" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span>, plus interest at LIBOR from the grant date. Until December 31,2023 the Liability was subject to LIBOR interest
    rate and commencing January 1,2024 the interest rate was replaced with Term SOFR (Secured Overnight Financing Rate). As of December
    31, 2024, the remaining contingent liability with respect to royalty payment on future sales equals approximately $<span id="xdx_90A_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20241231__dei--LegalEntityAxis__custom--IsraeliInnovationAuthorityMember_zu37c9wZAwJ7" title="Contingent consideration liability"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2024-12-31_custom_IsraeliInnovationAuthorityMember" id="Fact001023" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span>, excluding
    interest. Such contingent obligation has no expiration date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 7, 2022 (&#8220;the Closing Date&#8221;), the Company entered into Intellectual Property Purchase Agreement (the &#8220;Agreement&#8221;)
    with Paul Goode, which is the Company&#8217;s Chief Executive Officer (the &#8220;Seller&#8221;), under which it was agreed that
    on and subject to the terms and conditions of the Agreement, at the Closing Date, Seller sold and assigned to the Company, all of
    Seller&#8217;s right, title and interest in and to the following assets, properties and rights (collectively, the &#8220;Purchased
    Assets&#8221;): (i) all rights, title, interests in all current and future intellectual property, including, but not limited to patents,
    trademarks, trade secrets, industry know-how and other IP rights relating to an implantable continuous glucose sensor (collectively,
    the &#8220;Conveyed Intellectual Property&#8221;); and (ii) all the goodwill relating to the Purchased Assets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            consideration for the sale of the Purchased Assets to the Company, at the Closing Date, the
                                            Company paid to Seller cash in the amount of one dollar and obligated to issue up to <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221007__20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWZfCLCqLA46" title="Number of common shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember" id="Fact001025" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span>
                                            shares of Common Stock to be issued based upon specified performance milestones as set forth
                                            in the Agreement (the &#8220;Purchase Price&#8221;). In addition, if upon the final issuance,
                                            the aggregate <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221007__20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zXURTxGcQiSh" title="Number of common shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember" id="Fact001027" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span> shares represent less than <span id="xdx_905_ecustom--AggregateSalesPriceOfUnitsPercentage_iI_pid_dp_uPure_c20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zBos30nfLKbc" title="Commission as a percentage of aggregate sales price"><ix:nonFraction name="GCTK:AggregateSalesPriceOfUnitsPercentage" contextRef="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember" id="Fact001029" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span>% of the then outstanding Common Stock
                                            of the Company, the final issuance will include such number of additional shares so that
                                            the total aggregate issuance equals <span id="xdx_900_ecustom--AggregateSalesPriceOfUnitsPercentage_iI_pid_dp_uPure_c20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__custom--TrueupSharesMember_zgC4d7NKwUel" title="Commission as a percentage of aggregate sales price"><ix:nonFraction name="GCTK:AggregateSalesPriceOfUnitsPercentage" contextRef="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember_custom_TrueupSharesMember" id="Fact001031" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span>% of the outstanding shares (the &#8220;True-Up Shares&#8221;).
                                            All shares of Common Stock of the Company that will be issued under the agreement shall be
                                            (i) restricted over a limited period as defined in the Agreement and (ii) subject to the
                                            lockup provisions.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    the Company acquires net assets that do not constitute a business, as defined under ASU 2017-01 Business Combinations (Topic 805)
    Clarifying the Definition of a Business (such when there is no substantive process in the acquired entity) the transaction is accounted
    for as asset acquisition and no goodwill is recognized. The acquired In-Process Research and Development intangible asset (&#8220;IPR&amp;D&#8221;)
    to be used in research and development projects which have been determined not to have alternative future use at the acquisition
    date, is expensed immediately.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the Closing Date, it was determined that the asset acquisition represents the purchase of IPR&amp;D with no alternative future use.
    However, the achievement of each of the performance milestones is considered as a contingent event outside the Company&#8217;s control
    and thus the contingent consideration which is equal to the fair value of the Purchase Price as measured at the Closing Date will
    be recognized when and if it becomes probable that each target will be achieved within the reasonable period. Such additional contingent
    consideration will be recognized in subsequent periods if and when the contingency (the achievement of targets) is resolved.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            June 2023, the Company achieved the first performance milestone out of the five performance
                                            milestones outlined in the Agreement executed between the Company and the Seller as of the
                                            Closing Date. As a result, upon the date of the fulfilment of the first performance milestone
                                            the Company was committed to issue <span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20230601__20230630_zQKMDIv4s1Lc" title="Restricted shares to the seller"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" contextRef="From2023-06-012023-06-30" id="Fact001033" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000</ix:nonFraction></span> restricted shares to the Seller. Accordingly, the
                                            Company recorded an amount of $<span id="xdx_90C_eus-gaap--OtherResearchAndDevelopmentExpense_pn3n3_c20230601__20230630_zEyozOrEvXIj" title="Research and development expenses"><ix:nonFraction name="us-gaap:OtherResearchAndDevelopmentExpense" contextRef="From2023-06-012023-06-30" id="Fact001035" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">131</ix:nonFraction></span> as research and development expenses with a similar amount
                                            as an increase to additional paid-in capital. The first performance milestone shares were
                                            issued on February 6, 2024.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    May 2024, the Company achieved the second performance milestone out of the five performance milestones outlined in the Agreement
    executed between the Company and the Seller as of the Closing Date. As result, the Company is committed to issue <span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20240501__20240531_zJpI6oGbMYud" title="Restricted shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" contextRef="From2024-05-012024-05-31" id="Fact001037" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500</ix:nonFraction></span> restricted
    shares to the Seller. Accordingly, the Company recorded stock-based compensation expenses amounted to $<span id="xdx_907_eus-gaap--ShareBasedCompensation_pn3n3_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv06VEqaR4y1" title="Stock based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember" id="Fact001039" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">192</ix:nonFraction></span> which represents the quoted
    price of its Common Stock at the Closing Date, after taking into consideration a discount for lack of marketability in a rate of
    <span id="xdx_906_ecustom--MarketabilityDiscountRate_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgbT2MZMgaSd" title="Discount rate"><ix:nonFraction name="GCTK:MarketabilityDiscountRate" contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember" id="Fact001041" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>% over the applicable restriction period. The second performance milestone shares were issued on November 20, 2024, excluding <span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20241120__20241120_zSrsCQwxDCA" title="Restricted shares to the seller"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" contextRef="From2024-11-202024-11-20" id="Fact001043" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,000</ix:nonFraction></span>
    shares that were issued erroneously and were returned to the Company subsequent to the balance sheet date.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, the achievement of all other remaining performance milestones was not considered probable and thus no stock-based
    compensation expenses were recorded with respect to thereof.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001045" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80A_eus-gaap--LesseeOperatingLeasesTextBlock_zjFUoUFgp7m3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 - <span id="xdx_827_zzfNFJgSREwl">LEASE AGREEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 19, 2024, the Company entered into Lease Agreement (the &#8220;Agreement&#8221;) with Tapsak Enterprises LLC dba Virginia
    Analytical (the &#8220;Landlord&#8221;) under which it was agreed that the Company will lease from the Landlord a premises located
    in Front Royal, Virginia area for a monthly rental fee of $<span id="xdx_904_eus-gaap--OperatingLeasePayments_pn2n3_c20240219__20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_zqmazfV95FSj" title="Monthly rental fee"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-02-192024-02-19_us-gaap_LeaseAgreementsMember" id="Fact001047" format="ixt:numdotdecimal" decimals="-2" scale="3" unitRef="USD">2.5</ix:nonFraction></span> over a period of <span id="xdx_905_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_z4OzQoSgRKne" title="Lessee term of contract"><ix:nonNumeric contextRef="AsOf2024-02-19_us-gaap_LeaseAgreementsMember" format="ixt-sec:duryear" id="Fact001049" name="us-gaap:LesseeOperatingLeaseTermOfContract">3</ix:nonNumeric></span>-years commencing March 1, 2024 through February
    28, 2027 (the &#8220;Initial Lease Period&#8221;). Security deposit of $<span id="xdx_908_eus-gaap--SecurityDeposit_iI_pn2n3_c20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_zTcwS2iSUG91" title="Security deposit"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-02-19_us-gaap_LeaseAgreementsMember" id="Fact001051" format="ixt:numdotdecimal" decimals="-2" scale="3" unitRef="USD">2.5</ix:nonFraction></span> which represents payment of one month is held by the
    Landlord which will be return to the Company at the end of the Initial Lease Period.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, the Company has an option to renew the Initial Lease Period for another two additional
                                            periods of 3-years each following the Initial Lease Period (the &#8220;Option Term&#8221;),
                                            following advanced notice as defined in the Agreement. The monthly rental fee over the Option
                                            Term shall be the fair market rate determined as what is a comparable cost for similar property
                                            in Front Royal, Virginia area.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with the provision of ASC 842, Leases, at the commencement date of the Agreement, the Company recognized the right to
    use asset equals to lease liability in total amount of $<span id="xdx_90D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20240219_zSON18amzYVk" title="Lease liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-02-19" id="Fact001053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span>. The lease liability was measured at the present value of the future lease
    payments, which are discounted based on an estimate of the incremental interest rate that the Company would be required to pay to
    borrow a similar amount for a similar period in order to obtain a similar amount on the initial recognition date of the lease.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    part of the leasing period, the Company considered only the Initial Lease Period as the realization of the option to extend the period
    was not considered as reasonably certain.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001055" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zCv0w4IN9TN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zx0Wt3ZQECd7" style="display: none">SCHEDULE OF OPERATING LEASE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20241231_zROtWDANxNda" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zmiQMgLk0ir7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    right-of-use asset</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-12-31" id="Fact001057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_zVXHdFK7wvl8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Current operating lease
    liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-12-31" id="Fact001059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zM0gd3dxYT48" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-Current operating
    lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-12-31" id="Fact001061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_z0sRuQFxj291" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001063" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zOhVyechJiM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity
analysis of the Company&#8217;s lease liability:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_zhxN2Bz7Sp2f" style="display: none">SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20241231_zhk6aBE1hwgl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--LessThanOneYearMember_zQvMjhyypqvl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less than one year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-12-31_custom_LessThanOneYearMember" id="Fact001065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--BetweenOneYearToTwoYearsMember_zZ34HneL7Pj3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Between 1-2 years</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-12-31_custom_BetweenOneYearToTwoYearsMember" id="Fact001067" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--MoreThanTwoYearsMember_zG16V3qeFvE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">More than 2 years</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-12-31_custom_MoreThanTwoYearsMember" id="Fact001069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_zz2zcZcRKCyd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease
    payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-12-31" id="Fact001071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3n3_zpgSXldQotae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: imputed interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2024-12-31" id="Fact001073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zVtdeuD5xcGb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-12-31" id="Fact001075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_z6zNMXmlhw13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Additional
information on lease</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001077" name="GCTK:ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_z3IoBd8a5rOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the weighted average remaining lease terms and discount rate for the lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zXoNDsXyxAM7" style="display: none">SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease term (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zhDMnhG3g924" title="Lease term (years)"><ix:nonNumeric contextRef="AsOf2024-12-31" format="ixt-sec:duryear" id="Fact001079" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.17</ix:nonNumeric></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20241231_z46dRs2l8mE8" title="Weighted average discount rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-12-31" id="Fact001081" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.03</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zQb0mj22NE15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001083" name="us-gaap:FinancialInstrumentsDisclosureTextBlock"><p id="xdx_809_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zNWEnU769FUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_829_zaihkd8GrwPj">FINANCE (INCOME) EXPENSES, NET</span></b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001085" name="srt:ScheduleOfCondensedFinancialStatementsTableTextBlock"><p id="xdx_893_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zRY8tApv7TFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zhhyHkGx7s26" style="display: none">SCHEDULE OF FINANCE EXPENSES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20241231_zoPRSF7kunhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zUwuhKxaWOI" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Unaudited</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--DiscountAmortizationAndInterestExpensesOne_pn3n3_msFINztjv_zPDUlIGixaS8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount amortization and interest
    expenses related to June 27 Notes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:DiscountAmortizationAndInterestExpensesOne" contextRef="From2024-01-01to2024-12-31" id="Fact001087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--InterestExpense_pn3n3_msFINztjv_zvmQStutmMhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expenses related to July 18 Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-01-01to2024-12-31" id="Fact001090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--DiscountAmortizationAndInterestExpensesTwo_pn3n3_msFINztjv_zQdB24YN1PN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense and debt discount amortization
    related to July 30 Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:DiscountAmortizationAndInterestExpensesTwo" contextRef="From2024-01-01to2024-12-31" id="Fact001093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">563</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpenseDeposits_pn3n3_msFINztjv_zTdn9coQ6hs8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest on bank deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpenseDeposits" contextRef="From2024-01-01to2024-12-31" id="Fact001096" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">62</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpenseDeposits" contextRef="From2023-01-012023-12-31" id="Fact001097" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OtherExpenses_pn3n3_msFINztjv_zQZspfc7BTNg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate differentials,
    bank commissions and miscellaneous</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2024-01-01to2024-12-31" id="Fact001099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2023-01-012023-12-31" id="Fact001100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--FinanceIncomeNet_iNT_pn3n3_di_mtFINztjv_zWdZHG9yDxmj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance (income) expenses,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:FinanceIncomeNet" contextRef="From2024-01-01to2024-12-31" id="Fact001102" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">583</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GCTK:FinanceIncomeNet" contextRef="From2023-01-012023-12-31" id="Fact001103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zZjKSS2PwPY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001105" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zS2na9NIF4ci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8211; <span id="xdx_829_zkPT3d3hLrQh">COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    of the rights attached to the Common Stock</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    share of Common Stock entitles the holder to one vote, either in person or by proxy, on each matter submitted to the approval of
    the Company&#8217;s stockholders. The holders of Common Stock are not permitted to vote their shares cumulatively. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    Issuances</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>1.
                                            2023 Equity Issuances</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 13, 2023, the Company completed an underwritten public offering under which the Company received gross proceeds of approximately
    $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20230413__20230413_zxsMl0N5OWo8" title="Gross proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-04-132023-04-13" id="Fact001107" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction></span> million for issuance of (i) <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230413__20230413__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9pc7SVGJm8b" title="Common stock shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-04-132023-04-13_us-gaap_CommonStockMember" id="Fact001109" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">53,765</ix:nonFraction></span> shares of common stock and (ii) <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230413__20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zrEzQVIriFxg" title="Common stock shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-04-132023-04-13_custom_PrefundedWarrantsMember" id="Fact001111" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,765</ix:nonFraction></span> pre-funded warrants at a price to the public of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_z9NeeBducPe4" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-04-13_custom_PrefundedWarrantsMember" id="Fact001113" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136</ix:nonFraction></span>
    per share. The pre-funded warrants are exercisable for the same number of shares of common stock and may be exercised at any time
    until exercised in full at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zjwIA9gadBMe" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-04-13_custom_PrefundedWarrantsMember" id="Fact001115" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            satisfaction of customary closing conditions, the closing date of the above underwritten
                                            public offering was April 17, 2023 (the &#8220;Closing Date&#8221;). The Company received
                                            substantially all the pre-funded warrant&#8217;s proceeds upfront (without any conditions)
                                            as part of the pre-funded warrant&#8217;s purchase price and in return the Company is obligated
                                            to issue fixed number of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230417__20230417__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGgK4SiizlB7" title="Common stock shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-04-172023-04-17_custom_PrefundedWarrantsMember" id="Fact001117" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,765</ix:nonFraction></span> shares of Common Stock to the holders. Thus, pre-funded warrants
                                            were accounted for and were classified as additional paid-in capital as part of the Company&#8217;s
                                            stockholders&#8217; equity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    incremental and direct issuance costs amounted to $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230413__20230413_zEO8wFS4Gj74"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-04-132023-04-13" id="Fact001118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,270</ix:nonFraction></span> thousand. These expenses were deducted from additional paid-in capital as
    they were allocated to shares of Common Stock and pre-funded warrants.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 3, 2024, the above pre-funded warrants have been fully exercised to <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240103__20240103__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zykf73pA6Cxe" title="Exercises in period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-01-032024-01-03_custom_PrefundedWarrantsMember" id="Fact001120" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,765</ix:nonFraction></span> shares of Common Stock of the Company.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
    2024 Equity Issuances</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Notes 4H, 4I and 4J relating to the issuances of shares during 2024.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
    Subsequent event issuances</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Note 14 regarding a significant issuance of shares as a settlement of Series B Warrants subsequent to the balance sheet date.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock-based
    compensation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 11, 2010, the Company&#8217;s Board of Directors approved and adopted the 2010 Share Incentive Plan (the &#8220;Plan&#8221;),
    pursuant to which the Company&#8217;s Board of Directors may award share options to purchase the Company&#8217;s Common Stock as
    well as restricted shares, Restricted Stock Units (the &#8220;RSU&#8221;) and other share-based awards to designated participants.
    Subject to the terms and conditions of the Plan, <span id="xdx_90E_eus-gaap--DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability_c20100110__20100111_zAojIuIoyRRl" title="Plan description"><ix:nonNumeric contextRef="From2010-01-102010-01-11" id="Fact001122" name="us-gaap:DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability">the Company&#8217;s Board of Directors has full authority in its discretion, from
    time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the respective award
    agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of shares to be
    covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and the nature
    and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
    or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election
    as to the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and
    to take actions, as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions
    of the Plan and to amend from time to time the terms of the Plan</ix:nonNumeric></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
    of equity awards to employees </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    August 2023, the Company granted Ms. Drinda Benjamin, the Vice President, Marketing of the Company, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230801__20230831__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zc28hDhlxYLd" title="Share based options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-08-012023-08-31_custom_DrindaBenjaminMember_us-gaap_RestrictedStockUnitsRSUMember" id="Fact001124" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,220</ix:nonFraction></span> options estimated at fair
    value of $<span id="xdx_904_eus-gaap--OfficersCompensation_pn3n3_c20230801__20230831__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYpuTgAko2y1" title="Compensation"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2023-08-012023-08-31_custom_DrindaBenjaminMember_us-gaap_RestrictedStockUnitsRSUMember" id="Fact001126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51</ix:nonFraction></span>, to purchase the same number of Common Stock, with an exercise price per share equals to the greater of (A) $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230831__srt--TitleOfIndividualAxis__custom--MarkTapsakMember_zE1Yjk4iukvf" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-08-31_custom_MarkTapsakMember" id="Fact001128" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136</ix:nonFraction></span> per
    share or (B) the closing price of a share of Common Stock on the grant date, as reported by Bloomberg L.P., which shall vest in equal
    monthly installments over a period of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pid_dtY_c20230801__20230831__srt--TitleOfIndividualAxis__custom--MarkTapsakMember_zzHal6xMW2Ud" title="Grant date period"><ix:nonNumeric contextRef="From2023-08-012023-08-31_custom_MarkTapsakMember" format="ixt-sec:duryear" id="Fact001130" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3</ix:nonNumeric></span>-years following the grant date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 14, 2024, the Board of Directors approved the cancellation of all outstanding stock options previously granted to employees,
    directors, and officers of the Company. Concurrently, the Board authorized the issuance of new stock options to the relevant parties.
    The new stock options were issued in replacement with exercise price $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20240614__20240614__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z9ff6GRShmb" title="Exercise price of options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2024-06-142024-06-14_srt_BoardOfDirectorsChairmanMember" id="Fact001132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During
    the years ended December 31, 2024 and 2023, the Company recorded stock-based compensation expenses of $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20241231__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember_zyX7Tu2BKz3h" title="Stock based compensation income"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-12-31_custom_DrindaBenjaminMember" id="Fact001134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173</ix:nonFraction></span>
    and $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember_zqHZIqHqIbol" title="Stock based compensation income"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_custom_DrindaBenjaminMember" id="Fact001136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">281</ix:nonFraction></span>,
    respectively.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following table presents the Company&#8217;s stock options (excluding RSU) activity for employees and members of the Board of Directors
    of the Company under the Plan, for the years ended December 31, 2024 and 2023:</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001138" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"><p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zUnlVWsVFWIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z4lrO17mV4sf" style="display: none">SCHEDULE
OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            Options</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            Price</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>life</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>value</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231_zaAzo52k2B6i" title="Number outstanding beginning balance" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31" id="Fact001140" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,046</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_znEjOLrl6XJ4" title="Weighted average exercise price outstanding, beginning balance" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" id="Fact001142" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">152</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z4WJGfWup6U9" title="Weighted average remaining contractual life, Outstanding"><ix:nonNumeric contextRef="From2022-01-012022-12-31" format="ixt-sec:duryear" id="Fact001144" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">2.1</ix:nonNumeric></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20230101__20231231_zCUbl0Mjflgk" title="Intrinsic value outstanding, beginning balance" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231_zfU8A4GVfRV3" title="Number of share options outstanding, granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-12-31" id="Fact001148" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,221</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zZcDHiPYBGgl" title="Weighted average exercise price, granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31" id="Fact001150" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z2iQAj7uehRc" title="Weighted average remaining contractual life, Granted"><ix:nonNumeric contextRef="From2023-01-012023-12-31" format="ixt-sec:duryear" id="Fact001152" name="GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm">9.7</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20230101__20231231_z604wfjuE9x8" title="Intrinsic value outstanding, granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1154">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231_z5ztECF9ku5d" title="Number of share options outstanding, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-01-012023-12-31" id="Fact001156" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">269</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zlMwPp17oRUe" title="Weighted average exercise price, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31" id="Fact001158" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1290</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zkJDZf9fcDE5" title="Weighted average remaining contractual life, Forfeited or expired"><ix:nonNumeric contextRef="From2023-01-012023-12-31" format="ixt-sec:duryear" id="Fact001160" name="GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1">1.7</ix:nonNumeric></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20230101__20231231_zz1ROjgS7evc" title="Intrinsic value outstanding, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20241231_zUPtgFfsZwUe" title="Number outstanding beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31" id="Fact001164" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,998</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20241231_zrFV1luqjgE8" title="Weighted average exercise price outstanding, beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31" id="Fact001166" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">90</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zOLtT6oPq8za" title="Weighted average remaining contractual life, Outstanding"><ix:nonNumeric contextRef="From2023-01-012023-12-31" format="ixt-sec:duryear" id="Fact001168" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">8.0</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zkOXzBCL2CK7" title="Intrinsic value outstanding, beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20241231_zdoCwT2epni9" title="Number of share options outstanding, granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-01-01to2024-12-31" id="Fact001172" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,438</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_z1VtIh8cpZr9" title="Weighted average exercise price, granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="Fact001174" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">49.72</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20240101__20241231_zUsBUuVQFV1l" title="Weighted average remaining contractual life, Granted"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001176" name="GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm">9.37</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20240101__20241231_zjL9Ynrz5evl" title="Intrinsic value outstanding, granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_pid_c20240101__20241231_zeiu4L5S6Jcb" title="Number of share options outstanding, cancelled" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></span></td><td style="text-align: left">&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240101__20241231_zshCKLI4meTl" title="Number of share options outstanding, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_zQob9IMwjH9f" title="Weighted average exercise price, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20240101__20241231_zz2eaNDWu22k" title="Intrinsic value outstanding, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20241231_zWBSV3HSyHG5" title="Number outstanding ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-12-31" id="Fact001188" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,436</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zy9RbIAzzlF" title="Weighted average exercise price outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-12-31" id="Fact001190" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">49.72</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zssR7b6JLeE3" title="Weighted average remaining contractual life, Outstanding"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001192" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">9.37</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zGRFWdgoD0d2" title="Intrinsic value outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20241231_zQXojA8mW6ra" title="Number exercisable, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-12-31" id="Fact001196" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,249</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_fKg_____zefzLVfuQ09d" title="Weighted average exercise price exercisable, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-12-31" id="Fact001198" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">49.11</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_dtY_c20240101__20241231_z6OgQHJ6l88b" title="Weighted average remaining contractual life, Exercisable"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001200" name="GCTK:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue">9.41</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zMpdZmEQYNBd" title="Intrinsic value outstanding exercisable, Ending balance" style="border-bottom: Black 2.5pt double; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0E_zSs6eOY0FQQ4" style="width: 15pt; text-align: right">*</td><td id="xdx_F14_zB5eie8s33dc" style="text-align: justify"><ix:footnote id="Footnote001203" xml:lang="en-US">After modification of exercise price</ix:footnote></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A7_zqkTIkOoi42a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of
    the Company&#8217;s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied
    by the number of in-the-money share options) that would have been received by the share option holders had all share options holders
    exercised their share options on December 31 of each of the reported period. This amount is impacted by the changes in the fair market
    value of the Company&#8217;s Ordinary Share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the years ended December 31, 2024 and 2023, stock options have not been exercised into Common Stock. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following table presents the assumptions used to estimate the fair values of the share options granted in the reported periods presented:</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001205" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zjPjM1faXsEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zgQjCPA7XeD8" style="display: none">SCHEDULE
OF ASSUMPTIONS USED TO VALUE OPTIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 78%; margin-left: 1.5in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240101__20241231_zoco2NDkmdqg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zbXCx5X3LeV2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Volatility (%)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_z7KiyVdc2EG2" title="Volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2024-01-01to2024-12-31" id="Fact001207" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">207</ix:nonFraction></span>-<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_z3bFWhyk5vWb" title="Volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2024-01-01to2024-12-31" id="Fact001209" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">288</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231_z3XREW8cGXZ5" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-01-012023-12-31" id="Fact001211" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">220</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate (%)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zWBEKiGF8mKe" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2024-01-01to2024-12-31" id="Fact001213" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.51</ix:nonFraction></span>-<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zq7vmfW03l74" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-01-01to2024-12-31" id="Fact001215" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.64</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231_ztCnsGkLlJ26" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-12-31" id="Fact001217" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.7</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_zZ6L68M33u1e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yield (%)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231_z2u6oAWG6Yg4" title="Expected life (years)"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001222" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zdZdM8Yc69Id" title="Expected life (years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31" format="ixt-sec:duryear" id="Fact001224" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercise price ($)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MinimumMember_zKNewAmVrF39" title="Exercise price, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-12-31_srt_MinimumMember" id="Fact001226" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">41</ix:nonFraction></span>-<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MaximumMember_zryWBW8KOAwa" title="Exercise price, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-12-31_srt_MaximumMember" id="Fact001228" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">58</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231_zqzEfhJPHuyj" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2023-12-31" id="Fact001230" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">140</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price ($)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharePrice_iI_pid_c20241231_zhHl6wdu3URi" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-12-31" id="Fact001232" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">49.0</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zItWZe8rqN88" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-12-31" id="Fact001234" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">30</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zKazbGoLV2A9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, there was $<span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_c20241231_zrr03num4jtj"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2024-12-31" id="Fact001235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">298</ix:nonFraction></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    unrecognized compensation expense related to unvested stock options. The Company recognizes compensation expense on an accelerated
    vesting basis over the requisite service periods, which results in a weighted average period of approximately <span id="xdx_90B_eus-gaap--DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_dtY_c20240101__20241231_zBI5tkr03Bt1"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001236" name="us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm1">1.9</ix:nonNumeric> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years
    over which the unrecognized compensation expense is expected to be recognized.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
    of equity awards to non-employees</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    closing of underwritten U.S. public offering in 2023 as noted in Note 8B above, a down round protection feature of certain
    previously granted warrants, was triggered through the reduction of their original exercise prices from a price in a range of $<span id="xdx_908_ecustom--WarrantsOriginalExercisePrice_iI_pn3n3_c20230413__srt--RangeAxis__srt--MinimumMember_zFv73y5L1WMi" title="Warrants original exercise price"><ix:nonFraction name="GCTK:WarrantsOriginalExercisePrice" contextRef="AsOf2023-04-13_srt_MinimumMember" id="Fact001238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">335</ix:nonFraction></span>
    -$<span id="xdx_903_ecustom--WarrantsOriginalExercisePrice_iI_pn3n3_c20230413__srt--RangeAxis__srt--MaximumMember_zdRobEy8doxg" title="Warrants original exercise price"><ix:nonFraction name="GCTK:WarrantsOriginalExercisePrice" contextRef="AsOf2023-04-13_srt_MaximumMember" id="Fact001240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,020</ix:nonFraction></span>
    to a price of $<span id="xdx_902_ecustom--PublicOfferingPrice_iI_pid_c20230413_zOPLne8Rwys5" title="Public offering price"><ix:nonFraction name="GCTK:PublicOfferingPrice" contextRef="AsOf2023-04-13" id="Fact001242" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">136</ix:nonFraction></span>
    which represented the public offering price. Such reduction was accounted for in accordance with the provisions of ASU 2017-11 as a
    deemed dividend estimated at a total amount of $<span id="xdx_902_eus-gaap--AdditionalPaidInCapital_iI_pn3n3_c20230413_zej7ZbxDNmS4" title="Additional paid in capital"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-04-13" id="Fact001244" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">855</ix:nonFraction></span>
    thousand which was recorded as part of the additional paid-in capital versus increase of accumulated deficit. Regarding the effect
    of the loss per share, see also Note 2O above.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following table presents the Company&#8217;s warrants activity for the years ended December 31, 2024 and 2023:</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001246" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zz3x9OT8Q3Z6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z3KtLYkDtfp5" style="display: none">SCHEDULE
OF WARRANTS ACTIVITY</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            Warrants</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            Price</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>life</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>value</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"/><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20240101__20241231_zCnVzou8sMsc" title="Number of share warrants outstanding, beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1248">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20240101__20241231_zKLzb6IWIJN4" title="Weighted average exercise price outstanding, beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1250">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iS_pid_c20240101__20241231_zRqnnYeSaLk3" title="Intrinsic value outstanding, beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20240101__20241231_zPl8gX257xNf" title="Number of share warrants outstanding, granted" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2024-01-01to2024-12-31" id="Fact001254" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,278,259</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20240101__20241231_zeKl98MZJFah" title="Weighted average exercise price, granted" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-12-31" id="Fact001256" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">39.66</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z9dXKfNYeT23" title="Weighted average remaining contractual life, Granted"><ix:nonNumeric contextRef="From2023-01-012023-12-31" format="ixt-sec:duryear" id="Fact001258" name="GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm">9.31</ix:nonNumeric></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_pid_c20240101__20241231_zFRqZ3odyWHg" title="Number of share warrants outstanding, cancelled" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_pid_c20240101__20241231_zTR5NRmxVzJd" title="Weighted average exercise price, cancelled" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20240101__20241231_z3nkyB9LmqOg" title="Number of share options outstanding, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_pid_c20240101__20241231_zSMIyESEGBji" title="Weighted average exercise price, forfeited or expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20240101__20241231_zUS7LlIrOzhi" title="Number of share warrants outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2024-12-31" id="Fact001268" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,278,259</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20240101__20241231_zUI9uG1tRdr4" title="Weighted average exercise price outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2024-12-31" id="Fact001270" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">39.66</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_z4aCRMu8GOId" title="Weighted average remaining contractual life, Outstanding"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001272" name="GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2">9.31</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iE_pid_c20240101__20241231_zQPsNMwjNva3" title="Intrinsic value outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240101__20241231_zMGsGRoioc61" title="Number of share options exercisable, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2024-12-31" id="Fact001276" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,278,259</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zZaQRERu0qdj" title="Weighted average exercise price exercisable, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-12-31" id="Fact001278" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">39.66</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_dtY_c20240101__20241231_zOH7Lo6Ps39h" title="Weighted average remaining contractual life, Exercisable"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt-sec:duryear" id="Fact001280" name="GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3">9.31</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zjv2ltqCtgdl" title="Intrinsic value outstanding exercisable, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zArscaMVYNKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    total compensation cost related to all of the Company&#8217;s equity-based awards recognized during the years ended December 31,
    2024 and 2023 was comprised as follows:</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001284" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zN9EaBRuUQl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zwXR2MIxMf8c" style="display: none">SCHEDULE
OF TOTAL COMPENSATION COST EQUITY BASED AWARDS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240101__20241231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_zwVM0JAAKlac" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20231231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_z8tnmwU7QbD8" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zcDJHAAIkttl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">307</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">176</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zyyS2nvu4MK2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">364</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zxSSOebnpZq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total compensation cost
    </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember" id="Fact001292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">671</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember" id="Fact001293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">335</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zsyo2Y6jrSLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001295" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"><p id="xdx_80A_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_z5GT5QD7l5Wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_827_zbEbjiwqGhQa">RESEARCH AND DEVELOPMENT EXPENSES</span></b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001297" name="GCTK:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock"><p id="xdx_89D_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_zeYCwsmQlvV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_z3tS403mB4J" style="display: none">SCHEDULE
OF RESEARCH AND DEVELOPMENT EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240101__20241231_zieA5Qcf5x0k" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20231231_zaCiAlzk1Fma" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Research and
    Development</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--SalariesAndRelatedMember_zBPzX7Rqwqkf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Salaries and related expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-012024-12-31_custom_SalariesAndRelatedMember" id="Fact001299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,881</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_custom_SalariesAndRelatedMember" id="Fact001300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">930</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--ProfessionalFeesMember_ze9rs3UF3WU2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-012024-12-31_custom_ProfessionalFeesMember" id="Fact001302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,363</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_custom_ProfessionalFeesMember" id="Fact001303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,709</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--DepreciationMember_zSD4xvmiNPy2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-012024-12-31_custom_DepreciationMember" id="Fact001305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_custom_DepreciationMember" id="Fact001306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--OtherExpenseMember_zSfuba1NFXS9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-012024-12-31_us-gaap_OtherExpenseMember" id="Fact001308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">241</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_us-gaap_OtherExpenseMember" id="Fact001309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_zYw3VtnrXsgj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Research and Development
    Expense</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-12-31" id="Fact001311" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,499</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31" id="Fact001312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,704</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zqXIUkkgAa02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001314" name="GCTK:GeneralAndAdministrativeExpensesTextBlock"><p id="xdx_805_ecustom--GeneralAndAdministrativeExpensesTextBlock_zznxPwI2bId6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_824_zjBGTRGWPtph">GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001316" name="GCTK:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock"><p id="xdx_89A_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_z2CXkyoEzpk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zFHyXYGZvPRg" style="display: none">SCHEDULE
OF GENERAL AND ADMINISTRATIVE EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240101__20241231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM8UdbFpODS" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zT9wmhaz4rAe" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">General and
    Administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LaborAndRelatedExpense_pn3n3_maGAAEzQ9k_zCpat4NjDHgk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Salaries and related expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">476</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">340</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ProfessionalFees_pn3n3_maGAAEzQ9k_zi4SxpoWDAhl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees (including directors&#8217;
    fees)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,724</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,527</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepreciationAndAmortization_pn3n3_maGAAEzQ9k_zrUjIai7EGw1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentIncomeInvestmentExpense_pn3n3_maGAAEzQ9k_zIIKtdrgapB7" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Insurance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeInvestmentExpense" contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">313</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeInvestmentExpense" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherGeneralAndAdministrativeExpense_pn3n3_maGAAEzQ9k_zWX9v32IOFne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzQ9k_zw6DDv0l8y45" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total general and administrative
    expenses</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,655</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,278</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zH0EAE74M6el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001336" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zOjE6R0Asjge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211; <span id="xdx_821_znES89XFp9D7">INCOME TAX</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Measurement
    of results for tax purposes under the Israeli Income Tax (Inflationary Adjustments) Law, 1985 (the &#8220;Inflationary Adjustment
    Law&#8221;)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
    January 1, 2008, the results of operations of Integrity Israel for tax purposes have been measured on a nominal basis.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
    assessments</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    federal, state and local income tax purposes the Company remains open for examination by the tax authorities for the tax years from
    2019 through 2022 under the general statute of limitations. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding,
    pursuant and subject to the provisions of article 145 of the Income Tax Ordinance, Integrity Israel&#8217;s tax returns that were
    filed with the tax authority up to and including 2018 are considered final.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
    for the years ended December 31, 2024 and 2023 consists of the following:</b></span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001338" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z6iMj2VfIwxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B3_zLn2HZGvSjL" style="display: none">SCHEDULE
OF INCOME TAX LOSS FOR THE YEAR</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 55%; margin-left: 1in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20241231_z9llL1qhyTj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20230101__20231231_zN8DzbJCIRRb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationTaxSettlementsDomestic_z721b59wgzy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Domestic</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic" contextRef="From2024-01-01to2024-12-31" id="Fact001340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,502</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic" contextRef="From2023-01-012023-12-31" id="Fact001341" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,945</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationTaxSettlementsForeign_zZbKhuq8YfDa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign entity (Integrity
    Israel)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxSettlementsForeign" contextRef="From2024-01-01to2024-12-31" id="Fact001343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxSettlementsForeign" contextRef="From2023-01-012023-12-31" id="Fact001344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationTaxSettlements_zX2ikabwNa2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="display: none; font-size: 10pt">Total
    loss for the year</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxSettlements" contextRef="From2024-01-01to2024-12-31" id="Fact001346" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,597</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxSettlements" contextRef="From2023-01-012023-12-31" id="Fact001347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,097</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_z0Oj0ARLpWv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
    Operating Losses (NOL) carryforward </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, the Company had cumulative Net Operating Losses (NOL) carry forward for US federal purposes of approximately
    $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20241231_zr1c7rgsOgr4" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-12-31" id="Fact001349" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">31.6</ix:nonFraction></span> million to offset against future taxable income for an indefinite period of time. Integrity Israel has cumulative NOL carry
    forward for Israeli income tax purposes of approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zjHIp1RnvlI4" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-12-31_us-gaap_IsraelTaxAuthorityMember" id="Fact001351" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">38.5</ix:nonFraction></span> million to offset against future taxable income for an indefinite
    period of time.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31, 2024 and 2023, the main reconciling item is the recognition of valuation allowance in respect of deferred
    taxes relating to accumulated net operating losses carried forward and other permanent and temporary differences due to the uncertainty
    of the realization of such deferred taxes.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    taxes result principally from temporary differences in the recognition of certain revenue and expense items for financial and income
    tax reporting purposes. Significant components of the Company&#8217;s future tax assets are as follows:</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001353" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z3M5qgJqhpPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zoi4M9xEydMj" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20241231_zd3wTWWq6y94" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_z7RHaI1h04Bk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Composition
    of deferred tax assets:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsTaxVacationAccrual_iI_pn3n3_maDTAGzT7c_zf71lr31RLTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vacation accrual</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:DeferredTaxAssetsTaxVacationAccrual" contextRef="AsOf2024-12-31" id="Fact001355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">208</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="GCTK:DeferredTaxAssetsTaxVacationAccrual" contextRef="AsOf2023-12-31" id="Fact001356" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pn3n3_maDTAGzT7c_z4haGyC1HmA5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development credits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2024-12-31" id="Fact001358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,276</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2023-12-31" id="Fact001359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,033</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzT7c_zYDnguFiRVFb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net operating losses carry
    forwards</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-12-31" id="Fact001361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,981</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-12-31" id="Fact001362" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,368</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzT7c_maDTANzC5T_ztVwDgQk3JP6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset
    before deferred tax liabilities and valuation allowance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2024-12-31" id="Fact001364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,465</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-12-31" id="Fact001365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,467</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--DeferredTaxAssetValuationAllowance_iNI_pn3n3_di_msDTANzC5T_zeoDvg2oPx4d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GCTK:DeferredTaxAssetValuationAllowance" contextRef="AsOf2024-12-31" id="Fact001367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,465</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="GCTK:DeferredTaxAssetValuationAllowance" contextRef="AsOf2023-12-31" id="Fact001368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,467</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzC5T_zsCEpPYzmoXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zHIxdSaaxFkh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001373" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ziFcjqHPMZQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_82E_zMsUzROzqZq6">RELATED PARTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information regarding the intellectual property purchase agreement from the company&#8217;s CEO - See Note 5B above.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information regarding loans received from certain Stockholders - See Note 3 above.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tapsak
                                            Enterprises LLC, dba Virginia Analytical</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 25, 2022, the Company entered into agreement with Tapsak Enterprises LLC dba Virginia Analytical, which fully owned by Mark
    Tapsak, who serves as the Vice President of Sensor Science of the Company, under which, Tapsak Enterprises LLC dba Virginia Analytical,
    is providing laboratory space, equipment and materials to support the Company sensor development activities. During the years ended
    December 31, 2024 and 2023, a total amount of $<span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkTapsakMember__us-gaap--TypeOfArrangementAxis__custom--TapsakEnterprisesLLCAgreementMember_zvSz1aPhauI4" title="Research and development expense"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-012024-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember" id="Fact001375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkTapsakMember__us-gaap--TypeOfArrangementAxis__custom--TapsakEnterprisesLLCAgreementMember_zD5w8oGf5CY" title="Research and development expense"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember" id="Fact001377" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">162</ix:nonFraction></span> were recorded as part of the Company&#8217;s research and development
    expenses, respectively.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information regarding execution of lease agreement with Tapsak Enterprises LLC dba Virginia Analytical, see Note 6.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regarding
    the issuances of notes, shares, warrants and settlement of notes, ee Note 4 above.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001379" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_z1aHqmXzeOPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 &#8211; <span id="xdx_826_z9kq90wzW5mi">SEGMENT REPORTING</span>:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
280, &#8220;Segment Reporting&#8221; establishes standards for reporting information about operating segments on a basis consistent with
the Company&#8217;s internal organization structure as well as information about services categories, business segments and major customers
in financial statements. The Company has only one reportable segment, the Glucotrack CBGM Product Segment, as all their research and
development activities are related the development of the Glucotrack CBGM Product. Since the Company operates in one operating segment,
all required financial segment information can be found in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adheres to the provisions of ASC 280, Segment Reporting, which establishes standards for the way public business enterprises
report information about operating segments in annual financial statements and requires that those enterprises report selected information
about operating segments in financial statements issued to shareholders. As the Company is currently involved in the development of one
product, the Platform, the Company has determined that it operates in a single reportable segment. The Company&#8217;s Chief Operating
Decision Maker (CODM), its Chief Executive Officer (CEO), reviews the consolidated results of operations when making decisions about
allocating resources and assessing the performance of the Company as a whole and, hence, the Company has only one reportable segment.
The Company&#8217;s assets are located in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact001381" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zjINXV4Rhkzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14</b> &#8211; <b><span id="xdx_820_z2cIP0TmiaDf">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">2025 Reverse Stock
Split and Increase in Authorized Common Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Company filed with the Delaware
Secretary of State a Certificate of Amendment to its Certificate of Incorporation which became effective at 4:30 p.m. on February 3, 2025,
to implement a <span id="xdx_907_eus-gaap--StockholdersEquityReverseStockSplit_c20250203__20250203__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znlyfRrYAsRf" title="Reverse stock split"><ix:nonNumeric contextRef="From2025-02-032025-02-03_us-gaap_SubsequentEventMember" id="Fact001383" name="us-gaap:StockholdersEquityReverseStockSplit">reverse stock split at a ratio of 1-for-20</ix:nonNumeric></span> (the &#8220;2025 Reverse Stock Split&#8221;) of the shares of its Common Stock.
The 2025 Reverse Stock Split was approved by the Company&#8217;s stockholders at the special meeting of stockholders held on January 3,
2025 (the &#8220;Special Meeting&#8221;). All shares and per share numbers in the consolidated financial statements have been retroactively adjusted and are
reflected on a post-reverse share split basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On
January 3, 2025, the Company filed an amendment to the Company&#8217;s Certificate of Incorporation, as to increase the Company&#8217;s
authorized shares of Common Stock from <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250103__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhi3msvb42Gf"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-01-03_srt_MinimumMember_us-gaap_SubsequentEventMember" id="Fact001384" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> to <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250103__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4p1Qx4rViik"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-01-03_srt_MaximumMember_us-gaap_SubsequentEventMember" id="Fact001385" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span>. On February 3, 2025, the stockholders approved at the Special Meeting
the increase in the Company&#8217;s authorized shares of Common Stock from <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250203__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcWCRmZ1hj19"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-02-03_srt_MinimumMember_us-gaap_SubsequentEventMember" id="Fact001386" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span>
to <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250203__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z54fTH6c6nP3"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-02-03_srt_MaximumMember_us-gaap_SubsequentEventMember" id="Fact001387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span>,
as well as the full issuance of shares of Common Stock issuable by the Company upon the exercise of Series A Warrants and Series B Warrants
(see below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">ATM Sales Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On December 17, 2024, the Company entered
into an ATM sales agreement (the &#8220;Sales Agreement&#8221;) with Dawson James Securities, Inc. (&#8220;Dawson James&#8221;), pursuant
to which the Company have agreed to issue and sell shares of Common Stock, having an aggregate offering price of up to $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn4n6_c20241217__20241217__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_z1Q7vBemxfE6" title="Offering price"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-12-172024-12-17_custom_SalesAgreementMember" id="Fact001389" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">8.23</ix:nonFraction></span> million, from time
to time, through an &#8220;at-the-market&#8221; equity offering program under which Dawson James will act as sales agent (the &#8220;Agent&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On March 21, 2025, the Company sold <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250321__20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z770A3VPDTXg" title="Common stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-03-212025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember" id="Fact001391" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,377,967</ix:nonFraction></span>
shares of Common Stock at an average offering price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_c20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWJe4YJK2nHd" title="Share price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember" id="Fact001393" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.304</ix:nonFraction></span> per share pursuant to the Sales Agreement. for net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20250321__20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5ft65ZIrhHl" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2025-03-212025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember" id="Fact001395" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.6</ix:nonFraction></span>
million, after deducting fees owed to the Agent from such sale. The shares of Common Stock were offered by the Company pursuant
to a prospectus supplement dated December 17, 2024, and accompanying prospectus dated October 3, 2024, which forms a part of the Company&#8217;s
registration statement on Form S-3 (Registration No. 333-282297), which was declared effective by the Securities and Exchange Commission,
on October 3, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Registered Direct Offering</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On February 4, 2025, the Company
entered into a securities purchase agreement with certain institutional investors, relating to the registered direct offering and sale
of an aggregate of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zj5kwefqLKr6" title="Common stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-02-042025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact001397" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,638,042</ix:nonFraction></span> shares of Common Stock at an offering price of $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVQ4b0x48d8h" title="Share price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact001399" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.15</ix:nonFraction></span> per share. The net proceeds to the Company from the
offering were approximately $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYErQYbglKCk" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2025-02-042025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact001401" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.7</ix:nonFraction></span> million, after deducting fees owed to placement agent and other offering expenses. The February 2025
offering closed on February 5, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The shares of Common Stock from
the February 2025 registered direct offering was offered by the Company pursuant to a prospectus supplement dated February 4, 2025, and
accompanying prospectus dated October 3, 2024, which forms a part of the Company&#8217;s registration statement on Form S-3 (Registration
No. 333-282297), which was declared effective by the Securities and Exchange Commission, on October 3, 2024. Dawson James acted as the
placement agent for the offerings pursuant to a placement agency agreement, dated February 4, 2025, by and between the Company and Dawson
James.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Warrant Exchange</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Beginning
on January 6, 2025, through March 15, 2025, the Company received exchange notices from certain holders of the Series B Warrants, with
respect to an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBWarrantsMember_zTkYqUcZU36j"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember" id="Fact001402" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">359,612</ix:nonFraction></span>
of the Series B Warrants, requiring the delivery of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhyLm0xBnLU7"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" id="Fact001403" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,721,782</ix:nonFraction></span>
shares of Common Stock according to the alternative cashless exercise, as applicable to the Series B Warrants under the November
2024 offering. The remaining <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBWarrantsMember_zSSPMilZUlUe"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember" id="Fact001404" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100</ix:nonFraction></span>
Series B Warrants are exchangeable for an aggregate of approximately <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zORxgWiXwBD4"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" id="Fact001405" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,940</ix:nonFraction></span>
shares of Common Stock (subject to adjustment in the event of any stock dividend and split, reverse stock split, recapitalization,
reorganization or similar transaction).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Appointment of Peter C. Wulff as Chief Financial
Officer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">In connection with Mr.
Cardwell&#8217;s resignation, on January 28, 2025, the Board appointed Peter C. Wulff as Chief Financial Officer of the Company.</p>

</ix:nonNumeric><p id="xdx_814_zs6Kd6P3PAPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_026"></span>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLUCOTRACK,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Paul Goode</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Goode</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Peter Wulff</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Wulff</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    Paul Goode</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Goode</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Principal Executive Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    Peter Wulff</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Wulff</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal
Financial and Accounting Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    Erin Carter</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erin
    Carter</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    Luis Malave</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luis
    Malave</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    Robert Fischell</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Robert Fischell</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    Andrew Balo</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Balo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    Allen Danzig</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allen
    Danzig</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/</i>s<i>/
    John Ballantyne</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,
    2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Ballantyne</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 95; Options: NewSection Last; Value: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




























<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF THE REGISTRANT&rsquo;S SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTERED
PURSUANT TO SECTION 12 OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the capital stock of Glucotrack, Inc. (the &ldquo;Company&rdquo;), does not purport to be complete and is qualified
in its entirety by reference to our Certificate of Incorporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;), and our
bylaws, as amended (the &ldquo;Bylaws&rdquo;), each of which are incorporated by reference as an exhibit to the Annual Report on Form
10-K (the &ldquo;Annual Report&rdquo;), of which this exhibit is a part, and certain provisions of the General Corporation Law of the
State of Delaware, as amended (&ldquo;DGCL&rdquo;). Unless the context requires otherwise, all references to the &ldquo;Company,&rdquo;
&ldquo;Glucotrack,&rdquo; &ldquo;we,&rdquo; &ldquo;our,&rdquo; and &ldquo;us&rdquo; in this exhibit refer Glucotrack, Inc. Capitalized
terms used but not defined herein have the meanings set forth in the Annual Report to which this description is an exhibit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following summary of the material terms of our securities and is not intended to be a complete summary of the rights and preferences
of such securities. We urge you to read our Certificate of Incorporation and Bylaws in their entirety for a complete description of the
rights and preferences of our securities.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Authorized
Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 250,000,000 shares of common stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;),
and 10,000,000 shares of preferred stock, par value $0.001 per share (&ldquo;Preferred Stock&rdquo;), the rights and preferences of which
may be established from time to time by our Board. As of March 31, 2025, we had 25,585,853 shares of Common Stock outstanding and no
shares of Preferred Stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
all matters submitted to a vote of stockholders, each holder of Common Stock is entitled to one vote for each share registered in his
or her name on our books. Our Common Stock does not have cumulative voting rights. As a result, holders of a majority of our outstanding
Common Stock can elect all of the directors who are up for election in a particular year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividends</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our board of directors declares a dividend, holders of Common Stock will receive payments from our funds that are legally available to
pay dividends. However, this dividend right is subject to any preferential dividend rights we may grant to the persons who hold Preferred
Stock, if any is outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidation
and Dissolution</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are liquidated or dissolve, the holders of our Common Stock will be entitled to the right to receive ratably, all of the assets and
funds that remain after we pay our liabilities and any amounts we may owe to the persons who hold Preferred Stock, if any is outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Rights and Restrictions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our Common Stock do not have preemptive or subscription rights, and they have no right to convert their Common Stock into any other
securities. Our Common Stock is not subject to redemption by us. The rights, preferences and privileges of common stockholders are subject
to the rights of the stockholders of any series of Preferred Stock which we may designate in the future. Our Certificate of Incorporation
and our Bylaws do not restrict the ability of a holder of Common Stock to transfer his or her shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Listing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;GCTK.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transfer
Agent and Registrar</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is VStock Transfer, LLC, 18 Lafayette Place, Woodmere, New York 11598.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Delaware
Law Affecting Business Combinations</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the provisions of Section 203 of the DGCL. Subject to certain exceptions, Section 203 prohibits a publicly held Delaware
corporation from engaging in a &ldquo;business combination&rdquo; with an &ldquo;interested stockholder&rdquo; for a period of three
years after the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &ldquo;business
combination&rdquo; includes mergers, asset sales and other transactions resulting in a financial benefit to the interested stockholder.
Subject to exceptions, an &ldquo;interested stockholder&rdquo; is a person who, together with affiliates and associates, owns, or within
the prior three years did own, 15% or more of the corporation&rsquo;s voting stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Series
A Common Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the Series A Common Warrants is not complete and is subject to, and qualified in
its entirety by, the provisions of the Series A Common Warrant, the form of which is incorporated by reference as an exhibit to the Annual
Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of Common Stock upon exercise of the Series A Common Warrants was subject to stockholder approval under applicable rules and
regulations of Nasdaq, and the Company obtained such stockholder approval on January 3, 2025 (the &ldquo;Stockholder Approval Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration
and Exercise Price</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Series A Common Warrant will have an exercise price equal to $5.60 per share and will expire on January 3, 2030. The exercise price and
number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits,
reorganizations or similar events affecting our Common Stock and the exercise price. The Series A Common Warrants will be issued separately
from the Common Stock and may be transferred separately immediately thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Common Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed
exercise notice accompanied by payment in full for the number of shares of our Common Stock purchased upon such exercise (except in the
case of a cashless exercise as discussed below). Generally, a holder (together with its affiliates) may not exercise any portion of such
holder&rsquo;s Common Warrants to the extent that the holder would own more than 4.99% of the outstanding Common Stock (or at the election
of a holder prior to the date of issuance, 9.99%) immediately after exercise, except that upon at least 61 days&rsquo; prior notice from
the holder to us, the holder may increase the amount of ownership of outstanding stock after exercising the holder&rsquo;s warrants up
to 9.99% of the number of shares of our Common Stock outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cashless
Exercise</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its Series A Common Warrants, a registration statement registering the issuance of the shares of Common
Stock underlying the Series A Common Warrants under the Securities Act is not then effective or available for the issuance of such shares,
then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise
price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock
determined according to a formula set forth in the Series A Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transactions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we consummate a merger or consolidation with or into another person or other reorganization event in which our Common Stock
is converted or exchanged for securities, cash or other property, or we sell, lease, license, assign, transfer, convey or otherwise dispose
of all or substantially all of our assets or we or another person acquire 50% or more of our outstanding shares of Common Stock, then
following such event, the holders of the Warrants will be entitled to receive upon exercise of the Warrants the same kind and amount
of securities, cash or property which the holders would have received had they exercised the Warrants immediately prior to such fundamental
transaction. Any successor to us or surviving entity shall assume the obligations under the Warrants. Additionally, as more fully described
in the Series A Common Warrants, in the event of certain fundamental transactions, the holders of the warrants will be entitled to receive
consideration in an amount equal to the Black Scholes value of such warrants on the date of consummation of such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercise
Price Adjustments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, and subject to certain exemptions, if we sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter
into an agreement to sell, or grant any right to reprice (excluding Exempt Issuances, as defined in the Placement Agency Agreement),
or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any shares of Common
Stock, at an effective price per share less than the exercise price of the Series A Common Warrants then in effect, the exercise price
of the Series A Common Warrants will be reduced to the lower of such price or the lowest VWAP during the five consecutive trading days
immediately following such dilutive issuance or announcement thereof (subject to a floor price of $5.60, the &ldquo;Floor Price&rdquo;),
and the number of shares issuable upon exercise will be proportionately adjusted such that the aggregate exercise price will remain unchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time on or after the date of issuance there occurs any share split, share dividend, share combination recapitalization or other
similar transaction involving our Common Stock and the lowest daily volume weighted average price during the period commencing five consecutive
trading days immediately preceding and the five consecutive trading days commencing on the date of such event is less than the exercise
price of the Series A Common Warrants then in effect, then the exercise price of the Series A Common Warrants will be reduced to the
lowest daily volume weighted average price during such period and the number of shares issuable upon exercise will be proportionately
adjusted such that the aggregate price will remain unchanged, subject to the applicable floor price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the 11th trading day after the Stockholder Approval Date (the &ldquo;Reset Date&rdquo;), the Series A Common Warrants&rsquo; exercise
price was adjusted to the Floor Price according to the terms of the Series A Common Warrants, and the number of shares issuable upon
exercise was increased such that the aggregate exercise price of the warrants on the issuance date for the shares of Common Stock underlying
the warrants then outstanding remains unchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and the number of shares issuable upon exercise of the Series A Common Warrants is subject to appropriate adjustment in
the event of stock splits, stock dividends, recapitalizations, reorganizations, schemes, arrangements or similar events affecting our
Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reduction to the exercise prices of the Series A Warrants and resulting increase in the number of shares of Common Stock underlying the
Warrants will be subject to the Floor Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a Series A Common Warrant may be transferred at the option of the holder upon surrender of the Common Warrant to
us together with the appropriate instruments of transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fractional
Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of Common Stock will be issued upon the exercise of the Common Warrants. Rather, the number of shares of Common Stock
to be issued will, at our election, either be rounded up to the next whole share or we will pay a cash adjustment in respect of such
final fraction in an amount equal to such fraction multiplied by the exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trading
Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established trading market for the Series A Common Warrants, and we do not expect an active trading market to develop. We do not
intend to apply to list the Common Warrants on any securities exchange or other trading market. Without a trading market, the liquidity
of the Series A Common Warrants will be extremely limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the Series A Common Warrants or by virtue of such holder&rsquo;s ownership of our shares of Common Stock, the
holder of a Series A Common Warrant does not have the rights or privileges of a holder of our Common Stock, including any voting rights,
until the holder exercises the Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Waivers
and Amendments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Common Warrants may be modified or amended, or the provisions thereof waived with the written consent of the Company and the
respective holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Series
B Common Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the Series B Common Warrants is not complete and is subject to, and qualified in
its entirety by, the provisions of the Series B Common Warrant, the form of which is incorporated by reference as an exhibit to the Annual
Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of Common Stock upon exercise of the Series B Common Warrants was subject to stockholder approval under applicable rules and
regulations of Nasdaq, and the Company obtained such stockholder approval on the Stockholder Approval Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration
and Exercise Price</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Series B Common Warrant has an exercise price equal to $5.60 per share, and will expire on July 3, 2027. The exercise price and number
of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits,
reorganizations or similar events affecting our Common Stock and the exercise price. The Series B Common Warrants will be issued separately
from the Common Stock and may be transferred separately immediately thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Common Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed
exercise notice accompanied by payment in full for the number of shares of our Common Stock purchased upon such exercise (except in the
case of a cashless exercise as discussed below). Generally, a holder (together with its affiliates) may not exercise any portion of such
holder&rsquo;s Series B Common Warrants to the extent that the holder would own more than 4.99% of the outstanding Common Stock (or at
the election of a holder prior to the date of issuance, 9.99%) immediately after exercise, except that upon at least 61 days&rsquo; prior
notice from the holder to us, the holder may increase the amount of ownership of outstanding stock after exercising the holder&rsquo;s
warrants up to 9.99% of the number of shares of our Common Stock outstanding immediately after giving effect to the exercise, as such
percentage ownership is determined in accordance with the terms of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cashless
Exercise &amp; and Alternative Cashless Exercise</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its Series B Common Warrants, a registration statement registering the issuance of the shares of Common
Stock underlying the Series B Common Warrants under the Securities Act is not then effective or available for the issuance of such shares,
then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise
price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock
determined according to a formula set forth in the Series B Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
may also effect an &ldquo;alternative cashless exercise&rdquo; at any time while the Series B Common Warrants are outstanding following
the Initial Exercise Date. Under the alternate cashless exercise option, the holder of the Series B Common Warrant, has the right to
receive an aggregate number of shares equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable
upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transactions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we consummate a merger or consolidation with or into another person or other reorganization event in which our Common Stock
is converted or exchanged for securities, cash or other property, or we sell, lease, license, assign, transfer, convey or otherwise dispose
of all or substantially all of our assets or we or another person acquire 50% or more of our outstanding shares of Common Stock, then
following such event, the holders of the Series B Common Warrants will be entitled to receive upon exercise of the Series B Common Warrants
the same kind and amount of securities, cash or property which the holders would have received had they exercised the Series B Common
Warrants immediately prior to such fundamental transaction. Any successor to us or surviving entity shall assume the obligations under
the Series B Common Warrants. Additionally, as more fully described in the Series B Common Warrants, in the event of certain fundamental
transactions, the holders of the warrants will be entitled to receive consideration in an amount equal to the Black Scholes value of
Series B Common Warrants on the date of consummation of such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercise
Price Adjustments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time on or after the date of issuance there occurs any share split, share dividend, share combination recapitalization or other
similar transaction involving our Common Stock and the lowest daily volume weighted average price during the period commencing five consecutive
trading days immediately preceding and the five consecutive trading days commencing on the date of such event is less than the exercise
price of the Series B Common Warrants then in effect, then the exercise price of the Series B Common Warrants will be reduced to the
lowest daily volume weighted average price during such period and the number of shares issuable upon exercise will be proportionately
adjusted such that the aggregate price will remain unchanged, subject to the applicable floor price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the 11th trading day after Stockholder Approval Date (the &ldquo;Reset Date&rdquo;), the Series B Common Warrants&rsquo; exercise price
was adjusted to equal the Floor Price according to the terms of the Series B Common Warrants, and the number of shares issuable upon
exercise was increased such that the aggregate exercise price of the warrants on the issuance date for the shares of Common Stock underlying
the warrants then outstanding remains unchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and the number of shares issuable upon exercise of the Series B Common Warrants is subject to appropriate adjustment in
the event of stock splits, stock dividends, recapitalizations, reorganizations, schemes, arrangements or similar events affecting our
Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reduction to the exercise prices of the Series B Warrants and resulting increase in the number of shares of Common Stock underlying the
Series B Common Warrants will be subject to the Floor Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a Series B Common Warrant may be transferred at the option of the holder upon surrender of the Common Warrant to
us together with the appropriate instruments of transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fractional
Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of Common Stock will be issued upon the exercise of the Series B Common Warrants. Rather, the number of shares of Common
Stock to be issued will, at our election, either be rounded up to the next whole share or we will pay a cash adjustment in respect of
such final fraction in an amount equal to such fraction multiplied by the exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trading
Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established trading market for the Series B Common Warrants, and we do not expect an active trading market to develop. We do not
intend to apply to list the Series B Common Warrants on any securities exchange or other trading market. Without a trading market, the
liquidity of the Series B Common Warrants will be extremely limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the Series B Common Warrants or by virtue of such holder&rsquo;s ownership of our shares of Common Stock, the
holder of a Series B Common Warrant does not have the rights or privileges of a holder of our Common Stock, including any voting rights,
until the holder exercises the Series B Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Waivers
and Amendments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Common Warrants may be modified or amended, or the provisions thereof waived with the written consent of the Company and the
respective holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSIDIARIES
OF GLUCOTRACK, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Formation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integrity Applications, Ltd.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fahn
    Kanne &amp; Co.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
    Office</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32
    Hamasger Street</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel-Aviv
    6721118, ISRAEL</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PO
    Box 36172, 6136101</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T
    +972 3 7106666</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F
    +972 3 7106660</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>www.gtfk.co.il</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTERED
PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have issued our report dated March 31, 2025 with respect to the consolidated financial statements included in the Annual Report of
Glucotrack, Inc. on Form 10-K for the year ended December 31, 2024. We consent to the incorporation by reference of the said report in
the Registration Statements of Glucotrack, Inc. on Form S-8 (No. 333-281627), Form S-3 (No. 333-282297) and Form S-1 (No.
333-282158).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Fahn Kanne &amp; Co. Grant Thornton Israel</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FAHN
KANNE &amp; CO. GRANT THORNTON ISRAEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel-Aviv, Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO SECTION 302</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Paul Goode, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of Glucotrack, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 31, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Paul Goode</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Goode</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO SECTION 302</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Peter Wulff, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of Glucotrack, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.35pt; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 31, 2025</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Peter Wulff</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Wulff</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18
U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of Glucotrack, Inc. (the &ldquo;Company&rdquo;), for the year ended December 31, 2024,
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Paul Goode, Chief Executive Officer
of the Company, certify, pursuant to 18 U.S.C. &sect;1350, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company as of and for the periods covered by the Report.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 31, 2025</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Paul Goode</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Goode</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18
U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of Glucotrack, Inc. (the &ldquo;Company&rdquo;), for the year ended December 31, 2024,
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Peter Wulff, Chief Financial Officer
of the Company, certify, pursuant to 18 U.S.C. &sect;1350, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 89%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 89%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company as of and for the periods covered by the Report.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 31, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Peter Wulff</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Wulff</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>9
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99_001.jpg" ALT="" style="width:720px">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99_002.jpg" ALT="" style="width:720px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99_003.jpg" ALT="" style="width:720px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99_004.jpg" ALT="" style="width:720px">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99_005.jpg" ALT="" style="width:720px">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99_006.jpg" ALT="" style="width:720px">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !, /8# 2(  A$! Q$!_\0
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M_'TMM9VL]M?-IV] .NHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7PRO%I?[7)2A/SC9R2^4MO\ $]CSN),'3PZPU6.[5OZ^?_ ,?]N_]N/X&_\
M!.[]F?QY^U%^T/K%YI_@CP9!;6%AHFC06M]XH\=>+]78V?AWP-X0TF]O;!+_
M %_Q!?,-@EU"'2],TVRU'6]9U+3=%TS4M1A_%KP3^U?_ ,')'[5?A72OCO\
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M3_''[3_B"R\:_&CX5?&GXJ_ +Q1\0+.PMM+E\>#X<7>CMIGB;5[2QL]+T_\
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M;^]%U?,1@AG<<=OB+]BS]B.'X!VMKX[^(MSI^O?$^ZMGM[.VT_\ ?:-X)@O
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MEK8L?#-CX@<&^;3+'5/%B:2;D(NJZE$JBOZ:Z*^+/'/Y7OV2?V8/V]/VI_\
M@I%\>/\ @K3^TM^S59_L9^$=9_8D\3?LI_!?]F[Q%XQM?'WQO\4VU]=?VSI?
MC#Q=:Z38Z9IW@YVDM;R.7P_?KI>L"2_L-*&EN+#4M9U.G_P34_8?_;,\/?\
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M/":)>:SKO@_QO\,#JZB]E&M^-O%MGJ_]G:E_8X%WIVSQ6=6\,ZEIFL?UQT4
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)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex99_001.jpg
<TEXT>
begin 644 ex99_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P &! 0.
M!0X3# P3%A,0$Q$3%Q45%Q<6%!0:&AH7&!<7%QX<%Q@9&QP<)1L9'Q\?'Q\B
M'Q\?'Q\?'Q\?'Q\?'Q\?_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#ZIHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKPKX]_M*_P#"O9A8642371C5W9VS
M''DC:K*A#%BH)P2FT,C?,#BLKX:?#'6?&\*ZIK&JWD0N(U>.&VE\G"D)Y;G9
M^Z7*Y)14SR&9@VY:M_$>S\0_#"U>YTR\>]M%C<,ERBRW, .#Y_F !I=K;C\P
M*QJ1E'12R^M?#*[>\TJQEE8N[V5LS,Q+,S&)"6)/))/))Y)KI:**********
M****Y77?B'#I.HV>DXW3W?G-PRCRTCC=][#EOF9=J\ '#G=E,'JJ***\Z^-/
MQI@^%T$<DD9FFF8B*('8"%V^8Q?:P4 ,.Q))  QN9?%?A>?$'QN=KRXU"2TL
MHIF7%N1$S,2CM$OEE6PJ$8>4R%21@.2^/4+SX0:IH++<:/JMR\J\-#?R&Y@D
M&]#MR%!CX!RRJ7.=JLF23G_L]?$#4?%][J@U7"R6[6T7DI_JHF4W"R!1N?)+
M+\S;F)P #M50/;Z*********************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M****S_$.MIH-M->2@E((9)6"X+%44N0,D#.!QD@9[BOSA\/0GQIJL*7C$F\O
M8Q,Z[58F:4!V'R[0?F)'& >V.*_2ZHKNT2\1HI5#HZE65@&5E(P5(/!!'!!X
M(KBO%OBBV^$.D+(V9$MH8H84+*LDC!0B+G &<#<Y4$A0S!3C%>?_  XU+Q!\
M2=.FU07HM))6(M(DA@:WQ'\K,YD6:7#.&7[P*$%P'4JE:O[/W[0(^)0>VN4$
M=[&I<A WE/'N W+DL5(+!65B<Y#*2"RIG_M$?&;4OAA) ;86TD5QYNU9(I=Z
M>6(LY99P&R7)&%7  '/6N:UCX^ZUKFAI>Z; /.56>[N(U5HH%$SJJ+'(TC,^
MQ \F0PCC97( =63*L?VA-=TO0H]7F\B0M>FW7S;=U:1=C2>:&CFC0@,ICPL8
M&5.6+ UVOPT^)&N?%G3)Y+8P6<Z3,JSA"Z$JD;K$$=Y""2Q\R1@0JE0D<C%C
M'E?L]?M"WOB&].C:R!Y^V38^PQRF1"S/%(BKL!"9P<1[?+P=S-78?M"?'C_A
M6<<<5LB2WDV657.41%(!=U5E<[N53& 2&.[Y-K8GC;4O$'@'28M8DO1--$J&
M[MIH8!$3*0BJA@57S&[@']YA\;@5 V-Z5\*OB9!\1K);ZW!0[BDD;<E)  67
M. &&&!##J",A6RH\%^*7[3FL>!-1FTW;9R^5Y?[SR9DSOC23[OVEL8W8ZG.,
M^U3?'KXX:YI#QW&G(;;3F9TBN"L,OVA@?O\ S"0(A )AZ&1,R LI 3K_ (@_
MM%OX/CT^":-([R[MX);@R)+LM@Y0.QB&'?\ Y:@()%=2@W9R,XOQZ^(>K?"2
M>TEM[PW,4RS;HKB&#&Y-HSN@CA;'[P$ 8(*\E@VT>H:-XZO/'&D0ZCHT<*3S
M?PW3/Y:;79)/]4I9_F4A?N9!#'!&P_'7PDU_4_$/B"&[@>.34)&F8/<[_*)\
MB0-N\OY@ F0@7 7"@ *,5]B^)OB'-\/](-_K(A:Z7*^7;LRQR.SD1HAE^;[N
M&?@D .P4@8KS32?%&O\ B70KGQ"+U('\MY(+>.*+R52 E9MYEBED+,$<HH;
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M!(503U(49Z"O)/VH_P#D8KS_ +=__2>*OOJTM$LT6*)0B(H554!550,!0!P
M!P . *\:_:$UCP]HK1W.KPI<7T<9:WA^8.X#C ?;\OE;LG]Z&7'F;%8[E/C7
M[5=S>ZC!IMWJ&(WF6Z9;=5($*'R65&+@.TVU@)2=J@J D:X9G]Z_9<_Y%VS_
M .WC_P!*):^5?V7/^1BL_P#MX_\ 2>6O6_VY;MU33X@Q",URS+D[2RB$*Q'0
MD!F /4!CCJ:Z#X >$/\ A*O#L<'VZ=8G6YBE@B^R%5#22;D)>W>12R,&Y?.&
M!7 *UVOPO_9ZL/AO<M>6<D[N\+1$2M&R[2R.2-D:'.4'?&,\5Z?7YX?M">%W
M\.ZY>(^2)9FG1BI0,LQ\SC).X*S,FX'!*GH<@?;7P4U2/4]%L)(6W*+2&,G!
M'S1J(I!R!T=",]#C()&#7G7[2?B+5?A_;)?V%_(!)<F-HGAM750RNZ[&\D,
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MJVRJV!N"L9BR@]0"54D="5&>@KZ%^+'_ "!]0_Z\+O\ ]$O7RK^Q3_R&)_\
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M$A S!3C%?-]]\<-<U31)-=AG,;KJ(@:**&%K>.+R%;>?,CDD!,C 9:0KE@H
MR!7TA\+/%LWB[3+>_N8O)EFCW,GS <,5#KNYVN '7.?E8?,WWCS7QL\7ZKX'
MM)=3LVM7AC:+,4L,OF!6*QDB1)PK'>P.-B *3R2OS>5?"_\ :%\0_$BY:SLX
M]/1TA:4F5;E5VAD0@;)'.<N.V,9YKH/B9\2_%?P]@%W<P:?+"6VL\*W+B,G
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M,XC:8.P68CD*("'!3[GF93M?A)XX?QSIL.HR((S,TV$4DA56:1$&3U.U1DX
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M/7ZY_P"(6J2:1IMY<P-MEBM+B1&P#AEC9E.""#@@'!!'J*^2_P!BG_D,3_\
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MEDN&BD'(/5'(SU&<@@X->E?MS_\ ,._[>_\ VWKIOA=:)!X'F9%"E[+4F<@
M%FS.FXXZG:JKD\X '0"O+_V*?^0Q/_UX2?\ HZ"N?_:PU22]U^>.1LK#'!'&
M, ;5,2RD< 9^>1CDY/.,X  ^G_VH_P#D7;S_ +=__2B*O*OV&/\ F(_]NG_M
MQ7E7_,X?]Q[_ -O*]5_;G_YAW_;W_P"V]=K\'M4DTCP7]I@;;+%::A(C8!PR
MR7#*<$$'! .""/45XW^QA=I!K,BNP4O92J@) +-YD+[1GJ=JLV!S@$] :^K]
M0^%FF:A?)JLMNC7B;=LAW=5!"L5!V,P_A9E++A<$;5Q\J_MK?\AB#_KPC_\
M1T]?57PG_P"0/I__ %X6G_HE*ZJBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBO-?CI\&(_B=:J@;R[J'>8').S+8W(X&?E;:,D
M#<I (R-R-\]?"+QG>_ :[:QUN"2*TN67+'+*C@#,L90M'(,.HE"9; 7^)-C>
M]?\ #1VG:K^ZTA9M0NC]V&**1,9X#R/*B+'%N*JSG.W<#M(S75^#M+NKJWF;
M5U0O=2,[6V?-BAC:-(Q;Y8E7^5<R$ (SN^U<')^;_A?X7?X$ZZW]JY%I/"T$
M-X%(MRSNCIO;.(SB)@RDDJ?F.8_WE'Q0\+O\=M=7^RLFT@A6":\*DVX9'=WV
M-G$AQ*H5006/S#$?[RO=?C3\+D\9:0]A;H%>)5>U50%4/&I"(!N1 &0F,9^5
M V['RBO"OV9?B:? (NM&U""=9BQGBA2"5[AW\L;XM@^8$HJ,F55<;R[@;:\U
MT2.YU#Q.;AK>0/'JIGN(HE:Y:)5N@TN?*5BP4G&Y1@G&.H%>M?M/_!*X\0R+
MKNEQO+YL<0GA"2>?G 5)1&WS?=VHZ!59-H8J<N5/@?\ M1K:6L.E7-K<W$\4
M8CB-LJ2O(J[B!Y?[LKLC"C(+E@"S$'.?HKP5]NDA:74]BS2R%UA3!6!"%"PE
MQ_K&&"SOP"[,%^0+4WC;PNGBJRGL), 30N@9E#A6(^1]I(R5;##D'(!!!YKY
MO_9\_P"+-WUWIVN?Z,;CR_)G?Y;63R0Y;;*V%Y652,XQ]UMLF$.?I_@%_C'X
MDDUB&,C2EF@?S9HR$G6%4C*(K??#M$P.>$7[X#8C;T#]KNQFUZPALK.">>87
M,<I$4$TBA!',A)=$*9W$?+NW8(.,'-'[(EC-H-A-97D$\$QN9)0)8)HU*&.%
M 0[H$SN!^7=NP"<8&:]ZKQK]I75FU/2[C3+6WNI[B1H !%;3O& '24L9-GED
M87'RLQ#$ @88KX+\ (=2^&VH-=W.EWTD3V[Q-Y=O+O7+(X8!E ;E ""R\$G)
MQ@^X:_\ ':YM8G;3-$U W$C9)EM6B3=LV"1O+WLY&U%V_*2HQO7 KI?V>M)F
MLM*6:\C>.\N;BYGN1(K1NTKRL-Q0@;,HJX"A5Q@@<Y/R5\/X9OA-XAA_M""9
MFBDF14BC8O+N66!&B#^7O5G/RGC<.G/%?2OQOEOM8\.R6UQ;/]NN-A$%O'-<
MJ@6XCD",\:,H98L!B2JNX;R\C KA?V2-/N/!IO5U"VNH3*L+)NM;D@B)9V?E
M8B,X(P#RY(5 S'%>=?\ "'W_ /PDG]I?8KS[+_:_G^9]EN/]5]I\S=M\O=]W
MG&-W;&>*]J_:PBE\4:;;VUC!<S2FXBGVI;7!Q&8YE^8^7A6!8 HQ#C/*BLK]
MGKP2][H=[H>H0302W$D[+YUM*$4-%"B2 NBQEED&Y5W!\KN&,9'BFCSZI^S_
M *H)9H?[\;9!\F>+*,WER%?]Q@P^9&P'7[R'ZP\%_%N?XB/$^EVLD-H&+37%
MU'M5D!*^7 (Y#O<L"&<G;$%.Y69E6N?E^)3Z/K6HV6IQR/I,C6Z"=T+VD#O;
MQ!XY&*E523S%SEMJL02H$CN/.H?A1:ZWXI@N-!&=/BDBGGFC&^UCEC;S3#&P
MVH=W[OY$9MGF$@!4*+]:5\B_MN6EVUS:RLI-DL+*C8&T3,S&121\P)14(#<$
M*=G(>HO']U?>,_"=HL=C-''9>097? W)' R+-$N-SQ%6#N^%"9POF*)'3H/V
M._%_V&QFM#;W++]HFF:=(M\"@0Q#9D-O:4[1B-$=SN! QDCS7_A#[_\ X23^
MTOL5Y]E_M?S_ #/LMQ_JOM/F;MOE[ON\XQN[8SQ7HO[6^GW'C(V2Z?;74QB6
M9GVVMR !*L#)RT0&< Y Y0@JX5ABO1?V?M'%QH":5?0S(PCGCGCEBF@RLTLQ
MP&94W90\E&)7(R02*^?_  $TWP"UXC4D<6K^;!YYC;#Q91EF3:Q!P1&7 +LB
MEEVE\"JO[4&K3>*]8B*6TT>ZW2.!71EFF FE4.(B Z;G+!$8;V4*V!N 'US\
M(K@MI5I$R21O#;012++%+"P=(D# "55+ 'C<N5)S@G!KIM4U-=,C::0.57&1
M''),_) X2)7<]>< X&2> 37PU\<?"VH^,-8NKZTL+TPR-&$+6LZDA(DCW8*9
M )4D9P<$9 .0/8-/^,>IZ/HT-C:Z1J O8[98 Y@?RD*1F-)@3&Q<Y"MY;(!R
M5W$#+>?_  =_90N]7G2?6HS!:*J/Y98"67/(0A6+1C^_NVN/NJ Q+)G_ +7'
M@6ZTS59-3=,VMSY020<@,D2(8VX^5OD+ =&7D$E7"]A\;_$>I_%C2K>2STZ=
M+<31.P9'>9Y&BD(,2H#NMU5O]:P7>SH% VM7:_LB6,V@V$UE>03P3&YDE E@
MFC4H8X4!#N@3.X'Y=V[ )Q@9H\(_$I))K_3?$,9^Q-J-V+:YN4!LV59G(MR\
MB[,JT;-'N8C@H-I1%/'_  :^%$:>)9=0TP/_ &5;>889B"T<C.AA:*-VV[U5
MVDPZ[QB,!F)<,> ^/?@^_P#%6LW-[965Y)!)Y.Q_LMPN=L,:-P\:L/F4CD?I
M7T5^T'?GQ%H4L%I#<R2W'E^6@M;G?^[GC+[E,0,? )'F;=P&5S7G7[)&GW'@
MTWJZA;74)E6%DW6MR01$L[/RL1&<$8!Y<D*@9CBO.O\ A#[_ /X23^TOL5Y]
ME_M?S_,^RW'^J^T^9NV^7N^[SC&[MC/%>R_M/?!V7Q[!%JVG(6GBAPT15UED
MB/SJ C8(="6.PJ';<1]Y50^?_ ;]H@^!(AHE_;3R%)I%B$2J9E=G'[@Q,$)/
MF%SDL6W$)MP!CW75-;U&[TK4M1N ;56LIFM(/NW$2I%(1+(X.5F<D'8.(@JC
M)?>:X_\ X3#2_'.E_9O%:?9+R&W^?[0@@N.G-Q;[D5CO:/)2-3\R^6R,NW?Y
M_P##OP9JG@#P[?Z@BS07D]Q9+!%L(F_=W"*#M.6.]I&3RV4;E'1E<5VOQ/UO
M1OB/I<CWL7V?5DC"QV[KMU!9\9AA5=OFRQ.T@QA2I5]^$<$IV'[,'@.?P;I"
MI=@I+/,\[1L-K1AE1%4\GDJ@8@[2I;:R@J:]:KYU_:0_9OD\72'5-+&Z[;8)
MH2P42  (KJ7(5650 02%91D8<$28OP-_:%C\&P?V-XA$EL]LH\MY$F9]APRQ
M.FUG4A6'EG&WR\#Y=HW^G_\ "[6\4_NO#=N]XQX-Q(KV]G$>AW-(JN[+N1FB
M1=S(25;((K0^(7PK?Q9H?]D/*)+A(80EQ*I8F6(+^\.2S*7PRLP+, [?>Y!\
MJ_9S\7P?#"VNM*UPFRN$FDN )AM62/:D9,9Y\P[HC@)G>"#'OPVW*^"/PMG\
M5:Y+XCFB,5E]IGG@6>/#RF4L\3*I) "AU<2 D;@H0L<LFA^V%HUSXHDM(;&V
MN9V@^T>88[>=D'F"$IAQ'L;.TYVDX((.#Q6WX%DDT[PC)ITMO=+=?9KR+ROL
MET6+S&X:,#$6"",98':A(#E20#Y_^RIX:O/">JO+?6EU"DELT2LUM<;=[2PD
M D1D*,*26;"@#DBM#]K[X1S/<+K-G$\B/&1<[%9]AC7Y96^8D*8Q@D*$7R\L
M<O6A\4OC6/'OAEO(@D=W6$7<@1HX('26$L [95RSE=B*S,(VWOMVD&']BE'T
M[[498IE2Y\CR9/)E,+>5Y_F?O0AC&"<?,PRWRC)XKS7XKZ%=?#?Q$=0N8MT;
M7YNX2#A)%$WF[ VTX89"N""5)!P5*ENU_:0CU;XB_9+B#3KE+9?/$:&*1KK/
M[K>\J(&$2D@+$"=S;'<_*R@>R_LYV)70XM.O()$>-9EFBG@EC4K)-*P7]Z@2
M0%#\P4L #AL9Q7RUXA\&:I\"-32[1=RQ2?N;C83!(&5AL;^ZQ3<&3<'7DHV-
MKGZ:\'?'B?XCHD>CV<D<A91-/<+NLX0 IE 9'5IGY 1!Y9;<';:H->5?MJ>#
MKE[N#4D0M;BV$3LJL1&RRL<N0NU0WG*$R<L0PQP,^P?L_>,Y_$ME:K% 8[*W
MLHX3++P\L\81#Y2J2#"H5MSM@LQ"@ H]>M44444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444445\X>&?%-[\=-1NDM[R2STJT90HMF,5Q*6\Q8W\PH&4-M+,IX
M "+L+9D'2^*] UGX96LM[I=Z][#%&SR07Y\YP!S)*DRF)OE51B(_+C>PRY5:
M]%^&5V]YI5C+*Q=WLK9F9B69F,2$L2>22>23R346N_$.'2=1L])QNGN_.;AE
M'EI'&[[V'+?,R[5X .'.[*8/5445E>*_$T/A>UEOKDXBAC9VY4$XZ*NXJ"S'
M"J"1EB!WH\)Z[_PD%G;WNW9Y]O%+LSNV[T#[<X&<9QG SZ"M6BBBBBBBBBBB
MN5UWXAPZ3J-GI.-T]WYS<,H\M(XW?>PY;YF7:O !PYW93!ZJBBBN%^-/Q,'P
MYTY[T -*66.%&W;6D;)&=HZ!0SD97<%VA@6!KYOLM8USQOH,NJ6TUY+?+J8C
M?R)94Q +=!A8(66/_6,I)1-W)8G&XU]0?"S4+[4-,MY=539>-'F1=H0_>(1F
M4'Y6*;69>-K$C:N-HZ#5M4CTB&2YG;;%%&\CM@G"J"S' !)P 3@ GT%?)6M?
MM$:O\4;Z/3-!_P!$27S$!8IYC##$R,Y4F+;&N[$674[MK.=@'K5M^SW<K!MD
MUK4VN-K8D6=EBW<[#Y9+-@<9'F9;!P5SQR'BWQEXC\*7^FZ5J$T,D%Q?PXN8
ME\N:5%N%W1R $*GRLFX(N"I"^8X\S/TI1111111111145W"9T9%8H64@.NTL
MI(P&&]67(ZC<",]01Q7R!:?'36H/$*Z4UV7MUU46Y#16P9HQ<>602D*\E>I7
M'/(Q7V)6+XHT2XU5,6MW):N%?#(D$BEB!M+K-&Y(4CHK(2"03T(^,/"?[0_B
M+Q!>6]E]NV>?<11;_L]LVW>X3=CRQG&<XR,^HKT7XJ>-O%'PCEBGFNX[VUD9
ME4M;I&I8(/ED$:*4.22@64E@A)X!6O9?@Q\8(?B=:M<1IY,L<A22$NKE>Z,"
M I*L.A*K\RNHSMR>_HKS7]H/7+OPUI4NH6-P\,L'EX 6%T??+''\PEC<\ G&
MTKR><\ <5^RE\4M1\=_;?[2F\WROLWE_)&F-_G;O]6BYSM'7.,<=ZY3_ (JG
M_A*?^7S[)]O_ -K[']FW?]^/]1_P/?\ ]-J^JJ**********************
M************************************************************
M************************************************************
M************************************************************
M***********************************************************_
M/"[74?@;J["(E)8F.UF7$<\);@E0Q!1P.0&)1AC*R)D?2'PT_:^L=?VP:FOV
M2<[1OY:W8_(,[OO1Y8DX?*(HRTI->M:SIMWH]DEMHB0!XUCCC%PTOE)&@ _@
M#.YV@* 2.NXL<;6^(/A)K^I^(?$$-W \<FH2-,P>YW^43Y$@;=Y?S !,A N
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M2NJLI,:K$PPX#;E+><I3(PP#'/ S-^Q+X9FLK6[OI!B*XDB2/(8%O*\S>PR
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M]NKR2>3;O?=;KG:H1>$MU4?*H' _6O%?VUO^0Q!_UX1_^CIZ]5^)?_(C1_\
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M1_[=/_;BO,/VF+M[/Q+=2Q,4=&MF5E)5E86\)# CD$'D$<@U[U^VM_R!X/\
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MB%M:(O*QB&55=V95SG:3$(U1!$P)\PE2GH'[%/\ R!Y_^O\ D_\ 1,%?/_\
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MBBBBBBBBBBBOFOX)Z5XC^&UBLD]O]ILW^?[*KXO+<$EG=4=0IRH)\@-O+LN
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M!,;! R 9)E PKQYWG";6]EKS7]H3X@W7@32WNK%-TK2+'O(W+"&#?O2,$'!
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M&93@,NUA]_:&VDL5-<5\+/#,_P 5K0ZO=ZK>QRS32;H+2?R(80IVK%LP^#M
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MGZC>SQ&]M/M45Q)Y[M%YZ F-@@9 ,DR@85X\[SA-K>RU\J_MS_\ ,._[>_\
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M'<]:]E\0:[>^--3GT2PE>S@M(XVN[E0C2N9E!2"+<V8\QEF\X LKJ,!0!YG
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M4Z,JH<,=YD#6]+U:?XN:S?6<E[/8PZ>S110VLWE2RD2,DDSM@E@"@&W;A-Z
M$'<9.U\(>$=1\,:JL4EY/=Z<;*?RO..^1)?-@+"20*!(2"3$6.X+O10%4EO3
MZ***********************************************************
M****************^5?C[_R.&D_]N'_I9)7U57E7[4?_ "+MY_V[_P#I1%1^
MRY_R+MG_ -O'_I1+7E7P"_Y'#5O^W_\ ]+(Z/C[_ ,CAI/\ VX?^EDE>P?&O
MX0VOQ.CBMI9O)NH][P./F.W,8FS&67>O* D$%6V<X)5O!3XH\3? $QQWN+FP
M+*B;F,D7"H=D<A DB(12J*XV<.RQO@FOKK2=4CU>&.Y@;=%+&DB-@C*L RG!
M (R"#@@'U%<?\<_"[^)]%O+6+.\P[U"J79FB99@@4$$EBFT8R03G!Z'Q_P#8
MC\4));76G' =)EG7YAN9758VPN,X4QKELD9< XXS]-5%<W:6HW2,%!95!8@#
M<S!$7GN6(4#J20!R:^5?V)[D:=<ZA8S92X*PMY;*P8")I$DSD?*5:100<')Z
M<''K7[4?_(NWG_;O_P"E$5>%>-?.T[P-IT9WQ^9=G<IW+N1FNI4R.,J<(ZYX
M/RL.QKZ:^#MVEUHU@T;!@+*W4E2"-RQJCKQW# J1U!!!Y%>"_P#-0_\ /_0.
MJ:66P;QS=6^I11RI/#%%&)4C>,2F"W="?,X!(4HN 6+,% ^8U[U_PJ?1_P#H
M'V?_ (#0_P#Q%:OAA;5( E@J) DDT82-/+1625TE 4!0/WBMD@8)R02#D\+^
MTU:/=>'[U8U+$+"Q"@D[5GC=VX[!06)Z  D\"L_]D_5([W0((XVRT,D\<@P1
MM8RM*!R!GY)%.1D<XSD$#SK]MRT>\?3(HE+N[72JJ@LS,3;@* .22> !R37I
M_P"U'_R+MY_V[_\ I1%1^RY_R+MG_P!O'_I1+7JM> ?MK?\ ('@_Z_X__1,]
M>J_"?_D#Z?\ ]>%I_P"B4K5D\,PO>)J&,3I;R09 7YD=XY,,<;CM9/EYP-S\
M9;(\U_:/U2/5?#-W/ VZ-O(VM@@,!=1#<N0,J<95AE74AE)4@FU^RY_R+MG_
M -O'_I1+7E7_ #4/_/\ T#JZO]M;_D#P?]?\?_HF>NJ_YD__ +@/_MG7*_L4
M_P#('G_Z_P"3_P!$P5G_ +&&MI;6UWI4H,=U%<M*T;X5MI5(B-I._*O'A\@!
M2R#.3@>_Z_K\'AZ![N[<1PQKN=VZ =.W)).  ,EB0 "2!7E7QV^ T'Q/<20S
M"*_AA P?F5HR9#&KJ#E 9 VV0 \;QM? V^8:-\5]>^#UY#8>(3YUG))@3.3*
MWE[V#RI*N7?&X.4D#.$"J%CW"OK2N*^*_P 5[7X;VIN;D[I&R(80</(P[#KA
M1D%W((4$<%BJMROC?1]3U32;ZZU.;R0;"X864&T(F$E91+-\TDK8V!_+,41*
ME2KQL=W/_L4_\@>?_K_D_P#1,%<I_P U#_S_ - ZNK_;6_Y \'_7_'_Z)GKR
M_P#:,NW71/#\08A&L@S+D[2RP6P5B.A(#, >H#''4U]E6EVEXBRQ,'1U#*RD
M,K*1D,"."".01P17RU\ O^1PU;_M_P#_ $LCKZJKP#]M;_D#P?\ 7_'_ .B9
MZ]5^$_\ R!]/_P"O"T_]$I7G7[7^B6UYHIN)B%FAFC,!^4,S.P1XQD;B"F7*
MJ028PQX4UV'P#\33>)=$L[JY.Z4QLC-EB6\N1X@S%B26(0%B3RQ)XZ5XI^PQ
M_P Q'_MT_P#;BCX^_P#(X:3_ -N'_I9)7L'QK^$-K\3HXK:6;R;J/>\#CYCM
MS&)LQEEWKR@)!!5MG."5;P4^*/$WP!,<=[BYL"RHFYC)%PJ'9'(0)(B$4JBN
M-G#LL;X)KNOVO]4CU?0;6Y@;=%+=P2(V",JUO,RG! (R"#@@'U%>P?"?_D#Z
M?_UX6G_HE*^?_@%_R.&K?]O_ /Z61T?MS_\ ,._[>_\ VWJW\;M0L[#Q?ISZ
MDB/:FT1)!(J-&-[W,:LPD(7:K,&8G[H!(R0!7NO_  J?1_\ H'V?_@-#_P#$
M40Z3I<-M=V4<<,-JGF)=(BBWC&^!'<L5"#_4NI+@\#^(%>/G76O@!KOPMD>]
M\-W+RQ<EHQ@2X DP&B;,4^U3@$#>7;Y(AUKT_P"#OQ=B^+&F72ZFL<9C5TNE
M4O'%Y,B-A]S'Y 5#J?G)&POE0P \PUKX :[\+9'O?#=R\L7):,8$N ),!HFS
M%/M4X! WEV^2(=:]?_9[^,[?$VUD:X5$NH) )%C#A"K9,;C=G&<,I&YCE"QP
M& KU6OBO4?\ BVOC7S[CF*2[:3>_[E EV&#/N;(*QF5@6Z,8R"5YV_:E%?)?
M[1FJ1V'B73-0D;_18_L^Z4 L@,%Y)YZ@J#ED_C4993@$9(%?6E?+?P M';Q;
MK$H4E%:]5FP=H9KM2JD] 2%8@=2%..AJ'X^_\CAI/_;A_P"EDE>J_M1_\B[>
M?]N__I1%7@OBR[>#P)IZHQ4/>NK@$@,OF7;[3CJ-RJV#QD ]0*^G_@[=I=:-
M8-&P8"RMU)4@C<L:HZ\=PP*D=000>17@O_-0_P#/_0.H_;G_ .8=_P!O?_MO
M7T!\6/\ D#ZA_P!>%W_Z)>O!?V=[1[SPEJD42EW=KY55069F-I$ H Y))X '
M)-=U^R/XFAU/1([6,_O;625)%)7/SR/*C  D[2'P"0,LK@9VYKUK6=?@T4(U
MRX0231Q1YZM)(P5$ '))/IT +'"@D?,O[<__ ##O^WO_ -MZ^JJ*^5?V&/\
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MFZSID?B;29YDC?37TZ *K(@A$<AN$A8I(%547<K'(&Q1G&0!7T+_ ,*GT?\
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M8+JVADL\"W:&-H0J[%\LJ"F%P-HVXP,# XP*FU;2X]7ADMIUW12QO&ZY(RK
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M O\ D<-6_P"W_P#]+(Z]5_:C_P"1=O/^W?\ ]*(JYKX>VCVO@=UD4J3IVH,
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MG_L2ZI'+IMS;!OWJ7?F,N#PLD:*ASC!R8G& <C'(&1FW^VM_R!X/^O\ C_\
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MGE>1MW>1G=Y?\6,;_FV8^2M7X_\ P1O/'/V;4K I%J%O'AE$CC=M_>(L<F%
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M5*9CG;*X3)8J,%^ &[[1]*Z7>M>QK))$\+'.8Y#&77!(Y,3R)SC(PQX(S@Y
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MPU&\U%] U] MTJOL?;LD9URY1@@\L@Q_,CKL4J@Y<N#4O[:W_('@_P"O^/\
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MP6)41G*Y+D?1]97B:2\2$_V>D+SG('GN\<:\'#'RXW9L-CY?ER,_.IQGQ_\
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M,LWRUNAMQ<7,B$E0\WFD(F=H>/R\@J_+-@,:GP=^*]Z]]/X=UXH=0AW,DRE
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M ##O^WO_ -MZ^JJ^5?\ FH?^?^@=75_MK?\ ('@_Z_X__1,]>J_"?_D#Z?\
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M<3LVQ@C#=&^!O95V[2P([_X1>!W\#:7;Z=*XD>)7W,H(7<[M(0,\D M@$X)
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M;.5)]DTV&Z\':5;6\4!N[B&VABV1/&BETB"[B\S1X3<N,@%@"#L/./&_V9O
M6L?#B:>.^L7\JY\D>8DULWEE"XRR^<"5Q(22N6&W 1MW%K]HWP!?-JECK]C
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M#1G)DE5\JIW8"$-PNX9)7S_]FSP[JOP_MGL+^PD DN1(LJ36KJH941MZ^<&
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M9D5B@\L%6<(S!OFC0C!]EUG0V^(^ES65_;O:/-'M*.T<NUP%=9%,,A#JL@!
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M=<M=8MM-<16GV?:DEQ:J[^5*9CG;*X3)8J,%^ &[[1]"S:_-' LXLYV=FP8
MUMYJCYOF)-P(L<#[KL?F''WL?/7PL\%ZYX6URZUBYTUS%=_:-R1W%JSIYLHF
M&-TJ!\%0IR4X);MM/L'Q>^'/_"S=+-J1Y,YV2Q>9SY<H'W6\MF4_*S(Q!=1N
M+*&(%>=?#'XF:MX)MAIFLZ7>RO;K&D4EK )E,84;58HPC)48 96.1PX#JQ;J
MOA!\.[NVO;S7M64)>7;;4B#!S#"I 5"T>(W)"1C(!.$!+;G=1PO[3/@+6/B/
M-!'8V+^5;></,>:V7S"Y095?.)"XC!!;#'=@HNWGWK1-;N+RV,UQ:20S*IS
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MD<M((R-\CE%7YP<>66ROW\$@6_V<-6FU?0K2>YD>65O/W/(S.YQ/*!EF))P
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MPP(?RT^85T'A?Q7JWQ.T^"ZL7CL$DA_>3M$)Y6F5E5_*B,A18=RNNZ5FD/\
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M(C..ZHHJ);1%<RA0'955FP-Q52Q52>I +,0.@+''4UX+^VM_R!X/^O\ C_\
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MQ4$]2%8@<X/2OFK5/CSKFG^(%TF6&.01M(/L]KEC*9(/,@5I9@" A*EY%6,
M!V*E0!75Z+XOU[P/+>W?B8QOIT<.^.2 (0)"Z!(8P-DI!\PIF4<%03(%RS:'
M]D^)_%$/VQ+V'3V>/=%:+;B7 (WH)I)EWK*-VR3:A4;<A<DBI?@-\79?%XFT
M[4E":E9,4F *8DVL49P%/4,,2;<H"5*D!PJXGPM^*5W\8KJ[,$SV5G;;!&L:
M0M/)YF[:TC3),@QY3':BC[^"[;,M%\./BQJ&EZY-X9UB074FXF&Y1$BX\GS@
MKHH48,?/&2KY7+J0R[?Q;^*]U:7L&@Z&87U"XW[VD.1 NPL&(^[NVYD .XA4
M'[I_,3/"?M Z?K7AO1YTO;H:A;SM"C-]G6W>W995D1_W6Y61MI1MY4AC'M/)
M!]%_9<_Y%VS_ .WC_P!*):]5JKJDDT4;&V1'EXVK([1(>1G++'*1QDC"G)P.
M,Y'A7P;^+VJ>*M>NM-U PJEM;SJ8X$(C,L5PD9D#2;I#PQ&,A<8.T')K5_:,
M^)VK> +<7%FELL#R>2)&:22?<\997";$C3:4;[S2AOE)4#(J6VNO$7BS2HKN
MTFCMG-E#*G[N.:XN)?*8L&W%8($=BI3 =@"&8Q\Q _9H^,L_Q&MIDO0/M%LT
M09U7:KHZD*Q^8_.61RV J@%=HZ@>RT5XU9>,-4^*$]PNC7$=E86TQB%UY<=U
M+/*OWPJE_+$.&#!OO'Y""=SJF5'\2]6^'FKV^D:PXO;>\9!#=+"() [LL84A
M<1D*_P!Y1E@KJ^[I'70?$GXF7LFH)X?T(1F]>%Y)9Y,M%;IM;;D(&*N3M(+K
MM&Z,%7$GR\KX_P#$/B3X2A=0GNH]2LMR)*C6ZV[J68DM^Y4A1A0@=F8;G ,9
M.#7K^@>-!XLT]-1TQ1()5RBRLT R&VNK,J2D%2&'"L"1P=IW5XAX ^,^O>)-
M8N],9;9I8+>>-44&.U66.94\]V;?.5Y*A4^]E053YI%/B3\4=;^$>I0-?7"7
M=C<Y) MXXM@$@\U(PLGF;DC*[#(Y4[\'<5)'I7QS\=:EX(LGO[&.V:*+RS(T
MS2ESN?R]JQHJCJRG<91QN&SH:J?"KQ)JGBW0+>]CFA-\_GDO/$3&^V65%4B%
MHMGW5&X!L 'Y&)K*_9O^-=Y\3?M?VU(4\CR-GE*ZYW^;NSOD?^X,8QWZUE>+
M?C-K'A'7+31K@6<L5S);?O$BFC?9++Y3?*T[A6!#8Y88P3U*CM?CGXZU+P19
M/?V,=LT47EF1IFE+G<_E[5C15'5E.XRCC<-G0US7POU[7OB#I,$R7$=L76;?
M=O$DTSNLY"^7"I2)4" HS/EBP.(P,2-4_9W^,NH>)+NYT?6 #=6RL=ZJBDE)
M3'*KE&V$AF0)L4 @,22<$]!J_CC4/&6HSZ1HDD=O':*OVJ]94G99&Y2**/=M
M)^5E<OT(<?*R+OY7QG\0M:^#4\$FISC4K"=MKN+=;>6)ESE5\L^7D@AE#DE]
MC*/+P7-3]LM;V"P1_M %H]RB&!(RK,3&S@R2>8V\*T9*J$098%MS(IKT7X5Q
MZE;Z3:.KVTR_8+7RHBDMN1E(\;YO,N,X3.<0C<V/NC-<5\&_B]JGBK7KK3=0
M,*I;6\ZF.!"(S+%<)&9 TFZ0\,1C(7&#M!R:[7XL_%*;PW-:Z9IL:3:A>2 1
MJ^YHXT! :618SYFW&<$ #"NQ/[LJW%>,5\5^ K4:F;Z&]6&/=<6YME0#.U25
M,2J[JNXN6)BPJ;B""5'I7PU^)T?Q$T_[?9)B0;D:*1BH655!V%PC97YE(=5/
MRD$J&!0>2CXTZX/$J:++'!A6ES%"3M</;F6+?-,NX!,J7:-%) ?$;G:A/C)X
MW\2?#(6^I/<0312MLEMU@5+>.3RQM4,7-PX)#L&W+@KR &"5[_X>UM->MH;R
M($)/#'*H; 8*ZAP#@D9P><$C/<UH5XA^T#\5-9^&I2YMDM9+*1@@+I)YJ2;2
M=K8F4,"%+*R@8P58 A6?M?#VI:KKVE0WD4EJ+J>&.90T$HA"O$'$1Q<%\[SS
M("1M_P"61-<)\!/C-J7Q!NKBWOQ;6[6V-\ BE6=L[U;&^<[-CA0^4;[P4[20
M:] U35-2&J16EL]L;5HVEF#12F:)%**J[EFVEI6+^661 %C<@2%"#Y5^TC\8
M]:\!-'';BVABN/,$4BEIYQY;J2Q$B)$NY74;=LF/FP_W2/4/C2MZNF7,MC<"
MW,=M.[MY9>4A$WXC<2((R0I4MM<C=E=K*#7DO['-M>/ILC02PI +]]Z/ \DC
M?NX-VUQ.BKE< 91L'D[A\HQ/VB)C!XMTMU4N56Q(1=H9B+N4A1O95R>@W$#/
M4@<UW7QNUSQ#X-MQK$%S#Y4<D0EM4@4QJK,>6ED<RR?,5C)18BP.\)'@UZKX
M \8Q^,[&#4(1A9HP2O)VL"5D3)5<[7!7. &QD<$5T%<+\:5O5TRYEL;@6YCM
MIW=O++RD(F_$;B1!&2%*EMKD;LKM90:\E_8YMKQ]-D:"6%(!?OO1X'DD;]W!
MNVN)T5<K@#*-@\G</E&3^W/_ ,P[_M[_ /;>O2_BY<:_;V,NIV-PEMY,;2?9
M1#%+(4!4MYDTCLFY4#.5C3 .8PTN%<VO!7Q[M]5T)M<O!L\G*7"1AFQ*"JA5
MW ??WH5Y*KO"L_RLU5?[)\3^*(?MB7L.GL\>Z*T6W$N 1O0323+O64;MDFU"
MHVY"Y)%2_ ;XNR^+Q-IVI*$U*R8I, 4Q)M8HS@*>H88DVY0$J5(#A5]:HHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHKSKQ-X^MK#4TLK&V%UJS0@,5VH(8=ZL?.GVLT:<[P@5R3M^4&1
M"W@'[7]I>Q)ISZC+&\K+<Y2&,QPH0("VW>SR,23@L2 55<1H=Q;V_P#:C_Y%
MV\_[=_\ THBH_9<_Y%VS_P"WC_THEKQJ^^$7B#X+W,EYH#&YM68;D4"21D#*
M526+ +'+%=\/S!=[9B#$5W?A+]H7_A86CZE\OV:^MK"9_DD^]^Y;]['R'7:X
MY'.S*?.Q;B+]B>[1M*N(@P+K>LS+D;@K11!6(Z@$JP!Z$J<=#1^VQ:(VE6\I
M4%UO556P-P5HI2R@]0"54D="5&>@KU_X97;WFE6,LK%W>RMF9F)9F8Q(2Q)Y
M))Y)/)-=+7%?%'QII_A>.%]0C\^1KA/LT"QK-.TH("M$C8^9=WWLC&0 =S*K
M>:_'[^U+_0+N>_\ )MX_]&*VT69I!F6 ;99VPIPQ8E8XUY5,2LNX-U7[+G_(
MNV?_ &\?^E$M>5?L,?\ ,1_[=/\ VXKIOVV+1&TJWE*@NMZJJV!N"M%*64'J
M 2JDCH2HST%<S\??^1/TG_MP_P#2.2OH#X3_ /('T_\ Z\+3_P!$I7SU;6B6
MOQ"VQJ%!9F(4 #<U@7=N.Y8EB>I))/)J7X^_\CAI/_;A_P"EDE>J_M1_\B[>
M?]N__I1%7-?"F[>S\$M+$Q1TLM1964E65@]P0P(Y!!Y!'(-1?LQ^&[/Q!HD+
M>9<^9')-'*L=W>0HK>8S@!(YD3[CH25&"2<G=NKT"^^#FCI<1:A<H[3PR0^5
M+-=7,A5A(/*4&69@?WC#:IR"S8P2<'S3XU? G4[C4_\ A(-!E_TKY"T994<,
MJK$"A8!"I0?.DA (##+A]@/@_P#M)W5_>QZ+KL'DW38592/();8K(LD;XPS\
MD%<!F9%6, YKZ*HKY5^/O_(X:3_VX?\ I9)7T!\6/^0/J'_7A=_^B7KRK]BG
M_D#S_P#7_)_Z)@KE/^:A_P"?^@=7U517RK\??^1PTG_MP_\ 2R2O5?VH_P#D
M7;S_ +=__2B*C]ES_D7;/_MX_P#2B6O*O@%_R.&K?]O_ /Z61U[+XF\?6UAJ
M:65C;"ZU9H0&*[4$,.]6/G3[6:-.=X0*Y)V_*#(A;P#]K^TO8DTY]1EC>5EN
M<I#&8X4($!;;O9Y&))P6) *JN(T.XM[?^U'_ ,B[>?\ ;O\ ^E$5'[+G_(NV
M?_;Q_P"E$M>5? +_ )'#5O\ M_\ _2R.K?[5>ER>#[ZQ\26*[95D$<K9"JS*
M-T08*5D;?'YB.<D&-53*\9]@T7Q-#X_N+2>V/[B&W6\SE=V^=9K:*,[2R_*H
MN!,O!601@,0'%=_17*_%C_D#ZA_UX7?_ *)>O*OV*?\ D#S_ /7_ "?^B8*R
MHGBU/QQ=VMW+, UHD< CFN(3D103% T+H0N!(Y4D(6R<;B*]?U3X/:?J\;07
M/VF6)L;DDO;YT."",JUP0<$ C/< US7CWX'VGBK15TC3'$*03.\&&,D8E5I5
M='8EWQO=U;!W(W8[2A\:T_XD^(_@7LM-4@^T6*82)B?EP/,"+'.H.,XR$E5G
M$:@!(Q7JOQY\30^*/"<]];',4T=JZ\J2,W$65;:6 93E6 )PP([5J_LN?\B[
M9_\ ;Q_Z42UY+\=[1(/&.ELBA2[6#.0 "S?:G3<<=3M55R>< #H!6K\&X8?$
M.OZY!=RS^=]I9HPEQ<PDQQ32QG)AD0$(&C50Q.T'"#&ZO8-;^">F:\@BO%GG
M0,&"RWE[(H8 @, \Y&<$C/7!/K7DO[0.K6_AN;P[Y,FW3X;A9!M9I(_*A-MY
M;\%B^V,G:WS,0QP3N.?I2HENT9S$&!=55F7(W!6+!6(Z@$JP!Z$J<=#7RU^P
MQ_S$?^W3_P!N*[7]HCX$W7C6:+5-,EV7D$84(6\O(0O)&8W ^64.V!N(4Y!W
M)M.[E?!/[2>I^&KR/2O$\&UGD"_:&"P,H+NOF,.(GBW8&]"BA%9LR&OI^BOE
M7X^_\CAI/_;A_P"EDE3?MRW;JFGQ!B$9KEF7)VEE$(5B.A(#, >H#''4U]/V
MEVEXBRQ,'1U#*RD,K*1D,"."".01P17RUI__ !+OB"\<'[M)-V]4^56W60E;
M<!@',@#G/5_F//-?55%?*OQ]_P"1PTG_ +</_2R2OH#XL?\ ('U#_KPN_P#T
M2]>5?L4_\@>?_K_D_P#1,%<I_P U#_S_ - ZM#X-PP^(=?UR"[EG\[[2S1A+
MBYA)CBFEC.3#(@(0-&JAB=H.$&-U>P:W\$],UY!%>+/.@8,%EO+V10P! 8!Y
MR,X)&>N"?6NJ\/6T%K;0QV>#;K#&L)5MZ^6% 3#9.X;<8.3D<Y-:%?,'[0.J
M22^*M&MBW[I)+215P.&DNMKG.,G(B08)P,< 9.?I^OE7]AC_ )B/_;I_[<4?
M'W_D<-)_[</_ $LDKU7]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\ THEKSKX-
MPP^(=?UR"[EG\[[2S1A+BYA)CBFEC.3#(@(0-&JAB=H.$&-U>P:W\$],UY!%
M>+/.@8,%EO+V10P! 8!YR,X)&>N"?6O)?V@=6M_#<WAWR9-NGPW"R#:S21^5
M";;RWX+%]L9.UOF8AC@G<<_2E1+=HSF(,"ZJK,N1N"L6"L1U )5@#T)4XZ&O
MEK]AC_F(_P#;I_[<4:AJVSX@IY\F$3;&F]OE7?9':BY.!ND<X4=7;@9;GZEN
M[1+Q&BE4.CJ596 964C!4@\$$<$'@BOF#]AJ[=DU"(L2BM;,JY.T,PF#,!T!
M(503U(49Z"H?@%_R.&K?]O\ _P"ED=>U_'#X6_\ "RM/-FLGERI()8F/W"ZJ
MRA7X)VD.02.5.&PV"K?/^G_$GQ'\"]EIJD'VBQ3"1,3\N!Y@18YU!QG&0DJL
MXC4 )&*^JO"GB:'Q1:Q7UL<Q31JZ\J2,]5;:6 93E6 )PP([5JU\J_M%:M]E
M\5:3YTFV"+['(=S8C3-T_F/R=J_*@W-QPHR< 5]55\J_LZ_Z!XJU:UA^2 ?;
M,1+\L8V72+'\HPORJQ"\?*"0, FCX^_\CAI/_;A_Z625]545ROQ8_P"0/J'_
M %X7?_HEZ\J_8I_Y \__ %_R?^B8*Y3]N?\ YAW_ &]_^V]?0'Q8_P"0/J'_
M %X7?_HEZ^6O EV]KX'U-HV*DWH4E20=K&T1UX[%25(Z$$@\&O=?@_X2LM>T
MBRN(Y;H@VT2MMO;Z-0Z+Y<BA1.JJ ZL % 7 ^7Y<5T%C\)M)T6^CU$(?MI8J
MDLMQ/+(S>4RE1YLK;SY0;C!(521@+D=U17Q7IG_%&^.3]H^;??RXV<_\?:MY
M6=VWIYZ[_3#;=V!G[4HKY5_:*U;[+XJTGSI-L$7V.0[FQ&F;I_,?D[5^5!N;
MCA1DX KZJKY5_9U_T#Q5JUK#\D ^V8B7Y8QLND6/Y1A?E5B%X^4$@8!-'Q]_
MY'#2?^W#_P!+)*]5_:C_ .1=O/\ MW_]*(J/V7/^1=L_^WC_ -*):\J^ 7_(
MX:M_V_\ _I9'1\??^1PTG_MP_P#2R2OJ6[M$O$:*50Z.I5E8!E92,%2#P01P
M0>"*^1?V0M4M=*M=7FU!D6U6.U\WS!N0J?M"E2N#NW9VA<$L2% )(%>Z^$-?
MOO&$,<FGPII^FF/$1D0-=,F$"-'$I$,*@;_+9S,#A&\HH>?'_P!AC_F(_P#;
MI_[<4?'W_D<-)_[</_2R2O5?VH_^1=O/^W?_ -*(JB_9GM$O/#5K%*H='6Y5
ME8!E93<3 J0>""."#P17E7P+UP_##Q!=^'+ABMO-,1#O=3A_O0,2&5 98B V
M%W,_E+A<$#Z%^''^FV[:@>M](+D#LJ-''' ,<X;R(X_,&6'F[]IV[0.JHHHK
MP#]M;_D#P?\ 7_'_ .B9Z]5^$_\ R!]/_P"O"T_]$I755\J_L,?\Q'_MT_\
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M,'C&<$@^E_"?_D#Z?_UX6G_HE*^?_P#FH?\ G_H'5]545\J_ +_D<-6_[?\
M_P!+(Z]0_:JM$G\/W3.H8HUNR$@$JWGQIN&>AVLRY'."1T)KP_QKYVG>!M.C
M.^/S+L[E.Y=R,UU*F1QE3A'7/!^5AV-?2ND^"+'5X8[F"6\:*6-)$;[?J RK
M ,IP;@$9!!P0#ZBCPO\ "_2O"5XUS:1[+R>.3<S332R.N]&D;$LCY^<H6;&0
M2,GYN>UHKY5_YJ'_ )_Z!U=A^V?=O!HT:HQ4/>Q*X!(#+Y<S[3CJ-RJV#QD
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MU?'*S!0S*J&OG_\ ;G_YAW_;W_[;U] ?%C_D#ZA_UX7?_HEZ\J_8I_Y \_\
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M1I+*ULYO/N-GR,]JOE^7-&_SG[05^95)787_ -K::/V>-+O_  UIT>EZA:/
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M9"F\;5W"O&OA1XN\1_#6,:-/I,URJR 0LOR(GF'<RF9$DB9=S9W%AL)8,V
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M VZOFOPS?^+?@Z'TV&S-U#N+1GRI;F)1N8$QM"RE0Q&XH^"/O;%+-N]E\,^
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M3#&Z5 ^"H4Y*<$MVVGL/VB/@_=^)I;;5](Q]OM67"D@%U5P\9!D/E@HY+88
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M&FTHWWFE#?*2H&14MM=>(O%FE17=I-';.;*&5/W<<UQ<2^4Q8-N*P0([%2F
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MKZ ^+'_('U#_ *\+O_T2]>5?L4_\@>?_ *_Y/_1,%<I_S4/_ #_T#J/VY_\
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ME$5'[+G_ "+MG_V\?^E$M>2_'>T2#QCI;(H4NU@SD  LWVITW''4[55<GG
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M$&&!RP60'S"JE0>@^-%C-\7S;:/8P3QQ"83S7<\$T$4:JKQ[%69(VD<[\@#
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M ,P[_M[_ /;>O5?VH_\ D7;S_MW_ /2B*C]ES_D7;/\ [>/_ $HEKRKX!?\
M(X:M_P!O_P#Z61UTW[/VOB;7]>@E<M,]R60-N8^7#--'U.0 H>-0,],!1@''
MT)7DO[3%VEYX:NI8F#HZVS*RD,K*;B$A@1P01R"."*E_9<_Y%VS_ .WC_P!*
M):]5HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHK@/C/\'X?B=:K;R/Y,L<@>.8(KE>SJ02I*L.
MH#+\RHQSMP?.O!?C7Q!\-TBT[5M-DNK:-3%%/9J)I-D8(4E$.""-@3?Y+;02
M0[AA7=6WQ$U/Q/L73=.FMU:0K)/?JL*Q ;6)$"R>;-E20N"BA\9; ;:?$_X,
M1^+]+DT]&_T@R"99Y"2S3@;=\A3;G<F8^%VQH0(XPL:(.%^&/Q,U;P3;#3-9
MTN]E>W6-(I+6 3*8PHVJQ1A&2HP RL<CAP'5BW5?"#X=W=M>WFO:LH2\NVVI
M$&#F&%2 J%H\1N2$C&0"<("6W.ZCA?VF? 6L?$>:".QL7\JV\X>8\ULOF%R@
MRJ^<2%Q&""V&.[!1=O/JOBR]O?$&CW$7V&9+J>WEA\GS+5MK/"1OW^>%,08[
M<\2'KY0%<3^S'X7U/P+;R:?J%D\:R7#2K,);=T&8U4JRK*7'^K&"H?);D*%R
M>:N?!.LKXI_X2&/3I&M]RY1IK19=OV86[G G9<CE@-V&P 2N<C*_;<F,Z:8[
M*4++=$HVTLI(MR5.QF7(Z':2,]"1S7J&J?%_5-/C:S_LJYDU(80/'&6TYG)
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M[5L75MYAC0D!) ^W>A)^ZWR#82=N<AL!MZ^7Z#\6/&UZ@LUL2TK*X$\MJ\+
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M***Y_P ?ZQ=:-8SW%A#]HN4C)CB_O'(R<#EL#+;%PSXV*0Q!K@/AWK^K?$>
M)JUE]B2*XAD9R)$>5HI5GC5(I!N10RIOD9G# ,B#+%HO7Z**************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M*******************************************\*\-VOB/QA<7TJ:E]
MDM8K^YAMU-I#*66.1E)!94RHX4-N8E@X."O/%>/_ !AXB\):Q::-_:OF?:O(
M_>_9+9-GFS-%]S:V[&W/WAG...M>@>*_!_BC2;66XMM8\^6.-G6'[# I?;R5
M4J)#N(!V@*=S87C.1POQL\6:U8Z)9:HFH%$NH;)'BBB6*3>\!F>4S*V\$NI&
MU!&NTA<?>W>__#*[>\TJQEE8N[V5LS,Q+,S&)"6)/))/))Y)KI:***\%_:G\
M3ZMX3M%NK.[$4,DWD>6D($N'B9BQF9W((,9VF-8R-WWB5!KU7X97;WFE6,LK
M%W>RMF9F)9F8Q(2Q)Y))Y)/)-=+11117/^/]'NM9L9[>PF^SW+QD1R_W3D9&
M1RN1E=ZY9,[U!8 4> -'NM&L8+>_F^T7*1@22_WCDX&3RV!A=[89\;V 8D5T
M%%%%%%%%<!X/\'ZIIFJ7MY>7OG6<V/(@P?DYR.#\L>Q<I\A/FY\R3# "N_HH
MHHK@/BSX/U3Q)]E_LF]^Q^5<!IN#\R\8/&=^W!_=-B.3=\Y&T5W]%%>"_M3^
M)]6\)VBW5G=B*&2;R/+2$"7#Q,Q8S,[D$&,[3&L9&[[Q*@UZK\,KM[S2K&65
MB[O96S,S$LS,8D)8D\DD\DGDFNEHHHHHHKY5^(OB+6= \2:=87&H/+%+<6TF
MR)/LL866YV&(JCL9% 3 \QF."1W)/U517 ?";P?JGAO[5_:U[]L\VX+0\'Y5
MYR><;-V1^Z7,<>WY"=QKOZ*\@_:4O-3T;3I;^PO/L\44:J\2Q*9)#+(L1/G,
MV8]H;*[%# Y.[E=NK^SAJTVKZ%:3W,CRRMY^YY&9W.)Y0,LQ).  !GL *]*H
MHHHHHHHHHHHHHHHHHHHHKP7]J?Q/JWA.T6ZL[L10R3>1Y:0@2X>)F+&9G<@@
MQG:8UC(W?>)4&O2O T]SJ.C6;QR@7#V5JQEE5IP6,:%V8"2-F)YYW@Y.3GH?
M&_@7XWU/5_$E[9:A=O<+;6]S$.%BC)BN8T$GEQX0,<GGEL';N( KZ4HHHKR7
M]H_XP/\ #FR7[+C[7<,R1%@2$51^\EQ@JQ7<H"L0"6#89593S_CCX3:]HZ)?
M:-J=U<7BL3+%-(@A<N,,T<;XA0 DD1MD!<;&#(H;W#2?.\F/[5L\_P M/-\O
M=Y>_ W[=WS;=V=N><8SS5JBBBBBBBBBBO$/B)\2)]:URW\+V,YM@ZL;J=!F8
M#R7D\E"ZX0F, ^8NXJS*1@HRL:?\/O$'A#5H?L-Y)=Z9*R^>+N42O&J@[AD_
M-DY)C,0 +864;%W-E>$?%,_QSO;U([R>TT^T:(0K:MY,LI8RA9GE9-X!52?+
MP!RF?F0L]KPUX%\56T5_IDUZ#%Y.VSNW.Z8N7W=06D4%"R.7+-$Q0P%@N3ZU
MX T>ZT:Q@M[^;[1<I&!)+_>.3@9/+8&%WMAGQO8!B170444444444445\P?$
MSQEK.B>(M/TV:]W037%E*4AB^S)AIC$T9^>21U(4E@\A4EONX Q[_P"/]'NM
M9L9[>PF^SW+QD1R_W3D9&1RN1E=ZY9,[U!8 4> -'NM&L8+>_F^T7*1@22_W
MCDX&3RV!A=[89\;V 8D5T%%%%%%8OC3Q?!X.M);^[)$42@MM&YB20JJ!ZEB
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M*@)_%FP"0@9@IQBO.K?0O%WB"V^VB_@M)I%C9+06P\M%*H2'>5'E1QEMR[9
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M[TN]U1-:*.LZR+(41@L+2J21*RA=V[=ACA@K,,L"2^ZI^U'_ ,B[>?\ ;O\
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M1%KC9Q'YS,V6C#.3(&;A<J%7'U?HD%S"A%Y)'(^XX:*)H5VX& 5>:8DYSSN
MP0,<9/RA^QK)=-]OCLPBLWV4M-(-\<8'G\>6KQN[-G"@,J@!F9\JL<G=Z/\
M%#5/ _B!-$UJ<74%RL7D3^5'"P9\A"$A#<-*#$0_(($F57(;?^,WQEG\/7]I
MH=@ EQ>-$&N'7S%B260PJR)N7<X8%OF^4!0"&W';E?&CQ7JWPH-MJ,=X;NS,
MPBFMYXX$=F*NP*R0P1X&U3CC*L%)$BL5$O[0NLW6L^'FU&RG\FTEM[9VB\K]
M^ZS,J[&D$I55*R+N54).TJ7*,15O]ERVO/[&LW\V'[+_ *1^[\A_._UTH_UO
MG[?O<_ZK[OR]?FKVJOD7]M%;VW>U$]P'MY&G,<"1F)4*%,,Y,C^8^V3;NPH
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M64_*V=JJ1@J=X(9!MP:EJLVJR68DM?LL<,,S'R)?.VRRS(L0_P!(V9V0MF3
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M-?+7[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\ D_\
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M;N7N!>M+*6W%B)8T"N6/WBS1OGDG(R>HS[_=W:6:-+*P1$4LS,0JJH&2Q)X
M Y)/ %>7_M1_\B[>?]N__I1%1^RY_P B[9_]O'_I1+7E7P"_Y'#5O^W_ /\
M2R.OJJO!?VP/ !U_3DOT8![)F8AG5%,<FT/C<.7W*FT;AD;E 9RJUH>)OB1<
M^(M%-LMA>-J%W;FW>$VT\,<;RJ8WD,DBF,1 DLN7)P5#[?G9)?#OPX?X4^&K
MV!)BUQ]FNYWD0E0LOD8_=D88!=BX8_,2"WRY"K@?L3W:-I5Q$&!=;UF9<C<%
M:*(*Q'4 E6 /0E3CH:/VV+1&TJWE*@NMZJJV!N"M%*64'J 2JDCH2HST%>E>
M'-$3QIH%O;7Q,@N=.MQ(S89RS0H?,RX;YPWSAB"0P#=17BO[(WBP^''O]$O@
M(C;M)<.Q*[4,96&X#OOVX&$*D#& Y+8VU[_X M'$#7,RE9;J9YW# JX5L+ C
MKP%=+=8HW XW(22Q)9O!?V2["#Q59W7VB:Y:Z6[,DFRZNX<B5%VNWE2HK,S(
M^6.7X^8XVUZUXH^">C:HGFZBLDB0J[;I[R[=8UP"[9DG(484%CP,#GI6?^U'
M_P B[>?]N_\ Z414?LN?\B[9_P#;Q_Z42UY5^W/_ ,P[_M[_ /;>OH#XL?\
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M))LNKN'(E1=KMY4J*S,R/ECE^/F.-M>M>*/@GHVJ)YNHK)(D*NVZ>\NW6-<
MNV9)R%&%!8\# YZ5G_M1_P#(NWG_ &[_ /I1%1^RY_R+MG_V\?\ I1+7E7P"
M_P"1PU;_ +?_ /TLCH_;G_YAW_;W_P"V]=7^VM_R!X/^O^/_ -$SUZK\)_\
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M@_49]=\.RES*TLCH-IF'F;GE78R[)4W %%Y?<5 1F3>>U^!_[13^-KE]+U&
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M">,@ [02R\I\.OBIJ.@646F7>D7K7=NHMXS'%_HS[ (XBTS-M0' #N-Z8'F
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MFYB9/W9&UOXBI\6O#&LZCXBT_5'LG:!9+78L'[UU2.;S"LS9$:2Y8DG<(0"
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MGNT-JJ1;E!"D,=V[.' RQCW 1ON)67XP?!%U\,Q:7IX,CV31RA54EIF <3$
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M21RT@C(WR.45?G!QY9;*_?P2!;_9PU:;5]"M)[F1Y96\_<\C,[G$\H&68DG
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MA@-JGEN8]K>9'+,=Q0DMO^7?PA"X:W^S=\9Y/B1:R)=+BZMO+$C@ )('W;'
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MVD'V>URQE,D'F0*TLP! 0E2\BK&  [%2H KJ]%\7Z]X'EO;OQ,8WTZ.'?')
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M_P#S#O\ M[_]MZV_BW>QMXPTR"ZDD6 VVU0DDT9$DIN(UVF%E=2SB-6((R
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M7 8*ZE"1D$9P>,@C/8U\U_LG^+QX334M*U B(VC27#C#.P$8\NY)*;E(38F
MO)))7<.F)\7?M'P]UK3?$-S\LEQE[A%VO(NUMLL//[L[;:5(%=2-Y0R':QW'
MZ5T/_B<7T]V>4M\VL&.5.1')<R!A@',@2%E.[RWMVP06=1Y5^VM_R!X/^O\
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MJY.T,PF#,!T!(503U(49Z"H?^:A_Y_Z!U=7^VM_R!X/^O^/_ -$SUZK\)_\
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MXP1EOW;N0J_,6  R?E/8?#7P@/!VG6U@  8H5#[2S*9#\TK MS@R%B.!@'
M' \O_:<\+ZGXZMX]/T^R>18[A96F,MNB'$;*%56E#G_6')8)@KP&#9'3>&=%
MOM4T!](N;8VMPNG&U4O)%)$S>2T*L&A=V X#,&4$;L+OP37G7[-$VI^"X;C2
M)]-N?-^T/(DK;8[?)"1,&D? V@H#NB\YF4LR(VWYC]IGP%K'Q'F@CL;%_*MO
M.'F/-;+YA<H,JOG$A<1@@MACNP47;SZKXLO;WQ!H]Q%]AF2ZGMY8?)\RU;:S
MPD;]_GA3$&.W/$AZ^4!7$_LQ^%]3\"V\FGZA9/&LEPTJS"6W=!F-5*LJREQ_
MJQ@J'R6Y"A<GW6OF#XI^"]<\4ZY:ZQ;::XBM/L^U)+BU5W\J4S'.V5PF2Q48
M+\ -WVCNOCU\*Y?BGIT<D,1AO8&=XXI63<5/#Q$QRO$"^U65LL 0%)0,Q%7P
MA\:-6MX!:ZEI-[)J",T8>.$+;2,/E1VE)"1@M]]U#1@?O%^4[5Z#X#?#.?P?
M!-<Z@0VH7LQFN"O0$Y(C^4["0S.Q* #+%1N558]5\2O" \8Z=<V! )EA8)N+
M*HD'S1,2O.!(%)X.0,$$<'BOV7/"!\-Z'"7!#W+-<,"58 . (R-O0&)4;!)(
M).<?=!^T_P" Y_&6D,EH"\L$R3K&HW-(%5T91R.0KE@!N+%=JJ2PJI\+?&NH
MW6F16$.FSPW=O;1Q"2[7R;3<B%$<DD3."$R5CC)#$(S*I\RN%_92\,:GX-FO
M;>YLIE,DELID?;'"HC,PD(8DF3@_)Y2R*S;0S(K!Z/BGX+USQ3KEKK%MIKB*
MT^S[4DN+57?RI3,<[97"9+%1@OP W?:.U_:1\(WOCW15^RP.LT5P)F@<H9BJ
MK*A"^4\B,WS!@H8DKP/GPAV_@?XEN[VPM;6:PGMC;PI#*\^(U/E1A5**?WKE
MOE/*(@!<>8S( Y^TIX0'B;0[D8&^W7[0A8L #$"7/R]28MZ@$$9(SC[PW_A#
MX0/@_2;6Q<$/'"#(&*L1(Y,DJY7Y2 [,!C/ ')ZGL**^5?V?-(U/X57UW876
MGW,XF\L+- JF',0=@1)*8HMK*Y.2ZL& 0IN)"]!\8OAAJEAJ,'B?1HT:[2-3
M<P*3+EEC*LR[]AD4Q_NMJ*DG"LB[V)75\4^/M3^(MB^F6&FWEM<W$:I+)<QK
M#;Q1L0LV'?)DX)4!4#E274!EVUZKX \'1^#+&#3X3E88P"W(W,26D?!9L;G)
M;&2%S@< 5T%?,'Q!\-ZAX1\6)K\=G-=VKX.+=6D=1]G%NX8!3AAG>H.%<8 <
M'=M]:^(=_J&L:9<6]OI\C2W,,T2(9K92BL@3?*3+M!^9BJQF4$*NYHRQ"\?^
MS'X7U/P+;R:?J%D\:R7#2K,);=T&8U4JRK*7'^K&"H?);D*%R>:N?!.LKXI_
MX2&/3I&M]RY1IK19=OV86[G G9<CE@-V&P 2N<B+XS_!/4;:]7Q)H"NEPV)9
M8%\L2QN$RS*$)23=@B1 7+N3CS%D(6WH7C/QA\0MUDULFGQ/A9+HPS0R1J<D
MF,2RY9B%*C8"5)!+1Y#CZ*TG2X](ACMH%VQ11I&BY)PJ@*HR22<  9))]353
MQ-JL^F0F2UMWNI>0L:/%'S@D%FE= %R "1N89R$;!KP#]F;P%K'PXFGCOK%_
M*N?)'F)-;-Y90N,LOG E<2$DKEAMP$;=P?M,^ M8^(\T$=C8OY5MYP\QYK9?
M,+E!E5\XD+B,$%L,=V"B[>?5?%E[>^(-'N(OL,R74]O+#Y/F6K;6>$C?O\\*
M8@QVYXD/7R@*XG]F/POJ?@6WDT_4+)XUDN&E682V[H,QJI5E64N/]6,%0^2W
M(4+D\5^SYI&I_"J^N["ZT^YG$WEA9H%4PYB#L"))3%%M97)R75@P"%-Q(6W\
M9_@?J=C>KXBT,;;HXDGAA*DI($^=X\JGG*^"'4KOD9B=C"1E2WH7C/QA\0MU
MDULFGQ/A9+HPS0R1J<DF,2RY9B%*C8"5)!+1Y#CU7XCZ7/9:2^EZ5://OM'M
MHP)(D2-=@B4LTT@8X4DC <L5PQ7.ZN)_9C\+ZGX%MY-/U"R>-9+AI5F$MNZ#
M,:J595E+C_5C!4/DMR%"Y-7]HOX"7'BB:/5]'.+Z/RPR*5B9]I^257RN)5X&
M6;E%7:04"OS_ (9^)WC7Q!BS2Q2)S&%-S/;RP;>B&4F1Q&6!.[:J-G!Q&0"M
M>@>-/"U]X6L=,ATE'N[FVOTDD)8 R[H;@W3N\Q<)YA=\LQ.UG 4[MHK/\;?$
M"Z\8V4^DKHU[]JFA>/$L<8M%DQRXG9MC!&&Z-\#>RKMVE@1+JGP8NK;PFV@0
MLDMT(P<YV(S?:!<,BEOQ12VT$X+; 3BI^S7K5]8:=%I<VG7,3P2,#+,!#"4D
MD:0M^\Q(6 + *B.-P3>Z!R5]UKQ#]HCX/W?B:6VU?2,?;[5EPI(!=5</&09#
MY8*.2V& #ACDG:JL6WQHU;6K+[/#I-['JCPLJLT(BM%DP?WGF3G  'SA'!RV
M(]QSN/5?"KP ?A;I*VR(;B?<9)1$5!>1R =OGR(@"H%7)*;@F[:&;;7DO_"%
MZY_PE'_"1?V:_D>9CR_M%KYFSR/L^[_6[=VWY]N<9^3?CYZ^E=+O6O8UDDB>
M%CG,<AC+K@D<F)Y$YQD88\$9P<@&K:7'J\,EM.NZ*6-XW7)&58%6&001D$C(
M(/H:^:OAU::S\"KB2QFM)K[399'=)+6/S) P50'VJ<KD;59)"!D$QLP5M_80
M>&[OXHZO:ZK=V\EKIUBNZWAG 2XDF+'+E$;?&%=$.')#!%*J5D?;M?M*?#FX
M\>:7Y%D-T\5Q'*D?RC?@-&R[G957"R%LDG.W;C)R,_X4>-=1N["UT^/39X)H
M(8H99KI?*MT58V595!*RS$[ 3&JJ 6VM*@PYX7]E'P;K/A)IFFLMD%SY1,DT
MOD.@B=U8"+8\A8AR5#B-2%^_A@:/BGX+USQ3KEKK%MIKB*T^S[4DN+57?RI3
M,<[97"9+%1@OP W?:/I72[UKV-9)(GA8YS'(8RZX)')B>1.<9&&/!&<'(%JO
M$/#7C75/!;7:7FFW4]FVHWK6\ENL<DH5YW8*805DV$[W$K'!W* "I4U#X:\(
M7'C+Q#'XD:U>QMH;<HJS*J7,[E98BSQJ<Q[0V,N22J1[<JWR<K\4_!>N>*=<
MM=8MM-<16GV?:DEQ:J[^5*9CG;*X3)8J,%^ &[[1Z5\;]/O?&.C265K9S>?<
M;/D9[5?+\N:-_G/V@K\RJ2NPO_M;37DNL?"_5KWPNFD364D<]E,TZ%7@F69=
M[Y0!)=ZN%G9@-K!A'@'<X4>E?"WQKJ-UID5A#IL\-W;VT<0DNU\FTW(A1'))
M$S@A,E8XR0Q",RJ?,K@/V7?#VJ>!GOXI]/G+,T R?+BC_=F;?M>1@)"0<1E-
MR%MN]XT;S!+_ ,(7KG_"4?\ "1?V:_D>9CR_M%KYFSR/L^[_ %NW=M^?;G&?
MDWX^>O;_ (B> XOB/IS65R#"9%1U)"/)#(.0>"RY'*OL;YE+*K@-NKYK\,W_
M (M^#H?38;,W4.XM&?*EN8E&Y@3&T+*5#$;BCX(^]L4LV[WKX6^']4N9I-6U
M[8ET\?DPV\9/EP19!DZ2.I:1E5F.68!5&_'R)Y5\4_!>N>*=<M=8MM-<16GV
M?:DEQ:J[^5*9CG;*X3)8J,%^ &[[1Z5\;]/O?&.C265K9S>?<;/D9[5?+\N:
M-_G/V@K\RJ2NPO\ [6TUPN@_!^^\0^'1X>O[4VT\#/+;W#2Q20E_,9U!$4I<
M$K*Z'*.JK\^2VU*M_#'XF:MX)MAIFLZ7>RO;K&D4EK )E,84;58HPC)48 96
M.1PX#JQ;JOA!\.[NVO;S7M64)>7;;4B#!S#"I 5"T>(W)"1C(!.$!+;G=1PO
M[3/@+6/B/-!'8V+^5;></,>:V7S"Y095?.)"XC!!;#'=@HNWGT_QIX4D^*.D
M2VEY;&UN&4&-9'ADV3*H965XC+\FXE"V%D*;QM7<*\:^%'B[Q'\-8QHT^DS7
M*K(!"R_(B>8=S*9D22)EW-G<6&PE@S8 "9\/A+Q!IGBEM3:T-[+&N]V3%K;-
MOMEC*1RRC:1'YFP=7<(2P!W$=M^T!\!KOQ4\.L:8 FHHL0EB1PNYE.5D24B(
MET/&Y]I9%7&QD"MB>&?B=XU\08LTL4B<QA3<SV\L&WHAE)D<1E@3NVJC9P<1
MD K7J'BKPS=:#H;:18027LTMM-$TGF1Q@R2@^;-(9YM^6>1Y J[^?E)4$&N9
M_9C\+ZGX%MY-/U"R>-9+AI5F$MNZ#,:J595E+C_5C!4/DMR%"Y.WXOU;5/#V
MMM>6EG)=61TZ!;@(8U8,L\[ADW_-*ZH7_=(06+KN()2N/^)NGW'QT6WLK>PN
M;18K@/+=7D2PF-"C K&NXO)NQE@I #+'OP&#+VOQ9^(&M>&[RU@TK3_M4$N/
M,?#'G> 8]RD+#A>?,DRAW9QB-L^B^'M;37K:&\B!"3PQRJ&P&"NH< X)&<'G
M!(SW-:%?(%SX*U[X$WSG1(WN[.XP>(3/D(&"I*(P'1D\PD%2BR<'LR+Z+\.[
M;Q!\0KNWOM=BCMK*V;S8[<Q!6DF EC23;(SRH4WE@6(&0A1"277/_:-\ 7S:
MI8Z_8P/=+:^3YD,8&_\ =3B1,8+.V_S"#M1M@4L<@\:'QDUC4?'NBW*6NGSP
MQ,L!"S)F[D87"AD2"-F9 NT.9'.2O"QD-YBG@7PQJVC^&;G2KRT$9CLKY(]L
MPFFD>0.Z@1Q(R@'S"H_>%BR_<PP-;>D_%_4="AC@U?2KYKH1IN>VCCNHWP #
M(6B951F8,3&,[1@YP11^S[\,+CPDU]>W4:6[7MQO2U0JX@17E*KN3"'_ %F
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MY,3 ^RUYU\9TU!5L9M*A,\\6HHY0%%!C$$ZR@NX*(&1BFX]"PV_,5KE?&WQ
MNO&-E/I*Z->_:IH7CQ+'&+19,<N)V;8P1ANC? WLJ[=I8$6KOX+3P>%&T!9
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M)XUDN&E682V[H,QJI5E64N/]6,%0^2W(4+D[?B_5M4\/:VUY:6<EU9'3H%N
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M)!%)/(QP2%"QJ<9QC<VU 2 6&17S5^R3:W/@V:Z@O[.\B^T_9Q&[6L_EY0R
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M%&29)6PH]  ,L22. <9;"G:HHHHK%\,^+X/$AN!;$D6UR]O(2-H,B*A<#/)
M+;<D#)!QE<,=JBBBBN \8>#]4U/5+*\L[WR;.'/GP8/S\Y/ ^63>N$^<CRL>
M9'EB17?T44444444455U;5(](ADN9VVQ11O([8)PJ@LQP 2< $X )]!4/A[6
MTUZVAO(@0D\,<JAL!@KJ' ."1G!YP2,]S6A11111111111111165XFLKJ]A,
M=C,EO*<CS'B\_:"",JOF1C<"006W+Q@H<\>%?LD^/[[QG)J$VH3O,P^R;02
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M 3 \QF."1W)/U5111117B'Q$^)$^M:Y;^%[&<VP=6-U.@S,!Y+R>2A=<(3&
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MU#8X)4,I8 ]0&4D<9'6OFK2O&FK+XQBTF\O#-#&TQVH@MXB)+0S!2BLQ8*2
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M5).<8"XDMV)U[PUJ%C:WEU'>6=Q-,'F\E()@ZVTSK"55BNP[-X91NW*59@N
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MUBCA=L<H)4,;\9)0D(&8+OVJ3CO_ (>ZI)J^FV=S.VZ66TMY'; &6:-68X
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M! K%%!2<J6ED^:1@H !5(5RSY1OD*^Z_"?\ Y ^G_P#7A:?^B4KY_P#V&/\
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M*J2.A*C/05:^*UV]YX)665B[O9:<S,Q+,S%[<EB3R23R2>2:Z7]ES_D7;/\
M[>/_ $HEKRKX^_\ (X:3_P!N'_I9)7JO[4?_ "+MY_V[_P#I1%7@OBR[>#P)
MIZHQ4/>NK@$@,OF7;[3CJ-RJV#QD ]0*^FM)\$6.KPQW,$MXT4L:2(WV_4!E
M6 93@W (R"#@@'U%'A?X7Z5X2O&N;2/9>3QR;F:::61UWHTC8ED?/SE"S8R"
M1D_-SX5_S4/_ #_T#J^JJ*\J_:C_ .1=O/\ MW_]*(J/V7/^1=L_^WC_ -*)
M:\J^-ND[_&6E^1'EW^Q2/L7YFV7$FYVP,G;&@RQZ(O)PO!\??^1PTG_MP_\
M2R2O5?VH_P#D7;S_ +=__2B*L_\ 9]T1->\*0V<I(2>&\B8K@,%>:="1D$9P
M>,@C/8UY /"_B;X F22RQ<V!9G?:IDBX5QODC!$D1"*&=D.SA%:1\ 5]"_!C
MXP0_$ZU:XC3R98Y"DD)=7*]T8$!258="57YE=1G;D^*? +_D<-6_[?\ _P!+
M(ZZO]M;_ ) \'_7_ !_^B9Z]5^$__('T_P#Z\+3_ -$I7RU^S+=O9Z5K\L3%
M'2R5E92596$5T0P(Y!!Y!'(->H?LQ^&[/Q!HD+>9<^9')-'*L=W>0HK>8S@!
M(YD3[CH25&"2<G=NKT"^^#FCI<1:A<H[3PR0^5+-=7,A5A(/*4&69@?WC#:I
MR"S8P2<'S3XU? G4[C4_^$@T&7_2OD+1EE1PRJL0*%@$*E!\Z2$ @,,N'V ^
M#_[2=U?WL>BZ[!Y-TV%64CR"6V*R+)&^,,_)!7 9F15C .:/C5\"=3N-3_X2
M#09?]*^0M&65'#*JQ H6 0J4'SI(0" PRX?8#X/_ +2=U?WL>BZ[!Y-TV%64
MCR"6V*R+)&^,,_)!7 9F15C .:^BJ*\Z\3>/K:PU-+*QMA=:LT(#%=J"&'>K
M'SI]K-&G.\(%<D[?E!D0MX!^U_:7L2:<^HRQO*RW.4AC,<*$" MMWL\C$DX+
M$@%57$:'<6]J_:&^"3_$^"'[/*([BW9]@?/E,LFS>&*JS C8"I (X*D?-N7R
M71?C_KOPMD2R\26SRQ<!9#@2X CR5E7,4^U3D@G>7;YY1TKV_P",OPX3XK:8
M(()@IW)/!("&B9MC!<D9RC*Y^9>1D,-P&UO!=/\ B3XC^!>RTU2#[18IA(F)
M^7 \P(L<Z@XSC(256<1J $C%2_M=>,4\366E7-JY-O<+<2[=PQN A #!69=Z
M;G0\DJ2ZYZU]:VEVEXBRQ,'1U#*RD,K*1D,"."".01P17RUI_P#Q+OB"\<'[
MM)-V]4^56W60E;<!@',@#G/5_F//-=-^S]KXFU_7H)7+3/<ED#;F/EPS31]3
MD *'C4#/3 48!Q]"5Y+^TQ=I>>&KJ6)@Z.MLRLI#*RFXA(8$<$$<@C@BI?V7
M/^1=L_\ MX_]*):-#\>?\)%-/;^&K>$1K<$W%ZZ[;5I28_,*+%AKF4KNR2T:
M\*QD*NA;R#2[>2W\?JL\GFR<EGVA 2=/)PJC.%&<*"68*!N=VRQM?'W_ )'#
M2?\ MP_]+)*[#]L^[>#1HU1BH>]B5P"0&7RYGVG'4;E5L'C(!Z@5Z+I/@BQU
M>&.Y@EO&BEC21&^WZ@,JP#*<&X!&00<$ ^HH\+_"_2O"5XUS:1[+R>.3<S33
M2R.N]&D;$LCY^<H6;&02,GYN?GJ^^$7B#X+W,EYH#&YM68;D4"21D#*526+
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M] ZC]N?_ )AW_;W_ .V]?55?*'[.]HEGXMU2*)0B(M\JJH"JJB[B 4 <  <
M#@"I?^:A_P"?^@=1J&K;/B"GGR81-L:;V^5=]D=J+DX&Z1SA1U=N!EN?J6[M
M$O$:*50Z.I5E8!E92,%2#P01P0>"*^8/V&KMV34(BQ**ULRKD[0S"8,P'0$A
M5!/4A1GH*J?&28_"+Q-;ZU I6WNES.J[<.<A+A0BLF3M*2C><-,=Q)P0/?\
M0[M/$>H27D3!HK:$01LI!#M.L%U(^1D,GE_9_+((.?-R"-AKL**Y7XG^)-/\
M/6,D^K!'MN 8W59/,;.Y(U1N&8E<@'@8W$JJEAQ7C?4-4\1:3?7$J)96IL+A
MEA93)>L DI_>$D10;E";HPLK@,Z[XW *\_\ L4_\@>?_ *_Y/_1,%<I\ O\
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MY=I^5 ^TO\Q58PP7E/V4?#NL^%))A)I[K!<21*\LS_9C&(@[$B-D,DF1)A<
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M[8I9MWNOPXT75G>;6-<4&[,)C@M(6&V*,'<ZKF4QEY7122S' 509 N43R_\
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M*( >4"K!V#[L#MNST\,:SI_C!=4NK)Y%;>P-K\\.W[,\*#S9C"@88 ;>8RS
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M)64_*V=JJ1@J=X(9!MP:EJLVJR68DM?LL<,,S'R)?.VRRS(L0_TC9G9"V9,
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MS&C#JI&,YXZ=*[#XI?M&6/B*RETW1/,O+NZADB54@E(52 )"0P1R?++E=@<
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M^56(7CY02!@$T?'W_D<-)_[</_2R2O5?VH_^1=O/^W?_ -*(J/V7/^1=L_\
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M'_$SN+K4.@>3[,@[[+22:,EAS\QG>;!!P8O*X5MXKJJY7XL?\@?4/^O"[_\
M1+UY5^Q3_P @>?\ Z_Y/_1,%>J_$?X<6OCVU>VN40N8W$4I3<\3-C#J<JP^9
M5) 8!P-K9!(KR7]C?QY/KUE/8W!+BT:+RW8Y(CD#!8NF<*8S@DGA@HPJ 5S/
MP"_Y'#5O^W__ -+(Z/VY_P#F'?\ ;W_[;U[7\</A;_PLK3S9K)Y<J2"6)C]P
MNJLH5^"=I#D$CE3AL-@JWS_I_P 2?$?P+V6FJ0?:+%,)$Q/RX'F!%CG4'&<9
M"2JSB-0 D8KZ \7>)H?%'AVZOK8YBFTRY=>5)&87RK;2P#*<JP!.&!':O/\
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MR>4LBLVT,R*P>CXI^"]<\4ZY:ZQ;::XBM/L^U)+BU5W\J4S'.V5PF2Q48+\
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M"JR123RH3Y6]6E9U6-U$@#;58A?D<$,G5_&_QOJWA.&%]&L_M3/(PD.R278
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MZD<R((O.=2[B62)E52WE,R\.FUE'R%@=K/M^&I_$WQ7EBBU6WCL]-297N$>
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MVQ>RN5E-RN&W^4/W4,2GS9B^XJKD1J"-V'8&(XO[,?A[5_!EC)!=6.V)I&N
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M1111111111111111111111111111111111111111145W<BU1I&R0JEB%5G;
M&3A4!9CZ!023P 37RAYUS_PF']M_8;[['YFW?]DGW8^S?9_,V[-VW=\V,;]G
M\.[Y:^K[2Y%TBR+D!E# ,K(V",C*N RGU# $'@@&I:****\U^-_C?5O"<,+Z
M-9_:F>1A(=DDNP 94>7$5<[N?GSM7;@C+KC5\$_:O$;1:K?P?9)!;R1QVV_S
M'597C=VD8JF&/E)MC"@QC=O+,VR+M:***********XKXO>*-0\-6)N-)MOM5
MQYB#9AGVJ3R^Q"'?LN%((W;S\JD5E?#V_P!0\<I;7NJ6OV(V\C.D9+>9))Y3
MP,Y1U!BBQ))M0[G8E6W!5_>^E44444444444444444444444444444444444
M4444445E:['=3[8[4HBMD23$YDC'&#'&49'8\@%V"H<,4E ,9MZ7I<>E1K#"
MNU%SW+$DDLS,S$LS,Q+,S$LS$LQ))-6JXKQ]\//[;DBU&S*1:E:Y,$S+N1@0
M0T$H')B8,PR/GC+%D.=P;J]+N)+B-6GC\J3D,FX. 02,JPQE3C*DA6*D;D1L
MJ+5%<+K?A"?QE<@:@ NFQ,"MMG<UQ(K'#SX^7R1@-'""V\D--@KY0[JBBBBB
MBOG7PAJ6L_"*XN+:]LIM0MKJ[FN!=6B;Y"S*N]FB7A<G8-I,84[]C2*!7=K\
M5M0U]"FEZ5=++N52]\J6D*!@P$A^=I)0I +)&,[<_,"5!ZKP!X'3PA T0<RR
MRS//<2L IEFDP9)-J_*@.  J\  =3ECTM5=6MY+F&2."3RI6C<))M#[&((5]
MIX;!P<'@XP:^?_AEXJU3X40+HVHZ7<SQ0^:8KBS0W 8-*S $< 9)<Y+*X78#
M$,[CW;>/M4\6H(M+L9[0.S(]U>K'%Y& IWK!O9YCM)"YVIOV[B5W[>U\%^$(
M/!UI%86@(BB4A=QW,2269B?4L23@  G"@# &U11111111111575KB2VADD@C
M\V58W*1[@F]@"53<>%R<#)X&<FO%/ ?B_7/B5#<:=JMA]DBDC9)+@K+!B.0;
M"D<4H8O*1NP^_9'D,RM@))[K111111117/Z7H\UW(MW?A/-3/E11LTD46059
MPS)&7E8$@N578A,:*,RO-T%?*O[6UK<^,IK6"PL[R7[-]H$CK:S^7ES& JL4
M&['ED[ERA!4JS<X^E?#/B)?$$(G2.:+. 4GBD@D4X!*E9%&<9QN7<A((#'!K
M5HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHKYPCUP?&#Q'=:1>-)_9MG#,/LZNT2RR1RQ1LTOEMEP)"63E<
M!4. 2X;JO 'P+N? 6K-/8797265V-HQ9SO8 ;<'Y<#"L)<^9A1&P8%G/LM%%
M%%%%%%<+\:=.EN-,N9H;F>W,%M/*/(9$+LB>8@9BC2  ISY;(2"P8D'CS_\
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M>'9!XGU*UBNIXS$MXOG#R9)G"W4:_.9HI%);[S$*"6[@$@_7]I"8$5&8N54
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M<17,@E@>)D*SLBL08V4$R(0[L-OE_/N.3]BG_D#S_P#7_)_Z)@KW^O)?B_\
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M-'"!_P"$*LA;8 V0C,V?E,?06/@'4?"NH6/DWUU=:>TTWGQSMYLJO]FFV.9
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MNTA6CR&!<@^UZ?XX3P-X8MM1D0R"'3K/"*0"S-'$B#)Z#<PR<$@9(#$8.?\
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M9)6"X+%44N0,D#.!QD@9[BO +3X6GQ-X7N[J6("_OVDU [8UE;?O:6%(L$N
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MWV1VHN3@;I'.%'5VX&6Y^@/BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\ D_\
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M8I-O(60*K,F>A(##.,X.5.&! ^9?@%_R.&K?]O\ _P"ED='[<_\ S#O^WO\
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MVYV)T\LS'@ 9).%4*BC"HJJ HM?'W_D<-)_[</\ TLDKJ_VUO^0/!_U_Q_\
MHF>O0/"G@S0?%%K%?6UA9F*:-77_ $>W)&>JMM5@&4Y5@"<,".U;6D^'-,\.
MW*QVMO!!<2PR,#%"D;-&C1"3+(@X#/'P3R<$ X./GKQ!^S;?>&YO[6\(W64?
M#I$L@5MC&-E59"QCFB)^;$A **H/FDY/=_LZ_'"Y\;//IVJ($O;=0>%9&=5(
MCDWJ1M1U?&X J"7PJ*$->WU\H:S<C1?B DUSE$D:-8V*MAC)9B!,8'(,OR9'
M (.2,''U?7RW^PU:.J:A*5(1FME5L':643%E!Z$@,I(Z@,,]14/_ #4/_/\
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M22,%1 !R23Z= "QPH)'S7++8-XYNK?4HHY4GABBC$J1O&)3!;NA/F< D*47
M+%F"@?,:]Z_X5/H__0/L_P#P&A_^(K*\8K:IH-^E@J) EIJ$82-/+1603)*
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MEN)F!C9EBC?Y(AL)^>59#AT(C#!@ODNEZ?\ V?X_6/>\A&27D;<[$Z>69CP
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MC;@98>9&C+EL_+\V!CYV.<'BOPS#XHM9;&Y&8IHV1N%)&>C+N# ,IPRD@X8
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M;JWU.Z\0ZGLCNKJ-8UMXFWI%&%BX=R!NE'EJI*_)D,P)# )ZK7DOQY^"3_$
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MI@,8P(F12J$(,*5"DJ4X&TD J=K#P#PS\.O&W@G&G6$B"U$@(D#6\D*[\%F
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M]EC33IT,FKVYDNY5\QP9)H]@;E8]JF/!5<;PP)#[AN*@8\O_ .%6Z=_PF?\
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M50&VG:P((96!]0P!&002,,",@G@OPA!X.M(K"T!$42D+N.YB22S,3ZEB2<
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M+&VR58U!D\M'7<R.41F(*C.8OFV,X.5X\_9BM="LC=Z"9X=0MH69'263?*0
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M\U3YFX?(K1@##-Z+575+)KV-HXY7A8XQ)&(RZX(/ E21.<8.5/!.,'!'R_\
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MN%ANQ,Z\*T@NH@[#Y5X+9(X''8=*]%\6Z-JGBOQ+%9W<+MHD4?F%1D6\F$W
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MN^>/YYVOT_=LPRRPJ&2-8ED+-&K1D#.""/E!^RY\0Y'N+KP]+-]ICM-YM9P
M0T4<GE$;@[97YD:(#=A2R[]H0#*T)K+XM>(+^SUYO,-M))#8VP=XH]J2.)7&
MP@M+A%9OFRP+':51?+]0\(?" >#-56>R:3[!]BGC6!Y&DC@D:6!SY>]RP$FU
MF88.&4DM\RJ/+]":R^+7B"_L]>;S#;220V-L'>*/:DCB5QL(+2X16;YLL"QV
ME47R_4/"'P@'@S55GLFD^P?8IXU@>1I(X)&E@<^7O<L!)M9F&#AE)+?,JCT^
MN/\ BU\0$\ Z=-?-@NJ[85./GE;A%QN4L ?F<*=VQ6(Z5Q6@?L[VNN0)<^(A
M)>:A(NZ5I)I%$9;YC BPR! B,2!MR"2Q7"D*L7PB\.ZO\/[J[M+^3?HT4;/;
MSRRHY14V!%R65D419W@H(U9,I@$E^:\ Z,/C]+<ZGJCR-I\5SY=K9J[11X5&
M.^5$)R^V53O63.[>I_=A5KG_ (@65S^SK>P7FDF1],G9_,MI'9H@Y.63.W"$
MQA?*<EI/W;;BR AO</B]"VJ:3/=VEW-"L=I-.C6SQJ)-J>;&?,V,^WY1_JW3
M<K$$D$8\?_9A\*-XVTN<WT\S0-?SF2)'>,S,\$:R&:16\QU(8$("@+;C(9 5
M"9_PQ$OP\\7RZ%:R$V4C2D1$OL0/ +E"%+D%U"K'O;)90>A/'8?$[5KCXCZV
MGABUDFM[:&-I+Z2-E4R(T:$(!D$KB0(<Y!:0LT;+&"<3]H'X+VO@O1Y[C1P;
M="T*W4?F2.DL?FKLXD,GSI+M*D%,*9 2<XKL/@#X=7Q!X7M('DFBS]I(>"62
M"13Y\X#!HV&<9SM;<A(!*G KE?V-?%EYX@^W_;;B:?9]EV>;(\NW/G[L;R<9
MP,XZX'I63\3+JY\(^*-/LK6\O/LT\ED[Q/=3RI\UP8V7YW)*D)DABW)/\. /
M5?C5XON/,M="TR3R[V_D(:1=I>&W4$RR@%T(; .P]PL@0B0*1GZ_^R_ILT#O
M:"1-1V[X[MKB8R^>/F65SEERSC+E4SR2@5L$:'PU\*ZAK^D_8?$ZOYBR,@VS
MLKRQ; !YCV\OSYW,K!C\P +@M\Q\5_8U\,Q:W]O\UIEV?9<>5<7%OU\_.?(D
MCW=.-V<<XQDY^OZ***^5?^:A_P"?^@=7U57@'[:W_('@_P"O^/\ ]$SUJZ%\
M'H/'6@VD=_([R-80>20TJ0PG[.%B80I*J.R[LLSY9V+#*QE8TY_]D+QM<>)=
M/N=.FD?-KY:Q395G1)%<*BAT8?(8R5W[QA@NW:H!YK2O/L_'45G-<SW*0M,R
M&=]Y4RV1D?:%"H@W' "*H "C'%=+\?O%<=WK5CH>I2^3I4D:S7&"4WMNE$:2
M.,XBWQKG[H&XNS JK)TNK?L[VNC-;S:*)+<QWMI)/"LTC13QI.C'>))",QC,
MB'GHRA2S*5]EJ*[A,Z,BL4+*0'7:64D8##>K+D=1N!&>H(XKY*%O=IXU2P^V
MSR"-I3'),1,R>;9F278F%B0\D( FQ2$W(ZKM-O\ :N^&5OX5BM]8L6DCN/M*
MH[M+/+*S;"T3^9+*[*4\K QS\PY&T5ZK;?#6+XJ6$5YK,DDK7-M#(L<;O#;P
M,T;$-%&&8%P).7E,I)' 5#Y8XK]B[QC<ZO;75G<.9$MV@,19F9E5U=/+&YB
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M +,#E?#'X>CXS"77-?\ ,EAEFE%G:F5A%%&&"E@8F0YRGE]$W;"[ARZE?/\
MX@^%7\+>*]-M/,+VZS6/V568N\<)N3B(L0"0LF\)DL1'L4L<8'M7[2LVN/!;
M6VA+)B:8K-)#D2J?E,0WA@8T)W%WX V@,ZJQ#8'[1'PET[P]HYOK"$6UQ9-
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M^Z>2"-6R.6C$C.,9R,"5#DC!SP3@XJ?\U#_S_P! ZNK_ &UO^0/!_P!?\?\
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M\P?L_:7)+XJUFY"_NDDNXV;(X:2ZW(,9R<B)SD# QR1D9J?'W_D<-)_[</\
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MW;1GHCEMH SY+^Q'K:36%U9@'?'<K*QXV[98U10.<YS"V> ,$8)YQH?MK?\
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M9N<LH5R/)F*L9 JL%9NK2!&Q]B45\J_\U#_S_P! ZNK_ &UO^0/!_P!?\?\
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M R<Y/@O]G:^\):A)JT.I(]Q-YOF^99@H_F-O;(2X3'S@,-A7! 'W<@ZWQK^
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M2?:_,W?\>8\O&SR_+V_:,[?+^3.=^.=V_P":N@\4?#35+O4EU>RO(89X[".
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MBOFOXA_LIW'VX:AX<G2T+;BR%Y(?+8C!,31*Q"L"<IP%Y"G:P5.J^$OP"N-
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M7%UJ]W,DNJ74>TNL;"WB&U,1J@=6D4,BC<S*[*J_<8NS<I_PSM??VO\ V_\
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M91]UP"2!L8$;2G*^'?V8]4UF11XCU%[BUCD5Q LT\P<@,.6EV>7U RH9BI8
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MHHHHHHHHHHHKS#XL_!M_%<\.J:?<&UU*V4B.7ED91N*QL,\#<Q!8!@59U=)
M0!#I-OXNB\N.>32RHV!Y-MTTA' 9]H\I"W4X&Q2>!M'3I? _P_.A.]W>3F\O
MY5"/<NBQXC4Y6*-%RL:?Q,%^^^78G@+V%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%>8?%GX-OXKGAU33[@VNI6RD1R\LC*-Q6-A
MG@;F(+ ,"K.KI(" (=)M_%T7EQSR:65&P/)MNFD(X#/M'E(6ZG V*3P-HZ=+
MX'^'YT)WN[R<WE_*H1[ET6/$:G*Q1HN5C3^)@OWWR[$\!>PHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHK@/^%3?\3W^W_M4W_'OY7V?/R=-N,Y_P!5_'Y>/];^\W?P
MUJ_$_P"(</P_L9+^<;MN%2,,JM(['"H"?Q9L D(&8*<8K:U_23J\#VZRR0&1
M=OF1%5E4'KM+*P4D<9QD9RI# $?,'[.L3P>*]2BDEDF,4-U$))7,DK+'<PQH
M68]3M4#L/0 <5]7T45RNN_$.'2=1L])QNGN_.;AE'EI'&[[V'+?,R[5X .'.
M[*8.5\;]%DOM-GN(KJYMFMK>>9?L\@BWLD;,H=@I<J,?=5E!SDY(4KY_^Q3_
M ,@>?_K_ )/_ $3!7O\ 1111111117 >#_A-_P (WJE[JWVJ:7[9C]RQ^5><
M\G)W[<;8N%\N,E/FSFN_HK@/^%3?\3W^W_M4W_'OY7V?/R=-N,Y_U7\?EX_U
MO[S=_#75>*_$T/A>UEOKDXBAC9VY4$XZ*NXJ"S'"J"1EB!WH\)Z[_P )!9V]
M[MV>?;Q2[,[MN] ^W.!G&<9P,^@K5HHHHHHK*\3:&VMPF!)YK?=D%X#&LF""
M"H:2.3;USN7:X(!##G/SK^Q9JTVKR:G/<R/+*WV/<\C,[G G RS$DX  &>P
MKZ?JKJEDU[&T<<KPL<8DC$9=<$'@2I(G.,'*G@G&#@CY?_9[FF_X2K4()YYK
MC[/;W4"//(TLFR.ZC"@L?Q/&!DD@#-?55%17=VEFC2RL$1%+,S$*JJ!DL2>
M .23P!7/_#CQPGCFQCU&)#&DK2[58@MM25XP3C@$A<D#(!.,MC)BC^(<,VK'
M18QNE2T:XD<,N$^=$2,@9.XA]YSMPNPC=O\ EZJBBBBBBBBOG"/7!\8/$=UI
M%XTG]FV<,P^SJ[1++)'+%&S2^6V7 D)9.5P%0X!+ANJ\ ? NY\!:LT]A=E=)
M978VC%G.]@!MP?EP,*PESYF%$;!@6<^RT4444445E>)M#;6X3 D\UONR"\!C
M63!!!4-)')MZYW+M<$ AASGYU_8LU:;5Y-3GN9'EE;['N>1F=S@3@99B2<
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M\G&77:%",V?,*&OH#X->&=3\-V1MM8N!<S"9RD@=Y"(R%(4O(BNQ#[CSG (
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MW(3"D.V:[";3/$'PK74=4GN_[2@%ONCC;S PE,B9D\H!ECB16D++&X4HHSM
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M?]O?_MO7U57RK_S4/_/_ $#JZO\ ;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\
MKPM/_1*5U5<5\5_BO:_#>U-S<G=(V1#"#AY&'8=<*,@NY!"@C@L55N5\;Z/J
M>J:3?76IS>2#87#"R@VA$PDK*)9OFDE;&P/Y9BB)4J5>-CNY_P#8I_Y \_\
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M_('U#_KPN_\ T2]>7_L86CP:-(SJ5#WLK(2" R^7"FX9ZC<K+D<9!'4&N/\
M@%_R.&K?]O\ _P"ED=?55%>8:O\ %U]4U/\ L/15CEN$4M<SR$F"W570.-BE
M6F?G:55E"N5#-Q($\*_:_P!!ETI-.^TW,EU,RW(>1PB+\H@^Y'$JH@W%CG#.
M00K.P1-OHO[:W_('@_Z_X_\ T3/7JOPG_P"0/I__ %X6G_HE*\%AM'G^(3,B
ME@B[G(!(5?L"IN..@W,JY/&2!U(J'_FH?^?^@=7T!\6/^0/J'_7A=_\ HEZ\
MO_8PM'@T:1G4J'O960D$!E\N%-PSU&Y67(XR".H-<?\ L,?\Q'_MT_\ ;BCX
M^_\ (X:3_P!N'_I9)70?M7:A_8EYHNH2([06]V[R%5ST>WD"Y)"[F6-MH)&=
MI[ D?0MI=I>(LL3!T=0RLI#*RD9# C@@CD$<$5B:KX_L=)^T>?.B_9(XWN,D
MGRQ)N\L' /S-M.U!ESE<+\ZYXKP7XIU'XHQB^MW_ +/T\R,(MJQS7<P4R(6)
MD#Q0KNV_+LD<E&PX4J6\E_9WMA:^+=4C7)"K?*"S,[8%W$!EG)9CZEB23R23
M4O\ S4/_ #_T#J^@/BQ_R!]0_P"O"[_]$O7FG[&VER66BM)(N%FNY9(SD'<H
M6.(G@G'SQL,'!XSC!!/%? +_ )'#5O\ M_\ _2R.CX-0Z;J?B+6+'4((9I9;
MN=X/.CBD'[N:;S%7S,G<0X;"@Y5&)QM%?0'_  J?1_\ H'V?_@-#_P#$5M>'
MKF"ZMH9+/ MVAC:$*NQ?+*@IA<#:-N,# P.,"M"OE7]N?_F'?]O?_MO7T5XZ
M\=6O@>U>]O7VQKP .7=CG;&@R,L<<#@  LQ"@D<KX0EU/Q]#'?W4GV*UFCW)
M:P%7F>-PA5I+@C*Y&X@0K$ZJZGS ZX'C_P"PQ_S$?^W3_P!N*/VAO^+=^([#
M7X_E27'F[?GD;RL1S?*_R#= ZHN".03\I^8^B_&/PN_Q&M+]8\E+6%EMPJF3
MS+A"LTQ502&(""V1E(=':ZC96X!Y#]G_ ,9_\)EI=KHKMN>.XD6X4ON<VD0$
MH)#<")I'BMC&=P>+S%48#&/W3Q[X;M?$UE+97YVP3;$)W;"&+KY6TGC=YFW:
M#D,V%(8'!^8-0^&WB/X%[[O2Y_M%BF7E4#Y<#RR[20,3C.,%XF9Q&I)>,5]"
M_!;XF#XC:<EZ0%E#-',B[MJR+@G&X="I5P,MM#;2Q*DUW5<!\4?C!#X(:&UC
M3[1?7,B)!;!UC+;G"!F=@0BYX!(^9N!P'9?/_C]X>OAH%W<:G=>9)_HQ$$"B
M&U0F6!2!G=-+SO.9'V'<&\I65"O5?LN?\B[9_P#;Q_Z42UY5^PQ_S$?^W3_V
MXH^/O_(X:3_VX?\ I9)1J&K;/B"GGR81-L:;V^5=]D=J+DX&Z1SA1U=N!EN?
MH#XL?\@?4/\ KPN__1+UY5^Q3_R!Y_\ K_D_]$P5[_17RK^PQ_S$?^W3_P!N
M*M_&[4+.P\7Z<^I(CVIM$202*C1C>]S&K,)"%VJS!F)^Z 2,D 5[K_PJ?1_^
M@?9_^ T/_P 14NG>'M.FAN=.MH8TAW-%<11)Y*[I(49@=@3),4B?,IS@@9R,
M#Q#]G&WO_!GVNW@A?4---PWD7,#01JTB81V59Y(BZL %+*S(KQD1EP2]=?\
M#CX3SW>J3>)M8C$-Y(Q$-LC[UA0)Y(9W4D.YC&./E ); 9@L?G7[<_\ S#O^
MWO\ ]MZ^@/BQ_P @?4/^O"[_ /1+UY5^Q3_R!Y_^O^3_ -$P5RG_ #4/_/\
MT#J]K^*/Q@A\$-#:QI]HOKF1$@M@ZQEMSA S.P(1<\ D?,W X#LOG_Q^\/7P
MT"[N-3NO,D_T8B"!1#:H3+ I SNFEYWG,C[#N#>4K*A4^&G_ "(TG_7AJ?\
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M+RVCBA9L*C,8X"IRQ&06A:,;<DR83&<X^CZ^6_VG?%]E?3:+?@BXLUN;DOM
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MF#XW:A9V'B_3GU)$>U-HB2"14:,;WN8U9A(0NU68,Q/W0"1D@"O=?^%3Z/\
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M<(5;)C<;LXSAE(W,<H6. P%>JT445\J_L,?\Q'_MT_\ ;BOJJOE7_FH?^?\
MH'5U?[:W_('@_P"O^/\ ]$SUU7_,G_\ <!_]LZY7]BG_ ) \_P#U_P G_HF"
MLKXF_LVS:A=2ZUX<NMEPTDK-&)&0^;^\6?RYE;Y6+Y0QMA58N"ZJ @T/@?\
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M-OOWP!QAO-\O=LD?RP=I3C<$W*2>& 5O0/#.JZU>VXEN[6VAG$8'DF=CN?<
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M.*W\W:TDLN]_,$6<JL!"X*$##-D$'CI5OXO?!V^^*.GPK<_9H=0MY,HR23/
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M5\(_A>_P]LI 6%Q?SLTL\KDJ'E(X0R;&DV Y^9@S99WVC=L'G7_"F=>_M_\
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MC-%Y9LX8+?S1'NEF:1MY7+-B#:ORHORC=M.[YV!&/5?M.L?8_P#56?V[[O\
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ME7D6)5,P##/E@Y*EE+Y :O0/AOX'3P-I\&G1N9!"K9=@ 69F9W.!T&YC@9)
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M[G8IYDS0ML9W8]%W#=NPQ/\ #A1]2:)H<>C(8XC(P+%LRS33MG '#3.[ <=
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M+%3@$$*1XU^SUX2N?B1827EYJFIHZ7+Q 17;*NT1QN"=X<YRY[XQCBNU\8_
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MZA1P\31@/,Z;BJQ@$YW(F:J^.;"6PT"\BN9C<2KIUUOE94C+MY+DG;& JCL
M,D #)8Y8^-?LGZ'<:YH]Q D[VT!NY07@*BX9FAA!4-)&ZQJ%YW+F1F((:,1G
MS=#X4>-KWPIXBN?#5]/)=1.SM \C&:53Y8F3<[;3@P\. "!(!L !8G/_ &KO
M&6L^$FA6&]V07/F@1PQ>0Z")T929=[R%B' 8H8U(7[F&(KW_ ,?^,8_!EC/J
M$PRL,9(7D;F)"QID*V-SD+G!"YR> :\ZT#X9:CXP@2^U?4;VWN)5WB"TD^R1
M0HWS)$4*%F==V&9OF'"$MLW,?!?6=<L;VYT?6$DFA@4F"]="H=5*(JE@"CED
M(?EC(I#ARQ^YYAJGG?\ "?L+;9YIP%,F[8,Z> 6(7EL#)"@KO("[TSO7H/C^
M-3^&+6VM6>H7,P-QY<L4\BF%B8\H!#%'%$%*HX<\-N*LI#98?0GA[6TUZVAO
M(@0D\,<JAL!@KJ' ."1G!YP2,]S6A7@'P=U^^^+%U?7&J?:;>"WD6*&WBDFM
M41CGS5=XO*DDE0(F0S84NQV*&4#/^''C:]\(>)9O#,\\E[;NQ:.6=BTT9^S^
M>/F.=PV_(PX!8;U"996ROBQXXUKP[K]C8279FBDFLYO)MXUM0V9FB,.6E9F#
M;22))=A+<@!1C5^*O@;Q-IT#:TFJ%I8%$LEM$I@@1%S(X4%RLP3_ *:KNDC&
M&)("'JO@_P#$B[^*&D?N;B.#4(F,4\C0B7JIV2K&)4 + @AF&PNDBB,J!CS7
MX ^-->^(9OE6\*2EK4M<.B2I"@68%8X=RH'D8(#A=NU9&8B39NJ>(?$6N? ;
M48/ME[)>V$[*29"9&=$P)5"R2,T;KORNUPKG86)PR+[!^TQ=I>>&KJ6)@Z.M
MLRLI#*RFXA(8$<$$<@C@BC]F=7;PU:B(A7*W.UF4NH;[1-@E0RE@#U 921QD
M=:\_TKQIJR^,8M)O+PS0QM,=J(+>(B2T,P4HK,6"D@+YC.1C.<DUZAX^\6WM
M[J$6@:6WD3R6YN9KLHDHAB#%%"QNP#LT@"'/W5;(!))3S_XJ^#M0^%]NNM:=
MJ=Y,+:13-#>3-/'(KLL8  "CJV"#S@[E=&0;N[U[XTB'PZ?$-I&&)A0K&Q;:
MLC2+"RD[5+!)"<X"[PORD!@PYGP!\-KCQ18P:I_;-\;J>,39293:I*Q+;#!@
MJ51OD>/(4[67" [5]%^$T-[!IZ)JC%[M9KH2N<C<1<RA67*K\A7!CP -FW:
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MWS"&.Z18V+!I&.]F^1!A6!VF/L/&WPBU'0+*>?2-4U"2X$+YCGE^T!TQETC
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M0?Y@3B-6)QE1(,KT)^RK2[2\198F#HZAE92&5E(R&!'!!'((X(J6OE7]M_\
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MMK\"W(L=X^T-"THCZMY:LJ%SZ#<P SC<<[<[6Q\R_P#-0_\ /_0.KJ_VUO\
MD#P?]?\ '_Z)GKU7X3_\@?3_ /KPM/\ T2E=+=W:6:-+*P1$4LS,0JJH&2Q)
MX  Y)/ %>5>&/B)=_%1Y3I+"UT^&;RS=LHEN)F!C9EBC?Y(AL)^>59#AT(C#
M!@ODNEZ?_9_C]8][R$9)>1MSL3IY9F/  R2<*H5%&%154!1:^/O_ ".&D_\
M;A_Z625]55\M_L-6CJFH2E2$9K95;!VEE$Q90>A(#*2.H##/45#^PQ_S$?\
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M0K)B-89F>0EUP"P0$  A=Q:/TOP7X0@\'6D5A: B*)2%W'<Q))9F)]2Q).
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MBCE2>&**,2I&\8E,%NZ$^9P"0I1< L68*!\QKWK_ (5/H_\ T#[/_P !H?\
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M^(_AE=22>&Y?,@FR/O0APHP5$B3@1E@20KIDX#'$8?;7K7PJ^'>J"==5\1W
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M\8/@OP\^#.O>$=6GUEC8RM<^?YL8EN(Q^]<2G8WD/MPX&,AOER.I##H/CM\
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MWPSU7X;1/977V62WDF,N^.67S58H%(VM"%<'8F/F0K\QRW $UWIFO>'=3O\
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MPMAES!M;Y7;Y3MW';\Z@')\5?@SK'BW6(-7M39Q_9?*$2R2S/O\ *F>5&8+
MNW.X!E#'&#ASUKW72Y)I8U-RB)+SN6-VE0<G&&:.(GC!.5&#D<XR:GBS0O\
MA(+.XLMVSS[>6+?C=MWH4W8R,XSG&1GU%>(? +P9X@\ )/IDEK (6F:1+II@
M5#$+&6$:;GD!55=4;R#@,&D4L-L/Q#^#.O>+M6@UE38Q-;>1Y49EN)!^Z<RC
M>WD)NRY.<!?EP.H+'T#XM>$M2\<Z4VGQQVT<LVWS"9Y2B;)4D3:1;9DW!><B
M/:>F_K65\,O"6O>!=,735CL96C\WRI#/<*!O9G&]/LQWX=CG#)E<+P06//\
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MC*1S+"S*QE61B#F,J2B@,=SEE'!S[!:6B6:+%$H1$4*JJ JJH& H X  X '
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ML""&5@?4, 1D$$C# C()X+\(0>#K2*PM 1%$I"[CN8DDLS$^I8DG  !.% &
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MI 22)1+&GE#HORJQ+XW?,0ORE&!\D_;/\&VL-I'J80_:GN8HBYDD8>7Y4S;
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M&%\Q_O'DG '.%&=J+D[4"KDXR=#7]?@\/0/=W;B.&-=SNW0#IVY))P !DL2
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MCV/EH(8I-@N'+@[G*;Q)$3$^TAE(7RV3:Q<UB_%SP!+\$3'K7AUI(X?.5;F
MN\D&-N(]RD9*$[PQ=R5>1?+*DC'NFGW@^(VF0W$$\EL+B%79K=XF==R$/%O>
M-\%6)!90KJR\%2"*^=?V4[2Y\:/J#7-W. 6LFE=9&%Q+L,NQ#,6+JFU2K!,.
M1M"R(H97-7TH_"#Q9:6VEL4M;MK7=!NE,>V1WMR&S(3(0=TB%N%9@ ,#GN_B
M=JUQ\1];3PQ:R36]M#&TE])&RJ9$:-"$ R"5Q($.<@M(6:-EC!.)^T#\%[7P
M7H\]QHX-NA:%;J/S)'26/S5V<2&3YTEVE2"F%,@).<5V'P!\.KX@\+VD#R31
M9^TD/!+)!(I\^<!@T;#.,YVMN0D E3@5RO[&OBR\\0?;_MMQ-/L^R[/-D>7;
MGS]V-Y.,X&<=<#TK)^)EU<^$?%&GV5K>7GV:>2R=XGNIY4^:X,;+\[DE2$R0
MQ;DG^' 'JOQJ\7W'F6NA:9)Y=[?R$-(NTO#;J"990"Z$-@'8>X60(1(%(S]?
M_9?TV:!WM!(FH[=\=VUQ,9?/'S+*YRRY9QERJ9Y)0*V"-#X:^%=0U_2?L/B=
M7\Q9&0;9V5Y8M@ \Q[>7Y\[F5@Q^8 %P6^8^*_L:^&8M;^W^:TR[/LN/*N+B
MWZ^?G/D21[NG&[..<8R<_7]<?\6OB G@'3IKYL%U7;"IQ\\K<(N-RE@#\SA3
MNV*Q'2O,/!/P!M_'5C'J6O2375Y=VX<2&9@L*R%Y(Q$H"JN%D!*,'C5P0J[<
M@XGPS\6WOPUUX^&;V0R64C8M9)G.Y$V$P!'95# A1$44!1*,1X(8/-^V-X9B
ML--CN$:8N]^F0]Q<21C='.QVQR2-&G(XVJ-H^48!(KT_X.^$(;;3K"Z5IRYL
MK=L-=7+Q9:%<_NFE,6.>!MPO&T# QZ+7BO[6'AB"]T:>\D#F6'R/+_>RB-29
ME0MY8<1%MLC+N*EL'&>!@_9<\,Q?V-9WFZ;S/](^7[1<>3_KI5_U/F>3T_V/
MO?-][FO-=4MY+GQ^R0R>4YP-^T.5']GC<5#?+NVYVE@RAL%D< H=#]IKP-'X
M %KKVER217:W(1Y&EFGD<F,E"7FD?A5C*%2"'5]K?*,'T7XE?&233-)LKFU,
M,%UJ7V=8S-(-D E0.\QROS+'D L5V@LK,"/D;C]?^%_A/68'634HWO'7B]EO
MDFGW#[A8&58V  "8V@[!@$-\PZ#]E/XJS^-K*6WO&,D]HR+YA'+QN#Y>XY)9
MP48,2!D;22S%C7M]?&O[;6J22ZE;6Q;]TEIYBK@<-)(ZN<XR<B)!@G QP!DY
M^Q;2T2S18HE"(BA550%55 P% '  '  X J6L7Q)K=MX0MKC4)@$1%,LI&U6=
M@JHHY*AG(543)R3M7/2O#_A=\-U^,%N-<\0N]P9I)O(MUED2WA0,L?RHNUE;
M=$1P[!EVL^Z3)'/PZE=? +6H-.$KR:/=>4$\]_EC#-B1P^Q8T9)&9W"C:T;+
MOPQ5E]+_ &G(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,RH)3\LA^42!,A3MR,GG_
M ("?#N#Q?X=MH]19Y;<^<$@5Y88P!<2,2XBD7S6+C(+?*H"A$5M[R>?_ +.]
MA=6FI:EX:CNGCMU\[?+&-LV89! 6BW,R0L^\;VVNVU0%*L%=9?VA=#C^$%_9
M:GHYDBEF:9I@TTSK*8Y(I#O+.9&#EOW@+X8 < Y)[#]L*&XTRQ2[BN[E5DN!
M T"NJ0;'A<N"$17?/EC_ %CN!N8  '%3:9\!S\1](M'O[R=!]BMOL\$;*;:,
M+;JL;LC(#(Y)9W.5(#^4KE4#G$_9L\;7GAK4Y_#&JR.S+E;?<78*8EY1-R;O
M*>(!TR50*@VKF2NET+PWJ/C'Q#=_V[;E]-ME<6T;C-H6+;89 A8I*YB:0LQ#
M%&;:=A"*O'^(O^+3>++:#2?W5OJ'V;SX.L/[V=XCM48V[<;DP?D8LH_=DI70
M?MA0W&F6*7<5W<JLEP(&@5U2#8\+EP0B*[Y\L?ZQW W,  #BMO0/@Q%XYT2V
M%_-)(SZ=;"!=SI;V[" B.184=0[@/\[2,Q<@A?+0[!Q7[*E]-XWL+S3;N><)
M;M 89(YYHYH]\<D8565\;%$8*1D% Q)96X J? *\O$UV?2M;NKIYH%8Q*UW<
M+$SQNIX1BK2AD^=0?E,88LC @K[A\0O#PUJ]LH4FN8G:1WE$-Q- &MXD;=D(
MX3F:6%&('FE6^4@*2O=6EL+5%C7)"J%!9F=L 8&6<EF/J6))/))-%I:)9HL4
M2A$10JJH"JJ@8"@#@ #@ < 5\]?'[Q7'=ZU8Z'J4ODZ5)&LUQ@E-[;I1&DCC
M.(M\:Y^Z!N+LP*JR=+JW[.]KHS6\VBB2W,=[:23PK-(T4\:3HQWB20C,8S(A
MYZ,H4LRE?9:Y7XL?\@?4/^O"[_\ 1+U\W_LU?#V?QQI4]O+=26]A]IE!2W;R
MYI9&BB5Q([*P\D1X 0#YV9B_W%S507/[.FN0PM/(^DSL6(.[9L<A'9@$93-%
MA68QC<RA1\@DVCT#]K<3>';2+4;*ZNH)7N5B=8[F98F4Q.<[ ^U2/+&-@4'<
MQ8,2"/2O"^D'Q9HEDMQ-.KO96[&:*:6*;>T RY=&!8Y8MA]REL%E.*\E_8U\
M67GB#[?]MN)I]GV79YLCR[<^?NQO)QG SCK@>E5-":R^+7B"_L]>;S#;220V
M-L'>*/:DCB5QL(+2X16;YLL"QVE47R_4/"'P@'@S55GLFD^P?8IXU@>1I(X)
M&E@<^7O<L!)M9F&#AE)+?,JCQKXN0W&D>*-,M)+NYN(GN+"<K,Z[ _VAHLK'
M$D<2_*O9 <EB2<FO5?VG(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,RH)3\LA^42!
M,A3MR,GFO@/\-8O&&@6HU&222VVW"K;([PP_\?+-OD\M@\KAU^4E@BJ0!'O!
M=N?_ &6-4N="U>_T!Y3+;VZS;-Q;"M#<>7E%+E4#^8S.!DDA>>#G:7Q9I_Q0
MNKK^V+Z&+3[>X:""T6\6%+@)RUQ+@HTBEMC0E6"J5(P?F9^*\2>(=/\ @QJE
MO>^'[I);*X^6[M8I5N554* D'S"=Q#EH]Q!5PPW&-F0>B_M4^-'TD6.GO*8;
M.]F=;R1 ?-$*-$'52 V 5D8L I+8"\J65I?%?[-VG3Z?+)X?WP7$ENQC>&XD
M9)T9=WD-OE*-%)QSD#.UB2H*M%^U3XT?218Z>\IAL[V9UO)$!\T0HT0=5(#8
M!61BP"DM@+RI96E\5_LW:=/I\LGA_?!<26[&-X;B1DG1EW>0V^4HT4G'.0,[
M6)*@JWNM%%> ?MK?\@>#_K_C_P#1,]>G_#*$SZ)8HK%"VG6P#KM+*3 @##>K
M+D=1N!&>H(XKYU%O=IXU2P^VSR"-I3'),1,R>;9F278F%B0\D( FQ2$W(ZKM
M-O\ ::^&T?@.&UU?3YITNQ,(99VFF>XE+0D+(9#)\I"QLI"!00^.%4"OI7P1
MK;Z]86MY* 'GMH)6"Y"AGC5R!DDXR>,DG'<UM5X+H7AO4?&/B&[_ +=MR^FV
MRN+:-QFT+%ML,@0L4E<Q-(68ABC-M.PA%7C_ !%_Q:;Q9;0:3^ZM]0^S>?!U
MA_>SO$=JC&W;C<F#\C%E'[LE*[OX\>,;N_O;/PUICR07%TR2R7",%*0@ON"_
M,K$CRV=L,A(0("WF$#/^(/[/MEX1TFYN-'WP74=I())#*[":+81/'(IW(=R9
M8!53$H0J4 H_8I_Y \__ %_R?^B8*RO!6F?\-!7MSJ.H&;^R89%CMK0R;49P
MAR[^6P(8!]Q[YD""1DC*MYU^U7X '@I[."U8BP99VA@9VD\J3,?G[2X+!&_=
ML 7;YS(0%SS]/_&G3I;C3+F:&YGMS!;3RCR&1"[(GF(&8HT@ *<^6R$@L&)!
MX\Z_9 9M7T>Z,[.S2W\^]][B0EH8=S;P0X8Y)W AL\@YYKSJV\'6]KXZ^PQ^
M8L19F)6><2[FLC*[>:)/-R7))._)R0>#BO6OVA]&F\/Z-)<V5Y>0_9_**(L[
M'<7F",SRN&N&XE.%,NP;5^7Y:T/V9[M+/PU:RRL$1%N69F(5547$Q+$G@ #D
MD\ 5Q7@'1A\?I;G4]4>1M/BN?+M;-7:*/"HQWRHA.7VRJ=ZR9W;U/[L*M<_\
M0+*Y_9UO8+S23(^F3L_F6TCLT0<G+)G;A"8POE.2TG[MMQ9 0WI7[2$LHT>3
M5+&]GB$:P-&+>1$B??*J;RZ)YC I)P!)L.%;:2,G ^ _PUB\8:!:C49))+;;
M<*MLCO##_P ?+-OD\M@\KAU^4E@BJ0!'O!=N?_98U2YT+5[_ $!Y3+;VZS;-
MQ;"M#<>7E%+E4#^8S.!DDA>>#GZDHHKP#X.^$+[QA=7U[XJM=[+(L=O'.H>"
M/KYPAB<LFWY8@)0#OP<2,2Y/-?#B[?X>>+9O#]BQ_L^9BQB<E]C?9?/#(>H(
M/R9.2R8#[F56$/[<_P#S#O\ M[_]MZ^@/BQ_R!]0_P"O"[_]$O7E7[%/_('G
M_P"O^3_T3!7O]%?*O[#'_,1_[=/_ &XKH/VPH;C3+%+N*[N562X$#0*ZI!L>
M%RX(1%=\^6/]8[@;F  !Q6WH'P8B\<Z);"_FDD9].MA NYTM[=A 1'(L*.H=
MP'^=I&8N00OEH=@Y_P#8N\8W.KVUU9W#F1+=H#$69F95=73RQN8@(HB&U0
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MT!(U,DCLS!(XU4=69V"J.!DC) R1Y_\ M1_\B[>?]N__ *414?LN?\B[9_\
M;Q_Z42UY5^PQ_P Q'_MT_P#;BNF_;8NT72K>(L [7JLJY&XJL4H9@.I +*">
M@+#/45?^,.ER:1X+^S3KMEBM-/C=<@X99+=6&02#@@C()'H:B^%-H]YX):*)
M2[O9:BJJH+,S%[@!0!R23P .2:/V0/'D&J:6-,R%N+5I,IGYFC=S()0,#@,Y
M0@%L$ MC>HKV7Q%XFA\/K&\YQYMQ! @!7<SRR+&H )&<9+-C)"*Q .,5Y?\
M%3X"Z=\4Y99HY#!>PLL4LB)E2VR*11(AV[R(G&UE8$!@&+! H\U\ Z_KGP@U
M:TT75G,UE<,L<1&94RP2-/*=]CJ$?:K1GA5+,(R61C]7UROQ8_Y ^H?]>%W_
M .B7KRK]BG_D#S_]?\G_ *)@KE/VY_\ F'?]O?\ [;U] ?%C_D#ZA_UX7?\
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M1/*[$$@[0$P2 <,R XW9KYJ^/O\ R.&D_P#;A_Z625]55\J_ +_D<-6_[?\
M_P!+(Z/VY_\ F'?]O?\ [;U]545\J_ +_D<-6_[?_P#TLCKJ_P!M;_D#P?\
M7_'_ .B9Z]5^$_\ R!]/_P"O"T_]$I7RU^S+:/>:5K\42EW>R555069F,5T
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M*K?[-VER:9H%E',NUC&\@&0?EDE>6,\$]4<''49P0#D5X_\ L,?\Q'_MT_\
M;BCX^_\ (X:3_P!N'_I9)47P8N1I'C/48;C,;SM?+&K*P+$SK.O;@&)2X)P"
M,8)R,^M?M1_\B[>?]N__ *414?LN?\B[9_\ ;Q_Z42UY5^PQ_P Q'_MT_P#;
MBCX^_P#(X:3_ -N'_I9)6M\<M=_X0GQ3IFKW"_Z+]G,1?/3YI4E;"AF.Q9U?
M&WYONJ<YQ]*5E:!XDCUWSC"'VPW$D)9E**[1X$A3/WE#Y0MT+HP&0 3\U?L,
M?\Q'_MT_]N*^JJ\*_;)TN2]T59(URL-W%)(<@;5*R1 \D9^>11@9/.<8!([O
MX%:VFLZ'8RQ@@+;1Q'=@'="/)<\$\%D)'?&,@'@>-?&K2Y-3\9:5'"NYA':R
M$9 ^6.XFED/)'1$)QU., $X%=!^VM_R!X/\ K_C_ /1,]>J_"?\ Y ^G_P#7
MA:?^B4KJJ\J_:C_Y%V\_[=__ $HBH_9<_P"1=L_^WC_THEKRK_FH?^?^@=75
M_MK?\@>#_K_C_P#1,]<)\8-2?0;#PQJ(C,B6T,+MU52PCM9%0M@A2PC;'!.
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MV&/^8C_VZ?\ MQ75_MK?\@>#_K_C_P#1,]>J_"?_ ) ^G_\ 7A:?^B4KY_\
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MY:LR64;*DKJ(X5VA]I8;9)O,DRB."C  <_\ L4_\@>?_ *_Y/_1,%<I\ O\
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M^[Q_K?O?-T^6O'_!?[.U]X2U"35H=21[B;S?-\RS!1_,;>V0EPF/G 8;"N"
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M//\ X/\ PVUWP?:?V?/=6JPQL6A,<3S2?,2Y0EC"H3?RPVL[*SJLD1",N?\
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M)E#.0J[BJHF1E(TR178>(O!&J:[I[:?)?PAI(VCEF%F=[HRJIPOVG8K'Y][
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M/<@5:HHJKJFK0Z1&T]S(D42XW/(RH@R0!EF( R2 ,]R!5JBBBBBBBBBBJO\
M:T/G?9?,3S_+\SRMR^9LSMW[<[MN[C=C&>,YJU16?#XAMIYVLTFC:X1=SPAU
M,JK\OS% =P'S+R1CD>HK0HHHHJKJ&K0Z=L\^1(_,D6--[*NYVSM1<D98X.%'
M)["K55=/U:'4=_D2))Y<C1OL96VNN-R-@G##(RIY'<5:J*[NTLT:65@B(I9F
M8A550,EB3P !R2> *+2[2\198F#HZAE92&5E(R&!'!!'((X(J6BBBBBBBBBB
MBBBBHKN[2S1I96"(BEF9B%55 R6)/  '))X HM+M+Q%EB8.CJ&5E(964C(8$
M<$$<@C@BI:*********JZIJT.D1M/<R)%$N-SR,J(,D 99B ,D@#/<@5:HHH
MJ*[NTLT:65@B(I9F8A550,EB3P !R2> *+2[2\198F#HZAE92&5E(R&!'!!'
M((X(J6BBBBBBBBBBBBBBBJMQJT-M)'!)(BRR[O+0LH=]HR^U2<M@<G&<#DU+
M=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %%I=I>(LL3!T=0RLI#*RD9# C@@CD$
M<$5+111575-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"K5%5=0U:'3MGGR)'
MYDBQIO95W.V=J+DC+'!PHY/85:HHHHHHHHHHK/F\0VT$ZV;S1K<.NY(2ZB5E
M^;Y@A.XCY6Y QP?0UH444445E:[XLL_#^W[;<0P;\[/-D2+=C&[&\C.,C..F
M1ZU+HGB&VUY#+9S1SH&*EHG610P )4E"1G!!QUP1ZU;M+M+Q%EB8.CJ&5E(9
M64C(8$<$$<@C@BI:********************************************
M************************************************************
M***************************************^:_VT?#$"6,-_AS.;M(\F
M65D56AD+!8V<QIDQH254$D9)))S[5\)_^0/I_P#UX6G_ *)2NJHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHKBOB3\(;'XB^1]O#G[/(678Y3(;&^-NORMM7)&'
M&/E9<G/D'[:/AB!+&&_PYG-VD>3+*R*K0R%@L;.8TR8T)*J"2,DDDY]J^$__
M "!]/_Z\+3_T2E=57R!^VGX8@TR:SN8P_FS_ &GS&>667A3&RJHD=@B@R,0J
M!5&>!TKZ_HHHKR7]I_QY/X-TAGM"4EGF2!9%.UHPRN[,.#R50J"-I4MN5@5%
M8FA?L^Z7XL\/VD(A2&>2T@E%RB@S"5XPY9F/S.I9CE"=NWA=I5"OJO@#PE_P
MB%C!8>:\WDQA?,?[QY)P!SA1G:BY.U JY.,GH****************^0/VT_#
M$&F36=S&'\V?[3YC/+++PIC9542.P109&(5 JC/ Z5]?T45ROQ*^&MK\1+7[
M%>[P@D616C;:ZLN1D9#*?E9E(8$8)( (!'0:3I<>D0QVT"[8HHTC1<DX50%4
M9)).  ,DD^IJU1111111117%?\*AL?[7_M_#_:_+V_?/EYV>7YFWKN\OY,9V
M8YV[_FK0^(OCR#P+92WUR1A%/EH3M,DF"4B& QRQ'4 [1EC\JDB+1T7Q[I,)
MO5^6[M(7E2-I(@?,17904<.%.<$;N5RK9!.?G7]FS2X](\5:E;0+MBBCO(T7
M).%6ZB51DDDX  R23ZFOK2BBBBOD#XN>&(/#_B[3%MP_[R2PD=I)99G9OM+)
MDO*[M]U% &<  8%?0'QT\,0:WI-VTX<^5:7$B*)943<J%U+(CJLF&12 X8 C
M@<G/G_[%/_('G_Z_Y/\ T3!7O]?-?[:/AB!+&&_PYG-VD>3+*R*K0R%@L;.8
MTR8T)*J"2,DDDY]J^$__ "!]/_Z\+3_T2E=5111111111111117S7^VCX8@2
MQAO\.9S=I'DRRLBJT,A8+&SF-,F-"2J@DC))).?:OA/_ ,@?3_\ KPM/_1*5
MU5%%%%%%%%%?('[:?AB#3)K.YC#^;/\ :?,9Y99>%,;*JB1V"*#(Q"H%49X'
M2OK^BBN TOXKQZQKDFBVQ1T@M'DFD!)(E$L:>4.B_*K$OC=\Q"_*48'I?&GA
M"#QC:2V%V"8I5 ;:=K @AE8'U# $9!!(PP(R">"_"$'@ZTBL+0$11*0NX[F)
M)+,Q/J6))P  3A0!@#:HHHHHHHHHHHHHHJ*[MA=(T;9 92I*LR-@C!PR$,I]
M"I!!Y!!KY*T'08M!\?"WMP0@9V^9WD8L]BTCL6D9G8EV))))R:^H/&GA"#QC
M:2V%V"8I5 ;:=K @AE8'U# $9!!(PP(R">"_"$'@ZTBL+0$11*0NX[F))+,Q
M/J6))P  3A0!@#:HHHKY _;3\,0:9-9W,8?S9_M/F,\LLO"F-E51([!%!D8A
M4"J,\#I7U_17R!\7/#$'A_Q=IBVX?]Y)82.TDLLSLWVEDR7E=V^ZB@#.  ,"
MOK^BBBN ^)7Q7C\)7%E8QE'NKR[MX]A)RD3R!7E('_?*9(RQ)&X(RUW]%%%<
MU\1?'D'@6REOKDC"*?+0G:9),$I$,!CEB.H!VC+'Y5)$OA/46\4:;;W$_P K
M7-I$[^67CP9(PS;6#;UQN.TAMPX(.>:^8/"WA:W\*^.TLK)/+@CW;$W,V-U@
M7;ERS'YF)Y/Z5]?T4445XU^T?\<C\.H%M[3!O;A6V$E2(D''FE2<DDY$8(VD
MAB<A"C'PJ_9TLM&@6YU6$76H3*7G:XQ,%=\,R!270E6&#)\S,=Q#!6VBW\1?
MV>;36X)3I0%A=M"8P\&88I$.2T,J1X5D?/S':6X4G<J[#T'P,U)[_1;/S8S$
M\</D,C9W!H&:W.00I!)CR5(RI.WG&:[JBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBODO]LN&XTAK?%W<
MO%=>>'@9U6 "-XW10D:(#@N?F?>_RKEOEKTKXY?!Z#7-+N;NZD>2]@MY9EE+
M2^6I0"1TC@\WRHU94\L<,P&&=I) 6;FOV<M/E^(NC+!J$\AM;::6 0QN\1E0
MQ@[9I ^]D59=J1H8U 4!Q(-H7$^'3-\/O&$FAV+/]ADW_N7=V52ULMQN49 W
M H$#,&;R^"2?FKL/%?C6V\9ZM<Z5?7L=IIMFJ+(JW2P/=2N!OC9CC,*KOCEC
M5@P8@L2<!/.OB:FE_"^2WUCPK=PB99!%+;).+E)$8,Y9AYK/M^4*PSC)1E*.
MH9O=?B/=-XET-]1M+FYM5^P/<H(C'&[?NA-&';:[KC !$;KD%@2P(KR_]EKP
MT?&>E77V^622&2]FWQK)+&TCO%%YCRR(X>0%3C9D*27:02$IY?-> ]+F\!^+
MKC1-.E\N"XW*3M9]B&+[4FU6<J947,:22;P,LS(P8J=7]I?X<P> [:WU>PEN
M5OOM"0O<-<2O-(# X+LS,2&Q'CY-B[69=N-H70_:>UM]>\,:?>2@!YYK25@N
M0H9[65R!DDXR>,DG'<UH:%\!9/B+H]H^IWLRG[)!]GAA(%K$HA"PLT;*3)+@
MEI&W*3N,:D*JFLK]FSQM>>&M3G\,:K([,N5M]Q=@IB7E$W)N\IX@'3)5 J#:
MN9*Z7Q7XUMO&>K7.E7U['::;9JBR*MTL#W4K@;XV8XS"J[XY8U8,&(+$G 3S
MKXFII?PODM]8\*W<(F6012VR3BY21&#.68>:S[?E"L,XR492CJ&;W7XCW3>)
M=#?4;2YN;5?L#W*"(QQNW[H31AVVNZXP 1&ZY!8$L"*\*^!/PZNOBCI-U#<W
M;QVK7<KG9\TLMR4B;?,SYWQ+A6" @NY9F8%$-:'C:,>&;O2O">K7A;2UA$D\
MGS1&0F6?R(Y#N<K"I2-  0%'S%EVH8_2M6_9WM=&:WFT426YCO;22>%9I&BG
MC2=&.\22$9C&9$//1E"EF4K[+7FO[0FH:I9:6YT5':=I%1S&I:98F#!FC .[
M=NVC*@LJDL,$;UX_QC\$;(^''>[MPM_%9-<2S@AK@W"Q-+*7E^8R!I"P8$LN
M#\N-J%=7]F7QI=^-]&<W<I,L4TD"S  R[1'&RN2X96<;^K*0V 7#'<6\@U2W
MU%/&*Z?;7LDDD;2>3+='SA%YUIYDSK&H2,$!B4155"516&T&NZU;P9_PH!;[
M78+M[CSHU1+>X/S/,\B$2.ZL/-9?WCX"*VPN-P^9B?\ "#>&]>AWZUJ4-W?/
M'\\[7Z?NV89985#)&L2R%FC5HR!G!!'R@_9<^(<CW%UX>EF^TQVF\VLX (:*
M.3RB-P=LK\R-$!NPI9=^T(!]%5\Z_MA0W&F6*7<5W<JLEP(&@5U2#8\+EP0B
M*[Y\L?ZQW W,  #BJND_ &Z\?:;IUY<:@\-Q%;VYMA$N888A&GEX&Y'\\X5W
MEW?>^15VHA%I?%FG_%"ZNO[8OH8M/M[AH(+1;Q84N G+7$N"C2*6V-"58*I4
MC!^9GXKQ)XAT_P"#&J6][X?NDELKCY;NUBE6Y550H"0?,)W$.6CW$%7##<8V
M9!VOQ^\5QW>M6.AZE+Y.E21K-<8)3>VZ41I(XSB+?&N?N@;B[,"JLG2ZM^SO
M:Z,UO-HHDMS'>VDD\*S2-%/&DZ,=XDD(S&,R(>>C*%+,I7S#]LN&XTAK?%W<
MO%=>>'@9U6 "-XW10D:(#@N?F?>_RKEOEKO_ (C_ +-DGCV-[FYO9C?'>T49
M<-91%B"(E7RU8+M54,@PSD>:R$DI65^RY\7)KV.ZTW6)7^T6F^7?.S;UB!Q*
MKLZC;Y;]3(V[#[0 L?$7@'1A\?I;G4]4>1M/BN?+M;-7:*/"HQWRHA.7VRJ=
MZR9W;U/[L*M<_P#$"RN?V=;V"\TDR/ID[/YEM([-$')RR9VX0F,+Y3DM)^[;
M<60$-[A\7H6U329[NTNYH5CM)IT:V>-1)M3S8SYFQGV_*/\ 5NFY6()((QX_
M^S#X4;QMI<YOIYF@:_G,D2.\9F9X(UD,TBMYCJ0P(0% 6W&0R J$S_AB)?AY
MXOET*UD)LI&E(B)?8@> 7*$*7(+J%6/>V2R@]">-OQIJUOXV\4G0]:DQ8P1K
M]GA#-$DMQ)'&PWLI!+8D<)\R\A57EV$G=6/P,B\+:A8W.E&2.UCFF,]MYKO#
MN:VF1;@"20G?DK&<;B58$;0K%O)?VRX;C2&M\7=R\5UYX>!G58 (WC=%"1H@
M."Y^9][_ "KEOEKM?VUO^0/!_P!?\?\ Z)GJIH7P%D^(NCVCZG>S*?LD'V>&
M$@6L2B$+"S1LI,DN"6D;<I.XQJ0JJ:ROV;/&UYX:U.?PQJLCLRY6WW%V"F)>
M43<F[RGB =,E4"H-JYDJI^W/_P P[_M[_P#;>O=?C'\0_P#A7^F37ZA&E7:L
M2.VT,[,% ]6P,N5&"54\KRP\J_X0;PWKT._6M2AN[YX_GG:_3]VS#++"H9(U
MB60LT:M&0,X((^4'[+GQ#D>XNO#TLWVF.TWFUG !#11R>41N#ME?F1H@-V%+
M+OVA /HJOFO]L;PS%8:;'<(TQ=[],A[BXDC&Z.=CMCDD:-.1QM4;1\HP"17I
M_P '?"$-MIUA=*TY<V5NV&NKEXLM"N?W32F+'/ VX7C:!@8\ZLYO^%\:M>6\
MD[_V/8^6@ABDV"X<N#N<IO$D1,3[2&4A?+9-K%S6+\7/ $OP1,>M>'6DCA\Y
M5N8"[R08VXCW*1DH3O#%W)5Y%\LJ2,>G^,]7;QEX?;5+6YFMO] DN-MO)']]
M8_,\MI/++_(Z%&V&,GYE;T'BOP)^'5U\4=)NH;F[>.U:[E<[/FEEN2D3;YF?
M.^)<*P0$%W+,S HAKZ:^&_A!_!VGP:?),;@PJRB5@5)7<Q1<%GP%4A ,D *,
M8' J?%KX@)X!TZ:^;!=5VPJ<?/*W"+C<I8 _,X4[MBL1TKBM _9WM=<@2Y\1
M"2\U"1=TK232*(RWS&!%AD"!$8D#;D$EBN%(58OA%X=U?X?W5W:7\F_1HHV>
MWGEE1RBIL"+DLK(HBSO!01JR93 )+\UX!T8?'Z6YU/5'D;3XKGR[6S5VBCPJ
M,=\J(3E]LJG>LF=V]3^["K7/_$"RN?V=;V"\TDR/ID[/YEM([-$')RR9VX0F
M,+Y3DM)^[;<60$-[A\7H6U329[NTNYH5CM)IT:V>-1)M3S8SYFQGV_*/]6Z;
ME8@D@C'DG[+7AH^,]*NOM\LDD,E[-OC626-I'>*+S'ED1P\@*G&S(4DNT@D)
M3R^:\!Z7-X#\77&B:=+Y<%QN4G:S[$,7VI-JLY4RHN8TDDW@99F1@Q4ZO[2_
MPY@\!VUOJ]A+<K??:$A>X:XE>:0&!P79F8D-B/'R;%VLR[<;0O8?&35;O4?#
M<>MQW<]O+]FLI3%;N(HB\K(')(4S$8E("^9M^5202,GG_@_\)#\1- M8[VZG
MBM LRI!;R*JN?M,KM)+NC.X[MH1/F"!-X;=(57%^%&LWGP>UX>'K^9Y+.;"0
MD[Q%F0[H9$4JV-SDQN$(0.S%F;R\U:_;G_YAW_;W_P"V]>P?'3P;<ZS8RW&F
MSW,5Y%'NC$,\Z*X0EFC\N,E69E)VD*'+A%+;<BN/_9(UP^(;*6XN+B>:[CF:
M-_-NI9AL8(R,(F;:@." Q#,2KX?:=B]KIGA5;[5[F=9[HPP+ /*^U7 A^TLS
M3R90R<@1-!A!^YVN5VD@A?.OVPH;C3+%+N*[N562X$#0*ZI!L>%RX(1%=\^6
M/]8[@;F  !Q7I?@S0VUO0;"!)YK?=86H+P&-9,&W4%0TD<FWKG<NUP0"&'.?
M!/V4[2Y\:/J#7-W. 6LFE=9&%Q+L,NQ#,6+JFU2K!,.1M"R(H97-7TH_"#Q9
M:6VEL4M;MK7=!NE,>V1WMR&S(3(0=TB%N%9@ ,#GT7]J[XKW7@BUAMK([)+O
MS09@<.BILW!/1FWX#YRH!VC<0RV_BA\$['3]&GDME\N\M8VN4O#EKMI8LS,[
MR@J[,_S9).U2P95^10,_]E&[D\3V!OKR6>2>&YEB#-<W3JR^6C M&\S1$CS"
M!\@  4XW#<?>J^1?C%;WGPYUFU\S4+W^RKB9'8-=7!*(LB_:(LI(9&"HP(;
M8A@H+,I8^R_'3P?*VERW-A<W-O<6EON5ENKA5:.(%G5QN;>Q3<0Y&]G"[I-N
M:S_V5=>.OZ3]HEDGEN!,\4SS32R@LIWH4#R.%'ER*#M"DD<@X!KH/A]X8+/>
M74=Q=;))I8(%DN)9_)6$^1(X6<RKO,\<C*6WC9L&%RZ'Q72O/L_'45G-<SW*
M0M,R&=]Y4RV1D?:%"H@W' "*H "C'%;?[:/AB!+&&_PYG-VD>3+*R*K0R%@L
M;.8TR8T)*J"2,DDDY]5^"_AF*PTVRN$:8N]A;9#W%Q)&-T:,=L<DC1IR.-JC
M:/E& 2*\$^#NFOJ7BW5HED,:EK[S"N1(4^UIE%<$&,DX!<98+NV%'*R)-\;]
M,7X*:M9:OI9=1/YOGQ&21S+M=&EWR2M*3Y@D .0=K*)!EL$?6E9_B&:>"VF>
MS4/<+#(84;A6D"DHI^9>"V >1QW'6O%?@I\-7\564]WXHMC-=W$TBAKE3YJP
MXX5%;!MQYC2%0@C/(8?*$-<_^S+K\^CZO?\ AU7+V5LURT(?YG0QW"Q\$8 #
M!MS#&-WS*%);=G_'W_D<-)_[</\ TLDKZ ^+'_('U#_KPN__ $2]>5?L4_\
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M1UD'"@<-]WY>G%>:_L]Z[>?\))J&GSW=S<06\=TB">9Y?]7<QQJQ!.W=MSR
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MX:3_ -N'_I9)5O\ ;CTN26&QN0O[I))XV;(X:01L@QG)R(G.0,#')&1GZ/\
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MJ?P^M)+6:Y@ ,TLJK'&\H+M$L:EV<QDH"NXQHJ,2J_O@I9#G_P##.U]_:_\
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M'AG$30+O1< NBRN"6!<,P^4!\K%E0#4\!^!-=M;(:9J-W!'!'"L226BO]KV
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MKZ _;6_Y \'_ %_Q_P#HF>C]BG_D#S_]?\G_ *)@KY__ &7/^1BL_P#MX_\
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M,G !.2 H.!V%%>-?'KX-CQ:\>JM?R68LH7<D(TJH$/F&5 CHRN,?,5W%@J
M%>9OB'\&;CXHZ;8PWUR]O=0QQM. JR1M*8U$A9$9%+!L[64[5#. "&R.O^$3
MSOI=N;J8W#E7V3L,-+%O;[/*1DD%H=C$,2X)^?Y]U=A11111111111111111
M11111111111111165XFT-M;A,"3S6^[(+P&-9,$$%0TD<FWKG<NUP0"&'.?G
M7]BS5IM7DU.>YD>65OL>YY&9W.!.!EF))P  ,]@!7L'C#X3?\))JEEJWVJ:+
M['G]RI^5N<\'(V;L[9>&\R,!/EQFN_HHHHHHHKQ#]JSXJS^";**WLV,<]VSK
MY@'*1H!YFTY!5R74*0#@;B"K!353QQ^RW&R)<Z'/);:DC$M</-,6F+C;(SN"
MS*YR6W( "2RE<,"GN&DV\EM#''/)YLJQH'DVA-[  ,^T<+DY.!P,X%6J****
M****X#X3?";_ (5[]J_TJ:Y^TW!E_>G[O7D\G=*V?WDG&_"_*NWGOZ******
M*************Y7X?_$.'QPMS);#]U!=R6ZON5A)L1&,B[<C:2YVX)RH#<;M
MHZJBBBN \8?";_A)-4LM6^U31?8\_N5/RMSG@Y&S=G;+PWF1@)\N,UW]%5=4
MLFO8VCCE>%CC$D8C+K@@\"5)$YQ@Y4\$XP<$?+_[/<TW_"5:A!//-<?9[>Z@
M1YY&EDV1W484%C^)XP,DD 9KZJHHHHHHHHHHJ*[NTLT:65@B(I9F8A550,EB
M3P !R2> *Y_X<>.$\<V,>HQ(8TE:7:K$%MJ2O&"<< D+D@9 )QEL9/2T4444
M44444444444444444445\Z_MA0W&F6*7<5W<JLEP(&@5U2#8\+EP0B*[Y\L?
MZQW W,  #BO8/A/_ ,@?3_\ KPM/_1*4>&OB'#XBOKVP@&?L7D*\@92K/()"
MR #/W-@5LG._<I4;<MU5%%%%<KXZ^(</A%K6.0;Y;N[AMXT#*I^=PKR'/.U
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M RE"78,,G.T*?ERRL*OQ*\*7_P /-%CU.#4+K[=:K'YY>>2YAF:5EC<;)LH
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M5\M'B\B H44 *HZA@N5$@?ECECV&K:I'I$,ES.VV**-Y';!.%4%F. "3@ G
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MB.R,'#@Y'+*08F1^:^(/@C6?AW&FH:'>7UZZR!9K>X?[8&C)!RJX5A\RA6V
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M11111111111111111111111111111111111111111111111111111117RK\
MO^1PU;_M_P#_ $LCKZ:U_7X/#T#W=VXCAC7<[MT Z=N22<  9+$@ $D"O.O!
M?BG4?BC&+ZW?^S]/,C"+:L<UW,%,B%B9 \4*[MOR[)')1L.%*EO)?V=[86OB
MW5(UR0JWR@LS.V!=Q 99R68^I8DD\DDU]"_%C_D#ZA_UX7?_ *)>O*OV*?\
MD#S_ /7_ "?^B8*]_HHKRK]J/_D7;S_MW_\ 2B*O /V*?^0Q/_UX2?\ HZ"N
M@_;CTN.*:QN0O[UXYXV;)Y6,QL@QG P97.0,G/).!CA/ VOSW?A;6+21RT,#
M6#1(>0ADN<R8[@$J#CH#D@ LQ/HO[#'_ #$?^W3_ -N*\J_YG#_N/?\ MY7V
M5\6_A]:^/[/^S[M_+9Y,P.#\PE5'((4D;_DW[D[IN(*D!E^%==\,ZI\)+Y6<
M/!/%(3#,H/EO@#+(Q&UU*L RD=&V2*"2M?94OC7_ (3?PK/J!7:TNF7>\8P
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M%HUNK=T(9HSAON.4PX5MT9)')Z[&8']#ZBN[M+-&EE8(B*69F(554#)8D\
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M_MP_]+)*ZO\ ;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5X+#://\
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M$$IO\J_:Q\/7%CI,4M[=/<2F_  "K# @9)VVI&F2< *H:5Y7&#M9=[AO2O\
MF3_^X#_[9URO[%/_ "!Y_P#K_D_]$P5Q_P"R!INE>(;:XL[RV@FNHYO-!EBB
MD8Q,J( N\%R%=3NXVJ77G+5[UJWP[T/2(9+F>QLUBBC>1V^RQ'"J"S' C).
M"< $^@KS7]M;_D#P?]?\?_HF>O5?A/\ \@?3_P#KPM/_ $2E?/\ \??^1PTG
M_MP_]+)*]U^*_P 5[7X;VIN;D[I&R(80</(P[#KA1D%W((4$<%BJMROC?1]3
MU32;ZZU.;R0;"X864&T(F$E91+-\TDK8V!_+,41*E2KQL=W/_L4_\@>?_K_D
M_P#1,%<I\ O^1PU;_M__ /2R.O1?CM\!H/B>XDAF$5_#"!@_,K1DR&-74'*
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M"H)?"HH0UPG_ #4/_/\ T#JBUFY&B_$!)KG*)(T:QL5;#&2S$"8P.09?DR.
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MF1F( 51G:J +N;SIOAEJ_P /M>N-9TJV2]M[OSM\9G2*5?,*2MEG"*/WH.S
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MV+O>6 /SY>YO+B<KT+84$<@9P"?-?@SKNOPS&R\1JA>6.:6%P8O, B,".K"
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M0A3AAE:X_P#9^^&>J_#:)[*Z^RR6\DQEWQRR^:K% I&UH0K@[$Q\R%?F.6X
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M7 &_8!\P5MK;=IQ?"&L>+-$@%A<V,=S*C-''>O=1JFW[J22(,RR =20$D=<
MKYF6/8?!CX6_\*_M66:3SKR>0RW,QY+.?X0Q&]E')!<Y+,[X7?M'FGQ#^#.O
M>+M6@UE38Q-;>1Y49EN)!^Z<RC>WD)NRY.<!?EP.H+'V#Q7)JDNF2FR2%-1\
MMO+7>98@=W\+/'%EMG*[U"!\!LH"3S_P8UW5YEDLM?5!=Q1Q2[U*;BDLDZ*K
MB,>6&!A)!0D%&7(#AL^E4444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444445GZ_H$'B&![2[02
M0R+M=&Z$=>W((."",%2 000#6?X.T>ZT6,VUS-]I1/\ 53-Q.5RV$EZJ[*H4
M>:"#)D[D4J6?H**X_1/ [O=G5-1<2W(4K B@^3:HP&](\\N['AYB%9UPH2-,
MI78444444444444444444444444444444444444444444444444444444444
M44444444455U;SO)D^R[//\ +?RO,W>7OP=F[;\VW=C=CG&<<UXU\.-(\3:^
MDUGXD\M;1U(<XB-Q(K#:T*FW?RT0@$.Q7S,,1&P8AX_;Z******\*_:<\+ZG
MXZMX]/T^R>18[A96F,MNB'$;*%56E#G_ %AR6"8*\!@V1Z!\(3=VVGP6E]:O
M;2V]O#$<R0RH^Q=FY3%(QZ*"0RK@M@%L$UV%W,8$9U4N54D(NT,Q R%&]E7)
MZ#<0,]2!S7S+_P (7KG_  E'_"1?V:_D>9CR_M%KYFSR/L^[_6[=VWY]N<9^
M3?CYZ^FK28SHKLI0LH)1MI921DJ=C,N1T.TD9Z$CFI:*****************
M**************************************Q=;T!]9<)*X^R;1OA"$-(V
M3\KOOP82,;HP@+D8=VC9XVVJ*******************BNU=D81$*Y4[692ZA
ML<$J&4L >H#*2.,CK6?H6A?V=NDD;S+B3'FRXVYQG:BKD[(ER=B9.,LS,\CR
M2/JT444444444444444444445GZW:3W2!+:40DL-SF/S&V8(.S+!5?H59Q(H
M(^:-P<5-I>EQZ5&L,*[47/<L222S,S,2S,S$LS,2S,2S$DDT:I>M91M)'$\S
M#&(XS&';) X,KQIQG)RPX!QDX!^:OA9X+USPMKEUK%SIKF*[^T;DCN+5G3S9
M1,,;I4#X*A3DIP2W;:?I^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MJNJ1S2QL+9T27C:TB-*@Y&<JLD1/&0,,,'!YQ@PZ)HB:0A5269F+22-@R2.0
M 78@ 9P    JJ%1%5%51H444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444444444444445\E_ME
MPW&D-;XN[EXKKSP\#.JP 1O&Z*$C1 <%S\S[W^5<M\M?6E%%%%%%%%%%%%%%
M>:_M"?$J3X?:6]S;_P#'Q)(L,+%0RJS!F+D$CHB,5X8;]NY2N:\_M_V=H/%V
MDVVH0S3+J\EO;W O))I7=I"BNJL<G"C(560!T"H<M@AO:O &CW6C6,%O?S?:
M+E(P))?[QR<#)Y; PN]L,^-[ ,2*Z"BBBBBBBBBBBBBBBBBBBBBBBBBBJNJ6
M37L;1QRO"QQB2,1EUP0>!*DB<XP<J>"<8."/E_\ 9[FF_P"$JU"">>:X^SV]
MU CSR-+)LCNHPH+'\3Q@9)( S7U511117*^&OB'#XBOKVP@&?L7D*\@92K/(
M)"R #/W-@5LG._<I4;<MU5%%%%%%%%%<KKOQ#ATG4;/2<;I[OSFX91Y:1QN^
M]ARWS,NU> #ASNRF#U5%%?)?[9<-QI#6^+NY>*Z\\/ SJL $;QNBA(T0'!<_
M,^]_E7+?+7U5JVG_ -HPR0;WC\R-TWQMMD7<"-RM@X89RI['!KE/A#\-O^%=
M6(L//>XQ([[F&U1N/W47+;%XR1DY<LW&[ [6BBBBBBBBBBBBBBBOG7]L*&XT
MRQ2[BN[E5DN! T"NJ0;'A<N"$17?/EC_ %CN!N8  '%>P?"?_D#Z?_UX6G_H
ME*ROA-\)O^%>_:O]*FN?M-P9?WI^[UY/)W2MG]Y)QOPORKMY[^BBBBBBBBBB
MBBBBBBBBBBBBBBBBBN5^'_Q#A\<+<R6P_=07<ENK[E82;$1C(NW(VDN=N"<J
M W&[:.JHHHHHHHHHHKYE^&EQ%^T!>W\VJ^9)9P-"+6UWO%$JL9MLC+&_,VU>
M6W$?.X'RA OH'P;^$%[\.[FXC-X9M-*XMH&RS*2Q<L<@*A&6!\OB4MO8*5"U
MZU7*_#_XAP^.%N9+8?NH+N2W5]RL)-B(QD7;D;27.W!.5 ;C=M'S5^V7HLFD
MR6\ANKF5+F2=S#)(#!&8Q&J>7&JJJX60C)RQZDDEB?K^BBBBL7QIXO@\'6DM
M_=DB*)06VC<Q)(55 ]2Q &2 "<L0,D>"^ = O/CRTNIZO--#IID"0V,3ND4@
MC</ES@!US\I<?.SAMK1"-5KO_P#AG'3M*_>Z0TVGW0^[-%+(^<<A)$E=UDBW
M!69#C=M W 9K/_9VN[NUDU/3]58R7\5ZLLTF0R,LT2"(J1C VQ9"[5"*44 8
M*K[+11111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111111111111117R
MK^W/_P P[_M[_P#;>O=?BSX^D\&6J/;1>==7%Q';6Z$A4,LF[87)*X7Y3G!&
M3@94$NO'Z_\  [4=1@>0:S>F_*_*RR?9[0L/NCR81\@*@ E6)W9DPW*FW^SA
M\8'^(UDWVK'VNW94E*@@.K#]W+C 52VU@54D J6PJLJCBOA?//\ '(W.HW&H
M75H$F$<=I9S^2(XPNY7?@ERQ)&\JN2C8^7")Z5\-M!U'0KV\@OKF2ZMUAM/L
MDD@P0F;@,C$*JM,,#S'Y9QL9B,A5\U^%\\_QR-SJ-QJ%U:!)A'':6<_DB.,+
MN5WX)<L21O*KDHV/EPB>E?#;0=1T*]O(+ZYDNK=8;3[))(,$)FX#(Q"JK3#
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M6XF8&-F6*-_DB&PGYY5D.'0B,,&"^2Z7I_\ 9_C]8][R$9)>1MSL3IY9F/
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M]QXITN\NPDMC-80G]XJF,K,UPL<C++@!075V+8*@$XR,5] ?\*GT?_H'V?\
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MIF6Y#R.$1?E$'W(XE5$&XL<X9R"%9V")M]O_ &H_^1=O/^W?_P!*(J/V7/\
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M%<'8F/F0K\QRW &!<_!O6V\0?\)'&+)3N7,+3SL-OD"!QO%LO)7)!VX4D9#
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M#S3EL;/$CHKL6;$7FRGDLQ16*@G"@X=E0*/GV\^2_P#"F=>_M_\ X2/-CO\
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M[/*\C;N\C.[R_P"+&-_S;,?)7N'B'1'\1V$UG*1$]Q;21,5S(J-)&4)&1&7
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M36?B5IVC3I9SW,8N))HXEA#;Y=\F-@*)N90<CYF 7D9(R,]+11111117*_\
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MAU4JP#*>AP0"00PX()VJQ?%'C:R\*IYE_/'""KLH=@&8( 6V+]YR,CA03D@
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M8(-B +DC"(/X17J&F?L[:-ITUW,L&5O(_+>(G]RBDAV$:C&S+JK@Y)1E'E%
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M;0S&C]H*&>#PI,EXP>X6&S$SKPK2": .P^5>"V2.!QV'2N5^$GCA+#P_8:3
MD=Q?WJW:16\A'E;//G\R6;_IB%#949:3!1 ?F*^E?#KX#Z9X*@BC$,<\\;!S
M<21HTID&#N4D$Q@$#8JGY<9R6+,?1:**^5?^:A_Y_P"@=7M?QT\,0:WI-VTX
M<^5:7$B*)943<J%U+(CJLF&12 X8 C@<G/C_ .R5X%M?$FEO)?)YZ1W\A2&3
MYH WD1*9#'C:[%6P#)O"8!C"$N6RO!>G+X-\=265E\D$OFADPF-KVWVKRU 4
M!560+M"X(50I)&<]_P"7'\7M>G@G/F:;I.P>020DMT2P+NA0;E3:Z$$D94%=
MR2.IT/BY^SO!XA@C;1HX+*]@F5XY$3R 1W!,(R"#AE;:Q4K@;0S&O5?#T,\%
MM"EXP>X6&,3.O"M(% =A\J\%LD<#CL.E:%9_B&&>>VF2S8)<-#((7;E5D*D(
MQ^5N V">#QV/2O,/V>?AA<>&M/N$UB-&N;NXD>8,5F=T*A=LK?,'R=[8W,,.
M<_,S >:?LOZM]CU[4M-LY,Z>/M,D4:MYD?R7"1QNK$L3^[;&X'YQM+%MJD8O
MQG\)1:-XKTZ*U:1#,UBS2-(\\N\W+1A]UP9<D*B@!LK\H^4C(/H'[27PET[2
M]#FN;>$)-#-'+YOWYI&DF".))9-\K@^:6Y;.X+S@8J7PC\5Y/"7@V#4Y"DDZ
M1F&%7(0,5G>&-<+@MLC7<0/F94)+ Y8:'P(^"EDNG1WVHPQW=W>*+B2291<<
M29= /,7@[6!<\EG+99E"X\J\&^&1X8\=)9HY=(VD\O<6)6,V3-%%EF9B(T*Q
M@D\A1TZ#[$KQ7XY^,!-?6.@>8ZPW.^2\6**:69X%!*Q#R1OVR[)$?9EE49.$
MW!\7XB^!M"U73);:SL)XYXX2;=H].O(Y3(B'RU:1K;+AC\K^83G.XD, PO\
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MW5P!N4%P?5:^9?VA/%\%CXAT^VU8E]+CA6:2'&Y/,9IXUD91@N%*J2IW?*'
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M>#P9"Y5@=Y!Q/V5+D^+M">VU'%S%%<M$B2JLBB-$AD1"&!W!6;*YSM& ,!5
M\Z_X1.S_ .$[^P_9X?LO_/#RT\G_ (\-_P!S&W[WS=/O<]:^FF^&6E,@B-C:
ME%9F5?L\6T,P4,P&S )"J">I"C/05\R_L:^$[/Q!]O\ MMO#/L^R[/-C27;G
MS]V-X.,X&<=<#TKU#]J7P;:G0Y9PA4VRVZPHLDBPH/.2,8A5A%D([*#LR%.
M< 8VOV7/^1=L_P#MX_\ 2B6O*O@%_P CAJW_ &__ /I9'6M^VCX8@2QAO\.9
MS=I'DRRLBJT,A8+&SF-,F-"2J@DC))).>_BT^^U#PK!%I3[+QM,M!&VX(?\
M5QEU5B/E8IN56XVL0=RXW ^&7PPA\.^'ETW6(X0ICE>[!*A/F9GW.XQ\R(%!
M<'Y2@*OA5:O-?V+M4DUBUOM/N6\VUC\G9$X#(!+YWFK@@_*VT94_+G)QEF)Y
M_P#X1.S_ .$[^P_9X?LO_/#RT\G_ (\-_P!S&W[WS=/O<]:]*^+VM0:==6'A
MJV_<6D_F2745O!*SF 9<1*MN P65ED63RQN ^9L(6#T/B+X&T+5=,EMK.PGC
MGCA)MVCTZ\CE,B(?+5I&MLN&/ROYA.<[B0P##?\ AC\0[W2?#TM[K44B3V:R
MK_I&87F"J&BY= 06+"('#EF&269B*P/V?_AU!XSBF\1:Q%'<W%]-*460>;%'
M&K[-H24-@AD*KDMMC5%4KEP?.?B9X.C\*>+M/BMSB"2XLI8XAD)"&N3OC0%B
M ID#R *%52Y 4 9/V57RK^W/_P P[_M[_P#;>O1=?_9>T_Q# YNWDDU&1<O?
M,S[S)UW>4'\H(.%$8 VQ@*&# /7"_LF>(9$:]\,:@F[R?-;8V)$4!Q%<0G+,
MI7<P(505):0DG(SB:#H$&@>/A;6B"*)6=E1>%!>Q:1L#L-S$@#@#A0  *Z;]
MM'PI:Q6,.H+$BW37:1M*!M=E,,G#$8W8\M<%LE0,*0"0>E\6Z_/H'@N*YM',
M4JZ=8*KKPP#^1&V#V.UB 1R#RI! -9_P+T3PWXTTN*V2WMGN5M]MPCHGVK=@
M"60,<R[2SY1U;"[E4%&7:OH'A7X10:=I2Z-<EW@22XQMFEC+1O+*R*[1&(MF
M.0!U(V%L\$ &O%/V&/\ F(_]NG_MQ65^VGX8@TR:SN8P_FS_ &GS&>667A3&
MRJHD=@B@R,0J!5&>!TKV#XM?!_3WTF_F>/?=?9Y)VNGVO<M)$@<?.RG8I\L*
M4C"(%)5%0'CA/@!\1'\-^$[N\E8$6DTZP!E)4,R1O&AV88AIY>23D!OO!1QM
M_#C3M)NK5+[5+::]OKJ-)9YY=.O)P2V654S!)$JJK! 8L(RJI QM RO@[9W/
M@[7Y[*PM[P:+<;F0S13QQQN(A)OS-$K#YE:$9*E@4+,Y52<3PAXOTS4_$>II
MXC,<CB:2&U>Y"&WCCBED!C^?]VA("E6(Y(?YM[D/[AH7P?M?#>K'5+"-(4DM
M)(98T^5-V^%HW1%7:ORHP?! )VD+DNQ\/\(>+],U/Q'J:>(S'(XFDAM7N0AM
MXXXI9 8_G_=H2 I5B.2'^;>Y#^X:%\'[7PWJQU2PC2%)+22&6-/E3=OA:-T1
M5VK\J,'P0"=I"Y+L>_KQ7XY^,!-?6.@>8ZPW.^2\6**:69X%!*Q#R1OVR[)$
M?9EE49.$W!\7XB^!M"U73);:SL)XYXX2;=H].O(Y3(B'RU:1K;+AC\K^83G.
MXD, PZ7X0V=SXYT46OB"*Y22.1XG\QY[>29-ORLVSRF92LA1@Q8.4+,2W3QK
M]C[PA!XG%]'=@R0JUFQASB)V#3,AD P7"E>$8F,YRZ,0A6U\0]#B\">,M/;3
ME$(G:T+(J(L:B21K:154* H:-3GJ=S,P(.,1?&WPG9Z=XJTNU@MX8X)/L6^)
M(T6-MUU(K;E "G*@ Y'(X/%>X?%GX;Z>NC7B1P")([:YE6.$O;Q&18]RN\<+
M(DA#1H1O#8QQWKA/V/M)AU?0[B"YC26)K]]R2*KH<16Y&58$'! (SW -<5\$
MO"=GJ/BK5+6>WAD@C^V[(GC1HUVW4:KM4@J,*2!@<#@<5TO[8W@VUT_3K>ZB
M0JZW,<2#S)/*2/R7^2.(MY48_=)G8JYV\]ZZOQ+\1'\!>$K2Z@8+<-9644!9
M2XWM$F3CID1AV&[Y<J 0V=I-$\'Z!9VQ@N;.>YED4^?<2Z=J#S22,H624.\+
MR1ECEL(XVL25P>:ROV9Q?Z!=WFE20W0TU6DDLY;B.2,!1+M"C?$G,BL'*_*
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M^Q3_ ,@>?_K_ )/_ $3!7A6F:7)J?C(QPKN8:U+(1D#Y8[AI9#R1T1"<=3C
M!.!7O_[2OQ[F^'OE65@$-U-&[L[AF\M#E$91@*6+!B,E@NSYD(85YA\7?#(T
MOPI974CF:ZO+FUGGG<LTLA:VF,:LSLS$1H0BC.."P4%C7HO[%/\ R!Y_^O\
MD_\ 1,%?/_\ S.'_ ''O_;RO5?VY_P#F'?\ ;W_[;UZK^RY_R+MG_P!O'_I1
M+7FO[:W@5KB.WU>),^7F&=AO)"L=T)( *A0Q<%C@EG1?FR,=!^R5>S>(+);B
MX.Y;2-K. EV9^7\^8D8&%*&WC0$MM$)V[ Q!]_HHHKY5^ 7_ ".&K?\ ;_\
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M*SEY RC:)&+ $^8%WYY&2R[BRM7I5?*O[#'_ #$?^W3_ -N*/C[_ ,CAI/\
MVX?^EDE=7^VM_P @>#_K_C_]$SUZK\)_^0/I_P#UX6G_ *)2OG_]AC_F(_\
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M[%RQ!Q@^2_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2OG_\ 88_YB/\
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M.\W;MV\9\O\ V<>5^[KO_ O@6U\#VJ65DFV->23R[L<;I'.!ECCD\  !5 4
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M'5)-[!I!U(+-N#'=N^9P_%> _P!C>RT&<7%].;L(RLD?EB*(D9_U@+2%QG!
MRHXPP=217I_Q*^%J?$&/[/<W-S';_*6AA:)$8J20S%HG<]1\I;9E5;;N&:B\
M ?"=? L#6EI=W1A*N$20P.(V?!WIF#((.2%.8\EB4))-<_HW[.5OHMZ^IVU[
M>I=2-(TCAK;#&0EGRAMMA!;G!7 (! ! QB?%OX.R3ZC_ &];7TT=T(]EK H#
M,TXC<11QL3A8B?FE0HR[/.=V5"S)[K575+)KV-HXY7A8XQ)&(RZX(/ E21.<
M8.5/!.,'!'E7_#-%M]N_M;[=??;/,W^=YD&[.,8Q]GV[=OR[,;-GR;=O%=?X
MH^'C>);3[#/>W01E=963[.DDJL0=KE;?  'RX0(&4D/NR:ROAG\$X?AR2+*Z
MNC$S;GAD:%XF;:5W8$(93TR492VU0VX "LJY_9RM[G4/[7:]O1>AE;S5:V0Y
M50@^5;8)C8-I&,,,A@03FW\7/@+;?$>"-99"EW$JJMUL5G91]Y9%7RU8'E@!
MM",<KA2RMQ7@/]C>RT&<7%].;L(RLD?EB*(D9_U@+2%QG! RHXPP=217I_Q>
M^&W_  L6Q-AY[V^9$?<HW*=I^ZZY7>O.0,C#A6YVX/5Z3I_]G0QP;WD\N-$W
MR-ND;: -S-@98XRQ[G)JIXK\,P^*+66QN1F*:-D;A21GHR[@P#*<,I(.& /:
MO-?AK\#;WP;']D;59GL_F/D1Q)"<L06 E9I9$4C=D1&-@S%U=6R34\'?LQP^
M$=0FO;.[FBMY8V3R$"APC,C-'YS%GV_+@% DJC&)=P+-;\2?LT6WB6Z%_=7U
M\]RNS9()($*;.5V!+=0F#\PV@?,2WWB2>J\8_#$>+[(:?=W=R8C_ *P@6RO+
M\ZR)N(M\#:5&/+"9'WMW6JO@OX,V_A6UDTY;BYFLY8Y4:"9XR@$G#[62))%R
M,\!PN69L;CNKSK2_V2WT&=FT[5;JVMW:/?&F5E95Z@R1R(I/+;28R%W=&YS?
M?]D^U746O[>YFM(A&BPQ6O[F2,K&D1/G$N6W ,6^4,Q<EF/.[W"TMA:HL:Y(
M50H+,SM@# RSDLQ]2Q))Y))K$\=>!;7QQ:O97J;HVY!'#HPSMD0X.&&>#R""
M58%20?!;;]AZV6?=)>R-;[FQ&L2K+MYV#S"S+D<9/EX;!P%SQ[!XO^#MEK^D
MG18T$$*JODE5#&)U.5<;N22<[SD,X9P7!8M6)X.^"MQIEJ=.U#49KNR$?EK
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MQ(^/)!9F+ %BV1DDKD]AX!^%L/A226\DD>YOKC'GW,NW>< 91 H CBR,A!G
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M,54(K %TQ\@V.O*.N 5^]NZ_7_A?;>);)[#4&DN1(VXRR%?-5\;5=-B+'&5
MP B*I^;>K%Y"WBMM^P];+/NDO9&M]S8C6)5EV\[!YA9ER.,GR\-@X"YX^BM
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M#8!('#-GA?V*?^0//_U_R?\ HF"O?Z***BN[M+-&EE8(B*69F(554#)8D\
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MPJ[BH+,<*H)&6('>O/\ ]GS_ (O)?7>HZY_I)M_+\F!_FM8_.#AML397A8E
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MM?.MG-_POC5KRWDG?^Q['RT$,4FP7#EP=SE-XDB)B?:0RD+Y;)M8N:Q?BYX
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M^60_*) F0IVY&3Y?\-/@E/\ $[P_;K=7AAAC:3[+'&NY ?/D\V68$@R.265
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M! +8WJ*]E\1>)H?#ZQO.<>;<00( 5W,\LBQJ "1G&2S8R0BL0#C%?-7[<_\
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MNA'DN>">"R$COC&0#P/&OC5I<FI^,M*CA7<PCM9",@?+'<32R'DCHB$XZG&
M"<"N@_;6_P"0/!_U_P ?_HF>O5?A/_R!]/\ ^O"T_P#1*5U5?*OQ]_Y'#2?^
MW#_TLDKZ ^+'_('U#_KPN_\ T2]>5?L4_P#('G_Z_P"3_P!$P5RG_-0_\_\
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MJVHC6=&GCAN#-'*8Y%Q&)$Y,JE$?)+*K%60[F+L7YVU4^,'[/6L_$,P7$MW
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M;(2X3'S@,-A7! 'W<@ZWQK^ \WQ2DB,EVD,4&_RU%NSO\XCW[F-P W*9&%7
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M-K9X($(.6"  N"@?^*/Y4([KX=_"M]#N[C6-0E$^HW2JKLBF.&- $_=(N26
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M111111111111117B'@GX4^(;&]E;4-5,EE(SEE1F\UQD[54,F+4$,2WD,"N
MJ$$*Z>U6EHEFBQ1*$1%"JJ@*JJ!@* .  . !P!4M%%%%%%%%%%%%%%%96A>'
METK<[.\TSXWS2;/,8+G8OR*B*JY.U455R6<@N[LVK1111111111111111111
M11111111117FOQS\':EXWLGTVQ%LL4OEF22:24.-K[]JHD3#JJ_,6/&Y=G1J
M/@9X.U+P19)IM\+9HHO,,<D,DI<[GW[61XE'5F^8,.-J[.K5Z511117BLOPS
M\1G69+Q-4V6,DA^0?,ZQ<$1I#)&\"L,!!)G<1F0@EF0^P:7I<>E1K#"NU%SW
M+$DDLS,S$LS,Q+,S$LS$LQ))-6J****************************X_P"*
M6DW^N64MEIRP9N(9(G>>21 BN I*K'$^XE2V,LH4[3AQD5Q7[/WPSU7X;1/9
M77V62WDF,N^.67S58H%(VM"%<'8F/F0K\QRW 'LM%%%%5=6MY+F&2."3RI6C
M<))M#[&((5]IX;!P<'@XP:\?^%OPGUK3_,AUZ_\ M-HW/D!VF\PG&1))-&L@
MBPHS$IV29(?Y"ZR>U4444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444455U35H=(C:>YD2*)<;GD9409( RS$ 9) &>Y JU1145W=I9HTLK!
M$12S,Q"JJ@9+$G@ #DD\ 5+45I=I>(LL3!T=0RLI#*RD9# C@@CD$<$5+111
M11111165_P )99_:/L/VB'[5_P \/,3SON[_ +F=WW?FZ?=YZ5JT44444444
M44444444444444445%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %1:7JT.KQK/;
M2)+$V=KQLKH<$@X920<$$''<$5#HGB&VUY#+9S1SH&*EHG610P )4E"1G!!Q
MUP1ZUH4444444444444444444444444444444444444455U35H=(C:>YD2*)
M<;GD9409( RS$ 9) &>Y JU6?K?B&VT%!+>31P(6"AI76-2Q!(4%R!G )QUP
M#Z46WB&VNH/MD<T;6X5F,RNIBVKG>V\';@8.3G P<]*MVEVEXBRQ,'1U#*RD
M,K*1D,"."".01P14M%%%%%%%%%5;?5H;F22".1&EBV^8@92Z;AE-R@Y7(Y&<
M9'(JU1572]6AU>-9[:1)8FSM>-E=#@D'#*2#@@@X[@BK5%%%%%5=4U:'2(VG
MN9$BB7&YY&5$&2 ,LQ &20!GN0*EM+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BI
M:J_VM#YWV7S$\_R_,\K<OF;,[=^W.[;NXW8QGC.:M444444445GZWXAMM!02
MWDT<"%@H:5UC4L02%!<@9P"<=< ^E:%%%%%%%%%%%%%%%%%%%%%5=+U:'5XU
MGMI$EB;.UXV5T."0<,I(.""#CN"*+?5H;F22".1&EBV^8@92Z;AE-R@Y7(Y&
M<9'(JU1111111111111111573]6AU'?Y$B2>7(T;[&5MKKC<C8)PPR,J>1W%
M&J:M#I$;3W,B11+C<\C*B#) &68@#)( SW(%6J**************JZIJT.D1
MM/<R)%$N-SR,J(,D 99B ,D@#/<@5:HHHHHHHHHHHHHHHJKI>K0ZO&L]M(DL
M39VO&RNAP2#AE)!P00<=P15JBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBN/^*OQ,@^'-DU]< N=P2.->"\A!*KG!"C"DECT .
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MS8&XJI8JI/4@%F('0%CCJ:^<--\<77C'Q7-I&H0/)8Q^>BV[C]R@14*W$BA
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M -UJ6H6NN76H/]NBD5YE1?W&T-G[/#\R-'%M+(Q;>9-Q=E!9@?:J^5?VY_\
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MQOL=7U_4[#3K:.0Z5*RFZ:(L@9=Y$\<KJP*IY/W5)42%B!O8*%Y3]I[P=;>
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MP?\ 7_'_ .B9Z]5^$_\ R!]/_P"O"T_]$I7S_P#L,?\ ,1_[=/\ VXH^/O\
MR.&D_P#;A_Z625;N_&,?@;QQ<2WH\N"ZMXHA*^4108H=LF=I!7S(O+)R%4DE
MF 0BOI^O.O%WQRLO#VEG5QF6-II8854@^;(CR1C#*64(?*9@_P#<Y +$(:O@
M7P]<^-;:'4M9G+B>$2+:0EH;-4D6-@KJ#OG)4?.LK/'\[H$*\GR3]AC_ )B/
M_;I_[<4?\U#_ ,_] ZNK_;6_Y \'_7_'_P"B9ZZK3?#-CXK\/Z;IVHC*W%I:
MI%@'>)5M3(&1L':P1'()^4@%3D-M;Q7Q?\%=9^#'F:GH5T[VR_-(H'[Q5^<
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MJBL[L< (K'DX!\5_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\
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M_;G_ .8=_P!O?_MO7U5117@'[:W_ "!X/^O^/_T3/7JOPG_Y ^G_ /7A:?\
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M?MS_ /,._P"WO_VWKZJHKY5_;G_YAW_;W_[;U] ?%C_D#ZA_UX7?_HEZ^6O
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M02,L0.]>*_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2OG_\ 88_YB/\
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MRD?/%Y<T9P6;;DMC[PVGI[KX2^'LFB>;=3W'VK4I8]ANI(P%51_JXTB1E"1
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MMY."VU6\E65]JG[WRY);"*.ON'PK^%@\"I*\MQ)=W=PRF>XE+;G" K$H#,^
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M9H3'(3;F:7#9#X8SH@#(=N"A(Y(8'&WE?A%\&;WX:(UO#?1RV[S+(Z/:D-G
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M\B1)/+D:-]C*VUUQN1L$X89&5/([BK5%%%%5=4U:'2(VGN9$BB7&YY&5$&2
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M9=CE,AL;XVZ_*VU<D8<8^5ER<]+K^OP>'H'N[MQ'#&NYW;H!T[<DDX  R6)
M )(%<_\ "3QP_CG38=1D01F9IL(I)"JLTB(,GJ=JC)P 3D@*#@=A117 ?'3P
MQ!K>DW;3ASY5I<2(HEE1-RH74LB.JR89%(#A@".!R<^?_L4_\@>?_K_D_P#1
M,%>_U\@?MI^&(-,FL[F,/YL_VGS&>667A3&RJHD=@B@R,0J!5&>!TKZUU;2X
M]7ADMIUW12QO&ZY(RK JPR"",@D9!!]#7/\ PU^&MK\.[7[%9;RAD:1FD;<[
M,V!DX"J/E55 4 8 )!))/545\@?%SPQ!X?\ %VF+;A_WDEA([22RS.S?:63)
M>5W;[J* ,X  P*^OZ*XK_A4-C_:_]OX?[7Y>W[Y\O.SR_,V]=WE_)C.S'.W?
M\U<5^UAX8@O=&GO) YEA\CR_WLHC4F94+>6'$1;;(R[BI;!QG@8U?V7/^1=L
M_P#MX_\ 2B6N@\+_  AL?#6H7.K6X?[1=9WY<E%W,'DVC_;<!CN+8(PFU<BJ
MOQL^*\?PWL6N,HUR_P MO$Q/SMD9.%YVH#N;[H/";E9U-=_1111111111111
M1111111111117 ?$KXKQ^$KBRL8RCW5Y=V\>PDY2)Y KRD#_ +Y3)&6)(W!&
M6N_HHHHHHK@-=^*\=GK-GH<!1Y9O.:XY):)5A>2,8'&YR >3D(.5^=6'?T44
M4444445P'P]^*\?CB^O[>U*/;6GV=4E4EO,9Q+YASP-H*!5QD'!<,RLH'DG[
M9_@VUAM(]3"'[4]S%$7,DC#R_*F;8$+%%&Y0?E4<Y/5FS[A\)_\ D#Z?_P!>
M%I_Z)2NJHHHHHHHHHHK@-=^*\=GK-GH<!1Y9O.:XY):)5A>2,8'&YR >3D(.
M5^=6':ZMI<>KPR6TZ[HI8WC=<D95@589!!&02,@@^AKG_AK\-;7X=VOV*RWE
M#(TC-(VYV9L#)P%4?*JJ H P 2"22<K2_BO'K&N2:+;%'2"T>2:0$DB42QIY
M0Z+\JL2^-WS$+\I1@>_HHHK@/B5\5X_"5Q96,91[J\N[>/82<I$\@5Y2!_WR
MF2,L21N",M=+XO\ !MKXP@-I?(9(2RL4$DD8)'(SY;*6 /.#D9 .,@$?-_[#
M'_,1_P"W3_VXKZJHHJ*[NTLT:65@B(I9F8A550,EB3P !R2> *XKX2?$P?$.
M*ZN8P!#'>R0PD;LO&B1E9#N (+%BV,#:"%.2"Q[JN5^)7PUM?B):_8KW>$$B
MR*T;;75ER,C(93\K,I# C!) ! (Z#2=+CTB&.V@7;%%&D:+DG"J JC)))P !
MDDGU-6J***^0/VT_#$&F36=S&'\V?[3YC/+++PIC9542.P109&(5 JC/ Z5]
M:ZMI<>KPR6TZ[HI8WC=<D95@589!!&02,@@^AKG_ (:_#6U^'=K]BLMY0R-(
MS2-N=F; R<!5'RJJ@* , $@DDGJJ*****X#XV?%>/X;V+7&4:Y?Y;>)B?G;(
MR<+SM0'<WW0>$W*SJ:[75-,74XVAD+A6QDQR20OP0>'B9''3G!&1D'@D5\J_
MLV:7'I'BK4K:!=L44=Y&BY)PJW42J,DDG  &22?4U]:4444444445Q7PV^$-
MC\.O/^P!Q]HD#-O<O@+G9&O3Y5W-@G+G/S,V!CM:**BN[872-&V0&4J2K,C8
M(P<,A#*?0J00>00:^2M!T&+0?'PM[<$(&=OF=Y&+/8M([%I&9V)=B222<FOI
M#XE?#6U^(EK]BO=X02+(K1MM=67(R,AE/RLRD,",$D $ CH-)TN/2(8[:!=L
M44:1HN2<*H"J,DDG  &22?4U:HHHHHK@/B5\5X_"5Q96,91[J\N[>/82<I$\
M@5Y2!_WRF2,L21N",M'QT\,0:WI-VTX<^5:7$B*)943<J%U+(CJLF&12 X8
MC@<G/G_[%/\ R!Y_^O\ D_\ 1,%>_P!%%%%%%%%%%<U\1?'D'@6REOKDC"*?
M+0G:9),$I$,!CEB.H!VC+'Y5)%OP1K;Z]86MY* 'GMH)6"Y"AGC5R!DDXR>,
MDG'<UM4445\@?MI^&(-,FL[F,/YL_P!I\QGEEEX4QLJJ)'8(H,C$*@51G@=*
M^JO$WAB#Q+";:Z#F)L[E266'<""I5C$Z%E()!4DJ>XX%?-7[#'_,1_[=/_;B
MOJJBBLKQ-X8@\2PFVN@YB;.Y4EEAW @J58Q.A92"05)*GN.!7S5^PQ_S$?\
MMT_]N*^I;NV%TC1MD!E*DJS(V",'#(0RGT*D$'D$&ODK0=!BT'Q\+>W!"!G;
MYG>1BSV+2.Q:1F=B78DDDG)KZZHHHHJ*[NTLT:65@B(I9F8A550,EB3P !R2
M> *XKX2?$P?$.*ZN8P!#'>R0PD;LO&B1E9#N (+%BV,#:"%.2"Q^=?BGX-M?
M"OBW3([-"HEFLI9"TDDK-(UVX9RTK.Q)VC//7GJ37V)1117 :[\5X[/6;/0X
M"CRS><UQR2T2K"\D8P.-SD \G(0<K\ZL._K/UOP];:\@BO(8YT#!@LJ+(H8
M@, X(S@D9ZX)]:^1?@;X L;WQ1?V<T"26]M]L\J.0&1%V7"Q+D.3OPC$#?NY
MPWW@"/L6TM$LT6*)0B(H554!550,!0!P !P . *EHHHKBO%'PAL?$NH6VK7
M?[1:XV8<A&VL7CW#_8<EAM*Y)P^Y<"NUK*\3>&(/$L)MKH.8FSN5)98=P(*E
M6,3H64@D%22I[C@5\U?L,?\ ,1_[=/\ VXKZJHHHHHHHHHK*\3>&(/$L)MKH
M.8FSN5)98=P(*E6,3H64@D%22I[C@5\U?L,?\Q'_ +=/_;BOJJBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBOD7XSQW>C>)=.M1=3W0>:QG6.XE"Q>;Y[1+A88ECC&$ ++&6^9C\
MQ)!ZOXJ_LU3W,#:I!?75QJD"B0,YR&*9D9(5C7?$=Y+1(I8*<(,9WC:_9]^*
M]UXOT6=%/G:E9QNJ^8<^:2K-;%F.P<D&-LON.PN[ OFHO@I\-7\564]WXHMC
M-=W$TBAKE3YJPXX5%;!MQYC2%0@C/(8?*$-<_P#LRZ_/H^KW_AU7+V5LURT(
M?YG0QW"Q\$8 #!MS#&-WS*%);=B_MEPW&D-;XN[EXKKSP\#.JP 1O&Z*$C1
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MN[EXKKSP\#.JP 1O&Z*$C1 <%S\S[W^5<M\M>E?M8>&(+W1I[R0.98?(\O\
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MO&4+#!7YMY)CWR9WX/G6E>?9^.HK.:YGN4A:9D,[[RIELC(^T*%1!N. $50
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M5#LF\;2:Q?\ AEW2KZ'%_P"==7C1XDO'FF\YFQ@. 79!MX"!@P"JH;?@DR_
M^WUKPU!=0^(G!B@;=#<O*KED^<RLSEMVP8#*9 K ,0> %7BO .C#X_2W.IZH
M\C:?%<^7:V:NT4>%1COE1"<OME4[UDSNWJ?W85:Y_P"(%E<_LZWL%YI)D?3)
MV?S+:1V:(.3EDSMPA,87RG):3]VVXL@(;W#XO0MJFDSW=I=S0K':33HUL\:B
M3:GFQGS-C/M^4?ZMTW*Q!)!&/)/V6O#1\9Z5=?;Y9)(9+V;?&LDL;2.\47F/
M+(CAY 5.-F0I)=I!(2GE\UX#TN;P'XNN-$TZ7RX+C<I.UGV(8OM2;59RIE1<
MQI))O RS,C!BIU?VE_AS!X#MK?5["6Y6^^T)"]PUQ*\T@,#@NS,Q(;$>/DV+
MM9EVXVA>P^,FJW>H^&X];CNY[>7[-92F*W<11%Y60.20IF(Q*0%\S;\JD@D9
M//\ P?\ A(?B)H%K'>W4\5H%F5(+>155S]IE=I)=T9W'=M")\P0)O#;I"JXO
MPHUF\^#VO#P]?S/)9S82$G>(LR'=#(BE6QN<F-PA"!V8LS>7FN_\6Z-JGBOQ
M+%9W<+MHD4?F%1D6\F$W RX;$C"X"@1-G"J&\O:79N%_:%M$^#VHV6K:(HMY
M9EF66)0!;NL?E?*8UP &#?,!@9577;("Y]U^-.G2W&F7,T-S/;F"VGE'D,B%
MV1/,0,Q1I  4Y\MD)!8,2#QXU^S#X4;QMI<YOIYF@:_G,D2.\9F9X(UD,TBM
MYCJ0P(0% 6W&0R J$Q/ NF-X0\5S>'899/L$S2'RUEGAV!H5ND*F.4,'78L9
M?)+H&!^]@&@QWGA_Q0-&U6]O7M79_)+7MQ$'5D9H"6!0N21Y9"% 9N 2%*M]
M ?%K2#JL4$,<T\,\MS#%&T$TL#;2ZR7!^5@A(MXI67S P!&%&Y@&[#2],73(
MUAC+E5S@R223/R2>7E9W/7C).!@#@ 5:HKX[^,_@ZWTGQ7IT,/F 3-8M(S3S
MO*6-RT>[S7D:0$(B@$,"N!MP>:^G[OP.&MFM+>YNH [$M(L[338*[2HDNA.R
M#H1LVE6&5().?E7]G'0KWXD'4(;B[D6"5;?[7(&+7<H"RK%$)'W!4(SYA()*
MJL8^5FQJ_%GX>7?P<T:$VVI71?[:4'ER2V\0CDC9]OEB5U!#QE@RE<[VW X4
MCZ \+Z0?%FB62W$TZN]E;L9HII8IM[0#+ET8%CEBV'W*6P64XKR7]C7Q9>>(
M/M_VVXFGV?9=GFR/+MSY^[&\G&<#..N!Z54T)K+XM>(+^SUYO,-M))#8VP=X
MH]J2.)7&P@M+A%9OFRP+':51?+]*\-_!=?"VI;[1YAI[V%Q"(3-)M@=Y(&/E
M,9/,7S &8E>5=2=_S(%\0MO!UO:^.OL,?F+$69B5GG$NYK(RNWFB3S<ER23O
MR<D'@XKZZTO3%TR-88RY5<X,DDDS\DGEY6=SUXR3@8 X %<S\6OB G@'3IKY
ML%U7;"IQ\\K<(N-RE@#\SA3NV*Q'2O,/!/P!M_'5C'J6O2375Y=VX<2&9@L*
MR%Y(Q$H"JN%D!*,'C5P0J[<@XGPS\6WOPUUX^&;V0R64C8M9)G.Y$V$P!'95
M# A1$44!1*,1X(8/H?MA0W&F6*7<5W<JLEP(&@5U2#8\+EP0B*[Y\L?ZQW W
M,  #BJND_ &Z\?:;IUY<:@\-Q%;VYMA$N888A&GEX&Y'\\X5WEW?>^15VHA'
MTI7@'C/6Y/BGKK>'+>X>&QM[>1KQH7"22-C8T8<>8&53(BNC!1GS0P)5,97Q
M>^"*_#NW.M>&C-;3V^PRHDDCJT0;+L58.S8;8SJS>5Y:,67(Y]*\!:W!\9=&
MBFO%QOWI/%#-+&-R[D9&\IU;:RG?Y;DC:RYW8#'PK]C7PS%K?V_S6F79]EQY
M5Q<6_7S\Y\B2/=TXW9QSC&3GT#]M;_D#P?\ 7_'_ .B9ZU="^#T'CK0;2._D
M=Y&L(/)(:5(83]G"Q,(4E5'9=V69\L[%AE8RL:<_^R%\1Y-1T^YMKU_W=CY9
M661P L3*_P A) PJ>6Q!9CA6"C:J 55\-ZOI?Q5C.H>)+R%5>1_(T\W@BBA1
M3M1W0-$YG^_ER2&1QA5&U5Q/"7BJV^%_B&/3M)N1<Z5?M'F-'6=899&:- KA
M^H8+N).XQ, P=E1JB_;+AN-(:WQ=W+Q77GAX&=5@ C>-T4)&B X+GYGWO\JY
M;Y:]*;X W6I:A:ZY=:@_VZ*17F5%_<;0V?L\/S(T<6TLC%MYDW%V4%F!]JKP
M7Q7XUMO&>K7.E7U['::;9JBR*MTL#W4K@;XV8XS"J[XY8U8,&(+$G 3SKXFI
MI?PODM]8\*W<(F6012VR3BY21&#.68>:S[?E"L,XR492CJ&;U#X]:K+J.@_V
MW8W=U;CR;66.*-TB!\UT&7**9"=DN"HDV953@D9.5\!_AK%XPT"U&HR226VV
MX5;9'>&'_CY9M\GEL'E<.ORDL$52 (]X+MS/[,=W<:;JFH^')9GEM8HYU4[I
M$*F*?RB8]LG[K?YK,VT[MP4ALC)Q;;P=;VOCK[#'YBQ%F8E9YQ+N:R,KMYHD
M\W)<DD[\G)!X.*]_^*GAM[32+C[+=74 M[:XE!28M([*IE4/+,))\!EQ\LBD
MJ2I.W ' ?LDVYU_1KH7+R,9=1E9W666.4MY<#%O,C99,D]2&R>0<@FO/_@-X
M.MV\3ZE9+YD<,*WBQB*>>%@J74:*I>*178!>S,03@G) -=5^T]X:OO!\$6H:
M5=WL<(;RYT^UW4@!/,<GSNQ4$Y1B6 R8PJY))]E^%\<&JZ3!)%),Z7%NK.SW
M4L\H9D"R#S=P965@0?+\L*X)54.157X1>'A# ;XS7,OVB2=X?.N)ID%N\I-M
MM21R!F$(V7!E!9@Q'*COZ^._C/X.M])\5Z=##Y@$S6+2,T\[REC<M'N\UY&D
M!"(H!# K@;<'FOK31-#CT9#'$9&!8MF6::=LX X:9W8#CH#C.3C).?E#]C71
M&UC[?&TKI#_HI=8V>*1S^_V#S49711R6"89CM!<('230GMA\&/%EO::=D6=\
MMNKV^YMH$CM ,LYD+%9%,H/!PQC!"DD^@?&^QU?7]3L-.MHY#I4K*;IHBR!E
MWD3QRNK JGD_=4E1(6(&]@H7E/VGO!UMX"BM-;TA!9W<=RL0,"K&A5DE?+(%
MVD_+M/&&5F5PR[0/0/'EG'XY\-&^O =YTIKC:DDT<7F& 3 E%D"N%=05$F_&
M/<YX7]CGPS%?Z;)<.TP=+]\!+BXCC.V.!ANCCD6-^3SN4[A\IR !7TI7SK^V
M%#<:98I=Q7=RJR7 @:!75(-CPN7!"(KOGRQ_K'<#<P  .*Z76?%\_@_P?#?6
MA FCTZQ"%AN +B&/=@\$@,2,Y&0,@C(.!\)?@SH?C+3H=05I);UUW370GF%P
MER?G=OO!0Z.<H64Y 5SO#;F]4^$WAF?PQIZ6EVYDE2:ZW2,<M(&N9764_,_+
MJP<@DD$X;D&NPKYK\%:9_P -!7MSJ.H&;^R89%CMK0R;49PAR[^6P(8!]Q[Y
MD""1DC*MYU^U7X '@I[."U8BP99VA@9VD\J3,?G[2X+!&_=L 7;YS(0%SS]/
M_&G3I;C3+F:&YGMS!;3RCR&1"[(GF(&8HT@ *<^6R$@L&)!X\Z_9 EDU/1[I
MGD?S9+^<F7(:3<T,.9,R!P6R<Y8,">H/(KSK5+?44\8KI]M>R221M)Y,MT?.
M$7G6GF3.L:A(P0&)1%54)5%8;0:[K5O!G_"@%OM=@NWN/.C5$M[@_,\SR(1(
M[JP\UE_>/@(K;"XW#YF)_P (-X;UZ'?K6I0W=\\?SSM?I^[9AEEA4,D:Q+(6
M:-6C(&<$$?*#]ESXAR/<77AZ6;[3':;S:S@ AHHY/*(W!VROS(T0&["EEW[0
M@&KIEK_PNZ^NWN)';1;63[/%#&^R.YE #222-%(6=58*T?12"A7!$@:AXS^"
ME[X%G@OO!R%#NQ<VQG)BD R49EF<!AAG5OGRN5:,*VYQPG[:?AB#3)K.YC#^
M;/\ :?,9Y99>%,;*JB1V"*#(Q"H%49X'2OJK0O#,6B;O*:9M^,^;<7%QTSC'
MGR2;>O.W&>,YP,?,OP-MA=>+=8C;(#+J"DJS(V#=Q@X9"&4^A4@@\@@U4^(T
M=YX$\0V]O<WM[_95S-$RYO;A%5&8+(C2L> C'+ $MY17,BLV\?0OQ/TX1:7)
M'$\R2K&([9DGF20SN/)MPTBN&;,KJ"9&*DG=(>"PZ#PSX=7P_"($DFEQ@EYY
M9)Y&. "Q:1CC.,[5VH"20HR:U:^=;.;_ (7QJUY;R3O_ &/8^6@ABDV"X<N#
MN<IO$D1,3[2&4A?+9-K%S6+\7/ $OP1,>M>'6DCA\Y5N8"[R08VXCW*1DH3O
M#%W)5Y%\LJ2,>Z:?>#XC:9#<03R6PN(5=FMWB9UW(0\6]XWP58D%E"NK+P5(
M(KY@_9QT*]^)!U"&XNY%@E6W^UR!BUW* LJQ1"1]P5",^82"2JK&/E9L?2OP
M:^&;_#FR-@]P;D><[HQ4QA%8+\@4N^!N#-P0"6)QG)/2^)M#;6X3 D\UONR"
M\!C63!!!4-)')MZYW+M<$ AASGYU_8LU:;5Y-3GN9'EE;['N>1F=S@3@99B2
M<  #/8 5B?&>WN]+\2Z=9B]GF$DUC,HN"'B67SVB5A%"((\ *,A0K'+?,"Q-
M=7^T;\)8M)TUM8CGG:_MIHG^TR2N\I5IB BA62.(*\H9/+10NW  W$UU7@OX
MNOI?A2+6[U3,\<)4@$[I&68V\99G+'+$*9&Y.2S!3PM8'PN^!D7CBT35O$AD
MO+JZ42('E=5BB8L\:IY4@ #!M^WA4#!0BD-N\_\ !NDSZ1XZ2WNI3.\;2*)&
M.YVC%DWD[SM7<XBV!SCE@3DYR>Z_;"AN-,L4NXKNY59+@0- KJD&QX7+@A$5
MWSY8_P!8[@;F  !Q7JOP[LFO=#L8XY7A8V%GB2,1EUQ%&>!*DB<XP<J>"<8.
M"/FKX8Z;J&L^)+ZPCO9L1QW-N]Q*[2W2VT=R@*Q,W"RDX ;&$W.ZKN"BNVU#
M0)/V?;62"QO4=]1NXHK?[01&EL/G#W##+*^U3&'?8J@A&92,(9=?^%_A/68'
M634HWO'7B]EODFGW#[A8&58V  "8V@[!@$-\PM_L_?'LWVD74VJN6?3E4M(=
MH:2-E/E+EG&^8LC(,[=Q*9+.S&K_ (%^$R_$JU35O$N^XFN?WL,/F21P6\38
MV+&L4G\:!68D[C\H8;P[--X$^'NK?#_6C;V>7T&16(5Y1)Y!*NX5%=@ZGS<C
MY0P9'!<LXW+Y5\9_!UOI/BO3H8?, F:Q:1FGG>4L;EH]WFO(T@(1% (8%<#;
M@\U]%>/M#CT;1-1CB,C V5VV99IIVSY##AIG=@..@.,Y.,DY\O\ V/M,74]#
MN(9"X5K]\F.22%^(K<\/$R..G.",C(/!(KC]!CO/#_B@:-JM[>O:NS^26O;B
M(.K(S0$L"A<DCRR$* S< D*5;Z ^+6D'58H(8YIX9Y;F&*-H)I8&VEUDN#\K
M!"1;Q2LOF!@",*-S -V&EZ8NF1K#&7*KG!DDDF?DD\O*SN>O&2<# '  JIXK
M\30^%[66^N3B*&-G;E03CHJ[BH+,<*H)&6('>O'_  +\)E^)5JFK>)=]Q-<_
MO88?,DC@MXFQL6-8I/XT"LQ)W'Y0PWAV:;P)\/=6^'^M&WL\OH,BL0KRB3R"
M5=PJ*[!U/FY'RA@R."Y9QN7/\9ZW)\4]=;PY;W#PV-O;R->-"X221L;&C#CS
M RJ9$5T8*,^:&!*IC*^+WP17X=VYUKPT9K:>WV&5$DD=6B#9=BK!V;#;&=6;
MRO+1BRY'/JOPP\;-\3=(CNUD^SSOE9# 8W:-T?! $J2*NY0&VNK$(XP2</7S
M_P#"'3;K6?$FHV+7MSB*WN[?SV?S+H1)<HH5)'R$;."6"G&6V*K,'0_:#T$?
M!_4K35-(=XVG\PRH9)G\QHY$D<R.TI=UDWJ'0D [<Y);CJ_VT?#$"6,-_AS.
M;M(\F65D56AD+!8V<QIDQH254$D9)))SZ5\*_!JKI-I)!/<Q2R6%KEQ/)*%R
MD;G9%<&:!>F!B/Y5)"[:^?\ X8Z;J&L^)+ZPCO9L1QW-N]Q*[2W2VT=R@*Q,
MW"RDX ;&$W.ZKN"BNP\0:<?V;=.NOLEV99+V9%M(W1?W1&[S)2#)AR(RH9P@
M&\1!D*G ZNW_ &4M/U.V_P")I)//?R+&9;HSN\@<*@94+KM*?*0OF(S!3C(P
MNW$_9Y^(^H6>H7'AK67\R:'S#%+([>:Q5AE 9 &E5E8RQD_,$!/*;0G/_MS_
M /,._P"WO_VWKZJKY5_88_YB/_;I_P"W%= OBS3_ (H75U_;%]#%I]O<-!!:
M+>+"EP$Y:XEP4:12VQH2K!5*D8/S,_%>)/$.G_!C5+>]\/W22V5Q\MW:Q2K<
MJJH4!(/F$[B'+1[B"KAAN,;,@]@_:/\ B'<>'K>'3M/#B^U"3R875E39AHPW
MS-T9MX53\NW)?>I49AMOV:[72(//M))/[856=+YI9 [3G+;G4ET*,Q*NI1R8
MR02S$L?.OV&/^8C_ -NG_MQ7U57R!XIM[JY\=O'82)%<-M"R.N]4!L '<+_$
MP3<4!^4N%#?+FM7XV?L_3>$X6UW3+R\DNH?FF>21GN"A CWI)&JL-J_?W<>7
MD[E"X;T#PEJC_&?05GBGF@U"..2(R132P 7"A3N<1!497^1B-C;%=E0A@37'
M_LFZY-K4]W%J=Q=/>6S+MCFNIB IWQR P,PR5; <ON"EDP$89;U77_"JZYJZ
M*L]TB);/+<1Q75Q#&6=DBM05610 1'.W[K:=R R'Y@']%K@/CIX8@UO2;MIP
MY\JTN)$42RHFY4+J61'59,,BD!PP!' Y.?*OV.?#,5_ILEP[3!TOWP$N+B.,
M[8X&&Z..18WY/.Y3N'RG( %8G[1"NWBW2Q$0KE;':S*74-]KEP2H92P!Z@,I
M(XR.M=+^TO\ "N#3].;689)OMUM) WVAY97D8&3;A1O$<7[R3S!Y:*JD;450
M>.KTOX@ZGXB\++J=@F_4#;D 85RS)(8I954!5+%5:14 (W80*_1L_P"'?P1@
M\1:*JZ[;EK^Y5VFGE.Z\4[L0D2/N="L:Q_)T&"KIRX//_L?^,;GQ1976G7;E
MXK985B8,RRJD@E!0.K!@%V#800R9P&P$"\5;>#K>U\=?88_,6(LS$K/.)=S6
M1E=O-$GFY+DDG?DY(/!Q7UUI>F+ID:PQERJYP9)))GY)/+RL[GKQDG P!P *
MM5\J_ +_ )'#5O\ M_\ _2R.O2_VG(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,RH
M)3\LA^42!,A3MR,GFO@/\-8O&&@6HU&222VVW"K;([PP_P#'RS;Y/+8/*X=?
ME)8(JD 1[P7;G_V6-4N="U>_T!Y3+;VZS;-Q;"M#<>7E%+E4#^8S.!DDA>>#
MF70FLOBUX@O[/7F\PVTDD-C;!WBCVI(XE<;""TN$5F^;+ L=I5%\OU#PA\(!
MX,U59[)I/L'V*>-8'D:2."1I8'/E[W+ 2;69A@X922WS*H\:^+D-QI'BC3+2
M2[N;B)[BPG*S.NP/]H:+*QQ)'$ORKV0')8DG)KU7]H_XAW'AZWAT[3PXOM0D
M\F%U94V8:,-\S=&;>%4_+MR7WJ5&8;;]FNUTB#S[223^V%5G2^:60.TYRVYU
M)="C,2KJ4<F,D$LQ+'SK]AC_ )B/_;I_[<5T"^+-/^*%U=?VQ?0Q:?;W#006
MBWBPI<!.6N)<%&D4ML:$JP52I&#\S/Q7B3Q#I_P8U2WO?#]TDME<?+=VL4JW
M*JJ% 2#YA.XART>X@JX8;C&S(/8/VG(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,R
MH)3\LA^42!,A3MR,GR_X:?!*?XG>'[=;J\,,,;2?98XUW(#Y\GFRS D&1R2R
MH%91&H!Y+N*^G_#VFOI=M#;RR&9XX8T:5L[I&50I<Y+'+$9.23D]3UKR#XO^
M-I]:U:S\,:=.8&F;S+N6-MDJQJ#)Y:.NYD<HC,05&<Q?-L9P<KQY^S%:Z%9&
M[T$SPZA;0LR.DLF^4@ /G:&;>R!PHB\L%GP1MX'5?L_?%&7XEZ8YN'"7<3&)
MWC*;^4!2?8RLJDY. 5*%D8@;?D7Q75+?44\8KI]M>R221M)Y,MT?.$7G6GF3
M.L:A(P0&)1%54)5%8;0:]O\ AE\"?^$ U"XOHKR::*XC(:*7YG+EE;S7D# .
MV=^"4! <\GDMZK7Q7^REX7NO$OVVWAN7M;;_ $8SO"=ETQ'G>4D;X(1<Y:0X
M+':J#Y68U:\>>#KK]G:^M[_39II+&61=Z%L;B@^:&4A/*.Y68Q-MW+\Y5<IO
M;J_VDX+NPM8-=T6\O%M9L&55N+K8!+\\4H1C^[4Y*D$JJDQJJ DU[5\+XX-5
MTF"2*29TN+=6=GNI9Y0S(%D'F[@RLK @^7Y85P2JH<BJOPB\/"& WQFN9?M$
MD[P^=<33(+=Y2;;:DCD#,(1LN#*"S!B.5'?T444444444444444444444444
M44444444444444444444444444444444444444444444444445\J_'W_ )'#
M2?\ MP_]+)*^I;N[2S1I96"(BEF9B%55 R6)/  '))X KY*_90UM/!6G:GK%
MX"+56MU#+AF9TWY0+G.<S1@$X7+<L &(];^&TUY\5K=-5OIW@M7D<P6EK(\/
MRHTL>Z:9=LSMD_=1DC^16*DL57R_]G>T2S\6ZI%$H1$6^554!551=Q * .
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MZK117RK\??\ D<-)_P"W#_TLDKZJKY5_88_YB/\ VZ?^W%=7^VM_R!X/^O\
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M=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %>/_M!:VFO>%)KR($)/#9RJ&P&"O-
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MD>Q3<_)C;AMQDW=1MZ5#\+/AM>^ ;0V O(YHE63R=UL49'<[ADK<?.@8L2N
MQ+8$B@ #E?"W[/E[X9U.;6+?4(_.N&F,B-9DQ$2OYC+C[5O #X(PP/ !)&09
M?C!^S_=?$Z9)+B_2.*'S!#&EKG:'()+,;C+,0J@GY5^7*HN3GL/$?P[G\6:3
M+I6I7(D>15 GCA\DY0HZ,R&216.],OM* @[5"=:YKX)_#G6O!ENMA>7-M]EB
MDW((49YB"Q=X][A%52W4F.1RKN%:,A&7$^,'[,(\37/]IZ1*+6\W!V'S+&\@
M8$2ADRT;]22JMO8 X5BSL?#K]GW489XKKQ!J$ET()A+%;B:>2+S%QY<I:0J<
MJ2WRA1VRY4LAZ#X]? 5/B<D<L4@ANH5<*Q0%74C(C<CYP _*L-P0,_R,6XYJ
M#X*Z]X@LYK+7-02>(6Y%O$A(5I0C+$\\@A25E1MKX._>X#-G;AMKX#?!;4/A
MT@2XO0T3-([VT42&,R, @8S.OF$;%!V@)\V.2 =_LM>*_&#]G^Z^)TR27%^D
M<4/F"&-+7.T.0268W&68A5!/RK\N51<G/5^(O!&J:[I[:?)?PAI(VCEF%F=[
MHRJIPOVG8K'Y][ 8(8;%C*@G)^#'P;NOADK6ZWJ3VKR&1HS;;'#;-N5<3G&<
M+D,KC"X4*237*^"O@AK'PZU"YDT>:S%C<2+\DPF=T0,2N%7!9D#,JYE <<M@
MD;3QU^SQJ&M:M:ZQ#>)))')"\HG5@B&-PX$,<?\ RRZXC9PV<EIF9V<;7Q9_
M9^?QP(;R.Z,>IP*=LX4HC89I$0*AS$%D;Y'!=U7[YE?# N? GB/Q;!_9^K7=
MK#;,JB:2T64W,RC >,F0)&@<9+,JXSA=A1F6O4-+\.QZ!:K9Z>J0I'&5B&TL
MBGG!8;E9_F.YOF#.<DMDDUX__P ,[7W]K_V__:2?:_,W?\>8\O&SR_+V_:,[
M?+^3.=^.=V_YJ[#XI_#:]\?6@L#>1PQ,L?G;;8NSNAW'!:X^1"P4A<%@5P9&
M!(,7PU^&FH> [+^SXKV&6--QA,EHV4+.'8'9=+O7E\ X8,P._:H0\IX+_9VO
MO"6H2:M#J2/<3>;YOF68*/YC;VR$N$Q\X##85P0!]W(.W^T-\$G^)\$/V>41
MW%NS[ ^?*99-F\,55F!&P%2 1P5(^;<O8>!=.U2"-#J\\,DJQ[2L$95"<C]X
MS.<LQ"@@(L2*6<%7^0KRGQA^'D/C:^TN-SEX;B69D95>-K=!&9MRM@',@ACQ
MGI(S;'"G;ZK17/\ CKP+:^.+5[*]3=&W((X=&&=LB'!PPSP>002K J2#\X:)
M^RYXAT%S!9ZF(+4S$DQ37,;%20#(8D4)OV ?+OQD!=^!FO?_ (5?#.#X<V2V
M-N2YW%Y)&X+R$ ,V,D*,* %'0 9+-ECYUXF^ %YI>J'7/#URD,\DA::&?>87
MWDM+EEW,59L'RRO#99'4J@7;M/A7?^*;VVU'Q#+ QLV9K>WM5D6+?E&$KR2'
MS"<J/DQM^1#G!=6[#XC^%;KQ5:O96UPELDT;QRL8?/<JV 0O[U%7*[E)(8X;
M*E2 :Y3X,?!NZ^&2M;K>I/:O(9&C-ML<-LVY5Q.<9PN0RN,+A0I)-8MS^SY>
MS:Q_PD"ZA&EUN4[5LR8L"(0E=K73-AD&#\V>25*G!'0?&#X17/Q+MHK.6ZCB
M2-HY&*V[,S2JKH6&;@!4(?A"&8$?ZPUQ_P 7/"MUX5\)W-E<W"7*0QVD<3"'
MR'"K<1 !OWKJV%VJ" IPN6+$DUE? 31]<L]&MI]'FMGBF\XO#>>:5B99I$S"
M8>=K@ LC<!P64_.P'HOPF^#;^%)YM4U"X-UJ5RH$DO*HJG:6C49Y&Y0 Q"@*
MJ*B1@$'E-0^"6J^'M<FUK09;54N%;S(KCS<;G(:4?*KD@R*) 59""=F-@PT7
MQO\ V>-0^(7DW"WB/<1[E:-U:&U53SF)5\YU;@;][2%^H9%14KT7Q;X+U'Q#
M9261O8T,ZR+,XM<@(P5=D2F?Y 5#;B[2L2[%&C 4+B?!CX-W7PR5K=;U)[5Y
M#(T9MMCAMFW*N)SC.%R&5QA<*%))K%N?V?+V;6/^$@74(TNMRG:MF3%@1"$K
MM:Z9L,@P?FSR2I4X(]/\66\<NFW$>H28B-I*+B2-2N%\LB5U4^:1QDJ/G(X'
MS=\7X(^ SX&TFWLY !-M+S8"@^8YW,"5+!BH(CW9.0@Q@8 VO'^CW6LV,]O8
M3?9[EXR(Y?[IR,C(Y7(RN]<LF=Z@L *Y#X)66IZ()M.U6X%VT*Q,)07<J\C2
MEH#(^&<JBQR?, RB8#E/+->GUXK\<O@9=>,;RVU73)TBO+?8 )?]7A':6-QA
M'^8.>0RE6!'3:0_=+H^KW%L0]W!'=.J@LELSPQ_*VXHKS!V?>P^=V*%44>0I
M+%N%^#_[/]U\,9GDM[])(IO+$T;VN-P0D@JPN,JP#, ?F7YLLC8&.U^+WPQC
M^)%B;&1_+;S$DCDVE]C*<$[0Z;LH67!.!NSC(%<U\/O FNV5M#8:E=P);0*B
M#[*K_:)8PK*(FE<((@!L >-/-('$B/\ .<3X%_L]WOP[9I9;['F[#+!#&A1C
M&YV RS(S%=K,&"I&V6X?Y03H:9\-M=\*2W5QIEU:N+J]N9S;7$3^4OF.2)!+
M&?,+[%0%<!!ENI 8ZWA3X5W,^HKKNM2QR7J0^5#% K);PK\X)!8[Y"RN3\^
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MO>A2"^W*2@*0BR8Y!!P!(,D+P5<! O*^%_V;M7U)]GB#4Y)[3<A:W2>XE64
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M*I!C(QEBY)KS_P %_L[7WA+4)-6AU)'N)O-\WS+,%'\QM[9"7"8^<!AL*X(
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MORY5%R<^@?V+JGV/R/ML/VKI]I^R'[NS;N\O[1M\W=\V[/E_P^5BO/\ X/\
M[/\ =?#&9Y+>_22*;RQ-&]KC<$)(*L+C*L S 'YE^;+(V!C/^,'[,(\37/\
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ML%(7!8%<&1@2"?"SX;7O@&T-@+R.:)5D\G=;%&1W.X9*W'SH&+$K@,2V!(H
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MA;P='X1L4T^P.U8HV$;29D^8DL78!DW9<EF"E!R0NT8QY5_PSM??VO\ V_\
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MBBBBBBOG7XA_!G7O%VK0:RIL8FMO(\J,RW$@_=.91O;R$W9<G. ORX'4%C]
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M_P OS/*W+YFS.W?MSNV[N-V,9XSFI;N[2S1I96"(BEF9B%55 R6)/  '))X
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M&([9DGF20SN/)MPTBN&;,KJ"9&*DG=(>"PZ#PSX=7P_"($DFEQ@EYY9)Y&.
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ME^#%R-(\9ZC#<9C>=KY8U96!8F=9U[< Q*7!. 1C!.1GUK]J/_D7;S_MW_\
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M,?,E;$:MYL$9,4";88N-V"%,F'=3(P8Y/AI_R(TG_7AJ?_H5Q1^Q3_R!Y_\
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M;?/_  7^SM?>$M0DU:'4D>XF\WS?,LP4?S&WMD)<)CYP&&PK@@#[N0=;XU_
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M***X#XZ>&(-;TF[:<.?*M+B1%$LJ)N5"ZED1U63#(I <, 1P.3GS_P#8I_Y
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M7F"*)67Y?E+@;B/E7@G' ]!7G7[4?_(NWG_;O_Z415X!^Q3_ ,AB?_KPD_\
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MQ:M)E,_,T;N9!*!@<!G*$ M@@%L;U%>R^(O$T/A]8WG./-N(($ *[F>618U
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MCA5!(RQ [UJUPOQ0^'^G?$(1Z=?Y$I626%TXE54:-92K%64 ^8@96R&R"!E
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M (2B\.)IRQM)(Y6Y#S32/-,^T08W.Y)QDLP1=J*S,55=QS[?^U'_ ,B[>?\
M;O\ ^E$5'[+G_(NV?_;Q_P"E$M>5?'W_ )'#2?\ MP_]+)*^JJ^5?V&/^8C_
M -NG_MQ1\??^1PTG_MP_]+)*MW?C&/P-XXN);T>7!=6\40E?*(H,4.V3.T@K
MYD7EDY"J22S (17T_7 >,?$T/B70;^ZMCNB-IJ"*V5(;RQ-$64J2"I*$J0>5
M(/'2O/\ ]BG_ ) \_P#U_P G_HF"O?Z^6_@!:.WBW6)0I**UZK-@[0S7:E5)
MZ D*Q ZD*<=#7U)7B'AGXD3_ !DN[JUTZ<VNFVZJKS(,7DQD$BC875EA3@MG
M;YHVK@J7(C\T^,6@Q:+XMTF.$'!:Q9F9WED9OM;C<SR,SN=H"@L20JJHPJ@#
MV7]J/_D7;S_MW_\ 2B*C]ES_ )%VS_[>/_2B6O!?!]H]YK?B2*)2[O9:PJJH
M+,S&=0% '))/  Y)KT7]B75(Y=-N;8-^]2[\QEP>%DC14.<8.3$XP#D8Y R,
M\_\ MS_\P[_M[_\ ;>OJJOG7]K>XDT.;2=5$>^*TNV+#<%RV8I43N1N$+\A2
M!CGJ ?H#2=4CU>&.Y@;=%+&DB-@C*L RG! (R"#@@'U%5-.\21ZA<3VD8?=;
M>4)'*D1[I%+B-6/WF";68#A0Z<Y) ^:O^:A_Y_Z!U=7^VM_R!X/^O^/_ -$S
MUU7_ #)__<!_]LZY7]BG_D#S_P#7_)_Z)@KE/^:A_P"?^@=47[2MR-&\3Z7?
M7&4MT6U9I-K%<1W3O)C .XJK D#)P1QR,_5]?*O[#'_,1_[=/_;BCX^_\CAI
M/_;A_P"EDE>M_M-6CW7A^]6-2Q"PL0H).U9XW=N.P4%B>@ )/ H_9R\>0>*M
M(MTB($MM#'!+'G+*478C'('#JNX$9&<KN)1J[K5?$T.F3V]K(?WMU(Z1J"N?
MDB>5V()!V@)@D X9D!QNS7S5\??^1PTG_MP_]+)*]5_:C_Y%V\_[=_\ THBH
M_9<_Y%VS_P"WC_THEKG_ -LG2Y+W15DC7*PW<4DAR!M4K)$#R1GYY%&!D\YQ
M@$CN_@5K::SH=C+&" MM'$=V =T(\ESP3P60D=\8R >!XU\:M+DU/QEI4<*[
MF$=K(1D#Y8[B:60\D=$0G'4XP 3@5T'[:W_('@_Z_P"/_P!$SUZK\)_^0/I_
M_7A:?^B4KJJ\0\,_$B?XR7=U:Z=.;73;=55YD&+R8R"11L+JRPIP6SM\T;5P
M5+D1^:?&+08M%\6Z3'"#@M8LS,[RR,WVMQN9Y&9W.T!06)(554850!W?[:W_
M "!X/^O^/_T3/7JOPG_Y ^G_ /7A:?\ HE*^?_V&/^8C_P!NG_MQ7U57RK\?
M?^1PTG_MP_\ 2R2OJJOE7]AC_F(_]NG_ +<4?'W_ )'#2?\ MP_]+)*];^+/
MPBT[XHN;>9C'>P0JRRH/F"2&58P^1MD3?&QVY# @X9 Y+>%%]<_9TN8%FF,^
MDO-@A07CV;G+*%<CR9BK&0*K!6;JT@1L>B_MK?\ ('@_Z_X__1,]<U\=[1Y_
M!VELBE@BV#.0"0J_973<<=!N95R>,D#J17M_P4U2/4]%L)(6W*+2&,G!'S1J
M(I!R!T=",]#C()&#7A7_ #4/_/\ T#JMW?C&/P-XXN);T>7!=6\40E?*(H,4
M.V3.T@KYD7EDY"J22S (17T_65X8\30^)8!=6QW1&29%;*D-Y<KQ%E*D@J2A
M*D'E2#QTKYJ_88_YB/\ VZ?^W%?55>5?&#XSMX2N+;2K%4?4+N2()YH<01J\
MGEAW*X8Y8$ *<C!8]%5^5^/W@/\ LW0+NXN[B:\NO]&/F2MB-6\V",F*!-L,
M7&[!"F3#NID8,<]5^RY_R+MG_P!O'_I1+7E7[#'_ #$?^W3_ -N*/C[_ ,CA
MI/\ VX?^EDE1:S<C1?B DUSE$D:-8V*MAC)9B!,8'(,OR9' (.2,''T+\6/^
M0/J'_7A=_P#HEZ\J_8I_Y \__7_)_P"B8*]UU;5(](ADN9VVQ11O([8)PJ@L
MQP 2< $X )]!7C_P]\5W7QH\ZZ$KVFFQ7'EQQ0GR[J4KY4A,LHR47'&V$HQW
MLI<A0S^:Z7I<>E>/UAA7:BY[EB2=/+,S,Q+,S,2S,Q+,Q+,2237:_MK?\@>#
M_K_C_P#1,]>J_"?_ ) ^G_\ 7A:?^B4KY_\ V&/^8C_VZ?\ MQ4W[5.D3^#M
M1L_$MEA2&2-\#;F1-S+O*NKN)(]T;#C")M+88 >U?#;6T\:%]:0'RI%2*UW8
M!$2JK2G;EBKFX+QR8(5Q!$0"%5V[JN5^+'_('U#_ *\+O_T2]>5?L4_\@>?_
M *_Y/_1,%<_=^,8_ WCBXEO1Y<%U;Q1"5\HB@Q0[9,[2"OF1>63D*I)+, A%
M?3]<!XQ\30^)=!O[JV.Z(VFH(K94AO+$T192I(*DH2I!Y4@\=*\__8I_Y \_
M_7_)_P"B8*T/#/Q(G^,EW=6NG3FUTVW55>9!B\F,@D4;"ZLL*<%L[?-&U<%2
MY$?FGQBT&+1?%NDQP@X+6+,S.\LC-]K<;F>1F=SM 4%B2%55&%4 :'[<_P#S
M#O\ M[_]MZ^JJ^5?@%_R.&K?]O\ _P"ED=>B_M6> SXHTAIH@#+:-YX.%W&,
M*1,H8D;1M_>$#.XQA=I.,9_PE\=-\1=.TZTE?=,LA>Y?Y]V+&2%T^9RVZ5WD
MMF<\JR--@H^T#IOVFK1[KP_>K&I8A86(4$G:L\;NW'8*"Q/0 $G@4?LY>/(/
M%6D6Z1$"6VAC@ECSEE*+L1CD#AU7<",C.5W$HU=UJOB:'3)[>UD/[VZD=(U!
M7/R1/*[$$@[0$P2 <,R XW9K5HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKP7]ICP6\$
MMGXDMHC+)831M.BD@M"C^:&SD[0C @E48XD+-\L=>X:3JD>KPQW,#;HI8TD1
ML$95@&4X(!&00<$ ^HKYZ^('[*,IN_[1\.W LY"V?+R\2H6#!VCDB#,H.0/+
MVX +88+M0=5\)_@;=Z'/'J.M7LEY=1+((5,DLD4)?*NP:0[G+)@?=4#G(8A6
M7IOCSKO]DZ-=*J^9+<1_9HHP<.[S_N@$&"78!BX4 E@I'')!\"_AS_P@&EQ6
MKC$[_O9_^NK@97AF7Y5"IE3M;;NQEC7?T45YU\6/AM>^/X)+$7D<%K(T9*BV
M,DI"X;:7-P%QO ;Y44\!<D;MW"_#7]F*Z^'=U]MLM10N8VC99+3<C*V#@XN5
M8?,JL"I!R "2"0=KXP? 6Y^)Y@^TWL<0@5MH2U;)9UC\PDM<G@LF5 &5!VDN
M1N.AH/P@O-%T9]"2\A,31RQB0VK[PDOFF7(%T 6S(-C<!0I!5\Y'/_"3]FJ;
MX:WGVV"]27='Y;H]LPRA=';:1<?*WR !B& SRIK*\>_LFS>-[V74+F_199=F
MX1VK!!M18Q@-<L>BC.2><_2O2_B-\/+SQSIQTV6ZA3S,>=(MLYW;9%DCV*;G
MY,;<-N,F[J-O2N9^#_P%N?A@9_LU['*)U7<'M6R&19/+(*W(X#/E@1E@-H*$
M[AS7_#)LW]I?VO\ ;T\_[7]IV_96\O?YGFXQ]IW;=W&-V<=\\UTOQ@^ MS\3
MS!]IO8XA K;0EJV2SK'YA):Y/!9,J ,J#M)<C<>P^$O@&;P%9+I\DZ3Q1[O+
M(A:)QN=Y'W$S2!N6XP%P!SNSD>0?$K]D9KNZ^WZ#,ELYD5_*;?&D;#)+QO&&
M9/F"E4VX4Y*LH"H.O\'?"/5KY$B\2WPN[>)E*VJ*#'(4"^6TTA2.24 Y)C<$
M,P1G9N5KIOC/\'X?B=:K;R/Y,L<@>.8(KE>SJ02I*L.H#+\RHQSMP?.O#7P.
MUVVTB71+B]@C@VR^4(0YD;>KGRGE9%V0^:0SX1W=2Z;E7 )\"?V<;_X=W)OI
M;F#>RF)HUCDE4Q%HW)#EX2KDI@91U YPV<"_\6_V:IOB5>?;9[U(ML?EHB6S
M'"!W==Q-Q\S?.06 4''"BM;QI\"YO$VAQZ-+<H9;;RC;R+$T2'RHO*19%,DQ
M.06W,I&"00AVE6YKX4?LU7N@6US9ZC?$6URKJ]O;$A22H42>8ZAE/4,BJ X5
M!(SIF,Y/PO\ V8-6\$W[7$5_'#$59-\48DF>/S$;:4FC,<98+G<#)M8 8<$U
MV'[0G[/;?$MH[JUD2*ZBC,?[P/LD7>&4%E)V;<N00C%BP!( !'0?!_X977A>
M..35+C[1=16XMX@G$$, *X1!M3<S;$+R,NX[57HI+>:_$K]D9KNZ^WZ#,ELY
MD5_*;?&D;#)+QO&&9/F"E4VX4Y*LH"H.O\'?"/5KY$B\2WPN[>)E*VJ*#'(4
M"^6TTA2.24 Y)C<$,P1G9N5KV6N/^(OA.]\4P2V=M=1V\,T)CD)MS-+ALA\,
M9T0!D.W!0D<D,#C;Y!X+_9'G\'7<5_::D!+$Q*[K3<I!!5E(^T="I(."" <J
M0<$?0NEQS11J+ET>7G<T:-$AY.,*TDI'& <L<G)XS@8GQ(\#IXYT^?3I',8F
M5<.H!*LK*Z'!ZC<HR,@D9 *DY'BOP6_9JU/P7/))<7PCAD4+)%;%R95^;@NZ
MH8B#C#H#( SA'C)W5E:#^R9J/AC5!=Z=?1PPHS^5*R>;<*K(RX,;((F/S%2=
MP!'S@ X0=5\4/V9)_B'<K=7.H &.%8EQ:_,45G8,Y$ZJ7.\[BBHI/W44<5TN
MO?""\UK1DT)[R$1+'%&9!:OO*1>48L W1 ;,9WMR&# !4QDY_P '_@+<_# S
M_9KV.43JNX/:MD,BR>605N1P&?+ C+ ;04)W#FO^&39O[2_M?[>GG_:_M.W[
M*WE[_,\W&/M.[;NXQNSCOGFO4/B?\/[GQWI_]G&XCB$BIY[^0SEF5D<&,>>O
MEC<AR&,AP<9!&3S7P4^ \WPMDE,=VDT4^SS%-NR/\@DV;6%P0O+Y.5;(&!CK
M7*>/?V39O&][+J%S?HLLNS<([5@@VHL8P&N6/11G)/.?I7M5QXHA\-1QC5;N
MVCE?=AB5MD?!_A665SP"H/S-SSQD >=?%_X30>,M7TR8D>8C.TR,F]9+>%ED
M.0S!,"1UC(P683[B"L9%>RT5YU\6/AM>^/X)+$7D<%K(T9*BV,DI"X;:7-P%
MQO ;Y44\!<D;MW5^%["]LDV7]Q'<$*@5T@,#$@$,S_OI%);@_*$ .<#! '/^
M#?A-!X6U&^U.(@F]9&"[/FC/+38<LQ(DD.\@!0" ,$ 8Y_XN_!F]^):+;S7T
M<5NDS2(B6I+9P53>[7)W%58C*A 222OW=N5\*_V?+WX9O*]EJ$;"95#I+9EE
M)4DJPVW2,"-S#K@ACD$@$6OCE^SA!\13]KMV%O>A2"^W*2@*0BR8Y!!P!(,D
M+P5<! N!\/\ X,>)M'3[%<ZJ([+;C$.9I@N%3RXWFB5H1L!VLC$1L 53))KJ
MOB7\!!XLLH-)M)H[.R@971%@:1]ZB1<[S.@((D).5+%LL7))J7X4_""\^&UK
M+9VUY#(KR&16DM7RKGRU.=MT-R[$("C:=Q#;B!M/%> OV39O!%[%J%M?HTL6
M_:)+5BAW(T9R%N5/1CC!'./I6K\6_P!FJ;XE7GVV>]2+;'Y:(ELQP@=W7<3<
M?,WSD%@%!QPHKU7P'X>F\-V<5E/*DWDQI&CI&T/R(BHNX&67+<$E@5!SPHQS
MX7X _96NO!GD:C#<H=2AN Q3.+5HCE)(MQB:0,T9/[S8=N=H3($E=+XJ^!=W
M\2=1CO-;DCCM(%58[6"267<.3)ND=8=A9MN2B99 %RK*'/K^OZ!!XA@>TNT$
MD,B[71NA'7MR"#@@C!4@$$$ U\R_\,H:MX4O/M.@WZ(O9I&DBD W[A&PC21)
M5^52V0%<YS& !GVOP+\.;BSD2_UFY^VWR1[8VV+'% & \P1JH4%F.0TI =D"
MKA1D'B?BW^S5-\2KS[;/>I%MC\M$2V8X0.[KN)N/F;YR"P"@XX45ZA\.O"\_
MA:RBL;F<7!A4)'((O)/EJ $4@.X)4#&X8R,9!;+-TM%%97B:RNKV$QV,R6\I
MR/,>+S]H((RJ^9&-P)!!;<O&"ASQY5\'_P!G^Z^&,SR6]^DD4WEB:-[7&X(2
M0587&58!F /S+\V61L#%3QI^SM?>+=0CU:;4D2XA\KRO+LP$3RVWK@/</GYR
M6.\MDDC[N .V^(WP\O/'.G'39;J%/,QYTBVSG=MD62/8IN?DQMPVXR;NHV]*
MS_ 'P9?0-/;1K^>.]L"K@1M;F)QN8/\ ?$S<!MS [=X8@JXVJ*\??]E/6_#L
M\W]BZ@(;=V&T^=/!*RC.T2"&,JQ7<0#G!^\ NXJ/</A#\(8_AW',3,]Q=7$F
M^>=\@N06*_*6;&-Q))+,S,23C:J\3XT_9VOO%NH1ZM-J2)<0^5Y7EV8")Y;;
MUP'N'S\Y+'>6R21]W ';?$KX6-\1-,^P7LJ"<2+(L\<3JBLK$9$1F8G]VS(0
MSD9)8 $ #$^'W@37;*VAL-2NX$MH%1!]E5_M$L85E$32N$$0 V /&GFD#B1'
M^<XGP+_9[O?AVS2RWV/-V&6"&-"C&-SL!EF1F*[68,%2-LMP_P H)J_$K]F^
MZN]3_MO0KE+:Z,BNR,-B!MI#N&16SNXWHR$.6D+,0VVL_P >?L[:OXVLHVO[
MR.?4EF&&8M';1PX?<B+'$-SNQ1G=D!PJH" F7]0\(_"MK'3VTK5;C[?;F-(D
M1H8X42)%"JHV9<L, [RY8$*5VL"S>*7/[*.L>&YG_L+4?*@DP3NEFMY."VU6
M\E65]JG[WRY);"*.ON'PK^%@\"I*\MQ)=W=PRF>XE+;G" K$H#,^ JG'))))
MYV[57BO!?PV\1_#^TBL["ZLKA IS'<12HL+$EV$;PG?(&=VR9 " %V@9('5?
M#OX5OH=W<:QJ$HGU&Z55=D4QPQH G[I%R2P!11O?YBJKPK%RWHM>"Q? K4_#
M6NRZQH]Q (KEG,RW"NS 2OOE4*@7< P#IAXSD!&. 6;L/B5\,+[QQ9?V>]\D
M<3[3,?LH9W8.9-JGSE"1 [=JX:0!!OE?+$R_"SX;7O@&T-@+R.:)5D\G=;%&
M1W.X9*W'SH&+$K@,2V!(H  Y7PM^SY>^&=3FUBWU"/SKAIC(C69,1$K^8RX^
MU;P ^",,#P 21D&I\8/V81XFN?[3TB46MYN#L/F6-Y P(E#)EHWZDE5;>P!P
MK%G8^'7[/NHPSQ77B#4)+H03"6*W$T\D7F+CRY2TA4Y4EOE"CMERI9#[U7G7
MQ-^&UWXIN[*\L;H6CVBW6)/*$[;I1&@ 1R$QL#Y).0<8!SE>?U[X?Z_X^B-A
MK$]E#9LR-)]D29YG".K>7F?Y4!QG> 2&51M92P/-?M?Z7'I&@VMM NV**[@C
M1<DX5;>95&223@ #))/J:T/!&@^([+2K6/2KFU>"6R@=&NQ*;B%I(E)1"BLC
M(K',>]25!$9#*@SW?PA^$,?P[CF)F>XNKB3?/.^07(+%?E+-C&XDDEF9F))Q
MM5>4^*OP FUN^77-&N?LNH+M)W;C&Y4*@;(W%/W8*LNUTD "E1ERTNK?"O5?
MB(8HO$<MJMI#,)?(LUES,VUEP\DI#(!G'R<L&;E6",/1?'_@Z/QG8SZ?,<+-
M&0&Y.U@0T;X#+G:X#8R V,'@FO-?AK\,->\)0?V7]MMDL4D8Q31Q%[L*90Y0
M"0"%-P+DEA,4+$#< I7/\#_LXW?AW4[G4TOS )IK@!8U$\K0NX=-TMRKX?<%
M+DHY.W[Y+$CH-2^&VKZ?J5[J^EW4"&Y:#_1IHF:*18X5C!>12)$()=E" @X7
M<<$A2T^%=_XIO;;4?$,L#&S9FM[>U618M^482O)(?,)RH^3&WY$.<%U:I\<O
MV<(/B*?M=NPM[T*07VY24!2$63'((. )!DA>"K@(%Y7PO^S=J^I/L\0:G)/:
M;D+6Z3W$JR@$MM<R;-H#!3P&)&<%& :OH^N?\?\ @Z/QG8SZ?,<+-&0&Y.U@
M0T;X#+G:X#8R V,'@FO.OV7M2>UT]]&NHS#=Z?,Z2HV2=LK/+&^<;<'+ ;2P
M(4/G:ZUT'QI^"T'Q1@CCDD,,T+$Q2@;P VWS%*;E# A1W!! (.-RMRMMX$\4
MZC9?V3?7=D('A:*2Y59I[LH01C#B.-B1\A8X;:2V3)R?3_"W@Z/PC8II]@=J
MQ1L(VDS)\Q)8NP#)NRY+,%*#DA=HQCRK_AG:^_M?^W_[23[7YF[_ (\QY>-G
ME^7M^T9V^7\F<[\<[M_S5[A:*ZHHE(9PHW,JE%+8Y(4LQ4$] 68@<9/6L_Q-
M975["8[&9+>4Y'F/%Y^T$$95?,C&X$@@MN7C!0YX\J^#_P"S_=?#&9Y+>_22
M*;RQ-&]KC<$)(*L+C*L S 'YE^;+(V!BIXT_9VOO%NH1ZM-J2)<0^5Y7EV8"
M)Y;;UP'N'S\Y+'>6R21]W '=^,?!^I^);1[+[9!$)H6CE=;1RQ#%@VW?=,%!
MC(0@ACG<RLI*A>?^$7P9O?AHC6\-]'+;O,LCH]J0V<!7V.MR-I95 RP< @$+
M][=H?&?X%VOQ.C4NWDW4> DX7<=N<F-ERN]>20,@JW(."ZMY5X9_9GUY\6NH
M:JZ6(C"&*">XDW)PIB"R!$52F1G# <#8PSCZ5TG2X](ACMH%VQ11I&BY)PJ@
M*HR22<  9))]37FG[4?_ "+MY_V[_P#I1%7 ? 31]<L]&MI]'FMGBF\XO#>>
M:5B99I$S"8>=K@ LC<!P64_.P'HOPF^#;^%)YM4U"X-UJ5RH$DO*HJG:6C49
MY&Y0 Q"@*J*B1@$'E-0^"6J^'M<FUK09;54N%;S(KCS<;G(:4?*KD@R*) 59
M""=F-@PT7QO_ &>-0^(7DW"WB/<1[E:-U:&U53SF)5\YU;@;][2%^H9%14KL
M/B)\+M1\<6C6$VH1I%(R-+MM.NTY5%S<$JF55B"7<N&/F"-A$NA\(?AQ=?#Z
MW%C)=I<6R;S&/L_E2*6;<1O$S@KDL<%=V6^_M 6N4^.7P,NO&-Y;:KIDZ17E
MOL $O^KPCM+&XPC_ #!SR&4JP(Z;2'[I='U>XMB'NX([IU4%DMF>&/Y6W%%>
M8.S[V'SNQ0JBCR%)8MPOP?\ V?[KX8S/);WZ213>6)HWM<;@A)!5A<95@&8
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M5Z51111111111117-:EX'36+N.\NW,BV[;K># $*/@#SF')DF!W;&)"HI&U
MX,C=+1111111111111111111111111111111111111111111111111111111
M1111111111117/\ C_1[K6;&>WL)OL]R\9$<O]TY&1D<KD97>N63.]06 %<5
M\*/AMJFEQA=?O/M8CD#0Q ET!!W"1Y'1996#'**Y*1E5<998S'ZK11111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111156WU:&YDD@CD1I8MOF(&4NFX93<H.5R.1G
M&1R*M44445%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %%I=I>(LL3!T=0RLI#*
MRD9# C@@CD$<$5+575-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"K5%%%%%%
M5=0U:'3MGGR)'YDBQIO95W.V=J+DC+'!PHY/85:HHHHHHHHHHHHHHHHJKJ&K
M0Z=L\^1(_,D6--[*NYVSM1<D98X.%')["K5%%%%%%%%%%%%%8NM^-[#07$5Y
M=00.5#!998XV*DD!@'8'&01GID'TK:HHK/F\0VT$ZV;S1K<.NY(2ZB5E^;Y@
MA.XCY6Y QP?0UH44444444444455_M:'SOLOF)Y_E^9Y6Y?,V9V[]N=VW=QN
MQC/&<U:HJK;ZM#<R201R(TL6WS$#*73<,IN4'*Y'(SC(Y%6J************
M*********************JW&K0VTD<$DB+++N\M"RAWVC+[5)RV!R<9P.31J
MFK0Z1&T]S(D42XW/(RH@R0!EF( R2 ,]R!5JJNJ:M#I$;3W,B11+C<\C*B#)
M &68@#)( SW(%0Z)XAMM>0RV<T<Z!BI:)UD4, "5)0D9P0<=<$>M:%%%%%%%
M%%%%%%%%%%%%%%%%%%%%5?[6A\[[+YB>?Y?F>5N7S-F=N_;G=MW<;L8SQG-6
MJ*JV^K0W,DD$<B-+%M\Q RETW#*;E!RN1R,XR.11<:M#;21P22(LLN[RT+*'
M?:,OM4G+8')QG Y-6J******JW&K0VTD<$DB+++N\M"RAWVC+[5)RV!R<9P.
M35JBBBBBL^'Q#;3SM9I-&UPB[GA#J957Y?F* [@/F7DC'(]16A1111111111
M1111116?J7B&VTMXXKB:.-YFVQ*[JC2-D#:@8@L<L!@9.2/45H4444444444
M5GZEXAMM+>.*XFCC>9ML2NZHTC9 VH&(+'+ 8&3DCU%:%%%%17=VEFC2RL$1
M%+,S$*JJ!DL2>  .23P!1:7:7B++$P='4,K*0RLI&0P(X((Y!'!%2U5U#5H=
M.V>?(D?F2+&F]E7<[9VHN2,L<'"CD]A5JBBBBBBBBBBBBBJNJ:M#I$;3W,B1
M1+C<\C*B#) &68@#)( SW(%2VEVEXBRQ,'1U#*RD,K*1D,"."".01P14M%%%
M%%%%%5=+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*M55U35H=(C:>YD2*)<
M;GD9409( RS$ 9) &>Y JU11111111111111111111111111111111111111
M1111111111111111111111111111111111111111111111111111117'_%7X
MF0?#FR:^N 7.X)'&O!>0@E5S@A1A22QZ ' 9L*:&G_"L:I"YUJ1[BYGW>;Y<
MLT,**P"M;1*CH1!@ .#S,RAY<L%">*?L,?\ ,1_[=/\ VXKZJHHHHKYK_;1\
M,0)8PW^',YNTCR99615:&0L%C9S&F3&A)5021DDDG/M7PG_Y ^G_ /7A:?\
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MBBBBBBN*\4?"&Q\2ZA;:M<!_M%KC9AR$;:Q>/</]AR6&TKDG#[EP*[6BBBN
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M&ZY(RK JPR"",@D9!!]#7/\ PU^&MK\.[7[%9;RAD:1FD;<[,V!DX"J/E55
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M.19'X/.YCN/S') ->U?&+QJWPYL8+:QD1+BYN%@BDN9GD\H.27N&:4R.ZID
MEB53<N05 1N%U_X7^$]9@=9-2C>\=>+V6^2:?</N%@95C8  )C:#L& 0WS#H
M/V4_BK/XVLI;>\8R3VC(OF$<O&X/E[CDEG!1@Q(&1M)+,6->WU\B_&>.[T;Q
M+IUJ+J>Z#S6,ZQW$H6+S?/:)<+#$L<8P@!98RWS,?F)(/5_%7]FJ>Y@;5(+Z
MZN-4@42!G.0Q3,C)"L:[XCO):)%+!3A!C.\;7[/OQ7NO%^BSHI\[4K.-U7S#
MGS259K8LQV#D@QME]QV%W8%\U%\%/AJ_BJRGN_%%L9KNXFD4-<J?-6''"HK8
M-N/,:0J$$9Y##Y0AKG_V9=?GT?5[_P .JY>RMFN6A#_,Z&.X6/@C  8-N88Q
MN^90I+;N:^.4-]I'B*PM(;N:X9Y+.>-;IQY F\YHD)C@2-%7Y1NV(&Y8Y)->
MH6W[,8;4/[0NK^><30LEXC;HC.64JPWPR1E(<["(L, $"9*XQY?^QKX9BUO[
M?YK3+L^RX\JXN+?KY^<^1)'NZ<;LXYQC)S;_ &RX;C2&M\7=R\5UYX>!G58
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ME Z@XX!%<5\#_A[H_P 5K1]0U3-YJ33.;HM+*C(22(E"QM& GEJ"N 0#N12
MFQ/1?#MC)\)K#4[B\E>X5+B6>*2>4>9*OV>!8T9R6^;>OD@D L0"J %5KA=
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M .V]6_VX]+DEAL;D+^Z22>-FR.&D$;(,9R<B)SD# QR1D9^C_#VMIKUM#>1
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MB[9_]O'_ *42UZK7E7[4?_(NWG_;O_Z414?LN?\ (NV?_;Q_Z42UY5_S4/\
MS_T#JZO]M;_D#P?]?\?_ *)GJUKGQGC^&/AW3G"^9=36%N($(.S*PQ[G<C'R
MKN&0#N8D 8&YUUO&_@.9])OKK5KA[FY^P7#>6K,EE&RI*ZB.%=H?:6&V2;S)
M,HC@HP '/_L4_P#('G_Z_P"3_P!$P5RGP"_Y'#5O^W__ -+(Z^JJ*^5?V&/^
M8C_VZ?\ MQ75_MK?\@>#_K_C_P#1,]>J_"?_ ) ^G_\ 7A:?^B4KY_\ V&/^
M8C_VZ?\ MQ6MXP_9:M_$FS5_#EQ]F>79/$A#)#\VQT:,JHDAP,N!M;#$*HC
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M=UJOB:'3)[>UD/[VZD=(U!7/R1/*[$$@[0$P2 <,R XW9KYJ^/O_ ".&D_\
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MOL]P8'(*E=XCCD8 @G[OF!6S@AU8$<9.K7@'Q-_9JL?B.TNHZ9+Y%RTDJO\
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MW!@<@J5WB..1@""?N^8%;."'5@1QDZM?*OQ]_P"1PTG_ +</_2R2O5?VH_\
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M+0M*C*K)R[K:$9QABYF?<-VTPKPA96/JM%<?\5?AG!\1K)K&X)0[@\<B\E)
M"%;&0&&&(*GJ"<%6PPX#PAX$\4^%H!IL-W9/;*S)'/(LSW,<1X4JF!&2H^9$
M=F4'Y-Y0 #O_ (9_#.#P' 8XR99Y6WW%P_,LTAR2S$DG&2=JY.,DDLS,S<+\
M8/V?[KXG3))<7Z1Q0^8(8TM<[0Y!)9C<99B%4$_*ORY5%R<]U?> W\2:=)IF
ML3"X$BA6EBC-LQV[2KD>9(N\.N_(PA.!Y>W(/FO@?X7^)?ARCV>G7-E<6FX-
M&+H7"LA(R^U8]VT%B<C>P)&X!69L^@?"SX5IX%%Q*\IN+N[F,MQ.5$8=MS,
M(U)5 -['C)))YV[57G_C;\!A\0'BOK68VU_ N(Y/FVL%+/&IVD%")#D2+DJ"
M<J_R[<_4_ASX@\;VXTW6KFS2T/E&5[9)&N)=C*VT^8%C3<1N+(O#  (4)6O6
MK30(+6V6Q5 ;=81$(V^=?+"[ AWYW#;P=V<CKFOG73?V;=<\!7,DGAW4(TBE
M7#"8$-@,2JLOE31N5&,284Y+ *H)S;\3?LNWNH:G;ZA!>@.BI)/<R R3M<([
MN)%AQY00?NT2/<%1%QAL?-[_ *!82V$"17,QN)57YY65(R[=2=L8"J.P R0
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MZ[1)D$(2S;<'A? OP5UZ&---U?4$;2UCVM!"2974$$0F5H4D6(CAL.3L'EJ
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MQMR7.XO)(W!>0@!FQDA1A0 HZ #)9LL?.O&G[.U]XMU"/5IM21+B'RO*\NS
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MYF[_ (\QY>-GE^7M^T9V^7\F<[\<[M_S5V'Q<^#J?$RRCMKF01W$3*RSI$"
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M$R!EBRD[]K%!+\+/AM>^ ;0V O(YHE63R=UL49'<[ADK<?.@8L2N Q+8$B@
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M;6SP0(0<L$ !<% _\4?RH1W7P[^%;Z'=W&L:A*)]1NE579%,<,: )^Z1<DL
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M0*Y_P'X$UVULAIFHW<$<$<*Q)):*_P!KV $ "20+'&5 50PB=BN3E9,25B?
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MQNN2,JP*L,@@C()&00?0UXIX;^%/B#X=L;?1KRVGL?G*0WBR QEGS@&)23@
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MR-Q4-\N[;G:6#*&P61P"AS_"'A"#PG +:V!(+,\DCG?++(W+RR.>7=CR2?8
M!0 -JBBBBBBBBBBBBBBBO"M/^"NK?#ZX=_#5U"+.61G>TNQ(8U.T*NUD#N>I
MY!C;"H',N,UTR^'/$>OH8;^[M;1"RY:QCE>9T(82('G;$1P1M=59@V"",8;O
M] T"#P] EI:((X8UVHB] .O?DDG)).2Q)))))K0HHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK/AU^">=K1'#31KND1?F* [2N_&0
MA8-E V"X#%00K$<_XX^*=IX0=+>02374JEHK6",S7#J#\S!1P !DY8J"%;;D
MJ16+X*_:$TOQ5,UIO>VNED*>1<J(9"P*KM'S,I;<VT)N\S(/R8&:]*HJKJFJ
M1Z5&TTS;47'8L220JJJJ"S,S$*JJ"S,0J@D@5#;:VDD'VJ4&&,*S$RXC*HN?
MG8$_("HW8?:R@X=48,H-$UD:NAE1)$3<0OFHT3, !E@C@2*,Y7YU4DJ2 4*L
MUN[NTLT:65@B(I9F8A550,EB3P !R2> *\EU']J/2XKK[#9I<WLOS#_18A*"
M5W;E7<Z%\!=VY R%>0QYQJZ7^T%IDTBV][YVGSMDK'>Q-;DJ 3YFXYC"DAE!
M9@2RD 9QGL/!OB^#QA:I?6A)AD:0(6&TD)(T>[!Y )4D9P<$9 .0-JBBBBBB
MBBN?\8^/+3P;&)[YG2+NXAFE1>5'S-$CA,E@!NQN/ S@U5\"_%+3O'?F?V;-
MYOE;/,^21,;]VW_6(N<[3TSC'/:N4\<_M*:7X+OO[-NO.,B^7YCH@:./> PW
M98,<*0QV*W!P,ME1ZK111111111117->./B1I_@9$DU&<0B1BJ##NS$#)PJ*
MS8'&3C ) )!89\_MOVGK:Z@^V1Z?J;6X5F,RVRF+:N=[;Q+MP,')S@8.>E=A
M\//C'IGQ RMA-NE6-7>)E9)%!Z\,,-@\,4+*"1S\RD]K7G6N_':PTV>>TA$E
MU+:PRRW*P"/$21;=Y9I9(E8C=@K&78$,K $8K0^'WQ@T_P =6KWMM)L2+/G+
M+M1X@,G<_P Q4*5!8,"5P",Y5@.5U3]J#3;*W:^CBN9K,7 @$\:1!&E,8EVA
M998Y>%/)*!<@X)XS+XS_ &G](\+B!MTEP+B'S4,"JP";B@+>8\>#N5E*\LI5
M@X4XSZAI.J1ZO#'<P-NBEC21&P1E6 93@@$9!!P0#ZBK5%%%%%<+\5/C+9?#
M-(GO1(QF9@B1*&8A0"S'<R* -RCKDEA@$ D'BKXTZ=X<TZ/6&<RVTK*L1B&Y
MG9L_* Q4*0%8L'*E2I4_/A3M>!?'5KXXM4O;)]T;<$'AT88W1N,G##/(Y!!#
M*2I!/0445Y5/^TQHQO(=/MY'N)9K@0[HDS&K%U0$NY0,I)X:/>" 3W&?5:**
MBN[M+-&EE8(B*69F(554#)8D\  <DG@"O/\ 2OC]I.M:A%I5G*9YI&F7<BGR
ME,:ESEVVA@0IVF/>#C.0""=OQK\4],\$;1J%PD3-C"?,\A!W8;9&&?;\I&[&
MW(QG.!5KP%XUA\;V46H6RNL4N_:) H<;7:,Y"LPZJ<8)XQ]*Z"BBBBBBBBBB
MBBBHKN[2S1I96"(BEF9B%55 R6)/  '))X KS7PY^T;I/B;4(M,L6DF>96(D
M$92(%5=RI\PH^=J=D(Y'/7'I]%%%%9^OZ_!X>@>[NW$<,:[G=N@'3MR23@ #
M)8D  D@5YK#^TE::B6-A9ZA>Q*VWSK>U+Q%MJL5RS(P(W#(*@]QD$$ZME\?M
M)NQ&JRD3R7,5M]F92ERDKLJE7C;! 0GYWY0%2JLS84Z'Q#^,>F?#_"W\VV5H
MV=(E5GD8#IPHPN3PI<JI(//RL1J^ O&L/C>RBU"V5UBEW[1(%#C:[1G(5F'5
M3C!/&/I705Q7BCXO6/AK4+;2;@O]HNL;,(2B[F*1[C_MN"HVAL$9?:N#7:T4
M5Q_CCXIVGA!TMY!)-=2J6BM8(S-<.H/S,%'  &3EBH(5MN2I%97@#X\Z=XTG
M:RC,D%VK.#;W">7*=F-^,%ER.<INWC:Q*A1FNK\4>,;?PPGFW7F!-KL62">9
M55 "S.88W"  YRV 0#CH<<)_PU'X=_Y_/_(%S_\ &J/^&H_#O_/Y_P"0+G_X
MU7:^"O'MEXWA:YT^7S8ED,9;8Z88!6(Q(JGHP.<8YZ]:Z"BBBBBBBBBBN*^)
M/Q>L?AUY'V\N/M$A5=B%\!<;Y&Z?*NY<@9<Y^56P<=K1111117'_ ! ^+6G>
M 4W7TP5RN5A7YYGX;&$'(!*E0[;4W<%A7*W/[1L&GCS+O3]3MX0RAYI;39$@
M9@NYB')QDCH"3T )P*]%\,^*[7Q1"+FQE2:(X^9#G!(#;6'56 8$JP##/(%:
MM>2Z_P#M,:=I8>6&*ZNK>)MLES;P[[97W;=AD=D4GE2",J0R[6.:[#3_ (IZ
M9J%B^JQW"&SCW;Y#N7:5(!4JP#ACD;5V[FW+M!W+GBKC]J+3+&2-;F*\@@EW
M&*YEMV6"10,B1.3(RL"N"$S\RE@H)QTMI\:=.O-4718G+SO")%=1NA;*>:%#
M@\DQ?O 0-A7C?N^6NZHHHHHHHHHHKR77_P!IC3M+#RPQ75U;Q-MDN;>'?;*^
M[;L,CLBD\J01E2&7:QS7H'A#QI:>,8!=V$HEB+,NX @AAU4JP#*>AP0"00PX
M()VJQ?%_C2T\'0&[OY1%$&5=Q!)+'HH5068]3@ D %CP"1S_ ,,_C+9?$9[A
M+ 28MF0,[J%5PY<*R?,6P=A/S!2 1D9R!W5%%%%8OB_QI:>#H#=W\HBB#*NX
M@DECT4*H+,>IP 2 "QX!(\_MOVC8-0'F6FGZG<0EF"316F^)PK%=RDN#C(/4
M CH0#D5T&B_&[2=>EMK>SN!-)=-*$5 =RB-'=FD5MK1CY,+N +$@J"N6'=44
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444445YA\>?B9/X/@AMM/ ;
M4+V80VX;H"< R?,-A(9D4!R!E@QW*K*>ETNQT_X;6JQO*D,;2$O-/*JO+*^6
M:1Y'(WRM@DGT&  J@#YU^$GQ!MV\6:G>WMS"L3QW$<<KR1QQLJSPI"%;(5OW
M2#!&2P&[)Y->]7?PWT/QP[:DT$%R9H3$9E(=64':2"C;=XQM$B_O% VA@!@<
MU\%?'5T+JZ\.ZH_F7=C@QS'[\T!QMD?!90P5HR26W,' 8%U=CZ_7 ?&B+4(;
M:*]TF-)KFTN#,(G#-O4P30N%52I9@)=P4$$XP-S85N?L=3UKQQH3336B6^HI
M<12112;HTD^SSQ3+E'.^/=L*!789(#[E1P1J_!#QOJWBR&9]9L_LK)(HC.R2
M+>",L/+E+.-O'SYVMNP!E&S\U?M7?%=O%-\=-A.+:SD93@N-\N LA93@?(04
M7@_QL&*N /I7]GWX<1^"-+A79MN9XTEN&9"DA9AN$;!B2/+#;,<#(9MH9FKJ
MO'7@6U\<6KV5ZFZ-N01PZ,,[9$.#AAG@\@@E6!4D' ^ WAF;POH\%C<C$L,E
MTC<, <7,N&7<%)5AAE) RI![U:U;XS:5I<TEL]QOEAC>258HYKCRU0E7,AA2
M0)M(PP8@KQD#(ST'AGQ7:^*(1<V,J31''S(<X) ;:PZJP# E6 89Y JIJGQ"
MTW2)&@N;RVBE7&Y))XD<9 (RK,",@@C/8@UG^(_B]I/AR".[N;J,0S,RQ.A,
MP<KD-M\H.2%(PQ'"G )!(!T/#?C^Q\2VIO[6='MEW[Y"2@39RV\.%*8'S'<!
M\I#?=()Q?"'QQT?QA.+2QNA),59@A26,D#DX\Q%#$#G R< G& 2.JUOQ#;:"
M@EO)HX$+!0TKK&I8@D*"Y S@$XZX!]*S]/\ B%INH[_(O+:3RXVD?9/$VU%Q
MN=L,<*,C+'@=S65X.^-&D>,I#!8W2/+V0AXG;AC\JRJA? 4D[<[1R<9%<_\
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M)&V@XW$1JQ4$\ G )!QG:<3>$OBGIGB]E2PN$F=HY)-@W!PJ.J,65@&3YF&
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MQA6P?)!$KN4?^-P8D?(V*ZX4.S!OJ^TM$LT6*)0B(H554!550,!0!P !P .
M*\O^/?PT_P"$BMQJ5DN-3LMLMO(HRS>6PD\HKL?S.A,:D?ZS R%9PQ^U'_R+
MMY_V[_\ I1%7/_ WQ_8^#/#-E-J$Z0J?M&T$DNV+J0':B@N^-PSM!V@Y.!S7
MK?A#QI:>,8!=V$HEB+,NX @AAU4JP#*>AP0"00PX()R?$/C32-/NX(KN6 WH
MF6*%<+)<(\P   4,\8=< L=JD$;C@BNKN[M+-&EE8(B*69F(554#)8D\  <D
MG@"O.O\ AI'0/.^S_;4W^9LSLE\O.=N?,V>7MS_'NV8^;=CFNZUOQ#;:"@EO
M)HX$+!0TKK&I8@D*"Y S@$XZX!]*^6_A)\0;=O%FIWM[<PK$\=Q''*\D<<;*
ML\*0A6R%;]T@P1DL!NR>37T5I?A;2]7NEUVV2&6X:,HMS&P<$#*$@J2A88*%
MQ\^T%-VWY:ZJOE7]AC_F(_\ ;I_[<5]0:MJD>D0R7,[;8HHWD=L$X5068X )
M. "< $^@KF?#OAFR^&\5U(KQV]K+<^?AB(HHBZ11E<LVT NN0/E WA%4 #.A
MI?Q"TW5Y%@MKRVEE;.U(YXG<X!)PJL2< $G'8$T:I\0M-TB1H+F\MHI5QN22
M>)'&0",JS C(((SV(-:W]K0^3]J\Q/(\OS/-W+Y>S&[?NSMV[>=V<8YSBO/_
M /AI'0/.^S_;4W^9LSLE\O.=N?,V>7MS_'NV8^;=CFO2JXKQC\:-(\&R""^N
MD27N@#RNO"GYEB5RF0P(W8W#D9P:T/#/Q*T[Q/ ]W:7,;Q1J6D;=L,:C=\TB
MOM:,?(Q!< $#<,CFI=+^(6FZO(L%M>6TLK9VI'/$[G ).%5B3@ DX[ FC5/B
M%IND2-!<WEM%*N-R23Q(XR 1E68$9!!&>Q!JKXQ^*&G^$;47MS.GEM'OB"LK
M/,/EQY0S\^=R\CY0"&8A<FO.OV?OC3%XIBN);^YCCGGU&3R())D#K&4A$42*
M=I8 Y4$*-[;B<L37?^/_ !II&@!3JTL"F)DFC20+)*&W%4E2,!I,@YPRKD?,
M<@ UH:I\0M-TB1H+F\MHI5QN22>)'&0",JS C(((SV(-6]"\66?B#=]BN(9]
MF-_E2)+MSG;G83C.#C/7!]*J?\+"TWSOLOVRV\_S/+\KSXO,WYV[-N[=NW<;
M<9SQC-6_$WBNU\+PFYOI4AB&?F<XR0"VU1U9B%)"J"QQP#7->$/CCH_C"<6E
MC="28JS!"DL9(')QYB*&('.!DX!., D=U7*_%/QK_P (1IEQJ 7<T4?R#&07
M9A''N&Y?EWL-V"#MSCG KQK]E'PN^OFX\2:EF6[FF9(I)%.0H4"1T.=N#GRQ
MM4!!&R*0I91]'U\B^/[U_@+XA6YL04T^[5'EA5#Y14,5E1 6"EU_UB8*B/S
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MOV/<\C*B#)G RS$ 9) &>Y KZ$\#_%W2_'+O%IUP)7C4,R[9(VVDXW 2*I8
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M)GKJOV7/^1=L_P#MX_\ 2B6O5:^5?VY_^8=_V]_^V]=7\2_^1&C_ .O#3/\
MT*WKJOV7/^1=L_\ MX_]*):\J_;G_P"8=_V]_P#MO7U+=VB7B-%*H='4JRL
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M6'R8P2OLO[4?_(NWG_;O_P"E$5'[+G_(NV?_ &\?^E$M>5?MS_\ ,._[>_\
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M5^Z-@8 L"V5^U)H7_"<:II6C0-B=_/9^/N1.4S)\Q56PL,AVAMQVXZLN>_\
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M_,JHB*3SD%@Q4JK+M(S6AJG[.6AZO(T]S;O+*V-SR7-T[G  &6:8DX  &>P
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MVUT',39W*DLL.X$%2K&)T+*02"I)4]QP*Y7PS\!M'\+S"YL8'AE&/F2XN1D
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M.X^4--"P1V"@@*P970]1\Q7?A57=M&*/AK^SWI?P^D^T6R/)<?,%FF8.ZA@
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MQF6ZNQ+N;.]MXGW9.3DYR<G/6HM4_9RT/5Y&GN;=Y96QN>2YNG<X  RS3$G
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M#4(MK4.(EQM5Y99MH "A5,KN54  !00H[#DUGZO\/[;5-0M=5?(N+5950KM
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MLK!$12S,Q"JJ@9+$G@ #DD\ 5RG@?XNZ7XY=XM.N!*\:AF7;)&VTG&X"15+
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M<8W#&[.U<?8E?'?[9O@VUT6>VNX$(FNFN6F=I))"Q3R0GWV8* &( 7  P ,
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M.@KC_P!IJ[2Z\07K1L& :%25((W+!&CKQW# J1U!!!Y%?<GCWQ):^&[*6YU
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MJ*%9, *PSNW'<6&\KBN*_:6_9^T_PMIRW^E0&(Q3*)OWKNOEO\H8B5F.1)L
MV'HQ+ @96I^Q7X\-M//I$A 253/%DJI\Q=JR*!C<Y9,-C/RB(D+RQ'M?Q5\+
MZ=\2I6T*YREXEL+F"4+DHK.8B0<\C<H$D;;0P*E3N7<GQ_XA\(:G\$=1@FE
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MI5F[12WUJCHQ5E:XB5E8'!4@OD$'@@\@U;T3QO8:\YBL[J"=PI8K%+'(P4$
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M"N@HHHHKG_%OC^Q\(>5]OG2'SI-D>XGD]SP#A1D;G;"+D;F&1GH***YKQ?\
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MT.D1M/<R)%$N-SR,J(,D 99B ,D@#/<@5G^%?&EIXL226QE$R1S-$S*#MWJ
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MT;9(VN%)*G*D8.#D'T-:%?(MWX>MKSQ\UM+#&\+L6:-D5HV8V/F%BI&TDO\
M.21DM\W7FOHJ[^&6B6:-++8V2(BEF9K>!550,EB2F  .23P!65\,O@_%\/;N
M]DL\+:W*VOEQ9=FC:,2"0$N6+ E@P.<Y)7 "@MU>M^-[#07$5Y=00.5#!998
MXV*DD!@'8'&01GID'TK0TO5H=7C6>VD26)L[7C970X)!PRD@X((..X(HU#5H
M=.V>?(D?F2+&F]E7<[9VHN2,L<'"CD]A6?K?C>PT%Q%>74$#E0P666.-BI)
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M:+>Z!L M&VQ\?V>"RAL97(RI9<.H)*,K ,-7]K3P'9^&;.UU#3XDM9X[L(#
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M.Q3Y84I&$0*2J*@/''_LV^+Y].\+7EP"&-DUX858?* L*SA3MVD@R.Q/.<'
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M<JKA=R2@H6(SL\QE0;P*U?VY_P#F'?\ ;W_[;U[+\?OB(_@+29;J!@MPS)%
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ML,T4\3-\R,BL550<\,0"R !>4T'0(- \?"VM$$42L[*B\*"]BTC8'8;F) '
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M[_\ 1+UX_P#L?:3#J^AW$%S&DL37[[DD570XBMR,JP(." 1GN :\ZL?A]:>
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M^"@RB_NX]D0&5"!"5K$_8VU22]T5HY&RL-W+'&, ;5*QRD< 9^>1CDY/.,X
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M22%^+J4\/$R..G.",C(/!(KRK]FS2X](\5:E;0+MBBCO(T7).%6ZB51DDDX
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M.&P4E;==@AE#2[=IN#G;Q("@.\A,,%3BK2T2S^("Q1*$1%"JJ@*JJ--P% '
M '  X KZJN[M+-&EE8(B*69F(554#)8D\  <DG@"OF7]AS2Y(H;ZY*_NGD@C
M5LCEHQ(SC&<C E0Y(P<\$X./I^O /VUO^0/!_P!?\?\ Z)GKU7X3_P#('T__
M *\+3_T2E?/_ /S4/_/_ $#JZO\ ;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\
MKPM/_1*5E?'#XI?\*UT\WBQ^9*\@BB4_<#LK,&?D': A) Y8X7*Y++G_  O\
M#IK-M:ZOJCF]O9(8YE>4#RX?,6)PL,0_=1E=BY=5#LP+%@&VCR3]AC_F(_\
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MT9?,4[XDWGCRR&9 P8@N!'YU^V#X4M?"\.FVUC$D,0^U_*@QD@6R[F/5F(4
MLQ+'')-?1_CRQT[Q(\.CZG&)!<+++$K';EH#'N"L&5P^V3(V<E!)D[<@_-?Q
M/^!=W\&A_;6B7<@B1D$@)"RHI9-NXC"3(T@&Y"H RH*N-S#UKX[Z[_PD'A&2
M]V[//M[*79G=MWRP/MS@9QG&<#/H*B^">B/KW@Y;.(@//;7\2ELA0SRSH"<
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M)VG-XM\:V,%I\S6D=L\Y(?:@CE>X.2%/5'0*?NEW520<XJ?MS_\ ,._[>_\
MVWKM?VR=+DO=%62-<K#=Q22'(&U2LD0/)&?GD48&3SG& 2.[^#OQ5@^(UDEQ
M&P\]%1;B,#:4DQS@$L=C$$H<G(X)W*P&U'XQCN-0.F1#>\=NTL[#)$1+((8V
MPNT-(K.P!8,%3.TA@:\E\3? +2/B] FKV#&VEN5$ID3:Z,S;=XDC#;=XPRML
M93YA8N7(K*_9IUC4?#VHW?AK4W,AMX5DC)D\Q45?+0*F1NV,DB,JDJ$"XV!F
M;'T?17RK^U=;3>&]8T[7=GF01>2N 6'SPS--L9MI5=ZM\O4G:YVX7GZEM+M+
MQ%EB8.CJ&5E(964C(8$<$$<@C@BOFK]G+1'U#Q#J^JQ$-:^==1+(,E7:2X$H
M*, 48!$RV#D!T."&S6?_ ,U#_P _] ZNK_;6_P"0/!_U_P ?_HF>O5?A/_R!
M]/\ ^O"T_P#1*5\__L,?\Q'_ +=/_;BOJJBOE7X!?\CAJW_;_P#^ED=>J_M1
M_P#(NWG_ &[_ /I1%1^RY_R+MG_V\?\ I1+7E7P"_P"1PU;_ +?_ /TLCKT7
MQE\'](^,8FNDS#=QS30/,A7>'@9XL2("58?=89VR-'Y8W*N!7 ?!N+4?A9X@
M7PY=2F:UGAD:#Y_W84>9*LJH=Q0DI(KH"H+$L2X5&,/Q]_Y'#2?^W#_TLDJ+
M]J.8^'?$.F:K,I-NBP'*[2S&"X:210"PY"NN,X!)QG@X^I?[6A\G[5YB>1Y?
MF>;N7R]F-V_=G;MV\[LXQSG%?+_[#'_,1_[=/_;BHOV4?B GA&>X\.ZCB&5K
MEO+S@@S#$4D1<,5R=B^7@88[AN)9%/T?XZ\8Q^$;5[F0;G^[#$,[YI6SY<*!
M59BS-P,*<#+$8!-<5^U'_P B[>?]N_\ Z414?LN?\B[9_P#;Q_Z42U-XW^'>
MD?%F6>VN5(NK-DB:1&5)E5TCG4C[P9"&*KYBD!A+L .6/BGAWP]J/P&URRL_
M/,]A>S", 'RT=G,<;L8R7V.C,C;ARZ@*'&75?KJO%?CA\7KC1+ZST+3SY-S=
MR0;KDHL@C22;RAM1N&8E3G=@!>!EFW)G_'?X=VGACP_>RPJ7N'6V$ES*QFN9
M,3VZ_-(^6P=BG8,("/E45TO[+G_(NV?_ &\?^E$M>5?L,?\ ,1_[=/\ VXH^
M/O\ R.&D_P#;A_Z6255\::BO@WQU'>WOR02^45?*8VO;?9?,8E@%59 VXM@A
M5+ $8S]"?&*[2UT:_:1@H-E<*"Q &YHV1%Y[EB% ZDD <FO,/V*?^0//_P!?
M\G_HF"O?Z^5?C[_R.&D_]N'_ *625] ?%C_D#ZA_UX7?_HEZ\J_8I_Y \_\
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M:[_W#/\ TG:O,/VJ=(G\':C9^);+"D,D;X&W,B;F7>5=7<21[HV'&$3:6PP
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M_P#^ED='[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\
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ME$RRNJ;:RM+_ &+M/EC5KR:99VR76!E6!223L3S8Y)"J@[078LV-QP3@<_\
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M*J.?F5)F8E&QT9%4!R7" DUZ5X%\"VO@>U2RLDVQKR2>7=CC=(YP,L<<G@
M*H"@ <5\1?@.OB6^CUBQNGLKZ/8/,1$=6"AAEE^0LQ!"DLQ4QKL*$55\:?L\
M+XRMXXKZ\FEG%Q%)).ZH3M6/RY(H47;';JYPQPK$L%,GF%5(Z72/A,FC67V"
MVO+V,;0IE\\22[ '547S$>.( -@&%(V^5/FR,G$^'G[/%M\/YC/87=XN[:)$
M9X&CD"G(5E,'U&Y<. 6"L,FO5:S];TR344"13R6Y# [XA"6(P1M/G12KCG/
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M\K,=K$E^F6)&:M_$OX&6_P 0K6*WO)YFG@\TQ7!\L/E^H=$2.-ER%R%5&(0
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M^"".2Y'FEN?,[5E?#/X)P_#DD65U=&)FW/#(T+Q,VTKNP(0RGIDHREMJAMP
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M231Q+"&WR[Y,; 43<R@Y'S, O(R1D9U=?U^#P] ]W=N(X8UW.[= .G;DDG
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MJ:AXLL].F2UGN(8YY-NR)Y$61MQ*KM4D,<L"!@<G@<UJUBZWXWL-!<17EU!
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MKDMMC5%4KEP?.?B9X.C\*>+M/BMSB"2XLI8XAD)"&N3OC0%B ID#R *%52Y
M4 9/L'[6'AB"]T:>\D#F6'R/+_>RB-29E0MY8<1%MLC+N*EL'&>!BW^SAIBZ
MGX9M(9"X5O/R8Y)(7XNI3P\3(XZ<X(R,@\$BO"OA#\/H]4\2:CID;O#9I]K2
M2-"=TD"7**+<N3O53\N]@=S(&3(WDCT#Q[X6M_@S&+31IYH)M7NXHF.UKAX8
M5+AV@"*'++YRJ 6:1@?D.\;QTMWX&\-3VC6*V$Z(RD"1=.OS<*2=P82O;-)D
M'IN)&/E(*?+53]FKQ+?Z-IES%K<4\,5DH>.6>.13Y.QBR*"@9A'Y9(P6.'5
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M.YAD:(M.K))(H"LDA#*IZ-LR=Q8H6+%B<=UK?AZVUY!%>0QSH&#!94610P!
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M +,/PPM?'6E2#4<RV\=[+L@#21KYAB@S*Y1UW$* L8P-@:3.[>-F)XU\/_\
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M+%02!EE[72])ATB-8+:-(HESM2-51!DDG"J !DDDX[DFH=;\/6VO((KR&.=
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M1I'AVSU&]MUF7_0)RL/G/Y*E$$BMQAVP\8;;([INYV\+M/V*?^0//_U_R?\
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MBBBBBBBBBBBBBBBOE#P.S^ O&US#=@ 7S7'EN6*)MF<7$1!91O)9!#@<>82
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MZ42UY5^PQ_S$?^W3_P!N*^JJ^5?VY_\ F'?]O?\ [;U]55\J_ +_ )'#5O\
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MO8QP" N8]I)(^9D SGCWKP3XH3Q5907\> )H4<JK!PK$?.FX 9*ME3P#D$$
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MR;[8XS@@J<I\S-MWG<.?\-_LT6WAJZ-_:WU\ERV_?(9('+[^6WA[=@^3\QW
M_, WW@"/3]?T"#Q# ]I=H)(9%VNC=".O;D$'!!&"I (((!KYUN?V'K9I]T=[
M(MON7,;1*TNWC>/,#*N3S@^7A<C(;'/O7@7P+:^![5+*R3;&O))Y=V.-TCG
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MJU?@_P#LX67PY?[5N-Q=[2HE=0JH"3GRT^;:2I"L2S$@':55F4^M45XUXO\
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MBZG&T,A<*V,F.22%^"#P\3(XZ<X(R,@\$BI;2T2S18HE"(BA550%55 P% '
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M6:31M<(NYX0ZF55^7YB@.X#YEY(QR/45H5%=W:6:-+*P1$4LS,0JJH&2Q)X
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M2)&@N;RVBE7&Y))XD<9 (RK,",@@C/8@UT%5=4U:'2(VGN9$BB7&YY&5$&2
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MCBM"TNTO$66)@Z.H964AE92,A@1P01R"."*BU35H=(C:>YD2*)<;GD9409(
MRS$ 9) &>Y JIH7BRS\0;OL5Q#/LQO\ *D27;G.W.PG&<'&>N#Z5JUGOXAMD
M,RF:,&W4-.-ZYB4J7#2<_("H+ M@$#/2N*^)WQKLO"&G&_BFCE>59%M0C"59
M)!D?P,,HK?ZPAA@?+G>54]+\/=4DU?3;.YG;=++:6\CM@#+-&K,<  #)).
M/05T%%%97_"66?V?[=]HA^R_\]_,3R?O;/OYV_>^7K][CK5O2]6AU>-9[:1)
M8FSM>-E=#@D'#*2#@@@X[@BN?\4>%M+N+JVO[](?M,<@CMY)&"DNV2B $@.V
M<M&I#%6RR -DU:\=>.K7P/:O>WK[8UX '+NQSMC09&6..!P  68A02,7X'^+
MY_&.DP7]V0996G+;1M4 3R*J@>@4 #))(&6).2>ZHHHKYK_;:\3365K:6,9Q
M%<22O)@L"WE>7L4X(!7,FX@@_,J$8QSZ_P#$'X/Z?XZM4LKF/8D6/):+:CQ
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M +$(Q.,D#/3)'K6U7S+\*];?Q/XSU"6Z 8V\-S%#G)$:Q3QPJ4W%MI*EBVW
M)=^ &(KUMO@7I;:FVL&+]\\<BO'QY#&12DDC)CEF1BK G8V2Q4N2U;7@#0=.
MT"!K321&L44SK(L;^81+QO5V+,V\< ACN VKP !7%:I\:4NO$%IH5BX8!KC[
M60 1N6"1DB#9ZAAF3 R"%7=D2+7K5%%%%%%?(OQB\/6V@^+=)BLX8X$+6+%8
MD6-2QNW!8A !G  SUP!Z5]2ZAXLL].F2UGN(8YY-NR)Y$61MQ*KM4D,<L"!@
M<G@<UJURO@KPMI?AJ2Y@TQ(8Y3(KW"1L"ZEP2@9<DHN,F-/E0 DHHR:Z6[NT
MLT:65@B(I9F8A550,EB3P !R2> *RM$\;V&O.8K.Z@G<*6*Q2QR,%! +$(Q.
M,D#/3)'K7FG[57AZVGT6ZO'AC:X1;=4F**957[1'\H<C<!\S< XY/J:F_9PU
M:'2/#-I/<R)%$OG[GD9409NI0,LQ &20!GN0*]5TO5H=7C6>VD26)L[7C970
MX)!PRD@X((..X(JU6?K?AZVUY!%>0QSH&#!94610P! 8!P1G!(SUP3ZU\R_L
M,?\ ,1_[=/\ VXKZ5T+Q99^(-WV*XAGV8W^5(DNW.=N=A.,X.,]<'TK5KG]+
M^(6FZO(L%M>6TLK9VI'/$[G ).%5B3@ DX[ FN@HJ*[NTLT:65@B(I9F8A55
M0,EB3P !R2> *RM$\;V&O.8K.Z@G<*6*Q2QR,%! +$(Q.,D#/3)'K6U57^UH
M?.^R^8GG^7YGE;E\S9G;OVYW;=W&[&,\9S4.B>(;;7D,MG-'.@8J6B=9%#
ME24)&<$''7!'K6A6?K?B&VT%!+>31P(6"AI76-2Q!(4%R!G )QUP#Z5%I?BR
MSU=5>VN(95:0QJ8Y$<%PAD* J3E@@+%1SM!.,<U\M?MJ^'K;2WLI;>&.-YFN
MVE9$5&D;,)W.5 +'+$Y.3DGU-?4NN^++/P_M^VW$,&_.SS9$BW8QNQO(SC(S
MCID>M:M96N^++/P_M^VW$,&_.SS9$BW8QNQO(SC(SCID>M6]+U:'5XUGMI$E
MB;.UXV5T."0<,I(.""#CN"*M444444444444444444444444444444444444
M4444444444444444444444444444444444444445Y+\%%?Q-<WWB&4ATN9C#
M9G:>+:!F0,NYBZ"1^70A/G0OM^88\J^%C/\ "?Q5<:.X$=I>,?*RQ";?FDM2
M&D7<Y&6@P&P9&(RS*,_5]?)?[-_B32?%LER-=$,^IW%PK+)=+&XD4A42./?E
M0P8D;%"DJ4"AE3">]> _A5!X)O;VXLU$<%VMNWE@\)(AF\S:, *A#J5 )P=P
M 50HKP7]F_Q)I/BV2Y&NB&?4[BX5EDNEC<2*0J)''ORH8,2-BA25*!0RIA/;
M_#7P_M/AE/J&HPXALYH8I709(C:+SVF*JJ\)M92JC<0=P4*H5:\U^!>@0?%R
M6[\0ZN@N'^TF*WAE_>1PQJF[8!Q&XQ,!\T?#*9/ON2.?^.OA1_@S>V^O:$H@
MCD9HYHQGRBY)DVE2_*.H(V(%6/RP5*L5(]0^-GQ+9;&TM]*EVW.K20QVTOSI
MMCD*;I<^62O#JO\ "Z[]Z_,F*Z#2_@)HNGVJV7V.&11&4,DB*T[9SN8RX#AC
MDD%2NWC9M  &)\#_ (47_@6"ZT^^N1-:,W^C"-I$=%;?YAR K1%LJP".P5MS
M*0Q+-X_H.@Q:#X^%O;@A SM\SO(Q9[%I'8M(S.Q+L2223DUZA\9/AKJ?C/5M
M.*;'TN*2.2>-V78&1RSET(S)OCPB#Y@#N!"*S,W-?MGVT%E;6E\F$OUN56*1
M6V3>6JN[8P02%DV$'G8S<%=YSVOBBRB\5>&/MU_''-<#1WE61XT++(]J'9T^
M7Y"6 /RXY QT%<+^QSX3L]1TV2ZGMX9)X[]]DKQHTB[8X&7:Q!888DC!X/(Y
MJ7P=XBL/B1=W6IZJDEY%#<R0V,:V=Y/;QQ*.9"(XY(V>0.I82+O4JI&!L"XG
MQ!T\^%]4M=7\+V5X#\RW<,=I<V\+(ICPFU[<*-Z[@VT$!E60*)!N;ZJHHKRK
M]J/_ )%V\_[=_P#THBK%_:8^!H\<P'4+;(O;>$X4!F$L:[G\H* 3OR24*CYB
M=C<%62U^SA\<C\18&M[O O;=5WD%0)4/'FA0<@@X$@ V@E2,!PBZ'P"_YBW_
M &'K_P#]IUP'@+[/\=-:O+V\_?6-CY:6D#;O+^9B1-CY,[O))9)%;(<(V1&H
MJ']HWX7)X)2+Q#H2"UFMYE\WR@$7:P6-'"EM@ ;",BH1()"7! ;/NOPU\7CQ
MCIUM?@@F6%2^T,JB0?+*H#<X$@8#DY R"1R>EKRK]J/_ )%V\_[=_P#THBH_
M9<_Y%VS_ .WC_P!*):\0^,_A*+1O%>G16K2(9FL6:1I'GEWFY:,/NN#+DA44
M -E?E'RD9!] _:2^$NG:7H<US;PA)H9HY?-^_-(TDP1Q)+)OE<'S2W+9W!><
M#%5+3QI=V?@1;R*4I.D(B610%94%U]G &!P1%\H8?,#\V=WS5H? O1/#?C32
MXK9+>V>Y6WVW".B?:MV )9 QS+M+/E'5L+N5049=J^@>%?A%!IVE+HUR7>!)
M+C&V:6,M&\LK(KM$8BV8Y '4C86SP0 :\4_88_YB/_;I_P"W%;?C20?&'Q(N
MA2$?V?IZM+,$E;,S[4#*=N5!5W$9'#*/.PX9@JV_VGOA;9:?H\MY8Q1VKPM'
MO\F,1"6-Y44Q.(RJL ^R0%@V"GRXW$U:^$WB\>#O!B7Y(!BANBFX,RF0W$JQ
M*0O.#(5!Y& <D@<B+X<:=I-U:I?:I;37M]=1I+//+IUY."6RRJF8)(E558(#
M%A&55(&-H&5\';.Y\':_/96%O>#1;C<R&:*>..-Q$)-^9HE8?,K0C)4L"A9G
M*J3Q/QR\'KI'BBPAL7>*6;[&WG2/)=.)3<-&LA\]W+;0BX4G;A0.*][\.?L[
M:=X>U"+58&G^T1*VXO+Y@E=U='EDWJ6+MO).TJN<$*.<^GU\Z_M=^)O[-;3;
M>X+FQEN'>[A0X,J1/ =N05/1FP-P&[#'E5(Z77_A1H7Q.TQSI,=JKE<PS0*D
M1679N19#&FX#YAYD;+N .=H<*1H?M1_\B[>?]N__ *415S_[.'@.SUK0K26]
MB2Y/[\(LR)*D8$\H*QJRX7)^9FY=C@,Q5(U3D/V7+M_#VMZGH<3%K6-IV7>2
M6#0SK"&XP@+(WSD+EBJ= ,5W7@CX:ZFGB2\U?5-DD C>.T<LK%5=P4"*!F/9
M'N1R0I+.Q!<,S'SKXD7:>%?&=F=,81/<-:K=B,C#--.5D5UY +1[&(P#DK+]
M\AJ]:_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#MX_\ 2B6O*O@%_P CAJW_ &__
M /I9'7U5575-)AU>-H+F-)8FQN215=#@@C*L"#@@$9[@&ODKX)>$[/4?%6J6
ML]O#)!']MV1/&C1KMNHU7:I!484D# X' XKU#XL_"K4/$^IZ9';K&='MVB:2
M E%B4QOELQX^<-%B., ,%^8$(K$MS_[9]M!96UI?)A+];E5BD5MDWEJKNV,$
M$A9-A!YV,W!7><[7QAU235_!?VF=MTLMII\CM@#+-);LQP  ,DDX  ]!6+\)
M/'"6'A^PTF!([B_O5NTBMY"/*V>?/YDLW_3$*&RHRTF"B _,5]*^'7P'TSP5
M!%&(8YYXV#FXDC1I3(,'<I()C (&Q5/RXSDL68\!?^([7Q]KEW!J(DN+#3FB
M2&WBMKN9#/G]Y++Y*MDHR/&JR*8W4G:#\Y?G_C1X<A@-MJ7ABTNH-0AF Q!8
M7,"&,JY+,K6ZHQ#84_WE9E<,H&WZ4\/:D^J6T-Q+&87DAC=HFSNC9E#%#D*<
MJ3@Y .1T'2M"OD#]LKPG9^'_ +!]BMX8-_VK?Y4:1;L>1MSL SC)QGID^M?3
M47AS3/!:2WT5O!;".%VDDBA1&$:C>^?+3<1\N<#.2!P3BO%?@7H$'Q<EN_$.
MKH+A_M)BMX9?WD<,:INV <1N,3 ?-'PRF3[[DCG_ (Z^%'^#-[;Z]H2B".1F
MCFC&?*+DF3:5+\HZ@C8@58_+!4JQ4CNOVFM,M/$F@/JJ%WQ':R0'S)ECP\J
M/Y18)N*2L-S)O .,C QROP9^!-KX_P!"MY-2EF?/FBW"-Y8MU$[[P@PRLTC
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M$9%0B02$N" V?8/#=Q;_ !6TBWFN<LD\(,JQ//;J7VM'-&=CJ[('WKM8LK
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M\R1Y0K!@"& <!@1PP(YZUW]>5?M1_P#(NWG_ &[_ /I1%1^RY_R+MG_V\?\
MI1+7E7Q]_P"1PTG_ +</_2R2O5?VH_\ D7;S_MW_ /2B*L7X':W;:-X4M9;X
M V[-)%)NVE-LUX\.7WD+L&_+YXVYX/0\U\1OV0XXLWOA^1X+B/#I 7)4LNW;
MY<I8/&W!8%BP+D#,:C([K]F#QY/XRTA7NR7E@F>!I&.YI JHZL>!R%<*2=Q8
MKN9B6->7_L,?\Q'_ +=/_;BJOPQU%?"/C6^@O?D:ZDN4C)*;<S2I<0Y.[^-
M H&6WLJX!)QZU^U5=I!X?NE=@I=K=4!(!9O/C?:,]3M5FP.< GH#7G6F:7)J
M?P^,<*[F$<LA&0/ECO6ED/)'1$)QU., $X%=U^S'\58/%FG16)8+=VD*QO'C
M;F-,)'(N2=PV[0YXP^<JJLF?1=5\8QV5[;Z<HWSS[V91DF.)4<^<V%("F0+&
M-Q7<S_*25(KYU^/O_(X:3_VX?^EDE?55%<?X\L=.\2/#H^IQB07"RRQ*QVY:
M Q[@K!E</MDR-G)029.W(/S7\3_@7=_!H?VUHEW((D9!("0LJ*63;N(PDR-(
M!N0J ,J"KC<P]:^.^N_\)!X1DO=NSS[>REV9W;=\L#[<X&<9QG SZ"M7]ES_
M )%VS_[>/_2B6O*O@%_R.&K?]O\ _P"ED==-\//&+_'F[O!,\D.EVZQJMHC&
M-IO-$J[II(V#XV@YB5MA)0$ML)DX_P"-.DPZ1XKT>"VC2*)?L.U(U5$&;V4G
M"J !DDDX[DFO7_VH_P#D7;S_ +=__2B*C]ES_D7;/_MX_P#2B6O*O@%_R.&K
M?]O_ /Z61U]545\J_ +_ )'#5O\ M_\ _2R.NU\??$^XU[78O"UE(]JIS]IN
M%"F4@P&;RXB<[/D_Y:??#D%0 G[SFOVK_!=IX8T:,6D00R:BC2/DO+(QCN6W
M22.6DD.7;!=B1G P*V_B7_R(T?\ UX:9_P"A6]>=:!\'3JOARRUS2D(U2U:2
M0!%5C,([J0C*MPSH!E3ABP7RRK93;[_\#?BZGQ,LO/*B.XB8)/&"" V 0ZC)
M8(W.W=R"&7+;=Q\5^'_Q 3X;>)]3L]2Q%%>7+-YAP0K&1I8&9@V%1HYCN)!*
MDKNV .1]/Z_K\'AZ![N[<1PQKN=VZ =.W)).  ,EB0 "2!1X>U)]4MH;B6,P
MO)#&[1-G=&S*&*'(4Y4G!R <CH.E:%?*O[<__,._[>__ &WKZ0\;Z(^O6%U9
MQ$!Y[:>)2V0H9XV0$X!.,GG )QV->"_L7:[]GAO-)F7RYX;CS2K';(=P$4B^
M60&&QHP&/8N 0#C.K^V;_I6FVMK'\T\M_'Y<2\R/B.53M4?,WS.HX!Y91U(K
M0^-FB/H/@YK.4@O!;6$3%<E2R2P(2,@'&1QD X["MK]ES_D7;/\ [>/_ $HE
MKU6BOE7X!?\ (X:M_P!O_P#Z61T?MS_\P[_M[_\ ;>O5?VH_^1=O/^W?_P!*
M(J/V7/\ D7;/_MX_]*):YKQ-\ M(^+T":O8,;:6Y42F1-KHS-MWB2,-MWC#*
MVQE/F%BY<BLK]FG6-1\/:C=^&M3<R&WA62,F3S%15\M J9&[8R2(RJ2H0+C8
M&9L?1]?-?[;7AF:]M;2^C&8K>25),!B5\WR]C' ("YCVDDCYF0#.>/>O!/BA
M/%5E!?QX FA1RJL'"L1\Z;@!DJV5/ .000#Q7S_H.B/KWCNYO+<AH;5097&2
MH8VJV_EY4%=^\G*D@X1^ZD5G_'W_ )'#2?\ MP_]+)*^JJ*\J_:C_P"1=O/^
MW?\ ]*(J/V7/^1=L_P#MX_\ 2B6O*O@%_P CAJW_ &__ /I9'47[*/Q 3PC/
M<>'=1Q#*URWEYP09AB*2(N&*Y.Q?+P,,=PW$LBGZ/\=>,8_"-J]S(-S_ '88
MAG?-*V?+A0*K,69N!A3@98C )KR#]M;_ ) \'_7_ !_^B9Z]5^$__('T_P#Z
M\+3_ -$I755XK^USX9FUO12\ W?9[A)W #%M@5XV( !^[Y@9LX 16)/&#TO[
M/?BA/$6AV;I@&*%8'4,'*M"/+YP!M+*JOM(R PZC!/E7Q4T1_$_C/3XK4AC;
MPVTLV,D1K%/),P?:&VDJ5"[L ETY 8&O:OB]X0/C#2;JQ0$O)"3&%*J3(A$D
M2Y;Y0"ZJ#G'!/(ZCPO\ 9I\7CQ5I\7AYB 8II9)@ PW6JLDFPDY5C)/+Y;IC
M:UN)5;:Q4MD^,=2?X0^+GNK>,R)>0LX@BR\DC3!@$.\$J6NXPWR9(4@*#_JZ
M^I?"FA?V#:Q6I;>T<:AY,;3(_625AD_,[DNQ))+,22223\U?'W_D<-)_[</_
M $LDKU7]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\ THEKU6O"O'WQ/N->UV+P
MM92/:J<_:;A0IE(,!F\N(G.SY/\ EI]\.05 "?O.:_:O\%VGAC1HQ:1!#)J*
M-(^2\LC&.Y;=)(Y:20Y=L%V)&<# KC_VBM+DET'0;D+^Z2T2-FR.&DMX&08S
MDY$3G(&!CDC(S]:^%/$T/BBUBOK8YBFC5UY4D9ZJVTL RG*L 3A@1VKYE_9W
MNTO/%NJ2Q,'1UOF5E(964W<1# C@@CD$<$5[!^T?\/W\;:1+%#DS0,)XE&3O
M9%8,F K,Q*,P0#!+[>0,UQ7[/_B\^.]/L=/<EA9LS7!PH&+=HS91_)@J"71U
M<X+FUD0JZEVKU_XD>.$\#:?/J,B&00JN$4@%F9E1!D]!N89."0,D!B,'SKX1
M:%_PLZRCUG7&^U-+)(T5NPQ:0A'FB $.2DC<M^\E#N!M .5+-Y_\ O\ D<-6
M_P"W_P#]+(Z/C[_R.&D_]N'_ *625ZK^U'_R+MY_V[_^E$5<K\-/^1&D_P"O
M#4__ $*XH_8I_P"0//\ ]?\ )_Z)@J6V^(L_Q+U^;1899+6RLUE,WEG9/</%
M-&C+YBG?$F\\>60S(&#$%P(_.OVP?"EKX7ATVVL8DAB'VOY4&,D"V7<QZLQ"
M@%F)8XY)KWK]H/5+*PT6Y_M%2\3JJ+&KB.1Y"P,84GN& <\-A58E' *GFO O
MPIU32M&33K;5(5BDCW)+%;%W028=A%*+A RDEBLA3?ALJ5^7;Z5X%\"VO@>U
M2RLDVQKR2>7=CC=(YP,L<<G@  *H"@ ?.'[*/Q 3PC/<>'=1Q#*URWEYP09A
MB*2(N&*Y.Q?+P,,=PW$LBGZ/\=>,8_"-J]S(-S_=AB&=\TK9\N% JLQ9FX&%
M.!EB, FN@K/\0ZVF@VTUY*"4@ADE8+@L512Y R0,X'&2!GN*\5^$5V_QM2?4
M=58M:I<F.&P4E;==@AE#2[=IN#G;Q("@.\A,,%3BK2T2S^("Q1*$1%"JJ@*J
MJ--P% '  '  X KL/VUO^0/!_P!?\?\ Z)GKU7X3_P#('T__ *\+3_T2E?/_
M .PQ_P Q'_MT_P#;BM#]K[PG/I\MIXBM"0]NT<;G&X(5<R028V%<;RRL7."3
M&H7DUZW\']=_X3&%];*[/M?EK&I.62*$%#&<  XN#<,K8W,CKNQ@(G?T5\M_
MLK>,4\(7-YX<OGC1TN7,;[@JO*&6WDC!=E+$E4,:A=Q&\GL*]_\ '?CF+PG$
M&($EQ*RI;V_F)')-(SI&JKO(X#.N]N=BY8@XP?GK]JZVF\-ZQIVN[/,@B\E<
M L/GAF:;8S;2J[U;Y>I.USMPO/U+:7:7B++$P='4,K*0RLI&0P(X((Y!'!%?
M-7[.6B/J'B'5]5B(:U\ZZB609*NTEP)048 HP")EL'(#H<$-FL_X^_\ (X:3
M_P!N'_I9)7T!\6/^0/J'_7A=_P#HEZ\J_8I_Y \__7_)_P"B8*Y_]KC3F\6Z
MAI>D6OS73^<=N'PJRM&JR,54_*/*<L1DJJEB,8SG_$9G\">-;?5+D#[/<M%M
M<L415:$6DA9V7:"F?,8 D;2N2N[CZJN[M+-&EE8(B*69F(554#)8D\  <DG@
M"OG#]B7PS-96MW?2#$5Q)$D>0P+>5YF]AD %<R;003\RN#C'.3_S4/\ S_T#
MJ]K^.'Q2_P"%:Z>;Q8_,E>011*?N!V5F#/R#M 0D@<L<+E<EES_A?X'36;:U
MU?5'-[>R0QS*\H'EP^8L3A88A^ZC*[%RZJ'9@6+ -M'DG[#'_,1_[=/_ &XH
M_P":A_Y_Z!U6_P!H?Q#)X$\2:;K+)N@6W\L]&) >59PJ[E.X1S@J20I8CD@,
M*^C] U^#Q# EW:.)(9%W(Z]".G?D$'((."I!! ((K/\ !WC&/Q6LTMN,P1W#
M11RC)28*B;Y$)4 J)"\8*EE8H2&(.!T%?*'Q&9_ GC6WU2Y ^SW+1;7+%$56
MA%I(6=EV@IGS& )&TKDKNX^JKN[2S1I96"(BEF9B%55 R6)/  '))X KYP_8
ME\,S65K=WT@Q%<21)'D,"WE>9O89 !7,FT$$_,K@XQSD_ +_ )'#5O\ M_\
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M7@MK")BN2I9)8$)&0#C(XR <=A6U^RY_R+MG_P!O'_I1+7DO@=G\!>-KF&[
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MP;XF'B>U2\1"B2-)Y>X,"T8D98I<,JL!(@60 C@,.O4[5?*'@=G\!>-KF&[
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MG"<X8GDL3@$G/2^*_#,/BBUEL;D9BFC9&X4D9Z,NX, RG#*2#A@#VKS7X:_
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ME4[S#L+;@'W9W@/N%=+17"_#'X30> 7O)(2";NY:7"IY:I'DF.$*&*X3<V&
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M<,:[G=N@'3MR23@ #)8D  D@4:!K\'B&!+NT<20R+N1UZ$=._((.00<%2""
M016A6+XO\:6G@Z W=_*(H@RKN())8]%"J"S'J< $@ L> 2-6TNTO$66)@Z.H
M964AE92,A@1P01R"."*EHHHHHHHHHKG]8\?V.C74-A<3HES<9\J,DY;L,G&%
MR?E3<1O8%4RP(KH**X^Q^+VDZC=QZ=;W4<MQ*I9%B)E4@!F.70-&" A."P.,
M<<C/84445S7B_P")6G>#@3?W,<1"JVPMF4J6VAA&N9&&<\A2!@D\ XV])U2/
M5X8[F!MT4L:2(V",JP#*<$ C((." ?45:HHHHK%\4>-K+PJGF7\\<(*NRAV
M9@@!;8OWG(R.%!.2 !DBN/TO]I'0-3D6&.]0,V<&1)84X!/+RHB#IQDC)P!R
M0*[JTU^"[GEM(W#30+&TJ#DH)-QCSV!(4G'4#!( 92="BBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOD7]M7P];:6]E+;PQQO,UVTK(BHTC9A
M.YRH!8Y8G)R<D^IKZZK%UOQO8:"XBO+J"!RH8+++'&Q4D@, [ XR",],@^E:
MMI=I>(LL3!T=0RLI#*RD9# C@@CD$<$5GZ[XLL_#^W[;<0P;\[/-D2+=C&[&
M\C.,C..F1ZU+HGB&VUY#+9S1SH&*EHG610P )4E"1G!!QUP1ZU;N[M+-&EE8
M(B*69F(554#)8D\  <DG@"L^?Q99V_D[[B%?M&/(S(@\W.W'EY/SYW+C;G.X
M>HJWJ&K0Z=L\^1(_,D6--[*NYVSM1<D98X.%')["JFH>++/3IDM9[B&.>3;L
MB>1%D;<2J[5)#'+ @8')X'-:M<__ ,+"TWSOLOVRV\_S/+\KSXO,WYV[-N[=
MNW<;<9SQC-;=M=I=#=&P8!F4E2"-RL4=>.X8%2.H((/(J6LK7?%EGX?V_;;B
M&#?G9YLB1;L8W8WD9QD9QTR/6I=$\0VVO(9;.:.= Q4M$ZR*& !*DH2,X(..
MN"/6OE7XQ>'K;0?%NDQ6<,<"%K%BL2+&I8W;@L0@ S@ 9ZX ]*^I=0\66>G3
M):SW$,<\FW9$\B+(VXE5VJ2&.6! P.3P.:U:S];\0VV@H);R:.!"P4-*ZQJ6
M()"@N0,X!..N ?2C1/$-MKR&6SFCG0,5+1.LBA@ 2I*$C."#CK@CUK0HHKR7
MXJ?&E-!O[+1[-P;J>]M5G& WEPO(NY22<*[@@ 8)"$M\I,;'UJBN5N/"VEVV
MIQW\B0KJ,L;)&Q8"5PJ_.54GYF"<%P"X3Y2VSBNEN[M+-&EE8(B*69F(554#
M)8D\  <DG@"L_4/%EGIT*74]Q#'!)MV2O(BQMN!9=K$A3E02,'D<CBM"TNTO
M$66)@Z.H964AE92,A@1P01R"."*EKY%_;5\/6VEO92V\,<;S-=M*R(J-(V83
MN<J 6.6)R<G)/J:^I==\66?A_;]MN(8-^=GFR)%NQC=C>1G&1G'3(]:U:Y71
M_"VEZ-J$TUND*:A<1B24!AYK)NP7"9^52_WV4 .X!<E@#70:IJT.D1M/<R)%
M$N-SR,J(,D 99B ,D@#/<@5GZ7XWL-6#-;74$H5HU8I+&X#2-LC4[6."S?*H
M/+'@9-;5%<_JGQ"TW2)&@N;RVBE7&Y))XD<9 (RK,",@@C/8@UT%5=4U:'2(
MVGN9$BB7&YY&5$&2 ,LQ &20!GN0*AF\0VT$ZV;S1K<.NY(2ZB5E^;Y@A.XC
MY6Y QP?0UH5\B_MJ^'K;2WLI;>&.-YFNVE9$5&D;,)W.5 +'+$Y.3DGU-?4N
MN^++/P_M^VW$,&_.SS9$BW8QNQO(SC(SCID>M:M96N^++/P_M^VW$,&_.SS9
M$BW8QNQO(SC(SCID>M6]+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*-4U:'
M2(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*AF\0VT$ZV;S1K<.NY(2ZB5E^;Y@A.
MXCY6Y QP?0UH55U#5H=.V>?(D?F2+&F]E7<[9VHN2,L<'"CD]A534/%EGITR
M6L]Q#'/)MV1/(BR-N)5=JDACE@0,#D\#FM6LK7?%EGX?V_;;B&#?G9YLB1;L
M8W8WD9QD9QTR/6K>EZM#J\:SVTB2Q-G:\;*Z'!(.&4D'!!!QW!%2W=VEFC2R
ML$1%+,S$*JJ!DL2>  .23P!6)I_Q"TW4=_D7EM)Y<;2/LGB;:BXW.V&.%&1E
MCP.YK0U_0(/$,#VEV@DAD7:Z-T(Z]N00<$$8*D @@@&L_P +-I^D6*&P:%;&
M*-MKHZF$*I.]B^2#@AB[$D[MQ8YR:XKX0?%[_A8M]J/D'-G;_95M\IL8[A-Y
MDASEOF91M!QA N55BV>U\=>%K'Q+:O#JB(]LO[QB[% FS)W[P5*8&<L"/E)!
M.TD'6TGR?)C^R[/(\M/*\O;Y>S V;=OR[=N-N.,8QQ6?K?C>PT%Q%>74$#E0
MP666.-BI) 8!V!QD$9Z9!]*U;2[2\198F#HZAE92&5E(R&!'!!'((X(HN[M+
M-&EE8(B*69F(554#)8D\  <DG@"L_4/%EGIT*74]Q#'!)MV2O(BQMN!9=K$A
M3E02,'D<CBM"TNTO$66)@Z.H964AE92,A@1P01R"."*EHHHHKE?%'A;2[BZM
MK^_2'[3'(([>21@I+MDH@!(#MG+1J0Q5LL@#9-9_QB^*L'PYLGN)&'GNKK;Q
MD;B\F.,@%3L4D%SD8' .YE!U?!%R?$>E6LEYB4W%E TP95VN9(E+Y7&W!R<C
M&,'&,5\X:7I,.D>/U@MHTBB7.U(U5$&=/).%4 #)))QW)-?3_P#PEEG]H^P_
M:(?M7_/#S$\[[N_[F=WW?FZ?=YZ5JU%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/
M %>7_"#XO?\ "Q;[4?(.;.W^RK;Y38QW";S)#G+?,RC:#C"!<JK%L\+^V?X>
MMH-.CO$AC6X>]B5Y@BB5E\F;Y2X&XCY5X)QP/05ZKX!\0VV@Z)ITMY-' ALK
M10TKK&I8P*0H+D#. 3CK@'TKM;2[2\198F#HZAE92&5E(R&!'!!'((X(JIK?
MB&VT%!+>31P(6"AI76-2Q!(4%R!G )QUP#Z4:)XAMM>0RV<T<Z!BI:)UD4,
M"5)0D9P0<=<$>M:%<_X_\8Q^#+&?4)AE88R0O(W,2%C3(5L;G(7."%SD\ UX
M!\ /#/\ PMNXN?$.N!+@K)Y$,+#="F%W,/+8%=JK(HCR6^8N[ R8>OI75-)A
MU>-H+F-)8FQN215=#@@C*L"#@@$9[@&O'_AE\.?^%9ZY<6EJ/]!O;0SINY='
M@E5#"#N)*@3YRRY(*C<2KEO6M;\0VV@H);R:.!"P4-*ZQJ6()"@N0,X!..N
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M7Y1U!&Q JQ^6"I5BI'=?M-:38^)- ?5DC1Y!':O!/M*R;'E0 9(#;2LK'8W
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MEG\0%BB4(B*%55 554:;@* .  . !P!78?MK?\@>#_K_ (__ $3/7JOPG_Y
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MVE#U.0-;]B[7?L\-YI,R^7/#<>:58[9#N BD7RR PV-& Q[%P" <9U?VS?\
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MSS[>REV9W;=\L#[<X&<9QG SZ"M7]ES_ )%VS_[>/_2B6O*OV&/^8C_VZ?\
MMQ75_MK?\@>#_K_C_P#1,]97QA\,S:WX-L'@&[[/;V,[@!BVP6YC8@ '[OF!
MFS@!%8D\8/I_[/?BA/$6AV;I@&*%8'4,'*M"/+YP!M+*JOM(R PZC!/E7Q4T
M1_$_C/3XK4AC;PVTLV,D1K%/),P?:&VDJ5"[L ETY 8&MO\ ;6_Y \'_ %_Q
M_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\ [#'_ #$?^W3_ -N*^JJX_P"+WA ^
M,-)NK% 2\D),84JI,B$21+EOE +JH.<<$\CJ/"_V:?%X\5:?%X>8@&*:628
M,-UJK))L).58R3R^6Z8VM;B56VL5+9/C'4G^$/BY[JWC,B7D+.((LO)(TP8!
M#O!*EKN,-\F2%("@_P"KKZE\*:%_8-K%:EM[1QJ'DQM,C]9)6&3\SN2[$DDL
MQ))))/S5\??^1PTG_MP_]+)*ZO\ ;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\
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MC(!QV%<+^Q3_ ,@>?_K_ )/_ $3!7*?\U#_S_P! ZNK_ &UO^0/!_P!?\?\
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MA/?W=XVW<(T5X%CC#')55$'T&YLN0%#,<"O0/#.AMHD(@>>:XVX ><QM)@
M*6CCCW=,[FW.222QXQJU\E_M)Z7'J_BK3;:==T4L=G&ZY(RK74JL,@@C()&0
M0?0UZ?K?P&OO$:"RU#5YYM/##]R(8DF95!\L/.,F0@[2Q="'8;L!L%?5= T"
M#P] EI:((X8UVHB] .O?DDG)).2Q)))))KR6]_9J73+XZGH-X^G2MOWHL230
MX8#*JC% %R"VUMZAMI0)L45U?@[X2+I-T=4U"=[[4#'Y8GD5(TC4;AB*)!MC
MRIPQR23N(*[W!E^(GPH3QO/;7#W,]N;59]C6["*7=+Y8SO(; "HP( RV[J "
M&Y^Y^"U]XC'D:WJDEW:;E8P1P16@=E8$!WC)9DZY48.=K!@R@UT'C_X10^-(
M%LI)YX+150"WMS#'$=F=F<PLV!QA-VP;5(4,,U+\-?A:GP^C^SVUS<R6_P Q
M6&9HG12Q!+*5B1QT/RAMF69MNXYKBO"7[-[>#;Z6ZTS4)K:UEX:W6.-VQC*K
MOF\Q3M8_*S1EPA*[LLS'H/B#\";?QVJ17=U>>1%CRX5DCV A FXEXGDD; )W
M2.[ LV" Q%=!X.^'J>&K4V#3375MY?EK'<^5(%3Y@4RL2%E(.W:Y8!0%4*HQ
M7G6F_LVR^$[F2XT#49+))5P\30I=+]XL,;V484'"E@S@;OG.XBNZ\ _"V'PI
M)+>22/<WUQCS[F7;O. ,H@4 1Q9&0@S@!5+$(FW/^)GP3A^(Q O;JZ$2MN2&
M-H4B5MH7=@PEF/7!=F*[F"[02*U?"_P\;PU:?88+VZ**J+$S_9WDB523M0M;
MX((^7#APJ@!-N!7-?#S]GBV^'\QGL+N\7=M$B,\#1R!3D*RF#ZC<N' +!6&3
M7JM%<+\,?A-!X!>\DA()N[EI<*GEJD>28X0H8KA-S88!<@XQ@#%KQE\,X/%=
MW8WLY.;&9Y%3^%BP!&<$$%9$1P<D$*592&R.PKR#Q)^S1;>);H7]U?7SW*[-
MD@D@0ILY78$MU"8/S#:!\Q+?>))Z7X@?":+QSIW]FWDTCNK;X[A@@D60;MK%
M8EBC8 ,5*[1E>X?#BI\._A9=>%K9;6?49YQ$KK!A(XEC!7:IP1(TA3+;%D9X
M@-O[K,:$8O\ PS1;?;O[6^W7WVSS-_G>9!NSC&,?9]NW;\NS&S9\FW;Q70?$
M7X.1?$&&.VOKFY\J/8=J?9UW2*&7S6/D$[B'((4JGH@K:\!^"!X-@%HEQ//$
MBJL:SF)C&HS\JLD2,1S@!BP4*JKM Q72UXKX2_9O;P;?2W6F:A-;6LO#6ZQQ
MNV,95=\WF*=K'Y6:,N$)7=EF8]!\0?@3;^.U2*[NKSR(L>7"LD>P$($W$O$\
MDC8!.Z1W8%FP0&(K:\+_  \;PU:?88+VZ**J+$S_ &=Y(E4D[4+6^""/EPX<
M*H 3;@5S7P\_9XMOA_,9["[O%W;1(C/ T<@4Y"LI@^HW+AP"P5ADUB_%7]E.
MR\;3M>6\IM)Y&!DVH)(G/.YMF4(=B02P;!P25+,6K5^#_P"SA9?#E_M6XW%W
MM*B5U"J@).?+3YMI*D*Q+,2 =I5693ZU17E7Q#_9ST_Q=,+V(O9WB[F6:WVI
MF0G>LK@#YF#_ #;E*.V<%^%*FE_"W68E6"YUN9[?RRC".V@BG(V%01.QE<-T
M)<Y<\G<&.X=WX0\(0>$X!;6P)!9GDD<[Y99&Y>61SR[L>23[  * !YUXU_9S
MAU6^75],N'L+X2!V=$62-CAMS&,E?F;(#_-L<;MR,79CJZ%\'&>ZBU#6;M]0
MN;?=Y&Z..""/.TAQ$F0900?G)_N_+N1&'2^//! \90&T>XG@B=6618#$ID4X
M^5F>)V XP0I4,&96W XKG_AG\$X?AR2+*ZNC$S;GAD:%XF;:5W8$(93TR492
MVU0VX "LJY_9RM[G4/[7:]O1>AE;S5:V0Y50@^5;8)C8-I&,,,A@03G;^(OP
M<B^(,,=M?7-SY4>P[4^SKND4,OFL?()W$.00I5/1!6?KG@@>#= OK1+B>>)-
M.N5C6<Q,8U$,GRJR1(Q'. &+!0JJNT#%>-?LO^ KC5M-EO--O'LKK[6\4CB-
M;B.2(1Q.JM%(0NY68E7&& 9U.0PQ[5\/O@A#X:NGU2[F>]U&7.ZXD"J%SD?N
MT&=GR83J<*-J;$)6L_XC_ 4^)M1AUFPNS97<2@,ZQ+)O*\*Q^9,G:2C;MX=-
MJ$!00T7Q!_9X7QW:I'>WDTEY'C;<LJ!!G'F*((_+C"L1G/\ K0=H:5E4+6JO
MP5,VGKIDVH7AC%O'"_EF&,-&BA0@7R6V+P<X.]U8I+)*JH%E^&?P3A^')(LK
MJZ,3-N>&1H7B9MI7=@0AE/3)1E+;5#;@ *RKG]G*WN=0_M=KV]%Z&5O-5K9#
ME5"#Y5M@F-@VD8PPR&!!.?5;2$P(J,Q<JH!=MH9B!@L=BJN3U.T 9Z #BO/_
M (#>$(/#FG![4%8KN:2Z1"=VR.7!A3GG(A$8?)?Y]V'88->BUP'PF^$W_"O?
MM7^E37/VFX,O[T_=Z\GD[I6S^\DXWX7Y5V\]_11111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111111111111111111111111117A7
MC3]G:^\6ZA'JTVI(EQ#Y7E>79@(GEMO7 >X?/SDL=Y;))'W< >UZ7'-%&HN7
M1Y>=S1HT2'DXPK22D<8!RQR<GC.!:HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHKE?B/X5NO%5J]E;7"6R31O'*QA\]RK8!"_O45<KN4DACALJ5
M(!KE/@Q\&[KX9*UNMZD]J\AD:,VVQPVS;E7$YQG"Y#*XPN%"DDUZK111117B
M'@G]F,>';V6ZFOY[B"9G:2W;<@F))V_:&$A$X 9MP*@.2=PVED;V^BBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJM[JT-AGSI$3$;R'<RKA$QYC\D?*NX;
MFZ+D9(R*R?#7C^Q\4230V,Z3M!Y?F&,ED'F E,.!L;.TYVDX((.#Q705$MVC
M.8@P+JJLRY&X*Q8*Q'4 E6 /0E3CH:EHKG]4^(6FZ1(T%S>6T4JXW))/$CC(
M!&59@1D$$9[$&C2_B%INKR+!;7EM+*V=J1SQ.YP"3A58DX )..P)KH*****Y
M_P )>/['Q?YOV"=)O)DV2;2>#V/(&5.#M=<HV#M8X..@K%\4>-K+PJGF7\\<
M(*NRAV 9@@!;8OWG(R.%!.2 !DBM#2=4CU>&.Y@;=%+&DB-@C*L RG! (R"#
M@@'U%6J************YK6?B5IVC3I9SW,8N))HXEA#;Y=\F-@*)N90<CYF
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M>3R"*VA')9S_ !%0=[*. 0@R69$RN_<+6A?":SM862^1+V>602W$UQ&CM+*
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M8GG^7YGE;E\S9G;OVYW;=W&[&,\9S6?;>-["ZG^QQW4#7 9E,*RQF7<N=Z[
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M_P#88_YB/_;I_P"W%?55>2_%3XTIH-_9:/9N#=3WMJLXP&\N%Y%W*23A7<$
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MO8:"XBO+J"!RH8+++'&Q4D@, [ XR",],@^E:MI=I>(LL3!T=0RLI#*RD9#
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M)*J"2,DDDY[7P-\']/\ $.CVSWD?G33Z9;1F:3;))&IA^00[E*1;-YVE%!)
M>0N^6/FG[&7BG^S;/4OM#[;6W\J<_+G;E)?-;Y06/RQ+QS]WY1DG/:_!KPA#
M\1EE\1ZO&EQ)=22+;Q2[9HX+=)"JQA615#;E;+ '(PW#/)NMZM\!YM+UJVU?
M0GAM(1L6ZA4-&KH&&\*JJR'<G&W" .JR [SN7%^+^OCQUKUGX6#E;8-YMXHW
M 2%4,ZPG&QL;$!W*Y&9 V-\0K?\ BC^S?IVLZ<\.GVL<5U%"?L[(-K,R[3L<
M[T#EPFS?*6*EB^<YSG_LU>.?^%EZ7+9ZKLN9+>1$=9$W[XB T+2;P5=MRL,_
M>^0,WS'<W ?LV:7'I'BK4K:!=L44=Y&BY)PJW42J,DDG  &22?4U4_;3\*6N
MDS6=S;Q)'+/]I\YD&W>5,;!F P"V9&);&YL_,3@8]5_:P\,07NC3WD@<RP^1
MY?[V41J3,J%O+#B(MMD9=Q4M@XSP,<5\&?@3:^/]"MY-2EF?/FBW"-Y8MU$[
M[P@PRLTC EW=6.W:JA=@)Z6V^#6H1^(+.60B72+"V1;?S&1BI2 1 ; H_?>:
M!*7VXP%PX*J@XK]KN[3PKJ-CJ.GL(=0VRM(Z$"0JNQ8F=>A!&],L,.H*-N5<
M#W7XX^+Y_!^CW5]:$":-8PA8;@"\J1[L'@D!B1G(R!D$9!Y3]F/0(+G0UN94
M$DMZUPUT[_O&F/G2Q_.7SN&WC!XR6.,LQ/D'[//@VT7Q#J.E30QW%O"MP$$\
M44S9BN$C1LLG!VL=VW:&)R1PN/0+_P 1VOC[7+N#41)<6&G-$D-O%;7<R&?/
M[R67R5;)1D>-5D4QNI.T'YR_/_&CPY# ;;4O#%I=0:A#,!B"PN8$,95R696M
MU1B&PI_O*S*X90-O0?'[XBW.I6EAH]NH@NM66(2J[LLD"N8QY;!5#@,[%&8K
M@JDB["2=O=?\,^Z7:V/V*UA2*98\17>T&Z24'<D_F+L<L'PV RKQL "?+7C_
M .PQ_P Q'_MT_P#;BOJJOD#XV^$[/3O%6EVL%O#'!)]BWQ)&BQMNNI%;<H 4
MY4 '(Y'!XKTK]HCQA#\*]+^RZ4B6L]W(P3R$6': %\Z4;$V[MNU,Y5QN#*<I
MQTVA_LWZ+862V,UK'*2J>9,0PE=P%W.'WF2,,5SL1PHR1C!.?+_V>==NO FL
MW'A6]EW0KYAMP1D[AB4%=K,$5X2TA1B0&& 0Y8-]/U\=_&?PM'H/BO3DLR5>
M5K%R\KS7),GVEHU9C)*78!44;0Z\# (ZUZ5\1?V4M/U&RE:Q63^T I<3/*\C
MSR $D2>8X3,C=6&S:Q#?=!4Y_P"S!XZNO%&BW.G0OMO+2,I!*_S*!(K_ &?<
M6+YV.I&-NT1A  W(KJ_V>?AA<>&M/N$UB-&N;NXD>8,5F=T*A=LK?,'R=[8W
M,,.<_,S >:?LOZM]CU[4M-LY,Z>/M,D4:MYD?R7"1QNK$L3^[;&X'YQM+%MJ
MD97QM\)V>G>*M+M8+>&."3[%OB2-%C;==2*VY0 IRH .1R.#Q7N'Q9^&^GKH
MUXD< B2.VN95CA+V\1D6/<KO'"R)(0T:$;PV,<=Z\4_9J^$<'C_2IQJ$DC6Z
MW,JQ0(WEJDIBBW7&1]]PI54#@H@#_*V\XUO$6DP/J.G>!;663[#"SRW6X_-*
M3ONQ"Q18N-HX93@&1207B%=_\4?V;].UG3GAT^UCBNHH3]G9!M9F7:=CG>@<
MN$V;Y2Q4L7SG.:O[,/Q%E\?Z9+;7TIDG@;RV8%TE,3I^[<R*0=^0Z[U(?Y0S
M?,=S>56WA**R\=?8H&DBC+,25D=I3OLC)+^\<O)ERS9<-O&XE&5@K#:_:T^%
M^G^&M-M;BQ@2!H[@0_(JKO5HV;+MC>[#RAAF8GYF)R3D>E^,=,7QEX7%W?%W
ME_LCSSB22)&E^SK+N9(F2-\2*& 92JGH!DUS_P"Q3_R!Y_\ K_D_]$P5W6@?
M!;1O"UDD5Q;6L@@A_>SRPQDL0,R2LTFXJ"<M@L0@X&% KPKX5^"+;XNZU+JJ
MVL<&E6S*L=OY2HLC;3M4^4JHQ#?O9 Q<@,D1WQD$>@?$SQ+#XJUP:#=-(^GP
M6WG7,$,-S(\LI(\N-S;@N$57CE! V;OE?+;=F+\:O".FZG9>=HME<PZA!(CP
M&WT^[MB3O7=N(MT4X7+J20RLHVD98-[5\+-;NM;TRWGU")XKHQXE21=C[D8H
M7*[4V[]N\#  # #(P3E?'3XC?\(!I<MTAQ._[J#_ *ZN#AN59?E4,^&&UMNW
M.6%<I\(_@?IEUI<5Q?0I=7-[;K+/-*&>0F8-)P69BC 2;2Z%68@.?FQCS_P=
M<S?!KQ.=&W[=-O9-T2$,X'F!EA*X9V5A*!"6;[ZC>XQL9<K]M/PI:Z3-9W-O
M$D<L_P!I\YD&W>5,;!F P"V9&);&YL_,3@8^@/CIX4M==TF[>YB21X;2XDB<
MCYT94+@JWWE^9%R <,!A@1D5YU^QK;"ZT2YC;(#7LRDJS(V#! #AD(93Z%2"
M#R"#7FEWX)$?C5M/L99+8,Q)E5FDF >S\R<AY2[;WW. Y)*,V\9*@5]%> _@
M-IW@2]DO[ 2(9(3%Y1??$JDHQ(W R9)0'ER.3@ 8 ]%KXK_92_MC_3?[&^Q_
M\NWF_:O._P"FVS9Y7_ MV?;'>O5?B79>+[^S:&069@?<LXLD>2X,+(XE 2Y*
MJ_RGA4(D9MH4@$FMK]EQ=(73B-():4,/M32*J7!?G:6568*A&?+"LR@;ADR>
M8:\E^+GA2U\-^+M,2RB2%))+"1DC&U-WVEDR%'RK\J+D* "<DC))/JO[6'A2
MUO=&GO9(D-S#Y'ERXQ(H,RH5W#!*XD;Y3E<G=C< 14^#VJ2:1X+^TP-MEBM-
M0D1L X99+AE.""#@@'!!'J*YK]F:70O%-IY%Y%!-JAFE:8W*)+-,S%G#H9=S
M.-@^8+R&5F91NW-ZWX"^$4'A*WN[",NMK-=F:()-*DJ*8X04\Q"CC#HP&&)*
M8#,Q+5X5^S9I<>D>*M2MH%VQ11WD:+DG"K=1*HR22<  9))]353]M/PQ!IDU
MG<QA_-G^T^8SRRR\*8V55$CL$4&1B%0*HSP.E>P?%KX/Z>^DW\SQ[[K[/).U
MT^U[EI(D#CYV4[%/EA2D81 I*HJ \<)\ /B(_AOPG=WDK BTFG6 ,I*AF2-X
MT.S#$-/+R2<@-]X*.-OX<:=I-U:I?:I;37M]=1I+//+IUY."6RRJF8)(E558
M(#%A&55(&-H&5\';.Y\':_/96%O>#1;C<R&:*>..-Q$)-^9HE8?,K0C)4L"A
M9G*J3G^+O%]D_C&2WU\B2SBA2.V64!K>*26*%R[J?EP<L"[!L$H6PJ!D]:C^
M#^GF_L=9TN.&+RO,W>3M2*6*2"558+&NUFW.I# C*%LEL(!Y+XN\7V3^,9+?
M7R)+.*%([990&MXI)8H7+NI^7!RP+L&P2A;"H&3UJ/X/Z>;^QUG2XX8O*\S=
MY.U(I8I()55@L:[6;<ZD,",H6R6P@'I5%>2_!17\37-]XAE(=+F8PV9VGBV@
M9D#+N8N@D?ET(3YT+[?F&/*OA8S_  G\57&CN!':7C'RLL0FWYI+4AI%W.1E
MH,!L&1B,LRC/U?7R7^S?XDTGQ;)<C71#/J=Q<*RR72QN)%(5$CCWY4,&)&Q0
MI*E H94PGO7@/X50>";V]N+-1'!=K;MY8/"2(9O,VC "H0ZE0"<'< %4**\*
M\(>+],U/Q'J:>(S'(XFDAM7N0AMXXXI9 8_G_=H2 I5B.2'^;>Y#^X:%\'[7
MPWJQU2PC2%)+22&6-/E3=OA:-T15VK\J,'P0"=I"Y+L?*O 7V?XZ:U>7MY^^
ML;'RTM(&W>7\S$B;'R9W>22R2*V0X1LB-14/[1OPN3P2D7B'0D%K-;S+YOE
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M7RK^PQ_S$?\ MT_]N*Z;]L^Y%Q86EBF6N)KU6BC569G"QNC8P#D[I4 '4EN
M<''M_A/0O^$?L[>RW;_(MXHM^-N[8@3=C)QG&<9./4U\X:3;'5_B!+-;XD2!
M2TC*RD*!9K W?DB5@A R0<Y P<?4E>5?M1_\B[>?]N__ *414?LN?\B[9_\
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MV&+2$(\T0 AR4D;EOWDH=P-H!RI9O/\ X!?\CAJW_;__ .ED='[<_P#S#O\
MM[_]MZ^@/BQ_R!]0_P"O"[_]$O7R_P##K2Y-3\$:I'"NYA=F0C('RQBUED/)
M'1$)QU., $X%>P?LC^)H=3T2.UC/[VUDE2125S\\CRHP ).TA\ D#+*X&=N:
M\Z^.]VD_C'2U1@Q1K!7 ()5OM3OM..AVLK8/."#T(KZOKP#]M;_D#P?]?\?_
M *)GKU7X3_\ ('T__KPM/_1*5\__ /-0_P#/_0.KJ_VUO^0/!_U_Q_\ HF>N
M$^-,T^C:5X;U6%0PM88#EON^9Y5O)&I 8,0?);..PQD$C/TUX%\=6OCBU2]L
MGW1MP0>'1AC=&XR<,,\CD$$,I*D$FA>,8];NKFV@&Y+7RE>49*>:V_S(0=NT
MM&JH7PQP9 K!2"#\Z_ +_D<-6_[?_P#TLCKJ_P!M;_D#P?\ 7_'_ .B9Z]5^
M$_\ R!]/_P"O"T_]$I755\J_'W_D<-)_[</_ $LDKZJK*U;4(?"MG)/LVP6U
MN[[(U482)"=JKE5'RKA1P.@X%>-?"*[?XVI/J.JL6M4N3'#8*2MNNP0RAI=N
MTW!SMXD!0'>0F&"IQ5I:)9_$!8HE"(BA550%55&FX"@#@ #@ < 5V'[:W_('
M@_Z_X_\ T3/7JOPG_P"0/I__ %X6G_HE*^?_ -AC_F(_]NG_ +<4?'W_ )'#
M2?\ MP_]+)*ZO]M;_D#P?]?\?_HF>O5?A/\ \@?3_P#KPM/_ $2E?/\ \ O^
M1PU;_M__ /2R.O6_VC_A^_C;2)8H<F:!A/$HR=[(K!DP%9F)1F" 8)?;R!FN
M$_9B\8R>.H;>"8<:5&P).!N:0>5:NNU1]R 3Q,&X.4?YV.8_HJBO*OAW_P C
M%KO_ '#/_2=J\P_:ITB?P=J-GXELL*0R1O@;<R)N9=Y5U=Q)'NC8<81-I;#
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MAKN;YI,F*8D1J25@3]XP"1;1M(!W8R>:_8I_Y \__7_)_P"B8*Y3_FH?^?\
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M_,K@XQSD_ +_ )'#5O\ M_\ _2R.C]N?_F'?]O?_ +;UZK^U'_R+MY_V[_\
MI1%1^RY_R+MG_P!O'_I1+7-6WQ%G^)>OS:+#+):V5FLIF\L[)[AXIHT9?,4[
MXDWGCRR&9 P8@N!'YU^V#X4M?"\.FVUC$D,0^U_*@QD@6R[F/5F(4 LQ+'')
M-?3_ ,0=1M=.T^YEU#FU%O()5SM+*RE3&IW+\S9VJ-P)8@ @D5Y!\!/A[?:9
MI9DTV_AC@O-TR(T NF@+ H,2K+ KRJH42!H]@D0@)C=N]/\ AG\,X/ <!CC)
MEGE;?<7#\RS2')+,22<9)VKDXR22S,S-X!\/_B GPV\3ZG9ZEB**\N6;S#@A
M6,C2P,S!L*C1S'<2"5)7=L <CZ?U_7X/#T#W=VXCAC7<[MT Z=N22<  9+$@
M $D"OE#]H'6)+'6-&UR[A>*(V]I(T?!D5HIO.FBPVP[E$BCY@H)/;!Q]:_VM
M#Y/VKS$\CR_,\W<OE[,;M^[.W;MYW9QCG.*^7_V&/^8C_P!NG_MQ7U57RK\?
M?^1PTG_MP_\ 2R2M;]MKPS->VMI?1C,5O)*DF Q*^;Y>QC@$!<Q[221\S(!G
M/'O7@GQ0GBJR@OX\ 30HY56#A6(^=-P R5;*G@'(((!XKY_T'1'U[QW<WEN0
MT-JH,KC)4,;5;?R\J"N_>3E20<(_=2*^FJ^5?C[_ ,CAI/\ VX?^EDE?4&K:
MI'I$,ES.VV**-Y';!.%4%F. "3@ G !/H*^3_P!FW4G^'.BZCK]Q&7A9H%B0
M95G9&9,Y8;=F^8*6&X@J_P I*@'U#X1:%_PLZRCUG7&^U-+)(T5NPQ:0A'FB
M $.2DC<M^\E#N!M .5+-Y_\  +_D<-6_[?\ _P!+(Z/C[_R.&D_]N'_I9)7T
M!\6/^0/J'_7A=_\ HEZ\J_8I_P"0//\ ]?\ )_Z)@KC_ (C,_@3QK;ZI<@?9
M[EHMKEBB*K0BTD+.R[04SYC $C:5R5W<?55W=I9HTLK!$12S,Q"JJ@9+$G@
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M!N0J ,J"KC<P^K_">N_\)!9V][MV>?;Q2[,[MN] ^W.!G&<9P,^@K5HKY5^
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M-X:T2SM;D;91&SLN&!7S)'E"L& (8!P&!'# CGK7?U\J_ +_ )'#5O\ M_\
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M&(9WS2MGRX4"JS%F;@84X&6(P":\@_;6_P"0/!_U_P ?_HF>O5?A/_R!]/\
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MGN5V;)!) A39RNP);J$P?F&T#YB6^\23W^L>%FU/3YM/DG=VFMYHC-(L9?\
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M%5%B9_L[R1*I)VH6M\$$?+APX50 FW KFOAY^SQ;?#^8SV%W>+NVB1&>!HY
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MYM]WD;HXX((\[2'$29!E!!^<G^[\NY$8>E5YUXC^#"Z_>QZE+?7JS0,Q@"/
MJ1!B255?(P01\K;]Q=0%<L!7=Z79-91K')*\S#.9)!&';))Y$21IQG PHX S
MDY)Y3XE?"U/B#']GN;FYCM_E+0PM$B,5)(9BT3N>H^4MLRJMMW#-9_PS^"</
MPY)%E=71B9MSPR-"\3-M*[L"$,IZ9*,I;:H;< !7/Z!\!K[PC EOI.KSP@+^
M\66&*YB+=<Q(^/)!9F+ %BV1DDKD]AX!^%L/A226\DD>YOKC'GW,NW>< 91
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M*R(C@Y((4JRD-D=A7DOQ@_9PLOB,_P!JW&WN]H4RHH97 (QYB?+N(4%5(92
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MFCG0,5+1.LBA@ 2I*$C."#CK@CUJ;5-6ATB-I[F1(HEQN>1E1!D@#+,0!DD
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MBN(9]F-_E2)+MSG;G83C.#C/7!]*U:S]?U^#P] ]W=N(X8UW.[= .G;DDG
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MV]?5517=HEXC12J'1U*LK ,K*1@J0>""."#P17R+_P (G9_\)W]A^SP_9?\
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MN29-I4ORCJ"-B!5C\L%2K%2/9?B]IEIXRT.>[R[Q?8)IX<231(W[KS8V9%9
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M!C3K71KDV,$=K+;VTCI-&FV7;'&V]&=2KN)(]T;[V8'=N8,16+^Q3_R!Y_\
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M, PZ7X0V=SXYT46OB"*Y22.1XG\QY[>29-ORLVSRF92LA1@Q8.4+,2W3P_\
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M_P CAI/_ &X?^EDE?5596K:A#X5LY)]FV"VMW?9&JC"1(3M5<JH^5<*.!T'
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M6/\ D#ZA_P!>%W_Z)>O!?V<O'">!O#%[J,B&00WKX12 69H[9$&3T&YADX)
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MU^)VG-XM\:V,%I\S6D=L\Y(?:@CE>X.2%/5'0*?NEW520<XJ?'W_ )'#2?\
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M[M/#'A^]EA4O<.ML)+F5C-<R8GMU^:1\M@[%.P80$?*HJW\#M;MM&\*6LM\
M;=FDBDW;2FV:\>'+[R%V#?E\\;<\'H>:^(W[(<<6;WP_(\%Q'AT@+DJ67;M\
MN4L'C;@L"Q8%R!F-1D<)XJ\47?C[P;'//F1[+45265F!9D$95'.0I)S.B'[S
M,1O8G+$?2OP=^*L'Q&LDN(V'GHJ+<1@;2DF.< ECL8@E#DY'!.Y6 VH_&,=Q
MJ!TR(;WCMVEG89(B)9!#&V%VAI%9V +!@J9VD,#705Y5^U'_ ,B[>?\ ;O\
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M )J'_G_H'5%\/_B GPV\3ZG9ZEB**\N6;S#@A6,C2P,S!L*C1S'<2"5)7=L
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MP["*47"!E)+%9"F_#94K\NWTKP+X%M? ]JEE9)MC7DD\N['&Z1S@98XY/
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M1Q)#(NY'7H1T[\@@Y!!P5(((!!%9_@[QC'XK6:6W&8([AHHY1DI,%1-\B$J
M5$A>,%2RL4)#$' ^=?V&/^8C_P!NG_MQ73?MGW(N+"TL4RUQ->JT4:JS,X6-
MT;& <G=*@ ZDMP#@XR?VGM$?0?#&GV<I!>":TB8KDJ62UE0D9 .,CC(!QV%>
MX?"?_D#Z?_UX6G_HE*ZJO /VUO\ D#P?]?\ '_Z)GKU7X3_\@?3_ /KPM/\
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MMOEL#A2Y9@">?F8GH/ O@(^#XTMX[NYF@CCV)',86"C((PRPI(<#Y5!8J%X
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M$<GRWC\_:22<*WF1G: 0 &W-QDN<\>R?#/X567PY@-O8J<NVZ21R&E<\[=Q
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M1@$>9(9#N('WV#G/)#<Y[#P/X @\((XB:2665@TMQ._FW$A VIO<@9"K\J@
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M1"+FQE2:(X^9#G!(#;6'56 8$JP##/(%:M17=VEFC2RL$1%+,S$*JJ!DL2>
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M)*J"2,DDDY[7P-\']/\ $.CVSWD?G33Z9;1F:3;))&IA^00[E*1;-YVE%!)
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M-M[@N;&6X=[N%#@RI$\!VY!4]&; W ;L,>54CI=?^%&A?$[3'.DQVJN5S#-
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MUR;::9KF7Y[@R1Q95@_!091?W<>R(#*A A*UYU\#M4DO?!NI1R-E88]0CC&
M-JFW$I' &?GD8Y.3SC.  ,K]E_X56_CC396U)GEM4NW$=L&:.,2^7%NG8QLK
M.VTA%!.U!O(!+G&3XU\/_P##/>O6U_9[S8S;B4SD[,A9X/\ 6*7VAE>,O@;M
MFXN49C[!\<_& FOK'0/,=8;G?)>+%%-+,\"@E8AY(W[9=DB/LRRJ,G";@^+\
M1? VA:KIDMM9V$\<\<)-NT>G7D<ID1#Y:M(UMEPQ^5_,)SG<2& 8=?\  ^XO
MO$^C"#6H[F*>.0Q%W::WGD5=KI)N7RI!P0A()+["68EF%> ?"'X?1ZIXDU'3
M(W>&S3[6DD:$[I($N446Y<G>JGY=[ [F0,F1O)'TU\,_@U9?#E[A[ R8N60L
MCL&5 A<JJ?*&P-Y'S%B0!DYR3Q7[8&OSZ1HP6W<QB>Y2*3;P6C,<K,F>H!*C
M.,9&5.5)!M>%_!/ACXE:=Y=A! $,**Q18TO(3R%WM\T@<%#RQ828))D0G/0>
M(=$?0?#$UG*07@T>2)BN2I9+4H2,@'&1QD X["O*OV1/!UMKVE3->()T6]D"
MPRJKPJWE0YD",N"Y&%W-DJH(3;ODWY_@/_BAO&UQIEE\MK<;M\?15S;_ &I=
MJIM4;6RB9!VQLR]3FO0-8^&NIZUXIAU&YV2:9;QEH0S*0C&/;M"8SYOG8DWD
M8VJO[S<JH/.OVN[M/"NHV.HZ>PAU#;*TCH0)"J[%B9UZ$$;TRPPZ@HVY5P/H
M7XL?\@?4/^O"[_\ 1+UY5^Q3_P @>?\ Z_Y/_1,%<I_S4/\ S_T#J^JJ^5?V
MY_\ F'?]O?\ [;UZ+K_[+VG^(8'-V\DFHR+E[YF?>9.N[R@_E!!PHC &V,!0
MP8!ZXK]D'Q9/I\MWX=NP0]NTDB#.X(5<1SQYWE<;RK*$&"3(Q;D5-X"^S_'3
M6KR]O/WUC8^6EI V[R_F8D38^3.[R26216R'"-D1J*A_:-^%R>"4B\0Z$@M9
MK>9?-\H!%VL%C1PI;8 &PC(J$2"0EP0&S[!X;N+?XK:1;S7.62>$&58GGMU+
M[6CFC.QU=D#[UVL65@ ?FX-?,O[*7P^C\;?;8;MW-FOV8RVZDHLS?OO*+NI#
M[4PS! 0&<JQ/R 'NOC!\"-/\">';K[.T\A2:&5#+,Y57:2*(D1ILB)V$C<4+
M8)&[  $7P9^!-KX_T*WDU*69\^:+<(WEBW43OO"##*S2,"7=U8[=JJ%V DMM
M/M_B-KJ>'6=WTO2;0IY3,P\Z6(+ 68H(F#*S@9&Y?W;;,+*:Z#]H3X'VL5B^
MIZ3"EM>6FV4- /)S'&69\!61%9<^9O +G8$'48VOAW<P?'3P^J:IB63<\<K*
MOELDJ?<D4D8#^6RL2OR$LRE=I9*\P_9(TF'1=6O]/N8T>\@SY<H56">2[PS;
M'8!UW>8N, ;E!W8P <_]ICP39>!M3L]1M8(S"6C:XM54+%E'RNX?,BB9%=0-
M@!\J1L.=^/H7XD:39ZUI:6D<<,D=QY,-KM5'5/-'EK/$H!!\J%FF&S'[M&PR
MKEAU^@:!!X>@2TM$$<,:[41>@'7OR23DDG)8DDDDDU%XF\,0>)83;70<Q-G<
MJ2RP[@05*L8G0LI!(*DE3W' KY5_8U\,PZ]]O6Z'F0K]E)A8*T+D^?M9U(._
M;@E5)V!CO*EUC9#XG>'$\%^+[$:8?LWVC[-GRTB"Q^:[VLGEH8R@R@S\RM\[
M%O0#T#]HSX6:9H^A7-Q!;H)XY(Y!,=S3EI)U#EY6)DDR)&R'9AT.,JN-7X6_
M$;_A'_",.J7AW^1;R*H^[NV2O!!'E5.,X1-V#C[S9Y-97[/OPXM?%ME_;NKH
ME[>7DDQ9YDWA55_+"!&)CX,65(52JMY:X4<\5XKLV_9_UZ">R;RM+O/+$J'?
M(@5"JS @N\C,@;S4?@@N44,N]6Z#]M'PQ EC#?X<SF[2/)EE9%5H9"P6-G,:
M9,:$E5!)&222<]KX&^#^G^(='MGO(_.FGTRVC,TFV22-3#\@AW*4BV;SM**"
M2 \A=\L?-/V,O%/]FV>I?:'VVMOY4Y^7.W*2^:WR@L?EB7CG[ORC).=OX67=
MAXPB.M:[!)>7EPT@'^@WEQ;PQ*^U(8PL<L) *%MP^<%V5F+;BV?IMC+X/\21
M3Z#:7@TV[\M;I#;W$,"L[NI($L*[5CRLH[#+HK*C%1S7[5WPI@\)SV^JV<$:
MVTC+'+"H\N+S%RR\(ZL!(@((C"8V%MV]\U]*7;Z9!I#3K!&^FK;&X$*PH(VC
M"^>"(G"KD_> 8#YN3@\T?"WX=0>!;**VBBC2;R8Q/(@R9) "68N0'8;V8KN^
MZ#@!1P.FU;5(](ADN9VVQ11O([8)PJ@LQP 2< $X )]!7SU\"] @^+DMWXAU
M=!</]I,5O#+^\CAC5-VP#B-QB8#YH^&4R??<D<_\=?"C_!F]M]>T)1!'(S1S
M1C/E%R3)M*E^4=01L0*L?E@J58J1[+\7M,M/&6ASW>7>+[!-/#B2:)&_=>;&
MS(K('P55@)%.T]ADUX?^S5\(X/'^E3C4))&MUN95B@1O+5)3%%NN,C[[A2JH
M'!1 '^5MYQ]-> O!4/@BRBT^V9VBBW[3(5+G<[2')55'5CC '&/K7DO[3'C1
MYY;/PW;2F*2_FC6=U!)6%W\H+C W!V))"NIQ&5;Y9*ZO7/V;]%O[)K&&UCB(
M5_+F 8RHY#;7+[Q)(%+9V.Y4X Q@#'G_ .RUXOGOA=^&]6(D:U4HD3CS#Y89
MHIXF;YD9%8JJ@YX8@%D "\?_ ,(G9_\ "=_8?L\/V7_GAY:>3_QX;_N8V_>^
M;I][GK7L'[1^DPZ1X9NX+:-(HE\C:D:JB#-U$3A5  R22<=R363^SAX#L]:T
M*TEO8DN3^_"+,B2I&!/*"L:LN%R?F9N78X#,52-4Y#]ER[?P]K>IZ'$Q:UC:
M=EWDE@T,ZPAN,("R-\Y"Y8JG0#%:O@[Q%8?$B[NM3U5)+R*&YDAL8UL[R>WC
MB4<R$1QR1L\@=2PD7>I52,#8%Q/B#IY\+ZI:ZOX7LKP'YENX8[2YMX613'A-
MKVX4;UW!MH(#*L@42#<WH'[6'AB"]T:>\D#F6'R/+_>RB-29E0MY8<1%MLC+
MN*EL'&>!CBO@S\";7Q_H5O)J4LSY\T6X1O+%NHG?>$&&5FD8$N[JQV[54+L!
M/T?X>T1-!MH;.(DI!#'$I;!8JBA 3@ 9P.< #/85\E_&?PM'H/BO3DLR5>5K
M%R\KS7),GVEHU9C)*78!44;0Z\# (ZUZ5\1?V4M/U&RE:Q63^T I<3/*\CSR
M $D2>8X3,C=6&S:Q#?=!4U?V4_%Q\::3+I=T9,VC(H=))8G,3DM$HD202 J4
M9<+M41A%Y&ZO+_A#\/H]4\2:CID;O#9I]K22-"=TD"7**+<N3O53\N]@=S(&
M3(WDCM?BOI=K\ K&=-'DFCN=3D55R^?*CB+,YC;R\C E$8W/O^8.K;D)KU#0
M_P!F_1;"R6QFM8Y253S)B&$KN NYP^\R1ABN=B.%&2,8)SY?^SSKMUX$UFX\
M*WLNZ%?,-N",G<,2@KM9@BO"6D*,2 PP"'+!N:^,_A:/0?%>G)9DJ\K6+EY7
MFN29/M+1JS&24NP"HHVAUX& 1UKTKXB_LI:?J-E*UBLG]H!2XF>5Y'GD )(D
M\QPF9&ZL-FUB&^Z"IYKX$_'!M/\ #EX9SF738P(F<.ZL)=PMHVPQ8XE!3 V*
ML>P C!(Z#X<:=I-U:I?:I;37M]=1I+//+IUY."6RRJF8)(E558(#%A&55(&-
MH&5\';.Y\':_/96%O>#1;C<R&:*>..-Q$)-^9HE8?,K0C)4L"A9G*J3Q/QR\
M'KI'BBPAL7>*6;[&WG2/)=.)3<-&LA\]W+;0BX4G;A0.*]PL?V8-(M;N.^99
M)753YBS,L\<SL&#2RB5&+.2VX[2J[@"%'.?&OV-?"=GX@^W_ &VWAGV?9=GF
MQI+MSY^[&\'&<#..N!Z5%^U=\*8/"<]OJMG!&MM(RQRPJ/+B\Q<LO".K 2("
M"(PF-A;=O?-?2EV^F0:0TZP1OIJVQN!"L*"-HPOG@B)PJY/W@& ^;DX/-'PM
M^'4'@6RBMHHHTF\F,3R(,F20 EF+D!V&]F*[ON@X 4<#IM4TF'5XV@N8TEB;
M&Y)%5T."",JP(." 1GN :^2O^$3L_P#A._L/V>'[+_SP\M/)_P"/#?\ <QM^
M]\W3[W/6OIJ[^&^GW%LUBL BMW8L\<!>U5R5V-N^SM'N!7@AL@@#(.!CY0_9
M2^'T?C;[;#=NYLU^S&6W4E%F;]]Y1=U(?:F&8(" SE6)^0 ]5\2-#A^'T=KX
M0TJ>9#J5VCW$CE6=8I2EN%^6.,,K%22 P;"%6^62O6]<_9OT6_LFL8;6.(A7
M\N8!C*CD-M<OO$D@4MG8[E3@#& ,<)^R?XZNF:YT#47S-9<1*?F=51S'+&74
ME2J-L"#.<,0I** O"_&?PE%HWBO3HK5I$,S6+-(TCSR[S<M&'W7!ER0J* &R
MORCY2,@^B_M.?"_3[31)KJ&!(YX9(7\U57S9"TBQ-YDC R29$A9BS;F<!F).
M<Z'P%\'6WB_1[*]U-!=R+#)#&)E5XHHTE,:JD>T1@XB7,A4RGH7*X4<)^S/_
M ,23Q)JNFV_R6J_:,1_>_P!3<B.+YFRWRK(PZ\YRV2 1]544444444444444
M444444444444444444444444444444444444444444444444444444444444
M5\M_#_QBGPY\5:G8W[QI%>3-+YI8*B,=UQ$&=V0*#'*RMP29-H4XR3]%>,?&
M-MX0MGO+QPB(K$ LJL[!6<1IO90SD*=JYR37SU^V)H5UJVGV&HO%Y?D[A<1@
M^88FF6,@%E7:55D*%\@%F3 .[CZ%\$^*$\564%_'@":%'*JP<*Q'SIN &2K9
M4\ Y!! /%?/^@Z(^O>.[F\MR&AM5!E<9*AC:K;^7E05W[R<J2#A'[J16?\??
M^1PTG_MP_P#2R2O5?VH_^1=O/^W?_P!*(J/V7/\ D7;/_MX_]*):\J^ 7_(X
M:M_V_P#_ *61U]"^/)K*:*.QU)0\-[,+<!L!-Y1Y$!)92"3'A"OS>84VX/(^
M=?BO^S$_@Q)-8T"XDC,"O(T6\K(B8<R-'*"K85#C8V6*AOWC,0IROBUXXN]9
MTO0?$90%X)I=[,05:9'3:2J[#AS;NQ"@!1\N1P3]2>!?'5KXXM4O;)]T;<$'
MAT88W1N,G##/(Y!!#*2I!)H7C&/6[JYMH!N2U\I7E&2GFMO\R$';M+1JJ%\,
M<&0*P4@@S>-]$?7K"ZLXB \]M/$I;(4,\;("< G&3S@$X[&O!?V+M=^SPWFD
MS+Y<\-QYI5CMD.X"*1?+(##8T8#'L7 (!QG5_;-_TK3;6UC^:>6_C\N)>9'Q
M'*IVJ/F;YG4< \LHZD5W7B'1'T'PQ-9RD%X-'DB8KDJ62U*$C(!QD<9 ..PK
MA?V*?^0//_U_R?\ HF"O?Z^5?VY_^8=_V]_^V]?55?*OP"_Y'#5O^W__ -+(
MZ/VY_P#F'?\ ;W_[;U;_ &A_$,G@3Q)INLLFZ!;?RST8D!Y5G"KN4[A'."I)
M"EB.2 PKZ/T#7X/$,"7=HXDAD7<CKT(Z=^00<@@X*D$$ @BL_P '>,8_%:S2
MVXS!'<-%'*,E)@J)OD0E0"HD+Q@J65BA(8@X'05\J_ +_D<-6_[?_P#TLCKZ
MJKY+^'FHKXA\<3W.E\6H\\RE"BHZK$(FD^1L2*]QM<$9+$B0@$$BU\??^1PT
MG_MP_P#2R2O5?VH_^1=O/^W?_P!*(JS_ -GW6TT'PI#>2@E((;R5@N"Q5)IW
M(&2!G XR0,]Q6!\0/V3-.\5I]LT>06[R+O4*?,M9-P9P1@DH&++AD)14'RQ&
MK_[+'C.^U..]TW5&>2XL;@*7D<2/\Y<-&6YW;7C;#%FR&"C"J*XKX!?\CAJW
M_;__ .ED==7^VM_R!X/^O^/_ -$SUZK\)_\ D#Z?_P!>%I_Z)2OE_P#9:TN3
M5]-UVV@7=++:1QHN0,LT=TJC)( R2!DD#U-=W^R!\58+NT&B3,$N(6D:$8QY
MD;$R-@DG<ZLS$C"_)@@-M<CV_P 5^,8_#[01$;Y[FXCBBB&=[ NOFR *K';'
M&3(Y("@  LI8&N0\;_#O2/BS+/;7*D75FR1-(C*DRJZ1SJ1]X,A#%5\Q2 PE
MV '+'Q3P[X>U'X#:Y96?GF>PO9A& #Y:.SF.-V,9+['1F1MPY=0%#C+JOO?C
M[PMI?Q$F;2+]-T\5NL\;!@DBK*9(BT9!W':R N&4QY,6X,< ?.GC'P'??L[7
M4.I6%P\MC)<*'3<(RV-Y$,B_,KYBW;90ORMN8(AV;OLJLKQ7XFA\+VLM]<G$
M4,;.W*@G'15W%068X502,L0.]>-?#O\ 9ML=7M%O==A,VH73//,2\L6UI3OV
M;(S$%(!^<%<ARP!VA0)?'_[*>E7%C.NF6_EWGEDPMYLSY92&V8DFV?/C9EN%
MW;NU3?LC^/!XATD6;DF:S;8VXLQ,;EFA.2,  ;HPH)VB,= 5%=!XW^'>D?%F
M6>VN5(NK-DB:1&5)E5TCG4C[P9"&*KYBD!A+L .6/BGAWP]J/P&URRL_/,]A
M>S", 'RT=G,<;L8R7V.C,C;ARZ@*'&75?:_&_P .](^+,L]M<J1=6;)$TB,J
M3*KI'.I'W@R$,57S%(#"78 <L?%/#OA[4?@-KEE9^>9["]F$8 /EH[.8XW8Q
MDOL=&9&W#EU 4.,NJV_ [/X"\;7,-V !?-<>6Y8HFV9Q<1$%E&\ED$.!QYA(
M!)7!]_\ C%=I:Z-?M(P4&RN%!8@#<T;(B\]RQ"@=22 .37@'@WX?W*^![U7P
MAG9KM VY3Y49A?G*]66!F3&58,AW $X]0_9E^)</BK2X;4LBW5M'Y31 J&*1
M!524+O9BNUD#,0!YFX  8KNKOQS$NH1:7 !+,RR/.%D3,$:*I#.N=^6>2-47
M'(9GSA>?GKX^_P#(X:3_ -N'_I9)7I?[2/QGD^&]K&EJN;JY\P1N0"D83;O<
M@_>;YQL!&W.2V0NQI?%OPS@T;2KZ[N";J_\ [.NPUW-\TF3%,2(U)*P)^\8!
M(MHVD [L9/-?L4_\@>?_ *_Y/_1,%<I\ O\ D<-6_P"W_P#]+(Z/%GC7_A67
MC26]O%VVMU;Q*S@;V$1CC3S %;(Q-#A@06V!MJDE:^H/[6A\G[5YB>1Y?F>;
MN7R]F-V_=G;MV\[LXQSG%9_@WQ,/$]JEXB%$D:3R]P8%HQ(RQ2X958"1 L@!
M' 8=>IVJX_QY8Z=XD>'1]3C$@N%EEB5CMRT!CW!6#*X?;)D;.2@DR=N0?FOX
MG_ N[^#0_MK1+N01(R"0$A944LFW<1A)D:0#<A4 94%7&YA]7^$]=_X2"SM[
MW;L\^WBEV9W;=Z!]N<#.,XS@9]!7S5^W/_S#O^WO_P!MZ^JJ^9?V9=+&MZWJ
MVM0L3;M-,D3;&"R":<S9#-C!547*XSB0$[> <_\ YJ'_ )_Z!U=7^VM_R!X/
M^O\ C_\ 1,]=UX9UNVT;P]92WP!MVLK"*3=M*;9EBAR^\A=@WY?/&W/!Z'S#
MXC?LAQQ9O?#\CP7$>'2 N2I9=NWRY2P>-N"P+%@7(&8U&1W7[,'CR?QEI"O=
MDO+!,\#2,=S2!51U8\#D*X4D[BQ7<S$L:\O_ &&/^8C_ -NG_MQ1^W/_ ,P[
M_M[_ /;>OH#XL?\ ('U#_KPN_P#T2]?+_P .M+DU/P1JD<*[F%V9",@?+&+6
M60\D=$0G'4XP 3@5[+^S'\58/%FG16)8+=VD*QO'C;F-,)'(N2=PV[0YXP^<
MJJLF?1=5\8QV5[;Z<HWSS[V91DF.)4<^<V%("F0+&-Q7<S_*25(KSKQE\'](
M^,8FNDS#=QS30/,A7>'@9XL2("58?=89VR-'Y8W*N!7 ?!N+4?A9X@7PY=2F
M:UGAD:#Y_P!V%'F2K*J'<4)*2*Z J"Q+$N%1CW_C+X/Z1\8Q-=)F&[CFF@>9
M"N\/ SQ8D0$JP^ZPSMD:/RQN5<"N ^#<6H_"SQ OARZE,UK/#(T'S_NPH\R5
M950[BA)2170%06)8EPJ,?J2BBO*OV7/^1=L_^WC_ -*):B_:&^"R?$.T,MN@
M_M"%?W+9";USEHF)&"",E,X"OCYE5GSY5^S+XOO?$FNN-2),]MI4EN2X*RD)
M<QG$F>2X+%22 3@;LMN8GQ&9_ GC6WU2Y ^SW+1;7+%$56A%I(6=EV@IGS&
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MPR#ESQN *CL/BCX0'C?P]=:DP!FE5;Z(L6'EPQJ3%&,9.?LQ<LA+1BXEE92
MP81?LQ>))/&=O;F8/MTVW:$,RCRWDD;$93& &AMD"%OOD3L#@$F3W^BOE7]A
MC_F(_P#;I_[<4?'W_D<-)_[</_2R2O5?VH_^1=O/^W?_ -*(JX#PQX9F\2^
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MJ17=>(=$?0?#$UG*07@T>2)BN2I9+4H2,@'&1QD X["N%_8I_P"0//\ ]?\
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M7?O)RI(.$?NI%9_Q]_Y'#2?^W#_TLDKZ@U;5(](ADN9VVQ11O([8)PJ@LQP
M2< $X )]!7Q5\-? MU-X6UBZ5/DF^SF,'Y25M9/-FD&X!2H4D @DED=<9 !]
MZ_9C^*L'BS3HK$L%N[2%8WCQMS&F$CD7).X;=H<\8?.5563/HNJ^,8[*]M].
M4;YY][,HR3'$J.?.;"D!3(%C&XKN9_E)*D5\Z_'W_D<-)_[</_2R2OJJOE7]
MAC_F(_\ ;I_[<5] ?%/P5_PF^F7&GAMK2Q_(<X =6$D>X[6^7>HW8!.W..<&
MOGK]F3Q-/K 3PY<H5%G<FY<.-A\N-BWDD!0X=+PQ2\GY@'1B%4(_U?17RK_S
M4/\ S_T#J^JJ^5?V&/\ F(_]NG_MQ1^U=;3>&]8T[7=GF01>2N 6'SPS--L9
MMI5=ZM\O4G:YVX7GZEM+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BOFK]G+1'U#Q
M#J^JQ$-:^==1+(,E7:2X$H*, 48!$RV#D!T."&S6?\??^1PTG_MP_P#2R2O5
M?VH_^1=O/^W?_P!*(J/V7/\ D7;/_MX_]*):\J^ 7_(X:M_V_P#_ *61U]54
M444444444444444444444444444444444444444444444444444444444444
M44444444444445YK\9_@7:_$Z-2[>3=1X"3A=QVYR8V7*[UY) R"K<@X+JW"
M^ _V-[+09Q<7TYNPC*R1^6(HB1G_ %@+2%QG! RHXPP=217NFOZ!!XA@>TNT
M$D,B[71NA'7MR"#@@C!4@$$$ UY!X<_9YOO!9D31=6DM[>1E;RI+>*Y(8* 6
MRS*N3W*HI("AMVT&O1?A]\-;7P+&Z6V]Y)9#)-/*V^>5B2<N^!G&3@  <DXW
M,S'G_B]\$(?B&T-PLSVMY;_ZJ>,*2/G5AN^ZYVX)CPZ[&8MSD@Y_B?X%2^++
M&2VU&_DN+F18PLSQHL,6R7?NCMXRB!V0^6TA9GVD@,$)0[?@KX-P^"[=K:RN
MKQ<Y".TRR>6"RNRI$Z&W&2#EC$7^9OFYXY_PW^S1;>&KHW]K?7R7+;]\AD@<
MOOY;>'MV#Y/S'<#\P#?> (Z_XE_#A/'L4$,DTD(AN5G#Q$++N1)%3:QSL(9P
MV[!/RX&"=PY6[^#>I:FC6=WK,\E@RE&B$$*7#1XPJM<8+,>@D8K^\&X,!N-=
MU_P@%C]A_LGR$^Q^7L\G!VXSG.<[MV[YM^=^_P"?=NYKP6Y_8>MFGW1WLBV^
MY<QM$K2[>-X\P,JY/.#Y>%R,AL<^]>!? MKX'M4LK)-L:\DGEW8XW2.<#+''
M)X  "J H '05Y!XU_9SAU6^75],N'L+X2!V=$62-CAMS&,E?F;(#_-L<;MR,
M79CJZ%\'&>ZBU#6;M]0N;?=Y&Z..""/.TAQ$F0900?G)_N_+N1&'0>.O 1\8
M1O;R7=S#!)'L>.$PJ&&23EFA>09'RL P4KP1@MGG_AY\#(OA_E;"\O%B:17>
M)FMWC8CKPUOE<CABA5B .?E4CTJO.OC3\%H/BC!'')(89H6)BE W@!MOF*4W
M*&!"CN"" 0<;E;0\,^ KO3;<17.I7,TXC"+,%A3: P.0C1R*[%556>;S7^\4
M9"[9Y7PW^S1;>&KHW]K?7R7+;]\AD@<OOY;>'MV#Y/S'<#\P#?> (U?B=\"+
M;XD2))?7%SMCW>7'&8%1-P0/@F N<[ 3N9L'.,#BM75/A3;Z[I[:7J$LUW&<
M;))C&9T(4*K*Z1IEAR=S!F;<P<LK%:\:MOV'K99]TE[(UON;$:Q*LNWG8/,+
M,N1QD^7AL' 7/'T5H&@0>'H$M+1!'#&NU$7H!U[\DDY))R6)))))-&MZ9)J*
M!(IY+<A@=\0A+$8(VGSHI5QSG@ Y YQD'R73_P!E:STZ9[J"^U&.>3=OE2X1
M9&W$,VYA"&.6 )R>3R>:MZI^S9#J\;07.I:I+$V-R272NAP01E6B(." 1GN
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M,,!A@00>#C<JD<+I?P$U&*U72[G6)GT_RS&T4<$<4I3G""9FE<+T!4Y!3,>
MIX]:T#0(/#T"6EH@CAC7:B+T Z]^22<DDY+$DDDDFO.OB+\!U\2WT>L6-T]E
M?1[!YB(CJP4,,LOR%F((4EF*F-=A0BJOC3]GA?&5O'%?7DTLXN(I))W5"=JQ
M^7)%"B[8[=7.&.%8E@ID\PJI&K=? JWETI]%6>Y,4GD*TDLK3.$BE60(BL1%
M'\HV#8@ &TLK[<&I_P *FU6#_1X=;N19]"KQ0RW6UO\ 6 7)PX8Y.Q]N8_E
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M=SK$SZ?Y9C:*.".*4ISA!,S2N%Z J<@IF/ 4\>M:!H$'AZ!+2T01PQKM1%Z
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MQKM1%Z =>_)).22<EB222237G7Q5_9[M?'4RWT4CVE\FW;/&.I4J59U!4EE
MPC*R,.,E@JJ"+X)SZW)&^OW[ZA'!()(H/)BMH-V""9$3=YO;:"0!\P(9793Z
M!XFT-M;A,"3S6^[(+P&-9,$$%0TD<FWKG<NUP0"&'.?/_AY^SQ;?#^8SV%W>
M+NVB1&>!HY IR%93!]1N7#@%@K#)KH/B5\+4^(,?V>YN;F.W^4M#"T2(Q4DA
MF+1.YZCY2VS*JVW<,T?#7X6I\/H_L]M<W,EO\Q6&9HG12Q!+*5B1QT/RAMF6
M9MNXYK/^+OP-LOB8BF?,5Q&K".= -P!!PK@CYT#'=MR"#G:R[FSBK\#;W68U
MM-9U6:\LT\L^0L26Y<H05$DJL\DBX!W D,6P^\,H->M6EHEFBQ1*$1%"JJ@*
MJJ!@* .  . !P!7%?%?X30?$9+:.X(407*2L=FYGCP1)"&#(R!^,L#P5!P2!
MCNJX_P"%GPS@^'-H;*V)8&:21G;[S%CA<\XR(PB$J%#%=VT%B*["LKQ-H;:W
M"8$GFM]V07@,:R8((*AI(Y-O7.Y=K@@$,.<^?_#S]GBV^'\QGL+N\7=M$B,\
M#1R!3D*RF#ZC<N' +!6&31XU_9XMO&-XNH75W>"=,"(QO!'Y85VD15*P!OE9
MCM8DOTRQ(S70>,?AB/%]D-/N[NY,1_UA ME>7YUD3<1;X&TJ,>6$R/O;NM'P
MU^%J?#Z/[/;7-S);_,5AF:)T4L02RE8D<=#\H;9EF;;N.:XJ]_9J73+XZGH-
MX^G2MOWHL230X8#*JC% %R"VUMZAMI0)L45U?@[X2+I-T=4U"=[[4#'Y8GD5
M(TC4;AB*)!MCRIPQR23N(*[W!A^)GP3A^(Q O;JZ$2MN2&-H4B5MH7=@PEF/
M7!=F*[F"[02*U?"_P\;PU:?88+VZ**J+$S_9WDB523M0M;X((^7#APJ@!-N!
M7-?#S]GBV^'\QGL+N\7=M$B,\#1R!3D*RF#ZC<N' +!6&36+\5?V4[+QM.UY
M;RFTGD8&3:@DB<\[FV90AV)!+!L'!)4LQ:M7X/\ [.%E\.7^U;C<7>TJ)74*
MJ DY\M/FVDJ0K$LQ(!VE59E/K5>=?"KPA!IUSJ6I6X*B\O7&PG.# SQ2-@Y(
M+7'G,/F(V%,!#E1Z+17D'C7]G.'5;Y=7TRX>POA('9T19(V.&W,8R5^9L@/\
MVQQNW(Q=F.KH7P<9[J+4-9NWU"YM]WD;HXX((\[2'$29!E!!^<G^[\NY$8=+
MX\\$#QE ;1[B>")U99%@,2F13CY69XG8#C!"E0P9E;<#BN?^&?P3A^')(LKJ
MZ,3-N>&1H7B9MI7=@0AE/3)1E+;5#;@ *]%KG_'7@6U\<6KV5ZFZ-N01PZ,,
M[9$.#AAG@\@@E6!4D'S7PW\!-1\-1FRL]8FCL3(Y\H01F54<_,J3,Q*-CHR*
MH#DN$!)KTKP+X%M? ]JEE9)MC7DD\N['&Z1S@98XY/   50%  X#X@_L^?\
M"0:FFM:?=O97BX+N$\X,54(K %TQ\@V.O*.N 5^]NVO%_P &%\70&UN[Z]:)
MF5I%#P*'9?ND@08  V_(@6/*B0H92SM;\ ?"=? L#6EI=W1A*N$20P.(V?!W
MIF#((.2%.8\EB4))-<_HW[.5OHMZ^IVU[>I=2-(TCAK;#&0EGRAMMA!;G!7
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MS[,;_*D27;G.W.PG&<'&>N#Z5JT4445GZ_K\'AZ![N[<1PQKN=VZ =.W)).
M ,EB0 "2!1H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!P5(((!!%:%%%%%%%%%%%1
M7=VEFC2RL$1%+,S$*JJ!DL2>  .23P!46DZI'J\,=S VZ*6-)$;!&58!E."
M1D$'! /J*M4444444445S^L>/['1KJ&PN)T2YN,^5&2<MV&3C"Y/RIN(WL"J
M98$5T%%%%%%%%%%%%%%5=4U:'2(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*S_"O
MC2T\6))+8RB9(YFB9E!V[U ) ) ### AERI!X)K:HHHHHHHHKC]2^+VDZ=<Q
MV+W49N)9O*6-"96$FX)L?RPWEG<0/GV\Y]#CL******JZIJT.D1M/<R)%$N-
MSR,J(,D 99B ,D@#/<@5S_\ PMC1_P#H(6?_ ($P_P#Q='_"V-'_ .@A9_\
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M[/-D2+=C&[&\C.,C..F1ZU+IOB&VU0(UO-'*)%=D*.KAE1@CLNTG<%9@K$<
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ML&:VNH)0K1JQ26-P&D;9&IVL<%F^50>6/ R:VJS]?U^#P] ]W=N(X8UW.[=
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MW'&\.N"G'8:'^S?HMA9+8S6L<I*IYDQ#"5W 7<X?>9(PQ7.Q'"C)&,$Y\O\
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M$C?+*WS %A(<$A2[>9ECA*]@^#4-CJNBV[6L$*03VX$L:1D1L^T13*P?+/\
M,I0LY8N!DLPY,/P7\$V6E6HO[:".-[MI9PZJ XAGD,L,6?X L7E@QH?+#*2,
M_>/HM?.'[9_AZV@TZ.\2&-;A[V)7F"*)67R9OE+@;B/E7@G' ]!7J'P7\)V>
MG:;974%O#'/)86V^5(T61MT:,VY@ QRP!.3R>3S7@GP=T1-9\6ZM%*3Y6Z^+
MH,!9%^UI^[?C)0G!900' V/NC9T:;]IO28?AGJ&FZII4:6\O[S*1JL41\ID/
M*Q!"=XE9).?F3"\<Y]*^.?C 37UCH'F.L-SODO%BBFEF>!02L0\D;]LNR1'V
M995&3A-P?%^(O@;0M5TR6VL[">.>.$FW:/3KR.4R(A\M6D:VRX8_*_F$YSN)
M# ,.Z_9[UO4-4TM%U:*:.YAD:(M.K))(H"LDA#*IZ-LR=Q8H6+%B<>E5X!^V
MM_R!X/\ K_C_ /1,]>G_  RMA=:)8QMD!M.ME)5F1L&! <,A#*?0J00>00:^
M:[;PE%9>.OL4#211EF)*R.TIWV1DE_>.7DRY9LN&WC<2C*P5AM?M:?"_3_#6
MFVMQ8P) T=P(?D55WJT;-EVQO=AY0PS,3\S$Y)R-OX^^-+L>%+*<2D27BVBW
M#* I=9+9Y)%^4#:&91D+@$97[I(/5>%_!/ACXE:=Y=A! $,**Q18TO(3R%WM
M\T@<%#RQ828))D0G-OQY\/8U\-&UO,L]GI3#"2S)$9(H 0Q5619 'C#+YBG&
M.@R:Y7]C6[2ST2YEE8(B7LS,S$*JJ(("6)/  '))X K/^"NA1_&2]NO$FJQ)
M(@D$%M;L3+%&%0%LJZ[6^5U(_A+M(_EJ=A'"?M@> X/#$]K+9@10SK-F!!MB
M61/*#RJH.Q2Z%%8*JY\L$[B>/=?VB/'<N@06UC:S&">^N5A\Q(WEE2(X$LD8
M3DN"R  ?.=Q\OY@&7*N_ WAJ>T:Q6PG1&4@2+IU^;A23N#"5[9I,@]-Q(Q\I
M!3Y:A_9?GU*XT^?3=7AN8EAVK"\HE@<Q.K#RT;:CCR]O#!BRAU5=H5:\EN_!
M(C\:MI]C+);!F),JLTDP#V?F3D/*7;>^YP'))1FWC)4"OHKP'\!M.\"7LE_8
M"1#)"8O*+[XE4E&)&X&3)* \N1R< # '=ZII,.KQM!<QI+$V-R2*KH<$$95@
M0<$ C/< U\E?!+PG9ZCXJU2UGMX9((_MNR)XT:-=MU&J[5(*C"D@8' X'%>@
M?M&^*?*:Q\+6+_9S>20QR&-<".W9Q"B!0%!5CG*JR_+&4(VO78:Y^S?HM_9-
M8PVL<1"OY<P#&5'(;:Y?>)) I;.QW*G &, 8X3]D_P =73-<Z!J+YFLN(E/S
M.JHYCEC+J2I5&V!!G.&(4E% 7Z*KY5_;G_YAW_;W_P"V]>BZ_P#LO:?XA@<W
M;R2:C(N7OF9]YDZ[O*#^4$'"B, ;8P%#!@'KBOV0?%D^GRW?AV[!#V[22(,[
M@A5Q'/'G>5QO*LH08),C%N15OP=XBL/B1=W6IZJDEY%#<R0V,:V=Y/;QQ*.9
M"(XY(V>0.I82+O4JI&!L"XGQ!T\^%]4M=7\+V5X#\RW<,=I<V\+(ICPFU[<*
M-Z[@VT$!E60*)!N;ZJKE?BGI]]J&F7$6E/LO&CQ&VX(?O NJL1\K%-RJW&UB
M#N7&X<I\,OAA#X=\/+INL1PA3'*]V"5"?,S/N=QCYD0*"X/RE 5?"JU>=?L1
MZ_/=P7EI(Y:&!H&B0\A#)YQDQW )4''0') !9B?IJO*OVH_^1=O/^W?_ -*(
MJX#X"?\ "2?V-;?V;_9WV7]]Y?G_ &GSO]=)NW>7\OWLXQ_#C/.:Q/CI8:U=
M"-O$I TJ-HG8Z=&LH\S<R -]H=)$)1BN\[H@3&-C,37O6C>%-&\4:7#;6\4,
MVG&/]RH&5&0RE@3\ZRC<P9LB4.6W$/FO"OV&/^8C_P!NG_MQ65\7/"EKX;\7
M:8EE$D*226$C)&-J;OM+)D*/E7Y47(4 $Y)&22>U_:[\3?V:VFV]P7-C+<.]
MW"AP94B> [<@J>C-@;@-V&/*J1TNO_"C0OB=ICG28[57*YAF@5(BLNS<BR&-
M-P'S#S(V7< <[0X4B+]K#PQ!>Z-/>2!S+#Y'E_O91&I,RH6\L.(BVV1EW%2V
M#C/ QH?LSVPNO#5K&V0&6Y4E69&P;B8'#(0RGT*D$'D$&O%;;PE%9>.OL4#2
M11EF)*R.TIWV1DE_>.7DRY9LN&WC<2C*P5AM?M:?"_3_  UIMK<6,"0-'<"'
MY%5=ZM&S9=L;W8>4,,S$_,Q.2<CL/B-\4+FWT;2HDG,5YJ:VJ/*D322A'C0S
MRQK$!\X9U 5?F.X^6 P#+;N_ WAJ>T:Q6PG1&4@2+IU^;A23N#"5[9I,@]-Q
M(Q\I!3Y:/V4]0U-;*6QU6">,6[)Y#SHZ$QL"/*7>BDA"G!RV ZJ-JJHKSK]F
M_P 2:3XMDN1KHAGU.XN%99+I8W$BD*B1Q[\J&#$C8H4E2@4,J83WKP'\*H/!
M-[>W%FHC@NUMV\L'A)$,WF;1@!4(=2H!.#N "J%%>"_LW^)-)\6R7(UT0SZG
M<7"LLETL;B12%1(X]^5#!B1L4*2I0*&5,)[UX#^%4'@F]O;BS41P7:V[>6#P
MDB&;S-HP J$.I4 G!W !5"BNZHKR7PBK^+_$%YJ3$-:V"FRMQM/$QVO=.-S9
M1U/[LLJ@2(P 8A3GRKQ,S_"3Q@EX $L]08;V+$)ME*B<L\BD*4F F8*<!2HR
MJM@?5]?*'A#Q?IFI^(]33Q&8Y'$TD-J]R$-O''%+(#'\_P"[0D!2K$<D/\V]
MR']PT+X/VOAO5CJEA&D*26DD,L:?*F[?"T;HBKM7Y48/@@$[2%R78^'^$/%^
MF:GXCU-/$9CD<320VKW(0V\<<4L@,?S_ +M"0%*L1R0_S;W(?W#0O@_:^&]6
M.J6$:0I):20RQI\J;M\+1NB*NU?E1@^" 3M(7)=CY5X"^S_'36KR]O/WUC8^
M6EI V[R_F8D38^3.[R26216R'"-D1J*A_:-^%R>"4B\0Z$@M9K>9?-\H!%VL
M%C1PI;8 &PC(J$2"0EP0&SVOBKXZBQ\,QZU&P^T7$*QQ[58*+A@5DP'5^(V2
M1@&RK!-NX[@3M^!?@3I^BVJ)>V\-U=O^\N)YD6X=Y6P9"'E3=MW?=&!QRP+E
MF.5\(O@[>?#K4+ORYT.E3;FB@!<NCED*DAPV-J;D+!R7 0L,@!?'_BYX8@\/
M^+M,6W#_ +R2PD=I)99G9OM+)DO*[M]U% &<  8%>M?M*^ -6\<06UIIC#R6
MF(N4+A 1\IC=LC+(A#%E&225(1BH*U?VK= LH]!9G2-'@:%;3HA4ET5HXP,<
M>4&R@R,+NQ\@(VO@HJ^/= LY-65+MOWF3.B2Y,<LL2,=P.6"#&X_,>22223X
MK^QKX3L_$'V_[;;PS[/LNSS8TEVY\_=C>#C.!G'7 ]*[N_\ $=KX^UR[@U$2
M7%AIS1)#;Q6UW,AGS^\EE\E6R49'C59%,;J3M!^<OS_QH\.0P&VU+PQ:74&H
M0S 8@L+F!#&5<EF5K=48AL*?[RLRN&4#;]*>'M2?5+:&XEC,+R0QNT39W1LR
MABAR%.5)P<@'(Z#I6A17R!\7/"EKX;\7:8EE$D*226$C)&-J;OM+)D*/E7Y4
M7(4 $Y)&22?5?VL/"EK>Z-/>R1(;F'R/+EQB109E0KN&"5Q(WRG*Y.[&X C0
M_9GMA=>&K6-L@,MRI*LR-@W$P.&0AE/H5((/((->*VWA**R\=?8H&DBC+,25
MD=I3OLC)+^\<O)ERS9<-O&XE&5@K#:_:T^%^G^&M-M;BQ@2!H[@0_(JKO5HV
M;+MC>[#RAAF8GYF)R3D>P:MJDFK^%9+F=MTLNBO([8 RS6I9C@  9))P !Z"
MO/\ ]D#5(](T&ZN9VVQ17<\CM@G"K;PLQP 2< $X )]!47PLN[#QA$=:UV"2
M\O+AI /]!O+BWAB5]J0QA8Y82 4+;A\X+LK,6W%L_3;&7P?XDBGT&TO!IMWY
M:W2&WN(8%9W=20)85VK'E91V&7165&*B7]H3Q?!8^(=/MM6)?2XX5FDAQN3S
M&:>-9&48+A2JDJ=WRAP%.]E;T75?@_I/B46FH:5';(]O=P31RV_EI$ZI,GG(
MQB4J_P JMM[JX W*"X/G7[0GB^"Q\0Z?;:L2^EQPK-)#C<GF,T\:R,HP7"E5
M)4[OE#@*=[*WHNJ_!_2?$HM-0TJ.V1[>[@FCEM_+2)U29/.1C$I5_E5MO=7
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MN,$'85"[RZ_95%> ?MK?\@>#_K_C_P#1,]>J_"?_ ) ^G_\ 7A:?^B4KY_\
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M_P .[3PQX?O985+W#K;"2YE8S7,F)[=?FD?+8.Q3L&$!'RJ*Z7]ES_D7;/\
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M8WD0R+\ROF+=ME"_*VY@B'9N^RJY7XL?\@?4/^O"[_\ 1+UY5^Q3_P @>?\
MZ_Y/_1,%<I\??^1PTG_MP_\ 2R2O5?VH_P#D7;S_ +=__2B*N \%_%+_ (5K
MX-M+Q8_,E>2>*)3]P.T]PP9^0=H"$D#ECA<KDLOHOPO\#IK-M:ZOJCF]O9(8
MYE>4#RX?,6)PL,0_=1E=BY=5#LP+%@&VCR3]AC_F(_\ ;I_[<4?\U#_S_P!
MZOJJBOE7_FH?^?\ H'5]55\E^/\ 45UWQO:)IG^MAD@2=T*)O,99[C+*WS8@
M_=N&^8[&CP< &U^W/_S#O^WO_P!MZ^@/BQ_R!]0_Z\+O_P!$O7E7[%/_ "!Y
M_P#K_D_]$P5+XF^ 6D?%Z!-7L&-M+<J)3(FUT9FV[Q)&&V[QAE;8RGS"Q<N1
M65^S3K&H^'M1N_#6IN9#;PK)&3)YBHJ^6@5,C=L9)$95)4(%QL#,V,3_ )J'
M_G_H'5ZK^U'_ ,B[>?\ ;O\ ^E$5'[+G_(NV?_;Q_P"E$M>5? +_ )'#5O\
MM_\ _2R.HOV4?B GA&>X\.ZCB&5KEO+S@@S#$4D1<,5R=B^7@88[AN)9%/T?
MXZ\8Q^$;5[F0;G^[#$,[YI6SY<*!59BS-P,*<#+$8!-8'C[PMI?Q$F;2+]-T
M\5NL\;!@DBK*9(BT9!W':R N&4QY,6X,< ?.GC'P'??L[74.I6%P\MC)<*'3
M<(RV-Y$,B_,KYBW;90ORMN8(AV;OIKQY8Z=XD>'1]3C$@N%EEB5CMRT!CW!6
M#*X?;)D;.2@DR=N0?FOXG_ N[^#0_MK1+N01(R"0$A944LFW<1A)D:0#<A4
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MO^WO_P!MZ^JJ*^5?V&/^8C_VZ?\ MQ1^W/\ \P[_ +>__;>OH#XL?\@?4/\
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MYM [,SQ^6)8@3C_5@-&4&<DC+#G"A% %=_\ "+X&V7PS1C!F6XD51).X&X@
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MYQ7*_L4_\@>?_K_D_P#1,%>_UY+^T-\:4^'EH8K=Q_:$R_N5P'V+G#2L"<
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MDGCW;XDD1I%VD*VY02PPQ .1P>#S6A=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/
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MA:;I$C07-Y;12KC<DD\2.,@$95F!&001GL0:Z"BHKN[2S1I96"(BEF9B%55
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M(*GHS8&X#=ACRJD=+K_PHT+XG:8YTF.U5RN89H%2(K+LW(LAC3<!\P\R-EW
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MKR[0<L,1G;\LK5H?M"? ^UBL7U/284MKRTVRAH!Y.8XRS/@*R(K+GS-X!<[
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M" SE6)^0 ]U\8/@1I_@3P[=?9VGD*30RH99G*J[211$B--D1.PD;BA;!(W8
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M<QH(F<'S-N,9PP9L;6)0NK6_VL/#%OX%O-/U#3(TMY?G(6..-(PT#QO')L"
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M&&*YV(X49(Q@G/E_[/.NW7@36;CPK>R[H5\PVX(R=PQ*"NUF"*\):0HQ(##
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M\(R7NW9Y]O92[,[MN^6!]N<#.,XS@9]!6K^RY_R+MG_V\?\ I1+7E7_-0_\
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M/OI=7U";[9?/\L3F/RHX(L?ZN)-\FWJ06W%B">[2,_?T5\J_L,?\Q'_MT_\
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M)X<N4*BSN3<N'&P^7&Q;R2 H<.EX8I>3\P#HQ"J$?ZOHKY0\#L_@+QM<PW8
M%\UQY;EBB;9G%Q$064;R600X''F$@$E<'W_XQ7:6NC7[2,%!LKA06( W-&R(
MO/<L0H'4D@#DUPO[(WAF;1-%#SC;]HN'G0$,&V%4C4D$#[WEEEQD%&4@\X'G
M_P  O^1PU;_M_P#_ $LCKZJK%\9:W;:-:O+? &W9HXI-VTIMFD6'+[R%V#?E
M\\;<\'H?!?B-^R''%F]\/R/!<1X=("Y*EEV[?+E+!XVX+ L6!<@9C49&A\.?
M'D_C+PA?/=DO+!;7L#2,=S2!;?>K'@<A7"DG<6*[F8EC4O[%/_('G_Z_Y/\
MT3!7*?\ -0_\_P#0.JWXG\3?\*X\:FZN2GV>^MX49L\QHP2(,Q8HJXE@!8DL
M!%D_>X'T?<^(;:U@^V231K;E583,ZB+:V-C;R=N#D8.<'(QUJKX+\1GQ-:17
MIC,0F4NB,RLWEDDQ,=I(!:/:Y7)VEMI)(S7S?^PQ_P Q'_MT_P#;BCX^_P#(
MX:3_ -N'_I9)7U57S7^VUX9FO;6TOHQF*WDE23 8E?-\O8QP" N8]I)(^9D
MSGCWKP3XH3Q5907\> )H4<JK!PK$?.FX 9*ME3P#D$$ \5\_Z#HCZ]X[N;RW
M(:&U4&5QDJ&-JMOY>5!7?O)RI(.$?NI%9_Q]_P"1PTG_ +</_2R2OH#XL?\
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MVL8DAB'VOY4&,D"V7<QZLQ"@%F)8XY)KZ5^+'_('U#_KPN__ $2]>5?L4_\
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MNG_MQ7JO[4?_ "+MY_V[_P#I1%1^RY_R+MG_ -O'_I1+7E7P"_Y'#5O^W_\
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M>,/G*JK)GT75?&,=E>V^G*-\\^]F49)CB5'/G-A2 ID"QC<5W,_RDE2*^</
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M@?,2WWB2>J\8_#$>+[(:?=W=R8C_ *P@6RO+\ZR)N(M\#:5&/+"9'WMW6HO
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M[)\,_A59?#F V]BIR[;I)'(:5SSMW$!1A0<*  !R<;F8GL*X_P")GPJLOB-
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M;.9)<B0L"L[H$*@$K(IX*/7U?X \8Q^,[&#4(1A9HP2O)VL"5D3)5<[7!7.
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M;OG4@M&P&X@]K_PJ?1_^@?9_^ T/_P 17SK\8M)A^#?B&QUJUC1;:7=NA15
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MX502,L0.]>*_L<^!9-"T^6]G1T>[D0H&P 8D4^7(!C<-S._)^\H5E&""W*?
M+_D<-6_[?_\ TLCJ+]N6[1GT^(,"ZK<LRY&X*QA"L1U )5@#T)4XZ&OHKQOX
MF@T86\-V@>*\N1:,&&Y<R1RE05VMN#,HC(.!A]S' .?$/CM^R]8BUN-3TS_1
MY88WF>+),#*N]Y-HP2C8^Z%/EC:%"+DL.J\-^)IO$O@R2ZN3NE.F7J,V6);R
MUFB#,6))8A 6)/+$GCI65^Q3_P @>?\ Z_Y/_1,%<I_S4/\ S_T#JZO]M;_D
M#P?]?\?_ *)GKBOC9IUU:Z'H&KVO'V*WMR6 W%&>*!HI""I7:&BP2W&YD7!W
M5[5X%_:#TGQ1:I<R7$-M(>'AFECC=&&,@;BN]><JX&".H5@RKM>"/B GC*>Z
M-IA[.!HXDF&,23#>TX4[CN15:+:VT!B6*EUP:Y"?X>:-\<K&'4Y8?+EGC!,L
M1V3*P*I(A8H!)M,9C!=&&T$IC(-<)^S;IMSX"US4/#LD@EB2$3!AN W Q;&"
MDX4M',/,&"<JH#$+D]W/\/-&^.5C#J<L/ERSQ@F6([)E8%4D0L4 DVF,Q@NC
M#:"4QD&N$_9MTVY\!:YJ'AV202Q)")@PW ;@8MC!2<*6CF'F#!.54!B%R?I#
M^UH?.^R^8GG^7YGE;E\S9G;OVYW;=W&[&,\9S5JBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO.M;_9]
MT;7G$MY#).X4*&ENKN1@H)(4%YR<9)..F2?6L_\ X9<\._\ /G_Y'N?_ ([7
M2^$/A#I/@\A[&UCC<,S"0@R2@E=IQ)(6=05XP"!R>.3GL*\ETW]F32]+ED>W
M>ZC@F7;+:I<2);R+L*;7VXE8?,6P9",DC[I*UH77[.VC7UZ^H3P>8[>1LC)V
MP1B%%C55C3:I4JJY5]Z\8  )!M^*/@9IGB29;F5'26*WCAMVB=H?($9=D>(1
MX 8%\C<&4;5PHYS#H'P-M--G2[N9KJ^EA;= UY.9Q$W=D7"KD\'+!B"JLN",
MUH>,?@WIGC.03:A$\S#[H,]P$7(4':BRA$SM&=H&XC)R>:+/X.:;9VK:?&DR
MVK=8A=783!W[E \[A6WMO485R06!(!%7PS\!M'\+S"YL8'AE&/F2XN1D AMK
M#S<,I*@E6!4XY!H\3? ;1_%$QN;Z!YI3GYGN+DX!);:H\W"J"Q(50%&> *VM
M;^'%CKUH-/O(S/ &# 2R2R2!@20PE=S+GDC.[.TE/NG%>=>&?V1M%T283N)K
MC;@A)W5H\@@ABL:1[NF-K;D()!4\8]0\9>$(/&%J]C=@F&1HRX4[20DBR;<C
MD E0#C!P3@@X(X3_ (9TLHOW4-S?16?0V:73BU*G_61E2"^U\DN-^3N;!'&.
MKU/X86-_IPT;R]EF/*'EH2N0DBR[2W+?,R_.V=[98[@QW5RG_#.EE%^ZAN;Z
M*SZ&S2Z<6I4_ZR,J07VODEQOR=S8(XQZ+H&@0>'H$M+1!'#&NU$7H!U[\DDY
M))R6)))))-6[NV%TC1MD!E*DJS(V",'#(0RGT*D$'D$&N%T_X$:3ITSW4$<T
M<\F[?*EW>+(VXAFW,)PQRP!.3R>3S7?UP'B;X#:/XHF-S?0/-*<_,]Q<G )+
M;5'FX506)"J HSP!5_3_ (4V.EV4^FVPDBMYX9(F7SI9 JN'#&,3/(J'YR3M
M&">6!P*YK_AG2RLOET^YOK&+J8K:Z=(V;O(1()#N( !.<84<=2>KL?AA8Z9I
M\NDVL?D6TT<R.$)+_O5*LVY]Y+8. 6W8  ^Z *Y3_AG2RLOET^YOK&+J8K:Z
M=(V;O(1()#N( !.<84<=2>[\(>"[3P= +2PB$409FV@DDL>K%F)9CT&220 %
M'  '%>*/V=M.UN[_ +1A:>SNBSLTMK+Y+,S *6.58*2,Y*!2Q9B^XG-;_@?X
M66GA!WN(S)-=2J%ENIY#-<.H/RJ6/  &!A0H(5=V2H-=!K^@0>(8'M+M!)#(
MNUT;H1U[<@@X((P5(!!! ->-:7^QMHME(LDC7,RC.8Y)%"-D$<F*.-^,Y&&'
M(&<C(/K>M^#;76;86,J%;<*%\N*22!=FTIY9\EDRFTXV'Y<8XX&.:\,_ ;1_
M"\PN;&!X91CYDN+D9 (;:P\W#*2H)5@5..0:S_%_[/=EXDU ZL)[JVNBJ@O;
MRB,DA?+W9*,RDIA3M(! Z9+$GCC]G+2?%Z(LRR)(C$^>DA:X<$8VR23"5I ,
M#;OR4"A4*KD'?U_X3Z?KUD^G3QEHI&WEV=Y)Q)C:LOFR%W+JH"@L6^0",@Q_
M+57X=_!RT\"HJ0O/,(V<Q>?*9%CW##;(P%B0\M\X3?AW&[:Q%9_Q*_9[TOX@
MR?:+E'CN/E#30L$=@H("L&5T/4?,5WX55W;1BM#X9_!;3OAR";)"967:\TAW
MRLNXMMR %4=,A%4-M4MN(!KNJ*\EM/V:-/TI%33Y[VS.T"5[>Y>-IB!A6DR&
M7(^8C8$ +-QC ':^!_AW:>"T=;13OE8--,[&2:5\<N[MR23EL#"AF8JHW&NE
MKE?B'\,+'X@0B"_CW;=QC=25DC+#!96'X':V4)"EE.!7*:3^SE8VOEI=3WEY
M!#L,5O<SF2W0I@(PC544X7*A3E-K$%2#7JM>:^,?@#8^);T:FLES:WG\4UM,
M8W;Y%C'W@^W"#;\FW()W;LT:]^SQI&N>0LT;^7#)<2%!(_[UY]OF/*Y)F=LJ
M"&W@\ $E0%K0U;X(Z3J=I%IS6X2UBF$OE1DQAW$31 NRX=CM;);=N8JNYB,@
MXG_#.EE+^ZFN;Z6SZ"S>Z<VH4?ZN,* 'VI@%!OR-JY)YSV'B;X<6/B:!+.YC
M)MT4*L*22P1;1MVJ4A=%8+M&T,"%Q\N.:RO#/P1TKPL7:QBD@,BE7V7-TH8%
M67D";!(#':>J$[E(8 UG_P##.6A^=]J^SOY_F>9YOVFZ\S?G=OW>=NW;N=V<
MYYSFMKQ5\)M/\6)'%?)),D:J%5KBYV_*" Q E 9\,09&RY!Y8U;\,_#BQ\,P
M/9VT9%NZE6A>26>+:=VY0DSNJAMQW!0 V?FSQ7FMS^QYH<T_GKYZ)N4^0LH,
M6!C*Y96EPV.?GSR=I7C'K^@:!!X>@2TM$$<,:[41>@'7OR23DDG)8DDDDDUY
MK:?LT:?I2*FGSWMF=H$KV]R\;3$#"M)D,N1\Q&P( 6;C& .U\#_#NT\%HZVB
MG?*P::9V,DTKXY=W;DDG+8&%#,Q51N-<5:?LT:?I2*FGSWMF=H$KV]R\;3$#
M"M)D,N1\Q&P( 6;C& .U\#_#NT\%HZVBG?*P::9V,DTKXY=W;DDG+8&%#,Q5
M1N-9_P#PJ&Q_M?\ M_#_ &OR]OWSY>=GE^9MZ[O+^3&=F.=N_P":NUHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
>HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex99_002.jpg
<TEXT>
begin 644 ex99_002.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P &! 0.
M!0X3# P3%A,0$Q$3%Q45%Q<6%!0:&AH7&!<7%QX<%Q@9&QP<)1L9'Q\?'Q\B
M'Q\?'Q\?'Q\?'Q\?'Q\?_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#ZIHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHKE?&OC631-L%E;/>7CX*P(PC55^8^9+*P*1*=C!"W,CC:
M@.&*_/6M_M3:[X*NQ;:Q8P*0H9HUWHS*P.UED\R9"-W4@,,AEX8''TKX+\7P
M>,;2*_M"3%*I*[AM8$$JRD>H8$'!()&5)&"=JBO)?CKXWUGP% VHV(M9;564
M2+)'()8PVU5;<)PL@+G!PJE<KPPW,.%^"?[5LWBR^6PU..&/SOEADCW(H< G
M8XDD;.[[J;3G?A=K;LK[UXH@OY$SITD".%?Y9XI)%9L#8-T<T909SN.US@Y
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M\*OB9!\1K);ZW!0[BDD;<E)  67. &&&!##J",A6RH^,/V7/^1BL_P#MX_\
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MO_D1H_\ KPTS_P!"MZY3]AC_ )B/_;I_[<5Y5_S.'_<>_P#;ROLKXO>"]/\
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M3C(&1@C@@U:KQK]I75FU/2[C3+6WNI[B1H !%;3O& '24L9-GED87'RLQ#$
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M,LBQ$^<S9CVALKL4,#D[N5VZO[.&K3:OH5I/<R/+*WG[GD9G<XGE RS$DX
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M J.L<HC<$ )@AF&TA0&7[P5ER_HOQ5\+?\)5I=W9!/,>2W?RTW;<RJ-\/.5
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MG!+9*L1B-QNV^G^/=4U*QGM(]/>V"W%P(6$T4KE<133/(&29,_)%A4VC+=9
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M>I?!W4;>2[N#>Z;<JX\MHX4N$*;-[!HHXE8C<"N<!@61@I"R5+^VM_R!X/\
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M6\3197?M)D=X^6<;"ZL!Y+^SO"8/%NJ(S%RJWP+MM#,1=Q L=BJN3U.T 9Z
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M_P"1PU;_ +?_ /TLCKUN[\?)<ZA<V.@VT<U^%7[5<MB.VC95=8UFD16DE=2
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M+&-ETBQ_*,+\JL0O'R@D# )H^/O_ ".&D_\ ;A_Z625ZK^U'_P B[>?]N_\
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M75(YO,*S-D1I+EB2=PA ( E<([UZ7\<[34_%VE/I]K8.TMQY98^=;A(U67S
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M-L8(PW1O@;V5=NTL"#4_V=7U'PW!H3S@7%NQE20 ^492TK;#D%BG[UEW !N
M^WK&?-/!WQ#\9>&$32UT\S"-EAC:6VDVJJA8U42Q-'$4&W/F,2""6+E<$>]_
M!OPC>Z+;R7.KLDFH7<BR3LJ(I4+&D<<1:,!6V*N>!M#,VW=R[>/V7A^^^%7B
M2[U-K*YO+.[^T;7MHQ(X\QXYS\BLV-K_ +OYRFX9=<XVU%^TAX/UKXAO8B*R
M*G=>!8@RNR*#&0\TH;R$+JORQAB 01YCLVU/2OB%=:U=6]A<P68%Y'J,<AMX
MYEE'E?9YA*KRO$D:$AFC)&Y02I1V8J*RO&WQ NO&-E/I*Z->_:IH7CQ+'&+1
M9,<N)V;8P1ANC? WLJ[=I8$9]IX-U?X;KH\&GP_;GM[?4%N55DAC8320R!/,
ME! Q(05Z.XC)V@;@#XFZY<?%RR;2;/2[R.5Y(F\Z\B6VBA"NNZ0,S.2V#MVH
M-Y1G(S@J?:O">A?\(_9V]ENW^1;Q1;\;=VQ F[&3C.,XR<>IK5KYU^.?P7F\
M4:[8SVN]([F-XKJ2-63:B [V>558;I(7,2!Q@[0A)4X7UKXO>$#XPTFZL4!+
MR0DQA2JDR(1)$N6^4 NJ@YQP3R.HQ?V=O K>#=&@AE39/+F:8?/G<_W0P< J
MRQA$90  RGJ<DU/VA]+O_$NG2:7I]H\[3>43+YD$<:!9 Y'[R0.S?(!C:%PV
M=^05)^SQI=_X:TZ/2]0M'@:'S2)?,@DC<-(7 _=R%U;YR,;2N%SOR0H\J_9\
MTC4_A5?7=A=:?<SB;RPLT"J8<Q!V!$DIBBVLKDY+JP8!"FXD+V'[2/AG5O'M
MI#86EB6*3)+)+Y\ BW")EV1[W21QF1@6=(S\O"D-D=W\-KV]TG2X8+JQF2>U
MMX(O+62U?S=H$>Y&\]5'RJ&8.4QG:I<C)\J_9F\!:Q\.)IX[ZQ?RKGR1YB36
MS>64+C++YP)7$A)*Y8;<!&W<=?\ #GXMZOJ>H/9ZQIYM8GF:."0!@ X6:786
M=L3 QQ-^\B&T$#*XD4K[+7DO[1_P??XC62_9<?:[=F>(,2 ZL/WD6<A5+;5(
M9@0"H7*JS,,KPA\:-6MX!:ZEI-[)J",T8>.$+;2,/E1VE)"1@M]]U#1@?O%^
M4[5Z#X#?#.?P?!-<Z@0VH7LQFN"O0$Y(C^4["0S.Q* #+%1N558^7_%/P7KG
MBG7+76+;37$5I]GVI)<6JN_E2F8YVRN$R6*C!?@!N^T?2NEWK7L:R21/"QSF
M.0QEUP2.3$\B<XR,,>",X.0);N8P(SJI<JI(1=H9B!D*-[*N3T&X@9ZD#FOF
M7_A"]<_X2C_A(O[-?R/,QY?VBU\S9Y'V?=_K=N[;\^W.,_)OQ\]>B_'RQU#Q
M9I;:=8V,DCW"PLS-+;1K%AQ(4.9B6<% "%RF&R)#C!/@'8ZAX3TM=.OK&2-[
M=9F5EEMI%ERYD"#$P*N2Y #83"Y,@S@>?_#?P3K/A37[S5Y-.D>WNFNL!9K3
MS56283(=IGVD_*%(W #)()Q@Q?%/P7KGBG7+76+;37$5I]GVI)<6JN_E2F8Y
MVRN$R6*C!?@!N^T?0L2CQ/;2PWEM)"DBO$\4K1;F1EPQ!MY9  0Q'W@P(/ X
M)^>OAU::S\"KB2QFM)K[399'=)+6/S) P50'VJ<KD;59)"!D$QLP5M_80>&[
MOXHZO:ZK=V\EKIUBNZWAG 2XDF+'+E$;?&%=$.')#!%*J5D?;M?M#Z7?^)=.
MDTO3[1YVF\HF7S((XT"R!R/WD@=F^0#&T+AL[\@J3]GC2[_PUIT>EZA:/ T/
MFD2^9!)&X:0N!^[D+JWSD8VE<+G?DA1P'[3/@+6/B/-!'8V+^5;></,>:V7S
M"Y095?.)"XC!!;#'=@HNWGU7Q9>WOB#1[B+[#,EU/;RP^3YEJVUGA(W[_/"F
M(,=N>)#U\H"N)_9C\+ZGX%MY-/U"R>-9+AI5F$MNZ#,:J595E+C_ %8P5#Y+
M<A0N3S5SX)UE?%/_  D,>G2-;[ERC36BR[?LPMW.!.RY'+ ;L-@ E<Y'TK:3
M&=%=E*%E!*-M+*2,E3L9ER.AVDC/0D<UXK^T1\'[OQ-+;:OI&/M]JRX4D NJ
MN'C(,A\L%');# !PQR3M56+;XT:MK5E]GATF]CU1X656:$16BR8/[SS)S@ #
MYPC@Y;$>XYW'M?@M\,Q\.=.2R)#2EFDF==VUI&P#C<>@4*@.%W!=Q4%B*\5\
M-Z#J/PX\4W5V]C/<P7C3[)+==ZA9YA*A+-M12&4*X=D"@E\E0I;I?VB/#^L?
M$.SBLK73W!6X$S.T]L% ".J(!YH);$G[SHJ.I5&E4B0^@?#:]O=)TN&"ZL9D
MGM;>"+RUDM7\W:!'N1O/51\JAF#E,9VJ7(R?)/V<?AOJO@1[FVU+3R]O>+$C
M,);615"EU(=#+\R%9"6QN.%P$;=QS5S\.->^!M\]SHB/=V<F%VA#+N!#%5EB
MC(?<F"1(H"\CE=[1UZ5X 'B#XBS07&MQ)9V,$@F$*K)%)/*A/E;U:5G58W42
M -M5B%^1P0R'[3GA?4_'5O'I^GV3R+'<+*TQEMT0XC90JJTH<_ZPY+!,%> P
M;(] ^$)N[;3X+2^M7MI;>WAB.9(94?8NS<IBD8]%!(95P6P"V":X7PUXUU3P
M6UVEYIMU/9MJ-ZUO);K')*%>=V"F$%9-A.]Q*QP=R@ J5-0^&O"%QXR\0Q^)
M&M7L;:&W**LRJES.Y66(L\:G,>T-C+DDJD>W*M\GNM?+=AI-[\+/$]Y?FRNK
MRUNEF826\)D($TBS= 2I*NIC(9D)'[S&"JF']JGPQK/C#[+<163_ &>/S56-
M/W]TK/M+&582Z!3L&S8S@8R[*SJ@]+^.'@*]^*&DF*.+[//'<":*&1D9W"HR
M%&*,T<;$NQ7#NN FYD+,(\3X=?%34= LHM,N](O6N[=1;QF.+_1GV 1Q%IF;
M:@. '<;TP/,!VG:.E^#OPJFT2:?6M4;=J=YN,BJS-'"C$,(%RS;L;5&<D*%5
M$.T%GY#XV_"[4=-U2+Q-H*"2>-?WT6-S-M1D+A6;YPT7[LHFUP0"@+,66_XI
M\?:G\1;%],L--O+:YN(U262YC6&WBC8A9L.^3)P2H"H'*DNH#+MKU7P!X.C\
M&6,&GPG*PQ@%N1N8DM(^"S8W.2V,D+G X KY[^"VC:A\&;^[LKBPNKF*Y:,0
MSP(C*0DDB(S?/Y<88.6.^0&, ;AAMPA^)WA'7?$.O6.I)8[G@M[:8Q)(!&GE
MW#N8&N)-L;RY.3M P&P%<(9'] _:1\$ZAXUT55CB3[3#<"9X8W:7*JLJ$1EH
MXR[8<-MVJ3@JNYMH;0^$OB[4)-*A@&F3QRVMMY9$[);K(T,6(U3?^\)<A.61
M8T!?]XQ0*Y\%OBEJ?B9VMM:LC:RE9'A;8\2ND9B60%)6,@(,R$-RK@D#!0[O
M6J^9?B/X9O?"'BN'7X;6>\MY%!<01EV0B'[,Z_+NY"XD7<$#D[ 1M9A;_:1L
M]6\?Z9"]I8R) DR2-&^#>DE&5&$432 (!(0P),NX\QHJ%F]%\#:S?Z5H]LHT
M^9I8K2VC2)I((Y&=8?F9@\@$<60HR29LEMT"[?F\U_9F\!:Q\.)IX[ZQ?RKG
MR1YB36S>64+C++YP)7$A)*Y8;<!&W<'QD\!:QXAUZUU6QL7>*T\@8>:VC\PP
MW#RY7]\Q"L",%E##N@QBOHK2[UKV-9)(GA8YS'(8RZX)')B>1.<9&&/!&<'(
M'A7P!^$/_"(ZSJL^-L44@@MPK[DV2;;DJ=W[S<D9A&3QDL,OU'O]%?*OP0T^
M^^#^H7MA/87ES%-)$D<\,0*-L9Q&Q+,(E5EDW,3)^[(VM_$5/BUX8UG4?$6G
MZH]D[0+):[%@_>NJ1S>85F;(C27+$D[A" 0!*X1WKT#X^?"&X^*-C%-&/)O+
M?S6C@9U965RN8V8?*LNU%.06C5]R;F4B4>=:#\6/&UZ@LUL2TK*X$\MJ\+ X
M8ABSM';@J.%W+@D $,3S[5I/PVGM-#N--D>-[VZANS-,%\M'GN Y9CM7) +!
M=VW)51A5&%'F'[-$VI^"X;C2)]-N?-^T/(DK;8[?)"1,&D? V@H#NB\YF4LR
M(VWYCXB^$+[PEXHC\1P6LUY:ML#K H:1"8&MV4*"S-A5#[B%0DB,L#\U2_M"
M6>K?$;3H%M[&2-#>P^7&^&N6#0O^]D",4MT5F*D.S$D@OY.W#GQ!^'>K>)?#
M$-G-;"*>R6V9(DE%Q+*(8W@?(551#L/F*$:4M]S :NJ^%OC74;K3(K"'39X;
MNWMHXA)=KY-IN1"B.22)G!"9*QQDAB$9E4^97"_LI>&-3\&S7MO<V4RF22V4
MR/MCA41F82$,23)P?D\I9%9MH9D5@]'Q3\%ZYXIURUUBVTUQ%:?9]J27%JKO
MY4IF.=LKA,EBHP7X ;OM'TKI=ZU[&LDD3PL<YCD,9=<$CDQ/(G.,C#'@C.#D
M#)\?^#H_&=C/I\QPLT9 ;D[6!#1O@,N=K@-C(#8P>":\+^%7B'6?A(K:1J>G
MW-S;)N:WELXO/QND;()4J"K'+C>5E7.&4JRA.O\  _@N[\3ZT_B34HC B0B*
MQMW(\Y4*\R/Y9 4D._[M]S*SL#CRT+9_[3GA?4_'5O'I^GV3R+'<+*TQEMT0
MXC90JJTH<_ZPY+!,%> P;(] ^$)N[;3X+2^M7MI;>WAB.9(94?8NS<IBD8]%
M!(95P6P"V":[6OFOX]_"O4]'U$>)]"+O<?*)(U199$/EB .B%6WJ4X88+*?G
M&5)\NI9^(O%_Q25M/EMDL+:3Y+B9H'C/E.CJZA;AV+Y&?]6 P;;ET4DUZ!^T
M)\$_^$ZT^..Q5$N+3)@3[B%-H5H%P0B9VKM)& 4"Y569AG^$/C1JUO +74M)
MO9-01FC#QPA;:1A\J.TI(2,%OONH:,#]XORG:O0? ;X9S^#X)KG4"&U"]F,U
MP5Z G)$?RG82&9V)0 98J-RJK'R_XI^"]<\4ZY:ZQ;::XBM/L^U)+BU5W\J4
MS'.V5PF2Q48+\ -WVCTKXWZ?>^,=&DLK6SF\^XV?(SVJ^7Y<T;_.?M!7YE4E
M=A?_ &MIK%^%_A#4H/#\N@7EH;>7[->1QS-+#)"QEWE<^4[R*<R'(V,-JYW9
M(6N:_9HFU/P7#<:1/IMSYOVAY$E;;';Y(2)@TCX&T% =T7G,REF1&V_-#\<O
M@;J&GZA_PD/A[/G;C))'&$5U<*=TB# $@< ^9'AF=F/#AR%FT+QGXP^(6ZR:
MV33XGPLET89H9(U.23&)9<LQ"E1L!*D@EH\AQVOQQ\+W=]I']AZ19/*ACMT5
M_-A2.-(G5@O[V42,P$:CD8PV[>2"IE^ =CJ'A/2UTZ^L9(WMUF9666VD67+F
M0(,3 JY+D -A,+DR#.!Y_P##?P3K/A37[S5Y-.D>WNFNL!9K3S56283(=IGV
MD_*%(W #)()Q@Z'[4OPZU/X@R6T>GVCNMOYVZ0R6Z(WF"(C:&F#\;"#N5>>F
M1S57]K#59]3T&WDNK=[67[?$&C=XI.?L\Q)5HG<%<D@$[6.,E%R*VO!'Q9O?
M#&E6L$^F75Q(+*!H)+2,RV\D9B4P[WY:-_X9!M;!!=05916K\"_AA>Z5<W>M
MZU@7]VQ C#%_*CW9*YWNI!VH$7+;$10&Y91POQ3\%ZYXIURUUBVTUQ%:?9]J
M27%JKOY4IF.=LKA,EBHP7X ;OM&K^U3X$O?&]C:WMM;S>;!)*'MMJ23!9"HW
M_N9) <&->$WG:^X[=K5U>M^*]3^(6DW$%EITUO/+;O&_VS;"GS)B1(QN\QV(
M;$;.D<1.69P5*'G_ -DK3;[0+%[2YLYH0UW)(TDP$("^3$H"HW[UF+*.J+'M
MW'S-R[#RG[/FD:G\*KZ[L+K3[F<3>6%F@53#F(.P(DE,46UE<G)=6# (4W$A
M>F_: ^ UWXJ>'6-, 3446(2Q(X7<RG*R)*1$2Z'C<^TLBKC8R!6Q/#/Q.\:^
M(,6:6*1.8PIN9[>6#;T0RDR.(RP)W;51LX.(R 5KM?BE\!/[<T*/3[<^;>6W
M[R.5SAI96):XW-(78>:S,^W<%\S9N8*M<K\,/B'XDTB&/1)-*=YH\PQ7,F^*
MW14&U#(5C*2*F/O(X,B@!=SG<W/_  D\*:[X7UZ]NQ9O=;Y)H7GE(LHV\RX#
M&X&Y&W*?++%8E? 88_A#?6E>(?M1_!^[^(,%O+88>6V:3]T2%+K)Y8)#,0H*
M[ <' ()P<@*TNE_&_5-3M5BCT>\&I-&0!)$8;+>,_,9)70A<#<%."3B,/DAZ
MZ7X+?",?#V"1II#/>W+![J8LS!G&X@#=R0"S?,?F<DLV 0J^8?$7PA?>$O%$
M?B."UFO+5M@=8%#2(3 UNRA069L*H?<0J$D1E@?FJ7]H2SU;XC:= MO8R1H;
MV'RXWPURP:%_WL@1BENBLQ4AV8DD%_)VX?H-0TS6E\-):"U$5[ NG);JDJW$
MA>&XA&]QY8B0?('^_(H4G>5"FM6[^+MU,C6=WHEZUPZE&B"1SV;%QA5:XSY>
MP@@2,5(3+!@=IS4^#7@B^^%6C&(P&ZNY9GE,$;Q($9HU54:2215('E@.R[B"
MWRJZKN/(?LS> M8^'$T\=]8OY5SY(\Q)K9O+*%QEE\X$KB0DE<L-N C;N*GQ
M3\%ZYXIURUUBVTUQ%:?9]J27%JKOY4IF.=LKA,EBHP7X ;OM'I7QOT^]\8Z-
M)96MG-Y]QL^1GM5\ORYHW^<_:"OS*I*["_\ M;37*^!OA1<ZYH'_  CFKVKV
MS1^8T5R'MIU#&4R(P"R%U;YV5@  8PP\Q2^!YUX9O_%OP=#Z;#9FZAW%HSY4
MMS$HW,"8VA92H8C<4?!'WMBEFW>]?"WP_JES-)JVO;$NGC\F&WC)\N"+(,G2
M1U+2,JLQRS *HWX^1.:\->-=4\%M=I>:;=3V;:C>M;R6ZQR2A7G=@IA!6383
MO<2L<'<H *E34/AKPA<>,O$,?B1K5[&VAMRBK,JI<SN5EB+/&IS'M#8RY)*I
M'MRK?)-X:\:ZIX+:[2\TVZGLVU&]:WDMUCDE"O.[!3""LFPG>XE8X.Y0 5*F
MH?#7A"X\9>(8_$C6KV-M#;E%6952YG<K+$6>-3F/:&QER252/;E6^3W6BBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBL_7] @\0P/:7:"2&1=KHW0CKVY!!P01@J0""" :
MY_X?Z)=^&4_LZ<B:VB7;:SC"R")0H2*9,*-Z@X5TRKJI+B-\!^PHKA=;\(3^
M,KD#4 %TV)@5ML[FN)%8X>?'R^2,!HX06WDAIL%?*'=44444444444444444
M4444444444444444444444445S_C_6+K1K&>XL(?M%RD9,<7]XY&3@<M@9;8
MN&?&Q2&(-<!\.]?U;XCP!-6LOL217$,C.1(CRM%*L\:I%(-R*&5-\C,X8!D0
M98M%Z_111111111111111111111111111111111111111111111111111111
M1117/Z7H\UW(MW?A/-3/E11LTD46059PS)&7E8$@N578A,:*,RO-T%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%17;.J,8@&<*=JLQ12V.
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M)*L$6(E 2?6JQ?#/B^#Q(;@6Q)%M<O;R$C:#(BH7 SR0"VW) R0<97#'YO\
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M28)DN([8NLV^[>))IG=9R%\N%2D2H$!1F?+%@<1@8D:I^SO\9=0\27=SH^L
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M>OEA0$PV3N&W&#DY'.37BO[9]V\&C1JC%0][$K@$@,OES/M..HW*K8/&0#U
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MACDT^%-/TTQXB,B!KIDP@1HXE(AA4#?Y;.9@<(WE%#SX_P#L,?\ ,1_[=/\
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MMK?\@>#_ *_X_P#T3/7JOPG_ .0/I_\ UX6G_HE*^>K:T2U^(6V-0H+,Q"@
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M;V\,1S)#*C[%V;E,4C'HH)#*N"V 6P37:U\]_M@?#J]\4P6MS8Q&86[3"2-
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MI<?ZL8*A\EN0H7)YJY\$ZROBG_A(8].D:WW+E&FM%EV_9A;N<"=ER.6 W8;
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MY0,LQ).  !GL *]*HHHHHHHHHHHKBOB]<7UEI\]SI]PENT%O-*Q,(F=O+7S
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MT9555#MP&DC4,ZB0$.^%1O2_C1;7CZ;>M!+"D L+G>CP/)(W[M]VUQ.BKE<
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M=\/]@?\ "1^2^SR\^3E=V_S?(V[NFWS/XL9V?-LS\E<_X&N]9^(FD?VI#?\
MV:ZG\PPQ)# ;5/+<Q[6\R.68[BA);?\ +OX0A<,? /XUW7Q#L95,2/?6OE!R
MS^3#*'+;7RD<A1L(VX!"I8 KM#83C_!7QPUW7-7N]-9('GAAEBCBC5UMO.2X
M2-IWD(>0(J%V(+*'"JB@2NN:OCCXG^*OA3<I<ZIY%S:3,<+&N(5.[<8E?8DB
MN$!"&3>"I)_>,K;?6OBS\9X_!FDIJMLOG?:/+%OD%4)D1I$=P=K!=JDD !B<
M+\N2R\UK<NM3:$-:MM1*7!MA=M$8+;[.(RAF,2 Q/("J$!6=WW%?FQNRO8?
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MO<QR6R)J%I(JR1LSP0G<S #)6:2-E",&4JWS <C<0G/_  ;^+VJ>*M>NM-U
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M><;YV*ET=E;>%B+^7M"NC,&#Y6E?&#5[CQ3%H=WY$<2M-O2 ,X=6MC-$&DE
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M1111117RK^W/_P P[_M[_P#;>OJJOE7]AC_F(_\ ;I_[<4?'W_D<-)_[</\
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M?V3]4CO= @CC;+0R3QR#!&UC*TH'(&?DD4Y&1SC.00/6KF[2U&Z1@H+*H+$
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M /)%0^ _AQI?@9YHM,C$3R+$TJ^9)(VT&01L1([%03O (P"0>NWCP7_FH?\
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MXB# NMZS,N1N"M%$%8CJ 2K 'H2IQT-'[;%HC:5;RE076]55; W!6BE+*#U
M)521T)49Z"N9^*OBMK*'PM<W<K^5_H\\[,7?<4%HQE8#)=@&<YP6^9L?>.?J
MJHENT9S$&!=55F7(W!6+!6(Z@$JP!Z$J<=#7RU\ O^1PU;_M_P#_ $LCKVOX
MC>/+/P[<6T7V?[7J;^9]DA14,R[E(9R[?ZF([=KO_=#':RH^WQ_]K&WU!M)B
MEU"2$9OP%@@5BB@I.5+2R?-(P4  JD*Y9\HWR%>@^)?_ "(T?_7AIG_H5O75
M?LN?\B[9_P#;Q_Z42UYK^R780>*K.Z^T37+72W9DDV75W#D2HNUV\J5%9F9'
MRQR_'S'&VO6O%'P3T;5$\W45DD2%7;=/>7;K&N 7;,DY"C"@L>!@<]*]%KP7
M]L^[>#1HU1BH>]B5P"0&7RYGVG'4;E5L'C(!Z@5Z5\';M+K1K!HV# 65NI*D
M$;EC5'7CN&!4CJ""#R*\%^-O_$N\9:7)!^[>3[%O9/E9MUQ)$VXC!.8P$.>J
M?*>.*ZO]M;_D#P?]?\?_ *)GKU7X3_\ ('T__KPM/_1*5U5> ?MK?\@>#_K_
M (__ $3/7JOPG_Y ^G_]>%I_Z)2OG_\ YJ'_ )_Z!U=7^VM_R!X/^O\ C_\
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M1K]9%# 65PP# $;EC9T;GN& 8'J" 1R*\%^ 7_(GZM_V_P#_ *1QUU?[%/\
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M"*69UP!&D:MY@&QF'F!@OSO_ !1J&] ^+<]Y=V5S8V-G)<//;21AQ);QQ*9
MT9R9)5?*J=V A#<+N&25\_\ V;/#NJ_#^V>PO["0"2Y$BRI-:NJAE1&WKYP8
M!=@.5#E@2 H(&X_:3\.ZK\0+9+"PL)"([DR-*\UJBL%5T78OG%B&WDY8(5
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MI-JJH6-5$L31Q%!MSYC$@@EBY7!'N'PP\.W_ (8LYKW4U^U:E<R)),(5@23
M1(HXMQ:*)MBJ6/*J"7"[C\S^5?"SP7KGA;7+K6+G37,5W]HW)'<6K.GFRB88
MW2H'P5"G)3@ENVTR_$?PS>^$/%<.OPVL]Y;R*"X@C+LA$/V9U^7=R%Q(NX('
M)V C:S"W^TC9ZMX_TR%[2QD2!)DD:-\&])*,J,(HFD 0"0A@29=QYC14+-T&
MI>%-0\7>%?[,6V,$RV5DB+,Z*[O%Y;N-JE@@(0!/,96W$B1(@NYH?V:]:OK#
M3HM+FTZYB>"1@99@(82DDC2%OWF)"P!8!41QN";W0.2O"^//@[JWPRU,ZUX<
M0RPLS,T**"4#N-T!B3!DA)(V[!E ,G:8UD/2^&;_ ,3?%7%KJ=NECIYD'VDA
M)H)I47!:W >7S L@;#.H4;0PWG!C;Z*KG_'_ (.C\9V,^GS'"S1D!N3M8$-&
M^ RYVN V,@-C!X)KPOX5>(=9^$BMI&IZ?<W-LFYK>6SB\_&Z1L@E2H*L<N-Y
M65<X92K*$Z_P/X+N_$^M/XDU*(P(D(BL;=R/.5"O,C^60%)#O^[?<RL[ X\M
M"V?^TYX7U/QU;QZ?I]D\BQW"RM,9;=$.(V4*JM*'/^L.2P3!7@,&R/0/A";N
MVT^"TOK5[:6WMX8CF2&5'V+LW*8I&/102&5<%L M@FNUKR#]J7P+=>,-)$=D
MGF20W"S%!]]E5)%8(,?,WSY"]2 0N6PIM?!KQ7>S:;;V\FG7,36UN(I/-V1;
M_*C"J(ED979G^7&]8XERX,I* /YK_P (7KG_  E'_"1?V:_D>9CR_M%KYFSR
M/L^[_6[=VWY]N<9^3?CYZ[#]I7PIJ'CZP@L[&SD9Q-%.Q:2V14_=RH8CF?)<
M%AG:&3'1S535/A%<?$/0K?3;VW-E>V4,2PR.T$L;LB&,KNB9W".JJ7&%*ML(
M\T)@^?\ @[QAXR\#(FD+8&<(RK&\L4DJJK!=J":*18MBYZLQ"#*E@JA5^@/A
M7X9O;!);[5W#7]TRM(JD^7#&H/E6ZC<5PFYR2O5G;+28WMW5<!\9_@_#\3K5
M;>1_)ECD#QS!%<KV=2"5)5AU 9?F5&.=N#YUX+\:^(/AND6G:MILEU;1J8HI
M[-1-)LC!"DHAP01L";_);:"2'<,*[JV^(FI^)]BZ;ITUNK2%9)[]5A6(#:Q(
M@63S9LJ2%P44/C+8#;=KQ)\,X-=TZXTQR3]H4EYF^:1I?E*S-M*;BK*I"C:@
M55C55C 4>-_"KQ#K/PD5M(U/3[FYMDW-;RV<7GXW2-D$J5!5CEQO*RKG#*59
M0G7^!_!=WXGUI_$FI1&!$A$5C;N1YRH5YD?RR I(=_W;[F5G8''EH6S_ -IS
MPOJ?CJWCT_3[)Y%CN%E:8RVZ(<1LH55:4.?]8<E@F"O 8-D=M\-KV]TG2X8+
MJQF2>UMX(O+62U?S=H$>Y&\]5'RJ&8.4QG:I<C)\J_9F\!:Q\.)IX[ZQ?RKG
MR1YB36S>64+C++YP)7$A)*Y8;<!&W<'QD\!:QXAUZUU6QL7>*T\@8>:VC\PP
MW#RY7]\Q"L",%E##N@QBN4^/][<7OB72Y(8O)N3':>7'.5(5Q>3!-Y@>0;20
M"=C$[3V;@>H>,?BMJVMVSZ?IVE7L5_*K1M)(HCMXCM;S'CN ZJQ&"(GR@8X<
M9X1N@\!?!8>&="ET4R 2W$,XFE4,R^9,A0L%9AD*NU1]S<%W$*6->:?LW:GJ
M'@&*;2;O2[UG:Y=UD2-/*)V*K@R2O%$ /*!5@[!]V!VW9Z>&-9T_Q@NJ75D\
MBMO8&U^>';]F>%!YLQA0,, -O,99@2JX9 =#]H[P)K7Q)>V2VT\J+99=SFXM
MBK.Y0'9F16*#RP59PC,&^:-",'UOQ9>WOB#1[B+[#,EU/;RP^3YEJVUGA(W[
M_/"F(,=N>)#U\H"N)_9C\+ZGX%MY-/U"R>-9+AI5F$MNZ#,:J595E+C_ %8P
M5#Y+<A0N3-^UC\.W\6:?#+;J&N(;F-4RQ4E9V6'8,_)DR&(Y;  4_,.0?7_#
MVB)H-M#9Q$E((8XE+8+%44("< #.!S@ 9["N%^-_C?5O"<,+Z-9_:F>1A(=D
MDNP 94>7$5<[N?GSM7;@C+KCL/!OB,^([5+EXS"Y:1)(F97*212-%*NY258!
MT8!A]X8.!G VJ^6[#2;WX6>)[R_-E=7EK=+,PDMX3(0)I%FZ E25=3&0S(2/
MWF,%5,/[5/AC6?&'V6XBLG^SQ^:JQI^_NE9]I8RK"70*=@V;&<#&796=4'I?
MC?5=9%]87MA8.^R.^66!I8$8Q,+;:'D^>*-C*NY51W9D3.1F14Y_XFZY<?%R
MR;2;/2[R.5Y(F\Z\B6VBA"NNZ0,S.2V#MVH-Y1G(S@J?:O">A?\ "/V=O9;M
M_D6\46_&W=L0)NQDXSC.,G'J:Y_XT>#I/&6D75C ?WKQ@H./F:-UE5.64#<4
M"Y)PN<G.,5YK^SQXJOM'TZ/2)-+O%GA\TK)(@@MR'D+AF>7:RX:3#*B2OM4N
MJL<J.4^#_AC6?#/B*^N;JR=Y)H[CYX_DM"\LT4@82R'_ %7<A1),HS^Z9E91
ME>*;BZMO';R6$:2W"[2L;ML5P+ %T#?PL4W!"?E#E2WRYKT#XC>,]4^)EN=)
MTG3[RV\_ GGNT-JJ1;E!"D,=V[.' RQCW 1ON)7M=9\'1^#/#-SI\)RL.F70
M+<C<QBD:1\%FQN<EL9(7.!P!7BO[+_C>Z\)Z;*YLYKJS>[< VJ>;<)*(XB0\
M9*YB9,;7!^5E(8?.F.UT;PCJ'Q/UJ'6M2@>TT^TYM8)2RS.RLVV1D#CRVW@.
MQ( *K&@$BY>K7[3GA?4_'5O'I^GV3R+'<+*TQEMT0XC90JJTH<_ZPY+!,%>
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M9=C*YD#[HEM_ .QU#PGI:Z=?6,D;VZS,K++;2++ES($&)@5<ER &PF%R9!G
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M ;,##; )E&=A;<0OO5%%%%%%%%%%%5=6U2/2(9+F=ML44;R.V"<*H+,< $G
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M2-'D2"-AL+!%$(S+*';S&V[]RH<@G: 6KE?[)\3^*(?MB7L.GL\>Z*T6W$N
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M5RD@(C'E@HY"Y4@.&& =K,VU?>,-0\<W5Q8Z'(EM!:R>5<7DD32/YHR3' C
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M%!D[OXC>/+/P[<6T7V?[7J;^9]DA14,R[E(9R[?ZF([=KO\ W0QVLJ/M\?\
MVL;?4&TF*74)(1F_ 6"!6**"DY4M+)\TC!0 "J0KEGRC?(5]*_YD_P#[@/\
M[9URO[%/_('G_P"O^3_T3!7*?'W_ )'#2?\ MP_]+)*]5_:C_P"1=O/^W?\
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M>J_"?_D#Z?\ ]>%I_P"B4KPK]B[5)-7FU6YG;=++);2.V ,LQN&8X  &22<
M >@KH/VUO^0/!_U_Q_\ HF>O5?A/_P @?3_^O"T_]$I755\J_ +_ )'#5O\
MM_\ _2R.O4/VJK1)_#]TSJ&*-;LA(!*MY\:;AGH=K,N1S@D=":YKX5>)-/\
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M<B%$<DD3."$R5CC)#$(S*I\RN _9=\/:IX&>_BGT^<LS0#)\N*/]V9M^UY&
MD)!Q&4W(6V[WC1O,$O\ PA>N?\)1_P )%_9K^1YF/+^T6OF;/(^S[O\ 6[=V
MWY]N<9^3?CYZ^FK28SHKLI0LH)1MI921DJ=C,N1T.TD9Z$CFJGB%REM,5F%N
M1#)B=@I6([3B4AR%(7[Q#$ @<\5\P?">^\7>'=/C@TVT@N;/=(T$LF(RR,Q.
MY0\UO)L8Y="Z!B&S]W:!TNH?&?Q/X-V7>MZ="MB)%69H"&D4-D C%Q*!SC[P
M"L<)N4L#6?\ $?PS>^$/%<.OPVL]Y;R*"X@C+LA$/V9U^7=R%Q(NX(')V C:
MS"W^TC9ZMX_TR%[2QD2!)DD:-\&])*,J,(HFD 0"0A@29=QYC14+-TJR:G/X
M=73H=-F,KZ9';#?+;Q$,81&[NK2950&R@YD9E99$APK-4_9C\+ZGX%MY-/U"
MR>-9+AI5F$MNZ#,:J595E+C_ %8P5#Y+<A0N3ROQ3\%ZYXIURUUBVTUQ%:?9
M]J27%JKOY4IF.=LKA,EBHP7X ;OM'I7QOT^]\8Z-)96MG-Y]QL^1GM5\ORYH
MW^<_:"OS*I*["_\ M;31^SQI=_X:TZ/2]0M'@:'S2)?,@DC<-(7 _=R%U;YR
M,;2N%SOR0H]5KY@TOPAJGP,U26>PM7O-)NI%#) IDF1<N44+EI-T8+#<<QR*
M0&978;.E\5:5=_&Z>TA>TGM-*@F,MQ]J012S.N (TC5O, V,P\P,%^=_XHU#
M>B_%XW=SI\]I8VKW,MQ;S1#$D,2)O79N8RR*>C$@*K9*X)7(->?_ +,?A?4_
M MO)I^H63QK)<-*LPEMW09C52K*LI<?ZL8*A\EN0H7)]UKA?BW/>7=E<V-C9
MR7#SVTD8<26\<2F0-&<F257RJG=@(0W"[ADE?/\ ]FSP[JOP_MGL+^PD DN1
M(LJ36KJH941MZ^<& 78#E0Y8$@*"!NM_M$?!^[\32VVKZ1C[?:LN%) +JKAX
MR#(?+!1R6PP <,<D[55BV^-&K:U9?9X=)O8]4>%E5FA$5HLF#^\\R<X  ^<(
MX.6Q'N.=Q[#X0_#G_A66EBU \Z<;Y9?+X\R4C[J^8RJ/E544DHIVAF"DFO'_
M /A"]<_X2C_A(O[-?R/,QY?VBU\S9Y'V?=_K=N[;\^W.,_)OQ\]?35I,9T5V
M4H64$HVTLI(R5.QF7(Z':2,]"1S4M?+?AO0=1^''BFZNWL9[F"\:?9);KO4+
M/,)4)9MJ*0RA7#L@4$ODJ%+>B_'.TU/Q=I3Z?:V#M+<>66/G6X2-5E\P*Q:0
M%I<(NY5!C!8[97VY:7X!V.H>$]+73KZQDC>W69E99;:19<N9 @Q,"KDN0 V$
MPN3(,X'G_P -_!.L^%-?O-7DTZ1[>Z:ZP%FM/-59)A,AVF?:3\H4C< ,D@G&
M#E>//@[JWPRU,ZUX<0RPLS,T**"4#N-T!B3!DA)(V[!E ,G:8UD/2^&;_P 3
M?%7%KJ=NECIYD'VDA)H)I47!:W >7S L@;#.H4;0PWG!C;Z*KC_B[X'?QSI=
MQIT3B-Y53:S E=R.L@!QR 2N"1D@'.&Q@^0?!_QOJ/PVM/[(U/2KUS Q\J2U
MA^T*RR$RL&8/L)#-P48C!VD*R$MV'P^^&5UJ6IOXDUM?+NSE+:U63S$MXPIC
MY8,59F4L<+\F69\;VVQ\_P#M%_ 2X\431ZOHYQ?1^6&12L3/M/R2J^5Q*O R
MS<HJ[2"@5^?\,_$[QKX@Q9I8I$YC"FYGMY8-O1#*3(XC+ G=M5&S@XC(!6O4
M/%7AFZT'0VTBP@DO9I;::)I/,CC!DE!\V:0SS;\L\CR!5W\_*2H(-<S^S'X7
MU/P+;R:?J%D\:R7#2K,);=T&8U4JRK*7'^K&"H?);D*%R>:N?!.LKXI_X2&/
M3I&M]RY1IK19=OV86[G G9<CE@-V&P 2N<B+XS_!/4;:]7Q)H"NEPV)98%\L
M2QN$RS*$)23=@B1 7+N3CS%D(6WH7C/QA\0MUDULFGQ/A9+HPS0R1J<DF,2R
MY9B%*C8"5)!+1Y#CK_C7X=O-2TE]!TFPD= MO&DAFMTB6.,HXQYDQE8C8$PR
MKGEMQP-UO]GZQU#PMI\&E7]C)$8FF_?"6VDBVLS2@D+-Y@.6*8"L.C$@$[>%
M_:9\!:Q\1YH([&Q?RK;SAYCS6R^87*#*KYQ(7$8(+88[L%%V\^R:E#=>,=*N
M;>6 VEQ-;31;)7C=0[Q%=P>%I,IN;&2 Q )V#C/C?[-$VI^"X;C2)]-N?-^T
M/(DK;8[?)"1,&D? V@H#NB\YF4LR(VWYOI2O)?VC_@^_Q&LE^RX^UV[,\08D
M!U8?O(LY"J6VJ0S @%0N55F897A#XT:M;P"UU+2;V34$9HP\<(6VD8?*CM*2
M$C!;[[J&C _>+\IVKM?!+X<W'@BUN+R^'FZC>2-/.L>T$GYF6$998MVYF)(V
M)N<KN**K5YK\4_!>N>*=<M=8MM-<16GV?:DEQ:J[^5*9CG;*X3)8J,%^ &[[
M1]'Z)J<FHH7E@DMR&(V2F$L1@'</)EE7'..2#D'C&"="OE7X(:???!_4+VPG
ML+RYBFDB2.>&(%&V,XC8EF$2JRR;F)D_=D;6_B*GQ:\,:SJ/B+3]4>R=H%DM
M=BP?O75(YO,*S-D1I+EB2=PA ( E<([UU?[1'A_6/B'9Q65KI[@K<"9G:>V"
M@!'5$ \T$MB3]YT5'4JC2J1(?0/AM>WNDZ7#!=6,R3VMO!%Y:R6K^;M CW(W
MGJH^50S!RF,[5+D9/E7[,W@+6/AQ-/'?6+^5<^2/,2:V;RRA<99?.!*XD))7
M+#;@(V[CT7]I3P@/$VAW(P-]NOVA"Q8 &($N?EZDQ;U ((R1G'WAO_"'P@?!
M^DVMBX(>.$&0,58B1R9)5RORD!V8#&> .3U/855U;2X]7ADMIUW12QO&ZY(R
MK JPR"",@D9!!]#7S5\.K36?@5<26,UI-?:;+([I):Q^9(&"J ^U3E<C:K)(
M0,@F-F"MO["#PW=_%'5[75;NWDM=.L5W6\,X"7$DQ8Y<HC;XPKHAPY(8(I52
MLC[=#]J7P+=>,-)$=DGF20W"S%!]]E5)%8(,?,WSY"]2 0N6PIM?!KQ7>S:;
M;V\FG7,36UN(I/-V1;_*C"J(ED979G^7&]8XERX,I* /YK_PA>N?\)1_PD7]
MFOY'F8\O[1:^9L\C[/N_UNW=M^?;G&?DWX^>NP_:5\*:AX^L(+.QLY&<313L
M6DMD5/W<J&(YGR7!89VADQT<U4U3X17'Q#T*WTV]MS97ME#$L,CM!+&[(AC*
M[HF=PCJJEQA2K;"/-"8/G_@[QAXR\#(FD+8&<(RK&\L4DJJK!=J":*18MBYZ
MLQ"#*E@JA5]U^'^BZAH<$^I:FIN-1N61GAA9 (XUXBMT\V58L1[W9CN&2S?-
M(V&;R7X6>"]<\+:Y=:Q<Z:YBN_M&Y([BU9T\V43#&Z5 ^"H4Y*<$MVVGZ?HK
MY;\-Z#J/PX\4W5V]C/<P7C3[)+==ZA9YA*A+-M12&4*X=D"@E\E0I;I?VB/#
M^L?$.SBLK73W!6X$S.T]L% ".J(!YH);$G[SHJ.I5&E4B0^@?#:]O=)TN&"Z
ML9DGM;>"+RUDM7\W:!'N1O/51\JAF#E,9VJ7(R?)/V<?!.L_#%[D7FG2.EPL
M6&BFM"RM&7P"KSH"")#SNR" ,'.1%_PA>N?\)1_PD7]FOY'F8\O[1:^9L\C[
M/N_UNW=M^?;G&?DWX^>NE_:1\.ZK\0;2&QL;"3"S),\CS6J 'RF'E@"9B2#(
M0QX *?+O5@P]%^$)N[;3X+2^M7MI;>WAB.9(94?8NS<IBD8]%!(95P6P"V":
M\%U_P#JWP@UQ]6T6T-Q93-@Q1J'.R0[Y(=D:;XPKIF-E4JH\L,S$LA/CB^N_
M$G3(;AK&2WB6Y4+9JCSW+-LE!N'Q&K1HN-B+M!8NS,<>7GW7X-C4+:PBM=1M
M1:FWAAA3]\DS2".,*9"$7:@.!@;F.<YP "W=5\:_#?6+K1O%6JW%I#]H"27Q
MFB7_ %S1?:EWF(=&E!VL$.-ZAD!#%37H'Q%FU3XV>7IEG:7-C8B1'N9[M#"Q
M^]M58]_[Q1C=@;LR;-WE!=S'[4_PCFU/3[(Z7$\BV.8A!&K2/Y3JBJP^8NVW
MRU! #,0Q8D!2:ZO6_%>I_$+2;B"RTZ:WGEMWC?[9MA3YDQ(D8W>8[$-B-G2.
M(G+,X*E#S7[*MGJ'AG3I;>>QG4_:9I29-D)(\F,*B+(RNSEU &X)%@L3+N78
M<3_A"]<_X2C_ (2+^S7\CS,>7]HM?,V>1]GW?ZW;NV_/MSC/R;\?/7O_ (LT
MN3Q+IMQ;(OERW%I+&%D(^1I(RH#&,N."<,5+#@X)XSX7^S1-J?@N&XTB?3;G
MS?M#R)*VV.WR0D3!I'P-H* [HO.9E+,B-M^;V_XE>$!XQTZYL" 3+"P3<651
M(/FB8E><"0*3P<@8((X/%?LN>$#X;T.$N"'N6:X8$JP < 1D;>@,2HV"202<
MX^Z/4-6N)+:&22"/S95C<I'N";V )5-QX7)P,G@9R:Y3X0^*-0\2V(N-6MOL
MMQYCC9ADW*#P^QR73NN&))V[Q\K 5VM%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<+\:=7-
MKIES;I#/-+<6T\4:00RS'<Z;,L44J@&_)W$$@-M#$8KS7]D@S>';273KVUNH
M)7N6E1I+:98F4Q(,;RFU2/+.=Y4'<H4L20/H2BBBBBBBBBBBBBBBBO.OC]X'
MN_&NDRV=@X60LCE& Q*J'=Y6X_<)8*P;@94*Q"LQ'/Z)\>+V!#'J6C:@MPC%
M6-O 9X6*@ NK%EX+9P 7&W!$C9K0U/3KWXJ8MKRV>STH^5(ZRLGVJY^ZZ1%$
M9OLZJXS)EO-.%5=A+[?5:***************************************
M**************Y_Q_K%UHUC/<6$/VBY2,F.+^\<C)P.6P,ML7#/C8I#$&N
M^'>OZM\1X FK67V)(KB&1G(D1Y6BE6>-4BD&Y%#*F^1F<, R(,L6B]?HHHHH
MHHHHHHHHHHHHHHHHHHHJKJFIKID;32!RJXR(XY)GY('"1*[GKS@' R3P":^5
M?@Y-<Z%XBO-3NK&^CMKO[5L8VD[%/,F69=ZHC'HNT[=V&(_ARP^M******JZ
MM<26T,DD$?FRK&Y2/<$WL 2J;CPN3@9/ SDUXIX#\7ZY\2H;C3M5L/LD4D;)
M)<%98,1R#84CBE#%Y2-V'W[(\AF5L!)/=:**************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M*********************************************************S]?
MU^#P] ]W=N(X8UW.[= .G;DDG  &2Q( !) KD-/?6?$\+W"NFGB3<((I(//F
M2,@8EE!D0"?(W(@RD:DI*LK$&/S3]DGQ_?>,Y-0FU"=YF'V3:"0$7(F!VHH"
M)G:,[0-Q&3D\U]%5Q_Q UN[\,I_:, $UM$NZZ@.%D$2AB\L+Y4;U!RR/E750
M$,;Y+]!H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!P5(((!!%:%>8?&>PU:PMI]1T
MO4#"(87E:!X8)(RJ*"0CF(NIVJQ^;>&8@ HO(R?V</CD?B+ UO=X%[;JN\@J
M!*AX\T*#D$' D &T$J1@.$7UO5+)KV-HXY7A8XQ)&(RZX(/ E21.<8.5/!.,
M'!'C_@X:MJNKZCI\^J3>19_9]FR"S61O/0R+N8P,ORJ"IPHWD[AL VGVJBBB
MOF7]H[QMK/PQ>V-GJ,CI<++E98;0LK1E,D,D" @B0<;<@@G)S@?0'A?1+C2D
MQ=7<ETY5,LZ01J& .XHL,:$!B>C,Y   /4G:HHHKG_'^CW6LV,]O83?9[EXR
M(Y?[IR,C(Y7(RN]<LF=Z@L */ &CW6C6,%O?S?:+E(P))?[QR<#)Y; PN]L,
M^-[ ,2*Z"OF#]J[QEK/A)H5AO=D%SYH$<,7D.@B=&4F7>\A8AP&*&-2%^YAB
M*^GZ**********\E_:!OM0\+:?/JMA?21&)H?W)BMI(MK,L1 +0^8#E@^2S#
MJH !&WFOA;:^(O'>G0ZE_;/E>;YG[O[#;/C9(\?WOESG;GH,9Q[U%\4=.\5^
M#+1[ZWU07*1*6E7['!'(%RHW*%CE#  EG)*!54GGG'T)1111117 ?";P?JGA
MO[5_:U[]L\VX+0\'Y5YR><;-V1^Z7,<>WY"=QKQ_XF>,M9T3Q%I^FS7NZ":X
MLI2D,7V9,-,8FC/SR2.I"DL'D*DM]W &/I^BBBO)?V@;[4/"VGSZK87TD1B:
M']R8K:2+:S+$0"T/F Y8/DLPZJ  1MROV8?C3+X^@EMK]PUY"V[=A$+Q-T;:
MI&2K95B%50#'G+,2?;Z\P_:&^*I^'FG&2!@+N9O+@!"M@]7DVDC(5>APP#L@
M92I-<I^S9XBU7X@6SW]_?R$1W(C6)(;5%8*J.V]O)+$-O PI0J 2&)(V^]44
M4445\P?M7>,M9\)-"L-[L@N?- CAB\AT$3HRDR[WD+$. Q0QJ0OW,,17T_11
M1111117RK^U=XBUGPI)"8]0=8+B25DBA3[,8Q$$4 R*YDDR),MDA2PR% VA?
MJJBBBOF#]J[QEK/A)H5AO=D%SYH$<,7D.@B=&4F7>\A8AP&*&-2%^YAB*]J^
M+UQ?66GSW.GW"6[06\TK$PB9V\M?,"J6<(F=I4EDDX;( (R>*_9/\5W7BC3;
MBYOI7FE-_+\SG. 8X6VJ.BJ"Q(50%&> *]JHHHK@/^$/U3^W?[1^V_\ $M^S
M[?LN#][&,;?N_>_>>;GS/^66-G-=_111111111111117%?%[POJ'B6Q-OI-S
M]EN/,0[\LFY0>4WH"Z=FRH).W8?E8FNKTFWDMH8XYY/-E6- \FT)O8 !GVCA
M<G)P.!G JU17"_&GXF#X<Z<]Z &E++'"C;MK2-DC.T= H9R,KN"[0P+ UYJ_
MP[UK7],@UBSU2Z;4I(8+CRBZQ6C90.(A$H$:G&!ELI(P.]5#DK[)X ^W?88/
M[6V?;/+'G;,;<Y.,X^7=MQOV_)OW;/EQ704444444445BZ9XO@U.[N;"(DRV
MJP&7C"@S!F103U.U<G P P&2=P7FOBSX/U3Q)]E_LF]^Q^5<!IN#\R\8/&=^
MW!_=-B.3=\Y&T5W]%%%%%%8OBGQ?!X9$)N"<W%S#;QA1DF25L*/0 #+$DC@'
M&6PIVJ************Q?%/B^#PR(3<$YN+F&WC"C),DK84>@ &6))' .,MA2
M>+],N]3@,5A<BUE++^],(G(4<D!695R>!D[@!G R0R^%?L@>-KWQ4^HR7\\D
MQ#6S*'8E5+F<ML7[J X'"@#   P!7T?7%?%[POJ'B6Q-OI-S]EN/,0[\LFY0
M>4WH"Z=FRH).W8?E8FNKTFWDMH8XYY/-E6- \FT)O8 !GVCA<G)P.!G JU16
M5XFLKJ]A,=C,EO*<CS'B\_:"",JOF1C<"006W+Q@H<\>%?LD^/[[QG)J$VH3
MO,P^R;02 BY$P.U% 1,[1G:!N(R<GFOHJBBBBBBBL5O%\ OQI62;@VS7!&/E
M$8D6,$GU+$X SPI+8^7=M444445X+^U/XGU;PG:+=6=V(H9)O(\M(0)</$S%
MC,SN008SM,:QD;OO$J#7JOPRNWO-*L996+N]E;,S,2S,QB0EB3R23R2>2:Z6
MBBBBBL7QIXO@\'6DM_=DB*)06VC<Q)(55 ]2Q &2 "<L0,D;5%%%%%%%%%<5
M\7KB^LM/GN=/N$MV@MYI6)A$SMY:^8%4LX1,[2I+))PV0 1D\5^R?XKNO%&F
MW%S?2O-*;^7YG.< QPMM4=%4%B0J@*,\ 5[5111117 >,/!^J:GJEE>6=[Y-
MG#GSX,'Y^<G@?+)O7"?.1Y6/,CRQ(KOZ**********Q?!OB^#QA:I?6A)AD:
M0(6&TD)(T>[!Y )4D9P<$9 .0-JBBBBBBBBBBBBL7QIXO@\'6DM_=DB*)06V
MC<Q)(55 ]2Q &2 "<L0,D;5<!X/\'ZIIFJ7MY>7OG6<V/(@P?DYR.#\L>Q<I
M\A/FY\R3# "N_HHHHHHHHKA?C3\3!\.=.>] #2EECA1MVUI&R1G:.@4,Y&5W
M!=H8%@:\U?X=ZUK^F0:Q9ZI=-J4D,%QY1=8K1LH'$0B4"-3C RV4D8'>JAR5
M]D\ ?;OL,']K;/MGECSMF-N<G&<?+NVXW[?DW[MGRXKH****************
M************************************************************
M*********^</C_JA\9ZYIOAM%$D(FCGN4#J"1EBRG&&0K '; 8%A(,+D(3]'
MU\5_LI:QJ%M]MM])A22XE^S'S9MPM8E3SLF0I\Y9MP6-%Y/S.3M0@]A+\9/$
M'PLU&*U\1M'/:S,G[]4 4)T=XVBC0DH6!=&0L0H"A0ZN?J2OG#X :H?!FN:E
MX;=1'"9I)[9"ZD@94JHSEG+0%&P6)41G*Y+D?1]<K\6/^0/J'_7A=_\ HEZ^
M9?&WPJG\/:=IOB;0E,<T=E;O<^6>0?)3]^$Q@@C<)^H8'<R$&5J^BO@[\58/
MB-9)<1L//146XC VE),<X!+'8Q!*')R."=RL!B?#O_D8M=_[AG_I.U1?$GXF
M7LFH)X?T(1F]>%Y)9Y,M%;IM;;D(&*N3M(+KM&Z,%7$GR\KX_P#$/B3X2A=0
MGNH]2LMR)*C6ZV[J68DM^Y4A1A0@=F8;G ,9.#7M7@OQ?!XQM(K^T),4JDKN
M&U@02K*1ZA@0<$@D94D8)VJ^5?VY_P#F'?\ ;W_[;U]0:I)-%&QMD1Y>-JR.
MT2'D9RRQRD<9(PIR<#C.1\Z^ /C/KWB36+O3&6V:6"WGC5%!CM5ECF5//=FW
MSE>2H5/O94%4^:13XD_%'6_A'J4#7UPEW8W.20+>.+8!(/-2,+)YFY(RNPR.
M5._!W%21Z+\</B9/X5%K86 'VW4)O)@D?_51'<B&1AAB2#(NT;2.K-D+L?G_
M !MI_B;P993WT.HQWICA<M'):Q0%$ RTR%&PSH!D*^5(W?*S!5/2_'/QUJ7@
MBR>_L8[9HHO+,C3-*7.Y_+VK&BJ.K*=QE'&X;.AJW\!/%-QXJT:VO;U_,GD\
M[>^U5SMFD1>$"J/E4#@?K7$_\+&U/XEZG/8:!<0V]C:[/-O0BW#NQ5L*B/A2
MI8$ @8Q&7$I#*C>-_M5G4;)[.RU-Q<&)9WBNUC\GS5D,89&0#8KQLG.QB"C1
MD@,3GZO^)7Q!C\"VOVET>61Y%B@AC!+RROG9&, XS@DG!X!P&;:IX37_  OX
MLF@>YAU&!+G;E;2*WC,&1QM6:?<^64;OG&-YVY5/F&M\(OC$_P 2-.:YMXX_
MML3*DL+2F./=P=X94E=49<E<H3N5DR0I>O+_  A\=M>UC6+C3#%#+-''-"D<
M2E;5)4F56N97<M*(E7=D C?\B*@=LUZK\&?[?A^TQ>(=C[)%\B9?*^<?,'XB
MVX7Y59=Z*_S'/HOHMW=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5X?X7\4:[\6]U
M[I]PFF:>LDB0EH!/<2[=@W,)/W>W.[F-OE8,AW[=XJ^#/C5J'A?5%\/^)-CR
MR>6(;J)&57:0Y0$;4#*2?+#HBA70A@WS.O:_'/QUJ7@BR>_L8[9HHO+,C3-*
M7.Y_+VK&BJ.K*=QE'&X;.AKR_P .>._%?CK1XI]+ $L;-YL\BP(]PQE<!(49
M/*"(A7>[;"S JA)1PWT5X>FGGMH7O%"7#0QF9%Y59"H+J/F;@-D#D\=SUKSK
M]J/_ )%V\_[=_P#THBK@/@)\>]&\*Z-;65[<^7/'YV]/*G;&Z:1UY2-E/RL#
MP?UKTKX8?%J/X@WU\MHV^SMX[,1-@KN9Q,TKX9$<=%3!R/DW#&XUB?&;XRS^
M'K^TT.P 2XO&B#7#KYBQ)+(859$W+N<,"WS?* H!#;CMROC1XKU;X4&VU&.\
M-W9F8136\\<".S%78%9(8(\#:IQQE6"DB16*CN_&/CJ\721JVE1PE3:?:3]I
M9U*IL67&R)6WL4W#'F(%;!RPS7"?!#Q_K7Q+L+B3S8X7^TRJ+AHED5%,<92*
M*)70DH6+;Y2P V+B;<QCQ? ?Q>UG2-=N- U,_;)#N6W^2"#Y@/,21FCP$B:$
MEW&)9%PH52V5:U\8O&'B/X:)!JDEW;31R2+'):K;[84<Q$C:Q8S.N58[BZ'=
MM^7:2J^RRZ_<ZU817FE)&7GA22,7#M&JK)'O5F\I)2Q!*Y0%01G$@P,^7_LS
M?%Z^^)$E])?%-L?V7RXXT"HFX2A\$Y<YV G<S8.<8'%<5\??^1PTG_MP_P#2
MR2O2_CW\0=8^'L(O[);::U,BHZO#,9(\@;69DF"E2P(R0FTLB_,3FNE^#7BN
M[\7Z?'J-V\#"9<JL$4L80JSJZLTLC%SD '"J 0V"ZD-1X/U+5;Z\N8KJ2U-O
M;3)%^[@E261FMXYB?FN'6,+YJ ??+8;A.#7=5Y5^U'_R+MY_V[_^E$5>-?%2
M)_@OXFBUF$'[+=LSR*"3NR0+I,&0%CEA*F[:@=E &$KZUM+M+Q%EB8.CJ&5E
M(964C(8$<$$<@C@BO!?'/_%<RZK?GFUTNPOK6W_VKEX&^U2?PL-J[8MK!D;.
M]"#FC]BG_D#S_P#7_)_Z)@KJK[QAJ'CFZN+'0Y$MH+63RKB\DB:1_-&28X$8
M"-MA7;(7/1P4& K/RL_Q&U7X6:I#::]<)=V-YA8KG9#;M&P*ABRK@!07&_<2
M-A5U;*O&=7]HSXG:MX MQ<6:6RP/)Y(D9I))]SQEE<)L2--I1OO-*&^4E0,B
MK<-QK_BO1X+RSN$MIS:12*IABEFN'\G/+,XAB61S\JA"57:S,I9HDYKX"_&7
M5OB!:26ZB-[R&9-]S*H6%87.1E(F5I)N'"JHBCVJ"\@;AX5^)NK_  ^UZWT;
M5;E+VWN_)V2"!(I5\PO$N%0HH_>@;\F3Y "N&)6N?_;G_P"8=_V]_P#MO78>
M/-5\7:I =0TQ8[6!59TM=HDOV3C'F+)&\8? +B-"& ;RSOD %=+^SW\9V^)M
MK(UPJ)=02 2+&'"%6R8W&[.,X92-S'*%C@,!1?>,-0\<W5Q8Z'(EM!:R>5<7
MDD32/YHR3' C 1ML*[9"YZ."@P%9^5G^(VJ_"S5(;37KA+NQO,+%<[(;=HV!
M4,65< *"XW[B1L*NK95XSJ_M&?$[5O %N+BS2V6!Y/)$C-))/N>,LKA-B1IM
M*-]YI0WRDJ!D5S__  EOB[Q+9V6H:5$@C$<(D27R5FN6V*9)RK[52!F!5 CI
M(RG> %9=GT57C7BOQWJ'B?6F\/:1,+,V\/G7%R\:3,P*H5CC1LJ1^]3<6*DG
M.,!<26[$Z]X:U"QM;RZCO+.XFF#S>2D$P=;:9UA*JQ78=F\,HW;E*LP7 ;R_
M]N?_ )AW_;W_ .V]>E_%RXU^WL9=3L;A+;R8VD^RB&*60H"I;S)I'9-RH&<K
M&F <QAI<*YU?AO\ &>/Q1HKZS,N&MXYC<QQ@G#1+O8+OVYW)AE&X@;@I<D$U
MS7PH\7ZE\7;:YOUNS8A9GA@BABAD52JAQ)(TZ.TA_>*"$,0PA(P6X/@)\8+O
M7KNZT/5<27EHTV9T 5'6.41N" $P0S#:0H#+]X*RY?A/VY_^8=_V]_\ MO7T
M!\6/^0/J'_7A=_\ HEZ\J_8I_P"0//\ ]?\ )_Z)@KW^O-?CI\9X_AC:JX7S
M+J;>($(.S*XW.Y&/E7<,@'<Q( P-SKE>.K;7?#>F/J4=[YEW!^^FMQ#;BT,8
M8M)$A9%F"JG1C(7<(< .XVGP1^).I?$6S-^6MALDEC: 0RQY=4#)B;[1+A3O
M0LQA)'S *<!CS6E?&#5[CQ3%H=WY$<2M-O2 ,X=6MC-$&DE 8E?ER46,$[L@
MC %3XN?'#7?AO>QVDPLFAF562X,%TB8SM?<%FD.4/+!-YVE3C+;:]_MH+E8-
MLDD;7&UL2+$RQ;N=A\LS,V!QD>9EL'!7/'*_#+6M3ULSRWY@$4=S<P1"*)T:
M00R>7YQ+7$NT%E=?+*YR =Q&,\UI_BC5/BEOGT:X2QT])&2.X> S7$[)@,RI
M+MC6 EB >9-T>#MRRKD^#OB?J/A363X?\02),9_GM+H".($'<$5E7:!N*%0/
MOB7Y1YBNK+[K7 ?'#XI?\*UT\WBQ^9*\@BB4_<#LK,&?D': A) Y8X7*Y++Q
M^MRZU-H0UJVU$I<&V%VT1@MOLXC*&8Q(#$\@*H0%9W?<5^;&[*]+\)/BO-\1
M=+^VP0H+I)/*>-Y&CA+J$9F5PDK!2K@@%20WR$D#>?-? 'QGU[Q)K%WIC+;-
M+!;SQJB@QVJRQS*GGNS;YRO)4*GWLJ"J?-(I\2?BCK?PCU*!KZX2[L;G)(%O
M'%L D'FI&%D\S<D9789'*G?@[BI(VOCU\6];^&+QRQ):S6LS.%8PSAD8'(C<
MB?824Y5AM+E7^10O/JO@Z^N]6L$N)98'EFA62-XH95A >-63*22^8X!.<DQ%
MEP-J'-9_PYU34M7$LU\]L8EN+F&-88I4<^3,T/F,SS.!DHWR '@J?,ZK7:UX
MK^T9\3M6\ 6XN+-+98'D\D2,TDD^YXRRN$V)&FTHWWFE#?*2H&17:Z%K.H:G
MH]I<VHAEO)K2!V:=FBCW/"&+D11OGYR#L 0$$X9<"O)?@9\9=<^)#WFT0 JU
MKM+*1;P(2XEPJMYTKL%RJLX7(8F1!M1RV^*FL> O$$6BZM,+RWN6A$<ODQ12
M8DW(K*L3@*/.^5]^X[4+*!D9B_;&MKQ--C:>6%X#?IL1('CD7]W/MW.9W5L+
MD'"+D\C:/E/I_P ';2_73K!I)X&M_L5OB-;>19=ODKL'F&Y9<CC)\O#8. N>
M.?\ $?Q$U'Q;J<NB: T<(ME4W5ZZ^<$8NF8XP-T>\#<"LF"Q611L,>X\UXM^
M(FN_!NXBDU:5-1T^>3;YBPB&9-JY(P@6-6)8E59GWK&<&/DCVK4-9N-3LTN=
M($,K31J\33M)%'M="R.0L;N>JG80A()^92*^>_A7\</$'Q&-Y!:I'Y[+%Y4A
M4):6J[9!(Y.))'=R%\M&WC=N; C1E/07WQ \5>#-%DO=1@M?-@F&YY7W2/&[
M*BXCML1Y#N!N\Q?E4@QD_.VU\+=<UOXA:-#.MREM*WF!KEH(YI)"LSC*1J\<
M4:A5"$NK,YW81-JR2<K\%OC/K>M37NCW2I-J,6\QM((XX8RA\N42M#]Y0^W8
M(T9F8D%U3#I+\3/B7K7PBO[>2]NH[RRNF?=&MNL31JLB&0( ^XD(P$9>5@23
MO&0&/:_M#?&U_AA!#]GB$EQ<,^POGRE6/9O+!65B3O 4 @<EB?EVME?%^76O
MA_IZZG;:B9S;M%]ICF@M@D@9D3Y/*B5T&\\J7)VGB0,OS=KX<\5S_$;28K[3
M7%F\ZMDR1?:"A4O&^T"2-20ZY1FR"!\T?.!\_P#[(#7^IOJ,MO/&KLULTK3Q
M27+.S&<[LK<0D'.2Q.XL3VP<]A^TC\8]:\!-'';BVABN/,$4BEIYQY;J2Q$B
M)$NY74;=LF/FP_W2/=?%?B:'PO:RWUR<10QL[<J"<=%7<5!9CA5!(RQ [UX_
MX?G\3_$.W_M."[ATZ*2,M;6X@$K,-TFTRO,F5R-N'0,K(0XC7HTWPC^.%S>:
MA)X>UM M_$S+'*BLJ3;%RQ((&TLJF56 5'4\*F%#R_M&?$[5O %N+BS2V6!Y
M/)$C-))/N>,LKA-B1IM*-]YI0WRDJ!D5+;77B+Q9I45W:31VSFRAE3]W'-<7
M$OE,6#;BL$".Q4I@.P!#,8^8@?LT?&6?XC6TR7H'VBV:(,ZKM5T=2%8_,?G+
M(Y; 50"NT=0/9:^0/C3'J$7BC3(;FZ25S)9O#B%HX(BUQLXC\YF;+1AG)D#-
MPN5"KCZ%\:>/'^'.G2WVI/'.ZL!&L2&VWLV D8$DTQ)SEF8$D("0AVG/%6^A
M>+O$%M]M%_!:32+&R6@MAY:*50D.\J/*CC+;EVR ,,!@#\NA\"?CLWCYI;&^
MB\C4(-Y= KJA4.%) 8ED96(5T8YS@@G+*GK]>2_M#?&U_AA!#]GB$EQ<,^PO
MGRE6/9O+!65B3O 4 @<EB?EVME?%^76OA_IZZG;:B9S;M%]ICF@M@D@9D3Y/
M*B5T&\\J7)VGB0,OS=KX<\>7/C;28M1TJ&,2S*V$N)&5$92Z,<QQN7 D7@80
MLO)*'BO*O@9\9=<^)#WFT0 JUKM+*1;P(2XEPJMYTKL%RJLX7(8F1!M1RV^*
MFL> O$$6BZM,+RWN6A$<ODQ128DW(K*L3@*/.^5]^X[4+*!D9/BY\<-=^&][
M':3"R:&959+@P72)C.U]P6:0Y0\L$WG:5.,MMKWK[->?9]GFP_:O^>GD/Y/W
ML_ZKS]WW>/\ 6_>^;I\M8GPMU:_URRBO=1:#-Q#'*B01R($5P6 9I)7W$J5S
MA5"G<,N,&NPKY ^-,>H1>*-,AN;I)7,EF\.(6C@B+7&SB/SF9LM&&<F0,W"Y
M4*N/J_1(+F%"+R2.1]QPT430KMP, J\TQ)SGG<!@@8XR?E#]C62Z;[?'9A%9
MOLI::0;XXP//X\M7C=V;.% 95 #,SY58Y.[T?XH:IX'\0)HFM3BZ@N5B\B?R
MHX6#/D(0D(;AI08B'Y! DRJY#;7[1GQ.U;P!;BXLTME@>3R1(S223[GC+*X3
M8D:;2C?>:4-\I*@9%=KH6LZAJ>CVES:B&6\FM('9IV:*/<\(8N1%&^?G(.P!
M 03AEP*\0^%?QP\0?$8WD%JD?GLL7E2%0EI:KMD$CDXDD=W(7RT;>-VYL"-&
M4]5/\7=4^'>AO/X@6/\ M,S.EM&3'F5<(=[" E<)N;=C8"%520[AFU;;3_%&
MF0?VI<W4<LBJTKZ8MNFPKR3 DT>Z3>$X0@.#( I+KEF\Z_88_P"8C_VZ?^W%
M?55?.O[2/QCUKP$T<=N+:&*X\P12*6GG'ENI+$2(D2[E=1MVR8^;#_=(U?B/
M?^+;V-[[2O)@MTWM' $+WLD>0%9DFB*ABH,@C&QU#>6P:0;:Z#]GOXSM\3;6
M1KA42Z@D D6,.$*MDQN-V<9PRD;F.4+' 8"N?^%OQ2N_C%=79@F>RL[;8(UC
M2%IY/,W;6D:9)D&/*8[44??P7;9EHOAQ\6-0TO7)O#.L2"ZDW$PW*(D7'D^<
M%=%"C!CYXR5?*Y=2&7/_ &D?C'K7@)HX[<6T,5QY@BD4M/./+=26(D1(EW*Z
MC;MDQ\V'^Z1MWNK>+-4O;>[LXHX-/E8 P2B-I8HR<>=.I:-]Y5O,$<4GR[0C
M_,&W>7_!"/4)_%&HH+I'NDCN4DGFA:4.$N(H^$2:+9]T;0&*HHV 8P1Z!\;_
M (LZ]\+O)DQ9W$$VY?,%O<1[7'.QA]I=1E>5^;+;7^4!<GUKP=?7>K6"7$LL
M#RS0K)&\4,JP@/&K)E))?,< G.28BRX&U#FL_P"'.J:EJXEFOGMC$MQ<PQK#
M%*CGR9FA\QF>9P,E&^0 \%3YG5:[6O%?%OQ>N+_7XO#-B?L^>9[DHLD@Q%]H
MVQ*V4&4&TLZORQ(3Y 6Q?B9\2]2^#NHV\EW<&]TVY5QY;1PI<(4V;V#11Q*Q
M&X%<X# LC!2%DJ7]M;_D#P?]?\?_ *)GJIH5YXGU[1[0Z*L-I##:0*GG8-U.
M8X0K%5='B6)VXCW[6;:'+*CXK;_9U^.%SXV>?3M40)>VZ@\*R,ZJ1')O4C:C
MJ^-P!4$OA44(:U?B3\3+V34$\/Z$(S>O"\DL\F6BMTVMMR$#%7)VD%UVC=&"
MKB3Y>5\?^(?$GPE"ZA/=1ZE9;D25&MUMW4LQ);]RI"C"A [,PW. 8R<&NZU_
MXBW&JZ-_;FB/#Y:V\LS)<Q2$L(_OIE)4V,NQQT=78##!?G-3X"_$Z\^)6FS7
M<XABG6XDB0HCF,8CC9693)N;YG.0'7(& 0>:YK0?C3JJ^)1X=O5M60,^9(DE
M1BOV=IXR-\K!21MW## '(!/#5Y_^VBM[;O:B>X#V\C3F.!(S$J%"F&<F1_,?
M;)MW84  [57>V?J70K:\AW?;989<XV>5 \&.N[.^>;=GC&-N,'KGC5KQ#2_B
MQ=>/==N-%LY#:6]HLIDE5(WN)'B<0LH,HDC1-[@CY&8A.J[R%SV^*6H_#_Q
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M2/I2LKQ7XFA\+VLM]<G$4,;.W*@G'15W%068X502,L0.]>/^'Y_$_P 0[?\
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M/X<:7X&>:+3(Q$\BQ-*OF22-M!D$;$2.Q4$[P", D'KMX\%^ 7_(X:M_V_\
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MQ*Y / QN)55+#BO&^H:IXBTF^N)42RM387#+"RF2]8!)3^\)(B@W*$W1A97
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MW_\ 2B*C]ES_ )%VS_[>/_2B6O*O@%_R.&K?]O\ _P"ED='[<_\ S#O^WO\
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M\(C6X)N+UUVVK2DQ^846+#7,I7=DEHUX5C(5="WD&EV\EOX_59Y/-DY+/M"
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MU33)=EY!&%"%O+R$+R1F-P/EE#M@;B%.0=R;3NY7P3^TGJ?AJ\CTKQ/!M9Y
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MRHPBB:0! )"&!)EW'F-%0LW2K)J<_AU=.ATV8ROID=L-\MO$0QA$;NZM)E5
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M^<"5Q(22N6&W 1MW'?\ [0^EW_B73I-+T^T>=IO*)E\R".- L@<C]Y('9OD
MQM"X;._(*F+X!V.H>$]+73KZQDC>W69E99;:19<N9 @Q,"KDN0 V$PN3(,X'
MG_PW\$ZSX4U^\U>33I'M[IKK 6:T\U5DF$R':9]I/RA2-P R2"<8.A^U+\.M
M3^(,EM'I]H[K;^=ND,ENB-Y@B(VAI@_&P@[E7GID<UB_&WP]JE_?Z=XA33YR
M\#0K+:KY<S!H9//!#P-*2CEV0,44J4RRC>HKK_C'?ZG\1-$FCL+":)&VM(MR
M%CN65) V(HD=VW;DR?,V$K@1K(7!7;_9J@N]-TFWL[FUD@$2S[FEPC,S3NRA
M8\E\;2=QD$9!V[!(K%E\O_9\TC4_A5?7=A=:?<SB;RPLT"J8<Q!V!$DIBBVL
MKDY+JP8!"FXD+H?M'>!-:^)+VR6VGE1;++N<W%L59W* [,R*Q0>6"K.$9@WS
M1H1@^RZSH;?$?2YK*_MWM'FCVE':.7:X"NLBF&0AU60 @,4+;?F4 \^0?"KQ
M#K/PD5M(U/3[FYMDW-;RV<7GXW2-D$J5!5CEQO*RKG#*590G7^!_!=WXGUI_
M$FI1&!$A$5C;N1YRH5YD?RR I(=_W;[F5G8''EH6S_VG/"^I^.K>/3]/LGD6
M.X65IC+;HAQ&RA55I0Y_UAR6"8*\!@V1VWPVO;W2=+A@NK&9)[6W@B\M9+5_
M-V@1[D;SU4?*H9@Y3&=JER,GRK]F;P%K'PXFGCOK%_*N?)'F)-;-Y90N,LOG
M E<2$DKEAMP$;=Q]*5\U_M(^#-0CUBPURSMGNHH/(#1Q!FDW13/-@A58A6!P
M' 8 @[@,KN[_ .(/A&3XPZ7) \#VC?NI;8W! D$@!)+QQ.^Q2C;/F)<%G)B!
M1=_(?#'XF:MX)MAIFLZ7>RO;K&D4EK )E,84;58HPC)48 96.1PX#JQ;JOA!
M\.[NVO;S7M64)>7;;4B#!S#"I 5"T>(W)"1C(!.$!+;G=1ZU7SA^TGX)O8]5
MT_7;*"2[$#1*\,2EF!AE,RYV[VP^YESL(0J,DE@*VOC'?ZG\1-$FCL+":)&V
MM(MR%CN65) V(HD=VW;DR?,V$K@1K(7!6;X'WVI>&M#@M_[-G:2-9_E=X8&9
MVFD=/EE<,J=G9PK E#''*K,R\U^S-X"UCX<33QWUB_E7/DCS$FMF\LH7&67S
M@2N)"25RPVX"-NX/C)X"UCQ#KUKJMC8N\5IY P\UM'YAAN'ERO[YB%8$8+*&
M'=!C%?16EWK7L:R21/"QSF.0QEUP2.3$\B<XR,,>",X.0/"O@#\(?^$1UG59
M\;8HI!!;A7W)LDVW)4[OWFY(S",GC)89?J/?Z*^:_P!I'P9J$>L6&N6=L]U%
M!Y :.(,TFZ*9YL$*K$*P. X# $'<!E=WLB^,[RXMC=0Z=.257RH7DMXIB2K-
MEPTI6-/NK]YI0Q;,("@MXW^S-X"UCX<33QWUB_E7/DCS$FMF\LH7&67S@2N)
M"25RPVX"-NX/C)X"UCQ#KUKJMC8N\5IY P\UM'YAAN'ERO[YB%8$8+*&'=!C
M%:O[1&AZM\1[.*RLM.F7;<"5WEFLU^ZCHJ@)</G.\DDD8P.#GY>U\#ZMJ6A:
M3#;R:;,;JWMXH1&)K38Y1"JN'\[Y5^1=^5W*7 59 I->:_LS> M8^'$T\=]8
MOY5SY(\Q)K9O+*%QEE\X$KB0DE<L-N C;N.E_:>^"TOCZ"*YL$#7D+;=N40O
M$W5=S 9*MAE!95 ,F,LP!S_ OQ/\2>*(TTZ33WMK@QX?4)D>.) " 91"T:J\
MNT_*@?:7^8JL88+RG[*/AW6?"DDPDT]U@N)(E>69_LQC$0=B1&R&23(DPN %
M+#!8#<5^JJ^5?VY_^8=_V]_^V]>EZI\7]4T^-K/^RKF34AA \<9;3F<D!9!-
MN!$1!#D,%*\QNRD%Q4^%'P-FT72;R"^D_P!.U*.43R9:4IO1E56)?$C*79F8
M$;F8KN8*K'C_ -F[4]0\ Q3:3=Z7>L[7+NLB1IY1.Q5<&25XH@!Y0*L'8/NP
M.V[/3PQK.G^,%U2ZLGD5M[ VOSP[?LSPH/-F,*!A@!MYC+,"57#(#H?M'>!-
M:^)+VR6VGE1;++N<W%L59W* [,R*Q0>6"K.$9@WS1H1@_0OAG59]3A$EU;O:
MR\!HW>*3G )*M$[@KDD G:QQDHN17SAX;T'4?AQXINKM[&>Y@O&GV26Z[U"S
MS"5"6;:BD,H5P[(%!+Y*A2WTUI=Q)<QJ\T?E.<G9N#E1D[0Q7Y=VW&X*64-D
M*[@!SX5X;^$/V#QC<7ZC$"V_VE-KYQ+<;X6#A\M\S+.X"_*N%Y ^2O?Z*^6[
M#2;WX6>)[R_-E=7EK=+,PDMX3(0)I%FZ E25=3&0S(2/WF,%5,/[5/AC6?&'
MV6XBLG^SQ^:JQI^_NE9]I8RK"70*=@V;&<#&796=4'I?QP\!7OQ0TDQ1Q?9Y
MX[@310R,C.X5&0HQ1FCC8EV*X=UP$W,A9A'B?#KXJ:CH%E%IEWI%ZUW;J+>,
MQQ?Z,^P".(M,S;4!P [C>F!Y@.T[1TOP=^%4VB33ZUJC;M3O-QD569HX48AA
M N6;=C:HSDA0JHAV@L_(?&WX7:CINJ1>)M!023QK^^BQN9MJ,A<*S?.&B_=E
M$VN" 4!9BRW_ !3X^U/XBV+Z98:;>6US<1JDLES&L-O%&Q"S8=\F3@E0%0.5
M)=0&7;7H&F?#&/3-%.A0OM4VDL!DVD_-(K"27:7/5W+[=V!G:"!BO&O@%>:I
M\-H9](N-*NI)VF:6)T\O[.S&%?D>9F$2#Y!\P9SEBNW<H5JI\%ZXOBU]62S$
MHC:+<V\P6^)+41?+)(I:01Y(=D0EBI/EH6"#:_:U^'FH>++6SN;:'S'M_,$T
M41:5P9?*Y0;%:10R$$A0V"&V ;BOL'@7QA<>)XTFELIK13'EA.55]^0-JH,N
M5&&RT@B)&PJC!R4ZJOE7X(:???!_4+VPGL+RYBFDB2.>&(%&V,XC8EF$2JRR
M;F)D_=D;6_B*GQ:\,:SJ/B+3]4>R=H%DM=BP?O75(YO,*S-D1I+EB2=PA (
ME<([UU?[1'A_6/B'9Q65KI[@K<"9G:>V"@!'5$ \T$MB3]YT5'4JC2J1(?0/
MAM>WNDZ7#!=6,R3VMO!%Y:R6K^;M CW(WGJH^50S!RF,[5+D9/E7[,W@+6/A
MQ-/'?6+^5<^2/,2:V;RRA<99?.!*XD))7+#;@(V[CT7]I3P@/$VAW(P-]NOV
MA"Q8 &($N?EZDQ;U ((R1G'WAO\ PA\('P?I-K8N"'CA!D#%6(D<F25<K\I
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MZE&B"1SV;%QA5:XSY>P@@2,5(3+!@=ISY?JG[.]]I_A5K/[]XMV+TP1@.?\
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M<6T,5QY@BD4M/./+=26(D1(EW*ZC;MDQ\V'^Z1J_$>_\6WL;WVE>3!;IO:.
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M-\'P/^.&HWFHOH&OH%NE5]C[=DC.N7*,$'ED&/YD==BE4'+EP:A_:1^,>M>
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MCW7Q-)>)"?[/2%YSD#SW>.->#ACY<;LV&Q\ORY&?G4XSX+\#/C+KGQ(>\VB
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M^[23=O5/E5MUD)6W 8!S( YSU?YCSS1^W/\ \P[_ +>__;>OH#XL?\@?4/\
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MA(!*MY\:;AGH=K,N1S@D=":Y_P"'MV]UX'=I&+$:=J"@L23M4SHB\]@H"@=
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M?OO&$,<FGPII^FF/$1D0-=,F$"-'$I$,*@;_ "V<S X1O**'GQ_]AC_F(_\
M;I_[<4?\U#_S_P! ZNP_;/NW@T:-48J'O8E< D!E\N9]IQU&Y5;!XR >H%>B
MZ3X(L=7ACN8);QHI8TD1OM^H#*L RG!N 1D$'! /J*/"_P +]*\)7C7-I'LO
M)XY-S---+(Z[T:1L2R/GYRA9L9!(R?FY[6O*OVH_^1=O/^W?_P!*(J/V7/\
MD7;/_MX_]*):\E^.]HD'C'2V10I=K!G( !9OM3IN..IVJJY/. !T J7]N?\
MYAW_ &]_^V]?0OQ-NWL]*OI8F*.EE<LK*2K*PB<A@1R"#R".0:\@_8GNT;2K
MB(,"ZWK,RY&X*T405B.H!*L >A*G'0T?ML6B-I5O*5!=;U55L#<%:*4LH/4
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MYHOVB1TM1=O)-M:1<!'M_G_=D-N56?:R_.N3M()KV#_A6EK_ ,]+S_P/O_\
MY(J'P'\.-+\#/-%ID8B>18FE7S))&V@R"-B)'8J"=X!& 2#UV\>:_M6?#%/%
ML$4]L"VH1*_EQ(@=YHAAI <#< F=RDG;N;RP#),@K5_9I^*L'C.T:)V U%69
M[D8PTA)P)QDG<-NU#C C("*B1^4M8O[:W_('@_Z_X_\ T3/7JOPG_P"0/I__
M %X6G_HE*^>K:T2U^(6V-0H+,Q"@ ;FL"[MQW+$L3U)))Y-2_'W_ )'#2?\
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M7GM=;\5ZG\0M)N(++3IK>>6W>-_MFV%/F3$B1C=YCL0V(V=(XB<LS@J4//\
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ME2H*L<N-Y65<X92K*$Z_P/X+N_$^M/XDU*(P(D(BL;=R/.5"O,C^60%)#O\
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M#;I3SGLN,$$GM?COJEYX@\-27^^%+6>WLI?(\IVF7>\#;?.\X*<,<Y\D97C
M/S5H?LRVE^VBV31SP+;[ILQM;R-+M^T2;QY@N57)YP?+PN1D-CGR_P#;*MKR
M'[!]MEAES]JV>5 \&/\ 4;L[YYMV>,8VXP>N>/I_3[;4K?>T\MM-^[;8B02V
MV7XV[G,]QA>H.$)&<C.-I\;TKXP:O<>*8M#N_(CB5IMZ0!G#JUL9H@TDH#$K
M\N2BQ@G=D$8 ]*^+GQ)/@J"-;=!->W4RP6L)95#2-P&;+*=BDC<1W95+*&W#
ME-?\/>*-,@>_CU*.66-?--DMFGE-CYW@1QF9AC*H<!WX!*D[A;\!_M P:SH<
MFMWJ&(6[&.=4&X-( F/+&<X8R* &(VDD,VU=YB_LGQ/XHA^V)>PZ>SQ[HK1;
M<2X!&]!-),N]91NV2;4*C;D+DD5+\!OB[+XO$VG:DH34K)BDP!3$FUBC. IZ
MAAB3;E 2I4@.%7A?BG\<M:\):M:V$L<*Q226\ICM0US.\1<QO"&E2,,S%6VA
M8T894!^I/:^%KCQ2VKI)?QPC39HV+1HT3_9_D)1"WR2O*&50Y&^([V*X&-GK
M]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?%?Q_\ ^*1\6Q:A<?-$9+*Y
MPG+[(RD;##;1NS"V!G&",D<@?:E%>"_MGW;P:-&J,5#WL2N 2 R^7,^TXZC<
MJM@\9 /4"O2O@[=I=:-8-&P8"RMU)4@C<L:HZ\=PP*D=000>17@OQM_XEWC+
M2Y(/W;R?8M[)\K-NN)(FW$8)S& ASU3Y3QQ75_MK?\@>#_K_ (__ $3/7JOP
MG_Y ^G_]>%I_Z)2OG_\ 88_YB/\ VZ?^W%'Q]_Y'#2?^W#_TLDH_;G_YAW_;
MW_[;U]55\H?L[VB6?BW5(HE"(BWRJJ@*JJ+N(!0!P !P . *E_YJ'_G_ *!U
M>J_M1_\ (NWG_;O_ .E$51?LSW:6?AJUEE8(B+<LS,0JJHN)B6)/  '))X J
M7P7XOF\4QA?#MO#:Z='(RBXFB94?!DW^1;Q-%E=^TF1WCY9QL+JP'DO[.\)@
M\6ZHC,7*K? NVT,Q%W$"QV*JY/4[0!GH .*E_;G_ .8=_P!O?_MO7T!\6/\
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MBBBBBBL7P;XO@\86J7UH289&D"%AM)"2-'NP>0"5)&<'!&0#D#YO^(OB+6=
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MW[9YMP6AX/RKSD\XV;LC]TN8X]OR$[C7?T444444445P'_"'ZI_;O]H_;?\
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M(FD&\M8H/MJS21.)&DBMPP7>KKM$SL KQY4E"3OPR@#/G_P>^.&N_$$W:P)
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M>9DM\[%F+9]@_:/CFB\,W8N71Y?W&YHT:)#_ *5%C"M)*1Q@'+')R>,X'/\
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M!F1/D\J)70;SRI<G:>) R_-Z5\-_'">.=/@U&-#&)E;*,02K*S(XR.HW*<'
M)&"0I.!\]?L,?\Q'_MT_]N*^JJ**********************************
M***************************************************^5?\ FH?^
M?^@=7T+\3;M[/2KZ6)BCI97+*RDJRL(G(8$<@@\@CD&N%_9/U2.]T"".-LM#
M)/'(,$;6,K2@<@9^213D9'.,Y! ]:N;M+4;I&"@LJ@L0!N9@B+SW+$*!U)(
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MT?@SPS<Z?"<K#IET"W(W,8I&D?!9L;G);&2%S@< 5Q7[%/\ R!Y_^O\ D_\
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MDD\DUTO[+G_(NV?_ &\?^E$M>5?'W_D<-)_[</\ TLDKU7]J/_D7;S_MW_\
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M )AW_;W_ .V]?0'Q8_Y ^H?]>%W_ .B7KRK]BG_D#S_]?\G_ *)@KE/V&/\
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M7B;]GT".:,7.FJV3C,D W-&7VR "2$DMM42 (79F5'/-?37PP^(</Q L8[^
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M]%HKX[_;<T1X;^UO"1LDMFB4<[MT4C.Q/&,8F7').0<@<9^M/#VMIKUM#>1
MA)X8Y5#8#!74. <$C.#S@D9[FM"BOE7]AC_F(_\ ;I_[<4?'W_D<-)_[</\
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MVQ2S;O=?AQHNK.\VL:XH-V83'!:0L-L48.YU7,IC+RNBDEF. J@R!<HGE_\
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M\-W;VT<0DNU\FTW(A1'))$S@A,E8XR0Q",RJ?,K@/V7?#VJ>!GOXI]/G+,T
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M;N,3QY\'=6^&6IG6O#B&6%F9FA102@=QN@,28,D))&W8,H!D[3&LAZ7PS?\
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MZ2.I:1E5F.68!5&_'R)Z517@NK_!:[\!ZG_;7AE(V1U*SV+$1AE9T++$Q&U
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M X.[;W7QLBU7QGI<NGVNG2;YVBPS3VJ[$1U<[AYI^<LF JEEV,KF0/NB6W\
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M6T?F&&X>7*_OF(5@1@LH8=T&,5J_M$:'JWQ'LXK*RTZ9=MP)7>6:S7[J.BJ
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M(4+&IQG&-S;4!(!89%?-7[)-K<^#9KJ"_L[R+[3]G$;M:S^7E#("K,$.W/F
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M?.X'RA O0>&OV<[W2HK_ $PZC(--GAV6R DR(2_F$L#A5'WDD6,@3J[%O+.
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M$TMI%'&HR'C6,JKD.[+OD\W/EA3G:V<KX$^.=0U"\OO#-U<R2&V:<QWGR&X
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M) &8B0#./7_!?C-_'VEQ:A98@>93@2H9E1E<I("$DB+#*L%.Y3C#$#E:^>_
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M_P!LZY7]BG_D#S_]?\G_ *)@KE/VY_\ F'?]O?\ [;U] ?%C_D#ZA_UX7?\
MZ)>O*OV*?^0//_U_R?\ HF"O?Z\PU?XNOJFI_P!AZ*L<MPBEKF>0DP6ZJZ!Q
ML4JTS\[2JLH5RH9N) GA7[7^@RZ4FG?:;F2ZF9;D/(X1%^40?<CB540;BQSA
MG((5G8(FWV_]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\ THEKRKX!?\CAJW_;
M_P#^ED=:W[8'AF:Q:SU^S&);:14>0!F*X<26[%2&C"K)N!+8RSHIW9 'I7@3
MQC'\39+>^B&(+>W67 RP%U*)(GC+;4.Z&,."""'6X23: (V;TJBOE7X^_P#(
MX:3_ -N'_I9)7JO[4?\ R+MY_P!N_P#Z414?LN?\B[9_]O'_ *42UY5\ O\
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M=SD D*OV!4W''0;F5<GC) ZD5#^W/_S#O^WO_P!MZ^JJ*^5?VY_^8=_V]_\
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M"&:66[G>#SHXI!^[FF\Q5\S)W$.&PH.51B<;17T!_P *GT?_ *!]G_X#0_\
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M NYO.OB'\&=>\7:M!K*FQB:V\CRHS+<2#]TYE&]O(3=ER<X"_+@=06,WQO\
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M?=D&Y#Z?\5O"%[?PV,>BB.*2UO8I%W$Q0I''#,NPB/YMAR(RB#E6QPN2.?\
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M$.N-&U_.H"11@%(5*J.I'WPH\H%21M#9>3>2,7]H'X2ZGK.I6>MZ2J3RV_E
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M2,!AO5ER.HW C/4$<5\JZ5Y]GXZBLYKF>Y2%IF0SOO*F6R,C[0H5$&XX 15
M 48XKWKXO?#;_A8MB;#SWM\R(^Y1N4[3]UURN]><@9&'"MSMP>KTG3_[.AC@
MWO)Y<:)OD;=(VT ;F; RQQECW.35JBBBBBBBBBL7QIXO@\'6DM_=DB*)06VC
M<Q)(55 ]2Q &2 "<L0,D>%> ])O?CV)+_5Y9(=+\XK!91$QI(%9&/F/M!E0%
M<9SGS-Y0P[=I[#4?V7=*1=^F>=872[C'<0S3%U)1EP0[ME?F^8*48@8#@$YR
M?@U\:KJ:^E\.Z[_R$(Y)!',J;5E"@N00%3'R#?&^U5>/&0&P9.K_ &A/B5)\
M/M+>YM_^/B21886*AE5F#,7()'1$8KPPW[=RE<UY_;_L[0>+M)MM0AFF75Y+
M>WN!>232N[2%%=58Y.%&0JL@#H%0Y;!#9_Q#\6ZCH#:1X7FNY#<3M;_:[N+Y
M)2CS^6B1R9W9&&#.5#/M1F/SR(>@\0_LQ'2[F"\\,W!T]U95F&^5U9-P<L-Q
M8N<@9B<^7( ,E<'=W?@_X3?\(WJE[JWVJ:7[9C]RQ^5><\G)W[<;8N%\N,E/
MFSFN_HHHHHHHHKY0_:K^T> GLWTZ\O8A,LX=/MERZYC,9##?(S GS"#SC &
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MZ0*0H!"A69/-?BOV:/'.K>.K2:Q-R4-O-$[7;XGN/+D)/DHLBE<G8_[V0R;
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M=Q %>E>/O%M[>ZA%H&EMY$\EN;F:[*)*(8@Q10L;L [-( AS]U6R 224\_\
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MJJOEOX 6CMXMUB4*2BM>JS8.T,UVI52>@)"L0.I"G'0U#_S4/_/_ $#JZO\
M;6_Y \'_ %_Q_P#HF>O1? VOP>'M L[N[<1PQZ=:L[MT \E!VY))P !DL2
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M!*\G:P)61,E5SM<%<X ;&1P11XZ\=6O@>U>]O7VQKP .7=CG;&@R,L<<#@
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M02RA)CY93YC S-.ZN<LNX':D;,OU+I.EQZ1#';0+MBBC2-%R3A5 51DDDX
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MRC <+FO6KCP-HV@%+DV=K$5FA5'6WC#"1Y%CBP53(/F,H!['DD 9KP7]N?\
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M2:XKX*?!_4?!EI/I.HK:S65RTAD,<LZR@/%Y;K@PJ&!"J!AD*_,<L< >=2_
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M.$9Q$O0$ACEG<*-VP>?_ /"F=>_M_P#X2/-CO\S/D^;<;=GE>1MW>1G=Y?\
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M$X*MAA\]^&?AUXV\$XTZPD06HD!$@:WDA7?@LP$RF8*"2654^]N*JQ;+>Z^
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MWR! XWBV7DKD@[<*2,A@,'I?CU\-M2^)5G#90+;1;9(YG=YI3APDB-&H%O\
M,OS@AR5)QS&*/^$2U[^Q?[%\NQW_ &3[-YWGW&W9M\O/E_9L[O+XSOQO^;&/
MDJ']G[X9ZK\-HGLKK[+);R3&7?'++YJL4"D;6A"N#L3'S(5^8Y;@#FOB'\&=
M>\7:M!K*FQB:V\CRHS+<2#]TYE&]O(3=ER<X"_+@=06/T!I<DTL:FY1$EYW+
M&[2H.3C#-'$3Q@G*C!R.<9/C_A[X41Q>*[K54"&)+=& 4%/+N95V./E^5F,2
MM))NP?WZ-M.0]>U45Y+\5_"&M^+GMA:+91):WJ7*-)-.[.T1/E;E6!0@P3O4
M,QR0%<8RWI6B3W,R$WD<<;[CA8I6F7;@8)9X82#G/&TC !SS@>:_"#X!1?#N
M]O+Q&#"9MMNHWYBA)#E"68[CNVKDY.(PVX%V5;?QL\(:KXXM)=,LUM4AD:+,
MLLTOF%5*R$"-("JG>H&=[@J#P"WRGP3\(:KX'M(M,O%M7AC:7$L4TOF!6+2
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M82$@>8JHX(+>7@AK>J2^)?'5JVFS6<.GB6,)<733QW *'"S+'$FXAF!.W>Q
M4%=X8JX]*\"^!;7P/:I962;8UY)/+NQQND<X&6..3P  %4!0 /G7Q-^SIJ_@
M.^.H>%)/D;*B(N@D0,#N0^=^[DB! V[B7!*Y4E/,/=_#?X=ZYK4\%]XHN XM
MF9X+4"$@2G<@DD\M!&2H^:/!9E+9#(0RMG_'SX,ZQ\49HO+-G#!;^:(]TLS2
M-O*Y9L0;5^5%^4;MIW?.P(Q[5X9DO'A']H)"DXP#Y#O)&W RP\R-&7+9^7YL
M#'SL<X\?\ +XG\ V,%G+90WRK& FRZ$4T0R6\N5I@4?&X(@B^553&2-IKH/A
MK\-;JWU.Z\0ZGLCNKJ-8UMXFWI%&%BX=R!NE'EJI*_)D,P)# )ZK7D%WIFO>
M'=3O]0L88;FSGDMR+9YC%,Q2WCC,D1.8D^;[Y?YF6+ 'W":DW@;4_B1J%EJ&
MJP)806$C2)"LRW$\DFZ-P2RKY:Q91>/O_*PQAU9<KX^?!G6/BC-%Y9LX8+?S
M1'NEF:1MY7+-B#:ORHORC=M.[YV!&/1?$.FZKKVE36<L=J+J>&2%BL\HA"O$
M4,HS;E\[SQ&01M_Y:DUY5X1_9^U73-(O-"N3:M#<L94ECFE61)552@(:W*LA
M>*,-C:RKO(+$J!M? RP\0^&+)-)N+&&)(_,*7,EPK !WW8,41D:1@SLP&Z)6
M4!2Z'YC@?"_X0Z[X/UR\O'$,RSQS+]K=PB,9)8Y#)Y,>7+#!)B_=H2"HF VL
M;7Q#^#.O>+M6@UE38Q-;>1Y49EN)!^Z<RC>WD)NRY.<!?EP.H+'U#Q]INJ^(
M-.DL[>.U2:XAEBE+SRM'&K_)E-MN&D)0GJ(PC8X<9SRG[/WPSU7X;1/977V6
M2WDF,N^.67S58H%(VM"%<'8F/F0K\QRW 'LM> ?'SX,ZQ\49HO+-G#!;^:(]
MTLS2-O*Y9L0;5^5%^4;MIW?.P(Q[5X9DO'A']H)"DXP#Y#O)&W RP\R-&7+9
M^7YL#'SL<X^:O$W[.FK^ [XZAX4D^1LJ(BZ"1 P.Y#YW[N2($#;N)<$KE24\
MP]W\-_AWKFM3P7WBBX#BV9G@M0(2!*=R"23RT$9*CYH\%F4MD,A#*V5\<?@W
MK?Q3> D64"0+)M7SYY&+.5W$M]F08PBX&W(.22<@#VKPO/?R)C48X$<*GS02
MR2*S8.\[9(8R@SC:-SG!P3QD_-_B;]G35_ =\=0\*2?(V5$1=!(@8'<A\[]W
M)$"!MW$N"5RI*>8>[^&_P[US6IX+[Q1<!Q;,SP6H$) E.Y!))Y:",E1\T>"S
M*6R&0AE;/^/GP9UCXHS1>6;.&"W\T1[I9FD;>5RS8@VK\J+\HW;3N^=@1CVK
MPS)>/"/[02%)Q@'R'>2-N!EAYD:,N6S\OS8&/G8YQJU\X?\ "N-8\ >(;G5M
M*M!>VUTLA8-/%$X,K"1URY7:1*N1\KCRR 3O)*Q?M&?"'7?'WV>XC$+^7O7[
M+&X'E[L$R>=-Y7F[MHW#;'L^555OG<]U\6/"&M^.M/DTY%LHQ,T9=C-.Q148
M-L&(!O)9%;S"$ #&/RR5$K6_@OX0U7P-IXTZZ6UD$*RF%XYI069F+JCAH.!N
M9LR*20-H\MB"3PG_  IG7O[?_P"$CS8[_,SY/FW&W9Y7D;=WD9W>7_%C&_YM
MF/DKZ%M&=D4R@*Y4;E5BZAL<@,54L >A*J2.<#I7@O[:W_('@_Z_X_\ T3/4
MO@CQ!XBT/2K6&ULH[]6LH'@N/.CM]BM$I2*2)B"YC/&Y642)MR0Y8UTOP2^#
M<G@EKB^U"1)]0NY&:5T4!%!=F(0[%;YF.Y^%7(4!?D#-Q7Q#^#.O>+M6@UE3
M8Q-;>1Y49EN)!^Z<RC>WD)NRY.<!?EP.H+'W5M/;6[5K?4(T'FQR1RQQR.Z;
M6RI ?9$W*GD[5()(!X!/S!+\"?$?PRNI)/#<OF039'WH0X48*B1)P(RP)(5T
MR<!CB,/MKUKX5?#O5!.NJ^([@3W:PF.")1'L@5\-(WR(J^<?N%DXV@C>ZD!8
MKO3->\.ZG?ZA8PPW-G/);D6SS&*9BEO'&9(B<Q)\WWR_S,L6 /N$U)O VI_$
MC4++4-5@2P@L)&D2%9EN)Y)-T;@EE7RUBRB\??\ E88PZLMN[TS7O#NIW^H6
M,,-S9SR6Y%L\QBF8I;QQF2(G,2?-]\O\S+%@#[A-2;P-J?Q(U"RU#58$L(+"
M1I$A69;B>23=&X)95\M8LHO'W_E88PZLOM5>-?M _#/5?B3$EE:_98[>.82[
MY)9?-9@A4#:L)5 -[Y^9RWRG*\@]7X!TW5?#^G1V=Q':O-;PQ11%)Y5CD5/D
MR^ZW+1D(!T$@=L\(,8\O^'GP9U[PCJT^LL;&5KGS_-C$MQ&/WKB4[&\A]N'
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MF3R@K-YC-MD"#+F1B0 6(S_$.H>)/$UM-I3:=!$9H9(7NS=*UO@J5>18E4S
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M K"0AEX!0^B_"'Q=/\7-%#2SS6]PDCPSRP"*-G(7JI9)-N4D4ED",) =FU0
M?#_V<="O?B0=0AN+N18)5M_M<@8M=R@+*L40D?<%0C/F$@DJJQCY6;'TK\&O
MAF_PYLC8/<&Y'G.Z,5,816"_(%+O@;@S<$ EB<9R3W5%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%?*O[<_P#S#O\ M[_]MZ^JJQ=;N[3PR)M4NF$0
M$,:RRL3C9&SF-<<Y.Z5@ HW,6"\G:*T/[16*'[1/^Y41[W\PH/+ &YMS!F0;
M>=Q#%>"02.:^6OCAX+N?#URGC#3(A;K',C21L6CD;+!1.Z90J)2VR2($/M(:
M0!Y)5B^A?AA\0X?B!8QW\ V[LJ\996:-U.&0D?@RY )0JQ49Q7A7[&WC&/3E
MN=#N1Y5T+AI41\J['8$ECVE1AD\L$@G<03\H",:^BO%?B:'PO:RWUR<10QL[
M<J"<=%7<5!9CA5!(RQ [UX!-KO\ PAOCF1KI<1ZA;PQ1/G/WEB1&PH8\S0&/
M!VXSO)VCGZ4K@/&'B2/Q+X?O;R .(I+"]*;U*,RB.15D"GG:X ="<$HRD@9Q
M7G_[%/\ R!Y_^O\ D_\ 1,%<I_S4/_/_ $#J/VY_^8=_V]_^V]?55?*O[#'_
M #$?^W3_ -N*]%_:L\!GQ1I#31 &6T;SP<+N,84B90Q(VC;^\(&=QC"[2<8S
M_A+XZ;XBZ=IUI*^Z99"]R_S[L6,D+I\SEMTKO);,YY5D:;!1]H'3?M-6CW7A
M^]6-2Q"PL0H).U9XW=N.P4%B>@ )/ H_9R\>0>*M(MTB($MM#'!+'G+*478C
M'('#JNX$9&<KN)1J[K5?$T.F3V]K(?WMU(Z1J"N?DB>5V()!V@)@D X9D!QN
MS6K7S!^VMX%:XCM]7B3/EYAG8;R0K'="2 "H4,7!8X)9T7YLC'O7PU\7CQCI
MUM?@@F6%2^T,JB0?+*H#<X$@8#DY R"1R>EKX[^'%H?BMXNFU0*'M8)C+O E
M12L8\JT/J')5)"K%0P5^, I6U^W/_P P[_M[_P#;>OJJOE7_ )J'_G_H'5]5
M5\J_L,?\Q'_MT_\ ;BM;]CO7?[*^VZ#<+LNH;AY2,[LXV02KE05^1D7G<=V_
MY1A2:]_\4^)(_#5N]U,'94V@)&IDD=F8)'&JCJS.P51P,D9(&2/GKXX>)AX+
M\6:;J=PA^SK;!&?#!0&>>.0@A6W%%E#E0"2,#C<#7TK:7:7B++$P='4,K*0R
MLI&0P(X((Y!'!%9^A^)H=;:=(#N^SW!@<@J5WB..1@""?N^8%;."'5@1QD_-
M7[#'_,1_[=/_ &XKZJHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK
MQ#XJ?L^7OQ,>)[W4(U$*L$2*S*J"Q!9CNNG8D[5'7 "C !))VO\ A7?B+_H.
M_P#E/MO_ (JLK5O@-J/B6:V?5M5^UP6]PDOD-9QQQO@@E6"2!3E05RRMM#-@
M88@]A\1O =[XJEMVM[T6\,$T4QB\@R"62-PZ>8PFC)0%1A!CGYB20FSI=4TV
M:^M6@+0F5XPKF2%I(&S@2 Q>:I*L,@*9#C(R6P<^5?!_]G^Z^&,SR6]^DD4W
MEB:-[7&X(20587&58!F /S+\V61L#&?\8/V81XFN?[3TB46MYN#L/F6-Y P(
ME#)EHWZDE5;>P!PK%G8^'7[/NHPSQ77B#4)+H03"6*W$T\D7F+CRY2TA4Y4E
MOE"CMERI9#U?QR^!L'Q,@W+B.]C4^3-C@CD^5)@9*$]#R4)W+D%E?RK0_P!E
MS6[X+9ZKJ9^P!4!ABFGE!5&7;&$D5(U  ^5L,%(7"'M]'_\ "+6_V/\ LW9_
MHOV?R/+W-_JMGE[=V=WW>,YW=\YYKQKX<?!K7?AZ)K&RO+7[%*Q82O"[7$;F
M/:72/<$SN"C#R.N%#;<ED8/[.-V=<?6H[\Q -$4?:)[A\PB*?=YBB*,GYM@5
M710P"HBHJ5M_'OX&2?$BUMUAGQ=6V0K2X"2!]@D+^6GRM\@8%%VYRNP!@5Z#
M2]!UZ6U5;F^MH[KRRA:.V,B<Y'FG?+'NEX5EPJ1*2ZM%("A3E/@_^S_=?#&9
MY+>_22*;RQ-&]KC<$)(*L+C*L S 'YE^;+(V!CVJO,/@7\&A\,TNT)#&:Y)1
MPS,Q@48A5\JBAQN<MM&"6ZD  >E7=HEXC12J'1U*LK ,K*1@J0>""."#P17S
M+XB_9,OM&NFN?#E[]G23<"C230NBG:?+$D0=I%W G#!2 %R7.6KU#X1?!V7P
M@[7VHW4E[?O"L1D=W98X\AVB3>Q+#S.=QQD 81,MN]/J*[M$O$:*50Z.I5E8
M!E92,%2#P01P0>"*\:L_@KJ'@"1I/#-TBP22;I+.[#/!DAQN5T!D& 4  PS;
M09)& "U+J_@3Q'XU'V35+NUMK-E(E6R64RRJ63,9:<?("H8;E..2KHZG ]%\
M"^!;7P/:I962;8UY)/+NQQND<X&6..3P  %4!0 /,/BI^SY>_$QXGO=0C40J
MP1(K,JH+$%F.ZZ=B3M4=< *, $DGTK2],U.V@:.:Z@EF"QA)?LKH,C[[2(MS
MARPZ;#$%/."/E'E__#.U]_:_]O\ ]I)]K\S=_P >8\O&SR_+V_:,[?+^3.=^
M.=V_YJ]5U'3M0N+7RHKF&.Z.X-.+9F0 [@"D37!PPRI!9W4D'*$-@>:_!_\
M9_NOAC,\EO?I)%-Y8FC>UQN"$D%6%QE6 9@#\R_-ED; QE?&?]F-O$ETNIZ-
M(EM=F0-+DO&A8?,)E:-69)=P&<##'Y\JX8N?#S]G*^2ZAO\ Q#?/=O;2%X(A
M+-*BM\A5R\I5A\RY**H!*H68C*'TKXK_  HM?B1:FVN1MD7)AF R\;'N.F5.
M '0D!@!R&"LOB&@_LR^(=*<6T6K&"R5GV^5+<A@I+,"(040%F.6 DP"2<L1S
M[I8^ W\-Z='IFCS"W$:E5EEC-RPW;BS@>9&N\NV_)R@.1Y>W '"_!_\ 9_NO
MAC,\EO?I)%-Y8FC>UQN"$D%6%QE6 9@#\R_-ED; QVOQ>\+ZAXEL3;Z3<_9;
MCS$._+)N4'E-Z NG9LJ"3MV'Y6)KJ])MY+:&..>3S95C0/)M";V  9]HX7)R
M<#@9P*M44444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444445\B_M1_'B<78TS2YI(1;,?.DBDV[Y"!\@,9W )DA@
M6&7)#)F-2?KJBBOG7]JVTE\*6<>H6%U>0RO=['5;NX\LATD<_(TA"X*?*$VJ
M 2,'Y=O"_L]:5?\ Q02]%QJFH1/ L/E,ES(5W2"7EU8DL 4' 9"1D9&01E#X
MUZY\']1GTZ[F-Y'%-AEG8NS(=C*ZON=XRT>"%+.J%CN0MFOL_2=4CU>&.Y@;
M=%+&DB-@C*L RG! (R"#@@'U%6J***^:_P!KGXP77AMH=+L)'A>2/SI9$^5]
MN\K&B.K;E^9&+X )&T!L%U/,ZA\%M4NCHVJ>'DCA/]G6?F2H8XBLNW+RR @;
MPRR8; D9PK*RD$!OKJBBBBBBBBBN TOXKQZQKDFBVQ1T@M'DFD!)(E$L:>4.
MB_*K$OC=\Q"_*48')_:4\#7WC32_LNF_-(+B-WCWB/S$ 8%<L0IPQ5\,0/ER
M/F"@G[-?@:^\%Z7]EU+Y9#<2.D>\2>6A"@+E25&6#/A21\V3\Q8#U6BO*OVE
MW>PT:>]@EFAGA\KRWBFEAQOFB1LB-U5_E) W!MN3MP2:X#]C7Q9>>(/M_P!M
MN)I]GV79YLCR[<^?NQO)QG SCK@>E?2E?.O@OX=:EXUOM1NKK4;Z"S2_NHK>
M.&>6,G9,P+ MN01+]P!0<L&&5V8;Q7XS>(]2\$:K<:?;:C?-%%Y6TR74I<[H
MDD.2I4=6., <8^M>ZZ/\&KSQ!I,-W;:OJ*7DUI#*OF73F#>Z*Y4A0'"G) (8
ME>#A\8/=?L]W=S=:+;-?-(UP&N%D,I8R[EN)4VMO^;(QMP>1C':O1:******
MX#2_BO'K&N2:+;%'2"T>2:0$DB42QIY0Z+\JL2^-WS$+\I1@>_HHHHHHHHHK
M@/C9\5X_AO8M<91KE_EMXF)^=LC)PO.U =S?=!X3<K.IKOZ*******X_XNVY
M;2KN57DC>&VGEC:*66%@Z1.5),3*6 /.ULJ3C(.!7SK^R)XWO]>U6:*\NIYT
M%E(P666210PEA 8!V(S@D9ZX)]:^NJY7XG_$.'X?V,E_.-VW"I&&56D=CA4!
M/XLV 2$#,%.,5\J^$;[5OVB=0:&[N'AL5C0SQP^8L 56!5 I+*96;+ R%B,,
MPR(U2O=5_94T2&-5@2:*=/+*W,<\@G#(0?,&28PQ(Y(0 9)4*<8XK3[/6?#_
M (FTS3M3O'N[58YW@D*>6&(M94;?@'?*N.2SR,%<,2#(PK?_ &J?AEJ?CJ&U
M735\Q8I)3)%YBQY+!=DF'94.W##.=PW_ "@@L1V'PXMI_AYX?C_M3+26EM+)
M*%;S&"+OD6,$D E8\( #M!&%;: :^</A;JEU\:=0OTU!DED?3+O[.D@S!!([
M0HC1J0_EXX^907.,DLV2?9?V:O"6J> K*Y36F$-NC!H4>2-A&H#-,Y92RJAR
M#C=@%78JNXENU^$GQ,'Q#BNKF, 0QWLD,)&[+QHD960[@""Q8MC V@A3D@L>
MZHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHKFO%EV]\1IMLQ6293YLB$AX(2K@R@C&UV9?+BR<[B9 LBPR+7Q!^TQ:)9
MZ_=11*$1%ME55 5546T("@#@ #@ < 5^@E%%> ?MK?\ ('@_Z_X__1,]>=?L
M@>-K+PJFHR7\\<(*VS*'8!F""<ML7[SD9'"@G)  R17G7Q"GF^+6NW,NEPO-
MYLBA @8Y1 D"RL2J[%;"L2^T)NPQXS7V5XFTJ?PEH)CM;AXY;&P)61$B^<P6
MY #+*DH"L5!(&&'0/US\_P#P4_:#UOQ%>/:2RI<326["VCD2.*/S=\9+LT48
M;:D0DD89&X*57YRM:OPYE\2>&=;EDUJ2Y:QACN9+J5B[VAC$;.'CR-OWMI58
ME#J,KL4!U&M\&?%EY\;+ZYNKRXF@M+;;Y=I;R/ I\T,!OEB*2/M$6>3RYRNQ
M,HV3\%_C+?:+K3^'M1N/M, N)X$FF(617C:3:=Q+,WF,-@1F8@E C #:WFO[
M4&C7ND:E%'J%W]LE-HA$GDI;X7S)0$VQD@X()SUYQV%?57P#T:]L--MY+N[^
MT126EH8(_)2+R%\O.S<I)DX*C+8/RY[FO+_"OQ*N?C/KLEG%<R6^F6ZM*J0,
MT4DZQN(P6D&R50_F;BHP H"X#CS*RD^+=[\,_$DFDSW)GT]KE ?M#DF))UC9
M6$LC.X$2L =S%6 8D*S;EZ7]J7XBZG\/I+:33[MT6X\[=&8[=T7RQ$!M+0E^
M=Y)W,W/3 XKGT\;>(_B+H"RZ;)NDAWF[EC/E74CB5V$$2QHH&V'RW<J09-P1
M"6$B-M^%?B9J?PY\,R7NLB1KLW+1VJ7._P Q@P!&_CS, B5\2%2RJ%5@K1FJ
MGA_3;_Q1X;N=>N-1NOMDD,LL9262&*);9F!18H7CC)D$1#,1@;@0NX,7V_V<
M_B_=_$NWN+*]G\N[AV,D\8A69T9CN/EO&T?RD!68)C:ZC ?YF\E^&_[1GB+6
M=0@MA*+DRLR+$T4:)N96"NYAB\P(A(D?;@[5(R!DB7XL^,->^%FLH9=1>Y)C
MCF4',<#J=T91X%/EKRC [>>CAED/R^__ !#U6^\1:"-2L+C[%FP:ZD54$LC
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M-I:!D;&Q'.&.TD#^+;7U+JG[.6AZO(T]S;O+*V-SR7-T[G  &6:8DX  &>P
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M_P#U_P G_HF"OG_]ES_D8K/_ +>/_2>6NK_;6_Y#$'_7A'_Z.GKW_P#YD_\
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MX'&XA"0![?X4\/ZUXL:*?Q#Y,$4,BRI:VQ8%Y4?,;3MYC@JA4.B(Q5F(,GW
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MLF"""H:2.3;USN7:X(!##G/SK^Q9JTVKR:G/<R/+*WV/<\C,[G G RS$DX
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MF =R$GC_ ()7VN_$K39U6_>WW7<YEN6432'='#M@A'F+Y2KN=V*A-A,8B/\
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M,3[=J!V8DX2OJ7Q7XFA\+VLM]<G$4,;.W*@G'15W%068X502,L0.]?*OQO\
M#,VG>'8[Z^'^G7VIQW%QD-E-T,_E0#>!(JQQX4(Q;8V\ XKZ%\$:VF@^'K6\
ME!*0:5!*P7!8JENKD#) S@<9(&>XKE- \)ZA\3($U._OKJS29?,@M;.1(1%&
MWW=\@#M,60(^6"["S *N=HQ?@[X_O/#FKS^%=6G^TNFYK>X8N9&R@F\MB0Q/
M[MB^6;Y"K(&<%,<U\6/&FN:#K]CIQO!(DLUG*(HT-G$29FB\IF#3RE&VDON9
MQ\WW#M45T'[1OA?4=&T]M6@U*Z$L31"5$D^SP;&8J?+CA4'(D=<&1W;RP0SN
M0,[_ ("?4/BSI=O=7%W):1/"486I1;B62-PIF:4Q_N@6C;$42CAN96!V+S7[
M.7C^^;5+[0+Z=[I;7SO+FD(W_NIS&^<AG;?Y@(W.VP*%&0>.*\4W%U;^.W:P
MC22Y^41K(VR,%K *78CG:@)=@OS,%*K\Q%;?Q@\->)/A\G]MQ:M)<A& E7:L
M,:!@(D80%GA8$G!PH(8A\$[F7V7P-\6X?$&B_P!M/SY5O(]PB;=RO$I,JA2Y
MQG&Y S E&0G&:YG0/">H?$R!-3O[ZZLTF7S(+6SD2$11M]W?( [3%D"/E@NP
MLP"KG:,7X.^/[SPYJ\_A75I_M+IN:WN&+F1LH)O+8D,3^[8OEF^0JR!G!3'*
M?&/QWKOAK7+.Q%UYZR26LRP0H+-')E:+R"Q>1RK[3NWNR9;E<*,>E^%OA_X@
ML-734+S4$FM9(V^T6ZF18T8H0(XHV#+M5@F),I(PW;ADMN]?KP70O%%_\0?$
M-WIMUY]O862OA(6D@+N&V1/)*@23$B.TB(K*I"J</M9FQ=2\67GPM\30Z<MQ
M-=6=_P"1^ZN)'D:'S97B&QW+-\K GG[Z':^6 D&U^U/XGU;PG:+=6=V(H9)O
M(\M(0)</$S%C,SN008SM,:QD;OO$J#6AI?@S5/&VCP2OJ$T$C6%NT"0.8\R^
M2<23SE6FDWEE9U78J\C]XP$AYK]G'QYJ7Q&L+FTENY(KBV:(QW(6&1BKQNJ(
MZR1-O"M'O9B?,<G&]<$FI\ OB'K/BK59].U6\D5[569HDAM-K-'*L<B/((R<
M9.,)RP)(D7:-WL'C^"\GNK.*RO)+<S3%942.WE A2.2224"2)G4E_+BWEC&I
M=,H68!NUM(3 BHS%RJ@%VVAF(&"QV*JY/4[0!GH .*J:WIDFHH$BGDMR&!WQ
M"$L1@C:?.BE7'.> #D#G&0?E#X):-+=>*M4B2YFB=?MN9D6W,CXNHP=PDA>,
M9/S':B\CC R*]J^.'C2]^&^C&>U+W$YD$9GD5"8P^X^:RQ1I&<'"+E57<R;M
MQRK<_P")O US)X?.H->WT&H+:&ZE8W$ZY?RS-)"80Z1QKDE%"*A3"YSA@T7P
M\\;ZM\3]">[M9S!J%NTL0V) T=PZI'(I=9HR$+!MORLJAB7(VX1<_P#9?^)U
M[X^DG_M"^=Y8=K+;B*UC1T8,I<E8_-;#8SMV!3LRS[]H]+^),5_+<6<6G7;P
MM-<!98PL#J($5WFF&^"5PWW(PQ/EAWC4@%\G)^-OQ&N/!%K;V=B?-U&\D6"!
MI-H)/RJTQPJQ;MS* #L3<X;:45EK%USX):M;P-=6NL7LFH(SRA2P6VD8;G2(
M0EPD8+;5^9FC S\FTX70_9N^,\GQ(M9$NEQ=6WEB1P $D#[MC@#[K?(=X VY
MP5P&V+YI\8_'>N^&M<L[$77GK)):S+!"@LT<F5HO(+%Y'*OM.[>[)EN5PHQV
MK^'/$'A"[EUV\ODN;5+2>6XM5:2.,,L+L(HD99%"AE3$ORR$;BRDEM]#X6>&
M9_BM:'5[O5;V.6::3=!:3^1#"%.U8MF'P=H#9."592V22[>E?">PU&P6[BU:
M8W$JWK>7*5\M'B\B H44 *HZA@N5$@?ECECW5%?,'[5WC+6?"30K#>[(+GS0
M(X8O(=!$Z,I,N]Y"Q#@,4,:D+]S#$5U7Q'^''B/Q1&]Y;Z@]O(-[0V,7[@!2
M1MC>:.7YI2B@DMNC$I9481G?1^S9\9[CX@VL]K=2H=0ARR.R* R-]URB.F[8
M_#[0@VF,;MS%JX75/'OB"U\4KI:7 NGC:3RX\"UMOWMMYF9%0LSI%NW ,SN0
MF%(=LUVL5OJ_P@-_J^J7IU"R$(*1Y9)#,\D:IA&#)"@9V4B-B-N#L)557;_X
M5)J?B:'[3J&J7D%X\>1';,L%O 6&X1%(RWF['8@OY@9U &X8#5B? OXB7?B$
MW?A[4+@K?63%5N8L/(Z1R>6Y)FB="58*NYUW.K@[=ZLY\Z_L:7_A._L_VF;S
M/^?C;;^=_P >&[IY/D]/E_U?W?\ :^:OHKQ=XE/PUTR>_N9)KSRL$;_)1R79
M(T3,442A=Q!)*LP!)^; 6N5_X5)J?B:'[3J&J7D%X\>1';,L%O 6&X1%(RWF
M['8@OY@9U &X8#5D_ +XGWFKM=Z#?R(VH6/F(DY#R"0(YB+./DW;'VY)9'D5
MAG#!W/"ZIX]\06OBE=+2X%T\;2>7'@6MM^]MO,S(J%F=(MVX!F=R$PI#MFNU
MBM]7^$!O]7U2].H60A!2/+)(9GDC5,(P9(4#.RD1L1MP=A*JJ[?_  J34_$T
M/VG4-4O(+QX\B.V98+> L-PB*1EO-V.Q!?S SJ -PP&K/_9W^*-SJLMSH6IN
M)+RQ9E$H+,94C<Q.22HR5;:-QPSA@2NY78\5\6/&FN:#K]CIQO!(DLUG*(HT
M-G$29FB\IF#3RE&VDON9Q\WW#M45T'QY\/ZMX9L3K46ISFX@FC+HI$%KY;2D
M*JP*&W$,Z ^:[[D#;B>%J_>:K/\ $;PD;^6>:%_L%T95B,0$S0AU)<^5N"LT
M1)2,H-KLA+#%8'['.C2W6FR2I<S1(M^^846W,;XC@)W&2%Y!D?*=KKP.,')J
MI\3/&6LZ)XBT_39KW=!-<64I2&+[,F&F,31GYY)'4A26#R%26^[@#'JO[0GQ
M!NO FEO=6*;I6D6/>1N6$,&_>D8(." J[L+O9<[ON-RGB;P-<R>'SJ#7M]!J
M"VANI6-Q.N7\LS20F$.D<:Y)10BH4PN<X8-TW[.OQ,G^(6F?:;L 313-"[+P
M)"J(WF;0 %)#@$#C()&T$*ODGP"_Y'#5O^W_ /\ 2R.OJJOFO]M'0V6QANVG
MF9?M:(L!,8@7,,A+ +&'9ODX+NVW<X7 ;%>G_"+1+B#2K21;N1R^G0>7'*D#
M0QL8D*D"*.*5@O3#2Y*YR=V&'BNJ>/?$%KXI72TN!=/&TGEQX%K;?O;;S,R*
MA9G2+=N 9G<A,*0[9KM8K?5_A ;_ %?5+TZA9"$%(\LDAF>2-4PC!DA0,[*1
M&Q&W!V$JJKM_\*DU/Q-#]IU#5+R"\>/(CMF6"W@+#<(BD9;S=CL07\P,Z@#<
M,!JS_P!G?XHW.JRW.A:FXDO+%F42@LQE2-S$Y)*C)5MHW'#.&!*[E=CG_!W7
M[[XL75]<:I]IMX+>18H;>*2:U1&.?-5WB\J225 B9#-A2['8H90,_P"''C:]
M\(>)9O#,\\E[;NQ:.6=BTT9^S^>/F.=PV_(PX!8;U"996X_]M/0VLIK.=YYI
M?-^T@(YC\N,*8R%18XT_OX+-N=@J@L=HKZ5N?#-_%"\=OJ#F5\ 27$$$OEC#
M E%@6V&[)!S)YB_+C9R:\*_9F\9:O\09+XW-XX'^BEI!L+IQ* L,31M F[:#
M(Q4\+C86?S(\_5-;U/X5^)K>Q2ZGO+>Y6)8XKFY=LB8F(;V,;!"LRELHA.P!
M<_,PKL/CGX<U/PW8/K2ZI<_:K>2,^7&%AM"K3X5!"I/W?,7)E:4N%*MD$;>Z
M^''Q,.J>'X]:O 24MI7FV[2S&#>KL!A%!;RRP7@ G;G S7/Z!X3U#XF0)J=_
M?75FDR^9!:V<B0B*-ON[Y ':8L@1\L%V%F 5<[1B_!WQ_>>'-7G\*ZM/]I=-
MS6]PQ<R-E!-Y;$AB?W;%\LWR%60,X*8YKXL>--<T'7['3C>"1)9K.411H;.(
MDS-%Y3,&GE*-M)?<SCYON':HKH/CSX?U;PS8G6HM3G-Q!-&712(+7RVE(55@
M4-N(9T!\UWW(&W$\+5^\U6?XC>$C?RSS0O\ 8+HRK$8@)FA#J2Y\K<%9HB2D
M90;79"6&*P/V.=&ENM-DE2YFB1;]\PHMN8WQ' 3N,D+R#(^4[77@<8.37TI1
M7'_%WQP_@;2[C48D$CQ*FU6)"[G=8P3CD@%LD#!(&,KG(\Z\ ?#:X\46,&J?
MVS?&ZGC$V4F4VJ2L2VPP8*E4;Y'CR%.UEP@.U="0ZYI?A^2:2Z$5[;KJ$DTC
MPF5Y#%/*Z>7O9$1&1<*3&P\ME**H KA?@E?:[\2M-G5;][?==SF6Y91-(=T<
M.V"$>8OE*NYW8J$V$QB(_P"LVY^@>/M6^$&N)I.M79N+*9LB61@YV2'9'-OD
M??&%=,2*S%5'F%58E7/LOC[Q;>WNH1:!I;>1/);FYFNRB2B&(,44+&[ .S2
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ME6,4JE'2RME96!5E81("I!Y!!X(/(-=+7RK_ ,U#_P _] ZOH#XL?\@?4/\
MKPN__1+UY5^Q3_R!Y_\ K_D_]$P5RG_-0_\ /_0.KL/C)^SN/&]VVIZ5<B&_
MC:,2 LVWS$$9C;<A+PNL94C"G<-A 7)=N:^%_P 9]9\*ZG!H'B1?];M1)'&9
M064+#\\>Y959EV%CEM[$O)\C+53]N?\ YAW_ &]_^V]3?MRW;JFGQ!B$9KEF
M7)VEE$(5B.A(#, >H#''4U]/VEVEXBRQ,'1U#*RD,K*1D,"."".01P17RU\
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M)(V59H\%T)T[J,_D<%6QG:RMAAV'[/WCP^!)W\):N0D\4Q^SN"IB828D$0(
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M?EW;CL%!8GH "3P*]E^ GB:'Q!HMF\!SY5O' X)7<KQ*(V! )QG 9<X)1E)
MSBNOO]?@L)8;:5PLMPSK$G\3E$,CX [!1DD\ D#.64'P#]C#6TMK:[TJ4&.Z
MBN6E:-\*VTJD1&TG?E7CP^0 I9!G)P/?]?U^#P] ]W=N(X8UW.[= .G;DDG
M &2Q( !) KYP^-VH6=AXOTY]21'M3:(D@D5&C&][F-682$+M5F#,3]T D9(
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M$CR+'%@JF0?,90#V/)( S7F'[:W_ "!X/^O^/_T3/7JOPG_Y ^G_ /7A:?\
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M 14C4  #"*H)RQ!=F9O9?VH_^1=O/^W?_P!*(J/V7/\ D7;/_MX_]*):\J^
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M$=)\-SPO%:VT,\DC1PO'!&K[O*D=@&1,K^[1\DD C(SD@'Y_^/O_ ".&D_\
M;A_Z625ZK^U'_P B[>?]N_\ Z415ROPT_P"1&D_Z\-3_ /0KBC]BG_D#S_\
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M*M@@E"RAAG->5?#Q?%/P\A.G2V2:C#'M$$JW446U<<QYE&]E'10RJ5P0"R;
MO:_";X6S>&YKK4]2D2;4+R0F1DW-'&@)*Q1M(/,VXQD$@85% _=AFXKX^?!G
M6/BC-%Y9LX8+?S1'NEF:1MY7+-B#:ORHORC=M.[YV!&/:O#,EX\(_M!(4G&
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MXTZZ6UD$*RF%XYI069F+JCAH.!N9LR*20-H\MB"3PG_"F=>_M_\ X2/-CO\
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M .@D#MGA!C'G7P#^#.L?"Z:7S#9S07'E"3;+,LB["V&7,&UOE=OE.W<=OSJ
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M?O7$IV-Y#[<.!C(;Y<CJ0P^BJ\P_:*^&<_Q"TS[-:$":*99D5N!(51U\O<2
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M&=OF=Y&+/8M([%I&9V)=B222<FO>_C9\5X_AO8M<91KE_EMXF)^=LC)PO.U
M=S?=!X3<K.IKOZ****XKXT>,9/!ND75] /WJ1@(>/E:1UB5^58':7#8(PV,'
M&<UYA\%/A+IWC?P^DM]")+B[:X:6Y/S7._SW4.)&W,"-@./NL<[E;<^[T_X0
M_#;_ (5U8BP\][C$CON8;5&X_=1<ML7C)&3ERS<;L#M:*******^._BGX-M?
M"OBW3([-"HEFLI9"TDDK-(UVX9RTK.Q)VC//7GJ37V)116?K?AZVUY!%>0QS
MH&#!94610P! 8!P1G!(SUP3ZU\B_ WP!8WOBB_LYH$DM[;[9Y4<@,B+LN%B7
M(<G?A&(&_=SAOO $?8MI:)9HL42A$10JJH"JJ@8"@#@ #@ < 5+1117%>*/A
M#8^)=0MM6N _VBUQLPY"-M8O'N'^PY+#:5R3A]RX%=K65XF\,0>)83;70<Q-
MG<J2RP[@05*L8G0LI!(*DE3W' KYJ_88_P"8C_VZ?^W%?55%%%>=?&GX8Z9X
MU@CDU:4P);L2)A(D04/M4J3(&3#,%ZC.0 ",D'5^$6B/HFEV]NYD(57*";/G
M+$SL\,<F0,.D15&4#:K*57Y0*["BBBBBBBBBBBBBBN*\4?"&Q\2ZA;:M<!_M
M%KC9AR$;:Q>/</\ 8<EAM*Y)P^Y<"NUHHK@/A[\5X_'%]?V]J4>VM/LZI*I+
M>8SB7S#G@;04"KC(."X9E90-7XE?#6U^(EK]BO=X02+(K1MM=67(R,AE/RLR
MD,",$D $ CH-)TN/2(8[:!=L44:1HN2<*H"J,DDG  &22?4U:HHHHHHHHHHK
MBOAM\(;'X=>?]@#C[1(&;>Y? 7.R->GRKN;!.7.?F9L#%7XE?%>/PE<65C&4
M>ZO+NWCV$G*1/(%>4@?]\IDC+$D;@C+4/QZ\&VOB+2KF2Z0N;:VN98AYDBJL
MBQ,5<JC*K$8XW!L D#AFSPO[%/\ R!Y_^O\ D_\ 1,%>_P!%%%%%%>=?''P3
M9:UIE[<7,$;S1V4S1RE1YJF-&D3#CYP _. <')!!!(/B'[+_ ,&=*\;Z;+<Z
MA;^;*MV\8;S)DPHCB8#$;J.K$YQGGKTKJOBA^SM!X6M9]4\/S36,\%NS.J32
MA)(TS)(-V3(&( (^8H2@!4$EQZ!^SW\2I/B#I:7-Q_Q\1R-#,P4*K,H5@X )
MZHZEN%&_=M4+BO2J***JZMI<>KPR6TZ[HI8WC=<D95@589!!&02,@@^AKG_A
MK\-;7X=VOV*RWE#(TC-(VYV9L#)P%4?*JJ H P 2"22>JHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHKY \4V]U<^.WCL)$BN&VA9'7>J V #N%_B8)N* _*7"AOES6K\;/
MV?IO"<+:[IEY>274/S3/)(SW!0@1[TDC56&U?O[N/+R=RA<-ZAX ^-R:IX>;
M69R#+;0NLZLPC#31J,+NV*H,N4("@@&0(,D8KBM L-#\<P)?^);^">ZF7S/(
M-Z(H+8-R(XXUDC9#LV"0,6)=,EB<EL_X$^,U\):W+X:M[G[9I[[VM9 4D"-Y
M8G8!U;;MV[U?:"#* P5-SUE?MEPW&D-;XN[EXKKSP\#.JP 1O&Z*$C1 <%S\
MS[W^5<M\M>B_&SX,1:QIEW>7<TDUY%#).DC,XBCV(K/%%"KB-$81[?FWN-VY
MWD89K/\ @-\69D\-W.HZ@_FM9R7"JTDC!Y,(DJ(TCEOF9Y/+7CIL4*3US] L
M-#\<P)?^);^">ZF7S/(-Z(H+8-R(XXUDC9#LV"0,6)=,EB<ELKX*>*D\.:Q/
MX6AN3=Z;*LGV:1'!9&,7G,%EB<;1MWJQ3GS5#J(RSUB?&WPS%8>*M+MT:8H_
MV+)>XN))!NNI%.V221I$X'&UAM/S#!)-?3]OX-6QCDCMI[F-I-O[PSR7+KM.
M?E%V9T7.2#A>0?4*1\Z_L]S3?\)5J$$\\UQ]GM[J!'GD:639'=1A06/XGC R
M20!FLK]M/PQ!IDUG<QA_-G^T^8SRRR\*8V55$CL$4&1B%0*HSP.E>X?%2Z;X
M::/>7VGO(9@L04SS3W04M*L>Y1/)( 0)"1C@D+O# 8KBOA+\&=#\9:=#J"M)
M+>NNZ:Z$\PN$N3\[M]X*'1SE"RG("N=X;<WJGPF\,S^&-/2TNW,DJ376Z1CE
MI US*ZRGYGY=6#D$D@G#<@UV%%%?,&A-9?%KQ!?V>O-YAMI)(;&V#O%'M21Q
M*XV$%I<(K-\V6!8[2J+Y?I7AOX-?\(GJ7F6$LR6+6%Q$D9D\Q;:5I(&W1"8R
M??VLY!5E#H2Q(95'BMU#?1>,QI\5W-*Z>=Y,EPXD\HSV1>214""/Y2VY8U1$
M;:J$J/F&K\;/V?IO"<+:[IEY>274/S3/)(SW!0@1[TDC56&U?O[N/+R=RA<-
MVNG?M$8\,?VR=CWD>V!D<[0UQE5SPJ;LH1,43HN4##:6&5_P@WAO7H=^M:E#
M=WSQ_/.U^G[MF&66%0R1K$LA9HU:,@9P01\HB_9G^)QMI;S0[JX$T%BLCV]R
M=H3R(G\MB7WD;,%&C^\%7<-^U4 U?!/A8?&T2ZMK!D>Q>9UL;3>T42QQL5$[
M"*7)F)W*<GCY\90QA"/X4ZC\/=7MY/#P/]E2L@NK=IMT<>6599 LKAL[ K*R
MEWW*RG]V0C9_[84-QIEBEW%=W*K)<"!H%=4@V/"Y<$(BN^?+'^L=P-S   XK
MM8M0OM/\*P2Z4F^\73+0QKM#G_5QAV52?F8)N95YW, -K9VG%^'?P1@\1:*J
MZ[;EK^Y5VFGE.Z\4[L0D2/N="L:Q_)T&"KIRX.)^QIXZNM=M;BRN7WQVGD"$
MGEPK^9^[)SRJ[!L!Y4$KG:%"\_\ 'W_D<-)_[</_ $LDKZJHKR#]H_XAW'AZ
MWAT[3PXOM0D\F%U94V8:,-\S=&;>%4_+MR7WJ5&8;;]FNUTB#S[223^V%5G2
M^:60.TYRVYU)="C,2KJ4<F,D$LQ+'SK]AC_F(_\ ;I_[<5T%G-_POC5KRWDG
M?^Q['RT$,4FP7#EP=SE-XDB)B?:0RD+Y;)M8N:Q?BYX E^")CUKPZTD</G*M
MS 7>2#&W$>Y2,E"=X8NY*O(OEE21CUKQ)\:(=,T$:ZNS=+;H8H]RR#SG&!%G
M<F[8^?, PP5'. 5(K$T#]G>UUR!+GQ$)+S4)%W2M)-(HC+?,8$6&0($1B0-N
M026*X4A5B^$7@C6?"UU=Z7>,\ND>6PM93-F51\B1QJR,DL?[HD$!5573,17.
M7X70=3N]&\:C2EN[J2T#.1%+<2RKAK-I@I#L=P5F^7=DX ))89/0?M;B;P[:
M1:C975U!*]RL3K'<S+$RF)SG8'VJ1Y8QL"@[F+!B01Z5X7TZ7Q/HEDK7,\+R
M65N9)HF3SFW0#=EY4D()+;MZX<, 0PYSX+^R3%<>+I-0>ZN9F#?9#*1)(L\A
M F$8,RN)%50.0I#-A!O$8=),_P 2>'3\)?%EK#H[")+I8%5&$LD:K,YMV5AY
MH>4!U\T LHW;1_"#7=?M#_">WTC3)-8$MR^H6\D3I<O,QD^:X&% 7;&BJ9"4
M$21[2JX_BW:NC?&B;1?",.L3[)+H1^4@=F'F.LK0*Q)8L[;5,C@'+;7(*CE<
MK_A!O#>O0[]:U*&[OGC^>=K]/W;,,LL*ADC6)9"S1JT9 S@@CY1%^S/X]ENI
M;SPX]P9DMED^R72!"?*1_*R"QD4CYD:($.H&5)*!%KE!;W:>-4L/ML\@C:4Q
MR3$3,GFV9DEV)A8D/)" )L4A-R.J[3;_ &FOAM'X#AM=7T^:=+L3"&6=IIGN
M)2T)"R&0R?*0L;*0@4$/CA5 KJ_CS9Q^*O"ZZO<@_:#;6,JA9)A"KR/'N(B\
MPQDXE=0S!FVG&[@5M?LN>&8O[&L[S=-YG^D?+]HN/)_UTJ_ZGS/)Z?['WOF^
M]S7%:$UE\6O$%_9Z\WF&VDDAL;8.\4>U)'$KC806EPBLWS98%CM*HOE^H>$/
MA /!FJK/9-)]@^Q3QK \C21P2-+ Y\O>Y8"3:S,,'#*26^95'I]%%>%?M7?%
M>Z\$6L-M9'9)=^:#,#AT5-FX)Z,V_ ?.5 .T;B&6W\4/@G8Z?HT\ELOEWEK&
MUREX<M=M+%F9G>4%79G^;))VJ6#*OR*!E?LN2R^+M->[NI[DW,=Q-"LIN;A^
M#&C!S'+)) S+YAVYC*_*I*E@2>/TKS[/QU%9S7,]RD+3,AG?>5,MD9'VA0J(
M-QP BJ  HQQ6W^V-X9BL--CN$:8N]^F0]Q<21C='.QVQR2-&G(XVJ-H^48!(
MKTKX4>!X&TNRFWW.Y["#(^V7>SYX%#;4\[8N-QV[0-AP4VE01X+;>#K>U\=?
M88_,6(LS$K/.)=S61E=O-$GFY+DDG?DY(/!Q7K7[2/B>X^'FBJNG2.C27 A\
MQY))9E5UED8K)([/N^7 8DE5/R[2%*Q:!^SYH>IV276BR212M#^XOHIIO-#8
MVER-ZKD\K(FU",L@"'[OI_P]TN32--L[:==LL5I;QNN0<,L:JPR"0<$$9!(]
M#705YA^T-\53\/-.,D# 7<S>7 "%;!ZO)M)&0J]#A@'9 RE2:Y^W_92T_4[;
M_B:23SW\BQF6Z,[O('"H&5"Z[2GRD+YB,P4XR,+MQ/V>?B/J%GJ%QX:UE_,F
MA\PQ2R.WFL5890&0!I596,L9/S! 3RFT)RO[9<-QI#6^+NY>*Z\\/ SJL $;
MQNBA(T0'!<_,^]_E7+?+7I3? &ZU+4+77+K4'^W12*\RHO[C:&S]GA^9&CBV
MED8MO,FXNR@LP/M517=VEFC2RL$1%+,S$*JJ!DL2>  .23P!7SKX!T8?'Z6Y
MU/5'D;3XKGR[6S5VBCPJ,=\J(3E]LJG>LF=V]3^["K7/_$"RN?V=;V"\TDR/
MID[/YEM([-$')RR9VX0F,+Y3DM)^[;<60$-Z!^U+H=KK.ARZB"9"BV[0LLTA
MAPTR*) BOY3$I(P#[2=IX. ,2_LN>&8O[&L[S=-YG^D?+]HN/)_UTJ_ZGS/)
MZ?['WOF^]S7FNJ6\ESX_9(9/*<X&_:'*C^SQN*AOEW;<[2P90V"R. 4.A^TU
MX&C\ "UU[2Y)(KM;D(\C2S3R.3&2A+S2/PJQE"I!#J^UOE&#Z+\2OC))IFDV
M5S:F&"ZU+[.L9FD&R 2H'>8Y7YECR 6*[065F!'R-Q^O_"_PGK,#K)J4;WCK
MQ>RWR33[A]PL#*L;  !,;0=@P"&^8;7[+_Q/N/'NGSVEU(_VFVVH)P%+E)%8
M1L2^\-*I1LEDP0$+;V+D^8:I;ZBGC%=/MKV222-I/)ENCYPB\ZT\R9UC4)&"
M Q*(JJA*HK#:#7M_PR^!/_" :A<7T5Y--%<1D-%+\SERRMYKR!@';._!* @.
M>3R6]5KSKXX?$"7PG:)%8X.H7<R06JG8?G<@%\.RC"@X!.5#LF\;2:Q?^&7=
M*OH<7_G75XT>)+QYIO.9L8#@%V0;> @8, JJ&WX),OP/M]:\-074/B)P8H&W
M0W+RJY9/G,K,Y;=L& RF0*P#$'@!5XKP#HP^/TMSJ>J/(VGQ7/EVMFKM%'A4
M8[Y40G+[95.]9,[MZG]V%6N?^(%E<_LZWL%YI)D?3)V?S+:1V:(.3EDSMPA,
M87RG):3]VVXL@(;W#XO0MJFDSW=I=S0K':33HUL\:B3:GFQGS-C/M^4?ZMTW
M*Q!)!&/'_P!F'PHWC;2YS?3S- U_.9(D=XS,SP1K(9I%;S'4A@0@* MN,AD!
M4)G_  Q$OP\\7RZ%:R$V4C2D1$OL0/ +E"%+D%U"K'O;)90>A/&WXTU:W\;>
M*3H>M28L8(U^SPAFB26XDCC8;V4@EL2.$^9>0JKR["3NK'X&1>%M0L;G2C)'
M:QS3&>V\UWAW-;3(MP!)(3OR5C.-Q*L"-H5BWDO[9<-QI#6^+NY>*Z\\/ SJ
ML $;QNBA(T0'!<_,^]_E7+?+7M_Q[^)A^'FF/<Q@F:1O)A(VX21T<K(=P((4
M*6Q@[B IP"6'*^#OV:+66V2YU=IY=5=5=[DSR":*3:H4(RR,I,6 %9M^6&?N
MX0>:?LPPSP>)]02\8/<+#=B9UX5I!=1!V'RKP6R1P..PZ5Z!XK\:VWC/5KG2
MKZ]CM--LU19%6Z6![J5P-\;,<9A5=\<L:L&#$%B3@)YU\34TOX7R6^L>%;N$
M3+((I;9)Q<I(C!G+,/-9]ORA6&<9*,I1U#-[K\1[IO$NAOJ-I<W-JOV![E!$
M8XW;]T)HP[;7=<8 (C=<@L"6!%>%? GX=77Q1TFZAN;MX[5KN5SL^:66Y*1-
MOF9\[XEPK! 07<LS,"B&NK\3^ M:TU]*\/1M-<Z8,"ZF3=%O3S7\V&5A*2D2
MVY"(FX!^B[F552']I[P=;> HK36](06=W'<K$# JQH59)7RR!=I/R[3QAE9E
M<,NT#6^/-G'XJ\+KJ]R#]H-M8RJ%DF$*O(\>XB+S#&3B5U#,&;:<;N!6U^RY
MX9B_L:SO-TWF?Z1\OVBX\G_72K_J?,\GI_L?>^;[W->:_%R&XTCQ1IEI)=W-
MQ$]Q83E9G78'^T-%E8XDCB7Y5[(#DL23DUZ?^T1\19])%MH^FRB.^OYEC#YY
MBC9A'OR"70L[ *X5N%D*X=5(JZY^REI\D#/:23KJ*L\L=V\[^:TWS,AD(4KC
M>02R(LGR@AMV28?V7_BO=>*(Y],U,_Z79[1ESMG=<LK!T;YBT;*%=^IW*'&_
M+/YU\9[>[TOQ+IUF+V>8236,RBX(>)9?/:)6$4(@CP HR%"L<M\P+$UU?[1O
MPEBTG36UB.>=K^VFB?[3)*[RE6F("*%9(X@KRAD\M%"[< #<37J'P#\33>)=
M$L[JY.Z4QLC-EB6\N1X@S%B26(0%B3RQ)XZ5W]<K\4]0OM/TRXETI-]XL>8U
MVAS]X!V52?F8)N95YW, -K9VGSKX=_!&#Q%HJKKMN6O[E7::>4[KQ3NQ"1(^
MYT*QK'\G08*NG+@XG[&GCJZUVUN+*Y??':>0(2>7"OYG[LG/*KL&P'E02N=H
M4+S_ ,%=,T[XWR75WKQ^T:AY@V0^9)$D5N -OEJC+\N]F#?,V#M+89RS^R_#
M;X:OX*O;S9))):20V@MQ(YD,2QFXS;J68ML3<I3( P^WYF5F/HM%> ?!WPA?
M>,+J^O?%5KO99%CMXYU#P1]?.$,3EDV_+$!* =^#B1B7)YKX<7;_  \\6S>'
M[%C_ &?,Q8Q.2^QOLOGAD/4$'Y,G)9,!]S*K#ZDHKY+_ &RX;C2&M\7=R\5U
MYX>!G58 (WC=%"1H@."Y^9][_*N6^6O1;WX&3RWMOX@O]2*75NPEN,#%LL:G
M<88B61HH0F]&9R^\%G< LP/->&]7TOXJQG4/$EY"JO(_D:>;P110HIVH[H&B
M<S_?RY)#(XPJC:JXGA+Q5;?"_P 0QZ=I-R+G2K]H\QHZSK#+(S1H%</U#!=Q
M)W&)@&#LJ-72_'[Q7'=ZU8Z'J4ODZ5)&LUQ@E-[;I1&DCC.(M\:Y^Z!N+LP*
MJR=+JW[.]KHS6\VBB2W,=[:23PK-(T4\:3HQWB20C,8S(AYZ,H4LRE?.OVMK
MJY\&S6L]A>7D7VG[09$6ZG\O*&,AE4N=N?,(VKA  H55YS[A\:=(-UIES<)-
M/#+;VT\L;P32PG<B;\,$8*X.S!W D MM*DYKBOV1/$-SKVE32WDTD[B]D4-*
M[2,%$4)"@N2<9)..F2?6N$_YJ'_G_H'5E?MI^&(-,FL[F,/YL_VGS&>667A3
M&RJHD=@B@R,0J!5&>!TKZJT+PS%HF[RFF;?C/FW%Q<=,XQY\DFWKSMQGC.<#
M&K65XK\30^%[66^N3B*&-G;E03CHJ[BH+,<*H)&6('>O"OA=\-U^,%N-<\0N
M]P9I)O(MUED2WA0,L?RHNUE;=$1P[!EVL^Z3)'/PZE=? +6H-.$KR:/=>4$\
M]_EC#-B1P^Q8T9)&9W"C:T;+OPQ5E] _:C\,Q?V->7FZ;S/]'^7[1<>3_KHE
M_P!3YGD]/]C[WS?>YJ+]F7PA#<Z+973-.'#3-A;JY2+*W$F/W2RB+''(VX;G
M<#DY]OHKYK\::M;^-O%)T/6I,6,$:_9X0S1)+<21QL-[*02V)'"?,O(55Y=A
M)W5C\#(O"VH6-SI1DCM8YIC/;>:[P[FMID6X DD)WY*QG&XE6!&T*Q;R_P")
MEU<^$?%&GV5K>7GV:>2R=XGNIY4^:X,;+\[DE2$R0Q;DG^' 'I?[3EF]EI4V
MI6UQ<P7$'DA3#<2Q(P:54*LBL$/^L)W !\A1NVC:3X-^//[.\+Q:IJ4KR>7'
M<O([OND;;/*%4-(PRQP$0$\G:H[5D^!?A,OQ*M4U;Q+ON)KG][##YDD<%O$V
M-BQK%)_&@5F).X_*&&\.S3>!/A[JWP_UHV]GE]!D5B%>42>02KN%178.I\W(
M^4,&1P7+.-R^?_M$*[>+=+$1"N5L=K,I=0WVN7!*AE+ 'J RDCC(ZUTO[2_P
MK@T_3FUF&2;[=;20-]H>65Y&!DVX4;Q'%^\D\P>6BJI&U%4'CU7X+^,9/&6D
M6M]./WKQD.>/F:-VB9^%4#<4+8 PN<#.,UVM%?*OP"_Y'#5O^W__ -+(Z]+_
M &G(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,RH)3\LA^42!,A3MR,GFO@/\ #6+Q
MAH%J-1DDDMMMPJVR.\,/_'RS;Y/+8/*X=?E)8(JD 1[P7;G_ -EC5+G0M7O]
M >4RV]NLVS<6PK0W'EY12Y5 _F,S@9)(7G@YET)K+XM>(+^SUYO,-M))#8VP
M=XH]J2.)7&P@M+A%9OFRP+':51?+]0\(?" >#-56>R:3[!]BGC6!Y&DC@D:6
M!SY>]RP$FUF88.&4DM\RJ/&OBY#<:1XHTRTDN[FXB>XL)RLSKL#_ &AHLK'$
MD<2_*O9 <EB2<FO5?VC_ (AW'AZWAT[3PXOM0D\F%U94V8:,-\S=&;>%4_+M
MR7WJ5&8;;]FNUTB#S[223^V%5G2^:60.TYRVYU)="C,2KJ4<F,D$LQ+'SK]A
MC_F(_P#;I_[<5T"^+-/^*%U=?VQ?0Q:?;W#006BWBPI<!.6N)<%&D4ML:$JP
M52I&#\S/Q7B3Q#I_P8U2WO?#]TDME<?+=VL4JW*JJ% 2#YA.XART>X@JX8;C
M&S(/8/VG(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,RH)3\LA^42!,A3MR,GR_P"&
MGP2G^)WA^W6ZO###&TGV6.-=R ^?)YLLP)!D<DLJ!641J >2[BOIK1-"^Q6]
MO#<-Y\MO&@\YQEV=8_+:7YBQ#,"V3DG#$$G)SJU\J_!73-.^-\EU=Z\?M&H>
M8-D/F21)%;@#;Y:HR_+O9@WS-@[2V&<L_LOPV^&K^"KV\V2226DD-H+<2.9#
M$L9N,VZEF+;$W*4R ,/M^9E9CZ+17@'P=\(7WC"ZOKWQ5:[V618[>.=0\$?7
MSA#$Y9-ORQ 2@'?@XD8ER>:^'%V_P\\6S>'[%C_9\S%C$Y+[&^R^>&0]00?D
MR<EDP'W,JL-#QIJUOXV\4G0]:DQ8P1K]GA#-$DMQ)'&PWLI!+8D<)\R\A57E
MV$G=6/P,B\+:A8W.E&2.UCFF,]MYKO#N:VF1;@"20G?DK&<;B58$;0K%N%\:
M:M;^-O%)T/6I,6,$:_9X0S1)+<21QL-[*02V)'"?,O(55Y=A)W5C\#(O"VH6
M-SI1DCM8YIC/;>:[P[FMID6X DD)WY*QG&XE6!&T*Q;FO&>MR?%/76\.6]P\
M-C;V\C7C0N$DD;&QHPX\P,JF1%=&"C/FA@2J8ROB]\$5^'=N=:\-&:VGM]AE
M1))'5H@V78JP=FPVQG5F\KRT8LN1SZ5X&^-$.L:%_;EWL3RXY//1&4X="5V#
M<PPS_*41CGYT7<V0QY3P+\)E^)5JFK>)=]Q-<_O88?,DC@MXFQL6-8I/XT"L
MQ)W'Y0PWAV:;P)\/=6^'^M&WL\OH,BL0KRB3R"5=PJ*[!U/FY'RA@R."Y9QN
M7SKXN0W&D>*-,M)+NYN(GN+"<K,Z[ _VAHLK'$D<2_*O9 <EB2<FO:OVA-0U
M2RTMSHJ.T[2*CF-2TRQ,&#-& =V[=M&5!95)88(WKQ_C'X(V1\..]W;A;^*R
M:XEG!#7!N%B:64O+\QD#2%@P)9<'Y<;4*R_ #4W^*VAM%J[/*([AX"RR2Q/(
M@B0XD:)U,G$A5L\. "X9LL?-?V-?#,6M_;_-:9=GV7'E7%Q;]?/SGR)(]W3C
M=G'.,9.>U_;"AN-,L4NXKNY59+@0- KJD&QX7+@A$5WSY8_UCN!N8  '%=@?
MB G@'PM:WS8+KIUJL*G'SRM"@1<;E+ 'YG"G=L5B.E<UX)^ -OXZL8]2UZ2:
MZO+NW#B0S,%A60O)&(E 55PL@)1@\:N"%7;D'$^&?BV]^&NO'PS>R&2RD;%K
M),YW(FPF ([*H8$*(BB@*)1B/!#!]#]L*&XTRQ2[BN[E5DN! T"NJ0;'A<N"
M$17?/EC_ %CN!N8  '%;>@?!B+QSHEL+^:21GTZV$"[G2WMV$!$<BPHZAW ?
MYVD9BY!"^6AV#G_V+O&-SJ]M=6=PYD2W: Q%F9F575T\L;F("*(AM4  $MZC
M'T?6?K^C#6H'MF>2,.N/,B=HI5/4,KJ<@@\]P>C J2#\P?!^XO-+\32Z-K%[
M=3&-9/(#7%QMD=2DT;E4E9<- &8HY*X.Q@6XK5_:PTZ\\)I#J6GWEU"DDS1R
MQBZN-N]@TB,BEB%&%<, 0H 0(@^8U[+_ &A:?V+]L_TG[)]D^T_Z^;[5LV_:
M,>;YWF;L<8\S'\&=E1:!\.I[33$L)KVZ$Y7,]PLWFRL[)M=4>>-RB GY-BHR
M[0V0Q8MXU^Q9JTVKR:G/<R/+*WV/<\C,[G G RS$DX  &>P KFOC/X.M])\5
MZ=##Y@$S6+2,T\[REC<M'N\UY&D!"(H!# K@;<'FOHKQ]H<>C:)J,<1D8&RN
MVS+--.V?(8<-,[L!QT!QG)QDG/C7[)_@]?$VCW$5T[FU-W*IA1Y(=Q:&$,7>
M-U9UVG:(^$Y8N)"4\N+X47;_  Y\5W/AZ!BUE.SLD>2%C8PBX1ANWL2J#RB=
MP+C#MDJJCZDHKPKQ;HVJ>*_$L5G=PNVB11^85&1;R83<#+AL2,+@*!$V<*H;
MR]I=FX7]H6T3X/:C9:MHBBWEF6998E %NZQ^5\IC7  8-\P&!E5==L@+GZOH
MKE?BQ_R!]0_Z\+O_ -$O7SK^R_XJU72--ECT_3?MD1NW)D^U0V^&\N(%-L@)
M.  <].<=C6U\;OB!KM]:&TNK$:9:SJRS732O=*J@IA2UHC&,.?W9#(PD#[1@
M!C7J'P?\ :=INC1VUA,\UO/B5IXY)(7D<[0S QNKQ8V!2@(*A2CY;>3Y5^SW
MKMY_PDFH:?/=W-Q!;QW2()YGE_U=S'&K$$[=VW/( ZG& <54_:VNKGP;-:SV
M%Y>1?:?M!D1;J?R\H8R&52YVY\PC:N$ "A57G/I?[4OCJZ\'Z2)+)_+DFN%A
M+C[ZJR2,Q0Y^5ODP&Z@$E<-AAGZ!^SYH>IV276BR212M#^XOHIIO-#8VER-Z
MKD\K(FU",L@"'[NKXF\,W5AX:1/M$]I-9Z4"ZP/&I,D,"MM9PCN 'CP?+==P
M+ D@C'/_ +&MV]YI5S+*Q=WU&9F9B69F,4!+$GDDGDD\DUY_\9[>[TOQ+IUF
M+V>8236,RBX(>)9?/:)6$4(@CP HR%"L<M\P+$UU?[1OPEBTG36UB.>=K^VF
MB?[3)*[RE6F("*%9(X@KRAD\M%"[< #<36UHWQHFT7PC#K$^R2Z$?E('9AYC
MK*T"L26+.VU3(X!RVUR"HY7*_P"$&\-Z]#OUK4H;N^>/YYVOT_=LPRRPJ&2-
M8ED+-&K1D#.""/E!^RY\0Y'N+KP]+-]ICM-YM9P 0T4<GE$;@[97YD:(#=A2
MR[]H0#G_ (*Z9IWQODNKO7C]HU#S!LA\R2)(K< ;?+5&7Y=[,&^9L':6PSEG
M]E^&WPU?P5>WFR222TDAM!;B1S(8EC-QFW4LQ;8FY2F0!A]OS,K,?)=":R^+
M7B"_L]>;S#;220V-L'>*/:DCB5QL(+2X16;YLL"QVE47R_4/"'P@'@S55GLF
MD^P?8IXU@>1I(X)&E@<^7O<L!)M9F&#AE)+?,JCT^BBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOE7_F
MH?\ G_H'5[U\8KM+71K]I&"@V5PH+$ ;FC9$7GN6(4#J20!R:^</"WAF:'P'
M>.!O\^X\]0@9F")-!&Y88XQY+L<9 3DD<@>X?LY>/(/%6D6Z1$"6VAC@ECSE
ME*+L1CD#AU7<",C.5W$HU=UJOB:'3)[>UD/[VZD=(U!7/R1/*[$$@[0$P2 <
M,R XW9KYJ_;G_P"8=_V]_P#MO7T!\6/^0/J'_7A=_P#HEZ^6O EH]UX'U-8U
M+$7H8A02=JFT=VX[!06)Z  D\"OH#]G+QY!XJTBW2(@2VT,<$L><LI1=B,<@
M<.J[@1D9RNXE&KNM5\30Z9/;VLA_>W4CI&H*Y^2)Y78@D': F"0#AF0'&[-?
M-7Q]_P"1PTG_ +</_2R2OJJOE7X!?\CAJW_;_P#^ED='[<__ ##O^WO_ -MZ
M^D/&5I:7UJ\&HJ'MYFCB96!(+22+'&/EY!\QEPPP5.&RN,CYJ\5_LRZC\/G;
M4O#5U(QC7)BSBX*J48J-@V3@L"QC95!"A0LC'!]E_9[^)4GQ!TM+FX_X^(Y&
MAF8*%5F4*P< $]4=2W"C?NVJ%Q7I5%%> ?$W]FJQ^([2ZCIDOD7+22J_RGR)
M)8GDCDW+@,C&5<-(NY3M+!'9BQRO@KXZUGPSK/\ PC>NN\N^-S [?O"2NZ02
M"5B&>)E#C+;F5@J83:ZC)_YJ'_G_ *!U>]?&*[2UT:_:1@H-E<*"Q &YHV1%
MY[EB% ZDD <FOD";0)X?!BS%#L?6/-##YAY?D-!O.,[1YJE/FQSC^\N?LKX=
M>/(/'5E%?6Q&'4>8@.XQR8!>(Y"G*D]2!N&&'RL"<_XCZBNIPW.C0?/>7&F7
MCH@*#C B7=EAMW/( I(VG:^2-M>?_L?>,8]7TC["!B6SD8,.3E97>5'^Z ,D
MNN 2?DR<;@*]@U_Q)'H?DB0.S3W$<,:HI=BS9))QT545G=C@!%8\G /BO[:W
M_('@_P"O^/\ ]$SUTL?Q,@^'/AJQOK@%S]BM$CC7@O(8 57."%&%)+'H <!F
MPIM^!?#USXUMH=2UF<N)X1(MI"6ALU218V"NH.^<E1\ZRL\?SN@0KR?)/V&/
M^8C_ -NG_MQ1\??^1PTG_MP_]+)*^JJ*^4/VE;D:-XGTN^N,I;HMJS2;6*XC
MNG>3& =Q56!(&3@CCD9^KZ^5?V&/^8C_ -NG_MQ47[&LQT*_U'2KA2MP%0L/
ME*J8)'CD4D,<G=*,8R" 3GIGUK]J/_D7;S_MW_\ 2B*O%?''A:XA\#6&Y,>5
M<+._S+Q%*T_EMUYSYT? RPW<@8;'T_X \8Q^,[&#4(1A9HP2O)VL"5D3)5<[
M7!7. &QD<$5;_P"$DC-Y_9X#F46_G,P4^6JE]B!GZ;G(?:HR2(W)Q@9^:O\
MFH?^?^@=75_MK?\ ('@_Z_X__1,]>J_"?_D#Z?\ ]>%I_P"B4KY__88_YB/_
M &Z?^W%'Q]_Y'#2?^W#_ -+)*]5_:C_Y%V\_[=__ $HBKP7Q9://X$T]D4L$
MO79R 2%7S+M-QQT&YE7)XR0.I%?57PZ\>0>.K**^MB,.H\Q =QCDP"\1R%.5
M)ZD#<,,/E8$Z$GB:%+Q-/SF=[>2? *_*B/''EAG<-S/\O&#M?G*X/S5_S4/_
M #_T#JZO]M;_ ) \'_7_ !_^B9Z/B7_R(T?_ %X:9_Z%;UU7[+G_ "+MG_V\
M?^E$M<K\3?V:K'XCM+J.F2^1<M)*K_*?(DEB>2.3<N R,95PTB[E.TL$=F+'
M*^"OCK6?#.L_\(WKKO+OC<P.W[PDKND$@E8AGB90XRVYE8*F$VNH^E***\:_
M:E\+VVOZ=&DN1=&YCCL]JJS/-)E1"68J%1@,L2R@%5;YBH1IM0\)^(M6TM-(
ME>S1FC6&XNQ+/-(T6"CD1R0+F5D^\S2?,=Q&PL"G?^!? MKX'M4LK)-L:\DG
MEW8XW2.<#+'')X  "J H 'SK_P U#_S_ - ZNK_;6_Y \'_7_'_Z)GKU7X3_
M /('T_\ Z\+3_P!$I7S_ /\ -0_\_P#0.KZ ^(_AFQ\5VZZ=J(RMQ(4BP#O$
MJQR2!D;!VL$1R"?E(!4Y#;6^:O%_P5UGX,>9J>A73O;+\TB@?O%7YP#)&0T4
MJHK<OC*EBXC15+#Z5^%GC7_A-],M]0*[6EC^<8P ZL8Y-HW-\N]3MR2=N,\Y
M%=57S!^W'I<DL-C<A?W223QLV1PT@C9!C.3D1.<@8&.2,C/T?X>UM->MH;R(
M$)/#'*H; 8*ZAP#@D9P><$C/<U\X66ER7OQ!EDC7*PQB20Y VJ;)(@>2,_/(
MHP,GG., D5/VY_\ F'?]O?\ [;U]545S_P 0M+DU?3;RV@7=++:7$:+D#+-&
MRJ,D@#)(&20/4UXA^Q'K:36%U9@'?'<K*QXV[98U10.<YS"V> ,$8)YQH?MK
M?\@>#_K_ (__ $3/5KXPZ7)I'@O[-.NV6*TT^-UR#AEDMU89!(."",@D>AKH
M/V7/^1=L_P#MX_\ 2B6O*O\ FH?^?^@=75_MK?\ ('@_Z_X__1,]<)\8-2?0
M;#PQJ(C,B6T,+MU52PCM9%0M@A2PC;'!. 2 <&OJK0-?@\0P)=VCB2&1=R.O
M0CIWY!!R"#@J000""*BLO$T-[=36,9S+;QPO)@J0OF^9L4X)(;$>X@@?*R$9
MSQ\U?\U#_P _] ZOJJBOG7]K>XDT.;2=5$>^*TNV+#<%RV8I43N1N$+\A2!C
MGJ ?H#2=4CU>&.Y@;=%+&DB-@C*L RG! (R"#@@'U%<IXQU#_A)[;4],M$=Y
MTM'C)*[(S+- Y2)78A2P4HS?PJ)$R<D@>2_L1ZVDUA=68!WQW*RL>-NV6-44
M#G.<PMG@#!&"><:'[:W_ "!X/^O^/_T3/7:ZMI<FD>%9+:==LL6BO&ZY!PRV
MI5AD$@X((R"1Z&N*_8I_Y \__7_)_P"B8*Y3_FH?^?\ H'5Z+\5/@+IWQ3EE
MFCD,%["RQ2R(F5+;(I%$B';O(B<;65@0& 8L$"CS7P#K^N?"#5K31=6<S65P
MRQQ$9E3+!(T\IWV.H1]JM&>%4LPC)9&,O[<__,._[>__ &WJ;]N6T=DT^4*2
MBM<JS8.T,PA*J3T!(5B!U(4XZ&OIK2=4CU>&.Y@;=%+&DB-@C*L RG! (R"#
M@@'U%?+_ , O^1PU;_M__P#2R.K?P8\8Q^%_$VK:?>#RFO+MS$SY3+"61HT
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MBK&0*K!6;JT@1L;7[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7E7[%/\
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MDNZ@ \D?-7Q]_P"1PTG_ +</_2R2O5?VH_\ D7;S_MW_ /2B*C]ES_D7;/\
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MNA'DN>">"R$COC&0#P/&OC5I<FI^,M*CA7<PCM9",@?+'<32R'DCHB$XZG&
M"<"N@_;6_P"0/!_U_P ?_HF>O5?A/_R!]/\ ^O"T_P#1*5\__L,?\Q'_ +=/
M_;BOJJBOEO\ :@M'\%:OI_B*W4XW*LH0&/<T39VO*N>9(F,>""=D9'S+D#T7
MQIX;7XKV5]- ?,C-N\%B8V3$C1NLLCACQMDN(4B(;@+ 9(W"RYKSK]F3Q>/$
M]I:Z&Q&;6YDN)%PPW01E98B6YR_VR5& 7:"D1#\'$GU)7RK^PQ_S$?\ MT_]
MN*/C[_R.&D_]N'_I9)7T!\6/^0/J'_7A=_\ HEZ\J_8I_P"0//\ ]?\ )_Z)
M@KE/^:A_Y_Z!U?55%>-3_%B?QGK+Z#I$@@2W5VNKEDW2YCD17CA5P4SN.PO(
MK#EF5?D4R>0?M?\ A*+PXFG+&TDCE;D/--(\TS[1!C<[DG&2S!%VHK,Q55W'
M/V)17*_%C_D#ZA_UX7?_ *)>O*OV*?\ D#S_ /7_ "?^B8*]J\6?9_L=Q]N_
MX]?L\OG_ 'O]5L/F?<^;[N?N_-Z<U\]?L/7,[6U[&V?LZS1-&=N%\QE82X;'
M)VK'D9.T8.!NYS_@%_R.&K?]O_\ Z61T?MS_ /,._P"WO_VWKZ ^(_AFQ\5V
MZZ=J(RMQ(4BP#O$JQR2!D;!VL$1R"?E(!4Y#;6^:O%_P5UGX,>9J>A73O;+\
MTB@?O%7YP#)&0T4JHK<OC*EBXC15+#VJ7QK_ ,)OX5GU KM:73+O>,8 =8Y(
MY-HW-\N]3MR2=N,\Y%<K^Q3_ ,@>?_K_ )/_ $3!7*?'W_D<-)_[</\ TLDK
MU7]J/_D7;S_MW_\ 2B*O!?%EH\_@33V12P2]=G(!(5?,NTW''0;F5<GC) ZD
M5]5?#KQY!XZLHKZV(PZCS$!W&.3 +Q'(4Y4GJ0-PPP^5@3H2>)H4O$T_.9WM
MY)\ K\J(\<>6&=PW,_R\8.U^<K@^ >,/V6K?Q)LU?PY<?9GEV3Q(0R0_-L=&
MC*J)(<#+@;6PQ"J(P.-7]F_XE:G=W5SH6M[S=6T:LC.J[PJ[497<'Y\[D9'P
MQ<%F,C K1\3?V:K'XCM+J.F2^1<M)*K_ "GR))8GDCDW+@,C&5<-(NY3M+!'
M9BQRO@KXZUGPSK/_  C>NN\N^-S [?O"2NZ02"5B&>)E#C+;F5@J83:ZCZ4H
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHKQ7XJ_ ";6[Y=<T:Y^RZ@NTG=N,;E0J!LC<4_=@JR[720 *
M5&7+6]0^&VL>/=D'B">V2S217>WLA,/M&,D+(\I#*JL 0%SNR3\K*C+ZK_9,
M/D_9?+3R/+\ORMJ^7LQMV;<;=NWC;C&.,8KYJ\1?LF7VC737/AR]^SI)N!1I
M)H713M/EB2(.TB[@3A@I "Y+G+5ZA\(O@[+X0=K[4;J2]OWA6(R.[LL<>0[1
M)O8EAYG.XXR ,(F6W8GQ@_9_NOB=,DEQ?I'%#Y@AC2USM#D$EF-QEF(503\J
M_+E47)SVNK>$=0U?39-/GNX6EEC>)Y_LK#,;1F-OD%R )226W A.PB[US7PC
M^"$_P^BDLVNX[FRF9FDA>UP2638V&\YAA@%#!E<$+@!223YUXB_9,OM&NFN?
M#E[]G23<"C230NBG:?+$D0=I%W G#!2 %R7.6KTKX6_!JX\)^9>WEX]WJ4EO
MY2S2F26.)>'\L!I SKYOS$DH6  41DL6Y_QI^SM?>+=0CU:;4D2XA\KRO+LP
M$3RVWK@/</GYR6.\MDDC[N /6X;2_$#*\\!N"WR2"WD$07Y>#&;DLQ^]R)%'
M(XX.[R3P7^SM?>$M0DU:'4D>XF\WS?,LP4?S&WMD)<)CYP&&PK@@#[N0=O\
M:&^"3_$^"'[/*([BW9]@?/E,LFS>&*JS C8"I (X*D?-N4\0_#;5_&6DOI^I
MW4'G2+"A,43"/Y9XW>5BQW2/LCRJHL";F92"-K)+_8WBJW_T9;NQDBZ?:GAE
M2Z ;JXB0^1N3)" G:VU=_4U-I/P;?PEH<NDZ1<&*YD4L;ELY:4A0[8!/EAE7
M8"N6C&&&YQECX)66IZ()M.U6X%VT*Q,)07<J\C2EH#(^&<JBQR?, RB8#E/+
M->GT5XUIGPVUWPI+=7&F75JXNKVYG-M<1/Y2^8Y(D$L9\POL5 5P$&6ZD!CK
M>%/A7<SZBNNZU+')>I#Y4,4"LEO"OS@D%COD+*Y/SX"EV&& 0KX?XIT>36/'
M;P03/;RG:4F3!9&6P#J2#PRDJ Z'AT+*2,YKU#Q-\+]?^(H2TUFYM;>R#!I$
MLA,7E(92$;SN  ,E3R V"8W(4KZK<^"[2ZLO[+DB#6@A6(1,21L4 (,D[LC
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MVN^#[3^SY[JU6&-BT)CB>:3YB7*$L85";^6&UG96=5DB(1ES_P#AG:^_M?\
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MN[+??V@+7?T5XAX+^&WB/X?VD5G875E<(%.8[B*5%A8DNPC>$[Y SNV3( 0
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M4-*ZQJ6()"@N0,X!..N ?2M"BBBBBBN:M/B;I5XZQ17UJ[NP556XB9F8G 4
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MK_;1\,0)8PW^',YNTCR99615:&0L%C9S&F3&A)5021DDDG/M7PG_ .0/I_\
MUX6G_HE*ZJBBBBBBBHKNT2\1HI5#HZE65@&5E(P5(/!!'!!X(KXZ^.7@"QLO
M%%A9PP)';W/V/S8XP8T;?<-$V A&S** =FWG+?>))]PN_P!E7P_.C(MJ4+*0
M'6:<LI(P&&^1ER.HW C/4$<5YKH6LWOP;\0P:+-=276GW2Q)"CDR/&CLT4
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M122%59I$09/4[5&3@ G) 4' ["BBBBBBBBHKN[2S1I96"(BEF9B%55 R6)/
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MV10&8J-@&X!=Q8C=7845B^-O%">%;*>_DP1#"[A68(&8#Y$W$'!9L*."<D
MGBO"M L-#\<P)?\ B6_@GNIE\SR#>B*"V#<B..-9(V0[-@D#%B73)8G);/\
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M)C%%*$($L4H<*<H8PI/R%D+E JURG_",Q?\ "=_8]TWE_P![[1<>=_QX;O\
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M9QDHRE'4,WJ'[0GQ5GTS0(+_ $UC$;UH5#D8E2.6%Y>""0KX4#()VY)4AMK
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ML&Y$<<:R1LAV;!(&+$NF2Q.2V?\  GQFOA+6Y?#5O<_;-/?>UK("D@1O+$[
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M^B9Z[75M+DTCPK);3KMEBT5XW7(.&6U*L,@D'!!&02/0UQ7[%/\ R!Y_^O\
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MCQR*2&.3NE&,9! )STSZU^U'_P B[>?]N_\ Z415;_9NTN33- LHYEVL8WD
MR#\LDKRQG@GJC@XZC." <BO'_P!AC_F(_P#;I_[<4?'W_D<-)_[</_2R2O5?
MVH_^1=O/^W?_ -*(J/V7/^1=L_\ MX_]*):\J_88_P"8C_VZ?^W%=-^VQ=HN
ME6\18!VO595R-Q58I0S =2 64$] 6&>HJ_KWQ2F^'EKI6@P1H=5FM[*+;+N,
M$6=L)9VC/S9=64!"<8+$X"J]7X_> _[-T"[N+NXFO+K_ $8^9*V(U;S8(R8H
M$VPQ<;L$*9,.ZF1@QSU7[+G_ "+MG_V\?^E$M>5?L,?\Q'_MT_\ ;BCX^_\
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M5^ 7_(X:M_V__P#I9'1^W/\ \P[_ +>__;>OH#XL?\@?4/\ KPN__1+UX_\
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MJ(6!&#]0>#=$?1K5(IB#*S22R[<E/-FD::4)D [!([!,_-MQN).2?F_]N?\
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M?M>W(M=5TV2QR=25=P"JSM@2@VV%(*,?,\S  ))X8$;:]:_:C_Y%V\_[=_\
MTHBH_9<_Y%VS_P"WC_THEKRKX!?\CAJW_;__ .ED=>B_%3X"Z=\4Y99HY#!>
MPLL4LB)E2VR*11(AV[R(G&UE8$!@&+! H\U\ Z_KGP@U:TT75G,UE<,L<1&9
M4RP2-/*=]CJ$?:K1GA5+,(R61C+^W/\ \P[_ +>__;>OH#XL?\@?4/\ KPN_
M_1+UY5^Q3_R!Y_\ K_D_]$P5RG_-0_\ /_0.JW\&/&,?A?Q-JVGW@\IKR[<Q
M,^4RPED:- "O_+1)=R$D X4+N+K7TU=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/
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M .O#3/\ T*WKJOV7/^1=L_\ MX_]*):\U_8V\8QZ<MSH=R/*NA<-*B/E78[
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M2YRU>H?"+X.R^$':^U&ZDO;]X5B,CN[+''D.T2;V)8>9SN.,@#")EMVAX.\
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MLAS_ (%_"+4_A]:26LUS  9I956.-Y07:)8U+LYC)0%=QC148E5_?!2R'/\
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M\2W RQPQ)5T4$C" +@^5>"_V=K[PEJ$FK0ZDCW$WF^;YEF"C^8V]LA+A,?.
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MD92-,D5ZUX9LKJRA$=],EQ*,#S$B\C<  ,LOF2#<2"25VKS@(,<ZM>*_%7X
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M\-H9FR(Y5&!A]H8AE'W7 )(&Q@1M*<KX=_9CU369%'B/47N+6.17$"S3S!R
MPY:79Y?4#*AF*E@"APU>W_$CP.GCG3Y].D<QB95PZ@$JRLKH<'J-RC(R"1D
MJ3D>?_!_X;:[X/M/[/GNK588V+0F.)YI/F)<H2QA4)OY8;6=E9U62(A&7/\
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M.@ 'V?17%?%#QK#\-],GO%5%8;O*3"@/-(Q(^7<F[+DR28.XJ';DYKS7P3\
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M1WQC(!X'C7QJTN34_&6E1PKN81VLA&0/ECN)I9#R1T1"<=3C !.!70?MK?\
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M 6QO45[+XB\30^'UC><X\VX@@0 KN9Y9%C4 $C.,EFQDA%8@'&*U:Y7XL?\
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M .8=_P!O?_MO5O\ ;CTN26&QN0O[I))XV;(X:01L@QG)R(G.0,#')&1GZ/\
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MQ_\ HF>NUU;2Y-(\*R6TZ[98M%>-UR#AEM2K#()!P01D$CT-<5^Q3_R!Y_\
MK_D_]$P5[_45W:)>(T4JAT=2K*P#*RD8*D'@@C@@\$5\Z_L[^&;_ $ 7-QI!
MCN=)GF;[.+F62WE/EL4\T".*90#@H=RH[[$8K& %/H'PX^$3Z;=S:WJ[1SZI
M.Q^:,$0PH!L5(@P#9V *78;MORY.7:3C_P!M;_D#P?\ 7_'_ .B9Z]5^$_\
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M:)9^+=4BB4(B+?*JJ JJHNX@% '  '  X J7]N?_ )AW_;W_ .V]>J_M1_\
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M)$&90<@>7MP 6PP7:@ZKX3_ V[T.>/4=:O9+RZB600J9)9(H2^5=@TAW.63
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M41AVW,P C4E4 WL>,DDGG;M5>4^.7[.$'Q%/VNW86]Z%(+[<I* I"+)CD$'
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M-+&6WW!#L"W)VA6Q]P=*M_%+X+ZA\288[:[OX4BCD\S;%9LNYL%027NW/ +
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MX5XF^ %YI>J'7/#URD,\DA::&?>87WDM+EEW,59L'RRO#99'4J@7;M/A7?\
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M<C.562(GC(&&&#@\XP?%/!?[.U]X2U"35H=21[B;S?-\RS!1_,;>V0EPF/G
M8;"N" /NY!UOC7\!YOBE)$9+M(8H-_EJ+=G?YQ'OW,;@!N4R,*N <'/6MKQ?
M\)G\<Z8=.U:X$LJLK1W$<1A*NJ;5=H_-=6)RV\ JI#854(##E?"'@3Q3X6@&
MFPW=D]LK,D<\BS/<QQ'A2J8$9*CYD1V90?DWE  ._P#A5\,X/AS9+8VY+G<7
MDD;@O(0 S8R0HPH 4= !DLV6/G7C3]G:^\6ZA'JTVI(EQ#Y7E>79@(GEMO7
M>X?/SDL=Y;))'W< =M\1OAY>>.=..FRW4*>9CSI%MG.[;(LD>Q3<_)C;AMQD
MW=1MZ5#\+/AM>^ ;0V O(YHE63R=UL49'<[ADK<?.@8L2N Q+8$B@ #E?"W[
M/E[X9U.;6+?4(_.N&F,B-9DQ$2OYC+C[5O #X(PP/ !)&08?&G[.U]XMU"/5
MIM21+B'RO*\NS 1/+;>N ]P^?G)8[RV22/NX ] \9^$=0\2V+6(NX8FECDCG
MD6U9MRL<816N3L^3*L29"<Y4H0*Y_P"#'P;NOADK6ZWJ3VKR&1HS;;'#;-N5
M<3G&<+D,KC"X4*236+<_L^7LVL?\) NH1I=;E.U;,F+ B$)7:UTS89!@_-GD
ME2IP1GR_!#6/#>LR:SHTUGF>,^<DPF5&=\&;"CS6"M*HE7$@*D[.57YCXW_L
M\:A\0O)N%O$>XCW*T;JT-JJGG,2KYSJW W[VD+]0R*BI78?$3X7:CXXM&L)M
M0C2*1D:7;:==IRJ+FX)5,JK$$NY<,?,$;")=#X0_#BZ^'UN+&2[2XMDWF,?9
M_*D4LVXC>)G!7)8X*[LM]_: M=_17F'P+^#0^&:7:$AC-<DHX9F8P*,0J^51
M0XW.6VC!+=2  .O\?^#H_&=C/I\QPLT9 ;D[6!#1O@,N=K@-C(#8P>":\U^$
M/PY\0>#[<:;/<V:VB[RCQI)+<+O;<RKO$48Y+,K.LN&(!1T^497P_P#V>-0\
M&:M<WL-XA@FCD3S9%::[(D='8G=MC$N5.)&\Q20&:$ABJZOQ@_9_NOB=,DEQ
M?I'%#Y@AC2USM#D$EF-QEF(503\J_+E47)SVNL^ 9O$VES:7J<Z3/+'M$R0M
M#@J%,<C()F#,)%WD*41ON[0,YXKX:_##7O"4']E_;;9+%)&,4T<1>["F4.4
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M@^]N=F7<GFLP7#N@.W8?=;3]E_1].1?L@GM[A5 6ZBN)4N <89@<F,%AD-A
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MSR3@8^BJJR:7'+,ER5_>I')&K9/"R&-G&,X.3$AR1D8X(R<_-_CCXK7OCKQ
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MQUQGJ:^]/!6C7ND0M'J%W]LE,A(D\E+?"X4!-L9(.""<]><=A705\5_MK?\
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M )5@#T)4XZ&O@O\ 9GM'L_$MK%*I1T:Y5E8%65A;S J0>00>"#R#7I_[<_\
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MOP-J$&HQR64AA9LHTDX#*RLCC(@X.UC@X(!P2& P?J^OD7Q_^RKJ'AV]6_\
M#N)$69)(HV=!+$X)<<S81T5E&"S%N0K*V"Y]0\,^'_$?C6$6OB'R;:T&%F6$
MXNK@*!\C-'(T:1.2?,V;7.TH%5'S4O\ PC&M>']<O=6M(XYK*X:V22WWJMQ(
ML<,:>;&6P@*,7^5W0. PQDQN*LOPBE\8^((M=N[<6L%NJ8B9D:XFEC^:.5O(
M9D4!F &9'8B%59=K87*_:>^ UWX[EBO]. >6.'RGB9PA90^Y"FX!<C>Y?<X&
M NT$\'M?@IX9U:P@A?5W$1@MEMH;2(@H$3:/.E8,X>9@@"[3M1<X :1@OI]%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%1-=HKB(
ML [*S*N1N*J5#,!U(!903T!89ZBI:*BMKM+H;HV# ,RDJ01N5BCKQW# J1U!
M!!Y%2T45%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %1:3JD>KPQW,#;HI8TD1L
M$95@&4X(!&00<$ ^HJU11117*_\ "V-'_P"@A9_^!,/_ ,76KH7BRS\0;OL5
MQ#/LQO\ *D27;G.W.PG&<'&>N#Z5JT445GZ_K\'AZ![N[<1PQKN=VZ =.W))
M.  ,EB0 "2!1H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!P5(((!!%:%<UXO^)6G>
M#@3?W,<1"JVPMF4J6VAA&N9&&<\A2!@D\ XZ6BBBBBBBN/U+XO:3IUS'8O=1
MFXEF\I8T)E82;@FQ_+#>6=Q ^?;SGT..PHHHKFA\2M.:[33DN8WNI&E41(WF
M,&C!:17V9$9 !X<J200,D$5JZWXAMM!02WDT<"%@H:5UC4L02%!<@9P"<=<
M^E1>%O%-OXJMTO;)_,@DW;'VLN=K%&X<*P^92.1^E:M%%%%%%%<_X2\?V/B_
MS?L$Z3>3)LDVD\'L>0,J<':ZY1L':QP<=!111116?K^OP>'H'N[MQ'#&NYW;
MH!T[<DDX  R6)  )(%&@:_!XA@2[M'$D,B[D=>A'3OR"#D$'!4@@@$$5H444
M44455U35H=(C:>YD2*)<;GD9409( RS$ 9) &>Y K$\(?$C3_&+S1Z?.)C;L
MJRE0^T%BP7#%0K@[&P4+ @9S@C/2UB^+_&EIX.@-W?RB*(,J[B"26/10J@LQ
MZG !( +'@$C5M+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BI:*YKQ?\ $K3O!P)O
M[F.(A5;86S*5+;0PC7,C#.>0I P2> <;>DZI'J\,=S VZ*6-)$;!&58!E."
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MCR]D(>)VX8_*LJH7P%).W.T<G&172Z#K\&OQ"YM'$L3,ZJZ\J2CM&V#W&Y2
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M+$,HW9XR!G/>OG_]AC_F(_\ ;I_[<5]0:IJT.D1M/<R)%$N-SR,J(,D 99B
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M>KL69MXX!#'<!M7@ "MNXU:&VDC@DD199=WEH64.^T9?:I.6P.3C.!R:J?\
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MW\B0KJ,L;)&Q8"5PJ_.54GYF"<%P"X3Y2VSBNJK*_P"$LL_L_P!N^T0_9?\
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MZ;B1CY2"GRU4_9H34=1TZ;2]8ANHD@:+R9',]M(8SDB)'41R80IU#GY7"<(
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MV2I9+4. <$'&1S@@X[BN%_9'_P")_;W>LW7[V^FNWC>=N7*+'"P0=E4%ONJ
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M4 E6 /0E3CH:Z#]L*:?1GTO585#"UN9#EON^9F*2-2 P8@^2V<=AC()&?;_
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M ):??#D%0 G[SFOVK_!=IX8T:,6D00R:BC2/DO+(QCN6W22.6DD.7;!=B1G
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MR22<  9))]35JN5^+'_('U#_ *\+O_T2]>5?L4_\@>?_ *_Y/_1,%<I\??\
MD<-)_P"W#_TLDKU7]J/_ )%V\_[=_P#THBH_9<_Y%VS_ .WC_P!*):]5KY5_
MYJ'_ )_Z!U>J_M1_\B[>?]N__I1%1^RY_P B[9_]O'_I1+7E7P"_Y'#5O^W_
M /\ 2R.HOV4?B GA&>X\.ZCB&5KEO+S@@S#$4D1<,5R=B^7@88[AN)9%/T?X
MZ\8Q^$;5[F0;G^[#$,[YI6SY<*!59BS-P,*<#+$8!-=!7G7[0^B/K.@WL49
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M9)7JO[4?_(NWG_;O_P"E$5>%>)M+DO? =C)&N5ANWDD.0-JF:YB!Y(S\\BC
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MPD3]RCCH0RAU4J\G1G+"UX.^"MQIEJ=.U#49KNR$?EK $6W&SYLHTBEYRO(
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MJ<DQ,JDYW9C5"& V%1Q7"?#S]GBV^'\QGL+N\7=M$B,\#1R!3D*RF#ZC<N'
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M9#3[N[N3$?\ 6$"V5Y?G61-Q%O@;2HQY83(^]NZT?#7X6I\/H_L]M<W,EO\
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MND<X&6..3P  %4!0 /.KO]G8VNKMK.F7TEF96+31K&LNXNV9L&1BH#?> =)
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M%%%%%%5=0U:'3MGGR)'YDBQIO95W.V=J+DC+'!PHY/85:HHHHJKI^K0ZCO\
M(D23RY&C?8RMM=<;D;!.&&1E3R.XJU111111111111111111111116?HGB&V
MUY#+9S1SH&*EHG610P )4E"1G!!QUP1ZUH4444444455N-6AMI(X))$667=Y
M:%E#OM&7VJ3EL#DXS@<FK5%5;?5H;F22".1&EBV^8@92Z;AE-R@Y7(Y&<9'(
MJU11111111111111111111111157^UH?.^R^8GG^7YGE;E\S9G;OVYW;=W&[
M&,\9S5JBJMOJT-S))!'(C2Q;?,0,I=-PRFY0<KD<C.,CD5:HHHHHHHHHHHHH
MHHHJKI^K0ZCO\B1)/+D:-]C*VUUQN1L$X89&5/([BK5%%5;?5H;F22".1&EB
MV^8@92Z;AE-R@Y7(Y&<9'(JU11111111111111111111111111156XU:&VDC
M@DD199=WEH64.^T9?:I.6P.3C.!R:M455_M:'SOLOF)Y_E^9Y6Y?,V9V[]N=
MVW=QNQC/&<U:HHHHHHHHHHHHHHHHK/UOQ#;:"@EO)HX$+!0TKK&I8@D*"Y S
M@$XZX!]*T***************************************************
M************************************************************
M***********************************XKXD_"&Q^(OD?;PY^SR%EV.4R
M&QOC;K\K;5R1AQCY67)SVM%%%>*_M8>&(+W1I[R0.98?(\O][*(U)F5"WEAQ
M$6VR,NXJ6P<9X&-7]ES_ )%VS_[>/_2B6O5:*********BN[872-&V0&4J2K
M,C8(P<,A#*?0J00>00:^2M!T&+0?'PM[<$(&=OF=Y&+/8M([%I&9V)=B222<
MFOKJBBBBN ^)7Q7C\)7%E8QE'NKR[MX]A)RD3R!7E('_ 'RF2,L21N",M=_1
M7%?$GX0V/Q%\C[>'/V>0LNQRF0V-\;=?E;:N2,.,?*RY.>UHHHK@/CIX8@UO
M2;MIPY\JTN)$42RHFY4+J61'59,,BD!PP!' Y.?/_P!BG_D#S_\ 7_)_Z)@K
MW^BBBBBBBBBBN:^(OCR#P+92WUR1A%/EH3M,DF"4B& QRQ'4 [1EC\JDBWX(
MUM]>L+6\E #SVT$K!<A0SQJY R2<9/&23CN:VJ*S];\/6VO((KR&.= P8+*B
MR*& (# .",X)&>N"?6OCOX0_"W3O$'B34=-NH=]K!]K\J/?(NW9<I&GS*X8X
M4D<DYZG)YKW_ /X9<\._\^?_ )'N?_CM3?"?X/I\.;V_^RY^R7"VSQ!B"493
M/YD6<EF"[E(9@"0P7+,K,?3Z***\Z^/7@VU\1:5<R72%S;6US+$/,D55D6)B
MKE4958C'&X-@$@<,V>%_8I_Y \__ %_R?^B8*]_HK/UOP];:\@BO(8YT#!@L
MJ+(H8 @, X(S@D9ZX)]:^1?@;X L;WQ1?V<T"26]M]L\J.0&1%V7"Q+D.3OP
MC$#?NYPWW@"/L6TM$LT6*)0B(H554!550,!0!P !P . *EHHHKBO%'PAL?$N
MH6VK7 ?[1:XV8<A&VL7CW#_8<EAM*Y)P^Y<"NUK*\3>&(/$L)MKH.8FSN5)9
M8=P(*E6,3H64@D%22I[C@5\U?L,?\Q'_ +=/_;BOJJBBBBBBBBBBBBBN:^(O
MCR#P+92WUR1A%/EH3M,DF"4B& QRQ'4 [1EC\JDBWX(UM]>L+6\E #SVT$K!
M<A0SQJY R2<9/&23CN:VJ********XK_ (5#8_VO_;^'^U^7M^^?+SL\OS-O
M7=Y?R8SLQSMW_-7:UE>)O#$'B6$VUT',39W*DLL.X$%2K&)T+*02"I)4]QP*
M^:OV&/\ F(_]NG_MQ7U5111111111111117 ?&SXKQ_#>Q:XRC7+_+;Q,3\[
M9&3A>=J [F^Z#PFY6=37?UQ7PV^$-C\.O/\ L <?:) S;W+X"YV1KT^5=S8)
MRYS\S-@8[6BBN*\+_"&Q\-:A<ZM;A_M%UG?ER47<P>3:/]MP&.XM@C";5R*J
M_$KXKQ^$KBRL8RCW5Y=V\>PDY2)Y KRD#_OE,D98DC<$9:[^BBBBBBBBBBBB
MBBBBBBBBBBBBBHKNV%TC1MD!E*DJS(V",'#(0RGT*D$'D$&ODK0=!BT'Q\+>
MW!"!G;YG>1BSV+2.Q:1F=B78DDDG)KZZHKBO^%0V/]K_ -OX?[7Y>W[Y\O.S
MR_,V]=WE_)C.S'.W?\U=K117 :7\5X]8UR31;8HZ06CR32 DD2B6-/*'1?E5
MB7QN^8A?E*,#W]%%%%%%%%<!\/?BO'XXOK^WM2CVUI]G5)5);S&<2^8<\#:"
M@5<9!P7#,K*!W]%<!\/?BO'XXOK^WM2CVUI]G5)5);S&<2^8<\#:"@5<9!P7
M#,K*!\]?MF^#;719[:[@0B:Z:Y:9VDDD+%/)"??9@H 8@!< #  P !]B4445
MP'Q*^*\?A*XLK&,H]U>7=O'L).4B>0*\I _[Y3)&6)(W!&6N_HHHHHHHHHHK
M@/A[\5X_'%]?V]J4>VM/LZI*I+>8SB7S#G@;04"KC(."X9E90._HHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHK@-+^*\>L:Y)HML4=(+1Y)I 22)1+&GE#HORJQ+
MXW?,0ORE&![^BBBBBBBBBBBBN ^)7Q7C\)7%E8QE'NKR[MX]A)RD3R!7E('_
M 'RF2,L21N",M=_111111111111111111111111111111111111111111111
M11111111111111111111111111111111111117R7^V7#<:0UOB[N7BNO/#P,
MZK !&\;HH2-$!P7/S/O?Y5RWRU[U\:=.EN-,N9H;F>W,%M/*/(9$+LB>8@9B
MC2  ISY;(2"P8D'CQK]F'PHWC;2YS?3S- U_.9(D=XS,SP1K(9I%;S'4A@0@
M* MN,AD!4)G_  Q$OP\\7RZ%:R$V4C2D1$OL0/ +E"%+D%U"K'O;)90>A/'8
M?$[5KCXCZVGABUDFM[:&-I+Z2-E4R(T:$(!D$KB0(<Y!:0LT;+&"<3]H'X+V
MO@O1Y[C1P;="T*W4?F2.DL?FKLXD,GSI+M*D%,*9 2<XKJ_@CXH3PKX0BOY,
M$0PW;A68(&83S;$W$'!9L*."<D  GBN?T"PT/QS E_XEOX)[J9?,\@WHB@M@
MW(CCC62-D.S8) Q8ETR6)R6S_@3XS7PEK<OAJWN?MFGOO:UD!20(WEB=@'5M
MNW;O5]H(,H#!4W/6)\9X[O1O$NG6HNI[H/-8SK'<2A8O-\]HEPL,2QQC" %E
MC+?,Q^8D@]7\5?V:I[F!M4@OKJXU2!1(&<Y#%,R,D*QKOB.\EHD4L%.$&,[Q
MH?!+X\_;-!N+F]?S+G3HVWF1]IE!#&WRY3&YR/*'WW+*&;+. <_0+#0_',"7
M_B6_@GNIE\SR#>B*"V#<B..-9(V0[-@D#%B73)8G);/^!/C-?"6MR^&K>Y^V
M:>^]K60%) C>6)V =6V[=N]7V@@R@,%3<]8GQGM[O2_$NG68O9YA)-8S*+@A
MXEE\]HE810B"/ "C(4*QRWS L375_M&_"6+2=-;6(YYVO[::)_M,DKO*5:8@
M(H5DCB"O*&3RT4+MP -Q-=5X+^+KZ7X4BUN]4S/'"5(!.Z1EF-O&69RQRQ"F
M1N3DLP4\+6!\+O@9%XXM$U;Q(9+RZNE$B!Y758HF+/&J>5(  P;?MX5 P4(I
M#;O/_!NDSZ1XZ2WNI3.\;2*)&.YVC%DWD[SM7<XBV!SCE@3DYR?6OBEX^6^U
M2/03>I8VPM_/NKA;A(+C.2([=&8$(V=DC _,\9X(7(?S7XJ^&-!\(VZZKX:O
M(8+ZUD5D2&Y$[2!F5&&UY7/ ))P"I3>KJP.5]/U7Q)+X^\,G5H;B>T<64\K+
M 4BW2P@Y&XK)(J>9$=NQU9D;#DYP.%_9A\*-XVTN<WT\S0-?SF2)'>,S,\$:
MR&:16\QU(8$("@+;C(9 5"9_PQ$OP\\7RZ%:R$V4C2D1$OL0/ +E"%+D%U"K
M'O;)90>A/&5\9_!UOI/BO3H8?, F:Q:1FGG>4L;EH]WFO(T@(1% (8%<#;@\
MU]::)H<>C(8XC(P+%LRS33MG '#3.[ <= <9R<9)SH5\E_MEPW&D-;XN[EXK
MKSP\#.JP 1O&Z*$C1 <%S\S[W^5<M\M>]?&G2#=:9<W"33PRV]M/+&\$TL)W
M(F_#!&"N#LP=P) +;2I.:X3]D_6+CQ1H]P;Z::9C=RQ[WED,@4PP\*^[>N-Q
M(*D$$Y!!YKD-!U.[T;QJ-*6[NI+0,Y$4MQ+*N&LVF"D.QW!6;Y=V3@ DEAD]
MK\>/&-W?WMGX:TQY(+BZ9)9+A&"E(07W!?F5B1Y;.V&0D($!;S"!G_$']GVR
M\(Z3<W&C[X+J.TD$DAE=A-%L(GCD4[D.Y,L JIB4(5* 4?L4_P#('G_Z_P"3
M_P!$P5E?!37?^%WWUY>ZLN^"V\G[/9L=]JF\3#>R$;9)0H(WL/XFPH 0)S/C
MC3&\ ^)[;3[&62*QO9K>1K:*6>WB4S2&"3'DRH<Y3>I&T+\J;2BX/J'[0^C3
M>']&DN;*\O(?L_E%$6=CN+S!&9Y7#7#<2G"F78-J_+\M97P$^'<'B_P[;1ZB
MSRVY\X) KRPQ@"XD8EQ%(OFL7&06^50%"(K;WD\__9WL+JTU+4O#4=T\=NOG
M;Y8QMFS#(("T6YF2%GWC>VUVVJ I5@KK+^T+H<?P@O[+4]',D4LS3-,&FF=9
M3')%(=Y9S(P<M^\!?# #@')/N'QV^(\G@RUB2U>&.ZN[A((WF<*D0;.^X((.
M53C)(VJ64L&'R-YUK_PO\)ZS ZR:E&]XZ\7LM\DT^X?<+ RK&P  3&T'8, A
MOF&K^S1\2+KXAZ=-9W,\BW-LT2_:%$9D,;9*9,JR*S_(ZL63E=IR7+-7G7PA
MTVZUGQ)J-BU[<XBM[NW\]G\RZ$27**%21\A&S@E@IQEMBJS!T/V@]!'P?U*T
MU32'>-I_,,J&29_,:.1)',CM*7=9-ZAT) .W.26XZO\ ;1\,0)8PW^',YNTC
MR99615:&0L%C9S&F3&A)5021DDDG/JOP7\,Q6&FV5PC3%WL+;(>XN)(QNC1C
MMCDD:-.1QM4;1\HP"17?T45\:_#?6;W2/%6JR:?:?;)3)? Q^<EOA?M2DOND
M!!P0!CKSGL:]@\6?%#Q%96=Q+_8_D;+>5O.^VVTOEX0GS-FP[]N-VW^+&.]>
M@?"?_D#Z?_UX6G_HE*\J^#OA"^\875]>^*K7>RR+';QSJ'@CZ^<(8G+)M^6(
M"4 [\'$C$N3S7PXNW^'GBV;P_8L?[/F8L8G)?8WV7SPR'J"#\F3DLF ^YE5A
MZ+\2=?N/%.J0>'-/G> >6;B^FA91-'$"/+C5MX9&9B-WR[@KQM\T9=3D^.OV
M9;2RM7G\.H]KJ,?S0NEQ,I;J'CW.[8W(6 (V_-@,P0MGIM0FU";PQ<G5U"7O
M]G7@E"[",B.4*WR,R99 &.TXR3@*/E'E_P"R?X/7Q-H]Q%=.YM3=RJ84>2'<
M6AA#%WC=6==IVB/A.6+B0E/+B^%%V_PY\5W/AZ!BUE.SLD>2%C8PBX1ANWL2
MJ#RB=P+C#MDJJCZDHKY5^ 7_ ".&K?\ ;_\ ^ED=>E_M.0W%EI4U_;7=S T'
MDE8X76)&+2K&69E02GY9#\HD"9"G;D9/-? ?X:Q>,- M1J,DDEMMN%6V1WAA
M_P"/EFWR>6P>5PZ_*2P15( CW@NW/_LL:I<Z%J]_H#RF6WMUFV;BV%:&X\O*
M*7*H'\QF<#))"\\',NA-9?%KQ!?V>O-YAMI)(;&V#O%'M21Q*XV$%I<(K-\V
M6!8[2J+Y?J'A#X0#P9JJSV32?8/L4\:P/(TD<$C2P.?+WN6 DVLS#!PRDEOF
M51XU\7(;C2/%&F6DEW<W$3W%A.5F==@?[0T65CB2.)?E7L@.2Q).37JO[1_Q
M#N/#UO#IVGAQ?:A)Y,+JRILPT8;YFZ,V\*I^7;DOO4J,PVW[-=KI$'GVDDG]
ML*K.E\TL@=ISEMSJ2Z%&8E74HY,9()9B6/G7[#'_ #$?^W3_ -N*Z!?%FG_%
M"ZNO[8OH8M/M[AH(+1;Q84N G+7$N"C2*6V-"58*I4C!^9GXKQ)XAT_X,:I;
MWOA^Z26RN/EN[6*5;E55"@)!\PG<0Y:/<05<,-QC9D'L'[3D-Q9:5-?VUW<P
M-!Y)6.%UB1BTJQEF94$I^60_*) F0IVY&3Y?\-/@E/\ $[P_;K=7AAAC:3[+
M'&NY ?/D\V68$@R.265 K*(U /)=Q7T_X>TU]+MH;>60S/'#&C2MG=(RJ%+G
M)8Y8C)R2<GJ>M1>)M#;6X3 D\UONR"\!C63!!!4-)')MZYW+M<$ AASGY@_9
M)BN/%TFH/=7,S!OLAE(DD6>0@3",&97$BJH'(4AFP@WB,.DF?XD\.GX2^++6
M'1V$272P*J,)9(U69S;LK#S0\H#KYH!91NVC^$&NZ_:'^$]OI&F2:P);E]0M
MY(G2Y>9C)\UP,* NV-%4R$H(DCVE5Q_%N[7X4._Q%\/6KWDLR2M&Z^;#-+#+
MF-I(5D+J^68A=S!]R,_)7H!P'[&OBR\\0?;_ +;<33[/LNSS9'EVY\_=C>3C
M.!G'7 ]*R?B9=7/A'Q1I]E:WEY]FGDLG>)[J>5/FN#&R_.Y)4A,D,6Y)_AP!
MV'[5/C1])%CI[RF&SO9G6\D0'S1"C1!U4@-@%9&+ *2V O*EE:7Q7^S=IT^G
MRR>']\%Q);L8WAN)&2=&7=Y#;Y2C12<<Y SM8DJ"K8'[:/AB!+&&_P .9S=I
M'DRRLBJT,A8+&SF-,F-"2J@DC))).?5?@OX9BL--LKA&F+O86V0]Q<21C=&C
M';')(T:<CC:HVCY1@$BN_KQK]I6;7'@MK;0EDQ-,5FDAR)5/RF(;PP,:$[B[
M\ ;0&=58AL#]HCX2Z=X>T<WUA"+:XLF@,,D/[M^98X_G8?,Y&0P<G>&&0W+!
MATU'XD>&8]6@GGCU-87(^SS3Q)*(99%93%&2A=T!(VJ"9-H!5/E$O[(WB4>)
M+6:2XGN9KR*3;)YUQ-*GEO@QE48^6O*,/XG!#$L%<*.U\2^$SKNLPK'<7,<4
M=O)+=QQW-S&C[\16J@),@3)CE<F,<F,B0?.I/-?%_P ;3ZUJUGX8TZ<P-,WF
M7<L;;)5C4&3RT==S(Y1&8@J,YB^;8S@Y7CS]F*UT*R-WH)GAU"VA9D=)9-\I
M  ?.T,V]D#A1%Y8+/@C;P.J_9^^*,OQ+TQS<.$NXF,3O&4W\H"D^QE95)R<
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M#':*T/CU_:$.@_VD]S/:W44-JTD-NZ1Q>:SHDN64-*0/,8 "4I\JG!(R?/\
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MR&%IY'TF=BQ!W;-CD([, C*9HL*S&,;F4*/D$FT:'[9<-QI#6^+NY>*Z\\/
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M5O\ M_\ _2R.O5?VH_\ D7;S_MW_ /2B*C]ES_D7;/\ [>/_ $HEKRKX!?\
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M$#*V0V00,H&7YO\ $'@K7OV>_P#3+"Y\ZQ,@W@*?+R?+SYL+%@FXKL$B-NP
MN]"ZJ;?[0/B%8M8T;Q 4?[&]O:3+]SS"(YO/=-N[A@DJ=3M). QP<?7]?,'[
M/VER2^*M9N0O[I)+N-FR.&DNMR#&<G(B<Y P,<D9&:G_ #4/_/\ T#JZO]M;
M_D#P?]?\?_HF>K6N?&>/X8^'=.<+YEU-86X@0@[,K#'N=R,?*NX9 .YB0!@;
MG76\;^ YGTF^NM6N'N;G[!<-Y:LR64;*DKJ(X5VA]I8;9)O,DRB."C  <_\
ML4_\@>?_ *_Y/_1,%<I_S4/_ #_T#J^JJ*^5?^:A_P"?^@=75_MK?\@>#_K_
M (__ $3/7JOPG_Y ^G_]>%I_Z)2OG_\ 88_YB/\ VZ?^W%'P"_Y'#5O^W_\
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MFG>)(]0N)[2,/NMO*$CE2(]TBEQ&K'[S!-K,!PH=.<D@?-7P"_Y'#5O^W_\
M]+(ZV_VN=2?0;G1]1$9D2VN9';JJE@T$BH6P0I81MC@G ) .#7O^@:_!XA@2
M[M'$D,B[D=>A'3OR"#D$'!4@@@$$5S_B?XJV7AL7;3L2+*&"2;8 Y!F9UBC
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MJ2<[HD_9XU#3-?76K6\21?G9GNE:68,T3QD;(O)1EY&W#1!%PH4A!NZKXS_
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MDM[])(IO+$T;VN-P0D@JPN,JP#, ?F7YLLC8&#XB_L_W7C/4H]5^WI!+!L$
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M(R7:0Q0;_+46[._SB/?N8W #<ID85< X.>M>E>&;*ZLH1'?3)<2C \Q(O(W
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M!P\AW/E6. 555+/PQVL-#]H;X)/\3X(?L\HCN+=GV!\^4RR;-X8JK,"-@*D
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MG\/K22UFN8 #-+*JQQO*"[1+&I=G,9* KN,:*C$JO[X*60Y__#.U]_:_]O\
M]I)]K\S=_P >8\O&SR_+V_:,[?+^3.=^.=V_YJ]PM%=442D,X4;F52BEL<D*
M68J">@+,0.,GK1=J[(PB(5RIVLREU#8X)4,I8 ]0&4D<9'6O#_\ AG:^_M?^
MW_[23[7YF[_CS'EXV>7Y>W[1G;Y?R9SOQSNW_-6W\7/@S>_$N*.VGOHXH8V5
M]J6I):0)M+%FN2<9+E5&,!L,7*AJZ7P9X1U#PU8K8F[AE:*..."1K5EVJIQA
MU6Y&_P"3"J08R,98N2:XKX/_ +/]U\,9GDM[])(IO+$T;VN-P0D@JPN,JP#,
M ?F7YLLC8&,^+X%:GX:UV76-'N(!%<LYF6X5V8"5]\JA4"[@& =,/&<@(QP"
MS=W\0_@_#\0+$6E^^ZX7<T=RJ*K1NQR=J@_ZKHOELQ)0+N<R 25XUH/[,OB'
M2G%M%JQ@LE9]OE2W(8*2S B$%$!9CE@), DG+$<^Z6/@-_#>G1Z9H\PMQ&I5
M998S<L-VXLX'F1KO+MOR<H#D>7MP!POP?_9_NOAC,\EO?I)%-Y8FC>UQN"$D
M%6%QE6 9@#\R_-ED; QVOQ7^%%K\2+4VUR-LBY,,P&7C8]QTRIP Z$@, .0P
M5E\0T']F7Q#I3BVBU8P62L^WRI;D,%)9@1""B LQRP$F 23EB.?;W^&L>F:+
M+HEA\JFTGAC,C$_-(KY=B >KN6;:,#)VJ!@5RND^$?$WA*&.RL;FQNH(XT5'
MN8IH9$"@(L8$#,K*%4$,Q+DDYX KI?A9\*T\"BXE>4W%W=S&6XG*B,.VYF $
M:DJ@&]CQDDD\[=JKYU\-O@/JWPUOISIMU;?89\ ^>DDLP"@F,E$\H%E+%<B5
M5927*9VJOO5I"8$5&8N54 NVT,Q P6.Q57)ZG: ,] !Q4M> ?#;X#ZM\-;Z<
MZ;=6WV&? /GI)+, H)C)1/*!92Q7(E564ERF=JKH?%3]GB[^)#Q&ZU$!(%98
ME%J-WS$;G=A,H9R%7<55$R,I&F2*[K5O".H:OILFGSW<+2RQO$\_V5AF-HS&
MWR"Y $I)+;@0G81=Z\_\+_LU3:+I]SH[WJ36=SEBIMF5TEVC9(K+<#HZ1L58
M,K!-HV[F)M_"'X<^(/!]N--GN;-;1=Y1XTDEN%WMN95WB*,<EF5G67#$ HZ?
M*,KX?_L\:AX,U:YO8;Q#!-'(GFR*TUV1(Z.Q.[;&)<J<2-YBD@,T)#%5U?CE
M\#+KQC>6VJZ9.D5Y;[ !+_J\([2QN,(_S!SR&4JP(Z;2']0\+VE[$F_498WE
M94RD,9CA0@$MMWL\C$DX+$@%57$:'<6VJ\5^/?[.<?Q#Q=V92&^&T,S9$<JC
M P^T,0RC[K@$D#8P(VE.5\._LQZIK,BCQ'J+W%K'(KB!9IY@Y 8<M+L\OJ!E
M0S%2P!0X:O5?B]\.+KX@VYL8[M+>V?89!]G\V1BK;@-YF0!<A3@+NROW]I*T
M?"'X<77P^MQ8R7:7%LF\QC[/Y4BEFW$;Q,X*Y+'!7=EOO[0%KF?CE^SA!\13
M]KMV%O>A2"^W*2@*0BR8Y!!P!(,D+P5<! O*^%_V;M7U)]GB#4Y)[3<A:W2>
MXE64 EMKF39M 8*> Q(S@HP#5W7[0GP8;XFVL:V[(EU!(3&TA<(5; D0[<XS
MA6!VL<H%& Q-$O@+6O%FGR6&L7D,1>,INLXVWO\ * &D>0J"K'/F1QQQ[A@"
M15+(:OP ^$FH?#NW:VNIX3&;AY=D*LQ8M&D8W22!<+\N=JQAMP4^:5+(>?\
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M[F.(\*53 C)4?,B.S*#\F\H !W_PJ^&<'PYLEL;<ESN+R2-P7D( 9L9(484
M*.@ R6;+'SKQI^SM?>+=0CU:;4D2XA\KRO+LP$3RVWK@/</GYR6.\MDDC[N
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M!:[47RVW$1C!63]UL:*8\EP7(.2%RH16KU71-$32$*J2S,Q:21L&21R "[$
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M(^9@%Y&2,C/2T4444444444444445%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/
M%<UX>^*>F>)+I["RN$FGCC\QA'N9-ORC(D \MN74$*Q(.01D''55GZ_K\'AZ
M![N[<1PQKN=VZ =.W)).  ,EB0 "2!1H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!
MP5(((!!%:%%9^OZ_!X>@>[NW$<,:[G=N@'3MR23@ #)8D  D@5S^L_%[2=%@
M2ZN;J-$DACEC!)\UHY,;'$0'FD'V7C!SC!QTVDZI'J\,=S VZ*6-)$;!&58!
ME." 1D$'! /J*M444445S^L>/['1KJ&PN)T2YN,^5&2<MV&3C"Y/RIN(WL"J
M98$5T%%%%%%%%%%%%%%%%%%%%%%%17=VEFC2RL$1%+,S$*JJ!DL2>  .23P!
M6)X:\?V/BB2:&QG2=H/+\PQDL@\P$IAP-C9VG.TG!!!P>*Z"BJNJ:M#I$;3W
M,B11+C<\C*B#) &68@#)( SW(%8GA#XD:?XQ>:/3YQ,;=E64J'V@L6"X8J%<
M'8V"A8$#.<$9Z6BBBBN?T?Q_8ZS=36%O.CW-OCS8P3E>QP<8;!^5]I.QB%?#
M$"N@HHHHHHHHHHHHHHHHHHHK*\3>*[7PO";F^E2&(9^9SC) +;5'5F(4D*H+
M'' -<_X.^-&D>,I#!8W2/+V0AXG;AC\JRJA? 4D[<[1R<9%=K17'^+_B]I/@
M\E+ZZCC<,JF,$R2@E=PS'&&=05YR0!R.>1GL******X_Q?\ %[2?!Y*7UU'&
MX95,8)DE!*[AF.,,Z@KSD@#D<\C,7@[XT:1XRD,%C=(\O9"'B=N&/RK*J%\!
M23MSM')QD5TN@Z_!K\0N;1Q+$S.JNO*DH[1M@]QN4@$<$<J2"#6A11111111
M111111111116?K.OP:*$:Y<())HXH\]6DD8*B #DDGTZ %CA02-"BBBBBBBB
MBBN \3?'S1/#4QMKJ\02KG<J+)-M()4JQB1PK @@J2&'<<BK^M_&#2-%B%Q-
M>P;"H9=LBRLR[S'N58]SN-X()4$ JV<;3CL*Y_PEX_L?%_F_8)TF\F39)M)X
M/8\@94X.UURC8.UC@XZ"BBBBBBBN*\8_&C2/!L@@OKI$E[H \KKPI^98E<ID
M,"-V-PY&<&N@\,^*[7Q1"+FQE2:(X^9#G!(#;6'56 8$JP##/(%2Z_K\'AZ!
M[N[<1PQKN=VZ =.W)).  ,EB0 "2!1H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!P
M5(((!!%:%%%%%%%%%%%%%%%%%%%<_K'C^QT:ZAL+B=$N;C/E1DG+=ADXPN3\
MJ;B-[ JF6!%=!111111111111111117/ZQX_L=&NH;"XG1+FXSY49)RW89.,
M+D_*FXC>P*IE@170444444444444445Q]C\7M)U&[CTZWNHY;B52R+$3*I #
M,<N@:,$!"<%@<8XY&>PHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJ*[NTLT
M:65@B(I9F8A550,EB3P !R2> *RM$\;V&O.8K.Z@G<*6*Q2QR,%! +$(Q.,D
M#/3)'K6U7/\ _"PM-\[[+]LMO/\ ,\ORO/B\S?G;LV[MV[=QMQG/&,UT%5=0
MU:'3MGGR)'YDBQIO95W.V=J+DC+'!PHY/854U#Q99Z=,EK/<0QSR;=D3R(LC
M;B57:I(8Y8$# Y/ YK5KYE_9%UM_%5[JNI70#7$C6YW<DJKF8F-2Q9@@V( N
M2,(@_A%3?'?X%Z7X4TS4=3M8MLTGV?:IP8X<W$0?REP-F[//)VC*IM0E3W_[
M+G_(NV?_ &\?^E$M=7<>%M+MM3COY$A7498V2-BP$KA5^<JI/S,$X+@%PGRE
MMG%=57/Z7\0M-U>18+:\MI96SM2.>)W. 2<*K$G !)QV!-:&OZ_!X>@>[NW$
M<,:[G=N@'3MR23@ #)8D  D@5POP)^)4GQ$M[J]?B,7\L<"[0I6)8XB@;!;+
M?,68Y/S$@$*% ]*KY%^,7AZVT'Q;I,5G#' A:Q8K$BQJ6-VX+$( ,X &>N /
M2OJ74/%EGITR6L]Q#'/)MV1/(BR-N)5=JDACE@0,#D\#FM6L_6_$-MH*"6\F
MC@0L%#2NL:EB"0H+D#. 3CK@'THT3Q#;:\AELYHYT#%2T3K(H8 $J2A(S@@X
MZX(]:\U^*GQI30;^RT>S<&ZGO;59Q@-Y<+R+N4DG"NX( &"0A+?*3&Q]:HHH
MHKG_ /A86F^=]E^V6WG^9Y?E>?%YF_.W9MW;MV[C;C.>,9KH*Q=;\;V&@N(K
MRZ@@<J&"RRQQL5)(# .P.,@C/3(/I6K:7:7B++$P='4,K*0RLI&0P(X((Y!'
M!%1:AJT.G;//D2/S)%C3>RKN=L[47)&6.#A1R>PJIJ'BRSTZ9+6>XACGDV[(
MGD19&W$JNU20QRP(&!R>!S6K575-)AU>-H+F-)8FQN215=#@@C*L"#@@$9[@
M&OEK]G>T2S\6ZI%$H1$6^554!551=Q * .  . !P!7TUI_BRSU&9[6"XADGC
MW;XDD1I%VD*VY02PPQ .1P>#S4NOZ!!XA@>TNT$D,B[71NA'7MR"#@@C!4@$
M$$ U5\%VUE:VD4>E^6;15*Q&)@\> 2&PP)W'=G<222V2Q+9J'5/B%IND2-!<
MWEM%*N-R23Q(XR 1E68$9!!&>Q!K;ANTG+*C!BC;7 ()5MJOM..AVLK8/."#
MT(KR7]H;=KWV#0(]_P#Q,+L>;M\L?Z/!B2;YGSAAE77 .=A'.=K<?^V?X>MH
M-.CO$AC6X>]B5Y@BB5E\F;Y2X&XCY5X)QP/05ZKX!\0VV@Z)ITMY-' ALK10
MTKK&I8P*0H+D#. 3CK@'TKM;2[2\198F#HZAE92&5E(R&!'!!'((X(JIK?B&
MVT%!+>31P(6"AI76-2Q!(4%R!G )QUP#Z4:)XAMM>0RV<T<Z!BI:)UD4, "5
M)0D9P0<=<$>M3:IJT.D1M/<R)%$N-SR,J(,D 99B ,D@#/<@5#-XAMH)ULWF
MC6X==R0EU$K+\WS!"=Q'RMR!C@^AK0KE?%'A;2[BZMK^_2'[3'(([>21@I+M
MDH@!(#MG+1J0Q5LL@#9-=56?%XAMI4EE6:,I SK,P=2L;(,NKG.$*CE@V"HZ
MXHT3Q#;:\AELYHYT#%2T3K(H8 $J2A(S@@XZX(]:\U^*GQI30;^RT>S<&ZGO
M;59Q@-Y<+R+N4DG"NX( &"0A+?*3&Q]:KG]4^(6FZ1(T%S>6T4JXW))/$CC(
M!&59@1D$$9[$&N@JK<:M#;21P22(LLN[RT+*'?:,OM4G+8')QG Y-0Z;XAMM
M4>2*WFCD>%MLJHZNT;9(VN%)*G*D8.#D'T-5=;\;V&@N(KRZ@@<J&"RRQQL5
M)(# .P.,@C/3(/I6K:7:7B++$P='4,K*0RLI&0P(X((Y!'!%96M^-[#07$5Y
M=00.5#!998XV*DD!@'8'&01GID'TK0LM6AO\>3(CYC20;65LH^?+?@GY6VG:
MW1L'!.#7E_A'XTIXRU^73K%P]G!92,S@#$DPFB4LK9.Y%5L*1@,2Q^==C5ZA
MJFK0Z1&T]S(D42XW/(RH@R0!EF( R2 ,]R!6?I?C>PU8,UM=02A6C5BDL;@-
M(VR-3M8X+-\J@\L>!DUM45S5W\3=*LW:*6^M4=&*LK7$2LK X*D%\@@\$'D&
MNEJK_:T/G?9?,3S_ "_,\K<OF;,[=^W.[;NXW8QGC.:J:?XLL]1F>U@N(9)X
M]V^))$:1=I"MN4$L,,0#D<'@\UJURNHZMH_BB3^S[B2SN95D;_1W:&9PZ!@W
M[MBQ#*-V>,@9SWKY_P#V&/\ F(_]NG_MQ7U57DO[0WQI3X>6ABMW']H3+^Y7
M ?8N<-*P)P !D)G(9\?*RJ^/2M;\/6VO((KR&.= P8+*BR*& (# .",X)&>N
M"?6OF7]AC_F(_P#;I_[<5]*Z%XLL_$&[[%<0S[,;_*D27;G.W.PG&<'&>N#Z
M5JUS^E_$+3=7D6"VO+:65L[4CGB=S@$G"JQ)P 2<=@37045RNC^%M+T;4)IK
M=(4U"XC$DH##S63=@N$S\JE_OLH =P"Y+ &N@U35H=(C:>YD2*)<;GD9409(
M RS$ 9) &>Y JIKOBRS\/[?MMQ#!OSL\V1(MV,;L;R,XR,XZ9'K6A=W:6:-+
M*P1$4LS,0JJH&2Q)X  Y)/ %>7_"#XO?\+%OM1\@YL[?[*MOE-C'<)O,D.<M
M\S*-H.,(%RJL6SZK7/Z7\0M-U>18+:\MI96SM2.>)W. 2<*K$G !)QV!-=!6
M5+XLLXHY)VN(1%#(8Y7,B!(W! *.V<*P+ %3@Y(&.16A:7:7B++$P='4,K*0
MRLI&0P(X((Y!'!%8FE_$+3=7D6"VO+:65L[4CGB=S@$G"JQ)P 2<=@3705S_
M /PL+3?.^R_;+;S_ #/+\KSXO,WYV[-N[=NW<;<9SQC-6]6\5VND6\E[/*BV
M\6_?)G*@JQ1EXSE@X*;1EM_R@;N*XKX$_$J3XB6]U>OQ&+^6.!=H4K$L<10-
M@MEOF+,<GYB0"%"@=KKOBRS\/[?MMQ#!OSL\V1(MV,;L;R,XR,XZ9'K4NF^(
M;;5 C6\T<HD5V0HZN&5&".R[2=P5F"L1P"0#@FM"BN?TOXA:;J\BP6UY;2RM
MG:D<\3N< DX56). "3CL":Z"OF77M;?7O'=M9W #0VJD1(<E0QM6N/,PQ*[]
MY&& !PB=U!KV#Q#\%M.U[48-8E0BY@96RAVK(R8\MI !EBA *D$$@!7W( H[
M6[NTLT:65@B(I9F8A550,EB3P !R2> *\O\ A!\7O^%BWVH^0<V=O]E6WRFQ
MCN$WF2'.6^9E&T'&$"Y56+9\:_;5\/6VEO92V\,<;S-=M*R(J-(V83N<J 6.
M6)R<G)/J:^I==\66?A_;]MN(8-^=GFR)%NQC=C>1G&1G'3(]:U:RM=\66?A_
M;]MN(8-^=GFR)%NQC=C>1G&1G'3(]:MZ7JT.KQK/;2)+$V=KQLKH<$@X920<
M$$''<$5:KR7]H_XP/\.;)?LN/M=PS)$6!(15'[R7&"K%=R@*Q )8-AE5E-3]
MG3X50:-90ZK<J)M0NE^T-.Y\QU$H)4*S ,I*/^\(Y9F8%F4+CT#QY\.K+QU
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M@9+$G@ #DD\ 5B:?\0M-U'?Y%Y;2>7&TC[)XFVHN-SMACA1D98\#N:Z"N?\
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MF\T:W#KN2$NHE9?F^8(3N(^5N0,<'T-5=;\;V&@N(KRZ@@<J&"RRQQL5)(#
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M6-YHU:!0JQ,R$1A ?D"C&[+MND9W;SK]COQTUKI]_%=/BULMLP8[V**ZR-*
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M7RA^QKX3L_$'V_[;;PS[/LNSS8TEVY\_=C>#C.!G'7 ]*U?VY_\ F'?]O?\
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M:")G!\S;C&<,&;&UB4+JUO\ :P\,6_@6\T_4-,C2WE^<A8XXTC#0/&\<FP(
M6S)\Q;((51C@Y]5_:C\)V?\ 8UY??9X?M7^C_O\ RT\[_71)]_&[[OR]?N\=
M*B_9E\$6%UHME>26L#7 :9A,T49EW+<2;&WE=V1@8.<C QTKA/VY_P#F'?\
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M().W>S[G+#<5KA/BYX8@\/\ B[3%MP_[R2PD=I)99G9OM+)DO*[M]U% &<
M8%=K^UWXF_LUM-M[@N;&6X=[N%#@RI$\!VY!4]&; W ;L,>54CI=?^%&A?$[
M3'.DQVJN5S#- J1%9=FY%D,:;@/F'F1LNX YVAPI$7QS\8":^L= \QUAN=\E
MXL44TLSP*"5B'DC?MEV2(^S+*HR<)N#XOQ%\#:%JNF2VUG83QSQPDV[1Z=>1
MRF1$/EJTC6V7#'Y7\PG.=Q(8!AM?#WQAJB>&;F>_2:&^M+>Z"23H1(_EQ&2*
M4K(@SC(7+!MQ0LQ))%<?^S-+H7BFT\B\B@FU0S2M,;E$EFF9BSAT,NYG&P?,
M%Y#*S,HW;F]E^%OPUC^'R7-M;_\ 'O)=M-"I8LRJT42E"2!T=&"\L=FW<Q;-
M=K7BOP!^&NI^'[K4-0UO8]U<2(J2[E=V5=VYE( V1-E-J?*0$ ,:A5%>=>";
MM/#?C>6PTQA'9S,ZR11D&(LML967'(4I,&P!@I\T8VJ2M;?[:/AB!+&&_P .
M9S=I'DRRLBJT,A8+&SF-,F-"2J@DC))).>U\#?!_3_$.CVSWD?G33Z9;1F:3
M;))&IA^00[E*1;-YVE%!) >0N^6/E7[(6DP^+;/4--OXTFM5D@D6-U4[7D26
M-W5L;E;:B@,""N,J022<_P" 7A*#P?XFGTC48XY945OLTCIN;>A6:-T 9TC+
M1?O,GYD*A0ZDLK>__$3P39>*M0L(;F".1U:6=V=1EH8%*>46'S$>?<Q/Y9_=
ML%?=V5O0+2T2S18HE"(BA550%55 P% '  '  X KBOC5X>MM4TJ\EN(8Y'AL
MKMHF=%=HV\ICN0L"5.5!R,'('H*\E_8Y\)V>HZ;)=3V\,D\=^^R5XT:1=L<#
M+M8@L,,21@\'D<URGQ<\,0>'_%VF+;A_WDEA([22RS.S?:63)>5W;[J* ,X
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M50JUYK\"] @^+DMWXAU=!</]I,5O#+^\CAC5-VP#B-QB8#YH^&4R??<D<_\
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M -?\G_HF"O?Z^5?C[_R.&D_]N'_I9)7U!JVJ1Z1#)<SMMBBC>1VP3A5!9C@
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M/ASX\G\9>$+Y[LEY8+:]@:1CN:0+;[U8\#D*X4D[BQ7<S$L:E_8I_P"0//\
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MB/XJO=*TVU(:XD:X&WDE5<P@2,%#,$&QR6P1A'/\)K;_ &UO^0/!_P!?\?\
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MVGAR%B#=3"6ZV[3LM83N<L=KF,M)M$3;=K.I4L!D&7_AESP[_P ^?_D>Y_\
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MR *K';'&3(Y("@  LI8&O(/VUO\ D#P?]?\ '_Z)GKU7X3_\@?3_ /KPM/\
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MRU\^)2NZ-\LIRH=V569&,>XY*8/7-:&F^.8M5OY+"V E$$.Z>59$98Y#(42
MJ"6WG9(6R!L"J#DN,?/7_-0_\_\ 0.KJ_P!M;_D#P?\ 7_'_ .B9Z]5^$_\
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MF^9U' /+*.I%:'QLT1]!\'-9RD%X+:PB8KDJ626!"1D XR.,@''85M?LN?\
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M;(R25R>P\ _"V'PI)+>22/<WUQCS[F7;O. ,H@4 1Q9&0@S@!5+$(FWC[O\
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MGRH8HK)77#!XY#$"[HRG!4,@QGJ=I7TJTM$LT6*)0B(H554!550,!0!P !P
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MBBBBBBBBBBBBBBBBBBBN/\7_ !>TGP>2E]=1QN&53&"9)02NX9CC#.H*\Y(
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M:O6J*RO^$LL_L_V[[1#]E_Y[^8GD_>V??SM^]\O7[W'6I=$\0VVO(9;.:.=
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MEXWJ[%F;>. 0QW ;5X  KYJ^,7AZVT'Q;I,5G#' A:Q8K$BQJ6-VX+$( ,X
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M2ESDL<L1DY).3U/6HOBYX4M?#?B[3$LHDA222PD9(QM3=]I9,A1\J_*BY"@
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M 4")B7A*D1[=@!17$@R ?E.TDN3X+_PB=G_PG?V'[/#]E_YX>6GD_P#'AO\
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M[&\'&<#..N!Z5ZA^U+X-M3H<LX0J;9;=8462184'G)&,0JPBR$=E!V9"G .
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MW+1;7+%$56A%I(6=EV@IGS& )&TKDKNX^JKN[2S1I96"(BEF9B%55 R6)/
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MS*RD,K*;N(A@1P01R"."*^KZ^5?VY_\ F'?]O?\ [;U] ?%C_D#ZA_UX7?\
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MSUZK\)_^0/I__7A:?^B4KY__ &&/^8C_ -NG_MQ1_P U#_S_ - ZOH#XL?\
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M->?_ +%/_('G_P"O^3_T3!7*?'W_ )'#2?\ MP_]+)*]5_:C_P"1=O/^W?\
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M5=\WF*=K'Y6:,N$)7=EF8^RVEL+5%C7)"J%!9F=L 8&6<EF/J6))/))->?\
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M3FXL9S:!V9GC\L2Q G'^K :,H,Y)&6'.%"* *[_X1? VR^&:,8,RW$BJ))W
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MG:#PSF/D-Y>]5>LF[_9V-KJ[:SIE])9F5BTT:QK+N+MF;!D8J WW@'20(_S
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MC @;0%=PFU H4! , @D?>KL/A]\-;7P+&Z6V]Y)9#)-/*V^>5B2<N^!G&3@
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MBW8QNQO(SC(SCID>M6]+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*M5E?\
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MW.0P# [D"D@!F1E] ^#_ ,'[7X=VL:)&ANS&//G^\[,VTNJN55A%N4;5P!@
MD%RS&7XJ_!VR^(T#1W"!)]H$=PJ@RH1DJ,\%DRQRA.#DD;6PP/@=-.VCVL=V
MH2:!9+=U7D V\KV^,AF!.(QD@X)R1@8%=!K?C>PT%Q%>74$#E0P666.-BI)
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MQIO95W.V=J+DC+'!PHY/854U#Q99Z=,EK/<0QSR;=D3R(LC;B57:I(8Y8$#
MY/ YK5JKI^K0ZCO\B1)/+D:-]C*VUUQN1L$X89&5/([BK5%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?.&L
M7<7QD\3/I$[%M.T^&5GARZK+,I$3L2OENI5Y=H.6&(SM^65JT/VA/@?:Q6+Z
MGI,*6UY:;90T \G,<99GP%9$5ESYF\ N=@0=1CL/@MXQ/Q0T5)+MR9@S13F)
MI;=MZ,&4AHV1@60HS;"%)8K@#*CYZ^$/P^CU3Q)J.F1N\-FGVM)(T)W20)<H
MHMRY.]5/R[V!W,@9,C>2/IKX9_!JR^'+W#V!DQ<LA9'8,J!"Y54^4-@;R/F+
M$@#)SDGL-6U2/2(9+F=ML44;R.V"<*H+,< $G !. "?05\]? O0(/BY+=^(=
M707#_:3%;PR_O(X8U3=L XC<8F ^:/AE,GWW)'/_ !U\*/\ !F]M]>T)1!'(
MS1S1C/E%R3)M*E^4=01L0*L?E@J58J1TO[7^J1ZOH-K<P-NBENX)$;!&5:WF
M93@@$9!!P0#ZBM#P1^SUI_BS2K6?5#)<7$ME!LEWO'Y,9B7RHHT5O+ 0'.65
MM[[G;.[:.*_9WOY_AOKUSX9N2721F\L]MZ(9$EP)"J"2#E@-S9$:G&TU+^W/
M_P P[_M[_P#;>O:_CIX8@UO2;MIPY\JTN)$42RHFY4+J61'59,,BD!PP!' Y
M.?/_ -BG_D#S_P#7_)_Z)@K$\9ZV_C+QC!HE\!)86[;E@YV,_P!D,X>09^<A
MC@ _+M&W;\S[IOVVO#,+V=MJ&,3I<>1D!?F1T>3#'&X[63Y><#<_&6R.UL_#
M$\_AL2:)'#;ZA=6%J[/%'%;EV*(S\HBJK%6<(?E",V04^\+7PR^&$/AWP\NF
MZQ'"%,<KW8)4)\S,^YW&/F1 H+@_*4!5\*K5YA^QO<GQ%:7VFWN)[2)K=DAE
M59(U+F5FP&!X+(K8Z!LL &))Q/@EX3L]1\5:I:SV\,D$?VW9$\:-&NVZC5=J
MD%1A20,#@<#BO4/VI?!MJ=#EG"%3;+;K"BR2+"@\Y(QB%6$60CLH.S(4X!P!
MB'X-^,8_!G@^+4)AE88[DA>1N8W,JQID*V-SD+G!"YR> :J_L^_#BU\6V7]N
MZNB7MY>23%GF3>%57\L($8F/@Q94A5*JWEKA1SQ7BNS;]G_7H)[)O*TN\\L2
MH=\B!4*K,""[R,R!O-1^""Y10R[U;TK]K#PQ!>Z-/>2!S+#Y'E_O91&I,RH6
M\L.(BVV1EW%2V#C/ QG_ +.7PZLM<T6SN;Z(7+!;E8UF DBC4W#[@D9&P$LN
MXN09#G;OV!57BOV7(3X=\0ZGI4+$VZ+.,-M+,8+A8XV)"CD*[9Q@$G..!@\(
M>+],U/Q'J:>(S'(XFDAM7N0AMXXXI9 8_G_=H2 I5B.2'^;>Y#^X:%\'[7PW
MJQU2PC2%)+22&6-/E3=OA:-T15VK\J,'P0"=I"Y+L>_KY%_;5\/6VEO92V\,
M<;S-=M*R(J-(V83N<J 6.6)R<G)/J:^A?$4NG_"RQN=0@MH852,%EBC6+S&!
MVQ(3&AZNX4$@A=Q)XS7FO[/OPXM?%ME_;NKHE[>7DDQ9YDWA55_+"!&)CX,6
M5(52JMY:X4<\5XKLV_9_UZ">R;RM+O/+$J'?(@5"JS @N\C,@;S4?@@N44,N
M]6^M*X7XU>'K;5-*O);B&.1X;*[:)G17:-O*8[D+ E3E0<C!R!Z"O)?V.?"=
MGJ.FR74]O#)/'?OLE>-&D7;' R[6(+##$D8/!Y'-9/[<_P#S#O\ M[_]MZ]0
M^,'PHL+G2+V22,/<I;2RFZ98S=,\:^:"9-F0"5VE5VJL9\N,(@4#BO@A\59=
M)\)W%Y<,";%I8H2P=\G9&8$;!)(\R41C&T*@4< %JT/AQIVDW5JE]JEM->WU
MU&DL\\NG7DX);+*J9@DB555@@,6$954@8V@97P=L[GP=K\]E86]X-%N-S(9H
MIXXXW$0DWYFB5A\RM",E2P*%F<JI/TI7RW^W+=NJ:?$&(1FN69<G:640A6(Z
M$@,P!Z@,<=37O7PG_P"0/I__ %X6G_HE*ZJN?\?^,8_!EC/J$PRL,9(7D;F)
M"QID*V-SD+G!"YR> :\@_9]^'%KXMLO[=U=$O;R\DF+/,F\*JOY80(Q,?!BR
MI"J55O+7"CGBO%=FW[/^O03V3>5I=YY8E0[Y$"H568$%WD9D#>:C\$%RBAEW
MJWI7[6'AB"]T:>\D#F6'R/+_ 'LHC4F94+>6'$1;;(R[BI;!QG@8J?LX> [/
M6M"M);V)+D_OPBS(DJ1@3R@K&K+A<GYF;EV. S%4C5/,/@%X50ZWJF@F23["
M%N%DC#!&E6&?R8U=T"N!MD8L(R@<\-E"5-K]K+P];>!KG3;W2X8[:8-*V8D5
M%W0M"\;% -A(9CR5R1@-D  >H?M8>&(+W1I[R0.98?(\O][*(U)F5"WEAQ$6
MVR,NXJ6P<9X&.:^!?P;L?&VBVD^JJ9PJSK#'OEC2-?M$Q<X20;G=C\S<#:L:
MA04+/Q_@RSD^!OBE=-#/)9WGEHN<%F65ML+E5<+N24%"Q&=GF,J#>!7JNL?#
M74]:\4PZC<[)-,MXRT(9E(1C'MVA,9\WSL2;R,;57]YN54'G7[7=VGA74;'4
M=/80ZAME:1T($A5=BQ,Z]""-Z988=04;<JX'HO[6'AB"]T:>\D#F6'R/+_>R
MB-29E0MY8<1%MLC+N*EL'&>!C/\ V<OAU9:YHMG<WT0N6"W*QK,!)%&IN'W!
M(R-@)9=Q<@R'.W?L"JOG_P"SCH<5IKNJZ(ZB:R"S!HY420.;>Y5(6;*X) 9C
MP "3G&0N,JQ^'UIX \71V%[#')97#'R!*ID4+,&6$!=SY*RCR<R@C ,A"G:R
M_2'Q@\*6OBB.VL[F))'FNXHT9ARJJ?M-P X^=-\-NZ93DL5!(&67M=+TF'2(
MU@MHTBB7.U(U5$&22<*H &223CN2:M45\8?%&[>?QQ"KL6"7NFJ@))"KB!]H
MST&YF; XR2>I-?9]%<!\=/B-_P (!I<MTAQ._P"Z@_ZZN#AN59?E4,^&&UMN
MW.6%<I\(_@?IEUI<5Q?0I=7-[;K+/-*&>0F8-)P69BC 2;2Z%68@.?FQCS_P
M=<S?!KQ.=&W[=-O9-T2$,X'F!EA*X9V5A*!"6;[ZC>XQL9=;]M'PQ EC#?X<
MSF[2/)EE9%5H9"P6-G,:9,:$E5!)&222<]KX&^#^G^(='MGO(_.FGTRVC,TF
MV22-3#\@AW*4BV;SM**"2 \A=\L?-/V,576[74-/NE26U$EO)Y4B(Z;GW[B0
MP.?]4F <@%00 <DY7_")V?\ PG?V'[/#]E_YX>6GD_\ 'AO^YC;][YNGWN>M
M?5^B>'K;04,5G#' A8L5B18U+$ %B$ &< #/7 'I7S+^PQ_S$?\ MT_]N*RO
MBYX8@\/^+M,6W#_O)+"1VDEEF=F^TLF2\KNWW44 9P !@5[5^T%XVFT:W@TZ
MQD\N^U&X2WA?++L!91))N"-C&Y5XPXW[TY2M;2_@)HNGVJV7V.&11&4,DB*T
M[9SN8RX#ACDD%2NWC9M  ',_!_X(3^&()].U=H+VR$RO:1NGF!#^\#L4D0A"
MP8':K, 2^#EF+>2_L:^$[/Q!]O\ MMO#/L^R[/-C27;GS]V-X.,X&<=<#TKI
M?VA/%\%CXAT^VU8E]+CA6:2'&Y/,9IXUD91@N%*J2IW?*' 4[V5O1=5^#^D^
M)1::AI4=LCV]W!-'+;^6D3JDR><C&)2K_*K;>ZN -R@N#ZK7C7[4?Q1?P3IP
MAMG*75TQ2-E)#(BX,K@[2,X*H.58%]ZG*5K:'^S?HMA9+8S6L<I*IYDQ#"5W
M 7<X?>9(PQ7.Q'"C)&,$Y\O_ &>==NO FLW'A6]EW0KYAMP1D[AB4%=K,$5X
M2TA1B0&& 0Y8-S_[97A.S\/_ &#[%;PP;_M6_P J-(MV/(VYV 9QDXSTR?6O
MJ71/!%AH+F6SM8('*E2T44<;%202I**#C(!QTR!Z5M5\U_MH^&($L8;_  YG
M-VD>3+*R*K0R%@L;.8TR8T)*J"2,DDDY]5\&>&(/$N@V%M=!S$UA:[E266'<
M#;JI5C$Z%E()!4DJ>XX%?/7['WA"#Q.+Z.[!DA5K-C#G$3L&F9#(!@N%*\(Q
M,9SET8A"MKXAZ'%X$\9:>VG*(1.UH61418U$DC6TBJH4!0T:G/4[F9@0<8/V
MU?#UMI;V4MO#'&\S7;2LB*C2-F$[G*@%CEB<G)R3ZFOH#Q:]E\+M.N[^S@@M
MRL)(V0A%>3E8%<1!209' ZC 8G*C)KSKX<:=I-U:I?:I;37M]=1I+//+IUY.
M"6RRJF8)(E558(#%A&55(&-H&5\';.Y\':_/96%O>#1;C<R&:*>..-Q$)-^9
MHE8?,K0C)4L"A9G*J3Q/QR\'KI'BBPAL7>*6;[&WG2/)=.)3<-&LA\]W+;0B
MX4G;A0.*]5\3_";3/A<LGB6%YOM5K;R$&5VF2:>1'B627Y2Y9WD&XHR+GG"C
M)JK\.-.TFZM4OM4MIKV^NHTEGGETZ\G!+9953,$D2JJL$!BPC*JD#&T#*^#M
MG<^#M?GLK"WO!HMQN9#-%/''&XB$F_,T2L/F5H1DJ6!0LSE5)S_%WB^R?QC)
M;Z^1)9Q0I';+* UO%)+%"Y=U/RX.6!=@V"4+85 R>M1_!_3S?V.LZ7'#%Y7F
M;O)VI%+%)!*JL%C7:S;G4A@1E"V2V$ \*^-OA.ST[Q5I=K!;PQP2?8M\21HL
M;;KJ16W* %.5 !R.1P>*^K]$\/6V@H8K.&.!"Q8K$BQJ6( +$( ,X &>N /2
MK=W;"Z1HVR RE259D;!&#AD(93Z%2"#R"#7R5H.@Q:#X^%O;@A SM\SO(Q9[
M%I'8M(S.Q+L2223DUTW[:/AB!+&&_P .9S=I'DRRLBJT,A8+&SF-,F-"2J@D
MC))).>U\#?!_3_$.CVSWD?G33Z9;1F:3;))&IA^00[E*1;-YVE%!) >0N^6/
MFG[&7BG^S;/4OM#[;6W\J<_+G;E)?-;Y06/RQ+QS]WY1DG/:_!KPA#\1EE\1
MZO&EQ)=22+;Q2[9HX+=)"JQA615#;E;+ '(PW#/)NMZM\!YM+UJVU?0GAM(1
ML6ZA4-&KH&&\*JJR'<G&W" .JR [SN7*_;6_Y \'_7_'_P"B9ZU=;\*6NN^$
M8GN8DD>'15DB<CYT9;97!5OO+\R+D X8## C(K%_8UM$O-$N8I5#H][,K*P#
M*RF" %2#P01P0>"*XG0= @T#Q\+:T011*SLJ+PH+V+2-@=AN8D < <*  !7;
M?'C6'\;ZM9^$H7"Q2LDUTZR$/M4.YA( 8 B-/,4.&#,8FPH7+;_Q;^#&G6NC
M7)L8([66WMI'2:--LNV.-MZ,ZE7<21[HWWLP.[<P8BN:_9 U2/2-!NKF=ML4
M5W/([8)PJV\+,< $G !. "?05%\++NP\81'6M=@DO+RX:0#_ $&\N+>&)7VI
M#&%CEA(!0MN'S@NRLQ;<6S]-L9?!_B2*?0;2\&FW?EK=(;>XA@5G=U) EA7:
ML>5E'89=%948J/I^BN5^+'_('U#_ *\+O_T2]?.O[+_PJM_'&FRMJ3/+:I=N
M([8,T<8E\N+=.QC96=MI"*"=J#>0"7.,GQKX?_X9[UZVO[/>;&;<2F<G9D+/
M!_K%+[0RO&7P-VS<7*,QZO\ :^^$<*6ZZS9Q)&Z2$7.Q53>)&^65OF +"0X)
M"EV\S+'"5[!\&H;'5=%MVM8(4@GMP)8TC(C9]HBF5@^6?YE*%G+%P,EF')A^
M"_@FRTJU%_;01QO=M+.'50'$,\AEABS_  !8O+!C0^6&4D9^\?1:^1?VQ/A5
M!I!CUFU41F>8QW"@X#2%2ZR!<8!(5_,.1D[3M+%V/N&N^!])\;Z*N88;>V>T
M,L#M''']F$JB7S!M*A,'#2 ,%;!#$J37E7[%T\-O]LLIH4COH9,EV"K<%&PD
MD6"H<*CQ@L,X#.,@'&?6O"O@FRN=6N]6C@C5XV%O&ZJ &< R7,X(PI=GE,#G
M!93"ZE_F=!S7@CX:ZFGB2\U?5-DD C>.T<LK%5=P4"*!F/9'N1R0I+.Q!<,S
M'SKXD7:>%?&=F=,81/<-:K=B,C#--.5D5UY +1[&(P#DK+]\AJT/VOOA'"EN
MNLV<21NDA%SL54WB1OEE;Y@"PD."0I=O,RQPE>P?!J&QU71;=K6"%()[<"6-
M(R(V?:(IE8/EG^92A9RQ<#)9AR8?@OX)LM*M1?VT$<;W;2SAU4!Q#/(988L_
MP!8O+!C0^6&4D9^\?1:^>_B_KX\=:]9^%@Y6V#>;>*-P$A5#.L)QL;&Q =RN
M1F0-C?$*W_BC^S?IVLZ<\.GVL<5U%"?L[(-K,R[3L<[T#EPFS?*6*EB^<YSG
M_LU>.?\ A9>ERV>J[+F2WD1'61-^^(@-"TF\%7;<K#/WOD#-\QW-YK_PB=G_
M ,)W]A^SP_9?^>'EIY/_ !X;_N8V_>^;I][GK7U?HGAZVT%#%9PQP(6+%8D6
M-2Q !8A !G  SUP!Z5-JVJ1Z1#)<SMMBBC>1VP3A5!9C@ DX )P 3Z"OGKX6
M7=AXPB.M:[!)>7EPT@'^@WEQ;PQ*^U(8PL<L) *%MP^<%V5F+;BV?IMC+X/\
M213Z#:7@TV[\M;I#;W$,"L[NI($L*[5CRLH[#+HK*C%1W7[0WP(3Q[;&>RCC
M74$;>'P%:90NTQ,V0,X"[&?(4J%RBLS#E?@!\3K;Q;I/]C26<<D\"QQB#:OD
M3+DL)G#!M@5EW3N58;RI0/+*D5>J_"KX.V7PY@6.W0//M(DN&4"5R<%AGDJF
M5&$!P, G<V6/'_ 'X:ZGX?NM0U#6]CW5Q(BI+N5W95W;F4@#9$V4VI\I 0 Q
MJ%45YUX)NT\-^-Y;#3&$=G,SK)%&08BRVQE9<<A2DP; &"GS1C:I*UG_ +:?
MAB#3)K.YC#^;/]I\QGEEEX4QLJJ)'8(H,C$*@51G@=*]E^,'PHL+G2+V22,/
M<I;2RFZ98S=,\:^:"9-F0"5VE5VJL9\N,(@4#A?V5_#,/C'21_:(^T16MW*D
M$$@4P)E%=F*  2,3,V#+OV<>7LRV<3PK:)X3\=R6=BHA@D5E:-0-NUK47!49
MSM'FJ& 7  &T87Y:ROC/X6CT'Q7IR69*O*UBY>5YKDF3[2T:LQDE+L J*-H=
M>!@$=:]*^(O[*6GZC92M8K)_: 4N)GE>1YY "2)/,<)F1NK#9M8AON@J3]C_
M .(#^(=.>QFR7LF558Y.8I-QC7)8DE2K*!A55 @&<&N/^ 7_ ".&K?\ ;_\
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M@&VCR3]AC_F(_P#;I_[<4? +_D<-6_[?_P#TLCKU7]J/_D7;S_MW_P#2B*N
M\,>&9O$O@(6ML-TICF=5PQ+>7>/*54*"2Q"$* .6(''6NE_9 \4)JNBBU& ]
MK-(C#<"Q5V,RN5P"H)=E'4$H2#U Y3]KK1'\57NE:;:D-<2-<#;R2JN80)&"
MAF"#8Y+8(PCG^$UZ+^U'_P B[>?]N_\ Z414?LN?\B[9_P#;Q_Z42UY5\ O^
M1PU;_M__ /2R.O1?&7P?TCXQB:Z3,-W'-- \R%=X>!GBQ(@)5A]UAG;(T?EC
M<JX%<!\&XM1^%GB!?#EU*9K6>&1H/G_=A1YDJRJAW%"2DBN@*@L2Q+A48_4E
M?*O[<_\ S#O^WO\ ]MZ]K^/GAF;Q+HEY:VPW2F-75<,2WER)*54*"2Q"$* .
M6(''6N/_ &0/%":KHHM1@/:S2(PW L5=C,KE< J"791U!*$@]0.4_:ZT1_%5
M[I6FVI#7$C7 V\DJKF$"1@H9@@V.2V",(Y_A-?35<K\6/^0/J'_7A=_^B7KR
MK]BG_D#S_P#7_)_Z)@KE/VY_^8=_V]_^V]?0'Q8_Y ^H?]>%W_Z)>OE_X=:7
M)J?@C5(X5W,+LR$9 ^6,6LLAY(Z(A..IQ@ G KV7]F/XJP>+-.BL2P6[M(5C
M>/&W,:82.1<D[AMVASQA\Y559,^BZKXQCLKVWTY1OGGWLRC),<2HY\YL*0%,
M@6,;BNYG^4DJ1705XA^UI\.W\4Z8+J!0TMFSRDEBI\G8?. 'W2?E1N><(0IR
M=K:'[+/CI?$VC10L^Z>T_<R [ 0H_P!20%.=OEX0,0"S(_4@D^OUYA\=K1_%
MNEWVFV:F29(4D; )4,CQS"'Y<L9G0$HB@D J7*"2,OS_ .R!XH35=%%J,![6
M:1&&X%BKL9E<K@%02[*.H)0D'J!RG[76B/XJO=*TVU(:XD:X&WDE5<P@2,%#
M,$&QR6P1A'/\)KT7]J/_ )%V\_[=_P#THBH_9<_Y%VS_ .WC_P!*):\J^ 7_
M ".&K?\ ;_\ ^ED='[<__,._[>__ &WKU7]J/_D7;S_MW_\ 2B*C]ES_ )%V
MS_[>/_2B6O-?B=IS>+?&MC!:?,UI';/.2'VH(Y7N#DA3U1T"G[I=U4D'..EM
MOB+/\2]?FT6&62ULK-93-Y9V3W#Q31HR^8IWQ)O/'ED,R!@Q!<"/SK]L'PI:
M^%X=-MK&)(8A]K^5!C) MEW,>K,0H!9B6..2:]J_:C_Y%V\_[=__ $HBH_9<
M_P"1=L_^WC_THEKRKX!?\CAJW_;_ /\ I9'78?M@?#]_$.G)?0Y+V3,S*,G,
M4FT2-@*22I56)RJJ@<G.!6W\ O&,GQ&C75;@?/!;K:<X!\W(DNI %55VR*+<
M@$?(R.J@#+2>OT45\B_M:^$)_#6HP>(;0! S0@OG<PN(\M&Q1\C!C1<8!7*'
M< 2-WU+X4\30^*+6*^MCF*:-77E21GJK;2P#*<JP!.&!':M6O!?VG[1_&FA-
M<6:EHK>Y2;=@GS8E1T:6,+N)0&3.YMJE$:128RC/VO[/?BA/$6AV;I@&*%8'
M4,'*M"/+YP!M+*JOM(R PZC!/E7Q4T1_$_C/3XK4AC;PVTLV,D1K%/),P?:&
MVDJ5"[L ETY 8&MO]M;_ ) \'_7_ !_^B9Z]5^$__('T_P#Z\+3_ -$I7S_^
MPQ_S$?\ MT_]N*/^:A_Y_P"@=7U57RK^PQ_S$?\ MT_]N*/C[_R.&D_]N'_I
M9)70?M?^=H_]F:O#L/V2[;"MN.7;9+'P,97]P0WS \C'4D>X>#O&-MXOMDO+
M-PZ.JD@,K,C%5<QOL9@K@,-RYR#53PGXYB\4RW"VH#V\#1H+A9$>.21D\R15
MV%N$5H\L<99F4#Y"3\]?L,?\Q'_MT_\ ;BO:_'WA;2_B),VD7Z;IXK=9XV#!
M)%64R1%HR#N.UD!<,ICR8MP8X ^=/&/@.^_9VNH=2L+AY;&2X4.FX1EL;R(9
M%^97S%NVRA?E;<P1#LW?95?-?[;7AF:]M;2^C&8K>25),!B5\WR]C' ("YCV
MDDCYF0#.>/>O!/BA/%5E!?QX FA1RJL'"L1\Z;@!DJV5/ .000#Q7S_H.B/K
MWCNYO+<AH;5097&2H8VJV_EY4%=^\G*D@X1^ZD5G_MS_ /,._P"WO_VWKZJH
MKP#]M;_D#P?]?\?_ *)GKU7X3_\ ('T__KPM/_1*5\__ +#'_,1_[=/_ &XH
M^/O_ ".&D_\ ;A_Z624?MS_\P[_M[_\ ;>O8/VD=+DU/0+V.%=S"-)",@?+'
M*DLAY(Z(A..IQ@ G K$_9C^*L'BS3HK$L%N[2%8WCQMS&F$CD7).X;=H<\8?
M.5563/HNJ^,8[*]M].4;YY][,HR3'$J.?.;"D!3(%C&XKN9_E)*D5\Z_'W_D
M<-)_[</_ $LDKV#]I'2Y-3T"]CA7<PC20C('RQRI+(>2.B(3CJ<8 )P*Q/V8
M_BK!XLTZ*Q+!;NTA6-X\;<QIA(Y%R3N&W:'/&'SE55DSZ+JOC&.RO;?3E&^>
M?>S*,DQQ*CGSFPI 4R!8QN*[F?Y22I%<AXW^'>D?%F6>VN5(NK-DB:1&5)E5
MTCG4C[P9"&*KYBD!A+L .6/BGAWP]J/P&URRL_/,]A>S", 'RT=G,<;L8R7V
M.C,C;ARZ@*'&75=#X^_\CAI/_;A_Z625]545\J_\U#_S_P! ZNK_ &UO^0/!
M_P!?\?\ Z)GKU7X3_P#('T__ *\+3_T2E?,O[)^B/KUAK=G$0'GMHHE+9"AG
MCN4!. 3C)YP"<=C7=?L??$N&]L?[(E9$G@D;R5)56D1R\IV@N6=E8.6VJ J;
M.IR:]E\3>.8M&GM[) );JXF15A$B*ZQG>TDY#'=L5(W/ .Y@$'+9'DO[:W_(
M'@_Z_P"/_P!$SUU7_,G_ /<!_P#;.N5_8I_Y \__ %_R?^B8*Y3_ )J'_G_H
M'55\::BO@WQU'>WOR02^45?*8VO;?9?,8E@%59 VXM@A5+ $8S]"?&*[2UT:
M_:1@H-E<*"Q &YHV1%Y[EB% ZDD <FO$/V;-+DU?PKJ5M NZ662\C1<@99K6
M)5&20!DD#)('J:T/V0/BK!=V@T29@EQ"TC0C&/,C8F1L$D[G5F8D87Y,$!MK
MD>W^*_&,?A]H(B-\]S<1Q11#.]@77S9 %5CMCC)D<D!0  64L#7045ROQ8_Y
M ^H?]>%W_P"B7KRK]BG_ ) \_P#U_P G_HF"L3]JW2QXOU/2=(B8^<[2[]J,
MY2.5XU\W P" (I&(R,!"6VC!KZ*\0Z(FO6TUG*2$GADB8K@,%=2A(R",X/&0
M1GL:^1?@K>76@W5UX-NE_P"/BX /\*;5P;H9*"0K-:H1&XP0=A4+O+K]E45Q
M_P 7O"!\8:3=6* EY(28PI529$(DB7+?* 750<XX)Y'4>%_LT^+QXJT^+P\Q
M ,4TLDP 8;K562382<JQDGE\MTQM:W$JMM8J6R?&.I/\(?%SW5O&9$O(6<01
M9>21I@P"'>"5+7<8;Y,D*0%!_P!77U+X4T+^P;6*U+;VCC4/)C:9'ZR2L,GY
MG<EV)))9B2222?$/AYXQ?X\W=X)GDATNW6-5M$8QM-YHE7=-)&P?&T',2ML)
M* EMA,G'_&G28=(\5Z/!;1I%$OV':D:JB#-[*3A5  R22<=R37U)XAT1->MI
MK.4D)/#)$Q7 8*ZE"1D$9P>,@C/8U\B_!6\NM!NKKP;=+_Q\7 !_A3:N#=#)
M02%9K5"(W&"#L*A=Y=?LJBOE#XC,_@3QK;ZI<@?9[EHMKEBB*K0BTD+.R[04
MSYC $C:5R5W<?55W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5\X?L2^&9K*UN[Z
M08BN)(DCR&!;RO,WL,@ KF3:""?F5P<8YR?^:A_Y_P"@=7U57/\ Q"TN35]-
MO+:!=TLMI<1HN0,LT;*HR2 ,D@9) ]37B'[('Q5@N[0:),P2XA:1H1C'F1L3
M(V"2=SJS,2,+\F" VUR/;_%?C&/P^T$1&^>YN(XHHAG>P+KYL@"JQVQQDR.2
M H  +*6!K0UO6TTA S LS,%CC7!DD<@D(H) S@$DDA54,[LJ*S#Y@^-O@:]^
M'5W%XMLS&)3-FXB2,M#&[AESG W(ZG9([>6S2MYB[3*$C]Z\-_%>UUW23K49
MS'';O)-&AW.C1IODB^;9EAT&=H888?*P->=?"*[?XVI/J.JL6M4N3'#8*2MN
MNP0RAI=NTW!SMXD!0'>0F&"IQ5I:)9_$!8HE"(BA550%55&FX"@#@ #@ < 5
M+^W/_P P[_M[_P#;>OH#XL?\@?4/^O"[_P#1+UY5^Q3_ ,@>?_K_ )/_ $3!
M7*?\U#_S_P! ZCX^_P#(X:3_ -N'_I9)7U!JVJ1Z1#)<SMMBBC>1VP3A5!9C
M@ DX )P 3Z"OG7]B7PS-96MW?2#$5Q)$D>0P+>5YF]AD %<R;003\RN#C'.3
M\ O^1PU;_M__ /2R.CQ9XU_X5EXTEO;Q=MK=6\2LX&]A$8XT\P!6R,30X8$%
MM@;:I)6OJ#^UH?)^U>8GD>7YGF[E\O9C=OW9V[=O.[.,<YQ6?X-\3#Q/:I>(
MA1)&D\O<&!:,2,L4N&56 D0+( 1P&'7J=JBO!;;XBS_$O7YM%AEDM;*S64S>
M6=D]P\4T:,OF*=\2;SQY9#,@8,07 C\Z_;!\*6OA>'3;:QB2&(?:_E08R0+9
M=S'JS$* 68ECCDFOK^BOE7]AC_F(_P#;I_[<5TW[9]R+BPM+%,M<37JM%&JL
MS.%C=&Q@')W2H .I+< X..)^)\T_PFU;0[Z=0Z6^G06[E?F#&,/'<! 61LA)
M@4+;021GHP'U5H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!P5(((!!%9_@[QC'XK6
M:6W&8([AHHY1DI,%1-\B$J 5$A>,%2RL4)#$' ^=?V&/^8C_ -NG_MQ7O7CR
MQT[Q(\.CZG&)!<+++$K';EH#'N"L&5P^V3(V<E!)D[<@_-?Q/^!=W\&A_;6B
M7<@B1D$@)"RHI9-NXC"3(T@&Y"H RH*N-S"7]H'5)DO-&\5>5F![>T?RPS?*
MZ/\ :?+9]FT;E?"G&3M<[<+S]=6EVEXBRQ,'1U#*RD,K*1D,"."".01P17S5
M^SEHCZAXAU?58B&M?.NHED&2KM)<"4%& *, B9;!R Z'!#9K/^/O_(X:3_VX
M?^EDE>J_M1_\B[>?]N__ *414?LN?\B[9_\ ;Q_Z42UZK111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111117G7Q
M=^!ME\3$4SYBN(U81SH!N (.%<$?.@8[MN00<[67<V<5?@;>ZS&MIK.JS7EF
MGEGR%B2W+E""HDE5GDD7 .X$ABV'WAE!KT^YT<&#[-;.;8*JJC1+$"BKC"JL
MB/&!@;<%2 .F#@CS#PW^S1;>&KHW]K?7R7+;]\AD@<OOY;>'MV#Y/S'<#\P#
M?> (]?HKR#QK^SG#JM\NKZ9</87PD#LZ(LD;'#;F,9*_,V0'^;8XW;D8NS'5
MT+X.,]U%J&LW;ZA<V^[R-T<<$$>=I#B),@R@@_.3_=^7<B,.J\=>!;7QQ:O9
M7J;HVY!'#HPSMD0X.&&>#R""58%20?-?#?P$U'PU&;*SUB:.Q,CGRA!&951S
M\RI,S$HV.C(J@.2X0$FO2O O@6U\#VJ65DFV->23R[L<;I'.!ECCD\  !5 4
M #BOB'^SQ;?$"83W]W>-MW"-%>!8XPQR551!]!N;+D!0S' K;U?X6-JUE_9T
MVH7K1%2KMNMQ*Z80;&<6^XCY3DYW/O<2,X( J?#/X)P_#DD65U=&)FW/#(T+
MQ,VTKNP(0RGIDHREMJAMP %>=77PUT_X]7USJ!_=6UO(UJ)(&7SKB1 I,S,0
M\7E!2%BP"[J<LX5406_^&*='_P">]Y_W\A_^,5%\-?A^?'OA^YTB]G,L45[-
M%976Q6_=P[1%+&3G<F[>O#'Y"T2N !CK_!WP5N-,M3IVH:C-=V0C\M8 BVXV
M?-E&D4O.5Y "K(@"C80T9VU5^%'[/"_#R:9XKR9X99(V$05(\B,N8Q(XR[XW
M#.PQ*^"'5D8H(;O]G8VNKMK.F7TEF96+31K&LNXNV9L&1BH#?> =) C_ # 8
M"JO3>-?@\GC&W6RN;R\$ P717B'F.&9R[EH68_,V0@*Q+M79&H5<6OAK\+4^
M'T?V>VN;F2W^8K#,T3HI8@EE*Q(XZ'Y0VS+,VW<<UQ5[^S4NF7QU/0;Q].E;
M?O18DFAPP&55&* +D%MK;U#;2@38HKJ_!WPD72;HZIJ$[WVH&/RQ/(J1I&HW
M#$42#;'E3ACDDG<05WN#:^)7PM3X@Q_9[FYN8[?Y2T,+1(C%22&8M$[GJ/E+
M;,JK;=PS47@#X3KX%@:TM+NZ,)5PB2&!Q&SX.],P9!!R0IS'DL2A))KG]&_9
MRM]%O7U.VO;U+J1I&D<-;88R$L^4-ML(+<X*X! ( (&!/@?=:5+/=:9J<]M-
M<W,\TBF..>VQ*Y? A?@.!L7S-Q)"G@!L+M^#OA(NDW1U34)WOM0,?EB>14C2
M-1N&(HD&V/*G#')).X@KO<'OZ\Z^-/P6@^*,$<<DAAFA8F*4#> &V^8I3<H8
M$*.X((!!QN5MOP+X/N- C07M[->2I'L#.%C0#(YVIRS$*H+RM(^02K+O<'S^
M]_9J73+XZGH-X^G2MOWHL230X8#*JC% %R"VUMZAMI0)L45U?@[X2+I-T=4U
M"=[[4#'Y8GD5(TC4;AB*)!MCRIPQR23N(*[W![^JNK:7'J\,EM.NZ*6-XW7)
M&58%6&001D$C((/H:\D^''[/4O@9YHX=2G^Q2L2;=42-NN!F7+,I*?*SPB%R
M=K!E**!H?$/]GBV^($PGO[N\;;N$:*\"QQACDJJB#Z#<V7("AF.!72W?P\:\
ML&TV6]NG1U*-(WV=IFC,?EF(L;?!!')<CS2W/F=JROAG\$X?AR2+*ZNC$S;G
MAD:%XF;:5W8$(93TR492VU0VX "N \>?L;V6O3FXL9S:!V9GC\L2Q G'^K :
M,H,Y)&6'.%"* *[_ .$7P-LOAFC&#,MQ(JB2=P-Q  RJ #Y$+#=MR23C<S;5
MQZ+17C7B_P#9ALM2G-]IDLFG7050K6^$B4_=9MB[&!9"5.QT!^\026W:T/PO
MU:]#17^M3O$R]+>""SE#!E(/FJ'8#@@@8)SR<9![_0- @\/0):6B".&-=J(O
M0#KWY))R23DL22222:\EO?V:ETR^.IZ#>/ITK;]Z+$DT.& RJHQ0!<@MM;>H
M;:4";%%=7X.^$BZ3='5-0G>^U Q^6)Y%2-(U&X8BB0;8\J<,<DD[B"N]P;7Q
M*^%J?$&/[/<W-S';_*6AA:)$8J20S%HG<]1\I;9E5;;N&:B\ ?"=? L#6EI=
MW1A*N$20P.(V?!WIF#((.2%.8\EB4))-<_HW[.5OHMZ^IVU[>I=2-(TCAK;#
M&0EGRAMMA!;G!7 (! ! QH?$[X$6WQ(D22^N+G;'N\N.,P*B;@@?!,!<YV G
M<S8.<8'%<_\ '[0VT3PO=P//-<;?LP#SF-I,"> !2T<<>[IG<VYR226/&.5^
M GPYO;C1K:ZTG4'L6F\XSH84NHW9)I$215E(\MM@"L5X<*F0"N3ZK\+?@Q:_
M#_S)E9Y[R;F:YE.9&)P7 _NJ7RY!+,3C>[[5QS.O_L^RG5GUK2;\V,LJ_O%6
M!)4+$8<X+HI#8#$,K'S,OG.-L7Q2_9CA\>>7,UW,+M?E>>0++O3G:GEH88TV
MG[OEA <L75W;<.E\7_!A?%T!M;N^O6B9E:10\"AV7[I($&  -OR(%CRHD*&4
ML[6_ 'PG7P+ UI:7=T82KA$D,#B-GP=Z9@R"#DA3F/)8E"237/Z-^SE;Z+>O
MJ=M>WJ74C2-(X:VPQD)9\H;;806YP5P" 0 0,>@>-YH(+"Z>\4O;K;3F9%X9
MHQ&Q=1\R\E<@<CGN.M9_PL\%?\(1IEOIY;<T4?SG.079C))M.U?EWL=N0#MQ
MGG)JUX_\)?\ "7V,]AYKP^=&5\Q/O#D'!'&5.-KKD;D++D9R#P!X2_X1"Q@L
M/->;R8POF/\ >/). .<*,[47)VH%7)QD]!575-)AU>-H+F-)8FQN215=#@@C
M*L"#@@$9[@&O&K;]F8^&9_M.@:A/8EF8O&RK<Q$<A%V,4!"!F \SS#R""&&3
MTMM\(9]5V?VW?S7RQR%O)$<5M:N/E*B6*,'S=KJ&&YMO &W&[=Z+=VB7B-%*
MH='4JRL RLI&"I!X((X(/!%>*Z;^S;+X3N9+C0-1DLDE7#Q-"ETOWBPQO91A
M0<*6#.!N^<[B*[KP#\+8?"DDMY)(]S?7&//N9=N\X RB!0!'%D9"#. %4L0B
M;<_XF?!.'XC$"]NKH1*VY(8VA2)6VA=V#"68]<%V8KN8+M!(K5\+_#QO#5I]
MA@O;HHJHL3/]G>2)5).U"UO@@CY<.'"J $VX%<KX'_9RM_ SO)IU[>PF10KC
M=;.K '(RKVS+D<X.,@$@$!CF+_AFBV^W?VM]NOOMGF;_ #O,@W9QC&/L^W;M
M^79C9L^3;MXKO]1\+2WUK]D-Y<JWS!IT^SI.P.X;<B#8N-PPR(CC:"&SDGBO
MAY^SQ;?#^8SV%W>+NVB1&>!HY IR%93!]1N7#@%@K#)JKXD_9HMO$MT+^ZOK
MY[E=FR020(4V<KL"6ZA,'YAM ^8EOO$D^BW?A.+5+1K"_)NHW4JYE"!F!.1G
MRDC4%>-I55((# [ANKYZ_P"&'(?.W?;G\CS,[/)7S-F?N[_,V[MO&[9C/.S'
MRU[_ .!? MKX'M4LK)-L:\DGEW8XW2.<#+'')X  "J H 'FOA+]F]O!M]+=:
M9J$UM:R\-;K'&[8QE5WS>8IVL?E9HRX0E=V69CT'BCX+?VO>+J%O>W-K/%:1
MP0F-MWW'>3,QDW-.I8IN1B-VT[F8ME:D7P3GUN2-]?OWU"."0210>3%;0;L$
M$R(F[S>VT$@#Y@0RNRGU6L_7] @\0P/:7:"2&1=KHW0CKVY!!P01@J0""" :
M\@\.?L\WW@LR)HNK26]O(RMY4EO%<D,% +99E7)[E44D!0V[:#7HOP^^&MKX
M%C=+;>\DLADFGE;?/*Q).7? SC)P  .2<;F9CQ_CC]G*W\<NDFHWM[,8U*H-
MULBJ"<G"I;*N3QDXR0 "2%&/0/"_AV30D\M[J>Y 5%4S^264*"/O1Q1LQ/&X
MN6)(SG).=JO.OB9\$X?B,0+VZNA$K;DAC:%(E;:%W8,)9CUP79BNY@NT$BK>
MD?"QM)LO[.AU"]6(*%1MUN943#C8KFWW ?,,'.Y-B"-D (.)\//V>+;X?S&>
MPN[Q=VT2(SP-'(%.0K*8/J-RX< L%89-'C7]GBV\8WBZA=7=X)TP(C&\$?EA
M7:1%4K &^5F.UB2_3+$C-3?%3X%1?$2TBM[BXD^T0,QCN65&;#D%U9(Q#&P(
M  P%(*J<GY@_2^!?!]QH$:"]O9KR5(]@9PL: 9'.U.68A5!>5I'R"59=[@^2
M^//V-[+7IS<6,YM [,SQ^6)8@3C_ %8#1E!G)(RPYPH10!7?_"+X&V7PS1C!
MF6XD51).X&X@ 95 !\B%ANVY))QN9MJXQ?$G[-%MXENA?W5]?/<KLV2"2!"F
MSE=@2W4)@_,-H'S$M]XDGU72[)K*-8Y)7F89S)((P[9)/(B2-.,X&%' &<G)
M/@OCS]C>RUZ<W%C.;0.S,\?EB6($X_U8#1E!G)(RPYPH10!7?_"+X&V7PS1C
M!F6XD51).X&X@ 95 !\B%ANVY))QN9MJXJZU\%Y9[ZYU6QU">UNIVBP$5'MP
MJ1)$!)$_$IP'*DE0I8$#*Y:70O@XSW46H:S=OJ%S;[O(W1QP01YVD.(DR#*"
M#\Y/]WY=R(PJ?&+X"1_$.:"]BN'M+R#:%F4%_E4EU& Z;65SN5U((R00?E*]
MWX7T&72D_P!)N9+J9E0/(X1%^4'[D<2JB#<6.<,Y!"L[!$VZMW"9T9%8H64@
M.NTLI(P&&]67(ZC<",]01Q7DO_#-%M]N_M;[=??;/,W^=YD&[.,8Q]GV[=OR
M[,;-GR;=O%:OQ!^!D7C]4CO[R\:./!5%:W1-P0*9"%MQEC@G)R%+,$"J=M;7
MA?X>-X:M/L,%[=%%5%B9_L[R1*I)VH6M\$$?+APX50 FW KFOAY^SQ;?#^8S
MV%W>+NVB1&>!HY IR%93!]1N7#@%@K#)KG_BO^RC:^-[HWMM-]DD?)F B\Q'
M;_GH!O3:QYWD9#'#8#;BVW\'_P!G"R^'+_:MQN+O:5$KJ%5 2<^6GS;25(5B
M68D [2JLRG5^)GP3A^(Q O;JZ$2MN2&-H4B5MH7=@PEF/7!=F*[F"[02*V_!
MWP]3PU:FP:::ZMO+\M8[GRI J?,"F5B0LI!V[7+ * JA5&*\_P#"7[.D_A%I
M8;#5+F&QF^_"J1&;/E["RS,"$;/.Y(U;:%7.55A*?V8K1M4?5?M$\9+1&-(7
M,+#"!)=\N6ED,G)=P4<EG+,S-NKH/BI\#[3XB6T5O,\D;VZL(90QD894+\_F
M%C("54L20Y*_?&6)X_1/V86BMY;;4-0FO$^SM';)('\BW8QM&LHB:9U9D5L1
M\J$YQSM9>@^$/P"C^'.&6[N9F^<M'O,5J6;CS/)4G+! %R[./X@ 0NW%^*O[
M*=EXVG:\MY3:3R,#)M021.>=S;,H0[$@E@V#@DJ68M6K\'_V<++X<O\ :MQN
M+O:5$KJ%5 2<^6GS;25(5B68D [2JLRF+XV_!V/Q;<6^IS7TUJEKM&U 7))D
M4J8=I#).S$*"JR,["(*A*@-Z5X3^T?8[?[=_Q]?9XO/^[_K=@\S[GR_>S]WY
M?3BM"[M$O$:*50Z.I5E8!E92,%2#P01P0>"*\5TW]FV7PG<R7&@:C)9)*N'B
M:%+I?O%AC>RC"@X4L&<#=\YW$5W7@'X6P^%));R21[F^N,>?<R[=YP!E$"@"
M.+(R$&< *I8A$V]K7G7AOPA!)KU]JT0*NL,-K(,\-)LCF=\'/'E&W5<%>5DR
MG1CZ+117"_#'X30> 7O)(2";NY:7"IY:I'DF.$*&*X3<V& 7(.,8 Q:\9?#.
M#Q7=V-[.3FQF>14_A8L 1G!!!61$<')!"E64ALCL*\5T?]G:?PSJ$U[I6HO:
M07$@+VZ01.-N[<44L3&,$L(SY1,:G;\PW;CQ7^S'#K&H0:K!=S17$<D;S.P6
M=Y71E99!O(2-N,8"&( *%B55*M[!I>G_ -GQK'O>0C)+R-N=B269CP ,DG"J
M%11A455 4<)X;\(02:]?:M$"KK##:R#/#2;(YG?!SQY1MU7!7E9,IT8^BT5Q
M_P 3/A59?$: 6]\IRC;HY$(65#QNVDAAA@,,""#P<;E4CA=+^ FHQ6JZ7<ZQ
M,^G^68VBC@CBE*<X03,TKA>@*G(*9CP%/'J%IX3BTNT6PL";6-%"H8@A90#D
MX\U)%);G<65B22Q.X[J\Z_X9HMOMW]K?;K[[9YF_SO,@W9QC&/L^W;M^79C9
ML^3;MXKU72[)K*-8Y)7F89S)((P[9)/(B2-.,X&%' &<G)-JO$/BK^RG9>-I
MVO+>4VD\C R;4$D3GG<VS*$.Q()8-@X)*EF+5J_!_P#9PLOAR_VK<;B[VE1*
MZA50$G/EI\VTE2%8EF) .TJK,IZ#Q'\)UUS4(]5-W=1S0*RPJA@,4892C[4D
M@<$L"=Q;<3P,@*H7H/&/A@>)[9[-I9(4D5ED,7E;F1E9&0^;'( "&ZJ P(&&
M'.>/^'WP(MO RO#;W%S);2Y\VVF,$D#Y0H<KY (R#SM*[L*'W* *Y_X??L]W
M?@21TLM5F2SDD+&$00L_0A"'E\U WW=[+&-X4 @87:)^S'#8:NNL6-W-;XWL
MR +/(7='1W$MP9?O;LMO20Y+8897;H>./V;[3QLZ/>W=ZXB4K$GF1%44G.!N
MA+,>@+N6D8 ;W8@&NJN_AXUY8-ILM[=.CJ4:1OL[3-&8_+,18V^"".2Y'FEN
M?,[5E?#/X)P_#DD65U=&)FW/#(T+Q,VTKNP(0RGIDHREMJAMP %95S^SE;W.
MH?VNU[>B]#*WFJULARJA!\JVP3&P;2,889# @G/C_P"T1HB:AXGTNSN294DA
ML8I"V%9U:ZE1R?+" %@3G8% )^4#BO5=;^ U]XC066H:O/-IX8?N1#$DS*H/
MEAYQDR$':6+H0[#=@-@KZ7:>$XM+M%L+ FUC10J&((64 Y./-2126YW%E8DD
ML3N.ZO.O#?[-%MX:NC?VM]?)<MOWR&2!R^_EMX>W8/D_,=P/S -]X CK_B9\
M*K+XC0"WOE.4;='(A"RH>-VTD,,,!A@00>#C<JD>-^&?V);6RF$E]=O<1#!\
MM(_(W$$'#-YDAVD @A=K<Y#C'/K7Q3^%:>.=.&EQ2FU16C*^6H\O:G C:,%0
MR <A05 94;^'!B^">CR:+8FV,SW%O'(%M9GP"\0ABR5QSY7G>:(LEOW6S8S1
M[&/?UXUK_P"S[*=6?6M)OS8RRK^\58$E0L1AS@NBD-@,0RL?,R^<XVQ?%+]F
M.'QYY<S7<PNU^5YY LN].=J>6AAC3:?N^6$!RQ=7=MP]:T323IB%7EDF=F+-
M)*5+$X & BI&H  &$503EB"[,S:%?%?[*7@J3Q!]MGM+E[2\A^S"*=5$B[9/
M.$L;Q,=DBMM4@'E756!X(/O_ (9^ ZQ7PU?5[I]0O4P(F=$BAC  V%8EW ,I
MW$$$+N;?L\P;Z[7QUX%M?'%J]E>INC;D$<.C#.V1#@X89X/(()5@5)!\%MOV
M'K99]TE[(UON;$:Q*LNWG8/,+,N1QD^7AL' 7/'NLW@.*&R73;&22RA1=H-N
M45]I# C=(DA!);<7&)-WS;\DYX_X>?L\6WP_F,]A=WB[MHD1G@:.0*<A64P?
M4;EPX!8*PR:V_B)\*$\;SVUP]S/;FU6?8UNPBEW2^6,[R&P J," ,MNZ@ AN
M?N?@M?>(QY&MZI)=VFY6,$<$5H'96! =XR69.N5&#G:P8,H-=KXO^'5EXLLC
MIMS$! %41A $,1481H\#"%1P,#&,J05)4^=>&_@)J/AJ,V5GK$T=B9'/E"",
MRJCGYE29F)1L=&15 <EP@)->E>!? MKX'M4LK)-L:\DGEW8XW2.<#+'')X
M"J H ' >)/V:+;Q+="_NKZ^>Y79LD$D"%-G*[ ENH3!^8;0/F);[Q)/5>,?A
MB/%]D-/N[NY,1_UA ME>7YUD3<1;X&TJ,>6$R/O;NM'PU^%J?#Z/[/;7-S);
M_,5AF:)T4L02RE8D<=#\H;9EF;;N.:J_";X3?\*]^U?Z5-<_:;@R_O3]WKR>
M3NE;/[R3C?A?E7;SW]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>-7?[.QTF[:^T"^DTX
MR,6EB6-9K<G&%Q&610!N<@-O"EOW80*!6LOPCOM80PZQJL]S"64^5#%%9*ZX
M8/'(8@7=&4X*AD&,]3M*^E6EHEFBQ1*$1%"JJ@*JJ!@* .  . !P!4M%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<!\7OAQ=?$&W-C'=I;VS[#(/L_FR,5
M;<!O,R +D*<!=V5^_M)6CX0_#BZ^'UN+&2[2XMDWF,?9_*D4LVXC>)G!7)8X
M*[LM]_: M=_1111575M/_M&&2#>\?F1NF^-MLB[@1N5L'##.5/8X->2?"+]G
M(> 79IKR2YCW*Z08:*W$@(/FM'YCJ[C:NPG[A4-@L$*>RT44444444444444
M44444444444444444444444444444444444444444444445GS:#%/.MTX+2(
MN$R[E%^\-PC+>6'PS+Y@7?M)3=M)%:%%%%>->/\ ]G=_%6K+J\>H3VY"HI5
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M:M= \(1W,\9^VPPPON/F1%'GGC,@:+?L+A&$3,R[B$4' 557UK]ES_D7;/\
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M77OB/)X,\.Z4EJ\,=U=V]E!&\SA4B#0KON""#E4XR2-JEE+!A\C8NO\ PO\
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MHHHHHHHHHKFOB;:/>:5?11*7=[*Y554%F9C$X"@#DDG@ <DUY+^Q3_R!Y_\
MK_D_]$P5ZK\6/^0/J'_7A=_^B7KRK]BG_D#S_P#7_)_Z)@KJOVH_^1=O/^W?
M_P!*(JF_9EM'M?#]DLBE25F8!@0=K3R.C<]BI# ]""".#7I]?*OQ]_Y'#2?^
MW#_TLDKU7]J/_D7;S_MW_P#2B*C]ES_D7;/_ +>/_2B6O*O@%_R.&K?]O_\
MZ61UZ+/\6)_&>LOH.D2"!+=7:ZN63=+F.1%>.%7!3.X["\BL.695^13)Y!^U
M_P"$HO#B:<L;22.5N0\TTCS3/M$&-SN2<9+,$7:BLS%57<<^B_MK?\@>#_K_
M (__ $3/7G]]X;N/A9%IOBVP+RQO:6B7<#M(1A[=%^\,XB. %#Y6.41[0R[4
M3ZE\%^+X/&-I%?VA)BE4E=PVL""592/4,"#@D$C*DC!/S?\ 'W_D<-)_[</_
M $LDKZ ^+'_('U#_ *\+O_T2]>5?L4_\@>?_ *_Y/_1,%<I_S4/_ #_T#J[#
M]IGP.GB6?3TM',>K/,RVQ4!043$DCO(,,@B^^A4LV68)&Q8LO0>-O!&L_$&"
M+3KXVMO:LR&\:"22660)A@L:RP(L8+KGEG(XY8*RR>E:!H$'AZ!+2T01PQKM
M1%Z =>_)).22<EB222234VK:I'I$,ES.VV**-Y';!.%4%F. "3@ G !/H*\?
M^'OBNZ^-'G70E>TTV*X\N.*$^7=2E?*D)EE&2BXXVPE&.]E+D*&?S72]+CTK
MQ^L,*[47/<L23IY9F9F)9F9B69F)9F)9B22:M?MS_P#,._[>_P#VWKZ ^+'_
M "!]0_Z\+O\ ]$O7E7[%/_('G_Z_Y/\ T3!7O]?*O_-0_P#/_0.KU7]J/_D7
M;S_MW_\ 2B*C]ES_ )%VS_[>/_2B6O*O@%_R.&K?]O\ _P"ED=3?M4Z1/X.U
M&S\2V6%(9(WP-N9$W,N\JZNXDCW1L.,(FTMA@![?X8U2/Q;>MJ$#9@@MUAB.
M"I<W"074CD,,[?+^S[/NL&\T,I&PUY+^USJ3Z#<Z/J(C,B6US([=54L&@D5"
MV"%+"-L<$X!(!P:]_P! U^#Q# EW:.)(9%W(Z]".G?D$'((."I!! ((J*R\3
M0WMU-8QG,MO'"\F"I"^;YFQ3@DAL1[B"!\K(1G/'@'C#]EJW\2;-7\.7'V9Y
M=D\2$,D/S;'1HRJB2' RX&UL,0JB,#C5_9O^)6IW=U<Z%K>\W5M&K(SJN\*N
MU&5W!^?.Y&1\,7!9C(P*URGP"_Y'#5O^W_\ ]+(ZZO\ ;6_Y \'_ %_Q_P#H
MF>O5?A/_ ,@?3_\ KPM/_1*5\_\ [#'_ #$?^W3_ -N*/C[_ ,CAI/\ VX?^
MEDE:'QP\3#P7XLTW4[A#]G6V",^&"@,\\<A!"MN*+*'*@$D8'&X&OI6TNTO$
M66)@Z.H964AE92,A@1P01R"."*S]#\30ZVTZ0'=]GN# Y!4KO$<<C $$_=\P
M*V<$.K CC)^:OV&/^8C_ -NG_MQ1\??^1PTG_MP_]+)*/VY_^8=_V]_^V]?5
M5%?*OP"_Y'#5O^W_ /\ 2R.NK_;6_P"0/!_U_P ?_HF>O5?A/_R!]/\ ^O"T
M_P#1*5\Z_L7:I'I$.JW,[;8HH[:1VP3A5%PS' !)P 3@ GT%>E?#WQ7=?&CS
MKH2O::;%<>7'%"?+NI2OE2$RRC)1<<;82C'>RER%#/YKI>EQZ5X_6&%=J+GN
M6))T\LS,S$LS,Q+,S$LS$LQ))-6OVY_^8=_V]_\ MO7U517RK\ O^1PU;_M_
M_P#2R.C]N?\ YAW_ &]_^V]?0'Q8_P"0/J'_ %X7?_HEZ\?_ &0-4CTC0;JY
MG;;%%=SR.V"<*MO"S' !)P 3@ GT%=!\/?%=U\:/.NA*]IIL5QY<<4)\NZE*
M^5(3+*,E%QQMA*,=[*7(4,_FNEZ7'I7C]885VHN>Y8DG3RS,S,2S,S$LS,2S
M,2S$DDUZ?^U9X#/BC2&FB ,MHWG@X7<8PI$RAB1M&W]X0,[C&%VDXQE? CX@
M/\3H+2&?+&Q5FNB<_/*NU+-FWLWF!E,DK'[PN(5?Y $W^]55U;5(](ADN9VV
MQ11O([8)PJ@LQP 2< $X )]!7C_P]\5W7QH\ZZ$KVFFQ7'EQQ0GR[J4KY4A,
MLHR47'&V$HQWLI<A0S^:Z7I<>E>/UAA7:BY[EB2=/+,S,Q+,S,2S,Q+,Q+,2
M237:_MK?\@>#_K_C_P#1,]>J_"?_ ) ^G_\ 7A:?^B4KY_\ C[_R.&D_]N'_
M *625ZW^TU:/=>'[U8U+$+"Q"@D[5GC=VX[!06)Z  D\"C]G+QY!XJTBW2(@
M2VT,<$L><LI1=B,<@<.J[@1D9RNXE&KNM5\30Z9/;VLA_>W4CI&H*Y^2)Y78
M@D': F"0#AF0'&[-> ?L=Z[_ &5]MT&X79=0W#RD9W9QL@E7*@K\C(O.X[M_
MRC"DU[_XI\21^&K=[J8.RIM 2-3)([,P2.-5'5F=@JC@9(R0,D>*_MK?\@>#
M_K_C_P#1,]>J_"?_ ) ^G_\ 7A:?^B4KJJ^5?^:A_P"?^@=75_MK?\@>#_K_
M (__ $3/75?\R?\ ]P'_ -LZY7]BG_D#S_\ 7_)_Z)@H^)O[-5C\1VEU'3)?
M(N6DE5_E/D22Q/)')N7 9&,JX:1=RG:6".S%CE?!7QUK/AG6?^$;UUWEWQN8
M';]X25W2"02L0SQ,H<9;<RL%3";74=K\-]WB?7M3U9M_E6VW3X,^6!^[(>X!
M"Y8XE 9&)Y5R.V$M?M1_\B[>?]N__I1%1^RY_P B[9_]O'_I1+7E7P"_Y'#5
MO^W_ /\ 2R.K?[&WC&/3EN=#N1Y5T+AI41\J['8$ECVE1AD\L$@G<03\H",:
M^BO%?B:'PO:RWUR<10QL[<J"<=%7<5!9CA5!(RQ [UY_^U'_ ,B[>?\ ;O\
M^E$5'[+G_(NV?_;Q_P"E$M>JU\J_'W_D<-)_[</_ $LDKZEN[M+-&EE8(B*6
M9F(554#)8D\  <DG@"OFK]A[1'AMKV\)&R2:*)1SNW1*SL3QC&)EQR3D'('&
M<_X!?\CAJW_;_P#^ED='[<__ ##O^WO_ -MZ^@/B/X9L?%=NNG:B,K<2%(L
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MN"&,$48,9E9,CY3YK8)9=S)L7+,,>UZ3I<>D0QVT"[8HHTC1<DX50%49)).
M ,DD^IJU7A7C3]G:^\6ZA'JTVI(EQ#Y7E>79@(GEMO7 >X?/SDL=Y;))'W<
M=M\1OAY>>.=..FRW4*>9CSI%MG.[;(LD>Q3<_)C;AMQDW=1MZ5#\+/AM>^ ;
M0V O(YHE63R=UL49'<[ADK<?.@8L2N Q+8$B@ #E?"W[/E[X9U.;6+?4(_.N
M&F,B-9DQ$2OYC+C[5O #X(PP/ !)&0:FH?!+5?#VN3:UH,MJJ7"MYD5QYN-S
MD-*/E5R09%$@*LA!.S&P8:+XW_L\:A\0O)N%O$>XCW*T;JT-JJGG,2KYSJW
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M.6 DP"2<L1S[I8^ W\-Z='IFCS"W$:E5EEC-RPW;BS@>9&N\NV_)R@.1Y>W
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M  P;Y@,#*JZ[9 7/J'[3D-Q9:5-?VUW<P-!Y)6.%UB1BTJQEF94$I^60_*)
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M@GGFN/L]O=0(\\C2R;([J,*"Q_$\8&22 ,U5_;+AN-(:WQ=W+Q77GAX&=5@
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MA&S@E@IQEMBJS!T/V@]!'P?U*TU32'>-I_,,J&29_,:.1)',CM*7=9-ZAT)
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M[)M=4>>-RB GY-BHR[0V0Q8MXU^Q9JTVKR:G/<R/+*WV/<\C,[G G RS$DX
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M(2T-FJ2+&P5U!WSDJ/G65GC^=T"%>3Y)^PQ_S$?^W3_VXH^/O_(X:3_VX?\
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M^WO_ -MZ^JJ*^5?^:A_Y_P"@=75_MK?\@>#_ *_X_P#T3/7JOPG_ .0/I_\
MUX6G_HE*^?\ ]AC_ )B/_;I_[<4? +_D<-6_[?\ _P!+(ZT/CAXF'@OQ9INI
MW"'[.ML$9\,% 9YXY""%;<464.5 )(P.-P-?2MI=I>(LL3!T=0RLI#*RD9#
MC@@CD$<$5GZ'XFAUMIT@.[[/<&!R"I7>(XY& ()^[Y@5LX(=6!'&3\U?L,?\
MQ'_MT_\ ;BM#XX>)AX+\6:;J=PA^SK;!&?#!0&>>.0@A6W%%E#E0"2,#C<#7
MTK:7:7B++$P='4,K*0RLI&0P(X((Y!'!%<_+XOLM1AO3*0UO:-+%<D@21D+"
MDDHPN[< K[74C.X,NWCGP7QO^R1-I$AOO#=P\4J[RL3.R.,A\K',N",@A%5^
MQ)>6NZ_9J^*=WXT@N;;4P?MEI,%D8QB(E7W;591C#JR.K#:H "]6W&O.OV&/
M^8C_ -NG_MQ7U57*_%C_ ) ^H?\ 7A=_^B7KRK]BG_D#S_\ 7_)_Z)@KE/\
MFH?^?^@=75_MK?\ ('@_Z_X__1,]>J_"?_D#Z?\ ]>%I_P"B4KJJ*^4/A/,?
M#?C:^MKE2'N6O!'C:P =UNT8D-P#$N>,D$@$#G'T+\6/^0/J'_7A=_\ HEZ\
MT_8VTN2RT5I)%PLUW+)&<@[E"QQ$\$X^>-A@X/&<8()XKX!?\CAJW_;_ /\
MI9'7U57*_%C_ ) ^H?\ 7A=_^B7KRK]BG_D#S_\ 7_)_Z)@KG_VQ-/\ ^$@O
M-)T^%T$\LDJ ,WW?->".-F !8*6!YP<[6QD@BI?CAXF'@OQ9INIW"'[.ML$9
M\,% 9YXY""%;<464.5 )(P.-P-?2MI=I>(LL3!T=0RLI#*RD9# C@@CD$<$5
MGZ'XFAUMIT@.[[/<&!R"I7>(XY& ()^[Y@5LX(=6!'&3\U? +_D<-6_[?_\
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MPWEJS)91LJ2NHCA7:'VEAMDF\R3*(X*, !S_ .Q3_P @>?\ Z_Y/_1,%<I\
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M9'+1B1G&,Y&!*AR1@YX)P<5/^:A_Y_Z!U=7^VM_R!X/^O^/_ -$SUZK\)_\
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MRK]BG_D#S_\ 7_)_Z)@KE/\ FH?^?^@=7U57E7[4?_(NWG_;O_Z414?LN?\
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MA^RYJ>GP#R=5GL!(S.;:,O($)X 9XYH4D<(%#L$ )&%RH!J+QSX%USX46_\
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M,,P&7C8]QTRIP Z$@, .0P5E\0T']F7Q#I3BVBU8P62L^WRI;D,%)9@1""B
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M13>6)HWM<;@A)!5A<95@&8 _,OS99&P,>5>*='DUCQV\$$SV\IVE)DP61EL
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M=C)%T^U/#*ET W5Q$A\C<F2$!.UMJ[^IKI?A5\,X/AS9+8VY+G<7DD;@O(0
MS8R0HPH 4= !DLV6/85P'QS^&K?$33'LHM@G$D<D+2,ZHK*V&)V!B?W;.H!!
M&2#@$ CJO"GAF'PO:Q6-L,10QJB\*"<=6;:%!9CEF( RQ)[UQ_PI^$2> 9[^
M9&!%W<[XT0!$2(;F1 H'RE6D=>"5*A" IRH[#Q-975["8[&9+>4Y'F/%Y^T$
M$95?,C&X$@@MN7C!0YX\J^#_ .S_ '7PQF>2WOTDBF\L31O:XW!"2"K"XRK
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MHHHHHHHHHHHHHKY%_:U\(3^&M1@\0V@"!FA!?.YA<1Y:-BCY&#&BXP"N4.X
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M#JK ,"58!AGD"OFKX^_\CAI/_;A_Z625]2W=VEFC2RL$1%+,S$*JJ!DL2>
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M<;R7QC&XENIS7"?!+PI:ZAXJU2UEB1K=/MNV$C]SA;J-54QCY&4=55@55@K
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M(HE9?)F^4N!N(^5>"<<#T%>M?#O28=7T.Q@N8TEB:PL]R2*KH<11D95@0<$
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M-X5#EVWOGBOVVO#,-E=6E]&,2W$<J28"@-Y7E[&. "6Q)M))/RJ@&,<_7]>
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MWKW?F*N#RL<;JYSC P94&"<G/ .#CW#P1HCZ#86MG*07@MH(F*Y*EDC5"1D
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M;_M__P#2R.C]N?\ YAW_ &]_^V]:'[3MS/X(U?3O$4&6"*8F7;A<*S,4+D,
M9(Y74?+E0I9<D?+[!;?'70[F#[4M] $"LV&<)+A<Y_=-B7/' VY;C:#D9T/A
MOXQ;QE;O? )]G>XF%L5W[FBC;R@[[U7#,Z.P 'RH5!RP8U\__ +_ )'#5O\
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M? 6N:AX=DD$L20B8,-P&X&+8P4G"EHYAY@P3E5 8A<G/^ 7_ ".&K?\ ;_\
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M;G_YAW_;W_[;U]0?VM#Y/VKS$\CR_,\W<OE[,;M^[.W;MYW9QCG.*^>OV8-
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MLM?MULKH32P+GY&N;H[LL'^<^=NDPP!7>6V8^7 JIX.^#>F>#)#-I\3PL?O
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M21&D7:0K;E!+##$ Y'!X/-:M9^OZ_!X>@>[NW$<,:[G=N@'3MR23@ #)8D
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M9YO-?[Q1D+MGE?#?[-%MX:NC?VM]?)<MOWR&2!R^_EMX>W8/D_,=P/S -]X
MC5^)WP(MOB1(DE]<7.V/=Y<<9@5$W! ^"8"YSL!.YFP<XP.*[7PSH;:)"('G
MFN-N 'G,;28  "EHXX]W3.YMSDDDL>,6]6TN/5X9+:==T4L;QNN2,JP*L,@@
MC()&00?0UY)\./V>I? SS1PZE/\ 8I6)-NJ)&W7 S+EF4E/E9X1"Y.U@RE%
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M\*IYE_/'""KLH=@&8( 6V+]YR,CA03D@ 9(K0TG5(]7ACN8&W12QI(C8(RK
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M2RL$1%+,S$*JJ!DL2>  .23P!6)I?Q"TW5Y%@MKRVEE;.U(YXG<X!)PJL2<
M$G'8$UH:_K\'AZ![N[<1PQKN=VZ =.W)).  ,EB0 "2!7"_ GXE2?$2WNKU^
M(Q?RQP+M"E8ECB*!L%LM\Q9CD_,2 0H4#T#5-6ATB-I[F1(HEQN>1E1!D@#+
M,0!DD 9[D"JFA>++/Q!N^Q7$,^S&_P J1)=N<[<["<9P<9ZX/I6K6+-XWL((
M%O'NH%MW;:DQEC$3-\WRARVTGY6X!SP?0UG_ !!\+:7K$:3ZPD)BMY ZO,P1
M$)(&"Q*@JQP"C91SM#*<"NJKFKOXFZ59NT4M]:HZ,596N(E96!P5(+Y!!X(/
M(-=!=VB7B-%*H='4JRL RLI&"I!X((X(/!%?*&EZ3#I'C]8+:-(HESM2-51!
MG3R3A5  R22<=R37UI117/\ B;Q9ING9M=0N+:/S(SF*>2)=R-E3E9",J<$=
M,'D>M?->EZ3#I'C]8+:-(HESM2-51!G3R3A5  R22<=R37UI7/Z7\0M-U>18
M+:\MI96SM2.>)W. 2<*K$G !)QV!-=!7/ZI\0M-TB1H+F\MHI5QN22>)'&0"
M,JS C(((SV(-=!7*W'A;2[;4X[^1(5U&6-DC8L!*X5?G*J3\S!."X!<)\I;9
MQ70:IJT.D1M/<R)%$N-SR,J(,D 99B ,D@#/<@5GZ7XWL-6#-;74$H5HU8I+
M&X#2-LC4[6."S?*H/+'@9-0^.O"UCXEM7AU1$>V7]XQ=B@39D[]X*E,#.6!'
MRD@G:2#K:3Y/DQ_9=GD>6GE>7M\O9@;-NWY=NW&W'&,8XJIKOBRS\/[?MMQ#
M!OSL\V1(MV,;L;R,XR,XZ9'K5O2]6AU>-9[:1)8FSM>-E=#@D'#*2#@@@X[@
MBK597_"66?V?[=]HA^R_\]_,3R?O;/OYV_>^7K][CK5O2]6AU>-9[:1)8FSM
M>-E=#@D'#*2#@@@X[@BK5%17=VEFC2RL$1%+,S$*JJ!DL2>  .23P!65HGC>
MPUYS%9W4$[A2Q6*6.1@H(!8A&)QD@9Z9(]:VJJ_VM#YWV7S$\_R_,\K<OF;,
M[=^W.[;NXW8QGC.:J:?XLL]1F>U@N(9)X]V^))$:1=I"MN4$L,,0#D<'@\UJ
MT45S^J?$+3=(D:"YO+:*5<;DDGB1QD C*LP(R"",]B#6W:7:7B++$P='4,K*
M0RLI&0P(X((Y!'!%2T5%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %9^H>++/3H
M4NI[B&."3;LE>1%C;<"R[6)"G*@D8/(Y'%6]+U:'5XUGMI$EB;.UXV5T."0<
M,I(.""#CN"*J:%XLL_$&[[%<0S[,;_*D27;G.W.PG&<'&>N#Z5H7=VEFC2RL
M$1%+,S$*JJ!DL2>  .23P!6)I?Q"TW5Y%@MKRVEE;.U(YXG<X!)PJL2< $G'
M8$UH:_K\'AZ![N[<1PQKN=VZ =.W)).  ,EB0 "2!7"_ GXE2?$2WNKU^(Q?
MRQP+M"E8ECB*!L%LM\Q9CD_,2 0H4#/U3XTI=>(+30K%PP#7'VL@ C<L$C)$
M&SU##,F!D$*N[(D6O6JY_5/B%IND2-!<WEM%*N-R23Q(XR 1E68$9!!&>Q!K
MH*J_VM#YWV7S$\_R_,\K<OF;,[=^W.[;NXW8QGC.:AT3Q#;:\AELYHYT#%2T
M3K(H8 $J2A(S@@XZX(]:T*****S];\/6VO((KR&.= P8+*BR*& (# .",X)&
M>N"?6OF7]AC_ )B/_;I_[<5]*Z%XLL_$&[[%<0S[,;_*D27;G.W.PG&<'&>N
M#Z5JUS^E_$+3=7D6"VO+:65L[4CGB=S@$G"JQ)P 2<=@3705E2^++.*.2=KB
M$10R&.5S(@2-P0"CMG"L"P!4X.2!CD5H6EVEXBRQ,'1U#*RD,K*1D,"."".0
M1P16)I?Q"TW5Y%@MKRVEE;.U(YXG<X!)PJL2< $G'8$UT%%%8NM^-[#07$5Y
M=00.5#!998XV*DD!@'8'&01GID'TK0LM6AO\>3(CYC20;65LH^?+?@GY6VG:
MW1L'!.#5JBBN?U3XA:;I$C07-Y;12KC<DD\2.,@$95F!&001GL0:UM4TF'5X
MV@N8TEB;&Y)%5T."",JP(." 1GN :^6OV=[1+/Q;JD42A$1;Y550%55%W$ H
M X  X ' %?36G^++/49GM8+B&2>/=OB21&D7:0K;E!+##$ Y'!X/-:M%%9\7
MB&VE2659HRD#.LS!U*QL@RZN<X0J.6#8*CKBC1/$-MKR&6SFCG0,5+1.LBA@
M 2I*$C."#CK@CUK0KG]+^(6FZO(L%M>6TLK9VI'/$[G ).%5B3@ DX[ FN@K
M/?Q#;(9E,T8-NH:<;US$I4N&DY^0%06!; (&>E%MXAMKJ#[9'-&UN%9C,KJ8
MMJYWMO!VX&#DYP,'/2L_3_B%INH[_(O+:3RXVD?9/$VU%QN=L,<*,C+'@=S7
M05S^E_$+3=7D6"VO+:65L[4CGB=S@$G"JQ)P 2<=@37055N-6AMI(X))$667
M=Y:%E#OM&7VJ3EL#DXS@<FJG_"66?VC[#]HA^U?\\/,3SON[_N9W?=^;I]WG
MI6A=VB7B-%*H='4JRL RLI&"I!X((X(/!%>5?"_X;Z;H]^U]H\!BMQ;-%YA,
MS+.TDB/E/.8Y1%B4K(FZ.83?*W[LY]0U35H=(C:>YD2*)<;GD9409( RS$ 9
M) &>Y K/TOQO8:L&:VNH)0K1JQ26-P&D;9&IVL<%F^50>6/ R:VJ**Y__A86
MF^=]E^V6WG^9Y?E>?%YF_.W9MW;MV[C;C.>,9K;MKM+H;HV# ,RDJ01N5BCK
MQW# J1U!!!Y%96M^-[#07$5Y=00.5#!998XV*DD!@'8'&01GID'TK0_<ZS#_
M  2P2Q_[+QNCC\5964^X(/I7RKI>DPZ1X_6"VC2*)<[4C5409T\DX50 ,DDG
M'<DU[K\?/$TWAK1+RZMCME$:HK98%?,D2(LI4@A@')4@\, >>E<I^SKX4M=:
M\+PVUQ$CQ7'VCSE(QO/GR*&)&#N 10K9W+M7:1M&/0/AK\-;7X=VOV*RWE#(
MTC-(VYV9L#)P%4?*JJ H P 2"22>JKE;CPMI=MJ<=_(D*ZC+&R1L6 E<*OSE
M5)^9@G!< N$^4MLXKI;N[2S1I96"(BEF9B%55 R6)/  '))X K/U#Q99Z="E
MU/<0QP2;=DKR(L;;@67:Q(4Y4$C!Y'(XK0M+M+Q%EB8.CJ&5E(964C(8$<$$
M<@C@BO*O"/QI3QEK\NG6+A[."RD9G &))A-$I96R=R*K84C 8EC\Z[&KUJN?
M_P"%A:;YWV7[9;>?YGE^5Y\7F;\[=FW=NW;N-N,YXQFN@K/?Q#;(9E,T8-NH
M:<;US$I4N&DY^0%06!; (&>E3:7JT.KQK/;2)+$V=KQLKH<$@X920<$$''<$
M5D_\+"TWSOLOVRV\_P SR_*\^+S-^=NS;NW;MW&W&<\8S705S^J?$+3=(D:"
MYO+:*5<;DDGB1QD C*LP(R"",]B#6M+JT,2R.TB!8<^:2R@1X02'><_+A&#'
M./E(/0@UYI\(/B]_PL6^U'R#FSM_LJV^4V,=PF\R0YRWS,HV@XP@7*JQ;/HN
MM^(;;04$MY-' A8*&E=8U+$$A07(&< G'7 /I46E^++/5U5[:XAE5I#&ICD1
MP7"&0H"I.6" L5'.T$XQS6K1165_PEEG]G^W?:(?LO\ SW\Q/)^]L^_G;][Y
M>OWN.M2Z)XAMM>0RV<T<Z!BI:)UD4, "5)0D9P0<=<$>M1:?XLL]1F>U@N(9
M)X]V^))$:1=I"MN4$L,,0#D<'@\UJUS5W\3=*LW:*6^M4=&*LK7$2LK X*D%
M\@@\$'D&NEHHHHHK/?Q#;(9E,T8-NH:<;US$I4N&DY^0%06!; (&>E3:7JT.
MKQK/;2)+$V=KQLKH<$@X920<$$''<$5D_P#"PM-\[[+]LMO/\SR_*\^+S-^=
MNS;NW;MW&W&<\8S705BZWXWL-!<17EU! Y4,%EECC8J20& =@<9!&>F0?2M#
M2]6AU>-9[:1)8FSM>-E=#@D'#*2#@@@X[@BJFN^++/P_M^VW$,&_.SS9$BW8
MQNQO(SC(SCID>M2Z;XAMM4"-;S1RB179"CJX948([+M)W!68*Q' ) .":FU3
M5H=(C:>YD2*)<;GD9409( RS$ 9) &>Y JIH7BRS\0;OL5Q#/LQO\J1)=N<[
M<["<9P<9ZX/I6K56WU:&YDD@CD1I8MOF(&4NFX93<H.5R.1G&1R*J:%XLL_$
M&[[%<0S[,;_*D27;G.W.PG&<'&>N#Z5H7=VEFC2RL$1%+,S$*JJ!DL2>  .2
M3P!6)I?Q"TW5Y%@MKRVEE;.U(YXG<X!)PJL2< $G'8$UYU^U5X>MI]%NKQX8
MVN$6W5)BBF55^T1_*'(W ?,W ..3ZFIOV<-6ATCPS:3W,B11+Y^YY&5$&;J4
M#+,0!DD 9[D"O5=+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*^>OVS_  ];
M0:='>)#&MP][$KS!%$K+Y,WREP-Q'RKP3C@>@KV7X3_\@?3_ /KPM/\ T2E=
M511117/ZI\0M-TB1H+F\MHI5QN22>)'&0",JS C(((SV(-=!65KOBRS\/[?M
MMQ#!OSL\V1(MV,;L;R,XR,XZ9'K4NB>(;;7D,MG-'.@8J6B=9%#  E24)&<$
M''7!'K7RK^VKX>MM+>REMX8XWF:[:5D14:1LPG<Y4 L<L3DY.2?4U]5:WX>M
MM>017D,<Z!@P65%D4, 0& <$9P2,]<$^M?,O[#'_ #$?^W3_ -N*^JJ*X7XQ
M?%6#X<V3W$C#SW5UMXR-Q>3'&0"IV*2"YR,#@'<R@Z'A%5\6Z3:MJ"I/Y]I;
M22K(B,CL41R2F-OWN0,8!Q@# KYZ_9WM$L_%NJ11*$1%OE55 5547<0"@#@
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M#:NVTY7YX#&_&3T/0D="0?FO]FS2X](\5:E;0+MBBCO(T7).%6ZB51DDDX
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ME3N^4. IWLK>BZK\'])\2BTU#2H[9'M[N":.6W\M(G5)D\Y&,2E7^56V]U<
M;E!<'@/VT?#$"6,-_AS.;M(\F65D56AD+!8V<QIDQH254$D9)))SZ5HWC&/P
M9X9MM0F&5ATRU(7D;F,4:QID*V-SD+G!"YR> :XK]GWX<6OBVR_MW5T2]O+R
M28L\R;PJJ_EA C$Q\&+*D*I56\M<*.>*\5V;?L_Z]!/9-Y6EWGEB5#OD0*A5
M9@07>1F0-YJ/P07**&7>K>E?M8>&(+W1I[R0.98?(\O][*(U)F5"WEAQ$6VR
M,NXJ6P<9X&,_]G+X=66N:+9W-]$+E@MRL:S 211J;A]P2,C8"67<7(,ASMW[
M JKQ7[+D)\.^(=3TJ%B;=%G&&VEF,%PL<;$A1R%=LXP"3G' Q]7T5\X:Q=Q?
M&3Q,^D3L6T[3X96>'+JLLRD1.Q*^6ZE7EV@Y88C.WY96K0_:$^!]K%8OJ>DP
MI;7EIME#0#R<QQEF? 5D167/F;P"YV!!U&.P^"WC$_%#14DNW)F#-%.8FEMV
MWHP92&C9&!9"C-L(4EBN ,J/!/@EX&M[WQ)JFFG>MHL=[&8T=EW1+<QH(F<'
MS-N,9PP9L;6)0NK6_P!K#PQ;^!;S3]0TR-+>7YR%CCC2,- \;QR; @!;,GS%
ML@A5&.#GZ_HKE?BGI]]J&F7$6E/LO&CQ&VX(?O NJL1\K%-RJW&UB#N7&X<I
M\,OAA#X=\/+INL1PA3'*]V"5"?,S/N=QCYD0*"X/RE 5?"JU>=?L1Z_/=P7E
MI(Y:&!H&B0\A#)YQDQW )4''0') !9B?IJBOFO\ ;1\,0)8PW^',YNTCR996
M15:&0L%C9S&F3&A)5021DDDG/=>"/A18>(]$M1>1B:6;3H%\^18WFC5H%"K$
MS(1&$!^0*,;LNVZ1G=O'_P!D/1$\5P7EE>DR6D,UO,+?@1-(V[YI, -(!Y*X
MC9C$>K(S!2)OB3I,/@CQAIITR-+<2_9=ZQJH0^;-);R87&U<Q<':!SEA\Q+5
MZ5\9/AKJ?C/5M.*;'TN*2.2>-V78&1RSET(S)OCPB#Y@#N!"*S,W-?MGVT%E
M;6E\F$OUN56*16V3>6JN[8P02%DV$'G8S<%=YSVOBBRB\5>&/MU_''-<#1WE
M61XT++(]J'9T^7Y"6 /RXY QT%>?_LB>"+#7M*FEO+6"=Q>R*&EBCD8*(H2%
M!=2<9)..F2?6N:_X1.S_ .$[^P_9X?LO_/#RT\G_ (\-_P!S&W[WS=/O<]:]
M:^.GB4>";2TTK3&%F]Y<B%?)A9FCB8_OI(DB ^<,ZX"_.Q<E/G^9:MWX&\-3
MVC6*V$Z(RD"1=.OS<*2=P82O;-)D'IN)&/E(*?+53]FA-1U'3IM+UB&ZB2!H
MO)D<SVTAC.2(D=1')A"G4.?E<)P@ /DOPA^'T>J>)-1TR-WALT^UI)&A.Z2!
M+E%%N7)WJI^7>P.YD#)D;R1]-?#/X-67PY>X>P,F+ED+([!E0(7*JGRAL#>1
M\Q8D 9.<D]U6?K^@0>(8'M+M!)#(NUT;H1U[<@@X((P5(!!! -?)?P?\'6W@
MGQ=+I5R@G 606S,JR;& 2ZBD)95VN(E(+(,ASA?E.:VOVQOAQ:VD<6IVJ)'.
M9'$ZHF#(K$$SMM('RR,%9RN6:9 S9V ^RVFLV%YX?6[BM8'MGMA(MFHC:%I3
M\PMP FTN9_D ";C+_#OXKH/AUX#@\"V45C; 811YC@;3))@!Y3DL<L1T).T8
M4?*H ^9?V-?#,.O?;UNAYD*_9286"M"Y/G[6=2#OVX)52=@8[RI=8V30\9VB
M?#?QE9'35$272VRR1* D.V61K=U"1[!C""0 Y'FC><\"NU^)GB6'Q5K@T&Z:
M1]/@MO.N8(8;F1Y921Y<;FW!<(JO'*"!LW?*^6V[,7XU>$=-U.R\[1;*YAU"
M"1'@-OI]W;$G>N[<1;HIPN74DAE91M(RP;JO$%F_C;PL]SJ\4T=U'87+/&SR
MPYEB5MLCQ)Y2MEHEE570JN<+QR?+_P!FKX1P>/\ 2IQJ$DC6ZW,JQ0(WEJDI
MBBW7&1]]PI54#@H@#_*V\XZ"_P!/L[*_A\(M)/+I5G;/-<1)%<332RR2%TCD
M:U16V)YJ2*579NPKY;;MF^-7A'3=3LO.T6RN8=0@D1X#;Z?=VQ)WKNW$6Z*<
M+EU)(964;2,L&]J^%FMW6MZ9;SZA$\5T8\2I(NQ]R,4+E=J;=^W>!@ !@!D8
M)ZJBODO]F_Q)I/BV2Y&NB&?4[BX5EDNEC<2*0J)''ORH8,2-BA25*!0RIA/;
M_#'P4LM N;XI#&;.]6V8V[*'C$D;3,^$9=H3YD91DX;=@*H45XA^S9I<>D>*
MM2MH%VQ11WD:+DG"K=1*HR22<  9))]353]M/PI:Z3-9W-O$D<L_VGSF0;=Y
M4QL&8# +9D8EL;FS\Q.!CVK]H+QM-HUO!IUC)Y=]J-PEO"^678"RB23<$;&-
MRKQAQOWIRE:VE_ 31=/M5LOL<,BB,H9)$5IVSG<QEP'#')(*E=O&S:  ,GX"
M?#+4/AW'<6=Y<)/:^8#:A=V5&7\PD,HV;LJVQ6=0VX@Y)+>-?!W1$UGQ;JT4
MI/E;KXN@P%D7[6G[M^,E"<%E! <#8^Z-G1IOVF])A^&>H:;JFE1I;R_O,I&J
MQ1'RF0\K$$)WB5DDY^9,+QSGZTHK@/CIX8@UO2;MIPY\JTN)$42RHFY4+J61
M'59,,BD!PP!' Y.?#_V8?AA:^.M*D&HYEMX[V79 &DC7S#%!F5RCKN(4!8Q@
M; TF=V\;,3QKX?\ ^&>]>MK^SWFQFW$IG)V9"SP?ZQ2^T,KQE\#=LW%RC,?4
M/B9XEA\5:X-!NFD?3X+;SKF"&&YD>64D>7&YMP7"*KQR@@;-WROEMNS%^-7A
M'3=3LO.T6RN8=0@D1X#;Z?=VQ)WKNW$6Z*<+EU)(964;2,L&]5\(V;_$'1H%
MUF*:.5XRL\9>6V=BN^)BXB\D[9!ES&1LPP&#@&OFK]E+X?1^-OML-V[FS7[,
M9;=2469OWWE%W4A]J89@@(#.58GY #M?&OPK;?"6#3]+CDGDTVXO99[R)F7?
M*L?V8%,H(N-H) R!N(8G*J5]5U_X4:%\3M,<Z3':JY7,,T"I$5EV;D60QIN
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M>LZXWVII9)&BMV&+2$(\T0 AR4D;EOWDH=P-H!RI9O/_ (!?\CAJW_;_ /\
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M;P-&@N%D1XY)&3S)%786X16CRQQEF90/D)/SU\ O^1PU;_M__P#2R.C]N?\
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M %<R;003\RN#C'.3_P U#_S_ - ZNK_;6_Y \'_7_'_Z)GKU7X3_ /('T_\
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MF0+N24!PH.=GEJSC>37U+X+T1]%M(H9B#-M+3,N2K32$R3N,@8#2LS 84 '
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M.U"UO@@CY<.'"J $VX%<U\//V>+;X?S&>PN[Q=VT2(SP-'(%.0K*8/J-RX<
ML%89-'C7]GBV\8WBZA=7=X)TP(C&\$?EA7:1%4K &^5F.UB2_3+$C-9_C/\
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MMOWR&2!R^_EMX>W8/D_,=P/S -]X C5^)WP(MOB1(DE]<7.V/=Y<<9@5$W!
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M-'(%.0K*8/J-RX< L%89-9]W^SL;75VUG3+Z2S,K%IHUC67<7;,V#(Q4!OO
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M@@Y(4YCR6)0DDUS^C?LY6^BWKZG;7MZEU(TC2.&ML,9"6?*&VV$%N<%< @$
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M$GFM]V07@,:R8((*AI(Y-O7.Y=K@@$,.<^?_  \_9XMOA_,9["[O%W;1(C/
MT<@4Y"LI@^HW+AP"P5ADT>-?V>+;QC>+J%U=W@G3 B,;P1^6%=I$52L ;Y68
M[6)+],L2,UG^,_V>9-9O8-5M-0DM[V%<-.887>0@G8S"(0)D(QC;*D/&%4C
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M9Q<1$%E&\ED$.!QYA(!)7!]_^,5VEKHU^TC!0;*X4%B -S1LB+SW+$*!U)(
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MX:01L@QG)R(G.0,#')&1GZ*\*>)H?%%K%?6QS%-&KKRI(SU5MI8!E.58 G#
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MSATE,BG@[%W8(.1ZK^U5=I!X?NE=@I=K=4!(!9O/C?:,]3M5FP.< GH#6W\
M_#,WAK1+.UN1ME$;.RX8%?,D>4*P8 A@' 8$<,".>M>*?L,?\Q'_ +=/_;BC
MX^_\CAI/_;A_Z625]5444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4445XUK_ .S[*=6?6M)OS8RRK^\58$E0L1AS@NBD-@,0RL?,R^<XVQ?%+]F.
M'QYY<S7<PNU^5YY LN].=J>6AAC3:?N^6$!RQ=7=MPE_:)TDZ9X:O5>629V:
MW9I)2I8G[1"!@(J1J  !A%4$Y8@NS,W(? 3X<WMQHUM=:3J#V+3><9T,*74;
MLDTB)(JRD>6VP!6*\.%3(!7)]5^%OP8M?A_YDRL\]Y-S-<RG,C$X+@?W5+Y<
M@EF)QO=]JX\*_:3TN/5_%6FVTZ[HI8[.-UR1E6NI589!!&02,@@^AKT_6_@-
M?>(T%EJ&KSS:>&'[D0Q),RJ#Y8><9,A!VEBZ$.PW8#8*^EVGA.+2[1;"P)M8
MT4*AB"%E .3CS4D4EN=Q96))+$[CNKSKPW^S1;>&KHW]K?7R7+;]\AD@<OOY
M;>'MV#Y/S'<#\P#?> (]/U_0(/$,#VEV@DAD7:Z-T(Z]N00<$$8*D @@@&O(
M/#G[/-]X+,B:+JTEO;R,K>5);Q7)#!0"V695R>Y5%) 4-NV@UZ+\/OAK:^!8
MW2VWO)+(9)IY6WSRL23EWP,XR<  #DG&YF8_-7BGPW'XE\=O:3%U5]I#QL8Y
M$9; /'(K#HRNH93R,@9!&0?6M2^ -UXL>,:]J<E[;Q-O6!(8[12^1RYC)W#;
MN7H& 8['7)SZ7K?A@7]L+.WEDM$"A0;?RD8(%*!%WQN$ !&"@5E(&UAWX3X>
M?L\6WP_F,]A=WB[MHD1G@:.0*<A64P?4;EPX!8*PR:Z#XE?"U/B#']GN;FYC
MM_E+0PM$B,5)(9BT3N>H^4MLRJMMW#-1> /A%#X+@:RCGGGM&5P;>X,,D0WX
MWXQ"K8/.4W;#N8E2QS7'_#[]GN[\"2.EEJLR6<DA8PB"%GZ$(0\OFH&^[O98
MQO"@$#"[1/V8X;#5UUBQNYK?&]F0!9Y"[HZ.XEN#+][=EMZ2');##*[=#XK_
M +/<7CA[:Y@N)+6ZME1$FR\S%$)9,EI%?>KG<)-VXDG=N.TKW6A>%FMH6COI
MWO'DC"2F58UC88(91$BK&JDLV<AG((5W<*N/"_$W[$MK>S&2QNWMXCD^6\?G
M[223A6\R,[0"  VYN,ESGCU_X??"2S\ 6KVFG[T:3)><[&G)Y"L24V?)GY%V
M;!R2I+,6Y7_AFBV^W?VM]NOOMGF;_.\R#=G&,8^S[=NWY=F-FSY-NWBN@^(O
MP<B^(,,=M?7-SY4>P[4^SKND4,OFL?()W$.00I5/1!5K0OA3;Z=8MI5Q+-=V
M;1B,1W!C;8H)("M''&_&1M)8E-J^64VBO&KG]AZV:?='>R+;[ES&T2M+MXWC
MS RKD\X/EX7(R&QS[UX%\"VO@>U2RLDVQKR2>7=CC=(YP,L<<G@  *H"@ >=
M:!\!K[PC EOI.KSP@+^\66&*YB+=<Q(^/)!9F+ %BV1DDKD]AX!^%L/A226\
MDD>YOKC'GW,NW>< 91 H CBR,A!G "J6(1-O'Z!\!K[PC EOI.KSP@+^\66&
M*YB+=<Q(^/)!9F+ %BV1DDKD]AX!^%L/A226\DD>YOKC'GW,NW>< 91 H CB
MR,A!G "J6(1-O:UYU\7?@;9?$Q%,^8KB-6$<Z ;@"#A7!'SH&.[;D$'.UEW-
MG%7X&WNLQK::SJLUY9IY9\A8DMRY0@J))59Y)%P#N!(8MA]X90:]*U#03+"E
MO:RO:*FT+Y"P\*H*B,++%*@7IP%!&  0,@^:^&_V:+;PU=&_M;Z^2Y;?OD,D
M#E]_+;P]NP?)^8[@?F ;[P!'K5I"8$5&8N54 NVT,Q P6.Q57)ZG: ,] !Q4
MM>-7?[.QM=7;6=,OI+,RL6FC6-9=Q=LS8,C%0&^\ Z2!'^8# 55UO''P#A\;
M(D5[>WKQ(Q94\R$+O(^9S^XR23D@$[8PQ2)8X\(-_P +_#QO#5I]A@O;HHJH
ML3/]G>2)5).U"UO@@CY<.'"J $VX%<U\//V>+;X?S&>PN[Q=VT2(SP-'(%.0
MK*8/J-RX< L%89-8OQ5_93LO&T[7EO*;2>1@9-J"2)SSN;9E"'8D$L&P<$E2
MS%JU?@_^SA9?#E_M6XW%WM*B5U"J@).?+3YMI*D*Q+,2 =I5693ZU6+XT\(0
M>,;26PNP3%*H#;3M8$$,K ^H8 C(()&&!&0?&O#?[*+:+(8AJ=R=/:1S):+O
MB$BL-NQV24*<J KD("R@@;,@KH>'OV6H-(OY[];N>,2S,R16I^R*L;2%S S(
MQ9D^Z!L,> N1SC;U7Q=^!ME\3$4SYBN(U81SH!N (.%<$?.@8[MN00<[67<V
M> \!_L;V6@SBXOIS=A&5DC\L11$C/^L!:0N,X(&5'&&#J2*]D\=>!;7QQ:O9
M7J;HVY!'#HPSMD0X.&&>#R""58%20? -+_8<ABD4W-\[Q<[ECA6)SP<89I)0
M.<$Y4Y&1QG(^A;3PG%I=HMA8$VL:*%0Q!"R@')QYJ2*2W.XLK$DEB=QW5YUX
M;_9HMO#5T;^UOKY+EM^^0R0.7W\MO#V[!\GYCN!^8!OO $:&M?!>6>^N=5L=
M0GM;J=HL!%1[<*D21 21/Q*<!RI)4*6! RN6ET+X.,]U%J&LW;ZA<V^[R-T<
M<$$>=I#B),@R@@_.3_=^7<B,*GQ#_9XMOB!,)[^[O&V[A&BO L<88Y*JH@^@
MW-ER H9C@5W>B>&!86QL[B62[0J5)N/*=BA4(4;9&@<$ Y+AF8D[F/;RK3?V
M;9?"=S)<:!J,EDDJX>)H4NE^\6&-[*,*#A2P9P-WSG<17=> ?A;#X4DEO))'
MN;ZXQY]S+MWG &40* (XLC(09P JEB$3;G_$SX)P_$8@7MU=")6W)#&T*1*V
MT+NP82S'K@NS%=S!=H)%:OA?X>-X:M/L,%[=%%5%B9_L[R1*I)VH6M\$$?+A
MPX50 FW KFOAY^SQ;?#^8SV%W>+NVB1&>!HY IR%93!]1N7#@%@K#)KU6O*O
MB'^SQ;?$"83W]W>-MW"-%>!8XPQR551!]!N;+D!0S' KJ_\ A!Y?L?V'[?>>
MGG[K?[1LV;-F_P C_@6_'F[N?,KE/AY^SQ;?#^8SV%W>+NVB1&>!HY IR%93
M!]1N7#@%@K#)H\:_L\6WC&\74+J[O!.F!$8W@C\L*[2(JE8 WRLQVL27Z98D
M9J;XJ? J+XB6D5O<7$GVB!F,=RRHS8<@NK)&(8V!  & I!53D_,'W_"'@273
M(!#J-W)?GR6B/FJBQ%#P08U!WDJ%#-*TK'#;2H=PW :;^S;+X3N9+C0-1DLD
ME7#Q-"ETOWBPQO91A0<*6#.!N^<[B*[KP#\+8?"DDMY)(]S?7&//N9=N\X R
MB!0!'%D9"#. %4L0B;>UJKJVEQZO#);3KNBEC>-UR1E6!5AD$$9!(R"#Z&O&
MO"O[-<OA.61;'5;J&RD5@T"A/,^9 I82'**^Y01(L0<*-H8'YJ\ZTO2X]*\?
MK#"NU%SW+$DZ>69F9B69F8EF9B69B68DDFO:OB]\$(?B&T-PLSVMY;_ZJ>,*
M2/G5AN^ZYVX)CPZ[&8MSD@Y_B?X%2^++&2VU&_DN+F18PLSQHL,6R7?NCMXR
MB!V0^6TA9GVD@,$)0]+\-?A/;_#Z/RK:6YD7Y@HFF9T4,0Q58UV1#Y@6W!-^
M6;YL'%>8>//V-[+7IS<6,YM [,SQ^6)8@3C_ %8#1E!G)(RPYPH10!7?_"+X
M&V7PS1C!F6XD51).X&X@ 95 !\B%ANVY))QN9MJXJZU\%Y9[ZYU6QU">UNIV
MBP$5'MPJ1)$!)$_$IP'*DE0I8$#*Y:70O@XSW46H:S=OJ%S;[O(W1QP01YVD
M.(DR#*"#\Y/]WY=R(PJ?&+X"1_$.:"]BN'M+R#:%F4%_E4EU& Z;65SN5U((
MR00?E*ZVJ?"J77+5K6]U&\<R1A)VC^SPB0<94*L)"+G=G;\[JQ25Y%5 L/PS
M^"</PY)%E=71B9MSPR-"\3-M*[L"$,IZ9*,I;:H;< !6?\5?V>[7QU,M]%(]
MI?)MVSQCJ5*E6=05)90,(RLC#C)8*J@B^"<^MR1OK]^^H1P2"2*#R8K:#=@@
MF1$W>;VV@D ?,"&5V4^@>)M#;6X3 D\UONR"\!C63!!!4-)')MZYW+M<$ AA
MSGS_ .'G[/%M\/YC/87=XN[:)$9X&CD"G(5E,'U&Y<. 6"L,FCQK^SQ;>,;Q
M=0NKN\$Z8$1C>"/RPKM(BJ5@#?*S':Q)?IEB1FHOC-\%QXXLHHKG4)(A;-)(
M\LJQ%&4@DM(L?D1@H.%<8"KOR"6+#L/A;;W5MIT,=](\LR^8/,D79(\8D<0N
MRGYE8Q;"P?YP21)\^ZNJHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHK@/B]\.+KX@VYL8[M+>V?89!]G\V1BK;@-YF0!<A3@+NROW]I*T?"'X
M<77P^MQ8R7:7%LF\QC[/Y4BEFW$;Q,X*Y+'!7=EOO[0%KOZ\*\:?L[7WBW4(
M]6FU)$N(?*\KR[,!$\MMZX#W#Y^<ECO+9)(^[@#VO2XYHHU%RZ/+SN:-&B0\
MG&%:24CC .6.3D\9P+5%%%17:NR,(B%<J=K,I=0V."5#*6 /4!E)'&1UKP__
M (9VOO[7_M_^TD^U^9N_X\QY>-GE^7M^T9V^7\F<[\<[M_S5[A:*ZHHE(9PH
MW,JE%+8Y(4LQ4$] 68@<9/6I:***********************************
M**************************BNU=D81$*Y4[692ZAL<$J&4L >H#*2.,CK
M7A__  SM??VO_;_]I)]K\S=_QYCR\;/+\O;]HSM\OY,YWXYW;_FKW"T5U11*
M0SA1N95**6QR0I9BH)Z LQ XR>M2T4444444444445GZEH,6I/'),"QB;<J[
MW$>[((9D#!'*LH9"X8HP#)M;FM"BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBHK:[2Z&Z-@P#,I*D$;E8HZ\=PP*D=000>14M%1
M6UVET-T;!@&925((W*Q1UX[A@5(Z@@@\BI:*S];\0VV@H);R:.!"P4-*ZQJ6
M()"@N0,X!..N ?2HO"WBFW\56Z7MD_F02;MC[67.UBC<.%8?,I'(_2M6BBHK
MN[2S1I96"(BEF9B%55 R6)/  '))X K*\(>-+3QC +NPE$L19EW $$,.JE6
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M(P<@>@KSK]BG_D#S_P#7_)_Z)@KV_6_$-MH*"6\FC@0L%#2NL:EB"0H+D#.
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M0^3]J\Q/(\OS/-W+Y>S&[?NSMV[>=V<8YSBH=$\0VVO(9;.:.= Q4M$ZR*&
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MB&VT%!+>31P(6"AI76-2Q!(4%R!G )QUP#Z4:)XAMM>0RV<T<Z!BI:)UD4,
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M,4;:X!!*MM5]IQT.UE;!YP0>A%2U5U35H=(C:>YD2*)<;GD9409( RS$ 9)
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MC'<)O,D.<M\S*-H.,(%RJL6SZK17/ZI\0M-TB1H+F\MHI5QN22>)'&0",JS
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M1#'):R-(3%)%%(@#VQN=JJ4VH%? 3: 0HVY(+9^O[2T2S18HE"(BA550%55
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M2@ $_*/*W!57.YG/):M#X67=AXPB.M:[!)>7EPT@'^@WEQ;PQ*^U(8PL<L)
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M=A=DFA9'^9BJ9<"-U+/(V&'JOPX^%:>$GFO+B4W>H7#$S73J%8KGY8T4$B-
M /E!P2!_"J*G=5\X?MA33Z,^EZK"H86MS(<M]WS,Q21J0&#$'R6SCL,9!(S[
M?X%\=6OCBU2]LGW1MP0>'1AC=&XR<,,\CD$$,I*D$FA>,8];NKFV@&Y+7RE>
M49*>:V_S(0=NTM&JH7PQP9 K!2"#\Z_\U#_S_P! ZNK_ &UO^0/!_P!?\?\
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M5\R_L[W:7GBW5)8F#HZWS*RD,K*;N(A@1P01R"."*^KZ^5?VY_\ F'?]O?\
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MF^:3)BF)$:DE8$_>, D6T;2 =V,GS_\ 9AT1]>\,:A9Q$!YYKN)2V0H9[6)
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M$?6=!O8HR 5A$IW9 VPNLSC@'DJA [9QD@<C%_9E^)</BK2X;4LBW5M'Y31
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MP"1;1M(!W8R>:_8I_P"0//\ ]?\ )_Z)@KE/@%_R.&K?]O\ _P"ED='[<_\
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M-6$<Z ;@"#A7!'SH&.[;D$'.UEW-G@/ ?[&]EH,XN+Z<W81E9(_+$41(S_K
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M^'+_ &K<;B[VE1*ZA50$G/EI\VTE2%8EF) .TJK,IT/C/\"[7XG1J7;R;J/
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M?[/%M\0)A/?W=XVW<(T5X%CC#')55$'T&YLN0%#,<"O0/#.AMHD(@>>:XVX
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M*LI4/M!8L%PQ4*X.QL%"P(&<X(STM%%%%17=VEFC2RL$1%+,S$*JJ!DL2>
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MKRZ@@<J&"RRQQL5)(# .P.,@C/3(/I6AJFK0Z1&T]S(D42XW/(RH@R0!EF(
MR2 ,]R!1I>K0ZO&L]M(DL39VO&RNAP2#AE)!P00<=P11<:M#;21P22(LLN[R
MT+*'?:,OM4G+8')QG Y-5/\ A++/[1]A^T0_:O\ GAYB>=]W?]S.[[OS=/N\
M]*U:Y_5/B%IND2-!<WEM%*N-R23Q(XR 1E68$9!!&>Q!K;M+M+Q%EB8.CJ&5
ME(964C(8$<$$<@C@BHKC5H;:2."21%EEW>6A90[[1E]JDY; Y.,X')JI_P )
M99_:/L/VB'[5_P \/,3SON[_ +F=WW?FZ?=YZ5JT44444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444445\=_&?PM'H/BO3DLR5>5K%R\KS7),GVEHU9C)*78!44;0Z\#
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MF'!"L9&E@9F#85&CF.XD$J2N[8 Y'T_K^OP>'H'N[MQ'#&NYW;H!T[<DDX
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M+$X6&(?NHRNQ<NJAV8%BP#;1Y)^PQ_S$?^W3_P!N*/\ FH?^?^@=75_MK?\
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M(=ANP&P5]+M/"<6EVBV%@3:QHH5#$$+* <G'FI(I+<[BRL226)W'=7G7AO\
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M7ED<\N['DD^P "@ ;5%%%%%%%%%%%%%%%%%17:NR,(B%<J=K,I=0V."5#*6
M/4!E)'&1UKP__AG:^_M?^W_[23[7YF[_ (\QY>-GE^7M^T9V^7\F<[\<[M_S
M5[A:*ZHHE(9PHW,JE%+8Y(4LQ4$] 68@<9/6I:****\E^,GP'?XB7-O>17LE
MJ]NN% 4R*&W!Q(F)(RCY^\P))"ITV\^B^&?#<?AZ$01EW/!>21C)-(V IDD=
MN68A0,] H"J%554:M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%5;W5H;#
M/G2(F(WD.YE7")CS'Y(^5=PW-T7(R1D5D^&O']CXHDFAL9TG:#R_,,9+(/,!
M*8<#8V=ISM)P00<'BN@J);M&<Q!@7559ER-P5BP5B.H!*L >A*G'0U+1116?
M::_!=SRVD;AIH%C:5!R4$FXQY[ D*3CJ!@D ,I.A1111111575-6ATB-I[F1
M(HEQN>1E1!D@#+,0!DD 9[D"N*\,_'S1/$LPMK6\0RMC:KK)#N)(4*IE1 S$
MD *"6/8<&M_QCX_L?!D8FU"=(5/W022[8*@[44%WQN&=H.T')P.:S_"OQ>TG
MQ4DDEG=1L(E9I Q,3*B@%I"LH1@@W#+XVYXSD&M;PAXTM/&, N["42Q%F7<
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MC@>@KV7X3_\ ('T__KPM/_1*5U5<KXH\+:7<75M?WZ0_:8Y!';R2,%)=LE$
M) =LY:-2&*MED ;)KJJSXO$-M*DLJS1E(&=9F#J5C9!EU<YPA4<L&P5'7%&B
M>(;;7D,MG-'.@8J6B=9%#  E24)&<$''7!'K7FNJ?&E+KQ!::%8N& :X^UD
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MM\JJH"JJB[B 4 <  < #@"OIK3_%EGJ,SVL%Q#)/'NWQ)(C2+M(5MR@EAAB
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M6(V8) 9@#U 8XZFOF7X)>$[/4?%6J6L]O#)!']MV1/&C1KMNHU7:I!484D#
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M'0XRJXZ#X*:8OCGPU9Q7Y=T,<D9"220;D1Y8%1C"T99?+ 4JV0V,L">:\/\
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MRB=(D8%MVX&)MI.2'7&[=A<<_J/PZLOAYXNMK26(36-PRF.)@)L"</ BL)
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M************************^6]6MCI'Q BFN,1I.H:-F90&!LV@7OP3*I0
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M#_TLDKU7]J/_ )%V\_[=_P#THBH_9<_Y%VS_ .WC_P!*):\J^ 7_ ".&K?\
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MG_MP_P#2R2OH#XL?\@?4/^O"[_\ 1+UY5^Q3_P @>?\ Z_Y/_1,%<I_S4/\
MS_T#J/\ FH?^?^@=6W^V%-/HSZ7JL*AA:W,ARWW?,S%)&I 8,0?);..PQD$C
M/M_@7QU:^.+5+VR?=&W!!X=&&-T;C)PPSR.000RDJ02:%XQCUNZN;: ;DM?*
M5Y1DIYK;_,A!V[2T:JA?#'!D"L%((/SK\ O^1PU;_M__ /2R.MO]L*:?1GTO
M585#"UN9#EON^9F*2-2 P8@^2V<=AC()&?;_  +XZM?'%JE[9/NC;@@\.C#&
MZ-QDX89Y'(((925()-"\8QZW=7-M -R6OE*\HR4\UM_F0@[=I:-50OAC@R!6
M"D$'R7Q-\ M(^+T":O8,;:6Y42F1-KHS-MWB2,-MWC#*VQE/F%BY<BLK]FG6
M-1\/:C=^&M3<R&WA62,F3S%15\M J9&[8R2(RJ2H0+C8&9L8GP"_Y'#5O^W_
M /\ 2R.OJJBOD74M;3X+^+KFYN ?LMU#-*2<22,LH,I"!"H!-S&8UWX 7ECC
M]Y73?M,?#5O["2]FV->07'G7$@9\$W!"2HF1\RA_*2/?\R0Q*N[C#=_\"?$D
MGCJ$:O.'W"WAME+J%W-&-]S.F/E"R2L$(48/D*6.0$C/VH_^1=O/^W?_ -*(
MJ/V7/^1=L_\ MX_]*):\J^ 7_(X:M_V__P#I9'1\??\ D<-)_P"W#_TLDKH/
MVO\ SM'_ +,U>'8?LEVV%;<<NVR6/@8RO[@AOF!Y&.I(]P\'>,;;Q?;)>6;A
MT=5) 969&*JYC?8S!7 8;ESD&JGA/QS%XIEN%M0'MX&C07"R(\<DC)YDBKL+
M<(K1Y8XRS,H'R$GYZ^ 7_(X:M_V__P#I9'1^W/\ \P[_ +>__;>OJJBOE7X!
M?\CAJW_;_P#^ED=>U^/O"VE_$29M(OTW3Q6ZSQL&"2*LIDB+1D'<=K("X93'
MDQ;@QP!\Z>,? =]^SM=0ZE87#RV,EPH=-PC+8WD0R+\ROF+=ME"_*VY@B'9N
M^RJ*Q?&^B/KUA=6<1 >>VGB4MD*&>-D!. 3C)YP"<=C7@O[%VN_9X;S29E\N
M>&X\TJQVR'<!%(OED!AL:,!CV+@$ XSJ_MF_Z5IMK:Q_-/+?Q^7$O,CXCE4[
M5'S-\SJ. >64=2*[KQ#HCZ#X8FLY2"\&CR1,5R5+):E"1D XR.,@''85PO[%
M/_('G_Z_Y/\ T3!7O]%?*O[#'_,1_P"W3_VXH^/O_(X:3_VX?^EDE>J_M1_\
MB[>?]N__ *415S7PD\<)X&\'0ZC(AD$*S812 69KN1$&3T&YADX) R0&(P=#
MX1:%_P +.LH]9UQOM32R2-%;L,6D(1YH@!#DI(W+?O)0[@;0#E2S>?\ P"_Y
M'#5O^W__ -+(Z[#]L#X?OXATY+Z')>R9F91DYBDVB1L!225*JQ.554#DYP*V
M_@%XQD^(T:ZK<#YX+=;3G /FY$EU( JJNV11;D CY&1U4 9:3U^BOE7X!?\
M(X:M_P!O_P#Z61UZ7^UAJD=EH$\<C8::2".,8)W,)5E(X!Q\D;')P.,9R0#Y
M?\5O <^B>"[&$@DP313S!AY;1B;SB5*L<Y62=8R.N?F*@9Q[K\'?BK!\1K)+
MB-AYZ*BW$8&TI)CG )8[&()0Y.1P3N5@-J/QC'<:@=,B&]X[=I9V&2(B600Q
MMA=H:16=@"P8*F=I# UT%9_B'1$UZVFLY20D\,D3%<!@KJ4)&01G!XR",]C7
MRK\!M>N_ \NH>&G)6[,T8@(0%5=G6"6X4.H>0+&R7"J5VM%$S$HI+'ZPTG2X
M](ACMH%VQ11I&BY)PJ@*HR22<  9))]37R_\??\ D<-)_P"W#_TLDJW^T/XA
MD\">)--UEDW0+;^6>C$@/*LX5=RG<(YP5)(4L1R0&%?1^@:_!XA@2[M'$D,B
M[D=>A'3OR"#D$'!4@@@$$5G^#O&,?BM9I;<9@CN&BCE&2DP5$WR(2H!42%XP
M5+*Q0D,0<#YEU+6T^"_BZYN;@'[+=0S2DG$DC+*#*0@0J 3<QF-=^ %Y8X_>
M5TW[3'PU;^PDO9MC7D%QYUQ(&?!-P0DJ)D?,H?RDCW_,D,2KNXPW?_ GQ))X
MZA&KSA]PMX;92ZA=S1C?<SICY0LDK!"%&#Y"ECD!(_-?VA_$,G@3Q)INLLFZ
M!;?RST8D!Y5G"KN4[A'."I)"EB.2 PKZ/T#7X/$,"7=HXDAD7<CKT(Z=^00<
M@@X*D$$ @BO)?C!KO_"?>'M3:Q7?%%(!'(#\DJ0-#+-*A8*"JD2("I8,8R5)
MR!1^R/XFAU/1([6,_O;625)%)7/SR/*C  D[2'P"0,LK@9VYKSKX[W:3^,=+
M5&#%&L%< @E6^U.^TXZ':RM@\X(/0BOJ^N:^)'CA/ VGSZC(AD$*KA%(!9F9
M409/0;F&3@D#) 8C!\Z^$6A?\+.LH]9UQOM32R2-%;L,6D(1YH@!#DI(W+?O
M)0[@;0#E2S>?_ +_ )'#5O\ M_\ _2R.O1?&7P?TCXQB:Z3,-W'-- \R%=X>
M!GBQ(@)5A]UAG;(T?EC<JX%<!\&XM1^%GB!?#EU*9K6>&1H/G_=A1YDJRJAW
M%"2DBN@*@L2Q+A48_4E%%?*OP"_Y'#5O^W__ -+(Z/VY_P#F'?\ ;W_[;U]
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M))+'C'DOQ5_93LO&T[7EO*;2>1@9-J"2)SSN;9E"'8D$L&P<$E2S%JU?@_\
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M5M7R]F-NS;C;MV\;<8QQC%?.OB;]B6UO9C)8W;V\1R?+>/S]I))PK>9&=H!
M ;<W&2YSQZ_\/OA)9^ +5[33]Z-)DO.=C3D\A6)*;/DS\B[-@Y)4EF+<K_PS
M1;?;O[6^W7WVSS-_G>9!NSC&,?9]NW;\NS&S9\FW;Q7:^// *^,M.;2YY7VO
MY >7">8PCD1V/ 5 S;",A=JDY"$#;7*?\*FU6#_1X=;N19]"KQ0RW6UO]8!<
MG#ACD['VYC^4 ':*[#PA\.K+PG9#3;:(& JPD#@.92PP[29&'+#@Y&,84 *
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M\66&*YB+=<Q(^/)!9F+ %BV1DDKD]AX!^%L/A226\DD>YOKC'GW,NW>< 91
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M0900?G)_N_+N1&'2^//! \90&T>XG@B=6618#$ID4X^5F>)V XP0I4,&96W
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MM!KT7X??#6U\"QNEMO>260R33RMOGE8DG+O@9QDX  ').-S,QY3XA_L\6WQ
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M11111111111111111111145VKLC"(A7*G:S*74-C@E0RE@#U 921QD=:\/\
M^&=K[^U_[?\ [23[7YF[_CS'EXV>7Y>W[1G;Y?R9SOQSNW_-7N%HKJBB4AG"
MC<RJ44MCDA2S%03T!9B!QD]:EHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHK/FT&*>=;IP6D1<)EW*+]X;A&6\L/AF7S N_:2F[:2*T*
M************JZMI_P#:,,D&]X_,C=-\;;9%W C<K8.&&<J>QP:\D^$7[.0\
M NS37DES'N5T@PT5N) 0?-:/S'5W&U=A/W"H;!8(4]EHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHK/TW08M.>26,'?*V79G>1CR2%!=F*H"S%8UPB%FVJ-QSH444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444445S_P#PG]C]N_LGST^V>7O\
MG)W8QG&<;=VWYMF=^SY]NWFN@J*[NTLT:65@B(I9F8A550,EB3P !R2> *YK
MP]\4],\273V%E<)-/''YC"/<R;?E&1(!Y;<NH(5B0<@C(..JHHHKC_%_Q>TG
MP>2E]=1QN&53&"9)02NX9CC#.H*\Y( Y'/(SV%%%%%%%%%%<!XF^/FB>&IC;
M75X@E7.Y462;:02I5C$CA6!!!4D,.XY%=KI>K0ZO&L]M(DL39VO&RNAP2#AE
M)!P00<=P15JHKN[2S1I96"(BEF9B%55 R6)/  '))X KFO#WQ3TSQ)=/865P
MDT\<?F,(]S)M^49$@'EMRZ@A6)!R",@XZJBBBBHKN[2S1I96"(BEF9B%55 R
M6)/  '))X KSK5/VD= TR1H9+U"RXR8TEF3D \/$CH>O."<'(/((KI;+XE:=
M?01W<5S&\4TT4,;*V299-NR+:/F#_,"5(#*,LP4 D=+11111111111111111
M1111111116+K?C>PT%Q%>74$#E0P666.-BI) 8!V!QD$9Z9!]*S_ /A;&C_]
M!"S_ / F'_XNM#1/&]AKSF*SNH)W"EBL4L<C!00"Q",3C) STR1ZUM44445%
M=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %97A#QI:>,8!=V$HEB+,NX @AAU4JP
M#*>AP0"00PX()VJ**********S]?U^#P] ]W=N(X8UW.[= .G;DDG  &2Q(
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MHMW=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5E:)XWL-><Q6=U!.X4L5BECD8*"
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MF1(R5B\^+:L;@<)M8X"G;@G'!K0_9PU:'2/#-I/<R)%$OG[GD9409NI0,LQ
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MP11*R^3-\I<#<1\J\$XX'H*]0^"_A.ST[3;*Z@MX8YY+"VWRI&BR-NC1FW,
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M!(2X(#9[7Q5\=18^&8]:C8?:+B%8X]JL%%PP*R8#J_$;)(P#95@FW<=P)V_
MOP)T_1;5$O;>&ZNW_>7$\R+<.\K8,A#RINV[ONC XY8%RS'$^%OP4N_ M[>Q
MK.#I%PLAC@1Y5E1V*[2#]Y"J;DWK)N;",>0-GE6@Z#%H/CX6]N"$#.WS.\C%
MGL6D=BTC,[$NQ))).37JO[2O@#5O'$%M::8P\EIB+E"X0$?*8W;(RR(0Q91D
MDE2$8J"M7]JW0+*/069TC1X&A6TZ(5)=%:.,#''E!LH,C"[L?(",_1%7QGX.
M-[J2I<W,=A?[)941Y%*>:BL&()#8C7+?>8J&8EN:ROV.?"=GJ.FR74]O#)/'
M?OLE>-&D7;' R[6(+##$D8/!Y'-:%_XCM?'VN7<&HB2XL-.:)(;>*VNYD,^?
MWDLODJV2C(\:K(IC=2=H/SE^?^-'AR& VVI>&+2Z@U"&8#$%A<P(8RKDLRM;
MJC$-A3_>5F5PR@;?I3P]J3ZI;0W$L9A>2&-VB;.Z-F4,4.0IRI.#D Y'0=*X
MK]H;7Y] T.[N;1S%*JQ*KKPP#S1QM@]CM8@$<@\J00#7"_ O1/#?C32XK9+>
MV>Y6WVW".B?:MV )9 QS+M+/E'5L+N5049=J^J_"_P %?\(181Z>&W+%)<;#
MG)*-/))'N.U?FV,-V !NSCC!KYJ_8U\,PZ]]O6Z'F0K]E)A8*T+D^?M9U(._
M;@E5)V!CO*EUC9-#QG:)\-_&5D=-41)=+;+)$H"0[99&MW4)'L&,() #D>:-
MYSP*ZOXOZ^/'6O6?A8.5M@WFWBC<!(50SK"<;&QL0'<KD9D#8WQ"M_XH_LWZ
M=K.G/#I]K'%=10G[.R#:S,NT['.] Y<)LWREBI8OG.<Y_P"S5XY_X67I<MGJ
MNRYDMY$1UD3?OB(#0M)O!5VW*PS][Y S?,=S<!^S9I<>D>*M2MH%VQ11WD:+
MDG"K=1*HR22<  9))]353]M/PI:Z3-9W-O$D<L_VGSF0;=Y4QL&8# +9D8EL
M;FS\Q.!CZ5^+'_('U#_KPN__ $2]>5?L4_\ ('G_ .O^3_T3!65X;@C^./B"
MXN+L))I^F?NX8A(7CE8R/LE(P4=7\MF;&T$")#YBAB<G]KWX<6N@V<%Y8HEN
MK7"Q2Q1)Y<<AV2/%(54A-R8D4':6(D(W   _0'PG_P"0/I__ %X6G_HE*Z#5
M-,74XVAD+A6QDQR20OP0>'B9''3G!&1D'@D5\=?!OP)%J'B+4]+0F.T5;N-T
M5G#M"EW$/)#APRAMJJY.XM'O7AF#KM_M%_ &W\$V\>L:*'@\B2,2*LC';EOD
MG5G<N&#E5PI/56 7:Q;TKQ!?0?%+PL^IW"N&^P7,FQ9)8H_-B5LDHDNUU$L6
MZ,2;\#!P"2*\O_9J^$<'C_2IQJ$DC6ZW,JQ0(WEJDIBBW7&1]]PI54#@H@#_
M "MO.-;Q%I,#ZCIW@6UED^PPL\MUN/S2D[[L0L46+C:.&4X!D4D%XA7?_%']
MF_3M9TYX=/M8XKJ*$_9V0;69EVG8YWH'+A-F^4L5+%\YSG/_ &:O'C_$C2Y;
M34)7>>WD1&9'EAF,1 :)FEC96+%E=258,RK\^2Q+>8? ;PA WB?4K$ K;1+>
M)Y0.5>-+J-5B<MEF3IN&1O VN61G1I?VL/#%OX%O-/U#3(TMY?G(6..-(PT#
MQO')L" %LR?,6R"%48X.?9?BC\)=.72M0GEA$UR;::9KF7Y[@R1Q95@_!091
M?W<>R(#*A A*US7[)3-X@T%[:X9_+CNY(T\MWA=5Q%-@/$4?[[L2=V2"5)V\
M5Y?\&_ D6H>(M3TM"8[15NXW16<.T*7<0\D.'#*&VJKD[BT>]>&8.NW^T7\
M;?P3;QZQHH>#R)(Q(JR,=N6^2=6=RX8.57"D]58!=K%NE^*VJ6WC[PD=<>WC
M%TT,"^88U\Q&6Z2.148EG5"^_:-V=K<\DBNE_9<\)V?]C6=]]GA^U?Z1^_\
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MA'&UB2N#S65^S.+_ $"[O-*DANAIJM))9RW$<D8"B7:%&^).9%8.5^4 JQ"
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MX8@2QAO\.9S=I'DRRLBJT,A8+&SF-,F-"2J@DC))).=7XE_\B-'_ ->&F?\
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MT=0RLI#*RD9# C@@CD$<$5\U?LY:(^H>(=7U6(AK7SKJ)9!DJ[27 E!1@"C
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M,K@XQSD_ +_D<-6_[?\ _P!+(Z/VY_\ F'?]O?\ [;U] ?%C_D#ZA_UX7?\
MZ)>O*OV*?^0//_U_R?\ HF"N4^ 7_(X:M_V__P#I9'7I?[6&J1V6@3QR-AII
M((XQ@G<PE64C@''R1L<G XQG) /%>)_#,WAKP$;6Y&V41PNRX8%?,O$E"L&
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M8^*>'?#VH_ ;7+*S\\SV%[,(P ?+1V<QQNQC)?8Z,R-N'+J H<9=5T/VY_\
MF'?]O?\ [;UZK^U'_P B[>?]N_\ Z414?LN?\B[9_P#;Q_Z42UY5_P U#_S_
M - ZNK_;6_Y \'_7_'_Z)GK5U?XI?\*U\+V%XL?F2O:6<42G[@=K<,&?D':
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MY'#5O^W_ /\ 2R.OJJO"O'WQ/N->UV+PM92/:J<_:;A0IE(,!F\N(G.SY/\
MEI]\.05 "?O.:_:O\%VGAC1HQ:1!#)J*-(^2\LC&.Y;=)(Y:20Y=L%V)&<#
MKW#X3_\ ('T__KPM/_1*5\__ +#'_,1_[=/_ &XH^/O_ ".&D_\ ;A_Z6255
M^&.HKX1\:WT%[\C74ERD9)3;F:5+B')W?QH % RV]E7 )./6OVJKM(/#]TKL
M%+M;J@) +-Y\;[1GJ=JLV!S@$] :E_9<_P"1=L_^WC_THEKU6OE7_FH?^?\
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M]BG_ ) \_P#U_P G_HF"O?Z\J_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#MX_\
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M************************BN[1+Q&BE4.CJ596 964C!4@\$$<$'@BN/\
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MOOY;>'MV#Y/S'<#\P#?> (U?B=\"+;XD2))?7%SMCW>7'&8%1-P0/@F N<[
M3N9L'.,#BNU\,Z&VB0B!YYKC;@!YS&TF   I:../=TSN;<Y))+'C%O5M+CU>
M&2VG7=%+&\;KDC*L"K#(((R"1D$'T->2?#C]GJ7P,\T<.I3_ &*5B3;JB1MU
MP,RY9E)3Y6>$0N3M8,I10-#XA_L\6WQ F$]_=WC;=PC17@6.,,<E540?0;FR
MY 4,QP*Z6[^'C7E@VFRWMTZ.I1I&^SM,T9C\LQ%C;X((Y+D>:6Y\SM7*^'OV
M;;/0;:>PCN;IK6X5A+#(;=XRQ4JL@!M\HZG#*RD'<B%MP4"HOAK\#;WP;']D
M;59GL_F/D1Q)"<L06 E9I9$4C=D1&-@S%U=6R34\'?LQP^$=0FO;.[FBMY8V
M3R$"APC,C-'YS%GV_+@% DJC&)=P+-;^(/[/G_"0:FFM:?=O97BX+N$\X,54
M(K %TQ\@V.O*.N 5^]N]/T323IB%7EDF=F+-)*5+$X & BI&H  &$503EB"[
M,S:%>*WO[-2Z9?'4]!O'TZ5M^]%B2:'# 9548H N06VMO4-M*!-BBNK\'?"1
M=)NCJFH3O?:@8_+$\BI&D:C<,11(-L>5.&.22=Q!7>X,OQ$^$Z^/4:"ZN[I;
M=F1C!$8$CRHXR?(,C#/S89V&[! &U<'P[^$Z^ D6"UN[IK=6=A!*8'CRPYP?
M($BC/S85U&[)(.YL]U7'_%7X9P?$:R:QN"4.X/'(O)20 A6QD!AAB"IZ@G!5
ML,,7P+\);OPY:I:2ZI<R"+B$HD,8C7@ 8=)C)@%E D9HU4C;&K1QNN5X;_9H
MMO#5T;^UOKY+EM^^0R0.7W\MO#V[!\GYCN!^8!OO $:OQ.^!%M\2)$DOKBYV
MQ[O+CC,"HFX('P3 7.=@)W,V#G&!Q6KJGPIM]=T]M+U"6:[C.-DDQC,Z$*%5
ME=(TRPY.Y@S-N8.65BM>-6W[#ULL^Z2]D:WW-B-8E67;SL'F%F7(XR?+PV#@
M+GCZ*T#0(/#T"6EH@CAC7:B+T Z]^22<DDY+$DDDDFM"N:\>?#JR\=0&VOH@
MXVL$DP!+&3@[HW()4Y4$]FQA@RY!\ZT+X":CX2W1:1K$T%J<;(98([K9U+8+
MLJKEF9CL1,Y&[<1FNU\,_#)=.N!J%[<37MX(PJR3;!'$2H60PQ(JI%OVC=C+
M8&-QRY;5\=>!;7QQ:O97J;HVY!'#HPSMD0X.&&>#R""58%20?-?#?P$U'PU&
M;*SUB:.Q,CGRA!&951S\RI,S$HV.C(J@.2X0$FO2O O@6U\#VJ65DFV->23R
M[L<;I'.!ECCD\  !5 4 #@/$G[-%MXENA?W5]?/<KLV2"2!"FSE=@2W4)@_,
M-H'S$M]XDGJO&/PQ'B^R&GW=W<F(_P"L(%LKR_.LB;B+? VE1CRPF1][=UJ+
MP!\)U\"P-:6EW=&$JX1)# XC9\'>F8,@@Y(4YCR6)0DDUS^C?LY6^BWKZG;7
MMZEU(TC2.&ML,9"6?*&VV$%N<%< @$ $#'C7BGPW'XE\=O:3%U5]I#QL8Y$9
M; /'(K#HRNH93R,@9!&0?6M2^ -UXL>,:]J<E[;Q-O6!(8[12^1RYC)W#;N7
MH& 8['7)SVOQ$^&-MXTTYM+8")-J>2RHI\ID^X57&  /E(7:2A905SFN:\'?
M!6XTRU.G:AJ,UW9"/RU@"+;C9\V4:12\Y7D *LB *-A#1G;57X4?L\+\/)IG
MBO)GAEDC81!4CR(RYC$CC+OC<,[#$KX(=61B@/$G[-%MXENA?W5]?/<KLV2"
M2!"FSE=@2W4)@_,-H'S$M]XDGJO&/PQ'B^R&GW=W<F(_ZP@6RO+\ZR)N(M\#
M:5&/+"9'WMW6CX:_"U/A]']GMKFYDM_F*PS-$Z*6()92L2..A^4-LRS-MW'-
M9^I^$(-8\0P7P!6:RLB7.>'$[2QP+CD$*%N"V-IRT?+#(7T6BN?\=>!;7QQ:
MO97J;HVY!'#HPSMD0X.&&>#R""58%20?-?#?P$U'PU&;*SUB:.Q,CGRA!&95
M1S\RI,S$HV.C(J@.2X0$FO2O O@6U\#VJ65DFV->23R[L<;I'.!ECCD\  !5
M 4 #@/$G[-%MXENA?W5]?/<KLV2"2!"FSE=@2W4)@_,-H'S$M]XDGU72[)K*
M-8Y)7F89S)((P[9)/(B2-.,X&%' &<G)-JO%='_9VG\,ZA->Z5J+VD%Q("]N
MD$3C;NW%%+$QC!+",^43&IV_,-VX\5_LQPZQJ$&JP7<T5Q')&\SL%G>5T966
M0;R$C;C& AB "A8E52K>P:7I_P#9\:Q[WD(R2\C;G8DEF8\ #))PJA4485%5
M0%'/^.O 1\81O;R7=S#!)'L>.$PJ&&23EFA>09'RL P4KP1@MGA-$_9AMM!0
MQ6>H:G A8L5BN5C4L0 6(2(#. !GK@#TJ:X_9BL=3DCDU"ZOKU8]VV.YN2Z?
M,,'E51QT!^5ADJ,Y'%>GZ!H$'AZ!+2T01PQKM1%Z =>_)).22<EB222237F'
MB+]G]FU-M9TB]>PN9-WF@11RQ-N50<)E!R07??OW.0XVL :A\<_LRVWC%X&N
M;J=C&UP99&*O<2^80R*'("1)&P.V-(]@#-M569F/0>)O@K%KMI;V1N;I1!<I
M.9C,\MRSI$Z*1)(6\L[B'^50H(.U5+9&5=_!O4M31K.[UF>2P92C1""%+AH\
M856N,%F/02,5_>#<& W&NEUWX4V^HV*Z5;RS6EFL9C,=N8UWJ2"0S21R/S@[
MB&!?<WF%]QK/^&?P3A^')(LKJZ,3-N>&1H7B9MI7=@0AE/3)1E+;5#;@ *Q?
M$G[-%MXENA?W5]?/<KLV2"2!"FSE=@2W4)@_,-H'S$M]XDGJO&/PQ'B^R&GW
M=W<F(_ZP@6RO+\ZR)N(M\#:5&/+"9'WMW6HO 'PBA\%P-91SSSVC*X-O<&&2
M(;\;\8A5L'G*;MAW,2I8YKR7Q-^Q+:WLQDL;M[>(Y/EO'Y^TDDX5O,C.T @
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M9G>-\,>#N4*R[5"%54+7/_#S]GBV^'\QGL+N\7=M$B,\#1R!3D*RF#ZC<N'
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M$<GRWC\_:22<*WF1G: 0 &W-QDN<\>R?#/X567PY@-O8J<NVZ21R&E<\[=Q
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MH!U[\DDY))R6)))))-:%>0>-?V<X=5OEU?3+A["^$@=G1%DC8X;<QC)7YFR
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M\9 PPP<'G&#XIX+_ &=K[PEJ$FK0ZDCW$WF^;YEF"C^8V]LA+A,?. PV%<$
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MEM=AI96VHK1S1@MV7=)&JY/0 G).%&20*] N[M+-&EE8(B*69F(554#)8D\
M <DG@"N4A^+VDSI<RI=1M'9K&T\BDM&H<$IAP"KDX( 0L=WRXW$"K>B?$K3M
M:M#J,-S']E#%6E9O*56R%VMYFTH<D8# $AE(R&!.+/\ 'G1[;R3-.\2W&/)>
M6WN88W!V_,'DB5-OS EL[0""2!S6UX\^(MEX%@-S?2A!M8I'D&60C VQH2"Q
MRP![+G+%5R1YK^S]\:8O%,5Q+?W,<<\^HR>1!),@=8RD(BB13M+ '*@A1O;<
M3EB:[_Q#XTTC3[N"*[E@-Z)EBA7"R7"/,   %#/&'7 +':I!&XX(KL*\UU3]
MI'0-,D:&2]0LN,F-)9DY /#Q(Z'KS@G!R#R"*] TO5H=7C6>VD26)L[7C970
MX)!PRD@X((..X(K$\7_$K3O!P)O[F.(A5;86S*5+;0PC7,C#.>0I P2> <9_
MC'XT:1X-D$%]=(DO= 'E=>%/S+$KE,A@1NQN'(S@UU>EZM#J\:SVTB2Q-G:\
M;*Z'!(.&4D'!!!QW!%6J**\U_:$\0R:9I;VUNGF7%](ME"IQMW3AE.263'R!
M@IR0'V[AMS7DO[-UV_P[UJ]\-7;$EVW0G)VED4N&"+O53) 0Y)8$! C9; 'U
M)145W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5PNE_'S1-5NEL(+Q&G:0QJ-L@1
MF&1A9"@C.2,*0Q#D@*22,^*?L,?\Q'_MT_\ ;BO>O$/C32-/NX(KN6 WHF6*
M%<+)<(\P   4,\8=< L=JD$;C@BNFU35H=(C:>YD2*)<;GD9409( RS$ 9)
M&>Y KE)?C1I$5K)?FZ3[-%<&!I '(,HP=J *3)P0P*!E*Y8':"1MVGC:RNK1
M=26>,6C*&$S,$CP3M&2^-IW?*0V"&^4@-Q7*:!^T-H>OSI:6UV&EE;:BM'-&
M"W9=TD:KD] "<DX49) KT6O-=4_:1T#3)&ADO4++C)C269.0#P\2.AZ\X)P<
M@\@BNU_X2RS^S_;OM$/V7_GOYB>3][9]_.W[WR]?O<=:\0\(_M&VWB;7Y<W
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MN[1Q)#(NY'7H1T[\@@Y!!P5(((!!%:%>(?M6?%6?P3916]FQCGNV=?, Y2-
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MT(Z=^00<@@X*D$$ @BLK5_B/8Z7/]C:0O<!2S0PQRW,JJ-GS.D"2,@^=<%@
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MP$PY8>8LI<G>-JE2-U=?^T3#9^)?#DFKK GFO;V;Q2O&GGHDDT3!=W)7AR"
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M!9 64I*H&,;L^:_M'>(;?3-4M/$&C75M+*NU9%BEC9MR$E3)Y4@D=7C)C;@
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MZO:O&^MIKWAZZO(@0D^E3RJ&P&"O;LX!P2,X/."1GN:\Z_8I_P"0//\ ]?\
M)_Z)@KW^N5^+'_('U#_KPN__ $2]>5?L4_\ ('G_ .O^3_T3!7'_ +1%L+KQ
M;I<;9 9;%259D;!NY0<,A#*?0J00>00:]*_:ET" ^'90$"BV:W:%5^54/F)"
M,*N!@1NR@8P >!D CA;CXGW&A>![:=9'6YE_T6*1 H*!99%'/&W$$)4, 7#8
M;.[+#U7PS:KX<LQI\&CW/D>6$<'^S?WOR"-FD NPKLR@;R1\W?CBN/\ V?/
MNJ>#+^]BEMC;Z7,SR0*\L<C(PD C7"328)B;#DY)*)\_'/O5?%?[:W_(8@_Z
M\(__ $=/7VI17F'[1_Q ?P3I$LL.1-.P@B89&QG5BSY#*RD(K%",D/MX(S4O
MP-\!V>DZ+;(D2-]IM(GG+(A:7S5,A5R%&]1YC*H;.$XYY)\:@A/P@\8);0,5
MLM09#Y*;=N)B\<:E=J*H2?)7;RL7 ))93T'[9_AZV@TZ.\2&-;A[V)7F"*)6
M7R9OE+@;B/E7@G' ]!7J'PM\+6\^@VULR9CN;"'S@6;<_F6Z*^6SN^[A5P?D
M0*B;550/"OV+-+CU;[8+A?,6"2VDA1R6C21O,S*J$E!+^[4"3&]0,*P!(-KX
MV_\ $N\9:7)!^[>3[%O9/E9MUQ)$VXC!.8P$.>J?*>.*V_VS_#UM!IT=XD,:
MW#WL2O,$42LODS?*7 W$?*O!..!Z"NU^&WPDTS5=(M7N[:.XEN+*W,DLB(9<
M&WC155PH9 J!539@C&XDR%G;R7X)1R?#+Q3<: IWP3[@#D$@+&UQ ['8"6$9
M*,!M7<Y/(5:]5\&?":;PEK6H:_>W2-!-')LW%@R(S+(V]G.U%C6,(N"04&?W
M8&VO)/BGK\%WXOTRYTYP0[62O+%PLA-P\;X=<"0>7^[8@L, Q$Y5E'5_MG^'
MK:#3H[Q(8UN'O8E>8(HE9?)F^4N!N(^5>"<<#T%>E?"OP7:2:);QF($7>G6Z
MW#9/F2*T &UGSO("L509Q&N%3:H 'C7[$O\ I\.I6LWSP'[/F)OFC.\3+)\I
MROS*H#<?,  <@"JOP=TY?A)XIGTJXXBN(V2WD8)E@S"2']XRH>0#&PC^5I@%
MP=JE?H3Q/:)K>H6=LRAA;L]XY(#A656@@4C^$LTSR1N><V[!02"R=A17RK^P
MQ_S$?^W3_P!N*ZO]M;_D#P?]?\?_ *)GKT#X6^%K>?0;:V9,QW-A#YP+-N?S
M+=%?+9W?=PJX/R(%1-JJH'C_ .PYJDDL-];%OW2202*N!PT@D5SG&3D1(,$X
M&. ,G/=?!OX8O\)!?WFJWD;BXFC)F=B@VJS[9)'D(P[M+RN6 .,.Y;CS#PWJ
MD<GCTO9-M@FWYV HD@-GYC-C #JT@\P-RLAQ(I8$,;7Q]_Y'#2?^W#_TLDKZ
MJHKXU_8]\"VOB>2[DO4\U(?LY6%_F@+.)E\QXR"KLJA@A;(7>Q S@C6_:C^&
MD/@62UUW2E2W87"*R(%""51YD,B1["@_U;;Q]TD*=I)<GM?C=\0VUK3]*M8Q
M-&=7DMS(D+1[S"ZIYL >3: Q,R $A58!@Y"DJ>ZNT2ZM&TUM%G%HRE3"IT](
M\$[C@)>#:=WS K@AOF!#<UQ7P T[5/AGIEXNM0E+>V5IX0)(Y7*A'>9%VRLH
M V!E'R@L[$DY.-7]FO2!JEK)XAN</>ZA-,S/ALQQK(8U@4L[D(#'D8QQL4Y$
M:FM;QC\#DUS5[77+><V\T#1^:JH#YRHW0LK(P+(3&Q.\%-JX 4AO.M-U"'XJ
M>+YH+M-]KIUO.D4+JK1LZND,K.C%U.6=B"-I(2(GE2#VO[37PTA\5:7-=!46
MZMH_-64A0Q2(,SQ%MC,5VLY500/,VDD#-'[/?B1?B/H2)J(^TM'(T,WGJCK(
M4*R1D@YWX1D^9AN+J2<GYCY)\!M @D\6ZE%L CA:\:.,?+&I2[C$?R+A2%X*
M @A6564!D4BW^VQ;#3KG3[Z'*7!69?,5F# 1-&\>,'Y2K2,01@Y/7@8]P^(_
MA2UT[0]0ABB0(;2YD;(W%I%B+"5V;+/+N56,C$N6 8L2,UXI\#O'4GA;PA?W
MF]]T%Q,D&,/L:1(5CPKG:%$LN]ATY8X).#Z+\&)GT+3H)(M.NI9;B%)9KG=8
M>9.\F92[.UTDCC,C;/,&X*0#SFL#X<> -2\,^(IKNTLC:Z3<J0\;20G81'N#
M".*=P#YP(7&X(CL%"@_+S/BSX@Q^!/&DMUJ:.UNUO%'"[ MY*M''F6,$'*AQ
M(K;,'YI,;FRC>X6FFZ=X\N+/7+*2.1[9G E3YF*/"ZF!^05(,JOM<%D.1M7>
MQKNJ\E_:!^#=S\3DM8K>X$*13,95;<596 'F *<,Z $*IP"';YTYSE?M5:_9
M7&CW5H7C>ZC:W81C$DL9,L?[P@9:(%&*[VV@[PF<R*&T/@)I<?BOPO;6U^OG
MQ21S1LKDME5GD5 #G(VA5"$$%-J[2,#'FG[+O_%#ZUJ.A3_?/W'?]TS^0S;=
MJ').^.0RC!.$7(W [A%^UA:)X>U.TUFT4&XA:!I@0 FX.[VK-C:S%O)E5B&)
M"Q*#L^7=[UXTU2/Q%I\<5NV]-2\J&,X*EHIEWS.NX#:RVHED7>/O* 58D(V5
M\;OA;-XVTL:;I\B6^R2(A#N2%D0%1$?+!PHR&4;6&Y%&!PRY_P 17LO#6@2Z
M-<S1R31Z44CC(!E<QPE4E$0+N 'CW[AD1[2Y8!"PY7]D2T37M"FMKQ1/"+V1
M1'*!)&%"0R!0KY7&\E\8QN);J<UYS\(? MKKOBK4;69/]&ADNV$"_)"XCND$
M<;H!AH@<,$^Z61<@J"I[OXU^'++P0(--TN*2!M8O8TN1;L 9(5;#Q)YK[(B6
MG 4*%C(RKD)\I]*NT2ZM&TUM%G%HRE3"IT](\$[C@)>#:=WS K@AOF!#<US7
M[+_A/5_"-K/8ZK%Y<2R*]OF1)#\^[S5&R1PJ@A6 POS.YYSQ[57S7INH0_%3
MQ?-!=IOM=.MYTBA=5:-G5TAE9T8NIRSL01M)"1$\J0>U_::^&D/BK2YKH*BW
M5M'YJRD*&*1!F>(ML9BNUG*J"!YFTD@9JU^S/XZD\8:-')<.\D\,CPR.^,L5
MPR'(.6_=N@+-\Q8$G)^8^5? +_D<-6_[?_\ TLCKZJK/\0Z:^J6TUO%(87DA
MD195SNC9E*AQ@J<J3D8(.1U'6O-?@UX.3X,:88=5NH$,MR[ERXCB#,BJJ!I-
MFX[8]W13U !"[CY5^S5<B/Q/JD-OF.W*W3+%M:)0%ND$>8R%VE58@ J"@)7
MR17U?1111111111111111111111111111111111111111111111111111111
M11111111111111111117RAI?C(?!SQ5?17SE;*]9I6D,;  ONFC<!5=W"NSP
M_*0"26;!7:/:O&/Q]TCPY;/<+=P3N%;RXHI5D9W"LRH?*\PH"1C>PVJ2,GD
M^8?M>>#KK4]+M-0F*&6TXN5C_P!7F81JSJ78-M$J!5&"Q#@G&TU[5\+_ !U'
MXXT^"]C=&=HU$P3("2A1YD>&)888\ YRI# D$$^*^#]"_P"$J\;7NI0-F"RP
MKG'64V_V8QX8JP^99#N 9?W>.C*:R?VY_P#F'?\ ;W_[;U] ?%C_ ) ^H?\
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MM5=^X@E2X4JISR/*OVF[RZ\$:UI_B&%=T21B(X[E6D:2-F*,J^9%*54\MP[
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M$[@"K2_!WPW:Z'IL.J3'=<SVD<US=SMOF(:-'8-*_(B4* %R%"J"<MECX_\
ML,?\Q'_MT_\ ;BHKF[2U^(6Z1@H+*H+$ ;FL B+SW+$*!U)( Y->X?'OQ-#X
M?T6\><X\VWD@0 KN9Y5,:@ D9QDLV,D(K$ XQ7A4/@Z3PUX#N&F/S74D%R%X
M^57FMUC&0QSE$#]B-VT@%37K7[*MVD_A^U5&#%&N%< @E6\^1]IQT.UE;!YP
M0>A%>=>+[-?B'XUMX[1OET^.%IW&QE!@E:4@8<9^>1(F_B1RV5(4YJ?MS_\
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M68MG9LB_;#M+;1M&MK.W6.$?;0R0H%C&T1S;V5%QP&<;B!C+#/+<]U_S)_\
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M*8HQP#U=P,]!G)(&37*_LJ^#I/#6BQM,?FNI&N0O'RJZHL8R&.<H@?L1NVD
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MD9) K2R'!=VDD.,_Q-M0 $"N/_8I_P"0//\ ]?\ )_Z)@KE/@%_R.&K?]O\
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M,SS6X>2YESYMS,YDG?+ESEN ,D\[0N["E]S &CQC\&],\9R";4(GF8?=!GN
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M\PN;&!X91CYDN+D9 (;:P\W#*2H)5@5..0:E^*GP:LOB8D27ID4PLQ1XF"L
MP 93N5U(.U3TR"HP0"0:EW\"-/U*T:SO6GNBRD">XF>:X0DY#1L^5C/0'8JA
MPJB0.!SH>!OA#8^#[?[)$'F3RY(R9W,WR2,6D0*<1HK$C>J(H?:I<,0#7/\
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M\0;OL5Q#/LQO\J1)=N<[<["<9P<9ZX/I6?:?$W2KQUBBOK5W=@JJMQ$S,Q.
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M$&FQ64B1F9UA267SHLRX?;R5R$5B6"@MA2[J#]H;]HVVTJT-GI%P)+J=?]=
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M3I"I^Z"27;!4':B@N^-PSM!V@Y.!S6?X'^+NE^.7>+3K@2O&H9EVR1MM)QN
MD52P!X)&0"1G&X9["BN:U?XCV.ES_8VD+W 4LT,,<MS*JC9\SI DC(/G7!8
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M%]=(DO= 'E=>%/S+$KE,A@1NQN'(S@UJ^#O']CXSC,VGSI,H^\ 2'7)8#<C
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M'XT:1X-D$%]=(DO= 'E=>%/S+$KE,A@1NQN'(S@UJ^#O']CXSC,VGSI,H^\
M2'7)8#<C .F=IQN W 9&1S7 ?M(_$&WTS2+VUAN85O#&D9A\R,S;9'19!Y9)
M;F)R<XR%.X$<&LG]G#Q9IK:%::?<W%MYK^?&UO))%O;S)Y0$,;')W!AA2/F!
M'!S7K?A#P7:>#H!:6$0BB#,VT$DECU8LQ+,>@R22  HX  E\3>*[7PO";F^E
M2&(9^9SC) +;5'5F(4D*H+'' ->*_"#]H.W\47VHW%[<);6W^BK:Q3RQQX51
M-O(!*@LQPSXW$95-S*JFN4_;G_YAW_;W_P"V]>Z^,?C1I'@V007UTB2]T >5
MUX4_,L2N4R&!&[&X<C.#786EVEXBRQ,'1U#*RD,K*1D,"."".01P17'^,?C1
MI'@V007UTB2]T >5UX4_,L2N4R&!&[&X<C.#6WX0\:6GC& 7=A*)8BS+N ((
M8=5*L RGH<$ D$,.""=JBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO"O"<D?Q*\27ES<#=#I&R"WB<'
M E+OON,;RNX-$P4[>5\MB%>,&NV^,_P?A^)UJMO(_DRQR!XY@BN5[.I!*DJP
MZ@,OS*C'.W!\T_:?\7S>"M%MM)$CR3W$8BDG.X,Z0J@F8G?N#2,R@@[PR-(&
M.2"?9=#^'%AH]DNFI!&UN%0.KQQD2,H4>9( H5W.Q26(R2 >PKYZ^!LLGPU\
M2W/AQI'>VDWF)<AE#;%GCD8D)AO(!5R@PS[005567/\ VU?#UMI;V4MO#'&\
MS7;2LB*C2-F$[G*@%CEB<G)R3ZFO=?BCX+M+;0M0MTB 3[--,V"0S2QIYBRN
MV=\C[XU+,Y9G(^<MDYXK]C"[>?1I%=BP2]E5 22%7RX7VC/0;F9L#C))ZDUQ
M_P  O^1PU;_M_P#_ $LCKZ ^+'_('U#_ *\+O_T2]>2_L:VB7FB7,4JAT>]F
M5E8!E93! "I!X((X(/!%<?I>DPZ1X_6"VC2*)<[4C5409T\DX50 ,DDG'<DU
MZ+\;+\>*]6T[PPQ*PSL;FY^\!)'&)&2'*R*<,8GW9'RGRW4DJ17JNO\ @ZVU
MRR?39$"V[P^4%55 1<80H"I52F 4XPI ('%>:6?PS?X<^&M1L'N#<C[->NC%
M3&$5H#\@4N^!N#-P0"6)QG).+^Q3_P @>?\ Z_Y/_1,%>_UYA^T?\0'\$Z1+
M+#D33L((F&1L9U8L^0RLI"*Q0C)#[>",U+\#? =GI.BVR)$C?:;2)YRR(6E\
MU3(5<A1O4>8RJ&SA..>2?&H(3\(/&"6T#%;+4&0^2FW;B8O'&I7:BJ$GR5V\
MK%P"264]A^VM_P @>#_K_C_]$SUZK\)_^0/I_P#UX6G_ *)2NJK/UOP];:\@
MBO(8YT#!@LJ+(H8 @, X(S@D9ZX)]:^9?V&/^8C_ -NG_MQ65\;?"EKIGBK2
M[:UB2")_L6Y8!Y'+74BE@8MA#8 &X$,,#!&!7JO[3GA2UM?#DR11)&EO)#)"
MD8\M$9IE1B%3"\K*^01C+$XS@UG_  ]NWNO [M(Q8C3M04%B2=JF=$7GL% 4
M#H  !P*B_8I_Y \__7_)_P"B8*BT'Q%_PEOB'4+A[6>]33VC@MHQ]DV0.&/F
MR@3RQ_.98<I(I+;>&QA I\??!M_X]2"?3]-GAOX)E*SM+9QL(P&.T-'=L<B3
M:RY'RG<5(W'-_P#:)T1;[PY)?7UO"NH+;V8=PB,\;&:+S(T?YF"AF8 !B,$\
MG))ROV?/@YIGB70HIK^'[0\_F#,C,3&L<\FV.(J5:)=V78(079VW$@@"+P7?
M1ZOKEX([2>[M]*6"TLX1]E*6^P[7D N)D.\R0?)(&+[>'(^0"W\??!M_X]2"
M?3]-GAOX)E*SM+9QL(P&.T-'=L<B3:RY'RG<5(W')^U1->S^'+=YE*2M-;&[
M2/)C4F)RRMM9AL$VT#)(W;.2<&NJ\!_$S0_BM9#3<1H7A5'L7PA4 'Y8\!0X
M4)N5H^4 5B(VP!G_ !WT+_A'_",EENW^1;V46_&W=LE@3=C)QG&<9./4UJ_L
MN?\ (NV?_;Q_Z42UZK7A7[9/G?V*OE;]GVN+SMN[;LVR8WXXV^9LQNXW[>^*
MV_ ?Q,T/XK60TW$:%X51[%\(5 !^6/ 4.%";E:/E %8B-L ;?BS0O^$?\-W%
MENW^1I$L6_&W=LMBF[&3C.,XR<>IKS3]BG2X_P"S9[DKF7[7)&&))POEP,0H
M)PN3@L0 7VIN)V)MY_0/^*?\?306OR1S^9YH^]NWVHN7Y;)&9@&X(Q]T87BM
M;3=0A^*GB^:"[3?:Z=;SI%"ZJT;.KI#*SHQ=3EG8@C:2$B)Y4@]K^TU\-(?%
M6ES705%NK:/S5E(4,4B#,\1;8S%=K.54$#S-I) S4O[.7B\^/=#47I,[QM+;
MSF4*PD  (!Z[QY3JK%AEB&W9SN/E_P"PQ_S$?^W3_P!N*B^.]HD'C'2V10I=
MK!G( !9OM3IN..IVJJY/. !T KUK]J/_ )%V\_[=_P#THBKFOA-XO'@[P8E^
M2 8H;HIN#,ID-Q*L2D+S@R%0>1@')('(M_LK>%T:Q;7)L27M_-.\DNT*P7S6
M4H,': 74N=H4$D @A%->7_&'PS#HGC*P> ;?M%Q8SN %"[S<&-B  /O>6&;.
M279B3S@?7]%?'?PL\(0>*?%NIPW8+1)->R-'G$<A6[3:D@_C0,0^P\%E7=D
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M27:%8+YK*4&#M +J7.T*"2 00BFO+_C#X9AT3QE8/ -OVBXL9W "A=YN#&Q
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MRYN!NATC9!;Q.#@2EWWW&-Y7<&B8*=O*^6Q"O&#7;?&?X/P_$ZU6WD?R98Y
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M*!LP66%<XZRFW^S&/#%6'S+(=P#+^[QT9363^W/_ ,P[_M[_ /;>OH#XL?\
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MC*T;3LK"-AGYE5$12><@L&*E59=I&:[7QY\.[3QW%';WZEXHYA+L#% S!'0
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M22%1@,S'\3M7" EBJC)KG]4_9RT/5Y&GN;=Y96QN>2YNG<X  RS3$G   SV
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M23R\K.YZ\9)P, < "O'_ !-^R-HNMS&=!-;[LDI ZK'DDDL%D23;UQM7:@
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MATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"N*\%?'/3/&]XUCI[O*RVYF,FQDC
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M=0RLI#*RD9# C@@CD$<$5+111111116?K^OP>'H'N[MQ'#&NYW;H!T[<DDX
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MR 03Z+11111117%?\+>L?[7_ + R_P!K\O=]P^7G9YGE[NN[R_GSC9CC=O\
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M(!YX.!CW7Q3K/A_QQ;O;7MS9SP)MD<?:(_DPP57W)(&3YF"[@1G=LSAL'?\
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M2,C@LC^6JF0*0#\Q4 'Y20>*Z#PSXKM?%$(N;&5)HCCYD.<$@-M8=58!@2K
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M)*X&2*Z#2=4CU>&.Y@;=%+&DB-@C*L RG! (R"#@@'U%?+_P"_Y'#5O^W_\
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M:7JT.KQK/;2)+$V=KQLKH<$@X920<$$''<$5:HKCQXTTAM12W26!]1D66$;
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MLS,0JJH&2Q)X  Y)/ %<5-\<-)@"N\Y6)YO*2<PSBV9]S+@3F/R2,JWS!]N
M3G )K:TOXA:;J\BP6UY;2RMG:D<\3N< DX56). "3CL":Z"O*OVH_P#D7;S_
M +=__2B*N?\ @;X_L?!GAFRFU"=(5/VC:"27;%U(#M107?&X9V@[0<G YKU7
MP=X_L?&<9FT^=)E'W@"0ZY+ ;D8!TSM.-P&X#(R.:J_\+8T?_H(6?_@3#_\
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M*\O=YF_RVV;=OS;MV-N.<XQS7@'[+?QLTO2+%=*NF2UG621O,?"QS;BS[V?
M5650$^<C("!6).U?>O!'@.#P:+A+0!(I[DSK&HVK&6CB1E')X+(6 &T*&VJH
M"BOG#X):7'J'C#5/-7<$DO9%!)V[EO(]I(!PV#\RA@0KA7 #*I%K]LW_ (DE
MYINI6_R72^;B3[W^I>*2+Y6RORM(QZ<YPV0 !ZA^T#\&[GXG):Q6]P(4BF8R
MJVXJRL /, 4X9T (53@$.WSISG*_:JU^RN-'NK0O&]U&UNPC&))8R98_WA R
MT0*,5WMM!WA,YD4-T'[,MV]UX?LFD8L0LR@L23M6>1$7GL% 4#H  !P*\D^
M7_(X:M_V_P#_ *61T?MS_P#,._[>_P#VWKZJHKQK]JKP];3Z+=7CPQM<(MNJ
M3%%,JK]HC^4.1N ^9N <<GU-<U^SY\'-,\2Z%%-?P_:'G\P9D9B8UCGDVQQ%
M2K1+NR[!""[.VXD$ 1>"[Z/5]<O!':3W=OI2P6EG"/LI2WV':\@%Q,AWF2#Y
M) Q?;PY'R 6_C[X-O_'J03Z?IL\-_!,I6=I;.-A& QVAH[MCD2;67(^4[BI&
MXY]*\;S3S^'KI[Q0EPVE3F9%Y59#;L74?,W ;(')X[GK7G7[%/\ R!Y_^O\
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M_DM5^T8C^]_J;D1Q?,V6^59&'7G.6R0".@^"WBD^*[B]UUK.YO)&NWCMY/\
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MZ!!XA@>TNT$D,B[71NA'7MR"#@@C!4@$$$ U\R_LN_\ %#ZUJ.A3_?/W'?\
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M5E61C&FU^S3XZC\4:-;QAT,]M&L,J+D% F5B)#$GYHU!W#Y2VX#!4JO >/\
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M^/O_ ".&D_\ ;A_Z625]545\J_MS_P#,._[>_P#VWKZJKY5^ 7_(X:M_V_\
M_I9'47[<MVC/I\08%U6Y9ER-P5C"%8CJ 2K 'H2IQT-?0OQ8_P"0/J'_ %X7
M?_HEZ\J_8I_Y \__ %_R?^B8*Y3]N?\ YAW_ &]_^V]?55?*O[#'_,1_[=/_
M &XH^/O_ ".&D_\ ;A_Z625%\3_$T_PF\6?VO*A>UNX4#!!RT8C2-U!==N]7
MC63:I&1L!90YQ[U_PNO1?)^T?;[;9Y>_'FKYF,;L>7GS-V/X-N_/R[<\5J^
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MP'SE0#M&XAE]0\8^$++P/H6H+$ I>RN!+/(09II&20*TLAP7=I)#C/\ $VU
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M?>9#+(LTH(/S*(T2!(QP -W+<+'ZU\6/^0/J'_7A=_\ HEZ\J_8I_P"0//\
M]?\ )_Z)@H_;6_Y \'_7_'_Z)GKU7X3_ /('T_\ Z\+3_P!$I7S_ /L,?\Q'
M_MT_]N*/VY_^8=_V]_\ MO7U57RK^PQ_S$?^W3_VXH^/O_(X:3_VX?\ I9)7
MH'[5'B2RL[&&PO0F;NX55=U=_(52/,NE"8+,@8 *&4MOQ\R[T.?+X<T&YM(M
M,GUPRV43(1 UY9A65#E8V=(UE9!T"[\* NW:54CV7PSJUGJ,(_L^2&2"/$8\
MAD:-=H&$'EDJ,*1\O88XQBM6O*OVH_\ D7;S_MW_ /2B*HOV5;M)_#]JJ,&*
M-<*X!!*MY\C[3CH=K*V#S@@]"*X7Q'I:_$3QG ;=7:#38XOM$J%-BR1M),B[
MLL#^\949>'RL@  0L/=/'_@Z/QG8SZ?,<+-&0&Y.U@0T;X#+G:X#8R V,'@F
MOG#]EZ:]N)WT*[4B'3[EYWSF1!(N^+[,<,8\><1<1XZ20LX#$AT^KZ**^5?V
M&/\ F(_]NG_MQ1^W/_S#O^WO_P!MZ^@/BQ_R!]0_Z\+O_P!$O7S5\)O#,WB7
MP9J5K;#=*;MG5<,2WEK:RE5"@DL0A"@#EB!QUKM?V;OV@K.YL4T[4ID@GM8P
MJO*R1QR1 X0!CM4,JX4J?F8 ."Q+[?4(?BO;:QJ$&G:9)'<EEDEN'C99$CA5
M64'<KXWF8Q@*-Q"EBP4%6KNJ************************************
M***************************************\EU3]F+29IUN[,SV,P:1M
M]I*8CE^#C<'"  D 1[!AB,$8 V]"^"=EI\D5Q<R7-[/!(SPR7<[SF,D*/E7Y
M8QRH8$J6#8.<JN._KR6[_9GTY;EKRQENK!W4AA:3>2IRV\]58J"<?(I" *N%
M&*[7P/\ #NT\%HZVBG?*P::9V,DTKXY=W;DDG+8&%#,Q51N-9_C'X-Z9XSD$
MVH1/,P^Z#/<!%R%!VHLH1,[1G:!N(R<GFK>A?#&RT"W:RM1-% V/D6YNAMPQ
M?Y#YVZ/+$EMA7?GYLBLKPS\!M'\+S"YL8'AE&/F2XN1D AMK#S<,I*@E6!4X
MY!H\3? ;1_%$QN;Z!YI3GYGN+DX!);:H\W"J"Q(50%&> *\*_;3TQ=,CTR&,
MN57[9@R223/R8#R\K.YZ\9)P, < "O7]4_9RL=09D\^\2S:0.;&.<I9??$C*
M(]ORJ7RQ"L-I)V;<#'HN@:!!X>@2TM$$<,:[41>@'7OR23DDG)8DDDDDUYKX
M9_9HT_PS.\]I/>QH[$M ER\41'S;%)B"2D)N.W+D^I.3FW-^SEI/]H+J<*R6
M[JN/+MY#;1$[63=^Z"NAVGGRW0''S Y?=J^)O@?I/B<H;N N(U"QIYTZ11J%
M5=L<:2+'&,(N0B@'&3DUH:%\,;+0+=K*U$T4#8^1;FZ&W#%_D/G;H\L26V%=
M^?FR*Q-$^".B^"W-];1&V,:EFD%S<HH12'._,VTI\H+!\J0/F!%6_B)=VWBG
M2V@A:.X2]9+>)E*RKN=]C2J!D.80&F(!! B8[DVEE[#2=+CTB&.V@7;%%&D:
M+DG"J JC)))P !DDGU-9_C3PA!XQM);"[!,4J@-M.U@00RL#ZA@",@@D88$9
M!/!?A"#P=:16%H"(HE(7<=S$DEF8GU+$DX  )PH P!M45S7B_P"'5GXP!2^6
M21"JJ8Q/<1Q$!MPS''(J,0W.2">!SP,97A?X(Z5X5?S+"*2 ED9@ES=!6*$E
M=Z^=M<#)X8$8)!&":[#5-,74XVAD+A6QDQR20OP0>'B9''3G!&1D'@D5Y_I?
M[.6AZ1(L]M;O%*N=KQW-TCC((.&68$9!(..Q(K5\8_!O3/&<@FU")YF'W09[
M@(N0H.U%E")G:,[0-Q&3D\UH0_#BQCLFTLQE[1UVF*2268!0%"JID=F0+M!0
M*0$(W+AN:\UMOV/-#AG\]O/=-S'R&E BP<X7*JLN%SQ\^>!N+<Y]JM+1+-%B
MB4(B*%55 554# 4 <  < #@"I:Q?%'@ZW\3IY5UYA3:ZE4GGA5E< ,KB&1 X
M(&,-D $XZG/*:)^S[HV@N9;.&2!RI4M%=7<;%202I*3@XR <=,@>E:'C'X-Z
M9XSD$VH1/,P^Z#/<!%R%!VHLH1,[1G:!N(R<GFK>A?#&RT"W:RM1-% V/D6Y
MNAMPQ?Y#YVZ/+$EMA7?GYLBLKPS\!M'\+S"YL8'AE&/F2XN1D AMK#S<,I*@
ME6!4XY!K$M/V:-/TI%33Y[VS.T"5[>Y>-IB!A6DR&7(^8C8$ +-QC '8>$OA
ME9>%H98;97W3\SS-(YN)6(P9&E#!PQR6RI4*S,R!237/_P##.6A^=]J^SOY_
MF>9YOVFZ\S?G=OW>=NW;N=V<YYSFMKQQ\)]/\;6R6E[&7$2D12;W,R$KMW"1
MB68]"=^X,P!<,0*Y#PI^RUI/AM9Q&9I'GMY(?,D:-GC61&1S'B-55BK8W$,<
M<# +!MKX=_ '2? 3K/:Q%KA5=1/*Q>3#'G XC4X^7*HIVY!)W-F+XE?L]Z7\
M09/M%RCQW'RAIH6".P4$!6#*Z'J/F*[\*J[MHQ6A\,_@MIWPY!-DA,K+M>:0
M[Y67<6VY "J.F0BJ&VJ6W$ U+XQ^#>F>,Y!-J$3S,/N@SW 1<A0=J+*$3.T9
MV@;B,G)YK5\'> [3P;&8+%72+LAFFE1>6/RK*[A,EB3MQN/)S@5T%9_B'1$U
MZVFLY20D\,D3%<!@KJ4)&01G!XR",]C7G7_#.EE9?+I]S?6,74Q6UTZ1LW>0
MB02'<0 "<XPHXZD]AHGPXL=!M#I]G&8("Q8B*26.0L2"6,J.)<\ 9W9V@)]T
M8KFM+_9RT/2)%GMK=XI5SM>.YND<9!!PRS C()!QV)%:OC'X-Z9XSD$VH1/,
MP^Z#/<!%R%!VHLH1,[1G:!N(R<GFL7Q?^SGI?B>VALW\^-+=F,16>21E4JJ&
M,>>9@$PBX4 !2ORXRVZU=_ C3]2M&L[UI[HLI GN)GFN$).0T;/E8ST!V*H<
M*HD#@<V_"'P9L?"UJ+.%IV 5E$C3RK*JM)YK*C1M'Y0+ ;Q$$$FU?,W$9K/T
MO]G+0](D6>VMWBE7.UX[FZ1QD$'#+,",@D''8D5;\3? ;1_%$QN;Z!YI3GYG
MN+DX!);:H\W"J"Q(50%&> *ZKPSX8@\-0BVM0XB7&U7EEFV@ *%4RNY50  %
M!"CL.36K7*^-?A?8>-]HU"-Y57&$\Z=(P1NPVR.14W?,1NQNP<9Q@4>"OA?8
M>"-PT^-XE;.4\Z=XR3MRVR21DW?*!NQNP,9QD4?$/X86/Q A$%_'NV[C&ZDK
M)&6&"RL/P.ULH2%+*<"N/\!_LP:1X-G%VBR3RHRM&T[*PC89^951$4GG(+!B
MI567:1FNU\7_  ZL_& *7RR2(553&)[B.(@-N&8XY%1B&YR03P.>!C*\+_!'
M2O"K^98120$LC,$N;H*Q0DKO7SMK@9/# C!((P34OC'X-Z9XSD$VH1/,P^Z#
M/<!%R%!VHLH1,[1G:!N(R<GFM7P=X#M/!L9@L5=(NR&::5%Y8_*LKN$R6).W
M&X\G.!7%2_LY6(U"35()[R"6:0O(D,YB1MS!Y%)5?-VNPRP#C!/R[<+B;Q#^
MSEI.M7,%YMDAEA96+0R%&E*L'#2/@R,^<DRAEE8DEG)"E=#7?@-H^O;?M4#R
M!,[0UQ<[06QO8#S<;G(W2-C=(^7<LQ).KH7PQLM MVLK4310-CY%N;H;<,7^
M0^=NCRQ);85WY^;(KG]+_9RT/2)%GMK=XI5SM>.YND<9!!PRS C()!QV)%:O
MC'X-Z9XSD$VH1/,P^Z#/<!%R%!VHLH1,[1G:!N(R<GFN@\,^&(/#4(MK4.(E
MQM5Y99MH "A5,KN54  !00H[#DUJUYUK?[/NC:\XEO(9)W"A0TMU=R,%!)"@
MO.3C))QTR3ZUTNA>!;;0H6MK?SEB:,1[3<W+[% *@1EY6,6 < QE2,#GY1CE
M?^&<M#\[[5]G?S_,\SS?M-UYF_.[?N\[=NW<[LYSSG->BVEL+5%C7)"J%!9F
M=L 8&6<EF/J6))/))->57?[,^G+<M>6,MU8.ZD,+2;R5.6WGJK%03CY%(0!5
MPHQ7:^!_AW:>"T=;13OE8--,[&2:5\<N[MR23EL#"AF8JHW&L_QC\&],\9R"
M;4(GF8?=!GN BY"@[464(F=HSM W$9.3S5O0OAC9:!;M96HFB@;'R+<W0VX8
MO\A\[='EB2VPKOS\V165X9^ VC^%YA<V,#PRC'S)<7(R 0VUAYN&4E02K J<
M<@T>)O@-H_BB8W-] \TIS\SW%R< DMM4>;A5!8D*H"C/ %=KI>F+ID:PQERJ
MYP9)))GY)/+RL[GKQDG P!P *M5YUK?[/NC:\XEO(9)W"A0TMU=R,%!)"@O.
M3C))QTR3ZUU?A?P=;^&$\JU\P)M10KSSS*JH"%5!-(X0 '&%P" ,]!CC_&/P
M!L?$MZ-362YM;S^*:VF,;M\BQC[P?;A!M^3;D$[MV:->_9XTC7/(6:-_+ADN
M)"@D?]Z\^WS'E<DS.V5!#;P> "2H"UJWGP9TJZM5T_[/LM5ZQ1R30HY^3YI!
M$Z>:W[M?FDW-D9SG)H\'?!O3/!DAFT^)X6/W@)[@HV P&Y&E*/C<<;@=I.1@
M\U+\3/A59?$: 6]\IRC;HY$(65#QNVDAAA@,,""#P<;E4BAI?P0L+.U6RD:Y
MG01F/=)<S[_+.08AY;HJQ%<*T:!4<(A=6**0>&?@-H_A>87-C \,HQ\R7%R,
M@$-M8>;AE)4$JP*G'(-'B;X#:/XHF-S?0/-*<_,]Q<G )+;5'FX506)"J HS
MP!6UK?PXL=>M!I]Y&9X P8"62620,"2&$KN9<\D9W9VDI]TXKSKPS^R-HNB3
M"=Q-<;<$).ZM'D$$,5C2/=TQM;<A!(*GC'JOB;PQ!XEA-M=!S$V=RI++#N!!
M4JQB="RD$@J25/<<"N5\,_ ;1_"\PN;&!X91CYDN+D9 (;:P\W#*2H)5@5..
M0:[^BO,/%_[/=EXDU ZL)[JVNBJ@O;RB,DA?+W9*,RDIA3M(! Z9+$GCC]G+
M2?%Z(LRR)(C$^>DA:X<$8VR23"5I ,#;OR4"A4*KD'NM/\+6]C"]LJ;HY-WF
M"1FF:3< I\QI2[2?* OSD_( @^4 #Q__ (8VT7SO-W7.SS-WD^8OEXSGR\^7
MYFW'RYW[\?Q9YKV70- @\/0):6B".&-=J(O0#KWY))R23DL22222:\ZT_P#9
MMTS3+Y]1M7N8"^[=#!,T$.& RH\H)*%W /M#A0P  "@+6WXF^!^D^)RANX"X
MC4+&GG3I%&H55VQQI(L<8PBY"* <9.36UX.\!VG@V,P6*ND79#--*B\L?E65
MW"9+$G;C<>3G KA;O]F?3EN6O+&6ZL'=2&%I-Y*G+;SU5BH)Q\BD( JX48KM
M? _P[M/!:.MHIWRL&FF=C)-*^.7=VY))RV!A0S,54;C6?XQ^#>F>,Y!-J$3S
M,/N@SW 1<A0=J+*$3.T9V@;B,G)YJWH7PQLM MVLK4310-CY%N;H;<,7^0^=
MNCRQ);85WY^;(K*\,_ ;1_"\PN;&!X91CYDN+D9 (;:P\W#*2H)5@5..0:[^
MBO)=-_9DTO2Y9'MWNHX)EVRVJ7$B6\B["FU]N)6'S%L&0C)(^Z2M:%U^SMHU
M]>OJ$\'F.WD;(R=L$8A18U58TVJ5*JN5?>O&  "0=#Q-\#])\3E#=P%Q&H6-
M/.G2*-0JKMCC218XQA%R$4 XR<FM#0OAC9:!;M96HFB@;'R+<W0VX8O\A\[=
M'EB2VPKOS\V165X9^ VC^%YA<V,#PRC'S)<7(R 0VUAYN&4E02K J<<@UGZW
M^SMIVIZB-71I[>?<&<6\ODJ[<[V)5=ZEU)5RC(6!)^\68Z&N_ ;1]>V_:H'D
M"9VAKBYV@MC>P'FXW.1ND;&Z1\NY9B2=70OAC9:!;M96HFB@;'R+<W0VX8O\
MA\[='EB2VPKOS\V17/Z7^SEH>D2+/;6[Q2KG:\=S=(XR"#AEF!&02#CL2*]*
MHKS7X@_ #3_&UTFH2--;W28_>V[K&[%<;&8E&^9<?*PPV, DA5"Z&M_!'2M=
M01744DJ!@Q#7-T=S@$"1OWWSN%.P.V6"!4!V*JBUX5^$VG^$TDBL4DA216#*
MMQ<[?F !8 RD*^% $BX< <,*RK;]GW1K6?[9'#(MP69C,MU=B7<V=[;Q/NR<
MG)SDY.>M6_B9\%M.^(P!O4(E5=J31G9*J[@VW)!5AUP'5@NYBNTDFL_X:_L]
MZ7\/I/M%LCR7'S!9IF#NH8 %5"JB#H?F"[\,R[MIQ7I5%>=>(_@1I^N74NHE
MIXKV5E(N89GBEC"QI%M3'R %%(;<K$[VY V[;?A#X.6GAR<7KO/=W:JRI<74
MIGE1#_ F0%4?>Y"[OG<;MK$5%XF^ VC^*)C<WT#S2G/S/<7)P"2VU1YN%4%B
M0J@*,\ 5TNB>#;71K8V,2%K<J5\N622==FT)Y8\YGPFT8V#Y<9XY.>$\)?LV
MZ9X7FEE@>Y,4WW[=IF%N1G*JRH%,J@$KME:12K,'#9S6M\1?@C8^.YH[N<S1
M746P)/!(4D 0LRJ,AE&&8MN"AP0,-CBJFK_L^Z9J]NMM/YS_ .D0S32M*SSS
MM%&8E$LC[F*[6(VH4"Y/E[,FM!_@CI*Z?-I4-N(H)U <H2)258NC&1MSL5<Y
M7>6 ^[@K\M9_@[X V/AJ,V[27-U;_P ,%S,9+9>68_N5"1-ECN^=6PP#+M89
MH\"_L^Z9X+FDGMO.822(XC>5FA4H6:/"#:'VELH9?,9&564A@6)\0?@!I_C:
MZ34)&FM[I,?O;=UC=BN-C,2C?,N/E88;& 20JA=#6_@CI6NH(KJ*25 P8AKF
MZ.YP"!(W[[YW"G8';+! J [%51H>"OA?8>"-PT^-XE;.4\Z=XR3MRVR21DW?
M*!NQNP,9QD5B>/\ X#:=XTG6]D$D%VK(1<6[^7*=F=F<AER.,/MWC:H#!1BK
M?A#X.6GAR<7KO/=W:JRI<74IGE1#_ F0%4?>Y"[OG<;MK$5M>,? =IXRC$%\
MKO%W0331(W*GYEB= ^"H(W9VGD8R:RO!WP;TSP9(9M/B>%C]X">X*-@,!N1I
M2CXW'&X':3D8/-9]S^S[HUU/]LDAD:X#*PF:ZNS+N7&QMYGW9&!@YR,#'2O0
M+2V%JBQKDA5"@LS.V ,#+.2S'U+$DGDDFB[MA=(T;9 92I*LR-@C!PR$,I]"
MI!!Y!!KSK_AG+0_.^U?9W\_S/,\W[3=>9OSNW[O.W;MW.[.<\YS6UXJ^$VG^
M+$CBODDF2-5"JUQ<[?E! 8@2@,^&(,C9<@\L:Q=8_9ZTK4K'^RPLT=OYB2(%
MGF?RV4OR@F:1%SYCA@%PV[)&X*1+HGP(T^QMC9W+3WL6TJJW4SRK&NT(!&@V
MQQE0"$=%$BAB%< XJ;X:_!&Q^'RXMC-(?,9U,TA<*S($+*BA(@VT%=X3S-K,
MN_:=M8EI^S1I^E(J:?/>V9V@2O;W+QM,0,*TF0RY'S$; @!9N,8 [7P/\.[3
MP6CK:*=\K!IIG8R32OCEW=N22<M@84,S%5&XUTM17=HEXC12J'1U*LK ,K*1
M@J0>""."#P17DMO^S%8Z9)))I]U?62R;=T=M<E$^48'+*[GJ3\S'!8XP.*]%
M\(>"[3P= +2PB$409FV@DDL>K%F)9CT&220 %'  !XO\%VGC& VE_$)8BRMM
M)((8=&#*0RGJ,@@D$J>"0?+_  S^R-HNB3"=Q-<;<$).ZM'D$$,5C2/=TQM;
M<A!(*GC'M5>*^)OV1M%UN8SH)K?=DE('58\DDE@LB2;>N-J[4   4<Y]*\-^
M K+PS:FPLHO)@;?D(SJY+\,WF;O,W8X#;MR@ *0%&.5_X9RT/SOM7V=_/\SS
M/-^TW7F;\[M^[SMV[=SNSG/.<UM>*OA-I_BQ(XKY))DC50JM<7.WY00&($H#
M/AB#(V7(/+&M#P=X#M/!L9@L5=(NR&::5%Y8_*LKN$R6).W&X\G.!705GZ_H
M$'B&![2[020R+M=&Z$=>W((."",%2 000#7C6E_L;:+92+)(US,HSF.210C9
M!')BCC?C.1AAR!G(R#[A:6B6:+%$H1$4*JJ JJH& H X  X ' %>57?[,^G+
M<M>6,MU8.ZD,+2;R5.6WGJK%03CY%(0!5PHQ7:^!_AW:>"T=;13OE8--,[&2
M:5\<N[MR23EL#"AF8JHW&L_QC\&],\9R";4(GF8?=!GN BY"@[464(F=HSM
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M\(R-_HT$?VF;S'>6XED!WI;)).3(O[M_,=T9G,>8U,:AZZ#_ (9<\._\^?\
MY'N?_CM<_P#"GP-;^&_$%X-&W_V>MHL<X#L\*W8D4^4"Q)=EC!+<N8V=E)7<
M$KW6HKNT2\1HI5#HZE65@&5E(P5(/!!'!!X(KR6W_9BL=,DDDT^ZOK)9-NZ.
MVN2B?*,#EE=SU)^9C@L<8'%>B^$/!=IX.@%I81"*(,S;0226/5BS$LQZ#))(
M "C@ "U#XAMIYVLTFC:X1=SPAU,JK\OS% =P'S+R1CD>HKE?ACH$$;WFJ0H$
M-]<LWR_=:.(F*.08PK"7#7 < ;A-U< .>ZHHKRK3_P!FW3-,OGU&U>Y@+[MT
M,$S00X8#*CR@DH7< ^T.%#   * M:&M_L]Z+KCB2YMBY50J@SW(5$!)$:*)0
MJ(,G:B *HX4 5M_\*QLOL?\ 9N)OLO3R_M-U]W9Y?E[O.W>5MX\O/E]]N>:J
M>#O@WIG@R0S:?$\+'[P$]P4; 8#<C2E'QN.-P.TG(P>:YKQY^S!I'C*<W;K)
M!*[,TC0,JB1CCYF5T=0>,DJ%+%F9MQ.:[#X>?#"Q^'\)@L(]N[:9'8EI)"HP
M&9C^)VKA 2Q51DUU5%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>5?$/\ 9XMOB!,)[^[O
M&V[A&BO L<88Y*JH@^@W-ER H9C@5Z!X9T-M$A$#SS7&W #SF-I,  !2T<<>
M[IG<VYR226/&-6BBBBL7QIX0@\8VDMA=@F*50&VG:P((96!]0P!&002,,",@
M\U\+?@?I_P -?,:S#O+)PTLI5I O'[L%50!<C) &6.-Q.U0O?T4444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444445POQ,^"VG?$8 WJ$2JNU)HSLE5=P;;D@JPZX#JP7<Q7:2
M365;? .('%SJ&IW,3*RO#+>.8G5E*E6$81B.>@8 ]#D9![_0- @\/0):6B".
M&-=J(O0#KWY))R23DL22222:T****\EN_P!F#2+S46U659'9YC*T#,K6[.>2
M2I3>07^<J6VD_+C9\E>M4444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444445Y5>_M):89C;6"7
M.H2KOWK9PM-M"$*6)8H&4DX#(64^O*YMZ?\ M!:8V];[SK"5(VD\J\B:"1HQ
MCYT'S!\G(55)=BK80XS7=>'M;37K:&\B!"3PQRJ&P&"NH< X)&<'G!(SW-:%
M%%%%%%%17=VEFC2RL$1%+,S$*JJ!DL2>  .23P!7G^E?'[2=:U"+2K.4SS2-
M,NY%/E*8U+G+MM# A3M,>\'&<@$$]7XT\7P>#K26_NR1%$H+;1N8DD*J@>I8
M@#) !.6(&2#P7XO@\8VD5_:$F*525W#:P()5E(]0P(."02,J2,$[5%%%%%%%
M%%%<?\0/BUIW@%-U],%<KE85^>9^&QA!R 2I4.VU-W!85RMS^T;!IX\R[T_4
M[>$,H>:6TV1(&8+N8AR<9(Z D] "<"O1?#/BNU\40BYL94FB./F0YP2 VUAU
M5@&!*L PSR!6K7DNO_M,:=I8>6&*ZNK>)MLES;P[[97W;=AD=D4GE2",J0R[
M6.:[#3_BGIFH6+ZK'<(;./=OD.Y=I4@%2K .&.1M7;N;<NT'<N>*N/VHM,L9
M(UN8KR""7<8KF6W98)% R)$Y,C*P*X(3/S*6"@G'2VGQITZ\U1=%B<O.\(D5
MU&Z%LIYH4.#R3%^\! V%>-^[Y:[JBBBBBBBBBBBBBBO*O'7[3&C>#Y'MY)'F
MGCDV/'"FXJ<$G+,4C.#\K ,6#<$9#8]5HHHHHHKG_ WCJU\;V_VRQ??%YDB<
M\,"C%>5SE<C#J&PVQE) SBN@HHHJ*[NTLT:65@B(I9F8A550,EB3P !R2> *
M\_TKX_:3K6H1:59RF>:1IEW(I\I3&I<Y=MH8$*=ICW@XSD @G;^)7Q*M?AW:
M_;;W>4,BQJL:[G9FR<#)51\JLQ+$# (!)(!Z#2=4CU>&.Y@;=%+&DB-@C*L
MRG! (R"#@@'U%6J**XKXA_&/3/A_A;^;;*T;.D2JSR,!TX487)X4N54D'GY6
M(Y__ (:'M[7Y[VQU&T@'WYY[1EA3LNXHSL,MA1A3\Q'0<UV'A?XBV7BF>>VL
M91,;=83)(A#19EWE55P2&("9;' R!G<&"]+11111111117%?#;XO6/Q%\_[
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M$;L;AR,X-=7I>K0ZO&L]M(DL39VO&RNAP2#AE)!P00<=P17R_P#\U#_S_P!
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M(..X(KBO$WQ\T3PU,;:ZO$$JYW*BR3;2"5*L8D<*P((*DAAW'(KP^TNTO/B
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M\;*Z'!(.&4D'!!!QW!%8FK_$>QTN?[&TA>X"EFAACEN954;/F=($D9!\ZX+
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M3Y6;=<21-N(P3F,!#GJGRGCBL_\ ;5\/6VEO92V\,<;S-=M*R(J-(V83N<J
M6.6)R<G)/J:][U;X$Z3J]O);SVZ-)+O+W.R,71D9B[2^8$&&+DM@ )_ $\OY
M*\:_9&U>?0+^_P##TV&$322;E/RB2*18),90,P?*X)(P$^[EC4/_ #4/_/\
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MBOEL[ONX5<'Y$"HFU54#P_\ 8]\7G1K#5'F):WM5CN-BA=V?+E,A&<9)6%0
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MF@Z_!K_CX7-HXEB9G577E24L6C;![C<I (X(Y4D$&N[_ &UO^0/!_P!?\?\
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M1_PW<66[?Y&D2Q;\;=VRV*;L9.,XSC)QZFO/_P!BG_D#S_\ 7_)_Z)@KE/\
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:%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex99_003.jpg
<TEXT>
begin 644 ex99_003.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P &! 0.
M!0X3# P3%A,0$Q$3%Q45%Q<6%!0:&AH7&!<7%QX<%Q@9&QP<)1L9'Q\?'Q\B
M'Q\?'Q\?'Q\?'Q\?'Q\?_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#ZIHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK/U_7X/#T#W=VXCAC7<[MT Z=N22
M<  9+$@ $D"L7P5J%]K6Z\O$^SPOGR+8J/."';B2<DG$IP2(TVB-6*R&1\;.
MJHK@/$/CJ3P-=(-2=#I]S)LBN#A'AE;<XBF&0IB*@B.50-@7$V<^:>_HKYU^
M.WB#7?A>L6H6^H>?:M<)&89H+</G87P6BB3<K;'R5\ME!4 DY8>P?##XAP_$
M"QCOX!MW95XRRLT;J<,A(_!ER 2A5BHSBM#Q1HEQJJ8M;N2U<*^&1()%+$#:
M76:-R0I'160D$@GH1Y_^S]?:AXIT^#5;^^DE,K3?N1%;1Q;59H@"5A\PG*E\
MAE'12" =WK5%%17<)G1D5BA92 Z[2RDC 8;U9<CJ-P(SU!'%?,OQ3\::YX6U
MRUT>VU)S%=_9]KR6]JSIYLIA.=L2!\%2PP$X(7MN/T?HFF2:<A26>2X)8G?*
M(0P& -H\F*)<<9Y!.2><8 T****XKXO>%]0\2V)M])N?LMQYB'?EDW*#RF]
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M+M_J8CMVN_\ =#':RH^WQ_\ :QM]0;28I=0DA&;\!8(%8HH*3E2TLGS2,%
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M4HED+6))6/RHP/M;@*J[G8#C)W.Y+%B"%VHOLO[4?_(NWG_;O_Z414?LN?\
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M&#DY'.37G7[%/_('G_Z_Y/\ T3!1^VM_R!X/^O\ C_\ 1,]=5_S)_P#W ?\
MVSKE?V*?^0//_P!?\G_HF"O?Z*\U_:1U233- O9(6VL8TC)P#\LDJ12#D'JC
MD9ZC.00<&JG[+G_(NV?_ &\?^E$M>5?'W_D<-)_[</\ TLDKU7]J/_D7;S_M
MW_\ 2B*C]ES_ )%VS_[>/_2B6O*O@%_R.&K?]O\ _P"ED==!^U=JRV%YHOVB
M1TM1=O)-M:1<!'M_G_=D-N56?:R_.N3M()KV#_A6EK_STO/_  /O_P#Y(KE-
M1\!Z=\.M-U/^QU^SSFPDD?;-(T@VQS>2_P [LR?,'VL,9(/)*\5?V3]4CO=
M@CC;+0R3QR#!&UC*TH'(&?DD4Y&1SC.00/6KF[2U&Z1@H+*H+$ ;F8(B\]RQ
M"@=22 .37RU\??\ D<-)_P"W#_TLDKZJKY5_88_YB/\ VZ?^W%6_VJ]+D\'W
MUCXDL5VRK((Y6R%5F4;H@P4K(V^/S$<Y(,:JF5XS[!HOB:'Q_<6D]L?W$-NM
MYG*[M\ZS6T49VEE^51<"9>"L@C 8@.*[^BOE7]B75OM4VI>=)NGE^SR'<V9'
MP9O,?D[F^9QN;GEADY(KU#]JJT2?P_=,ZABC6[(2 2K>?&FX9Z':S+D<X)'0
MFK?[,MV]UX?LFD8L0LR@L23M6>1$7GL% 4#H  !P*\D_88_YB/\ VZ?^W%?5
M5%?*O[#'_,1_[=/_ &XH_;G_ .8=_P!O?_MO7T!\6/\ D#ZA_P!>%W_Z)>OE
M_P"'6J2:9X(U22%MK&[,9. ?ED%K%(.0>J.1GJ,Y!!P:]U_9<_Y%VS_[>/\
MTHEKRKX^_P#(X:3_ -N'_I9)7JO[4?\ R+MY_P!N_P#Z414?LN?\B[9_]O'_
M *42UY5\ O\ D<-6_P"W_P#]+(ZZ#]J[5EL+S1?M$CI:B[>2;:TBX"/;_/\
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MVC$J_+(-AA:/YAAOE9B5Y^4DD8)->J_M1_\ (NWG_;O_ .E$5'[+G_(NV?\
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M'Q8_Y ^H?]>%W_Z)>O)?V-;M+/1+F65@B)>S,S,0JJH@@)8D\  <DG@"NO\
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MY#$;)3"6(P#N'DRRKCG')!R#QC!/-?%?X46OQ(M3;7(VR+DPS 9>-CW'3*G
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M'@FO"_A5XAUGX2*VD:GI]S<VR;FMY;.+S\;I&R"5*@JQRXWE95SAE*LH3K_
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M<BMKP1\6;WPQI5K!/IEU<2"R@:"2TC,MO)&8E,.]^6C?^&0;6P074%645J_
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MY:01D;Y'**OS@X\LME?OX) M_LX:M-J^A6D]S(\LK>?N>1F=SB>4#+,23@
M9[ "O2J***********^8/B9XRUG1/$6GZ;->[H)KBRE*0Q?9DPTQB:,_/)(Z
MD*2P>0J2WW< 8^GZ***Y_P ?Z/=:S8SV]A-]GN7C(CE_NG(R,CE<C*[URR9W
MJ"P H\ :/=:-8P6]_-]HN4C DE_O')P,GEL#"[VPSXWL Q(KH***********
M*******Q6\7P"_&E9)N#;-<$8^41B18P2?4L3@#/"DMCY=WBO[5VKZMX:MA=
MVM\8K>6:*$011B.0':\AD,^XR9)3&%V#;@'/S%O7_AE=O>:58RRL7=[*V9F8
MEF9C$A+$GDDGDD\DUTM%%%%%%%%%%%%%%%%%%%%%<5\7KB^LM/GN=/N$MV@M
MYI6)A$SMY:^8%4LX1,[2I+))PV0 1D\5^R?XKNO%&FW%S?2O-*;^7YG.< QP
MMM4=%4%B0J@*,\ 5[5111117/^/]'NM9L9[>PF^SW+QD1R_W3D9&1RN1E=ZY
M9,[U!8 4> -'NM&L8+>_F^T7*1@22_WCDX&3RV!A=[89\;V 8D5T%%%%>(?$
M3XD3ZUKEOX7L9S;!U8W4Z#,P'DO)Y*%UPA,8!\Q=Q5F4C!1E8T_X?>(/"&K0
M_8;R2[TR5E\\7<HE>-5!W#)^;)R3&8@ 6PLHV+N;V^BBBBBBBBBBBBBBBBBB
MBBL75_%\&E75K8R$^==M*(@!D8BC,DC$]  ,#N26&!C<5Y_XR'4+:PENM.NA
M:FWAFF?]RDS2".,L(P7;:@.#D[6.<8P 0W%?LB>(;G7M*FEO)I)W%[(H:5VD
M8*(H2%!<DXR2<=,D^M>WT444445X!KOQCO?B!JBZ-X8F2-(LO<WA5)%VJ0K>
M6K@AU!8 $#,CD;2L0+MTMI\!Y[5%9=9U,W"J"':??#Y@'#&%U.Y-W)C9CE?E
M+'K65X4\3ZOIGB%-.UN0&)K*9+1XT9(KAU:-VE8#<!,(T;>I(6/H@ D!D]OH
MHHHHHHHHHHHHHHHHHHHHHK%;Q? +\:5DFX-LUP1CY1&)%C!)]2Q. ,\*2V/E
MW0^/]'NM9L9[>PF^SW+QD1R_W3D9&1RN1E=ZY9,[U!8 4> -'NM&L8+>_F^T
M7*1@22_WCDX&3RV!A=[89\;V 8D5T%%<_P"/]'NM9L9[>PF^SW+QD1R_W3D9
M&1RN1E=ZY9,[U!8 4> -'NM&L8+>_F^T7*1@22_WCDX&3RV!A=[89\;V 8D5
M,WB^ 7XTK)-P;9K@C'RB,2+&"3ZEB< 9X4EL?+NVJ*****************Q6
M\7P"_&E9)N#;-<$8^41B18P2?4L3@#/"DMCY=VU11117"_&0ZA;6$MUIUT+4
MV\,TS_N4F:01QEA&"[;4!P<G:QSC& "&XK]D3Q#<Z]I4TMY-).XO9%#2NTC!
M1%"0H+DG&23CIDGUKV^BBBBBBBN?\,>+8_&5D+W3VPDGG")Y$)&4=XPY3<K%
M2R[@,JQ7 .TYQ\]^'/$NK6GC&+2KZ_DN4C5E.%%O$X-H\PS#&=A(9NIR3@'/
M  ^I*****Q?&GB^#P=:2W]V2(HE!;:-S$DA54#U+$ 9( )RQ R1M44444444
M444445BZOXO@TJZM;&0GSKMI1$ ,C$49DD8GH !@=R2PP,;BL/C_ $>ZUFQG
MM[";[/<O&1'+_=.1D9'*Y&5WKEDSO4%@!1X T>ZT:Q@M[^;[1<I&!)+_ 'CD
MX&3RV!A=[89\;V 8D5T%%%%%%<+\9#J%M82W6G70M3;PS3/^Y29I!'&6$8+M
MM0'!R=K'.,8 (;BOV1/$-SKVE32WDTD[B]D4-*[2,%$4)"@N2<9)..F2?6O;
MZ*****RO$UE=7L)CL9DMY3D>8\7G[001E5\R,;@2""VY>,%#GCPK]DGQ_?>,
MY-0FU"=YF'V3:"0$7(F!VHH")G:,[0-Q&3D\U]%4444444445POQI^)@^'.G
M/>@!I2RQPHV[:TC9(SM'0*&<C*[@NT,"P->:O\.]:U_3(-8L]4NFU*2&"X\H
MNL5HV4#B(1*!&IQ@9;*2,#O50Y*^R> /MWV&#^UMGVSRQYVS&W.3C./EW;<;
M]OR;]VSY<5T%97B:RNKV$QV,R6\IR/,>+S]H((RJ^9&-P)!!;<O&"ASQX5^R
M3X_OO&<FH3:A.\S#[)M!("+D3 [44!$SM&=H&XC)R>:ROB9XRUG1/$6GZ;->
M[H)KBRE*0Q?9DPTQB:,_/)(ZD*2P>0J2WW< 8^GZ********************
M*********************************************************\:\
M5^.]0\3ZTWA[2)A9FWA\ZXN7C29F!5"L<:-E2/WJ;BQ4DYQ@+B2W8G7O#6H6
M-K>74=Y9W$TP>;R4@F#K;3.L)56*[#LWAE&[<I5F"X#9_BWXO7%_K\7AFQ/V
M?/,]R46208B^T;8E;*#*#:6=7Y8D)\@+8OQ,^)>I?!W4;>2[N#>Z;<JX\MHX
M4N$*;-[!HHXE8C<"N<!@61@I"R5U_P"U'_R+MY_V[_\ I1%1^RY_R+MG_P!O
M'_I1+573_%&J?%+?/HUPECIZ2,D=P\!FN)V3 9E27;&L!+$ \R;H\';EE7)\
M'?$_4?"FLGP_X@D28S_/:70$<0(.X(K*NT#<4*@??$ORCS%=67W6BBO$+;QW
MJWQ0NYX=#FCL["UF$;7;1BXDF<"3/E YA9,[3C<&"E'W?/Y=8EQ\8=4^$^H1
MV/B-TNK.?<R7<<1C=1NVC*JJH=N TD:AG42 AWPJ-ZU\4M?O] LI;K3D@<PP
MR2N9WD "Q@.0J1H=Y*A@,O& =IRPR*\0^'_Q5\2_$73[G^SU07*W$C_:'6-(
MD3:C):P@JP>4G=EI<A$*[WW.K+[U\-YM0FT^ ZNH2]VL)0NPC(9@K?(S)ED
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M5"I&)$RP^\6<[!\JA)=S^7TOPH^+&H6NM7/AS6Y!+*K.;>;8D;, H=5*Q H
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MO*5U>.T@3;+YKLR!I&+%454+EBS%U'EHX%67XR>(/A9J,5KXC:.>UF9/WZH
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MK%'"[8Y02H8WXR2A(0,P7?M4G'?_  ]U235]-L[F=MTLMI;R.V ,LT:LQP
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M_7FO[2.J2:9H%[)"VUC&D9. ?EDE2*0<@]4<C/49R"#@U4_9<_Y%VS_[>/\
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M<J6ED^:1@H !5(5RSY1OD*^Z_"?_ ) ^G_\ 7A:?^B4KY_\ V&/^8C_VZ?\
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ME=IWL'RGC7A#X[:]K&L7&F&*&6:..:%(XE*VJ2I,JM<RNY:41*N[(!&_Y$5
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MEL< L%8J">I"L0.<'I7SA=?'+6K7Q$-(FCA(C\[$%N&;SB]N9;>-I9$+##%
MT@2-%^9W'ECB'XF>,O&'P](U.Y>UEM2VUHH8V>",E0J[RRI. S'((D(W_*2
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M0D E6\^--PST.UF7(YP2.A-<U\-/^1&D_P"O#4__ $*XH_8I_P"0//\ ]?\
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M4^ 7_(X:M_V__P#I9'7JO[4?_(NWG_;O_P"E$5'[+G_(NV?_ &\?^E$M>5?
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M?6T\:&P2 'RI%BOI5; (B5=]NK%2Q5S<&-T&0KB"8;B%96[JOE7]AC_F(_\
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M(9VD8S2 (K2$DA2Y7=\JD#CR#]F;P%K'PXFGCOK%_*N?)'F)-;-Y90N,LOG
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M;P"UU+2;V34$9HP\<(6VD8?*CM*2$C!;[[J&C _>+\IVKT'P&^&<_@^":YU
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M.6D$9&^1RBK\X./++97[^"0+?[.&K3:OH5I/<R/+*WG[GD9G<XGE RS$DX
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M&1/,LTAWQE&FVKF:0>8[$,@?:L(QN*[2!NJ_%#QK_P )OX+DU KM:6.WWC&
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M 0&&7#[ ?!_]I.ZO[V/1==@\FZ;"K*1Y!+;%9%DC?&&?D@K@,S(JQ@'-<_\
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M#SX_^PQ_S$?^W3_VXH^/O_(X:3_VX?\ I9)7JO[4?_(NWG_;O_Z414?LN?\
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M/^8C_P!NG_MQ7JO[4?\ R+MY_P!N_P#Z414?LN?\B[9_]O'_ *42UY5\ O\
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MP&==\;@%>?\ V*?^0//_ -?\G_HF"N4_YJ'_ )_Z!U=7^VM_R!X/^O\ C_\
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ME@3NVJC9P<1D K7J'BKPS=:#H;:18027LTMM-$TGF1Q@R2@^;-(9YM^6>1Y
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MOVC%OM;@TYK(F"\%Z'ALG6)YY)$^Y(#&TL8$8R[;F\K8^9&#!5,7_"9>.?\
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MAED6(GSF;,>T-E=BA@<G=RNW5_9PU:;5]"M)[F1Y96\_<\C,[G$\H&68DG
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M,I=&.8XW+@2+P,(67DE#Q7"?LS?%Z^^)$E])?%-L?V7RXXT"HFX2A\$Y<YV
MG<S8.<8'%3:7\6+KQ[KMQHMG(;2WM%E,DJI&]Q(\3B%E!E$D:)O<$?(S$)U7
M>0N>WQ2U'X?^($T?4YOMMK>>5]G?9''-%YDC1IN\M(U;Y@5?U4+(NTYC.?\
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MEB2K$".(/]T*Q.<R_$KQ!XQT*/\ M9?LR6T>UGM(AY[HF2Q,K-'EL#"2M"X
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MI88L?9=_FP//G_7[<;)X=N.<YW9R.F.?KJT5U11*0SA1N95**6QR0I9BH)Z
MLQ XR>M9_B:RNKV$QV,R6\IR/,>+S]H((RJ^9&-P)!!;<O&"ASQ\M?L@-?ZF
M^HRV\\:NS6S2M/%)<L[,9SNRMQ"0<Y+$[BQ/;!SH?MS_ /,._P"WO_VWKTOX
MN7&OV]C+J=C<);>3&TGV40Q2R% 5+>9-([)N5 SE8TP#F,-+A7.U\+/C!%XO
MT@ZM<8B,*R?:@H<JC1+O<CC<04PX W$!MN68&L72[O7?B/&M_:72:99OEK=#
M;BXN9$)*AYO-(1,[0\?EY!5^6; 8U/@[\5[U[Z?P[KQ0ZA#N9)E*!9EP' PN
MWYMC!UVJ"8\[U1D8M[57SA^VQXH>RLK:P3(%Q,[NP8@%80OR%0/F!:16Y. 4
M!P3@CU7X%:(FC:'8Q1DD-;1RG=@G=,/.<< <!G('?&,DGD]U6*NB6VC3W&I$
MB,RPQ"=CM1-L'F$2,<#D*Y#,Q(VJHX"\^2>%_%&N_%O=>Z?<)IFGK)(D): 3
MW$NW8-S"3]WMSNYC;Y6#(=^W>*O@SXU:AX7U1?#_ (DV/+)Y8ANHD95=I#E
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M6!+>-3L&U0Q>:;+ .P;<0K+R"I"'T_QS\5[7PMI?]L9\R)XXV@4'RVE,@!C
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MG<6)[8.?KJBBOD#Q3XIM_"OCM[V]?RX(]N]]K-C=8!%X0,Q^9@.!^E>E>/\
M]JS2K>QG;3+CS+SRR(5\J9,,Q"[\R0[/DSOPW#;=O>O<+N[2S1I96"(BEF9B
M%55 R6)/  '))X KP_POXHUWXM[KW3[A-,T]9)$A+0">XEV[!N82?N]N=W,;
M?*P9#OV[Q5\&?&K4/"^J+X?\2;'ED\L0W42,JNTAR@(VH&4D^6'1%"NA#!OF
M=>U^.?CK4O!%D]_8QVS11>69&F:4N=S^7M6-%4=64[C*.-PV=#7E_ASQWXK\
M=:/%/I8 EC9O-GD6!'N&,K@)"C)Y01$*[W;868%4)*.&^BO#TT\]M"]XH2X:
M&,S(O*K(5!=1\S<!L@<GCN>M> ?MEK>P6"/]H M'N40P)&59B8V<&23S&WA6
MC)50B#+ MN9%->H?!>VO$TVR:>6%X#86VQ$@>.1?W:;=SF=U;"Y!PBY/(VCY
M3X)\'9IX_%NK+:J&D9KY0S?ZN,?:T)D8;E9@,<(O+L54LBEI$[#QK\3=7^%&
MK6PU2Y2ZTZZW;B($@$7S@/L"&24^6K(1N+;U8KRXWCU7XD_$%O#/D6MJGFWU
MY(8[9"',8(QOED* D11A@SX^8CI@;G7S_P =67BGPQ:OJD>H0S&+]]-:"VB2
M(1KEY$21LR.J@8&2CL@)#>9@'N_"7Q=MO$>D-K:J0D<,KS1 J\B-$I9TZ@9P
M,INVEE96(7=@<)X&GU_XF6_]K0ZDEC!/))Y-NEK%<[$1C'\SR;6+%E)/4'J-
MH.Q>P^'OB^]CM[^;7C'&]I<R!_*!,2Q);PRAEQN=@58R?-E_FVX& @Q=+N]=
M^(\:W]I=)IEF^6MT-N+BYD0DJ'F\TA$SM#Q^7D%7Y9L!C4^#OQ7O7OI_#NO%
M#J$.YDF4H%F7 <#"[?FV,'7:H)CSO5&1BWM5>*_M&?$[5O %N+BS2V6!Y/)$
MC-))/N>,LKA-B1IM*-]YI0WRDJ!D5GOK7BKQ?IT%SI300K]F@<O(N+FXD\D-
M*51XC"B-(Q5,A=Q3>KB)US+\ /C=>>.?M.FWX2+4+>/*L8W&[;^[=I(\J RR
M;=ZAH]V_:JIM)J+0?C3JJ^)1X=O5M60,^9(DE1BOV=IXR-\K!21MW## '(!/
M#5J_M _$S5?AM$E[:_99+>281;)(I?-5BA8'<LP5P=CY^5"ORC#<D=KINOW^
MM:5;7EFD!NI[:&0B5Y(X5:2(.6&Q)78!R/DRI*Y_> CGPOX5_'#Q!\1C>06J
M1^>RQ>5(5"6EJNV02.3B21W<A?+1MXW;FP(T93D^//C+XL\!6D,6HB"*69I0
MDNV-[C$9C8L0C-;@$2!!\F< D@'#GT7XCW_BV]C>^TKR8+=-[1P!"][)'D!6
M9)HBH8J#((QL=0WEL&D&VN@_9[^,[?$VUD:X5$NH) )%C#A"K9,;C=G&<,I&
MYCE"QP& K%MO'>K?%"[GAT.:.SL+681M=M&+B29P),^4#F%DSM.-P8*4?=\_
MEUB7'QAU3X3ZA'8^(W2ZLY]S)=QQ&-U&[:,JJJAVX#21J&=1("'?"HWI?QP^
M*7_"M=/-XL?F2O((HE/W [*S!GY!V@(20.6.%RN2R\__ ,(KXITF'[2NI0W=
MPD>?LKVL4<+MCE!*AC?C)*$A S!=^U2<:L_Q5_X1S0[/4KI7N+FXM[54CC7Y
MYKB6(,$ 5<+DY)P. "%4MM4XFO\ A?Q9- ]S#J,"7.W*VD5O&8,CC:LT^Y\L
MHW?.,;SMRJ?,-#X7?'B'Q=I,VIS)LEM(W:YB0JQ^1"^] 6SM< [-Y'S!EW-M
MW'G_  -/K_Q,M_[6AU)+&">23R;=+6*YV(C&/YGDVL6+*2>H/4;0=B]W\)];
MU'4UNTU<1K<0WK1!8O\ 5!/(@="I)+$-OW_,=PW8(7&U>ZHKRK]J/_D7;S_M
MW_\ 2B*N5^ EEJ>L>';:&QF2R5?. G:);F1S]HD8E$,BHBC[A+AF8EL(@5'D
MT/V=_C!=^)I;G2-7Q]OM6;+  %U5RD@(C'E@HY"Y4@.&& =K,UKQ'\1-1\6Z
MG+HF@-'"+95-U>NOG!&+IF.,#='O W K)@L5D4;#'N/->+?B)KOP;N(I-6E3
M4=/GDV^8L(AF3:N2,(%C5B6)569]ZQG!CY(^@-)U2/5X8[F!MT4L:2(V",JP
M#*<$ C((." ?45\O_L,?\Q'_ +=/_;BO2_BW\5[JTO8-!T,POJ%QOWM(<B!=
MA8,1]W=MS( =Q"H/W3^8F>$_:!T_6O#>CSI>W0U"WG:%&;[.MN]NRRK(C_NM
MRLC;2C;RI#&/:>2#W?[.$DT7AFT-LB/+^_VK([1(?]*ESEECE(XR1A3DX'&<
MCG_@W\7M4\5:]=:;J!A5+:WG4QP(1&98KA(S(&DW2'AB,9"XP=H.353]I'XQ
MZUX":..W%M#%<>8(I%+3SCRW4EB)$2)=RNHV[9,?-A_ND=+\5KKQ%!93ZE:3
M1VH@5I%MECCFE:(!"[2RRDQJZ .VR)67C:))20U=!\!OB@_Q(TX7DRA)DFDB
ME"@K'N&'4KEW;&QUSDYW;N,8KFO!WQ2N/BU?7$6F3?9=/M/+W3*BM=3,XD"[
M1,CQQQ$KN^9#)\J_=WL$YK6?BQK7@O7$T*XECFBN9H_(N98%:4)*0B I!-;H
M0L@*L2%8X9P,%4KZ%TN.:*-1<NCR\[FC1HD/)QA6DE(XP#ECDY/&<"6[9U1C
M$ SA3M5F**6QP"P5BH)ZD*Q YP>E?(NK>#O&O@)Y+FWF>X5][OY#">,-+*6?
M;;R(,,7.XF.+ #'D#>!ZU^S]^T"/B4'MKE!'>QJ7(0-Y3Q[@-RY+%2"P5E8G
M.0RD@LJ<KX^\+OX+\5VWB&;+64[;9752%MV,*VBF5R0BH6=6W%@<;QM)4;JG
MB32#\3_%EK=6&7L[)8/-NE"R6Y>)S<[%=7VL3YB(0#N4EFV%5)/I?Q,NW\93
MCPY:,0DB[M0FC)WP0\,D6>%#SX*@$L1'N8Q,AR/2K2T2S18HE"(BA550%55
MP% '  '  X J6BO$+;QWJWQ0NYX=#FCL["UF$;7;1BXDF<"3/E YA9,[3C<&
M"E'W?/Y=8EQ\8=4^$^H1V/B-TNK.?<R7<<1C=1NVC*JJH=N TD:AG42 AWPJ
M-ZU\4M?O] LI;K3D@<PPR2N9WD "Q@.0J1H=Y*A@,O& =IRPR*\0^'_Q5\2_
M$73[G^SU07*W$C_:'6-(D3:C):P@JP>4G=EI<A$*[WW.K+[U\-YM0FT^ ZNH
M2]VL)0NPC(9@K?(S)ED 8[3C). H^41?%C_D#ZA_UX7?_HEZ\J_8I_Y \_\
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M8$=>.Q4E2.A!(/!KH/@_X2LM>TBRN(Y;H@VT2MMO;Z-0Z+Y<BA1.JJ ZL %
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M.Q4E2.A!(/!KZ?\ @_X2LM>TBRN(Y;H@VT2MMO;Z-0Z+Y<BA1.JJ ZL % 7
M^7Y<5T%C\)M)T6^CU$(?MI8JDLMQ/+(S>4RE1YLK;SY0;C!(521@+D>'_P#-
M0_\ /_0.KZ ^+'_('U#_ *\+O_T2]>5?L4_\@>?_ *_Y/_1,%<I\ O\ D<-6
M_P"W_P#]+(Z/VBM6^R^*M)\Z3;!%]CD.YL1IFZ?S'Y.U?E0;FXX49. *^JJ^
M5?V=?] \5:M:P_) /MF(E^6,;+I%C^487Y58A>/E!(& 31\??^1PTG_MP_\
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M5.I2>[;[1*K JR,ZJ$B(..8XE2(G"EC'O90S-7SU\??^1PTG_MP_]+)*ZO\
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M:.O'8J2I'0@D'@U4_95NTG\/VJHP8HUPK@$$JWGR/M..AVLK8/."#T(KR_\
M;:_T";3;J'Y)Q]HQ*ORR#886C^88;Y68E>?E))&"37JO[4?_ "+MY_V[_P#I
M1%1^RY_R+MG_ -O'_I1+7JM> ?MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_
MZ)2OG_X!?\CAJW_;_P#^ED='[<__ ##O^WO_ -MZV_BW>QMXPTR"ZDD6 VVU
M0DDT9$DIN(UVF%E=2SB-6((R  YV@UZ_=_"FRO$:*5KIT=2K*U]?,K*1@J0;
MC!!'!!X(J+1?AEIFFV-UI%BOE02^:DRI(SNK2PJK<R-(5;RRI /&"&Q@\_.
M\+^)O@"9)++%S8%F=]JF2+A7&^2,$21$(H9V0[.$5I'P!7:^,_C6GQ$\*7]U
M;@V\T;112Q"0,P5YHAG*[6*.C%3E5!(=,$ D]K\'_"5EKVD65Q'+=$&VB5MM
M[?1J'1?+D4*)U50'5@ H"X'R_+BN@L?A-I.BWT>HA#]M+%4EEN)Y9&;RF4J/
M-E;>?*#<8)"J2,!<CNJ\ _;6_P"0/!_U_P ?_HF>O5?A/_R!]/\ ^O"T_P#1
M*5\]6UHEK\0ML:A069B%  W-8%W;CN6)8GJ223R:E_YJ'_G_ *!U=7^VM_R!
MX/\ K_C_ /1,]>J_"?\ Y ^G_P#7A:?^B4KY_P#V&/\ F(_]NG_MQ1^W/_S#
MO^WO_P!MZ^JJ^*_ G_$FUCQ%]E_=>58:OY7E_)LV3+LV[<;=N!MQC&!BO4/V
M)[M&TJXB# NMZS,N1N"M%$%8CJ 2K 'H2IQT-'[;%HC:5;RE076]55; W!6B
ME+*#U )521T)49Z"M_Q%\.'^*WAJR@>8K<?9K2=)')8-+Y&/WA.6(;>V6'S
MD-\V"K>2Z?\ $GQ'\"]EIJD'VBQ3"1,3\N!Y@18YU!QG&0DJLXC4 )&*Z#]H
M/QY;ZRV@7PE=;&6X,\FUV!4*]ON)\EB1+&&=?D)=&W!3FO=?^%:6O_/2\_\
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M+D -A,+DR#.!Y_\ #?P3K/A37[S5Y-.D>WNFNL!9K3S56283(=IGVD_*%(W
M#)()Q@Z'[4OPZU/X@R6T>GVCNMOYVZ0R6Z(WF"(C:&F#\;"#N5>>F1S70?'[
M59]3\+W<EU;O:R_Z,&C=XI.?/@)*M$[@KDD G:QQDHN17*_ 3XCW7A31K:.>
MPN;FW?SC;R6<?GL )I!(DREEV,'R5(RKHP PR-G?^%O@+4/$.KR>)]:B\AO+
MVVEL79FC5D #'YOEPC,"C $R/(YCC(7/(6&DWOPL\3WE^;*ZO+6Z69A);PF0
M@32+-T!*DJZF,AF0D?O,8*J8?VJ?#&L^,/LMQ%9/]GC\U5C3]_=*S[2QE6$N
M@4[!LV,X&,NRLZH/1?C9%JOC/2Y=/M=.DWSM%AFGM5V(CJYW#S3\Y9,!5++L
M97,@?=$MOX!V.H>$]+73KZQDC>W69E99;:19<N9 @Q,"KDN0 V$PN3(,X'G_
M ,-_!.L^%-?O-7DTZ1[>Z:ZP%FM/-59)A,AVF?:3\H4C< ,D@G&#[K\2O" \
M8Z=<V! )EA8)N+*HD'S1,2O.!(%)X.0,$$<'BOV7/"!\-Z'"7!#W+-<,"58
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MCDCDAD9-^ULHP)AD=1E>05?(!'(/ ^=?AU::S\"KB2QFM)K[399'=)+6/S)
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MX[J-\  R%HF549F#$QC.T8.<$5D_"CX%M%;ZF-3B2!-3D.+5/+?[.@:4QX8
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MCCW,L:B&006L:AF!VEV/RC+.YRTA^=C2?B_J.A0QP:OI5\UT(TW/;1QW4;X
M!D+1,JHS,&)C&=HP<X(JI\%/AS>^"(]2U"2W1)[N1I(;!'0! AE:.+S5_=C<
M7VC VJH!/)*KH?!;XI:GXF=K;6K(VLI61X6V/$KI&8ED!25C("#,A#<JX) P
M4.[UJO*OVA]+O_$NG2:7I]H\[3>43+YD$<:!9 Y'[R0.S?(!C:%PV=^05,7P
M#L=0\)Z6NG7UC)&]NLS*RRVTBRY<R!!B8%7)<@!L)A<F09P//_AOX)UGPIK]
MYJ\FG2/;W376 LUIYJK),)D.TS[2?E"D;@!DD$XP9O&W@#5/AMK4GB'1(/M5
MO/DW$"@M)\[(95P2SG<_[Q6C!V'(9!&N'VO']_J'QE@72K*SNK*!YD-W/>1)
M"!&N7540LSR$NH/R%=I558A7)'K6H%O"MFD6GVKW'E1K'%"DD:8"H0FYYI%P
MORA2WSOSG:W->%_LS> M8^'$T\=]8OY5SY(\Q)K9O+*%QEE\X$KB0DE<L-N
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M)Q7=44445\]_M;F;Q%:1:=96MU/*ERLKM';3-$JB)QC>$VL3Y@QL+ ;6#%2
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M%%%%%%%%%%%%%?/?A'Q3/\<[V]2.\GM-/M&B$*VK>3+*6,H69Y63> 54GR\
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MR('0J22Q#;]_S'<-V"%QM7NJ\:\1_$34?%NIRZ)H#1PBV53=7KKYP1BZ9CC
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ML77CW7;C1;.0VEO:+*9)52-[B1XG$+*#*)(T3>X(^1F(3JN\A<]OBEJ/P_\
M$":/J<WVVUO/*^SOLCCFB\R1HTW>6D:M\P*OZJ%D7:<QGA/VT5O;=[43W >W
MD:<QP)&8E0H4PSDR/YC[9-N["@ ':J[VS]-07EQH4,USJ<\+Q1QF0M%!)%L5
M S2$@SSE^!D!0",'ALC' :7=Z[\1XUO[2Z33+-\M;H;<7%S(A)4/-YI")G:'
MC\O(*ORS8#&I\'?BO>O?3^'=>*'4(=S),I0+,N X&%V_-L8.NU03'G>J,C%O
M:J\U^+/Q2F\-S6NF:;&DVH7D@$:ON:.- 0&ED6,^9MQG!  PKL3^[*MQ7C%?
M%?@*U&IF^AO5ACW7%N;94 SM4E3$JNZKN+EB8L*FX@@E1Z5\-?B='\1-/^WV
M28D&Y&BD8J%E50=A<(V5^92'53\I!*A@4'C6J?'G7-/\0+I,L,<@C:0?9[7+
M&4R0>9 K2S $!"5+R*L8 #L5*@"O1?AE_P )+!J%Q'KGDO9F,M%)%Y817W*1
M&@^67;M9@3*I.4&&Y)?U6O&K+QAJGQ0GN%T:XCLK"VF,0NO+CNI9Y5^^%4OY
M8APP8-]X_(03N=4RH_B7JWP\U>WTC6'%[;WC((;I81!('=EC"D+B,A7^\HRP
M5U?=TCKL/BS\4IO#<UKIFFQI-J%Y(!&K[FCC0$!I9%C/F;<9P0 ,*[$_NRK<
M5XQ7Q7X"M1J9OH;U88]UQ;FV5 ,[5)4Q*KNJ[BY8F+"IN(()4>B_#_XH#XA:
M=]OTZ,&4-L>&5VC59!M+J9%CDR-K;E8(=P(!"'<%\J^&OQEUSQ-K=SIDP@S!
M#-&5C4BW22.=4:X8NWG. "0$5EWDH"(P6E2I\4/B7KGPGU.V>]NA<V$[%V5;
M>&(;0^)8D&\R91&5D9I,$D!BV&SW?Q,?Q"+.XU&VN8;)8(Y)4MQ$L\C1JBNW
MFROO191A\+$A0'"F5Q\XT/@U\5+GXAZ2;U(HS=I,\3H6:" L"K9# 3N!Y;KU
M4DN",!<&O-/!7QPUW7-7N]-9('GAAEBCBC5UMO.2X2-IWD(>0(J%V(+*'"JB
M@2NN:OCCXG^*OA3<I<ZIY%S:3,<+&N(5.[<8E?8DBN$!"&3>"I)_>,K;?;_&
MGQ5M_#FGQZE&KW N/*6UCC5M\SRKNB0#;E<CDY&0 0%+84\?K_A?Q9- ]S#J
M,"7.W*VD5O&8,CC:LT^Y\LHW?.,;SMRJ?,+?PS^*$_Q9TPR6<D=I>HWES[H_
MM 4E#B2-/-0@,3E#)N *NA5P-Q\?_9 :_P!3?49;>>-79K9I6GBDN6=F,YW9
M6XA(.<EB=Q8GM@Y]0_:,^)VK> +<7%FELL#R>2)&:22?<\997";$C3:4;[S2
MAOE)4#(K0\3:GJ.J>&DOH+H0RG2A/-)Y6Z5F\A96\MEDC6(G# L$8C=E-I4&
MN%_8YMKQ]-D:"6%(!?OO1X'DD;]W!NVN)T5<K@#*-@\G</E'=?$GXF7LFH)X
M?T(1F]>%Y)9Y,M%;IM;;D(&*N3M(+KM&Z,%7$GR\KX_\0^)/A*%U">ZCU*RW
M(DJ-;K;NI9B2W[E2%&%"!V9AN< QDX->OZ!XT'BS3TU'3%$@E7*+*S0#(;:Z
MLRI*05(8<*P)'!VG=7@OA#X[:]K&L7&F&*&6:..:%(XE*VJ2I,JM<RNY:41*
MN[(!&_Y$5 [9KU7X,_V_#]IB\0['V2+Y$R^5\X^8/Q%MPORJR[T5_F.?1=#X
MQ:_J?ARR>^TI8)# KO-',KDF,#+,A61 "H!)4YW#[I# *_-? 7XDZE\2K.:]
MG:VBVR20HB0RG#A(W61B;CYE^<@H I..)!7-3?&36[#7ET"[-E$)&_=W!@GV
M.I1FB(5KE,EF CP&($F5!8CGU3XE:M?Z7%&VF-!YSS1Q+%-'(_F,[J,@QRHR
MA$WR/A9#L1FPH4FN5_:85U\-70E(9PMMN95**6^T0Y(4LQ4$] 68@<9/6N:^
M EEJ>L>';:&QF2R5?. G:);F1S]HD8E$,BHBC[A+AF8EL(@5'DT/V=_C!=^)
MI;G2-7Q]OM6;+  %U5RD@(C'E@HY"Y4@.&& =K,UKQ'\1-1\6ZG+HF@-'"+9
M5-U>NOG!&+IF.,#='O W K)@L5D4;#'N/->+?B)KOP;N(I-6E34=/GDV^8L(
MAF3:N2,(%C5B6)569]ZQG!CY(]:\9?$R#PYI+ZT@,T(ACDC"_(7$I41?> *@
MEUR2,J,G:2-IX7PII/B7Q!:Q:F-4A1IHUG2U^R1F##_O(X6ER)0I4A6(RZ\X
M9R QZ#PS\2I-(T-M6USY98I+D3+&H.&6ZDA6)0I(."%126(Z,S]6K*_LGQ/X
MHA^V)>PZ>SQ[HK1;<2X!&]!-),N]91NV2;4*C;D+DD5+\!OB[+XO$VG:DH34
MK)BDP!3$FUBC. IZAAB3;E 2I4@.%7UJO)?BI\1+M=1M?#NEL(+JZ7S6N742
M+'$OF$A$.0SD1-]X!0, '+;XZFK0>(O![6[R7T=[;RWMI%.S6\=O+$CSHF4"
M,58/NV/D%ERI0#YF7%_;6_Y \'_7_'_Z)GK5T*RUO5=!M'TR9+1H[" Q1F*.
M>:8I;@*"[R>5$LC8VC:S*H5V=2S1)H?LX?&!_B-9-]JQ]KMV5)2H(#JP_=RX
MP%4MM8%5) *EL*K*HQ/A;\4KOXQ75V8)GLK.VV"-8TA:>3S-VUI&F29!CRF.
MU%'W\%VV9:+X<?%C4-+UR;PSK$@NI-Q,-RB)%QY/G!710HP8^>,E7RN74AES
M_P!I'XQZUX":..W%M#%<>8(I%+3SCRW4EB)$2)=RNHV[9,?-A_ND= VL>*=2
MU"UO((4BTR610]L_E>>D6[!EFW;664JQ=4B9MFT(ZE@V^WI_BC5/BEOGT:X2
MQT])&2.X> S7$[)@,RI+MC6 EB >9-T>#MRRKD^#OB?J/A363X?\02),9_GM
M+H".($'<$5E7:!N*%0/OB7Y1YBNK+H>*_'>H>)]:;P]I$PLS;P^=<7+QI,S
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M:@9Z8"C ./H2N/\ B;=I>:)?2Q,'1].N65E(964P.0P(X((Y!'!%>8?L4_\
M('G_ .O^3_T3!787?CY+G4+FQT&VCFOPJ_:KEL1VT;*KK&LTB*TDKJ0%$:C.
M"PWIL?;XI\8K2>W\6Z3]JE$LA:Q)*Q^5&!]K<!57<[ <9.YW)8L00NU%T/VY
M_P#F'?\ ;W_[;UZW^TU=O:^'[UHV*DK"I*D@[6GC1UX[%25(Z$$@\&JGP?\
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M(HD^^R^5<N8AANJKL5=N1\@VJ5X(\PL-2\3?L^@1S1BYTU6R<9D@&YHR^V0
M20DEMJB0!"[,RHYYKH/V@?B<GCGPQ;WMJ3&)KV-)H@X)5ECF9HWVGD;E5UW
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M!_#C2_ SS1:9&(GD6)I5\R21MH,@C8B1V*@G> 1@$@]=O'85\J_\U#_S_P!
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MK,$;RT9B[2.Q3]V%8@D +AL8.3RG@OQ?-XIC"^';>&UTZ.1E%Q-$RH^#)O\
M(MXFBRN_:3([Q\LXV%U8#R7]G>$P>+=41F+E5O@7;:&8B[B!8[%5<GJ=H ST
M '%2_'W_ )'#2?\ MP_]+)*]5_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#MX_\
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MM;)!"!BH.5XV^(%UXQLI])71KW[5-"\>)8XQ:+)CEQ.S;&",-T;X&]E7;M+
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MB&-DWP206S$!Y-GR.(LD L@"N"<!F,A. >J^!OQ=3XF67GE1'<1,$GC!! ;
M(=1DL$;G;NY!#+EMNX]KK>F2:B@2*>2W(8'?$(2Q&"-I\Z*5<<YX .0.<9!\
MJ^#,NJ^('NWO]1DD%IJ,MLJ)!:Q*XA(+,_[IVP^X#"E2H!PY)!7V6BBBOF7]
MH[QMK/PQ>V-GJ,CI<++E98;0LK1E,D,D" @B0<;<@@G)S@?0'A?1+C2DQ=7<
METY5,LZ01J& .XHL,:$!B>C,Y   /4G:HHHKG_'^CW6LV,]O83?9[EXR(Y?[
MIR,C(Y7(RN]<LF=Z@L */ &CW6C6,%O?S?:+E(P))?[QR<#)Y; PN]L,^-[
M,2*Z"OF#]J[QEK/A)H5AO=D%SYH$<,7D.@B=&4F7>\A8AP&*&-2%^YAB*^GZ
M*******^5?B+XBUG0/$FG6%QJ#RQ2W%M)LB3[+&%EN=AB*H[&10$P/,9C@D=
MR3]5445%=J[(PB(5RIVLREU#8X)4,I8 ]0&4D<9'6OFK2O&FK+XQBTF\O#-#
M&TQVH@MXB)+0S!2BLQ8*2 OF,Y&,YR37HO[0^N:GX:TZ34-/N4@6'RB5\A9)
M'+2",C?(Y15^<''EELK]_!(%O]G#5IM7T*TGN9'EE;S]SR,SN<3R@99B2<
M#/8 5Z57SW^U=J^K>&K87=K?&*WEFBA$$48CD!VO(9#/N,F24QA=@VX!S\Q;
MU_X97;WFE6,LK%W>RMF9F)9F8Q(2Q)Y))Y)/)-=+117%?%ZXOK+3Y[G3[A+=
MH+>:5B81,[>6OF!5+.$3.TJ2R2<-D $9/%?LG^*[KQ1IMQ<WTKS2F_E^9SG
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MU7'F.=^6?:I/";W =^[98 C=L'RJ#7:T445%=J[(PB(5RIVLREU#8X)4,I8
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M1T^>3;YBPB&9-JY(P@6-6)8E59GWK&<&/DCZ TG5(]7ACN8&W12QI(C8(RK
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M(['Q&Z75G/N9+N.(QNHW;1E554.W :2-0SJ) 0[X5&]@^+'_ "!]0_Z\+O\
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M^8 J$.,J$RVTJ6VL5J+]ERVO/[&LW\V'[+_I'[OR'\[_ %TH_P!;Y^W[W/\
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MFOE#-_JXQ]K0F1AN5F QPB\NQ52R*6D3L/&OQ-U?X4:M;#5+E+K3KK=N(@2
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M^6?:?+*,P\O_ &HK?5M$L(;349Q>Q27(E2Y$(MVC=(W4PNJ9C(8.'C;(;*R
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M N=P2.->"\A!*KG!"C"DECT . S84\AIUMKOB32?[2CO?+O)[=9H+>&&W-L
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M><$'H17E_P"VU_H$VFW4/R3C[1B5?ED&PPM'\PPWRLQ*\_*22,$FNK_;6_Y
M\'_7_'_Z)GKU7X3_ /('T_\ Z\+3_P!$I7S_ / +_D<-6_[?_P#TLCH_;G_Y
MAW_;W_[;UM_%N]C;QAID%U)(L!MMJA))HR))3<1KM,+*ZEG$:L01D !SM!KU
M^[^%-E>(T4K73HZE65KZ^964C!4@W&""."#P15OP'X-T_P 'Q26FF((T$Q:1
M!(\A$A1#SO9F4E-AQQP0<<Y/SU\ O^1PU;_M_P#_ $LCKZJHKY@729OAAXO>
MXCC>XM[Z.6201*UQ<1I(ZL[F.,!U59P,-M8&,E5+R @;?Q,\&R_&_4;>W6&>
MWL+-7:6YEB>!I3+L/EPI,BL2/+P7884DDJ<()>?_ &Y;MU33X@Q",URS+D[2
MRB$*Q'0D!F /4!CCJ:^G[2[2\198F#HZAE92&5E(R&!'!!'((X(KY:T__B7?
M$%XX/W:2;MZI\JMNLA*VX# .9 '.>K_,>>:Z#]LWP*NH6,6J1I^]MI DC#8/
MW4AP-V1N;$NT* ?EWN<<DCM=-\:_\+'TBS 7$FH829,87RHWVWQX9V6)E1XD
M<'<'EA!9&8,LW[35V]KX?O6C8J2L*DJ2#M:>-'7CL5)4CH02#P:J?!_PE9:]
MI%E<1RW1!MHE;;>WT:AT7RY%"B=54!U8 * N!\ORXKH+'X3:3HM]'J(0_;2Q
M5)9;B>61F\IE*CS96WGR@W&"0JDC 7(\/^/O_(X:3_VX?^EDE?55?*OP"_Y'
M#5O^W_\ ]+(Z/VY_^8=_V]_^V]>J_M1_\B[>?]N__I1%1^RY_P B[9_]O'_I
M1+7E7P"_Y'#5O^W_ /\ 2R.C]N?_ )AW_;W_ .V]>M_M'^ #XTTB6-&"R0,+
MA"SK'&2BL&#,PP!Y;-@DJ VTLP4&N9^%_P 79=/T& R6-Y)=0VZI%%':W&R9
M5 6%UD".@4IM+,3G(<JA&P-K?LW?!B3X;VLCW39NKGRS(@(*1A-VQ 1]YOG.
M\@[<X"Y"[V]?HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKYPUK2S\/O&5O>!A':ZHKQG
M:BX,A55,>%W-EIQ%(9,+DN<D@.3[UXK\,P^*+66QN1F*:-D;A21GHR[@P#*<
M,I(.& /:OE#2="\3_ N>6"P@-Y:RL=FV*2>)B-N)=D3;XGVD*02 V"!Y@16'
MLOPPT_6O%=Q'JNOHEND,9^S6J;E^>1<-<.OF,0PC9HPCY*[F^2,C+VOVG?%/
M_"/Z%<;7V23[8$^7=NWG]XO0@9A$G)QCL0VVMOX(^ SX&TFWLY !-M+S8"@^
M8YW,"5+!BH(CW9.0@Q@8 [JO)?V@;'4/%.GSZ586,DIE:']\9;:.+:K+*2 T
MWF$Y4)@JHZL"0!N] \+ZW<:JF;JTDM7"IE7>"12Q!W!&AD<D*1U94)!! Z@0
M^.O MKXXM7LKU-T;<@CAT89VR(<'##/!Y!!*L"I(/%?LZ_#FX^']G<V5T/\
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M7HOQ\L=0\6:6VG6-C)(]PL+,S2VT:Q8<2%#F8EG!0 A<IALB0XP9?V>-+O\
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M0.H&U7SK^TG\'[V_NH-=T6/==0X,JKLWDQ?/%*$9?WC#!4@EF8"-50@&B_\
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MR,Y$B/*T4JSQJD4@W(H94WR,SA@&1!EBT7K]%5=4U-=,C::0.57&1''),_)
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MEJQP"/,D>,;03]]@@QR0O.-#PQX8N_$5W'K&L1B"6!9$M+1'$GD[QMEEDD7
MD=P,*H^1$QP9"2OHM%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%17:NR,(B%<J
M=K,I=0V."5#*6 /4!E)'&1UKYJTKQIJR^,8M)O+PS0QM,=J(+>(B2T,P4HK,
M6"D@+YC.1C.<DU]-44445E>)K*ZO83'8S);RG(\QXO/V@@C*KYD8W D$%MR\
M8*'/'A7[)/C^^\9R:A-J$[S,/LFT$@(N1,#M10$3.T9V@;B,G)YKZ*HKG_&/
MVZ",3Z;L>6/DV\F%29<J64/P8Y< B-CF,%B)$.0R'@7QU:^.+5+VR?=&W!!X
M=&&-T;C)PPSR.000RDJ03T%%%%%%%%%%%%%%>(?$3XD3ZUKEOX7L9S;!U8W4
MZ#,P'DO)Y*%UPA,8!\Q=Q5F4C!1E8T_X?>(/"&K0_8;R2[TR5E\\7<HE>-5!
MW#)^;)R3&8@ 6PLHV+N;V^BBBBBBBBBBBBBBBBBN \8>#]4U/5+*\L[WR;.'
M/GP8/S\Y/ ^63>N$^<CRL>9'EB17?T4444445S_C_P 8Q^#+&?4)AE88R0O(
MW,2%C3(5L;G(7."%SD\ UXKX8\*ZI\5]*&KG5+F"\F\[R8H7,%H@25U6-EC^
M=L[2/,+%P"N0^SYO5?A#_:_V$?V_L^U^8_W=F[9GY=_E_N]V<XV<;-N?GW5V
MM%%%%%%%>2_M WVH>%M/GU6POI(C$T/[DQ6TD6UF6(@%H?,!RP?)9AU4  C;
MS7PMM?$7CO3H=2_MGRO-\S]W]AMGQLD>/[WRYSMST&,X]ZJ>.?&'B?X2?Z5=
M20ZG8F2,,YB$,D8XR"(@!'O)*JY\U00N0I8(WNOA3Q-#XHM8KZV.8IHU=>5)
M&>JMM+ ,IRK $X8$=JU:***Y_P ?Z/=:S8SV]A-]GN7C(CE_NG(R,CE<C*[U
MRR9WJ"P H\ :/=:-8P6]_-]HN4C DE_O')P,GEL#"[VPSXWL Q(KH*******
M****\@_:A^(\G@O2]MJ^RYN9!$C*X615P6DD48).  F1@H9%8,&"Y[7X6>-?
M^$WTRWU KM:6/YQC #JQCDVC<WR[U.W))VXSSD5U5%%%%%%%%%<!_P (?JG]
MN_VC]M_XEOV?;]EP?O8QC;]W[W[SS<^9_P LL;.:[^BBL7PSXO@\2&X%L21;
M7+V\A(V@R(J%P,\D MMR0,D'&5PQVJ**************************Q6\7
MP"_&E9)N#;-<$8^41B18P2?4L3@#/"DMCY=V)\7O"^H>);$V^DW/V6X\Q#OR
MR;E!Y3>@+IV;*@D[=A^5B:ZO2;>2VACCGD\V58T#R;0F]@ &?:.%R<G X&<"
ML_3/%\&IW=S81$F6U6 R\84&8,R*">IVKDX& & R3N"[5%%%%%%%5=6U2/2(
M9+F=ML44;R.V"<*H+,< $G !. "?05\__#][[XZ6]SJ$E_<V*I<216T-JPC2
M/$:-ND8 //\ >7@E,$/M*A\+Z!\$-/UW3H9H-?=)/+D5+=PP:1D48+,R@94X
M!4O^])WF3^&O2JY_PQXMC\960O=/;"2><(GD0D91WC#E-RL5++N RK%< [3G
M'SWX<\2ZM:>,8M*OK^2Y2-64X46\3@VCS#,,9V$AFZG). <\ #ZDHHHHKBOB
MO\5[7X;VIN;D[I&R(80</(P[#KA1D%W((4$<%BJMYUX'\%:U\1H(]1U?4I[:
M.56D@M[)EMRJ2;6C9I%!W#;]U&#LH()D#%UK0\5^#]=\"VLLVB7LUZ/+;,%V
M!<3@G[TL,GRDLH"[86!0_.<,Q"GNO@_KXU_2+*Y#F4M;1*[MN+&1%\N7);DG
MS%8$]SR"0<UV%%%%%%%%%%%%%%%%%%%%%%%<!X/\'ZIIFJ7MY>7OG6<V/(@P
M?DYR.#\L>Q<I\A/FY\R3# "NE\:>+X/!UI+?W9(BB4%MHW,22%50/4L0!D@
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M,JNTAR@(VH&4D^6'1%"NA#!OF=?0/C9\5X_AO8M<91KE_EMXF)^=LC)PO.U
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MZ>DC)'</ 9KB=DP&94EVQK 2Q /,FZ/!VY95R?!WQ/U'PIK)\/\ B"1)C/\
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M6PN]*FCT^&2&.6W\R-9[B3<K'$O+Q0H<H1L$KX^9BIS%7/\ [/GQIO?B%97
MDCCDO;9H1DDP12(XP&9E68A\I(6VQA?NA0 3MY3P5\<-=US5[O362!YX898H
MXHU=;;SDN$C:=Y"'D"*A=B"RAPJHH$KKFKXX^)_BKX4W*7.J>1<VDS'"QKB%
M3NW&)7V)(KA 0ADW@J2?WC*VWV_QI\5;?PYI\>I1J]P+CREM8XU;?,\J[HD
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M8($=BI3 =@"&8Q\Q#E?A?\<-9\;Z9<RVP@>]L5#,C02,)T*93;Y4RD3$QRY
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MXMH8KCS!%(I:><>6ZDL1(B1+N5U&W;)CYL/]TC5^(]_XMO8WOM*\F"W3>T<
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M;( PP& /RZ'P)^.S>/FEL;Z+R-0@WET"NJ%0X4D!B61E8A71CG.""<LJ<?\
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MKZJKP7]L^[>#1HU1BH>]B5P"0&7RYGVG'4;E5L'C(!Z@5Z5\';M+K1K!HV#
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M?^EDE'[<_P#S#O\ M[_]MZ^JJ^4/V=[1+/Q;JD42A$1;Y550%55%W$ H X
MX ' %>M:'X\_X2*:>W\-6\(C6X)N+UUVVK2DQ^846+#7,I7=DEHUX5C(5="W
MD&EV\EOX_59Y/-DY+/M" DZ>3A5&<*,X4$LP4#<[MECVO[:W_('@_P"O^/\
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M;G_YAW_;W_[;UZK^U'_R+MY_V[_^E$5'[+G_ "+MG_V\?^E$M>JU\J_MS_\
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MSB;RPLT"J8<Q!V!$DIBBVLKDY+JP8!"FXD+T'QB^&&J6&HP>)]&C1KM(U-S
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MMGL+^PD DN1(LJ36KJH941MZ^<& 78#E0Y8$@*"!N]ZKA?CCX0G\8:/=6-H
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M[1%HEXFEQ2J'1]<L596 964B4%2#P01P0>"*\:\2:7=?L[:R+VS5_P"R+F1
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MI?A_9&XOR+J=YEBMX[>%XC)(X_=Q8:2<Y)5B6STX5"V W*:_X7\630/<PZC
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M&">23R;=+6*YV(C&/YGDVL6+*2>H/4;0=B]W\)];U'4UNTU<1K<0WK1!8O\
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M6:I#::]<)=V-YA8KG9#;M&P*ABRK@!07&_<2-A5U;*O&=KXS?&6?P]?VFAV
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M*(6*M@@L6#JRJ%=6R%0 ;CQ'\1-1\6ZG+HF@-'"+95-U>NOG!&+IF.,#='O
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M^5?C[_R.&D_]N'_I9)7U517E7Q]_YA/_ &'K#_VI7=^-/"$'C&TEL+L$Q2J
MVT[6!!#*P/J& (R""1A@1D'Y?\#^+Y_V=M1?1=3(DL)F$JRH/F4-\@GVC+8.
MS;)&<E2NZ,MC][Z!\*;M[/P2TL3%'2RU%E92596#W!# CD$'D$<@U5_8GNT;
M2KB(,"ZWK,RY&X*T405B.H!*L >A*G'0T?ML6B-I5O*5!=;U55L#<%:*4LH/
M4 E5)'0E1GH*]?\ AE=O>:58RRL7=[*V9F8EF9C$A+$GDDGDD\DUTM<K\6/^
M0/J'_7A=_P#HEZ\J_8I_Y \__7_)_P"B8*Y3]N?_ )AW_;W_ .V]?0'Q8_Y
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M"=I#D$CE3AL-@JWS_I_Q)\1_ O9::I!]HL4PD3$_+@>8$6.=0<9QD)*K.(U
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M>OH#XL?\@?4/^O"[_P#1+UY5^Q3_ ,@>?_K_ )/_ $3!7"7WPB\0?!>YDO-
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M'/2IOB-X\L_#MQ;1?9_M>IOYGV2%%0S+N4AG+M_J8CMVN_\ =#':RH^WQ_\
M:QM]0;28I=0DA&;\!8(%8HH*3E2TLGS2,%  *I"N6?*-\A7U#3_ Z>.?#%MI
MTCF,3:=9X=0"598XG0X/4;E&1D$C(!4G(\*L-2\3?L^@1S1BYTU6R<9D@&YH
MR^V0 20DEMJB0!"[,RHYYKH/V@?B<GCGPQ;WMJ3&)KV-)H@X)5ECF9HWVGD;
ME5UW $C8^U20![I\';M+K1K!HV# 65NI*D$;EC5'7CN&!4CJ""#R*\%^-O\
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MN@_:NU9;"\T7[1(Z6HNWDFVM(N CV_S_ +LAMRJS[67YUR=I!->P?\*TM?\
MGI>?^!]__P#)%>5?%[P'IWP\T+4DTA?(EDCM/."S2,Y1IQ&N0[L0K R+V#C<
M#G! Z7X/^$K+7M(LKB.6Z(-M$K;;V^C4.B^7(H43JJ@.K !0%P/E^7%=!8_"
M;2=%OH]1"'[:6*I++<3RR,WE,I4>;*V\^4&XP2%4D8"Y'A_[<_\ S#O^WO\
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MR&(V2F$L1@'</)EE7'..2#D'C&">:^*_PHM?B1:FVN1MD7)AF R\;'N.F5.
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M\R#[20DT$TJ+@M;@/+Y@60-AG4*-H8;S@QMV'B_5M4\/:VUY:6<EU9'3H%N
MAC5@RSSN&3?\TKJA?]TA!8NNX@E*X_XFZ?<?'1;>RM["YM%BN \MU>1+"8T*
M,"L:[B\F[&6"D ,L>_ 8,O8>+]6U3P]K;7EI9R75D=.@6X"&-6#+/.X9-_S2
MNJ%_W2$%BZ[B"4KC_B;I]Q\=%M[*WL+FT6*X#RW5Y$L)C0HP*QKN+R;L98*0
M RQ[\!@R_15%?,OQR^!NH:?J'_"0^'L^=N,DD<8175PIW2(, 2!P#YD>&9V8
M\.'(6;0O&?C#XA;K)K9-/B?"R71AFADC4Y),8EERS$*5&P$J2"6CR''JOQ'T
MN>RTE]+TJT>??:/;1@21(D:[!$I9II QPI)& Y8KABN=U<3^S'X7U/P+;R:?
MJ%D\:R7#2K,);=T&8U4JRK*7'^K&"H?);D*%R>:N?!.LKXI_X2&/3I&M]RY1
MIK19=OV86[G G9<CE@-V&P 2N<@_:&\):B^JZ=K]K:23I"MOO@3YYE>.5Y]C
MB(2  AMN]=ZA@<GE-W=_$KP WQHT_#P/92IMDM6G$?FEBIW(ZQF0QQ,"H/S"
M3>,O&/+42>2>#O&'C+P,B:0M@9PC*L;RQ22JJL%VH)HI%BV+GJS$(,J6"J%7
MWOX;>'[[289]0U7]]J%SAWBC(VQH@/DVL>^01_*6;YLJ"[G<[X\P^/\ _"%Z
MY_PE'_"1?V:_D>9CR_M%KYFSR/L^[_6[=VWY]N<9^3?CYZ]O^)LQGT2^=E*%
MM.N24;:64F!R5.QF7(Z':2,]"1S7SW^R_P"-[KPGILKFSFNK-[MP#:IYMPDH
MCB)#QDKF)DQM<'Y64AA\Z8[71O".H?$_6H=:U*![33[3FU@E++,[*S;9&0./
M+;> [$@ JL: 2+EZM?M.>%]3\=6\>GZ?9/(L=PLK3&6W1#B-E"JK2AS_ *PY
M+!,%> P;(] ^$)N[;3X+2^M7MI;>WAB.9(94?8NS<IBD8]%!(95P6P"V":\5
M^*?@O7/%.N6NL6VFN(K3[/M22XM5=_*E,QSME<)DL5&"_ #=]H]%\>ZEJRWN
MG7VFV,DA6&_6XMWD@C.QC %5I=TL:DNJNH5BS!2. ' YKXFZY<?%RR;2;/2[
MR.5Y(F\Z\B6VBA"NNZ0,S.2V#MVH-Y1G(S@J9?C%^S@?$NF6L5HP:]L+9(D)
M54$Z(BKL).2IRI:/+%5+,#@,77C_  M\2_&MCLTW^S_.DCW)YT\4HW;,\M-Y
ML<+<# ?/S\'<S-D^MR>![G1] OH)W-U?W%M=R3NH9C)-)"5"HOH%"1HJJH(4
M81<XK/TGXOZCH4,<&KZ5?-="--SVT<=U&^  9"T3*J,S!B8QG:,'."*/V??A
MA<>$FOKVZC2W:]N-Z6J%7$"*\I5=R80_ZS "C 4#N2J^OT5\Z_'/X+S>*-=L
M9[7>D=S&\5U)&K)M1 =[/*JL-TD+F) XP=H0DJ<+ZU\7O"!\8:3=6* EY(28
MPI529$(DB7+?* 750<XX)Y'48O[.W@5O!NC00RILGES-,/GSN?[H8. 598PB
M,H  93U.2:G[0^EW_B73I-+T^T>=IO*)E\R".- L@<C]Y('9OD QM"X;._(*
MF+X!V.H>$]+73KZQDC>W69E99;:19<N9 @Q,"KDN0 V$PN3(,X'G_P -_!.L
M^%-?O-7DTZ1[>Z:ZP%FM/-59)A,AVF?:3\H4C< ,D@G&#%\4_!>N>*=<M=8M
MM-<16GV?:DEQ:J[^5*9CG;*X3)8J,%^ &[[1VOQ\^$L_Q5L8IX5>"\M_-,<$
MIB^<,5#(6C=T#'8I0ARO.U\9+)YUH/Q8\;7J"S6Q+2LK@3RVKPL#AB&+.T=N
M"HX7<N"0 0Q//O7@;P[/X)T[;*OVJ\:22:X,"Q1M++-(7=AYC1(=N[&6*Y1!
MA1P@\5^%G@O7/"VN76L7.FN8KO[1N2.XM6=/-E$PQNE0/@J%.2G!+=MIU?VI
M?AUJ?Q!DMH]/M'=;?SMTADMT1O,$1&T-,'XV$'<J\],CFO=?#.JSZG")+JW>
MUEX#1N\4G. 25:)W!7)(!.UCC)1<BM6O"OVG/"^I^.K>/3]/LGD6.X65IC+;
MHAQ&RA55I0Y_UAR6"8*\!@V1Z!\(3=VVGP6E]:O;2V]O#$<R0RH^Q=FY3%(Q
MZ*"0RK@M@%L$UX+X\^#NK?#+4SK7AQ#+"S,S0HH)0.XW0&),&2$DC;L&4 R=
MIC60]+X9O_$WQ5Q:ZG;I8Z>9!]I(2:":5%P6MP'E\P+(&PSJ%&T,-YP8VS_B
M/X9O?"'BN'7X;6>\MY%!<01EV0B'[,Z_+NY"XD7<$#D[ 1M9A;_:1L]6\?Z9
M"]I8R) DR2-&^#>DE&5&$432 (!(0P),NX\QHJ%FZ"_@U2X\,Q6]M:R17<,.
MEK K^693+'+ 2Y3+*B+M!S(0PP_FQQJN6U;OXNW4R-9W>B7K7#J4:()'/9L7
M&%5KC/E[""!(Q4A,L&!VG.5\-/@$]AX>GT;46 DNV:5@N6$+E8_+&58;RC1J
MQP0I.4RR_,W-?"KQ#K/PD5M(U/3[FYMDW-;RV<7GXW2-D$J5!5CEQO*RKG#*
M590G7^!_!=WXGUI_$FI1&!$A$5C;N1YRH5YD?RR I(=_W;[F5G8''EH6S_VG
M/"^I^.K>/3]/LGD6.X65IC+;HAQ&RA55I0Y_UAR6"8*\!@V1VWPVO;W2=+A@
MNK&9)[6W@B\M9+5_-V@1[D;SU4?*H9@Y3&=JER,GQ3X)?"76/#$-_I]]9ND6
MH6XA\]);:3RCB2/>R>>I90)2QVG=\N IW9&A^S=J>H> 8IM)N]+O6=KEW61(
MT\HG8JN#)*\40 \H%6#L'W8';=GIX8UG3_&"ZI=63R*V]@;7YX=OV9X4'FS&
M% PP V\QEF!*KAD!T/B5X"U?PQKD?BFSMQ=@K&9H(RSLC>2MNZ+P'D!4DI(J
M9!R7C"K\W5^+_$.H_%: Z7I]G=6,4K*MU<W:?9RD74K&@DW2EMI5@/E .U\"
M3>GI6@>'(O .GI:6,4DJ0+A8U9#*Y9LNV97C3)9BYY4=0H'"UX+\+/!>N>%M
M<NM8N=-<Q7?VC<D=Q:LZ>;*)AC=*@?!4*<E."6[;3]/UX!\ ?A#_ ,(CK.JS
MXVQ12""W"ON39)MN2IW?O-R1F$9/&2PR_4>_T5S7Q(\#IXYT^?3I',8F5<.H
M!*LK*Z'!ZC<HR,@D9 *DY'S!X9\1>+?A2'TJ&R-S#"Q$9^S2S1 %F<M')#L+
M!B^3O)*_=PA#+7NOP?\ "^J"6?5=?\O[9,JQ1QHL>8(4>1_+#H3D,SYQECA4
M+NS<+YUXV\ :I\-M:D\0Z)!]JMY\FX@4%I/G9#*N"6<[G_>*T8.PY#((UP^U
MX_O]0^,L"Z596=U90/,ANY[R)(0(URZJB%F>0EU!^0KM*JK$*Y([OXI?#G^V
M]"FTBQ&S;;QK GWO]24>./+L/O>6$W,W&=QSCGS_ .!GB/4_#=@FBMI=S]JM
MY)!YDA6&T*M/EG,S _=\QL")92X4,N03MYKX3^"]<T'7[[419B1)9KR(RR.;
M.(DS++YJJ5GE*-M 3:KCYOOG:QK0_:9\!:Q\1YH([&Q?RK;SAYCS6R^87*#*
MKYQ(7$8(+88[L%%V\^G^-/"DGQ1TB6TO+8VMPR@QK(\,FR95#*RO$9?DW$H6
MPLA3>-J[A7C7PH\7>(_AK&-&GTF:Y59 (67Y$3S#N93,B21,NYL[BPV$L&;
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M$Y,DN"3&IQ&2I,CC 5YO"'A"#PG +:V!(+,\DCG?++(W+RR.>7=CR2?8 !0
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M&Y67/_9F^)=[\0[&>RNI72:U\D+=)L:9E<N0&$L<B%AY94N02RMDC>"[>?\
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M6UHZQ':"B[VE&6?YE=2'4'<"R;$;:<KPY\0]3^%VM1>']5F>^MKCR1!.P43
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M$. Q0QJ0OW,,17=?&?P?J-WIT^H)?SP7,$+RB&"7R;557#2)E(Q-*1&I"L[
M-)\P6)&*+B_ S7M3^)^DHDMT\"022033QE7NY_DRN'=-L.U9$RX$DLA4G=&<
MLV5\.O%]]X2\42>')[J:\M6WE&G8-(A,"W"L6(9FPJE-H*H23(%!^6JG[5WC
M+6?"30K#>[(+GS0(X8O(=!$Z,I,N]Y"Q#@,4,:D+]S#$5[U\2/'">!M/GU&1
M#((57"*0"S,RH@R>@W,,G!(&2 Q&#YU\)M*N/B5IW]JZE=W(ENO-$:6\TEI'
M;JLDB (L3@.V<G?*') 12#M);BO@;XQUC7]2N=#O[^8-:1N!)$+9LF&186!,
MUK(\F=P(=B&X.X,6XJ?MS_\ ,._[>_\ VWKT7XS^#]1N].GU!+^>"Y@A>40P
M2^3:JJX:1,I&)I2(U(5G8!I/F"Q(Q19OA#XNG^+FBAI9YK>X21X9Y8!%&SD+
MU4LDFW*2*2R!&$@.S:H /C_[&NC2ZE]O\JYFM]OV7/E+;MNSY^,^?#+TQQMV
M]3G/&/K^JNJ1S2QL+9T27C:TB-*@Y&<JLD1/&0,,,'!YQ@_.OP+\;ZGJ_B2]
MLM0NWN%MK>YB'"Q1DQ7,:"3RX\(&.3SRV#MW$ 5W_B#7;WQIJ<^B6$KV<%I'
M&UW<J$:5S,H*01;FS'F,LWG %E=1@* /,X#XFQZA\#Y+?5;:^N;RT:00S6UW
M,TI)8,^5;&U?E0X8*&1@/OH[(/3_ (I_&"+PAI U:WQ*9EC^RA@X5VE7>A/&
MX )ER#M)"[<JQ%<K;_!+5M;MO/O=8O8K^58V(B81V\1VINC,4+JK$88;T9 Q
MPVT\[JGP$^,NH>)Y;K1=2 &HVRS$3;49,HXC99$C9%)1V&-A =>,JPW/Q]UX
M[UVW\5#2C=?:#'YWE1A!;VY:6T,B>8BON:*-BI.YY) J$IF0X,WQ@\->)/A\
MG]MQ:M)<A& E7:L,:!@(D80%GA8$G!PH(8A\$[F7TJ'XVO?^&VUVTB$MQ'#^
M\B&=J2AE24E59V"+DRX)#&+!)7.X97P[\(7?C[15O;V\O8;^Z5W$JS2PK& V
MV(K!&T<11D16/RY<.S!QN5EA_91^*]UXWM9K:].^2T\H"8G+NK[]H?U9=F"^
M<L"-PW LW%?&/QWKOAK7+.Q%UYZR26LRP0H+-')E:+R"Q>1RK[3NWNR9;E<*
M,>@:9X4USPSJ)UG4M122Q%O+)=PKYHCCQ&Q*Q1;7!5"JD2925P&W EFWXO@6
MWU'XTO-J4][=6>G":1+.*V/V:5E!4;W8!@XP,'EQYGF!2BKM;S3X@Z;=Z5XK
MTVVO)#,(IK%8)GQYLD/VDLID()W.K,T98A2^P.5RV3[U^T/KFI^&M.DU#3[E
M(%A\HE?(621RT@C(WR.45?G!QY9;*_?P2!5^#FK7VK^%DGBD>6^:WO/*>1@[
MF423"++2D@X(4#=\N  >*ZK_ (1:ZL(?,NM6N1LCW2R>781QC:,N^&M6V+P3
MRQVCJQQFO*O@[XTUCQ_JD[Q7<QT>WD8+(T-MNF*D!8]PMXBNX?O&"IN1"$)#
M,KUVOB#7;WQIJ<^B6$KV<%I'&UW<J$:5S,H*01;FS'F,LWG %E=1@* /,X#X
MFQZA\#Y+?5;:^N;RT:00S6UW,TI)8,^5;&U?E0X8*&1@/OH[(/HK2=4CU>&.
MY@;=%+&DB-@C*L RG! (R"#@@'U%&J637L;1QRO"QQB2,1EUP0>!*DB<XP<J
M>"<8."/D7X#>'9!XGU*UBNIXS$MXOG#R9)G"W4:_.9HI%);[S$*"6[@$@^@?
MME0F#1+9&8N5O807;:&8B"<%CL55R>IV@#/0 <5M:%X$OO%>@V@2]FM9!80&
MW2WD$4>1;@1-+((C,VXG+JI5%&%"LR>:\7[*?Q5G\;64MO>,9)[1D7S".7C<
M'R]QR2S@HP8D#(VDEF+&I?#:WOQGC.H-=7-AIYD=;:&W9(IW"'9Y\DPWL,MO
M4PX"C:I!;&YN?\.^+[SX6:\NA:A=/=V=YM>"69GDGC+EDC4G!SETV$?<Y64>
M7EU/T5575(YI8V%LZ)+QM:1&E0<C.562(GC(&&&#@\XP?G7X%^-]3U?Q)>V6
MH7;W"VUO<Q#A8HR8KF-!)Y<>$#')YY;!V[B *J?M7>,M9\)-"L-[L@N?- CA
MB\AT$3HRDR[WD+$. Q0QJ0OW,,17:_&'P9JESI]SJ']H30W$$;S1PV[F"V1%
M5&DC9E7S9VVH^UV* L1B.)211\$?%5W\5]%)NKB:&=+B6&2>#R4DD&T,,9A*
MQX64#* ."@8."2*\J_8UT:74OM_E7,UOM^RY\I;=MV?/QGSX9>F.-NWJ<YXQ
M[KX^\6WM[J$6@:6WD3R6YN9KLHDHAB#%%"QNP#LT@"'/W5;(!))3S_XJ^#M0
M^%]NNM:=J=Y,+:13-#>3-/'(KLL8  "CJV"#S@[E=&0;NUU_QS=>)M!_MG29
MTML6DLSYA\]PT0W-$K.R*,,CQEFC<,#N4# )\E^$ESXA^*.F7217A@'VF1S=
M,[&5Y"D;+;($(,$(/S.R?WU5$*B0'T"TU?6K4V?A@3@:C]F>>YO]JSK'"LCI
M%M23RS*[$)&[,,@$M\[$NN)\5?!VH?"^W76M.U.\F%M(IFAO)FGCD5V6,  !
M1U;!!YP=RNC(-VW\2_CZ]AX>@UG3E DNV6)2V6$+E9/,.&4;RC1LHR I.'PR
M_*UJT^#=W!;+<Z=K5[)=>2&BDEF$]F[%?O&-E<%&!.TY<ID,-Y49YKXW:'<7
M7A2.XNI[E9(K2P,L#%0KREHU=I=T?G,V7)*EPN]58KN&:Z#]ES1I?[&L[C[3
M-Y?^D?Z/MM_)_P!=*O7R?.Z_-_K/O?[/RUBZ7JT_Q<UF^LY+V>QAT]FBBAM9
MO*EE(D9))G;!+ % -NW";T (.XR=KX0\(ZCX8U58I+R>[TXV4_E><=\B2^;
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M5VM%?*O[#'_,1_[=/_;BNK_;6_Y \'_7_'_Z)GJ7XK6CV?@E8I5*.EEIRLK
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MHEKR7X,7(TCQGJ,-QF-YVOEC5E8%B9UG7MP#$I<$X!&,$Y&?H7XL?\@?4/\
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M;U]545Y5^U'_ ,B[>?\ ;O\ ^E$5'[+G_(NV?_;Q_P"E$M>5? +_ )'#5O\
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M)P1\T:B*0<@='0C/0XR"1@UXA\=+1[KQCI*QJ6(6R8A02=JW4KNW'8*"Q/0
M$G@5TO[:W_('@_Z_X_\ T3/7JOPG_P"0/I__ %X6G_HE*^4/#G@R?QEKVN6-
MK.;>21;_  P^ZP^V1YB<X+!&Z,5P<==R[D;V3]F_XKK<QCP]J!\O4+/?"%)3
M$BQ$KM4I\I:-5VD<EE7S S?/M]UHKY5^/O\ R.&D_P#;A_Z625ZW^TU:/=>'
M[U8U+$+"Q"@D[5GC=VX[!06)Z  D\"L_]D_5([W0((XVRT,D\<@P1M8RM*!R
M!GY)%.1D<XSD$#SK]MRT>\?3(HE+N[72JJ@LS,3;@* .22> !R37I_[4?_(N
MWG_;O_Z414?LN?\ (NV?_;Q_Z42UZK7*_%C_ ) ^H?\ 7A=_^B7KRK]BG_D#
MS_\ 7_)_Z)@KE/C[_P CAI/_ &X?^EDE>J_M1_\ (NWG_;O_ .E$5> >,O\
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MNE)IWVFYDNIF6Y#R.$1?E$'W(XE5$&XL<X9R"%9V")M]O_:C_P"1=O/^W?\
M]*(J/V7/^1=L_P#MX_\ 2B6O*O@%_P CAJW_ &__ /I9'6M^V!X9FL6L]?LQ
MB6VD5'D 9BN'$ENQ4AHPJR;@2V,LZ*=V0!Z5X$\8Q_$V2WOHAB"WMUEP,L!=
M2B2)XRVU#NAC#@@@AUN$DV@"-F]*HKY0^#%R-(\9ZC#<9C>=KY8U96!8F=9U
M[< Q*7!. 1C!.1GZ%^+'_('U#_KPN_\ T2]>7_L86CP:-(SJ5#WLK(2" R^7
M"FX9ZC<K+D<9!'4&N/\ @%_R.&K?]O\ _P"ED=?55%?*O[0W_%N_$=AK\?RI
M+CS=OSR-Y6(YOE?Y!N@=47!'()^4_,?1?C'X7?XC6E^L>2EK"RVX53)YEPA6
M:8JH)#$!!;(RD.CM=1LK< \A^S_XS_X3+2[717;<\=Q(MPI?<YM(@)02&X$3
M2/%;&,[@\7F*HP&,?TI7RK^PQ_S$?^W3_P!N*/C[_P CAI/_ &X?^EDE=7^V
MM_R!X/\ K_C_ /1,]2_$*T>Z\#HL:EB-.T]B%!)VJ8'=N.P4%B>@ )/ KN_@
M)XFA\0:+9O <^5;QP."5W*\2B-@0"<9P&7."4920,XKK[_7X+"6&VE<++<,Z
MQ)_$Y1#(^ .P49)/ ) SEE!^9?C[_P CAI/_ &X?^EDE>J_M1_\ (NWG_;O_
M .E$5'[+G_(NV?\ V\?^E$M>JU\J_MS_ /,._P"WO_VWKZ ^+'_('U#_ *\+
MO_T2]>5?L4_\@>?_ *_Y/_1,%<I_S4/_ #_T#J/VY_\ F'?]O?\ [;U]"_$K
MPS!XGTZYM+MQ'$\+;I&.%C*_.LI^9.$90Y!(! PW!->0?L]:EJWAO23 ;&2Z
MB#2/92I)!"CHQ8@$3M#*B,^75V1F*R9V *H/5?!3X/OX9EGUC4,?VE>M(\B(
M3Y4*R/YK1+R=QW8+,2P& J$@%W\O_;G_ .8=_P!O?_MO7T!\6/\ D#ZA_P!>
M%W_Z)>O*OV*?^0//_P!?\G_HF"N4_88_YB/_ &Z?^W%?55%?*OP"_P"1PU;_
M +?_ /TLCH^#4.FZGXBUBQU""&:66[G>#SHXI!^[FF\Q5\S)W$.&PH.51B<;
M17T!_P *GT?_ *!]G_X#0_\ Q%?.O[8BQWMGI-S9+_H?ER^6RH4C572!H5Q@
M;,HI*J0#A3Q\IQ]5:3JD>KPQW,#;HI8TD1L$95@&4X(!&00<$ ^HKYEAM'G^
M(3,BE@B[G(!(5?L"IN..@W,JY/&2!U(J'_FH?^?^@=7T!\6/^0/J'_7A=_\
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M&T;<8&!@<8%:%?*OP"_Y'#5O^W__ -+(ZZO]M;_D#P?]?\?_ *)GKU7X3_\
M('T__KPM/_1*5\J_LX?\@?Q#_P!> _\ 1-W7I7[+>A:/XJTA4EM+:6ZMY)$F
M,D,+R'<[21MDAF*[6VJ6QRC <+FO6KCP-HV@%+DV=K$5FA5'6WC#"1Y%CBP5
M3(/F,H!['DD 9KL**^5?@%_R.&K?]O\ _P"ED='[<_\ S#O^WO\ ]MZ^@/BQ
M_P @?4/^O"[_ /1+UY5^Q3_R!Y_^O^3_ -$P5RG[#'_,1_[=/_;BII9;!O'-
MU;ZE%'*D\,448E2-XQ*8+=T)\S@$A2BX!8LP4#YC7O7_  J?1_\ H'V?_@-#
M_P#$5E>,5M4T&_2P5$@2TU",)&GEHK()DE 4!0/WBMD@8)R02#D^?_L4_P#(
M'G_Z_P"3_P!$P5S4LM@WCFZM]2BCE2>&**,2I&\8E,%NZ$^9P"0I1< L68*!
M\QKWK_A4^C_] ^S_ / :'_XBN?\ &GP\TOQYI@TR,I;Q?:)5M_+41!+B)IE<
M+'\@?!67<H'S+O92.''@M_IOB;]GT&2&07.FJV!G,D W-($W1DB2$DMN8QD(
M7959W/%>G_&3QC'XS\'RZA",+-';$KR=K"YB61,E5SM<%<X ;&1P170?LN?\
MB[9_]O'_ *42UP'Q-_9MFU"ZEUKPY=;+AI)6:,2,A\W]XL_ES*WRL7RAC;"J
MQ<%U4!!H? _XX:C>:B^@:^@6Z57V/MV2,ZY<HP0>608_F1UV*50<N7!KZ$HH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHKYP_X5QK'@#Q#<ZMI5H+VVNED+!IXHG!E82.N7*[2)5R/E<>
M60"=Y)6+]HSX0Z[X^^SW$8A?R]Z_98W \O=@F3SIO*\W=M&X;8]GRJJM\[GK
M_C3\&KOXHV48D,$-[#,6B :5XA&P59(S)M4L25$F_P H8P(PN-TC8O@6P\7Z
MG&FF:GLMK<1[9+P.DEZ5!'RHR2NHE*_*)&3*C+DM(!NROV;OA+KW@221IEMH
M8)I(Q,LA,T^V,,08_)?RQN+E<NQ(QNV$ !O>O&WA=/%5E/828 FA= S*'"L1
M\C[21DJV&'(.0""#S7%?L[?#N7P3I:17BE;IV<R*S))L4._EQJR9&S!,@7)
M>20\%B*[7QIX0@\8VDMA=@F*50&VG:P((96!]0P!&002,,",@_+^F_"/Q?\
M#-Y+;19!+;R-OW*UOM)!*@E+G[CE0"VS((VC>VT8]U^%?P[N]#>74-8N!=:C
M.JHSJ (XXD)VQQ_(A 8G>^ JEL?*64NWG7Q#^#.O>+M6@UE38Q-;>1Y49EN)
M!^Z<RC>WD)NRY.<!?EP.H+'V#Q=I]UK>DW5NT:"ZEM+F-8XY-Z;F1U0!W2+K
MD9)50"2,X&3Q6DZWXG\+PQVD]A#J#)&@%Q%>"+( "XD%RN]I3M+,XPIW# R#
M5KX8?!AM%CU!]49)9]3DD-RD1=8%5C)\B$XDY$K9)((R .5WMY!+\"?$?PRN
MI)/#<OF039'WH0X48*B1)P(RP)(5TR<!CB,/MKUKX5?#O5!.NJ^([@3W:PF.
M")1'L@5\-(WR(J^<?N%DXV@C>ZD!>/\ B'\&=>\7:M!K*FQB:V\CRHS+<2#]
MTYE&]O(3=ER<X"_+@=06/T!I<DTL:FY1$EYW+&[2H.3C#-'$3Q@G*C!R.<9/
MC_C#X41ZYXILM04(5BMS+<( 58-$V+:1F3JS.PVA\ I;N 6"E1[517FO[0GP
MUD^(.EO;6_\ Q\1R+-"I8*K,H92A)!ZH[!>5&_;N8+FLKX<1^(?[/339[:&Q
M>&W2%+HRK<'"J55U@3<K,%50=\JKN.\*P!CKBO@'\+M>^'#7B"WMCYDEN \M
MP51EC>3>4$4<K?,K'!<1E25)1\,@M?\ "F=>_M__ (2/-CO\S/D^;<;=GE>1
MMW>1G=Y?\6,;_FV8^2O9=4N]5,"_9H+7[0RR;@]Q*8D;_EF05M@T@[L"(B/N
M@G.X>0? [X-ZW\+'G(%E.DZQ[E\^>-@R%MI#?9G&,.V1MR3@@C!![KXZ?!B/
MXG6JH&\NZAWF!R3LRV-R.!GY6VC) W*0",C<C>/^%O!WCK1=FG03)';1;D25
MVMI(PJYVX)22?:< ("N5!4$*HP/:]/\ @Q:II#Z+<L\RS;FGF)VS22LXD,Q(
MSE@X!7=O^555RX!SX)IOPU\9_#YY+/2)#):AOW;;[8QE<E@5CN&)B)+'>% !
M;/+@*Q]U^#_P]O?# GN=6NC=7MRR[SN+1(B-(42/<JD#,C,0 JC.U4 7<WG7
MQ!^%NKZ3XC3Q%I4*7:M@O$72$KB$0,I+NN=R9*,,[6SN3"C?[UHC7+H6O!&K
MECA(F9U5<  %W5"Y)!;.Q  0F#MWMH5\X:7\+]:\"^([C4[&".[MKMI=S-*L
M&Q9I1(0<EG!1U!)5) R= ';"=U\7O!VL>-]..FQ"S7SMC32-),-NV3S!&BB)
MMV-J RL1OPQ\F/("S?!?PAJO@;3QIUTMK((5E,+QS2@LS,75'#0<#<S9D4D@
M;1Y;$$GBO _P;UOPGK-SK2"R<7+7&^$SS@A99!+@.+;J&"\E2",C )!&?\5_
MV=+ZTU ZYX;DVW!D,KQ%PK^:S?,R,_R%6W,720A<;E&Y6$:Z'@[X=^)?&+H/
M$]P!91S+(UL!;EIFC*LBOY*;#"6^\K,Q)7&P$JZ_0E%?%?[*5QJ=A]MN=,C2
MX"?9A+:LRQ-(&\[:Z2MD(R$9(8;71F_B"5ZU<_#/5/BCJ,%]KL4=I96C$Q68
M>.XD=OW;-O8*4*.PPP/.U-@0%C(>P^.?@[4O&]D^FV(MEBE\LR2322AQM??M
M5$B8=57YBQXW+LZ-1\#/!VI>"+)--OA;-%%YACDADE+G<^_:R/$HZLWS!AQM
M79U:N*^(WP8U/1M4/B'PVR><^#-;,5C60DJ' ^ZC*_WY [*P<%U<N5VZ'BKP
MUK7Q;2.QO[8:99+,KSD7*W$TR@':B"-=@ ;EO,R VQU!*%3W_P 3;1+/1+Z*
M)0B)IURJJH"JJB!P% '  '  X KY[_9?U'5]&TV6?3H$O8&NW1K8R);R(XCB
M;SED<%65E.UD(R"J,O!>O1?"GPJU#Q/JZ^(=?6.(Q+MM;1"DOE@,^SS'P58K
MN\Q2I)+L&S&$$=6OV@?V?A\2@ES;.([V-0@+EO*>/<3M; 8J06+*R@YR58$%
M63A?#/A?QUJ>+.ZN?LMOY81I7-M))MX0[6B#RF7:2P8LI)&3(K$&O=8O#TWA
M33X['1HX2T481//=HT'RG]XWE1-O8OAG ";R6.Y3U\J^ ?P9UCX732^8;.:"
MX\H2;99ED786PRY@VM\KM\IV[CM^=0#GW^BOBO\ 92N-3L/MMSID:7 3[,);
M5F6)I WG;725LA&0C)##:Z,W\02O6KGX9ZI\4=1@OM=BCM+*T8F*S#QW$CM^
M[9M[!2A1V&&!YVIL" L9#V'QT^#$?Q.M50-Y=U#O,#DG9EL;D<#/RMM&2!N4
M@$9&Y&\?\+>#O'6B[-.@F2.VBW(DKM;21A5SMP2DD^TX 0%<J"H(51@>X:#X
M,N?!&G"TTWR[BZ+.\DUR[1^9*^YGG<QQR.YWX&TD,4 4RY4$^=? /X,ZQ\+I
MI?,-G-!<>4)-LLRR+L+89<P;6^5V^4[=QV_.H!SV'QL\(:KXXM)=,LUM4AD:
M+,LLTOF%5*R$"-("JG>H&=[@J#P"WRGP3\(:KX'M(M,O%M7AC:7$L4TOF!6+
M2 &-X K'>Q&=Z *1P2OS<_\ &WX)7>LW<6N:'*(=0A7YEX3S-H;:0VW!<C]V
M1)\CIA6*JI#&O1^)/B':'2[BSCTX2J@N+K[2LN4!7S5CCB)8%N?E=RI3<C-E
M@U>GZ3X>_P"$2L8[/38T;R8T2-9'\E6P1N9FCB?#'EF(0[G)SC)(\5^'GP9U
M[PCJT^LL;&5KGS_-C$MQ&/WKB4[&\A]N' QD-\N1U(8>M?%+2;_7+*6RTY8,
MW$,D3O/)(@17 4E5CB?<2I;&64*=IPXR*XK]G[X9ZK\-HGLKK[+);R3&7?'+
M+YJL4"D;6A"N#L3'S(5^8Y;@# N?@WK;>(/^$CC%DIW+F%IYV&WR! XWBV7D
MKD@[<*2,A@,'I?CU\-M2^)5G#90+;1;9(YG=YI3APDB-&H%O\R_."')4G',8
MK$\8_!_4_$OAY-)N5@^TV:P&V,,K[)3$K1[7$L*[#Y1P,,0TG),:<5M_#B/Q
M#_9Z:;/;0V+PVZ0I=&5;@X52JNL";E9@JJ#OE5=QWA6 ,=<?^SU\*]<^';WL
M;PP 2-#MD>8[7$1E^XL:.V'W ;GV&,,'\N4J8ZE_X4SKW]O_ /"1YL=_F9\G
MS;C;L\KR-N[R,[O+_BQC?\VS'R5U?QZ^&VI?$JSALH%MHMLD<SN\TIPX21&C
M4"W^9?G!#DJ3CF,4-\';CQ5HJ:)K/DHUO'$+>>WDD?YHU:-'9)(X^B$*PW,'
MRQ'EG:1Y5X9\%^.O#6+&UDQ;K(%61Y+::-5&$#+YN^58@H!"!00.D>XD5[K\
M.OA<VAZ;)8ZE,]W+=;S=.[N=Q>-8F16)$FT1H%!)W'&1MR%7PJ7X$^(_AE=2
M2>&Y?,@FR/O0APHP5$B3@1E@20KIDX#'$8?;7K7PJ^'>J"==5\1W GNUA,<$
M2B/9 KX:1OD15\X_<+)QM!&]U("^M5E>*_#,/BBUEL;D9BFC9&X4D9Z,NX,
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M,L\ERER=B2*Y5$A ._(!&XA2 RD@L"/7_#VB)H-M#9Q$E((8XE+8+%44("<
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M,"48$O@8$;N>H.0.3T/7^ /!T?@RQ@T^$Y6&, MR-S$EI'P6;&YR6QDA<X'
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M'S?^PQ_S$?\ MT_]N*^JJ****Y7XG_$.'X?V,E_.-VW"I&&56D=CA4!/XLV
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M%%%<!\=/#$&MZ3=M.'/E6EQ(BB65$W*A=2R(ZK)AD4@.& (X')SY_P#L4_\
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M#@8]O^#MHEKHU@L:A0;*W8A0 -S1J[MQW+$L3U)))Y-=A6+XHUNV\*P3ZE<
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M4A5/@OX2UKP7>W-A=,9=)52;25Y%D=<%%CC'(=1Y>0R[ @9/W> 27\Z^/O\
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M K"0AEX!0^B_"'Q=/\7-%#2SS6]PDCPSRP"*-G(7JI9)-N4D4ED",) =FU0
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M)-Y%NLLB6\*!EC^5%VLK;HB.'8,NUGW29(Y^'4KKX!:U!IPE>31[KR@GGO\
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M/V-M+DLM%:21<+-=RR1G(.Y0L<1/!./GC88.#QG&"">*^ 7_ ".&K?\ ;_\
M^ED=?55%?*O[<_\ S#O^WO\ ]MZ^JJ^5?V&/^8C_ -NG_MQ1\??^1PTG_MP_
M]+)*MW?C&/P-XXN);T>7!=6\40E?*(H,4.V3.T@KYD7EDY"J22S (17T_65X
M8\30^)8!=6QW1&29%;*D-Y<KQ%E*D@J2A*D'E2#QTK5KP#]L;P+)KNGQ7L".
M[VDCEPN"!$ZCS)",;CM9$Y'W5+,PP"5[#]FOQ>/$VAVQR-]NOV=PH8 &( (/
MFZDQ;&)!(R3C'W1Z?7E7[2/_ !--&O;*'YIQ;I.R#^&*.9'9F)^5?E1RH)#/
ML?8&*-C/_9)UM-1T&*) 0;>:>)\XP6+F;(P3D;95'.#D'C&">%_;1TN35YM*
MMH%W2RR7,:+D#+,;=5&20!DD#)('J:]*_:C_ .1=O/\ MW_]*(J/V7/^1=L_
M^WC_ -*):\J^ 7_(X:M_V_\ _I9'1^W/_P P[_M[_P#;>O5?VH_^1=O/^W?_
M -*(J/V7/^1=L_\ MX_]*):\P^,EL=:\9Z9#;8=XUM&D4,N5$<\L[YR>"(OG
MP>2", Y&>_G^+$_C/67T'2)! ENKM=7+)NES'(BO'"K@IG<=A>16'+,J_(ID
M\@_:_P#"47AQ-.6-I)'*W(>::1YIGVB#&YW).,EF"+M169BJKN.?;_VH_P#D
M7;S_ +=__2B*C]ES_D7;/_MX_P#2B6O*O@%_R.&K?]O_ /Z61UT'[8O@Z26W
MM]:M3LELY '=<+(%=E\M]^X-\DH 4#)!D+#;AB>U^$?C7_A9_E:FRX2WMU3;
MC"B[?<+DA2S'Y8Q'Y+@Y$<\BEB694]5HHHKY5_88_P"8C_VZ?^W%'Q]_Y'#2
M?^W#_P!+)*]5_:C_ .1=O/\ MW_]*(J\*\3:7)>^ [&2-<K#=O)(<@;5,US$
M#R1GYY%&!D\YQ@$CZJ\ >,8_&=C!J$(PLT8)7D[6!*R)DJN=K@KG #8R."*M
M_P#"21F\_L\!S*+?SF8*?+52^Q S]-SD/M49)$;DXP,_-7Q]_P"1PTG_ +</
M_2R2NK_;6_Y \'_7_'_Z)GKU7X3_ /('T_\ Z\+3_P!$I7S_ /L,?\Q'_MT_
M]N*B_8GN1IUSJ%C-E+@K"WELK!@(FD23.1\I5I%!!P<GIP<=A^VM_P @>#_K
M_C_]$SUZK\)_^0/I_P#UX6G_ *)2OG_]AC_F(_\ ;I_[<4?MS_\ ,._[>_\
MVWKZ ^+'_('U#_KPN_\ T2]>2_L:VB7FB7,4JAT>]F5E8!E93! "I!X((X(/
M!%5/V=_#-_H N;C2#'<Z3/,WV<7,LEO*?+8IYH$<4R@'!0[E1WV(Q6, *?0/
MAQ\(GTV[FUO5VCGU2=C\T8(AA0#8J1!@&SL 4NPW;?ER<NTGI]%> ?$W]FJQ
M^([2ZCIDOD7+22J_RGR))8GDCDW+@,C&5<-(NY3M+!'9BQRO@KXZUGPSK/\
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M((X(K/T/Q-#K;3I =WV>X,#D%2N\1QR, 03]WS K9P0ZL".,GYJ_88_YB/\
MVZ?^W%?55%%?-?QRUW_A"?%.F:O<+_HOV<Q%\]/FE25L*&8[%G5\;?F^ZISG
M'TI7D'QQU#_A,- U-+-'/D2;&++Y:M]GECDG9"Q&Y4VNI/=T8+NX)A_9)UM-
M1T&*) 0;>:>)\XP6+F;(P3D;95'.#D'C&">%_;1TN35YM*MH%W2RR7,:+D#+
M,;=5&20!DD#)('J:Z#]M;_D#P?\ 7_'_ .B9Z]5^$_\ R!]/_P"O"T_]$I7S
M_P#L,?\ ,1_[=/\ VXK6\8?LM6_B39J_ARX^S/+LGB0ADA^;8Z-&5420X&7
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M;$2J R@2MNM[5@3DL1;)+YG.S,JD L,1^H?%C_D#ZA_UX7?_ *)>O*OV*?\
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MV>!\Q8\ Y!)R/)/!?[.U]X2U"35H=21[B;S?-\RS!1_,;>V0EPF/G 8;"N"
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MM(@20X4_("H"@*<@ <ELL?.O"7P5USX932KH=U;2V<OS>5>"4;6SP0(0<L$
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M"C^8V]LA+A,?. PV%<$ ?=R#K?&OX#S?%*2(R7:0Q0;_ "U%NSO\XCW[F-P
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M,2S,2S$DDU:HHHHHHHHHHHHHHHHHKC_BK\,X/B-9-8W!*'<'CD7DI( 0K8R
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MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBHKN$SHR*Q0LI
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M\OJ!E0S%2P!0X:O9/BK\,X/B-9-8W!*'<'CD7DI( 0K8R PPQ!4]03@JV&'
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M0[ MR=H5L?<'2I?CC\#KGXE6D ,\8O;=I-K;&BMW60KN!7=,Z$*JX.Y@2""
M&!3L/#>C:RUJ5U"[A%T;=XU:"'*+(>%G;S#^\88#!56%,LZE6&PJ?"'POJ'A
MJQ%OJUS]JN/,<[\L^U2>$WN []VRP!&[8/E4&NUHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHJKJ&K0Z=L\^1(_,D6--[*NYVSM1<D98X.%
M')["K5%5?[6A\[[+YB>?Y?F>5N7S-F=N_;G=MW<;L8SQG-6J*******SX?$-
MM/.UFDT;7"+N>$.IE5?E^8H#N ^9>2,<CU%:%%%%5?[6A\[[+YB>?Y?F>5N7
MS-F=N_;G=MW<;L8SQG-&J:M#I$;3W,B11+C<\C*B#) &68@#)( SW(%6J***
MJZ?JT.H[_(D23RY&C?8RMM=<;D;!.&&1E3R.XH_M:'SOLOF)Y_E^9Y6Y?,V9
MV[]N=VW=QNQC/&<U:HHHHHHHHHHHHHHHHHHHHHHJ*[NTLT:65@B(I9F8A550
M,EB3P !R2> *BTO5H=7C6>VD26)L[7C970X)!PRD@X((..X(JU1111111115
M6WU:&YDD@CD1I8MOF(&4NFX93<H.5R.1G&1R*+C5H;:2."21%EEW>6A90[[1
ME]JDY; Y.,X')JU111111111111111111116?K?B&VT%!+>31P(6"AI76-2Q
M!(4%R!G )QUP#Z5%H7BRS\0;OL5Q#/LQO\J1)=N<[<["<9P<9ZX/I6A;7:70
MW1L& 9E)4@C<K%'7CN&!4CJ""#R*EHHHHHHHHHHHHHHHHHJK<:M#;21P22(L
MLN[RT+*'?:,OM4G+8')QG Y-6J*****BN[M+-&EE8(B*69F(554#)8D\  <D
MG@"BTNTO$66)@Z.H964AE92,A@1P01R"."*EHHHHHHHHHHHHHJKJ&K0Z=L\^
M1(_,D6--[*NYVSM1<D98X.%')["K5%9^I>(;;2WCBN)HXWF;;$KNJ-(V0-J!
MB"QRP&!DY(]16A11111111111575-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[
MD"K5%%%%%%5=/U:'4=_D2))Y<C1OL96VNN-R-@G##(RIY'<5:HHHHHHHHHHH
MHHHHHHHHHHHHHJ*[NTLT:65@B(I9F8A550,EB3P !R2> *+2[2\198F#HZAE
M92&5E(R&!'!!'((X(J6BBBBBJMOJT-S))!'(C2Q;?,0,I=-PRFY0<KD<C.,C
MD5:HHHHHHHK/UOQ#;:"@EO)HX$+!0TKK&I8@D*"Y S@$XZX!]*T**JV^K0W,
MDD$<B-+%M\Q RETW#*;E!RN1R,XR.15JBBL_1/$-MKR&6SFCG0,5+1.LBA@
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M,;%5$*$GNO%'P(T[5$W6<8L+I%?R;FU'D21LP )(B*!P0-I#<[2P4J6S6?\
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M@51G@=*^OZ******XKX;?"&Q^'7G_8 X^T2!FWN7P%SLC7I\J[FP3ESGYF;
MQVM%%%%%%%%%%%%%%9^OZ_!X>@>[NW$<,:[G=N@'3MR23@ #)8D  D@5S_PD
M\</XYTV'49$$9F:;"*20JK-(B#)ZG:HR< $Y("@X'844444445B^-/"$'C&T
MEL+L$Q2J VT[6!!#*P/J& (R""1A@1D$\%^$(/!UI%86@(BB4A=QW,2269B?
M4L23@  G"@# &U111117%>%_A#8^&M0N=6MP_P!HNL[\N2B[F#R;1_MN QW%
ML$83:N17:T4444445\=_MF^#;719[:[@0B:Z:Y:9VDDD+%/)"??9@H 8@!<
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M>P K$^,]O=Z7XETZS%[/,))K&91<$/$LOGM$K"*$01X 49"A6.6^8%B:ZO\
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MPL\.SF'5+HF"9)(EB(MXQYDD<;*<;Y<?.S;1(J%B&V;@2>K^">MOH/@Y;R(
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M>7_LG^#U\3:/<173N;4W<JF%'DAW%H80Q=XW5G7:=HCX3EBXD)3RXOA1=O\
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MN>Q4A@>A!!'!KZDKYP^&W@RYT;7-0O/#_EO8"9X)H9W:V3S@=[QQ"*.3B)B
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M^"X]$TF*4R37$[7XS-/(9'PR3NRJ/ECB7.T%8D12$3<"5!'I7_,G_P#<!_\
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MYGD9G<[0%!8DA551A5 'LO[4?_(NWG_;O_Z414?LN?\ (NV?_;Q_Z42UY5\
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MQ<%5*,5&P;)P6!8QLJ@A0H61C@^R_L]_$J3X@Z6ES<?\?$<C0S,%"JS*%8.
M">J.I;A1OW;5"XKQ_P#88_YB/_;I_P"W%'Q]_P"1PTG_ +</_2R2O5?VH_\
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MGY0$8U]%>*_$T/A>UEOKDXBAC9VY4$XZ*NXJ"S'"J"1EB!WKQ7]M;_D#P?\
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MYW#)6X^= Q8E<!B6P)%  '*^"?V?+WP5>RW]CJ$<8G9S);BS(MB"2RJ$%T"
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M=J+GN6)))9F9F)9F9B69F)9F)9B22:\*T_X :E\/KY[SPU<PB"7<'MKKS?+
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MV]D)A]HQDA9'E(955@" N=V2?E949?6K2T2S18HE"(BA550%55 P% '  '
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M /NY!UOC7\!YOBE)$9+M(8H-_EJ+=G?YQ'OW,;@!N4R,*N <'/6M7QC\&_\
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MGDAF#:NJ?!:ZO-#;0WO3,66VC5WBCCCCCBF1OD2-=Y/EJ!AY&W,H^9 34O\
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M?L5[O""19%:-MKJRY&1D,I^5F4A@1@D@ @$=!I.EQZ1#';0+MBBC2-%R3A5
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M^T6N-F'(1MK%X]P_V')8;2N2</N7 KI=?U^#P] ]W=N(X8UW.[= .G;DDG
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MM]13QBNGVU[)))&TGDRW1\X1>=:>9,ZQJ$C! 8E$550E45AM!KV_X9? G_A
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M;C2&M\7=R\5UYX>!G58 (WC=%"1H@."Y^9][_*N6^6OHKXL?\@?4/^O"[_\
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MA^:9Y)&>X*$"/>DD:JPVK]_=QY>3N4+AO:_@7\1O^$_TN*Z<YG3]U/\ ]=4
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M7O\ PZKE[*V:Y:$/\SH8[A8^", !@VYAC&[YE"DMN^FJ\J_:C_Y%V\_[=_\
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M;Q7Q?\%=9^#'F:GH5T[VR_-(H'[Q5^< R1D-%*J*W+XRI8N(T52P]JE\:_\
M";^%9]0*[6ETR[WC& '6.2.3:-S?+O4[<DG;C/.17F'[.]H]YX2U2*)2[NU\
MJJH+,S&TB 4 <DD\ #DFMK]B75(Y=-N;8-^]2[\QEP>%DC14.<8.3$XP#D8Y
M R,\_P#MS_\ ,._[>_\ VWK;_:YU)]!N='U$1F1+:YD=NJJ6#02*A;!"EA&V
M."< D X->_Z!K\'B&!+NT<20R+N1UZ$=._((.00<%2"" 0145EXFAO;J:QC.
M9;>.%Y,%2%\WS-BG!)#8CW$$#Y60C.>/FK_FH?\ G_H'5]545\H?L:S'0K_4
M=*N%*W 5"P^4JI@D>.120QR=THQC((!.>F?6OVH_^1=O/^W?_P!*(JM_LW:7
M)IF@64<R[6,;R 9!^625Y8SP3U1P<=1G! .17C_[#'_,1_[=/_;BOJJBOE7]
MAC_F(_\ ;I_[<4?'W_D<-)_[</\ TLDKJ_VUO^0/!_U_Q_\ HF>O1?!%S!:^
M'K62\P;==*@:8,N]?+%NI?*X.X;<Y&#D<8->->-_V2)M(D-]X;N'BE7>5B9V
M1QD/E8YEP1D$(JOV)+RUW7[-7Q3N_&D%S;:F#]LM)@LC&,1$J^[:K*,8=61U
M8;5  7JVXU[+7RA\)YCX;\;7UM<J0]RUX(\;6 #NMVC$AN 8ESQD@D @<X^A
M?BQ_R!]0_P"O"[_]$O7FG[&VER66BM)(N%FNY9(SD'<H6.(G@G'SQL,'!XSC
M!!/%? +_ )'#5O\ M_\ _2R.OJJBOE7X!?\ (X:M_P!O_P#Z61T?MS_\P[_M
M[_\ ;>M#XX>)AX+\6:;J=PA^SK;!&?#!0&>>.0@A6W%%E#E0"2,#C<#7TK:7
M:7B++$P='4,K*0RLI&0P(X((Y!'!%9^A^)H=;:=(#N^SW!@<@J5WB..1@""?
MN^8%;."'5@1QD_-7P"_Y'#5O^W__ -+(Z^JJ*^5?^:A_Y_Z!U?4&K:7'J\,E
MM.NZ*6-XW7)&58%6&001D$C((/H:S_&GB^#P=:2W]V2(HE!;:-S$DA54#U+$
M 9( )RQ R1YU\-IKSXK6Z:K?3O!:O(Y@M+61X?E1I8]TTR[9G;)^ZC)'\BL5
M)8JOE_[.]HEGXMU2*)0B(M\JJH"JJB[B 4 <  < #@"I?C[_ ,CAI/\ VX?^
MEDE>J_M1_P#(NWG_ &[_ /I1%1^RY_R+MG_V\?\ I1+7E7P"_P"1PU;_ +?_
M /TLCH_;G_YAW_;W_P"V]?0'Q8_Y ^H?]>%W_P"B7KRK]BG_ ) \_P#U_P G
M_HF"JG[8O@Z26WM]:M3LELY '=<+(%=E\M]^X-\DH 4#)!D+#;AB>U^$?C7_
M (6?Y6ILN$M[=4VXPHNWW"Y(4LQ^6,1^2X.1'/(I8EF5/5:*\J_YG#_N _\
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MRA8XB>"<?/&PP<'C.,$$^ZU\J_\ -0_\_P#0.KWKXQ7:6NC7[2,%!LKA06(
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M5VHRNX/SYW(R/ABX+,9&!6O?Z\ _;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\
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M2OW=O2^!?".H>&+5+*2[AF2*W\N%C:LC@K@1E]MR5=54;2H",P )?.2?/_\
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MI8RV^X(=@6Y.T*V/N#I5OXI?!?4/B3#';7=_"D4<GF;8K-EW-@J"2]VYX!8
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MOF%O,!VDHQ&3QCN_&WA=/%5E/828 FA= S*'"L1\C[21DJV&'(.0""#S6?\
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MR!D^9F#!4R5Z."05E^,'[,(\37/]IZ1*+6\W!V'S+&\@8$2ADRT;]22JMO8
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M!VJH"I\P;G_&G[.U]XMU"/5IM21+B'RO*\NS 1/+;>N ]P^?G)8[RV22/NX
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ML2QX90">!M&VO+_!?[.U]X2U"35H=21[B;S?-\RS!1_,;>V0EPF/G 8;"N"
M/NY!];\:>$(/&-I+878)BE4!MIVL""&5@?4, 1D$$C# C(/C_@?X7^)?ARCV
M>G7-E<6FX-&+H7"LA(R^U8]VT%B<C>P)&X!69L^@?"SX5IX%%Q*\IN+N[F,M
MQ.5$8=MS, (U)5 -['C)))YV[57P7]I/3_[1\5:;!O>/S([--\;;9%W74HW*
MV#AAG*GL<&O2O$W@+Q-XKA.FW5Y9Q6C962XACF%U(@! #(2(QO./,5&4#)4$
MIE6]*\+>!;7PU8II<*;K9(V0K)^\WAB3)NR,'<6)88"\D !< > >(OV3+[1K
MIKGPY>_9TDW HTDT+HIVGRQ)$':1=P)PP4@!<ESEJ]0^$7P=E\(.U]J-U)>W
M[PK$9'=V6./(=HDWL2P\SG<<9 &$3+;N9\:?L[7WBW4(]6FU)$N(?*\KR[,!
M$\MMZX#W#Y^<ECO+9)(^[@#VO2XYHHU%RZ/+SN:-&B0\G&%:24CC .6.3D\9
MP+5> ?&?]F-O$ETNIZ-(EM=F0-+DO&A8?,)E:-69)=P&<##'Y\JX8N?#S]G*
M^2ZAO_$-\]V]M(7@B$LTJ*WR%7+RE6'S+DHJ@$JA9B,H?3_BK\,X/B-9-8W!
M*'<'CD7DI( 0K8R PPQ!4]03@JV&' >$/ GBGPM --AN[)[969(YY%F>YCB/
M"E4P(R5'S(CLR@_)O*  =_\ "KX9P?#FR6QMR7.XO)(W!>0@!FQDA1A0 HZ
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MCRTW2Y2-?]60<,<\>_\ @/S_ (M:#:3W=S/;S,SL\MH_V=V,;RP\D!AA@ S
M #=@@  "OD7X":!_PD&LVUKYTT&_SOWL#^5,N(9&^5L'&<8/'*DCO7TK^TG\
M4)/AUI\&EV4[F[EC"F5F#SB)%V-(6R&$KMP'V\XD*E74$9]M\'[1?#']HR9;
M4/LS:B+Q25N?.\LW"?O"6; X4C.&(,@"R'<-7]E/XQ3^-();&^<//;*A20M^
M]EC.1E@>6*$ ,_?>N[YLL_FO[5?B6\\)ZJD5C=W4*26RRLJW-QMWM+,"0#(0
MHPH 5<* . *U?%_P\USXL:-9W<4I=8X8!':29CDD(C5)+IY)'VN[/N:/=@&
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M#A<U[5H_A/3?#\P^R6]M!.\;X\N.**1D!3?]T!BH8IN[ E<\D5T%?*O[<_\
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M4SYBN(U81SH!N (.%<$?.@8[MN00<[67<V<K6?@7+XM2UM]9O#<6]HHPD:/
MTS@(H>9WGFWG:K E0C9=B'&:U?C+\(D\>Z8-.@80&%D>   1!D1D5" .$VL1
M\O*\$!@-IROV>?@D_P ,()OM$HDN+ADWA,^4JQ[]@4LJL2=Y+$@#D*!\NYO6
MJ\Z^+'PVO?'\$EB+R."UD:,E1;&24A<-M+FX"XW@-\J*> N2-V[A?AK^S%=?
M#NZ^VV6HH7,;1LLEIN1E;!P<7*L/F56!4@Y !)!(.U\8/@+<_$\P?:;V.(0*
MVT):MDLZQ^826N3P63*@#*@[27(W'0T'X07FBZ,^A)>0F)HY8Q(;5]X27S3+
MD"Z +9D&QN H4@J^<CG_ (2?LU3?#6\^VP7J2[H_+='MF&4+H[;2+CY6^0 ,
M0P&>5-;=S\+]3T_6+G7+"YC G:!3:2!Q%+&D42'?(N3&X(<QE8WQQDE7=:EB
M^$DWB#68]=U7R5:WC"06T6Z9.,LLCR2HF6#NY4+&NTB-@Q*G//\ Q;_9JF^)
M5Y]MGO4BVQ^6B);,<('=UW$W'S-\Y!8!0<<**]0\'>$WTBP33KQX[A(X5A&(
M3&K1+&L85U>24,2 =QR%(.-H[^*^$/V;=3^'6IB\T>Z@:!E9'%PCEQ&SY*[8
M\!RH56#!XMS#!"KG.)XI_9"U#Q'J+W,]\CQ2;2\[AFN"WE@,1$%2,+Y@(1!)
MA(]H!.W!^@/$W@"/QG8FPU;9,6R2\:&':V3LDC#/*490<9+,&Y!&UBE?/^A?
MLR>(/ ]PTFC:A"B''+&2/?\ *1\\7ES1G!9MN2V/O#:>GO7@?X?G0G>[O)S>
M7\JA'N718\1J<K%&BY6-/XF"_??+L3P%["O$/BI^SY>_$QXGO=0C40JP1(K,
MJH+$%F.ZZ=B3M4=< *, $DG0^%OP7U#X;0R6UI?PO%))YFV6S9MK8"D@I=H>
M0%!!)'RC &3GE/\ ADV;^TO[7^WIY_VO[3M^RMY>_P SS<8^T[MN[C&[..^>
M:Z7XP? 6Y^)Y@^TWL<0@5MH2U;)9UC\PDM<G@LF5 &5!VDN1N/3?#GX>7G@;
M3AIL5U"_EY\F1K9QMW2-))O47/SYW87:8]O4[NE>:> OV39O!%[%J%M?HTL6
M_:)+5BAW(T9R%N5/1CC!'./I7JOQ7^%%K\2+4VUR-LBY,,P&7C8]QTRIP Z$
M@, .0P5EXK_A7OB#^R_["\ZS\G_4?:OWGG?9,;-OD^5L\W9QGS,;?ESO_?5V
MOPH^%%K\-[46UL-TC8,TQ&'D8=SUPHR0B D*">2Q9F\_^+?[-4WQ*O/ML]ZD
M6V/RT1+9CA [NNXFX^9OG(+ *#CA17J'PZ\+S^%K**QN9Q<&%0D<@B\D^6H
M12 [@E0,;AC(QD%LLW"_&OX#S?%*2(R7:0Q0;_+46[._SB/?N8W #<ID85<
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M445%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %5-$\0VVO(9;.:.= Q4M$ZR*&
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MOFO]M'PQ EC#?X<SF[2/)EE9%5H9"P6-G,:9,:$E5!)&222<^U?"?_D#Z?\
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MO]M'PQ EC#?X<SF[2/)EE9%5H9"P6-G,:9,:$E5!)&222<^U?"?_ ) ^G_\
M7A:?^B4JIX7^$-CX:U"YU:W#_:+K._+DHNY@\FT?[;@,=Q;!&$VKD5VM%%%<
M?\5?B9!\.;)KZX!<[@D<:\%Y""57."%&%)+'H <!FPIRF\.7NAV%Y?22&XU9
MK:X9&12\<3^7E(+>)@V$#(F>"TS*&DW':JY7P2^,&D>+7ELM+BD@=5\YQ(BA
MI,E4>5G5Y"[YV[VD;>Q(.6PQ&)\$_C3I^JW"Z:\,T6JRQ_Z5)+$JM+/$I,JE
M@S.-OS[%<*L:#RU" *E5?VB/V=[SXCWD5[92PKMMQ$Z2EU^Z[NK HCYSO(((
M&,#DY^7VKPGH7_"/V=O9;M_D6\46_&W=L0)NQDXSC.,G'J:U:***X_XN^!W\
M<Z7<:=$XC>54VLP)7<CK( <<@$K@D9(!SAL8/%?LX_!*Y^&*7)O)8W>X:+"Q
M;BJK&'P2SJA))D/&W  !R<X'LM?)?[;^DPVTEE/'&BRR_:?,<*H=]H@";F R
MV!P,YP.!7K_[+G_(NV?_ &\?^E$M>JT5X5K_ ,%M/L=:AOK&:9-1ENXYVB65
M=BQ[B]S*ZA3*L3JLD8.=AED6/A&P#XU?!;3]6NO[02::+5)MBVZ12JI>5-J)
M-M*M)MC!1I6B(V1(7QNR3Z+\0/#,]TGVW37,=_"NZ, _NYPH8BWF4LJNC;F"
MEB#$S%T9<MN/A5\3(/B-9+?6X*'<4DC;DI( "RYP PPP(8=01D*V5'845Q7A
M?X0V/AK4+G5K</\ :+K._+DHNY@\FT?[;@,=Q;!&$VKD5VM%%?-?CG7?^$T\
M86NB7:[[&W^8PL<QR2_9GG$C* ,XRJ[6++A6[2.I[J]_9PLEU:WU>Q8V9A8-
M)#"H1)"HPN,8$8(^64 $2+D85BS-ZU1111111117 ?&SXKQ_#>Q:XRC7+_+;
MQ,3\[9&3A>=J [F^Z#PFY6=37?UQ7PV^$-C\.O/^P!Q]HD#-O<O@+G9&O3Y5
MW-@G+G/S,V!CM:*********S]?T&+7X'M+D%HI5VNJN\9*]UW1LK8/0@'!&5
M.02*^6_V;-+CTCQ5J5M NV**.\C1<DX5;J)5&223@ #))/J:^M**********
M*******^._VS?!MKHL]M=P(1-=-<M,[222%BGDA/OLP4 ,0 N !@ 8  ^Q**
M****XKQ1\(;'Q+J%MJUP'^T6N-F'(1MK%X]P_P!AR6&TKDG#[EP*[6BBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBO$/VD_@,_Q"1+RQ ^VQ*5(9RJR1 .X0<%=^\_*247#-O;
M 7;Y)X(_:HU3P5(+'7(7F5-@;S%,5V@(3!.X#?\ )E@' =RP)EQ7UAX0\:6G
MC& 7=A*)8BS+N ((8=5*L RGH<$ D$,.""?#U\6:?\4+JZ_MB^ABT^WN&@@M
M%O%A2X"<M<2X*-(I;8T)5@JE2,'YF?BO$GB'3_@QJEO>^'[I);*X^6[M8I5N
M554* D'S"=Q#EH]Q!5PPW&-F0>P?$G7[CQ3JD'AS3YW@'EFXOIH6431Q CRX
MU;>&1F8C=\NX*\;?-&74Y/CK]F6TLK5Y_#J/:ZC'\T+I<3*6ZAX]SNV-R%@"
M-OS8#,$+9UO$&G:AJ'AQ[G5'FMM2M[2YD+6\[0_-'N92PA<Q/O6-2PP0NYM@
MC)XR?V3]8N/%&CW!OIIIF-W+'O>60R!3##PK[MZXW$@J003D$'FN0T'4[O1O
M&HTI;NZDM SD12W$LJX:S:8*0['<%9OEW9. "26&3M?MA0W&F6*7<5W<JLEP
M(&@5U2#8\+EP0B*[Y\L?ZQW W,  #BJND_ &Z\?:;IUY<:@\-Q%;VYMA$N88
M8A&GEX&Y'\\X5WEW?>^15VHA'/\ Q<AN-(\4:9:27=S<1/<6$Y69UV!_M#19
M6.)(XE^5>R Y+$DY-=!^VCX8@2QAO\.9S=I'DRRLBJT,A8+&SF-,F-"2J@DC
M))).?3_A%X3CM]*M)8I)UDETZ ;C/-*J%HD.Y(IGDA4@_=PF /EQM)4^*Z5Y
M]GXZBLYKF>Y2%IF0SOO*F6R,C[0H5$&XX 15  48XKT7XI>/EOM4CT$WJ6-L
M+?S[JX6X2"XSDB.W1F!"-G9(P/S/&>"%R'\U^*OAC0?"-NNJ^&KR&"^M9%9$
MAN1.T@9E1AM>5SP"2< J4WJZL#E?3]>^,L\_A0Z]:@)<-"@Y7*K(9EMY&52S
M<!MS1[B>-N\'E:P/A+\&=#\9:=#J"M)+>NNZ:Z$\PN$N3\[M]X*'1SE"RG("
MN=X;<WJGPF\,S^&-/2TNW,DJ376Z1CEI US*ZRGYGY=6#D$D@G#<@UV%> ?M
MK?\ ('@_Z_X__1,]=5%J%]I_A6"72DWWBZ9:&-=H<_ZN,.RJ3\S!-S*O.Y@!
MM;.TXOP[^",'B+1577;<M?W*NTT\IW7BG=B$B1]SH5C6/Y.@P5=.7!Y_]C_Q
MC<^*+*ZTZ[<O%;+"L3!F654D$H*!U8, NP;""&3. V @7E#;WGA#Q1!I.HZA
M>RV,S?NRUU<!G65'2$'R9-P(GPA/R@E=Q"H:]%_:DT.YTZQ;5M/NKFWDBDC\
MY4N9TC9&*Q#;&&*A@Q4_+L!!<MN;%=A\$;J/Q#H=O-OG8SPD2M)-,TID4>3*
MRN9&= 70E-C+MSN 5B:S_"SOX:T6ZU>.6:9Y;>XNX5N)I9U2+:\MM%AW)&(R
MHDPQ9GW?O& 0CSKX'_#W1_BM:/J&J9O-2:9S=%I949"21$H6-HP$\M05P" =
MR*0$V)[!\)_!,_A!;N&XEDN ]ZTD<TK;Y7C,$"KN.225*F/)QG9N"JI KNJ\
M:_:5FUQX+:VT)9,33%9I(<B53\IB&\,#&A.XN_ &T!G56(; _:(^$NG>'M'-
M]80BVN+)H##)#^[?F6./YV'S.1D,')WAAD-RP;M?AIJ=U\2]!MY[BXD@FE61
M9);<1QNP5Y(>KI($) #$H%(;E"HXKQ3]E.TN?&CZ@US=S@%K)I761A<2[#+L
M0S%BZIM4JP3#D;0LB*&5S5]*/P@\66EMI;%+6[:UW0;I3'MD=[<ALR$R$'=(
MA;A68 # Y]+^/'C&[O[VS\-:8\D%Q=,DLEPC!2D(+[@OS*Q(\MG;#(2$" MY
MA S_ (@_L^V7A'2;FXT??!=1VD@DD,KL)HMA$\<BG<AW)E@%5,2A"I0"C]BG
M_D#S_P#7_)_Z)@KW^N%^-.G2W&F7,T-S/;F"VGE'D,B%V1/,0,Q1I  4Y\MD
M)!8,2#Q\]? GX=77Q1TFZAN;MX[5KN5SL^:66Y*1-OF9\[XEPK! 07<LS,"B
M&NPNM0/AR6U\(RZF(((+9I;F]\];:X(+MY%M&7,@B*@QDKNRT(^7:HVOS7Q5
M\,:#X1MUU7PU>0P7UK(K(D-R)VD#,J,-KRN> 23@%2F]75@<KZU<_&UU\,_\
M)#'$&E\E<HV53S?-%NYP&8[!)E@-VYE !*DY&)\$O MKX]TH:GK"?;;J\\X/
M)/\ .45994$</ \E1RP$>TAF)! "!> _9^@GN=8O-"O+FYF@M(Y5C*W-W!M\
MB980%6*=552K?=.[&%"D#.;7Q,NKGPCXHT^RM;R\^S3R63O$]U/*GS7!C9?G
M<DJ0F2&+<D_PX ]+_:<LWLM*FU*VN+F"X@\D*8;B6)&#2JA5D5@A_P!83N #
MY"C=M&TZO[.&K3:OH5I/<R/+*WG[GD9G<XGE RS$DX  &>P KQ_X!?\ (X:M
M_P!O_P#Z61UW?QOL=7U_4[#3K:.0Z5*RFZ:(L@9=Y$\<KJP*IY/W5)42%B!O
M8*%Y3]I[P=;> HK36](06=W'<K$# JQH59)7RR!=I/R[3QAE9E<,NT#6^/-G
M'XJ\+KJ]R#]H-M8RJ%DF$*O(\>XB+S#&3B5U#,&;:<;N!6U^RYX9B_L:SO-T
MWF?Z1\OVBX\G_72K_J?,\GI_L?>^;[W->:_%R&XTCQ1IEI)=W-Q$]Q83E9G7
M8'^T-%E8XDCB7Y5[(#DL23DUZ?\ M$?$6?21;:/ILHCOK^98P^>8HV81[\@E
MT+.P"N%;A9"N'52*NN?LI:?) SVDDZZBK/+'=O._FM-\S(9"%*XWD$LB+)\H
M(;=DF']E_P"*]UXHCGTS4S_I=GM&7.V=URRL'1OF+1LH5WZG<H<;\L_G7QGM
M[O2_$NG68O9YA)-8S*+@AXEE\]HE810B"/ "C(4*QRWS L375_M&_"6+2=-;
M6(YYVO[::)_M,DKO*5:8@(H5DCB"O*&3RT4+MP -Q-:MI\5;VU\&+JZL#=K"
M(P[ OR+C[,)#O)W/M^8EL@OR5*_+57X2_!G0_&6G0Z@K22WKKNFNA/,+A+D_
M.[?>"AT<Y0LIR KG>&W-ZI\)O#,_AC3TM+MS)*DUUND8Y:0-<RNLI^9^75@Y
M!)()PW(-=A7R7^V7#<:0UOB[N7BNO/#P,ZK !&\;HH2-$!P7/S/O?Y5RWRUW
M_P 1_P!FR3Q[&]S<WLQOCO:*,N&LHBQ!$2KY:L%VJJ&089R/-9"24K*_9<^)
M=UX@CNM%U&687D.]DDD^:=5)V.#YD;#='(01YFXG>%V[4Q7"ZI;ZBGC%=/MK
MV222-I/)ENCYPB\ZT\R9UC4)&" Q*(JJA*HK#:#7H%YX)3X!"^UQ+R2830E(
MX)L,\EP[*4=W$D?FD-O8X4.(V<@D@EI?!/P!M_'5C'J6O2375Y=VX<2&9@L*
MR%Y(Q$H"JN%D!*,'C5P0J[<@XGPS\6WOPUUX^&;V0R64C8M9)G.Y$V$P!'95
M# A1$44!1*,1X(8/M_MK?\@>#_K_ (__ $3/6KH7P>@\=:#:1W\CO(UA!Y)#
M2I#"?LX6)A"DJH[+NRS/EG8L,K&5C3G_ -D+QM<>)=/N=.FD?-KY:Q395G1)
M%<*BAT8?(8R5W[QA@NW:H!YK2O/L_'45G-<SW*0M,R&=]Y4RV1D?:%"H@W'
M"*H "C'%1?M)^=_PE6F_9=GG^79^5YF[R]_VJ79NV_-MW8W8YQG'-=+\5?V:
MI[F!M4@OKJXU2!1(&<Y#%,R,D*QKOB.\EHD4L%.$&,[QTO[,_P 2Y/'NEO;S
MRO\ ;+;]V\O#2%7!\F7+QE"PP5^;>28]\F=^#YUI7GV?CJ*SFN9[E(6F9#.^
M\J9;(R/M"A40;C@!%4 !1CBL_P#;3\,0:9-9W,8?S9_M/F,\LLO"F-E51([!
M%!D8A4"J,\#I7U5H7AF+1-WE-,V_&?-N+BXZ9QCSY)-O7G;C/&<X&-6OFO\
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M<1HC"/;\V]QNW.\C#-6OV4?&-SXGT@M>.9'AN98A(S,\C+M24%F=F)(,A4=
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M&@5U2#8\+EP0B*[Y\L?ZQW W,  #BMO0/@Q%XYT2V%_-)(SZ=;"!=SI;V["
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M] ZNK_;6_P"0/!_U_P ?_HF>O5?A/_R!]/\ ^O"T_P#1*5\__'W_ )'#2?\
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M"F3#NID8,<]5^RY_R+MG_P!O'_I1+7E7[#'_ #$?^W3_ -N*/C[_ ,CAI/\
MVX?^EDE1:S<C1?B DUSE$D:-8V*MAC)9B!,8'(,OR9' (.2,''T+\6/^0/J'
M_7A=_P#HEZ\J_8I_Y \__7_)_P"B8*]_KE?BQ_R!]0_Z\+O_ -$O7E7[%/\
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M7[#VB/#;7MX2-DDT42CG=NB5G8GC&,3+CDG(.0.,Y_\ S4/_ #_T#J/VY_\
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M7EVYB9\IEA+(T: %?^6B2[D)(!PH7<76OIJ[NTLT:65@B(I9F8A550,EB3P
M!R2> *\?_:"UM->\*37D0(2>&SE4-@,%>:!P#@D9P><$C/<UH?LN?\B[9_\
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MB20Y VJ;)(@>2,_/(HP,GG., D5/VY_^8=_V]_\ MO7T!\6/^0/J'_7A=_\
MHEZ\5_96T+_A(/#=]9;MGGW%U%OQNV[[:%-V,C.,YQD9]163_P ,,?\ 41_\
MEO\ [HKJ_BEX%_X03P9-IOF>;Y7E_O-NS.^]23[NYL8W8ZG.,^U=5^RY_P B
M[9_]O'_I1+7F'QDMCK7C/3(;;#O&MHTBAERHCGEG?.3P1%\^#R01@'(S#\??
M^1PTG_MP_P#2R2O5?VH_^1=O/^W?_P!*(J\J_P":>?Y_Z"->J_LN?\B[9_\
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M%?+<-H\_Q"9D4L$7<Y )"K]@5-QQT&YE7)XR0.I%?4E%?*OP"_Y'#5O^W_\
M]+(ZZO\ ;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\ [#'_ #$?
M^W3_ -N*/^:A_P"?^@=7:_MDZ7)>Z*LD:Y6&[BDD.0-JE9(@>2,_/(HP,GG.
M, D=W\"M;36=#L98P0%MHXCNP#NA'DN>">"R$COC&0#P/&OC5I<FI^,M*CA7
M<PCM9",@?+'<32R'DCHB$XZG& "<"JG[<_\ S#O^WO\ ]MZ^JJ^5?^:A_P"?
M^@=75_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2OG7]B[5(](AU6YG;;
M%%';2.V"<*HN&8X ). "< $^@KTKX>^*[KXT>=="5[338KCRXXH3Y=U*5\J0
MF649*+CC;"48[V4N0H9_-=+TN/2O'ZPPKM1<]RQ).GEF9F8EF9F)9F8EF8EF
M)))JU^W/_P P[_M[_P#;>OJJOE7]AC_F(_\ ;I_[<5%\)YCX;\;7UM<J0]RU
MX(\;6 #NMVC$AN 8ESQD@D @<X^A?BQ_R!]0_P"O"[_]$O7FG[&VER66BM)(
MN%FNY9(SD'<H6.(G@G'SQL,'!XSC!!/%? +_ )'#5O\ M_\ _2R.C]N?_F'?
M]O?_ +;U]545\X?ME^%W$%KK%ME9;:;8SHI#A6^:-S(I!4)(N%SQNEX()^;N
MM+O8?C-$KDXM5M"KB-U8K<W-N5D0-@?-!!*5.59&:<Y4/"0/$/V?M;>U2Z\)
MW("337JJ4Y.4 (U!&=2R@>1 8T*?-OD!5L?.GV)7RK\ O^1PU;_M_P#_ $LC
MH_;G_P"8=_V]_P#MO6A\</$P\%^+--U.X0_9UM@C/A@H#//'(00K;BBRARH!
M)&!QN!KZ5M+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BL_0_$T.MM.D!W?9[@P.0
M5*[Q''(P!!/W?,"MG!#JP(XR?FK]AC_F(_\ ;I_[<4?'W_D<-)_[</\ TLDK
MZJHKY5_88_YB/_;I_P"W%=-^VQ=HNE6\18!VO595R-Q58I0S =2 64$] 6&>
MHK$_:3TN32/"NFVTZ[98I+.-UR#AEM9589!(."",@D>AKW7X3_\ ('T__KPM
M/_1*5\__ +#'_,1_[=/_ &XH^/O_ ".&D_\ ;A_Z625[!^TCI<FIZ!>QPKN8
M1I(1D#Y8Y4ED/)'1$)QU., $X%'[.OC&/Q1HMLT8PUO&MM(O)PT2JH.2JYW)
MM?C(&[;DD&NUU'Q)'8W$%F0[2W'FE=JEE58U#/([=%4%D0$\EW4 'DCYJ_;G
M_P"8=_V]_P#MO7T!\6/^0/J'_7A=_P#HEZ^>OV?OB9!\.?#5Q?7 +G^T9$CC
M7@O(8(2JYP0HPI)8] #@,V%/L'@7P]<^-;:'4M9G+B>$2+:0EH;-4D6-@KJ#
MOG)4?.LK/'\[H$*\GR3]AC_F(_\ ;I_[<5U?Q-_9JL?B.TNHZ9+Y%RTDJO\
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MPWC>K8!%5+NP\7JC0Q3:8P"E%G9;A)CQ@2E &B5S]XJ R!N,%>*Z#X6?"M/
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M,2_#CX9:OX5TN/3Q>P1/&LJJ4MVF5?,=W+Y>2,NX)!0[41075XY<JRY_P?\
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MY8[9)%MF96)42M(SR2+@ C:(PC$L5E*IBU\-/A)=:+I!T?49T:)K>YAV0+C
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M&%$1+>*3) E^5(_-<+C864>42^T$D,/3Z*BN[M+-&EE8(B*69F(554#)8D\
M <DG@"O"OV9_!;SRWGB2YB,4E_-(T",22L+OYI;.1N#L0 613B,,ORR5[U57
M5(YI8V%LZ)+QM:1&E0<C.562(GC(&&&#@\XP?%/!?[.U]X2U"35H=21[B;S?
M-\RS!1_,;>V0EPF/G 8;"N" /NY!Z#XS_!NZ^)JK;M>I!:I()%C%MO<MLVY9
MS.,XRV JH,-A@Q -=!X,\(ZAX:L5L3=PRM%'''!(UJR[54XPZK<C?\F%4@QD
M8RQ<DUPOPK_9\O?AF\KV6H1L)E4.DMF64E22K#;=(P(W,.N"&.02 1#_ ,,[
M7W]K_P!O_P!I)]K\S=_QYCR\;/+\O;]HSM\OY,YWXYW;_FKV!M&;4K5K74"D
MOFQR1R^6KPHROE2 OF2,ORG!.\G.2". /%?"7P5USX932KH=U;2V<OS>5>"4
M;6SP0(0<L$ !<% _\4?RH1W7P[^%;Z'=W&L:A*)]1NE579%,<,: )^Z1<DL
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M&W4%0TD<FWKG<NUP0"&'.?'_ -BS5IM7DU.>YD>65OL>YY&9W.!.!EF))P
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MYZX49(1 2%!/)8LS=K7RAXIF/AGQ[#<W"G9<-"(]NTDB6W^R*V-W $N0<X.
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MW C(SE=Q*-7=:KXFATR>WM9#^]NI'2-05S\D3RNQ!(.T!,$@'#,@.-V:\O\
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M[4;J2]OWA6(R.[LL<>0[1)O8EAYG.XXR ,(F6W<?\9_V8V\272ZGHTB6UV9
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MO/GR*&)&#N 10K9W+M7:1M&.Z\ > ++X7V36]NQ6%6>6225QG.!N=CA44!%
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M;DD570X((RK @X(!&>X!KY:_9WM$L_%NJ11*$1%OE55 5547<0"@#@ #@ <
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MJ*[NTLT:65@B(I9F8A550,EB3P !R2> *RM$\;V&O.8K.Z@G<*6*Q2QR,%!
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M@\$BOFKX)>!K>]\2:IIIWK:+'>QF-'9=T2W,:")G!\S;C&<,&;&UB4+JUO\
M:P\,6_@6\T_4-,C2WE^<A8XXTC#0/&\<FP( 6S)\Q;((51C@Y]5_:C\)V?\
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MR"'<I2+9O.THH)(#R%WRQ\__ &'-4DEAOK8M^Z22"15P.&D$BN<XR<B)!@G
MQP!DY^GZ^>_B_KX\=:]9^%@Y6V#>;>*-P$A5#.L)QL;&Q =RN1F0-C?$*W_B
MC^S?IVLZ<\.GVL<5U%"?L[(-K,R[3L<[T#EPFS?*6*EB^<YSR'PN^)\WC7PO
MJ<5Y)YES:VERA8AMYB:W8Q,['AF)5U)'S$*"^6.YN?\ V7_A5;^.--E;4F>6
MU2[<1VP9HXQ+Y<6Z=C&RL[;2$4$[4&\@$N<9/C7P_P#\,]Z];7]GO-C-N)3.
M3LR%G@_UBE]H97C+X&[9N+E&8^R_M5>'K:?1;J\>&-KA%MU28HIE5?M$?RAR
M-P'S-P#CD^IJ+]ESPG9_V-9WWV>'[5_I'[_RT\[_ %TJ??QN^[\O7[O'2CX
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M54^4-@;R/F+$@#)SDGL-4TF'5XV@N8TEB;&Y)%5T."",JP(." 1GN :^2O\
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ML2;02SJ"A\=/$H\$VEII6F,+-[RY$*^3"S-'$Q_?21)$!\X9UP%^=BY*?/\
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MD4+,&6$!=SY*RCR<R@C ,A"G:R_2'Q@\*6OBB.VL[F))'FNXHT9ARJJ?M-P
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M_'@":%'*JP<*Q'SIN &2K94\ Y!! /%>-?MK?\@>#_K_ (__ $3/7JOPG_Y
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M-Y(]:\4?LYZ7X4TS5)8//(>VEE$;3R")6B222(;4*>8%;!'F^81@<Y+$\_\
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M@@]!7@'[:W_('@_Z_P"/_P!$SUZK\)_^0/I__7A:?^B4KY_^ 7_(X:M_V_\
M_I9'1^W/_P P[_M[_P#;>O5?VH_^1=O/^W?_ -*(J/V7/^1=L_\ MX_]*):\
ME\#L_@+QM<PW8 %\UQY;EBB;9G%Q$064;R600X''F$@$E<'W_P",5VEKHU^T
MC!0;*X4%B -S1LB+SW+$*!U)( Y-<+^R-X9FT310\XV_:+AYT!#!MA5(U)!
M^]Y99<9!1E(/.!Y_\ O^1PU;_M__ /2R.O5?VH_^1=O/^W?_ -*(J/V7/^1=
ML_\ MX_]*):\J^ 7_(X:M_V__P#I9'1^W/\ \P[_ +>__;>O2_VD?C/)\-[6
M-+5<W5SY@C<@%(PFW>Y!^\WSC8"-N<ELA=C2^+?AG!HVE7UW<$W5_P#V==AK
MN;YI,F*8D1J25@3]XP"1;1M(!W8R>:_8I_Y \_\ U_R?^B8*Y3]AC_F(_P#;
MI_[<5U?[:W_('@_Z_P"/_P!$SUE?&'PS-K?@VP> ;OL]O8SN &+;!;F-B  ?
MN^8&;. $5B3Q@^G_ +/?BA/$6AV;I@&*%8'4,'*M"/+YP!M+*JOM(R PZC!/
ME7Q4T1_$_C/3XK4AC;PVTLV,D1K%/),P?:&VDJ5"[L ETY 8&MO]M;_D#P?]
M?\?_ *)GKU7X3_\ ('T__KPM/_1*5\__ +#'_,1_[=/_ &XKZJKY0^(S/X$\
M:V^J7('V>Y:+:Y8HBJT(M)"SLNT%,^8P!(VE<E=W'U5=W:6:-+*P1$4LS,0J
MJH&2Q)X  Y)/ %?(O[/OAF:R\.ZW?2#$5Q:3)'D,"WE0S[V&0 5S)M!!/S*X
M.,<^@?L4_P#('G_Z_P"3_P!$P5B?M6Z6/%^IZ3I$3'SG:7?M1G*1RO&OFX&
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M3XC1KJMP/G@MUM.< ^;D274@"JJ[9%%N0"/D9'50!EI/7Z*^5?VY_P#F'?\
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M$_,K@XQSD_\ -0_\_P#0.KJ_VUO^0/!_U_Q_^B9Z]5^$_P#R!]/_ .O"T_\
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M@XP:X_\ 9!\4/8B[\/W>5N+6:1U4L7 7<(YD& 44)( >&PQD) X8G0_;6_Y
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MDK G[Q@$BVC:0#NQD\U^Q3_R!Y_^O^3_ -$P5RGP"_Y'#5O^W_\ ]+(ZZO\
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M,,!A@00>#C<JD<+I?P$U&*U72[G6)GT_RS&T4<$<4I3G""9FE<+T!4Y!3,>
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M9?.<;8OBE^S'#X\\N9KN87:_*\\@67>G.U/+0PQIM/W?+" Y8NKNVX=+XO\
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MEI\VTE2%8EF) .TJK,IU?C3\%H/BC!'')(89H6)BE W@!MOF*4W*&!"CN""
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M_>V,UL73U&PKAB6&&)-9_@?]G*W\#.\FG7M["9%"N-ULZL <C*O;,N1S@XR
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M,.!L;.TYVDX((.#Q705S6L_$K3M&G2SGN8Q<231Q+"&WR[Y,; 43<R@Y'S,
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M<CBM"TNTO$66)@Z.H964AE92,A@1P01R"."*\JU3XTI=>(+30K%PP#7'VL@
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M-M!.MF\T:W#KN2$NHE9?F^8(3N(^5N0,<'T-8MQX6TNVU.._D2%=1EC9(V+
M2N%7YRJD_,P3@N 7"?*6V<5U5<_I?Q"TW5Y%@MKRVEE;.U(YXG<X!)PJL2<
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M;MSEA53P+\"=/T6U1+VWANKM_P!Y<3S(MP[RM@R$/*F[;N^Z,#CE@7+,>?\
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MA2=N% XKW"Q_9DTNRNX[]'NA,BG>PN)%:5V#!Y7=<2AVW$ML=%)_AP6!\5^
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MY.Q?+P,,=PW$LBGZ/\=>,8_"-J]S(-S_ '88AG?-*V?+A0*K,69N!A3@98C
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MV,I\PL7+D5E?LTZQJ/A[4;OPUJ;F0V\*R1DR>8J*OEH%3(W;&21&525"!<;
MS-C$^ 7_ ".&K?\ ;_\ ^ED='[<__,._[>__ &WKH/VO_.T?^S-7AV'[)=MA
M6W'+MLECX&,K^X(;Y@>1CJ2/</!WC&V\7VR7EFX='520&5F1BJN8WV,P5P&&
MY<Y!JIX3\<Q>*9;A;4![>!HT%PLB/')(R>9(J["W"*T>6.,LS*!\A)^>O@%_
MR.&K?]O_ /Z61T?MS_\ ,._[>_\ VWKZJHKY5_88_P"8C_VZ?^W%'Q]_Y'#2
M?^W#_P!+)*]5_:C_ .1=O/\ MW_]*(J/V7/^1=L_^WC_ -*):\J_88_YB/\
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M<E)&Y;]Y*'<#: <J6;S_ . 7_(X:M_V__P#I9'1\??\ D<-)_P"W#_TLDKZ
M^+'_ "!]0_Z\+O\ ]$O7E7[%/_('G_Z_Y/\ T3!7'_LHL_@K5[_0[P!9F488
ML5W- S8"*ZJSATE,BG@[%W8(.1ZK^U5=I!X?NE=@I=K=4!(!9O/C?:,]3M5F
MP.< GH#6W\ _#,WAK1+.UN1ME$;.RX8%?,D>4*P8 A@' 8$<,".>M>*?L,?\
MQ'_MT_\ ;BCX^_\ (X:3_P!N'_I9)7U57'^/+'3O$CPZ/J<8D%PLLL2L=N6@
M,>X*P97#[9,C9R4$F3MR#\U_$_X%W?P:']M:)=R")&02 D+*BEDV[B,),C2
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MU()#%L#((4,H:NU^+OPBMOB9;+;W#&-XV9HI5"EE8J5P=PR4)P64%2Q5?F&
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M)7S-F?N[_,V[MO&[9C/.S'RU[_X%\"VO@>U2RLDVQKR2>7=CC=(YP,L<<G@
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MG*[ ENH3!^8;0/F);[Q)/I7]C2_9_L_VF;S/^?C;;^=][=T\GR>GR_ZO[O\
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M!D$')"G,>2Q*$DFN?T;]G*WT6]?4[:]O4NI&D:1PUMAC(2SY0VVP@MS@K@$
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M,VTY=MQW,78,<@\__P *FU6#_1X=;N19]"KQ0RW6UO\ 6 7)PX8Y.Q]N8_E
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MK=W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5E:)XWL-><Q6=U!.X4L5BECD8*"
M6(1B<9(&>F2/6MJBBN%^,7Q5@^'-D]Q(P\]U=;>,C<7DQQD J=BD@N<C X!W
M,H.U\/=4DU?3;.YG;=++:6\CM@#+-&K,<  #)).  /05T%?(O[:OAZVTM[*6
MWACC>9KMI61%1I&S"=SE0"QRQ.3DY)]37UK=VB7B-%*H='4JRL RLI&"I!X(
M(X(/!%<_X T'3M @:TTD1K%%,ZR+&_F$2\;U=BS-O' (8[@-J\  5MZAJT.G
M;//D2/S)%C3>RKN=L[47)&6.#A1R>PK/UOQO8:"XBO+J"!RH8+++'&Q4D@,
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MINKR+!;7EM+*V=J1SQ.YP"3A58DX )..P)K0UOP];:\@BO(8YT#!@LJ+(H8
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M[=^P*J\5^RY"?#OB'4]*A8FW19QAMI9C!<+'&Q(4<A7;., DYQP,;?@+[/\
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M<QZLQ"@%F)8XY)K5KX[^,_A*+1O%>G16K2(9FL6:1I'GEWFY:,/NN#+DA44
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M9O+,4AB8[20"T>URN3M+;221FN%_8I_Y \__ %_R?^B8*]_KP#]M;_D#P?\
M7_'_ .B9Z]5^$_\ R!]/_P"O"T_]$I7S_P#L,?\ ,1_[=/\ VXH^ 7_(X:M_
MV_\ _I9'7I?[6&J1V6@3QR-AII((XQ@G<PE64C@''R1L<G XQG) /A7Q>^&E
MYHWAK29)5_X]O/\ .7#[D^U.)8]P*#;MQL?=C$A51NSFOKKP3XH3Q5907\>
M)H4<JK!PK$?.FX 9*ME3P#D$$ \5\_Z#HCZ]X[N;RW(:&U4&5QDJ&-JMOY>5
M!7?O)RI(.$?NI%9_[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7E7[%/\
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M<I\ O^1PU;_M_P#_ $LCH_;G_P"8=_V]_P#MO7TUXAT1->MIK.4D)/#)$Q7
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M<J'=E5F1C'N.2F#US6AIOCF+5;^2PM@)1!#NGE61&6.0R%$@*@EMYV2%L@;
MJ@Y+C'SU_P U#_S_ - ZNK_;6_Y \'_7_'_Z)GKU7X3_ /('T_\ Z\+3_P!$
MI7S_ /L,?\Q'_MT_]N*J_L=ZBOAO4+_2+KY+I]H"DIC=;M(LL8(;YF^?("[@
M55VS@<]A^VQ=HNE6\18!VO595R-Q58I0S =2 64$] 6&>HKUKX3_ /('T_\
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M4E;==@AE#2[=IN#G;Q("@.\A,,%3BK2T2S^("Q1*$1%"JJ@*JJ--P% '  '
M X J7]N?_F'?]O?_ +;U]55\J_L,?\Q'_MT_]N*B\#L_@+QM<PW8 %\UQY;E
MBB;9G%Q$064;R600X''F$@$E<'W_ .,5VEKHU^TC!0;*X4%B -S1LB+SW+$*
M!U)( Y-<+^R-X9FT310\XV_:+AYT!#!MA5(U)! ^]Y99<9!1E(/.!Y_\ O\
MD<-6_P"W_P#]+(Z/VY_^8=_V]_\ MO7U5117SW\//&+_ !YN[P3/)#I=NL:K
M:(QC:;S1*NZ:2-@^-H.8E;824!+;"9./^-.DPZ1XKT>"VC2*)?L.U(U5$&;V
M4G"J !DDDX[DFNU_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\
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MC=&XR<,,\CD$$,I*D$FA>,8];NKFV@&Y+7RE>49*>:V_S(0=NTM&JH7PQP9
MK!2"#\Z_ +_D<-6_[?\ _P!+(Z/VY_\ F'?]O?\ [;U] ?%C_D#ZA_UX7?\
MZ)>O*OV*?^0//_U_R?\ HF"N4_88_P"8C_VZ?^W%=-^V?<BXL+2Q3+7$UZK1
M1JK,SA8W1L8!R=TJ #J2W .#CG_VE=(G\#6VAW$.)1IS+'O885I$6!H\H'W8
M;R&) / &-P)&?H3P+XZM?'%JE[9/NC;@@\.C#&Z-QDX89Y'(((925()-"\8Q
MZW=7-M -R6OE*\HR4\UM_F0@[=I:-50OAC@R!6"D$'YU^ 7_ ".&K?\ ;_\
M^ED=?55%%>"VWQ%G^)>OS:+#+):V5FLIF\L[)[AXIHT9?,4[XDWGCRR&9 P8
M@N!'YU^V#X4M?"\.FVUC$D,0^U_*@QD@6R[F/5F(4 LQ+'')-?2OQ8_Y ^H?
M]>%W_P"B7KRK]BG_ ) \_P#U_P G_HF"N4_YJ'_G_H'5ZW^T?\/W\;:1+%#D
MS0,)XE&3O9%8,F K,Q*,P0#!+[>0,UPG[,7C&3QU#;P3#C2HV!)P-S2#RK5U
MVJ/N0">)@W!RC_.QS']%45\J_'W_ )'#2?\ MP_]+)*]5_:C_P"1=O/^W?\
M]*(J/V7/^1=L_P#MX_\ 2B6O*O@%_P CAJW_ &__ /I9'786WQ%G^)>OS:+#
M+):V5FLIF\L[)[AXIHT9?,4[XDWGCRR&9 P8@N!'YU^V#X4M?"\.FVUC$D,0
M^U_*@QD@6R[F/5F(4 LQ+'')->@?MK?\@>#_ *_X_P#T3/7:Z3I<FK^%8[:!
M=TLNBI&BY RS6H51DD 9) R2!ZFO.OV0/BK!=V@T29@EQ"TC0C&/,C8F1L$D
M[G5F8D87Y,$!MKD>W^*_&,?A]H(B-\]S<1Q11#.]@77S9 %5CMCC)D<D!0
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M8$#*Y:70O@XSW46H:S=OJ%S;[O(W1QP01YVD.(DR#*"#\Y/]WY=R(PJ?$/\
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MX&*ON1C'&V6P,KM=W0Y;*\X$J? ^ZTJ6>ZTS4Y[::YN9YI%,<<]MB5R^!"_
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MRJCGYE29F)1L=&15 <EP@)->E>!? MKX'M4LK)-L:\DGEW8XW2.<#+'')X
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M$K2[>-X\P,JY/.#Y>%R,AL<^]>!? MKX'M4LK)-L:\DGEW8XW2.<#+'')X
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M-_G>9!NSC&,?9]NW;\NS&S9\FW;Q7:^.?AQ;^-['^SKYG=?W9\T",3!D(_>
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MZ**J+$S_ &=Y(E4D[4+6^""/EPX<*H 3;@5S7P\_9XMOA_,9["[O%W;1(C/
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M@^3\QW _, WW@"-7XG? BV^)$B27UQ<[8]WEQQF!43<$#X)@+G.P$[F;!SC
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M,L<MA'&UB2N#S65^S.+_ $"[O-*DANAIJM))9RW$<D8"B7:%&^).9%8.5^4
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MWE64(,$F1BW(KL/@#\-=3\/W6H:AK>Q[JXD14EW*[LJ[MS*0!LB;*;4^4@(
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M,I &R)LIM3Y2 @!C4*HKSKP3=IX;\;RV&F,([.9G62*,@Q%EMC*RXY"E)@V
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MNP\6_#.#1M*OKNX)NK_^SKL-=S?-)DQ3$B-22L"?O& 2+:-I .[&3S7[%/\
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M0V:S_C[_ ,CAI/\ VX?^EDE?55%?*O[#'_,1_P"W3_VXKJ_VUO\ D#P?]?\
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M#;P-_%($:64LY(!#,<@\\[8_+V_BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\
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ML[74.I6%P\MC)<*'3<(RV-Y$,B_,KYBW;90ORMN8(AV;O2_VUO\ D#P?]?\
M'_Z)GKU7X3_\@?3_ /KPM/\ T2E?/_[#'_,1_P"W3_VXH^/O_(X:3_VX?^ED
ME'BSQK_PK+QI+>WB[;6ZMXE9P-["(QQIY@"MD8FAPP(+; VU22M?4']K0^3]
MJ\Q/(\OS/-W+Y>S&[?NSMV[>=V<8YSBN4_X6#:WVF?VC=IMLYI/+Q(,*T4EQ
M]GCE82A,1.C+(VX<1L?O=_(/B-^R''%F]\/R/!<1X=("Y*EEV[?+E+!XVX+
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M3^,]/BM2&-O#;2S8R1&L4\DS!]H;:2I4+NP"73D!@:^FJ^5?VY_^8=_V]_\
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M0RGIDHREMJAMP %95S^SE;W.H?VNU[>B]#*WFJULARJA!\JVP3&P;2,889#
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MRI,S$HV.C(J@.2X0$FO2O O@6U\#VJ65DFV->23R[L<;I'.!ECCD\  !5 4
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M0 "6D=F:K6K?L9:/:PR2?:KF+;&[>9(\)C3 )WL/*3*CJWS+P#\PZUTOP_\
M#MU\1_#MK'J5U=1&6&192GEI)+&9"(][21.Y!C5>5(\Q6)<N&KH/AG\$X?AR
M2+*ZNC$S;GAD:%XF;:5W8$(93TR492VU0VX "L7X@_L^?\)!J::UI]V]E>+@
MNX3S@Q50BL 73'R#8Z\HZX!7[V[:\7_!A?%T!M;N^O6B9E:10\"AV7[I($&
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MNMK?ZP"Y.'#')V/MS'\H .T5VO@7P+:^![5+*R3;&O))Y=V.-TCG RQQR>
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M[5\/O@A#X:NGU2[F>]U&7.ZXD"J%SD?NT&=GR83J<*-J;$)6MKXF?"JR^(T
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MK*1D,"."".01P14M%%%%%8OB_P :6G@Z W=_*(H@RKN())8]%"J"S'J< $@
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MWV*XAGV8W^5(DNW.=N=A.,X.,]<'TK5JKJVJ1Z1#)<SMMBBC>1VP3A5!9C@
MDX )P 3Z"OEKX5L_Q_U>74=5 -I9*ODVNXF-6D8[ 1MQ(,1L9"=I=@@(,8\L
M?4O]DP^3]E\M/(\OR_*VKY>S&W9MQMV[>-N,8XQBO&K+X7)\//$5O>Z<@6UO
MUN()H\#;$XC-POEX8$!S"?EVE4"L!@,BK[+JFK0Z1&T]S(D42XW/(RH@R0!E
MF( R2 ,]R!530O%EGX@W?8KB&?9C?Y4B2[<YVYV$XS@XSUP?2M6JMOJT-S))
M!'(C2Q;?,0,I=-PRFY0<KD<C.,CD5GZ)XWL-><Q6=U!.X4L5BECD8*" 6(1B
M<9(&>F2/6I=0\66>G3):SW$,<\FW9$\B+(VXE5VJ2&.6! P.3P.:U:JV^K0W
M,DD$<B-+%M\Q RETW#*;E!RN1R,XR.1530O%EGX@W?8KB&?9C?Y4B2[<YVYV
M$XS@XSUP?2O+_P!JKP];3Z+=7CPQM<(MNJ3%%,JK]HC^4.1N ^9N <<GU-:'
M[+G_ "+MG_V\?^E$M=7H_A;2]&U"::W2%-0N(Q)* P\UDW8+A,_*I?[[* '<
M N2P!KI;N[2S1I96"(BEF9B%55 R6)/  '))X K$TOXA:;J\BP6UY;2RMG:D
M<\3N< DX56). "3CL":Z"L^+Q#;2I+*LT92!G69@ZE8V09=7.<(5'+!L%1UQ
M1HGB&VUY#+9S1SH&*EHG610P )4E"1G!!QUP1ZU;N[M+-&EE8(B*69F(554#
M)8D\  <DG@"LK1/&]AKSF*SNH)W"EBL4L<C!00"Q",3C) STR1ZUM5S_ /PL
M+3?.^R_;+;S_ #/+\KSXO,WYV[-N[=NW<;<9SQC-=!17S+^TI\4;G5+V/PMI
MKB,SM#'<2$LIW3$!82=O";65G*[BP;9P ZM[KX#^'5EX%@%M8Q!!M4/)@&60
MC)W2. "QRQ([+G"A5P!Y_P#M%_"J#6;*;5;91#J%JOVA9T/ENPB +!F4%F(1
M/W9/*LJ@,JELV_V</C _Q&LF^U8^UV[*DI4$!U8?NY<8"J6VL"JD@%2V%5E4
M>?Z]K;Z]X[MK.X :&U4B)#DJ&-JUQYF&)7?O(PP .$3NH->P>(?@MIVO:C!K
M$J$7,#*V4.U9&3'EM( ,L4(!4@@D *^Y %'C_P"R+K;^*KW5=2N@&N)&MSNY
M)57,Q,:EBS!!L0!<D81!_"*]0TS]G;1M.FNYE@RMY'Y;Q$_N44D.PC48V9=5
M<')*,H\HH!BNP\%VUE:VD4>E^6;15*Q&)@\> 2&PP)W'=G<222V2Q+9J77?%
MEGX?V_;;B&#?G9YLB1;L8W8WD9QD9QTR/6K>EZM#J\:SVTB2Q-G:\;*Z'!(.
M&4D'!!!QW!%2W=VEFC2RL$1%+,S$*JJ!DL2>  .23P!65HGC>PUYS%9W4$[A
M2Q6*6.1@H(!8A&)QD@9Z9(]:VJQ9O&]A! MX]U MN[;4F,L8B9OF^4.6VD_*
MW .>#Z&MJBBODN#Q$W[0NO"RD;&DVOF2B)6=#*J$(LA^4-N=G7@[3'$652'R
MS?56EZ3#I$:P6T:11+G:D:JB#)).%4 #)))QW)-?-7Q_\,_\*DN+;Q#H82W+
M2>1-"HVPOE=RCRU 7:RQL),%?F".H$F7KW_P!XQC\9V,&H0C"S1@E>3M8$K(
MF2JYVN"N< -C(X(KH***Y_2_B%INKR+!;7EM+*V=J1SQ.YP"3A58DX )..P)
MKH*Y_2_B%INKR+!;7EM+*V=J1SQ.YP"3A58DX )..P)J+Q?\1;+PG9'4KF4&
M JIC*$.92PRBQX.'+#D8.,98D*"PRO@?XOG\8Z3!?W9!EE:<MM&U0!/(JJ!Z
M!0 ,DD@98DY)T/%'A;2[BZMK^_2'[3'(([>21@I+MDH@!(#MG+1J0Q5LL@#9
M-=57/_\ "PM-\[[+]LMO/\SR_*\^+S-^=NS;NW;MW&W&<\8S7055U#5H=.V>
M?(D?F2+&F]E7<[9VHN2,L<'"CD]A534/%EGITR6L]Q#'/)MV1/(BR-N)5=JD
MACE@0,#D\#FM6N?_ .%A:;YWV7[9;>?YGE^5Y\7F;\[=FW=NW;N-N,YXQFMN
MVNTNANC8, S*2I!&Y6*.O'<,"I'4$$'D5+6?K?B&VT%!+>31P(6"AI76-2Q!
M(4%R!G )QUP#Z5%H7BRS\0;OL5Q#/LQO\J1)=N<[<["<9P<9ZX/I6A=W:6:-
M+*P1$4LS,0JJH&2Q)X  Y)/ %9^H>++/3H4NI[B&."3;LE>1%C;<"R[6)"G*
M@D8/(Y'%:%I=I>(LL3!T=0RLI#*RD9# C@@CD$<$54UOQ#;:"@EO)HX$+!0T
MKK&I8@D*"Y S@$XZX!]*^2_VP;2P<6-YIRP$7#7C/- (\2L&ARS/']\ABV22
M2"6[YK[$HJK<:M#;21P22(LLN[RT+*'?:,OM4G+8')QG Y-0Z;XAMM4>2*WF
MCD>%MLJHZNT;9(VN%)*G*D8.#D'T-5=;\;V&@N(KRZ@@<J&"RRQQL5)(# .P
M.,@C/3(/I6K:7:7B++$P='4,K*0RLI&0P(X((Y!'!%5-;\0VV@H);R:.!"P4
M-*ZQJ6()"@N0,X!..N ?2HO^$LL_L_V[[1#]E_Y[^8GD_>V??SM^]\O7[W'6
MM6BBHKN[2S1I96"(BEF9B%55 R6)/  '))X K*T3QO8:\YBL[J"=PI8K%+'(
MP4$ L0C$XR0,],D>M:MW=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5B:?\0M-U'?
MY%Y;2>7&TC[)XFVHN-SMACA1D98\#N:Q?C%\58/AS9/<2,//=76WC(W%Y,<9
M *G8I(+G(P. =S*#M?#W5)-7TVSN9VW2RVEO([8 RS1JS'   R23@ #T%3:W
MXWL-!<17EU! Y4,%EECC8J20& =@<9!&>F0?2M"RU:&_QY,B/F-)!M96RCY\
MM^"?E;:=K=&P<$X-6J\5_:Y\33:)HI2 [?M%PD#D%@VPJ\C $$?>\L*V<@HS
M CG(V_"_PZLO%OARRL+F(>4]E;N-H"LDC1!C*IQP^YF).#N+,&#!F!ZK0-&L
MOAOIZ6RN(;6W7'F2N ,LV2S.Q"@L[9[#)PH P*T-"\66?B#=]BN(9]F-_E2)
M+MSG;G83C.#C/7!]*U:SW\0VR&93-&#;J&G&]<Q*5+AI.?D!4%@6P"!GI4VE
MZM#J\:SVTB2Q-G:\;*Z'!(.&4D'!!!QW!%6JQ=;\;V&@N(KRZ@@<J&"RRQQL
M5)(# .P.,@C/3(/I6AI>K0ZO&L]M(DL39VO&RNAP2#AE)!P00<=P1537?%EG
MX?V_;;B&#?G9YLB1;L8W8WD9QD9QTR/6I=-\0VVJ!&MYHY1(KLA1U<,J,$=E
MVD[@K,%8C@$@'!-1:[XLL_#^W[;<0P;\[/-D2+=C&[&\C.,C..F1ZU+IOB&V
MU0(UO-'*)%=D*.KAE1@CLNTG<%9@K$< D X)K%\4>%M+N+JVO[](?M,<@CMY
M)&"DNV2B $@.V<M&I#%6RR -DUU5<_I?Q"TW5Y%@MKRVEE;.U(YXG<X!)PJL
M2< $G'8$U%XO^(MEX3LCJ5S*# 54QE"',I8918\'#EAR,'&,L2%!897P/\7S
M^,=)@O[L@RRM.6VC:H GD55 ] H &220,L2<D]+KOBRS\/[?MMQ#!OSL\V1(
MMV,;L;R,XR,XZ9'K4NB>(;;7D,MG-'.@8J6B=9%#  E24)&<$''7!'K5N[NT
MLT:65@B(I9F8A550,EB3P !R2> *S]0\66>G0I=3W$,<$FW9*\B+&VX%EVL2
M%.5!(P>1R.*T+2[2\198F#HZAE92&5E(R&!'!!'((X(JIK?B&VT%!+>31P(6
M"AI76-2Q!(4%R!G )QUP#Z4:)XAMM>0RV<T<Z!BI:)UD4, "5)0D9P0<=<$>
MM6[N[2S1I96"(BEF9B%55 R6)/  '))X K*T3QO8:\YBL[J"=PI8K%+'(P4$
M L0C$XR0,],D>M;5%5;C5H;:2."21%EEW>6A90[[1E]JDY; Y.,X')J'3?$-
MMJCR16\T<CPMME5'5VC;)&UPI)4Y4C!P<@^AJKK?C>PT%Q%>74$#E0P666.-
MBI) 8!V!QD$9Z9!]*U;2[2\198F#HZAE92&5E(R&!'!!'((X(J+5-6ATB-I[
MF1(HEQN>1E1!D@#+,0!DD 9[D"JFA>++/Q!N^Q7$,^S&_P J1)=N<[<["<9P
M<9ZX/I6K7-7?Q-TJS=HI;ZU1T8JRM<1*RL#@J07R"#P0>0:Z6JMQJT-M)'!)
M(BRR[O+0LH=]HR^U2<M@<G&<#DU#IOB&VU1Y(K>:.1X6VRJCJ[1MDC:X4DJ<
MJ1@X.0?0UG^)O%FFZ=FUU"XMH_,C.8IY(EW(V5.5D(RIP1TP>1ZU\UZ7I,.D
M>/U@MHTBB7.U(U5$&=/).%4 #)))QW)-?2GCKPM8^);5X=41'ME_>,78H$V9
M._>"I3 SE@1\I()VD@ZVD^3Y,?V79Y'EIY7E[?+V8&S;M^7;MQMQQC&.*+?5
MH;F22".1&EBV^8@92Z;AE-R@Y7(Y&<9'(JIH7BRS\0;OL5Q#/LQO\J1)=N<[
M<["<9P<9ZX/I6K7/_P#"PM-\[[+]LMO/\SR_*\^+S-^=NS;NW;MW&W&<\8S7
M045S_CKPM8^);5X=41'ME_>,78H$V9._>"I3 SE@1\I()VD@ZVD^3Y,?V79Y
M'EIY7E[?+V8&S;M^7;MQMQQC&.*+?5H;F22".1&EBV^8@92Z;AE-R@Y7(Y&<
M9'(JIH7BRS\0;OL5Q#/LQO\ *D27;G.W.PG&<'&>N#Z5;U35H=(C:>YD2*)<
M;GD9409( RS$ 9) &>Y K/TOQO8:L&:VNH)0K1JQ26-P&D;9&IVL<%F^50>6
M/ R:A\=>%K'Q+:O#JB(]LO[QB[% FS)W[P5*8&<L"/E)!.TD'6TGR?)C^R[/
M(\M/*\O;Y>S V;=OR[=N-N.,8QQ537?%EGX?V_;;B&#?G9YLB1;L8W8WD9QD
M9QTR/6OE7XKZ39Z=XJTC^SXX8X)/[/D'D*BQMNNGPX\L!3E0/F[C'.,5]?US
M_P#PL+3?.^R_;+;S_,\ORO/B\S?G;LV[MV[=QMQG/&,UT%%<KXH\+:7<75M?
MWZ0_:8Y!';R2,%)=LE$ ) =LY:-2&*MED ;)KJJSXO$-M*DLJS1E(&=9F#J5
MC9!EU<YPA4<L&P5'7%&B>(;;7D,MG-'.@8J6B=9%#  E24)&<$''7!'K7SW^
MVUXFFLK6TL8SB*XDE>3!8%O*\O8IP0"N9-Q!!^94(QCGU_X@_!_3_'5JEE<Q
M[$BQY+1;4>(# VI\I4*5 4J05P <952-N6]LO!=M%'+)';6\:I%&99 B@*N$
M0-(W)VKW)) )YYJUHGB&VUY#+9S1SH&*EHG610P )4E"1G!!QUP1ZUH5BS>-
M[""!;Q[J!;=VVI,98Q$S?-\H<MM)^5N <\'T-:&J:M#I$;3W,B11+C<\C*B#
M) &68@#)( SW(%5-=\66?A_;]MN(8-^=GFR)%NQC=C>1G&1G'3(]:M_VM#Y/
MVKS$\CR_,\W<OE[,;M^[.W;MYW9QCG.*AT3Q#;:\AELYHYT#%2T3K(H8 $J2
MA(S@@XZX(]:MW=VEFC2RL$1%+,S$*JJ!DL2>  .23P!6)I?Q"TW5Y%@MKRVE
ME;.U(YXG<X!)PJL2< $G'8$T>.O'5KX'M7O;U]L:\ #EW8YVQH,C+'' X  +
M,0H)&+\#_%\_C'28+^[(,LK3EMHVJ )Y%50/0* !DDD#+$G).AXH\+:7<75M
M?WZ0_:8Y!';R2,%)=LE$ ) =LY:-2&*MED ;)KJJY_\ X6%IOG?9?MEMY_F>
M7Y7GQ>9OSMV;=V[=NXVXSGC&:Z"JNH:M#IVSSY$C\R18TWLJ[G;.U%R1EC@X
M4<GL*J:AXLL].F2UGN(8YY-NR)Y$61MQ*KM4D,<L"!@<G@<UJT5E:[XLL_#^
MW[;<0P;\[/-D2+=C&[&\C.,C..F1ZU+IOB&VU0(UO-'*)%=D*.KAE1@CLNTG
M<%9@K$< D X)KY5^,7AZVT'Q;I,5G#' A:Q8K$BQJ6-VX+$( ,X &>N /2OJ
M74/%EGITR6L]Q#'/)MV1/(BR-N)5=JDACE@0,#D\#FM6L76_&]AH+B*\NH('
M*A@LLL<;%22 P#L#C((STR#Z5JVEVEXBRQ,'1U#*RD,K*1D,"."".01P14M%
M17=HEXC12J'1U*LK ,K*1@J0>""."#P17RAI>DPZ1X_6"VC2*)<[4C5409T\
MDX50 ,DDG'<DU]:5Y5\4-6T?QCIMYY<EG=SP6%W)'M:&>2/]V<NN"S)\P7YA
MCG;SG%<K^Q3_ ,@>?_K_ )/_ $3!7O5W:)>(T4JAT=2K*P#*RD8*D'@@C@@\
M$5\H:7I,.D>/U@MHTBB7.U(U5$&=/).%4 #)))QW)-?3_P#PEEG]H^P_:(?M
M7_/#S$\[[N_[F=WW?FZ?=YZ5JUE:[XLL_#^W[;<0P;\[/-D2+=C&[&\C.,C.
M.F1ZU;TO5H=7C6>VD26)L[7C970X)!PRD@X((..X(JU11111111111111111
M1111111111111111111111111111111111111111111111111111111117R!
M^VGX8@TR:SN8P_FS_:?,9Y99>%,;*JB1V"*#(Q"H%49X'2OJKQ-X8@\2PFVN
M@YB;.Y4EEAW @J58Q.A92"05)*GN.!7RA^Q]X0@\3B^CNP9(5:S8PYQ$[!IF
M0R 8+A2O",3&<Y=&(0K:^(>AQ>!/&6GMIRB$3M:%D5$6-1)(UM(JJ% 4-&IS
MU.YF8$'&/KJN5^*>GWVH:9<1:4^R\:/$;;@A^\"ZJQ'RL4W*K<;6(.Y<;ARG
MPR^&$/AWP\NFZQ'"%,<KW8)4)\S,^YW&/F1 H+@_*4!5\*K5YK^Q=XKD%K?0
MW,N+6V\F1-Y 2(/YS2G<?NK\@8@G:#EL LQ-OX*Z%'\9+VZ\2:K$DB"006UN
MQ,L485 6RKKM;Y74C^$NTC^6IV$<)^V!X#@\,3VLMF!%#.LV8$&V)9$\H/*J
M@[%+H45@JKGRP3N)X]:_:F^$</B'3Y=1MXD6\M_WKN%57DB5<2*S;ESM0!@6
MW, FQ -YJW^R5=VM[HRO;P)%,DC0SNJX,C)\ZN6+,S?+*/O$!6+!%5-HK;T7
MX<6&J:S<:LL$>(E2%/W<>QKA9&FGN1\IW.K,D?F!@XD29&&5!K$UCX:ZGK7B
MF'4;G9)IEO&6A#,I",8]NT)C/F^=B3>1C:J_O-RJ@\Z_:[NT\*ZC8ZCI["'4
M-LK2.A D*KL6)G7H01O3+##J"C;E7 ]%_:P\,07NC3WD@<RP^1Y?[V41J3,J
M%O+#B(MMD9=Q4M@XSP,9_P"SE\.K+7-%L[F^B%RP6Y6-9@)(HU-P^X)&1L!+
M+N+D&0YV[]@55XK]ER$^'?$.IZ5"Q-NBSC#;2S&"X6.-B0HY"NV<8!)SC@8[
M7X>V$'QEU"ZUJ] N+*WF:VL8'^:( *IEF:-HU!+AE9=V2N2K#,<9%OXH?L^/
M=SVVH>&S!87<#')53$C*>AQ&K+D<J04(D5RKG:H4R_'/Q@)KZQT#S'6&YWR7
MBQ132S/ H)6(>2-^V79(C[,LJC)PFX/B_$7P-H6JZ9+;6=A/'/'"3;M'IUY'
M*9$0^6K2-;9<,?E?S"<YW$A@&'=?L]ZWJ&J:6BZM%-'<PR-$6G5DDD4!620A
ME4]&V9.XL4+%BQ./2J*^5?VY_P#F'?\ ;W_[;UZ+K_[+VG^(8'-V\DFHR+E[
MYF?>9.N[R@_E!!PHC &V,!0P8!Z\U_9G*:P+SPIK, E$#22(CX<1L&\F=5;>
M=A#."AC (+2-OR165\ O"4'@_P 33Z1J,<<LJ*WV:1TW-O0K-&Z ,Z1EHOWF
M3\R%0H=265O?_B)X)LO%6H6$-S!'(ZM+.[.HRT,"E/*+#YB//N8G\L_NV"ON
M[*WH%I:)9HL42A$10JJH"JJ@8"@#@ #@ < 5%JFDPZO&T%S&DL38W)(JNAP0
M1E6!!P0",]P#7R5\$O"=GJ/BK5+6>WAD@C^V[(GC1HUVW4:KM4@J,*2!@<#@
M<5[+^TQ:)9^&KJ*)0B(MLJJH"JJBXA 4 <  < #@"L3]G#P'9ZUH5I+>Q)<G
M]^$69$E2,">4%8U9<+D_,S<NQP&8JD:IR'[+EV_A[6]3T.)BUK&T[+O)+!H9
MUA#<80%D;YR%RQ5.@&*U?!WB*P^)%W=:GJJ27D4-S)#8QK9WD]O'$HYD(CCD
MC9Y ZEA(N]2JD8&P+B?$'3SX7U2UU?PO97@/S+=PQVES;PLBF/";7MPHWKN#
M;00&59 HD&YOJJO,/VFKM[7P_>M&Q4E85)4D':T\:.O'8J2I'0@D'@UQ_P"Q
M3_R!Y_\ K_D_]$P5[_17S7X"^S_'36KR]O/WUC8^6EI V[R_F8D38^3.[R26
M216R'"-D1J*A_:-^%R>"4B\0Z$@M9K>9?-\H!%VL%C1PI;8 &PC(J$2"0EP0
M&S[!X;N+?XK:1;S7.62>$&58GGMU+[6CFC.QU=D#[UVL65@ ?FX-?/7[&OAF
M'7OMZW0\R%?LI,+!6A<GS]K.I!W[<$JI.P,=Y4NL;(?$[PXG@OQ?8C3#]F^T
M?9L^6D06/S7>UD\M#&4&4&?F5OG8MZ >@?M&?"S3-'T*YN(+=!/')'()CN:<
MM).H<O*Q,DF1(V0[,.AQE5QT'P4TQ?'/AJSBOR[H8Y(R$DD@W(CRP*C&%HRR
M^6 I5LAL98$\UX?^R?X$B\:)?6UX2;4-:-)$K.GFL!<",,R.IV*27*XR7$;;
M@$*O;^.GPP'P:N[36]%RD0F ,99BJ2*,A<[Q(R2H'#KDX 8%L.JCU_\ :"UM
M->\*37D0(2>&SE4-@,%>:!P#@D9P><$C/<U-^SAIBZGX9M(9"X5O/R8Y)(7X
MNI3P\3(XZ<X(R,@\$BO*OV;-+CTCQ5J5M NV**.\C1<DX5;J)5&223@ #))/
MJ:]*^,GPUU/QGJVG%-CZ7%)')/&[+L#(Y9RZ$9DWQX1!\P!W A%9F;FOVS[:
M"RMK2^3"7ZW*K%(K;)O+57=L8()"R;"#SL9N"N\Y[#QCIB^,O"XN[XN\O]D>
M><221(TOV=9=S)$R1OB10P#*54] ,FO/_P!DKP+:^)-+>2^3STCOY"D,GS0!
MO(B4R&/&UV*M@&3>$P#&$)<ME>"].7P;XZDLK+Y()?-#)A,;7MOM7EJ H"JL
M@7:%P0JA22,Y[_RX_B]KT\$Y\S3=)V#R"2$ENB6!=T*#<J;70@DC*@KN21U.
MA\7/V=X/$,$;:-'!97L$RO'(B>0".X)A&00<,K;6*E<#:&8UE?%+Q5,)=+\/
M7DQ+7$(?4C!#-))*B)\R((%5]DSI(K>6H95&2%3*M5^(O@;0M5TR6VL[">.>
M.$FW:/3KR.4R(A\M6D:VRX8_*_F$YSN)# ,.Z_9[UO4-4TM%U:*:.YAD:(M.
MK))(H"LDA#*IZ-LR=Q8H6+%B<>E5\8?#V[>Z\=NTC%B+W4%!8DG:L<Z(O/8*
M H'0  #@5]GT5\3?L>6B:IJ-S9W"B6WDLBSPN \3,DT.QF1LJQ7<=I(R,G&,
MUM?\(G9_\)W]A^SP_9?^>'EIY/\ QX;_ +F-OWOFZ?>YZU]--\,M*9!$;&U*
M*S,J_9XMH9@H9@-F 2%4$]2%&>@KYE_8U\)V?B#[?]MMX9]GV79YL:2[<^?N
MQO!QG SCK@>E>H?M2^#;4Z'+.$*FV6W6%%DD6%!YR1C$*L(LA'90=F0IP#@#
M$/P;\8Q^#/!\6H3#*PQW)"\C<QN95C3(5L;G(7."%SD\ UH?!WX46VIV2:IJ
M\<=[?7RI/++,JS *PS$B!T 0",@$*, _*"45 IX9^"5SX/UY]0TV6.+3)U/G
MVHW*=VQL!5VLF!)AU(*% S1J G#8%_XCM?'VN7<&HB2XL-.:)(;>*VNYD,^?
MWDLODJV2C(\:K(IC=2=H/SE^?^-'AR& VVI>&+2Z@U"&8#$%A<P(8RKDLRM;
MJC$-A3_>5F5PR@;>J_:/TJ/Q#X=;5+F*2*X6&T=8FEF"Q.\B!@8\K&7 E="S
M)NQQQ@ <U\&?@3:^/]"MY-2EF?/FBW"-Y8MU$[[P@PRLTC EW=6.W:JA=@)^
MC_#VB)H-M#9Q$E((8XE+8+%44("< #.!S@ 9["M"N5^+'_('U#_KPN__ $2]
M?/\ ^PQ_S$?^W3_VXKZJKRK]J/\ Y%V\_P"W?_THBKQKX1Z!!XD\(7YO$$IM
MFO6MV?EHB+>*;]VW5 9!N8*0&.=P()![;]C6T2\T2YBE4.CWLRLK ,K*8( 5
M(/!!'!!X(KB=!T"#0/'PMK1!%$K.RHO"@O8M(V!V&YB0!P!PH  %>@?$SQ+#
MXJUP:#=-(^GP6WG7,$,-S(\LI(\N-S;@N$57CE! V;OE?+;=F+\:O".FZG9>
M=HME<PZA!(CP&WT^[MB3O7=N(MT4X7+J20RLHVD98-#\;/'>HR>$[6:X$EM<
MW$R072LOER,H28/D;$*"0QARH &UMG*$Y[7POX)\,?$K3O+L(( AA16*+&EY
M">0N]OFD#@H>6+"3!),B$YQ?CEX#ATCPM_I$4+WEK:6,'GA%9QLDA1@CLH<*
M<MCIPQR.36K^RYX3L_[&L[[[/#]J_P!(_?\ EIYW^NE3[^-WW?EZ_=XZ5Y5\
M7/#$'A_Q=IBVX?\ >26$CM)++,[-]I9,EY7=ONHH S@ # KT7]ICQH\\MGX;
MMI3%)?S1K.Z@DK"[^4%Q@;@[$DA74XC*M\LE=7KG[-^BW]DUC#:QQ$*_ES ,
M94<AMKE]XDD"EL['<J< 8P!CA/V3_'5TS7.@:B^9K+B)3\SJJ.8Y8RZDJ51M
M@09SAB%)10%X7XS^$HM&\5Z=%:M(AF:Q9I&D>>7>;EHP^ZX,N2%10 V5^4?*
M1D'T#]I+X2Z=I>AS7-O"$FAFCE\W[\TC23!'$DLF^5P?-+<MG<%YP,54M/&E
MW9^!%O(I2DZ0B)9% 5E077V< 8'!$7RAA\P/S9W?-6A\"]$\-^--+BMDM[9[
ME;?;<(Z)]JW8 ED#',NTL^4=6PNY5!1EVKZK\+_!7_"$6$>GAMRQ27&PYR2C
M3R21[CM7YMC#=@ ;LXXP:ZJO%?!'PUU-/$EYJ^J;)(!&\=HY96*J[@H$4#,>
MR/<CDA26=B"X9F/G7Q(NT\*^,[,Z8PB>X:U6[$9&&::<K(KKR 6CV,1@')67
M[Y#5M_MH^&($L8;_  YG-VD>3+*R*K0R%@L;.8TR8T)*J"2,DDDY[7P-\']/
M\0Z/;/>1^=-/IEM&9I-LDD:F'Y!#N4I%LWG:44$D!Y"[Y8^=?L3Z^;>VU".9
MPMO"T,N6VJJ%ED$CECC VQ+G)P N>,G.A\%="C^,E[=>)-5B21!((+:W8F6*
M,*@+95UVM\KJ1_"7:1_+4[".$_; \!P>&)[66S BAG6;,"#;$LB>4'E50=BE
MT**P55SY8)W$\?9]17=L+I&C;(#*5)5F1L$8.&0AE/H5((/((-?&MWX)$?C5
MM/L99+8,Q)E5FDF >S\R<AY2[;WW. Y)*,V\9*@5Z+\0O!5C\"+>YUK26>&Z
MFC6VAC<F:%2[(S%0REMP6)G!D=DW#!!!"UMZ)X/T"SMC!<V<]S+(I\^XET[4
M'FDD90LDH=X7DC+'+81QM8DK@\US_P"S[J=WX)EU"SNXKI-(@6>>WGN(I4"1
MQN<@!HE8ET82%1C!5B(\NU1? W1_^%P7%SKVL#SX4N'CM;61O-AARJE_W90(
M<(8U5L?,P9W7>%8<3^U[X%M?"<EM)8)Y"77F&6&/Y("T 18Y!&H"AMLK D<<
MD@ LY;V#]K#PI:WNC3WLD2&YA\CRY<8D4&94*[A@E<2-\IRN3NQN (M_LX:3
M#J_AFT@N8TEB;S]R2*KH<74I&58$'! (SW ->5?LV:7'I'BK4K:!=L44=Y&B
MY)PJW42J,DDG  &22?4UV%_XCM?'VN7<&HB2XL-.:)(;>*VNYD,^?WDLODJV
M2C(\:K(IC=2=H/SE^?\ C1X<A@-MJ7ABTNH-0AF Q!87,"&,JY+,K6ZHQ#84
M_P!Y697#*!MM?M->.',&C_;$DCM+EA->VH)#E4^SN82?W;97>PP2@W88@,JE
M>UU_X4:%\3M,<Z3':JY7,,T"I$5EV;D60QIN ^8>9&R[@#G:'"D<K^V?X>MH
M-.CO$AC6X>]B5Y@BB5E\F;Y2X&XCY5X)QP/05ZA\%_"=GIVFV5U!;PQSR6%M
MOE2-%D;=&C-N8 ,<L 3D\GD\UX5^S?XDTGQ;)<C71#/J=Q<*RR72QN)%(5$C
MCWY4,&)&Q0I*E H94PGO7@/X50>";V]N+-1'!=K;MY8/"2(9O,VC "H0ZE0"
M<'< %4**[JOFO]L;PG9Z=IL=U!;PQSR7Z;Y4C19&W1SLVY@ QRP!.3R>3S7I
M_P '?!%A:Z=87D=K MP;*W8S+%&)=S0KO;>%W9.3DYR<G/6O,/ 7V?XZ:U>7
MMY^^L;'RTM(&W>7\S$B;'R9W>22R2*V0X1LB-14/[1OPN3P2D7B'0D%K-;S+
MYOE (NU@L:.%+;  V$9%0B02$N" V?8/#=Q;_%;2+>:YRR3P@RK$\]NI?:T<
MT9V.KL@?>NUBRL #\W!KYE_92^'T?C;[;#=NYLU^S&6W4E%F;]]Y1=U(?:F&
M8(" SE6)^0 _4GPO^%]M\-[9K.S:1T>9I292K-N*HA V(@QA!VSG/-=!XAAG
MGMIDLV"7#0R"%VY59"I",?E;@-@G@\=CTKS#]GGX87'AK3[A-8C1KF[N)'F#
M%9G="H7;*WS!\G>V-S##G/S,P'FG[+^K?8]>U+3;.3.GC[3)%&K>9'\EPD<;
MJQ+$_NVQN!^<;2Q;:I$7A#Q?IFI^(]33Q&8Y'$TD-J]R$-O''%+(#'\_[M"0
M%*L1R0_S;W(?W#0O@_:^&]6.J6$:0I):20RQI\J;M\+1NB*NU?E1@^" 3M(7
M)=CX?X0\7Z9J?B/4T\1F.1Q-)#:O<A#;QQQ2R Q_/^[0D!2K$<D/\V]R']PT
M+X/VOAO5CJEA&D*26DD,L:?*F[?"T;HBKM7Y48/@@$[2%R78_/\ \7/#$'A_
MQ=IBVX?]Y)82.TDLLSLWVEDR7E=V^ZB@#.  ,"O4/VP-?GTC1@MNYC$]RD4F
MW@M&8Y69,]0"5&<8R,J<J2#:\+^"?#'Q*T[R["" (845BBQI>0GD+O;YI X*
M'EBPDP23(A.<7XY> X=(\+?Z1%"]Y:VEC!YX16<;)(48([*'"G+8Z<,<CDUJ
M_LN>$[/^QK.^^SP_:O\ 2/W_ ):>=_KI4^_C=]WY>OW>.E'P!^&NI^'[K4-0
MUO8]U<2(J2[E=V5=VYE( V1-E-J?*0$ ,:A5%>=>";M/#?C>6PTQA'9S,ZR1
M1D&(LML967'(4I,&P!@I\T8VJ2M;?[:/AB!+&&_PYG-VD>3+*R*K0R%@L;.8
MTR8T)*J"2,DDDY[7P-\']/\ $.CVSWD?G33Z9;1F:3;))&IA^00[E*1;-YVE
M%!) >0N^6/FG[&7BG^S;/4OM#[;6W\J<_+G;E)?-;Y06/RQ+QS]WY1DG/:_!
MKPA#\1EE\1ZO&EQ)=22+;Q2[9HX+=)"JQA615#;E;+ '(PW#/)NMZM\!YM+U
MJVU?0GAM(1L6ZA4-&KH&&\*JJR'<G&W" .JR [SN7%O_ !':^/M<NX-1$EQ8
M:<T20V\5M=S(9\_O)9?)5LE&1XU613&ZD[0?G+\_\:/#D,!MM2\,6EU!J$,P
M&(+"Y@0QE7)9E:W5&(;"G^\K,KAE V_2GA[4GU2VAN)8S"\D,;M$V=T;,H8H
M<A3E2<'(!R.@Z5;N[872-&V0&4J2K,C8(P<,A#*?0J00>00:^-;OP2(_&K:?
M8RR6P9B3*K-), ]GYDY#REVWON<!R249MXR5 KT7XA>"K'X$6]SK6DL\-U-&
MMM#&Y,T*EV1F*AE+;@L3.#([)N&"""%K;T3P?H%G;&"YLY[F613Y]Q+IVH/-
M)(RA9)0[PO)&6.6PCC:Q)7!YK*_9G%_H%W>:5)#=#35:22SEN(Y(P%$NT*-\
M2<R*P<K\H!5B$!9C63X#UM_B!XONEU$"1-/6Y%K'SY<;1W$<0D"YP7(^8L<G
M=@C&R,+S_P"V?H<6D7MEJ4*@32K('!1&1C"8RC,K*0YP^UM^X%55<8'/L'QI
M^'5U-I#V/AR*. R3*9HHA';^9&5*NH.%7)^3=DKN12I)!V-%XZ\"VNC^%7LK
MU(?]%L,@CY4%RL9VR(<*=S3'@\&0N58'>0<G]DK5IO$6AO#=2.ZQW$D"'<RN
ML7E1$*KJ0XQO.T@[E& I 50/);OP2(_&K:?8RR6P9B3*K-), ]GYDY#REVWO
MN<!R249MXR5 KU7Q/X)T[X"Q76O:<I$S0K!%;R2YAW.\?W=P,K$;#(5WDE0X
M&T8*V_@1\%+)=.COM1ACN[N\47$DDRBXXDRZ >8O!VL"YY+.6RS*%QY5X-\,
MCPQXZ2S1RZ1M)Y>XL2L9LF:*++,S$1H5C!)Y"CIT'8?MH^&($L8;_#F<W:1Y
M,LK(JM#(6"QLYC3)C0DJH)(R223GU7P9X8@\2Z#86UT',36%KN5)98=P-NJE
M6,3H64@D%22I[C@5\]?L?>$(/$XOH[L&2%6LV,.<1.P:9D,@&"X4KPC$QG.7
M1B$*VOB'H<7@3QEI[:<HA$[6A9%1%C422-;2*JA0%#1J<]3N9F!!QCL/VR_'
M5UH5K;V5L^R.[\\3$<.53R_W8.>%;>=X'+ !<[2P;N_BW\.K(>'KFQCB$<-M
M;22PA0,H\2M(I!8,<L00[?>8.^6RQ-<)^QMH]O>Z:UU)#";B&[ECCF\J,3*I
MCC8CS H<_P"L89))VG;G: !]%5\U_MH^&($L8;_#F<W:1Y,LK(JM#(6"QLYC
M3)C0DJH)(R223GU7P9X8@\2Z#86UT',36%KN5)98=P-NJE6,3H64@D%22I[C
M@5\]?L?>$(/$XOH[L&2%6LV,.<1.P:9D,@&"X4KPC$QG.71B$*VOB'H<7@3Q
MEI[:<HA$[6A9%1%C422-;2*JA0%#1J<]3N9F!!QCH/VA/%\%CXAT^VU8E]+C
MA6:2'&Y/,9IXUD91@N%*J2IW?*' 4[V5O1=5^#^D^)1::AI4=LCV]W!-'+;^
M6D3JDR><C&)2K_*K;>ZN -R@N#P'[:/AB!+&&_PYG-VD>3+*R*K0R%@L;.8T
MR8T)*J"2,DDDY]/\.>*$\*^&K>_DP1#I5NX5F"!F$";$W$'!9L*."<D  GBN
M _9_^'4'C.*;Q%K$4=S<7TTI19!YL4<:OLVA)0V"&0JN2VV-452N7!\Y^)G@
MZ/PIXNT^*W.()+BRECB&0D(:Y.^- 6("F0/( H55+D!0!D^P?'/Q@)KZQT#S
M'6&YWR7BQ132S/ H)6(>2-^V79(C[,LJC)PFX/B_$7P-H6JZ9+;6=A/'/'"3
M;M'IUY'*9$0^6K2-;9<,?E?S"<YW$A@&'=?L]ZWJ&J:6BZM%-'<PR-$6G5DD
MD4!620AE4]&V9.XL4+%BQ./2J^0/BYX8@\/^+M,6W#_O)+"1VDEEF=F^TLF2
M\KNWW44 9P !@5] ?'3PQ!K>DW;3ASY5I<2(HEE1-RH74LB.JR89%(#A@".!
MR<^/_LE>!;7Q)I;R7R>>D=_(4AD^: -Y$2F0QXVNQ5L R;PF 8PA+ELKP7IR
M^#?'4EE9?)!+YH9,)C:]M]J\M0% 55D"[0N"%4*21G-3]LKPG9^'_L'V*WA@
MW_:M_E1I%NQY&W.P#.,G&>F3ZU]-1>'-,\%I+?16\%L(X7:22*%$81J-[Y\M
M-Q'RYP,Y('!.*\5^!>@0?%R6[\0ZN@N'^TF*WAE_>1PQJF[8!Q&XQ,!\T?#*
M9/ON2.?^.OA1_@S>V^O:$H@CD9HYHQGRBY)DVE2_*.H(V(%6/RP5*L5([K]I
MK3+3Q)H#ZJA=\1VLD!\R98\/*@#^46";BDK#<R;P#C(P,<K\&?@3:^/]"MY-
M2EF?/FBW"-Y8MU$[[P@PRLTC EW=6.W:JA=@)X_]K+X>VO@Y--2V\QCY,L1>
M6625BD0A$8&]BJ ;V.V,(H+'"@8 ]U^,'PHL+G2+V22,/<I;2RFZ98S=,\:^
M:"9-F0"5VE5VJL9\N,(@4#A?V5_#,/C'21_:(^T16MW*D$$@4P)E%=F*  2,
M3,V#+OV<>7LRV<3PK:)X3\=R6=BHA@D5E:-0-NUK47!49SM'FJ& 7  &T87Y
M:]%^,GPUU/QGJVG%-CZ7%)')/&[+L#(Y9RZ$9DWQX1!\P!W A%9F;FOVS[:"
MRMK2^3"7ZW*K%(K;)O+57=L8()"R;"#SL9N"N\YM_&>RBU[PFNJW4<<EZUEI
M[&<QIYH+R0E\,%!4$NW"X'S$8P:VOV7/"=G_ &-9WWV>'[5_I'[_ ,M/._UT
MJ??QN^[\O7[O'2O*OBYX8@\/^+M,6W#_ +R2PD=I)99G9OM+)DO*[M]U% &<
M  8%>B_M,>-'GEL_#=M*8I+^:-9W4$E87?R@N,#<'8DD*ZG$95OEDKJ]<_9O
MT6_LFL8;6.(A7\N8!C*CD-M<OO$D@4MG8[E3@#& ,<)^R?XZNF:YT#47S-9<
M1*?F=51S'+&74E2J-L"#.<,0I** O"_&?PE%HWBO3HK5I$,S6+-(TCSR[S<M
M&'W7!ER0J* &RORCY2,@^@?M)?"73M+T.:YMX0DT,T<OF_?FD:28(XDEDWRN
M#YI;EL[@O.!BNZ_9NU234] LI)FW,(WC!P!\L<KQ1C@#HB 9ZG&22<FO2J^4
M/"'B_3-3\1ZFGB,QR.)I(;5[D(;>..*60&/Y_P!VA("E6(Y(?YM[D/[AH7P?
MM?#>K'5+"-(4DM)(98T^5-V^%HW1%7:ORHP?! )VD+DNQ\/_ &B(3/XMTM%8
MH66Q ==I92;N4!AO5ER.HW C/4$<5V'[3GPOT^TT2:ZA@2.>&2%_-55\V0M(
ML3>9(P,DF1(68LVYG 9B3G);_&R;1O"$.J3-F\DC:WB;YF+2J\D2R,7$F6"1
MF5M_RNRD<;@*U?A'\#],NM+BN+Z%+JYO;=99YI0SR$S!I."S,48"3:70JS$!
MS\V,>?\ @ZYF^#7B<Z-OVZ;>R;HD(9P/,#+"5PSLK"4"$LWWU&]QC8RY7[:?
MA2UTF:SN;>)(Y9_M/G,@V[RIC8,P& 6S(Q+8W-GYB<#'T!\=/"EKKNDW;W,2
M2/#:7$D3D?.C*A<%6^\OS(N0#A@,,",BO/\ ]BG_ ) \_P#U_P G_HF"N4_Y
MJ'_G_H'5TWQXUA_&^K6?A*%PL4K)-=.LA#[5#N82 & (C3S%#A@S&)L*%RV_
M\6_@QIUKHUR;&".UEM[:1TFC3;+MCC;>C.I5W$D>Z-][,#NW,&(K%_8I_P"0
M//\ ]?\ )_Z)@KW^OD#Q3H\FL^.WMX9GMV?:#+'CS%7[ /,"D_=8IE5?DH2'
M ) %=+\=_P!F'3]/TZ2]TB(PRVRF1TWNZR1C!DSYKG:44%P5/(!7:Q92O2_#
MKXX-+X6DU2<_Z19QO"6<.ZR2JJB G#,[;_,C#L2OSES\J\U5^'&G:3=6J7VJ
M6TU[?74:2SSRZ=>3@ELLJIF"2)556" Q81E52!C:!E?!VSN?!VOSV5A;W@T6
MXW,AFBGCCC<1"3?F:)6'S*T(R5+ H69RJD_2E%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?*O[<_P#S
M#O\ M[_]MZ^JJ^5?V&/^8C_VZ?\ MQ1\??\ D<-)_P"W#_TLDKZJK@/CA\4O
M^%:Z>;Q8_,E>011*?N!V5F#/R#M 0D@<L<+E<EES_A?X'36;:UU?5'-[>R0Q
MS*\H'EP^8L3A88A^ZC*[%RZJ'9@6+ -M'@G[+6ER:OINNVT"[I9;2.-%R!EF
MCNE49) &20,D@>IKMOV)?$T+V=SI^<3I<>?@E?F1T2/*C.X[63YN,#<G.6P,
M3]N6[1GT^(,"ZK<LRY&X*QA"L1U )5@#T)4XZ&OJ^OD#X>7DGP.UV^TUU>2*
M:WD:V3@&=D#26HWE%)9AOA_=JP,S;0K8&/JKPMH7]A6Z0%M[C<TDF-N^5V,D
MTFW)"[Y&9MH.U<[5P !7C5M\19_B7K\VBPRR6ME9K*9O+.R>X>*:-&7S%.^)
M-YX\LAF0,&(+@1^=?M@^%+7PO#IMM8Q)#$/M?RH,9(%LNYCU9B% +,2QQR37
MM7[4?_(NWG_;O_Z414?LN?\ (NV?_;Q_Z42UY5\ O^1PU;_M_P#_ $LCJ;]E
M;QBGA"YO/#E\\:.ERYC?<%5Y0RV\D8+LI8DJAC4+N(WD]A7O_COQS%X3B#$"
M2XE94M[?S$CDFD9TC55WD<!G7>W.Q<L0<8/@O[0_B&3P)XDTW663= MOY9Z,
M2 \JSA5W*=PCG!4DA2Q') 85]'Z!K\'B&!+NT<20R+N1UZ$=._((.00<%2""
M 016?X.\8Q^*UFEMQF".X:*.49*3!43?(A*@%1(7C!4LK%"0Q!P.@HKY5_;G
M_P"8=_V]_P#MO7U57S+^S+I8UO6]6UJ%B;=IIDB;8P6033F;(9L8*JBY7&<2
M G;P"?M?>$Y]/EM/$5H2'MVCC<XW!"KF2"3&PKC>65BYP28U"\FO6_@_KO\
MPF,+ZV5V?:_+6-2<LD4(*&,X !Q<&X96QN9'7=C 1._HKY5^ 7_(X:M_V_\
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M91ZSKC?:FEDD:*W88M(0CS1 "')21N6_>2AW V@'*EF\_P#@%_R.&K?]O_\
MZ61UZ+XR^#^D?&,3729ANXYIH'F0KO#P,\6)$!*L/NL,[9&C\L;E7 K@/@W%
MJ/PL\0+X<NI3-:SPR-!\_P"["CS)5E5#N*$E)%= 5!8EB7"HQ[_QE\'](^,8
MFNDS#=QS30/,A7>'@9XL2("58?=89VR-'Y8W*N!7 ?!N+4?A9X@7PY=2F:UG
MAD:#Y_W84>9*LJH=Q0DI(KH"H+$L2X5&,/Q]_P"1PTG_ +</_2R2OH7QY-93
M11V.I*'AO9A;@-@)O*/(@)+*028\(5^;S"FW!Y'SK\5_V8G\&))K&@7$D9@5
MY&BWE9$3#F1HY05;"H<;&RQ4-^\9B%/2^//&,GC+P.U]./WKQP!SQ\S1W:1,
M_"J!N*%L 87.!G&:Z7]GW6TT'PI#>2@E((;R5@N"Q5)IW(&2!G XR0,]Q65\
M(KM_C:D^HZJQ:U2Y,<-@I*VZ[!#*&EV[3<'.WB0% =Y"88*G%6EHEG\0%BB4
M(B*%55 554:;@* .  . !P!78?MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_
MZ)2OF7]D_1'UZPUNSB(#SVT42ELA0SQW* G )QD\X!..QKNOV/OB7#>V/]D2
MLB3P2-Y*DJK2(Y>4[07+.RL'+;5 5-G4Y->R^)O',6C3V]D@$MU<3(JPB1%=
M8SO:2<ACNV*D;G@'<P"#ELCYU^'_ ,0$^&WB?4[/4L117ERS>8<$*QD:6!F8
M-A4:.8[B02I*[M@#D?3^OZ_!X>@>[NW$<,:[G=N@'3MR23@ #)8D  D@4>'M
M2?5+:&XEC,+R0QNT39W1LRABAR%.5)P<@'(Z#I6A7RK_ ,U#_P _] ZNU_;)
MTN2]T59(URL-W%)(<@;5*R1 \D9^>11@9/.<8!([OX._%6#XC627$;#ST5%N
M(P-I23'. 2QV,02AR<C@G<K ;4?C&.XU Z9$-[QV[2SL,D1$L@AC;"[0TBL[
M %@P5,[2&!KQ6\\-P^+_ !7+<Z3<);W=C&AG=]MPLSE?**K$'4A5C_=3,'4J
MY50BOF1O1;3X3/?ZBNJZO<"[>%0+6%8C#;P-_%($:64LY(!#,<@\\[8_+Q?V
MD?C/)\-[6-+5<W5SY@C<@%(PFW>Y!^\WSC8"-N<ELA=C2^+?AG!HVE7UW<$W
M5_\ V==AKN;YI,F*8D1J25@3]XP"1;1M(!W8R>:_8I_Y \__ %_R?^B8*Y3_
M )J'_G_H'5VO[9.ER7NBK)&N5ANXI)#D#:I62('DC/SR*,#)YSC )';? 3Q-
M#X@T6S> Y\JWC@<$KN5XE$; @$XS@,N<$HRD@9Q7A]M=I=?$+=&P8!F4E2"-
MRV!1UX[A@5(Z@@@\BNP_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5
M\_\ [#'_ #$?^W3_ -N*/C[_ ,CAI/\ VX?^EDE>B_M2R65SIT=G>$"6XN8U
MMBTHB6.3E3.Y.?W**Q$GRMPP'RDAUMR_![4;K3HM&EU("U14C=HK7RKB2%>/
M)+^>R*"F%R(\D ;]X+AO2M T"#P] EI:((X8UVHB] .O?DDG)).2Q)))))K0
MKP#]M;_D#P?]?\?_ *)GKU7X3_\ ('T__KPM/_1*5\__ +#'_,1_[=/_ &XH
M^/O_ ".&D_\ ;A_Z625[7X^\+:7\1)FTB_3=/%;K/&P8)(JRF2(M&0=QVL@+
MAE,>3%N#' 'SIXQ\!WW[.UU#J5A</+8R7"ATW",MC>1#(OS*^8MVV4+\K;F"
M(=F[TO\ ;6_Y \'_ %_Q_P#HF>K7CC2Y-3\$)'"NYAIEC(1D#Y8Q#+(>2.B(
M3CJ<8 )P*M_LC^)H=3T2.UC/[VUDE2125S\\CRHP ).TA\ D#+*X&=N:\Z^.
M]VD_C'2U1@Q1K!7 ()5OM3OM..AVLK8/."#T(K0_:'\0R>!/$FFZRR;H%M_+
M/1B0'E6<*NY3N$<X*DD*6(Y(#"OH_0-?@\0P)=VCB2&1=R.O0CIWY!!R"#@J
M000""*S_  =XQC\5K-+;C,$=PT4<HR4F"HF^1"5 *B0O&"I96*$AB#@=!7RK
M\??^1PTG_MP_]+)*^@/BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\ D_\ 1,%<
MI_S4/_/_ $#J/VY_^8=_V]_^V]?2'C?1'UZPNK.(@//;3Q*6R%#/&R G )QD
M\X!..QKP7]B[7?L\-YI,R^7/#<>:58[9#N BD7RR PV-& Q[%P" <9U?VS?]
M*TVUM8_FGEOX_+B7F1\1RJ=JCYF^9U' /+*.I%:'QLT1]!\'-9RD%X+:PB8K
MDJ626!"1D XR.,@''85M?LN?\B[9_P#;Q_Z42UY5^W/_ ,P[_M[_ /;>OH#X
ML?\ ('U#_KPN_P#T2]>5?L4_\@>?_K_D_P#1,%<I_P U#_S_ - ZNU\??$^X
MU[78O"UE(]JIS]IN%"F4@P&;RXB<[/D_Y:??#D%0 G[SFOVK_!=IX8T:,6D0
M0R:BC2/DO+(QCN6W22.6DD.7;!=B1G P*V_B7_R(T?\ UX:9_P"A6]=5^RY_
MR+MG_P!O'_I1+7E7Q]_Y'#2?^W#_ -+)*/VKK:;PWK&G:[L\R"+R5P"P^>&9
MIMC-M*KO5OEZD[7.W"\_4MI=I>(LL3!T=0RLI#*RD9# C@@CD$<$5\U?LY:(
M^H>(=7U6(AK7SKJ)9!DJ[27 E!1@"C (F6P<@.AP0V:S_C[_ ,CAI/\ VX?^
MEDE>J_M1_P#(NWG_ &[_ /I1%1^RY_R+MG_V\?\ I1+7JM>->,O@_I'QC$UT
MF8;N.::!YD*[P\#/%B1 2K#[K#.V1H_+&Y5P*X#X-Q:C\+/$"^'+J4S6L\,C
M0?/^["CS)5E5#N*$E)%= 5!8EB7"HQA^/O\ R.&D_P#;A_Z625ZK^U'_ ,B[
M>?\ ;O\ ^E$5>*ZMX9FUOP':/ -WV>XEG< ,6V":YC8@ '[OF!FS@!%8D\8/
MO7[/?BA/$6AV;I@&*%8'4,'*M"/+YP!M+*JOM(R PZC!/E7Q4T1_$_C/3XK4
MAC;PVTLV,D1K%/),P?:&VDJ5"[L ETY 8&L_]N?_ )AW_;W_ .V]?0'Q8_Y
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M)'2RU69+.20L81!"S]"$(>7S4#?=WLL8WA0"!A=HG[,<-AJZZQ8W<UOC>S(
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MLR2[2P#;$=$)W!U=7<&KXD_9HMO$MT+^ZOKY[E=FR020(4V<KL"6ZA,'YAM
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M-QYGDJ3E@@"Y=G'\0 (7;ZK7E7Q5_9[M?'4RWT4CVE\FW;/&.I4J59U!4EE
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M6B>-[#7G,5G=03N%+%8I8Y&"@@%B$8G&2!GIDCUK:HKR75/C2EUX@M-"L7#
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MUX[A@5(Z@@@\BNP_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\
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M-RT[$_O2[@D[#]W"[1MV^RZ!HPT6!+97DD"+CS)7:65CU+,['))//8#HH"@
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MW*B5Y[V59F<!VE4Q1$JY;)<9=SALC+-_>.?3_AM\(;'X=>?]@#C[1(&;>Y?
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M4OE<;<')R,8P<8Q7SAI>DPZ1X_6"VC2*)<[4C5409T\DX50 ,DDG'<DU]/\
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M\J1)=N<[<["<9P<9ZX/I7RU\8O#UMH/BW28K.&.!"UBQ6)%C4L;MP6(0 9P
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M'.FWLUJ[NR*;:5XF9F)5HU,;G)).TJ,9)P1VKYU_9WM$L_%NJ11*$1%OE55
M5547<0"@#@ #@ < 5]7T4444444444444444444444444444444444444444
M4444444444444444444444444444444445X!^VM_R!X/^O\ C_\ 1,]>G_#*
MV%UHEC&V0&TZV4E69&P8$!PR$,I]"I!!Y!!KYKMO"45EXZ^Q0-)%&68DK([2
MG?9&27]XY>3+EFRX;>-Q*,K!6&U^UI\+]/\ #6FVMQ8P) T=P(?D55WJT;-E
MVQO=AY0PS,3\S$Y)R/2_$VCV_BCPV=3OH89KPZ*9/.>*,R!C;&3*G;\N'8L
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MS(_DN$CC=6)8G]VV-P/SC:6+;5(/VY_^8=_V]_\ MO7T!\6/^0/J'_7A=_\
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MKT_X.^"+"UTZPO([6!;@V5NQF6*,2[FA7>V\+NR<G)SDY.>M>BU\P?M2WO\
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MM]J\M0% 55D"[0N"%4*21G-3XV^$[/3O%6EVL%O#'!)]BWQ)&BQMNNI%;<H
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MM'&!CCR@V4&1A=V/D!%KX>>-+NY\(G49)2UU'97K+*P#-NB,RQL<@AB BY+
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MR9F91DYBDVB1L!225*JQ.554#DYP*V_@%XQD^(T:ZK<#YX+=;3G /FY$EU(
MJJNV11;D CY&1U4 9:3U^L7QOHCZ]875G$0'GMIXE+9"AGC9 3@$XR>< G'8
MUX?^Q]\2X;VQ_LB5D2>"1O)4E5:1'+RG:"Y9V5@Y;:H"ILZG)KV7Q-XYBT:>
MWLD ENKB9%6$2(KK&=[23D,=VQ4C<\ [F 0<MD?.OQ&9_ GC6WU2Y ^SW+1;
M7+%$56A%I(6=EV@IGS& )&TKDKNX^JKN[2S1I96"(BEF9B%55 R6)/  '))X
M KYP_8E\,S65K=WT@Q%<21)'D,"WE>9O89 !7,FT$$_,K@XQSD_\U#_S_P!
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M@:1CN:0*J.K'@<A7"DG<6*[F8EC7I7B'6TT&VFO)02D$,DK!<%BJ*7(&2!G
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M920,XKP^VNTNOB%NC8, S*2I!&Y; HZ\=PP*D=000>17U?7*_%C_ ) ^H?\
M7A=_^B7KRK]BG_D#S_\ 7_)_Z)@KE/C[_P CAI/_ &X?^EDE>J_M1_\ (NWG
M_;O_ .E$5<!X+^*7_"M?!MI>+'YDKR3Q1*?N!VGN&#/R#M 0D@<L<+E<EE]%
M^%_@=-9MK75]4<WM[)#',KR@>7#YBQ.%AB'[J,KL7+JH=F!8L VT>2?L,?\
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M@0D9 .,CC(!QV%;7[+G_ "+MG_V\?^E$M>5? +_D<-6_[?\ _P!+(Z/VY_\
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M%%%%%%%%%%%%%%%%%%%%%8J^$((KLZA$#'.ZJLI0X655#!!(IRK%=V5< 2
M)O\ ++(=JBL75O"$&L3Q7-R#(8&#PQL?W22#</-V# 9\-@%]VS ,81BQ;:HH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHJ*[NTLT:65@B(I9F8A550,EB3P !R2>
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MC9VG.TG!!!P>*Z"HFNT5Q$6 =E9E7(W%5*AF ZD LH)Z L,]14M%%%<UXO\
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M)7DP6!;RO+V*<$ KF3<00?F5",8Y]?\ B#\']/\ '5JEE<Q[$BQY+1;4>(#
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M1FAOKN:YDODD$DUPLAC:9P589 !\I5V[8UA*%$P-Q*AAY)H.@Q:#X^%O;@A
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MB@R,0J!5&>!TKV"?]F6QU&:&^NYKF2^20237"R&-IG!5AD 'RE7;MC6$H43
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M$9&&::<K(KKR 6CV,1@')67[Y#5U?QXUA_&^K6?A*%PL4K)-=.LA#[5#N82
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MR.IV*27*XR7$;;@$*O;^.GPP'P:N[36]%RD0F ,99BJ2*,A<[Q(R2H'#KDX
M8%L.JCH/VL-/LM9TBTUN"$)-<30'S-H65HY+=W"R;20Q 1 ,EMN,*<$Y]E\&
M>%+7Q1H-A;7T231&PM?E<9P3;JNY3U5@&(#*0PSP17BG[#'_ #$?^W3_ -N*
MY_X;^$O^$K\5:K:O*\<#27QG5/E::(72Y@+##(K,5WE?F9 R9 8D:W[1?P!M
M_!-O'K&BAX/(DC$BK(QVY;Y)U9W+A@Y5<*3U5@%VL6^BOA9XU_X3?3+?4"NU
MI8_G&, .K&.3:-S?+O4[<DG;C/.17S_^PQ_S$?\ MT_]N*ROBYX8@\/^+M,6
MW#_O)+"1VDEEF=F^TLF2\KNWW44 9P !@5[5^T%XVFT:W@TZQD\N^U&X2WA?
M++L!91))N"-C&Y5XPXW[TY2M;2_@)HNGVJV7V.&11&4,DB*T[9SN8RX#ACDD
M%2NWC9M  &3\!/AEJ'P[CN+.\N$GM?,!M0N[*C+^82&4;-V5;8K.H;<0<DEO
M5:**********************************************************
M*****************^5?VY_^8=_V]_\ MO7U57RK_P U#_S_ - ZO5?VH_\
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M,\;("< G&3S@$X[&O!?V+M=^SPWFDS+Y<\-QYI5CMD.X"*1?+(##8T8#'L7
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M:RM;N^D&(KB2)(\A@6\KS-[#( *YDV@@GYE<'&.?I2O /VUO^0/!_P!?\?\
MZ)GKU7X3_P#('T__ *\+3_T2E?/_ /S4/_/_ $#J]+_:1^,\GPWM8TM5S=7/
MF"-R 4C";=[D'[S?.-@(VYR6R%V-+XM^&<&C:5?7=P3=7_\ 9UV&NYOFDR8I
MB1&I)6!/WC )%M&T@'=C)\Z_9LTN35_"NI6T"[I99+R-%R!EFM8E49) &20,
MD@>IJW^Q+XFA>SN=/SB=+CS\$K\R.B1Y49W':R?-Q@;DYRV!B?MRW:,^GQ!@
M75;EF7(W!6,(5B.H!*L >A*G'0UT'[84T^C/I>JPJ&%K<R'+?=\S,4D:D!@Q
M!\ELX[#&02,^W^!?'5KXXM4O;)]T;<$'AT88W1N,G##/(Y!!#*2I!)H7C&/6
M[JYMH!N2U\I7E&2GFMO\R$';M+1JJ%\,<&0*P4@@]!7E7[4?_(NWG_;O_P"E
M$5'[+G_(NV?_ &\?^E$M>5? +_D<-6_[?_\ TLCH_;G_ .8=_P!O?_MO7U51
M7SW\//&+_'F[O!,\D.EVZQJMHC&-IO-$J[II(V#XV@YB5MA)0$ML)DX_XTZ3
M#I'BO1X+:-(HE^P[4C5409O92<*H &223CN2:^M**\%\3? +2/B] FKV#&VE
MN5$ID3:Z,S;=XDC#;=XPRML93YA8N7(KBOA7)JUH-7\(WA,TJ:=-Y ,H95/E
MK&B(6QA'66,J"RB,+RBEFQT'[('Q5@N[0:),P2XA:1H1C'F1L3(V"2=SJS,2
M,+\F" VUR/;_ !7XQC\/M!$1OGN;B.**(9WL"Z^;( JL=L<9,CD@*  "RE@:
M^>_A_P",4^'/BK4[&_>-(KR9I?-+!41CNN(@SNR!08Y65N"3)M"G&2?HKQCX
MQMO"%L]Y>.$1%8@%E5G8*SB--[*&<A3M7.2:\Z_:-N)+GPO<23Q^5*T=H7CW
M!]C&>$LFX<-@Y&1P<9%6OV7/^1=L_P#MX_\ 2B6O*O@%_P CAJW_ &__ /I9
M'1^W/_S#O^WO_P!MZ^JJ^5?^:A_Y_P"@=1^W/_S#O^WO_P!MZ^JJ^4/VB+"?
MX;Z];>)K8%TD9?,';>B"-XLF,J@D@X4G<V1(PQM%?0OPU_TNU^W'[U[(USGO
MLDP+<,!P&6V6)&"\;E)RQ)=NJHHKY0^(S/X$\:V^J7('V>Y:+:Y8HBJT(M)"
MSLNT%,^8P!(VE<E=W'U5=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %?.'[$OAF:
MRM;N^D&(KB2)(\A@6\KS-[#( *YDV@@GYE<'&.<G_FH?^?\ H'5]545\MZM;
M'2/B!%-<8C2=0T;,R@,#9M O?@F52@!P2<8!R,_4E?*O[#'_ #$?^W3_ -N*
MZ;]L^Y%Q86EBF6N)KU6BC569G"QNC8P#D[I4 '4EN <''M_A/0O^$?L[>RW;
M_(MXHM^-N[8@3=C)QG&<9./4U\X?&2V.M>,],AML.\:VC2*&7*B.>6=\Y/!$
M7SX/)!& <C/U)17RK^PQ_P Q'_MT_P#;BNK_ &UO^0/!_P!?\?\ Z)GKU7X3
M_P#('T__ *\+3_T2E?+_ .RUI<FKZ;KMM NZ66TCC1<@99H[I5&20!DD#)('
MJ:[O]D#XJP7=H-$F8)<0M(T(QCS(V)D;!).YU9F)&%^3! ;:Y'M_BOQC'X?:
M"(C?/<W$<440SO8%U\V0!58[8XR9') 4  %E+ UT%%?*OP"_Y'#5O^W_ /\
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M==@AE#2[=IN#G;Q("@.\A,,%3BK2T2S^("Q1*$1%"JJ@*JJ--P% '  '  X
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MEKHU^TC!0;*X4%B -S1LB+SW+$*!U)( Y->(?LV:7)J_A74K:!=TLLEY&BY
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M<SXS_98CU.^;5--O9K&XDDDD<J"_S./F*$/&Z9RQ8;F!W84*HQ47B;]DV#Q
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M^!G&3@  <DXW,S'E/B'^SQ;?$"83W]W>-MW"-%>!8XPQR551!]!N;+D!0S'
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M/F0YP2 VUAU5@&!*L PSR!6K11111117'V/Q>TG4;N/3K>ZCEN)5+(L1,JD
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M[*'8!F" %MB_><C(X4$Y( &2*T-)U2/5X8[F!MT4L:2(V",JP#*<$ C((."
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M-D2+=C&[&\C.,C..F1ZU+IOB&VU0(UO-'*)%=D*.KAE1@CLNTG<%9@K$< D
MX)K0K/UOQ#;:"@EO)HX$+!0TKK&I8@D*"Y S@$XZX!]*BTOQ99ZNJO;7$,JM
M(8U,<B."X0R% 5)RP0%BHYV@G&.:T+N[2S1I96"(BEF9B%55 R6)/  '))X
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M111111111111111111111111111111111111111111111111111117QA\?\
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MT:M H58F9"(P@/R!1C=EVW2,[MX_^R'HB>*X+RRO29+2&:WF%OP(FD;=\TF
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MZ/VY_P#F'?\ ;W_[;UVO[9.ER7NBK)&N5ANXI)#D#:I62('DC/SR*,#)YSC
M)';? 3Q-#X@T6S> Y\JWC@<$KN5XE$; @$XS@,N<$HRD@9Q7A]M=I=?$+=&P
M8!F4E2"-RV!1UX[A@5(Z@@@\BOJ^O*OVH_\ D7;S_MW_ /2B*C]ES_D7;/\
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M[@9Z#.20,FN*_9&\,S:)HH><;?M%P\Z A@VPJD:D@@?>\LLN,@HRD'G \_\
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M'U#_ *\+O_T2]>5?L4_\@>?_ *_Y/_1,%<I_S4/_ #_T#JB\#L_@+QM<PW8
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MIF#((.2%.8\EB4))-<_HW[.5OHMZ^IVU[>I=2-(TCAK;#&0EGRAMMA!;G!7
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MG[223A6\R,[0"  VYN,ESGCV3X9_"JR^',!M[%3EVW22.0TKGG;N("C"@X4
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M?!!')<CS2W/F=JROAG\$X?AR2+*ZNC$S;GAD:%XF;:5W8$(93TR492VU0VX
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M0.RL" [QDLR=<J,'.U@P90:]5M+1+-%BB4(B*%55 554# 4 <  < #@"N?\
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M&,JG'#[F8DX.XLP8,&8'M?!?A"#P=:16%H"(HE(7<=S$DEF8GU+$DX  )PH
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M:T***^9?VE/BC<ZI>Q^%M-<1F=H8[B0EE.Z8@+"3MX3:RLY7<6#;. '5O=?
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MB25Y,%@6\KR]BG! *YDW$$'YE0C&.?7_ (@_!_3_ !U:I97,>Q(L>2T6U'B
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M+E58MGJ_B#X6TO6(TGUA(3%;R!U>9@B(20,%B5!5C@%&RCG:&4X%=5117/\
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M(;;04$MY-' A8*&E=8U+$$A07(&< G'7 /I1HGB&VUY#+9S1SH&*EHG610P
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MHD=@B@R,0J!5&>!TKZ ^.GAB#6])NVG#GRK2XD11+*B;E0NI9$=5DPR*0'#
M$<#DY\?_ &2O MKXDTMY+Y//2._D*0R?- &\B)3(8\;78JV 9-X3 ,80ERV5
MX+TY?!OCJ2RLOD@E\T,F$QM>V^U>6H"@*JR!=H7!"J%)(SGL+_Q':^/M<NX-
M1$EQ8:<T20V\5M=S(9\_O)9?)5LE&1XU613&ZD[0?G+\_P#&CPY# ;;4O#%I
M=0:A#,!B"PN8$,95R696MU1B&PI_O*S*X90-O2_M/>,;I/#L$R![9[N2!9XN
MCJLD,DCPL2JL/F4*W"D@%2,%E.UX7\$^&/B5IWEV$$ 0PHK%%C2\A/(7>WS2
M!P4/+%A)@DF1"<\U^T1+=>"O"]I9))M?_1;6<QGAU6W?>H) ;:S1C/0LN5/!
M8'I?"_@GPQ\2M.\NP@@"&%%8HL:7D)Y"[V^:0."AY8L),$DR(3GTOP1HCZ#8
M6MG*07@MH(F*Y*EDC5"1D XR.,@''85M45\@?&WPG9Z=XJTNU@MX8X)/L6^)
M(T6-MUU(K;E "G*@ Y'(X/%>X?%GX;Z>NC7B1P")([:YE6.$O;Q&18]RN\<+
M(DA#1H1O#8QQWKQ3]FKX1P>/]*G&H22-;K<RK% C>6J2F*+=<9'WW"E50."B
M /\ *V\X[#Q/\ +V.YTK3[-O.T:UD$DJ3.A^;SWED,BA%\S<C>7& K ?,&"!
MF9HOVS[:"RMK2^3"7ZW*K%(K;)O+57=L8()"R;"#SL9N"N\Y]:T+3%\>:/:?
MV@7?S[2!Y=DDD&\O"-X;R6CRIW'*?</]W@8^</V/O"$'B<7T=V#)"K6;&'.(
MG8-,R&0#!<*5X1B8SG+HQ"%;7Q#T.+P)XRT]M.40B=K0LBHBQJ))&MI%50H"
MAHU.>IW,S @XQT'[0GB^"Q\0Z?;:L2^EQPK-)#C<GF,T\:R,HP7"E5)4[OE#
M@*=[*WHNJ_!_2?$HM-0TJ.V1[>[@FCEM_+2)U29/.1C$I5_E5MO=7 &Y07!R
MOC)\-=3\9ZMIQ38^EQ21R3QNR[ R.6<NA&9-\>$0?, =P(169FYK]L^V@LK:
MTODPE^MRJQ2*VR;RU5W;&""0LFP@\[&;@KO.=KX@?$NZ71=,MX)=NI:M':1I
M+]S:9%C\Z7*1D+RX7Y=K+OWQ\IBNVTOX":+I]JME]CAD41E#)(BM.V<[F,N
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M%*ECDJ_2^.O MKH_A5[*]2'_ $6PR"/E07*QG;(APIW-,>#P9"Y5@=Y!Y_\
M9:5?&NAF#5%2ZCM[MHXEF1)0BK%&5 W@_=\Q@I.2JG:"%  \_P#V-?"=GX@^
MW_;;>&?9]EV>;&DNW/G[L;P<9P,XZX'I7HOQ,\2P^*M<&@W32/I\%MYUS!##
M<R/+*2/+C<VX+A%5XY00-F[Y7RVW9B_&KPCINIV7G:+97,.H02(\!M]/N[8D
M[UW;B+=%.%RZDD,K*-I&6#>U?"S6[K6],MY]0B>*Z,>)4D78^Y&*%RNU-N_;
MO P  P R,$]517R!^V5X3L_#_P!@^Q6\,&_[5O\ *C2+=CR-N=@&<9.,],GU
MKZ?T_P"'VGZ9O-K;0P,\;1L\$:P2;6QD!X@CCH#D$$$ @@@&OF70=!BT'Q\+
M>W!"!G;YG>1BSV+2.Q:1F=B78DDDG)KU#]K#PQ!>Z-/>2!S+#Y'E_O91&I,R
MH6\L.(BVV1EW%2V#C/ QG_LY?#JRUS1;.YOHA<L%N5C68"2*-3</N"1D; 2R
M[BY!D.=N_8%5>*_9<A/AWQ#J>E0L3;HLXPVTLQ@N%CC8D*.0KMG& 2<XX&/1
M?!'PUU-/$EYJ^J;)(!&\=HY96*J[@H$4#,>R/<CDA26=B"X9F/G7Q(NT\*^,
M[,Z8PB>X:U6[$9&&::<K(KKR 6CV,1@')67[Y#5M_MH^&($L8;_#F<W:1Y,L
MK(JM#(6"QLYC3)C0DJH)(R223GM? WP?T_Q#H]L]Y'YTT^F6T9FDVR21J8?D
M$.Y2D6S>=I1020'D+OECYI^QEXI_LVSU+[0^VUM_*G/RYVY27S6^4%C\L2\<
M_=^49)SVOP:\(0_$99?$>KQI<274DBV\4NV:."W20JL85D50VY6RP!R,-PSR
M;K>K? >;2]:MM7T)X;2$;%NH5#1JZ!AO"JJLAW)QMP@#JL@.\[ES_B9XEA\5
M:X-!NFD?3X+;SKF"&&YD>64D>7&YMP7"*KQR@@;-WROEMNS%^-7A'3=3LO.T
M6RN8=0@D1X#;Z?=VQ)WKNW$6Z*<+EU)(964;2,L&]J^%FMW6MZ9;SZA$\5T8
M\2I(NQ]R,4+E=J;=^W>!@ !@!D8)ZJBO%=8^&NIZUXIAU&YV2:9;QEH0S*0C
M&/;M"8SYOG8DWD8VJO[S<JH/.OVN[M/"NHV.HZ>PAU#;*TCH0)"J[%B9UZ$$
M;TRPPZ@HVY5P/2OCCK;Z]=V7A>VD,37K%[IE)1A;('+H#Y;#,@1P,'JFUQLD
M-=!K_P  M(U*R>QBM((2T.R.98E,J,!\C[QMD8@@$Y?+\AB0QS5^%7PMGTS3
M%TW7_(O1%,3"&7ST2,( B_O8U.5)<#@[5(4': H\/_8U\)V?B#[?]MMX9]GV
M79YL:2[<^?NQO!QG SCK@>E'[:?AB#3)K.YC#^;/]I\QGEEEX4QLJJ)'8(H,
MC$*@51G@=*]U^.GPCA\?V,H2)#?)'F"7:OF90EA%N++\K99<,=BEM^,J*\U_
M8IN[6ZM;A%@1;N&0;YPOSO'+RJERQ;AHCE0%3 0X+EFKT77_ (<6'B[6DN)(
M(W%I"YN"8XV666942&.3*MO,<2%RK$,@D@9<JQKSK]M'PQ EC#?X<SF[2/)E
ME9%5H9"P6-G,:9,:$E5!)&222<]?J7AZVU3PE'+<0QR/#H>Z)G17:-OL@.Y"
MP)4Y4'(P<@>@KBOV1/!%AKVE32WEK!.XO9%#2Q1R,%$4)"@NI.,DG'3)/K7%
M?&+X?6GPY\0VMW)#'_9EQ,DC1LI,2;65;A=B,68+N$@7 0[A&$9%*GZ5^+'A
MZVNM)DLS#&0RQP6RE%*12S$6L#@8^0(THY4;E7.T$X!Z7PSX4M?"\(MK&)(8
MACY4&,D +N8]68A0"S$L<<DUJT45E>)O#$'B6$VUT',39W*DLL.X$%2K&)T+
M*02"I)4]QP*^5?V-?#,.O?;UNAYD*_9286"M"Y/G[6=2#OVX)52=@8[RI=8V
M0^)WAQ/!?B^Q&F'[-]H^S9\M(@L?FN]K)Y:&,H,H,_,K?.Q;T ] _:,^%FF:
M/H5S<06Z">.2.03'<TY:2=0Y>5B9),B1LAV8=#C*KC/TSXL3^%O!5O?"0"Z*
MFW@+)N&5F>-1@#;E8(R06X)4;MQ.&Z#1/!^@6=L8+FSGN99%/GW$NG:@\TDC
M*%DE#O"\D98Y;".-K$E<'FLK]F<7^@7=YI4D-T--5I)+.6XCDC 42[0HWQ)S
M(K!ROR@%6(0%F-><_'+P>ND>*+"&Q=XI9OL;>=(\ETXE-PT:R'SW<MM"+A2=
MN% XKWOPY^SMIWA[4(M5@:?[1$K;B\OF"5W5T>63>I8NV\D[2JYP0HYSYI^R
M[K;_ !#U&_UC40)+J-8%A;G;"C^=N2-22%&% SRV"V6)=RW-?&/PQ;Z/XPL_
M+C1DO)+5YHWCC>(F69H)/D9"OS*NXD@MO8N"#C'I7Q>UJ#3KJP\-6W[BTG\R
M2ZBMX)6<P#+B)5MP&"RLLBR>6-P'S-A"P>A\1? VA:KIDMM9V$\<\<)-NT>G
M7D<ID1#Y:M(UMEPQ^5_,)SG<2& 8=+\(;.Y\<Z*+7Q!%<I)'(\3^8\]O),FW
MY6;9Y3,I60HP8L'*%F);IX5^RE\/H_&WVV&[=S9K]F,MNI*+,W[[RB[J0^U,
M,P0$!G*L3\@!VOC7X5MOA+!I^EQR3R:;<7LL]Y$S+OE6/[,"F4$7&T$@9 W$
M,3E5*^JZ_P#"C0OB=ICG28[57*YAF@5(BLNS<BR&--P'S#S(V7< <[0X4CV6
MBBOFOP%]G^.FM7E[>?OK&Q\M+2!MWE_,Q(FQ\F=WDDLDBMD.$;(C45#^T;\+
MD\$I%XAT)!:S6\R^;Y0"+M8+&CA2VP -A&14(D$A+@@-GV#PW<6_Q6TBWFN<
MLD\(,JQ//;J7VM'-&=CJ[('WKM8LK  _-P:^9?V4OA]'XV^VPW;N;-?LQEMU
M)19F_?>47=2'VIAF" @,Y5B?D /U)\+_ (7VWPWMFL[-I'1YFE)E*LVXJB$#
M8B#&$';.<\UV%%>*^"/AKJ:>)+S5]4V20"-X[1RRL55W!0(H&8]D>Y')"DL[
M$%PS,?.OB1=IX5\9V9TQA$]PUJMV(R,,TTY6177D M'L8C .2LOWR&KT#XAS
MCXD:Y%X;WD6=O";F^169#*<H8H>$R0"R,<-@AS@K)&I&U\3_ -GS3_%%C);V
M5O;6USPT4J1+'AE/1C&%)5AE3G<!G?M9E K/\6>,+WX4^&PVHS";40I@CD4E
M@TC,_E-EH_F*1#<2Z_.4(9BS9,7P2^#]K<:?'J&JQI>WEY''-)+<?Z20I7]R
MBF521B,KNZDMD;BJH!Y5X3\-Q^%O'$6GVY?[/!YHA5V+[%DM))S&I/10\K8'
M7G+$L2Q/BYX4M?#?B[3$LHDA222PD9(QM3=]I9,A1\J_*BY"@ G)(R23ZK^U
MAX4M;W1I[V2)#<P^1Y<N,2*#,J%=PP2N)&^4Y7)W8W $6_V<-,74_#-I#(7"
MMY^3'))"_%U*>'B9''3G!&1D'@D5Y5^S9I<>D>*M2MH%VQ11WD:+DG"K=1*H
MR22<  9))]36U^T)XO@L?$.GVVK$OI<<*S20XW)YC-/&LC*,%PI525.[Y0X"
MG>RMZ+JOP?TGQ*+34-*CMD>WNX)HY;?RTB=4F3SD8Q*5?Y5;;W5P!N4%P> _
M;1\,0)8PW^',YNTCR99615:&0L%C9S&F3&A)5021DDDG/7ZEX>MM4\)1RW$,
M<CPZ'NB9T5VC;[(#N0L"5.5!R,'('H*Y#]CGPG9ZCILEU/;PR3QW[[)7C1I%
MVQP,NUB"PPQ)&#P>1S7*?MI^&(-,FL[F,/YL_P!I\QGEEEX4QLJJ)'8(H,C$
M*@51G@=*]:_:C^*+^"=.$-LY2ZNF*1LI(9$7!E<':1G!5!RK OO4Y2M;0_V;
M]%L+);&:UCE)5/,F(82NX"[G#[S)&&*YV(X49(Q@G/E_[/.NW7@36;CPK>R[
MH5\PVX(R=PQ*"NUF"*\):0HQ(## (<L&Y_\ ;3\,0:9-9W,8?S9_M/F,\LLO
M"F-E51([!%!D8A4"J,\#I7L'Q:^#^GOI-_,\>^Z^SR3M=/M>Y:2) X^=E.Q3
MY84I&$0*2J*@/'%?L\>*;BU\)WTJ/A[3[;Y!VJ=FV!9QP1AOWCLWS9ZXZ "H
M?V9I="\4VGD7D4$VJ&:5IC<HDLTS,6<.AEW,XV#Y@O(969E&[<WLOPM^&L?P
M^2YMK?\ X]Y+MIH5+%F56BB4H20.CHP7ECLV[F+9KM:*****************
M**********************************************************^5
M?C[_ ,CAI/\ VX?^EDE>@?M<^&9M;T4O -WV>X2=P Q;8%>-B  ?N^8&;. $
M5B3Q@]+^SWXH3Q%H=FZ8!BA6!U#!RK0CR^< ;2RJK[2,@,.HP3Y5\5-$?Q/X
MST^*U(8V\-M+-C)$:Q3R3,'VAMI*E0N[ )=.0&!KZ:HHHKY0_:(M$O/%NEQ2
MJ'1UL596 964W<H*D'@@C@@\$5+K$4G[-NJ?:+6-Y='O=@D7 +1LI<B-7)SN
M0$L@? D0LA)9#*OU+:7:7B++$P='4,K*0RLI&0P(X((Y!'!%?+7P"_Y'#5O^
MW_\ ]+(Z/VY_^8=_V]_^V]'[5UM-X;UC3M=V>9!%Y*X!8?/#,TVQFVE5WJWR
M]2=KG;A>?J6TNTO$66)@Z.H964AE92,A@1P01R"."*^:OV<M$?4/$.KZK$0U
MKYUU$L@R5=I+@2@HP!1@$3+8.0'0X(;-:W[:'A ZGIT-^@)-K,0W*A1'-M4L
M0>2?,6,#:> Q)!'*]5\/];B^,</VJX >!+;[.\8WHIN)H5-V0"2P"HXBB<$.
M ]P,LK*Q\5_9^N9[*YNO"DN7!O5:1D7="J6['[5O)"LR3>5'!AL+M<Y&3LD^
MQ*^5?@%_R.&K?]O_ /Z61U%\/_B GPV\3ZG9ZEB**\N6;S#@A6,C2P,S!L*C
M1S'<2"5)7=L <CZ?U_7X/#T#W=VXCAC7<[MT Z=N22<  9+$@ $D"OF#]L))
M]8L-+U%X3$"LGFHQ^:.2:.*18B"%8D>6X)VC!7G!(%?37A3Q-#XHM8KZV.8I
MHU=>5)&>JMM+ ,IRK $X8$=J^9?V=[M+SQ;JDL3!T=;YE92&5E-W$0P(X((Y
M!'!%=K^TSHUEXNGT_2)'$=[-,WE2EP$BC./,WIG+F0J%A7Y=\BX$B@,K=7XA
M^$][XP2"UU6_$MI&RM-%#;FV:X*@;?,<3O@;AN(15!). K!&0_:&T S^';NV
MM$ $<,3*B[458X9(Y&P.  L:$@#L,*"<"LG]F/XJP>+-.BL2P6[M(5C>/&W,
M:82.1<D[AMVASQA\Y559,^BZKXQCLKVWTY1OGGWLRC),<2HY\YL*0%,@6,;B
MNYG^4DJ17045XK^USX9FUO12\ W?9[A)W #%M@5XV( !^[Y@9LX 16)/&#TO
M[/?BA/$6AV;I@&*%8'4,'*M"/+YP!M+*JOM(R PZC!/E7Q4T1_$_C/3XK4AC
M;PVTLV,D1K%/),P?:&VDJ5"[L ETY 8&MO\ ;6_Y \'_ %_Q_P#HF>O5?A/_
M ,@?3_\ KPM/_1*5U5%>5?M1_P#(NWG_ &[_ /I1%1^RY_R+MG_V\?\ I1+7
MFOQ.TYO%OC6Q@M/F:TCMGG)#[4$<KW!R0IZHZ!3]TNZJ2#G&?\/_ (@)\-O$
M^IV>I8BBO+EF\PX(5C(TL#,P;"HT<QW$@E25W; '(^G]?U^#P] ]W=N(X8UW
M.[= .G;DDG  &2Q( !) KE?&^I/JGAZZN)8S"\FE3NT39W1LUNS%#D*<J3@Y
M .1T'2O.OV*?^0//_P!?\G_HF"N4_P":A_Y_Z!U5?ACJ*^$?&M]!>_(UU)<I
M&24VYFE2XAR=W\: !0,MO95P"3CUK]JJ[2#P_=*[!2[6ZH"0"S>?&^T9ZG:K
M-@<X!/0&I?V7/^1=L_\ MX_]*):\J^ 7_(X:M_V__P#I9'1^W/\ \P[_ +>_
M_;>OH#XL?\@?4/\ KPN__1+UY5^Q3_R!Y_\ K_D_]$P5G_#;PRGB#7-0UG0;
MJ.!$F>&2.11=B9G.^6;"R1F.%Y &B*R,7*MRJ?NZ]0\)?"C^S[Z75]0F^V7S
M_+$YC\J."+'^KB3?)MZD%MQ8@GNTC/W]%%?&OQ>TN3X3>)X=91=MK/<><-A$
MCD$*MXFV0\,V]B.0H#C8RD$)]BVEVEXBRQ,'1U#*RD,K*1D,"."".01P11=W
M:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %?*'[3,\VF:IIGB+R7^SIY0".&C?=!.\
MRA_E;R_,1@4#?O  V^-64K7U?:7:7B++$P='4,K*0RLI&0P(X((Y!'!%?-7[
M.6B/J'B'5]5B(:U\ZZB609*NTEP)048 HP")EL'(#H<$-FL_X^_\CAI/_;A_
MZ625ZK^U'_R+MY_V[_\ I1%1^RY_R+MG_P!O'_I1+7E7P"_Y'#5O^W__ -+(
MZ/C[_P CAI/_ &X?^EDE?4&K:I'I$,ES.VV**-Y';!.%4%F. "3@ G !/H*^
M3_V;=2?X<Z+J.OW$9>%F@6)!E6=D9DSEAMV;Y@I8;B"K_*2H!]0^$6A?\+.L
MH]9UQOM32R2-%;L,6D(1YH@!#DI(W+?O)0[@;0#E2S>?_ +_ )'#5O\ M_\
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M1^ VN65GYYGL+V81@ ^6CLYCC=C&2^QT9D;<.74!0XRZKH?MS_\ ,._[>_\
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MC&3QEI%K?3C]Z\9#GCYFC=HF?A5 W%"V ,+G SC-=K17RK\??^1PTG_MP_\
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MA'/\)KT7]J/_ )%V\_[=_P#THBH_9<_Y%VS_ .WC_P!*):\J^ 7_ ".&K?\
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M)"GJCH%/W2[JI(.<9_@=G\!>-KF&[  OFN/+<L43;,XN(B"RC>2R"' X\PD
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MC2WCN[F:"./8D<QA8*,@C#+"DAP/E4%BH7@# 7'545Y5^U'_ ,B[>?\ ;O\
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M%)7D54"P_#/X)P_#DD65U=&)FW/#(T+Q,VTKNP(0RGIDHREMJAMP %97Q'^
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M#_-+G;NE;8A7Q7_AAR'SMWVY_(\S.SR5\S9G[N_S-N[;QNV8SSLQ\M>_^!?
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MB&_&_&(5;!YRF[8=S$J6.:\E\3?L2VM[,9+&[>WB.3Y;Q^?M)).%;S(SM (
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M<T<Z!BI:)UD4, "5)0D9P0<=<$>M>:_M#?&E/AY:&*W<?VA,O[E<!]BYPTK
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M.98?(\O][*(U)F5"WEAQ$6VR,NXJ6P<9X&,_]G+X=66N:+9W-]$+E@MRL:S
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M$JC)))P !DDGU-5/VT_#$&F36=S&'\V?[3YC/+++PIC9542.P109&(5 JC/
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MW,;?O?-T^]SUKVKXQ^(H?A+HTTNF1PVTLDBI"J1*J&5\!FVHH7<(D9@6^7*
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MNB>#] L[8P7-G/<RR*?/N)=.U!YI)&4+)*'>%Y(RQRV$<;6)*X/-97[,XO\
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MD6S>=I1020'D+OECY5^R%I,/BVSU#3;^-)K59()%C=5.UY$EC=U;&Y6VHH#
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MO_\ Z61T?MS_ /,._P"WO_VWKU7]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\
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ML7+JH=F!8L VT>2?L,?\Q'_MT_\ ;BC_ )J'_G_H'5]55\J_L,?\Q'_MT_\
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M_8E\,S65K=WT@Q%<21)'D,"WE>9O89 !7,FT$$_,K@XQSD_ +_D<-6_[?_\
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M]_\ MO7T!\6/^0/J'_7A=_\ HEZ\E_8UNTL]$N996"(E[,S,Q"JJB" EB3P
M!R2> *J?L[^#'(N=5T*YC@M+F9D6UFB-VZ+&QV%V2:%D?YF*IEP(W4L\C88>
MJ_#CX5IX2>:\N)3=ZA<,3-=.H5BN?EC102(T  ^4'!('\*HJ=U7*_%C_ ) ^
MH?\ 7A=_^B7KRK]BG_D#S_\ 7_)_Z)@KE/C[_P CAI/_ &X?^EDE>J_M1_\
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MMX;:6;&2(UBGDF8/M#;25*A=V 2Z<@,#6W^VM_R!X/\ K_C_ /1,]>J_"?\
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M78S%N<D'/\3_  *E\66,EMJ-_)<7,BQA9GC188MDN_=';QE$#LA\MI"S/M)
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M@@Y(4YCR6)0DDUS^C?LY6^BWKZG;7MZEU(TC2.&ML,9"6?*&VV$%N<%< @$
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MRM'(SK)$&)W;5/RN692,X'I7PS^%5E\.8#;V*G+MNDD<AI7/.W<0%&%!PH
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M&YY&5$&2 ,LQ &20!GN0*XKP5\<],\;WC6.GN\K+;F8R;&2, .J%/WFU]WS
M_=VX/WLY%5/'7[1.C>#6>*:?S9TZPPCS7SO*,I/$:LI!+*[JP Z9(!]*KBOA
MM\7K'XB^?]@+G[/(%;>A3(;.R1>ORMM; .'&/F5<C/:T4444444444444444
M5Q7PV^+UC\1?/^P%S]GD"MO0ID-G9(O7Y6VM@'#C'S*N1GM:JZMJD>D0R7,[
M;8HHWD=L$X5068X ). "< $^@KG_ (:_$JU^(EK]MLMX02-&RR+M=67!P<%E
M/RLK J2,$ D$$#JJ********YKQQ\2-/\#(DFHSB$2,508=V8@9.%16; XR<
M8!(!(+#-3X7_ !0MOB1;->6:R(B3-$1*%5MP5')&QW&,..^<YXKL*******J
MZMJD>D0R7,[;8HHWD=L$X5068X ). "< $^@KG_AK\2K7XB6OVVRWA!(T;+(
MNUU9<'!P64_*RL"I(P0"000.JHHHHHHHHHHHHHHHHHHJKJVJ1Z1#)<SMMBBC
M>1VP3A5!9C@ DX )P 3Z"N?^&OQ*M?B):_;;+>$$C1LLB[75EP<'!93\K*P*
MDC! )!! ZJBBBBBBBBL_7]?@\/0/=W;B.&-=SNW0#IVY))P !DL2  20*\PN
M/VHM,L9(UN8KR""7<8KF6W98)% R)$Y,C*P*X(3/S*6"@G'K5I=I>(LL3!T=
M0RLI#*RD9# C@@CD$<$5+111111111111111111111111111111111111111
M11111111111111111111111111111111117@'[:W_('@_P"O^/\ ]$SUZK\)
M_P#D#Z?_ ->%I_Z)2I1\2M.:[33DN8WNI&E41(WF,&C!:17V9$9 !X<J200,
MD$5B_P#"_M"^T?8_MT/F?WLGR?N[O]=CR>G^W][Y?O<5W5W=I9HTLK!$12S,
MQ"JJ@9+$G@ #DD\ 5YUI?[2.@:G(L,=Z@9LX,B2PIP">7E1$'3C)&3@#D@5V
MJ^*[7[*NH-*B6KQQR++(?*3:^-A)?;MSN& <') QGBL_P!KVG:M RZ08S;PS
M/$1$FR(.,.X7"JI!W[MRY5LY!-1>-?BGIG@C:-0N$B9L83YGD(.[#;(PS[?E
M(W8VY&,YP*^9?VN/&EIXQ@TV[L)1+$6O5W $$,/L^5*L RGH<$ D$,.""?L2
MO-=4_:1T#3)&ADO4++C)C269.0#P\2.AZ\X)P<@\@BO1;2[2\198F#HZAE92
M&5E(R&!'!!'((X(KGQ\2M.:[33DN8WNI&E41(WF,&C!:17V9$9 !X<J200,D
M$5%X2^*>F>+II;:PN$FEA^^J[AQG:64L '7/&Y"R\KS\RYY__AI'0/.^S_;4
MW^9LSLE\O.=N?,V>7MS_ ![MF/FW8YKNM!U^#7XA<VCB6)F=5=>5)1VC;![C
M<I (X(Y4D$&M"N?\0^/;+P_(EO<2_OY/N0QH\T[##'<(HE>3;A&RVW:,$$YJ
MKX2^*6G>+9I;6SFW3P_ZR)DDAD7!VGY941CAN&P#M) ;!(SM:WXAMM!02WDT
M<"%@H:5UC4L02%!<@9P"<=< ^E<U<?&C2+:RCU*2Z1;:7=Y;$.'?:_EOMC*^
M:V&ZX4X'S'Y>:U?!WC^Q\9QF;3YTF4?> )#KDL!N1@'3.TXW ;@,C(YH\8^/
M['P9&)M0G2%3]T$DNV"H.U%!=\;AG:#M!R<#FOGO]I[XD:?XYT2.33IQ,(]1
MB5QAT928)R,JZJV#S@XP2" 25./>OA/_ ,@?3_\ KPM/_1*5U5?*OQ]_Y'#2
M?^W#_P!+)*^JJX7PWX&LIK]?$-@0HN;(JRK&$602R).LYX5MYYW;@2P*YVE3
MNU=7^(]CI<_V-I"]P%+-##'+<RJHV?,Z0)(R#YUP6 !SQFCP/\2-/\<H\FG3
MB81L%<8=&4D9&5=5;!YP<8)! )*G!XO^)6G>#@3?W,<1"JVPMF4J6VAA&N9&
M&<\A2!@D\ XS_&/QHTCP;((+ZZ1)>Z /*Z\*?F6)7*9# C=C<.1G!K0F^)6G
M062ZH]S&MHZY24M@-PQV@'YB_P K#RP-^05V[@147@KXIZ9XWW#3[A)67.4^
M9) !MRVR0*^WY@-V-N3C.<BI?'FOZ9I<!35W@$+JS>7/L82"/#';&V3(0<$!
M0QSMP,D5MZ3JD>KPQW,#;HI8TD1L$95@&4X(!&00<$ ^HKY:_8CNTLTU.65@
MB(MJS,Q"JJ@7!+$G@ #DD\ 5]"_\+8T?_H(6?_@3#_\ %UJZAXLL].A2ZGN(
M8X)-NR5Y$6-MP++M8D*<J"1@\CD<5+HGB&VUY#+9S1SH&*EHG610P )4E"1G
M!!QUP1ZUH5\Z_M6>#I/&5WIEC ?WKQZD4''S-'#'*J<LH&XH%R3A<Y.<8JW^
MR#\2_P"W[%M,G;,]IC9DY9H6/R]7+'8V4. %1#$HY->_U\5_M0W,WBB>?4 ^
M;.SNX["%0& ,OE/+<L0S<,KJ$+!0KKLP3LR?JKX3_P#('T__ *\+3_T2E5/&
M/QHTCP;((+ZZ1)>Z /*Z\*?F6)7*9# C=C<.1G!K;\(>-+3QC +NPE$L19EW
M $$,.JE6 93T." 2"&'!!-3Q?\2M.\' F_N8XB%5MA;,I4MM#"-<R,,YY"D#
M!)X!QG^,?C1I'@V007UTB2]T >5UX4_,L2N4R&!&[&X<C.#6A-\2M.@LEU1[
MF-;1URDI; ;ACM /S%_E8>6!OR"NW<"*B\%?%/3/&^X:?<)*RYRGS)( -N6V
M2!7V_,!NQMR<9SD5\_\ _-0_\_\ 0.KVO_A?VA?:/L?VZ'S/[V3Y/W=W^NQY
M/3_;^]\OWN*[^N*\8_&C2/!L@@OKI$E[H \KKPI^98E<ID,"-V-PY&<&MOPA
MXTM/&, N["42Q%F7< 00PZJ58!E/0X(!((8<$$U-9^)6G:-.EG/<QBXDFCB6
M$-OEWR8V HFYE!R/F8!>1DC(S%I_Q3TS4+Y]*BN$:\3=NC&[JH!90Q&QF'\2
MJQ9<-D#:V,37_P!H;0] G>TN;L++$VUU6.:0!NZ[HXV7(Z$ Y!RIP0178>'O
M%=KXD5WLI4F2.3RV>,[DW;%? 8?*WRNN2I(!R"<@@:M97B;Q7:^%X3<WTJ0Q
M#/S.<9(!;:HZLQ"DA5!8XX!KGXOC)IC74=@\KQ7,V/+CF@N+<MG(7!FB0<D%
M5Y^9OE&6XKJ]4U:'2(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*Y27XT:1%:R7YN
MD^S17!@:0!R#*,':@"DR<$,"@92N6!V@D;=IXVLKJT74EGC%HRAA,S!(\$[1
MDOC:=WRD-@AOE(#<5RF@?M#:'K\Z6EM=AI96VHK1S1@MV7=)&JY/0 G).%&2
M0*]%HKFA\2M.:[33DN8WNI&E41(WF,&C!:17V9$9 !X<J200,D$5B_\ "_M"
M^T?8_MT/F?WLGR?N[O\ 78\GI_M_>^7[W%=U=W:6:-+*P1$4LS,0JJH&2Q)X
M  Y)/ %<I#\7M)G2YE2ZC:.S6-IY%):-0X)3#@%7)P0 A8[OEQN(%:'AOQ_8
M^);4W]K.CVR[]\A)0)LY;>'"E,#YCN ^4AOND$\K_P -(Z!YWV?[:F_S-F=D
MOEYSMSYFSR]N?X]VS'S;L<UZ+:7:7B++$P='4,K*0RLI&0P(X((Y!'!%?+7_
M #4/_/\ T#J]PM/CGHMY=KI\5Y&\[L%4+N:-F(R%$H7RB3T #9+?)][BNPU3
M5H=(C:>YD2*)<;GD9409( RS$ 9) &>Y K$\ :]IVK0,ND&,V\,SQ$1)LB#C
M#N%PJJ0=^[<N5;.037SK\#;M+/Q;K$LK!$1=09F8A551=QDL2>  .23P!7NN
MB?'/1=;N396]Y&TP8J =R*S;@@5'=0DA+$;0C,6'*Y'-=K=W:6:-+*P1$4LS
M,0JJH&2Q)X  Y)/ %<IX5\::1=&[&GRP8A8373QA5BW2*6,K2 "-R0AWL&8C
M;AR"*\KU3]HVVU7Q!:65M<".PA:X^T3LZI!*_D2!!N.,HK="6VNY! .U'/O6
MEZM#J\:SVTB2Q-G:\;*Z'!(.&4D'!!!QW!%>?ZI^TCH&F2-#)>H67&3&DLR<
M@'AXD=#UYP3@Y!Y!%>BVEVEXBRQ,'1U#*RD,K*1D,"."".01P17'^,?C1I'@
MV007UTB2]T >5UX4_,L2N4R&!&[&X<C.#7SU\7M?@\0^*-%N[1Q)#(M@R.O0
MC[9(._((.00<%2"" 017UU575-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"O
ME6]^(-O>^.(KJ2YA-G#&8XYO,C$*J;1V(\P$*?WLC#)).X[<\ #WK4K?0O$#
MQZW,]K*;1MJW7FH8XV)&%9@VPD,P*!\E&8,F&;)EE^-&D16LE^;I/LT5P8&D
M <@RC!VH I,G!# H&4KE@=H)&W:>-K*ZM%U)9XQ:,H83,P2/!.T9+XVG=\I#
M8(;Y2 W%<?I?[2.@:G(L,=Z@9LX,B2PIP">7E1$'3C)&3@#D@5Z57-#XE:<U
MVFG)<QO=2-*HB1O,8-&"TBOLR(R #PY4D@@9((KG[G]H?0;:?[*U[&7+*N5#
MO%EL8_>JIBQSR=V%YW$8.-OQK\4],\$;1J%PD3-C"?,\A!W8;9&&?;\I&[&W
M(QG.!6KX9\5VOBB$7-C*DT1Q\R'."0&VL.JL P)5@&&>0*U:RO$VK6>G0G^T
M)(8X),QGSV18VW Y0^80IRH/R]QGC&:B\%Z]::]:17&G$&U*E8MJ&-0J$Q[0
MK*I4 J0!@# XXQ6?I_Q5TO49GMX+N&1X[=IW*.&C6)2%9FD&8Q@D9!;<!\Q&
M.:S]$^.>BZW<FRM[R-I@Q4 [D5FW! J.ZA)"6(VA&8L.5R.:ZK7]?@\/0/=W
M;B.&-=SNW0#IVY))P !DL2  20*X73_VD= O]^R]0;(V<[TECR%QD+YB+O;G
MA%R[=E.#7:^)M6L].A/]H20QP29C/GLBQMN!RA\PA3E0?E[C/&,U%X+UZTUZ
MTBN-.(-J5*Q;4,:A4)CVA652H!4@# &!QQBL_P :_%/3/!&T:A<)$S8PGS/(
M0=V&V1AGV_*1NQMR,9S@5\R_M<>-+3QC!IMW82B6(M>KN ((8?9\J58!E/0X
M(!((8<$$_8E>:ZI^TCH&F2-#)>H67&3&DLR<@'AXD=#UYP3@Y!Y!%>BVEVEX
MBRQ,'1U#*RD,K*1D,"."".01P17-:?\ %72]1F>W@NX9'CMVG<HX:-8E(5F:
M09C&"1D%MP'S$8YJ7P/\2-/\<H\FG3B81L%<8=&4D9&5=5;!YP<8)! )*G'0
M7=VEFC2RL$1%+,S$*JJ!DL2>  .23P!7@&J?M&VVJ^(+2RMK@1V$+7'VB=G5
M()7\B0(-QQE%;H2VUW((!VHY]JF\;V$$"WCW4"V[MM28RQB)F^;Y0Y;:3\K<
M YX/H:Y^_P#CCH]A:0ZC+=!;>X9UB;9+N<H2KX0)YF 1@DK@$CGYESJZM\2-
M/TLQ(\X=YU#11Q![B61"K,)%C@61V3:C'>!MXZU%X2^*6G>+9I;6SFW3P_ZR
M)DDAD7!VGY941CAN&P#M) ;!(STMW=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5P
MNE_'S1-5NEL(+Q&G:0QJ-L@1F&1A9"@C.2,*0Q#D@*22,^*?L,?\Q'_MT_\
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M[:F_S-F=DOEYSMSYFSR]N?X]VS'S;L<UZ57RK\ O^1PU;_M__P#2R.C]N?\
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M</&^'7 D'E_NV(+# ,1.591ZK^U5X>MI]%NKQX8VN$6W5)BBF55^T1_*'(W
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MVX# .9 '.>K_ #'GFLKQ3X;C\2^.WLYRXBDVA]C%&918!FC+#G:X!1P,$HS
M$9S7I7[07P)T^^TN:YLK>&WN+6-YE:-%A5E4;I$<(GS9124R,AP/F52^<7X:
M?&"6U\'SWCY$MDK6L3J$8[L1K;MM(5<)YJ*0=Q(0L=Q.*ZKX,3/H6G021:==
M2RW$*2S7.ZP\R=Y,REV=KI)'&9&V>8-P4@'G-8'PX\ :EX9\137=I9&UTFY4
MAXVDA.PB/<&$<4[@'S@0N-P1'8*%!^7S_P"//@ZVL_$^FV=F@M4E6S!-NJP,
MK-=2(9%V+@.!C#8)! ]*]O\ %/P7T[1+::]TRU\J^@L+A+9X#(LF[R)$4@(W
MSRG=C>P:0G'S$@8\U_9;^-FEZ18KI5TR6LZR2-YCX6.;<6?>SX"JRJ GSD9
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MEXGY;*R1NJ*J*6#-%"N$.6\QMK;>BVOV;OV@K.YL4T[4ID@GM8PJO*R1QR1
MX0!CM4,JX4J?F8 ."Q+[?4(?BO;:QJ$&G:9)'<EEDEN'C99$CA564'<KXWF8
MQ@*-Q"EBP4%6KP_X^_\ (X:3_P!N'_I9)7TKXLUW_A'[.XO=N_R+>679G;NV
M(7VYP<9QC.#CT->:^-?@%HWQ/A6^@7R99XQ*EQ$NS?O#.K21D -DN&8D+*<
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M@<!G*$ M@@%L;U%>?_&?7X-7\8Z<MNXD,$UC%)MY"R"Z9F3/0D!AG&<'*G#
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MK*1D,"."".01P14M?+?PKA'AGQMJ%M<,-]PMR8]NX@F5X[M5SMX(BR3G R"
M3QGWKXL?\@?4/^O"[_\ 1+UY+^Q/=HVE7$08%UO69ER-P5HH@K$=0"58 ]"5
M..AK/_:*TM?B+K6G:) KR-%ODNC&4_=12M%N)))VL$0MAASOCVABX%:O[:W_
M "!X/^O^/_T3/7I_PRNTL]$L996"(FG6S,S$*JJ($)8D\  <DG@"O!?V&/\
MF(_]NG_MQ7H'[5WPY_X2K2S=1C,]ENE'O$0//7EE4?*H?.&;]WM49:I?V;-;
MN?%]HNIWP.](4M(RVYMZQ%FDG5G).9"R)+C(9X 23PJ>RU\J_L,?\Q'_ +=/
M_;BCX^_\CAI/_;A_Z625ZK^U'_R+MY_V[_\ I1%57]G+5(](\+V]S.VV**.[
MD=L$X59YF8X ). "< $^@KSKX*76D2B?58M2&ES7,T@>SCEMXXHT#9C79=1R
M!SCYA(@55WM&BH RUZU\*H-#\.;K73;R&XN;B1I)':XBGNIF^9B6*G+8&3@
M ?,Q&XLQ]*KR#]JKP=)XET61H3\UK(MR5X^945UD&2PQA'+]R=NT EA5K]FG
MQU'XHT:WC#H9[:-8947(*!,K$2&)/S1J#N'REMP&"I5> \?Z%_PFOC6TBMV_
MX\;>"6X./N>7*TX7#%=V[S(URN[;OS@[6 U?VUO^0/!_U_Q_^B9Z]5^$_P#R
M!]/_ .O"T_\ 1*5U5<KXJUNU>ZM](O8DD2]CN"JR+YB,T'E/L*%64_*S."Q
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MG&,X./0UYKXU^ 6C?$^%;Z!?)EGC$J7$2[-^\,ZM)&0 V2X9B0LIP 7%>->
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MS75]+"VZ!KR<SB)N[(N%7)X.6#$%59<$9KT6O)?'G[,&D>,IS=NLD$KLS2-
MRJ)&./F971U!XR2H4L69FW$YKL/AY\,+'X?PF"PCV[MID=B6DD*C 9F/XG:N
M$!+%5&37/ZI^SEH>KR-/<V[RRMC<\ES=.YP !EFF).  !GL *["]\)175E)I
MQ:3RI898F9I'EEVR!@QWS&1B?F.-Q8#@8P *X3_AG2RLOET^YOK&+J8K:Z=(
MV;O(1()#N( !.<84<=2>[\(>"[3P= +2PB$409FV@DDL>K%F)9CT&220 %'
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M!I_C:Z34)&FM[I,?O;=UC=BN-C,2C?,N/E88;& 20JA=#6_@CI6NH(KJ*25
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MC < ,Y9JZ6[_ &9_#5FC2RVH1$4LS-<7"JJ@9+$F;  '))X H_9GT1](TZ5
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MJL3O 55<;55H61E P!A2!CY>A(KA=+_9RT/2)%GMK=XI5SM>.YND<9!!PRS
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M8@J[%<8&, 8P/#/P&T?PO,+FQ@>&48^9+BY&0"&VL/-PRDJ"58%3CD&CXI?
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M-Y57&$\Z=(P1NPVR.14W?,1NQNP<9Q@5#X5^$VG^$TDBL4DA216#*MQ<[?F
M!8 RD*^% $BX< <,*RK;]GW1K6?[9'#(MP69C,MU=B7<V=[;Q/NR<G)SDY.>
MM>BUS_C'P':>,HQ!?*[Q=T$TT2-RI^98G0/@J"-V=IY&,FL7PS\$=*\+%VL8
MI(#(I5]ES=*&!5EY FP2 QVGJA.Y2& -9_\ PSEH?G?:OL[^?YGF>;]INO,W
MYW;]WG;MV[G=G.><YK:\5?";3_%B1Q7R23)&JA5:XN=OR@@,0)0&?#$&1LN0
M>6-:'@[P':>#8S!8JZ1=D,TTJ+RQ^597<)DL2=N-QY.<"N@KX[^&/A"#Q9XH
MU>VN00 UZ\<B'9+%(MY&4EC<<HZGD$>X(*D@^]>'?@#8Z7=+?W$ES>W,>WRI
M+N8SF/;N(VC"CJVX;@VU@&3:V2?1;NT2\1HI5#HZE65@&5E(P5(/!!'!!X(K
MR6W_ &8K'3)))-/NKZR63;NCMKDHGRC Y97<]2?F8X+'&!Q7HOA#P7:>#H!:
M6$0BB#,VT$DECU8LQ+,>@R22  HX  Y3Q'\"-/URZEU$M/%>RLI%S#,\4L86
M-(MJ8^0 HI#;E8G>W(&W;;\(?!RT\.3B]=Y[N[565+BZE,\J(?X$R JC[W(7
M=\[C=M8BJGB/X$:?KEU+J):>*]E92+F&9XI8PL:1;4Q\@!12&W*Q.]N0-NVW
MX0^#EIX<G%Z[SW=VJLJ7%U*9Y40_P)D!5'WN0N[YW&[:Q%:'Q#^&%C\0(1!?
MQ[MNXQNI*R1EA@LK#\#M;*$A2RG KC_ ?[,&D>#9Q=HLD\J,K1M.RL(V&?F5
M41%)YR"P8J55EVD9KM?'GP[M/'<4=O?J7BCF$NP,4#,$= "5PV!O)X(.0,DC
M(/'_ /#.EE+^ZFN;Z6SZ"S>Z<VH4?ZN,* 'VI@%!OR-JY)YSU?C'X86/BZWA
MLKJ/_1H)%=(D)B3Y8WC5?DP0H#Y 4KR!_#D'E/\ AG2RE_=37-]+9]!9O=.;
M4*/]7&% #[4P"@WY&U<D\Y[#Q-\.+'Q- EG<QDVZ*%6%))8(MHV[5*0NBL%V
MC:&!"X^7'-9_@[X-Z9X,D,VGQ/"Q^\!/<%&P& W(TI1\;CC<#M)R,'FL_P ?
M_ ;3O&DZWL@D@NU9"+BW?RY3LSLSD,N1QA]N\;5 8*,5;\(?!RT\.3B]=Y[N
M[565+BZE,\J(?X$R JC[W(7=\[C=M8BMKQCX#M/&48@OE=XNZ"::)&Y4_,L3
MH'P5!&[.T\C&365X.^#>F>#)#-I\3PL?O 3W!1L!@-R-*4?&XXW [2<C!YK/
MN?V?=&NI_MDD,C7 96$S75V9=RXV-O,^[(P,'.1@8Z5Z!:6PM46-<D*H4%F9
MVP!@99R68^I8DD\DDU+7DMW^S/IRW+7EC+=6#NI#"TF\E3EMYZJQ4$X^12$
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ML?$NH7.DVY?[1:YWY0A&VL$DVG_8<A3N"Y)RFY<FNUHHHKBOAM\7K'XB^?\
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M9FD&8Q@D9!;<!\Q&.:RM+^/FB:K=+807B-.TAC4;9 C,,C"R%!&<D84AB')
M4DD9M>,?C1I'@V007UTB2]T >5UX4_,L2N4R&!&[&X<C.#75Z7JT.KQK/;2)
M+$V=KQLKH<$@X920<$$''<$5RGC'XT:1X-D$%]=(DO= 'E=>%/S+$KE,A@1N
MQN'(S@UM^$/&EIXQ@%W82B6(LR[@""&'52K ,IZ'! )!##@@F7Q-XKM?"\)N
M;Z5(8AGYG.,D MM4=68A20J@L<< UROAGX^:)XEF%M:WB&5L;5=9(=Q)"A5,
MJ(&8D@!02Q[#@UW5W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5S6G?%72]1\\Q7
M<+);>5YTF\"%?-SY?[TXC.2,?*QPWRG!XJIX.^-&D>,I#!8W2/+V0AXG;AC\
MJRJA? 4D[<[1R<9%=7JFK0Z1&T]S(D42XW/(RH@R0!EF( R2 ,]R!7":!^T-
MH>OSI:6UV&EE;:BM'-&"W9=TD:KD] "<DX49) KT6L_6_$-MH*"6\FC@0L%#
M2NL:EB"0H+D#. 3CK@'TK/TOXA:;J\BP6UY;2RMG:D<\3N< DX56). "3CL"
M:J_\+8T?_H(6?_@3#_\ %UJZAXLL].A2ZGN(8X)-NR5Y$6-MP++M8D*<J"1@
M\CD<5S_Q$U:'5]#OI[:1)8FL+S:\;*Z'$4@.&4D'!!!QW!%>0?LG^*[7POH-
MQ<WTJ0Q"_E^9SC)%O"VU1U9B%)"J"QQP#7M_@?XD:?XY1Y-.G$PC8*XPZ,I(
MR,JZJV#S@XP2" 25.-#Q-XKM?"\)N;Z5(8AGYG.,D MM4=68A20J@L<< URO
MAGX^:)XEF%M:WB&5L;5=9(=Q)"A5,J(&8D@!02Q[#@UW]%<KI_Q5TO49GMX+
MN&1X[=IW*.&C6)2%9FD&8Q@D9!;<!\Q&.:RM+^/FB:K=+807B-.TAC4;9 C,
M,C"R%!&<D84AB') 4DD9M>,?C1I'@V007UTB2]T >5UX4_,L2N4R&!&[&X<C
M.#75Z7JT.KQK/;2)+$V=KQLKH<$@X920<$$''<$5B:O\1['2Y_L;2%[@*6:&
M&.6YE51L^9T@21D'SK@L #GC-1>$OBGIGBV&6YLKA'B@_P!:S;HM@QNW,) A
M"X!.XC:<-S\IP?\ "V-'_P"@A9_^!,/_ ,76KJ'BRSTZ%+J>XAC@DV[)7D18
MVW LNUB0IRH)&#R.1Q4NB>(;;7D,MG-'.@8J6B=9%#  E24)&<$''7!'K6A7
MR7^Q9JT.D1ZG/<R)%$OV/<\C*B#)G RS$ 9) &>Y KW_ ,'?&C2/&4A@L;I'
ME[(0\3MPQ^5950O@*2=N=HY.,BMO6_&]AH+B*\NH('*A@LLL<;%22 P#L#C(
M(STR#Z5+_P )99_9_MWVB'[+_P ]_,3R?O;/OYV_>^7K][CK533_ (A:;J._
MR+RVD\N-I'V3Q-M1<;G;#'"C(RQX'<U5_P"%L:/_ -!"S_\  F'_ .+K5U#Q
M99Z="EU/<0QP2;=DKR(L;;@67:Q(4Y4$C!Y'(XJ71/$-MKR&6SFCG0,5+1.L
MBA@ 2I*$C."#CK@CUK0KE?&OQ3TSP1M&H7"1,V,)\SR$'=AMD89]ORD;L;<C
M&<X%'@KXIZ9XWW#3[A)67.4^9) !MRVR0*^WY@-V-N3C.<BN@U35H=(C:>YD
M2*)<;GD9409( RS$ 9) &>Y KE)?C1I$5K)?FZ3[-%<&!I '(,HP=J *3)P0
MP*!E*Y8':"1TN@:_!XA@2[M'$D,B[D=>A'3OR"#D$'!4@@@$$4:_K\'AZ![N
M[<1PQKN=VZ =.W)).  ,EB0 "2!7"Z?^TCH%_OV7J#9&SG>DL>0N,A?,1=[<
M\(N7;LIP:]%N[M+-&EE8(B*69F(554#)8D\  <DG@"O.O^&D= \[[/\ ;4W^
M9LSLE\O.=N?,V>7MS_'NV8^;=CFO2J^5?@%_R.&K?]O_ /Z61T?MS_\ ,._[
M>_\ VWKZJHKSK7_VAM#T"=[2YNPLL3;758YI &[KNCC9<CH0#D'*G!!%=AX>
M\5VOB17>RE29(Y/+9XSN3=L5\!A\K?*ZY*D@'()R"!S_ (Q^-&D>#9!!?72)
M+W0!Y77A3\RQ*Y3(8$;L;AR,X-;?A#QI:>,8!=V$HEB+,NX @AAU4JP#*>AP
M0"00PX()E\3>*[7PO";F^E2&(9^9SC) +;5'5F(4D*H+'' -<KX9^/FB>)9A
M;6MXAE;&U762'<20H53*B!F)( 4$L>PX-;^J?$+3=(D:"YO+:*5<;DDGB1QD
M C*LP(R"",]B#5O4/%EGIT*74]Q#'!)MV2O(BQMN!9=K$A3E02,'D<CBC0O%
MEGX@W?8KB&?9C?Y4B2[<YVYV$XS@XSUP?2L_6?B5IVC3I9SW,8N))HXEA#;Y
M=\F-@*)N90<CYF 7D9(R,Q:?\4],U"^?2HKA&O$W;HQNZJ 64,1L9A_$JL67
M#9 VMB'PYXTTC5+V2&PE@ENY(5EE:$*Y9$(C4O*@*L5W !2VX \ *<UYA^TC
M^T%#X=MWT[39MU])E6>)E/D -AP6&<2G!4*,.G+DJ0F[V73?&]AJB22V]U!(
MD*[I626-UC7!.YRK$*,*3DX& ?0UG^"O%.EZO)<PZ4\+LDBR7!A4;"\H)#EU
M&R1FVG<P+'(PQ!&*U?$WBNU\+PFYOI4AB&?F<XR0"VU1U9B%)"J"QQP#7->$
M/CCH_C"<6EC="28JS!"DL9(')QYB*&('.!DX!., D=5K^OP>'H'N[MQ'#&NY
MW;H!T[<DDX  R6)  )(%<+I_[2.@7^_9>H-D;.=Z2QY"XR%\Q%WMSPBY=NRG
M!KJO'7@Z/Q=:O;2':_WH91G?#*N?+F0JRL&5N1AAD94G!(KD/@-\3)_&$$UM
MJ "ZA93&&X"]"1D"3Y1L!+*ZD(2,J6&U651Z?11111111111111111111111
M1111111111111111111111111111111111111111111111111111117R+^VK
MX>MM+>REMX8XWF:[:5D14:1LPG<Y4 L<L3DY.2?4U[W\5_"UNN@WMKL_=):3
MR ;FSO0-,KLV=S,95#LS$EVR7+;CGS3]C;2X[[36N9E\R6"[ECA9R7\I3'&S
M"(,2(]QD8N4"E\_.3@8Y_3_^)=\07C@_=I)NWJGRJVZR$K;@, YD <YZO\QY
MYKU";X-W,_B9?$#W :W2'"1'<75O*:'RQD[0GS-)N!SN)79R7KQK]KWQ7:ZC
M-I]UILJ/+'Y^;B [L%3$T:B9.-R$EMH;='O#$+O4M[5^U'_R+MY_V[_^E$59
M_P"S[K::#X4AO)02D$-Y*P7!8JDT[D#) S@<9(&>XK%_9]U29[+^U9+&YN[R
M[DF:6[!L06&_RQ&A>>*18@(EPA4*&!VC;MQ4N_ VIP^)(-9TNP>VMY-BW@DE
MMU#[W832%(KE\_(5< =94#E6;):+]L_P];0:='>)#&MP][$KS!%$K+Y,WREP
M-Q'RKP3C@>@KI?A[\"-(UO1[-KV#SY);>WF>5W?SLF%0J"1"K")5PB1@[ JJ
M<%AN/E_QB\/6V@^+=)BLX8X$+6+%8D6-2QNW!8A !G  SUP!Z5[!^T#\&[GX
MG):Q6]P(4BF8RJVXJRL /, 4X9T (53@$.WSISG*_:JU^RN-'NK0O&]U&UNP
MC&))8R98_P!X0,M$"C%=[;0=X3.9%#=!^S+=O=>'[)I&+$+,H+$D[5GD1%Y[
M!0% Z   <"O)/@%_R.&K?]O_ /Z61U]545GZWX>MM>017D,<Z!@P65%D4, 0
M& <$9P2,]<$^M?*O[%6@0:F][).@D,36C1AOF57S,1(%/R[QCY7QN0%@I 9L
MV_C/;#2/&>G36^8WG:Q:1E9@6)G:!N_ ,2A"!@$9R#DYZ#XEZVGCKQ78Z!,#
M]EMF,LJ'&V27R3<*&!+(Z; J\J&P\JYPP->J_%'X46WC33GL5CC1TA*VK;57
MRF&THJG8Q1"457"#)3(':O-?V1/%Y\4Z9/IMX3,+=E0"0*R>1*A"1<Y+ %'!
M## 4JH.T;5X3_A%+5?'?V)8D2V_YY(/+CQ]@WE2J;058YWJ?E<%E<,K$'L/V
MS] @M]*M)$0*8;E8H@ORJD;1.60*,*!^Z3'' 7 P"<R_%S28=3\(1ZA<1I)>
M?8-._P!(=5>?YGA+?O&!?G>V>>=QSU-:'[-WPXL-8T6VNKR".YD995!FCCD"
M(EQ/A$#+P-S,Q)RQ+8+%515\ZAT?_A2WB^""S&;6\\I%C+;F$4[^7M+,A/R3
M)N7!+%%56?+,:T/CO:)!XQTMD4*7:P9R  6;[4Z;CCJ=JJN3S@ = *]5_:JM
M$G\/W3.H8HUNR$@$JWGQIN&>AVLRY'."1T)KFOAI_P B-)_UX:G_ .A7%<U^
MR)\.K+7[":[O8A<%;F2-(Y0)(4'EPLSK&P*AV^4,_)VHH&!G//\ QM\-I\%M
M<L]8TU0L4K._D@@ ,I"SHH*$(CQR +C<4);:%"H![?\ M1_\B[>?]N__ *41
M55_9PTF'5_#-I!<QI+$WG[DD570XNI2,JP(." 1GN :\O_9WM$L_%NJ11*$1
M%OE55 5547<0"@#@ #@ < 5W7BB2/XC>)X]&N!FTTZW-S)$P)2:5A'L! ?:5
M594(W+U\Q""CYKTOXG_#R'X@6,EA.=N[#)(%5FC=3E7 /XJV""4+*&&<U+\-
M_"#^#M/@T^28W!A5E$K J2NYBBX+/@*I" 9( 48P.!JZWX>MM>017D,<Z!@P
M65%D4, 0& <$9P2,]<$^M?,O[#'_ #$?^W3_ -N*S_VU?#UMI;V4MO#'&\S7
M;2LB*C2-F$[G*@%CEB<G)R3ZFO=?BCX+M+;0M0MTB 3[--,V"0S2QIYBRNV=
M\C[XU+,Y9G(^<MDYXK]C"[>?1I%=BP2]E5 22%7RX7VC/0;F9L#C))ZDUQ_P
M"_Y'#5O^W_\ ]+(ZZ#]ISQ-_:]]IWAK+I%=7$#W#*=I*/-Y2*#D@X(=B&0C<
ML;#H17LNN?#BPUBR;37@C6W*N$5(XP(V8,/,C!4JCC>Q# 9!)/<UX5^R5K\^
MCW=]X=NG+FV9VC ^:)#'*8Y]I;#@,[(RC&/O-A6)W<K\>?!UM9^)]-L[-!:I
M*MF";=5@96:ZD0R+L7 <#&&P2"!Z5]"Q? '0HI(YA8P[HHPB@@E" ",NA)21
MN3EW#.3@EL@$>"? ;0()/%NI1; (X6O&CC'RQJ4NXQ'\BX4A>"@((5E5E 9%
M(M_ML6PTZYT^^AREP5F7S%9@P$31O'C!^4JTC$$8.3UX&/</B/X4M=.T/4(8
MHD"&TN9&R-Q:18BPE=FRSR[E5C(Q+E@&+$C-<)^QA=O/HTBNQ8)>RJ@))"KY
M<+[1GH-S,V!QDD]2:U?@W\,7^$@O[S5;R-Q<31DS.Q0;59]LDCR$8=VEY7+
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M *\ MK1+7XA;8U"@LS$* !N:P+NW'<L2Q/4DDGDUU?[;%HC:5;RE076]55;
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M07,:2Q-C<DBJZ'!!&58$'! (SW -?+7[.]HEGXMU2*)0B(M\JJH"JJB[B 4
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M_9*U^?1[N^\.W3ES;,[1@?-$ACE,<^TMAP&=D91C'WFPK$[OIJOE7Q9\08_
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MQ<!P,8;!(('I7T+%\ ="BDCF%C#NBC"*""4( (RZ$E)&Y.7<,Y."6R 1X?\
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M,09&RY!Y8U-H7PQLM MVLK4310-CY%N;H;<,7^0^=NCRQ);85WY^;(K*\,_
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MB%90B;W1<R&,ECL*L2/+ '.,$Y!.","T_9]M&=6OKF]OT1@RPW=P9H0X/#[
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M\SR]W7=Y?SYQLQQNW_+7:T444444445GZ_K\'AZ![N[<1PQKN=VZ =.W)).
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M[P0">XSZK1111111111111116+XT\7P>#K26_NR1%$H+;1N8DD*J@>I8@#)
M!.6(&2#P7XO@\8VD5_:$F*525W#:P()5E(]0P(."02,J2,$[5<K\2OB5:_#N
MU^VWN\H9%C58UW.S-DX&2JCY59B6(& 0"20#T&DZI'J\,=S VZ*6-)$;!&58
M!E." 1D$'! /J*M44444445B^+_&EIX.@-W?RB*(,J[B"26/10J@LQZG !(
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MA7XO:3XJ222SNHV$2LT@8F)E10"TA64(P0;AE\;<\9R#4W_"V-'_ .@A9_\
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M=7D6"VO+:65L[4CGB=S@$G"JQ)P 2<=@31JGQ"TW2)&@N;RVBE7&Y))XD<9
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MM^[= 6;YBP).3\Q\@^"6EQZAXPU3S5W!)+V102=NY;R/:2 <-@_,H8$*X5P
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M?YOG1I?F:-LHP^4J5^6NP_;-TF&UT>U\N-%\J[CCCVJHV(89<HN!\J_(ORC
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M_P!?\?\ Z)GKU7X3_P#('T__ *\+3_T2E?/_ .PQ_P Q'_MT_P#;BC_FH?\
MG_H'5] >*M;M7NK?2+V))$O8[@JLB^8C-!Y3["A5E/RLS@L0 8P!DL,?.OQ^
M_9TM_!-N=:T>1X/(DC9HR[';ED1'B?EPP<ACN8]259=H5OIKP1K;Z]86MY*
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M]O'_ *42UY5^W/\ \P[_ +>__;>OH#XL?\@?4/\ KPN__1+UY5^Q3_R!Y_\
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MJ\;7NI0-F"RPKG'64V_V8QX8JP^99#N 9?W>.C*:^E*\J_:C_P"1=O/^W?\
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M\4:@]II[)/;P6^Z>9"K()9&7R(T8/\V464N0I4$*-P;<M8M]X7TGXS13_:X
M9;>YN;5I%RLT;0NZKB3:N05<2!#OC#-A@Q4UY)\-O"4WPB\5II,,OF6MY;NP
MW;MVP+*\98#:OFJT17=@@HS$!2Y"_55?+?[7.D3Z!?V'B&'#")HX]K#Y1)%(
MT\><.&8/EL@ 8"?>RPKZ4T#7X/$,"7=HXDAD7<CKT(Z=^00<@@X*D$$ @BOG
MO]F?0O[9UC5=>B;-K)<7$4)QC?YDPG+8)#+M4)PR\[^H*D5D_'W_ )'#2?\
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MW-;5?*OP"_Y'#5O^W_\ ]+(ZZO\ ;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\
MKPM/_1*5U5%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%17=L+I&C;(#*5)5F1L$8.&0AE/H5((/((->=
M:I^SEH>KR-/<V[RRMC<\ES=.YP !EFF).  !GL *[K1-#CT9#'$9&!8MF6::
M=LX X:9W8#CH#C.3C).>:\8_!O3/&<@FU")YF'W09[@(N0H.U%E")G:,[0-Q
M&3D\U;T+X8V6@6[65J)HH&Q\BW-T-N&+_(?.W1Y8DML*[\_-D5B:)^S[HV@N
M9;.&2!RI4M%=7<;%202I*3@XR <=,@>E1?\ #.6A^=]J^SOY_F>9YOVFZ\S?
MG=OW>=NW;N=V<YYSFM7QC\'M.\9?9Q?H\J6T<B1JTLG\?EY9F#"1F C RS'.
M6+;C@C%M/V?;1G5KZYO;]$8,L-W<&:$.#P^P*H8@97#94JS J<UZ?17QA^R?
MX @\7I?"5I(I8FM&BN('\JXB)%PK[' . R_*P((([9"D?2'@KX(V/A6X:_S-
M<WC9'VFYD,TP!54V@X51\JX#8W[25W;3MK5\:_"^P\;[1J$;RJN,)YTZ1@C=
MAMD<BIN^8C=C=@XSC H\%?"^P\$;AI\;Q*V<IYT[QDG;EMDDC)N^4#=C=@8S
MC(H^(?PPL?B!"(+^/=MW&-U)62,L,%E8?@=K90D*64X%<II/[.5C:^6EU/>7
MD$.PQ6]S.9+="F C"-513A<J%.4VL05(->EZIIBZG&T,A<*V,F.22%^"#P\3
M(XZ<X(R,@\$BO/\ 2_V<M#TB19[:W>*5<[7CN;I'&00<,LP(R"0<=B16KXQ^
M#>F>,Y!-J$3S,/N@SW 1<A0=J+*$3.T9V@;B,G)YJKJ'P(TG484M9XYI((]N
MR)[N\:-=H*KM4SE1A20,#@<#BM7P5\+[#P1N&GQO$K9RGG3O&2=N6V22,F[Y
M0-V-V!C.,BN:\4?L[:=K=W_:,+3V=T6=FEM9?)9F8!2QRK!21G)0*6+,7W$Y
MK?\  _PLM/"#O<1F2:ZE4++=3R&:X=0?E4L>  ,#"A00J[LE0:T/&/@.T\91
MB"^5WB[H)IHD;E3\RQ.@?!4$;L[3R,9-97@[X-Z9X,D,VGQ/"Q^\!/<%&P&
MW(TI1\;CC<#M)R,'FL76_P!G;3M3U$:NC3V\^X,XMY?)5VYWL2J[U+J2KE&0
ML"3]XLQVO$/P;TSQ%&D%U$[Q1\JGGW"INRQ,C*LH#2DNQ:1LR,6)9CFK?@KX
M7V'@C<-/C>)6SE/.G>,D[<MLDD9-WR@;L;L#&<9%<UXH_9VT[6[O^T86GL[H
ML[-+:R^2S,P"ECE6"DC.2@4L68ON)S6_X'^%EIX0=[B,R374JA9;J>0S7#J#
M\JECP !@84*"%7=DJ#4WC7X7V'C?:-0C>55QA/.G2,$;L-LCD5-WS$;L;L'&
M<8%0^%?A-I_A-)(K%)(4D5@RK<7.WY@ 6 ,I"OA0!(N' '#"LJV_9]T:UG^V
M1PR+<%F8S+=78EW-G>V\3[LG)R<Y.3GK7HM9^OZ!!XA@>TNT$D,B[71NA'7M
MR"#@@C!4@$$$ UYAI_[,5CIV^."ZOH[621F>U2Y*V[!L!HV4*&*E0$)+;RO!
M;/->GZ!H$'AZ!+2T01PQKM1%Z =>_)).22<EB222237"ZI^SEH>KR-/<V[RR
MMC<\ES=.YP !EFF).  !GL *Z#7?AC9:_;K970FE@7/R-<W1W98/\Y\[=)A@
M"N\MLQ\N!1X*^%]AX(W#3XWB5LY3SIWC).W+;))&3=\H&[&[ QG&1755YKJG
M[.6AZO(T]S;O+*V-SR7-T[G  &6:8DX  &>P KH-=^&-EK]NME=":6!<_(US
M='=E@_SGSMTF& *[RVS'RX%5/!WP;TSP9(9M/B>%C]X">X*-@,!N1I2CXW'&
MX':3D8/-9]S^S[HUU/\ ;)(9&N RL)FNKLR[EQL;>9]V1@8.<C QTJ+6/V?M
M.U*=[T-<Q7C>6%N8[B19XPD20[58DYRB$,SAW;>^6Y&-#PA\'+3PY.+UWGN[
MM594N+J4SRHA_@3("J/O<A=WSN-VUB*B\3? ;1_%$QN;Z!YI3GYGN+DX!);:
MH\W"J"Q(50%&> *VH?AQ8QV3:68R]HZ[3%))+, H"A54R.S(%V@H%("$;EPW
M->=:7^R-HNGW2W>)G59"X@D=7@[E5(V;V4<8#.=V 'W D'5@_9GT8WDVH7$;
MW$LUP9MLKYC5B[.0$0(&4D\K)O!  [G/5_$/X86/Q A$%_'NV[C&ZDK)&6&"
MRL/P.ULH2%+*<"N/\!_LP:1X-G%VBR3RHRM&T[*PC89^951$4GG(+!BI567:
M1FNZ\8^ [3QE&(+Y7>+N@FFB1N5/S+$Z!\%01NSM/(QDUE>#O@WIG@R0S:?$
M\+'[P$]P4; 8#<C2E'QN.-P.TG(P>:[6HKNT2\1HI5#HZE65@&5E(P5(/!!'
M!!X(KR_PE^S;IGA>:66![DQ3??MVF86Y&<JK*@4RJ 2NV5I%*LP<-G-:WB;X
M#:/XHF-S?0/-*<_,]Q<G )+;5'FX506)"J HSP!75>&?#$'AJ$6UJ'$2XVJ\
MLLVT !0JF5W*J   H(4=AR:\Z\,_LT:?X9G>>TGO8T=B6@2Y>*(CYMBDQ!)2
M$W';ER?4G)S;F_9RTG^T%U.%9+=U7'EV\AMHB=K)N_=!70[3SY;H#CY@<ONT
M/B#\"]+\<QI'<1>6T48CBDAQ&Z(""$ P4*C& K*P4%M@4DFN?TK]EK2=,LKB
MQ0S'[3L#S%HS.%1TD$:GR]JKN0$C;ENY.U-O0>$?@3I7A*-H[2)T>2-$DF$T
MRSL%(;B1'5DW, 7$>Q6X!&  *FE_LY:'I$BSVUN\4JYVO'<W2.,@@X99@1D$
M@X[$BK?B;X#:/XHF-S?0/-*<_,]Q<G )+;5'FX506)"J HSP!6K_ ,*QLOL?
M]FXF^R]/+^TW7W=GE^7N\[=Y6WCR\^7WVYYKE+[P9H_P8M;C5K6%XO*CR4%Q
M<[)&Y2)&4NZG+/M!96"%MW&,US_@7X(:1X\M4UC4(TN;F]_?R-&SPQ(SXW0J
ML,@'R$%6+%I&<.SMN.!0^+7[/WA_0-.FEB@,5PR[+;;+/)(\Y_U42HS2;R[#
M:0%)V[CE<;A[5X(MI[6PM8[S)N%MH%F+-O;S!&H?+9.X[LY.3D\Y-;5>2^&?
MV:-/\,SO/:3WL:.Q+0)<O%$1\VQ28@DI";CMRY/J3DYMS?LY:3_:"ZG"LENZ
MKCR[>0VT1.UDW?N@KH=IY\MT!Q\P.7W>-?'W28?^$JTFU\M/(\NPC\K:OE[/
MM4B[-N-NW;QMQC'&,5ZU-^S1I]V52YGO9[6-LQVDER[6R *RHJ@ . BG"8?(
M P202#ZK:6B6:+%$H1$4*JJ JJH& H X  X ' %?&O[)_@"#Q>E\)6DBEB:T
M:*X@?RKB(D7"OL< X#+\K @@CMD*1](>"O@C8^%;AK_,US>-D?:;F0S3 %53
M:#A5'RK@-C?M)7=M.VM7QK\+[#QOM&H1O*JXPGG3I&"-V&V1R*F[YB-V-V#C
M.,"JGA[X.:;X;C>"R2:&.3[RQW5VHSE3N&)OE;Y%!9<,5RI.TD'*TO\ 9RT/
M2)%GMK=XI5SM>.YND<9!!PRS C()!QV)%=AXO\%VGC& VE_$)8BRMM)((8=&
M#*0RGJ,@@D$J>"0?+_#/[(VBZ),)W$UQMP0D[JT>000Q6-(]W3&UMR$$@J>,
M>B^//AW:>.XH[>_4O%',)=@8H&8(Z $KAL#>3P0<@9)&0>/_ .&=+*7]U-<W
MTMGT%F]TYM0H_P!7&% #[4P"@WY&U<D\Y]0M+1+-%BB4(B*%55 554# 4 <
M < #@"I:\U^(/P T_P ;72:A(TUO=)C][;NL;L5QL9B4;YEQ\K##8P"2%4+U
M4O@*RGM9+"2+S()L^:)&>5W)P S2.S2,P"J%8MN0*@4@*N. T_\ 9BL=.WQP
M75]':R2,SVJ7)6W8-@-&RA0Q4J A);>5X+9YKT_0- @\/0):6B".&-=J(O0#
MKWY))R23DL22222:T**XKXA_!S3/B!AK^'=*L;(DJLR2*#TY4X;!Y4.&4$GC
MYF!Y_2_V>+>R589+[49K81F,VTEVP@9"A385B6,[0#PH(' !!7(/HN@:!!X>
M@2TM$$<,:[41>@'7OR23DDG)8DDDDDUQ7C_X#:=XTG6]D$D%VK(1<6[^7*=F
M=F<AER.,/MWC:H#!1BK?A#X.6GAR<7KO/=W:JRI<74IGE1#_  )D!5'WN0N[
MYW&[:Q%;7C'P':>,HQ!?*[Q=T$TT2-RI^98G0/@J"-V=IY&,FLKP=\&],\&2
M&;3XGA8_> GN"C8# ;D:4H^-QQN!VDY&#S6?<_L^Z-=3_;)(9&N RL)FNKLR
M[EQL;>9]V1@8.<C QTK5\5?";3_%B1Q7R23)&JA5:XN=OR@@,0)0&?#$&1LN
M0>6-8OB?P':>#=#U""Q5TB^P76$,TTJ+^ZE/RK*[A,EB3MQN/)S@5XU^S#\,
M8/%FE23^;/;7"7LJ">UD\B8QF* F)FP=R;L, 1PPRI&6S[U\/OA#8^!F>:W#
MR7,N?-N9G,D[Y<N<MP!DGG:%W84ON8 UG_$?X%V7CVYAOII)X;B%0J202!&P
MK;T^\CX*L25*[3D\DX7$7B3]GW3/$EJ+6Z\Z20;,73RM+=_+_P!-)=^%/),8
M'E L65%;!%M?@7ICVJV,RS2Q+'&AWW-QEU3&Q7VR*"JD;D3 CC9F,:)N;-KP
M=\&],\&2&;3XGA8_> GN"C8# ;D:4H^-QQN!VDY&#S6?<_L^Z-=3_;)(9&N
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M;'P55U*L06#9;YB2S;B6)9LDG/%?\,Z65E\NGW-]8Q=3%;73I&S=Y")!(=Q
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M.W+;))&3=\H&[&[ QG&17G_B;]D;1=;F,Z":WW9)2!U6/)))8+(DFWKC:NU
M  %'.?4/"'@NT\'0"TL(A%$&9MH))+'JQ9B68]!DDD !1P !M5Q_CSX3Z?X]
M>%]1C,HA64(F]T7,AC)8["K$CRP!SC!.03@C M/V?;1G5KZYO;]$8,L-W<&:
M$.#P^P*H8@97#94JS J<UW^OZ!!XA@>TNT$D,B[71NA'7MR"#@@C!4@$$$ U
MY!;?L>:'#/Y[>>Z;F/D-*!%@YPN559<+GCY\\#<6YS[5:6B6:+%$H1$4*JJ
MJJH& H X  X ' %>*Z_^Q_HVKSO<*9X!(V[RXFC6)2>NT-$Q4$\XS@9PH"@
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M?/ W%N<^G^)_ MKXDLCIDR;;4^2/+C_=C;$Z.L8VCY5^0*0N"%R%*G!'%?\
M#.EE%^ZAN;Z*SZ&S2Z<6I4_ZR,J07VODEQOR=S8(XQU>I_#"QO\ 3AHWE[+,
M>4/+0E<A)%EVEN6^9E^=L[VRQW!CNKE/^&=+*+]U#<WT5GT-FETXM2I_UD94
M@OM?)+C?D[FP1QCT70- @\/0):6B".&-=J(O0#KWY))R23DL22222:T*X76_
M@CI6N7(OKF*1[A6#+(;FZ#(0Q<;,3#8 Q)4)@*?N@5V&EZ8NF1K#&7*KG!DD
MDF?DD\O*SN>O&2<# '  KG_&OPOL/&^T:A&\JKC">=.D8(W8;9'(J;OF(W8W
M8.,XP*J>#O@WIG@R0S:?$\+'[P$]P4; 8#<C2E'QN.-P.TG(P>:YJT_9HT_2
MD5-/GO;,[0)7M[EXVF(&%:3(9<CYB-@0 LW&, =KX'^'=IX+1UM%.^5@TTSL
M9)I7QR[NW)).6P,*&9BJC<:XJT_9HT_2D5-/GO;,[0)7M[EXVF(&%:3(9<CY
MB-@0 LW&, =KX'^'=IX+1UM%.^5@TTSL9)I7QR[NW)).6P,*&9BJC<:Y_P ?
M_ ;3O&DZWL@D@NU9"+BW?RY3LSLSD,N1QA]N\;5 8*,5;\(?!RT\.3B]=Y[N
M[565+BZE,\J(?X$R JC[W(7=\[C=M8BNUN[1+Q&BE4.CJ596 964C!4@\$$<
M$'@BO#_^&-M%\[S=USL\S=Y/F+Y>,Y\O/E^9MQ\N=^_'\6>:];M/!MK8VBZ=
M AAMT4*JQ220L #NX>-EDR3RQW98D[B=QSQ^E_LY:'I$BSVUN\4JYVO'<W2.
M,@@X99@1D$@X[$BI?B/\"[+Q[<PWTTD\-Q"H5)() C85MZ?>1\%6)*E=IR>2
M<+B+Q)^S[IGB2U%K=>=)(-F+IY6EN_E_Z:2[\*>28P/*!8LJ*V"-K2_A/I]C
M9-IK1F:%X8XG,SO*[)&,(-S'*!3ED6/8L;$M&J$UB_#SX V/@;(ADN94\Q9!
M'-,3"KKT?RHQ'&S9"D,ZL59$9"I4&M#XF?!;3OB, ;U")57:DT9V2JNX-MR0
M58=<!U8+N8KM))K/^&O[/>E_#Z3[1;(\EQ\P6:9@[J& !50JH@Z'Y@N_#,N[
M:<5M>//A/I_CUX7U&,RB%90B;W1<R&,ECL*L2/+ '.,$Y!.","T_9]M&=6OK
MF]OT1@RPW=P9H0X/#[ JAB!E<-E2K,"IS7I]5=4TQ=3C:&0N%;&3'))"_!!X
M>)D<=.<$9&0>"17G^E_LY:'I$BSVUN\4JYVO'<W2.,@@X99@1D$@X[$BM#Q1
M\$=*\5/YE_%).0SLH>YNBJER"VQ?.VH#@<* ,  # %:OA#X=6?@\!+%9(T"L
MHC,]Q)$ 6W'$<DC(I+<Y !Y//)STM%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%97B;0VU
MN$P)/-;[L@O 8UDP005#21R;>N=R[7! (8<Y\_\ AY^SQ;?#^8SV%W>+NVB1
M&>!HY IR%93!]1N7#@%@K#)KU6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBHKNT2\1HI5#HZE65@&5E(P5(/!!'!!X(KR6W_9
MBL=,DDDT^ZOK)9-NZ.VN2B?*,#EE=SU)^9C@L<8'%=5X6^$5EH$R7C&:YO$C
M:-;FYF>>8*Q)P-QV+C<5!15.TD$G<V>UHHHKR#Q)^S1;>);H7]U?7SW*[-D@
MD@0ILY78$MU"8/S#:!\Q+?>))]5TNR:RC6.25YF&<R2",.V23R(DC3C.!A1P
M!G)R34\3:&VMPF!)YK?=D%X#&LF"""H:2.3;USN7:X(!##G/G_P\_9XMOA_,
M9["[O%W;1(C/ T<@4Y"LI@^HW+AP"P5ADUZK111111111111111111111111
M7->//! \90&T>XG@B=6618#$ID4X^5F>)V XP0I4,&96W XKG_AG\$X?AR2+
M*ZNC$S;GAD:%XF;:5W8$(93TR492VU0VX "O1:*****\E\(?LP:1X6O1J$*R
M.ZLS1QR,KQ1L3E64; Q*]$+LQ'WN7 8>M444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44445Y5/^TQHQO(=/MY'N)9K@0[HDS&K%U0$NY0,I)X:/>" 3W&?5:******
M***********X7QY\;M)\#$QWEP/."L?)0&27(4,%(7(0L&&WS"@.<YP"1U7A
M[6TUZVAO(@0D\,<JAL!@KJ' ."1G!YP2,]S6A11111111111111111111111
M7%>%_B]8^)=0N=)MR_VBUSORA"-M8))M/^PY"G<%R3E-RY-=K17/^,?']CX,
MC$VH3I"I^Z"27;!4':B@N^-PSM!V@Y.!S57X=?$JU^(,,ES8[_*CN'AW.NW<
M5"MO49)VD."-P5O5175444444444444445ROC7XIZ9X(VC4+A(F;&$^9Y"#N
MPVR,,^WY2-V-N1C.<"K7@+QK#XWLHM0ME=8I=^T2!0XVNT9R%9AU4XP3QCZ5
MT%<+X\^-VD^!B8[RX'G!6/DH#)+D*&"D+D(6##;YA0'.<X!(ZKP]K::];0WD
M0(2>&.50V P5U#@'!(S@\X)&>YKFOAM\7K'XB^?]@+G[/(%;>A3(;.R1>ORM
MM; .'&/F5<C/:T445Q7A?XO6/B74+G2;<O\ :+7._*$(VU@DFT_[#D*=P7).
M4W+DUVM%%<?XX^*=IX0=+>02374JEHK6",S7#J#\S!1P !DY8J"%;;DJ165X
M ^/.G>-)VLHS)!=JS@V]PGERG9C?C!9<CG*;MXVL2H49KT6BBBBBBBBBBBN*
M^&WQ>L?B+Y_V N?L\@5MZ%,AL[)%Z_*VUL X<8^95R,]K111111165XF\5VO
MA>$W-]*D,0S\SG&2 6VJ.K,0I(506.. :Y_X>_%ZQ^(,EQ'IY=UM_*W2%"B-
MY@8C:&P_&P@[E7GID<UVM%%%%%%%%%%>53_M,:,;R'3[>1[B6:X$.Z),QJQ=
M4!+N4#*2>&CW@@$]QGU6BBBBBBBBBBBBBBBBBBBBBBBBBBO-?'7[1.C>#6>*
M:?S9TZPPCS7SO*,I/$:LI!+*[JP Z9(!]*HHHHHK%\7^-+3P= ;N_E$4095W
M$$DL>BA5!9CU. "0 6/ )'G]I^TQIRW*V=]%=6#NH*F[A\E3EM@Z,Q4$Y^=@
M$ 5LL,5ZU7E4_P"TQHQO(=/MY'N)9K@0[HDS&K%U0$NY0,I)X:/>" 3W&?5:
M*XKX;?%ZQ^(OG_8"Y^SR!6WH4R&SLD7K\K;6P#AQCYE7(SVM%%%%%%%%>53_
M +3&C&\AT^WD>XEFN!#NB3,:L75 2[E RDGAH]X(!/<9]5HHHHHHHHHHHHHK
MBOB3\7K'X=>1]O+C[1(578A? 7&^1NGRKN7(&7.?E5L'':T5Q7BCXO6/AK4+
M;2;@O]HNL;,(2B[F*1[C_MN"HVAL$9?:N#7:T4444444445Q7A?XO6/B74+G
M2;<O]HM<[\H0C;6"2;3_ +#D*=P7).4W+DUVM8OB_P :6G@Z W=_*(H@RKN(
M))8]%"J"S'J< $@ L> 2.?\ AG\9;+XC/<)8"3%LR!G=0JN'+A63YBV#L)^8
M*0",C.0.ZHHHKRJ?]IC1C>0Z?;R/<2S7 AW1)F-6+J@)=R@923PT>\$ GN,^
MJT44445YKXF_:"TS1;@V$7G7=XLA1K>UB::0$*6;D[4.W&&"L64Y!'RM@TOX
M_6,LBPWT=SIS/GRS?0FV23 )?:Y+(-O&=Q7EE R3BNP\&^+X/&%JE]:$F&1I
M A8;20DC1[L'D E21G!P1D Y VJ*********************************
M************************************************************
M****YKQQ\2-/\#(DFHSB$2,508=V8@9.%16; XR<8!(!(+#.?X6^-&D>*F2.
MRNDDDDD9$CPZR$K&9&.QU5@NU3\Y&S/R[MW%:%I\3=*O'6**^M7=V"JJW$3,
MS$X"@!\DD\ #DFK>M^-[#07$5Y=00.5#!998XV*DD!@'8'&01GID'TK0TO5H
M=7C6>VD26)L[7C970X)!PRD@X((..X(KE/&/QHTCP;((+ZZ1)>Z /*Z\*?F6
M)7*9# C=C<.1G!K5\'>/['QG&9M/G291]X D.N2P&Y& =,[3C<!N R,CFOG7
MX^_\CAI/_;A_Z625[AK?QST71+D65Q>1K,6"D#<ZJVXH5=T4I&0P.X.RE1RV
M!S7=45S0^)6G-=IIR7,;W4C2J(D;S&#1@M(K[,B,@ \.5)((&2"*Q?\ A?VA
M?:/L?VZ'S/[V3Y/W=W^NQY/3_;^]\OWN*[^N \3?'S1/#4QMKJ\02KG<J+)-
MM()4JQB1PK @@J2&'<<BNOT#7X/$,"7=HXDAD7<CKT(Z=^00<@@X*D$$ @BL
MH?$K3FNTTY+F-[J1I5$2-YC!HP6D5]F1&0 >'*DD$#)!%1>$OBGIGBZ:6VL+
MA)I8?OJNX<9VEE+ !USQN0LO*\_,N>?_ .&D= \[[/\ ;4W^9LSLE\O.=N?,
MV>7MS_'NV8^;=CFNZT'7X-?B%S:.)8F9U5UY4E':-L'N-RD C@CE200:Y#Q-
M\?-$\-3&VNKQ!*N=RHLDVT@E2K&)'"L"""I(8=QR*ZKPSXKM?%$(N;&5)HCC
MYD.<$@-M8=58!@2K ,,\@5%XH\;67A5/,OYXX05=E#L S! "VQ?O.1D<*"<D
M #)%8FO_ !HTCP_##<75TB)/'')$,.TC(X+(_EJID"D _,5 !^4D'BN@\,^*
M[7Q1"+FQE2:(X^9#G!(#;6'56 8$JP##/(%:M> ?MK?\@>#_ *_X_P#T3/7J
MOPG_ .0/I_\ UX6G_HE*RO$WQ\T3PU,;:ZO$$JYW*BR3;2"5*L8D<*P((*DA
MAW'(KK] U^#Q# EW:.)(9%W(Z]".G?D$'((."I!! ((K/\0^/;+P_(EO<2_O
MY/N0QH\T[##'<(HE>3;A&RVW:,$$YJKX2^*6G>+9I;6SFW3P_P"LB9)(9%P=
MI^65$8X;AL [20&P2,Z'BCQM9>%4\R_GCA!5V4.P#,$ +;%^\Y&1PH)R0 ,D
M5B:M\:-(T?[-]HND3[7&DD.X.,H^-CM\O[M3G[TFT<-S\K8T-9^)6G:-.EG/
M<QBXDFCB6$-OEWR8V HFYE!R/F8!>1DC(SE:W\<]%T2Y%E<7D:S%@I W.JMN
M*%7=%*1D,#N#LI4<M@<UVMI=I>(LL3!T=0RLI#*RD9# C@@CD$<$5YU_PTCH
M'G?9_MJ;_,V9V2^7G.W/F;/+VY_CW;,?-NQS7=:#K\&OQ"YM'$L3,ZJZ\J2C
MM&V#W&Y2 1P1RI((-:%<T/B5IS7::<ES&]U(TJB)&\Q@T8+2*^S(C( /#E22
M"!D@BN?N?VA]!MI_LK7L9<LJY4.\66QC]ZJF+'/)W87G<1@XV_&OQ3TSP1M&
MH7"1,V,)\SR$'=AMD89]ORD;L;<C&<X%:OAGQ7:^*(1<V,J31''S(<X) ;:P
MZJP# E6 89Y JIXA\>V7A^1+>XE_?R?<AC1YIV&&.X11*\FW"-EMNT8()S57
MPE\4M.\6S2VMG-NGA_UD3))#(N#M/RRHC'#<-@':2 V"1GRK]I']H*'P[;OI
MVFS;KZ3*L\3*?( ;#@L,XE."H48=.7)4A-WM6A>++/Q!N^Q7$,^S&_RI$EVY
MSMSL)QG!QGK@^E<_XQ^-&D>#9!!?72)+W0!Y77A3\RQ*Y3(8$;L;AR,X-;?A
M#QI:>,8!=V$HEB+,NX @AAU4JP#*>AP0"00PX()J:S\2M.T:=+.>YC%Q)-'$
ML(;?+ODQL!1-S*#D?,P"\C)&1F+3_BGIFH7SZ5%<(UXF[=&-W50"RAB-C,/X
ME5BRX;(&UL0^'/&FD:I>R0V$L$MW)"LLK0A7+(A$:EY4!5BNX *6W '@!3FM
MOQ-XKM?"\)N;Z5(8AGYG.,D MM4=68A20J@L<< US\7QDTQKJ.P>5XKF;'EQ
MS07%N6SD+@S1(.2"J\_,WRC+<5;^+'_('U#_ *\+O_T2]>5?L4_\@>?_ *_Y
M/_1,%>_T5%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %<UIWQ5TO4?/,5W"R6WE
M>=)O A7S<^7^].(SDC'RL<-\IP>*J>#OC1I'C*0P6-TCR]D(>)VX8_*LJH7P
M%).W.T<G&170>)O%=KX7A-S?2I#$,_,YQD@%MJCJS$*2%4%CC@&N5\,_'S1/
M$LPMK6\0RMC:KK)#N)(4*IE1 S$D *"6/8<&N_KE=/\ BKI>HS/;P7<,CQV[
M3N4<-&L2D*S-(,QC!(R"VX#YB,<UGZ)\<]%UNY-E;WD;3!BH!W(K-N"!4=U"
M2$L1M",Q8<KD<UT'BCQM9>%4\R_GCA!5V4.P#,$ +;%^\Y&1PH)R0 ,D5B:_
M\:-(\/PPW%U=(B3QQR1##M(R."R/Y:J9 I /S%0 ?E)!XK;T3QM9:Y;&^MIX
MWMU4LT@8!4 4.=^<;"%(+!\%1]X"H=+^(6FZO(L%M>6TLK9VI'/$[G ).%5B
M3@ DX[ FC5/B%IND2-!<WEM%*N-R23Q(XR 1E68$9!!&>Q!KA?VF+M+SPU=2
MQ,'1UMF5E(964W$)# C@@CD$<$5B? WQ_8^#/#-E-J$Z0J?M&T$DNV+J0':B
M@N^-PSM!V@Y.!S7JO@[Q_8^,XS-I\Z3*/O $AUR6 W(P#IG:<;@-P&1D<UY!
M^VM_R!X/^O\ C_\ 1,]>G_#*[2ST2QEE8(B:=;,S,0JJH@0EB3P !R2> *F\
M%>*=+U>2YATIX79)%DN#"HV%Y02'+J-DC-M.Y@6.1AB",5J^)O%=KX7A-S?2
MI#$,_,YQD@%MJCJS$*2%4%CC@&N5\,_'S1/$LPMK6\0RMC:KK)#N)(4*IE1
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M*H+'' -<KX9^/FB>)9A;6MXAE;&U762'<20H53*B!F)( 4$L>PX-=_7*Z?\
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MEM=AI96VHK1S1@MV7=)&JY/0 G).%&20*] N[M+-&EE8(B*69F(554#)8D\
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MU.U57)YP .@%>J_M56B3^'[IG4,4:W9"0"5;SXTW#/0[69<CG!(Z$US7PO\
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M6]'[-'POT_4M&@O+N!+F67S1^_59EC5)I5$<:N"$7.YR!RSLQ)/ 'G\.C_\
M"EO%\$%F,VMYY2+&6W,(IW\O:69"?DF3<N"6**JL^68UZ!^VM_R!X/\ K_C_
M /1,]>B^ ?#UMKVB:=%>0QSH+*T8+*BR*&$"@, X(S@D9ZX)]:\/_88_YB/_
M &Z?^W%=KX3DC^)7B2\N;@;H=(V06\3@X$I=]]QC>5W!HF"G;ROEL0KQ@UVW
MQG^#\/Q.M5MY'\F6.0/',$5RO9U()4E6'4!E^948YVX/7^'M-?2[:&WED,SQ
MPQHTK9W2,JA2YR6.6(R<DG)ZGK4VJ:3#J\;07,:2Q-C<DBJZ'!!&58$'! (S
MW -?+7[.]HEGXMU2*)0B(M\JJH"JJB[B 4 <  < #@"JG[:OAZVTM[*6WACC
M>9KMI61%1I&S"=SE0"QRQ.3DY)]37NOQ1\%VEMH6H6Z1 )]FFF;!(9I8T\Q9
M7;.^1]\:EF<LSD?.6R<\5^QA=O/HTBNQ8)>RJ@))"KY<+[1GH-S,V!QDD]2:
MX_X!?\CAJW_;_P#^ED==A^V!\0'\/:<EC#D/>LRLPR,11[3(N0P(+%E4C#*R
M%P<9%>JZ'\.+#1[)=-2"-K<*@=7CC(D90H\R0!0KN=BDL1DD ]A7SU\#99/A
MKXEN?#C2.]M)O,2Y#*&V+/'(Q(3#>0"KE!AGV@@JJLN?^VKX>MM+>REMX8XW
MF:[:5D14:1LPG<Y4 L<L3DY.2?4U[JG[/FBN(?.MA-)$Q8RR,S2RNS!W>9@1
MYQ9ADB0,HR550IVUX+_PBEJOCO[$L2);?\\D'EQX^P;RI5-H*L<[U/RN"RN&
M5B#VO[;6EQRZ;;7)7]ZEWY:MD\+)&[.,9P<F)#DC(QP1DY]0^%>@03:5;RR(
M))+NRMVN9)/WLDQ:($^:[[FD'SD ,2%4[5 4 5XK^PU=NR:A$6)16MF5<G:&
M83!F Z D*H)ZD*,]!7?_  ;^&+_"07]YJMY&XN)HR9G8H-JL^V21Y",.[2\K
ME@#C#N6X\P\-ZI')X]+V3;8)M^=@*)(#9^8S8P ZM(/,#<K(<2*6!#&U^W/_
M ,P[_M[_ /;>OIK6_#UMKR"*\ACG0,&"RHLBA@" P#@C."1GK@GUKYE_88_Y
MB/\ VZ?^W%:VFZA#\5/%\T%VF^UTZWG2*%U5HV=72&5G1BZG+.Q!&TD)$3RI
M![7]IKX:0^*M+FN@J+=6T?FK*0H8I$&9XBVQF*[6<JH('F;22!FC]GOQ(OQ'
MT)$U$?:6CD:&;SU1UD*%9(R0<[\(R?,PW%U).3\Q\?\ @EX4M=0\5:I:RQ(U
MNGVW;"1^YPMU&JJ8Q\C*.JJP*JP5@ RJ1H?ML6PTZYT^^AREP5F7S%9@P$31
MO'C!^4JTC$$8.3UX&/J^N5^*?A*;Q=IEQ86TODRS1[5?Y@.&#%&V\[7 *-C/
MRL?E;[IY_P %:/:_#32+?2=3FA=C'*I0\^<7=GDBCC.7F_UFP*JEGR/D!8+7
MDO[#5V[)J$18E%:V95R=H9A,&8#H"0J@GJ0HST%<S^Q[X%M?$\EW)>IYJ0_9
MRL+_ #0%G$R^8\9!5V50P0MD+O8@9P1K?M1_#2'P+):Z[I2I;L+A%9$"A!*H
M\R&1(]A0?ZMMX^Z2%.TDN3TO[2GQ=<:%:+"IC?5(4=L$G9%LCDD3<"A))D5#
M\I5DW@@9%>U:'\.+#1[)=-2"-K<*@=7CC(D90H\R0!0KN=BDL1DD ]A7SU\#
M99/AKXEN?#C2.]M)O,2Y#*&V+/'(Q(3#>0"KE!AGV@@JJLL7QWM$@\8Z6R*%
M+M8,Y  +-]J=-QQU.U57)YP .@%>J_M56B3^'[IG4,4:W9"0"5;SXTW#/0[6
M9<CG!(Z$U+^RY_R+MG_V\?\ I1+7E7[#'_,1_P"W3_VXKZJKRK]J/_D7;S_M
MW_\ 2B*C]ES_ )%VS_[>/_2B6O)?VB+877BW2XVR RV*DJS(V#=R@X9"&4^A
M4@@\@@UZ5^U+H$!\.R@(%%LUNT*K\JH?,2$85<# C=E Q@ \#(!'F%SXZGO?
M#FBZ8SS%[^X-N_D^4CM;13& PAF*JK%6C4$X# ,)&P6W>WW:)=6C::VBSBT9
M2IA4Z>D>"=QP$O!M.[Y@5P0WS AN:Y7]FKP1JGAVRN=-UJ "W+ PJ[QS!ED#
M":,A9'4)P#MP 2[D[LG'E_\ PBEJOCO[$L2);?\ /)!Y<>/L&\J53:"K'.]3
M\K@LKAE8@]K^VUI<<NFVUR5_>I=^6K9/"R1NSC&<')B0Y(R,<$9.?4/A7H$$
MVE6\LB"22[LK=KF23][),6B!/FN^YI!\Y #$A5.U0% %>*_L-7;LFH1%B45K
M9E7)VAF$P9@.@)"J">I"C/05]25Y+\2?@W<^+M9T_4TN MO:,C/$VXD,DGF[
MD .TE\*CD[2H53\^ H\__;(U^RU2PBCA>.6XAO0KE,2-$/+E#QNRY\LLRCY&
M*ERA(!\MMI\?+NYO/"&GRAI'+K8-<-EFW*;<G=(>X,NPY;@OM_BQ7H'@/XF:
M'\5K(:;B-"\*H]B^$*@ _+'@*'"A-RM'R@"L1&V /1?">A?\(_9V]ENW^1;Q
M1;\;=VQ F[&3C.,XR<>IK5KQKX-_#%_A(+^\U6\C<7$T9,SL4&U6?;)(\A&'
M=I>5RP!QAW+<>8>&]4CD\>E[)ML$V_.P%$D!L_,9L8 =6D'F!N5D.)%+ AC]
M:5POQJ\/6VJ:5>2W$,<CPV5VT3.BNT;>4QW(6!*G*@Y&#D#T%>'_ +)_PPL?
M%.FW$]_'Y_\ I$L*HY)CC!CA+NB\;)6RH,@^<!%"E<'.M<65M_;T>@V]K-<:
M?IMHT@L@8'B,TIW-*WVJ4>8H2X&-S;D?[@"[BW2_'7PY<_$;3VMX]+G^U(RM
M!)))9*$.Y?,Y2[9L,@((P03M)&5!''_'9-4B\)6J:@KK<I<1)=!6,@**)5C:
M1E=PVXB)F)8@RD=&P!Z+X#^)FA_%:R&FXC0O"J/8OA"H /RQX"APH3<K1\H
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M@I=K=4!(!9O/C?:,]3M5FP.< GH#7%>#O"[^)_ GV6+.\PW#J%4NS-%=23!
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M[\X.U@-7]M;_ ) \'_7_ !_^B9Z]5^$__('T_P#Z\+3_ -$I7S_^PQ_S$?\
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M?4(?BO;:QJ$&G:9)'<EEDEN'C99$CA564'<KXWF8Q@*-Q"EBP4%6KP_X^_\
M(X:3_P!N'_I9)7U57RK\ O\ D<-6_P"W_P#]+(ZZ#Q]XSF\9>)HO#$C/%8KG
MSQ$[(\^;4S%'9<$1$'84'4%F+9V;(OVP[2VT;1K:SMUCA'VT,D*!8QM$<V]E
M1<<!G&X@8RPSRW/=?\R?_P!P'_VSKE?V*?\ D#S_ /7_ "?^B8*]OA\0VT\[
M6:31M<(NYX0ZF55^7YB@.X#YEY(QR/45H45\J_L,?\Q'_MT_]N*/C[_R.&D_
M]N'_ *6255L;G_A4_C.5KQT2VOO.;S7& $G8R*?E8[<3IY99^-H+D*I!'O\
M\:]4CTS1;^29MJFTFC!P3\TBF*,< ]7<#/09R2!DURO[*O@Z3PUHL;3'YKJ1
MKD+Q\JNJ+&,ACG*('[$;MI *FO-/@%_R.&K?]O\ _P"ED='[<_\ S#O^WO\
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M>/NS%%#Y+#HZ*N "3OSP%->P?"_QU'XXT^"]C=&=HU$P3("2A1YD>&)888\
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M!VY7?(6?;\H.W.W(SC.37%>.OV6M)\873WLAFADDY<0M&J,W.9"&C?#'^(C
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M.-#ON;C+JF-BOMD4%5(W(F!'&S,8T3<V;7@[X-Z9X,D,VGQ/"Q^\!/<%&P&
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M33MG '#3.[ <= <9R<9)SH5YKJG[.6AZO(T]S;O+*V-SR7-T[G  &6:8DX
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MQERJYP9)))GY)/+RL[GKQDG P!P *M5YKJG[.6AZO(T]S;O+*V-SR7-T[G
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MSD*S#JIQ@GC'TK*_X6]8_P!K_P!@9?[7Y>[[A\O.SS/+W==WE_/G&S'&[?\
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M(I95VR2-M!QN(C5BH)X!. 2#C.TXF\)?%/3/%[*EA<),[1R2;!N#A4=48LK
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M$^+>FZS=G38IBMV%+>3+%-!)C ;@31ID[3NP.=N6QM!(YK]J/_D7;S_MW_\
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MM\+J/[/#,\32$D*9$7>43('F';ROE[MX^YNJ;P5\4],\;[AI]PDK+G*?,D@
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M!;:HZLQ"DA5!8XX!KFO"'QQT?QA.+2QNA),59@A26,D#DX\Q%#$#G R< G&
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M=G5()7\B0(-QQE%;H2VUW((!VHY]TMO$-M=0?;(YHVMPK,9E=3%M7.]MX.W
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MC(8$<$$<@C@BI:*Q=;\;V&@N(KRZ@@<J&"RRQQL5)(# .P.,@C/3(/I4-O\
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MA7?C>5/E!R"3ER6[C'FOQETY?@UKUGJ]C^YM;C EAA"*-L9C6>,1A53:R%2
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M;6S)F.YL(?.!9MS^9;HKY;.[[N%7!^1 J)M55 \?_8<U226&^MBW[I)()%7
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MK/(B+SV"@*!T   X%>GUY+-\&[F?Q,OB![@-;I#A(CN+JWE-#Y8R=H3YFDW
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MQSB?M#>*KKQ VE>')_\ 1Y[S[*]V5&Y%:1Q$$&)2'59 [%22"5C*OD$U[_\
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M#) "C&!P/G#]B#2X[F2]F=<O%]FV9)PI83J6"YV[MN5#8W!6=00'<&U\7O\
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MF[G;?,0T:.P:5^1$H4 +D*%4$Y;+'Q_]AC_F(_\ ;I_[<4? +_D<-6_[?_\
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MACECE+S2?+$&"R#:F[&]BR@#@'<5!S_VH_\ D7;S_MW_ /2B*C]ES_D7;/\
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MB6,LK!$33K9F9B%55$"$L2>  .23P!7@O[#'_,1_[=/_ &XH^/O_ ".&D_\
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M_D#Z?_UX6G_HE*^:OV1-=_X1^SUF]V[_ "+>&79G;NV)<OMS@XSC&<''H:]
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MAI$=F"XV]R0 5PX^4@U\Z_LV:I'J_BK4KF!MT4L=Y(C8(RK743*<$ C((."
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M+'"P.X2-+$PC";<[MV<@C(VY8D*"1Y_^Q3_R!Y_^O^3_ -$P5RG_ #4/_/\
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M:H?\*(TG[/\ 8?+F^R_\\/M=YY/WM_W//V_>^;I][GK4OA?X(Z5X5?S+"*2
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MR2-<S*,YCDD4(V01R8HXWXSD88<@9R,@^X6EHEFBQ1*$1%"JJ@*JJ!@* .
M. !P!7FOBC]G;3M;N_[1A:>SNBSLTMK+Y+,S *6.58*2,Y*!2Q9B^XG-;_@?
MX66GA!WN(S)-=2J%ENIY#-<.H/RJ6/  &!A0H(5=V2H-3>-?A?8>-]HU"-Y5
M7&$\Z=(P1NPVR.14W?,1NQNP<9Q@5#X5^$VG^$TDBL4DA216#*MQ<[?F !8
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MXN3@$EMJCS<*H+$A5 49X KM=+TQ=,C6&,N57.#))),_))Y>5G<]>,DX& .
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M&#$-<W1W. 0)&_??.X4[ [98(%0'8JJ+7A7X3:?X322*Q22%)%8,JW%SM^8
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M%3]T$DNV"H.U%!=\;AG:#M!R<#FLKP=\:-(\92&"QND>7LA#Q.W#'Y5E5"^
MI)VYVCDXR*Y_]J/_ )%V\_[=_P#THBK*_9X\66?A_P .V/VVXA@W_:=GFR)%
MNQ<2;L;R,XR,XZ9'K7I6E_$+3=7D6"VO+:65L[4CGB=S@$G"JQ)P 2<=@31J
MGQ"TW2)&@N;RVBE7&Y))XD<9 (RK,",@@C/8@UT%%5=4U:'2(VGN9$BB7&YY
M&5$&2 ,LQ &20!GN0*\D\4_''1_&&G7]I8W0DF.G7C!"DL9($+DX\Q%#$#G
MR< G& 2,7]BG_D#S_P#7_)_Z)@KT\>--(;44MTE@?49%EA&P+),%CS))$[("
M8P""=KE06!P"P-=!K^OP>'H'N[MQ'#&NYW;H!T[<DDX  R6)  )(%<+I_P"T
MCH%_OV7J#9&SG>DL>0N,A?,1=[<\(N7;LIP:]%N[M+-&EE8(B*69F(554#)8
MD\  <DG@"O.O^&D= \[[/]M3?YFS.R7R\YVY\S9Y>W/\>[9CYMV.:]%M+M+Q
M%EB8.CJ&5E(964C(8$<$$<@C@BOEK]AC_F(_]NG_ +<5]*^)O%=KX7A-S?2I
M#$,_,YQD@%MJCJS$*2%4%CC@&N5\,_'S1/$LPMK6\0RMC:KK)#N)(4*IE1 S
M$D *"6/8<&N_KSK7_P!H;0] G>TN;L++$VUU6.:0!NZ[HXV7(Z$ Y!RIP017
M8>'O%=KXD5WLI4F2.3RV>,[DW;%? 8?*WRNN2I(!R"<@@<_XQ^-&D>#9!!?7
M2)+W0!Y77A3\RQ*Y3(8$;L;AR,X-;?A#QI:>,8!=V$HEB+,NX @AAU4JP#*>
MAP0"00PX()A\8^/['P9&)M0G2%3]T$DNV"H.U%!=\;AG:#M!R<#FOGO]I[XD
M:?XYT2.33IQ,(]1B5QAT928)R,JZJV#S@XP2" 25./>OA/\ \@?3_P#KPM/_
M $2E=545W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5PNH_'G1].C^T2SN(#(T:S
M"WN6@9E+ A)5B,;\JV"K$'!() KNK2[2\198F#HZAE92&5E(R&!'!!'((X(K
MGQ\2M.:[33DN8WNI&E41(WF,&C!:17V9$9 !X<J200,D$5B_\+^T+[1]C^W0
M^9_>R?)^[N_UV/)Z?[?WOE^]Q7?UYU<_M#Z#;3_96O8RY95RH=XLMC'[U5,6
M.>3NPO.XC!QXU\ O^1PU;_M__P#2R.OJJBN:U?XCV.ES_8VD+W 4LT,,<MS*
MJC9\SI DC(/G7!8 '/&:/ _Q(T_QRCR:=.)A&P5QAT921D95U5L'G!Q@D$ D
MJ<;>J:M#I$;3W,B11+C<\C*B#) &68@#)( SW(%>2>*?CCH_C#3K^TL;H23'
M3KQ@A26,D"%R<>8BAB!S@9. 3C )&+^Q3_R!Y_\ K_D_]$P5ZKXU^*>F>"-H
MU"X2)FQA/F>0@[L-LC#/M^4C=C;D8SG J7P/\2-/\<H\FG3B81L%<8=&4D9&
M5=5;!YP<8)! )*G&KK^OP>'H'N[MQ'#&NYW;H!T[<DDX  R6)  )(%<KX9^.
M>B^)BZVUY&2BEF#[H#M"L[,/.5-P55+,5R% RV!BM6Q^)6G7EI'J(N8TM96*
MI+*WD*S LI4>;L.<HW&,D D<<UH:%XLL_$&[[%<0S[,;_*D27;G.W.PG&<'&
M>N#Z5GVGQ-TJ\=8HKZU=W8*JK<1,S,3@* 'R23P .2:T/$WBNU\+PFYOI4AB
M&?F<XR0"VU1U9B%)"J"QQP#7/Q?&33&NH[!Y7BN9L>7'-!<6Y;.0N#-$@Y(*
MKS\S?*,MQ6AX\^(MEX%@-S?2A!M8I'D&60C VQH2"QRP![+G+%5R1YK^S]\:
M8O%,5Q+?W,<<\^HR>1!),@=8RD(BB13M+ '*@A1O;<3EB:]/\8^/['P9&)M0
MG2%3]T$DNV"H.U%!=\;AG:#M!R<#FL_P/\7=+\<N\6G7 E>-0S+MDC;:3C<!
M(JE@#P2,@$C.-PSV%%> ?M(_M!0^';=].TV;=?295GB93Y #8<%AG$IP5"C#
MIRY*D)N]ETWQO8:HDDMO=02)"NZ5DEC=8UP3N<JQ"C"DY.!@'T-9_@KQ3I>K
MR7,.E/"[)(LEP85&PO*"0Y=1LD9MIW,"QR,,01BI?%_Q*T[P<";^YCB(56V%
MLRE2VT,(US(PSGD*0,$G@'&?XQ^-&D>#9!!?72)+W0!Y77A3\RQ*Y3(8$;L;
MAR,X-:$WQ*TZ"R75'N8UM'7*2EL!N&.T _,7^5AY8&_(*[=P(J+P5\4],\;[
MAI]PDK+G*?,D@ VY;9(%?;\P&[&W)QG.16KXF\5VOA>$W-]*D,0S\SG&2 6V
MJ.K,0I(506.. :YKPA\<='\83BTL;H23%68(4EC) Y./,10Q YP,G )Q@$CN
MJ*S];\0VV@H);R:.!"P4-*ZQJ6()"@N0,X!..N ?2N:N/C1I%M91ZE)=(MM+
MN\MB'#OM?RWVQE?-;#=<*<#YC\O-6_"7Q3TSQ;#+<V5PCQ0?ZUFW1;!C=N82
M!"%P"=Q&TX;GY3C/T3XYZ+K=R;*WO(VF#%0#N16;<$"H[J$D)8C:$9BPY7(Y
MK:U3XA:;I$C07-Y;12KC<DD\2.,@$95F!&001GL0:MZAXLL].A2ZGN(8X)-N
MR5Y$6-MP++M8D*<J"1@\CD<4:%XLL_$&[[%<0S[,;_*D27;G.W.PG&<'&>N#
MZ5B>./B[I?@9TBU&X$3R*65=LDC;0<;B(U8J"> 3@$@XSM.#P[\7M)\1C=:W
M4;@0RRMR4*1QLJN\@<*8P"PQOV[A\RY4$CRO5/VC;;5?$%I96UP(["%KC[1.
MSJD$K^1($&XXRBMT);:[D$ [4<^]:7JT.KQK/;2)+$V=KQLKH<$@X920<$$'
M'<$5:KRK]J/_ )%V\_[=_P#THBKG_@;X_L?!GAFRFU"=(5/VC:"27;%U(#M1
M07?&X9V@[0<G YKUOPAXTM/&, N["42Q%F7< 00PZJ58!E/0X(!((8<$$P^(
M?'MEX?D2WN)?W\GW(8T>:=AACN$42O)MPC9;;M&""<U5\)?%+3O%LTMK9S;I
MX?\ 61,DD,BX.T_+*B,<-PV =I(#8)&3_A;&C_\ 00L__ F'_P"+K:MO$-M=
M0?;(YHVMPK,9E=3%M7.]MX.W P<G.!@YZ55T3QO8:\YBL[J"=PI8K%+'(P4$
M L0C$XR0,],D>M9_C7XIZ9X(VC4+A(F;&$^9Y"#NPVR,,^WY2-V-N1C.<"I?
M _Q(T_QRCR:=.)A&P5QAT921D95U5L'G!Q@D$ DJ<=+17-:S\2M.T:=+.>YC
M%Q)-'$L(;?+ODQL!1-S*#D?,P"\C)&1G*UOXYZ+HER+*XO(UF+!2!N=5;<4*
MNZ*4C(8'<'92HY; YKM;2[2\198F#HZAE92&5E(R&!'!!'((X(KE-4^+>FZ:
M\L;3%S I:<PQ37"Q %P?,:".18R-C9#D$ $D8K6\(>-+3QC +NPE$L19EW $
M$,.JE6 93T." 2"&'!!.3XX^+NE^!G2+4;@1/(I95VR2-M!QN(C5BH)X!. 2
M#C.TXF\)?%/3/%[*EA<),[1R2;!N#A4=48LK ,GS,,!PI8'*@@$B'QQ\7=+\
M#.D6HW B>12RKMDD;:#C<1&K%03P"< D'&=IQ-X2^*>F>+V5+"X29VCDDV#<
M'"HZHQ96 9/F88#A2P.5! )%KQCX_L?!D8FU"=(5/W022[8*@[44%WQN&=H.
MT')P.:S_  /\7=+\<N\6G7 E>-0S+MDC;:3C<!(JE@#P2,@$C.-PSU=W=I9H
MTLK!$12S,Q"JJ@9+$G@ #DD\ 5PNE_'S1-5NEL(+Q&G:0QJ-L@1F&1A9"@C.
M2,*0Q#D@*22,^*?L,?\ ,1_[=/\ VXKZJJKJFK0Z1&T]S(D42XW/(RH@R0!E
MF( R2 ,]R!7RK>_$&WO?'$5U)<PFSAC,<<WF1B%5-H[$>8"%/[V1ADDG<=N>
M !]")H.D>-YX=40074MLQ6.9'60*W#;248JQ7=N4-DH3N7:3FJ'B;X^:)X:F
M-M=7B"5<[E19)MI!*E6,2.%8$$%20P[CD5U7AGQ7:^*(1<V,J31''S(<X) ;
M:PZJP# E6 89Y K/\7_$K3O!P)O[F.(A5;86S*5+;0PC7,C#.>0I P2> <1:
MA\4],T^^32I;A%O'V[8SNZL"54L!L5C_  JS!FRN =RYZJLKQ-XKM?"\)N;Z
M5(8AGYG.,D MM4=68A20J@L<< UXK\(/V@[?Q1?:C<7MPEM;?Z*MK%/+''A5
M$V\@$J"S'#/C<1E4W,JJ:/VUO^0/!_U_Q_\ HF>NJ\.?%/3/!&CZ<-0N$B9K
M"SPGS/(081AMD89]ORD;L;<C&<X%>BZ!K\'B&!+NT<20R+N1UZ$=._((.00<
M%2"" 016+XU^*>F>"-HU"X2)FQA/F>0@[L-LC#/M^4C=C;D8SG J7P/\2-/\
M<H\FG3B81L%<8=&4D9&5=5;!YP<8)! )*G'2T5Q_CCXNZ7X&=(M1N!$\BEE7
M;)(VT'&XB-6*@G@$X!(.,[3B;PE\4],\7LJ6%PDSM'))L&X.%1U1BRL R?,P
MP'"E@<J" 2+7C'Q_8^#(Q-J$Z0J?N@DEVP5!VHH+OC<,[0=H.3@<UG^!_B[I
M?CEWBTZX$KQJ&9=LD;;2<;@)%4L >"1D D9QN&>KN[M+-&EE8(B*69F(554#
M)8D\  <DG@"O.O\ AI'0/.^S_;4W^9LSLE\O.=N?,V>7MS_'NV8^;=CFNPU+
MQO8:6D<MQ=01I,NZ)GEC19%P#N0LP### Y&1@CU%2Z?XLL]1A>Z@N(9((]V^
M5)$:-=H#-N8$J,*03D\#D\54TOXA:;J\BP6UY;2RMG:D<\3N< DX56). "3C
ML":F\4>-K+PJGF7\\<(*NRAV 9@@!;8OWG(R.%!.2 !DBL35OC1I&C_9OM%T
MB?:XTDAW!QE'QL=OE_=J<_>DVCAN?E;$OB'QII&GW<$5W+ ;T3+%"N%DN$>8
M   *&>,.N 6.U2"-QP157XJ_&*R^',#27#AY]H,=NK 2N3D*<<E4RIRY&!@@
M;FPIY_\ 9[^)D7B'3;9+N[CDU"1KAGC:5//)\Z5O]6#N "8(  "H!@!0*ZH>
M--(;44MTE@?49%EA&P+),%CS))$[("8P""=KE06!P"P-=7=W:6:-+*P1$4LS
M,0JJH&2Q)X  Y)/ %>=?\-(Z!YWV?[:F_P S9G9+Y><[<^9L\O;G^/=LQ\V[
M'->E5YK_ ,-(Z!YWV?[:F_S-F=DOEYSMSYFSR]N?X]VS'S;L<UW6@Z_!K\0N
M;1Q+$S.JNO*DH[1M@]QN4@$<$<J2"#6A575-6ATB-I[F1(HEQN>1E1!D@#+,
M0!DD 9[D"N9B^+VDR6TM\+J/[/#,\32$D*9$7>43('F';ROE[MX^YNH\#_%W
M2_'+O%IUP)7C4,R[9(VVDXW 2*I8 \$C(!(SC<,T/^%_:%]H^Q_;H?,_O9/D
M_=W?Z['D]/\ ;^]\OWN*[^N%OOCAI-FDDQG+PQ,%>:*&>>W5B%(4S11O%GYU
MXW9!(!YXKJM U^#Q# EW:.)(9%W(Z]".G?D$'((."I!! ((K*'Q*TYKM-.2Y
MC>ZD:51$C>8P:,%I%?9D1D 'ARI)! R017'^+/BGIGB[3=5MK"X2:6&PN]ZK
MN''ENI92P =<\;D++RO/S+GE?V*?^0//_P!?\G_HF"O5?^%L:/\ ]!"S_P#
MF'_XNN@U35H=(C:>YD2*)<;GD9409( RS$ 9) &>Y KA- _:&T/7YTM+:[#2
MRMM16CFC!;LNZ2-5R>@!.2<*,D@5T'CSXBV7@6 W-]*$&UBD>099",#;&A(+
M'+ 'LN<L57)'FO[/WQIB\4Q7$M_<QQSSZC)Y$$DR!UC*0B*)%.TL <J"%&]M
MQ.6)KO\ QQ\7=+\#.D6HW B>12RKMDD;:#C<1&K%03P"< D'&=IQ-X2^*>F>
M+V5+"X29VCDDV#<'"HZHQ96 9/F88#A2P.5! )'555U35H=(C:>YD2*)<;GD
M9409( RS$ 9) &>Y KP7PC^T;;>)M?ES<"#38K*1(S,ZPI++YT69</MY*Y"*
MQ+!06PI=U'O7]K0^3]J\Q/(\OS/-W+Y>S&[?NSMV[>=V<8YSBO/_ /AI'0/.
M^S_;4W^9LSLE\O.=N?,V>7MS_'NV8^;=CFO1;2[2\198F#HZAE92&5E(R&!'
M!!'((X(J6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBOE7X^_P#(X:3_ -N'_I9)7T!\6/\ D#ZA_P!>
M%W_Z)>O'_P!BG2X_[-GN2N9?M<D88DG"^7 Q"@G"Y."Q !?:FXG8FWG] _XI
M_P ?306OR1S^9YH^]NWVHN7Y;)&9@&X(Q]T87BO4)O@W<S^)E\0/<!K=(<)$
M=Q=6\IH?+&3M"?,TFX'.XE=G)>O&OVO?%=KJ,VGW6FRH\L?GYN(#NP5,31J)
MDXW(26VAMT>\,0N]2WM7[4?_ "+MY_V[_P#I1%1^RY_R+MG_ -O'_I1+7JM%
M?*O[#'_,1_[=/_;BNK_;6_Y \'_7_'_Z)GKT#X6^%K>?0;:V9,QW-A#YP+-N
M?S+=%?+9W?=PJX/R(%1-JJH'A_['OB\Z-8:H\Q+6]JL=QL4+NSY<ID(SC)*P
MJ "<9';))[#]GW5)GLO[5DL;F[O+N29I;L&Q!8;_ "Q&A>>*18@(EPA4*&!V
MC;MQ4N_ VIP^)(-9TNP>VMY-BW@DEMU#[W832%(KE\_(5< =94#E6;);Z*HK
MY%^,7AZVT'Q;I,5G#' A:Q8K$BQJ6-VX+$( ,X &>N /2OH#XU>'K;5-*O);
MB&.1X;*[:)G17:-O*8[D+ E3E0<C!R!Z"O*OV,- @GTZ2[= TT=[*L;M\Q0&
M&$-LSD(6#8<K@N H8D*H'/Z-;#1?B \-ME$D:1I%#-AC)9F=\Y/(,OSX/ (&
M ,#$O[<__,._[>__ &WKZ:\0ZVF@VTUY*"4@ADE8+@L512Y R0,X'&2!GN*\
M+_96M$\6"\\07BB2]EO74,P#>4HC4A8B^YT&V4IC<1L5%Z#GG_VJ_"9\&SVO
MB+2R+>83&.0QA4)D;?(LF F'+#S%E+D[QM4J1NKUKXDPV?C'09M0>!'SID\\
M!EC1I(]]N9 03NV-PN=IZ@<G ->/_LG_  PL?%.FW$]_'Y_^D2PJCDF.,&.$
MNZ+QLE;*@R#YP$4*5P<S?M3?#73O!VC0"PMHXB+U%WA<RE3'.Q4R-F1AG'!8
M@8 ' &/9?A;X6MY]!MK9DS'<V$/G LVY_,MT5\MG=]W"K@_(@5$VJJ@>%?L6
M:7'JWVP7"^8L$EM)"CDM&DC>9F54)*"7]VH$F-Z@85@"0;7QM_XEWC+2Y(/W
M;R?8M[)\K-NN)(FW$8)S& ASU3Y3QQ7J'Q)^#=SXNUG3]32X"V]HR,\3;B0R
M2>;N0 [27PJ.3M*A5/SX"CS_ /;(U^RU2PBCA>.6XAO0KE,2-$/+E#QNRY\L
MLRCY&*ERA(!\MMO0?%:[>\\$K+*Q=WLM.9F8EF9B]N2Q)Y))Y)/)-=+^RY_R
M+MG_ -O'_I1+7C7QB\/6V@^+=)BLX8X$+6+%8D6-2QNW!8A !G  SUP!Z5V'
M[3GB;^U[[3O#672*ZN('N&4[24>;RD4')!P0[$,A&Y8V'0BO9=<^'%AK%DVF
MO!&MN5<(J1Q@1LP8>9&"I5'&]B& R"2>YKPK]DK7Y]'N[[P[=.7-LSM&!\T2
M&.4QS[2V' 9V1E&,?>;"L3NYKXV^%+73/%6EVUK$D$3_ &+<L \CEKJ12P,6
MPAL #<"&&!@C KU7]ISPI:VOAR9(HDC2WDADA2,>6B,TRHQ"IA>5E?((QEB<
M9P:V_P!F6[>Z\/V32,6(6906))VK/(B+SV"@*!T   X%>GUPOQJ\/6VJ:5>2
MW$,<CPV5VT3.BNT;>4QW(6!*G*@Y&#D#T%>7_L4Z7'_9L]R5S+]KDC#$DX7R
MX&(4$X7)P6( +[4W$[$V\?%H,47CN6S4$03LYFC#N%DWVOVAU?YOG1I?F:-L
MHP^4J5^6NP_;-TF&UT>U\N-%\J[CCCVJHV(89<HN!\J_(ORC ^5>.!7:ZI_Q
M-_"+/<_O6;11(QD^<EQ;"0.2V<L' 8,>=P!SGFN5_8I_Y \__7_)_P"B8*X^
MVM$M?B%MC4*"S,0H &YK N[<=RQ+$]222>36A^T/XM_X1'Q)IM_=Q/-9PV^X
M)U3>7E5W3=\GFIF-^QRL>67Y6'K3OI/Q>C@N;2:.5[2Y@GC< ^;&4E#,I0E'
M02+&RX<8/#A6VK7C7[<__,._[>__ &WKZJHKP#]M;_D#P?\ 7_'_ .B9ZZ#X
M6_!K2[S1[9KJW2XDN+2%Y)9@))OGA0!5D(W1JBX2,(5V*H(^;+'RKX)1R?#+
MQ3<: IWP3[@#D$@+&UQ ['8"6$9*,!M7<Y/(5:[#0?$7_"6^(=0N'M9[U-/:
M."VC'V39 X8^;*!/+'\YEARDBDMMX;&$"GQ]\&W_ (]2"?3]-GAOX)E*SM+9
MQL(P&.T-'=L<B3:RY'RG<5(W'/NGAZ:>>VA>\4)<-#&9D7E5D*@NH^9N V0.
M3QW/6M"OD7]M7P];:6]E+;PQQO,UVTK(BHTC9A.YRH!8Y8G)R<D^IKWO5O@3
MI.KV\EO/;HTDN\O<[(Q=&1F+M+Y@088N2V  G\ 3R_DKQK]D;5Y] O[_ ,/3
M881-))N4_*)(I%@DQE S!\K@DC 3[N6-5/V=[1+/Q;JD42A$1;Y550%55%W$
M H X  X ' %'[<MHBOI\H4!V6Y5FP-Q53"54GJ0"S$#H"QQU-=A^VM_R!X/^
MO^/_ -$SUT'PM^#6EWFCVS75NEQ)<6D+R2S 23?/"@"K(1NC5%PD80KL501\
MV6/E7P2CD^&7BFXT!3O@GW '() 6-KB!V.P$L(R48#:NYR>0JU:_;G_YAW_;
MW_[;U]-:WX>MM>017D,<Z!@P65%D4, 0& <$9P2,]<$^M?,O[#'_ #$?^W3_
M -N*[7X"R1_$.]O?$TPW/]H-M:*P.8(D13D9=U5G60;]O1O,VG$C"NF^,GP.
M3XBO;W,4YM+JW;Y9D0,Q7(8#(9'!5QN0AL*2_&6R(?VH_P#D7;S_ +=__2B*
MLKX#>&8?%'A."QN1F*:.Z1N%)&;B7#+N# ,IPRD@X8 ]JX7]E&Y/@S4;_0+W
M"7&X,AVJN\Q[@V&8+(X9&62,8(V!W 7)W>Z-:)K&KB4J"+&V95; ;][<LI90
M?X'2*%21RS)<#.U2-_845\X?&/4A\0/$5EX9=Q]DC99KA=K;FD6.27RRV5.#
M#@ H1M,A)W,H"^E?'#P=;:IH5U;L@5+>V>6$*JCRV@0N@7Y2%&%V': =A901
MFN _8UM$O-$N8I5#H][,K*P#*RF" %2#P01P0>"*X_2])ATCQ^L%M&D42YVI
M&JH@SIY)PJ@ 9))..Y)KI?VPM2?2WTNX>,S6L=S(\L1SY,C*8F1'R&3+() N
MX$[2^ 1N%=U+KNC?'C3Y+.&5&=HRP1QB>"0*-LNS<K'8S@%D)1LE-Y!(.+\;
M+\>*]6T[PPQ*PSL;FY^\!)'&)&2'*R*<,8GW9'RGRW4DJ17JNO\ @ZVURR?3
M9$"V[P^4%55 1<80H"I52F 4XPI ('%<_P#!KX9O\.;(V#W!N1YSNC%3&$5@
MOR!2[X&X,W! )8G&<D^'_L,?\Q'_ +=/_;BM;3=0A^*GB^:"[3?:Z=;SI%"Z
MJT;.KI#*SHQ=3EG8@C:2$B)Y4@]K^TU\-(?%6ES705%NK:/S5E(4,4B#,\1;
M8S%=K.54$#S-I) S63\*?'5UXP\*W$BO-)?0V]W#O'^M:18RT10H=S-M= &^
M^7!)R?F/*_LM_&S2](L5TJZ9+6=9)&\Q\+'-N+/O9\!595 3YR,@(%8D[5]*
M\464/P>TG4[JR'EJ\C31)&BXBEE2*!<!R5*B4;R,!54E50A0#G_!B9]"TZ"2
M+3KJ66XA26:YW6'F3O)F4NSM=)(XS(VSS!N"D \YK ^''@#4O#/B*:[M+(VN
MDW*D/&TD)V$1[@PCBG< ^<"%QN"([!0H/RY_PBGC^+7B"\UBY*2Q6.R.S7RR
MJA3)*89?F(.X!&;YP3ODW#9L0 _;:\,PO9VVH8Q.EQY&0%^9'1Y,,<;CM9/E
MYP-S\9;(]J^$_P#R!]/_ .O"T_\ 1*5U5>=?'GX<7/Q"TXV5G,(G\Z-R&+".
M15SE&*9.,D./E8;D7@?>7*^(KV7AK0)=&N9HY)H]**1QD RN8X2J2B(%W #Q
M[]PR(]I<L A8<U^QW_Q,]#F@N/WD7VN:/8_SIL:*(LFULC:2[$KT)8DCDUY_
M_P (I:KX[^Q+$B6W_/)!Y<>/L&\J53:"K'.]3\K@LKAE8@]A^V?H$%OI5I(B
M!3#<K%$%^54C:)RR!1A0/W28XX"X& 3F+XS_ !/FT/PO81+)FYO[2%)&<-([
M1&W4SMN.1N)=5);+$.2OS#<OM7@7X<6OA'3TTR-$:/R\393B9F4+([JQ;.[N
M"2 N$'R@"OF_]F'1$T'Q/J%G$24@ANXE+8+%4NHD!. !G YP ,]A7UU17C7P
M;^&+_"07]YJMY&XN)HR9G8H-JL^V21Y",.[2\KE@#C#N6X\P\-ZI')X]+V3;
M8)M^=@*)(#9^8S8P ZM(/,#<K(<2*6!#'I?C'J0^('B*R\,NX^R1LLUPNUMS
M2+')+Y9;*G!AP 4(VF0D[F4!?2OCAX.MM4T*ZMV0*EO;/+"%51Y;0(70+\I"
MC"[#M .PLH(S7FO[)>MIH/AZ\O)02D%S<2L%P6*I;PN0,D#.!QD@9[BM#]GW
M5)GLO[5DL;F[O+N29I;L&Q!8;_+$:%YXI%B B7"%0H8':-NW%2[\#:G#XD@U
MG2[![:WDV+>"26W4/O=A-(4BN7S\A5P!UE0.59LELI9(_B]XO>WNANL]-CE"
MPN"5=HW6-RPWE>97W9QAXXT1TZX[K]K+0(+_ $.:YE0-+;M$T3_Q(7FCC?!'
M8J<$'@D XRJD6_V9[1+SPU:Q2J'1UN596 964W$P*D'@@C@@\$5Y?^PQ_P Q
M'_MT_P#;BHOCO:)!XQTMD4*7:P9R  6;[4Z;CCJ=JJN3S@ = *]5^)/P;N?%
MVLZ?J:7 6WM&1GB;<2&23S=R ':2^%1R=I4*I^? 4>?_ +9&OV6J6$4<+QRW
M$-Z%<IB1HAY<H>-V7/EEF4?(Q4N4) /EMM]+N[M[SPDTLK%W?0RS,Q+,S&TR
M6)/))/))Y)KC_P!BG_D#S_\ 7_)_Z)@JI\%O%)\5W%[KK6=S>2-=O';R?Z$/
M(A1<QQ()9XVC;;,?,V95L@DEBY,7Q;\&ZKK6HVFLZ+ILD-W Q,SR2VJ>:%V"
M-6\J[.X;=Z/]TLA"$E0 OT?17RK^W/\ \P[_ +>__;>OIK6_#UMKR"*\ACG0
M,&"RHLBA@" P#@C."1GK@GUKYE_88_YB/_;I_P"W%9_[:OAZVTM[*6WACC>9
MKMI61%1I&S"=SE0"QRQ.3DY)]37O?Q7\+6ZZ#>VNS]TEI/(!N;.] TRNS9W,
MQE4.S,27;)<MN.?-/V-M+COM-:YF7S)8+N6.%G)?RE,<;,(@Q(CW&1BY0*7S
M\Y.!CG]/_P")=\07C@_=I)NWJGRJVZR$K;@, YD <YZO\QYYKIM!\1?\);XA
MU"X>UGO4T]HX+:,?9-D#ACYLH$\L?SF6'*2*2VWAL80*?'WP;?\ CU()]/TV
M>&_@F4K.TMG&PC 8[0T=VQR)-K+D?*=Q4C<<^Z>'IIY[:%[Q0EPT,9F1>560
MJ"ZCYFX#9 Y/'<]:T*\:_:J\/6T^BW5X\,;7"+;JDQ13*J_:(_E#D;@/F;@'
M')]34W[*>EQV^A6\ZK^\E\[>Q))(6>8*HR3A1DD*,*&9VQN=B?'_ (">%K=_
M$FIZ8R;K./[5BW9F:%O*N5CBWHQ*R[58[?,#8;YA\P!&K^VU_H$VFW4/R3C[
M1B5?ED&PPM'\PPWRLQ*\_*22,$FNF_;8M$;2K>4J"ZWJJK8&X*T4I90>H!*J
M2.A*C/05ZI\,K1+S1+&*50Z/IULK*P#*RF! 5(/!!'!!X(KP7]AC_F(_]NG_
M +<55\%?%6W\ >)-5_MA74SW$BI<.K.\:*[M&F-ID\IXRFW;D86/Y2N&7Z$T
MGPS9:E?KKUD\;&2VD@>2(AUE'F1%6+JQ4E/*9,X)((4L @%>"_\ -0_\_P#0
M.KZJHKRK]J/_ )%V\_[=_P#THBJK^RGI<=OH5O.J_O)?.WL222%GF"J,DX49
M)"C"AF=L;G8GS3]F?_B2>)-5TVW^2U7[1B/[W^IN1'%\S9;Y5D8=><Y;) (]
M+\&?":;PEK6H:_>W2-!-')LW%@R(S+(V]G.U%C6,(N"04&?W8&VO)/BGK\%W
MXOTRYTYP0[62O+%PLA-P\;X=<"0>7^[8@L, Q$Y5E&M^V%\/3:O#K]L@)5DC
MN 45UR#F&1U,95A_RS<R$@CRD"D9KW_0/'D&J:8FKN0D)MO/DVGS1& FZ5<J
M,L4(92 ,Y4C:#Q65X8L4\!Z=<7UQ&4=VNK^Z12'8.^97C!W;&*(!&""JN4WX
M7<:\Z_9]U29[+^U9+&YN[R[DF:6[!L06&_RQ&A>>*18@(EPA4*&!VC;MQ4N_
M VIP^)(-9TNP>VMY-BW@DEMU#[W832%(KE\_(5< =94#E6;);Z*HKY ^-OAB
MWTCQ5I=O8QI:J_V(_N(XX\,;J1?,"["A88'+*PX ((XKVKQU^SKI>N:>]G:V
MT,$RQ_N)54(X=5(3?(%9W4]'W;B02WWPK#SK]D[7Y_$^D7NCAS$85*PSK]Z,
M7"RXP%V'*2*S@[LDM@%0HKT#X->#D^#&F&'5;J!#+<NY<N(X@S(JJ@:39N.V
M/=T4]0 0NX^5?LU7(C\3ZI#;YCMRMTRQ;6B4!;I!'F,A=I56( *@H"5P,D5%
MX*^*MOX \2:K_;"NIGN)%2X=6=XT5W:-,;3)Y3QE-NW(PL?RE<,OT)I/AFRU
M*_77K)XV,EM) \D1#K*/,B*L75BI*>4R9P200I8! *^>_!7Q5M_ 'B35?[85
MU,]Q(J7#JSO&BN[1IC:9/*>,IMVY&%C^4KAE^A-)\,V6I7ZZ]9/&QDMI('DB
M(=91YD15BZL5)3RF3."2"%+ (!7DOP6\4GQ7<7NNM9W-Y(UV\=O)_H0\B%%S
M'$@EGC:-MLQ\S9E6R"26+DQ?%OP;JNM:C::SHNFR0W<#$S/)+:IYH78(U;RK
ML[AMWH_W2R$(25 "V_VH_$[ZE-8^&H9!&+Z:+[0=A=E0S(D)&<+C>&8@$,2@
M&54G=Z_=_#JRGTYM&6():-"8PB@':#R'&\-\X;YP[9._YSEN:^>OV&/^8C_V
MZ?\ MQ7U517RK_S4/_/_ $#J];_:/^(#^"=(EEAR)IV$$3#(V,ZL6?(964A%
M8H1DA]O!&:E^!O@.STG1;9$B1OM-I$\Y9$+2^:ID*N0HWJ/,95#9PG'/)/C4
M$)^$'C!+:!BMEJ#(?)3;MQ,7CC4KM15"3Y*[>5BX!)+*:G[:OAZVTM[*6WAC
MC>9KMI61%1I&S"=SE0"QRQ.3DY)]37O=C\"-(MFMY6@WW%O)YBW#._GO+O$A
MEE=2OFL7&[Y\J,D* IQ7?T5\J_L,?\Q'_MT_]N*ZO]M;_D#P?]?\?_HF>O0/
MA;X6MY]!MK9DS'<V$/G LVY_,MT5\MG=]W"K@_(@5$VJJ@>'_L>^+SHUAJCS
M$M;VJQW&Q0N[/ERF0C.,DK"H )QD=LDGL/V?=4F>R_M62QN;N\NY)FENP;$%
MAO\ +$:%YXI%B B7"%0H8':-NW%2[\#:G#XD@UG2[![:WDV+>"26W4/O=A-(
M4BN7S\A5P!UE0.59LEOHJBODOP5\5;?P!XDU7^V%=3/<2*EPZL[QHKNT:8VF
M3RGC*;=N1A8_E*X9?H32?#-EJ5^NO63QL9+:2!Y(B'64>9$58NK%24\IDS@D
M@A2P" 5Y+\%O%)\5W%[KK6=S>2-=O';R?Z$/(A1<QQ()9XVC;;,?,V95L@DE
MBY,7Q;\&ZKK6HVFLZ+ILD-W Q,SR2VJ>:%V"-6\J[.X;=Z/]TLA"$E0 O0?&
MR_'BO5M.\,,2L,[&YN?O 21QB1DARLBG#&)]V1\I\MU)*D5ZKK_@ZVURR?39
M$"V[P^4%55 1<80H"I52F 4XPI ('%>7I\*/^$#\,ZAIT\WVM!;W<J%X]JI^
MZW*JJ7D Q(ID!!&'.X 'DY7[%/\ R!Y_^O\ D_\ 1,%<?;6B6OQ"VQJ%!9F(
M4 #<U@7=N.Y8EB>I))/)KH/VS_#UM!IT=XD,:W#WL2O,$42LODS?*7 W$?*O
M!..!Z"NE^'OP(TC6]'LVO8//DEM[>9Y7=_.R85"H)$*L(E7")&#L"JIP6&X^
M7_&+P];:#XMTF*SAC@0M8L5B18U+&[<%B$ &< #/7 'I7LO[4?\ R+MY_P!N
M_P#Z415%^S/:)>>&K6*50Z.MRK*P#*RFXF!4@\$$<$'@BO)=+TF'2/'ZP6T:
M11+G:D:JB#.GDG"J !DDDX[DFN_^-WB$ZGK.FZ'LFFA;=<W%O'Y($X3<T*$S
M,JLH:%S(C%5*D8RX7;M_$73'\6:9+IHTB< 0D6X+6")%(J$0L-EYE IP/E'W
M<K@J2IX6]T?6=#\%W5G?HZ7$.$CV/YCFV\R)FW-&[_*$,B$< 1+@C:"3M? #
MXP:1KFG0:/+Y<$RPB%K>0*(YL[4+*2 CF5GR4/SEB_RL!O;UKP'X.C\&VBV,
M!_=)).4'/RK),\JIRS$[0X7).6QDXSBN@KA?C5X>MM4TJ\EN(8Y'ALKMHF=%
M=HV\ICN0L"5.5!R,'('H*\O_ &*=+C_LV>Y*YE^UR1AB2<+Y<#$*"<+DX+$
M%]J;B=B;>/BT&*+QW+9J"()V<S1AW"R;[7[0ZO\ -\Z-+\S1ME&'RE2ORUV'
M[9NDPVNCVOEQHOE7<<<>U5&Q##+E%P/E7Y%^48'RKQP*[N;P]<^._#$5K'.4
MN+C3K7,K%B68QQNX=@=Q#X*N>3AB2&^Z9?!6CVOPTTBWTG4YH78QRJ4//G%W
M9Y(HXSEYO]9L"JI9\CY 6"UX_P#L2_Z?#J5K-\\!^SYB;YHSO$RR?*<K\RJ
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MNW(PL?RE<,OT)I/AFRU*_77K)XV,EM) \D1#K*/,B*L75BI*>4R9P200I8!
M*["BOE7X!?\ (X:M_P!O_P#Z61UT'[3GB;^U[[3O#672*ZN('N&4[24>;RD4
M')!P0[$,A&Y8V'0BO9=<^'%AK%DVFO!&MN5<(J1Q@1LP8>9&"I5'&]B& R"2
M>YKPK]DK7Y]'N[[P[=.7-LSM&!\T2&.4QS[2V' 9V1E&,?>;"L3N^FJ*****
M************************************************************
M*********^5?C[_R.&D_]N'_ *625] ?%C_D#ZA_UX7?_HEZ\J_8I_Y \_\
MU_R?^B8*Y3_FH?\ G_H'5MZ/XH?XK^);G3+[(L+%9]MLK'RIGAGC0/,,#S!N
M^<(?E7:HP?G+\U^VUY-K_9MK#L7RH[C$2[1L0^2L?RC[J_(0O 'RD#H:]?\
MVH_^1=O/^W?_ -*(J/V7/^1=L_\ MX_]*):]5HKY5_88_P"8C_VZ?^W%=7^V
MM_R!X/\ K_C_ /1,]>J_"?\ Y ^G_P#7A:?^B4KYE_9/T1]>L-;LXB \]M%$
MI;(4,\=R@)P"<9/. 3CL:VOV8/C9#X=C;0=6;[.T4DIB>7;&B\EI('W!=C!]
MS N3DDIE2$5O:]6^,5G+-;66FS0W5U<W"*$C=)56)2'N)'*N NV$,4&2S/C:
MK -COZ*^5?C[_P CAI/_ &X?^EDE?0'Q8_Y ^H?]>%W_ .B7KRK]BG_D#S_]
M?\G_ *)@KE/^:A_Y_P"@=1^W/_S#O^WO_P!MZ^E?%FA?\)!9W%ENV>?;RQ;\
M;MN]"F[&1G&<XR,^HKYU_8_\3?V')>:!>%([A+AG2,GYV=08[A0P)1MOEJ0%
MY(WL-R@E>@_;$_XF5G9:;%\UU<7Z>3'TW81XS\QPH^:5!\Q'WL] 2/0/%FA?
M\(_X;N++=O\ (TB6+?C;NV6Q3=C)QG&<9./4UY_^Q3_R!Y_^O^3_ -$P4?MK
M?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2OG_\ 88_YB/\ VZ?^W%'Q]_Y'
M#2?^W#_TLDKH/'WC.;QEXFB\,2,\5BN?/$3LCSYM3,4=EP1$0=A0=068MG9L
MB_;#M+;1M&MK.W6.$?;0R0H%C&T1S;V5%QP&<;B!C+#/+<Z'Q+_Y$:/_ *\-
M,_\ 0K>NJ_9<_P"1=L_^WC_THEKRKX^_\CAI/_;A_P"EDE3?M<Z1/H%_8>(8
M<,(FCCVL/E$D4C3QYPX9@^6R !@)][+"OI30-?@\0P)=VCB2&1=R.O0CIWY!
M!R"#@J000""*^>_V9]"_MG6-5UZ)LVLEQ<10G&-_F3"<M@D,NU0G#+SOZ@J1
M63\??^1PTG_MP_\ 2R2O5?VH_P#D7;S_ +=__2B*C]ES_D7;/_MX_P#2B6O5
M:Y7XL?\ ('U#_KPN_P#T2]>5?L4_\@>?_K_D_P#1,%<I_P U#_S_ - ZNK_;
M6_Y \'_7_'_Z)GKJO^9/_P"X#_[9URO[%/\ R!Y_^O\ D_\ 1,%<?;7:77Q"
MW1L& 9E)4@C<M@4=>.X8%2.H((/(KWKQ#/8^*KR30;^%)?\ 1$N5#@MD,\L#
ME3M_=LGRX8,'_>?+C:37SA\:/A&/@M/;:[I$A""Y \IV8E7.]PH9=K-"44HR
MLV['!9]YV[7[<_\ S#O^WO\ ]MZ^JJ*\ _;6_P"0/!_U_P ?_HF>O3_@[=I=
M:-8-&P8"RMU)4@C<L:HZ\=PP*D=000>17C?PVTM?''BZ\UR!7-G;YCCF!3RW
ME6)+<@$%MZE-[@J> 8RQ&X*>9TOQV_P8\3WR:@#]DO9FD9E4D!9)&DAF&4W.
M$WNCA#C._&]D4'Z U_XXZ-HL#W+7L$@1<^7%+'+*QZ!516R23QV ZL0H)'5>
M'IIY[:%[Q0EPT,9F1>560J"ZCYFX#9 Y/'<]:T*^5?VY_P#F'?\ ;W_[;U]0
M?VM#Y/VKS$\CR_,\W<OE[,;M^[.W;MYW9QCG.*^;_P!ES2#K^JZGXA3*V\LT
M\<2L%W$RRK.V<.=I10F1@@E^&^4UG_ +_D<-6_[?_P#TLCJ+]N6[1GT^(,"Z
MK<LRY&X*QA"L1U )5@#T)4XZ&NP_;6_Y \'_ %_Q_P#HF>O3_@[=I=:-8-&P
M8"RMU)4@C<L:HZ\=PP*D=000>17C?PVTM?''BZ\UR!7-G;YCCF!3RWE6)+<@
M$%MZE-[@J> 8RQ&X*<G]N?\ YAW_ &]_^V]?55?*O[#'_,1_[=/_ &XJK\!?
M'L?PFU"]T#5)?+@%P?*ED0QCS RQAB-K%5ECV.&9]B*H.<,6KVKQA\<K&S5(
M-.N;:XOKB1(K>,2&2/>\B1AI&A#[57?N()4N%*J<\BI^U'_R+MY_V[_^E$5'
M[+G_ "+MG_V\?^E$M>5?M1^'YO!&IVOB>QX8R(LG+ &5%^0-B0,5DB4HRJ%7
M:AR<R5]"_#NT>.T6>92LURSW$JL")%:4[UB8G#$Q(5A!(!VQJ-J@!1TM%?)?
MQ1O&^'7C*'6+I<VLVPAQOP%, M922$.63_6%%W$J4&06X]U^,WBNUL=#NYY)
M4$<]I+'"P.X2-+$PC";<[MV<@C(VY8D*"1Y_^Q3_ ,@>?_K_ )/_ $3!7*?\
MU#_S_P! ZOH#Q5K=J]U;Z1>Q)(E['<%5D7S$9H/*?84*LI^5F<%B #& ,EAC
MYU^/W[.EOX)MSK6CR/!Y$D;-&78[<LB(\3\N&#D,=S'J2K+M"L?&;Q)=:+<:
M)XM49:2TA$J*NV,$KYCQ[V\S;YB32*H(+*$+ L1Q[U;?'70[F#[4M] $"LV&
M<)+A<Y_=-B7/' VY;C:#D9T/AOXQ;QE;O? )]G>XF%L5W[FBC;R@[[U7#,Z.
MP 'RH5!RP8U\_P#[#'_,1_[=/_;BJMC<_P#"I_&<K7CHEM?><WFN, ).QD4_
M*QVXG3RRS\;07(52"/?_ (UZI'IFBW\DS;5-I-&#@GYI%,48X!ZNX&>@SDD#
M)KS_ . .ER?#KPS)?3+O9HY[X1Y"_+Y0,:[@7^\D8;.,KOP5RISK>-?@%HWQ
M/A6^@7R99XQ*EQ$NS?O#.K21D -DN&8D+*< %Q7C7@+1+_5=#USPYD2/93(8
MPOF/EEF9Y8TX)()MR8U"J2[DM][CNOV;OV@K.YL4T[4ID@GM8PJO*R1QR1 X
M0!CM4,JX4J?F8 ."Q+[?4(?BO;:QJ$&G:9)'<EEDEN'C99$CA564'<KXWF8Q
M@*-Q"EBP4%6KY_\ V8=7'PYU>\T/4<1RRLB(Y+*K21,P15W(,B19-T;';N 4
M $NHKJ_VV-?@6PM['>/M#7*RB/JWEK'*A<^@W, ,XW'.W.UL>R_"?_D#Z?\
M]>%I_P"B4KJJ\*_:N^*]UX(M8;:R.R2[\T&8'#HJ;-P3T9M^ ^<J =HW$,O3
M>,?"%EX'T+4%B 4O97 EGD(,TTC)(%:60X+NTDAQG^)MJ  @5Q_[%/\ R!Y_
M^O\ D_\ 1,%<I_S4/_/_ $#JZO\ ;6_Y \'_ %_Q_P#HF>O/_P!H+PS->^'=
M$OHQF*WM(4DP&)7S88-C' ("YCVDDCYF0#.>/I7P+\1[7Q=IZ:G&Z+'Y>9LO
MQ"RJ&D1V8+C;W) !7#CY2#7SK^S9JD>K^*M2N8&W12QWDB-@C*M=1,IP0",@
M@X(!]17UI65XLUW_ (1^SN+W;O\ (MY9=F=N[8A?;G!QG&,X./0UXK^SG_Q<
MI9M=U7]_<K=LD"/\T%N%2&0&&-LA&SMR_+G8IW;BY;C[:[2Z^(6Z-@P#,I*D
M$;EL"CKQW# J1U!!!Y%1?%&\;X=>,H=8NES:S;"'&_ 4P"UE)(0Y9/\ 6%%W
M$J4&06X]U^,WBNUL=#NYY)4$<]I+'"P.X2-+$PC";<[MV<@C(VY8D*"1Y)^S
M#HCZ]X8U"SB(#SS7<2ELA0SVL2 G )QD\X!..QK/_9@^-D/AV-M!U9OL[122
MF)Y=L:+R6D@?<%V,'W,"Y.22F5(16]KU;XQ6<LUM9:;-#=75S<(H2-TE58E(
M>XD<JX"[80Q09+,^-JL V/"O"%XWPZ\:W$=ZN%OI)EC<;]N+B5982/D^;+J(
MFQA5?=\V$.?6OVJKM(/#]TKL%+M;J@) +-Y\;[1GJ=JLV!S@$] :E_9<_P"1
M=L_^WC_THEKRK]AC_F(_]NG_ +<5%\=[M)_&.EJC!BC6"N 02K?:G?:<=#M9
M6P><$'H172^/O&<WC+Q-%X8D9XK%<^>(G9'GS:F8H[+@B(@["@Z@LQ;.S9%^
MV':6VC:-;6=NL<(^VADA0+&-HCFWLJ+C@,XW$#&6&>6Y[K_F3_\ N _^V=<K
M^Q3_ ,@>?_K_ )/_ $3!7G_P ^(W_"I;ZYT#6#Y<;7'RR'Y8TE V[R656\J1
M0A5S\J@*VT*S,OO7B_XVV%A 187$%U>2LL5M#'+'*7FD^6(,%D&U-V-[%E '
M .XJ#Z+17RK^W/\ \P[_ +>__;>OJJOE7]AC_F(_]NG_ +<4?MS_ /,._P"W
MO_VWKZ ^+'_('U#_ *\+O_T2]>5?L4_\@>?_ *_Y/_1,%<I_S4/_ #_T#JS]
M+\=O\&/$]\FH _9+V9I&95) 621I(9AE-SA-[HX0XSOQO9%!^@-?^..C:+ ]
MRU[!($7/EQ2QRRL>@545LDD\=@.K$*"1U7AZ:>>VA>\4)<-#&9D7E5D*@NH^
M9N V0.3QW/6M"O*OVH_^1=O/^W?_ -*(J/V7/^1=L_\ MX_]*):\J^ 7_(X:
MM_V__P#I9'1^W/\ \P[_ +>__;>NK_;6_P"0/!_U_P ?_HF>O3_AE=I9Z)8R
MRL$1-.MF9F(5540(2Q)X  Y)/ %>"_L,?\Q'_MT_]N*];OO"^D_&:*?[7 #+
M;W-S:M(N5FC:%W5<2;5R"KB0(=\89L,&*FO)/AMX2F^$7BM-)AE\RUO+=V&[
M=NV!97C+ ;5\U6B*[L$%&8@*7(4_YJ'_ )_Z!U?55%>5?M1_\B[>?]N__I1%
M1^RY_P B[9_]O'_I1+7E7P"_Y'#5O^W_ /\ 2R.M;X*:[_PN^^O+W5EWP6WD
M_9[-COM4WB8;V0C;)*%!&]A_$V% "!,3X[W:3^,=+5&#%&L%< @E6^U.^TXZ
M':RM@\X(/0BOH_Q_X.C\9V,^GS'"S1D!N3M8$-&^ RYVN V,@-C!X)KYP_9R
MU2>Y27PM<J<PWK/.I?=B! WG1 <IL-PD:2*"PE2XDPN-SCZ5\;Z(^O6%U9Q$
M!Y[:>)2V0H9XV0$X!.,GG )QV-?-_P"S!\;(?#L;:#JS?9VBDE,3R[8T7DM)
M ^X+L8/N8%R<DE,J0BM[7JWQBLY9K:RTV:&ZNKFX10D;I*JQ*0]Q(Y5P%VPA
MB@R69\;58!L=_17RA^T1=I9^+=+EE8(B+8LS,0JJHNY26)/  '))X KZ:\5^
M)H?"]K+?7)Q%#&SMRH)QT5=Q4%F.%4$C+$#O7RU\"II_AGX=O_$(4.9FB6&-
MOND)(81(2K$D>9*V4PI(CX8!PP]5_9ST1-<L8M=O2;C4)VF)FEP[1JLLL8CA
MXQ$F"Q*I@$L1]W:J^:_L[W:7GBW5)8F#HZWS*RD,K*;N(A@1P01R"."*]@OO
M"^D_&:*?[7 #+;W-S:M(N5FC:%W5<2;5R"KB0(=\89L,&*FO)/AMX2F^$7BM
M-)AE\RUO+=V&[=NV!97C+ ;5\U6B*[L$%&8@*7(7UN^\+Z3\9HI_M< ,MO<W
M-JTBY6:-H7=5Q)M7(*N) AWQAFPP8J:\D^&WA*;X1>*TTF&7S+6\MW8;MV[8
M%E>,L!M7S5:(KNP049B I<A<KX ?$;_A4M]<Z!K!\N-KCY9#\L:2@;=Y+*K>
M5(H0JY^50%;:%9F7WKQ?\;;"P@(L+B"ZO)66*VACECE+S2?+$&"R#:F[&]BR
M@#@'<5!\:_:NMIO#>L:=KNSS((O)7 +#YX9FFV,VTJN]6^7J3M<[<+S]%?\
M"?V/V'^UO/3['Y>_SLG;C.,8QNW;OEV8W[_DV[N*^=?V&/\ F(_]NG_MQ7U5
M17RK_P U#_S_ - ZO2_VJO!TGB719&A/S6LBW)7CYE17609+#&$<OW)V[0"6
M%6OV:?'4?BC1K>,.AGMHUAE1<@H$RL1(8D_-&H.X?*6W 8*E5X#Q_H7_  FO
MC6TBMV_X\;>"6X./N>7*TX7#%=V[S(URN[;OS@[6 R?VY_\ F'?]O?\ [;U]
M5445\J_L,?\ ,1_[=/\ VXKJ_P!M;_D#P?\ 7_'_ .B9Z]5^$_\ R!]/_P"O
M"T_]$I7S+^R?HCZ]8:W9Q$!Y[:*)2V0H9X[E 3@$XR>< G'8UM?LP?&R'P[&
MV@ZLWV=HI)3$\NV-%Y+20/N"[&#[F!<G))3*D(K>UZM\8K.6:VLM-FANKJYN
M$4)&Z2JL2D/<2.5<!=L(8H,EF?&U6 ;'?T5YA?>%])^,T4_VN &6WN;FU:1<
MK-&T+NJXDVKD%7$@0[XPS88,5->2?#;PE-\(O%::3#+YEK>6[L-V[=L"RO&6
M VKYJM$5W8(*,Q 4N0N5\ /B-_PJ6^N= U@^7&UQ\LA^6-)0-N\EE5O*D4(5
M<_*H"MM"LS+[UXO^-MA80$6%Q!=7DK+%;0QRQREYI/EB#!9!M3=C>Q90!P#N
M*@^5?M.W,_@C5].\1098(IB9=N%PK,Q0N0P!DCE=1\N5"EER1\OL%M\==#N8
M/M2WT 0*S89PDN%SG]TV)<\<#;EN-H.1G$U#QBWC+P_J5\ GV=[?4!;%=^YH
MHXWB#OO5<,SH[  ?*A4'+!C7*_L4_P#('G_Z_P"3_P!$P5Q]M=I=?$+=&P8!
MF4E2"-RV!1UX[A@5(Z@@@\BNP_;6_P"0/!_U_P ?_HF>O5?A/_R!]/\ ^O"T
M_P#1*5\__'W_ )'#2?\ MP_]+)*]5_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#M
MX_\ 2B6O*O\ FH?^?^@=5O\ :;O+KP1K6G^(85W1)&(CCN5:1I(V8HRKYD4I
M53RW#L -H->RZ!\<=&UJ!+E;V",.N?+EECBE4]"K(S9!!X[@]5)4@G/MOC/&
MVG3ZVZ_Z"MW''"Y!5F@,D,$DY4;VXE,K*NU69%4%5)S7-?%']E/3O$Z/+8*+
M2ZVG;L^6W9@% #Q@$*,+C,84@L78.>#+^R-XFFUO10DYW?9[AX$)+%M@5)%!
M))^[YA5<8 15 '&3[57*_%C_ ) ^H?\ 7A=_^B7KRK]BG_D#S_\ 7_)_Z)@K
ME/\ FH?^?^@=75_MK?\ ('@_Z_X__1,]2^,OB9/\/?"FGW-H 9I;:SA1FY$9
M:VW>9M((8@(0 >,D$[@"K=A\'?#=KH>FPZI,=US/:1S7-W.V^8AHT=@TK\B)
M0H 7(4*H)RV6/C_[#'_,1_[=/_;BC_FH?^?^@=7T!\6/^0/J'_7A=_\ HEZ^
M;_@9\*H/B-X:N;>11YZ7L[6\A.TI)Y$&,D!CL8@!Q@Y'(&Y5(]%_9[^*]U=2
M2:!KAV:A;8">8?WLJ@$D$\J[*H#!PQ,J$/AMKNW"_$_Q-/\ ";Q9_:\J%[6[
MA0,$'+1B-(W4%UV[U>-9-JD9&P%E#G'O7_"Z]%\G[1]OMMGE[\>:OF8QNQY>
M?,W8_@V[\_+MSQ65K?B&3Q)X;N[V5/+\ZPOI(UXSY3)*8"V&<!C#L9@#PQ(P
M.@XK]BG_ ) \_P#U_P G_HF"NPOO"^D_&:*?[7 #+;W-S:M(N5FC:%W5<2;5
MR"KB0(=\89L,&*FO)/AMX2F^$7BM-)AE\RUO+=V&[=NV!97C+ ;5\U6B*[L$
M%&8@*7(7ZJHKY5^ 7_(X:M_V_P#_ *61U-^USI$^@7]AXAAPPB:./:P^4212
M-/'G#AF#Y;( & GWLL*^E- U^#Q# EW:.)(9%W(Z]".G?D$'((."I!! ((KY
M[_9GT+^V=8U77HFS:R7%Q%"<8W^9,)RV"0R[5"<,O._J"I%?2E%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%<!\4O@?I_P 2O+:\#I+'PLL159"O/[LEE<%<G(!&5.=I&Y@TMS\%M/OX
M/LUUY]P"JB1I;JY9Y=N"OF$2KN 8%U3&Q&9VC52[9E\'?!O3/!DAFT^)X6/W
M@)[@HV P&Y&E*/C<<;@=I.1@\UGW/[/NC74_VR2&1K@,K"9KJ[,NY<;&WF?=
MD8&#G(P,=*S_ !)^SE8ZU>C4DGO+>Y$:)YD,Y#G:GEAB\BR2;C& K'=\P&3E
MBQ,WCC]G+2?%Z(LRR)(C$^>DA:X<$8VR23"5I ,#;OR4"A4*KD'KY? 5E/:R
M6$D7F039\T2,\KN3@!FD=FD9@%4*Q;<@5 I 5<<K\//@#8^!LB&2YE3S%D$<
MTQ,*NO1_*C$<;-D*0SJQ5D1D*E0:]*HKRK3_ -FW3-,OGU&U>Y@+[MT,$S00
MX8#*CR@DH7< ^T.%#   * M;?B;X'Z3XG*&[@+B-0L:>=.D4:A57;'&DBQQC
M"+D(H!QDY-:&A?#&RT"W:RM1-% V/D6YNAMPQ?Y#YVZ/+$EMA7?GYLBLKPS\
M!M'\+S"YL8'AE&/F2XN1D AMK#S<,I*@E6!4XY!JI\2OV>]+^(,GVBY1X[CY
M0TT+!'8*" K!E=#U'S%=^%5=VT8K0^&?P6T[X<@FR0F5EVO-(=\K+N+;<@!5
M'3(15#;5+;B :[JBO-=4_9RT/5Y&GN;=Y96QN>2YNG<X  RS3$G   SV %=!
MKOPQLM?MULKH32P+GY&N;H[LL'^<^=NDPP!7>6V8^7 JIX.^#>F>#)#-I\3P
ML?O 3W!1L!@-R-*4?&XXW [2<C!YK/N?V?=&NI_MDD,C7 96$S75V9=RXV-O
M,^[(P,'.1@8Z4:W^S[HVO.);R&2=PH4-+=7<C!020H+SDXR2<=,D^M=7X7\'
M6_AA/*M?,";44*\\\RJJ A5032.$ !QA< @#/08Y3Q_\!M.\:3K>R"2"[5D(
MN+=_+E.S.S.0RY'&'V[QM4!@HQ5OPA\'+3PY.+UWGN[M594N+J4SRHA_@3("
MJ/O<A=WSN-VUB*VO&/@.T\91B"^5WB[H)IHD;E3\RQ.@?!4$;L[3R,9-97@[
MX-Z9X,D,VGQ/"Q^\!/<%&P& W(TI1\;CC<#M)R,'FCQC\&],\9R";4(GF8?=
M!GN BY"@[464(F=HSM W$9.3S5O0OAC9:!;M96HFB@;'R+<W0VX8O\A\[='E
MB2VPKOS\V165X9^ VC^%YA<V,#PRC'S)<7(R 0VUAYN&4E02K J<<@T>)O@-
MH_BB8W-] \TIS\SW%R< DMM4>;A5!8D*H"C/ %9_C/\ 9XT_Q3+!</+=136Z
M[4E2X=I<!S(N7G\U\J[,5(((SC.%4++XD_9]TSQ):BUNO.DD&S%T\K2W?R_]
M-)=^%/),8'E L65%;!&UI?PGT^QLFTUHS-"\,<3F9WE=DC&$&YCE IRR+'L6
M-B6C5":Q?AY\ ;'P-D0R7,J>8L@CFF)A5UZ/Y48CC9LA2&=6*LB,A4J#1JG[
M.6AZO(T]S;O+*V-SR7-T[G  &6:8DX  &>P KL+OP;:WUHVG3H9K=U*LLLDD
MS$$[N7D9I,@\J=V5(&TC:,>=:?\ LQ6.G;XX+J^CM9)&9[5+DK;L&P&C90H8
MJ5 0DMO*\%L\UZ?H&@0>'H$M+1!'#&NU$7H!U[\DDY))R6)))))-<+JG[.6A
MZO(T]S;O+*V-SR7-T[G  &6:8DX  &>P KH-=^&-EK]NME=":6!<_(US='=E
M@_SGSMTF& *[RVS'RX%'@KX7V'@C<-/C>)6SE/.G>,D[<MLDD9-WR@;L;L#&
M<9%=57/^,? =IXRC$%\KO%W0331(W*GYEB= ^"H(W9VGD8R:RO!WP;TSP9(9
MM/B>%C]X">X*-@,!N1I2CXW'&X':3D8/-9]S^S[HUU/]LDAD:X#*PF:ZNS+N
M7&QMYGW9&!@YR,#'2M7Q5\)M/\6)'%?)),D:J%5KBYV_*" Q E 9\,09&RY!
MY8UH>#O =IX-C,%BKI%V0S32HO+'Y5E=PF2Q)VXW'DYP*X73?V9-+TN61[=[
MJ."9=LMJEQ(EO(NPIM?;B5A\Q;!D(R2/NDK6A=?L[:-?7KZA/!YCMY&R,G;!
M&(46-56--JE2JKE7WKQ@  D&WXH^!FF>))EN94=)8K>.&W:)VA\@1EV1XA'@
M!@7R-P91M7"CG,.@? VTTV=+NYFNKZ6%MT#7DYG$3=V1<*N3P<L&(*JRX(S6
MK\3/A59?$: 6]\IRC;HY$(65#QNVDAAA@,,""#P<;E4B;P+\-[?P;&D<3S2L
MD?EK)/*TKJF0=B@X2->%!6-4#!$W!BH-=56?K^@0>(8'M+M!)#(NUT;H1U[<
M@@X((P5(!!! ->8:?^S%8Z=OC@NKZ.UDD9GM4N2MNP; :-E"ABI4!"2V\KP6
MSS7I^@:!!X>@2TM$$<,:[41>@'7OR23DDG)8DDDDDUB_$/X86/Q A$%_'NV[
MC&ZDK)&6&"RL/P.ULH2%+*<"N/\  ?[,&D>#9Q=HLD\J,K1M.RL(V&?F541%
M)YR"P8J55EVD9KUJBOE7]N?_ )AW_;W_ .V]>JZI^SE8Z@S)Y]XEFT@<V,<Y
M2R^^)&41[?E4OEB%8;23LVX&/1= T"#P] EI:((X8UVHB] .O?DDG)).2Q))
M)))KA?&/P!L?$MZ-362YM;S^*:VF,;M\BQC[P?;A!M^3;D$[MV:->_9XTC7/
M(6:-_+ADN)"@D?\ >O/M\QY7),SME00V\'@ DJ M=+#\-=.@LFTM+:-;1UP\
M07 ;A1N)'S%_E4^83OR V[< :X73_P!F*QT[?'!=7T=K)(S/:I<E;=@V T;*
M%#%2H"$EMY7@MGFO3] T"#P] EI:((X8UVHB] .O?DDG)).2Q)))))KD/$WP
M&T?Q1,;F^@>:4Y^9[BY. 26VJ/-PJ@L2%4!1G@"M7_A6-E]C_LW$WV7IY?VF
MZ^[L\OR]WG;O*V\>7GR^^W/-97AGX#:/X7F%S8P/#*,?,EQ<C(!#;6'FX925
M!*L"IQR#1\4O@?I_Q*\MKP.DL?"RQ%5D*\_NR65P5R<@$94YVD;F#5/AK^SW
MI?P^D^T6R/)<?,%FF8.ZA@ 54*J(.A^8+OPS+NVG%=!XU^%]AXWVC4(WE5<8
M3SITC!&[#;(Y%3=\Q&[&[!QG&!53P]X%TKX91O-;_P"BP?Q^9<S>0"Q5=Q66
M4QAB0JAL!NB@X.*J_$S2[7QO#:6#JD\5U<1R!E._;%$#,\JE3G:X"P>8K+M^
MT*=QR%;OZ**Y7XA_#"Q^($(@OX]VW<8W4E9(RPP65A^!VME"0I93@5Q7A3]E
MK2?#:SB,S2//;R0^9(T;/&LB,CF/$:JK%6QN(8XX& 6#:O@;]GC2/!OSV\;M
M/Y<B>>\C^=A\@E2A18VVG:'C5'"_Q9))/^&<M#\[[5]G?S_,\SS?M-UYF_.[
M?N\[=NW<[LYSSG-:OC'X/:=XR^SB_1Y4MHY$C5I9/X_+RS,&$C,!&!EF.<L6
MW'!&+:?L^VC.K7US>WZ(P98;NX,T(<'A]@50Q RN&RI5F!4YKO\ 7] @\0P/
M:7:"2&1=KHW0CKVY!!P01@J0""" :\:TO]C;1;*19)&N9E&<QR2*$;((Y,4<
M;\9R,,.0,Y&0?6];\&VNLVPL94*VX4+Y<4DD"[-I3RSY+)E-IQL/RXQQP,<U
MX9^ VC^%YA<V,#PRC'S)<7(R 0VUAYN&4E02K J<<@UJ_$/X86/Q A$%_'NV
M[C&ZDK)&6&"RL/P.ULH2%+*<"N4TG]G*QM?+2ZGO+R"'88K>YG,ENA3 1A&J
MHIPN5"G*;6(*D&O1?$.B)KUM-9RDA)X9(F*X#!74H2,@C.#QD$9[&O.O^&=+
M*R^73[F^L8NIBMKITC9N\A$@D.X@ $YQA1QU)[OPAX+M/!T M+"(11!F;:"2
M2QZL68EF/09))  4<  >?^//V8-(\93F[=9()79FD:!E42,<?,RNCJ#QDE0I
M8LS-N)S78?#SX86/P_A,%A'MW;3([$M)(5& S,?Q.U<("6*J,FN?^)7[/>E_
M$&3[1<H\=Q\H::%@CL%! 5@RNAZCYBN_"JN[:,5E2?LM:2=/&EJ9E3[0LSRA
MH_/=E5T4,QC*[560@*% '7J6+=UX'^&^G^!D>/3H!")&#.<N[,0,#+.S-@<X
M&< DD %CGI:Y7XE?#6U^(EK]BO=X02+(K1MM=67(R,AE/RLRD,",$D $ C$T
M3X$:?8VQL[EI[V+:55;J9Y5C7:$ C0;8XRH!".BB10Q"N <4> /@1I_@F)H8
M&GD#,[ R3/E"Z"-F01^6B/LR!*JB4!F4/M.*B_X9RT/SOM7V=_/\SS/-^TW7
MF;\[M^[SMV[=SNSG/.<UM>*OA-I_BQ(XKY))DC50JM<7.WY00&($H#/AB#(V
M7(/+&C3?A)ING6DFFI"3:2KM:%Y9I8P,EOD$DC>6=Q+93:=V&SN (X72_P!D
M;1=/NEN\3.JR%Q!(ZO!W*J1LWLHXP&<[L /N!(.K!^S/HQO)M0N(WN)9K@S;
M97S&K%V<@(@0,I)Y63>" !W.?5:*\E\,_LT:?X9G>>TGO8T=B6@2Y>*(CYMB
MDQ!)2$W';ER?4G)S;F_9RTG^T%U.%9+=U7'EV\AMHB=K)N_=!70[3SY;H#CY
M@<ONW_''PET[QI;)9W<(V1*1"4_=M%\NP;-O  &/D(*$JNY3M%<AX4_9:TGP
MVLXC,TCSV\D/F2-&SQK(C(YCQ&JJQ5L;B&..!@%@VU\._@#I/@)UGM8BUPJN
MHGE8O)ACS@<1J<?+E44[<@D[FS%\2OV>]+^(,GVBY1X[CY0TT+!'8*" K!E=
M#U'S%=^%5=VT8K0^&?P6T[X<@FR0F5EVO-(=\K+N+;<@!5'3(15#;5+;B :/
MB9\%M.^(P!O4(E5=J31G9*J[@VW)!5AUP'5@NYBNTDFO-?C/\++3P7X<NS"9
M)91#:PB:>0RRB);J-DB4G"H@SPL:JIPI8$C-=?\ LN?\B[9_]O'_ *42U-=_
ML\:>]^VIV\MU;2R,6F$%P\2REI/,?<>9 &.,A'4  ;0I&:-6_9MT75I8GFA)
MCAMA!'"KLD04.TF_Y"LA<EVR2Y#9)8%OFH\9_LZZ9XFE@G7S+1[9=L9M&2
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M[7R2XWY.YL$<8]%T#0(/#T"6EH@CAC7:B+T Z]^22<DDY+$DDDDFM"N?\8^
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M=WE_/G&S'&[?\M=K111111116+XT\7P>#K26_NR1%$H+;1N8DD*J@>I8@#)
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M^S_;OM$/V7_GOYB>3][9]_.W[WR]?O<=:BT3QO8:\YBL[J"=PI8K%+'(P4$
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M)=(MM+N\MB'#OM?RWVQE?-;#=<*<#YC\O-:O@[Q_8^,XS-I\Z3*/O $AUR6
MW(P#IG:<;@-P&1D<U;\3>*[7PO";F^E2&(9^9SC) +;5'5F(4D*H+'' -<UX
M0^..C^,)Q:6-T))BK,$*2QD@<G'F(H8@<X&3@$XP"1V&J:M#I$;3W,B11+C<
M\C*B#) &68@#)( SW(%<I+\:-(BM9+\W2?9HK@P-( Y!E&#M0!29."&!0,I7
M+ [02#7?'^BWMBMQ>SVSV<\9=!*599 A#,!&X+.RL!E I=7PNT-Q75Z3JD>K
MPQW,#;HI8TD1L$95@&4X(!&00<$ ^HKBO$WQ\T3PU,;:ZO$$JYW*BR3;2"5*
ML8D<*P((*DAAW'(KJO#/BNU\40BYL94FB./F0YP2 VUAU5@&!*L PSR!5O5-
M6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"O)/%/QQT?QAIU_:6-T))CIUXP0I
M+&2!"Y./,10Q YP,G )Q@$C%_8I_Y \__7_)_P"B8*]_KY+_ &QOB#;ZY#9V
MUC<PSQ>9-)*L4D<N&4(L1)4DKP\@ R >>#@8]_U1]%^)T;6$DMM>+Q(8XYE=
MUVD#>#$^]<;MI8$<,5)PQ!B\3?%W1? )2SN;B.$JH5845G**JKM4I"K>6-I&
MT,%!'W<@'&UX.\?V/C.,S:?.DRC[P!(=<E@-R, Z9VG&X#<!D9'-:&M^(;;0
M4$MY-' A8*&E=8U+$$A07(&< G'7 /I7*W_QQT>PM(=1EN@MO<,ZQ-LEW.4)
M5\($\S (P25P"1S\RY[6TNTO$66)@Z.H964AE92,A@1P01R"."*BU35H=(C:
M>YD2*)<;GD9409( RS$ 9) &>Y KE)?C1I$5K)?FZ3[-%<&!I '(,HP=J *3
M)P0P*!E*Y8':"1H3?$K3H+)=4>YC6T=<I*6P&X8[0#\Q?Y6'E@;\@KMW BL7
MPS\?-$\2S"VM;Q#*V-JNLD.XDA0JF5$#,20 H)8]AP:Z_6_$-MH*"6\FC@0L
M%#2NL:EB"0H+D#. 3CK@'TJ+0O%EGX@W?8KB&?9C?Y4B2[<YVYV$XS@XSUP?
M2L^T^)NE7CK%%?6KN[!55;B)F9B<!0 ^22> !R37%?'?X[VW@&VDAAD#Z@ZE
M(XT*LT3%01+("&"@!@RJPS(< #;N9>@^$7C>VUZPM(ENHY[H64#3*)5DF#"-
M [.-Q?.\X8MSN//)JT/&FD-J*6Z2P/J,BRPC8%DF"QYDDB=D!,8!!.URH+ X
M!8&M;Q1XVLO"J>9?SQP@J[*'8!F" %MB_><C(X4$Y( &2*Q-?^-&D>'X8;BZ
MND1)XXY(AAVD9'!9'\M5,@4@'YBH /RD@\5T'AGQ7:^*(1<V,J31''S(<X)
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MMCB*E6B7=EV"$%V=MQ(( X7XQ>"[30?$^DV5G$((2MB"(B8V.;IT+%T(??M
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MJQEE8N[V5LS,Q+,S&)"6)/))/))Y)KI:*BN[M+-&EE8(B*69F(554#)8D\
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M#CY6&Y%X'WEROB*]EX:T"71KF:.2:/2BD<9 ,KF.$JDHB!=P \>_<,B/:7+
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MBW@$MM)4L.#G#%<D$YVOV7/^1=L_^WC_ -*):\E_9WM$L_%NJ11*$1%OE55
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MEK\0ML:A069B%  W-8%W;CN6)8GJ223R:[#]M;_D#P?]?\?_ *)GKU7X3_\
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M-;A[V)7F"*)67R9OE+@;B/E7@G' ]!7I7PK\%VDFB6\9B!%WIUNMPV3YDBM
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M$854VLA4@$D^;N?*D*1Z?^U5X>MI]%NKQX8VN$6W5)BBF55^T1_*'(W ?,W
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MXP BJ .,GS_]AC_F(_\ ;I_[<4?'W_D<-)_[</\ TLDKU7]J/_D7;S_MW_\
M2B*O%=6\,S:WX#M'@&[[/<2SN &+;!-<QL0 #]WS S9P BL2>,'UKX._M&V'
MB>R3[?<1V]W$J),)GCB$C8_UJ$[%(;!)4 %#\I&W:S=AX>^)</BC4'M-/9)[
M>"WW3S(59!+(R^1&C!_FRBRER%*@A1N#;EK%OO"^D_&:*?[7 #+;W-S:M(N5
MFC:%W5<2;5R"KB0(=\89L,&*FO)/AMX2F^$7BM-)AE\RUO+=V&[=NV!97C+
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MO7_VH_\ D7;S_MW_ /2B*C]ES_D7;/\ [>/_ $HEKRK_ )J'_G_H'5]%>/\
MP='XSL9]/F.%FC(#<G:P(:-\!ESM<!L9 ;&#P37SA^R]->W$[Z%=J1#I]R\[
MYS(@D7?%]F.&,>/.(N(\=)(6<!B0Z?5]%?*&E^,A\'/%5]%?.5LKUFE:0QL
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M]LI++&J3R">-\E.1N41N>%5MQ+X0Y]5_:RU^"PT.:VE<++<-$L2?Q.4FCD?
M'8*,DG@$@9RR@Z'[+G_(NV?_ &\?^E$M>JU\U_!37?\ A=]]>7NK+O@MO)^S
MV;'?:IO$PWLA&V24*"-[#^)L* $"8GQWNTG\8Z6J,&*-8*X!!*M]J=]IQT.U
ME;!YP0>A%?5]<_X\\8Q^#;1KZ<?NDD@#GGY5DF2)GX5B=H<M@#+8P,9S7F'Q
M1_93T[Q.CRV"BTNMIV[/EMV8!0 \8!"C"XS&%(+%V#G@\U\'O$TVM^#;])SN
M^SV]] A)8ML%N)%!))^[YA5<8 15 '&3J_L4_P#('G_Z_P"3_P!$P5Q]M=I=
M?$+=&P8!F4E2"-RV!1UX[A@5(Z@@@\BNP_;6_P"0/!_U_P ?_HF>O5?A/_R!
M]/\ ^O"T_P#1*5\__'W_ )'#2?\ MP_]+)*^JJ^5?@%_R.&K?]O_ /Z61U%I
M?C(?!SQ5?17SE;*]9I6D,;  ONFC<!5=W"NSP_*0"26;!7:/:O&/Q]TCPY;/
M<+=P3N%;RXHI5D9W"LRH?*\PH"1C>PVJ2,GD Z'Q"\[^P;S[5L\_^S+CS?+W
M>7O^SMOV[OFV[L[<\XQGFO&OV8=$?7O#&H6<1 >>:[B4MD*&>UB0$X!.,GG
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MY[_]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\ THEKU6N5^+'_ "!]0_Z\+O\
M]$O7E7[%/_('G_Z_Y/\ T3!7%6-S_P *G\9RM>.B6U]YS>:XP D[&13\K';B
M=/++/QM!<A5((]_^->J1Z9HM_),VU3:31@X)^:13%&. >KN!GH,Y) R:Y7]E
M7P=)X:T6-IC\UU(UR%X^575%C&0QSE$#]B-VT@%37FG[#'_,1_[=/_;BHOCO
M=I/XQTM48,4:P5P""5;[4[[3CH=K*V#S@@]"*[#]M;_D#P?]?\?_ *)GKU7X
M3_\ ('T__KPM/_1*5\__ /-0_P#/_0.KJ_VUO^0/!_U_Q_\ HF>O5?A/_P @
M?3_^O"T_]$I7S+^R?HCZ]8:W9Q$!Y[:*)2V0H9X[E 3@$XR>< G'8UM?LP?&
MR'P[&V@ZLWV=HI)3$\NV-%Y+20/N"[&#[F!<G))3*D(K>UZM\8K.6:VLM-FA
MNKJYN$4)&Z2JL2D/<2.5<!=L(8H,EF?&U6 ;'?UROQ8_Y ^H?]>%W_Z)>O*O
MV*?^0//_ -?\G_HF"N4_YJ'_ )_Z!U=7^VM_R!X/^O\ C_\ 1,]=5_S)_P#W
M ?\ VSKE?V*?^0//_P!?\G_HF"N/^,2O\.?%EKKDA'V>X9-S,I(15C6VN!A&
M+L5C8.#@ E@ &VG/T_=Z_!:VS7S.#;K"93(OSKY87>7&S.X;>1MSD=,UX+^Q
M;X.DTRQGU"0X6[D01KQ]V$NI?(8]7=EP0"-F>0PKG_\ FH?^?^@=7T!\6/\
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M *\UO?V>-/DEDNK>6ZM;J::622XM[AXI6$CM(T9ZILW$8 4'Y%RQ.2=_P/\
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MENKL2[FSO;>)]V3DY.<G)SUJ+5/V<M#U>1I[FW>65L;GDN;IW.  ,LTQ)P
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MDN+D9 (;:P\W#*2H)5@5..0:J:I^SEH>KR-/<V[RRMC<\ES=.YP !EFF).
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M+K]G;1KZ]?4)X/,=O(V1D[8(Q"BQJJQIM4J55<J^]>,  $@V]=^ VCZ]M%U
M\BIGRT-Q<^7&#C*QH)0D:\ !4"J      -7PW\,;+PU&8+,31Q&-TV"YNBBA
MSEBBM,0C9Y#IM<$DAADUS^J?LY:'J\C3W-N\LK8W/)<W3N<  99IB3@  9[
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MZ+I>EQZ5&L,*[47/<L222S,S,2S,S$LS,2S,2S$DDUYI^U'_ ,B[>?\ ;O\
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M&JA5:XN=OR@@,0)0&?#$&1LN0>6-4/\ A1&D_9_L/ES?9?\ GA]KO/)^]O\
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M>&.50V P5U#@'!(S@\X)&>YK0HHHHHJKJFK0Z1&T]S(D42XW/(RH@R0!EF(
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MWVRONV[#([(I/*D$94AEVL<UZ!X0\:6GC& 7=A*)8BS+N ((8=5*L RGH<$
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M(\O9"'B=N&/RK*J%\!23MSM')QD5V%W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\
M5YU_PTCH'G?9_MJ;_,V9V2^7G.W/F;/+VY_CW;,?-NQS7HMW=I9HTLK!$12S
M,Q"JJ@9+$G@ #DD\ 5RD/Q>TF=+F5+J-H[-8VGD4EHU#@E,. 5<G! "%CN^7
M&X@46WQ*TC7[+[6;F!K.5FA9I66-"V#NB99MO)7)VL,E?FP5(-:W@O7K37K2
M*XTX@VI4K%M0QJ%0F/:%95*@%2 , 8''&*S_ !K\4],\$;1J%PD3-C"?,\A!
MW8;9&&?;\I&[&W(QG.!1X*^*>F>-]PT^X25ESE/F20 ;<MLD"OM^8#=C;DXS
MG(KJJ\ZN?VA]!MI_LK7L9<LJY4.\66QC]ZJF+'/)W87G<1@X\:^ 7_(X:M_V
M_P#_ *61U]55GZWXAMM!02WDT<"%@H:5UC4L02%!<@9P"<=< ^E<U<?&C2+:
MRCU*2Z1;:7=Y;$.'?:_EOMC*^:V&ZX4X'S'Y>:M^$OBGIGBV&6YLKA'B@_UK
M-NBV#&[<PD"$+@$[B-IPW/RG&?HGQST76[DV5O>1M,&*@'<BLVX(%1W4)(2Q
M&T(S%ARN1S78:IJT.D1M/<R)%$N-SR,J(,D 99B ,D@#/<@5Q4_QYT>V\DS3
MO$MQCR7EM[F&-P=OS!Y(E3;\P);.T @D@<UU6N^++/P_M^VW$,&_.SS9$BW8
MQNQO(SC(SCID>M5-+^(6FZO(L%M>6TLK9VI'/$[G ).%5B3@ DX[ FC5/B%I
MND2-!<WEM%*N-R23Q(XR 1E68$9!!&>Q!KH*\J_:C_Y%V\_[=_\ THBKG_@;
MX_L?!GAFRFU"=(5/VC:"27;%U(#M107?&X9V@[0<G YKU7P=X_L?&<9FT^=)
ME'W@"0ZY+ ;D8!TSM.-P&X#(R.:UM4U:'2(VGN9$BB7&YY&5$&2 ,LQ &20!
MGN0*X30/VAM#U^=+2VNPTLK;45HYHP6[+NDC5<GH 3DG"C)(%>BT5S0^)6G-
M=IIR7,;W4C2J(D;S&#1@M(K[,B,@ \.5)((&2"*Q?^%_:%]H^Q_;H?,_O9/D
M_=W?Z['D]/\ ;^]\OWN*[^O-=4_:1T#3)&ADO4++C)C269.0#P\2.AZ\X)P<
M@\@BO1;2[2\198F#HZAE92&5E(R&!'!!'((X(KFO&OQ3TSP1M&H7"1,V,)\S
MR$'=AMD89]ORD;L;<C&<X%'@KXIZ9XWW#3[A)67.4^9) !MRVR0*^WY@-V-N
M3C.<BM7Q-XKM?"\)N;Z5(8AGYG.,D MM4=68A20J@L<< US7A#XXZ/XPG%I8
MW0DF*LP0I+&2!R<>8BAB!S@9. 3C )'5:_K\'AZ![N[<1PQKN=VZ =.W)).
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MS(S-MD=%D'EDEN8G)SC(4[@1P:R?V</%FFMH5II]S<6WFOY\;6\DD6]O,GE
M0QL<G<&&%(^8$<'->BVUMI/PFLMJ^7:6JLS?,QRSD%CRQ9Y'*KP/F8A0JC
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M=NC&[JH!90Q&QF'\2JQ9<-D#:V/GKX&W:6?BW6)96"(BZ@S,Q"JJB[C)8D\
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M,\;2IYY/G2M_JP=P 3!   5 , *!7K55=4U:'2(VGN9$BB7&YY&5$&2 ,LQ
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MA($(7 )W$;3AN?E..?TO]I'0-3D6&.]0,V<&1)84X!/+RHB#IQDC)P!R0*]
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M\NT[9Y5(RL #,(H_^6AWF7A?+KNOB]XO/@_2;J^0D/'"1&5"L1(Y$<38;Y2
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MB^5+>)E(?*W'R-*H'WPD3-,0#@HC'<JY8=7:6B6:+%$H1$4*JJ JJH& H X
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MB<9P:X6YNWNOA[ND8L0JJ"Q).U;\(B\]@H"@=   .!7I_P"RY_R+MG_V\?\
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MJJH'A7[%FEQZM]L%POF+!);20HY+1I(WF9E5"2@E_=J!)C>H&%8 D&U\;?\
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M\=HL\RE9KEGN)58$2*TIWK$Q.&)B0K""0#MC4;5 "CI:\J_:C_Y%V\_[=_\
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M/N<*K[B-F/8/A4FC:+ NFZ-/!($4NPCFCEE8\!I7V')). 3@ ?*H 4*H\/\
MVY_^8=_V]_\ MO7T!\6/^0/J'_7A=_\ HEZ\J_8I_P"0//\ ]?\ )_Z)@KE/
M@%_R.&K?]O\ _P"ED='[<_\ S#O^WO\ ]MZ^JJ^5?^:A_P"?^@=6A^T[<S^"
M-7T[Q%!E@BF)EVX7"LS%"Y# &2.5U'RY4*67)'R^P6WQUT.Y@^U+?0! K-AG
M"2X7.?W38ESQP-N6XV@Y&?/_ (A?'VYT_0WU>S6/%Q>R6]FXW$K$HD43NKJ,
MN6A=E3 50R;MQ5@W8?!WPW:Z'IL.J3'=<SVD<US=SMOF(:-'8-*_(B4* %R%
M"J"<MECX_P#L,?\ ,1_[=/\ VXH^/O\ R.&D_P#;A_Z625ZK^U'_ ,B[>?\
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MKC">=.D8(W8;9'(J;OF(W8W8.,XP*A\*_";3_":216*20I(K!E6XN=OS  L
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M++B=F0I&A4")F6/YLX*AP;=I^RKX?@14:U+E5 +M-.&8@8+'9(JY/4[0!GH
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M6HFB@;'R+<W0VX8O\A\[='EB2VPKOS\V165X9^ VC^%YA<V,#PRC'S)<7(R
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M<9PJA9?$G[/NF>)+46MUYTD@V8NGE:6[^7_II+OPIY)C \H%BRHK8(Z7PO\
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M<W2.,@@X99@1D$@X[$BNE\>?#NT\=Q1V]^I>*.82[ Q0,P1T )7#8&\G@@Y
MR2,@\?\ \,Z64O[J:YOI;/H+-[IS:A1_JXPH ?:F 4&_(VKDGG/:^*? MKXE
ML7TN9-ML\:H%C_=[ I!CVX&!M*@J,%> ""N09O!?A"#P=:16%H"(HE(7<=S$
MDEF8GU+$DX  )PH P!M44444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444445Y5XY_9KTOQI??VE=><)&\OS$1PL<FP!1NRI894!3L
M9>!D8;+'U"TM$LT6*)0B(H554!550,!0!P !P . *EHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHJ*[M$O$:*50Z.I5E8!E92,%2#P01P0>"*\EM_V8K'
M3)))-/NKZR63;NCMKDHGRC Y97<]2?F8X+'&!Q75>%OA%9:!,EXQFN;Q(VC6
MYN9GGF"L2<#<=BXW%0453M)!)W-GM:****RO$VAMK<)@2>:WW9!> QK)@@@J
M&DCDV]<[EVN" 0PYSY_\//V>+;X?S&>PN[Q=VT2(SP-'(%.0K*8/J-RX< L%
M89->JT444444444444444445ROQ*^&MK\1+7[%>[P@D616C;:ZLN1D9#*?E9
ME(8$8)( (!$/PS^%5E\.8#;V*G+MNDD<AI7/.W<0%&%!PH  ')QN9B>PHHHH
MHHHHHHHHHHHHHHHHHHHHHKRKQS^S7I?C2^_M*Z\X2-Y?F(CA8Y-@"C=E2PRH
M"G8R\#(PV6/J%I:)9HL42A$10JJH"JJ@8"@#@ #@ < 5+1111111165XFT-M
M;A,"3S6^[(+P&-9,$$%0TD<FWKG<NUP0"&'.?/\ X>?L\6WP_F,]A=WB[MHD
M1G@:.0*<A64P?4;EPX!8*PR:]5HHHHHHHHHHHHHHHHHHHKR7PA^S!I'A:]&H
M0K([JS-''(RO%&Q.591L#$KT0NS$?>Y<!AZU111116+XO\%VGC& VE_$)8BR
MMM)((8=&#*0RGJ,@@D$J>"0?.M+_ &;(=(C6"VU+5(HESM2.Z5$&22<*L0 R
M22<=R37?^$O 5EX2\TV46QIY/,E=F>61V]6>1G<]2<$X!+'&6)/044444444
M444444444444444444444455U2R:]C:..5X6.,21B,NN"#P)4D3G&#E3P3C!
MP1Y5X;_9HMO#5T;^UOKY+EM^^0R0.7W\MO#V[!\GYCN!^8!OO $>OT444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444444444444444445__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex99_004.jpg
<TEXT>
begin 644 ex99_004.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P &! 0.
M!0X3# P3%A,0$Q$3%Q45%Q<6%!0:&AH7&!<7%QX<%Q@9&QP<)1L9'Q\?'Q\B
M'Q\?'Q\?'Q\?'Q\?'Q\?_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#ZIHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKQ7X\?$G6/AI"E["UG-!)
M<&,(T,RR)D,\?(N"K_*I#-A.<87!.WM?A?JFI:Y:P7VH/;;9[=9%BABE4KOP
MR9D>9\_(?F78,,>&(7+<U\1/BK.-4M_#FE-&MW.K-+/(/,6!-COPBGF;:N]0
M^%QLR"KDKE:?J/BCPIJT-G<XU*QN&7-P(D@,2@'S"?+PJ$9W8?>)0H6,ARP7
MV^BBBBBHKM79&$1"N5.UF4NH;'!*AE+ 'J RDCC(ZU\]?$/XS:]X1U:#1E%C
M*USY'E2&*XC'[US$-Z^>^W#@YP6^7!ZDJ/>M$@N84(O)(Y'W'#11-"NW P"K
MS3$G.>=P&"!CC)T****XKXO?VO\ 83_8&S[7YB?>V;MF?FV>9^[W9QG?QLW8
M^?;75Z3YWDQ_:MGG^6GF^7N\O?@;]N[YMN[.W/.,9YJU7SKX]^,>M:'KECI,
MHMH8KBXM&/DEIW,3RF)XV>5$')#'*QJP&T!NN?HJBBBBN/\ BEK]_H%E+=:<
MD#F&&25S.\@ 6,!R%2-#O)4,!EXP#M.6&17*_LU?$2[\?6$]Y?,&<7LJJ%4(
MJ)Y<3A!CD@%C@L6;'5C7K5%%%%%%%%%%%%9]IK\%W/+:1N&F@6-I4')02;C'
MGL"0I..H&"0 RD_/?[2/Q:U[P))&L+6T,$TDAA:,&:?;&%!$GG)Y8W%PV$4D
M8V[R 2WTI11116?K^OP>'H'N[MQ'#&NYW;H!T[<DDX  R6)  )(%>*^&?&WB
M#XLEY]-:/3=-$Q$<[Q":YD558'".3&PWXW$;0I^57D*.#T%W;^)/!:-<^?'J
M\:J6> PK:7  ''DF+>K$YW,'!)"!8P6:MOX$^.I/'&E17MPZ-.TDXD"8 0B5
M]D> 21B,I@-EBI#$DG)[^BBBBBBBBBBBBBBBBBHKMG5&,0#.%.U68HI;' +!
M6*@GJ0K$#G!Z5\Z^'/BQKDGBF+1=1D@5%5A+';H?*8_9GG5MTH,N>5S@J/EQ
MCJ3]'T44444444445Q7Q9UW4M!LWN],6V/DQRRS&X,OW(T+;46,#+''5G4#&
M,'=E>5_9?\>WOC?39;G4)?-E6[>,-L1,*(XF Q&JCJQ.<9YZ]*]?HHHHHHHH
MHHHHK/U_7X/#T#W=VXCAC7<[MT Z=N22<  9+$@ $D"M"BBBBBBBN*^+W]K_
M &$_V!L^U^8GWMF[9GYMGF?N]V<9W\;-V/GVUU>D^=Y,?VK9Y_EIYOE[O+WX
M&_;N^;;NSMSSC&>:M45GZ_K\'AZ![N[<1PQKN=VZ =.W)).  ,EB0 "2!6A1
M17 >,/[=_M2R_L[R?[-Y^U;L;NOS9S\WW<>5Y?\ RTSYOR8KOZ***S]?U^#P
M] ]W=N(X8UW.[= .G;DDG  &2Q( !) HU]KE8'^PB-KC;^[$K,L6[U8HK-@=
M< 9;&W*YW#POX*?%C5O$VOWFG:E)'LMX9AY42 1"2*:*(LK,/-(/S'YF/7H.
M /H2BBBBBBBBBBBLKQ7XFA\+VLM]<G$4,;.W*@G'15W%068X502,L0.]>*Z9
MK'B7XB:<=9TVZAM=_F^19K#')N5)&7YYI@<2G! PHC.%)V;FVVHO%'BWQ+8V
MEQ;6T-K<?:V$Z2@INB!&QRDI+I%]Y9 "9CM5XOE;%>ZU5U22:*-C;(CR\;5D
M=HD/(SEECE(XR1A3DX'&<CPKX-_%[5/%6O76FZ@852VMYU,<"$1F6*X2,R!I
M-TAX8C&0N,':#DU[_11116??Z_!82PVTKA9;AG6)/XG*(9'P!V"C))X!(&<L
MH,VK>=Y,GV79Y_EOY7F;O+WX.S=M^;;NQNQSC..:Y3X0_P!K_81_;^S[7YC_
M '=F[9GY=_E_N]V<XV<;-N?GW5VM%>*_M&?$[5O %N+BS2V6!Y/)$C-))/N>
M,LKA-B1IM*-]YI0WRDJ!D5Z5\/=4DU?3;.YG;=++:6\CM@#+-&K,<  #)).
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M[!N567(P7KU#Q?\ $6R\)V1U*YE!@*J8RA#F4L,HL>#ARPY&#C&6)"@L//\
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M/_T3/7H'@S59],T&PDM;=[J7[!:A8T>*/G[.I!9I70!<@ D;F&<A&P:Y_P"
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M)2OG_P#YJ'_G_H'5]545Y+H.K:=X:N;G3_#=F)KHS!KKRSY5O$Q95Q),^X*
M&<K%"LA4K(HC4[J\ETOSO^$_4W.SS3DL(]VP9T\D*"W+8& 6(7>06V)G8MK]
MN?\ YAW_ &]_^V]?0'Q8_P"0/J'_ %X7?_HEZ\J_8I_Y \__ %_R?^B8*]_K
MY5^/O_(X:3_VX?\ I9)7U57RK^PQ_P Q'_MT_P#;BCX^_P#(X:3_ -N'_I9)
M73?M'?#/5KN]M]>T4EIK>'843 E4(9)-Z@G$@8.4:/!+<*%<,P6'X<?M1Q^)
M+A-*UNU\FZ:X2-2%+1>:)"4#1OEXF5U0 Y?#_,3&!Q;_ &UO^0/!_P!?\?\
MZ)GK0\7ZV^C>"5EC );2K.([LD;9DBA<\$<A7)';.,@C@ZO[*MHD'A^U9%"E
MVN&<@ %F\^1-QQU.U57)YP .@%>7_'W_ )'#2?\ MP_]+)*Z;XJ:G)/XNTNT
M:X-O&MM(R.HA#+)*)XS@RHZDOY:( P;GA &.:]/U;X<3:O#);3ZC>-%+&\;K
MML1E6!5AD68(R"1D$'T-2_"_X7VWPWMFL[-I'1YFE)E*LVXJB$#8B#&$';.<
M\UX+^PQ_S$?^W3_VXKZJKE?BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\ D_\
M1,%97[+'G^*K.[G-_-%.]_))*D2VG)D2,^:5DMY&7<P8#&$^4A1D&N_\=?L]
MP>._+_M*]O)?*W^7_P >B8W[=W^KM5SG:.N<8X[UH?%"71=$GMM1U.(27B,5
MM%5&DGD?JJ(B_?(8C87&V.1@0R,P)\E_:QU&^U'28I+J!+:+[> D9D$T[?).
M%9R@$4?RC)56FSO'SKL(?VKX>Z7'J^@V=M.NZ*73+>-UR1E6MU5AD$$9!(R"
M#Z&O"OV9=4;P)K-[X;N6<[I&\DL'0%HMQW"/#!?-AQ)N+ %449;*U] >%_\
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M2Q+() N+-,, R@YCM5/1B,9QSTZ5W7A[1$T&VALXB2D$,<2EL%BJ*$!. !G
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M@E(9PM]N95**6^UQ9(4LQ4$] 68@<9/6I?C[_P CAI/_ &X?^EDE?0'Q8_Y
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M'.S;MW[1YN=O&[S-V_OOW;N<UTLWAZVGG6\>&-KA%VI,44RJOS?*'(W ?,W
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ML;=Q/@7X%N]7U&[\3:O"89IV*VT4@ DC3[A)4QJRD(JQHWRLR^864APQ\_\
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ME#>:6ED9\D]5&V,@HO?U\H:WHT_P$UV35X;4RZ5<*P<QC_4I(\9=?E"I&5D
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M^-XTGLDF,31[B[Q-&BG('E[GP';.X$Q>8BE"&893=TMW<BU1I&R0JEB%5G;
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MVC"X!&:F\;>%T\564]A)@":%T#,H<*Q'R/M)&2K88<@Y ((/-?)7A7XNZG\
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M;/\ @._/E;N/,KY__9)M;GP;-=07]G>1?:?LXC=K6?R\H9 59@AVY\P'<V$
M#%F7C/U57SW^UN9O$5I%IUE:W4\J7*RNT=M,T2J(G&-X3:Q/F#&PL!M8,5(
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M=LC:0N0:\E\,_M*ZGXNLKA]-L1->QS.PC4.8HK<!"A<EE,LS'>J)'M9]K,$
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M_2R2OJJBOE7]N?\ YAW_ &]_^V]?55?*O[#'_,1_[=/_ &XH^/O_ ".&D_\
M;A_Z625T$5[+J_C6[MVNGMRE@D<)C%OO(Q!.8@)HI W+/(>"^ <$*"*]+\4_
M"0^*K=[*]U"\D@DV[TQ9+G:P=>4M%8?,H/!_2JFM^"H?!'AN[T^V9VBBL+[:
M9"I<[DED.2JJ.K'& .,?6N*_8I_Y \__ %_R?^B8*J17LNK^-;NW:Z>W*6"1
MPF,6^\C$$YB FBD#<L\AX+X!P0H(KTOQ3\)#XJMWLKW4+R2"3;O3%DN=K!UY
M2T5A\R@\']*W_ 7@J'P191:?;,[11;]ID*ESN=I#DJJCJQQ@#C'UKH*^5?VY
M_P#F'?\ ;W_[;UZW^T5\,Y_B%IGV:T($T4RS(K<"0JCKY>XD!20Y()XR #M!
M++X_X4_::U'X?.NF^);61C&N!+C%P54NH8[SLG!8!1(K*"%+%I&.3]/^'KF"
MZMH9+/ MVAC:$*NQ?+*@IA<#:-N,# P.,"M"O*K[4]+\*:G<+I=I]HUFXCWR
MQ0X! VE@TDCD10*S!2^"'=F1RCDJ3XU\8FN7\6Z2UX(U<M8X2)F=57[6X +N
MJ%R2"V=B  A,';O;V7]J/_D7;S_MW_\ 2B*C]ES_ )%VS_[>/_2B6O*O@%_R
M.&K?]O\ _P"ED=1>.+D?!CQ8FHKD6=\I:8[6V@2/B?#$2%BLBK.0F#AA& %(
MS]"Q_P#$ZU,L.8K&-DYY!N)E1R0#C:T<& ' .Y;ET#+M<'JJ*^6_V,+DZS<Z
MI?7&'N':!FDVJ&S(T[R8P!M#,H) P,@<<#'2_MK?\@>#_K_C_P#1,]=5_P R
M?_W ?_;.N5_8I_Y \_\ U_R?^B8*Y3_FH?\ G_H'5T$5[+J_C6[MVNGMRE@D
M<)C%OO(Q!.8@)HI W+/(>"^ <$*"*]+\4_"0^*K=[*]U"\D@DV[TQ9+G:P=>
M4M%8?,H/!_2N/^)O[/QN_#\>C:6Y8VLQFB$I7=(?WI:,L BJ3YIVDC&0 V 2
MX\_\*?M-:C\/G73?$MK(QC7 EQBX*J74,=YV3@L HD5E!"EBTC')]*_:"N8+
MKPI-)9X%NT-FT(5=B^69H"F%P-HVXP,# XP*T/V7/^1=L_\ MX_]*):\J^/O
M_(X:3_VX?^EDE6_V@=4DE\5:-;%OW226DBK@<-)=;7.<9.1$@P3@8X R<_3]
M?*O[,_\ Q)/$FJZ;;_):K]HQ'][_ %-R(XOF;+?*LC#KSG+9(!!\??\ D<-)
M_P"W#_TLDKU7]J/_ )%V\_[=_P#THBH_9<_Y%VS_ .WC_P!*):]5KS7Q;=Z-
MX:U2*Z:#S=8GCV0I"N^X=<[2^"RQ)A<@RR%#Y:NH<JI4>"_M?W=[>)ITM_%'
M 66YVPI(9F4X@+;Y-J*3R%VJI"E21(X<!/6OVF/A5?>-8[6ZTMO])M)'94#"
M-SO,?SHY90K(8P1DC(R0P90K<+X3_:L>U)TSQ3:E25"2/Y9!VLJ#]] XZ%2S
ML4X(("PX-?4E%?*OP"_Y'#5O^W__ -+(ZM_M ZI)+XJT:V+?NDDM)%7 X:2Z
MVN<XR<B)!@G QP!DY^GZ^5?V9_\ B2>)-5TVW^2U7[1B/[W^IN1'%\S9;Y5D
M8=><Y;) (^JJQ?&WA=/%5E/828 FA= S*'"L1\C[21DJV&'(.0""#S7@O['_
M (S^PVMYIEZWE-9R-+B5]I1#D2KL?&Q8W3<YZ!I/F"GEN4^(&H3>"_$>G^(K
MI/*CO,.X=6S&G,#*8P?,65+5XBX^8><7V[E&T?2NG?\ $WU.:?HMG&;91T)>
M98+F8GKE0@@"$8.[S0P(V&O*OVUO^0/!_P!?\?\ Z)GKU7X3_P#('T__ *\+
M3_T2E?+_ .RUJDFD:;KMS VV6*TCD1L X98[IE.""#@@'!!'J*]0_9JT235-
M#MVAU">,*TZM%$+-EC;SG;:?,MI'!*L'PS$X8$84@5U>J? &WUF_M]5O+JZF
MN+9HC&6-LJXCD,BJ1%;ID;B<]#@XSTQY)\??^1PTG_MP_P#2R2OJJOE7]AC_
M )B/_;I_[<4?'W_D<-)_[</_ $LDKH(KV75_&MW;M=/;E+!(X3&+?>1B"<Q
M312!N6>0\%\ X(4$5Z7XI^$A\56[V5[J%Y)!)MWIBR7.U@Z\I:*P^90>#^E5
M-;\%0^"/#=WI]LSM%%87VTR%2YW)+(<E54=6., <8^M<5^Q3_P @>?\ Z_Y/
M_1,%>_T5\J_ +_D<-6_[?_\ TLCH_;G_ .8=_P!O?_MO7T!\6/\ D#ZA_P!>
M%W_Z)>O*OV*?^0//_P!?\G_HF"N4^ 7_ ".&K?\ ;_\ ^ED=6_VX]4DBAL;8
M-^Z>2>1EP.6C$:H<XR,"5Q@'!SR#@8^GZ^5= _XI_P ?306OR1S^9YH^]NWV
MHN7Y;)&9@&X(Q]T87BC]N?\ YAW_ &]_^V]?55?*O_-0_P#/_0.KJ_VUO^0/
M!_U_Q_\ HF>O5?A/_P @?3_^O"T_]$I7S_\ L,?\Q'_MT_\ ;BO4-!U;3O#5
MS<Z?X;LQ-=&8-=>6?*MXF+*N))GW!0 SE8H5D*E9%$:G=7DNE^=_PGZFYV>:
M<EA'NV#.GDA06Y; P"Q"[R"VQ,[%M?MS_P#,._[>_P#VWKZJKY5_88_YB/\
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M=TB1YR3N*JQ )R<$\\G/JN@ZMIWAJYN=/\-V8FNC,&NO+/E6\3%E7$DS[@H
M9RL4*R%2LBB-3NKR72_._P"$_4W.SS3DL(]VP9T\D*"W+8& 6(7>06V)G8MK
M]N?_ )AW_;W_ .V]?0'Q8_Y ^H?]>%W_ .B7KRK]BG_D#S_]?\G_ *)@KC_A
M_<CX.>*I](Y6RO618LJP +_-;X)#NX5V:#.X DEW(*X'T+X;_P")O>7%_P!8
MT_T6'//^J=_M,BYP4W3'RF7 W?9D?+*4V]57FO[2.J2:9H%[)"VUC&D9. ?E
MDE2*0<@]4<C/49R"#@U4_9<_Y%VS_P"WC_THEKRK]LW_ (DEYINI6_R72^;B
M3[W^I>*2+Y6RORM(QZ<YPV0 !ZK^U'_R+MY_V[_^E$5'[+G_ "+MG_V\?^E$
MM>JUE>*]+M=5M98=05&M6C;S?,.U H^8L6R-NW&X-D%2 P((!KA? _BH:C!'
M;>&[0+IZ*R)=3%H8 1MR8XR#/.0S,7+>2'=&'G;B6'DG[#'_ #$?^W3_ -N*
M/^:A_P"?^@=75_MK?\@>#_K_ (__ $3/7:Z-X.C\9^&;;3YCA9M,M0&Y.UA%
M&T;X#+G:X#8R V,'@FO+_P!E/XGC2[2ZTK4<Q&P66?#*P98@29U*JF04D.2"
M2Y,FT+A*]Z\#:7)8V^ZX7;<32233 D,RM(Q81%P3O\I"L*MT*1KM"KA1T%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%?)>D^*5^%_B^^GUIW$=Q'+Y<NV21=DCI)#VW%55/*^0,%==@
M^5214_;&U:;6_L<RVTR6B><J3R(T>]WV;D\MP)(\"/Y?,"F3YBBE%W-Z5^T1
MX';XFZ7]JLX9OM%K(S0J\;QR2QD*)@L;E''0$;TWL8L1J5D5FP/AA^U!(T,>
MDW5G<S:JF851<?O&08!E:5P\;<'SF(8+AI#@95>)^"FM76A>)-0N)[6:YE:2
MXAE^QQ[XTEDN5;):1D"1$QMAG88 R>A(V_C%X#U/X9:L_B/106AE9WF50[A"
M1OF$JY),+D%]V0$/ \LK&QV]"_:7U3XC;K+1M.\N=L+]H:4RPP;L_O'_ '*J
M/E5BH)Y8<*Y^1C]HWX)S16MC>:.LTEQ81PV_[O<TYB3'E2#81\R..?+3<=Y8
MX5..U^''[0T?CBW1;:WFEOOD26,1E($<QEC*TN76. LK 9+3''RQ.< ^:?L,
M?\Q'_MT_]N*/B*K?#[QA'KE\K_89-G[Y$=E4M;-;[6. -P*%RJEF\OD GY:M
M_M/>*V\;:7 +&"9H&OX!'*Z/&9F>"1HQ#&R^8ZD,07(0%MHC$@+%#XEVM]KG
MA"&)+:YM_L<=IYZR@(TJ1(T4F(T9GVJX60^:L8V*)!G%=K\(?C+;ZGI,%MI\
M4US>V]I#&UN(V0;T38-TS#R(U;86#,^2O 4R?NZ\U_8UOFT6:_MI8IO.:2U0
MH(G^0J9Q)YC$!(]N22'96;:50.^%)\0=0_X0#QHFK:@CI9R8*2!=P(^RBW9A
M@_P.<NOWPN"%.Y=W5?M"?#BX\>QQZWI*3)=6N0%9)(9Y8U(=7C1BKJT;E]H9
M$=^2N0(M_/\ A;]KO4!LT^?37N;Y-R.$=HY&9,[LPB!RK  [P. 0Q 4?*/</
M =O<^'+*2\U;)N[B8SW"0HTP1F"11Q(D*,Y"1I&K8WG(9B[+\U>"_!R:YT+Q
M%>:G=6-]';7?VK8QM)V*>9,LR[U1&/1=IV[L,1_#EA]/^*_#,/BBUEL;D9BF
MC9&X4D9Z,NX, RG#*2#A@#VKQ#]D'P'/H$%W-=@JXN9($1AD(8\+.R/DJ0[A
M4<IP3 N6;:-OT)17S!^TGX)O/#6IP>)]*C=F7#7&T.P4Q+P[[7W>4\0*/@*@
M5#N;,E:&M?M"GXCZ5>0:7:2"1;*5KJ2;:+>&,Q.9-KHQ9W."L0*IN/SL J,*
MJ?L@^)'TJPDMI+6Z*/-/<"X6$M;[%CC0@-G?(^^,J$C5V)Z#AMN+YUS_ ,)A
M_;?V&^^Q^9MW_9)]V/LWV?S-NS=MW?-C&_9_#N^6O5?$GQ8?PSK&9(KF33WT
MRWDD9(97^SL9I\2R*=IB7R]QDROF?NU&/E(KSKXT7%C\<C;0Z AN+Q9@LESY
M4L<4,)5SME=U7@M\R##'Y7"89MKZO[2/@.]T>]A\5:4 6ME3ST4%7PA8^:VP
MAI$*'RY1D%8P,Y3<4RM#_:VU/Q4%M--TP27I5,L'=X@=RJ[E JE$R<9:4!,@
MLY Y]OT91\.M+ACG6:>5(_W@@2:ZDEG8-+,PX+?/*6.Y]J@L 2N0*\*_9)M;
MGP;-=07]G>1?:?LXC=K6?R\H9 59@AVY\P'<V$ #%F7C,6MZ-/\  379-7AM
M3+I5PK!S&/\ 4I(\9=?E"I&5D \I6^5D(0-NW,G5_%/XA1_%^T&C>'<W+SS1
MBXE,4R0P1J?,#.[JNTED&WAMRJX WE >U^(=H_P[T 1:0IWVS62PJ =TC?:8
M0581;"QD)(D"X+EV_O5DZ_\ ';0]=@?3]1CG$LJ[6L);:87+,>8T 52H=OE:
M,AP02K;E/3BO ?[/-SJOAB33KP"&YEN3=0!]V8V\M$42 8VEE5@0=Q0."5WK
MM''^#OV@]4^$$9TG5[1Y3'Q")',3J@++M#;)!+%E<1L.  0K,NT+[W\+[G4?
M%MRVL:G ;-%A:"UMF/[P*S(T\LFZ-7RSQ($SM 53\G(=_"G-S^SIKDTRP2/I
M,[!01NV;')=%4EV4S1895$AW,H8_()-PE_:,^)LGQ"TF&ZMK=XM/%VH$DV%E
MDEV3#$:HS+Y2J&#.3\SD*H&QZ^@/@AK4E]IL%O+:W-LUM;P0M]HC$6]DC56*
M*6+E1C[S*H.<#)#!>_KY5_:@BD\/Z]INLRQN;.+[,&=0#\T5P\K1\D88H<J&
M(#<X/RMCT#XO>&(_C5I9;3XW:6+9+:RR1FW63</GC4S(LA5H\'=A8F<Q_O#L
M<+S_ ,)OVCK3P]9IIFO*]E=6D<405HICO0(!&VT(S(VT#<& !R&4X8JFW\(/
M!,^M:M>>)]1@,#3-Y=I%(NR58U C\QT;<R.415!##.9?EV,A/M]<_P#$+2Y-
M7TV\MH%W2RVEQ&BY RS1LJC)( R2!DD#U-?/?[)OCV+P];7.D313F]6Y>00K
M"[,<K'$5)QMC*NFUC,8T4LN7 W;8?VMK6Y\936L%A9WDOV;[0)'6UG\O+F,!
M58H-V/+)W+E""I5FYQ[+XW\5+KVB731070>>VGA6%K6X$PD>!L*4$9.,G:9!
MF+=QO->0? ?P>VHZ->>'=3MKJW>YF=XY)+:=8@?+0HV\!5!1X0Q5V0/\J@MD
M@<IX5^)FK_L^O)INHVYGMMS>2"S)'N!!9X92C!D(8%DQE6()".7#>U?#?Q-J
M/Q0NH-1NK4V5A;*SPHS;GGFDC9%DRT:DPB&5L;0H+,#NDP0GLM> ?MK?\@>#
M_K_C_P#1,]2^"/VA=/\ ">E6L&J"2WN(K*#9%L>3SHQ$OE2QNJ^60X&,,R['
MW(V-NXGP+\"W>KZC=^)M7A,,T[%;:*0 21I]PDJ8U92$58T;Y69?,+*0X8\U
M^TYI,VBZUIVO-&[V<'D>:8U9BGDW/F'<<!%W>8!'EAN8$<8!.W\>/B5%XPT"
MZ.G1R26VVW9KET>&'_CY5=D?F*'E<.OS *$5229-X"-D^%?"VH>(_"4FA+9S
MPW"*Q#3JD$;LMT+@(H=_,R4. S(L>X$%QC-'P*^.=CX%T]='UH26=Q;,W$D4
MI+K(S3 [5C+(1OP0PP1M92<D+U?@3P==^,]:/B>_22UBB5HK*VD4+-LVNC/*
M-H*@EW8*<MN;[WEJIDROVMS-XBM(M.LK6ZGE2Y65VCMIFB51$XQO";6)\P8V
M%@-K!BI ![_X5^*EMM(MUG@NHGM;:WBEC>UN/,W*HBRBK&QD!*[ODW%5(+A>
M0/$/@Y-<Z%XBO-3NK&^CMKO[5L8VD[%/,F69=ZHC'HNT[=V&(_ARPM?&SP[J
M'PJU=O%&F*C6\O$J!6"(S($82JC+N5WQ('R!YN-PW;2]NS_:,U;XHJVGZ+8>
M3))\DEP99'2%71QO+)''Y;#!9&)8Y4A49B!7NOBG6(_AUI;SP0O)%:6ZA(4R
MS;4 102=Q"J,%W.XJ@9B&Q@VO 'BW_A+[&"_\IX?.C#>6_WAR1D'C*G&Y&P-
MR%6P,X'05XU^TKJS:GI=QIEK;W4]Q(T  BMIWC #I*6,FSRR,+CY68AB 0,,
M5B_9UU\Z%I$-A>6UY#/#]H+![2YVD;Y)MRLL;*?E;:%)#LXVJI)7=YK\8YKG
M7?$5GJ=K8WTEM:?9=["TG4OY<S3-L5T4]&VC=MRP/\.&/U)HFN1ZRADB$B@,
M5Q+#- V< \+,B,1SU QG(SD'&A7S+^VYH$]W!9W<:%H8&G65QR$,GDB//< E
M2,] < D%E!];TOXUVFKVJWUK#>31-&6_=VLS'?SB(87#,2K*60M$K*0\B;DW
M^*?LDVMSX-FNH+^SO(OM/V<1NUK/Y>4,@*LP0[<^8#N;" !BS+QD^.EK<W_B
M2RU"UL[R>"T^S"4QVLYR8KF21U4LBJ_RD;6!V-D8;'-6_CM\.[ZXNHO%/A\3
M>=\@D013)<AES&LHBE4,5*@(Z; "H#%71W8'AG]KC4/%&+2QTOSKPQCE)6,8
M8X7S&3R_EB#L,[I  #@R#[U>B^*[67PKX?EL)$GN[RXMKH-Y$+S;I[C<TS9C
MC5$3S)B5W!#L&%#,"*Y7]D@S>';273KVUNH)7N6E1I+:98F4Q(,;RFU2/+.=
MY4'<H4L20,_]HOX4:A:7T?B30PYN%\L2I$&>;<HV+*%^;>I3$;H%QM&65E:0
MK4\,_M<:AXHQ:6.E^=>&,<I*QC#'"^8R>7\L0=AG=(  <&0?>KW_ ,!>'I/#
M]E%;W#^9/\\DS\8:65VEF*X5!M\QVVC:,+@$9KH*^5?VMK6Y\936L%A9WDOV
M;[0)'6UG\O+F,!58H-V/+)W+E""I5FYQZA\0OB;-!;V%]8P71)U&-9;9H)DG
M9#;S-*GEG9YA5?F!!:/S$!W$*:YKXH?%O1O'FGSZ:J33WS1MY5I]FG^TQW"J
M<?P@*T9SYF&/RJZ_.#M;T7X'>$)_!^CVMC=@":-9"X4[@"\KR;<C@D!@#C(R
M#@D8)[JOD7]G[QE'\,]3U'3]:>074TT2AQ'-,99%>0<84RL9/-#H=OSCDD$J
M#%\:=6FN?%&F7L]M-#;B2S$+,C,\J)<;V<1H"ZM\^/*(\T#;N16<(/5?VA]<
M?7=&DLK:UO))[GRBB+;2MA%F#AW*J53*QY"$^:NY=\:'=ME_9OU9M(T>.QN[
M>Z@FMEG9Q);3J&4RM)E"$(<X< (/WA(;"$ $^:_"?[1X;\2WVHW-G>BUN6O!
M'*+.Y8 /.LJ,5$>\ JN.%)!(R ,D>H?M3>!5\3:-+,J;I[3]]&1L!"C_ %P)
M89V^7ERH(+,B=2 #TOP/\+OX;TBUAFR9FA1Y2RE) S*-J,"2V8TVPC/(6-1A
M0 H[JBOD" 3?L[:[-,T4QTB?*@HK,I#!I(D4M+M,L;*4_>-O,>]PHW@UM_M5
M>-AXJTB*2VBD%J+V$K/*K0B4M;R.IB1P'9-K'<[!!D )Y@+%/7_#VB/KWAB&
MSB(#SZ/'$I;(4,]J$!. 3C)YP"<=C7C7[-'Q&@\!VUQI%_%<K??:'F2W6WE>
M:0&!"$554D-B//S[%VLK;L;BN>;B[3QJ]_\ 8IY!&T0DCA F9/-LQ'%O?*Q(
M>07)?8I#[7=5W'H/V@/A=J,=W#XFT5)%N=L7G1(-]PK@; ^U6D1QLQ'(B97
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M]_''XR:W\+'@!-E.DZR;6\B>-@R%=P*_:7&,.N#NR3D$# )Z_P#XK#_J$?\
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M#:F[C(+L 0=K8->:_"G]HF]^(3W0M[$,4:V$48D*JJN6$KS3LNW P"JI'YC
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MT&>>2X . >"2/,-*^/UWJ/B"+09+,6PW3>;OD$LI40&:$CRCY:$@ L,RCYL
M@C)]%^)7Q!C\"VOVET>61Y%B@AC!+RROG9&, XS@DG!X!P&;:IX37_%GBG0H
M'U&6WT\V\2^;);K),;E8A\SIYAQ$75,Y8 J2"55N%/3>"OC98^)=+;67;R(8
MLK.'S^[<!24! ^?.Y=FT9?<HVAR4'/\ _"9>)/$D/V[2[6SBMFCWPQW,CO<3
M*1OC<>2PBCWJ5 1VRK [FVX-;7P6^+@^(4$BS1F"]MF"74)5E"N=P!&[D E6
M^4_,A!5L@!FX7XA_M,W'A'4(+&XLOLT3R0.\LSK*_P!G9BLC".W9PK AMOSO
MPO*?, .@\+?$_6M2U=+6ZTUX-/GC9HI65C(@V%D,K*SQJS%"#$0CH74$G'S^
MOU%=S&!&=5+E5)"+M#,0,A1O95R>@W$#/4@<UX4/VCKLZXFBR6!B :4.FX3W
M#YA,L&WRV$49/R[RS.BAB6=%1GJ+XO?&;7OAM)#/<6UFUG+)MQ&UQ(Z[0I9&
ME98D5F^8Q_NSP#E6VG/:ZQXUU;7H?M'A^VA:'RTDCFNFDC\\$.2L40"..BXD
MF:-6SE0R$254^"'QK;XFV<T@B1+R#:&CWN(V+)E'W>6VQ6=7&!YC(%R=V1G/
MT'X_3W6N#P]=V(AEW.&D6X\U<+"TRL!Y*9#*!C)4@-\P!!6M#XS_ !DNOADJ
MW#623VKR"-9!<['#;-V&0P'&<-@JSC"Y8J2!72W'Q,@T[2$UR[!CB:VAF9%_
M>,#*JE8QPN26<*"=HR<MM&2.*T#Q9XIUV!-1BM]/%O*OFQV[23"Y:(_,B>8,
MQ!V3&&("@D%E7E1->_$75M4T"35+6&&"X$=ZT@E:0- (99% "&)O,E"(0=YC
M42 $J5)0<?\ LB:I?W-A,ZI'*DFHR--++<2+-N:.$NP7R) YQ\V6D4LQ(./O
M'Z/HKY+_ &D]4CTCQ5IMS.VV**.SD=L$X5;J5F. "3@ G !/H*[#Q_\ '3Q!
MX;"ZA_98BTW<F3*P:<JS'!81R?N"RX7#HP20[26)"UZU\,/B'#\0+&._@&W=
ME7C+*S1NIPR$C\&7(!*%6*C.*Y27XEZAXPDDC\-16TD$,A1[RXD;R&D4 O%&
MD7[QN'4B7[APP&1M8U?A]\8KQ]3?0=>@2&].6MWA#^1,@4L2-Q8]%9@V<'#(
MP21-K>OT4444444444444444444444444444444444444444444444444444
M4444444444444444444445\J_MS_ /,._P"WO_VWKZ _X5/H_P#T#[/_ ,!H
M?_B*\/\ CKHTOP;-OJV@N;>%KEA/:[W-L\CJ6#>3G8 45E;!7:!'Y84C</8/
M&^MIKWAZZO(@0D^E3RJ&P&"O;LX!P2,X/."1GN:\Z_8I_P"0//\ ]?\ )_Z)
M@KE/^:A_Y_Z!U=-^T=\,]6N[VWU[126FMX=A1,"50ADDWJ"<2!@Y1H\$MPH5
MPS!8?AQ^U''XDN$TK6[7R;IKA(U(4M%YHD)0-&^7B975 #E\/\Q,8'%O]M;_
M ) \'_7_ !_^B9Z]5^$__('T_P#Z\+3_ -$I7S_^PQ_S$?\ MT_]N*/C[_R.
M&D_]N'_I9)7017LNK^-;NW:Z>W*6"1PF,6^\C$$YB FBD#<L\AX+X!P0H(KT
MOQ3\)#XJMWLKW4+R2"3;O3%DN=K!UY2T5A\R@\']*S]?^"2-X??P]8RE1M_=
MO+ACN\_[1ABBKP6^7(7*@YPQ&#X?X0^-6L_!CR],UVU=[9?EC8G]XJ_(2(Y
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M=.#+ 0#%'E8?F;JTC.-A4Q*7#)U7[+G_ "+MG_V\?^E$M>5?L,?\Q'_MT_\
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MFYV>:<EA'NV#.GDA06Y; P"Q"[R"VQ,[%[7]M;_D#P?]?\?_ *)GKU7X3_\
M('T__KPM/_1*5\O_ ++6J2:1INNW,#;98K2.1&P#AECNF4X((." <$$>HKVO
M]D_R?[ @\K9O\R?SMNW=O\UL;\<[O+V8W<[-O;%>GZEX>MM4>.6XACD>%MT3
M.BNT;9!W(6!*G*@Y&#D#T%> ?"*:;Q'KNNAKV2"47*J%B%MN>.%YH5RLT$O"
M*$7*@<L-Y)(->B^-?@@GC>%;;4+Z\EB602!<6:88!E!S':J>C$8SCGITKNO#
MVB)H-M#9Q$E((8XE+8+%44("< #.!S@ 9["M"O$/VP]$?4=#\U" +>YAE?.<
ME2&AP, Y.Z53S@8!YS@'0_9/U2.]T"".-LM#)/'(,$;6,K2@<@9^213D9'.,
MY! ]?KY+_;CU2.6:QM@W[U(YY&7!X60QJASC!R8G& <C'(&1GT7XV:(^@^#F
MLY2"\%M81,5R5+)+ A(R <9'&0#CL*VOV7/^1=L_^WC_ -*):\J_;G_YAW_;
MW_[;U]55\J_\U#_S_P! ZNK^).J++XQTFVNF3[.EN\B*X3:)9//52"1RQ>*(
M(,\.%V@,>??Z^>_VKK*+PKH0MK"..WBGO8EE2*-$5AL>3D*HP=T2'(P<*!G&
M17JEIX8GO$66+5;IT=0RLJZ>RLI&0P(L\$$<@C@BLKP+\#K3P=?S:K%-/+<7
M"R"0RF+:3)(LCL!'%'@[E[< $C'3'C7Q]_Y'#2?^W#_TLDKZJHHKY5_YJ'_G
M_H'5U?[:W_('@_Z_X_\ T3/7JOPG_P"0/I__ %X6G_HE*^?_ -AC_F(_]NG_
M +<4?\U#_P _] ZNK_;6_P"0/!_U_P ?_HF>NED\#OXY\)V^G1.(WETZRVLP
M)7<B12 ''(!*X)&2 <X;&#XUX0^-6L_!CR],UVU=[9?EC8G]XJ_(2(Y 6BE5
M%;A,Y4L$,B*H4>ZZWXDM?$WAN[O; ;8)K"^<#;L(8I+YNX#C=YF[<1D,V6!8
M')XK]BG_ ) \_P#U_P G_HF"O?Z*^5?C[_R.&D_]N'_I9)7U!JVEQZO#);3K
MNBEC>-UR1E6!5AD$$9!(R"#Z&OD7]ES7Y]+TK7)(7*F"V66(?>59/*N#O"ME
M<G8N>.0H!R *]*_9JT235-#MVAU">,*TZM%$+-EC;SG;:?,MI'!*L'PS$X8$
M84@5U>J? &WUF_M]5O+JZFN+9HC&6-LJXCD,BJ1%;ID;B<]#@XSTQZ?11111
M111111111111111111111111111111111111111111111111111111111111
M1111111117RA^U7]H\>O9IIUG>RB%9R[_8[E%S(8P%&^-6)'EDGC&",$G('K
M7_"_?^H3J_\ X!__ &RO,/B!H>N?'>>"$6DEAIT4S@O.2KD_\]6A)5F(3 0*
MK ,SKYNTL5]_\0^$!/I4VE68"!K*2WA#%BJ@Q&- 3\S8'&3R<<\FOGK]FCXC
M0> [:XTB_BN5OOM#S);K;RO-(# A"*JJ2&Q'GY]B[65MV-Q7/-Q=IXU>_P#L
M4\@C:(21P@3,GFV8CBWOE8D/(+DOL4A]KNJ[CZWXD^*LWA;6/](@N38OIEO)
M-LC:;[,_G3_/)Y;LB+L#^8R[RWEKM+!:\Z^-%Q8_'(VT.@(;B\68+)<^5+'%
M#"5<[97=5X+?,@PQ^5PF&;:_0?M;F;Q%:1:=96MU/*ERLKM';3-$JB)QC>$V
ML3Y@QL+ ;6#%2 #VOP\\=+I.C6XFMKU9;:VAB>'['<&4ND97"@)M8-Y9PVX*
MNY!(4+ 5Y)^R3:W/@V:Z@O[.\B^T_9Q&[6L_EY0R JS!#MSY@.YL( &+,O&3
MXZ6MS?\ B2RU"UL[R>"T^S"4QVLYR8KF21U4LBJ_RD;6!V-D8;'-6_CM\.[Z
MXNHO%/A\3>=\@D013)<AES&LHBE4,5*@(Z; "H#%71W8'AG]KC4/%&+2QTOS
MKPQCE)6,88X7S&3R_EB#L,[I  #@R#[U>B^,8;WP'X>S"QFOTFMY&*Y/FSRW
ML<DR 1K&2CR2,H0!24.WN:J:_P#';0]=@?3]1CG$LJ[6L);:87+,>8T 52H=
MOE:,AP02K;E/3BO!&@:G\,_"DLNPK>/>VT\4(WF0AIK6-8G5-K9?:0T8.2K;
M6PQ91VNO_';0]=@?3]1CG$LJ[6L);:87+,>8T 52H=OE:,AP02K;E/2;]EKP
M+=>#]),=ZGER37#3!#]]59(U4.,?*WR9*]0" V&RH]?J*[N1:HTC9(52Q"JS
MM@#)PJ LQ] H))X )KP_1_%YU/7IK^^M+Y;>"W$5BQLKEH^3^_E*B-W65^ C
M )F$%9 &P*]UKY5_:<M;G5]2M+O1[.\>ZM<AYUM9S'E) T*KO0J^U@[;@I1@
MR_,XX7TOQC\3[F_T-[ZUMKFWOHY+(_9Y89T8N;J)?*!VIYRO@J0ARR, P4MM
MJ'7_ ([:'KL#Z?J,<XEE7:UA+;3"Y9CS&@"J5#M\K1D.""5;<IZ<5X(T#4_A
MGX4EEV%;Q[VVGBA&\R$--:QK$ZIM;+[2&C!R5;:V&+*.UU_X[:'KL#Z?J,<X
MEE7:UA+;3"Y9CS&@"J5#M\K1D.""5;<IZ<K\-/@)/>^&)]-OT$<]Q,UQ &X>
M)_+C$1?*,4)*$. "PC<J<,2HS_@K\95^&4']A>(HGLV@WM#(8Y&#JTK%@0@?
M/SEMDB9C=01D%07Z7POX>?XF>(/^$@FA*Z?:PI'9&1#&TS<NLVR0,2@,C.C_
M "'/E$#<L@&5^TCX#O='O8?%6E %K94\]%!5\(6/FML(:1"A\N49!6,#.4W%
M,K0_VMM3\5!;33=,$EZ53+!W>('<JNY0*I1,G&6E 3(+.0.?;]&4?#K2X8YU
MFGE2/]X($FNI)9V#2S,."WSRECN?:H+ $KD"O"OV2;6Y\&S74%_9WD7VG[.(
MW:UG\O*&0%68(=N?,!W-A  Q9EXSG_L_>,H_AGJ>HZ?K3R"ZFFB4.(YIC+(K
MR#C"F5C)YH=#M^<<D@E08OC3JTUSXHTR]GMIH;<268A9D9GE1+C>SB- 75OG
MQY1'F@;=R*SA!Z+^U7I\_BC0DGMX9,17*S.K+MD6)4F3S"F=P'S*Q4@.BG,B
MH5<++X#U>R^*OA^+1T68G[(EO*YB<1PR0QKMD+Y2-\2*C+&CEV#+N0+YA7R7
MPK\3-7_9]>33=1MS/;;F\D%F2/<""SPRE&#(0P+)C*L02$<N&]J^&_B;4?BA
M=0:C=6ILK"V5GA1FW//-)&R+)EHU)A$,K8VA068'=)@A/9:*^>_VMS-XBM(M
M.LK6ZGE2Y65VCMIFB51$XQO";6)\P8V%@-K!BI !Z71/$3KX7E18[FVN;32&
M1A+%+;NKQV[*&1F4!N4W HQ*@KNVL<5#:?M%::+98-?22SN'A F@GM9@KAEP
M[*NV3,+-N4;CD@$,/7/_ &8? $WAUM0NV@>VMKJX7[-#*&6=8HWFV[U8DKPX
M RQ8[2?NE6;W6BODOXQS7.N^(K/4[6QOI+:T^R[V%I.I?RYFF;8KHIZ-M&[;
ME@?X<,?5?V@[\^(M"E@M(;F26X\ORT%K<[_W<\9?<IB!CX!(\S;N RN:A_9O
MU9M(T>.QN[>Z@FMEG9Q);3J&4RM)E"$(<X< (/WA(;"$ $^:_"?[1X;\2WVH
MW-G>BUN6O!'*+.Y8 /.LJ,5$>\ JN.%)!(R ,D5/V?O&4?PSU/4=/UIY!=33
M1*'$<TQED5Y!QA3*QD\T.AV_..202H,7QIU::Y\4:9>SVTT-N)+,0LR,SRHE
MQO9Q&@+JWSX\HCS0-NY%9P@]%_:KT^?Q1H23V\,F(KE9G5EVR+$J3)YA3.X#
MYE8J0'13F14*N%E\!ZO9?%7P_%HZ+,3]D2WE<Q.(X9(8UVR%\I&^)%1EC1R[
M!EW(%\PKY+X5^)FK_L^O)INHVYGMMS>2"S)'N!!9X92C!D(8%DQE6()".7#>
MU?#?Q-J/Q0NH-1NK4V5A;*SPHS;GGFDC9%DRT:DPB&5L;0H+,#NDP0GG7[6U
MK<^,IK6"PL[R7[-]H$CK:S^7ES& JL4&['ED[ERA!4JS<X^D-$\61ZM;&[$<
M\8526CE@FCF!"ABHC*;G(SC]WO#,"$+&OF7SKG_A,/[;^PWWV/S-N_[)/NQ]
MF^S^9MV;MN[YL8W[/X=WRUH?M-7,NEZKI.MR>8UA&T+;=KJRNDHF?*2! CO'
MM #%6)C(8#972_'?Q^OC;0)SI,,US VQI)Q')%'&D<H8N/-1&E^:,AO+#",!
MFD9  &E_9[\=QZ-X?ME,%U*8UN"?*MII 6,\K(BD+ARPS\RYC0C;*\;,@;C_
M -DFUN?!LUU!?V=Y%]I^SB-VM9_+RAD!5F"';GS =S80 ,69>,_55%?.O[27
MPONA>6OB+28/.N()(C-&J[F8QNK0R;$ =_[DA#%@@3 "JS#;MOVJ;'6;+=8K
M(^IO"WEV2PRS/YH!XRBJK(,;R0P;RP3@/\HVO@)\-/\ A66EG[2O^E2;I;C8
M/-88!V1+Y:%GVJ/NC?\ O&?82&%>0>=<_P#"8?VW]AOOL?F;=_V2?=C[-]G\
MS;LW;=WS8QOV?P[OEKZOM+D72+(N0&4, RLC8(R,JX#*?4, 0>" :EJ*[N1:
MHTC9(52Q"JSM@#)PJ LQ] H))X )KY0\ZY_X3#^V_L-]]C\S;O\ LD^['V;[
M/YFW9NV[OFQC?L_AW?+7:_M812^*--M[:Q@N9I3<13[4MK@XC,<R_,?+PK L
M 48AQGE17FGQO2YU7P_IA$5S"EC''%=130SPX<QK''+\R"-E!C<!@Q*^:BD
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M1B6.5(5&8@5TO[57@MSH$4%A$3%9S0L54EBD,<,D>[DEF"[ER>2!EFX#$2^
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MN5,3E0I3[P."7 .,#/E5W\5O&]FC2RK=(B*69FL4554#)8DV^  .23P!7O\
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M +<3R([A8;J5U,4CQ,L+3#8 )E92=B_,68#GY3D8Y7]GK]H6_P#B1?R6=Y'
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MGQK]JNYO=1@TV[U#$;S+=,MNJD"%#Y+*C%P':;:P$I.U05 2-<,S^]?LN?\
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MM%;VW>U$]P'MY&G,<"1F)4*%,,Y,C^8^V3;NPH !VJN]L^R_$_7]>\&V,E_
M]G<^5AGC%K<(VS.&<$7<F=N0S9  0,Q;Y<$^ 'Q%OOB):M?W3VP02/'Y4,4R
MNK+L(+/)*RGY6SM52,%3O!#(-N#4M5FU62S$EK]ECAAF8^1+YVV669%B'^D;
M,[(6S)@#<1B(C..ZKA?C2MZNF7,MC<"W,=M.[MY9>4A$WXC<2((R0I4MM<C=
ME=K*#7DO['-M>/ILC02PI +]]Z/ \DC?NX-VUQ.BKE< 91L'D[A\H[KXD_$R
M]DU!/#^A",WKPO)+/)EHK=-K;<A Q5R=I!==HW1@JXD^7E?'_B'Q)\)0NH3W
M4>I66Y$E1K=;=U+,26_<J0HPH0.S,-S@&,G!KVKP7XO@\8VD5_:$F*525W#:
MP()5E(]0P(."02,J2,$[5>->*_'>H>)]:;P]I$PLS;P^=<7+QI,S JA6.-&R
MI'[U-Q8J2<XP%Q);L3KWAK4+&UO+J.\L[B:8/-Y*03!UMIG6$JK%=AV;PRC=
MN4JS!<!L_P 6_%ZXO]?B\,V)^SYYGN2BR2#$7VC;$K9090;2SJ_+$A/D!;%^
M)GQ+U+X.ZC;R7=P;W3;E7'EM'"EPA39O8-%'$K$;@5S@,"R,%(62MK]J.VO/
M[&O'\V'[+_H_[OR'\[_71#_6^?M^]S_JON_+U^:HOV9;2_;1;)HYX%M]TV8V
MMY&EV_:)-X\P7*KD\X/EX7(R&QSTOBGQS>:Q?/HFB[$GBC5[JYE1VC@5P-BQ
M@#:\Y5O,4.1&0I!W'=LX7QGXSUSX.SP7>I70U'396\J3$,-O*CG+ JJ=3M4E
M<L5;#*P0E'KV3Q3XZM?#5B^J3/NMDC5PT?[S>&($>W!P=Q8!3D+R"2%R1P'P
M[U35?B99-JAN_L23>8+6&".&4($>1 \QGC=I&W  A#&I501@N0O*?!WXQ:UX
MPO)](NFMH;JUC;>S6[3;C&XBEW&.[B4-N(/R*4/S8V@ &WXM^,VL>$=<M-&N
M!9RQ7,EM^\2*:-]DLOE-\K3N%8$-CEAC!/4J.U^.?C'4O!%D^I6)MFBB\L21
MS1RESN?9N5TE4=67Y2HXW-OZ+6?H/QM=?#0\17L09PKYCBRBEOM#01@;V8J"
M=NXY8@9(!X6L_P #7>L_$32/[4AO_LUU/YAAB2& VJ>6YCVMYD<LQW%"2V_Y
M=_"$+AK?[-WQGD^)%K(ETN+JV\L2.  D@?=L< ?=;Y#O &W."N VQ>*^*?QR
MUKPEJUK82QPK%));RF.U#7,[Q%S&\(:5(PS,5;:%C1AE0'ZD]?H.J>)K35!<
MZHL$>DO"[RJ'B*VH",RAG.R1G4J!(PWQ89BN!C9E>&?&>M?%R>XFTJZCL--@
MF>**40K<2SL-A!*S8VC;\_1"N\(1(067RKX@W-ZWBO38-2PTT$UC$)E4HDZ?
M:2Z3!2 %)#[752RB17"G' ^SZRO%FN_\(_9W%[MW^1;RR[,[=VQ"^W.#C.,9
MP<>AKY@_8JT_^TKR_P!0F=WG6.-"6;=N\YVDD9B06+;HASGNV<D@CZTK*\1>
M&8?$"QI.,^5<03H0%W*\4BR*02#C."K8P2C, 1G-<5\6?BE-X;FM=,TV-)M0
MO) (U?<T<: @-+(L9\S;C." !A78G]V5;BO&*^*_ 5J-3-]#>K#'NN+<VRH!
MG:I*F)5=U7<7+$Q85-Q!!*CTKX:_$Z/XB:?]OLDQ(-R-%(Q4+*J@["X1LK\R
MD.JGY2"5# H/)1\:=<'B5-%EC@PK2YBA)VN'MS+%OFF7< F5+M&BD@/B-SM0
MGQY\7>(OAL8;]+R.6WDF"M$MM'%$K!0RI\TDLS"0*Y)#@K@X9<J!Z!>W6M>.
MK87>E31Z?#)#'+;^9&L]Q)N5CB7EXH4.4(V"5\?,Q4YBKG_V?/C3>_$*RN!)
M'')>VS0C))@BD1Q@,S*LQ#Y20MMC"_="@ G;RG@KXX:[KFKW>FLD#SPPRQ1Q
M1JZVWG)<)&T[R$/($5"[$%E#A510)77-7QQ\3_%7PIN4N=4\BYM)F.%C7$*G
M=N,2OL217" A#)O!4D_O&5MOK7Q9^,\?@S24U6V7SOM'EBWR"J$R(TB.X.U@
MNU22  Q.%^7)9>:UN76IM"&M6VHE+@VPNVB,%M]G$90S&) 8GD!5" K.[[BO
MS8W97I?A)\5YOB+I?VV"%!=))Y3QO(T<)=0C,RN$E8*5<$ J2&^0D@;SYKX
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M0BD% S'YFQD'*MM)1TW@>J_\++L_[+_MO=_HOV?S>J;NG^J^_M\W=^[V[O\
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MN@_:NU9;"\T7[1(Z6HNWDFVM(N CV_S_ +LAMRJS[67YUR=I!->P?\*TM?\
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MAK]]XPACDT^%-/TTQXB,B!KIDP@1HXE(AA4#?Y;.9@<(WE%#SX_^PQ_S$?\
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M86:/3XY!@'<HMS*!R#CYXU.1@\8S@D'W7X3_ /('T_\ Z\+3_P!$I7S_ /\
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M3_\ KPM/_1*5\_\ _-0_\_\ 0.H^/O\ R.&D_P#;A_Z625ZK^U'_ ,B[>?\
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MVK\J#<W'"C)P!7U57RK^SK_H'BK5K6'Y(!]LQ$ORQC9=(L?RC"_*K$+Q\H)
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M +Q1C=@;LR;-WE!=S'[4_P (YM3T^R.EQ/(MCF(01JTC^4ZHJL/F+MM\M00
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M%8>R_##3]:\5W$>JZ^B6Z0QG[-:IN7YY%PUPZ^8Q#"-FC"/DKN;Y(R,OY_\
M$'PWJ'A'Q8FOQV<UW:O@XMU:1U'V<6[A@%.&&=Z@X5Q@!P=VWTKXFWFJWD5E
M<V%F_P!HBU-'$!>'>8A;SK+YC@O#%N#,@(=\!D((D;8N+XV^(%UXQLI])71K
MW[5-"\>)8XQ:+)CEQ.S;&",-T;X&]E7;M+ BT=/U/X0^'8+;3H1?7<38<*KL
MJB21Y'8(I$D@4ML&-IP?,("JRUVOPM\9S^*K3S+V VUU&RI/$>@<Q1S @9+
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MI_,,,20P&U3RW,>UO,CEF.XH26W_ "[^$(7#6_V;OC/)\2+61+I<75MY8D<
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MRZD,NA^T9\3M6\ 6XN+-+98'D\D2,TDD^YXRRN$V)&FTHWWFE#?*2H&17/\
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MP%X@BT75IA>6]RT(CE\F**3$FY%95B<!1YWROOW':A90,C/*?MHK>V[VHGN
M]O(TYC@2,Q*A0IAG)D?S'VR;=V%  .U5WMGZ*U?Q-+X(M)[_ %>:.2*)5(\B
MW>)LD[0N'N)MQ9F4+R@4\L<<KR']D^)_%$/VQ+V'3V>/=%:+;B7 (WH)I)EW
MK*-VR3:A4;<A<DBI?@-\79?%XFT[4E":E9,4F *8DVL49P%/4,,2;<H"5*D!
MPJ^7_'W_ )'#2?\ MP_]+)*]5_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#MX_\
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M-YC[G=@6,FQ4'FY\Q,Q>!?C5K/AG64T+Q)L?S9-J3A-I)?"PE#&H5XF8;1E
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MT1]&M4BF(,K-)++MR4\V:1II0F0#L$CL$S\VW&XDY)VJ\J_:C_Y%V\_[=_\
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M/!_U_P ?_HF>O5?A/_R!]/\ ^O"T_P#1*5\__L,?\Q'_ +=/_;BO5=#\>?\
M"133V_AJWA$:W!-Q>NNVU:4F/S"BQ8:YE*[LDM&O"L9"KH6\@TNWDM_'ZK/)
MYLG)9]H0$G3R<*HSA1G"@EF"@;G=LL>U_;6_Y \'_7_'_P"B9Z]5^$__ "!]
M/_Z\+3_T2E?-7BNWNKGQS*FGR)%=&-A$\B[T5O[.X)'\CA@#@E' *'T#]F7Q
MK_9WG:!J:^3J<=Q+(P<8>??\[.SEF\V7J=W\46QE+*K,/6OB1X'3QSI\^G2.
M8Q,JX=0"5965T.#U&Y1D9!(R 5)R/F"PU+Q-^SZ!'-&+G35;)QF2 ;FC+[9
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MX/\ K_C_ /1,]>J_"?\ Y ^G_P#7A:?^B4KY_P#V&/\ F(_]NG_MQ1_S4/\
MS_T#J]Z^,5HEUHU^LBA@+*X8!@"-RQLZ-SW# ,#U! (Y%>"_L\>)-/\ #WAF
M[GU8(]M]O<&-U63S&\J!DC5&X9B5R >!C<2JJ6'I?C?4-4\1:3?7$J)96IL+
MAEA93)>L DI_>$D10;E";HPLK@,Z[XW *\_^Q3_R!Y_^O^3_ -$P5RG_ #4/
M_/\ T#JZO]M;_D#P?]?\?_HF>O0/"/AF'Q1X=M;&Y&8IM,MD;A21F%,,NX,
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MB\K%>*_LS> M8^'$T\=]8OY5SY(\Q)K9O+*%QEE\X$KB0DE<L-N C;N#XR>
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M#%?6O OC"X\3QI-+936BF/+"<JK[\@;509<J,-EI!$2-A5&#DIY5^TE\(?\
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MHHHHHHHHHHHHHHHHHHHHHHKA?C3JYM=,N;=(9YI;BVGBC2"&68[G39EBBE4
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ML"7.%!RWT?\ #7Q>/&.G6U^""985+[0RJ)!\LJ@-S@2!@.3D#()')X_X!?\
M$\CN]=;EM1NY&C)X<6\),,$;J/D#+M;)7.0069CTXK]I'XQZUX":..W%M#%<
M>8(I%+3SCRW4EB)$2)=RNHV[9,?-A_ND>H?&E;U=,N9;&X%N8[:=W;RR\I")
MOQ&XD01DA2I;:Y&[*[64&O)?V.;:\?39&@EA2 7[[T>!Y)&_=P;MKB=%7*X
MRC8/)W#Y1B?M$3&#Q;I;JI<JMB0B[0S$7<I"C>RKD]!N(&>I YKNOC=KGB'P
M;;C6(+F'RHY(A+:I IC568\M+(YED^8K&2BQ%@=X2/!KT#2_BO:W>C+KSG;!
M]G,CKGD,N5:)2_EAF\P&->@=L8X(KS_P_/XG^(=O_:<%W#IT4D9:VMQ )68;
MI-IE>9,KD;<.@960AQ&O1IOA'\<+F\U"3P]K:!;^)F6.5%94FV+EB00-I95,
MJL J.IX5,*'S_CY\9M8^%TT7EBSF@N/-,>Z*99%V%<JV)]K?*Z_,-NX[OD4
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MH;Y25 R*Y_\ X2WQ=XEL[+4-*B01B.$2)+Y*S7+;%,DY5]JI S J@1TD93O
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M<J_R*%Y]5\'7UWJU@EQ++ \LT*R1O%#*L(#QJR9227S' )SDF(LN!M0YK/\
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M_:&"P,H+NOF,.(GBW8&]"BA%9LR&N@_;6_Y \'_7_'_Z)GKU7X3_ /('T_\
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MPOM&>@W,S8'&23U)KC_@%_R.&K?]O_\ Z61T?MS_ /,._P"WO_VWKU7]J/\
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M/5/E/'%'[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\
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M2RL$1%+,S$*JJ!DL2>  .23P!7E_@OQ?-XIC"^';>&UTZ.1E%Q-$RH^#)O\
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MP'\.-+\#/-%ID8B>18FE7S))&V@R"-B)'8J"=X!& 2#UV\>"_ +_ )'#5O\
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M:B:39&"%)1#@@C8$W^2VT$D.X85W5M\1-3\3[%TW3IK=6D*R3WZK"L0&UB1
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MJAF#E,9VJ7(R?*OV9O 6L?#B:>.^L7\JY\D>8DULWEE"XRR^<"5Q(22N6&W
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M=V"B[>?9-2ANO&.E7-O+ ;2XFMIHMDKQNH=XBNX/"TF4W-C) 8@$[!QGQO\
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MO\Y^T%?F525V%_\ :VFHO@'8ZAX3TM=.OK&2-[=9F5EEMI%ERYD"#$P*N2Y
M#83"Y,@S@>?_  W\$ZSX4U^\U>33I'M[IKK 6:T\U5DF$R':9]I/RA2-P R2
M"<8-6PTF]^%GB>\OS975Y:W2S,)+>$R$":19N@)4E74QD,R$C]YC!53#^U3X
M8UGQA]EN(K)_L\?FJL:?O[I6?:6,JPET"G8-FQG QEV5G5!]-:)?RWR%YH3
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MHHHHHHHHHHHHHHHHHHHHHHHHHHHKG_'^L76C6,]Q80_:+E(R8XO[QR,G Y;
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M;5'15!8D*H"C/ %>U4444444445B^-/%\'@ZTEO[LD11*"VT;F))"JH'J6(
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MQ+L+B3S8X7^TRJ+AHED5%,<92**)70DH6+;Y2P V+B;<QCQ? ?Q>UG2-=N-
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M/."#T(KR_P#;:_T";3;J'Y)Q]HQ*ORR#886C^88;Y68E>?E))&"37JO[4?\
MR+MY_P!N_P#Z414?LN?\B[9_]O'_ *42UZK7S+^W#HCS6UE> C9'-+$PYW;I
M55U(XQC$+9Y!R1@'G'L'P*UM-9T.QEC! 6VCB.[ .Z$>2YX)X+(2.^,9 / [
MJN:^)MV]GI5]+$Q1TLKEE92596$3D,".00>01R#7D'[$]VC:5<1!@76]9F7(
MW!6BB"L1U )5@#T)4XZ&C]MBT1M*MY2H+K>JJM@;@K12EE!Z@$JI(Z$J,]!7
M:W=V]YX2:65B[OH99F8EF9C:9+$GDDGDD\DUQ_[%/_('G_Z_Y/\ T3!7*?\
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M_0)/E27/E;OGD;RLR0_,GR#= [.V0.0!\I^4Y_[2,,\B67BF%@I-SB ]66(
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M3Y6S=32?8)R3EMABDD>8DN[[FMHY-CL"&N <KL#$>_T5\J_'W_D<-)_[</\
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M W.[98VOVY_^8=_V]_\ MO7T!\6/^0/J'_7A=_\ HEZ\J_8I_P"0//\ ]?\
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MZJX>,@R'RP4<EL, '#').U58MOC1JVM67V>'2;V/5'A959H1%:+)@_O/,G.
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M**************************^</B_^T-=C4UT#0S&DK310O<OB0"5W0;5
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MG+Y7E_O/)F3.^-)/N_:6QC=CJ<XS[5U?QV\8>(?!\<6L6TB1VOF(LEIY2R%
M22AED ;.[[LFQD5&*I&TA/FGT7X+?$P?$;3DO2 LH9HYD7=M61<$XW#H5*N!
MEMH;:6)4FO-;;XTWWQ&US^R-'<06<+,TURHBFE=(R5=D\PO'L=V54(5V&1(?
MEW(#6_C9=_"K5QINLRBZLIE$L=P(PEQ$CL44.L2JCA61MVU=S [P<XBKU_XC
MZM<Z+83WEFT8>"&64B6-I%98XV<H-DL14D@?-E@!GY3GCP7X4_M4ZAXHN)8+
MBVAD<6Y,$, :.664R1HJ9EE90H5F=SCY$5I#PI%'PB^+OB'4_$)TO5!\G[_S
MH?)4"$!2Z,K(-VW=L569G5E<<L65J[#P#\:#\5[^YLK68VD4"[HFB17FG42,
MAE+3Q-'&F&C/EF/S-S B3"LIXKP!^T;J&E:RVB:JPNT-Z]LLZQI#*'\P1(VU
M"$V;ADC&X;B0[;0IVOVN?$6K:39E8FABT^:1(6*-(;IRR.[*V5")$=N"%)9L
M<MM=D'/_ +)/]L?8S]A^Q_8?MY\_S?.^T?<A\SR]GR?<QMW?Q9SQ7=_&OXY3
MZ'>P:%I/E_;;AHT:60[DA,IV1C:I)WY(<[E("[3L</\ +S_Q;^)>L?!RYM'D
MN!?6\\)$B2QQ1,9(V0RLGDQIL!5E";C+M);<&PIKW_P]K::];0WD0(2>&.50
MV P5U#@'!(S@\X)&>YK0K\UOBQ_R&-0_Z_[O_P!'/7TU\9_VHM+N].GL]-D,
M\UQ"\6?*D6-%;".6\SRVR49MFT, P&X8ZXG[+?P&GL+A=;NW0+'Y@@6*2*=7
M+*T;N7B9TVC+* #N+@YVA</U?Q!^.%[JFLIX;T(HDAD"371"2E",22;%9MA\
MM%8.'RQ;<BA64,Q\2?BEJ/P<OH#=S?;M/NL\.D:747E@"3:8DBC;)D5AN'.-
MGR8\QO7]4\=6NG:>VKL^;46XF5ONEE90R!0Y7YFR JG!+$+P37D'PF\:ZS\7
M_M5Z+C[!:QYB@2**";,O+[I#,KLVQ60,%$:R9&TH0V;7P:^/<VKWTN@:N$^W
M1221I-$&\N4P@B3(Q\K?(SA@%1AD;4(4/Q7[<_\ S#O^WO\ ]MZ]0_9G5V\-
M6HB(5RMSM9E+J&^T38)4,I8 ]0&4D<9'6HOA=XUUSQE<3._V-=/AN'C2X6*4
MFY"2%2T0^TE0I4']YEU#$ "3#[<3XK_'$Z?K5MHD-T+.(,AN[K8KLI92R0@2
MHT:@@J3)A@I<$X".&Z"_\3ZIX?US3])DD$ME<K._G,D:W#M'#*S1,8]J85C&
MP98HR1M7+$.6]:KS#X]?&D?#"VC=(Q+<3LZQ(Q95 5<M(<*=P5F0%,J6#<,,
M$CBOC-X[U+P986FM6&H&:.>:+=$]O"L+K)&9EV#RUFC3"$;6=Y-K#,@926[_
M .#7Q0?XF:8;M%$-PK/$^07B$JHK;PH=6*'>IVEE8<KN. Y\0U;]KG4O#^I2
M65U';/!!=O%*\<4JR,B2%'90UP5#%02H)(!QDD5+\9/C!XH\#7-O-/Y$$,R[
MT@C"3+\K M%*[#>7"LJNT95",&,@Y(^BOAOXX3QSI\&HQH8Q,K91B"5969'&
M1U&Y3@X!(P2%)P/$-'^-6H_%'71I^CS_ &?3X][O,L49F:)0@9B)]X&9/ECV
MJ&57#2(VT@>5?M:_:(]62*Z^8QVD:I+\H,J;Y6$C*O"L"Q1@ H9D+JJ*ZHOU
M_P#"?_D#Z?\ ]>%I_P"B4KJJ^ /VH_\ D8KS_MW_ /2>*OJ7P-\8-(T#1K,W
M-[ IBLK5719%DE#>6BE?+CW29!Z@+D<DX -?*OA;X=7OQFU.:YMXC#!/<S22
M3,"T409_,9-V%#N X 08+9!.U<LOVU\3_B'#\/[&2_G&[;A4C#*K2.QPJ G\
M6; )"!F"G&*\?TGQ1K_B70KGQ"+U('\MY(+>.*+R52 E9MYEBED+,$<HH; ;
M!+8;:G5_ 3X\?\+#M;B2]1();3#3.#M@V-O97&]B5P$;?N) P&#<E5Y_X;?%
M+4?C'?3FTF^PZ?:XX1(WNI?,!$>XRI+&N#&S':.,[/GSYBY7P&^/>HW^IOH6
MMCS+@R2JL@$:E'B5C)&PC 1E^1L,N2&X^96!35^(/QPO=4UE/#>A%$D,@2:Z
M(24H1B238K-L/EHK!P^6+;D4*RAF/B3\4M1^#E] ;N;[=I]UGATC2ZB\L 2;
M3$D4;9,BL-PYQL^3'F-[4NH-K=JMQI\B#S8XY(I)(W=-K88$IOB;E3P-RD$@
MD<$'YE^''[7=_K=]';WL, A9921"DGG,RQ.\<<>^8J7=PJ*N,LS!1R14L/QE
M\2P^(X-/NXO)CFN(O]$$<<JB%^"XE0%GVJ&=G#;0ZME0JE!M^//CAJ'B'7(_
M#^@2"("81S3F)&<.A?S\"5MC(B#.-JLS(0C%2-W%?MD0W5F]C!<,9HU6X:.X
M;RUD8L8M\;+&J+E-H(<*@975=I9&=_9?V<M4CTCPO;W,[;8HH[N1VP3A5GF9
MC@ DX )P 3Z"N?\ @K\3KOXJ274IOOLTJ2!H;)8H718@!AW9X_-F4L0K['B8
M'.&3S(PO:_ GQK?>+;>ZDU142XAOY8#'& $3RXX@R@[GS\Y8DEFR2<';@#TJ
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBOE7Q'\0[KXE>)1X?$SPZ<MQ)%)&HV-*(4D,ZNR.'*R;70 ,%V%6*;P
M<\5^TY\#(_ <D=[IZ;+&7;&5+ERDN&.!ORVUE7<#EL,'!*C8#[U^R?XOG\2:
M,!<D$VTQMXR!M)C2.,H#C@D!MN0!D 9RV6/LM%?(O[;GA=X[FUU$9*/"T#?*
M=JLC-(N6SC+"1L+@'"$C/..K_8CUM)K"ZLP#OCN5E8\;=LL:HH'.<YA;/ &"
M,$\X^CZ*^!OV9[M[SQ+:RRL7=VN69F)9F8V\Q+$GDDGDD\DUZ?\ MS_\P[_M
M[_\ ;>O6_P!F6[>Z\/V32,6(6906))VK/(B+SV"@*!T   X%?)7[,MHEUX@L
MED4, TS , 1N6"1T;GN& 8'J" 1R*_02O@#]J/\ Y&*\_P"W?_TGBKZJ_:C_
M .1=O/\ MW_]*(J\%_9ENWL]*U^6)BCI9*RLI*LK"*Z(8$<@@\@CD&HOV*?^
M0Q/_ ->$G_HZ"C]M;_D,0?\ 7A'_ .CIZ^A;N[>\\)-+*Q=WT,LS,2S,QM,E
MB3R23R2>2:^=?V,+1)]9D9U#%+*5D) )5O,A3<,]#M9ER.<$CH37VS7SKX;\
M4:5::L;#PC;0M=7&\W%V1,]M"B/N<*H(RIP0HC:*$L80'88"^"VD)@\6JC,7
M*ZX 7;:&8B[P6.Q57)ZG: ,] !Q7T+^VM_R!X/\ K_C_ /1,]'[%/_('G_Z_
MY/\ T3!7SUK^H&7Q6\D\QC"ZQ@S,RYC1+G:K9D#( B*,;@54* 1M&*^K_'7[
M/<'COR_[2O;R7RM_E_\ 'HF-^W=_J[5<YVCKG&..]=KX"\%0^"+*+3[9G:*+
M?M,A4N=SM(<E54=6., <8^M=!7YK?%C_ )#&H?\ 7_=_^CGK[D^/O@ZV\1Z1
M=M<("\%M-+%)M4R(R+YN%9E)4,8PKXP67(R."/CO]GSQU=>%]6MX[9\1W-Q#
M#,AY1E=PN2,CYEW$HPY!R.59E;0_9GNWO/$MK+*Q=W:Y9F8EF9C;S$L2>22>
M23R37I_[<_\ S#O^WO\ ]MZY_P :ZM,_@;3LR.=]V8VRS?,B-=;$//*KL3:I
MX&U<#Y1CTO\ 8I_Y \__ %_R?^B8*\%MKM[7QCNC8J3KC*2I(.UKHHZ\=BI*
MD=""0>#7I_[<_P#S#O\ M[_]MZY"X^)FK>%/#.G1V(,$$K7B/<#!=CYLAVJ0
M"(@0QVMD2LT;%0BH&D^BOV=_B9%XYTR/: DULJ0RQC8HRJ +(J(%"HP'RC:H
M!#(N0F3X_P#M7_ V>:637[/,J,J_:8\9:,(BH)5P.4VJ-XZH<ORA/E\U^S3\
M;)K&]M]+U!O.MI)%6!I-SO;RE#%&(SAB%8'RMO"J&R"J[P_VI7F'QZFT&"VC
M?Q"H<*SF!!O$S,%RRIY;*V#P&R1'NV;R#M->'_';6[KQ+X=M;^6)+2U>[B%M
M:(O*QB&55=V95SG:3$(U1!$P)\PE2GH'[%/_ "!Y_P#K_D_]$P5\_P#_ #.'
M_<>_]O*]5_;G_P"8=_V]_P#MO78?"F[>S\$M+$Q1TLM1964E65@]P0P(Y!!Y
M!'(->2_L4_\ (8G_ .O"3_T=!1^VM_R&(/\ KPC_ /1T]?57PG_Y ^G_ /7A
M:?\ HE*ZJO@#]J/_ )&*\_[=_P#TGBKN_BY\&$N- T[5]/@ DCLK<W0C0 NC
M0JYG;!&2K9WL%+$/N=ML?$O[(/Q<_LV9M&O)<0RX-MO;Y5ES\T2_+QYF[(!8
M+O7"@O)SM_MRW;JFGQ!B$9KEF7)VEE$(5B.A(#, >H#''4UT'P \(?\ "5>'
M8X/MTZQ.MS%+!%]D*J&DDW(2]N\BED8-R^<,"N 5K$^)7P%L_A;H]_?:?-<^
M:]O' V]TQLDN8-X^2-#R!M/."I((.:ROV'-4CBFOK8M^]>."15P>5C,BN<XP
M,&5!@G)SP#@X^I(?#UM!.UXD,:W#KM>8(HE9?E^4N!N(^5>"<<#T%?"W[,]V
M]YXEM996+N[7+,S$LS,;>8EB3R23R2>2:]/_ &Y_^8=_V]_^V]>M_LRW;W7A
M^R:1BQ"S*"Q).U9Y$1>>P4!0.@  ' KY*_9EM$NO$%DLBA@&F8!@"-RP2.C<
M]PP# ]00".17Z"5\#?LSW;WGB6UEE8N[M<LS,2S,QMYB6)/))/))Y)KT_P#;
MG_YAW_;W_P"V]>B_L^Z(FO>%(;.4D)/#>1,5P&"O-.A(R",X/&01GL:^4/B'
M\/M0^$%\%WNA^8V]S$6CWKC:2"IRK -ATSD9ZLK*S?6O[-7Q5_X6!9RM.J+>
M12(+AD7;YN4"QSMA0NYEC*$ G'EY 52JCU^BBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO /%WP,NO#FLKXCT)$F
M?S'DFM9'V%FDRDAC=OE&Y79L.0$894."(Q:^,7@[5?BWY&GI;?8K-)%FDGN'
MA>0L,Q[$2WEESA'9OF(#'C<F,OT$OPMN/!_AZ32M#DQ>>62)OEB>1V8&4Y ^
M5BF4C).4&P>8-N\>=?L@>#M7T%[AKQ)(+)EP(959&:;*8D5'7< $RK-P&)4?
M,4^3Z:KG_'7@6U\<6KV5ZFZ-N01PZ,,[9$.#AAG@\@@E6!4D'Y5TOX7Z]\#=
M06^LH/MT!S&WDJ7+QLQ.QD :2-L1JVY0R*VT%W!*GW7_ (7?<7_[NRT?46G/
MW!/$MK"<<MNE=V5/E!QD'<V%ZFNE\!^'+VT>:]U62-[N=8D*0*5MXXXC(8U3
M>/,8DR.[,YZMM4!5!/BOB7X2W?P]\0+XCLX9+VU:::6:./!N(VFW(X5.L@S*
M63:,X!5RH'F--\9O"=Y\;+ZVM;.WF@M+;=YEW<1O I\T*3LBE"2/M$6.!RYP
MVQ,.WO5E8CPK91V]M').+>&*)$4Q>:RH%0',C11YP,G)4<' S@5\E?"+X)Z_
MX&U2WU&6P,B1,^Y5GM0VUT:,D9EP2 V0#@$C&5SD?9]? '[4?_(Q7G_;O_Z3
MQ5]"_M"ZW?\ B33QH]I8SM<SS1K/B*1X$565P5N,)&0SA"K'@1[O-6)QM'5_
ML\_"H_#S3A'.H%W,WF3D%6P>B1[@!D*O498!V<JQ4BO+_!7PONO@CK37*037
M>G3QF$2Q+YLT0=E<&2*,%VV^7AF5=I4AA\Y$5'C7X7W7QNUI;EX)K33H(Q"9
M95\J:4(S.3'%( Z[O,PK,NT*"Q^<&*O=?BE;SWNFW-M:PO/+/;S0JJ-$NTR1
MNH=C+)&-H) ."6YX4\X^>OV=?A1K7P]U/[3=V),,L+0NRSVQ,89T;S-HE)8
MH 0.<$D;B K?37BS3YM1L[B"U?RYY+>5(GW,NUV0A&W*"PPQ!R.1U'-?('P
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M>1F=SB>4#+,23@  9[ "O2J****Q?&GB^#P=:2W]V2(HE!;:-S$DA54#U+$
M9( )RQ R1M44445B^*?%\'AD0FX)S<7,-O&%&29)6PH]  ,L22. <9;"GG_C
M(=0MK"6ZTZZ%J;>&:9_W*3-((XRPC!=MJ X.3M8YQC !#<5^R)XAN=>TJ:6\
MFDG<7LBAI7:1@HBA(4%R3C))QTR3ZU[?7DO[1_Q@?X<V2_9<?:[AF2(L"0BJ
M/WDN,%6*[E 5B 2P;#*K*>?\<?";7M'1+[1M3NKB\5B98II$$+EQAFCC?$*
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M 4>=\K[]QVH64#(SVOQ4^(EVNHVOAW2V$%U=+YK7+J)%CB7S"0B'(9R(F^\
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MKFOA?KVO?$'28)DN([8NLV^[>))IG=9R%\N%2D2H$!1F?+%@<1@8D:I^SO\
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MEV\EOX_59Y/-DY+/M" DZ>3A5&<*,X4$LP4#<[MEC]:5\J_L,?\ ,1_[=/\
MVXKZJKE?BQ_R!]0_Z\+O_P!$O7E7[%/_ "!Y_P#K_D_]$P5RG[<__,._[>__
M &WKZ ^+'_('U#_KPN__ $2]>-?LEZ(FO>'KRSE)"3W-Q$Q7 8*]O"A(R",X
M/&01GL:XH>%_$WP!,DEEBYL"S.^U3)%PKC?)&")(B$4,[(=G"*TCX KZ%^#'
MQ@A^)UJUQ&GDRQR%)(2ZN5[HP("DJPZ$JOS*ZC.W)\4^ 7_(X:M_V_\ _I9'
M5N]U22]^(,4<C96&,QQC &U39/*1P!GYY&.3D\XS@ #W7XL?\@?4/^O"[_\
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M &Z?^W%'Q]_Y'#2?^W#_ -+)*[7]HCX$W7C6:+5-,EV7D$84(6\O(0O)&8W
M^64.V!N(4Y!W)M.[E?!/[2>I^&KR/2O$\&UGD"_:&"P,H+NOF,.(GBW8&]"B
MA%9LR&JG[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\
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MJP'DO[.\)@\6ZHC,7*K? NVT,Q%W$"QV*JY/4[0!GH .*E^/O_(X:3_VX?\
MI9)7K?[35V]KX?O6C8J2L*DJ2#M:>-'7CL5)4CH02#P:J?!_PE9:]I%E<1RW
M1!MHE;;>WT:AT7RY%"B=54!U8 * N!\ORXKH+'X3:3HM]'J(0_;2Q5)9;B>6
M1F\IE*CS96WGR@W&"0JDC 7([JO,/VFKM[7P_>M&Q4E85)4D':T\:.O'8J2I
M'0@D'@UM?!35(]3T6PDA;<HM(8R<$?-&HBD'('1T(ST.,@D8-=A-=I 55V"E
MVVH"0"S;6?:,]3M5FP.< GH#7RU^Q+JWVJ;4O.DW3R_9Y#N;,CX,WF/R=S?,
MXW-SRPR<D5ZA^U5:)/X?NF=0Q1K=D) )5O/C3<,]#M9ER.<$CH35O]F6[>Z\
M/V32,6(6906))VK/(B+SV"@*!T   X%>2?L,?\Q'_MT_]N*/C[_R.&D_]N'_
M *625ZK^U'_R+MY_V[_^E$5<K\-/^1&D_P"O#4__ $*XH_8I_P"0//\ ]?\
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M +=__2B*C]ES_D7;/_MX_P#2B6O*O@%_R.&K?]O_ /Z61T?MS_\ ,._[>_\
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M*4)//RAN*N?AQKWP-OGN=$1[NSDPNT(9=P(8JLL49#[DP2)% 7D<KO:.O2O
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M>@RH+JA9@H->=?##XA^)-(ACT232G>:/,,5S)OBMT5!M0R%8RDBIC[R.#(H
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M?NY"ZM\Y&-I7"YWY(48O[6/P[?Q9I\,MNH:XAN8U3+%25G98=@S\F3(8CEL
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MWX93^SIR)K:)=MK.,+((E"A(IDPHWJ#A73*NJDN(WP'["BN%UOPA/XRN0-0
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MRQ?'SXS:Q\+IHO+%G-!<>:8]T4RR+L*Y5L3[6^5U^8;=QW?(H SZ?\4M6O\
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MQ^:52Q'R(,H/4(/$FH7&A6MY:!);Z:WL#^\5C&6F,*R2,L6"% =G8K@* 3C
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M6VJ0S @%0N55F897A#XT:M;P"UU+2;V34$9HP\<(6VD8?*CM*2$C!;[[J&C
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M%K'PXFGCOK%_*N?)'F)-;-Y90N,LOG E<2$DKEAMP$;=Q[?\2O" \8Z=<V!
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MDD\DU]244455U2R:]C:..5X6.,21B,NN"#P)4D3G&#E3P3C!P1\O_L]S3?\
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M11*RLJH47<OS@87 /LOQD\=W.@I;V.F@'4+Z;RH"RLRQJ /-G(5&!$8()!X
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MLFT$@(N1,#M10$3.T9V@;B,G)YK5\6^,=0\0>)8O#ZB:"Q6/S9GAW))*H3S
MWFA0T<7F@0DQE2274OE@J\U\:?$=W\%M1M+ZSN)Y[:X619+2>:6:,"/R]VUY
M7=E+;@0>2C \LC&,>B_M#ZYJ?AK3I-0T^Y2!8?*)7R%DD<M((R-\CE%7YP<>
M66ROW\$@<U\&]'U'Q[HML]UJ$\,3+."T+YNY&%PQ5WGD5F0+M*"-!DKRTA#>
M6N5^S/\ $'49-1O-!U.8W!MEDVR,V\JT4WER#<RB1PQD!!<Y4*   <#JI]3O
M?BAJ-U8VMQ)::99-Y4LL *7$\_!9$D=/W8C9<-MR2.NY)5*8'C/2=<^%,\%U
MI4M[JEK(VVXMYR;IP5SC:RJ70,K'!5<*R+YA<,J5Z+\4O&MQI4EIIFGK_IE_
M(Z1RD*R0I&%::8JS+O94;<B=&(.<X"/PGQ%^%>HZ!92ZG::O>M=VZFXD$DO^
MC/L!DE"PJNU <$HAWI@>61M.X>@?!;XF#XC:<EZ0%E#-',B[MJR+@G&X="I5
MP,MM#;2Q*DUVMW"9T9%8H64@.NTLI(P&&]67(ZC<",]01Q7S!8^-M?TOQ%'H
M.J:B5A=CMF6&UB\Q6C9H2ID@9<LX"$#<-^Y%)(!KNOVD-4UCPE:G5-+NW6-9
M$$T)CMG1%;"*ZEX]_P!_ ()<DOD;54BNP^$NK2>)](ANFNI)9+B'+2E(4:.3
M;LD5%$*)A)%;;O5\GJ77%1?#Z+4;ZR>Y:\\UIY"]JTT$91+?>?)8K!]G9VDB
MPYRR;2RC8I5@WE7P+\;ZGJ_B2]LM0NWN%MK>YB'"Q1DQ7,:"3RX\(&.3SRV#
MMW$ 5Q_QG\.R:?XKTZ-KJ>5Y6L6\V3R2Z$W+(-BK$L2@;=P&P@L69@VXU]::
M)IDFG(4EGDN"6)WRB$,!@#:/)BB7'&>03DGG& /E#]C6RN+[[?'!+Y"'[*9)
M5"M,,>?M5%D1XQDYW,P;"C:J$N)(^EMO$U[\*?$T6E374]W8WBPA!/(;B93(
M6C1LML"D3 [MN08CDAG"[?IJO-?VA/B#=>!-+>ZL4W2M(L>\C<L(8-^](P0<
M$!5W87>RYW?<;E/$W@:YD\/G4&O;Z#4%M#=2L;B=<OY9FDA,(=(XUR2BA%0I
MA<YPP;IOV=?B9/\ $+3/M-V )HIFA=EX$A5$;S-H "DAP"!QD$C:"%7R3X!?
M\CAJW_;_ /\ I9'75_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2NJKP#
MX.Z_??%BZOKC5/M-O!;R+%#;Q236J(QSYJN\7E222H$3(9L*78[%#*!G_#CQ
MM>^$/$LWAF>>2]MW8M'+.Q::,_9_/'S'.X;?D8< L-ZA,LK9_P"U=XRUGPDT
M*PWNR"Y\T".&+R'01.C*3+O>0L0X#%#&I"_<PQ%=5\1_AQXC\41O>6^H/;R#
M>T-C%^X 4D;8WFCE^:4HH)+;HQ*65&$9WU%^SK\9;OXAVD]K--&-1A8,LCQ
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M57RW\ +1V\6ZQ*%)16O59L':&:[4JI/0$A6('4A3CH:A^ 7_ ".&K?\ ;_\
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M?S!%G*K 0N"A PS9!!XZ5B_%[X5ZYKMS8:U!#!)?VS1K)%',3"PB831R 3)
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M0I\H"L%;S?*M!\+>/9$%BTQBB974RRRV\C*"&)S(GFW&<G"E<E3C!4#(^C_
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MY#1X /"_ /X,ZQ\+II?,-G-!<>4)-LLRR+L+89<P;6^5V^4[=QV_.H!SG_\
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MS-F122!M'EL02>*\#_!O6_">LW.M(+)Q<M<;X3/."%ED$N XMNH8+R5((R,
MD$0_$'X6ZOI/B-/$6E0I=JV"\1=(2N(1 RDNZYW)DHPSM;.Y,*-_I?CC2]8U
M_3YK2)+-9;F.6-MTLQ2)&4)P1#F9B"YW%80A*C;)M);E/@3\-M8^&=O+9RK9
MS1/(\JLLTR.',87:<VY!4E$&1@H-S8?A:Y__ (4SKW]O_P#"1YL=_F9\GS;C
M;L\KR-N[R,[O+_BQC?\ -LQ\E=7\>OAMJ7Q*LX;*!;:+;)',[O-*<.$D1HU
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MJJH&2Q)X  Y)/ %<UX#\8K\0-.6^@#P+-YX0_(9%"R/$K\JR;OE#8(90>#O
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MA9V'B_3GU)$>U-HB2"14:,;WN8U9A(0NU68,Q/W0"1D@"O=?^%3Z/_T#[/\
M\!H?_B*S]6\':1JUE=:2$C@MS,D4RQ*MN!,XA>(@A54N=\6W[P8[4(;E:^>M
M0^&WB/X%[[O2Y_M%BF7E4#Y<#RR[20,3C.,%XF9Q&I)>,5]"_!;XF#XC:<EZ
M0%E#-',B[MJR+@G&X="I5P,MM#;2Q*DUW517=VEFC2RL$1%+,S$*JJ!DL2>
M .23P!7E7ACXB7?Q4>4Z2PM=/AF\LW;*);B9@8V98HW^2(;"?GE60X="(PP8
M+Y+I>G_V?X_6/>\A&27D;<[$Z>69CP ,DG"J%11A455 46OVY_\ F'?]O?\
M[;U] ?%C_D#ZA_UX7?\ Z)>OEKP)=O:^!]3:-BI-Z%)4D':QM$=>.Q4E2.A!
M(/!KW7]E6[2?P_:JC!BC7"N 02K>?(^TXZ':RM@\X(/0BO+_ (^_\CAI/_;A
M_P"EDE?55%%?*O[#'_,1_P"W3_VXH^/O_(X:3_VX?^EDE>J_M1_\B[>?]N__
M *414?LN?\B[9_\ ;Q_Z42UZK6?K^OP>'H'N[MQ'#&NYW;H!T[<DDX  R6)
M )(%>=>"_%.H_%&,7UN_]GZ>9&$6U8YKN8*9$+$R!XH5W;?EV2.2C8<*5+>2
M_L[VPM?%NJ1KDA5OE!9F=L"[B RSDLQ]2Q))Y))KH/@/K::1XCUK3[@&.:XN
M7EB#87<J2S/@;B&)9)0ZX!!0,V< 9^BKN[2S1I96"(BEF9B%55 R6)/  '))
MX KYJ^(OB^#3O%6D:NY/V*:R0),1L0B7SU#$R;0 HF1GS@HIR1G /TU7D'[0
MFJ1^(M U*.S;SF@DCCE" MM:.6&60' _@0Y<C(7#!B"K '[)^J1WN@01QMEH
M9)XY!@C:QE:4#D#/R2*<C(YQG(('G7[;EH]X^F11*7=VNE55!9F8FW 4 <DD
M\ #DFNE_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\ [$NK?:IM
M2\Z3=/+]GD.YLR/@S>8_)W-\SC<W/+#)R175_MK?\@>#_K_C_P#1,]=KH/CJ
MU\#^';*]O7VQK86@ '+NQA7;&@R,L<<#@  LQ"@D'A"74_'T,=_=2?8K6:/<
MEK 5>9XW"%6DN",KD;B!"L3JKJ?,#K@>/_L,?\Q'_MT_]N*/C[_R.&D_]N'_
M *625ZK^U'_R+MY_V[_^E$5>"^++1Y_ FGLBE@EZ[.0"0J^9=IN..@W,JY/&
M2!U(KZZ\*>)H?%%K%?6QS%-&KKRI(SU5MI8!E.58 G# CM7-?%O7X%L+ZQWC
M[0VE7LHCZMY:QE"Y]!N8 9QN.=N=K8\O_9;T+1_%6D*DMI;2W5O)(DQDAA>0
M[G:2-LD,Q7:VU2V.48#A<UZU<>!M&T I<FSM8BLT*HZV\882/(L<6"J9!\QE
M /8\D@#-=A17F'[2GA >)M#N1@;[=?M"%BP ,0)<_+U)BWJ 01DC./O#C_@G
MXZD\4Z#;:?&[BZ,CV;.,(T<48#/,I0Y79;ND<<A7BX:(."&W'BO#.J1_!OQ7
M>07#>58W$<L@.##"JE3<1E4 (DV$/ @7DL6"@'*'Z4\"Z7)86J-<KBZF_?7'
M(8B63#.FX$Y5.(H\EML2(NXA0:^=?C[_ ,CAI/\ VX?^EDE>J_M1_P#(NWG_
M &[_ /I1%1^RY_R+MG_V\?\ I1+7E7_-0_\ /_0.KJ_VUO\ D#P?]?\ '_Z)
MGKU7X3_\@?3_ /KPM/\ T2E=517RK^PQ_P Q'_MT_P#;BC]N?_F'?]O?_MO7
MT!\6/^0/J'_7A=_^B7KY5\&_\B-J?_7_ !_^A6=>W_ _POHGBS2+6X6RM7=8
M4BF+00-)YL:A'+<,<L1O&X[BK*Q S7=V_A'2?#<\+Q6MM#/)(T<+QP1J^[RI
M'8!D3*_NT?)) (R,Y(!ZJBO$/VL_ \7B+3HYBX2YAF MP0[-*TF%-NBIDEW(
M4K\K'*<[4+L+6MW^OZ]I TYM/*WL\(M[B:6:U^SJKJ8Y9QY4N\DK\VQ8P%).
M-X4*]N3X9P?#GPU?6-N2Y^Q7;R2-P7D,!#-C)"C"@!1T &2S98\?^RWH6C^*
MM(5);2VENK>21)C)#"\AW.TD;9(9BNUMJEL<HP'"YKUJX\#:-H!2Y-G:Q%9H
M51UMXPPD>18XL%4R#YC* >QY) &:\%_;G_YAW_;W_P"V]?0'Q8_Y ^H?]>%W
M_P"B7KY5\&_\B-J?_7_'_P"A6=>W_ _POHGBS2+6X6RM7=84BF+00-)YL:A'
M+<,<L1O&X[BK*Q S7=V_A'2?#<\+Q6MM#/)(T<+QP1J^[RI'8!D3*_NT?))
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MI/0$A6('4A3CH:A_YJ'_ )_Z!U?55?*O[#'_ #$?^W3_ -N*/C[_ ,CAI/\
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MRSCRI=Y)7YMBQ@*2<;PH5^U^%7PS@^'-DMC;DN=Q>21N"\A #-C)"C"@!1T
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MGCNF=5="J((QD$'Y\':&*@>8@R&]0;X>0V^DMHML?+B-I);J^U21O0H9&"[
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MK':VBGRMH 9F=V/SM*Z^83@(H*HA;V#Q-\,;CXBZ6;+7'A6Y\PR1O:K((XF
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M%G=7/V6W\L(TKFVDDV\(=K1!Y3+M)8,64DC)D5B#7J'C_P"!L&O:&NB6N(S
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M9 KX:1OD15\X_<+)QM!&]U("^M45B^-/"$'C&TEL+L$Q2J VT[6!!#*P/J&
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ML3]H-+GX7K:ZQIEW<@+<+$]M-//<P2;DD?<1+*QZ*5(SW5D*,NYN@^.^N_\
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M D*,<;"S1[=PR69E&" R26M6^&6H^%VMY=/U&]GB-[:?:HKB3SW:+ST!,;!
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M-Y./,N89B LBDA?F!0#+!V9A]-:79-91K')*\S#.9)!&';))Y$21IQG PHX
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MQ1D*%6"XWH7KG_$OC/4_@)J$,=U<S:AIESYC?OBK3KA@&"NS%BR+L/.R)]S
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M2:/:2P7"0W4UI [S/")N7A!9E0/$H;<0PSN08P4(/'BO[,WC+5_B#)?&YO'
M_P!%+2#873B4!88FC:!-VT&1BIX7&PL_F1Y^J:WJ?PK\36]BEU/>6]RL2QQ7
M-R[9$Q,0WL8V"%9E+91"=@"Y^9A78?'/PYJ?ANP?6EU2Y^U6\D9\N,+#:%6G
MPJ"%2?N^8N3*TI<*5;((V]+H'QI,'AE/$%W&9'6'#JI4%Y!+]GW9"JJAG 8X
M4[ 2 &P 8O\ A4FI^)H?M.H:I>07CQY$=LRP6\!8;A$4C+>;L=B"_F!G4 ;A
M@-6?^SO\4;G59;G0M3<27EBS*)068RI&YB<DE1DJVT;CAG# E=RNQXKXL>--
M<T'7['3C>"1)9K.411H;.(DS-%Y3,&GE*-M)?<SCYON':HKH/CSX?U;PS8G6
MHM3G-Q!-&712(+7RVE(55@4-N(9T!\UWW(&W$\+5^\U6?XC>$C?RSS0O]@NC
M*L1B F:$.I+GRMP5FB)*1E!M=D)88K _8YT:6ZTV25+F:)%OWS"BVYC?$<!.
MXR0O(,CY3M=>!Q@Y-;6A>*+_ .(/B&[TVZ\^WL+)7PD+20%W#;(GDE0))B1'
M:1$5E4A5.'VLS8NI>++SX6^)H=.6XFNK._\ (_=7$CR-#YLKQ#8[EF^5@3S]
M]#M?+ 2 _;1T-EL8;MIYF7[6B+ 3&(%S#(2P"QAV;Y."[MMW.%P&Q7I7PKT*
M[BTFTDAO'+/86NQ)HH9((\I&>%B2"5L*"J[I3URVXBO-?@7XWU/5_$E[9:A=
MO<+;6]S$.%BC)BN8T$GEQX0,<GGEL';N( KJOB'XROO%.KCPUI$WV;;;M)>7
M*J'DC#)\J*&*?WXSOC8N"ZE2OEOGFOBGX<U;X21#6--U&ZN8HVC6:"[<7"[6
M?E\L5X+;$PBB0!F(D SCU_P7XS?Q]I<6H66('F4X$J&9497*2 A)(BPRK!3N
M4XPQ Y6O!?ACXNUWQ#KU]IKWVYX+>YA$KQ@1IY=PB"=;>/;&\N3@;B,!LEG"
M"-SXS:YJ?P9U*VO(+ZYN;:XW&2*>57W%)%>9 OE"*)65E5"B[E^<#"X!^JJJ
MZI'-+&PMG1)>-K2(TJ#D9RJR1$\9 PPP<'G&#\Z_ OQOJ>K^)+VRU"[>X6VM
M[F(<+%&3%<QH)/+CP@8Y//+8.W<0!6UXK\33^./$3>'?M4EC;V\/F%H)/+N+
MB0QHX0/_  A5D+; &R$9FS\ICZ"Q\ ZCX5U"Q\F^NKK3VFF\^.=O-E5_LTVQ
MS($!\G( V,0JR;6 9F&WUJO,/VBOB9/\/=,^TV@!FEF6%&;D1ED=O,VD$,0$
M( /&2"=P!5LFT^#=W!;+<Z=K5[)=>2&BDEF$]F[%?O&-E<%&!.TY<ID,-Y49
MYKXW:'<77A2.XNI[E9(K2P,L#%0KREHU=I=T?G,V7)*EPN]58KN&:V_V9]$N
M&T.UGBNY%!6YVPLD#VX;SIE!($:SL WSD"923QD+Q7G^J>/?$%KXI72TN!=/
M&TGEQX%K;?O;;S,R*A9G2+=N 9G<A,*0[9KT7PO\,O$FC75RS:LDL$T9VO+$
M\SK(<'<D)=8XMI9L!79" H:(C 3G_P!DGQ_?>,Y-0FU"=YF'V3:"0$7(F!VH
MH")G:,[0-Q&3D\UV'B_Q'>^+=6.@Z;*;:&"%9+ZY1290)!A+>-F0HCLC!PX.
M1RRD&)D?FOB#X(UGX=QIJ&AWE]>NL@6:WN'^V!HR0<JN%8?,H5M@+[7)#(%8
MGFOVL+674M(M-2F>>,RS09LW*"*%I+=V<$"))&=2N,R$E<N%"AL#V7X+Z-+:
MZ;92O<S2HUA;8A=;<1IF-"-ICA20X'RC<[<'G)P:\4_YJ'_G_H'5-\>?'>N_
M#2]A1-0D:RG4%9&M[-Y5*D"9<".,.0"K#/E@[@N<JS5]%7=BUG:,DMW(A12S
M73?9UD50=Y8YA\@ +\I)CP%Y^]\U9/PML[Y+**;4[B2:XFAC=T>**$1,P+%
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M&$#[4B\Q?,P3D/$ X)+2*QVN6SE)?VUO^0/!_P!?\?\ Z)GK5T+P)?>*]!M
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MZ(O PO'JO[4?_(NWG_;O_P"E$5'[+G_(NV?_ &\?^E$M>5? +_D<-6_[?_\
MTLCH_;G_ .8=_P!O?_MO7T!\6/\ D#ZA_P!>%W_Z)>O*OV*?^0//_P!?\G_H
MF"L3X4^'+KX?ZY?QZ5$;W3"VR00M&IAD!9XXMUPZ"1X@Q1PLAP'#2$./+'86
M7PMN/&^M#7-8A^S1VNQ+.W#J\C>6QD2:5HW91AF)"*>H"ME5S+[57@'[:W_(
M'@_Z_P"/_P!$SUZ!X4\&:#XHM8KZVL+,Q31JZ_Z/;DC/56VJP#*<JP!.&!':
MMK2?#FF>';E8[6W@@N)89&!BA2-FC1HA)ED0<!GCX)Y." <''SU\??\ D<-)
M_P"W#_TLDKU7]J/_ )%V\_[=_P#THBKE?AI_R(TG_7AJ?_H5Q1^Q3_R!Y_\
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MWF7L?FJ"8]P:-,;L8.3$^T]&"EE)7FOJK2=4CU>&.Y@;=%+&DB-@C*L RG!
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MY_\ @%_R.&K?]O\ _P"ED=1?!BY&D>,]1AN,QO.U\L:LK L3.LZ]N 8E+@G
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MQS--=R89AY32HJ1I"XP7V$N5&S<-[!?2K2T2S18HE"(BA550%55 P% '  '
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MGR?\M/OAR"H 3]YB_M%-?_"](-2TB\GC1V,$L<LTEVNX@R(ZK<^< <(P8Y!
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M!DKRTA#>6N5^S/\ $'49-1O-!U.8W!MEDVR,V\JT4WER#<RB1PQD!!<Y4*
M <#5U_Q7>_$[67T72KF2VL;1?]-GC0I*TBR8,228)4Y7:I^3.)F/FH%!\_\
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M4.885)+.%DQ&Y(20X))PA 7<Z,.5\>?"_5O!%D=3T[5KV6>UA9Y8YY!+%(
M)&5)&V(%3>X5A*3A0IW $]_\&OB@_P 3-,-VBB&X5GB?(+Q"545MX4.K%#O4
M[2RL.5W' <^0#QIKB^+4TE[P2B-I=J[#!;XDM3+\T<;%I!'D%%=R6*@>8A8N
M)?VD].U/P L&JV>I7C;K@)(LDJA-P3=%MBBBCAVXC;S RD,2,@Y8UZ4WAR^^
M)MFEX]]-8I/;Q2P0VK >661B&EE*K)-D.I*+Y2#&WYB!)7(?LO\ Q,U'QO97
M5M-*&N+9H/+GE3S1L<$;&1&A9R/*8[S)N8OEB=N&Y3X=>-->US7;W3?MAEEB
MAG@65D18(Q'<QJUR8%949PFX)PY+LBN?*#,L7Q27Q'\&YH]3&HO>032;7$@Q
M&'),AC\EG=55E0[6B*E0&4>6-N[U7XL_&>33-!36-(7?]H\L*Y <0!PV7<+N
M7<K#RR"=HE(#;L;&R?$W@:YD\/G4&O;Z#4%M#=2L;B=<OY9FDA,(=(XUR2BA
M%0IA<YPP;H/@!\2KKXB:2UQ-L6ZCD>'S-NY&941EE9%*?WQN56 )!*E 0%\P
M'C37%\6II+W@E$;2[5V&"WQ):F7YHXV+2"/(**[DL5 \Q"Q<2_'^UU?X:I;:
MM;:G<RR-)Y4P=D$)<Q?*R6ZQ^2JX1R0VXABI!+9:CXT_$77/#MG9:S87;K:W
ML:,T3QVLGDO(GFI&K^2K.NTL 2I(\O+,2X ]U\!B74=-BE>ZFE>XMTD$SQV\
M<B^9&I&U(XS&,$[@K>;@G!9P!6?\+8+RYC>[N[R2X1YKA8%:.W1/)64K#+NB
MB1G+H@<."(V60$)T8]5J6@0:F\<DZ"0Q-NC#?,JOD$2!3\N\8^5\;D!8*0&;
M,7BS7?\ A'[.XO=N_P BWEEV9V[MB%]N<'&<8S@X]#7B'PL\,S_%:T.KW>JW
ML<LTTFZ"TG\B&$*=JQ;,/@[0&R<$JRELDEV]*^$]AJ-@MW%JTQN)5O6\N4KY
M:/%Y$!0HH 51U#!<J) _+'+'NJ^8/VKO&6L^$FA6&]V07/F@1PQ>0Z")T929
M=[R%B' 8H8U(7[F&(KM?C#X,U2YT^YU#^T)H;B"-YHX;=S!;(BJC21LRKYL[
M;4?:[% 6(Q'$I(J7X&_%B[\4:%-?W"&XNK9KA<+A6G9$$R*%CC 4D.(P K$D
M;N2<5E?!1+OXJV4^I:I/=1O)-)' ()I;2*.-1D/&L957(=V7?)YN?+"G.ULU
M?V=/B+>OJ-[X=OI3="T:X,=RY/FD1S")E;)8L"6W+EB4Y7++MV8G[5WC+6?"
M30K#>[(+GS0(X8O(=!$Z,I,N]Y"Q#@,4,:D+]S#$5W7QG\'ZC=Z=/J"7\\%S
M!"\HA@E\FU55PTB92,32D1J0K.P#2?,%B1BBXOP,U[4_B?I*)+=/ D$DD$T\
M95[N?Y,KAW3;#M61,N!)+(5)W1G+-E?#KQ??>$O%$GAR>ZFO+5MY1IV#2(3
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M+Y]]:1R"6) %:5E4O$55=Y'F !<A0#('")@ 5B?!1+OXJV4^I:I/=1O)-)'
M()I;2*.-1D/&L957(=V7?)YN?+"G.ULY7P)\<ZAJ%Y?>&;JYDD-LTYCO/D-P
M!%.L;*1,LRL&W9&[<4&5!(V;,KPEX[UV7Q$WA_4=0D4*TH5XK>S#.%C,L;$F
M-Q&&CP_1R#A" 267V_XJ"[$$?V"Z>VN'N(8D"QPRAO,E0.Q22-F;RXA))A&3
M"JS,=JY&KJ.C7OV7[/:W>V?Y@;B:%)GP=W(2(V\88$C:2I7"X9&))KP#]F;Q
MEJ_Q!DOC<WC@?Z*6D&PNG$H"PQ-&T";MH,C%3PN-A9_,CS]4UO4_A7XFM[%+
MJ>\M[E8ECBN;EVR)B8AO8QL$*S*6RB$[ %S\S"NP^.?AS4_#=@^M+JES]JMY
M(SY<86&T*M/A4$*D_=\Q<F5I2X4JV01M[KX<?$PZIX?CUJ\!)2VE>;;M+,8-
MZNP&$4%O++!> "=N<#-<_H'A/4/B9 FIW]]=6:3+YD%K9R)"(HV^[OD =IBR
M!'RP7868!5SM&+\'?']YX<U>?PKJT_VETW-;W#%S(V4$WEL2&)_=L7RS?(59
M S@ICFOBQXTUS0=?L=.-X)$EFLY1%&ALXB3,T7E,P:>4HVTE]S./F^X=JBN@
M^//A_5O#-B=:BU.<W$$T9=%(@M?+:4A56!0VXAG0'S7?<@;<3PM7[S59_B-X
M2-_+/-"_V"Z,JQ&("9H0ZDN?*W!6:(DI&4&UV0EABL#]CG1I;K39)4N9HD6_
M?,*+;F-\1P$[C)"\@R/E.UUX'&#DUH:7JT_Q<UF^LY+V>QAT]FBBAM9O*EE(
MD9))G;!+ % -NW";T (.XR=KX0\(ZCX8U58I+R>[TXV4_E><=\B2^; 6$D@4
M"0D$F(L=P7>B@*I+>GT44444444444444444444444444444444444444444
M44444444444444444444444444444444444444444445\J_\U#_S_P! ZOH7
MXFVCWFE7T42EW>RN555!9F8Q. H Y))X ')->=?LC^)H=3T2.UC/[VUDE212
M5S\\CRHP ).TA\ D#+*X&=N:]:UG7X-%"-<N$$DT<4>>K22,%1 !R23Z= "Q
MPH)&A7RK^PQ_S$?^W3_VXKZJKRK]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\
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M_P#7A:?^B4KY_P#^:A_Y_P"@=75_MK?\@>#_ *_X_P#T3/7JOPG_ .0/I_\
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ME$60CMM*[F(8!G4+L/=?&KQ-_P (UHUY= NK"W9$:,X=7DQ%&P.1C#N"2#D
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M_P M2:X_X$_#;6/AG;RV<JV<T3R/*K+-,CAS&%VG-N05)1!D8*#<V'X6N?\
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M0'V1-RIY.U2"2 > 3\P2_ GQ'\,KJ23PW+YD$V1]Z$.%&"HD2<",L"2%=,G
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MDCF=WFE.'"2(T:@6_P R_."')4G',8KK_A;I-_H=E%9:BL&;>&.)'@DD<.J
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M117SK^V%#<:98I=Q7=RJR7 @:!75(-CPN7!"(KOGRQ_K'<#<P  .*]@^$_\
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M%GIUM*+8W\S1R79/,$8:-7<9*@'$F=Y8;0IQAB'2KXV^$6HZ!93SZ1JFH27
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MMIRO#GQ#U/X7:U%X?U69[ZVN/)$$[!1,#*Q4/DN[%?-+(PD8L%4,F% 1^_\
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MR:9H%E',NUC&\@&0?EDE>6,\$]4<''49P0#D5X_^PQ_S$?\ MT_]N*/VY_\
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MY"@@%0Q&!DBOJ^TNTO$66)@Z.H964AE92,A@1P01R"."*^6O@%_R.&K?]O\
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MF/J6))/))-2_MS_\P[_M[_\ ;>OH#XL?\@?4/^O"[_\ 1+UY5^Q3_P @>?\
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MMG_V\?\ I1+7E7_-0_\ /_0.KU7]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\
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MBJMROC?1]3U32;ZZU.;R0;"X864&T(F$E91+-\TDK8V!_+,41*E2KQL=W/\
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M:-F,@N3)E &4(@*Q(^2-Y>5T ($;$JXROV9? FK>"K1[6^ACA0W,DI)D$LK
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M75VP"2N\"QR#RX"9$ +N(UP%15"[B -WT_:*ZHHE(9PHW,JE%+8Y(4LQ4$]
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M(WNI 7C_ (A_!G7O%VK0:RIL8FMO(\J,RW$@_=.91O;R$W9<G. ORX'4%C]
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M#%<>698V#3SCRW8!08W2)=RNQW;I,?+E/O >?_#?[='XJU673-C3127SM"^
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M@[$Q\R%?F.6X P+GX-ZVWB#_ (2.,62G<N86GG8;?($#C>+9>2N2#MPI(R&
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M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>(>"5\8W%[+#J1@CM&9_WRK$Y102
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M&\M<K]F?X@ZC)J-YH.IS&X-LLFV1FWE6BF\N0;F42.&,@(+G*A0  #@:NO\
MBN]^)VLOHNE7,EM8VB_Z;/&A25I%DP8DDP2IRNU3\F<3,?-0*#Y_^U%X.N_"
M5A#"+J>[LI+D,S73B6:.98W"A7^5BCHS97:0K1Y# N0?8)/'#^!O"=OJ,2"1
MXM.LMJL2%W.D48)QR0"V2!@D#&5SD8G@#X;7'BBQ@U3^V;XW4\8FRDRFU25B
M6V&#!4JC?(\>0IVLN$!VKZ+\)H;V#3T35&+W:S70E<Y&XBYE"LN57Y"N#'@
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MK\??^1PTG_MP_P#2R2O5?VH_^1=O/^W?_P!*(J/V7/\ D7;/_MX_]*):\J^
M7_(X:M_V_P#_ *61T?MS_P#,._[>_P#VWH_:*U;[+XJTGSI-L$7V.0[FQ&F;
MI_,?D[5^5!N;CA1DX KZJKY5_88_YB/_ &Z?^W%'Q]_Y'#2?^W#_ -+)*]U^
M+?P^M?']G_9]V_EL\F8'!^82JCD$*2-_R;]R=TW$%2 R_.%_IOB;]GT&2&07
M.FJV!G,D W-($W1DB2$DMN8QD(7959W/%;7QO^(,>L+X>\0JC_9EN&DEV@ML
M99(&>+<P0%LQ2*N=H?86'R\U]2VEVEXBRQ,'1U#*RD,K*1D,"."".01P152T
MU^"[GEM(W#30+&TJ#DH)-QCSV!(4G'4#!( 92?F7X!?\CAJW_;__ .ED=1:S
M<C1?B DUSE$D:-8V*MAC)9B!,8'(,OR9' (.2,''U?7RW^PU:.J:A*5(1FME
M5L':643%E!Z$@,I(Z@,,]14/B#]FV^\-S?VMX1NLH^'2)9 K;&,;*JR%C'-$
M3\V)" 450?-)R=#P=\<+GQMI6KZ=JB!+VWTZY/"LC.JQ-')O4C:CJ^-P!4$O
MA44(:T/V6]"T?Q5I"I+:6TMU;R2),9(87D.YVDC;)#,5VMM4MCE& X7->M7'
M@;1M *7)L[6(K-"J.MO&&$CR+'%@JF0?,90#V/)( S7@OP2U;?XRU3SY,N_V
MV--[?,VRXCVHN3D[8T.%'1%X&%X]5_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#M
MX_\ 2B6O5:^5?VY_^8=_V]_^V]?55?*OP"_Y'#5O^W__ -+(Z/VY_P#F'?\
M;W_[;UZK^U'_ ,B[>?\ ;O\ ^E$5'[+G_(NV?_;Q_P"E$M>5? +_ )'#5O\
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M"#M:>1T;GL5(8'H001P:\D_88_YB/_;I_P"W%?55<_XZ\=6O@>U>]O7VQKP
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MTT=Y@6[0R+,6;8OEE2'RV1M&W.3D8'.17RWK7P UWX6R/>^&[EY8N2T8P)<
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MAYKP^=&5\Q/O#D'!'&5.-KKD;D++D9R#P!X2_P"$0L8+#S7F\F,+YC_>/).
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M:!E4_.X5Y#GG:@/. ?F**=N[<.JHHHHHKY+_ &RX;C2&M\7=R\5UYX>!G58
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M<5\@6WAV2V\=?9ENIRY9F^T-Y+SY:R,A^]$8L<[ /+PJ8"@8!'JO[0/C[5/
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MED^SVA8?='DPCY 5 !*L3NS)AN5-O]G#XP/\1K)OM6/M=NRI*5! =6'[N7&
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M\\?,<[AM^1AP"PWJ$RRMG_M7>,M9\)-"L-[L@N?- CAB\AT$3HRDR[WD+$.
MQ0QJ0OW,,17:_&'P9JESI]SJ']H30W$$;S1PV[F"V1%5&DC9E7S9VVH^UV*
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M7$<0?]VH(R">-Q'/? -5?VF?'NL?#B:"2QOG\JY\X^6\-LWEE"APK>2"5Q(
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M#!+Y<4DJQ1+%E6,JQ$E5 ;E) !DD<\#(S\Z_ +_D<-6_[?\ _P!+(Z^JJ*\
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M_P#C]X>OAH%W<:G=>9)_HQ$$"B&U0F6!2!G=-+SO.9'V'<&\I65"O5?LN?\
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M^0/J'_7A=_\ HEZ\O_8PM'@T:1G4J'O960D$!E\N%-PSU&Y67(XR".H-<?\
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M'M'T_0YI;:QAA@E\N*258HEBRK&58B2J@-RD@ R2.>!D9^=?@%_R.&K?]O\
M_P"ED=?0'Q8_Y ^H?]>%W_Z)>O*OV*?^0//_ -?\G_HF"NU\??&#^RKV+1=,
M1+C4I\_(S[(H1L+B24@$G &_RUP[("002F_RK]K'P]<6.DQ2WMT]Q*;\  *L
M,"!DG;:D:9)P JAI7E<8.UEWN&Z#XE_\B-'_ ->&F?\ H5O75?LN?\B[9_\
M;Q_Z42UY5\ O^1PU;_M__P#2R.CX):MO\9:IY\F7?[;&F]OF;9<1[47)R=L:
M'"CHB\#"\>J_M1_\B[>?]N__ *414?LN?\B[9_\ ;Q_Z42UZK117RK_S4/\
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M?EV2.2C8<*5+>2_L[VPM?%NJ1KDA5OE!9F=L"[B RSDLQ]2Q))Y))J7X^_\
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MEN'FA&MUED0JX9%^S+@@CY6$AV_,&V.5VU[5\5?AG!\1K)K&X)0[@\<B\E)
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MR,8GP\^#.O>$=6GUEC8RM<^?YL8EN(Q^]<2G8WD/MPX&,AOER.I##G_VY_\
MF'?]O?\ [;UZ7JFL^*;>-M/@M(99N(UU+SHDB() \]K8@L&"GYE&Y0X)573"
MG:^!OPB3X9V7D%A)<2L'GD  !;  13@,47G;NY)+-A=VT>=-\,M7^'VO7&LZ
M5;)>V]WYV^,SI%*OF%)6RSA%'[T'9@2?("&PQ#5%\<_@UKGQ(>SW& %6NMP5
MB+>!"4,669?.E=@N&94"Y"@1H-SOZ5XMT36]8TR2RS9/<7$,D<C_ +^&*-71
M5957$[2GE\.6B ^0F,\BN/\ @_\ !G4O"=C<Z-?FV>SNO-WR0RRB=/,A\IL*
M\&QL[5QDKM^8G?PHRO@3X7\0_#=9=->QAE@>X>1;@W2Q(#L"DD*LLA5@B[!Y
M:LI)WC!^6JGPAUW3/%"ZR1#=H=[&4N+6,9@>(1E!YTB[1@*0LNX;2S9+E=_]
MICX.7WC^UM9+4I)<VV\/& (A)YGEAF0NY"X*9"LQ^4GYRR@-V$.@WOQ"T]K3
M7[>.V26';)'%*9)3(&4K("!LC"LF]4S/NW*'8;&5_"M-^$?B_P"&;R6VBR"6
MWD;?N5K?:2"5!*7/W'*@%MF01M&]MHQ[K\*_AW=Z&\NH:Q<"ZU&=51G4 1QQ
M(3MCC^1" Q.]\!5+8^4LI=O1:RO%?AF'Q1:RV-R,Q31LC<*2,]&7<& 93AE)
M!PP![5X5\/O"_B7X2,]C!;IJ=B<M%B>.W,9+GIYO*Y'S/& R!B"KYW[NU\ _
M#6ZFU.7Q#K&P74D8CM[=&\U+:/:,C>P_UO56,>$RTC D287/_:!^&>J_$F)+
M*U^RQV\<PEWR2R^:S!"H&U82J ;WS\SEOE.5Y![7X6Z3?Z'9166HK!FWACB1
MX))'#J@*@LLD2;2%"YPS!CN.$&!7855U22:*-C;(CR\;5D=HD/(SEECE(XR1
MA3DX'&<CY_\ AY\&=>\(ZM/K+&QE:Y\_S8Q+<1C]ZXE.QO(?;AP,9#?+D=2&
M&K^T1\&=2^)\D MC;1Q6_F[6DEEWOY@BSE5@(7!0@89L@@\=*[OQ#INJZ]I4
MUG+':BZGADA8K/*(0KQ%#*,VY?.\\1D$;?\ EJ37'_ GX;:Q\,[>6SE6SFB>
M1Y599ID<.8PNTYMR"I*(,C!0;FP_"US_ /PIG7O[?_X2/-CO\S/D^;<;=GE>
M1MW>1G=Y?\6,;_FV8^2NP\3:-KMOJHU33XX&0:=#'/!),X61UEED9(B%4;U!
MVI)*JJ!(3MY<+B>,?!^K_&)8;/4K1-.LXKA996^T)<SR81U"Q^6NQ<;B&+_W
ME90VUE;0_:!^&>J_$F)+*U^RQV\<PEWR2R^:S!"H&U82J ;WS\SEOE.5Y!ZO
MP'X4NXM,&DZND#(ELMOF"64B2/88R&#1QLAV8!*LVXEB-G KP67X$^(_AE=2
M2>&Y?,@FR/O0APHP5$B3@1E@20KIDX#'$8?;7K7PJ^'>J"==5\1W GNUA,<$
M2B/9 KX:1OD15\X_<+)QM!&]U("\+\+?AUK?PFU"[AL[-+JQN)$"2O<QQ%55
MF\MV."WRK(PD B)+#*9  8^)7PAUW5]<LM840W"QR6[%%<0I (I0_EEGR\B\
MD^:$+L=W[E $0]K\;_@Q<?$ZQA4M#'?0R,RG,GDA7/SQ9Y)P G[PIEF3(2,.
M0O/^!;#Q?J<::9J>RVMQ'MDO Z27I4$?*C)*ZB4K\HD9,J,N2T@&[*_9N^$N
MO>!))&F6VA@FDC$RR$S3[8PQ!C\E_+&XN5R[$C&[80 &^E*Y7XI^"O\ A-],
MN-/#;6EC^0YP ZL)(]QVM\N]1NP"=N<<X->:? RP\0^&+)-)N+&&)(_,*7,E
MPK !WW8,41D:1@SLP&Z)64!2Z'YC@?"_X0Z[X/UR\O'$,RSQS+]K=PB,9)8Y
M#)Y,>7+#!)B_=H2"HF VL;7Q#^#.O>+M6@UE38Q-;>1Y49EN)!^Z<RC>WD)N
MRY.<!?EP.H+'T#XM>$M2\<Z4VGQQVT<LVWS"9Y2B;)4D3:1;9DW!><B/:>F_
MK1\#/!VI>"+)--OA;-%%YACDADE+G<^_:R/$HZLWS!AQM79U:N?\8?"B/7/%
M-EJ"A"L5N9;A "K!HFQ;2,R=69V&T/@%+=P"P4J/:J**^=;GX0ZO\-M4?4_#
MH2>TGD!FLBZ0\$LS*,[8PJG_ %3 [TW;=C('+]!?^!M3^*5U:S:S EE8VDAD
M^R><MR\\@VE2^U?)\K&5P07QYBXQ(&7NOB[X'?QSI=QIT3B-Y53:S E=R.L@
M!QR 2N"1D@'.&Q@\+^S_ */KOANRCTR]M88(H9"1,TPD=D=VD=1'$7!;)9=S
M21A0RL$DV,K<_P#$/X,Z]XNU:#65-C$UMY'E1F6XD'[IS*-[>0F[+DYP%^7
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M:R8((*AI(Y-O7.Y=K@@$,.<_.O[%FK3:O)J<]S(\LK?8]SR,SN<"<#+,23@
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MF(D SCU7PYXKG^(VDQ7VFN+-YU;)DB^T%"I>-]H$D:DAURC-D$#YH^<#Y_\
M@=XM\0?$TWT NRGF+!YETV"8%"R*$AA0HJO)QEUVA0C-GS"AKZ ^#7AG4_#=
MD;;6+@7,PF<I('>0B,A2%+R(KL0^X\YP" #@ #NJ*\5^(?C*^\4ZN/#6D3?9
MMMNTEY<JH>2,,GRHH8I_?C.^-BX+J5*^6^>:^*?AS5OA)$-8TW4;JYBC:-9H
M+MQ<+M9^7RQ7@ML3"*) &8B0#./7_!?C-_'VEQ:A98@>93@2H9E1E<I("$DB
M+#*L%.Y3C#$#E:^>_ 'C?Q#K>O7>F+=^=)%'/;^<X6.&%8[A5-T+=,(\O544
MY.YU#L8U->U?!GP1JWA'[3%JMY]LB:13;LSR/( -P<MY@RN1L.P.ZJ0V#R2W
MI5> ?!W7[[XL75]<:I]IMX+>18H;>*2:U1&.?-5WB\J225 B9#-A2['8H90,
M_P"''C:]\(>)9O#,\\E[;NQ:.6=BTT9^S^>/F.=PV_(PX!8;U"996S_VKO&6
ML^$FA6&]V07/F@1PQ>0Z")T929=[R%B' 8H8U(7[F&(KM?C#X,U2YT^YU#^T
M)H;B"-YHX;=S!;(BJC21LRKYL[;4?:[% 6(Q'$I(K*^&?C'6/B3H,EU;W+Q:
MA;R3QJ0ELR7# )*@97B"I\K>6"K* ?G<M]T1?LN?$/4/B ;B6_O)'-NT?[H0
MVT<3+(L@!++'YA.5)P-@7 R7#%5]%\0V5[>ZI%!;7TT,!MY99XTCM7V8,4<*
MJSP,R;V,C9<ON\MU0  E>_JKJVJ1Z1#)<SMMBBC>1VP3A5!9C@ DX )P 3Z"
MO"O 6FZG\98SJUY>W-E:-)*+:VM'6([047>THRS_ #*ZD.H.X%DV(VTY7ASX
MAZG\+M:B\/ZK,]];7'DB"=@HF!E8J'R7=BOFED82,6"J&3"@(^_^TYXHU/P+
M;QZAI]Z\:R7"Q-"8K=T&8V8,K-$7'^K.0Q?);@J%P?0-"%WXJT>TE2Z>WNI;
M2"0S)'"^7:$$[DDC92NYMQ5=AXP&49KS#]EWXEZE\0DOTU"X+&-8!$ZQPHR%
MQ,&88CVD_*I&\,,CH02#Y_;>'9+;QU]F6ZG+EF;[0WDO/EK(R'[T1BQSL \O
M"I@*!@$>J_'CQS=>#XK+2HKDH]],\<E_+Y:R11AXP[@1K#&"!+]\;=JJ3]\B
M13QM\(M1T"RGGTC5-0DN!"^8YY?M =,9=(P(]R3''[MU^;/R@KNW#:_:'US4
M_#6G2:AI]RD"P^42OD+)(Y:01D;Y'**OS@X\LME?OX) M_LX:M-J^A6D]S(\
MLK>?N>1F=SB>4#+,23@  9[ "N%T77+WXWZA<&TNY[31K9D5&@!@GFDVMR)"
M"<9)9E)X3RLQ!V++Y5^U7X>N_#;V=I-/)<VJK.]O-.0]P&8Q^=$[@@N%*JRL
M54@2;,L$&/J3XL^/I/!EJCVT7G75Q<1VUNA(5#+)NV%R2N%^4YP1DX&5!+KQ
M^O\ P.U'48'D&LWIORORLLGV>T+#[H\F$?("H )5B=V9,-RIM_LX?&!_B-9-
M]JQ]KMV5)2H(#JP_=RXP%4MM8%5) *EL*K*H]:KQ#XW^.]1AU.PT.Q$D45XR
M^;<1+F4H7*2I&Q1@ACC_ 'C.,LN4;* '=B?M!I<_"];76-,N[D!;A8GMIIY[
MF"3<DC[B)96/12I&>ZLA1EW-T'Q;\8W\6A)X@T^Y>U8V]K(8-D$T9$Q4$;I(
MMX8>:/FSM(3&P%BPZ#X,ZY=^-]"M[FYN'6YE\W=-&L(<;9W485HVB^ZH4Y0\
M9/WN:\_^!?Q)U75]>O=*U"Z^T16T=R ?*ABRT5Q'$'_=J",@GC<1SWP#6W\5
M/'=[XAU2+PSHDQ@E*LU[.(RWE1E 5"MV.UL[AM^=HE6526QRG[0/P^N_"&CS
MO;WEU=V\K0I<I=RB<HHE5HY8V.PJ1( C* P<29(&P$=W^SA'-+X9M!;.B2_O
M]K2(TJ#_ $J7.562(GC(&&&#@\XP>*^!?C?4]7\27MEJ%V]PMM;W,0X6*,F*
MYC02>7'A QR>>6P=NX@"N4_;3T-K*:SG>>:7S?M(".8_+C"F,A46.-/[^"S;
MG8*H+':*^BO$6L'X=6-SJ%W<S72QQ@JLHA7YL[40&WMTQO=E4E@P7@\ -GSK
MPI\/]6^(EHNJ:AJ=U;2W$.^"&U80PQ*Q=HRP1CYH*LC#)60+\CN2,K5^$?Q5
MU#1]8D\+ZPQN'5F6"XP@?:D7F+YF"<AX@'!):16.URV<I:_:G\3ZMX3M%NK.
M[$4,DWD>6D($N'B9BQF9W((,9VF-8R-WWB5!K*M/"?B?QM86%_;7PM72&#RX
M3)(?,01J?M$TBA_,>1@&\IT950X8[S(&^CZ\P^//Q,G\'P0VVG@-J%[,(;<-
MT!. 9/F&PD,R* Y RP8[E5E//ZY\$M6MX&NK76+V34$9Y0I8+;2,-SI$(2X2
M,%MJ_,S1@9^3:<+H?LW?&>3XD6LB72XNK;RQ(X "2!]VQP!]UOD.\ ;<X*X#
M;%\T^,?CO7?#6N6=B+KSUDDM9E@A06:.3*T7D%B\CE7VG=O=DRW*X48]+\+?
M#_Q!8:NFH7FH)-:R1M]HMU,BQHQ0@1Q1L&7:K!,2921ANW#);=Z_7RK^W/\
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M?%!_B9IANT40W"L\3Y!>(2JBMO"AU8H=ZG:65ARNXX#GQ75/'OB"U\4KI:7
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MFXE3F0B3+-"J,$QA3YBLP8\E4XKQ)X@O/@3JEN9[V:\TR]^5A<R/+-#L*!Y
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MSCD _1]<+\0]?@U?2-56W<2&"VO(I-O(606Y9DST) 89QG!RIPP('G7[%/\
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M%X&%X]5_:C_Y%V\_[=__ $HBH_9<_P"1=L_^WC_THEKRKX!?\CAJW_;_ /\
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M=U]GL7PLP7[+YTB')9$,"'&<!6W,HVM]V0;D/T?:6B6:+%$H1$4*JJ JJH&
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MCRA)MEF61=A;#+F#:WRNWRG;N.WYU .>4\3?LZ:OX#OCJ'A23Y&RHB+H)$#
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M1L&P%<X=<"O&O@'\&=8^%TTOF&SF@N/*$FV699%V%L,N8-K?*[?*=NX[?G4
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MBBBBBBBBBBBBBHKN8P(SJI<JI(1=H9B!D*-[*N3T&X@9ZD#FOF7_ (0O7/\
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MABE95*XPJ0BV3(;# N'&<A@P( \:_9)\?WWC.34)M0G>9A]DV@D!%R)@=J*
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M@&290,*\>=YPFUO9:Y_Q_P",8_!EC/J$PRL,9(7D;F)"QID*V-SD+G!"YR>
M:\E\*?#_ %;XB6BZIJ&IW5M+<0[X(;5A##$K%VC+!&/F@JR,,E9 OR.Y(RM7
MX1_%74-'UB3POK#&X=698+C"!]J1>8OF8)R'B <$EI%8[7+9RF?^V-HTMKIL
M<KW,TJ-?IB%UMQ&F8YR-ICA20X'RC<[<'G)P:]/^#N@30Z=83M>3NGV*W/D,
MML(L&%<+E;=9<+GCY\\#<6YSZ+7R!^VGH;64UG.\\TOF_:0$<Q^7&%,9"HL<
M:?W\%FW.P506.T5]5:%HTNF[O-N9KC=C'FK;KMQG./(ABZYYW;N@QCG/RU\'
M89[CQ;JT=LPC+-?!I#RR)]K3+(I4JS] N_Y5)WL'"^6^W\4O$%]\%M6M+S[;
M<W5E<[_.BGD$IX=3-LC"Q1)A70Q;=N&!4XC^4^P?%+QK<:5)::9IZ_Z9?R.D
M<I"LD*1A6FF*LR[V5&W(G1B#G. C\)\1?A7J.@64NIVFKWK7=NIN)!)+_HS[
M 9)0L*KM0'!*(=Z8'ED;3N'H'P6^)@^(VG)>D!90S1S(N[:LBX)QN'0J5<#+
M;0VTL2I-=U7QA^RO,/%7B.XO[E1YIAN;A=NX*LDDJ*Q W'(VRN &+<'/4 U]
MGU5U;2X]7ADMIUW12QO&ZY(RK JPR"",@D9!!]#7G7QY^)D_@^"&VT\!M0O9
MA#;AN@)P#)\PV$AF10'(&6#'<JLIY_7/@EJUO UU:ZQ>R:@C/*%+!;:1AN=(
MA"7"1@MM7YF:,#/R;3A=#]F[XSR?$BUD2Z7%U;>6)'  20/NV. /NM\AW@#;
MG!7 ;8OG7Q8\::YH.OV.G&\$B2S6<HBC0V<1)F:+RF8-/*4;:2^YG'S?<.U1
M70?M&^%]1T;3VU:#4KH2Q-$)423[/!L9BI\N.%0<B1UP9'=O+!#.Y SO^ GU
M#XLZ7;W5Q=R6D3PE&%J46XEDC<*9FE,?[H%HVQ%$HX;F5@=B\K^S[X]U&34=
M0\/W-P;@VRS^1/*-Y5HIC&2PR)'#&0-AI<J%V*0#D8EUX[UVW\5#2C=?:#'Y
MWE1A!;VY:6T,B>8BON:*-BI.YY) J$IF0X,WQ@\->)/A\G]MQ:M)<A& E7:L
M,:!@(D80%GA8$G!PH(8A\$[F7TJ'XVO?^&VUVTB$MQ'#^\B&=J2AE24E59V"
M+DRX)#&+!)7.X97P[\(7?C[15O;V\O8;^Z5W$JS2PK& VV(K!&T<11D16/RY
M<.S!QN5EA_91^*]UXWM9K:].^2T\H"8G+NK[]H?U9=F"^<L"-PW LW(?%CQI
MKF@Z_8Z<;P2)+-9RB*-#9Q$F9HO*9@T\I1MI+[F<?-]P[5%=!\>?#^K>&;$Z
MU%J<YN()HRZ*1!:^6TI"JL"AMQ#.@/FN^Y VXGA:EO?&.L>(?#46O6%R\5S'
M;DRQ;+9XY!"[I-+\\0*,0IDPI*@+L5"QW5M?LR^+[SQK9/?WUW),XFDB,9BM
MXHE($;A@8T#L=K=2RCYBNP[0YZ:RLKV[U:95OIOL<,<+F(1VI'FR/(S0&3R-
MP58E0E,^;ME1S(,@MW]<5\7KB^LM/GN=/N$MV@MYI6)A$SMY:^8%4LX1,[2I
M+))PV0 1D\5^R?XKNO%&FW%S?2O-*;^7YG.< QPMM4=%4%B0J@*,\ 5POQ8\
M::YH.OV.G&\$B2S6<HBC0V<1)F:+RF8-/*4;:2^YG'S?<.U170?'GP_JWAFQ
M.M1:G.;B":,NBD06OEM*0JK H;<0SH#YKON0-N)X6NO\+?&/'AI->O1ETMVW
MC/\ K)4<P+RB87S) .B[4W>BYK/T#X9:CXP@2^U?4;VWN)5WB"TD^R10HWS)
M$4*%F==V&9OF'"$MLW,?!?6=<L;VYT?6$DFA@4F"]="H=5*(JE@"CED(?EC(
MI#ARQ^YB^&]2OOCA<7$\5Y-9Z3;W'EPBV(CFG*J^7,AQ(G#(Q1D*%6"XWH7K
MG_$OC/4_@)J$,=U<S:AIESYC?OBK3KA@&"NS%BR+L/.R)]S *C$LOM7Q>N+Z
MRT^>YT^X2W:"WFE8F$3.WEKY@52SA$SM*DLDG#9 !&3X+\)+GQ#\4=,NDBO#
M /M,CFZ9V,KR%(V6V0(08(0?F=D_OJJ(5$@.A\7]1\1_#O1;=I]00R&0V\GE
M19D8.LA5S/(=Q950 ,J1OEB69F 8Z%IX3\3^-K"PO[:^%JZ0P>7"9)#YB"-3
M]HFD4/YCR, WE.C*J'#'>9 W8+?7OQ4NKJW@N)K'3[.X:V=H=BW-Q*G,A$F6
M:%48)C"GS%9@QY*IQ7B3Q!>? G5+<SWLUYIE[\K"YD>6:'84#R A3]WS P"@
M;URC+N5)*]%^*'C*]DO;;0M(<175PIEFN&C,@MX$/W]I4H2[ H-QP" IVF17
M7F?'7PHU/PM:O?:+J6HSW</S"&:9;E)%Y5P(V4*6"DLN0Y)7"KO*D:'BN6[\
M;>&9;N\,]C,+*Z::W0"/>T8; ?S8S*J-Y>=JLI*.59G'-<A^QSHTMUILDJ7,
MT2+?OF%%MS&^(X"=QDA>09'RG:Z\#C!R:^E*\P^//Q,G\'P0VVG@-J%[,(;<
M-T!. 9/F&PD,R* Y RP8[E5E//ZY\$M6MX&NK76+V34$9Y0I8+;2,-SI$(2X
M2,%MJ_,S1@9^3:<+:_9Y^,L_Q*LIHY0$O;945I2NZ)RX?RY"BLASE#O0%0>J
MLH;:GFNJ>/?$%KXI72TN!=/&TGEQX%K;?O;;S,R*A9G2+=N 9G<A,*0[9KUK
MX9?#_6O#.H7$NH:A]LLY8R5#%@XEW*VX1D,D2C+KMC?:1M^7@!?5:^6_BQXT
MUS0=?L=.-X)$EFLY1%&ALXB3,T7E,P:>4HVTE]S./F^X=JBN@_:-\+ZCHVGM
MJT&I70EB:(2HDGV>#8S%3Y<<*@Y$CK@R.[>6"&=R!G?\!/J'Q9TNWNKB[DM(
MGA*,+4HMQ+)&X4S-*8_W0+1MB*)1PW,K [%YK]G+Q_?-JE]H%].]TMKYWES2
M$;_W4YC?.0SMO\P$;G;8%"C(/&5\3/&6LZ)XBT_39KW=!-<64I2&+[,F&F,3
M1GYY)'4A26#R%26^[@#'J'[17Q,G^'NF?:;0 S2S+"C-R(RR.WF;2"&("$ '
MC)!.X JV3:?!N[@MEN=.UJ]DNO)#122S">S=BOWC&RN"C G:<N4R&&\J,[>K
M>=_PBLGVK?Y_]BOYOF;O,W_93OW;OFW;L[L\YSGFN*_8I_Y \_\ U_R?^B8*
MU?#:WOQGC.H-=7-AIYD=;:&W9(IW"'9Y\DPWL,MO4PX"C:I!;&YN?\.^+[SX
M6:\NA:A=/=V=YM>"69GDGC+EDC4G!SETV$?<Y64>7EU.W\;_ !WJ,.IV&AV(
MDBBO&7S;B)<RE"Y25(V*,$,<?[QG&67*-E #NQ/V@TN?A>MKK&F7=R MPL3V
MTT\]S!)N21]Q$LK'HI4C/=60HR[F] \:?&>/PWH<>LNNV2XMXC!%@R#S98O,
M1&(V94<ECE<JIQ\Q53S7@[X4ZMK=LFH:CJM[%?RJLBQQL([>([5\M)+<HJL1
M@&5,(&.4.>7;S3]F&:>?Q/J#WBA+AH;LS(O*K(;J(NH^9N V0.3QW/6MO]J[
MQEK/A)H5AO=D%SYH$<,7D.@B=&4F7>\A8AP&*&-2%^YAB*]J^+UQ?66GSW.G
MW"6[06\TK$PB9V\M?,"J6<(F=I4EDDX;( (R?)?V>[S5OB-IT[7%])&AO9O,
MD3#7+!H4_=1EU*6Z*S!@45B22$\G;EZGPQ\9:CX4\32^'+NXDNK=FE\LRR>8
MZYB$\3EV3>3Y:A60%4#,S ''/8?'#XO7&B7UGH6GGR;F[D@W7)19!&DDWE#:
MC<,Q*G.[ "\#+-N3/^.'AV[\ :<FIZ5>W2RVK()3-<RW"RH^(MS1S>9&7WLI
M&%10"Q R$ [#X$:Q<^*-.@U2ZN9I&FC<-$XMA&&20H77RK>)QG82 68 -@[B
M U>E44444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444445\H?!BY&D>,]1AN,QO.U\L:LK L3.LZ]N 8E+@G (Q@G(S]"_%
MC_D#ZA_UX7?_ *)>O+_V,+1X-&D9U*A[V5D)! 9?+A3<,]1N5ER.,@CJ#7'_
M  "_Y'#5O^W_ /\ 2R.OJJBOE7_FH?\ G_H'5]55\J_L,?\ ,1_[=/\ VXH^
M/O\ R.&D_P#;A_Z625ZK^U'_ ,B[>?\ ;O\ ^E$5<_\ !;QU:^!_"=M>WK[8
MU^T  <N[&XFVQH,C+'' X  +,0H)'5^$)=3\?0QW]U)]BM9H]R6L!5YGC<(5
M:2X(RN1N($*Q.JNI\P.N!X_^PQ_S$?\ MT_]N*/^:A_Y_P"@=75_MK?\@>#_
M *_X_P#T3/7%?%74/[$L_"VH2([06\=N\A5<]$M) N20NYEC;:"1G:>P)'U?
M:7:7B++$P='4,K*0RLI&0P(X((Y!'!%5+37X+N>6TC<-- L;2H.2@DW&//8$
MA2<=0,$@!E)^9?\ FH?^?^@=7L'C[XP?V5>Q:+IB)<:E/GY&?9%"-A<22D D
MX W^6N'9 2""4W^5?M8^'KBQTF*6]NGN)3?@ !5A@0,D[;4C3). %4-*\KC!
MVLN]PWNOPG_Y ^G_ /7A:?\ HE*^?_V&/^8C_P!NG_MQ7U57FOQK^$-K\3HX
MK:6;R;J/>\#CYCMS&)LQEEWKR@)!!5MG."5;P4^*/$WP!,<=[BYL"RHFYC)%
MPJ'9'(0)(B$4JBN-G#LL;X)KNOVO]4CU?0;6Y@;=%+=P2(V",JUO,RG! (R"
M#@@'U%>H>!M?@\/:!9W=VXCACTZU9W;H!Y*#MR23@ #)8D  D@5B>"_%.H_%
M&,7UN_\ 9^GF1A%M6.:[F"F1"Q,@>*%=VWY=DCDHV'"E2WDO[.]L+7Q;JD:Y
M(5;Y069G; NX@,LY+,?4L22>22:E^/O_ ".&D_\ ;A_Z625K?M=ZA#IUYHT]
MTGF01W$SRIM5MR*]L77:Q"G*@C!X/0\5[):?#+1+Q%EBL;)T=0RLMO RLI&0
MP(3!!'((X(K0\/:/I^AS2VUC##!+Y<4DJQ1+%E6,JQ$E5 ;E) !DD<\#(S\Z
M_P#-0_\ /_0.KJ_VUO\ D#P?]?\ '_Z)GKU7X3_\@?3_ /KPM/\ T2E?*O[.
M'_('\0_]> _]$W=>E?LMZ%H_BK2%26TMI;JWDD28R0PO(=SM)&V2&8KM;:I;
M'*,!PN:]:N/ VC: 4N39VL16:%4=;>,,)'D6.+!5,@^8R@'L>20!FO,/VUO^
M0/!_U_Q_^B9Z]5^$_P#R!]/_ .O"T_\ 1*5\_P#[#'_,1_[=/_;BCX!?\CAJ
MW_;_ /\ I9'7HOQV^ T'Q/<20S"*_AA P?F5HR9#&KJ#E 9 VV0 \;QM? V^
M8:-\5]>^#UY#8>(3YUG))@3.3*WE[V#RI*N7?&X.4D#.$"J%CW"OK2O!?VS[
M1Y]&C9%+!+V)G(!(5?+F3<<=!N95R>,D#J17HOP4U2/4]%L)(6W*+2&,G!'S
M1J(I!R!T=",]#C()&#7B'QTM'NO&.DK&I8A;)B%!)VK=2N[<=@H+$]  2>!7
M2_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2NJKY5_;G_ .8=_P!O?_MO
M7U57RK\ O^1PU;_M_P#_ $LCH_;G_P"8=_V]_P#MO5OXW:A9V'B_3GU)$>U-
MHB2"14:,;WN8U9A(0NU68,Q/W0"1D@"O=?\ A4^C_P#0/L__  &A_P#B*T/#
M%E9:<);:PCCB$4VV5(HQ$HD,<<G(55!)C=#D9XP,Y! VJ^*_@#_Q;CQ3)IMQ
M_'Y]J)'_ '/\0DBD"MG/F>6H1<\^8I4MP&^U**^2_P!HK5([+Q)I.INW^A^7
M9R"907C94N7D<J5!WX1E;"Y.&4X^89^M*^6_@!:.WBW6)0I**UZK-@[0S7:E
M5)Z D*Q ZD*<=#4/Q]_Y'#2?^W#_ -+)*]5_:C_Y%V\_[=__ $HBH_9<_P"1
M=L_^WC_THEKRKX!?\CAJW_;_ /\ I9'1_P U#_S_ - ZOH#XL?\ ('U#_KPN
M_P#T2]>'_LU>+X/ 'AR>_P!0)CB-[*8^/FE/E1*%C!QO)9&'!P"K%B K$>H>
M$)=3\?0QW]U)]BM9H]R6L!5YGC<(5:2X(RN1N($*Q.JNI\P.N!X_^PQ_S$?^
MW3_VXH^/O_(X:3_VX?\ I9)7JO[4?_(NWG_;O_Z414?LN?\ (NV?_;Q_Z42U
MXUX!U<?!+Q-<Z=<XAL+IOD8EO+5"6>V?>Z%F"[FB<Y"ABS,Y\O-?2OP_M'%M
M]JG4I/=M]HE5@59&=5"1$'',<2I$3A2QCWLH9FKI:Y7XL?\ ('U#_KPN_P#T
M2]>5?L4_\@>?_K_D_P#1,%<I\??^1PTG_MP_]+)*]5_:C_Y%V\_[=_\ THBK
MP7Q9://X$T]D4L$O79R 2%7S+M-QQT&YE7)XR0.I%?77A3Q-#XHM8KZV.8IH
MU=>5)&>JMM+ ,IRK $X8$=JY_P"*&J1W5G>:9&V^\DTR[D2%06D*[#&#A0>K
MN%4=6.0H.UL>5?L2ZI'+IMS;!OWJ7?F,N#PLD:*ASC!R8G& <C'(&1FW^VM_
MR!X/^O\ C_\ 1,]=A=VCV?A)HI5*.FAE65@596%I@J0>00>"#R#7'_L4_P#(
M'G_Z_P"3_P!$P4?MK?\ ('@_Z_X__1,]>J_"?_D#Z?\ ]>%I_P"B4KYZ_9 T
MW2O$-M<6=Y;0374<WF@RQ12,8F5$ 7>"Y"NIW<;5+KSEJ]ZU;X=Z'I$,ES/8
MV:Q11O([?98CA5!9C@1DG !. "?05Y+I^MIX=\=W(N@4%Y;1Q0LV%1F,<!4Y
M8C(+0M&-N29,)C.<?1]<+X[U^#7]"O[FT<2Q-97RJZ\J2B2QM@]QN4@$<$<J
M2"#7G7[%/_('G_Z_Y/\ T3!7O]?*'[2MR-&\3Z7?7&4MT6U9I-K%<1W3O)C
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M_P!>%W_Z)>O*OV*?^0//_P!?\G_HF"N4_P":A_Y_Z!U=-^U!X'>^N=/U#3G
MU19EC@BP6DEV-YJLH.4 B;+NS@)M8[W&$5M_XE6.K?$BTCTI;$VB7#1_:YYI
M8)%B5"LF(UAF9Y"77 +! 0 "%W%H_2_!?A"#P=:16%H"(HE(7<=S$DEF8GU+
M$DX  )PH P!M444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444445XA\;?@E=ZS=Q:YH<HAU"%?F7A/,VAMI#;<%R/W9$G
MR.F%8JJD,:]'XD^(=H=+N+./3A*J"XNOM*RY0%?-6..(E@6Y^5W*E-R,V6#5
MZ?I/A[_A$K&.STV-&\F-$C61_)5L$;F9HXGPQY9B$.YR<XR2/%?AY\&=>\(Z
MM/K+&QE:Y\_S8Q+<1C]ZXE.QO(?;AP,9#?+D=2&'T5575))HHV-LB/+QM61V
MB0\C.66.4CC)&%.3@<9R/G__ (4SKW]O_P#"1YL=_F9\GS;C;L\KR-N[R,[O
M+_BQC?\ -LQ\E>U:C<ZD;7-O%;"\.X;7GE,"_>VMN6 ._P#"2NV/.2 XP"?(
M/@'\&=8^%TTOF&SF@N/*$FV699%V%L,N8-K?*[?*=NX[?G4 YJ?$/X,Z]XNU
M:#65-C$UMY'E1F6XD'[IS*-[>0F[+DYP%^7 Z@L?0/BUX2U+QSI3:?'';1RS
M;?,)GE*)LE21-I%MF3<%YR(]IZ;^M>:ZC\!-6NO#W]B3"V=[:1IK9XII 7;<
MQ,3K) %Y667:P=1N\L, -S5VOPXC\0_V>FFSVT-B\-ND*71E6X.%4JKK FY6
M8*J@[Y57<=X5@#'7'_L]?"O7/AV][&\, $C0[9'F.UQ$9?N+&CMA]P&Y]AC#
M!_+E*F.I?^%,Z]_;_P#PD>;'?YF?)\VXV[/*\C;N\C.[R_XL8W_-LQ\E=7\>
MOAMJ7Q*LX;*!;:+;)',[O-*<.$D1HU M_F7YP0Y*DXYC%#?!VX\5:*FB:SY*
M-;QQ"WGMY)'^:-6C1V22./HA"L-S!\L1Y9VD>5>&?!?CKPUBQM9,6ZR!5D>2
MVFC51A R^;OE6(* 0@4$#I'N)%>]?"_P+<^"K!HYIC=WLC-+*\LC;6E,:(J!
MRKN$"QJNXAFP"VT#"#R__A3.O?V__P )'FQW^9GR?-N-NSRO(V[O(SN\O^+&
M-_S;,?)1X\^&6KZ;K]OXCTRV2X=HU-Q#YZ*JN(O(=5:01':8R-C88[PS,@&$
M-OX[?#[7?B3I\16.&)HY$<V2R"1V)4KO,[B- R;B/+ V8W-YKG8H[KPC8ZSI
M&E06ZQ6JW$5M!$B/-(54I%M,CND1W'=M'E(   Q%PVX;>%^ ?P9UCX732^8;
M.:"X\H2;99ED786PRY@VM\KM\IV[CM^=0#GW^O-?B?X;U:^OK&\T8PJUO'>"
M3SVD6%A((56-EB^=L[2X'W0R D@[0>:\966O?%"U?2I["/3X96C,L\ERER=B
M2*Y5$A ._(!&XA2 RD@L"-#XT_!B3Q)H<.EZ>V7L_),0D(S((HFB"%OE56*M
MD' 7< #M!++DZ=X&UGQ;H/\ 8FHP0VFRW6)7\[S'D,(4V_RHKK&I94\QM[L0
MKA8EWJR'P,L/$/ABR32;BQAB2/S"ES)<*P =]V#%$9&D8,[,!NB5E 4NA^8X
M'PO^$.N^#]<O+QQ#,L\<R_:W<(C&26.0R>3'ERPP28OW:$@J)@-K'5_:!^$N
MIZSJ5GK>DJD\MOY0,+%4P8I&F1\LZ!E).U@"K#C&<DIVOBWX?3?%+3VMM7C2
MU8^6\*Q2-.\4H5OG=L1H_P!_88PI4 ,5E)93'XKX9^'7C;P3C3K"1!:B0$2!
MK>2%=^"S 3*9@H))953[VXJK%LM[U\./ <_A*VFEGD%UJ5RQEGE8[%>3;A(@
MP0LL*8VK\IV@L5101&/+_P#A3.O?V_\ \)'FQW^9GR?-N-NSRO(V[O(SN\O^
M+&-_S;,?)75_'KX;:E\2K.&R@6VBVR1S.[S2G#A)$:-0+?YE^<$.2I..8Q72
M^ =-U7P_IT=G<1VKS6\,4412>58Y%3Y,ONMRT9" =!(';/"#&/.O@'\&=8^%
MTTOF&SF@N/*$FV699%V%L,N8-K?*[?*=NX[?G4 YY3Q-^SIJ_@.^.H>%)/D;
M*B(N@D0,#N0^=^[DB! V[B7!*Y4E/,/=_#?X=ZYK4\%]XHN XMF9X+4"$@2G
M<@DD\M!&2H^:/!9E+9#(0RM:_:!^&>J_$F)+*U^RQV\<PEWR2R^:S!"H&U82
MJ ;WS\SEOE.5Y!ZOP#INJ^'].CL[B.U>:WABBB*3RK'(J?)E]UN6C(0#H) [
M9X08QYU\ _@SK'PNFE\PV<T%QY0DVRS+(NPMAES!M;Y7;Y3MW';\Z@'.?I?P
MOUKP+XCN-3L8([NVNVEW,TJP;%FE$A!R6<%'4$E4D#)T =L)V&NZ'X@M=4&J
M6:VTBBPCCF@:21$D(GFE\N,_\]40A%FE"(2Y8(H9D3)\8^#]7^,2PV>I6B:=
M9Q7"RRM]H2YGDPCJ%C\M=BXW$,7_ +RLH;:RM[K65XK\,P^*+66QN1F*:-D;
MA21GHR[@P#*<,I(.& /:O"OA]X7\2_"1GL8+=-3L3EHL3QVYC)<]/-Y7(^9X
MP&0,05?._=VO@'X:W4VIR^(=8V"ZDC$=O;HWFI;1[1D;V'^MZJQCPF6D8$B3
M"Y7QX^&VL?$N%+*%;.&".X,@=IIFD? 9(^!;A4^5B67+\XPV =W:_"_2]2T.
MU@L=02VVP6ZQK+#+*Q;9A4S&\*8^0?,V\Y8<* V%[6O$/VH_@_=_$&"WEL,/
M+;-)^Z)"EUD\L$AF(4%=@.#@$$X.0%;NO#.JZU>VXEN[6VAG$8'DF=CN?< 6
M+I'(L2A0S*H\\MN4%T*G=Y5\//@SKWA'5I]98V,K7/G^;&);B,?O7$IV-Y#[
M<.!C(;Y<CJ0PU?VB/@SJ7Q/D@%L;:.*W\W:TDLN]_,$6<JL!"X*$##-D$'CI
M6M\3O@[<?%+3T34/)AU"#<87ADDD@)94WA@\:,JNR],.T>%(=_F1O-/"W@[Q
MUHNS3H)DCMHMR)*[6TD85<[<$I)/M. $!7*@J"%48'T+\._ Z>"[1;17,K[G
M>:9@!)+*YW/(QZDD\#<68*%4LV,UTM>5?&?X$Q^/V6]@E>WU"",""4,0F5?>
M@; +##%L.F&4MN(?:JUE:%XB\7>']UO>V$.H[<;+B*XAMMV<LV0X&<9"C$<>
M-I^_G=75Z=H^J>)I-VK"&"R,:_Z%$QF=RP4LEQ*R*"JD$;(@$D#%)&>,$/#\
M<OA$GQ,LO(#".XB8O!(0" V""C'!8(W&[;R"%;#;=IY7PAK'BS1(!87-C'<R
MHS1QWKW4:IM^ZDDB#,L@'4D!)'7 *^9ECV'P8^%O_"O[5EFD\Z\GD,MS,>2S
MG^$,1O91R07.2S.^%W[1YI\0_@SKWB[5H-94V,36WD>5&9;B0?NG,HWMY";L
MN3G 7Y<#J"Q] ^+7A+4O'.E-I\<=M'+-M\PF>4HFR5)$VD6V9-P7G(CVGIOZ
MU%\%_"&J^!M/&G72VL@A64PO'-*"S,Q=4<-!P-S-F122!M'EL02>*\#_  ;U
MOPGK-SK2"R<7+7&^$SS@A99!+@.+;J&"\E2",C )!'">*;>ZN/';K82)'<_*
M8VD7?&2M@&*,!SM< HQ7YE#%E^8"O1?'>D^(OBI$-,ELX]-M796GE>>.Z9U5
MT*H@C&00?GP=H8J!YB#(;;^+/P/76=!32-.&'M?+>!240.R!E;>0H7<ZNY)^
M4&4AF(&ZCX<1^(?[/339[:&Q>&W2%+HRK<'"J55U@3<K,%50=\JKN.\*P!CK
ME/V;_A3K/P]FNX[B*%8I9(!YQEW[EC,N3'&@R=P; ,C1%-P;9)@QT?$/X,Z]
MXNU:#65-C$UMY'E1F6XD'[IS*-[>0F[+DYP%^7 Z@L?0/BUX2U+QSI3:?'';
M1RS;?,)GE*)LE21-I%MF3<%YR(]IZ;^M'P,\':EX(LDTV^%LT47F&.2&24N=
MS[]K(\2CJS?,&'&U=G5JY_X]?"B/QQ?:6<(6%PRSH00SVR@22$NGSA5V[%["
M2=1N0MS[517'_%+2;_7+*6RTY8,W$,D3O/)(@17 4E5CB?<2I;&64*=IPXR*
MXK]G[X9ZK\-HGLKK[+);R3&7?'++YJL4"D;6A"N#L3'S(5^8Y;@#FOB'\&=>
M\7:M!K*FQB:V\CRHS+<2#]TYE&]O(3=ER<X"_+@=06/H'Q:\):EXYTIM/CCM
MHY9MOF$SRE$V2I(FTBVS)N"\Y$>T]-_6L3P!\'[N'1V\.ZRL#VNU]LMO+*)<
MF42KE7A5<JY+!MV.%4QL-Q/E6F_#7QG\/GDL](D,EJ&_=MOMC&5R6!6.X8F(
MDL=X4 %L\N K'W7X/_#V]\,">YU:Z-U>W++O.XM$B(TA1(]RJ0,R,Q "J,[5
M0!=S>=7/PAU?X;:H^I^'0D]I/(#-9%TAX)9F49VQA5/^J8'>F[;L9 Y?H+_P
M-J?Q2NK6;68$LK&TD,GV3SEN7GD&TJ7VKY/E8RN""^/,7&) R]U\4M)O]<LI
M;+3E@S<0R1.\\DB!%<!256.)]Q*EL990IVG#C(KBOV?OAGJOPVB>RNOLLEO)
M,9=\<LOFJQ0*1M:$*X.Q,?,A7YCEN #]H'X9ZK\28DLK7[+';QS"7?)++YK,
M$*@;5A*H!O?/S.6^4Y7D'M?A;I-_H=E%9:BL&;>&.)'@DD<.J J"RR1)M(4+
MG#,&.XX08%>-_%?]G2^M-0.N>&Y-MP9#*\1<*_FLWS,C/\A5MS%TD(7&Y1N5
MA&NAX.^'?B7QBZ#Q/< 64<RR-; 6Y:9HRK(K^2FPPEOO*S,25QL!*NN_^T#\
M#W\;A-1T]S'J5LH\LABH=58NJ Y&QPQ)1Q@9.'."&3@-#\'>.=<"V-W=&UMP
MJ!IB\!EVJR]'@S,SXYRSJ'P0[_-S[_=^!T;2FT>)RJ&R-JKL [!?*\H,0-H8
M@<D#:"?2O(/@%X,\0> $GTR2U@$+3-(ETTP*AB%C+"--SR JJNJ-Y!P&#2*6
M&WZ$KSKXY?")/B99>0&$=Q$Q>"0@$!L$%&."P1N-VWD$*V&V[3ROA#6/%FB0
M"PN;&.YE1FCCO7NHU3;]U))$&99 .I("2.N 5\S+'JOA'\+W^'ME("PN+^=F
MEGE<E0\I'"&38TFP'/S,&;+.^T;M@\Z_X4SKW]O_ /"1YL=_F9\GS;C;L\KR
M-N[R,[O+_BQC?\VS'R5]"VC.R*90%<J-RJQ=0V.0&*J6 /0E5)'.!TJ6OG7X
MA_!G7O%VK0:RIL8FMO(\J,RW$@_=.91O;R$W9<G. ORX'4%CZ!\6O"6I>.=*
M;3XX[:.6;;YA,\I1-DJ2)M(MLR;@O.1'M/3?UJ+X+^$-5\#:>-.NEM9!"LIA
M>.:4%F9BZHX:#@;F;,BDD#:/+8@D\5X'^#>M^$]9N=:063BY:XWPF><$++()
M<!Q;=0P7DJ01D8!((A^(?P9U[Q=JT&LJ;&)K;R/*C,MQ(/W3F4;V\A-V7)S@
M+\N!U!8^@?$WP_JWB"WLFLA#%>0WZ3-^^D:!52.<89Q''(ZN&5&54!.\J?ER
MU8GB'4/$GB:VFTIM.@B,T,D+W9NE:WP5*O(L2J9@&&?+!R5+*7R U:%U\,;S
M0M"&@Z489-UO-%)-<.\>/-)+LJ1QOG.]]H+#9\N3)SG/_9^^&>J_#:)[*Z^R
MR6\DQEWQRR^:K% I&UH0K@[$Q\R%?F.6X \Z\3?LZ:OX#OCJ'A23Y&RHB+H)
M$# [D/G?NY(@0-NXEP2N5)3S#W?PW^'>N:U/!?>*+@.+9F>"U A($IW())/+
M01DJ/FCP692V0R$,K97Q'^%^J:5XBA\1:/ +H%1YL;2QQX81^0P&\I@-$1M(
M+D.&+#;M4R_';X?:[\2=/B*QPQ-'(CFR602.Q*E=YG<1H&3<1Y8&S&YO-<[%
M&KJOPAO/&7A^/2KX0P3PV]J+<!WEVRQ1[2TC+M7YE)C*JLBQ\N'E)4+S7P[T
M7QEX>1='*P+;*SHMY(RS-%'C ,:B568#&8EDCX)"OM087/\ AG\%=>\(ZQ=W
MMOY*Q/))&)KQS/))$\P<R@0,"TN$#'S#'DMCC)*]!\?/@SK'Q1FB\LV<,%OY
MHCW2S-(V\KEFQ!M7Y47Y1NVG=\[ C'=>+=-UO7],DLO+LEN)X9(I'\^<Q!61
M59U7[/NR<OA2V$PA+29('/\ [/WPSU7X;1/977V62WDF,N^.67S58H%(VM"%
M<'8F/F0K\QRW &!<_!O6V\0?\)'&+)3N7,+3SL-OD"!QO%LO)7)!VX4D9# 8
M)\7_  S>^,-6LSI%P8]3M(=TZARUG;!@6!+[ =\A^39Y;&:(!G1$7YI?^$-\
M<_\ 03L_^^$_^0ZZKX(>,=3U"2]TO6@C7=C)$#,FT"19@[H<*JJ/E4$$!258
M!D5U8G6^$W]N_P"E?V_Y/_'P?L_E8^YSG&W_ )9=/+W_ +W[WF?PUW]%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%17<Q@1G52Y520B[0S$#(4;V5<GH-Q SU('-?,O_"%ZY_PE'_"
M1?V:_D>9CR_M%KYFSR/L^[_6[=VWY]N<9^3?CYZ^FK28SHKLI0LH)1MI921D
MJ=C,N1T.TD9Z$CFI:****\U^-_\ ;_DP_P#".;-_F-YV?*\S&/DV^?\ N]N<
M[OX\[-O&^MKP/I%[<B._UCRQ>^2R".$$10H[*[KDNY=V*)O;<5&P+& -[R=A
M111111111111111111111111111111111111111111111117A6J^!M=\#:I<
M:IHVR^@O9(S/;S.$F7:6.%=BJA57*1G)VJX4Q.$#5TT/BWQ)JH:./2X+1]N5
MEN+Q9HLAERNRW3>25SCE0,9)Z*W5>!_ Z>&$=F<SW4[![FY< 22N!@<#A$4?
M+'&ORQKP,DDGI:**********************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M*****JV^K0W,DD$<B-+%M\Q RETW#*;E!RN1R,XR.11J&K0Z=L\^1(_,D6--
M[*NYVSM1<D98X.%')["K5%5;C5H;:2."21%EEW>6A90[[1E]JDY; Y.,X')J
MU1111111111111111111111111111574-6AT[9Y\B1^9(L:;V5=SMG:BY(RQ
MP<*.3V%6J**************************JZ7JT.KQK/;2)+$V=KQLKH<$@
MX920<$$''<$5:HHHHHK/U+Q#;:6\<5Q-'&\S;8E=U1I&R!M0,06.6 P,G)'J
M*T*******Q=;\;V&@N(KRZ@@<J&"RRQQL5)(# .P.,@C/3(/I5JV\0VUU!]L
MCFC:W"LQF5U,6U<[VW@[<#!R<X&#GI6A1111111111111111575-6ATB-I[F
M1(HEQN>1E1!D@#+,0!DD 9[D"I;2[2\198F#HZAE92&5E(R&!'!!'((X(J6B
MBBJO]K0^=]E\Q//\OS/*W+YFS.W?MSNV[N-V,9XSFK5%%%%%%9\/B&VGG:S2
M:-KA%W/"'4RJOR_,4!W ?,O)&.1ZBM"BBBBBBBBBBBJMOJT-S))!'(C2Q;?,
M0,I=-PRFY0<KD<C.,CD5:HHHHHHHHHHHHHJKJ&K0Z=L\^1(_,D6--[*NYVSM
M1<D98X.%')["K5%%%%%%%%%%%%%%%17=VEFC2RL$1%+,S$*JJ!DL2>  .23P
M!1:7:7B++$P='4,K*0RLI&0P(X((Y!'!%2T44455U35H=(C:>YD2*)<;GD94
M09( RS$ 9) &>Y JU111111111116?IOB&VU1Y(K>:.1X6VRJCJ[1MDC:X4D
MJ<J1@X.0?0UH444444444445GZWXAMM!02WDT<"%@H:5UC4L02%!<@9P"<=<
M ^E:%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<?\5?B9!\.;)KZX!<[@D<:\%Y"
M"57."%&%)+'H <!FPIF\%>$IM.W76H2^??2Y+L-WDQ [<P0*WW(AM7)^_*RA
MY"2%"]517E7Q*U&3X8-_;5OO>S,BK>VH(V*'<_Z5"&8!)?,;$BK\LQ?<^U@9
M*]+TG5(]7ACN8&W12QI(C8(RK ,IP0",@@X(!]15JJNJ:3#J\;07,:2Q-C<D
MBJZ'!!&58$'! (SW -?'5W\-]/NO&K:4T %FS%C"I=%R;/SCC8P*CS.0%( '
MR@!>*]Z_X9<\._\ /G_Y'N?_ ([47@CX%0> M9-]IRE;66REC:,MN$<@D@*X
M+,7(=0QP<[2I^;#*H]:HHHHHHHHHHHHHHHHHHHHHHHHHHHHKBO"_PAL?#6H7
M.K6X?[1=9WY<E%W,'DVC_;<!CN+8(PFU<BOG7XN>&(/#_B[3%MP_[R2PD=I)
M99G9OM+)DO*[M]U% &<  8%?7]17=L+I&C;(#*5)5F1L$8.&0AE/H5((/((-
M?)6@Z#%H/CX6]N"$#.WS.\C%GL6D=BTC,[$NQ))).37UU111111111111111
M11111111111117%?$GX0V/Q%\C[>'/V>0LNQRF0V-\;=?E;:N2,.,?*RY.>U
MHHHK/U_7X/#T#W=VXCAC7<[MT Z=N22<  9+$@ $D"N?^$GCA_'.FPZC(@C,
MS38122%59I$09/4[5&3@ G) 4' ["BN ^-GQ7C^&]BUQE&N7^6WB8GYVR,G"
M\[4!W-]T'A-RLZFN_HHHHHHHHHHHK@-=^*\=GK-GH<!1Y9O.:XY):)5A>2,8
M'&YR >3D(.5^=6'?T4455U;2X]7ADMIUW12QO&ZY(RK JPR"",@D9!!]#7/_
M  U^&MK\.[7[%9;RAD:1FD;<[,V!DX"J/E55 4 8 )!))/54445GZ_K\'AZ!
M[N[<1PQKN=VZ =.W)).  ,EB0 "2!7/_  D\</XYTV'49$$9F:;"*20JK-(B
M#)ZG:HR< $Y("@X'S7\4_!MKX5\6Z9'9H5$LUE+(6DDE9I&NW#.6E9V).T9Y
MZ\]2:^Q******\ _:+^-%QIDT>@:/_Q_7'EJTBLH:/S#M2-3N&R5L@[FV[$9
M67E@R=AX#_9RTCPK (GMX[F4JOF2SHLA9ADY57W+&.< +S@+N+D;JY3XW?L\
MQ7EE<3:*#;2E0\MO#O$%RL8RJ&%/EWC&8]JX+D[AEMZ^R^$]=_X2"SM[W;L\
M^WBEV9W;=Z!]N<#.,XS@9]!6K1111111111111117'_%7P!9>-[)K?4F,<,;
M"7S%<1F,H#E\L"F-A8'<" "3P0",KX%^%4\,V4D-O))):&YE:U,K!G\K"H6&
MT*FQY%>6,I\K1NK_ 'F->BT455U33%U.-H9"X5L9,<DD+\$'AXF1QTYP1D9!
MX)%?*O[-FEQZ1XJU*V@7;%%'>1HN2<*MU$JC)))P !DDGU-?6E%%%%%9^OZ#
M%K\#VER"T4J[757>,E>Z[HV5L'H0#@C*G()%?+?[-FEQZ1XJU*V@7;%%'>1H
MN2<*MU$JC)))P !DDGU-?6E%%%%%%%%%%97B;PQ!XEA-M=!S$V=RI++#N!!4
MJQB="RD$@J25/<<"OFK]AC_F(_\ ;I_[<5]544444444444445\@?%SPQ!X?
M\7:8MN'_ 'DEA([22RS.S?:63)>5W;[J* ,X  P*^OZ************X#7?B
MO'9ZS9Z' 4>6;SFN.26B587DC&!QN<@'DY"#E?G5AW]%?-?[:/AB!+&&_P .
M9S=I'DRRLBJT,A8+&SF-,F-"2J@DC))).?:OA/\ \@?3_P#KPM/_ $2E=511
M117R!^VGX8@TR:SN8P_FS_:?,9Y99>%,;*JB1V"*#(Q"H%49X'2OK^BBBBBB
MBBBBL7Q?X-M?&$!M+Y#)"65B@DDC!(Y&?+92P!YP<C(!QD CYO\ V&/^8C_V
MZ?\ MQ7U57 ?&SXKQ_#>Q:XRC7+_ "V\3$_.V1DX7G:@.YON@\)N5G4UW]%1
M7=VEFC2RL$1%+,S$*JJ!DL2>  .23P!7%?"3XF#XAQ75S& (8[V2&$C=EXT2
M,K(=P!!8L6Q@;00IR06/=44445P'P]^*\?CB^O[>U*/;6GV=4E4EO,9Q+YAS
MP-H*!5QD'!<,RLH'SU^V;X-M=%GMKN!")KIKEIG:220L4\D)]]F"@!B %P ,
M #  'V)11111111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111117S+\2=2/C#QEI^F!RB63)(<J
MI'F!?M;X((8AD2-,D_*02%/\7T!XV\4)X5LI[^3!$,+N%9@@9@/D3<0<%FPH
MX)R0 ">*\*T"PT/QS E_XEOX)[J9?,\@WHB@M@W(CCC62-D.S8) Q8ETR6)R
M6S_@3XS7PEK<OAJWN?MFGOO:UD!20(WEB=@'5MNW;O5]H(,H#!4W/7T5XLT+
M_A(+.XLMVSS[>6+?C=MWH4W8R,XSG&1GU%>(?L7^+SJ>G36#DDVLP*\*%$<V
MY@H(Y)\Q9"=PX#  D<+]"45\@>*=1N-.\=O+90?:9UV[(?,6'=FP ;YW!484
MEN>N,=37M7_"Q/$7_0"_\J%M_P#$U;_9RU235]#M[F=MTLLEW([8 RS74S,<
M  #)).  /05XK^V7#<:0UOB[N7BNO/#P,ZK !&\;HH2-$!P7/S/O?Y5RWRUZ
M+>_L]7>LWMOK-QJ4D=^C!I3$@,2KGB& ,1L0*64^8)!)DNZ?,ZMY)\,=-U#6
M?$E]81WLV(X[FW>XE=I;I;:.Y0%8F;A92< -C";G=5W!178>(-./[-NG77V2
M[,LE[,BVD;HO[HC=YDI!DPY$94,X0#>(@R%3@=7;_LI:?J=M_P 322>>_D6,
MRW1G=Y X5 RH77:4^4A?,1F"G&1A=N)^SS\1]0L]0N/#6LOYDT/F&*61V\UB
MK#* R -*K*QEC)^8(">4VA.5_;+AN-(:WQ=W+Q77GAX&=5@ C>-T4)&B X+G
MYGWO\JY;Y:]*;X W6I:A:ZY=:@_VZ*17F5%_<;0V?L\/S(T<6TLC%MYDW%V4
M%F!\_P#@KIFG?&^2ZN]>/VC4/,&R'S)(DBMP!M\M49?EWLP;YFP=I;#.6?V7
MX;?#5_!5[>;)))+22&T%N)',AB6,W&;=2S%MB;E*9 &'V_,RLQ]%HHKQ#XO^
M-I]:U:S\,:=.8&F;S+N6-MDJQJ#)Y:.NYD<HC,05&<Q?-L9P<KQY^S%:Z%9&
M[T$SPZA;0LR.DLF^4@ /G:&;>R!PHB\L%GP1MX'5?L_?%&7XEZ8YN'"7<3&)
MWC*;^4!2?8RLJDY. 5*%D8@;?D7Q75+?44\8KI]M>R221M)Y,MT?.$7G6GF3
M.L:A(P0&)1%54)5%8;0:]O\ AE\"?^$ U"XOHKR::*XC(:*7YG+EE;S7D# .
MV=^"4! <\GDMZK7D'[3D-Q9:5-?VUW<P-!Y)6.%UB1BTJQEF94$I^60_*) F
M0IVY&3PGP?\ A(?B)H%K'>W4\5H%F5(+>155S]IE=I)=T9W'=M")\P0)O#;I
M"JXOPHUF\^#VO#P]?S/)9S82$G>(LR'=#(BE6QN<F-PA"!V8LS>7FNU\9ZW)
M\4]=;PY;W#PV-O;R->-"X221L;&C#CS RJ9$5T8*,^:&!*IC*^+WP17X=VYU
MKPT9K:>WV&5$DD=6B#9=BK!V;#;&=6;RO+1BRY'/HOA/XNOXB\/2:TBQBXBM
MKEGC!+HLL*N<$ AE#;5?:3N"L/F/#'S3X'_#W1_BM:/J&J9O-2:9S=%I949"
M21$H6-HP$\M05P" =R*0$V)Z+X>T2Z^&6G:K*\KW+I)<7,$L[>8\BK:1; Y#
M;CM9#&>5)"Y 4%17G7P/^'NC_%:T?4-4S>:DTSFZ+2RHR$DB)0L;1@)Y:@K@
M$ [D4@)L3U7X>?#VZ\.PWMK)=3L9+TR173-')<-'Y-N!DRK*I(V&(EEY"[E5
M05QXU^SW--_PE6H03SS7'V>WNH$>>1I9-D=U&%!8_B>,#)) &:J_M)^=_P )
M5IOV79Y_EV?E>9N\O?\ :I=F[;\VW=C=CG&<<UTOQ5_9JGN8&U2"^NKC5(%$
M@9SD,4S(R0K&N^([R6B12P4X08SO'5?LN?%%_&VG&&Y<O=6K!)&8DLZ-DQ.3
MM S@,AY9B4WL<O7G7_-0_P#/_0.KT#XI>/EOM4CT$WJ6-L+?S[JX6X2"XSDB
M.W1F!"-G9(P/S/&>"%R'\U^*OAC0?"-NNJ^&KR&"^M9%9$AN1.T@9E1AM>5S
MP"2< J4WJZL#E?HKX6>-?^$WTRWU KM:6/YQC #JQCDVC<WR[U.W))VXSSD5
MU5<5\8_B'_PK_3)K]0C2KM6)';:&=F"@>K8&7*C!*J>5Y8>5?\(-X;UZ'?K6
MI0W=\\?SSM?I^[9AEEA4,D:Q+(6:-6C(&<$$?*(OV9_'LMU+>>''N#,ELLGV
M2Z0(3Y2/Y606,BD?,C1 AU RI)0(M<5JEOJ*>,5T^VO9))(VD\F6Z/G"+SK3
MS)G6-0D8(#$HBJJ$JBL-H->M>%_V;6\-W5S/;ZG>+%=1E7 \OSV8X)=I65P6
MR7(98TD7=PX^;=XU^SCH5[\2#J$-Q=R+!*MO]KD#%KN4!95BB$C[@J$9\PD$
ME56,?*S8[#Q)#=?"*QM_#%A>^9>W]WB.4KY?D12%(R !)(T>Z4DJZ@]92H$B
MAJ[#7/V4M/D@9[22==15GECNWG?S6F^9D,A"E<;R"61%D^4$-NR3#^R_\5[K
MQ1'/IFIG_2[/:,N=L[KEE8.C?,6C90KOU.Y0XWY9_-?CE#?:1XBL+2&[FN&>
M2SGC6Z<>0)O.:)"8X$C15^4;MB!N6.237HM]\&Y_ EQ/XF2_DGN(K*YDF25/
MEGD$+G!\MTVPA@A6+#;0@ ;A2O/_  /^'NC_ !6M'U#5,WFI-,YNBTLJ,A)(
MB4+&T8">6H*X! .Y%(";$]@^$_@F?P@MW#<2R7 >]:2.:5M\KQF"!5W'))*E
M3'DXSLW!54@5W597BOQ-#X7M9;ZY.(H8V=N5!..BKN*@LQPJ@D98@=Z\*^%W
MPW7XP6XUSQ"[W!FDF\BW661+>% RQ_*B[65MT1'#L&7:S[I,D<_#J5U\ M:@
MTX2O)H]UY03SW^6,,V)'#[%C1DD9G<*-K1LN_#%67TO]IR&XLM*FO[:[N8&@
M\DK'"ZQ(Q:58RS,J"4_+(?E$@3(4[<C)\O\ AI\$I_B=X?MUNKPPPQM)]ECC
M7<@/GR>;+,"09')+*@5E$:@'DNXKZ?\ #VFOI=M#;RR&9XX8T:5L[I&50I<Y
M+'+$9.23D]3UK0KY%^,]O=Z7XETZS%[/,))K&91<$/$LOGM$K"*$01X 49"A
M6.6^8%B:ZO\ :B^$%JFER:H&D:[@:'=++))*TB,^PH%+B.,;Y=^(T55(*HBJ
MW'0?"[PT?BMH]K<ZU+)-&86B^SK)+%$WERA!+*5?S)IB8MVYF"#/RQALNW'_
M +,>K3:+K6HZ"LCO9P>?Y0D9F*>3<^6-HR$7=YA,F%&Y@#Q@@Y7[9<-QI#6^
M+NY>*Z\\/ SJL $;QNBA(T0'!<_,^]_E7+?+7JO[4OCJZ\'Z2)+)_+DFN%A+
MC[ZJR2,Q0Y^5ODP&Z@$E<-AAGZ!^SYH>IV276BR212M#^XOHIIO-#8VER-ZK
MD\K(FU",L@"'[N?\8_$U]\./"]G% ?)N3':VLC @O'BW8R;&4D!LQ[0PS@$E
M2&VL-#0/V?-#U.R2ZT622*5H?W%]%--YH;&TN1O5<GE9$VH1ED 0_=Q/C=X#
M6U\*1O=JXNK2TL$"^=(8T=6CB<^6K^2S8=UW[2<'AL 5T'[+GAF+^QK.\W3>
M9_I'R_:+CR?]=*O^I\SR>G^Q][YOO<UGZ%X;U'QCXAN_[=MR^FVRN+:-QFT+
M%ML,@0L4E<Q-(68ABC-M.PA%7C_$7_%IO%EM!I/[JWU#[-Y\'6'][.\1VJ,;
M=N-R8/R,64?NR4K*_;3\,0:9-9W,8?S9_M/F,\LLO"F-E51([!%!D8A4"J,\
M#I7T?K+6_P .;*ZOPTC".%GVSW4\H9E!V(K3R2;"S$*-HRQ*C#$ 5Y!H%AH?
MCF!+_P 2W\$]U,OF>0;T106P;D1QQK)&R'9L$@8L2Z9+$Y+9_P "?&:^$M;E
M\-6]S]LT]][6L@*2!&\L3L ZMMV[=ZOM!!E 8*FYZQ/C/;W>E^)=.LQ>SS"2
M:QF47!#Q++Y[1*PBA$$> %&0H5CEOF!8FNK_ &HOA!:II<FJ!I&NX&AW2RR2
M2M(C/L*!2XCC&^7?B-%52"J(JMQT'PN\-'XK:/:W.M2R31F%HOLZR2Q1-Y<H
M02RE7\R:8F+=N9@@S\L8;+MQ_P"S'JTVBZUJ.@K([V<'G^4)&9BGDW/EC:,A
M%W>83)A1N8 \8(/2^*_&MMXSU:YTJ^O8[33;-4615NE@>ZE<#?&S'&857?'+
M&K!@Q!8DX">=?$U-+^%\EOK'A6[A$RR"*6V2<7*2(P9RS#S6?;\H5AG&2C*4
M=0S>H?'K59=1T'^V[&[NK<>3:RQQ1ND0/FN@RY13(3LEP5$FS*J<$C)RO@/\
M-8O&&@6HU&222VVW"K;([PP_\?+-OD\M@\KAU^4E@BJ0!'O!=N9_9CN[C3=4
MU'PY+,\MK%'.JG=(A4Q3^43'MD_=;_-9FVG=N"D-D9.+;>#K>U\=?88_,6(L
MS$K/.)=S61E=O-$GFY+DDG?DY(/!Q7K7[2/B>X^'FBJNG2.C27 A\QY))9E5
MUED8K)([/N^7 8DE5/R[2%*Q:!^SYH>IV276BR212M#^XOHIIO-#8VER-ZKD
M\K(FU",L@"'[OI_P]TN32--L[:==LL5I;QNN0<,L:JPR"0<$$9!(]#705POQ
MITZ6XTRYFAN9[<P6T\H\AD0NR)YB!F*-( "G/ELA(+!B0>/.OV0)9-3T>Z9Y
M'\V2_G)ER&DW-##F3,@<%LG.6# GJ#R*X06]VGC5+#[;/((VE,<DQ$S)YMF9
M)=B86)#R0@";%(3<CJNTV_VFOAM'X#AM=7T^:=+L3"&6=IIGN)2T)"R&0R?*
M0L;*0@4$/CA5 KZ5\$:V^O6%K>2@!Y[:"5@N0H9XU<@9).,GC))QW-;5>*_M
M8>&(+W1I[R0.98?(\O\ >RB-29E0MY8<1%MLC+N*EL'&>!@_9<\,Q?V-9WFZ
M;S/](^7[1<>3_KI5_P!3YGD]/]C[WS?>YKSK]HA7;Q;I8B(5RMCM9E+J&^UR
MX)4,I8 ]0&4D<9'6NE_:7^%<&GZ<VLPR3?;K:2!OM#RRO(P,FW"C>(XOWDGF
M#RT55(VHJ@\=!%\=)+'PM'KLJHUTT8C578*))1(82V%"YSM:4QJ!\H*@@#<.
M?_X0;PWKT._6M2AN[YX_GG:_3]VS#++"H9(UB60LT:M&0,X((^4'[+GQ#D>X
MNO#TLWVF.TWFUG !#11R>41N#ME?F1H@-V%++OVA /HJBOC#PA<G7O';-=8D
M*WMXHW*N ((Y5AXQC*B-,'KE0V=W-?9]%>*_'WQU)X=CM-"TAT@N[V2.%"N%
M$,1(B!&T[H\L0J,$.%639AU4B+7/V4M/D@9[22==15GECNWG?S6F^9D,A"E<
M;R"61%D^4$-NR3#^R_\ %>Z\41SZ9J9_TNSVC+G;.ZY96#HWS%HV4*[]3N4.
M-^6?SKXSV]WI?B73K,7L\PDFL9E%P0\2R^>T2L(H1!'@!1D*%8Y;Y@6)KJ_V
MHOA!:II<FJ!I&NX&AW2RR22M(C/L*!2XCC&^7?B-%52"J(JMQT'PN\-'XK:/
M:W.M2R31F%HOLZR2Q1-Y<H02RE7\R:8F+=N9@@S\L8;+MQ7[-VH3Z9J^I^'H
MYI/LL*W(A+-O>(Q7'EJR!@8@3YI9_P!V0S!21C(.)=0WT7C,:?%=S2NGG>3)
M<.)/*,]D7DD5 @C^4MN6-41&VJA*CYAJ_&S]GZ;PG"VNZ9>7DEU#\TSR2,]P
M4($>])(U5AM7[^[CR\G<H7#>M_"SXF3^.-"-[; 27\<,D;(W"M<1IE<\1+A\
MHY"D*H?;N^4D<I\%/AJ_BJRGN_%%L9KNXFD4-<J?-6''"HK8-N/,:0J$$9Y#
M#Y0AKG_V9=?GT?5[_P .JY>RMFN6A#_,Z&.X6/@C  8-N88QN^90I+;N?^,]
MO=Z7XETZS%[/,))K&91<$/$LOGM$K"*$01X 49"A6.6^8%B:ZO\ :-^$L6DZ
M:VL1SSM?VTT3_:9)7>4JTQ 10K)'$%>4,GEHH7;@ ;B:EM[._P#'WA:'4K:X
MN8]1CMV"F&XN%$H@DD0JR*S;Y712=P =I=HW!/EK0_9(UP^(;*6XN+B>:[CF
M:-_-NI9AL8(R,(F;:@." Q#,2KX?:=B]KIGA5;[5[F=9[HPP+ /*^U7 A^TL
MS3R90R<@1-!A!^YVN5VD@A?0+FT2Z&V10P#*P# $;E8.C<]PP# ]00".14M?
M,&A-9?%KQ!?V>O-YAMI)(;&V#O%'M21Q*XV$%I<(K-\V6!8[2J+Y?J'A#X0#
MP9JJSV32?8/L4\:P/(TD<$C2P.?+WN6 DVLS#!PRDEOF51Z?17QK\-]'NM9\
M5:K;VDWV</)?":5?]<L7VI=XB/192=JASG8I9P"P45;^,_PBNOA$RZYH]W<G
M,@%P[MOEW,^\.[*@5XF8 .)!@OMSOWX7W#6_CE!:^'QK\> 9(1Y49.?WYRGE
M?,8RX60-O*X)1&=>,5Q_@GX V_CJQCU+7I)KJ\N[<.)#,P6%9"\D8B4!57"R
M E&#QJX(5=N0<3X9^+;WX:Z\?#-[(9+*1L6LDSG<B;"8 CLJA@0HB** HE&(
M\$,'ZOXO^-I]:U:S\,:=.8&F;S+N6-MDJQJ#)Y:.NYD<HC,05&<Q?-L9P<KQ
MY^S%:Z%9&[T$SPZA;0LR.DLF^4@ /G:&;>R!PHB\L%GP1MX'7_LY_%>3XB:>
M9+HI]J@D\N3:0"PV@I*4&-F[)''RED8K@?*ODOP-NTL_%NL2RL$1%U!F9B%5
M5%W&2Q)X  Y)/ %>H:%X>E^(5\VL&:\@TTQA8(%N+B'[00"/M1174PQ$8\M1
MM:3 E;:&*O4_:1\3W'P\T55TZ1T:2X$/F/))+,JNLLC%9)'9]WRX#$DJI^7:
M0I6+0/V?-#U.R2ZT622*5H?W%]%--YH;&TN1O5<GE9$VH1ED 0_=]/\ A[I<
MFD:;9VTZ[98K2WC=<@X98U5AD$@X((R"1Z&N@KS7]H34-4LM+<Z*CM.TBHYC
M4M,L3!@S1@'=NW;1E06526&"-Z\?XQ^"-D?#CO=VX6_BLFN)9P0UP;A8FEE+
MR_,9 TA8,"67!^7&U"NK^S+XTN_&^C.;N4F6*:2!9@ 9=HCC97)<,K.-_5E(
M; +ACN+>5"WNT\:I8?;9Y!&TICDF(F9/-LS)+L3"Q(>2$ 38I";D=5VFW^TU
M\-H_ <-KJ^GS3I=B80RSM-,]Q*6A(60R&3Y2%C92$"@A\<*H%=K\6/B[=II&
MGPV:E=1U>&$1M&1&J,ZPF3:7)(),H1#D%02^\,HSJVW[-=KI$'GVDDG]L*K.
ME\TL@=ISEMSJ2Z%&8E74HY,9()9B6/G7[#'_ #$?^W3_ -N*^JJ*^0/CE#?:
M1XBL+2&[FN&>2SGC6Z<>0)O.:)"8X$C15^4;MB!N6.237HM[\*3\-[J3Q3+?
MR3/%;2M<)+MC%Q(8V4('5@L:%_+$<6R3:555)^7&5H%AH?CF!+_Q+?P3W4R^
M9Y!O1%!;!N1''&LD;(=FP2!BQ+IDL3DMG_ GQFOA+6Y?#5O<_;-/?>UK("D@
M1O+$[ .K;=NW>K[0090&"IN>NUUV[D^*6LRZ1',Z:98QK]L\I@IGE?</LS.D
MF[RMNX. !\RR(V&\MEROB#^STWAR-+WPBKV]]'(-RK.X$L9()4^<S*V&56VL
M51EW!@QVBK7QG^)=]86MAI,#)!JVH^2DFTC$&_:DA!5W9,RMM1P'^59"K;U4
MU-KG[*6GR0,]I).NHJSRQW;SOYK3?,R&0A2N-Y!+(BR?*"&W9)A_9?\ BO=>
M*(Y],U,_Z79[1ESMG=<LK!T;YBT;*%=^IW*'&_+/YK\<H;[2/$5A:0W<UPSR
M6<\:W3CR!-YS1(3' D:*ORC=L0-RQR2:]0M_@V? E\_B::_GG,5M-)=H47=.
M1$Q8+M=%5!A3'$0P4HHW8 *\_P##'X>CXS"77-?\R6&6:46=J96$4488*6!B
M9#G*>7T3=L+N'+J5\_\ B#X5?PMXKTVT\PO;K-8_959B[QPFY.(BQ )"R;PF
M2Q$>Q2QQ@>J_M4^-'TD6.GO*8;.]F=;R1 ?-$*-$'52 V 5D8L I+8"\J65I
M?%?[-VG3Z?+)X?WP7$ENQC>&XD9)T9=WD-OE*-%)QSD#.UB2H*M[K17D'[3D
M-Q9:5-?VUW<P-!Y)6.%UB1BTJQEF94$I^60_*) F0IVY&3S_ ,!/AW!XO\.V
MT>HL\MN?."0*\L,8 N)&)<12+YK%QD%OE4!0B*V]Y//_ -G>PNK34M2\-1W3
MQVZ^=OEC&V;,,@@+1;F9(6?>-[;7;:H"E6"NLO[0NAQ_""_LM3T<R12S-,TP
M::9UE,<D4AWEG,C!RW[P%\, . <D]M^UN)O#MI%J-E=74$KW*Q.L=S,L3*8G
M.=@?:I'EC&P*#N8L&)!'I7A?2#XLT2R6XFG5WLK=C-%-+%-O: 9<NC L<L6P
M^Y2V"RG%>2_L:^++SQ!]O^VW$T^S[+L\V1Y=N?/W8WDXS@9QUP/2JFA-9?%K
MQ!?V>O-YAMI)(;&V#O%'M21Q*XV$%I<(K-\V6!8[2J+Y?I7AOX+KX6U+?:/,
M-/>PN(1"9I-L#O) Q\IC)YB^8 S$KRKJ3O\ F0+XA;>#K>U\=?88_,6(LS$K
M/.)=S61E=O-$GFY+DDG?DY(/!Q7UUI>F+ID:PQERJYP9)))GY)/+RL[GKQDG
M P!P *M5X!^VM_R!X/\ K_C_ /1,]5-"^ LGQ%T>T?4[V93]D@^SPPD"UB40
MA86:-E)DEP2TC;E)W&-2%5365^S9XVO/#6IS^&-5D=F7*V^XNP4Q+RB;DW>4
M\0#IDJ@5!M7,E=+XK\:VWC/5KG2KZ]CM--LU19%6Z6![J5P-\;,<9A5=\<L:
ML&#$%B3@)YU\34TOX7R6^L>%;N$3+((I;9)Q<I(C!G+,/-9]ORA6&<9*,I1U
M#-]7^'M;37K:&\B!"3PQRJ&P&"NH< X)&<'G!(SW-:%?*O[<_P#S#O\ M[_]
MMZ[#QY^S5/XZ@-Q?7TCZCM9D7.+"-SC]W'&5+JFU0A?.YB/,96;*FK^RC\4;
MG61<:1J;R-=V[,ZF4L9=FX)(C;ER"DA'WV+?/M "IQPGQRAOM(\16%I#=S7#
M/)9SQK=./($WG-$A,<"1HJ_*-VQ W+'))KTIOA,OPYO6\476HS2^5;R-=JZH
M#.Q0KM4AT55+;/*A(8!E10WW=N5\+OANOQ@MQKGB%WN#-)-Y%NLLB6\*!EC^
M5%VLK;HB.'8,NUGW29(Y^'4KKX!:U!IPE>31[KR@GGO\L89L2.'V+&C)(S.X
M4;6C9=^&*LO3?M;B;P[:1:C975U!*]RL3K'<S+$RF)SG8'VJ1Y8QL"@[F+!B
M01Z5X7T@^+-$LEN)IU=[*W8S132Q3;V@&7+HP+'+%L/N4M@LIQ7DO[&OBR\\
M0?;_ +;<33[/LNSS9'EVY\_=C>3C.!G'7 ]*M>/O&<WC+Q-%X8D9XK%<^>(G
M9'GS:F8H[+@B(@["@Z@LQ;.S9E?M2^#H_ T-OJNC'[#*9#;2"VS;[U<-*I/E
M,H^4QG/RY;(R?D45[?\ "NT5K"WO,R%[FVMY7#SW$ZAFC#D)]HEE*C+'H<D8
MW$X%?.'[&NB-K'V^-I72'_12ZQL\4CG]_L'FHRNBCDL$PS':"X0.DFA/;#X,
M>++>TT[(L[Y;=7M]S;0)': 99S(6*R*90>#AC&"%))S_ -M/PQ!IDUG<QA_-
MG^T^8SRRR\*8V55$CL$4&1B%0*HSP.E?56A>&8M$W>4TS;\9\VXN+CIG&//D
MDV]>=N,\9S@8U:X#XZ>&(-;TF[:<.?*M+B1%$LJ)N5"ZED1U63#(I <, 1P.
M3GRK]CGPS%?Z;)<.TP=+]\!+BXCC.V.!ANCCD6-^3SN4[A\IR !6KXSUN3XI
MZZWARWN'AL;>WD:\:%PDDC8V-&''F!E4R(KHP49\T,"53&5\7O@BOP[MSK7A
MHS6T]OL,J))(ZM$&R[%6#LV&V,ZLWE>6C%ER.?7_ (.?$/\ X6!ID-^P196W
M+*B-N"NK%2/5<C#A3DA6'+<,>UK*\3>&(/$L)MKH.8FSN5)98=P(*E6,3H64
M@D%22I[C@5\J_L:^&8M;^W^:TR[/LN/*N+BWZ^?G/D21[NG&[..<8R<ZO[<_
M_,._[>__ &WKT#XY?!Z#7-+N;NZD>2]@MY9EE+2^6I0"1TC@\WRHU94\L<,P
M&&=I) 6:I\%OC))/X;FU*_.^2R\Z,O)(%,Q1%>(%BO#-O6($[F9@&)9FQ6+H
M%AH?CF!+_P 2W\$]U,OF>0;T106P;D1QQK)&R'9L$@8L2Z9+$Y+9_P "?&:^
M$M;E\-6]S]LT]][6L@*2!&\L3L ZMMV[=ZOM!!E 8*FYZ^GZ************
M************************************************************
M*************^6YK1X/B$K.I4.NY"00&7[ R;AGJ-RLN1QD$=0:]5_::M'N
MO#]ZL:EB%A8A02=JSQN[<=@H+$]  2>!1^SEX\@\5:1;I$0);:&."6/.64HN
MQ&.0.'5=P(R,Y7<2C5W6J^)H=,GM[60_O;J1TC4%<_)$\KL02#M 3!(!PS(#
MC=FM6OEO]AJT=4U"4J0C-;*K8.TLHF+*#T) 921U 89ZBOJ2BOE7_FH?^?\
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MA/,?#?C:^MKE2'N6O!'C:P =UNT8D-P#$N>,D$@$#G'T+\6/^0/J'_7A=_\
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M50,EB3P !R2> *^:OV'M$>&VO;PD;))HHE'.[=$K.Q/&,8F7').0<@<9S_\
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M,Y7<2C5W6J^)H=,GM[60_O;J1TC4%<_)$\KL02#M 3!(!PS(#C=FOFKX^_\
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M%!LKA06( W-&R(O/<L0H'4D@#DUY!^S5K:> ?#,^IWP*P&YEE4KAV=<10
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M2,]S6A7E7[4?_(NWG_;O_P"E$5'[+G_(NV?_ &\?^E$M>5? +_D<-6_[?_\
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MYM*MH%W2RR7,:+D#+,;=5&20!DD#)('J:Z#]M;_D#P?]?\?_ *)GKU7X3_\
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MI%W G#!2 %R7.6KU#X1?!V7P@[7VHW4E[?O"L1D=W98X\AVB3>Q+#S.=QQD
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M%O!T?A&Q33[ [5BC81M)F3YB2Q=@&3=ER68*4')"[1C'E7_#.U]_:_\ ;_\
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MO?#&/XD6)L9'\MO,22.3:7V,IP3M#INRA9<$X&[.,@5S7P^\":[96T-AJ5W
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M'(D7)4$Y5_EVY^I_#GQ!XWMQINM7-FEH?*,KVR2-<2[&5MI\P+&FXC<61>&
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M[MT Z=N22<  9+$@ $D"N?\ A)XX?QSIL.HR((S,TV$4DA56:1$&3U.U1DX
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M%.V221I$X'&UAM/S#!)-?32_#VV5#'ONL,RL3]MO2V5# 8;S]P'S'(! 8X+
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M2*/S"HR+>3";@9<-B1A<!0(FSA5#>7M+LW"_M"VB?![4;+5M$46\LRS++$H
MMW6/ROE,:X #!OF P,JKKMD!<^M?M1_\B[>?]N__ *414?LN?\B[9_\ ;Q_Z
M42UY5_S4/_/_ $#J^JJ\@_:<AN++2IK^VN[F!H/)*QPNL2,6E6,LS*@E/RR'
MY1($R%.W(R>$^#_PD/Q$T"UCO;J>*T"S*D%O(JJY^TRNTDNZ,[CNVA$^8($W
MAMTA5<7X4:S>?![7AX>OYGDLYL)"3O$69#NAD12K8W.3&X0A [,69O+S1^V7
M#<:0UOB[N7BNO/#P,ZK !&\;HH2-$!P7/S/O?Y5RWRUZ+>_ R>6]M_$%_J12
MZMV$MQ@8MEC4[C#$2R-%"$WHS.7W@L[@%F!Y_P  Z,/C]+<ZGJCR-I\5SY=K
M9J[11X5&.^5$)R^V53O63.[>I_=A5KG_ (@65S^SK>P7FDF1],G9_,MI'9H@
MY.63.W"$QA?*<EI/W;;BR AO</B]"VJ:3/=VEW-"L=I-.C6SQJ)-J>;&?,V,
M^WY1_JW3<K$$D$8\D_9:\-'QGI5U]OEDDADO9M\:R2QM([Q1>8\LB.'D!4XV
M9"DEVD$A*>7S7@/2YO ?BZXT33I?+@N-RD[6?8AB^U)M5G*F5%S&DDF\#+,R
M,&*G5_:7^','@.VM]7L);E;[[0D+W#7$KS2 P."[,S$AL1X^38NUF7;C:%]5
M\8W5QXE\.C45N9K67^S/M+"V*QAG\E9@-S*\JJ&&,(ZDJ2&+9KR7]G?P5/\
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MVTZ0'=]GN# Y!4KO$<<C $$_=\P*V<$.K CC)^:OV&/^8C_VZ?\ MQ1\??\
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M?\B[9_\ ;Q_Z42UY5\??^1PTG_MP_P#2R2O5?VH_^1=O/^W?_P!*(J/V7/\
MD7;/_MX_]*):\J^ 7_(X:M_V_P#_ *61U]54444444444444444444444444
M44444444444444444444444444444444444444444444444445X+J'P2U7P]
MKDVM:#+:JEPK>9%<>;C<Y#2CY5<D&11("K(03LQL&&B^-_[/&H?$+R;A;Q'N
M(]RM&ZM#:JIYS$J^<ZMP-^]I"_4,BHJ5Z5XN^'LGC'3)]-OKC+SX/F1QB-$*
MLC(%0L[;=R L&D9F)?#H"H3E?@G\.=:\&6ZV%Y<VWV6*3<@A1GF(+%WCWN$5
M5+=28Y'*NX5HR$9<2+X%:GX:UV76-'N(!%<LYF6X5V8"5]\JA4"[@& =,/&<
M@(QP"S=W\0_@_#\0+$6E^^ZX7<T=RJ*K1NQR=J@_ZKHOELQ)0+N<R 25XUH/
M[,OB'2G%M%JQ@LE9]OE2W(8*2S B$%$!9CE@), DG+$<^Z6/@-_#>G1Z9H\P
MMQ&I5998S<L-VXLX'F1KO+MOR<H#D>7MP!POP?\ V?[KX8S/);WZ213>6)HW
MM<;@A)!5A<95@&8 _,OS99&P,'Q%_9_NO&>I1ZK]O2"6#8( EKNVB.1I8RV^
MX(=@6Y.T*V/N#I4OQQ^!US\2K2 &>,7MNTFUMC16[K(5W KNF="%5<'<P)!!
M # IV'AG2M:2W'VZZMC=",*-D#-#G<,R/F2-I&*KP$\A%9VRK@)M\_\ !?[.
MU]X2U"35H=21[B;S?-\RS!1_,;>V0EPF/G 8;"N" /NY!V_C;\!A\0'BOK68
MVU_ N(Y/FVL%+/&IVD%")#D2+DJ"<J_R[<_4_ASX@\;VXTW6KFS2T/E&5[9)
M&N)=C*VT^8%C3<1N+(O#  (4)6O55T9M-M5M=/*1>5'''%YBO,BJF% *^9&S
M?*, [P<X))Y!\?\ !?[.U]X2U"35H=21[B;S?-\RS!1_,;>V0EPF/G 8;"N"
M /NY!UOC7\!YOBE)$9+M(8H-_EJ+=G?YQ'OW,;@!N4R,*N <'/6O2O#-E=64
M(COIDN)1@>8D7D;@ !EE\R0;B022NU><!!CFWJVEQZO#);3KNBEC>-UR1E6!
M5AD$$9!(R"#Z&O"O"7P5USX932KH=U;2V<OS>5>"4;6SP0(0<L$ !<% _P#%
M'\J$=U\._A6^AW=QK&H2B?4;I55V13'#&@"?ND7)+ %%&]_F*JO"L7+97Q=^
M#-[\2T6WFOHXK=)FD1$M26S@JF]VN3N*JQ&5" DDE?N[>J^'7A.]\+016=S=
M1W$,,(CC(MS#+A<!,L)W0A4&W 0$\$L3G=V%>2_M#?!)_B?!#]GE$=Q;L^P/
MGRF639O#%59@1L!4@$<%2/FW+TOAG2M:2W'VZZMC=",*-D#-#G<,R/F2-I&*
MKP$\A%9VRK@)M\_\%_L[7WA+4)-6AU)'N)O-\WS+,%'\QM[9"7"8^<!AL*X(
M ^[D'6^-?P'F^*4D1DNTAB@W^6HMV=_G$>_<QN &Y3(PJX!P<]:U?&/P;_X3
MS3Q9:O,DMS'S#=1P^2Z':HW%?,<-N(S(H*(PQM5&56'DN@_LR^(=*<6T6K&"
MR5GV^5+<A@I+,"(040%F.6 DP"2<L1S]%>"_"$'@ZTBL+0$11*0NX[F))+,Q
M/J6))P  3A0!@#:K@/BO\$['XD1G[0NRY6,K%<+G>G.X C(#KG^%N@9MA1F+
M5RFA>#_%GA7=!!>V=[ ,>6]X)Q,.K-GR]S'YF(^:23Y57;M&5KL-#\$7MU.M
MWK%T)RJH8[6%#%:1R#:68@NSSD.@:-I?N-EU56*[+7Q5^&<'Q&LFL;@E#N#Q
MR+R4D (5L9 888@J>H)P5;##@/"'@3Q3X6@&FPW=D]LK,D<\BS/<QQ'A2J8$
M9*CYD1V90?DWE  ._P#A5\,X/AS9+8VY+G<7DD;@O(0 S8R0HPH 4= !DLV6
M/G7C3]G:^\6ZA'JTVI(EQ#Y7E>79@(GEMO7 >X?/SDL=Y;))'W< =M\1OAY>
M>.=..FRW4*>9CSI%MG.[;(LD>Q3<_)C;AMQDW=1MZ5#\+/AM>^ ;0V O(YHE
M63R=UL49'<[ADK<?.@8L2N Q+8$B@ #E?"W[/E[X9U.;6+?4(_.N&F,B-9DQ
M$2OYC+C[5O #X(PP/ !)&0?+_%.CR:QX[>""9[>4[2DR8+(RV =20>&4E0'0
M\.A921G->H>)OA?K_P 10EIK-S:V]D&#2)9"8O*0RD(WG<  9*GD!L$QN0I7
MT_4/#TUK9I9:7*EKY<:QH[QM<;$5"B[094RP^4AG+CCYE;->:_!_]G^Z^&,S
MR6]^DD4WEB:-[7&X(20587&58!F /S+\V61L#!\8/V?[KXG3))<7Z1Q0^8(8
MTM<[0Y!)9C<99B%4$_*ORY5%R<GQ>^!=Y\0=/AAFN89+ZWDS',8G@1D95617
M59)0&8J'+*N,J$5$!)K5E\!:UXLT^2PUB\AB+QE-UG&V]_E #2/(5!5CGS(X
MXX]PP!(JED.5\%/A!JW@"S>U:ZME)N&E4+#).I)2-/G9GA)7"DA4",'"L92N
MZ)JG@O\ 9VOO"6H2:M#J2/<3>;YOF68*/YC;VR$N$Q\X##85P0!]W(.M\:_@
M/-\4I(C)=I#%!O\ +46[._SB/?N8W #<ID85< X.>M:OC'X-_P#">:>++5YD
MEN8^8;J.'R70[5&XKYCAMQ&9%!1&&-JHRJP\:T']ESQ#"@LI=3$-D5=62*:Y
M==K!B5$16)"&8_,"P&"3R>#]'^%O MKX:L4TN%-ULD;(5D_>;PQ)DW9&#N+$
ML,!>2  N / /$7[)E]HUTUSX<O?LZ2;@4:2:%T4[3Y8DB#M(NX$X8*0 N2YR
MU>H?"+X.R^$':^U&ZDO;]X5B,CN[+''D.T2;V)8>9SN.,@#")EMWI]9^OZ!!
MXA@>TNT$D,B[71NA'7MR"#@@C!4@$$$ UY+H_P *=:^'N(-!O(9K,[R+>^5C
MY9.PEE>!0QRP8[?D1=Q.UF):C6/A3K7Q"_<:]>0PV8V$V]BK#S"-Y#,\ZEAA
MBIV_.C;0=JL U>JZ7X=CT"U6ST]4A2.,K$-I9%/."PW*S_,=S?,&<Y);))KQ
M_P :?L[7WBW4(]6FU)$N(?*\KR[,!$\MMZX#W#Y^<ECO+9)(^[@#U7[%J7D[
M?M%MY_F9W_99?+V8^[L^U[MV[G=OQCC9GYJ\J\%_L[7WA+4)-6AU)'N)O-\W
MS+,%'\QM[9"7"8^<!AL*X( ^[D'T7QYX3O?$]D;&*ZC@,L+1SR?9S(6# !O+
M!G C!&X$-YA ;A@R[CS7P8^#=U\,E:W6]2>U>0R-&;;8X;9MRKB<XSA<AE<8
M7"A22:X#XA_LIW'VX:AX<G2T+;BR%Y(?+8C!,31*Q"L"<IP%Y"G:P5.J^$OP
M"N- NEU76;M[R^2-DBR\CI$#O!P\AW/E6. 555+/PQVL.@^,_P "[7XG1J7;
MR;J/ 2<+N.W.3&RY7>O)(&05;D'!=6\J\,_LSZ\^+74-5=+$1A#%!/<2;DX4
MQ!9 B*I3(SA@.!L89Q[_ *AX>FM;-++2Y4M?+C6-'>-KC8BH47:#*F6'RD,Y
M<<?,K9KS7X/_ +/]U\,9GDM[])(IO+$T;VN-P0D@JPN,JP#, ?F7YLLC8&/:
MJ\J_:C_Y%V\_[=__ $HBK@/@)H^N6>C6T^CS6SQ3><7AO/-*Q,LTB9A,/.UP
M 61N X+*?G8#T7X3?!M_"D\VJ:A<&ZU*Y4"27E453M+1J,\C<H 8A0%5%1(P
M"##\9_@W=?$U5MVO4@M4D$BQBVWN6V;<LYG&<9; 54&&PP8@&NK^''A6Z\*V
MJ65S<)<I#&D<3"'R'"KD -^]=6PNU00%.%RQ8DFO/_BK\ )M;OEUS1KG[+J"
M[2=VXQN5"H&R-Q3]V"K+M=)  I49<M+JWPKU7XB&*+Q'+:K:0S"7R+-9<S-M
M9</)*0R 9Q\G+!FY5@C#N_B/X5NO%5J]E;7"6R31O'*QA\]RK8!"_O45<KN4
MDACALJ5(!KE/@Q\&[KX9*UNMZD]J\AD:,VVQPVS;E7$YQG"Y#*XPN%"DDUBW
M/[/E[-K'_"0+J$:76Y3M6S)BP(A"5VM=,V&08/S9Y)4J<$=!\8/A%<_$NVBL
MY;J.)(VCD8K;LS-*JNA89N %0A^$(9@1_K#7'_%SPK=>%?"=S97-PERD,=I'
M$PA\APJW$0 ;]ZZMA=J@@*<+EBQ)-97P$T?7+/1K:?1YK9XIO.+PWGFE8F6:
M1,PF'G:X +(W <%E/SL!Z+\)O@V_A2>;5-0N#=:E<J!)+RJ*IVEHU&>1N4 ,
M0H"JBHD8!!J?M#?!)_B?!#]GE$=Q;L^P/GRF639O#%59@1L!4@$<%2/FW+MZ
M7H.O2VJK<WUM'=>64+1VQD3G(\T[Y8]TO"LN%2)275HI 4*<I\'_ -G^Z^&,
MSR6]^DD4WEB:-[7&X(20587&58!F /S+\V61L#'M5>5?LZ?#R'PA8R20'>EU
M<231.RJ)#;YQ;;F&"<Q@28(7:9&4HISGU6BO%?B+\$+RZU>/Q#HLT,5VNP/'
M.',;X1HV8L-Y&8]L>U57@%PX?FHOB=\$M3^(=I%%>7D?G?:8G945X[:&/RBD
MHC3+/,^\[@TK#C(3R0S!L_XN>#9_"7A.YM9[I[KRX[2-,QQ1(BI<1*H547=]
MW:"7=R2N01DBLKX":/KEGHUM/H\UL\4WG%X;SS2L3+-(F83#SM< %D;@."RG
MYV ]%^$WP;?PI/-JFH7!NM2N5 DEY5%4[2T:C/(W* &(4!5142, @U/C;\!A
M\0'BOK68VU_ N(Y/FVL%+/&IVD%")#D2+DJ"<J_R[<_4_ASX@\;VXTW6KFS2
MT/E&5[9)&N)=C*VT^8%C3<1N+(O#  (4)6O55T9M-M5M=/*1>5'''%YBO,BJ
MF% *^9&S?*, [P<X))Y!\?\ !?[.U]X2U"35H=21[B;S?-\RS!1_,;>V0EPF
M/G 8;"N" /NY!UOC7\!YOBE)$9+M(8H-_EJ+=G?YQ'OW,;@!N4R,*N <'/6O
M2O#-E=64(COIDN)1@>8D7D;@ !EE\R0;B022NU><!!CD\5^&8?%%K+8W(S%-
M&R-PI(ST9=P8!E.&4D'# 'M7@'A'X >(_ DC0:5J<*6<DB,Y:/<_0!G$3QRH
M&ZCB0;PJ[F&!MEA_9=O=-UAM2T^]%NBKF*5P;NY:1HE29I%E"H2[-(Q;<<$C
M"C^'M?BY\%;OXC11VLE^([>)E8#[,'E=PFS?(XE12>7(")&HW8*G"D&J?!Z]
MO]#;09;N.4;;:.*7R#$R1QS(S;@)7#D1J%0 )DJ-[$L7$O\ 8WBJW_T9;NQD
MBZ?:GAE2Z ;JXB0^1N3)" G:VU=_4UK>"O@G8^&M+;1G7SX9<M.7S^\<A07
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M&.WY$7<3M9B6HUCX4ZU\0OW&O7D,-F-A-O8JP\PC>0S/.I888J=OSHVT':K
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M_2.*'S!#&EKG:'()+,;C+,0J@GY5^7*HN3GU7PS975E"([Z9+B48'F)%Y&X
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M44444444444444444444444445P'Q*^*\?A*XLK&,H]U>7=O'L).4B>0*\I
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M;@,I ^;YD\U^(OP_\,Q64MWIVH1KJ4*F=+@7HFGEE0%^09>7=AG<@5A(0R\
MH?1?@QXD'Q<TN*YO6F%Q!))#(T,TUJKL C;\6\J;LH4)R  ^_8JJ>?'_ -C7
MPS%K?V_S6F79]EQY5Q<6_7S\Y\B2/=TXW9QSC&3GZZM+86J+&N2%4*"S,[8
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MB4KY_P#V&/\ F(_]NG_MQ1_S4/\ S_T#JT/CAXF'@OQ9INIW"'[.ML$9\,%
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MQK;0ZEK,Y<3PB1;2$M#9JDBQL%=0=\Y*CYUE9X_G= A7D^2?L,?\Q'_MT_\
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MVPQ<;L$*9,.ZF1@QSU7[+G_(NV?_ &\?^E$M>5?L,?\ ,1_[=/\ VXH^/O\
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M)>O*OV*?^0//_P!?\G_HF"O?Z^8/@QXQC\+^)M6T^\'E->7;F)GRF6$LC1H
M5_Y:)+N0D@'"A=Q=:^FKN[2S1I96"(BEF9B%55 R6)/  '))X KQ_P#:"UM-
M>\*37D0(2>&SE4-@,%>:!P#@D9P><$C/<UH?LN?\B[9_]O'_ *42UY5^W/\
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M%VHK,Q55W'/HO[:W_('@_P"O^/\ ]$SUV%I:/>>$EBB4N[Z&%55!9F8VF H
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M\F%4@QD8RQ<DUPOPK_9\O?AF\KV6H1L)E4.DMF64E22K#;=(P(W,.N"&.02
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MT<N[=@LD[!D(:13N1F4R;@3L5:Z#P'X$UVULAIFHW<$<$<*Q)):*_P!KV $
M"20+'&5 50PB=BN3E9,25B? OX#ZA\-YKD-=0FWEDA/R(S3.L1D(!+X2+=N
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M\-H9FR(Y5&!A]H8AE'W7 )(&Q@1M*<KX=_9CU369%'B/47N+6.17$"S3S!R
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MK@,IVJ$'*_LV>%+7XCV-[J&L1)=74]V\;RRC<^T0QX"'_EEC><&/:0-H! 1
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MP !DDGU-?6E%17=VEFC2RL$1%+,S$*JJ!DL2>  .23P!7%?"3XF#XAQ75S&
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M8]/-A20L-I RH!QAOIJBO,/V@=7G^Q)I=C@W6HS"V0$\K&P)GD*['8HJ#:[
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M5Y54,,81U)4D,6S7FO[,/A1O&VESF^GF:!K^<R1([QF9G@C60S2*WF.I# A
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M(J:$UE\6O$%_9Z\WF&VDDAL;8.\4>U)'$KC806EPBLWS98%CM*HOE^H>$/A
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M@K-\N[)P 22PR>E_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\]?
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M+*478C'('#JNX$9&<KN)1J[K5?$T.F3V]K(?WMU(Z1J"N?DB>5V()!V@)@D
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M6 **-[_,55>%8N6]%KQ#XC_!*_N=:A\0:)+!'.JCS5G\S:S!?+S\JOD-$=C
M!"H7<IW,2#XN?!+4_B191K<7D8NHV5A"BO%99(P^<F65G&3MD/&T;1$A=VK:
M7X8:I/I*Z2]]#&#:1VS[+4R (J!"$+3*2S#<KNPPR[3''"P8L?!CX-W7PR5K
M=;U)[5Y#(T9MMCAMFW*N)SC.%R&5QA<*%))K%N?V?+V;6/\ A(%U"-+K<IVK
M9DQ8$0A*[6NF;#(,'YL\DJ5."(?C+^SG-XTFBU.RN$@U"..,.P1HHY'0@K*&
M0O)&P&<$F4X6-<C;N-#Q'\"M<\::?+%K%]'/=!E^RHN8K9#N0O*_EPHSN4#(
M@*$(&8C)?*=U\$_AA>^ +=;:ZO?/B6/"0+$B1QLS&20[\&63YB0I)48)RG*A
M?2J\E^-OP&'Q >*^M9C;7\"XCD^;:P4L\:G:04(D.1(N2H)RK_+MS]3^'/B#
MQO;C3=:N;-+0^497MDD:XEV,K;3Y@6--Q&XLB\,  A0E:]0ET273K:*UTUHX
M1$J(OFQO<*(T7:% $T39X'S%CP#D$G(\D\%_L[7WA+4)-6AU)'N)O-\WS+,%
M'\QM[9"7"8^<!AL*X( ^[D'T#QUX1U#Q/:O91W<,*2V_ES,+5G<ELB0INN0J
M*RG:%(=E!)#YP1S7PB^#-[\-$:WAOHY;=YED='M2&S@*^QUN1M+*H&6#@$ A
M?O;I?C/\&[KXFJMNUZD%JD@D6,6V]RVS;EG,XSC+8"J@PV&#$ UM^%_AL]MI
MW]CZI+'>VPA2)1Y!A;8N<!B)7!*@*$90C*5#$L_S#PI_V4];\.SS?V+J AMW
M8;3YT\$K*,[1((8RK%=Q .<'[P"[BH]P^$/PAC^'<<Q,SW%U<2;YYWR"Y!8K
M\I9L8W$DDLS,Q).-JKPGQ@_9A'B:Y_M/2)1:WFX.P^98WD# B4,F6C?J255M
M[ '"L6=CX=?L^ZC#/%=>(-0DNA!,)8K<33R1>8N/+E+2%3E26^4*.V7*ED/2
M_&?X-W7Q-5;=KU(+5)!(L8MM[EMFW+.9QG&6P%5!AL,&(!KJ_AQX5NO"MJEE
M<W"7*0QI'$PA\APJY #?O75L+M4$!3A<L6))KA-,^&VN^%);JXTRZM7%U>W,
MYMKB)_*7S')$@EC/F%]BH"N @RW4@,=;PI\*[F?45UW6I8Y+U(?*AB@5DMX5
M^<$@L=\A97)^? 4NPPP"%?3Z\:^.GP2N?&=S::GI<L<-[;,/FEW;2JMYD9&%
MD7*/DX*88.=QPH!F\=?"W5OB%ICVNH7<,4_WECMDD6V9E8E1*TC/)(N "-HC
M",2Q64JF)?AQ\,M7\*Z7'IXO8(GC655*6[3*OF.[E\O)&7<$@H=J(H+J\<N5
M9<_X/_L_W7PQF>2WOTDBF\L31O:XW!"2"K"XRK ,P!^9?FRR-@8[7XK_  HM
M?B1:FVN1MD7)AF R\;'N.F5. '0D!@!R&"LOB&@_LR^(=*<6T6K&"R5GV^5+
M<A@I+,"(040%F.6 DP"2<L1S]%>"_"$'@ZTBL+0$11*0NX[F))+,Q/J6))P
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M=TLUO)P6VJWDJROM4_>^7)+811U]P^%?PL'@5)7EN)+N[N&4SW$I;<X0%8E
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M-QEF(503\J_+E47)SVNK>$=0U?39-/GNX6EEC>)Y_LK#,;1F-OD%R )226W
MA.PB[US7PC^"$_P^BDLVNX[FRF9FDA>UP2638V&\YAA@%#!E<$+@!223YUXB
M_9,OM&NFN?#E[]G23<"C230NBG:?+$D0=I%W G#!2 %R7.6KU#X1?!V7P@[7
MVHW4E[?O"L1D=W98X\AVB3>Q+#S.=QQD 81,MN]/J*[M$O$:*50Z.I5E8!E9
M2,%2#P01P0>"*\*U+]FZY\-3O>>%[TV194_T=]TD#,,J2S,9,C:Q*ATD(?)4
MJ"-O5PZ9XIU,-%<7.GVH*_++;PS3RA@RG&V=ECP1D$G<1V&3N7NO#/AN/P]"
M((R[G@O)(QDFD; 4R2.W+,0H&>@4!5"JJJ/'_$WP O-+U0ZYX>N4AGDD+30S
M[S"^\EI<LNYBK-@^65X;+(ZE4"[=I\*[_P 4WMMJ/B&6!C9LS6]O:K(L6_*,
M)7DD/F$Y4?)C;\B'."ZMV'Q'\*W7BJU>RMKA+9)HWCE8P^>Y5L A?WJ*N5W*
M20QPV5*D URGP8^#=U\,E:W6]2>U>0R-&;;8X;9MRKB<XSA<AE<87"A22:Q;
MG]GR]FUC_A(%U"-+K<IVK9DQ8$0A*[6NF;#(,'YL\DJ5.".@^,'PBN?B7;16
M<MU'$D;1R,5MV9FE570L,W "H0_"$,P(_P!8:X_XN>%;KPKX3N;*YN$N4ACM
M(XF$/D.%6XB #?O75L+M4$!3A<L6))K*^ FCZY9Z-;3Z/-;/%-YQ>&\\TK$R
MS2)F$P\[7 !9&X#@LI^=@/1?A-\&W\*3S:IJ%P;K4KE0))>515.TM&HSR-R@
M!B% 545$C (/*:A\$M5\/:Y-K6@RVJI<*WF17'FXW.0TH^57)!D42 JR$$[,
M;!AHOC?^SQJ'Q"\FX6\1[B/<K1NK0VJJ><Q*OG.K<#?O:0OU#(J*E>B^+?!>
MH^(;*2R-[&AG619G%KD!&"KLB4S_ " J&W%VE8EV*-& H7$^#'P;NOADK6ZW
MJ3VKR&1HS;;'#;-N5<3G&<+D,KC"X4*236+<_L^7LVL?\) NH1I=;E.U;,F+
M B$)7:UTS89!@_-GDE2IP1[5:*ZHHE(9PHW,JE%+8Y(4LQ4$] 68@<9/6O+_
M -G3X>0^$+&22 [TNKB2:)V51(;?.+;<PP3F,"3!"[3(RE%.<^JT5POQ;^'\
M_C6*UCM9Q;O!>QW E*>85,:2;"$.%8[V7AB!C)YQM/-:MX1\3:_#)IMS<V*V
MLL;Q/<I%,;ID(*EC&S"$,XX< @)N8H<A:]%\%^$(/!UI%86@(BB4A=QW,226
M9B?4L23@  G"@# &AJD<TL;"V=$EXVM(C2H.1G*K)$3QD###!P><8/BG@O\
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MA3@+NROW]I*U#\+/AM>^ ;0V O(YHE63R=UL49'<[ADK<?.@8L2N Q+8$B@
M#E?"W[/E[X9U.;6+?4(_.N&F,B-9DQ$2OYC+C[5O #X(PP/ !)&0<_P5\$-8
M^'6H7,FCS68L;B1?DF$SNB!B5PJX+,@9E7,H#CEL$C:>.OV>-0UK5K76(;Q)
M)(Y(7E$ZL$0QN' ACC_Y9=<1LX;.2TS,[..@^*7P3OOB+#':W.H(L,<GF86T
M&XN01R?/'RKN81J "$($C2N/,/:_#CPK=>%;5+*YN$N4AC2.)A#Y#A5R &_>
MNK87:H("G"Y8L23755X!X*^"&L?#K4+F31YK,6-Q(OR3"9W1 Q*X5<%F0,RK
MF4!QRV"1M/'7[/&H:UJUKK$-XDDD<D+RB=6"(8W#@0QQ_P#++KB-G#9R6F9G
M9QZ!\2OA1_PL#3/[/NIOWPD619_+X5PQSMC5U^78S1JK,Q"D%F=QN.)\/O F
MNV5M#8:E=P);0*B#[*K_ &B6,*RB)I7""( ; 'C3S2!Q(C_.<3X%_L]WOP[9
MI9;['F[#+!#&A1C&YV RS(S%=K,&"I&V6X?Y035^)7[-]U=ZG_;>A7*6UT9%
M=D8;$#;2'<,BMG=QO1D(<M(68AMM9_CS]G;5_&UE&U_>1SZDLPPS%H[:.'#[
MD18XAN=V*,[L@.%5 0$R_I7A?X?:IX=L/L,>I!W54CBD>TCVQ1)&4541)%+.
M#@[Y'D7"@&/[Q/-?!_\ 9_NOAC,\EO?I)%-Y8FC>UQN"$D%6%QE6 9@#\R_-
MED; Q4^(/P,U"76T\0Z+/"L_!D2XW;,K&(L+L1B5:/*L#AE.65\D;/2]9\"_
M\)18S:?JLGG"?[QC7R%3!4IY8W2,,,H?YVDR^<_NR(U\O\#_  O\2_#E'L].
MN;*XM-P:,70N%9"1E]JQ[MH+$Y&]@2-P"LS9] ^%GPK3P*+B5Y3<7=W,9;B<
MJ(P[;F8 1J2J ;V/&223SMVJO'_&#]G^Z^)TR27%^D<4/F"&-+7.T.0268W&
M68A5!/RK\N51<G/JOAFRNK*$1WTR7$HP/,2+R-P  RR^9(-Q())7:O. @QSY
M+X+^&WB/X?VD5G875E<(%.8[B*5%A8DNPC>$[Y SNV3( 0 NT#) ZKX=_"M]
M#N[C6-0E$^HW2JKLBF.&- $_=(N26 **-[_,55>%8N6]%KP74/@EJOA[7)M:
MT&6U5+A6\R*X\W&YR&E'RJY(,BB0%60@G9C8,-%\;_V>-0^(7DW"WB/<1[E:
M-U:&U53SF)5\YU;@;][2%^H9%14KT7Q;X+U'Q#9261O8T,ZR+,XM<@(P5=D2
MF?Y 5#;B[2L2[%&C 4+B?!CX-W7PR5K=;U)[5Y#(T9MMCAMFW*N)SC.%R&5Q
MA<*%))K%N?V?+V;6/^$@74(TNMRG:MF3%@1"$KM:Z9L,@P?FSR2I4X(A^,O[
M.<WC2:+4[*X2#4(XXP[!&BCD=""LH9"\D; 9P293A8UR-NXT/$?P*USQII\L
M6L7T<]T&7[*BYBMD.Y"\K^7"C.Y0,B H0@9B,E\IW7P3^&%[X MUMKJ]\^)8
M\) L2)'&S,9)#OP99/F)"DE1@G*<J%]*KQ7XJ_ ";6[Y=<T:Y^RZ@NTG=N,;
ME0J!LC<4_=@JR[720 *5&7+2ZM\*]5^(ABB\1RVJVD,PE\BS67,S;67#R2D,
M@&<?)RP9N58(P];U;2X]7ADMIUW12QO&ZY(RK JPR"",@D9!!]#7A_PX^#6N
M_#T36-E>6OV*5BPE>%VN(W,>TND>X)G<%&'D=<*&VY+(P?V<;LZX^M1WYB :
M(H^T3W#YA$4^[S%$49/S; JNBA@%1%14K;^/?P,D^)%K;K#/BZMLA6EP$D#[
M!(7\M/E;Y P*+MSE=@# KM)X3U?5M,GM=2N('N);*> "*-DB+NA02R.V68]#
M\B1*NYQL?Y"N+I/A'Q-X2ACLK&YL;J".-%1[F*:&1 H"+&! S*RA5!#,2Y).
M> *VO /PF?P5%<O#<"34+N;S9KF6(F-FWLV!#'+&%&';HX.YB<[0J#C_  7^
MSM?>$M0DU:'4D>XF\WS?,LP4?S&WMD)<)CYP&&PK@@#[N09OCA^SJ_C:Y35-
M.G%O>HJ#D%5=D8%)/,C&]'5<@-AR0J*-@7-97B/X%:YXTT^6+6+Z.>Z#+]E1
M<Q6R'<A>5_+A1G<H&1 4(0,Q&2^4[7X/_"6Z\&VGV&^NQ=6YA*"V\F,0J9"6
MF!8@R2@EB!NVC:3E.0%\O\1?LF7VC737/AR]^SI)N!1I)H713M/EB2(.TB[@
M3A@I "Y+G+5ZA\(O@[+X0=K[4;J2]OWA6(R.[LL<>0[1)O8EAYG.XXR ,(F6
MW>GT44444444444444444444444444444444444444444444444444444444
M444444444444444444444444444445S7A7P.GA5Y%M'*VLC,XMB 8XG8@GR3
MP8T)W,T9W+N8&/RP&#]+7/\ C'PE_P )5&+665TMF_UR1_(\HRO[LOU6(C<)
M H#N" )%4,K[=I:)9HL42A$10JJH"JJ@8"@#@ #@ < 5+111111111111114
M5VSJC&(!G"G:K,44MC@%@K%03U(5B!S@]*^>O^%,Z]_;_P#PD>;'?YF?)\VX
MV[/*\C;N\C.[R_XL8W_-LQ\E?0MHSLBF4!7*C<JL74-CD!BJE@#T)521S@=*
MEHHHKS7XW^"-6\60PIHUY]E9)&,@WR1;P1A3YD09QMY^3&UMV2<HN>@\"^%K
MC38TFU.?[5?>7M>7:J(H)#&.-55 %R!N; >0JI?A8T3JJ***************
M*******************************BNV=48Q ,X4[59BBEL< L%8J">I"L
M0.<'I7SU_P *9U[^W_\ A(\V._S,^3YMQMV>5Y&W=Y&=WE_Q8QO^;9CY*^A;
M1G9%,H"N5&Y58NH;'(#%5+ 'H2JDCG Z5+11111111111111111111111165
MXFDO$A/]GI"\YR!Y[O'&O!PQ\N-V;#8^7Y<C/SJ<9\5^ ?P9UCX732^8;.:"
MX\H2;99ED786PRY@VM\KM\IV[CM^=0#GW^BBBBBBBBBBBBBBBBBBBO$/!/PI
M\0V-[*VH:J9+*1G+*C-YKC)VJH9,6H(8EO(8%<!4((5T]JM+1+-%BB4(B*%5
M5 554# 4 <  < #@"I:*****************************\U^.?@[4O&]D
M^FV(MEBE\LR2322AQM??M5$B8=57YBQXW+LZ-1\#/!VI>"+)--OA;-%%YACD
MADE+G<^_:R/$HZLWS!AQM79U:O2J*****\0\$_"GQ#8WLK:AJIDLI&<LJ,WF
MN,G:JADQ:@AB6\A@5P%0@A73VJTM$LT6*)0B(H554!550,!0!P !P . *EHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHJKI>K0ZO&L]M(DL39VO&RNAP2#AE)!P00<=P
M11;ZM#<R201R(TL6WS$#*73<,IN4'*Y'(SC(Y%6J********************
M******BN[M+-&EE8(B*69F(554#)8D\  <DG@"BTNTO$66)@Z.H964AE92,A
M@1P01R"."*EHHHHHHHHHHHHHHHHHHHK%T3QO8:\YBL[J"=PI8K%+'(P4$ L0
MC$XR0,],D>M:&J:M#I$;3W,B11+C<\C*B#) &68@#)( SW(%0Z)XAMM>0RV<
MT<Z!BI:)UD4, "5)0D9P0<=<$>M3:7JT.KQK/;2)+$V=KQLKH<$@X920<$$'
M'<$5:HHHHHHHHHK/TWQ#;:H\D5O-'(\+;951U=HVR1M<*25.5(P<'(/H:T**
M**JZ?JT.H[_(D23RY&C?8RMM=<;D;!.&&1E3R.XHU#5H=.V>?(D?F2+&F]E7
M<[9VHN2,L<'"CD]A5JBJMOJT-S))!'(C2Q;?,0,I=-PRFY0<KD<C.,CD5:HH
MHHHHHHHHJKI>K0ZO&L]M(DL39VO&RNAP2#AE)!P00<=P15JBBBBBBBBJMQJT
M-M)'!)(BRR[O+0LH=]HR^U2<M@<G&<#DU:HHHHHHHHK/UOQ#;:"@EO)HX$+!
M0TKK&I8@D*"Y S@$XZX!]*FTO5H=7C6>VD26)L[7C970X)!PRD@X((..X(JU
M1111111111573]6AU'?Y$B2>7(T;[&5MKKC<C8)PPR,J>1W%6J*S]$\0VVO(
M9;.:.= Q4M$ZR*& !*DH2,X(..N"/6M"BBBL^;Q#;03K9O-&MPZ[DA+J)67Y
MOF"$[B/E;D#'!]#6A111116+;>-["ZG^QQW4#7 9E,*RQF7<N=Z[ V[(P<C&
M1@YZ5H?VM#YWV7S$\_R_,\K<OF;,[=^W.[;NXW8QGC.:M44444444455U35H
M=(C:>YD2*)<;GD9409( RS$ 9) &>Y JU11574-6AT[9Y\B1^9(L:;V5=SMG
M:BY(RQP<*.3V%6J****************************JZIJT.D1M/<R)%$N-
MSR,J(,D 99B ,D@#/<@5+=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %%I=I>(LL
M3!T=0RLI#*RD9# C@@CD$<$5+11111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111111117BO[6'AB"]T:>\D#F6'R/
M+_>RB-29E0MY8<1%MLC+N*EL'&>!C5_9<_Y%VS_[>/\ THEKH/"_PAL?#6H7
M.K6X?[1=9WY<E%W,'DVC_;<!CN+8(PFU<BJOQ*^*\?A*XLK&,H]U>7=O'L).
M4B>0*\I _P"^4R1EB2-P1EKOZ********Y_QCX L?&<8AU"!)E'W200ZY*D[
M74ATSM&=I&X#!R.*^1OAE\1'^#FKSV<C2?V0;VY@8LI?#1-L$J[=HWJ#'YNT
M$E"/D)\O'VI:7:7B++$P='4,K*0RLI&0P(X((Y!'!%>"_$+X5:6FOZ-&MI"D
M<WVWS8T0)&_DQ"2+<BX4X8G.1\P^5]R@"O==+TF'2(U@MHTBB7.U(U5$&22<
M*H &223CN2:M444444444445\U_MH^&($L8;_#F<W:1Y,LK(JM#(6"QLYC3)
MC0DJH)(R223GVKX3_P#('T__ *\+3_T2E=51111111111111111117SA^TCX
MH?4M7TSP^^?LD\UL]PH8J)5DN/+"': P"[&/#8)8' 9%-=AX\_9ET_Q%-;W-
MG_H$L,BEFMD6/<H.[@+M"2@\K* 2/XE?"[>$\+ZDGQ.\6W<.I1B6WLH;A+>"
M3$D2LDL4+/MP%8OEF.X,1E1D^6A'=V/[,]CI^IRW\#O';3V\T4EFF4B;S5*R
M#<I!$1!W", ;7 96"JJ#M?AK\-;7X=VOV*RWE#(TC-(VYV9L#)P%4?*JJ H
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M;04"KC(."X9E90._HK/U_7X/#T#W=VXCAC7<[MT Z=N22<  9+$@ $D"N?\
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M:4N5&-S*K#"!V SG/G_@GX V_CJQCU+7I)KJ\N[<.)#,P6%9"\D8B4!57"R
ME&#QJX(5=N0<3X9^+;WX:Z\?#-[(9+*1L6LDSG<B;"8 CLJA@0HB** HE&(\
M$,'T/VPH;C3+%+N*[N562X$#0*ZI!L>%RX(1%=\^6/\ 6.X&Y@  <55TGX W
M7C[3=.O+C4'AN(K>W-L(ES##$(T\O W(_GG"N\N[[WR*NU$(J:$UE\6O$%_9
MZ\WF&VDDAL;8.\4>U)'$KC806EPBLWS98%CM*HOE^H>$/A /!FJK/9-)]@^Q
M3QK \C21P2-+ Y\O>Y8"3:S,,'#*26^95'I]%%> >$?AY#\0+'6["<[=VO7S
M)(%5FC=3&5< _BK8()0LH89S7*? ?XAS?#&^?PIJXZW 6&16:15>0*43':*3
M<&7 4H[$R+\S%/5?B)_R,6A?]Q/_ -)UK/\ VB/B+/I(MM'TV41WU_,L8?/,
M4;,(]^02Z%G8!7"MPLA7#JI%77/V4M/D@9[22==15GECNWG?S6F^9D,A"E<;
MR"61%D^4$-NR3#^R_P#%>Z\41SZ9J9_TNSVC+G;.ZY96#HWS%HV4*[]3N4.-
M^6?W6O%?BEX^6^U2/03>I8VPM_/NKA;A(+C.2([=&8$(V=DC _,\9X(7(?S7
MXJ^&-!\(VZZKX:O(8+ZUD5D2&Y$[2!F5&&UY7/ ))P"I3>KJP.5]U\(ZRWQ2
MT:"Z6::T:>,B1H/+1]R[XI54R+-M7>"48$2 !3N!R*\*_9)BN/%TFH/=7,S!
MOLAE(DD6>0@3",&97$BJH'(4AFP@WB,.DF?XD\.GX2^++6'1V$272P*J,)9(
MU69S;LK#S0\H#KYH!91NVC^$&NZ_:'^$]OI&F2:P);E]0MY(G2Y>9C)\UP,*
M NV-%4R$H(DCVE5Q_%NT-+U6[\6^$5OWNYX)HK*Y8M"X5I&MRXC9W=7ER?)!
M<HZ%BSYX( XK]G?P5/\ $72KB.YNYXK=KVX:4PR8FGDDBA#>8SHWR!=V1EO-
M:0E@OEKORD%S^SIKD,+3R/I,[%B#NV;'(1V8!&4S185F,8W,H4?()-H]%_;6
M_P"0/!_U_P ?_HF>NE/Q 3P#X6M;YL%UTZU6%3CYY6A0(N-RE@#\SA3NV*Q'
M2N:\$_ &W\=6,>I:])-=7EW;AQ(9F"PK(7DC$2@*JX60$HP>-7!"KMR#B?#/
MQ;>_#77CX9O9#)92-BUDF<[D383 $=E4,"%$110%$HQ'@A@^+^TG87_P^NH+
MJUN[X:?-A71;RX)5U^\@=]^W>G*;BYW"0[=JA:^C[N&SM=.9FED-FL)E,RW%
MP\GEC]Z7$R2&9ACD;6.5^497BL_X<>'F\):>DE_-,T_V='NGN;AY@C!2TG+N
M8T522,I@%5!8L1NKR#PWJ^E_%6,ZAXDO(55Y'\C3S>"**%%.U'= T3F?[^7)
M(9'&%4;57$\)>*K;X7^(8].TFY%SI5^T>8T=9UAED9HT"N'ZA@NXD[C$P#!V
M5&KT7XI>/EOM4CT$WJ6-L+?S[JX6X2"XSDB.W1F!"-G9(P/S/&>"%R'\U^*O
MAC0?"-NNJ^&KR&"^M9%9$AN1.T@9E1AM>5SP"2< J4WJZL#E?HKX6>-?^$WT
MRWU KM:6/YQC #JQCDVC<WR[U.W))VXSSD5J^*_$T/A>UEOKDXBAC9VY4$XZ
M*NXJ"S'"J"1EB!WKPKX7?#=?C!;C7/$+O<&:2;R+=99$MX4#+'\J+M96W1$<
M.P9=K/NDR1S\.I77P"UJ#3A*\FCW7E!//?Y8PS8D</L6-&21F=PHVM&R[\,5
M9?2_VG(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,RH)3\LA^42!,A3MR,GR_X:?!*
M?XG>'[=;J\,,,;2?98XUW(#Y\GFRS D&1R2RH%91&H!Y+N*^G_#VFOI=M#;R
MR&9XX8T:5L[I&50I<Y+'+$9.23D]3UK@/VAOBJ?AYIQD@8"[F;RX 0K8/5Y-
MI(R%7H<, [(&4J37/V_[*6GZG;?\322>>_D6,RW1G=Y X5 RH77:4^4A?,1F
M"G&1A=O/_ 3Q]?K>W7A;6Y"\D:S>7,TDB3M@C<BN=LCAD8RQ."'5 2"5V[./
M^-OAF*P\5:7;HTQ1_L62]Q<22#==2*=LDDC2)P.-K#:?F&"2:^FE^'MLJ&/?
M=89E8G[;>ELJ& PWG[@/F.0" QP6!*KCYE^"7AF*_P#%6J6[M,$3[;@I<7$<
MAVW4:C=)'(LC\'G<QW'YCD@&O>OBIX;>TTBX^RW5U +>VN)04F+2.RJ95#RS
M"2? 9<?+(I*DJ3MP!PO[(&K?\2>ZNKJ3_E_GDEED;_IC"SNS,?J68GU)-2^"
M?"P^-HEU;6#(]B\SK8VF]HHECC8J)V$4N3,3N4Y/'SXRAC"$?PIU'X>ZO;R>
M'@?[*E9!=6[3;HX\LJRR!97#9V!65E+ON5E/[LA&T/BEX^6^U2/03>I8VPM_
M/NKA;A(+C.2([=&8$(V=DC _,\9X(7(?S7XJ^&-!\(VZZKX:O(8+ZUD5D2&Y
M$[2!F5&&UY7/ ))P"I3>KJP.5]/U7Q)+X^\,G5H;B>T<64\K+ 4BW2P@Y&XK
M)(J>9$=NQU9D;#DYP/)?@3\.KKXHZ3=0W-V\=JUW*YV?-++<E(FWS,^=\2X5
M@@(+N69F!1#7TU\-_"#^#M/@T^28W!A5E$K J2NYBBX+/@*I" 9( 48P.!E?
M''Q?/X/T>ZOK0@31K&$+#< 7E2/=@\$@,2,Y&0,@C(/FOPE^#.A^,M.AU!6D
MEO77=-=">87"7)^=V^\%#HYRA93D!7.\-N;U3X3>&9_#&GI:7;F25)KK=(QR
MT@:YE=93\S\NK!R"203AN0:^</V-=$;6/M\;2ND/^BEUC9XI'/[_ &#S4971
M1R6"89CM!<('230GMA\&/%EO::=D6=\MNKV^YMH$CM ,LYD+%9%,H/!PQC!"
MDD^@?&^QU?7]3L-.MHY#I4K*;IHBR!EWD3QRNK JGD_=4E1(6(&]@H7E/VGO
M!UMX"BM-;TA!9W<=RL0,"K&A5DE?+(%VD_+M/&&5F5PR[0/5?$.MOKWAB:\E
M #SZ/)*P7(4,]J7(&23C)XR2<=S7"_L4_P#('G_Z_P"3_P!$P5RGQ]_Y'#2?
M^W#_ -+)*^JJJZI9->QM''*\+'&)(Q&77!!X$J2)SC!RIX)Q@X(^7_V>YIO^
M$JU"">>:X^SV]U CSR-+)LCNHPH+'\3Q@9)( S57]LN&XTAK?%W<O%=>>'@9
MU6 "-XW10D:(#@N?F?>_RKEOEKTKXY?!Z#7-+N;NZD>2]@MY9EE+2^6I0"1T
MC@\WRHU94\L<,P&&=I) 6;FOV<M/E^(NC+!J$\AM;::6 0QN\1E0Q@[9I ^]
MD59=J1H8U 4!Q(-H7$^'3-\/O&$FAV+/]ADW_N7=V52ULMQN49 W H$#,&;R
M^"2?FJK^V7#<:0UOB[N7BNO/#P,ZK !&\;HH2-$!P7/S/O?Y5RWRUW_Q'_9L
MD\>QO<W-[,;X[VBC+AK*(L01$J^6K!=JJAD&&<CS60DE*ROV7/BY->QW6FZQ
M*_VBTWR[YV;>L0.)5=G4;?+?J9&W8?: %CXJ^&]7TOXJQG4/$EY"JO(_D:>;
MP110HIVH[H&B<S_?RY)#(XPJC:JXGA+Q5;?"_P 0QZ=I-R+G2K]H\QHZSK#+
M(S1H%</U#!=Q)W&)@&#LJ-78?$[5KCXCZVGABUDFM[:&-I+Z2-E4R(T:$(!D
M$KB0(<Y!:0LT;+&"<3]H'X+VO@O1Y[C1P;="T*W4?F2.DL?FKLXD,GSI+M*D
M%,*9 2<XKJ_@CXH3PKX0BOY,$0PW;A68(&83S;$W$'!9L*."<D  GBN?T"PT
M/QS E_XEOX)[J9?,\@WHB@M@W(CCC62-D.S8) Q8ETR6)R6S_@3XS7PEK<OA
MJWN?MFGOO:UD!20(WEB=@'5MNW;O5]H(,H#!4W/7T_7C7[1'Q%GTD6VCZ;*(
M[Z_F6,/GF*-F$>_()="SL KA6X60KAU4BKKG[*6GR0,]I).NHJSRQW;SOYK3
M?,R&0A2N-Y!+(BR?*"&W9)A_9?\ BO=>*(Y],U,_Z79[1ESMG=<LK!T;YBT;
M*%=^IW*'&_+/YK\<H;[2/$5A:0W<UPSR6<\:W3CR!-YS1(3' D:*ORC=L0-R
MQR2:]@\+? &30=736SJ$TTIC87*NH'G,R%3@HRA(@=C)$5<)L4!N%V^OU\E_
M%R&XTCQ1IEI)=W-Q$]Q83E9G78'^T-%E8XDCB7Y5[(#DL23DU[U\:=.EN-,N
M9H;F>W,%M/*/(9$+LB>8@9BC2  ISY;(2"P8D'CQK]F'PHWC;2YS?3S- U_.
M9(D=XS,SP1K(9I%;S'4A@0@* MN,AD!4)G_#$2_#SQ?+H5K(392-*1$2^Q \
M N4(4N074*L>]LEE!Z$\97QG\'6^D^*].AA\P"9K%I&:>=Y2QN6CW>:\C2 A
M$4 A@5P-N#S7M7Q<\5GX9V4<%A*%N+RY6*.2[N)91%N&'G)G:5MB87(^XA8,
MP.2K\5K_ ,+_  GK,#K)J4;WCKQ>RWR33[A]PL#*L;  !,;0=@P"&^8;7[+_
M ,3[CQ[I\]I=2/\ :;;:@G 4N4D5A&Q+[PTJE&R63! 0MO8N3YAJEOJ*>,5T
M^VO9))(VD\F6Z/G"+SK3S)G6-0D8(#$HBJJ$JBL-H->O^#/V;8_#-[/=?;;J
M2&=?FC\V:&4R9#>;)-!+&9#DO@%1]_G)&3Y+^QKX9BUO[?YK3+L^RX\JXN+?
MKY^<^1)'NZ<;LXYQC)S[!\8O'/\ 8$ECHD%REL+K<)KF2?;+#;Q@;B'DWD2R
M ,L<KD_.I_B.]/.OB+\/_#,5E+=Z=J$:ZE"IG2X%Z)IY94!?D&7EW89W(%82
M$,O *'T7X0^+I_BYHH:6>:WN$D>&>6 11LY"]5+))MRDBDL@1A(#LVJ #X?^
MSCH5[\2#J$-Q=R+!*MO]KD#%KN4!95BB$C[@J$9\PD$E56,?*S8[NXMI/A)#
M:>&5U! +RXFDENG<6[6UL A=8PS2B-I")/+D.!YA; W'>N?\1?A_X9BLI;O3
MM0C74H5,Z7 O1-/+*@+\@R\N[#.Y K"0AEX!0^M?L]_$J3X@Z6ES<?\ 'Q'(
MT,S!0JLRA6#@ GJCJ6X4;]VU0N*]%N[872-&V0&4J2K,C8(P<,A#*?0J00>0
M0:^2C;WGA#Q1!I.HZA>RV,S?NRUU<!G65'2$'R9-P(GPA/R@E=Q"H:]%_:DT
M.YTZQ;5M/NKFWDBDC\Y4N9TC9&*Q#;&&*A@Q4_+L!!<MN;%=A\$;J/Q#H=O-
MOG8SPD2M)-,TID4>3*RN9&= 70E-C+MSN 5B:J^!/!CZIIQE6]O4%ZS3*WGF
M66."3>8(5,ZR^61$ZEV3]YY@.)64+7E_[%FK3:O)J<]S(\LK?8]SR,SN<"<#
M+,23@  9[ "N:^,_@ZWTGQ7IT,/F 3-8M(S3SO*6-RT>[S7D:0$(B@$,"N!M
MP>:^BO'VAQZ-HFHQQ&1@;*[;,LTT[9\AAPTSNP''0'&<G&2<^-?LG^#U\3:/
M<173N;4W<JF%'DAW%H80Q=XW5G7:=HCX3EBXD)3RXOA1=O\ #GQ7<^'H&+64
M[.R1Y(6-C"+A&&[>Q*H/*)W N,.V2JJ/J2O%?VL/#$%[HT]Y(',L/D>7^]E$
M:DS*A;RPXB+;9&7<5+8.,\#!^RYX9B_L:SO-TWF?Z1\OVBX\G_72K_J?,\GI
M_L?>^;[W->:ZI;R7/C]DAD\IS@;]H<J/[/&XJ&^7=MSM+!E#8+(X!0Z'[37@
M:/P +77M+DDBNUN0CR-+-/(Y,9*$O-(_"K&4*D$.K[6^48/HOQ*^,DFF:397
M-J88+K4OLZQF:0;(!*@=YCE?F6/(!8KM!968$?(W'Z_\+_">LP.LFI1O>.O%
M[+?)-/N'W"P,JQL  $QM!V# (;YAT'[*?Q5G\;64MO>,9)[1D7S".7C<'R]Q
MR2S@HP8D#(VDEF+&O;Z^0/VRO#,6B?8/*:9M_P!JSYMQ<7'3R,8\^23;UYVX
MSQG.!CZ?T_P5%IN\P2W*N\;(&>YN+C;G'S*MS)+'N! ()4^AR"0?G#2O/L_'
M45G-<SW*0M,R&=]Y4RV1D?:%"H@W' "*H "C'%>H?M.0W%EI4U_;7=S T'DE
M8X76)&+2K&69E02GY9#\HD"9"G;D9/-? ?X:Q>,- M1J,DDEMMN%6V1WAA_X
M^6;?)Y;!Y7#K\I+!%4@"/>"[<_\ LL:I<Z%J]_H#RF6WMUFV;BV%:&X\O**7
M*H'\QF<#))"\\'/5:%X;U'QCXAN_[=MR^FVRN+:-QFT+%ML,@0L4E<Q-(68A
MBC-M.PA%7C_$7_%IO%EM!I/[JWU#[-Y\'6'][.\1VJ,;=N-R8/R,64?NR4KH
M/VPH;C3+%+N*[N562X$#0*ZI!L>%RX(1%=\^6/\ 6.X&Y@  <5MZ!\&(O'.B
M6POYI)&?3K80+N=+>W80$1R+"CJ'<!_G:1F+D$+Y:'8.:_8Y\>37=G>07LN8
M+3R71Y'8^6C(X9=SMM6)5A!4# 7+'H>-KP3X6'QM$NK:P9'L7F=;&TWM%$L<
M;%1.PBER9B=RG)X^?&4,80C^%.H_#W5[>3P\#_94K(+JW:;=''EE660+*X;.
MP*RLI=]RLI_=D(V?^V%#<:98I=Q7=RJR7 @:!75(-CPN7!"(KOGRQ_K'<#<P
M  .*[6+4+[3_  K!+I2;[Q=,M#&NT.?]7&'95)^9@FYE7G<P VMG:<7X=_!&
M#Q%HJKKMN6O[E7::>4[KQ3NQ"1(^YT*QK'\G08*NG+@XG[&GCJZUVUN+*Y??
M':>0(2>7"OYG[LG/*KL&P'E02N=H4+S_ ,??^1PTG_MP_P#2R2OJJL7QOK;Z
M#875Y$ 7@MIY5#9*EDC9P#@@XR.<$''<5\__  /^'NC_ !6M'U#5,WFI-,YN
MBTLJ,A)(B4+&T8">6H*X! .Y%(";$]+\&_"(VMO>V&I2SW,4MZTB2//*DLL3
M6\,861HI%9@,-&5;"MM#; -H'A_[&OAF+6_M_FM,NS[+CRKBXM^OGYSY$D>[
MIQNSCG&,G/I7BW1M4\5^)8K.[A=M$BC\PJ,BWDPFX&7#8D87 4")LX50WE[2
M[-PO[0MHGP>U&RU;1%%O+,LRRQ* +=UC\KY3&N  P;Y@,#*JZ[9 7/HO[6'A
MB"]T:>\D#F6'R/+_ 'LHC4F94+>6'$1;;(R[BI;!QG@8B_9GT6WL]#M=0EDD
M0HMRS%KF=;=5$TP+&(R^0 %Y)*X!^?[W-<UX;U?2_BK&=0\27D*J\C^1IYO!
M%%"BG:CN@:)S/]_+DD,CC"J-JKB>$O%5M\+_ !#'IVDW(N=*OVCS&CK.L,LC
M-&@5P_4,%W$G<8F 8.RHU=+^V%#<:98I=Q7=RJR7 @:!75(-CPN7!"(KOGRQ
M_K'<#<P  .*Z#0O@]!XZT&TCOY'>1K"#R2&E2&$_9PL3"%)51V7=EF?+.Q89
M6,K&GG7[)<ESXJM+C39+B2*UMYH90(F9)F\PL3$)=V8X<Q$LL81V9R1(H+!H
MM=TQ?A%XJLK72"\=M=_9?-@,DC1'S))+<Y&[+8&73>6VN21\N%KTKXI>/EOM
M4CT$WJ6-L+?S[JX6X2"XSDB.W1F!"-G9(P/S/&>"%R'\U^*OAC0?"-NNJ^&K
MR&"^M9%9$AN1.T@9E1AM>5SP"2< J4WJZL#E?=?".LM\4M&@NEFFM&GC(D:#
MRT?<N^*55,BS;5W@E&!$@ 4[@<BO!/V4[2Y\:/J#7-W. 6LFE=9&%Q+L,NQ#
M,6+JFU2K!,.1M"R(H97-7TH_"#Q9:6VEL4M;MK7=!NE,>V1WMR&S(3(0=TB%
MN%9@ ,#F+]M/PQ!IDUG<QA_-G^T^8SRRR\*8V55$CL$4&1B%0*HSP.E?56A>
M&8M$W>4TS;\9\VXN+CIG&//DDV]>=N,\9S@8U:\%T+PWJ/C'Q#=_V[;E]-ME
M<6T;C-H6+;89 A8I*YB:0LQ#%&;:=A"*O'^(O^+3>++:#2?W5OJ'V;SX.L/[
MV=XCM48V[<;DP?D8LH_=DI1^UM=7/@V:UGL+R\B^T_:#(BW4_EY0QD,JESMS
MYA&U<( %"JO.?</C3I!NM,N;A)IX9;>VGEC>":6$[D3?A@C!7!V8.X$@%MI4
MG-<5^R)XAN=>TJ:6\FDG<7LBAI7:1@HBA(4%R3C))QTR3ZUS7@K3/^&@KVYU
M'4#-_9,,BQVUH9-J,X0Y=_+8$, ^X]\R!!(R1E6\Z_:K\ #P4]G!:L18,L[0
MP,[2>5)F/S]I<%@C?NV +M\YD("YY]Z_:<AN++2IK^VN[F!H/)*QPNL2,6E6
M,LS*@E/RR'Y1($R%.W(R3]G#3%U/PS:0R%PK>?DQR20OQ=2GAXF1QTYP1D9!
MX)%>-? ;P=;MXGU*R7S(X85O%C$4\\+!4NHT52\4BNP"]F8@G!.2 :^O[2V%
MJBQKDA5"@LS.V ,#+.2S'U+$DGDDFN*^-.G2W&F7,T-S/;F"VGE'D,B%V1/,
M0,Q1I  4Y\MD)!8,2#QX5^SOX*G^(NE7$=S=SQ6[7MPTIADQ-/))%"&\QG1O
MD"[LC+>:TA+!?+7?E(+G]G37(86GD?29V+$'=LV.0CLP",IFBPK,8QN90H^0
M2;1W7[84-QIEBEW%=W*K)<"!H%=4@V/"Y<$(BN^?+'^L=P-S   XJKI/P!NO
M'VFZ=>7&H/#<16]N;81+F&&(1IY>!N1_/.%=Y=WWOD5=J(1:LYO^%\:M>6\D
M[_V/8^6@ABDV"X<N#N<IO$D1,3[2&4A?+9-K%S6+\7/ $OP1,>M>'6DCA\Y5
MN8"[R08VXCW*1DH3O#%W)5Y%\LJ2,>M>)/C1#IF@C75V;I;=#%'N60><XP(L
M[DW;'SY@&&"HYP"I%8F@?L[VNN0)<^(A)>:A(NZ5I)I%$9;YC BPR! B,2!M
MR"2Q7"D*L7PB\.ZO\/[J[M+^3?HT4;/;SRRHY14V!%R65D419W@H(U9,I@$E
M^5\-ZOI?Q5C.H>)+R%5>1_(T\W@BBA13M1W0-$YG^_ER2&1QA5&U5Q/"7BJV
M^%_B&/3M)N1<Z5?M'F-'6=899&:- KA^H8+N).XQ, P=E1JZ7X_>*X[O6K'0
M]2E\G2I(UFN,$IO;=*(TD<9Q%OC7/W0-Q=F!563I=6_9WM=&:WFT426YCO;2
M2>%9I&BGC2=&.\22$9C&9$//1E"EF4KS7Q^\5QW>M6.AZE+Y.E21K-<8)3>V
MZ41I(XSB+?&N?N@;B[,"JLG2ZM^SO:Z,UO-HHDMS'>VDD\*S2-%/&DZ,=XDD
M(S&,R(>>C*%+,I7V6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBO&I_BQ/XSUE]!TB00);J[75RR;I<QR(KQPJX*9W'87D5ARS*OR*9/
M(/VO_"47AQ-.6-I)'*W(>::1YIGVB#&YW).,EF"+M169BJKN.?;_ -J/_D7;
MS_MW_P#2B*C]ES_D7;/_ +>/_2B6O*O@%_R.&K?]O_\ Z61U%\&+D:1XSU&&
MXS&\[7RQJRL"Q,ZSKVX!B4N"< C&"<C/K7[4?_(NWG_;O_Z414?LN?\ (NV?
M_;Q_Z42UY5\ O^1PU;_M_P#_ $LCH^/O_(X:3_VX?^EDE=K^V3I<E[HJR1KE
M8;N*20Y VJ5DB!Y(S\\BC R><XP"1W?P*UM-9T.QEC! 6VCB.[ .Z$>2YX)X
M+(2.^,9 / \:^-6ER:GXRTJ.%=S".UD(R!\L=Q-+(>2.B(3CJ<8 )P*Z#]M;
M_D#P?]?\?_HF>O5?A/\ \@?3_P#KPM/_ $2E>5?$W]FJQ^([2ZCIDOD7+22J
M_P I\B26)Y(Y-RX#(QE7#2+N4[2P1V8L<KX*^.M9\,ZS_P (WKKO+OC<P.W[
MPDKND$@E8AGB90XRVYE8*F$VNH^E***\J^ 7_,6_[#U__P"TZ/C[\$X?B+:M
M)&N+Z&-C XV@OC+"!MQ4%6/0DC8QW X+JWB'P@^)E[XJUK2K'4@3/8M?H9'R
M)6#6Y&V0$9WJ8R"QY;C<-P9FU?VHYCX=\0Z9JLRDVZ+ <KM+,8+AI)% +#D*
MZXS@$G&>#CZOKY@_9^TN27Q5K-R%_=))=QLV1PTEUN08SDY$3G(&!CDC(S]/
MU\P7?C&/P-XXN);T>7!=6\40E?*(H,4.V3.T@KYD7EDY"J22S (17T_65X8\
M30^)8!=6QW1&29%;*D-Y<KQ%E*D@J2A*D'E2#QTKYJ_88_YB/_;I_P"W%'Q]
M_P"1PTG_ +</_2R2O5?VH_\ D7;S_MW_ /2B*N5^&G_(C2?]>&I_^A7%'[%/
M_('G_P"O^3_T3!7-?MGVQUFYTNQM\/<.TZK'N4-F1H$CSDC:&92 3@9!YX..
ME_;6_P"0/!_U_P ?_HF>N?\ CCI<E[X-TV2-<K#'I\DAR!M4VYB!Y(S\\BC
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M.,EFQDA%8@'&*\5_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\
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M ,P[_M[_ /;>O5?VH_\ D7;S_MW_ /2B*C]ES_D7;/\ [>/_ $HEKRKX!?\
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M[^4F4+#&!^\^8 99>WO7@#X>#P19-:V\IDGD9Y9+B7=(9)W W2LN\'&0/E#
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MD;9%R89@,O&Q[CIE3@!T) 8 <A@K+XAH/[,OB'2G%M%JQ@LE9]OE2W(8*2S
MB$%$!9CE@), DG+$<_17@OPA!X.M(K"T!$42D+N.YB22S,3ZEB2<  $X4 8
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MQAU6Y&_Y,*I!C(QEBY)KBO@_^S_=?#&9Y+>_22*;RQ-&]KC<$)(*L+C*L S
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M /PY>SU;0T%D=SQ2O!MB5CE98D:-<*X.QR<J0P4!\@(*]T^$OQ 3Q]IT-\N
M[+MF48^25>'7&YBH)^9 QW;&4GK7845XA^U5X)LIM'NK\P1_:D:W83!0LN?-
MCBY889AL8C#$CH<952/GK]E_P%9>-]2EMM0B\V);1Y NYTPPDB4',;*>C$8S
MCGITKH/C!I-]\"+Y#HUS-%9W'F211EP\:O@)*A1BROM4H5=US@J,LR%J^C_@
M;\74^)EEYY41W$3!)XP00&P"'49+!&YV[N00RY;;N/HM%%%%%%%%%%%%%%%%
M9^OZ_!X>@>[NW$<,:[G=N@'3MR23@ #)8D  D@5POP)^)4GQ$M[J]?B,7\L<
M"[0I6)8XB@;!;+?,68Y/S$@$*% ]*KQ#]JKP393:/=7Y@C^U(UNPF"A9<^;'
M%RPPS#8Q&&)'0XRJD?/7[+_@*R\;ZE+;:A%YL2VCR!=SIAA)$H.8V4]&(QG'
M/3I78?M%?!R+X7"#5M%>2W#3&)E65]R,T9VF-L;P"JR;]SDY8!1MR!ZK^RG\
M59_&UE+;WC&2>T9%\PCEXW!\O<<DLX*,&) R-I)9BQKV^BN%^,7Q5@^'-D]Q
M(P\]U=;>,C<7DQQD J=BD@N<C X!W,H.U\/=4DU?3;.YG;=++:6\CM@#+-&K
M,<  #)).  /05T%%%%%>2_%3XTIH-_9:/9N#=3WMJLXP&\N%Y%W*23A7<$ #
M!(0EOE)C8^B^+-"_X2"SN++=L\^WEBWXW;=Z%-V,C.,YQD9]17BO[._[.]Y\
M.+R6]O986W6YB1(B[?>='9B71,8V   '.3R,?-[_ $444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444445\(?&#0)_AIXC_ +0E0R1->B\B;[BR#S1,\88;\%6.PYYQ
MA]H#*#[7^V5=I>:);2Q,'1[V%E92&5E,$Y# C@@CD$<$5:_8PM'@T:1G4J'O
M960D$!E\N%-PSU&Y67(XR".H->]45Y5^U'_R+MY_V[_^E$5> ?L4_P#(8G_Z
M\)/_ $=!7J'[;%HC:5;RE076]55; W!6BE+*#U )521T)49Z"O.?V)=4DBU*
MYM@W[I[3S&7 Y:.1%0YQD8$KC .#GD' QH>(_'3_ !C\21Z,LQ&E+,RE$)"3
MK"IED+&.3YP[18C;.$7:ZJ&W;M#]H/\ XLW?6FHZ'_HQN/,\Z!/EM9/)"!=T
M2X7E96!QC'WEVR9<^P>)/C1#IF@C75V;I;=#%'N60><XP(L[DW;'SY@&&"HY
MP"I%>2_ GP.GQ8L+[4=5<W%[*T]K'+,!*L"F-9 T<9PJD/*2 N H "; 6W:'
M[+FC:UI+76DZE#-%8I&X4ONC*RL^TK#(K*2K#>Q:,E58*ZLI?+^7VGCG4;7Q
M.MBMY=&W76!$(VN)W7RQ=; AWN=PV\'=G(ZYKT7]L+6;GPO):36-S<P-/]H\
MP1W$ZH?+$(3""38N-QSM R22<GFO4/V>[V7Q#X?MGNY))'D6X5Y&D?S2//E7
M_6!MX(7 !!!7 P1@5\OW?CG5[7Q"UC9WDY"ZJ8H8YKBX>' N-B))\Y9DZ!NI
M*YZFM#]ICX=2> [JUU 7<T]U<[WDE;".)8O+^="F-B_,-B#_ %84 ,1@+VNI
M^'K[XN^'&UC5+K;Y%O+);PPJ%C8P;Q)+,#]Z5]C*NPJD8^90=[)57]B[QU=3
M7$VD.^ZU6W>9%/)1A)&I"G/"MO)*\C<-PP2^[:_:S^-<^A/'I.G3&*0J)+B2
M-L2*"08XPZMN0G!9Q@$J8\-M9@<_]HOX:VOPTTVRNM)WV]Q!<&$3(VR9Q+&[
M.[R* [-\F!@A55F4*%( T-:^(\WB[P@VK^?(E_;,L3O!)-;@.9XE)98V5'+1
M,K'@JI9M@3D#E?V<;O5_B(]S:37]TMJ%B>699F:X# OY<4;R,QC#G+.RJ21$
M$) ;GC_A1KMU\-_$0T^VEW1M?BTF!&$D43>5O*[CAADLA!)4DC)4L&]:_;/\
M,F.TCOS<3L&N8HQ;EU^S*/*F;>$" [\@_.S,<,5^[M S_P!DGP!_;-F;[[7>
M1>5?G]Q%-LMWV)"_[Q-IW;L[6Y&5 %?55>5?M1_\B[>?]N__ *415\M_LU>.
MD\$W\]Y+#/.@LI0P@C$C(HDB<R-EE"H O+$X!(]:Z7XL_&!OCC<6NCZ<GDPF
MX!5IWC3>[*%5FP#LVY<!5=S)N&%+[5KZ%^"WPC@^$ME(TT@,TBA[J8MMB 0,
M0!NP B M\QP6R6; PJ^-?#KQ-_PO3Q!(-0+O801O/;VI.V'Y)%2(R1@LK-ME
M)?DY;Y<F+Y*Q-1\:/\'?%$UM:RF/3C<QM-"06A5)TB>5EC0  H#^[*C<%55.
MY<AN?_:K\,G0-51&N)[DR6RR%YW5V!:68%%V(BJ@QD(H !)Q@<5]*_!+P8GA
MJPM]2EO;IT?3H6:.><-:Q*8XY"RJ5 0*!@$G"ID>]>2_#KQ-_P +T\02#4"[
MV$$;SV]J3MA^214B,D8+*S;927Y.6^7)B^2L34?&C_!WQ1-;6LICTXW,;30D
M%H52=(GE98T  * _NRHW!553N7(:W^U7XEO/">JI%8W=U"DELLK*MS<;=[2S
M D R$*,* %7"@#@"I?B-X,OM?\,1:UJ=W,98X[9DM\AH#$2L,;L-S%IW$GFM
M*Q+?.8RBX&.E_94\27?C33KS2I[B1$MU@6&:,@7"))YF45V5P !'A#C<@)"L
M,)L\%_L#_BI/L/G3?\A?RO/W_P"D?\?.SS=^/];_ !;L?>YQ7V+XH\$'PQHE
MZJW=[,\<-Q<1S2W4OG*ZP': \1C)0%=VQLJ6))!XQXI^R)XWO]>U6:*\NIYT
M%E(P666210PEA 8!V(S@D9ZX)]:/$?CI_C'XDCT99B-*69E*(2$G6%3+(6,<
MGSAVBQ&V<(NUU4-NW:'[0?\ Q9N^M-1T/_1C<>9YT"?+:R>2$"[HEPO*RL#C
M&/O+MDRY[OXQ>*SKGAD:W:2R0R^3;NA@N)5"-)+$DJ-Y3(LA7YD.]25(; 4Y
MKRK]G&[U?XB/<VDU_=+:A8GEF69FN P+^7%&\C,8PYRSLJDD1!"0&YX_X4:[
M=?#?Q$-/MI=T;7XM)@1A)%$WE;RNXX89+(025)(R5+!OO2BBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBJNJ:3#J\;07,:2Q-C<DBJZ'!!&58$'! (SW -?'7[0.DV7
MB;5[70]"MX$E5F25X8PB^8[ %7\J/I$J;G8;MH9P0I1A7U5X+\,P?#_3HK0.
M%BMH3OD8[5SR\LIW,VT%BSD9PH.!P*/ _P 2-/\ '*/)ITXF$;!7&'1E)&1E
M756P><'&"00"2IQTM>5?M1_\B[>?]N__ *415X!^Q3_R&)_^O"3_ -'05W7[
M;GBA([:UTX8+O,T[?,-RJBM&N5QG#&1L-D#*$#/.(OV*? K6\=QJ\J8\S$,#
M'>"54[IB 0%*E@@##)#(Z_+@Y\J_9RTN32/%%O;3KMEBDNXW7(.&6"96&02#
M@@C()'H:]*_;G_YAW_;W_P"V]97CCPM<0^!K#<F/*N%G?YEXBE:?RVZ\Y\Z/
M@98;N0,-CI?V(_%"26UUIQP'299U^8;F5U6-L+C.%,:Y;)&7 ..,_35? '_,
MX?\ <>_]O*]5_;G_ .8=_P!O?_MO7JO[+G_(NV?_ &\?^E$M?*O_ #.'_<>_
M]O*]5_;G_P"8=_V]_P#MO75_#3_D1I/^O#4__0KBO*OV*?\ D,3_ /7A)_Z.
M@KFOVJK1X/$%TSJ5#K;LA((#+Y$:;AGJ-RLN1QD$=0:^NO"G@S0?%%K%?6UA
M9F*:-77_ $>W)&>JMM5@&4Y5@"<,".U<I^T%I-GI'AR_@L8X8E62W\Q(51 '
M,UN?F5 ,,4*GGG:5/3%>?_L,?\Q'_MT_]N*\J_YG#_N/?^WE?0'[:W_('@_Z
M_P"/_P!$ST?L4_\ ('G_ .O^3_T3!7O]>5?M1_\ (NWG_;O_ .E$5> ?L4_\
MAB?_ *\)/_1T%<5\??A0WPZU!HT&;6;=);D!\!2QS$2V<LG /S,2I1C@M@?3
M7A#XF'XH^&KS:"U['93PRQC:SO(8&"R*B '$A^Z-H^8,BY"Y/SK^S!+8-JZV
M^I11RI/"\48E2-XQ*61T)\S@$A2BX!8LP4#YC7V3=_#+1+-&EEL;)$12S,UO
M JJH&2Q)3  '))X KY;_ &UO^0Q!_P!>$?\ Z.GKZ%M+1[SPDL42EW?0PJJH
M+,S&TP% '))/  Y)KY5_9@EL&U=;?4HHY4GA>*,2I&\8E+(Z$^9P"0I1< L6
M8*!\QK[)N_AEHEFC2RV-DB(I9F:W@554#)8DI@ #DD\ 5\M_MK?\AB#_ *\(
M_P#T=/7JOQ+_ .1&C_Z\-,_]"MZY3]AC_F(_]NG_ +<5Y5_S.'_<>_\ ;ROM
M7XL?\@?4/^O"[_\ 1+U\J_L4_P#(8G_Z\)/_ $=!7/\ [.6ER:1XHM[:==LL
M4EW&ZY!PRP3*PR"0<$$9!(]#7I7[<_\ S#O^WO\ ]MZMZGI<FF?#X1S+M8QQ
M2 9!^62]66,\$]4<''49P0#D54_88_YB/_;I_P"W%>5?\SA_W'O_ &\K[_HH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHK@/%?PYO?%K2PW6H/'8RQLGD6T*0N07R-\
MTAF9LK\CA0BN.P!96U?AY\,+'X?PF"PCV[MID=B6DD*C 9F/XG:N$!+%5&34
MOQ(\#IXYT^?3I',8F5<.H!*LK*Z'!ZC<HR,@D9 *DY'E_P"SO^SO-\-YI;V]
ME1YWC,2)$6,80E'9B716+%E    4 \L6^7W6O.OBQ\-KWQ_!)8B\C@M9&C)4
M6QDE(7#;2YN N-X#?*BG@+DC=N\Z\%?LJWO@B9KG3]6\J5HS&6^QH^5)5B,2
M3,.J@YQGCKUK5T_]D^UOKA[[6KF:_N'D9GS^XC8%0J@JA9QM_AV.J@!5"A1@
M^X6EHEFBQ1*$1%"JJ@*JJ!@* .  . !P!7C_ (X^ KG44U[0Y([>^1BSQR(3
M;RLWRNS;<LA9&8.5!+D@C8^Z0Q>+?@I>?$N^BN-<>&.SM_\ 56MNSR,^X9EW
MS-'"PRRI]U?N#:NQLNWJNJ>%+75;5M/FB1K5HQ'Y6-J!1C:%"XV[<#:5P5(!
M4@@&OF6;]D74_#5ZMWHE[&HC;=&\I>.5#EAL.R.1'&S 8G:'RP,87@^X>!?A
MS<6<B7^LW/VV^2/;&VQ8XH P'F"-5"@LQR&E(#L@5<*,@^5?%?\ 93N-7U Z
MGHLZ0O)(99!(\BE)=V[S(W1789;+8.-C<J<$*FKXZ_96D\:>7/=ZB[W@WB6=
MH059?E$4:1+*B1*F&) R7=V8GD >B_##X?W/@33_ .SA<1RB-7\A_(9"K,SN
M3(//;S!N<8"F,X&,DG(\O_X9-F_M+^U_MZ>?]K^T[?LK>7O\SS<8^T[MN[C&
M[..^>:Z7XP? 6Y^)Y@^TWL<0@5MH2U;)9UC\PDM<G@LF5 &5!VDN1N.AH/P@
MO-%T9]"2\A,31RQB0VK[PDOFF7(%T 6S(-C<!0I!5\Y'/_"3]FJ;X:WGVV"]
M27='Y;H]LPRA=';:1<?*WR !B& SRIKJ_C/\"[7XG1J7;R;J/ 2<+N.W.3&R
MY7>O)(&05;D'!=6\U^'/P-\4^$L6\6IPP6ISD*&NMGWF&R.>)57+-\VUDSG<
M=Q %>B^*_@D-2TMM&LYA#%*V^XEDC:XN)9-Z2>:S^;'EV9/G+!L@@*$"@5D_
M!_X"W/PP,_V:]CE$ZKN#VK9#(LGED%;D<!GRP(RP&T%"=PYK_ADV;^TO[7^W
MIY_VO[3M^RMY>_S/-QC[3NV[N,;LX[YYKU#XI_"\?$;3A87,@64-&ZS*C;5D
M7AF$?F="I=0K.VT-G)*@UYU\%_V?-0\*_N=2ND:S2X2X2W@+;7G7;M>1S'&Y
M5=BL(\E6<*S8VX;W^O.OBQ\-KWQ_!)8B\C@M9&C)46QDE(7#;2YN N-X#?*B
MG@+DC=NX7X:_LQ77P[NOMMEJ*%S&T;+):;D96P<'%RK#YE5@5(.0 202#Z!\
M5?A)'\2+%;6Z9%N4VE+A8S\C97S"J>9G:X!&PNP'RDEF137"?#/]FV]^',YN
M+'4QAUVR1O:EHG'.W<!<J<J3E2"".1G:S XOQ*_9&:[NOM^@S);.9%?RFWQI
M&PR2\;QAF3Y@I5-N%.2K* J#K_!WPCU:^1(O$M\+NWB92MJB@QR% OEM-(4C
MDE .28W!#,$9V;E:B_:$_9[;XEM'=6LB17449C_>!]DB[PR@LI.S;ER"$8L6
M )  (Z#X/_#*Z\+QQR:I<?:+J*W%O$$X@A@!7"(-J;F;8A>1EW':J]%);S7X
ME?LC-=W7V_09DMG,BOY3;XTC89)>-XPS)\P4JFW"G)5E 5!U_@[X1ZM?(D7B
M6^%W;Q,I6U108Y"@7RVFD*1R2@'),;@AF",[-RM9_P 6_P!FJ;XE7GVV>]2+
M;'Y:(ELQP@=W7<3<?,WSD%@%!QPHKH->^$%YK6C)H3WD(B6.*,R"U?>4B\HQ
M8!NB V8SO;D,& "IC)J_!3X#S?"V24QW:313[/,4V[(_R"39M87!"\ODY5L@
M8&.M<5\1OV6KR[U0ZOHUQ#$[7 GV2AQY<H*ON!VS!]TFYR"JJN0H!'3U6;X8
MS#39[".ZW3W?F&ZN9HVE:0RQ^4[*BRQK'A0JQJ"41%"[6/S5Q/PD_9JF^&MY
M]M@O4EW1^6Z/;,,H71VVD7'RM\@ 8A@,\J:T/''P%<ZBFO:')';WR,6>.1";
M>5F^5V;;ED+(S!RH)<D$;'W2&+Q;\%+SXEWT5QKCPQV=O_JK6W9Y&?<,R[YF
MCA8994^ZOW!M78V7;L/B?\-G\8Z?_95M+':V[*BL/(,A"QLCQK'MEB5 -F""
M&!' VXYY3X/_  %N?A@9_LU['*)U7<'M6R&19/+(*W(X#/E@1E@-H*$[AS7_
M  R;-_:7]K_;T\_[7]IV_96\O?YGFXQ]IW;=W&-V<=\\U]"VBNJ*)2&<*-S*
MI12V.2%+,5!/0%F('&3UJ6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBL_1/$-MKR&6SFCG0,5+1.LBA@ 2I*$C."#CK
M@CUK0HHHHHK%UOQO8:"XBO+J"!RH8+++'&Q4D@, [ XR",],@^E6K;Q#;74'
MVR.:-K<*S&974Q;5SO;>#MP,')S@8.>E:%%%%%%%%%%%%%%%%%%%%%%%%%5=
M4U:'2(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*EM+M+Q%EB8.CJ&5E(964C(8$<
M$$<@C@BI:*********************JZ?JT.H[_(D23RY&C?8RMM=<;D;!.&
M&1E3R.XJU11116+HGC>PUYS%9W4$[A2Q6*6.1@H(!8A&)QD@9Z9(]:VJ**JZ
M7JT.KQK/;2)+$V=KQLKH<$@X920<$$''<$47&K0VTD<$DB+++N\M"RAWVC+[
M5)RV!R<9P.35JBBBBBBBJNH:M#IVSSY$C\R18TWLJ[G;.U%R1EC@X4<GL*M4
M5GZEXAMM+>.*XFCC>9ML2NZHTC9 VH&(+'+ 8&3DCU%:%%%%%%5=/U:'4=_D
M2))Y<C1OL96VNN-R-@G##(RIY'<47&K0VTD<$DB+++N\M"RAWVC+[5)RV!R<
M9P.35JBJMQJT-M)'!)(BRR[O+0LH=]HR^U2<M@<G&<#DU:HHHHHHHHHHHHHH
MHJKJ&K0Z=L\^1(_,D6--[*NYVSM1<D98X.%')["K5%%%%%%%%%%5=4U:'2(V
MGN9$BB7&YY&5$&2 ,LQ &20!GN0*M44455U35H=(C:>YD2*)<;GD9409( RS
M$ 9) &>Y JU1111111111111573]6AU'?Y$B2>7(T;[&5MKKC<C8)PPR,J>1
MW%6J***JZ?JT.H[_ ")$D\N1HWV,K;77&Y&P3AAD94\CN*M4444444444444
M5GS>(;:"=;-YHUN'7<D)=1*R_-\P0G<1\K<@8X/H:T*****************J
MZAJT.G;//D2/S)%C3>RKN=L[47)&6.#A1R>PJU1111111111111572]6AU>-
M9[:1)8FSM>-E=#@D'#*2#@@@X[@BK5%%%%%%%%%%%%%%%%%%%17=VEFC2RL$
M1%+,S$*JJ!DL2>  .23P!1:7:7B++$P='4,K*0RLI&0P(X((Y!'!%2T44444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444445Q_Q5^)D'PYLFOK@%SN"1QKP7D()5<X(484D
ML>@!P&;"F;P5X2FT[==:A+Y]]+DNPW>3$#MS! K?<B&U<G[\K*'D)(4+U5%>
M5?$K49/A@W]M6^][,R*M[:@C8H=S_I4(9@$E\QL2*ORS%]S[6!DKTO2=4CU>
M&.Y@;=%+&DB-@C*L RG! (R"#@@'U%6J\:\;_!:+Q]KXN;]"UG#IT2[<N@>5
MII\+N4#(5<LP#*P)CSE6(/F'[4'P9TKP1IL5SI]OY4K7:1EO,F?*F.5B,2.P
MZJ#G&>.O6N_^'O[.&A:OIMG<SVFZ66TMY';SK@99HU9C@2@#)).  /05@+\#
M(-#T35K6\1W6TN+V>T8O*JD?9(FBE(7RTD9<;22I4.)%7@MG5_8I_P"0//\
M]?\ )_Z)@KW^BBBBO /VB_C1<:9-'H&C_P#']<>6K2*RAH_,.U(U.X;)6R#N
M;;L1E9>6#)V'@/\ 9RTCPK (GMX[F4JOF2SHLA9ADY57W+&.< +S@+N+D;JY
M3XW?L\Q7EE<3:*#;2E0\MO#O$%RL8RJ&%/EWC&8]JX+D[AEMZ^R^$]=_X2"S
MM[W;L\^WBEV9W;=Z!]N<#.,XS@9]!6K111111111111111111111117S+^V?
MX-M8;2/4PA^U/<Q1%S)(P\ORIFV!"Q11N4'Y5'.3U9L^X?"?_D#Z?_UX6G_H
ME*ZJBBBN:^(OCR#P+92WUR1A%/EH3M,DF"4B& QRQ'4 [1EC\JDBWX(UM]>L
M+6\E #SVT$K!<A0SQJY R2<9/&23CN:VJ**************X#XZ>&(-;TF[:
M<.?*M+B1%$LJ)N5"ZED1U63#(I <, 1P.3GS_P#8I_Y \_\ U_R?^B8*]_HH
MHKYP_:1\4/J6KZ9X??/V2>:V>X4,5$JR7'EA#M 8!=C'AL$L#@,BFNP\>?LR
MZ?XBFM[FS_T"6&12S6R+'N4'=P%VA)0>5E )'\2OA=OK]%>*_M8>&(+W1I[R
M0.98?(\O][*(U)F5"WEAQ$6VR,NXJ6P<9X&-#]F>V%UX:M8VR RW*DJS(V#<
M3 X9"&4^A4@@\@@UX_H.@Q:#X^%O;@A SM\SO(Q9[%I'8M(S.Q+L2223DU]=
M44444445Q7Q)^$-C\1?(^WAS]GD++L<ID-C?&W7Y6VKDC#C'RLN3GL+N[2S1
MI96"(BEF9B%55 R6)/  '))X KBOA)\3!\0XKJYC $,=[)#"1NR\:)&5D.X
M@L6+8P-H(4Y(+'YU^*?@VU\*^+=,CLT*B6:RED+222LTC7;AG+2L[$G:,\]>
M>I-?8E%%%%<!\=/#$&MZ3=M.'/E6EQ(BB65$W*A=2R(ZK)AD4@.& (X')SYU
M^QK;"ZT2YC;(#7LRDJS(V#! #AD(93Z%2"#R"#7$Z#H,6@^/A;VX(0,[?,[R
M,6>Q:1V+2,SL2[$DDDY-?7517=L+I&C;(#*5)5F1L$8.&0AE/H5((/((-?)6
M@Z#%H/CX6]N"$#.WS.\C%GL6D=BTC,[$NQ))).37UU1111111111111117R!
M\7/#$'A_Q=IBVX?]Y)82.TDLLSLWVEDR7E=V^ZB@#.  ,"OK^BBBBBBBBBBO
MD#]M/PQ!IDUG<QA_-G^T^8SRRR\*8V55$CL$4&1B%0*HSP.E?7]%%<!\/?BO
M'XXOK^WM2CVUI]G5)5);S&<2^8<\#:"@5<9!P7#,K*!J_$KX:VOQ$M?L5[O"
M"19%:-MKJRY&1D,I^5F4A@1@D@ @$=!I.EQZ1#';0+MBBC2-%R3A5 51DDDX
M  R23ZFK5%%%%%%%%%%%<!\=/#$&MZ3=M.'/E6EQ(BB65$W*A=2R(ZK)AD4@
M.& (X')SY_\ L4_\@>?_ *_Y/_1,%>_T5P'QL^*\?PWL6N,HUR_RV\3$_.V1
MDX7G:@.YON@\)N5G4UW]<5\-OA#8_#KS_L <?:) S;W+X"YV1KT^5=S8)RYS
M\S-@8[6BBBBBBN TOXKQZQKDFBVQ1T@M'DFD!)(E$L:>4.B_*K$OC=\Q"_*4
M8'OZ***YKXB^/(/ ME+?7)&$4^6A.TR28)2(8#'+$=0#M&6/RJ2)?">HMXHT
MVWN)_E:YM(G?RR\>#)&&;:P;>N-QVD-N'!!SS7S!X6\+6_A7QVEE9)Y<$>[8
MFYFQNL"[<N68_,Q/)_2OK^BBBBBBBBN ^-GQ7C^&]BUQE&N7^6WB8GYVR,G"
M\[4!W-]T'A-RLZFN_HHHHJ*[NTLT:65@B(I9F8A550,EB3P !R2> *XKX2?$
MP?$.*ZN8P!#'>R0PD;LO&B1E9#N (+%BV,#:"%.2"QE^)/PAL?B+Y'V\.?L\
MA9=CE,AL;XVZ_*VU<D8<8^5ER<]K1111111111117BO[6'AB"]T:>\D#F6'R
M/+_>RB-29E0MY8<1%MLC+N*EL'&>!C5_9<_Y%VS_ .WC_P!*):]5HHHHHHHH
MHHHHHHHHHHK@-+^*\>L:Y)HML4=(+1Y)I 22)1+&GE#HORJQ+XW?,0ORE&!Z
M7QIX0@\8VDMA=@F*50&VG:P((96!]0P!&002,,",@G@OPA!X.M(K"T!$42D+
MN.YB22S,3ZEB2<  $X4 8 VJ************************************
M******************************************************^9?B3J
M1\8>,M/TP.42R9)#E5(\P+]K?!!#$,B1IDGY2"0I_B^FJ\ ^#OA"^\875]>^
M*K7>RR+';QSJ'@CZ^<(8G+)M^6("4 [\'$C$N3S7PXNW^'GBV;P_8L?[/F8L
M8G)?8WV7SPR'J"#\F3DLF ^YE5A]'^+-"_X2"SN++=L\^WEBWXW;=Z%-V,C.
M,YQD9]17B'[%_B\ZGITU@Y)-K,"O"A1'-N8*".2?,60G<. P )'"_0E%> ?M
MK?\ ('@_Z_X__1,]>J_"?_D#Z?\ ]>%I_P"B4H^+'_('U#_KPN__ $2]>%?L
MG^#U\3:/<173N;4W<JF%'DAW%H80Q=XW5G7:=HCX3EBXD)3RXOA1=O\ #GQ7
M<^'H&+64[.R1Y(6-C"+A&&[>Q*H/*)W N,.V2JJ.J\5^-;;QGJUSI5]>QVFF
MV:HLBK=+ ]U*X&^-F.,PJN^.6-6#!B"Q)P$\Z^)J:7\+Y+?6/"MW")ED$4ML
MDXN4D1@SEF'FL^WY0K#.,E&4HZAF^K_#VMIKUM#>1 A)X8Y5#8#!74. <$C.
M#S@D9[FM"OC#PA<G7O';-=8D*WMXHW*N ((Y5AXQC*B-,'KE0V=W-?9]%>*_
M'WQU)X=CM-"TAT@N[V2.%"N%$,1(B!&T[H\L0J,$.%639AU4B+7/V4M/D@9[
M22==15GECNWG?S6F^9D,A"E<;R"61%D^4$-NR3#^R_\ %>Z\41SZ9J9_TNSV
MC+G;.ZY96#HWS%HV4*[]3N4.-^6?SKXSV]WI?B73K,7L\PDFL9E%P0\2R^>T
M2L(H1!'@!1D*%8Y;Y@6)KJ_VHOA!:II<FJ!I&NX&AW2RR22M(C/L*!2XCC&^
M7?B-%52"J(JMQT'PN\-'XK:/:W.M2R31F%HOLZR2Q1-Y<H02RE7\R:8F+=N9
M@@S\L8;+MQ7[-VH3Z9J^I^'HYI/LL*W(A+-O>(Q7'EJR!@8@3YI9_P!V0S!2
M1C(.)=0WT7C,:?%=S2NGG>3)<.)/*,]D7DD5 @C^4MN6-41&VJA*CYAJ_&S]
MGZ;PG"VNZ9>7DEU#\TSR2,]P4($>])(U5AM7[^[CR\G<H7#>M_"SXF3^.-"-
M[; 27\<,D;(W"M<1IE<\1+A\HY"D*H?;N^4D<I\%/AJ_BJRGN_%%L9KNXFD4
M-<J?-6''"HK8-N/,:0J$$9Y##Y0AKG_V9=?GT?5[_P .JY>RMFN6A#_,Z&.X
M6/@C  8-N88QN^90I+;N?^,]O=Z7XETZS%[/,))K&91<$/$LOGM$K"*$01X
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M;YMZ^2"0"Q *H 56N%T"PT/QS E_XEOX)[J9?,\@WHB@M@W(CCC62-D.S8)
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M)Y8_>EQ,DAF88Y&UCE?E&5XJI\+?"<OAZRB%U)/)=/#&9S/.\Y$F"65<NR*
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M6&T&NZU;P9_PH!;[78+M[CSHU1+>X/S/,\B$2.ZL/-9?WCX"*VPN-P^9B?\
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M\U_9[UV\_P"$DU#3Y[NYN(+>.Z1!/,\O^KN8XU8@G;NVYY '4XP#BJG[<_\
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MJ.@"A1CC)Y#X*:[_ ,+OOKR]U9=\%MY/V>S8[[5-XF&]D(VR2A01O8?Q-A0
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M,OF>0;T106P;D1QQK)&R'9L$@8L2Z9+$Y+9_P)\9KX2UN7PU;W/VS3WWM:R
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MQQ+G:"L2(I")N!*@CTK_ )D__N _^V=<K^Q3_P @>?\ Z_Y/_1,%<I_S4/\
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MG&2S8R0BL0#C%>*_MK?\@>#_ *_X_P#T3/7JOPG_ .0/I_\ UX6G_HE*\?\
MVQ?!TDMO;ZU:G9+9R .ZX60*[+Y;[]P;Y)0 H&2#(6&W#$]WX&\7CXD&PN01
MB"V2ZEVAE'GRK/:!%#9)12MR'S@Y$)5V7?6_\5?B9!\.;)KZX!<[@D<:\%Y"
M"57."%&%)+'H <!FPIP/ OAZY\:VT.I:S.7$\(D6TA+0V:I(L;!74'?.2H^=
M96>/YW0(5Y/DG[#'_,1_[=/_ &XH^ 7_ ".&K?\ ;_\ ^ED=>J_M1_\ (NWG
M_;O_ .E$5>:Z9I<FI_#XQPKN81RR$9 ^6.]:60\D=$0G'4XP 3@5W7[).MIJ
M.@Q1("#;S3Q/G&"Q<S9&"<C;*HYP<@\8P3PO[:.ER:O-I5M NZ662YC1<@99
MC;JHR2 ,D@9) ]37I7[4?_(NWG_;O_Z414?LN?\ (NV?_;Q_Z42UY5\ O^1P
MU;_M_P#_ $LCKZJHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKP7]ICP6\$MGXDMHC+)8
M31M.BD@M"C^:&SD[0C @E48XD+-\L=>R_P"C^+;/_GI:W5O_ +2;XI4_X"RY
M5O9AGL:\:^$?PBU_X<&2T@N;)K*29GW/'-)*#MVA@BF(98*@93*P7&5).=T2
M?L\:AIFOKK5K>)(OSLSW2M+,&:)XR-D7DHR\C;AH@BX4*0@W=U\;M7.A:'<1
M\SS30BUC4E1++),/)X5$ 9\,7V(HSM( 4<B;X%_#G_A -+BM7&)W_>S_ /75
MP,KPS+\JA4RIVMMW8RQKOZ*\E^+OP9O?B6BV\U]'%;I,TB(EJ2V<%4WNUR=Q
M56(RH0$DDK]W;U7PZ\)WOA:"*SN;J.XAAA$<9%N89<+@)EA.Z$*@VX" G@EB
M<[IOB/X5NO%5J]E;7"6R31O'*QA\]RK8!"_O45<KN4DACALJ5(!KE/@Q\&[K
MX9*UNMZD]J\AD:,VVQPVS;E7$YQG"Y#*XPN%"DDUBW/[/E[-K'_"0+J$:76Y
M3M6S)BP(A"5VM=,V&08/S9Y)4J<$2_&?]FZ/XAJMTDB0Z@L8#R!"L4Q"8 9=
MS,GS  /EV5/E(DPFWFO"_P"S=J^I/L\0:G)/:;D+6Z3W$JR@$MM<R;-H#!3P
M&)&<%& :OH^BN5^(?PPL?B!"(+^/=MW&-U)62,L,%E8?@=K90D*64X%>:>&?
MAEXF\!X@T^_MKNU$8 2\69=AX4!/+\Q@H50%'F!!EOW8.&/86/@C4]>>.36[
MJ,Q*IWV5JCQV[ME@#)([F25"C?/$0L;$ ,K '?J_%7X9P?$:R:QN"4.X/'(O
M)20 A6QD!AAB"IZ@G!5L,. \(>!/%/A: :;#=V3VRLR1SR+,]S'$>%*I@1DJ
M/F1'9E!^3>4  [_X5?#.#X<V2V-N2YW%Y)&X+R$ ,V,D*,* %'0 9+-ECYUX
MT_9VOO%NH1ZM-J2)<0^5Y7EV8")Y;;UP'N'S\Y+'>6R21]W ';?$;X>7GCG3
MCILMU"GF8\Z1;9SNVR+)'L4W/R8VX;<9-W4;>E0_"SX;7O@&T-@+R.:)5D\G
M=;%&1W.X9*W'SH&+$K@,2V!(H  Y7PM^SY>^&=3FUBWU"/SKAIC(C69,1$K^
M8RX^U;P ^",,#P 21D'R_P 4Z/)K'CMX()GMY3M*3)@LC+8!U)!X925 =#PZ
M%E)&<UZAXF^%^O\ Q%"6FLW-K;V08-(ED)B\I#*0C>=P !DJ>0&P3&Y"E?1?
M%/PYM]=TM]& V0&W6*/[S;-@'DM]X,VQE4X+?-C#$@FO/_A#\.?$'@^W&FSW
M-FMHN\H\:22W"[VW,J[Q%&.2S*SK+AB 4=/E&5\/_P!GC4/!FK7-[#>(8)HY
M$\V16FNR)'1V)W;8Q+E3B1O,4D!FA(8JMKQI^SM?>+=0CU:;4D2XA\KRO+LP
M$3RVWK@/</GYR6.\MDDC[N .V^(WP\O/'.G'39;J%/,QYTBVSG=MD62/8IN?
MDQMPVXR;NHV]*/A#\.+KX?6XL9+M+BV3>8Q]G\J12S;B-XF<%<EC@KNRWW]H
M"UD_&'X>0^-K[2XW.7AN)9F1E5XVMT$9FW*V <R"&/&>DC-L<*=OJM%8OC?1
M'UZPNK.(@//;3Q*6R%#/&R G )QD\X!..QKSK2?"/B;PE#'96-S8W4$<:*CW
M,4T,B!0$6,"!F5E"J"&8ER2<\ 5T'PW^#\/A&.Z^T/\ :[B]D=[N1T54DW%S
MM\H$HJ_.V1SDL<_+M5?'_$7[)E]HUTUSX<O?LZ2;@4:2:%T4[3Y8DB#M(NX$
MX8*0 N2YRU>H?"+X.R^$':^U&ZDO;]X5B,CN[+''D.T2;V)8>9SN.,@#")EM
MW*?&#]F$>)KG^T](E%K>;@[#YEC>0,")0R9:-^I)56WL <*Q9V/AU^S[J,,\
M5UX@U"2Z$$PEBMQ-/)%YBX\N4M(5.5);Y0H[9<J60]+\9_@W=?$U5MVO4@M4
MD$BQBVWN6V;<LYG&<9; 54&&PP8@&MOPOX&O=&T[^S);F"X"PI%$TEH=OEC*
MLDJ"X D'EX08*<#+[R3GE/A%\"KWX9NP@U$2V\C*9('MCM)!&60BX^1RHV[L
M$$8W*VU<&F?#;7?"DMU<:9=6KBZO;F<VUQ$_E+YCDB02QGS"^Q4!7 09;J0&
M.MX4^%=S/J*Z[K4L<EZD/E0Q0*R6\*_."06.^0LKD_/@*7888!"OI]<!\</A
M;_PLK3S9K)Y<J2"6)C]PNJLH5^"=I#D$CE3AL-@JT/PE\)ZOX?MH;74[B!DM
MUV(L$;%G15VQAY'VC"@XVI&K$HA,IRZMQ_B;X 7FEZH=<\/7*0SR2%IH9]YA
M?>2TN67<Q5FP?+*\-ED=2J!=NT^%=_XIO;;4?$,L#&S9FM[>U618M^482O)(
M?,)RH^3&WY$.<%U;UJBO /C/^S&WB2Z74]&D2VNS(&ER7C0L/F$RM&K,DNX#
M.!AC\^5<,7/AY^SE?)=0W_B&^>[>VD+P1"6:5%;Y"KEY2K#YER450"50LQ&4
M/=?&GX+0?%&"..20PS0L3%*!O #;?,4IN4,"%'<$$ @XW*W*VW@3Q3J-E_9-
M]=V0@>%HI+E5FGNRA!&,.(XV)'R%CAMI+9,G)]/\+>#H_"-BFGV!VK%&PC:3
M,GS$EB[ ,F[+DLP4H.2%VC&/*O\ AG:^_M?^W_[23[7YF[_CS'EXV>7Y>W[1
MG;Y?R9SOQSNW_-73?&#X17/Q+MHK.6ZCB2-HY&*V[,S2JKH6&;@!4(?A"&8$
M?ZPUM>#/".H>&K%;$W<,K11QQP2-:LNU5.,.JW(W_)A5(,9&,L7)-<5\'_V?
M[KX8S/);WZ213>6)HWM<;@A)!5A<95@&8 _,OS99&P,>/_#?1[K4O%6JFPF\
MFYBDOI(]W,,A%TJF*51R8F#$';\RMM=?F0 ^MZM\&]5^(D\3>)+B 6D#!A:V
M?FA)6^;+.TA#*>BY&X[2P3RV)9O1?B/X5NO%5J]E;7"6R31O'*QA\]RK8!"_
MO45<KN4DACALJ5(!KE/@Q\&[KX9*UNMZD]J\AD:,VVQPVS;E7$YQG"Y#*XPN
M%"DDUM_''1$UW1[JU<D&58UB"X!:8RI]G3)! #3;%).  22RCYAT'@GPNGA6
MR@L(\$0PHA95"!F ^=]H)P6;+'DG))))YK:J*[5V1A$0KE3M9E+J&QP2H92P
M!Z@,I(XR.M>'^-/V=K[Q;J$>K3:DB7$/E>5Y=F B>6V]<![A\_.2QWELDD?=
MP![+HD%S"A%Y)'(^XX:*)H5VX& 5>:8DYSSN P0,<9/BOA#X':K\.;^:31)[
M7[%<LN^.=)6:-1(Q4*%;<Y1&(!:5 Y)W $!A%XO_ &;[[Q%J5OJ!U#$D%O"3
M</&))&N(Y&<,L(V0QQ8(PH/4?,KLSR-VOQ*^%E[XTLO[-^W[8&VF5Y+=))Y"
MKEP"T;PQJH.S 6,-\@RY!8&7X6?#:]\ VAL!>1S1*LGD[K8HR.YW#)6X^= Q
M8E<!B6P)%  ''_\ #.U]_:_]O_VDGVOS-W_'F/+QL\OR]OVC.WR_DSG?CG=O
M^:O<+175%$I#.%&YE4HI;')"EF*@GH"S$#C)ZUY?\)/AY#I&H:IJD1WK<W;K
M&S*N\;&)N0&X(4W)=-I XA5LN"K5ZK117E7@_P"!\>A:[>ZTP3;-@VZ@EV1I
M!FYD;>ORL7SM*-@([J0 0!H?&OX1)\2X((68(8KF-R^!O\H_+,BMAMI*G<."
MI9$##'S+Z+7BOQ@_9_NOB=,DEQ?I'%#Y@AC2USM#D$EF-QEF(503\J_+E47)
MSZ+%X7GU&PEL-2G$QEA>)I8HOL[%'CV%BI>5=_).0 N2 $ '/E_P=^#FM?#[
MS[);NV%C)(SJZQL]P#PFY0VU$9D /SF=$95PC MD\:?L[7WBW4(]6FU)$N(?
M*\KR[,!$\MMZX#W#Y^<ECO+9)(^[@#MOB-\/+SQSIQTV6ZA3S,>=(MLYW;9%
MDCV*;GY,;<-N,F[J-O2CX0_#BZ^'UN+&2[2XMDWF,?9_*D4LVXC>)G!7)8X*
M[LM]_: M=_7@NH?!+5?#VN3:UH,MJJ7"MYD5QYN-SD-*/E5R09%$@*LA!.S&
MP8:+XW_L\:A\0O)N%O$>XCW*T;JT-JJGG,2KYSJW W[VD+]0R*BI7HOBWP7J
M/B&RDLC>QH9UD69Q:Y 1@J[(E,_R J&W%VE8EV*-& H7G_A'\&;WX:126T%]
M'+#(S/M>U(*R%-H8,MR#C(0LISD+A2A8M6)_PSM??VO_ &__ &DGVOS-W_'F
M/+QL\OR]OVC.WR_DSG?CG=O^:O<+175%$I#.%&YE4HI;')"EF*@GH"S$#C)Z
MT7:NR,(B%<J=K,I=0V."5#*6 /4!E)'&1UKP_P#X9VOO[7_M_P#M)/M?F;O^
M/,>7C9Y?E[?M&=OE_)G._'.[?\U'CSX(:E/J]OK^DS6RW:QJ)_-$JQNZIY98
M*/.(5XSL*@@H "'+DL)OBY\$M3^)%E&MQ>1BZC96$**\5EDC#YR996<9.V0\
M;1M$2%W:O1?AMX:NO#MG#;7DR2-%;P1*L:;(U$:!>K%G=CT9B54A5VQ1G=NY
M3XF_ ^/QQJEAJ$@3RK?>+A6)+2*IWP1A"KQE?,+>8#M)1B,GC'=^-O"Z>*K*
M>PDP!-"Z!F4.%8CY'VDC)5L,.0<@$$'FL_X6>"O^$(TRWT\MN:*/YSG(+LQD
MDVG:OR[V.W(!VXSSDUB?$WX;7?BF[LKRQNA:/:+=8D\H3MNE$: !'(3&P/DD
MY!Q@'.5Y_7OA_K_CZ(V&L3V4-FS(TGV1)GF<(ZMY>9_E0'&=X!(95&UE+ ^M
MZ3I<>D0QVT"[8HHTC1<DX50%49)).  ,DD^IHU;2X]7ADMIUW12QO&ZY(RK
MJPR"",@D9!!]#7A_PC^$6O\ PX,EI!<V364DS/N>.:24';M#!%,0RP5 RF5@
MN,J2<[HD_9XU#3-?76K6\21?G9GNE:68,T3QD;(O)1EY&W#1!%PH4A!NT/BI
M^SQ=_$AXC=:B D"LL2BU&[YB-SNPF4,Y"KN*JB9&4C3)%=UJWA'4-7TV33Y[
MN%I98WB>?[*PS&T9C;Y!<@"4DEMP(3L(N]<U\(_@A/\ #Z*2S:[CN;*9F:2%
M[7!)9-C8;SF&& 4,&5P0N %))/G^F_LVZYX"N9)/#NH1I%*N&$P(; 8E59?*
MFC<J,8DPIR6 503FWXF_9=O=0U.WU""] =%22>YD!DG:X1W<2+#CR@@_=HD>
MX*B+C#8^;W_0+"6P@2*YF-Q*J_/*RI&7;J3MC 51V &2 !DL<L;=VKLC"(A7
M*G:S*74-C@E0RE@#U 921QD=:\/_ .&=K[^U_P"W_P"TD^U^9N_X\QY>-GE^
M7M^T9V^7\F<[\<[M_P U>P:IX=CU^U:SU!4F22,+*-I5&/&2HW,R?,-R_,60
MX(;(!KYJN?V4=8\-S/\ V%J/E028)W2S6\G!;:K>2K*^U3][Y<DMA%'7W#X5
M_"P>!4E>6XDN[NX93/<2EMSA 5B4!F? 53CDDDD\[=JKXUI/P:;X@WESKVBW
MDVG6UQ(XC=2[23G>?/EPLD311-*ORH[,Q(+%8UV(-N[_ &<];5&,7B"Z9PIV
MJQG12V. 6%RQ4$]2%8@<X/2NJ\&J_P 8_#*)J)'F7,,B,ZJ0 \<K+'+M5ER0
MT:N5!56.1@*<5G_#7X8:]X2@_LO[;;)8I(QBFCB+W84RAR@$@$*;@7)+"8H6
M(&X!2N?X'_9QN_#NIW.II?F 337 "QJ)Y6A=PZ;I;E7P^X*7)1R=OWR6)&A\
M8/V?[KXG3))<7Z1Q0^8(8TM<[0Y!)9C<99B%4$_*ORY5%R<GQ>^!=Y\0=/AA
MFN89+ZWDS',8G@1D9561759)0&8J'+*N,J$5$!)K5E\!:UXLT^2PUB\AB+QE
M-UG&V]_E #2/(5!5CGS(XXX]PP!(JED-7X ?"34/AW;M;74\)C-P\NR%68L6
MC2,;I) N%^7.U8PVX*?-*ED//_#;X#ZM\-;Z<Z;=6WV&? /GI)+, H)C)1/*
M!92Q7(E564ERF=JKTOQ<^"MW\1HH[62_$=O$RL!]F#RNX39OD<2HI/+D!$C4
M;L%3A2.E\'> 9M,T\Z3J$Z7=N+?R%Q"UN_E;60JQ69\_(0H*A& &268YKS7P
ME\%=<^&4TJZ'=6TMG+\WE7@E&UL\$"$'+!  7!0/_%'\J$=U\._A6^AW=QK&
MH2B?4;I55V13'#&@"?ND7)+ %%&]_F*JO"L7+9_QG^#=U\356W:]2"U202+&
M+;>Y;9MRSF<9QEL!508;#!B :Z#P9X1U#PU8K8F[AE:*..."1K5EVJIQAU6Y
M&_Y,*I!C(QEBY)KBO@_^S_=?#&9Y+>_22*;RQ-&]KC<$)(*L+C*L S 'YE^;
M+(V!B+P7\-O$?P_M(K.PNK*X0*<QW$4J+"Q)=A&\)WR!G=LF0 @!=H&2!U7P
M[^%;Z'=W&L:A*)]1NE579%,<,: )^Z1<DL 44;W^8JJ\*Q<MZ+7 ?%[X<77Q
M!MS8QW:6]L^PR#[/YLC%6W ;S,@"Y"G 7=E?O[25H^$/PXNOA];BQDNTN+9-
MYC'V?RI%+-N(WB9P5R6."N[+??V@+7,_'+]G"#XBG[7;L+>]"D%]N4E 4A%D
MQR"#@"09(7@JX"!>5\+_ +-VKZD^SQ!J<D]IN0M;I/<2K* 2VUS)LV@,%/ 8
MD9P48!J]E^(_A6Z\56KV5M<);)-&\<K&'SW*M@$+^]15RNY22&.&RI4@&N*^
M%WP'F\$6\VGR7:7-C<;_ #83;M$YWQF-MLB7&5R-N<AN%^7:26K$^$?PBU_X
M<&2T@N;)K*29GW/'-)*#MVA@BF(98*@93*P7&5).=T2?L\:AIFOKK5K>)(OS
MLSW2M+,&:)XR-D7DHR\C;AH@BX4*0@W=!\>_@9)\2+6W6&?%U;9"M+@)('V"
M0OY:?*WR!@47;G*[ &!7H-+T'7I;55N;ZVCNO+*%H[8R)SD>:=\L>Z7A67"I
M$I+JT4@*%.4^#_[/]U\,9GDM[])(IO+$T;VN-P0D@JPN,JP#, ?F7YLLC8&#
MXP?L_P!U\3IDDN+](XH?,$,:6N=H<@DLQN,LQ"J"?E7Y<JBY.>UU;PCJ&KZ;
M)I\]W"TLL;Q//]E89C:,QM\@N0!*22VX$)V$7>N5^%WPPF^#=O,9+Y);%=\\
MJFU977;&=S*R3,>BJ2"KY"X4*22?.O _[.ESJ2/J.EWT^EVUTPDA@1FDD\DC
M,+2/'-&,D,2J'>45@&D9]QK0\5_!G7/"5K+J,.NW,KVT;3>7)YH1A'\[ [IY
M5/R@X5D*L<*V 21[UX(UM]>L+6\E #SVT$K!<A0SQJY R2<9/&23CN:VJ\%B
M^!6I^&M=EUC1[B 17+.9EN%=F E??*H5 NX!@'3#QG(",< LW5_%3X')\2+2
M*&[G(NH69DN @VC>09$\H,!LP $!8NH5=TCG>7Y^V\">*=1LO[)OKNR$#PM%
M)<JLT]V4((QAQ'&Q(^0L<-M);)DY/JO@OPA!X.M(K"T!$42D+N.YB22S,3ZE
MB2<  $X4 8 VJX#XX?"W_A96GFS63RY4D$L3'[A=590K\$[2'()'*G#8;!5J
MGPP\(ZUH5G':7US;?Z/&8X1%$SY 3;%YK,T>Y5SRB)&[;$)FY<-RG_#.U]_:
M_P#;_P#:2?:_,W?\>8\O&SR_+V_:,[?+^3.=^.=V_P":NF^,'PBN?B7;16<M
MU'$D;1R,5MV9FE570L,W "H0_"$,P(_UAJ6R^#?V[2QHNKS)=P)&B0NL/D31
M[ 0C;O,D4LJD*I"K\H(D\P.V?']._9:U[P_)Y&GZIY5F9%9BDEQ"_(4._E)E
M"PQ@?O/F &67M] ?#7X?1^!;7[,CO+(\C2SS2$EY97QOD.2<9P !D\ 9+-N8
M]57E7QG^#=U\356W:]2"U202+&+;>Y;9MRSF<9QEL!508;#!B :ZOX<>%;KP
MK:I97-PERD,:1Q,(?(<*N0 W[UU;"[5! 4X7+%B2:\O^,'[,(\37/]IZ1*+6
M\W!V'S+&\@8$2ADRT;]22JMO8 X5BSL?#K]GW489XKKQ!J$ET()A+%;B:>2+
MS%QY<I:0J<J2WRA1VRY4LAZ#]H;X)/\ $^"'[/*([BW9]@?/E,LFS>&*JS C
M8"I (X*D?-N7JO"&AZC+ $UR6"<F%HWBBBQ$^>&:0R9WDJ.BI$@WN"CC85\0
M\1?LF7VC737/AR]^SI)N!1I)H713M/EB2(.TB[@3A@I "Y+G+5ZA\(O@[+X0
M=K[4;J2]OWA6(R.[LL<>0[1)O8EAYG.XXR ,(F6W<SXT_9VOO%NH1ZM-J2)<
M0^5Y7EV8")Y;;UP'N'S\Y+'>6R21]W ';?$;X>7GCG3CILMU"GF8\Z1;9SNV
MR+)'L4W/R8VX;<9-W4;>E9_@+X/3^'-.ET6YNQ/9R0SQKM@\F9!-G=A_-D4C
MYG(#(3N;[VT!:YGX._!S6OA]Y]DMW;"QDD9U=8V>X!X3<H;:B,R 'YS.B,JX
M1@6S;^,'[/\ =?$Z9)+B_2.*'S!#&EKG:'()+,;C+,0J@GY5^7*HN3GNK[P&
M_B33I-,UB87 D4*TL49MF.W:5<CS)%WAUWY&$)P/+VY!\U\#_"_Q+\.4>STZ
MYLKBTW!HQ="X5D)&7VK'NV@L3D;V!(W *S-GT#X6?"M/ HN)7E-Q=W<QEN)R
MHC#MN9@!&I*H!O8\9))/.W:J\?\ &#]G^Z^)TR27%^D<4/F"&-+7.T.0268W
M&68A5!/RK\N51<G/:ZMX1U#5]-DT^>[A:66-XGG^RL,QM&8V^07( E));<"$
M["+O7/\ P8^#=U\,E:W6]2>U>0R-&;;8X;9MRKB<XSA<AE<87"A22:]5KQ#X
MC_!*_N=:A\0:)+!'.JCS5G\S:S!?+S\JOD-$=C !"H7<IW,2#XN?!+4_B191
MK<7D8NHV5A"BO%99(P^<F65G&3MD/&T;1$A=VK:7X8:I/I*Z2]]#&#:1VS[+
M4R (J!"$+3*2S#<KNPPR[3''"P8L?!CX-W7PR5K=;U)[5Y#(T9MMCAMFW*N)
MSC.%R&5QA<*%))K%N?V?+V;6/^$@74(TNMRG:MF3%@1"$KM:Z9L,@P?FSR2I
M4X(A^,O[.<WC2:+4[*X2#4(XXP[!&BCD=""LH9"\D; 9P293A8UR-NXT/$?P
M*USQII\L6L7T<]T&7[*BYBMD.Y"\K^7"C.Y0,B H0@9B,E\IW7P3^&%[X MU
MMKJ]\^)8\) L2)'&S,9)#OP99/F)"DE1@G*<J%]*KY5_;G_YAW_;W_[;UZ7J
MG@_Q-Y;:=;7MM]E.$6[D$W]HB(D9)V_NFE"Y4.-K/@/N1SN7JOAK\,8_AWI_
MV"R?,AW.TLBE@TK*%WE ZX7Y5 16'R@ L6)<^?\ _#.U]_:_]O\ ]I)]K\S=
M_P >8\O&SR_+V_:,[?+^3.=^.=V_YJ]@U3P['K]JUGJ"I,DD864;2J,>,E1N
M9D^8;E^8LAP0V0#7S5<_LHZQX;F?^PM1\J"3!.Z6:WDX+;5;R597VJ?O?+DE
ML(HZ^X?"OX6#P*DKRW$EW=W#*9[B4MN<("L2@,SX"J<<DDDGG;M5>*\%_#;Q
M'\/[2*SL+JRN$"G,=Q%*BPL2781O"=\@9W;)D ( 7:!D@=5\._A6^AW=QK&H
M2B?4;I55V13'#&@"?ND7)+ %%&]_F*JO"L7+>:_$#]E&4W?]H^';@6<A;/EY
M>)4+!@[1R1!F4'('E[< %L,%VH.J^$_P-N]#GCU'6KV2\NHED$*F262*$OE7
M8-(=SEDP/NJ!SD,0K+H?&?X-W7Q-5;=KU(+5)!(L8MM[EMFW+.9QG&6P%5!A
ML,&(!KJ_AQX5NO"MJEE<W"7*0QI'$PA\APJY #?O75L+M4$!3A<L6))K:\0Z
M(FO6TUG*2$GADB8K@,%=2A(R",X/&01GL:Y#X&?#5OAWIB64NPSF2229HV=D
M9F;"D;PI'[M44@ #()P223+\:?AF/B-ISV0(64,LD+MNVK(N0,[3T*ED)PVT
M-N"DJ!7/^ _ FNVMD-,U&[@C@CA6))+17^U[ " !)(%CC*@*H81.Q7)RLF)*
MQ/@7\!]0^&\UR&NH3;RR0GY$9IG6(R$ E\)%NW . )25+!'1@'J*+X%:GX:U
MV76-'N(!%<LYF6X5V8"5]\JA4"[@& =,/&<@(QP"S=A\2OAA?>.++^SWODCB
M?:9C]E#.[!S)M4^<H2(';M7#2 (-\KY8FW\(?AQ=?#ZW%C)=I<6R;S&/L_E2
M*6;<1O$S@KDL<%=V6^_M 6O/]/\ @!J7P^OGO/#5S"()=P>VNO-\L# V+E-S
M/M8L58['084LX9\]AX4^%=S/J*Z[K4L<EZD/E0Q0*R6\*_."06.^0LKD_/@*
M7888!"NA\7OAQ=?$&W-C'=I;VS[#(/L_FR,5;<!O,R +D*<!=V5^_M)6H?A9
M\-KWP#:&P%Y'-$JR>3NMBC([G<,E;CYT#%B5P&); D4  <KX6_9\O?#.IS:Q
M;ZA'YUPTQD1K,F(B5_,9<?:MX ?!&&!X )(R#[?111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111117->%? Z>%7D6T<K:R,SBV(!CB=B"?)/!C0G<S1G<NY@8_+ 8/TM%<U;
M>!T:]_M*Y<S3JK) " (H$8G/EISAV7 DD8LS8PNR,^6.EHHHHHHHHHHHHHHH
MHHHHHJ*[9U1C$ SA3M5F**6QP"P5BH)ZD*Q YP>E?/7_  IG7O[?_P"$CS8[
M_,SY/FW&W9Y7D;=WD9W>7_%C&_YMF/DKZ%M&=D4R@*Y4;E5BZAL<@,54L >A
M*J2.<#I4M%%%%>:_&_P1JWBR&%-&O/LK)(QD&^2+>",*?,B#.-O/R8VMNR3E
M%ST'@7PM<:;&DVIS_:K[R]KR[51%!(8QQJJH N0-S8#R%5+\+&B=51111111
M111111111111111111111575))HHV-LB/+QM61VB0\C.66.4CC)&%.3@<9R/
MG_X>?!G7O".K3ZRQL96N?/\ -C$MQ&/WKB4[&\A]N' QD-\N1U(8?15%<_X_
MT>ZUFQGM[";[/<O&1'+_ '3D9&1RN1E=ZY9,[U!8 5Q7PH^&VJ:7&%U^\^UB
M.0-#$"70$'<)'D=%EE8,<HKDI&55QEEC,?JM%%%%%%%%%>*R_#/Q&=9DO$U3
M98R2'Y!\SK%P1&D,D;P*PP$$F=Q&9""69#[!I>EQZ5&L,*[47/<L222S,S,2
MS,S$LS,2S,2S$DDU:HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJ
MKJVEQZO#);3KNBEC>-UR1E6!5AD$$9!(R"#Z&O%/#?PI\0?#MC;Z->6T]C\Y
M2&\60&,L^< Q*2< #D,J%F=O*!.:Z9O!&L^+$$.M74$5N6836]DD@\^,A2%:
M:5_,0$@AEC4;D+*6^;Y?2K2T2S18HE"(BA550%55 P% '  '  X J6BBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBL7QIX0@\8VDMA=@F*50&VG:P((96!]0P!&002
M,,",@^5>%_ GBGP2GV.SN[*ZM45%A-TLRR(H!RH$0)QDX 9W 55"[!\M=+%\
M/=0\4-&VOW$+P+AFL;>-EMGD5R8VDDD9I)5Q@F,A4+!<@A3O]*HHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKP#X^?!G6/BC-%Y9LX8+?S1'NEF
M:1MY7+-B#:ORHORC=M.[YV!&/:O#,EX\(_M!(4G& ?(=Y(VX&6'F1HRY;/R_
M-@8^=CG&K111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111117/^,?']CX,
MC$VH3I"I^Z"27;!4':B@N^-PSM!V@Y.!S57P5\4],\;[AI]PDK+G*?,D@ VY
M;9(%?;\P&[&W)QG.1754444444444445S7B_XE:=X.!-_<QQ$*K;"V92I;:&
M$:YD89SR%(&"3P#CI:******S]!U^#7XA<VCB6)F=5=>5)1VC;![C<I (X(Y
M4D$&M"N:\7_$K3O!P)O[F.(A5;86S*5+;0PC7,C#.>0I P2> <=!=W:6:-+*
MP1$4LS,0JJH&2Q)X  Y)/ %8GAKQ_8^*))H;&=)V@\OS#&2R#S 2F' V-G:<
M[2<$$'!XKH*S];\0VV@H);R:.!"P4-*ZQJ6()"@N0,X!..N ?2L7_A;&C_\
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M!0"1TM%%%%%%%%%%%%%%%%<UXX^)&G^!D2349Q")&*H,.[,0,G"HK-@<9.,
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M3CN2:]/_ &JO#UM/HMU>/#&UPBVZI,44RJOVB/Y0Y&X#YFX!QR?4UH?LN?\
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M8ACY4&,D +N8]68A0"S$L<<DUX_\>_A'#;J/$6FQ(E]92+<LH55CF"2"5S(
MR98<N6!WN 4.XE"ONM<__P +"TWSOLOVRV\_S/+\KSXO,WYV[-N[=NW<;<9S
MQC-=!574-6AT[9Y\B1^9(L:;V5=SMG:BY(RQP<*.3V%9^M^-[#07$5Y=00.5
M#!998XV*DD!@'8'&01GID'TK0U35H=(C:>YD2*)<;GD9409( RS$ 9) &>Y
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MI?V7/^1=L_\ MX_]*):ZO1_"VEZ-J$TUND*:A<1B24!AYK)NP7"9^52_WV4
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M58#:>P^._P"S#I^GZ=)>Z1$89;93(Z;W=9(Q@R9\USM**"X*GD KM8LI7H/
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M',YNTCR99615:&0L%C9S&F3&A)5021DDDG/5:Y\1O^$ \)VMTAQ.]A:10?\
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M8&UGNVA20'/FPB2%Y'4$A2K@KLW$ CD@*V"O0?#CX=65]X<@L/*"Q75E$\N
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MT2L/F5H1DJ6!0LSE5)Y3XV^$[/3O%6EVL%O#'!)]BWQ)&BQMNNI%;<H 4Y4
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M9X./J7^UH?)^U>8GD>7YGF[E\O9C=OW9V[=O.[.,<YQ7R_\ L,?\Q'_MT_\
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M<.-A\N-BWDD!0X=+PQ2\GY@'1B%4(_U?17*_%C_D#ZA_UX7?_HEZ\J_8I_Y
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M .O"T_\ 1*5\M>%9;OX,:Y=Z+ 3B]416LC $!Y"19SL6C^<(SE)0HVYWX#E
MI^Q=)TN/2(8[:!=L44:1HN2<*H"J,DDG  &22?4U:HKP7Q-\ M(^+T":O8,;
M:6Y42F1-KHS-MWB2,-MWC#*VQE/F%BY<BLK]FG6-1\/:C=^&M3<R&WA62,F3
MS%15\M J9&[8R2(RJ2H0+C8&9L?1]>5?M1_\B[>?]N__ *414?LN?\B[9_\
M;Q_Z42UYK\3M.;Q;XUL8+3YFM([9YR0^U!'*]P<D*>J.@4_=+NJD@YQG^!V?
MP%XVN8;L "^:X\MRQ1-LSBXB(+*-Y+((<#CS"0"2N#[_ /&*[2UT:_:1@H-E
M<*"Q &YHV1%Y[EB% ZDD <FN%_9&\,S:)HH><;?M%P\Z A@VPJD:D@@?>\LL
MN,@HRD'G \_^ 7_(X:M_V_\ _I9'75_MK?\ ('@_Z_X__1,]8GQJT1]1\&6$
MJ$ 6\.GROG.2I@$.!@')W2J><# /.< ^R_"/XEP_$"QBND9//\M?/B4KNC?+
M*<J'=E5F1C'N.2F#US6AIOCF+5;^2PM@)1!#NGE61&6.0R%$@*@EMYV2%L@;
M J@Y+C'SU\??^1PTG_MP_P#2R2K?[0_B&3P)XDTW663= MOY9Z,2 \JSA5W*
M=PCG!4DA2Q') 85]'Z!K\'B&!+NT<20R+N1UZ$=._((.00<%2"" 017/V'Q,
M@O;2\U% 6M;5IMLB<B9(HE>1X]P56 ??&""58H2'P>/*_B!^R9IWBM/MFCR"
MW>1=ZA3YEK)N#.",$E Q9<,A**@^6(U?_98\9WVIQWNFZHSR7%C<!2\CB1_G
M+AHRW.[:\;88LV0P48517NM>5?M1_P#(NWG_ &[_ /I1%1^RY_R+MG_V\?\
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MWS.HX!Y91U(KNO$.B/H/AB:SE(+P:/)$Q7)4LEJ4)&0#C(XR <=A7"_L4_\
M('G_ .O^3_T3!7*?\U#_ ,_] ZOJJN ^/GAF;Q+HEY:VPW2F-75<,2WER)*5
M4*"2Q"$* .6(''6N/_9 \4)JNBBU& ]K-(C#<"Q5V,RN5P"H)=E'4$H2#U Y
M3]KK1'\57NE:;:D-<2-<#;R2JN80)&"AF"#8Y+8(PCG^$UZ+^U'_ ,B[>?\
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M226\DD>YOKC'GW,NW>< 91 H CBR,A!G "J6(1-O:UY5^U'_ ,B[>?\ ;O\
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M*T<C.LD08G=M4_*Y9E(S@>E?#/X567PY@-O8J<NVZ21R&E<\[=Q 484'"@
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MXACGDV[(GD19&W$JNU20QRP(&!R>!S6K6+K?C>PT%Q%>74$#E0P666.-BI)
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MXBRQ,'1U#*RD,K*1D,"."".01P1536_$-MH*"6\FC@0L%#2NL:EB"0H+D#.
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MC[1%:W<J002!3 F45V8H !(Q,S8,N_9QY>S+9Q/"MHGA/QW)9V*B&"165HU
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M8XVWHSJ5=Q)'NC?>S [MS!B*YK]D#5(](T&ZN9VVQ17<\CM@G"K;PLQP 2<
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MD4+,&6$!=SY*RCR<R@C ,A"G:R_2'Q@\*6OBB.VL[F))'FNXHT9ARJJ?M-P
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M1=6BFCN89&B+3JR22* K)(0RJ>C;,G<6*%BQ8G'C7[$=HEXFIQ2J'1UM596
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M@;@[$DA74XC*M\LE=7KG[-^BW]DUC#:QQ$*_ES ,94<AMKE]XDD"EL['<J<
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M$?6=!O8HR 5A$IW9 VPNLSC@'DJA [9QD@<C%_9E^)</BK2X;4LBW5M'Y31
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M =]^SM=0ZE87#RV,EPH=-PC+8WD0R+\ROF+=ME"_*VY@B'9N^RJ*^5?VY_\
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M7'GX)7YD=$CRHSN.UD^;C W)SEL#$_;ENT9]/B# NJW+,N1N"L80K$=0"58
M]"5..AKZ*\>364T4=CJ2AX;V86X#8";RCR("2RD$F/"%?F\PIMP>1\Z_%?\
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M1^5C:@48VA0N-NW VE<%2 5((!KR7PY^SS?>"S(FBZM);V\C*WE26\5R0P4
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M(AP<,,\'D$$JP*D@^:^&_@)J/AJ,V5GK$T=B9'/E"",RJCGYE29F)1L=&15
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M+$QC!+",^43&IV_,-VX\5_LQPZQJ$&JP7<T5Q')&\SL%G>5T9660;R$C;C&
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M*********************\0\$_LQCP[>RW4U_/<03,[26[;D$Q).W[0PD(G
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M"0Y=1LD9MIW,"QR,,01BM7Q-XKM?"\)N;Z5(8AGYG.,D MM4=68A20J@L<<
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M3K@2O&H9EVR1MM)QN D52P!X)&0"1G&X9ZN[NTLT:65@B(I9F8A550,EB3P
M!R2> *X72_CYHFJW2V$%XC3M(8U&V0(S#(PLA01G)&%(8AR0%))&?%/V&/\
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MU^[^'5E/IS:,L02T:$QA% .T'D.-X;YPWSAVR=_SG+<U\]?L,?\ ,1_[=/\
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M47<0"@#@ #@ < 5+^W/_ ,P[_M[_ /;>OIK6_#UMKR"*\ACG0,&"RHLBA@"
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MC&T1S;V5%QP&<;B!C+#/+<]U_P R?_W ?_;.N5_8I_Y \_\ U_R?^B8*\_\
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M)W-@CC'HN@:!!X>@2TM$$<,:[41>@'7OR23DDG)8DDDDDUH5POQ,^"VG?$8
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M\PN;&!X91CYDN+D9 (;:P\W#*2H)5@5..0:/$WP&T?Q1,;F^@>:4Y^9[BY.
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M;5+;B :[JN:\7_#JS\8 I?+)(A55,8GN(XB VX9CCD5&(;G)!/ YX&,KPO\
M!'2O"K^98120$LC,$N;H*Q0DKO7SMK@9/# C!((P353XC_ NR\>W,-]-)/#<
M0J%22"0(V%;>GWD?!5B2I7:<GDG"XB\2?L^Z9XDM1:W7G22#9BZ>5I;OY?\
MII+OPIY)C \H%BRHK8(ZKP9X&M_"$*P6V\XCC0O([2R%8QA%W,3A1DE47;&I
M9BB+N.?,-?\ V/\ 1M7G>X4SP"1MWEQ-&L2D]=H:)BH)YQG SA0%  ]/\-^
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MV'[1#]J_YX>8GG?=W_<SN^[\W3[O/2M6L76_&]AH+B*\NH('*A@LLL<;%22
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M0VV@H);R:.!"P4-*ZQJ6()"@N0,X!..N ?2C1/$-MKR&6SFCG0,5+1.LBA@
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M66?B#=]BN(9]F-_E2)+MSG;G83C.#C/7!]*MZIJT.D1M/<R)%$N-SR,J(,D
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M/K7TU6?K?AZVUY!%>0QSH&#!94610P! 8!P1G!(SUP3ZU\H?L:^$[/Q!]O\
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M'/E6EQ(BB65$W*A=2R(ZK)AD4@.& (X')SYU^QK;"ZT2YC;(#7LRDJS(V#!
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M)*J"2,DDDY[7P-\']/\ $.CVSWD?G33Z9;1F:3;))&IA^00[E*1;-YVE%!)
M>0N^6/BG[,G@R'X@Z?J6FW:H57RV@<HK/#+*KAI%8;7_ .6,>5W!6";3P6SK
M?L?VL.FZA>:?=VR?;H-S+*0KO'Y;&&:,/N(7EQ@QCY@7W,0$ ]J^)/@.S\:W
MUG!+$C20R"XF?8C-Y,8<1P.Q5CMDF?(1L*Z1SD$,G/-?&CQ+'#=Z?X<B8Q6T
MRLUU'!#,\AMXQ\D"" ;@DGENC>6-RJ,G"9#97Q%\#:%JNF2VUG83QSQPDV[1
MZ=>1RF1$/EJTC6V7#'Y7\PG.=Q(8!AM?#WQAJB>&;F>_2:&^M+>Z"23H1(_E
MQ&2*4K(@SC(7+!MQ0LQ))%<?^S-+H7BFT\B\B@FU0S2M,;E$EFF9BSAT,NYG
M&P?,%Y#*S,HW;F]5\$?!2R\.0W%B\,<UH]Z;B&.51/L#0Q)@^8O4,'"GYCL(
MRQ8M7@O[&OA.S\0?;_MMO#/L^R[/-C27;GS]V-X.,X&<=<#TH_;3\,0:9-9W
M,8?S9_M/F,\LLO"F-E51([!%!D8A4"J,\#I7U+XWUM]!L+J\B +P6T\JALE2
MR1LX!P0<9'."#CN*\:_9'_XG]O=ZS=?O;Z:[>-YVY<HL<+!!V506^ZH P%&,
M(@'G6C>#;32O&[Z:(8Y+61I"8I(HI$ >V-SM52FU KX";0"%&W)!;/JOQ9^%
M6H>)]3TR.W6,Z/;M$TD!*+$IC?+9CQ\X:+$<8 8+\P(16);G_P!L^V@LK:TO
MDPE^MRJQ2*VR;RU5W;&""0LFP@\[&;@KO.;?QGLHM>\)KJMU'')>M9:>QG,:
M>:"\D)?#!05!+MPN!\Q&,&MK]ESPG9_V-9WWV>'[5_I'[_RT\[_72I]_&[[O
MR]?N\=*\J^+GAB#P_P"+M,6W#_O)+"1VDEEF=F^TLF2\KNWW44 9P !@5Z+^
MTQXT>>6S\-VTIBDOYHUG=025A=_*"XP-P=B20KJ<1E6^62NKUS]F_1;^R:QA
MM8XB%?RY@&,J.0VUR^\22!2V=CN5. ,8 QPG[)_CJZ9KG0-1?,UEQ$I^9U5'
M,<L9=25*HVP(,YPQ"DHH"\+\9_"46C>*].BM6D0S-8LTC2//+O-RT8?=<&7)
M"HH ;*_*/E(R#Z!^TE\)=.TO0YKFWA"30S1R^;]^:1I)@CB263?*X/FEN6SN
M"\X&*[K]F[5)-3T"RDF;<PC>,' 'RQRO%&. .B(!GJ<9))R:]*KY+_:3MY+G
MQ5IL<$GE2M'9A)-H?8QNI0K[3PV#@X/!Q@UW7Q%_92T_4;*5K%9/[0"EQ,\K
MR//( 21)YCA,R-U8;-K$-]T%35_95^*HNM(GAO6(&FKN:0AF_<%7=>[,2FQP
M % "!%4$YJI\++NP\81'6M=@DO+RX:0#_0;RXMX8E?:D,86.6$@%"VX?."[*
MS%MQ;/TVQE\'^)(I]!M+P:;=^6MTAM[B&!6=W4D"6%=JQY64=AET5E1BHZKR
MX_B]KT\$Y\S3=)V#R"2$ENB6!=T*#<J;70@DC*@KN21U.A\7/V=X/$,$;:-'
M!97L$RO'(B>0".X)A&00<,K;6*E<#:&8UG_M!?$NZ\!:+!;M+_Q,KF-(VEC^
M7!15^TRJ1& ,DA5QL8>8'3!3 Z;0_P!F_1;"R6QFM8Y253S)B&$KN NYP^\R
M1ABN=B.%&2,8)SY?^SSKMUX$UFX\*WLNZ%?,-N",G<,2@KM9@BO"6D*,2 PP
M"'+!N?\ VT_#$&F36=S&'\V?[3YC/+++PIC9542.P109&(5 JC/ Z5[+\8/A
M187.D7LDD8>Y2VEE-TRQFZ9XU\T$R;,@$KM*KM58SY<81 H'"_LK^&8?&.DC
M^T1]HBM;N5(() I@3**[,4  D8F9L&7?LX\O9ELXGA6T3PGX[DL[%1#!(K*T
M:@;=K6HN"HSG:/-4, N  -HPORUU=_XCM?'VN7<&HB2XL-.:)(;>*VNYD,^?
MWDLODJV2C(\:K(IC=2=H/SE^?^-'AR& VVI>&+2Z@U"&8#$%A<P(8RKDLRM;
MJC$-A3_>5F5PR@;>E_:>\8W2>'8)D#VSW<D"SQ='59(9)'A8E58?,H5N%) *
MD8+*=KPOX)\,?$K3O+L(( AA16*+&EY">0N]OFD#@H>6+"3!),B$Y]+\$:(^
M@V%K9RD%X+:")BN2I9(U0D9 .,CC(!QV%;5?*%W=I9_$!I96"(BEF9B%55&F
MY+$G@ #DD\ 5Z+9^%+7XTWD6M3Q(=/M]Z6V1^\NBKX:24=H%=2(HF^9B7:0!
M6V-Z+=_#?3[BV:Q6 16[L6>. O:JY*[&W?9VCW KP0V00!D' Q\P?L?>$(/$
MXOH[L&2%6LV,.<1.P:9D,@&"X4KPC$QG.71B$*VOB'H<7@3QEI[:<HA$[6A9
M%1%C422-;2*JA0%#1J<]3N9F!!QCMOB_KX\=:]9^%@Y6V#>;>*-P$A5#.L)Q
ML;&Q =RN1F0-C?$*W_BC^S?IVLZ<\.GVL<5U%"?L[(-K,R[3L<[T#EPFS?*6
M*EB^<YSE?LZ^+Q\5M(GT_5R+EXF$<@8-N:)E!B=F[ON5P'4AP45S\_SMYK\'
M_!UMX)\72Z5<H)P%D%LS*LFQ@$NHI"65=KB)2"R#(<X7Y3FMK]L;X<6MI'%J
M=JB1SF1Q.J)@R*Q!,[;2!\LC!6<KEFF0,V=@/LMIK-A>>'UNXK6![9[82+9J
M(VA:4_,+< )M+F?Y  FXR_P[^*MZ!\&['2M,32"I,07]Z8WE@,SE-DCOY<@9
M@^3E&9E VKC"KCYU_8^\(0>)Q?1W8,D*M9L8<XB=@TS(9 ,%PI7A&)C.<NC$
M(5M?$/0XO GC+3VTY1")VM"R*B+&HDD:VD55"@*&C4YZG<S,"#C'UU6?K?AZ
MVUY!%>0QSH&#!94610P! 8!P1G!(SUP3ZU\H?L:^$[/Q!]O^VV\,^S[+L\V-
M)=N?/W8W@XS@9QUP/2NPUB[B^,GB9](G8MIVGPRL\.7599E(B=B5\MU*O+M!
MRPQ&=ORRM6A^T)\#[6*Q?4])A2VO+3;*&@'DYCC+,^ K(BLN?,W@%SL"#J,=
MU\ ?B(_CW28KJ=@UPK/%.54H-ZG@XZ9,91CM^7+$ +C:/1:\:_:5\ :MXX@M
MK33&'DM,1<H7" CY3&[9&61"&+*,DDJ0C%05J_M6Z!91Z"S.D:/ T*VG1"I+
MHK1Q@8X\H-E!D87=CY 1J_!^W/Q%\.VO]J/),7697(EEB9U626$*[1,C."@P
MP8D.?F;+<UXK^Q]X0@\3B^CNP9(5:S8PYQ$[!IF0R 8+A2O",3&<Y=&(0K:^
M(>AQ>!/&6GMIRB$3M:%D5$6-1)(UM(JJ% 4-&ISU.YF8$'&/KJBOE7X^_P#(
MX:3_ -N'_I9)7TKXF\,0>)83;70<Q-G<J2RP[@05*L8G0LI!(*DE3W' KY0_
M8^\(0>)Q?1W8,D*M9L8<XB=@TS(9 ,%PI7A&)C.<NC$(5M?$/0XO GC+3VTY
M1")VM"R*B+&HDD:VD55"@*&C4YZG<S,"#C'0?M">+X+'Q#I]MJQ+Z7'"LTD.
M-R>8S3QK(RC!<*54E3N^4. IWLK>BZK\'])\2BTU#2H[9'M[N":.6W\M(G5)
MD\Y&,2E7^56V]U< ;E!<'@/VT?#$"6,-_AS.;M(\F65D56AD+!8V<QIDQH25
M4$D9)))SVMW\0_\ A7_A6UOU"-*MA9+$CMM#.T<:@>K8&7*C!*J>5Y89_P "
M/@I9+IT=]J,,=W=WBBXDDF47'$F70#S%X.U@7/)9RV690N/*O!OAD>&/'26:
M.72-I/+W%B5C-DS1199F8B-"L8)/(4=.@]*^)GB6'Q5K@T&Z:1]/@MO.N8(8
M;F1Y921Y<;FW!<(JO'*"!LW?*^6V[,7XU>$=-U.R\[1;*YAU""1'@-OI]W;$
MG>N[<1;HIPN74DAE91M(RP;U7PC9O\0=&@768IHY7C*SQEY;9V*[XF+B+R3M
MD&7,9&S# 8. :^:OV4OA]'XV^VPW;N;-?LQEMU)19F_?>47=2'VIAF" @,Y5
MB?D /U)\+_A?;?#>V:SLVD='F:4F4JS;BJ(0-B(,80=LYSS7845\J_MS_P#,
M._[>_P#VWKU#XP?"BPN=(O9)(P]REM+*;IEC-TSQKYH)DV9 )7:57:JQGRXP
MB!0.*^"'Q5ETGPG<7EPP)L6EBA+!WR=D9@1L$DCS)1&,;0J!1P 6K0^'&G:3
M=6J7VJ6TU[?74:2SSRZ=>3@ELLJIF"2)556" Q81E52!C:!E?!VSN?!VOSV5
MA;W@T6XW,AFBGCCC<1"3?F:)6'S*T(R5+ H69RJD_2E<!\=/B-_P@&ERW2'$
M[_NH/^NK@X;E67Y5#/AAM;;MSEA7*?"/X'Z9=:7%<7T*75S>VZRSS2AGD)F#
M2<%F8HP$FTNA5F(#GYL8\_\ !US-\&O$YT;?MTV]DW1(0S@>8&6$KAG96$H$
M)9OOJ-[C&QEUOVT?#$"6,-_AS.;M(\F65D56AD+!8V<QIDQH254$D9)))SH>
M%_V;K+QMI5E/J,T\EPUM;LLJN$V1>4/+MU0J\81002=N]GW.6&XK7T)11111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111117RWJUL=(^($4UQB-)U#1LS* P-FT"]^"95* '!)Q
M@'(S[U\6/^0/J'_7A=_^B7KRK]BG_D#S_P#7_)_Z)@K$_:MTL>+]3TG2(F/G
M.TN_:C.4CE>-?-P, @"*1B,C 0EMHP:^FJ^6])MCJ_Q EFM\2) I:1E92% L
MU@;OR1*P0@9(.<@8./J2BOE7_FH?^?\ H'5] ?%C_D#ZA_UX7?\ Z)>O*OV*
M?^0//_U_R?\ HF"O?Z*^5?V&/^8C_P!NG_MQ1^W/_P P[_M[_P#;>OH#XL?\
M@?4/^O"[_P#1+U\O_#K2Y-3\$:I'"NYA=F0C('RQBUED/)'1$)QU., $X%>R
M_LQ_%6#Q9IT5B6"W=I"L;QXVYC3"1R+DG<-NT.>,/G*JK)GT75?&,=E>V^G*
M-\\^]F49)CB5'/G-A2 ID"QC<5W,_P I)4BN@KPK]LG2Y+W15DC7*PW<4DAR
M!M4K)$#R1GYY%&!D\YQ@$CN_@[\58/B-9)<1L//146XC VE),<X!+'8Q!*')
MR."=RL!M1^,8[C4#ID0WO';M+.PR1$2R"&-L+M#2*SL 6#!4SM(8&CQ-J'VG
M-A"B2S2QG>LB[X4B;*F249&5."J1Y#3,"H*HLLD?S!9/-^S9K0@9O,TR\V%G
M96W! Q&[<J',L6XEE3(=&!*JSKL^NK2[2\198F#HZAE92&5E(R&!'!!'((X(
MKY:_88_YB/\ VZ?^W%>B^,O@_I'QC$UTF8;N.::!YD*[P\#/%B1 2K#[K#.V
M1H_+&Y5P*X#X-Q:C\+/$"^'+J4S6L\,C0?/^["CS)5E5#N*$E)%= 5!8EB7"
MHQA_YJ'_ )_Z!U;?[84T^C/I>JPJ&%K<R'+?=\S,4D:D!@Q!\ELX[#&02,^W
M^!?'5KXXM4O;)]T;<$'AT88W1N,G##/(Y!!#*2I!)H7C&/6[JYMH!N2U\I7E
M&2GFMO\ ,A!V[2T:JA?#'!D"L%((/SK\ O\ D<-6_P"W_P#]+(Z/VY_^8=_V
M]_\ MO6A^T3K;^ O$.F:XP#1"%HBHR7VJSB8@949\NX^3YL;A\PP.?HJV\0V
MUU!]LCFC:W"LQF5U,6U<[VW@[<#!R<X&#GI7DOQ=UIO'WAS49+2/,2R$1/OC
M82Q6\T;2SKM8@+F.3:,EF5 P'SA:E_9C^*L'BS3HK$L%N[2%8WCQMS&F$CD7
M).X;=H<\8?.5563/HNJ^,8[*]M].4;YY][,HR3'$J.?.;"D!3(%C&XKN9_E)
M*D5T%>*_M<^&9M;T4O -WV>X2=P Q;8%>-B  ?N^8&;. $5B3Q@]+^SWXH3Q
M%H=FZ8!BA6!U#!RK0CR^< ;2RJK[2,@,.HP3Y5\5-$?Q/XST^*U(8V\-M+-C
M)$:Q3R3,'VAMI*E0N[ )=.0&!K;_ &UO^0/!_P!?\?\ Z)GKU7X3_P#('T__
M *\+3_T2E=57D'[2/QGD^&]K&EJN;JY\P1N0"D83;O<@_>;YQL!&W.2V0NQI
M?%OPS@T;2KZ[N";J_P#[.NPUW-\TF3%,2(U)*P)^\8!(MHVD [L9/-?L4_\
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M,54_*/*<L1DJJEB,8SG_ !&9_ GC6WU2Y ^SW+1;7+%$56A%I(6=EV@IGS&
M)&TKDKNX^JKN[2S1I96"(BEF9B%55 R6)/  '))X KY0_9G\"W5UH>KRHF?M
MMN\-NI^4NR13*2"P"[2TH4-NQN5P<;:Z7]D#XJP7=H-$F8)<0M(T(QCS(V)D
M;!).YU9F)&%^3! ;:Y'M_BOQC'X?:"(C?/<W$<440SO8%U\V0!58[8XR9')
M4  %E+ U\Z_MS_\ ,._[>_\ VWKZ ^+'_('U#_KPN_\ T2]>"_LY>.$\#>&+
MW49$,@AO7PBD LS1VR(,GH-S#)P2!D@,1@]U\(M"_P"%G64>LZXWVII9)&BM
MV&+2$(\T0 AR4D;EOWDH=P-H!RI9O/\ X!?\CAJW_;__ .ED=?55?-?[;7AF
M:]M;2^C&8K>25),!B5\WR]C' ("YCVDDCYF0#.>/>O!/BA/%5E!?QX FA1RJ
ML'"L1\Z;@!DJV5/ .000#Q7S_H.B/KWCNYO+<AH;5097&2H8VJV_EY4%=^\G
M*D@X1^ZD5G_MS_\ ,._[>_\ VWKZJHKE?BQ_R!]0_P"O"[_]$O7E7[%/_('G
M_P"O^3_T3!7*?\U#_P _] ZNK_;6_P"0/!_U_P ?_HF>O5?A/_R!]/\ ^O"T
M_P#1*5\__L,?\Q'_ +=/_;BC_FH?^?\ H'5[K\:]4CTS1;^29MJFTFC!P3\T
MBF*,< ]7<#/09R2!DU\JZAX%NK'P4D[I\K:FMT0?E98FB-NC$,%SN?:5V[LH
MZMTSCZE^#OQ5@^(UDEQ&P\]%1;B,#:4DQS@$L=C$$H<G(X)W*P&U'XQCN-0.
MF1#>\=NTL[#)$1+((8VPNT-(K.P!8,%3.TA@:^=?^:A_Y_Z!U=7^VM_R!X/^
MO^/_ -$SUYI^T5I<DN@Z#<A?W26B1LV1PTEO R#&<G(B<Y P,<D9&?K7PIXF
MA\46L5];',4T:NO*DC/56VE@&4Y5@"<,".U?,O[.]VEYXMU26)@Z.M\RLI#*
MRF[B(8$<$$<@C@BI?VY_^8=_V]_^V]?0'Q8_Y ^H?]>%W_Z)>O*OV*?^0//_
M -?\G_HF"N4_YJ'_ )_Z!U=A^TSHUEXNGT_2)'$=[-,WE2EP$BC./,WIG+F0
MJ%A7Y=\BX$B@,K=7XA^$][XP2"UU6_$MI&RM-%#;FV:X*@;?,<3O@;AN(15!
M). K!&3TJTM$LT6*)0B(H554!550,!0!P !P . *EKQK]J62RN=.CL[P@2W%
MS&ML6E$2QR<J9W)S^Y16(D^5N& ^4D.MN7X/:C=:=%HTNI 6J*D;M%:^5<20
MKQY)?SV104PN1'D@#?O!<-V&L>!8TTF;2-/1(4:TFAB7D(I=&4%CAF/S-EF^
M9B26.23GQ7]B[7?L\-YI,R^7/#<>:58[9#N BD7RR PV-& Q[%P" <9U?VS?
M]*TVUM8_FGEOX_+B7F1\1RJ=JCYF^9U' /+*.I%>R^"-$?0;"ULY2"\%M!$Q
M7)4LD:H2,@'&1QD X["OEKX>7DGP.UV^TUU>2*:WD:V3@&=D#26HWE%)9AOA
M_=JP,S;0K8&/JKPMH7]A6Z0%M[C<TDF-N^5V,DTFW)"[Y&9MH.U<[5P !7S+
M\/\ X@)\-O$^IV>I8BBO+EF\PX(5C(TL#,P;"HT<QW$@E25W; '(^G]?U^#P
M] ]W=N(X8UW.[= .G;DDG  &2Q( !) KE?&^I/JGAZZN)8S"\FE3NT39W1LU
MNS%#D*<J3@Y .1T'2O.OV*?^0//_ -?\G_HF"N4_;G_YAW_;W_[;U] ?%C_D
M#ZA_UX7?_HEZ\J_8I_Y \_\ U_R?^B8*Y3X!?\CAJW_;_P#^ED='[<__ ##O
M^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7A7[-FER:OX5U*V@7=++)>1HN0,LUK$J
MC)( R2!DD#U-:'[('Q5@N[0:),P2XA:1H1C'F1L3(V"2=SJS,2,+\F" VUR/
M;_%?C&/P^T$1&^>YN(XHHAG>P+KYL@"JQVQQDR.2 H  +*6!KYU_;G_YAW_;
MW_[;U] ?%C_D#ZA_UX7?_HEZ\J_8I_Y \_\ U_R?^B8*Y3]AC_F(_P#;I_[<
M5]545\J_ +_D<-6_[?\ _P!+(ZZO]M;_ ) \'_7_ !_^B9Z]5^$__('T_P#Z
M\+3_ -$I7S_^PQ_S$?\ MT_]N*/C[ITGPZ\0VGB6/>8)9(Q,5 <@HHBDC&Y0
M@WP?<!;<6$A!4*"/H#P/_P 3-I]2;K<2%(O3[/ [I"5(P'5R7G5\<K,%#,JH
M:\*_:'\0R>!/$FFZRR;H%M_+/1B0'E6<*NY3N$<X*DD*6(Y(#"OH_0-?@\0P
M)=VCB2&1=R.O0CIWY!!R"#@J000""*Y^P^)D%[:7FHH"UK:M-MD3D3)%$KR/
M'N"JP#[XP02K%"0^#QY7\0/V3-.\5I]LT>06[R+O4*?,M9-P9P1@DH&++AD)
M14'RQ&K_ .RQXSOM3CO=-U1GDN+&X"EY'$C_ #EPT9;G=M>-L,6;(8*,*HKB
MOV&/^8C_ -NG_MQ1^W/_ ,P[_M[_ /;>OJ6[NTLT:65@B(I9F8A550,EB3P
M!R2> *^=?V=_!CD7.JZ%<QP6ES,R+:S1&[=%C8["[)-"R/\ ,Q5,N!&ZEGD;
M##U7X<?"M/"3S7EQ*;O4+AB9KIU"L5S\L:*"1&@ 'R@X) _A5%3A/'WQ/N->
MUV+PM92/:J<_:;A0IE(,!F\N(G.SY/\ EI]\.05 "?O.:_:O\%VGAC1HQ:1!
M#)J*-(^2\LC&.Y;=)(Y:20Y=L%V)&<# K;^)?_(C1_\ 7AIG_H5O75?LN?\
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MO[7/AF;6]%+P#=]GN$G< ,6V!7C8@ '[OF!FS@!%8D\8/2_L]^*$\1:'9NF
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M@^3\QW _, WW@"-7XG? BV^)$B27UQ<[8]WEQQF!43<$#X)@+G.P$[F;!SC
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MB;&1_+;S$DCDVE]C*<$[0Z;LH67!.!NSC(%=A:6B6:+%$H1$4*JJ JJH& H
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MD;EY9'/+NQY)/L  H &U1111111111111111111111111111111111117/\
MCKP+:^.+5[*]3=&W((X=&&=LB'!PPSP>002K J2#YUHGP6UCPXAM['6Y$MPQ
M\M);6*X9$ "H@>1^@4 84*N<D(N378>&?ADNG7 U"]N)KV\$859)M@CB)4+(
M88D54BW[1NQEL#&XY<MVM%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9^I:#%J3QR3 L8FW*N]Q'NR"&9
M P1RK*&0N&*, R;6YK0HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKC_%_P 7M)\'
MDI?74<;AE4Q@F24$KN&8XPSJ"O.2 .1SR,]A111111111111111145W=I9HT
MLK!$12S,Q"JJ@9+$G@ #DD\ 5E>$/&EIXQ@%W82B6(LR[@""&'52K ,IZ'!
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MG&1G'3(]:U:***Y_2_B%INKR+!;7EM+*V=J1SQ.YP"3A58DX )..P)J+Q?\
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M#+9S1SH&*EHG610P )4E"1G!!QUP1ZU-JFK0Z1&T]S(D42XW/(RH@R0!EF(
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MP=V7BO2])\GR8_LNSR/+3RO+V^7LP-FW;\NW;C;CC&,<5GZWXWL-!<17EU!
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MVUY#+9S1SH&*EHG610P )4E"1G!!QUP1ZU;N[M+-&EE8(B*69F(554#)8D\
M <DG@"L_4/%EGIT*74]Q#'!)MV2O(BQMN!9=K$A3E02,'D<CBM"TNTO$66)@
MZ.H964AE92,A@1P01R"."*\J\(_&E/&6ORZ=8N'LX+*1F< 8DF$T2EE;)W(J
MMA2,!B6/SKL:O4-4U:'2(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*S]+\;V&K!F
MMKJ"4*T:L4EC<!I&V1J=K'!9OE4'ECP,FMJBO)=4^-*77B"TT*Q<, UQ]K(
M(W+!(R1!L]0PS)@9!"KNR)%JI^U5X>MI]%NKQX8VN$6W5)BBF55^T1_*'(W
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M4/\ KPN__1+UY5^Q3_R!Y_\ K_D_]$P5RGQ]_P"1PTG_ +</_2R2O5?VH_\
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M:[F^:3)BF)$:DE8$_>, D6T;2 =V,GFOV*?^0//_ -?\G_HF"N4_88_YB/\
MVZ?^W%'BSQK_ ,*R\:2WMXNVUNK>)6<#>PB,<:>8 K9&)H<,""VP-M4DK7U!
M_:T/D_:O,3R/+\SS=R^7LQNW[L[=NWG=G&.<XKA/$WB8>)_#U[>(A1)+*_\
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M9&,=RVZ21RTDAR[8+L2,X&!1\:M$?4?!EA*A %O#I\KYSDJ8!#@8!R=TJGG
MP#SG /LOPC^)</Q L8KI&3S_ "U\^)2NZ-\LIRH=V569&,>XY*8/7-:&F^.8
MM5OY+"V E$$.Z>59$98Y#(42 J"6WG9(6R!L"J#DN,?/7P"_Y'#5O^W_ /\
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M7VSW?[F,#825/^N)#'.WR\H6 )5G3H2"#]E[X<2>"]+W72;+FYD,KJR!9%7
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M /LZ[#7<WS29,4Q(C4DK G[Q@$BVC:0#NQD\U^Q3_P @>?\ Z_Y/_1,%<I\
MO^1PU;_M_P#_ $LCH_;G_P"8=_V]_P#MO47[4<Q\.^(=,U692;=%@.5VEF,%
MPTDB@%AR%=<9P"3C/!Q]2_VM#Y/VKS$\CR_,\W<OE[,;M^[.W;MYW9QCG.*^
M7_V&/^8C_P!NG_MQ7U57FO[2.ER:GH%['"NYA&DA&0/ECE260\D=$0G'4XP
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M(XHHAG>P+KYL@"JQVQQDR.2 H  +*6!KR#]M;_D#P?\ 7_'_ .B9Z]5^$_\
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M@/\ #O,RE@#G&1D# )8@L?:OAG\*K+X<P&WL5.7;=)(Y#2N>=NX@*,*#A0
M.3C<S$\5=_L[&UU=M9TR^DLS*Q::-8UEW%VS-@R,5 ;[P#I($?Y@,!57UO2]
M/_L^-8][R$9)>1MSL22S,> !DDX50J*,*BJH"BU7D'Q!_9\_X2#4TUK3[M[*
M\7!=PGG!BJA%8 NF/D&QUY1UP"OWMW5>(OAD=?M6LIKV\"2;O.96A5Y0=HVG
M]QM10J[=L0C5@6,@<NQ.?\,_@G#\.21975T8F;<\,C0O$S;2N[ A#*>F2C*6
MVJ&W  5E7/[.5O<ZA_:[7MZ+T,K>:K6R'*J$'RK;!,;!M(QAAD,""<Z'Q2^
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M*;I)74@MF5W1CAFC9E#5#\)O@8WP^MWMQ?32!I)'78D<**[QK'YFTB0NP .
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MR^.IZ#>/ITK;]Z+$DT.& RJHQ0!<@MM;>H;:4";%%=7X.^$BZ3='5-0G>^U
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MC>PUYS%9W4$[A2Q6*6.1@H(!8A&)QD@9Z9(]:VJY_P =>.K7P/:O>WK[8UX
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MMTLMI;R.V ,LT:LQP  ,DDX  ]!6AK?B&VT%!+>31P(6"AI76-2Q!(4%R!G
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MSH&*EHG610P )4E"1G!!QUP1ZUYK^T-\:4^'EH8K=Q_:$R_N5P'V+G#2L"<
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M:.:,9\HN29-I4ORCJ"-B!5C\L%2K%2/J72=4CU>&.Y@;=%+&DB-@C*L RG!
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M00(D/F*&)R?VO?AQ:Z#9P7EBB6ZM<+%+%$GEQR'9(\4A52$W)B10=I8B0C<
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M,&DX+,Q1@)-I="K,0'/S8QY_X.N9O@UXG.C;]NFWLFZ)"&<#S RPE<,[*PE
MA+-]]1O<8V,O=_$.<?$C7(O#>\BSMX3<WR*S(93E#%#PF2 61CAL$.<%9(U(
MVOB?^SYI_BBQDM[*WMK:YX:*5(ECPRGHQC"DJPRISN SOVLR@5G^*_A^\OAF
M6+7?+NKVULKIEGY9E90SQLLA5'SM2,.>"Y4[]P)S@?L:VB7FB7,4JAT>]F5E
M8!E93! "I!X((X(/!%<3H.@0:!X^%M:((HE9V5%X4%[%I&P.PW,2 . .%
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M /,._P"WO_VWKZ*^(6ER:OIMY;0+NEEM+B-%R!EFC95&20!DD#)('J:\0_9
M^*L%W:#1)F"7$+2-",8\R-B9&P23N=69B1A?DP0&VN1[?XK\8Q^'V@B(WSW-
MQ'%%$,[V!=?-D 56.V.,F1R0%  !92P-8'C[PMI?Q$F;2+]-T\5NL\;!@DBK
M*9(BT9!W':R N&4QY,6X,< ?.GC'P'??L[74.I6%P\MC)<*'3<(RV-Y$,B_,
MKYBW;90ORMN8(AV;N@^/O_(X:3_VX?\ I9)7U!JVJ1Z1#)<SMMBBC>1VP3A5
M!9C@ DX )P 3Z"OEK]ESX?W.HZ-JK#"B^A:" ON4%ECF0N?E.4W2A<KN.5<8
MRO.W^Q=KOV>&\TF9?+GAN/-*L=LAW 12+Y9 8;&C 8]BX! .,ZO[9O\ I6FV
MMK'\T\M_'Y<2\R/B.53M4?,WS.HX!Y91U(KNO$.B/H/AB:SE(+P:/)$Q7)4L
MEJ4)&0#C(XR <=A7"_L4_P#('G_Z_P"3_P!$P5RG_-0_\_\ 0.KUOQO\.](^
M+,L]M<J1=6;)$TB,J3*KI'.I'W@R$,57S%(#"78 <L?%/#OA[4?@-KEE9^>9
M["]F$8 /EH[.8XW8QDOL=&9&W#EU 4.,NJZ'[<__ ##O^WO_ -MZ^JJ^0/AY
M>2? [7;[375Y(IK>1K9. 9V0-):C>44EF&^']VK S-M"M@8^JO"VA?V%;I 6
MWN-S228V[Y78R32;<D+OD9FV@[5SM7  %?,OP_\ B GPV\3ZG9ZEB**\N6;S
M#@A6,C2P,S!L*C1S'<2"5)7=L <CZ?U_7X/#T#W=VXCAC7<[MT Z=N22<  9
M+$@ $D"CP]J3ZI;0W$L9A>2&-VB;.Z-F4,4.0IRI.#D Y'0=*\Z_:C_Y%V\_
M[=__ $HBK%^">B/KW@Y;.(@//;7\2ELA0SRSH"< G&3S@$X[&N:_8NUW[/#>
M:3,OESPW'FE6.V0[@(I%\L@,-C1@,>Q< @'&=7]LW_2M-M;6/YIY;^/RXEYD
M?$<JG:H^9OF=1P#RRCJ17LO@C1'T&PM;.4@O!;01,5R5+)&J$C(!QD<9 ..P
MKFOCA\4O^%:Z>;Q8_,E>011*?N!V5F#/R#M 0D@<L<+E<EES_A?X'36;:UU?
M5'-[>R0QS*\H'EP^8L3A88A^ZC*[%RZJ'9@6+ -M'DG[#'_,1_[=/_;BOJJO
M!?$WP"TCXO0)J]@QMI;E1*9$VNC,VW>)(PVW>,,K;&4^86+ER*ROV:=8U'P]
MJ-WX:U-S(;>%9(R9/,5%7RT"ID;MC)(C*I*A N-@9FQB? +_ )'#5O\ M_\
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MVS_[>/\ THEKD/AYXQ?X\W=X)GDATNW6-5M$8QM-YHE7=-)&P?&T',2ML)*
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MF*Y*EDC5"1D XR.,@''85YU^TC\9Y/AO:QI:KFZN?,$;D I&$V[W(/WF^<;
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M5?VH_P#D7;S_ +=__2B*O-=,TN34_A\8X5W,(Y9",@?+'>M+(>2.B(3CJ<8
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MUHEG:W(VRB-G9<,"OF2/*%8, 0P#@,".&!'/6O%/V&/^8C_VZ?\ MQ1\??\
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MA=DFA9'^9BJ9<"-U+/(V&'JOPX^%:>$GFO+B4W>H7#$S73J%8KGY8T4$B-
M/E!P2!_"J*G=5Q_Q>\('QAI-U8H"7DA)C"E5)D0B2)<M\H!=5!SC@GD=1X7^
MS3XO'BK3XO#S$ Q32R3 !ANM59)-A)RK&2>7RW3&UK<2JVUBI;)\8ZD_PA\7
M/=6\9D2\A9Q!%EY)&F# (=X)4M=QAODR0I 4'_5U]2^%-"_L&UBM2V]HXU#R
M8VF1^LDK#)^9W)=B2268DDDDGYJ^/O\ R.&D_P#;A_Z625ZK^U'_ ,B[>?\
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M)A/?W=XVW<(T5X%CC#')55$'T&YLN0%#,<"O0/#.AMHD(@>>:XVX ><QM)@
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MVE FQ175^#OA(NDW1U34)WOM0,?EB>14C2-1N&(HD&V/*G#')).X@KO<'?\
M'7@6U\<6KV5ZFZ-N01PZ,,[9$.#AAG@\@@E6!4D'P6V_8>MEGW27LC6^YL1K
M$JR[>=@\PLRY'&3Y>&P<!<\>ZS> XH;)=-L9)+*%%V@VY17VD,"-TB2$$EMQ
M<8DW?-OR3GC_ (>?L\6WP_F,]A=WB[MHD1G@:.0*<A64P?4;EPX!8*PR:/&O
M[/%MXQO%U"ZN[P3I@1&-X(_+"NTB*I6 -\K,=K$E^F6)&:S_ !G^SS)K-[!J
MMIJ$EO>PKAIS#"[R$$[&81"!,A&,;94AXPJD8!W3?$']GA?'=JD=[>327D>-
MMRRH$&<>8H@C\N,*Q&<_ZT':&E95"UW7@'P8?"=M';-/)<%(8HPS[54+&NU5
M1$ 51U.3ND((#R.%7'07=HEXC12J'1U*LK ,K*1@J0>""."#P17BNF_LVR^$
M[F2XT#49+))5P\30I=+]XL,;V484'"E@S@;OG.XBNZ\ _"V'PI)+>22/<WUQ
MCS[F7;O. ,H@4 1Q9&0@S@!5+$(FWG_B'^SQ;?$"83W]W>-MW"-%>!8XPQR5
M51!]!N;+D!0S' KT#PSH;:)"('GFN-N 'G,;28  "EHXX]W3.YMSDDDL>,:M
M?&OPW\)?\)+XJU5$E>">*2^E@F3[T<HNE4,5/RNI5F5T;Y71F'!((]KB_9_;
M7+J.\\07KZB8,>3$8H[> =2V^-"P?)VD_=SM"OO7"CT_7] @\0P/:7:"2&1=
MKHW0CKVY!!P01@J0""" :^=;G]AZV:?='>R+;[ES&T2M+MXWCS RKD\X/EX7
M(R&QS[AX9^'%OX4L1IVG,]NHP?-01M,6R-TC&2-T9FQ@DJ0%X4* H7BO#?[-
M%MX:NC?VM]?)<MOWR&2!R^_EMX>W8/D_,=P/S -]X CT7QIX0@\8VDMA=@F*
M50&VG:P((96!]0P!&002,,",@\)\*/@K<>!8Q;2:C-/;+('2%46% <[B"V9)
M=I8!MB.B$[@ZNKN#E:/^SM/X9U":]TK47M(+B0%[=((G&W=N**6)C&"6$9\H
MF-3M^8;MQXK_ &8X=8U"#58+N:*XCDC>9V"SO*Z,K+(-Y"1MQC 0Q !0L2JI
M5MOQQ\ X?&R)%>WMZ\2,65/,A"[R/F<_N,DDY(!.V,,4B6./"#?\+_#QO#5I
M]A@O;HHJHL3/]G>2)5).U"UO@@CY<.'"J $VX%<AX;_9HMO#5T;^UOKY+EM^
M^0R0.7W\MO#V[!\GYCN!^8!OO $:OQ.^!%M\2)$DOKBYVQ[O+CC,"HFX('P3
M 7.=@)W,V#G&!Q7:^&=#;1(1 \\UQMP \YC:3   4M'''NZ9W-N<DDECQC$^
M*OPS@^(UDUC<$H=P>.1>2D@!"MC(###$%3U!."K884/AA\,KCP?#'!<W\UTD
M.1"A588U7&U0<;I'V@L%#R&, KB,&-&'/^-?V<X=5OEU?3+A["^$@=G1%DC8
MX;<QC)7YFR _S;'&[<C%V8ZNA?!QGNHM0UF[?4+FWW>1NCC@@CSM(<1)D&4$
M'YR?[OR[D1AZ57 ?&?X/P_$ZU6WD?R98Y \<P17*]G4@E258=0&7YE1CG;@Y
M\/P7EU:R;3]:U">]C*[5 5+<# 78Y*;I)74@MF5W1CAFC9E#54^%_P !I/ E
MLULFH3G,S2*8DAB56*HA8JZS;SM4KART>"&$8D59!%X;_9HMO#5T;^UOKY+E
MM^^0R0.7W\MO#V[!\GYCN!^8!OO $:OQ.^!%M\2)$DOKBYVQ[O+CC,"HFX('
MP3 7.=@)W,V#G&!Q7:^&=#;1(1 \\UQMP \YC:3   4M'''NZ9W-N<DDECQC
MG_B5\+4^(,?V>YN;F.W^4M#"T2(Q4DAF+1.YZCY2VS*JVW<,U%X ^$Z^!8&M
M+2[NC"5<(DA@<1L^#O3,&00<D*<QY+$H22:YK_AFBV^W?VM]NOOMGF;_ #O,
M@W9QC&/L^W;M^79C9L^3;MXKH/B+\'(OB##';7US<^5'L.U/LZ[I%#+YK'R"
M=Q#D$*53T05M> _! \&P"T2XGGB156-9S$QC49^562)&(YP Q8*%55V@8K*\
M3_":#7M6L]9<C?:JZLC)O$@PQAZMM0QNS."%))(Y&U2.ZKSKXN_ VR^)B*9\
MQ7$:L(YT W $'"N"/G0,=VW((.=K+N;/ > _V-[+09Q<7TYNPC*R1^6(HB1G
M_6 M(7&<$#*CC#!U)%>E?$3X4)XWGMKA[F>W-JL^QK=A%+NE\L9WD-@!48$
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M#KL9BW.2#G^)_@5+XLL9+;4;^2XN9%C"S/&BPQ;)=^Z.WC*('9#Y;2%F?:2
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MP(9793ZK7G7Q,^"</Q&(%[=70B5MR0QM"D2MM"[L&$LQZX+LQ7<P7:"170>
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M& 1YDAD.X@??8.<\D-SGL/ _@"#P@CB)I)996#2W$[^;<2$#:F]R!D*ORJ
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M0,EB3P !R2> *\_TKX_:3K6H1:59RF>:1IEW(I\I3&I<Y=MH8$*=ICW@XSD
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M.L,(\U\[RC*3Q&K*02RNZL .F2 ?2J*****JZIJT.D1M/<R)%$N-SR,J(,D
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MG9C?C!9<CG*;MXVL2H49KT6BBBBBBBL_7]?@\/0/=W;B.&-=SNW0#IVY))P
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M*J:7\0M-U>18+:\MI96SM2.>)W. 2<*K$G !)QV!-=!7RK\??^1PTG_MP_\
M2R2O<-;^.>BZ)<BRN+R-9BP4@;G56W%"KNBE(R&!W!V4J.6P.:[6TNTO$66)
M@Z.H964AE92,A@1P01R"."*YKQK\4],\$;1J%PD3-C"?,\A!W8;9&&?;\I&[
M&W(QG.!4O@?XD:?XY1Y-.G$PC8*XPZ,I(R,JZJV#S@XP2" 25..EK/UOQ#;:
M"@EO)HX$+!0TKK&I8@D*"Y S@$XZX!]*Y6_^..CV%I#J,MT%M[AG6)MDNYRA
M*OA GF8!&"2N 2.?F7.KXF^)6G>&($N[NYC2*10T;;MYD4[?FC5-S2#YU)*
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M11*\FW"-EMNT8()S57PE\4M.\6S2VMG-NGA_UD3))#(N#M/RRHC'#<-@':2
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MG@C:-0N$B9L83YGD(.[#;(PS[?E(W8VY&,YP*/!7Q3TSQON&GW"2LN<I\R2
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MOEYSMSYFSR]N?X]VS'S;L<UW6M^(;;04$MY-' A8*&E=8U+$$A07(&< G'7
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M/]J1E:"222R4(=R^9REVS89 01@@G:2,J"./^.R:I%X2M4U!76Y2XB2Z"L9
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MOBUS18[=2!+:LT<B@(G!9GC?:G8J<%V +NKD[CECVOP]M$N#=:DJ@&\N68,
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M+,Q"@ ;FL"[MQW+$L3U)))Y-=A^VM_R!X/\ K_C_ /1,]:'B7XB/X"\)6EU
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MV4XF9E"R.ZL6SN[@D@+A!\H KYO_ &8=$30?$^H6<1)2"&[B4M@L52ZB0$X
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M <* .>M?7]>5?M1_\B[>?]N__I1%6?\ L^ZVF@^%(;R4$I!#>2L%P6*I-.Y
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M44444444444444444444444444444444444444444445\J_'W_D<-)_[</\
MTLDKTO\ :J\'2>)=%D:$_-:R+<E>/F5%=9!DL,81R_<G;M )85:_9I\=1^*-
M&MXPZ&>VC6&5%R"@3*Q$AB3\T:@[A\I;<!@J57@/'^A?\)KXUM(K=O\ CQMX
M);@X^YY<K3A<,5W;O,C7*[MN_.#M8#Z4KP#X_P#Q'NHM4L/#UL[V\=U);&:>
M)]D^V2<Q;$;'R8VEB1DMD+PH8/H?M":!9>$/#-S:6B1VZ,UNJ(N%+N)8CW^:
M1]D9))RQ"DDG!-;7[+G_ "+MG_V\?^E$M>5? +_D<-6_[?\ _P!+(Z/VY_\
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MZE\ACU=V7! (V9Y#"N?_ .:A_P"?^@=75_MK?\@>#_K_ (__ $3/7JOPG_Y
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M!]E4*5<_*VUY%<;@54 A2PQ4^/O_ ".&D_\ ;A_Z625ZK^U'_P B[>?]N_\
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MO]F?0O[9UC5=>B;-K)<7$4)QC?YDPG+8)#+M4)PR\[^H*D5D_'W_ )'#2?\
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MW/-5/!WP;TSP9(9M/B>%C]X">X*-@,!N1I2CXW'&X':3D8/-9]S^S[HUU/\
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MU7'EV\AMHB=K)N_=!70[3SY;H#CY@<ON]*M+1+-%BB4(B*%55 554# 4 <
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M,6!C*Y96EPV.?GSR=I7C&UK'[,^C:U>O?7,;OOCC00A_*@0(B1IL$01AA4
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MS3^>OGHFY3Y"R@Q8&,KEE:7#8Y^?/)VE>,>M:7X6M](M5L+9/*MUC**L;,A
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MB1CCYF5T=0>,DJ%+%F9MQ.:[#X>?#"Q^'\)@L(]N[:9'8EI)"HP&9C^)VKA
M2Q51DUU5<?\ $SX567Q&@%O?*<HVZ.1"%E0\;MI(888## @@\'&Y5(B\,_"2
MTT"W%JKW,F(Q&)7N9O.5 P8(C1LGE+\J@K$$#JBAPVT5E:7^SEH>D2+/;6[Q
M2KG:\=S=(XR"#AEF!&02#CL2*U?&/P;TSQG()M0B>9A]T&>X"+D*#M190B9V
MC.T#<1DY/-:$/PXL8[)M+,9>T==IBDDEF 4!0JJ9'9D"[04"D!"-RX;FO-;;
M]CS0X9_/;SW3<Q\AI0(L'.%RJK+A<\?/G@;BW.?:K2T2S18HE"(BA550%55
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MK>U+Q%MJL5RS(P(W#(*@]QD$$ZME\?M)NQ&JRD3R7,5M]F92ERDKLJE7C;!
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MA@L;I'E[(0\3MPQ^5950O@*2=N=HY.,BM75/B%IND2-!<WEM%*N-R23Q(XR
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M.K$*"1RG[04T\_A29[Q0EPT-F9D7E5D,T!=1\S<!L@<GCN>M:'[+G_(NV?\
MV\?^E$M>-:7X[?X,>)[Y-0!^R7LS2,RJ2 LDC20S#*;G";W1PAQG?C>R*#]
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MRL=N)T\LL_&T%R%4@CW_ .->J1Z9HM_),VU3:31@X)^:13%&. >KN!GH,Y)
MR:Y7]E7P=)X:T6-IC\UU(UR%X^575%C&0QSE$#]B-VT@%37FGP"_Y'#5O^W_
M /\ 2R.C]N?_ )AW_;W_ .V]?0'BK6[5[JWTB]B21+V.X*K(OF(S0>4^PH59
M3\K,X+$ &, 9+#'SK\?OV=+?P3;G6M'D>#R)(V:,NQVY9$1XGY<,'(8[F/4E
M67:%;Z:\$:V^O6%K>2@!Y[:"5@N0H9XU<@9).,GC))QW->=?M5>#I/$NBR-"
M?FM9%N2O'S*BNL@R6&,(Y?N3MV@$L*M?LT^.H_%&C6\8=#/;1K#*BY!0)E8B
M0Q)^:-0=P^4MN P5*KP'C_0O^$U\:VD5NW_'C;P2W!Q]SRY6G"X8KNW>9&N5
MW;=^<':P&K^VM_R!X/\ K_C_ /1,]>J_"?\ Y ^G_P#7A:?^B4KJJ^5?VY_^
M8=_V]_\ MO7U57RK\ O^1PU;_M__ /2R.C]N?_F'?]O?_MO5O]IN\NO!&M:?
MXAA7=$D8B..Y5I&DC9BC*OF12E5/+<.P V@U[+H'QQT;6H$N5O8(PZY\N66.
M*53T*LC-D$'CN#U4E2"=#X=>-?\ A-(9+V-<6K7#K;.1M:2) J-(1N)&9A(%
M!"ML"Y4'KU5?&NM:<WP,\4QWC\6-Q)(P\L/%&L4K,KQE55@WDDJ^Q<Y"QG"E
M@%^P-+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*J:[XFAT;:KG=-)D0PJ5,
MTI&,JBDC.,@LQ(1%^>1E0%A\U?M7:7=:%>:=XB"INB\F-DSOC26-VG0;LQNZ
MMEQD*F F206 'TUH&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!P5(((!!%?/?[,^A?
MVSK&JZ]$V;62XN(H3C&_S)A.6P2&7:H3AEYW]05(K)^/O_(X:3_VX?\ I9)7
MJO[4?_(NWG_;O_Z414?LN?\ (NV?_;Q_Z42UY5\ O^1PU;_M_P#_ $LCJ*YN
MTM?B%ND8*"RJ"Q &YK (B\]RQ"@=22 .37N'Q[\30^']%O'G./-MY($ *[F>
M53&H )&<9+-C)"*Q .,5S_[*O@Z3PUHL;3'YKJ1KD+Q\JNJ+&,ACG*('[$;M
MI *FO-/V&/\ F(_]NG_MQ1^W/_S#O^WO_P!MZ[7]J[XKW7@BUAMK([)+OS09
M@<.BILW!/1FWX#YRH!VC<0R]-XQ\(67@?0M06(!2]E<"6>0@S32,D@5I9#@N
M[22'&?XFVH "!7'_ +%/_('G_P"O^3_T3!7*?\U#_P _] ZNK_;6_P"0/!_U
M_P ?_HF>O.OB+<S^"!X>\1098)IUK$R[<+A8PQ0N0P!DCE=1\N5"EER1\OT5
M;?'70[F#[4M] $"LV&<)+A<Y_=-B7/' VY;C:#D9X_QI>7'Q7\.7TEJJ%)9'
M-H%\PO)%;S+R04W>;(T+E$"\!HU)SN-<_P#LW?M!6=S8IIVI3)!/:QA5>5DC
MCDB!P@#':H95PI4_,P <%B7V^H0_%>VUC4(-.TR2.Y++)+</&RR)'"JLH.Y7
MQO,QC 4;B%+%@H*M7=5XA^U9\*I_&UE%<6:F2>T9V\L'EXW \S:,$LX**5 (
MR-P 9BHKI?V??B/'XWTN%M^ZY@C2*X5G+R!E&T2,6 )\P+OSR,EEW%E:NZU_
M7X/#T#W=VXCAC7<[MT Z=N22<  9+$@ $D"OF7]G;PE=>-M9F\572ND!DG,&
MY]Q9GS&$!9<M%'&2F1M&X*JY"NJG[<__ ##O^WO_ -MZ^JJ^5?\ FH?^?^@=
M7U57RK^PQ_S$?^W3_P!N*J_ 7Q['\)M0O= U27RX!<'RI9$,8\P,L88C:Q59
M8]CAF?8BJ#G#%J]J\8?'*QLU2#3KFVN+ZXD2*WC$ADCWO(D8:1H0^U5W[B"5
M+A2JG/(\J_:;O+KP1K6G^(85W1)&(CCN5:1I(V8HRKYD4I53RW#L -H->RZ!
M\<=&UJ!+E;V",.N?+EECBE4]"K(S9!!X[@]5)4@G0^'7C7_A-(9+V-<6K7#K
M;.1M:2) J-(1N)&9A(%!"ML"Y4'K\_\ [#'_ #$?^W3_ -N*^JJ*^5?@%_R.
M&K?]O_\ Z61T?MS_ /,._P"WO_VWKZ ^+'_('U#_ *\+O_T2]>5?L4_\@>?_
M *_Y/_1,%>_U\J_'W_D<-)_[</\ TLDKU7]J/_D7;S_MW_\ 2B*O,-&^)D_P
M]\%6=S: &:6::%&;D1EIKEO,VD$,0$( /&2"=P!5O6O@[X;M=#TV'5)CNN9[
M2.:YNYVWS$-&CL&E?D1*% "Y"A5!.6RQ\?\ V&/^8C_VZ?\ MQ1\??\ D<-)
M_P"W#_TLDKU7]J/_ )%V\_[=_P#THBKYK\;^&9KWPGI%]&,Q6\EZDF Q*^;<
M-L8X! 7,>TDD?,R 9SQ]?^!?B/:^+M/34XW18_+S-E^(650TB.S!<;>Y( *X
M<?*0:^=?V;-4CU?Q5J5S VZ*6.\D1L$95KJ)E." 1D$'! /J*M?MS_\ ,._[
M>_\ VWKZJKY5_88_YB/_ &Z?^W%'Q]_Y'#2?^W#_ -+)*]5_:C_Y%V\_[=__
M $HBJK^SEJD>D>%[>YG;;%%'=R.V"<*L\S,< $G !. "?05YU\%+K2)1/JL6
MI#2YKF:0/9QRV\<4:!LQKLNHY YQ\PD0*J[VC14 9:]:^%4&A^'-UKIMY#<7
M-Q(TDCM<13W4S?,Q+%3EL#)P  /F8C<68^E5S_CSQC'X-M&OIQ^Z22 .>?E6
M29(F?A6)VARV ,MC QG->8?%']E/3O$Z/+8*+2ZVG;L^6W9@% #Q@$*,+C,8
M4@L78.>#S7P>\33:WX-OTG.[[/;WT"$EBVP6XD4$DG[OF%5Q@!%4 <9.K^Q3
M_P @>?\ Z_Y/_1,%<?;7:77Q"W1L& 9E)4@C<M@4=>.X8%2.H((/(JW\2M>?
MX6>+H]4D)^RWL,:S'80H3"PNH;:Y8H8XYB% 8@A. V3[5<_'70[:#[4U] 4*
MJV%</+AL8_=+F7//(VY7G<!@XS]9UV;Q!X9N;VX5$>?3+J4(A9E5'BD>)26
M)81E0YP 7W;0!BN*_8I_Y \__7_)_P"B8*Y3_FH?^?\ H'5]544444444444
M444444444444444444444444444444444444444444444444444444444444
M4445ROQ#^&%C\0(1!?Q[MNXQNI*R1EA@LK#\#M;*$A2RG KE-)_9RL;7RTNI
M[R\@AV&*WN9S);H4P$81JJ*<+E0IRFUB"I!KTO5-,74XVAD+A6QDQR20OP0>
M'B9''3G!&1D'@D5Y_I?[.6AZ1(L]M;O%*N=KQW-TCC((.&68$9!(..Q(KTJB
MO)?'G[,&D>,IS=NLD$KLS2- RJ)&./F971U!XR2H4L69FW$YHU']F#2+^"TM
M"LBQ6C.VU653,S^7YC2MLW,6\L#*E"!\J[0%"]AI_P +-,T^Q?2H[=!9R;M\
M9W-N+$$L68ERPP-K;MR[5VD;5QQ6G_LQ6.G;XX+J^CM9)&9[5+DK;L&P&C90
MH8J5 0DMO*\%L\UZ?H&@0>'H$M+1!'#&NU$7H!U[\DDY))R6)))))-<A\4O@
M?I_Q*\MKP.DL?"RQ%5D*\_NR65P5R<@$94YVD;F#5/AK^SWI?P^D^T6R/)<?
M,%FF8.ZA@ 54*J(.A^8+OPS+NVG%=KXI\+6_BJW>RO4\R"3;O3<RYVL'7E"K
M#YE!X/Z5Q7@GX V/A3RP)+FX2&0201W$Q>&%QO\ G2)0D>[+D[BK%6^92IR2
M>!?V=M&\&LDL,'FSITFF/FOG>'5@.(U92 %9$5@!UR22:I^SEH>KR-/<V[RR
MMC<\ES=.YP !EFF).  !GL *Z#7?AC9:_;K970FE@7/R-<W1W98/\Y\[=)A@
M"N\MLQ\N!4/A7X3:?X322*Q22%)%8,JW%SM^8 %@#*0KX4 2+AP!PPK*MOV?
M=&M9_MD<,BW!9F,RW5V)=S9WMO$^[)R<G.3DYZU;^)GP6T[XC &]0B55VI-&
M=DJKN#;<D%6'7 =6"[F*[22:S_AK^SWI?P^D^T6R/)<?,%FF8.ZA@ 54*J(.
MA^8+OPS+NVG%=!XU^%]AXWVC4(WE5<83SITC!&[#;(Y%3=\Q&[&[!QG&!4/A
M7X3:?X322*Q22%)%8,JW%SM^8 %@#*0KX4 2+AP!PPK*MOV?=&M9_MD<,BW!
M9F,RW5V)=S9WMO$^[)R<G.3DYZU%\0?@!I_C:Z34)&FM[I,?O;=UC=BN-C,2
MC?,N/E88;& 20JA>ZT308M%0QP@X+%F9G>61FP!N9Y&9W.T!06)(554850!-
MJFF+J<;0R%PK8R8Y)(7X(/#Q,CCIS@C(R#P2*\_TO]G+0](D6>VMWBE7.UX[
MFZ1QD$'#+,",@D''8D5+XC^!&GZY=2ZB6GBO964BYAF>*6,+&D6U,?( 44AM
MRL3O;D#;MM^$/@Y:>')Q>N\]W=JK*EQ=2F>5$/\  F0%4?>Y"[OG<;MK$5W5
M9^OZ!!XA@>TNT$D,B[71NA'7MR"#@@C!4@$$$ UY+I?[(VBZ?=+=XF=5D+B"
M1U>#N54C9O91Q@,YW8 ?<"0=6#]F?1C>3:A<1O<2S7!FVROF-6+LY 1 @923
MRLF\$ #N<ZWB;X#:/XHF-S?0/-*<_,]Q<G )+;5'FX506)"J HSP!4NK?!33
M=5M(M.F21K6&82+$T\SC*Q-$J;G=G5 K9"(R@$#L6#8G_#.EE+^ZFN;Z6SZ"
MS>Z<VH4?ZN,* 'VI@%!OR-JY)YS%^TQ:)9^&KJ*)0B(MLJJH"JJBXA 4 <
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ML"J&(&5PV5*LP*G->GT5Y+=_LSZ<MRUY8RW5@[J0PM)O)4Y;>>JL5!./D4A
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M@[L-LC#/M^4C=C;D8SG J7P/\2-/\<H\FG3B81L%<8=&4D9&5=5;!YP<8)!
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M0<%2"" 016A7G5S^T/H-M/\ 96O8RY95RH=XLMC'[U5,6.>3NPO.XC!QXU\
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M;.:FO?V>-/DEDNK>6ZM;J::622XM[AXI6$CM(T9ZILW$8 4'Y%RQ.2=_P/\
M"RT\(.]Q&9)KJ50LMU/(9KAU!^52QX  P,*%!"KNR5!J+_A4-C_:_P#;^'^U
M^7M^^?+SL\OS-O7=Y?R8SLQSMW_-7:T44444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444444444444444444444444444444445P
M%G\=-+U'48M)M9?M$\N_YHL/"NV/S>9,A3E00-F_# AMIKOZXJ]^+%L+PZ;9
MJ]Y=+&[R1V[0'R@CB,AVEFB4-N.-@)<8RR@$$V_!?Q+L_%K20PMLN89)4EMI
M"@G0QOL8E4=P5R1AT+(<@;MV0.JHHK*\3>*[7PO";F^E2&(9^9SC) +;5'5F
M(4D*H+'' ->/V?[3<GB:Z:VT'39KY$X:4R"W0'Y\$ED=55E3*&1D9CE=@(P=
MN;X^'PV57Q!8SV =L+*"MW; ;6*@R0\AR58; K$##'Y22.U^''CA/'-C'J,2
M&-)6EVJQ!;:DKQ@G' )"Y(&0"<9;&3TM%%%%%%%%<+\4/B[#\-T6:\@G>%V5
M1+$(67>0Y"$/,CYVH3G;MQCYL\5:^%_Q0MOB1;->6:R(B3-$1*%5MP5')&QW
M&,..^<YXKSK_ (:IA_MK^Q?LK[/M?V;SO,7=OW>7GR]N-OF<9WYV?-C/R5[K
M111111111111117F'QQ^.*?"Q("8#.\[2;5WB-0J!=Q+;7.<NN!MP1DDC !Z
MKX;^.$\<Z?!J,:&,3*V48@E65F1QD=1N4X. 2,$A2<#H)KM("JNP4NVU 2 6
M;:S[1GJ=JLV!S@$] :YKXC?$)/ =N;V>&:6!<>8\7E'9EE1<B26-CEF &T-C
M!W8&,Y7PH^-=G\3?.^Q),GD>7O\ -5%SOW[<;)'_ +ASG';K7?T5B^*/$4FA
M)YB6L]R KLP@\DLH4 _=DEC9B>=H0,21C&2,^/VG[96E7CK%%;7KN[!558HF
M9F)P% $^22> !R37M6B:G)J*%Y8)+<AB-DIA+$8!W#R995QSCD@Y!XQ@G0HH
MJ*&[2<LJ,&*-M< @E6VJ^TXZ':RM@\X(/0BI:*********\U^)WQWMOAO(D=
M];W.V3=Y<D8@9'VA"^ 9PXQO .Y5R<XR.:ZKP%XUA\;V46H6RNL4N_:) H<;
M7:,Y"LPZJ<8)XQ]*Z"N?\8^/['P9&)M0G2%3]T$DNV"H.U%!=\;AG:#M!R<#
MFO*O#W[1][XRD<:-I$UQ G_+629+<9 7<I+(T88%AA1(S%<-@#(&M>_M'0^&
MLQZY:7-C.(W8 JL\,A7!$<4L9VNQ5ER2%1&)5F! SZ5X3UW_ (2"SM[W;L\^
MWBEV9W;=Z!]N<#.,XS@9]!6K111145W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\
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M<U%\2/'">!M/GU&1#((57"*0"S,RH@R>@W,,G!(&2 Q&#ROP.^.*?%-)R(#
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M $HEKU6OSK^)7C6X^+6K>9&N3)(L%K'A4(0N1$K'<1N)?+$L1N8X(4 #[_\
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M#M9ER.<$CH31^U];#1M=CN;;,<KVT$K.K,&\Q7DC5P<_*0L: ;<<C/4DGO\
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M4\_-$44* #\A4 ;'0;??_@IXQT_XD:D^LP#[/?"T:"XM3M;<OF1M'<*X5"^
MH1B02/D4A0%,GBOP;\8R>,_&$6H3##327)"\':HMI5C3(5<[4 7. 6QD\DU[
MU\7/V:+;XB7L=^9C 0JK.J1J3*JG@ALC:^W*[F$@P$&W"X;SK]N?_F'?]O?_
M +;UT'@/QC)X-\#K?0#]ZD<X0\?*TEV\2ORK [2X;!&&Q@XSFN:_8:M$9]0E
M*@NJVRJV!N"L9BR@]0"54D="5&>@KBOC=XH?PKXOEOX\DPS6CE58H6400[TW
M ' 9<J>",$@@CBO4/VVM+NKFUM)HE<VL4DOGX/R*S>6L+,H/^^H8C +;<@N
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M"58 ]"5..AKRKX;>$#XU\6S7,(,EK!J,]P\T94H )9)(#NY4AW"@ 9++N*X
M+#K_ -N?_F'?]O?_ +;UU?PT_P"1&D_Z\-3_ /0KBO*OV*?^0Q/_ ->$G_HZ
M"N4_:C_Y&*\_[=__ $GBK[5^+'_('U#_ *\+O_T2]?*'[&%VD&LR*[!2]E*J
M D LWF0OM&>IVJS8'. 3T!J7]K/_ (J3Q!#96GSSBWMX"GW?WKR.Z+EL+RLJ
M'.=HSR00<>@?M4Z%_P (_P"&[&RW;_(N+6+?C;NV6TR;L9.,XSC)QZFM7]BG
M_D#S_P#7_)_Z)@KY_P#^9P_[CW_MY7JO[97Q'NK":'2K=WBB:W,LQ1]OF!R\
M0C; !V@(V1N*OO\ F7Y0:YKXHZ_I\_A+3;2P<,T<T+2HN]BDABG,N_.=A:5F
M*!L;P&,0**2/0/V,/$-M!ITEF\T:W#WLK)"742LODP_,$)W$?*W(&.#Z&O#_
M /F</^X]_P"WE>J_MS_\P[_M[_\ ;>NF^'7A ^,/!"V* EY(;DQA2JDR)<R2
M1+EOE +JH.<<$\CJ/"OV?OB8/A=J;B_$B0R*89U^8&-PXQ(T>,L4(92,;E#/
MMR?E;[)3XKV%Y/#:64@O)96.5MFCF$:+C?+*P<*B#(')W,2%16/%?&WQW\+W
M?P^UV2\7($ER;JVFVC:6+B4@ EE)C<[2&Y( 8J%<9^K_  S^T-HVL68O)+J&
M%A&#+$[XD1@@=T5657EQG:"BD.1A<GBNU\+:Q)K-NEQ-"]NS[B(I,>8J[CY9
M8#[K%,,R<E"2A)()K5KX@\-_"AK/Q>=+B&V"*X>1@H>5!;%/-$3[L':\;K ^
MXD$N5.\'#=W^VYX0!2UU50 0S6\ARVX@AI(@!]W Q)D\'+ <C[OM7P/\+OX;
MTBUAFR9FA1Y2RE) S*-J,"2V8TVPC/(6-1A0 H\/_;G_ .8=_P!O?_MO7JO[
M+G_(NV?_ &\?^E$M?*'[/=VGASQ!;-?,+<1-<+(92(@C>1*FUM^-IW?+@X.>
M.M?37Q[\21^)?"MS>0!Q%)Y)3>I1F47<:K(%/.UP Z$X)1E) SBO/_V&/^8C
M_P!NG_MQ7E7_ #.'_<>_]O*^_P"HKN[2S1I96"(BEF9B%55 R6)/  '))X K
M\UOAE=I9ZK8RRL$1+VV9F8A551*A+$G@ #DD\ 5]L_M1_P#(NWG_ &[_ /I1
M%7E7[#'_ #$?^W3_ -N*\J_YG#_N/?\ MY7T+^V?://HT;(I8)>Q,Y )"KY<
MR;CCH-S*N3QD@=2*YK]DGQU:Z'IIM9'W7,^IE8X$^>8AHX09"@.1$H5F=SA0
MJMR6PI\E^._A>[^'VNR7BY DN3=6TVT;2Q<2D $LI,;G:0W) #%0KC/U?X9_
M:&T;6+,7DEU#"PC!EB=\2(P0.Z*K*KRXSM!12'(PN3Q7/_'O6)-9\*W-Q-"]
MNS^21%)CS%7[7'Y98#[K%,,R<E"2A)()KSK]AJ[17U"(L [+;,JY&XJIF#,!
MU(!903T!89ZBOJ^O@#]ES_D8K/\ [>/_ $GEKJ_VUO\ D,0?]>$?_HZ>O=;_
M ,8R>#?"$-] /WJ:99A#Q\K2)%$K\JP.TN&P1AL8.,YKQK]E#QM:Q7M[=ZI.
M6O9(8EB>1I))9%SB2-?O&1R5B"(-TC8Q&"-PKSK]G#5H=(UVTGN9$BB7S]SR
M,J(,P2@99B ,D@#/<@5ZU^VY=I>)IDL3!T=;IE92&5E(MR&!'!!'((X(KUK]
MES_D7;/_ +>/_2B6O5:^ /C[\$YOAU=-)&N;&:1C XW$)G+"!MQ8AE'0DG>H
MW Y#JOV+\'?BK!\1K)+B-AYZ*BW$8&TI)CG )8[&()0Y.1P3N5@#QY\58-!)
ML;5A/JDBLL%J@\QS)M!7S "HC0!@[%V3]V&92<5YU^V-X%DUW3XKV!'=[21R
MX7! B=1YDA&-QVLB<C[JEF88!*]!^S!JT,7ARW=I$"P_:?-)90(\322'><_+
MA&#'./E(/0@UX5^QUX%DU/4SJ;(X@MHY L@P$,KJ$\LY&6_=NS$+]T["Q 8!
MC]M;_D,0?]>$?_HZ>O5?B7_R(T?_ %X:9_Z%;URG[#'_ #$?^W3_ -N*\P_:
MJM'@\073.I4.MNR$@@,OD1IN&>HW*RY'&01U!K[9\->.K7Q/)-'9/YJ0^6&F
M3YH"S@MY:2 E795"EPN0N]03G('PW=W:6?BUI96"(FN%F9B%55%WDL2>  .2
M3P!7Z"5\3?$GP@?!7BV&YF!CM9]1@N$FD*A"#+').=W"@(Y8$'!5=I;((8^J
M_ML7:+I5O$6 =KU65<C<56*4,P'4@%E!/0%AGJ*Z_P#9G\"R>#]&CCN$>.>:
M1YI$?&5+85!@#*_NT0E6^8,2#@_*/E7]ES_D8K/_ +>/_2>6OJ#7==L?B'?W
M_A75%0&/R7MB"5E;= LC,A(($L98D8/S(Q!0JLA;P6+X1S_#[Q996-G(9 TT
M4\;!MDGD;W\U7/R@D1QR!@.)%Z*"VP?;-?*O[97Q'NK":'2K=WBB:W,LQ1]O
MF!R\0C; !V@(V1N*OO\ F7Y0:YKXHZ_I\_A+3;2P<,T<T+2HN]BDABG,N_.=
MA:5F*!L;P&,0**2/0/V,/$-M!ITEF\T:W#WLK)"742LODP_,$)W$?*W(&.#Z
M&O#_ /F</^X]_P"WE>J_MS_\P[_M[_\ ;>O0/@1H7_"0>$8[+=L\^WO8M^-V
MW?+.F[&1G&<XR,^HKPK]ES45\&^('L[[]W*\<UKR4VK*)$;:6W8.3$47;NW.
M5 SG-1?M@:_!J^LA;=Q(8+9(I-O(6022LR9Z$@,,XS@Y4X8$#ZZ^$_\ R!]/
M_P"O"T_]$I755^??[35VEUX@O6C8, T*DJ01N6"-'7CN&!4CJ""#R*^E=,^/
M&F>"M M)#-'//'96R"WCD1I3((5&U@"3& 0=[,/EQC!8JI^>O@G\$[SXE7BW
M=VK_ &/S/,FFDW_O_G.]$;(9V9@P=PWR<DG=M5OI_P#:C_Y%V\_[=_\ THBK
MRK]AC_F(_P#;I_[<5W;-IWQS-YI.H@)=6-[<)&8VVS")9-BRKO5AA@ DB_.N
MX*Q"EH]ODGP1^'UUX,\7'3T?S%MXY3,Z'8K1/$#&64D9^>2+*?-M?D$A=U>=
M:WIL_P '==!V2*+:Y$D66VM+!O.WYT&"'C!5R!C)967(91]E6GQ_TB\M%O(I
MP[.HVVRE6O&<G:(A"&WER_RC'RG[V[9\U>*_MN3&=-,=E*%ENB4;:64D6Y*G
M8S+D=#M)&>A(YKJ_AUX0/C#P0MB@)>2&Y,84JI,B7,DD2Y;Y0"ZJ#G'!/(ZC
MF?V)?] FU*UF^2<?9\Q-\L@V&99/E.&^5F ;CY20#@D5R'Q*\('XA>,9K2W!
MEC::W$S1%3LC2*%)V+'*J4P5Y_CPF"Q"GZ4^)OQ,@\*7=E97PC^QWRW4<KR?
M=4J(PF[(*E&WE'#  !@Q8*K _-?[2?[/T'P^1+^P<_9Y9C&T3G<R.P=UV-CE
M-JD88E@0"6?<=NU^U=I=U;Z;HINU<RQV[QSNQWXE,=OD,X)!8E'.<G=M8@G!
M-:O@?XGV-AX.>Q\S?=FWOH?LZ M,"_G2;RO!\I8VWO)]Q5##)<;:Y7]BG_D,
M3_\ 7A)_Z.@KU7]M;_D#P?\ 7_'_ .B9ZB_8GNT;2KB(,"ZWK,RY&X*T405B
M.H!*L >A*G'0T?MD> Y]>LH+ZW!<6C2^8BC)$<@4M+USA3&,@ \,6.%0FN9_
M93^.%KI5J=)U*9(=DA-N\AV(5?<[H6VA5VL"P+MEC(%7[H%?0'A[XAP^);IX
M+$>=;Q1YDND93 )3M*0(PSYC;"6<J=L?RJ3N?"]57RK^UK\$YKJ1M>LEWKY:
MBZ0;BXV#:)QDG*A JN% V!0Y!!=EV_V0/BK!=V@T29@EQ"TC0C&/,C8F1L$D
M[G5F8D87Y,$!MKD>W^,?']CX,C$VH3I"I^Z"27;!4':B@N^-PSM!V@Y.!S7F
M'QF\-W?Q(\.F1K>1+I)C<0VX 678)'5 Z[G._P"S/N9%.[S/E S\E97[$]VC
M:5<1!@76]9F7(W!6BB"L1U )5@#T)4XZ&O*OAMX0/C7Q;-<P@R6L&HSW#S1E
M2@ EDD@.[E2'<* !DLNXK@ L.O\ VY_^8=_V]_\ MO75_#3_ )$:3_KPU/\
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MJ QQU-%I\,M*LW66*QM4=&#*RV\2LK Y# A,@@\@CD&HO^%3Z/\ ] ^S_P#
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MFW>FYESM8.O*%6'S*#P?TK5KG]4^'NFZO(T]S9VTLK8W/)!$[G  &6923@
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M,6W-&S$8+&(MY1)ZDE<EOG^]S6UJGP]TW5Y&GN;.VEE;&YY((G<X  RS*2<
M #/8 5;T+PG9^']WV*WA@WXW^5&D6[&=N=@&<9.,],GUK5J*[M$O$:*50Z.I
M5E8!E92,%2#P01P0>"*\UN_V9?#]T[2-9 %F+$++.BY)R<*D@51Z!0 !P !7
M7^#O %CX,C,.GP)"I^\0"7;!8C<[$N^-QQN)V@X&!Q705P%Y\!-&NO-'V;8D
M^SS8XI9X(7V?<S%%(D9P>1\OWLMU)-=KI>DPZ1&L%M&D42YVI&JH@R23A5
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MP1DYZO5-)AU>-H+F-)8FQN215=#@@C*L"#@@$9[@&N?_ .%3Z/\ ] ^S_P#
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ML*V5R=B\XR!D @$YR=+^$FFZ:\4BPES H6 32S7"Q %"/+6>218R-BX* $
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IHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex99_005.jpg
<TEXT>
begin 644 ex99_005.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P &! 0.
M!0X3# P3%A,0$Q$3%Q45%Q<6%!0:&AH7&!<7%QX<%Q@9&QP<)1L9'Q\?'Q\B
M'Q\?'Q\?'Q\?'Q\?'Q\?_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#ZIHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJ*[NTLT:65
M@B(I9F8A550,EB3P !R2> *YKP5XMF\6;KI(O*L3D0,^X33CY<3A3M\J+[VP
M-N>12KXC  ?JJ*X^;QP^BWJV6H($CG;%K<J3Y3N2Q%NX.?+FVXV98K-ABFQO
MW0["BO,/B[X\U/0KO3[#2(X));UK@'SP^U1$(V+91TP K,6X8D#"@G@\SX]\
M:^*O!%E+J%RNEM%%LW",79<[G6,8#,HZL,Y(XS]*/ 7C7Q5XWLHM0METM8I=
M^T2"[#C:[1G(5F'53C!/&/I6MX"\?:YK4FIV%S%9K?6?V<18,JP,90[!V;,K
M%=H5P %8YVML))7FO@I\6-6\3:_>:=J4D>RWAF'E1(!$)(IHHBRLP\T@_,?F
M8]>@X ^A*****BN[M+-&EE8(B*69F(554#)8D\  <DG@"O"K#XIZO\4[F:'P
M\([?3XF1#?31LTA8,"YC1OD)*=$9<A<%WC9U Z7_ (1WQ+X?_?QW\.HX^];2
MV\=IN4?,?+DB)Q*<;5WCRQN+-T%3? ?XF3^/(KR2\ BFBO706_1X8PB!%8$!
M\[P^68#+!P H7:OI]%%%%%%%%%%%%%%%%%>5?M >,=6\(64E[IPMA!'&!(\G
MF-.&D=8T,:!1'\I8-ERP/39A?GUO@)XIN/%6C6U[>OYD\GG;WVJN=LTB+P@5
M1\J@<#]:[^BBBBBBBBBLKQ-)>)"?[/2%YSD#SW>.->#ACY<;LV&Q\ORY&?G4
MXSX_^S-\7K[XD27TE\4VQ_9?+CC0*B;A*'P3ESG8"=S-@YQ@<5[K11116?K^
MOP>'H'N[MQ'#&NYW;H!T[<DDX  R6)  )(%:%%%%?.O[2/QCUKP$T<=N+:&*
MX\P12*6GG'ENI+$2(D2[E=1MVR8^;#_=(^BJ************SVU^!;D6.\?:
M&A:41]6\M65"Y]!N8 9QN.=N=K8T***********\Z^.7Q=3X9V7GA1)<2L4@
MC) !;!)=AD,47C=MY)*KE=VX<5XX_P"$N\(HFH07$=^-Q\ZS2V 5-PP FW]_
M*BL<9W*^ K,&4OM]PTFXDN88Y)X_*E:-"\>X/L8@%DW#AL'(R.#C(JU7 ?";
M^W?]*_M_R?\ CX/V?RL?<YSC;_RRZ>7O_>_>\S^&N_HHK/TG7X-7,JV[B0P3
M&*3;R%D"JS)GH2 PSC.#E3A@0-"BBBBBBBBOG7]I'XQZUX":..W%M#%<>8(I
M%+3SCRW4EB)$2)=RNHV[9,?-A_ND?15%%%%%%%%%9]IK\%W/+:1N&F@6-I4'
M)02;C'GL"0I..H&"0 RDZ%%%%<?\4M?O] LI;K3D@<PPR2N9WD "Q@.0J1H=
MY*A@,O& =IRPR*Y7]FKXB7?CZPGO+Y@SB]E50JA%1/+B<(,<D L<%BS8ZL:]
M:HHHK/M-?@NYY;2-PTT"QM*@Y*"3<8\]@2%)QU P2 &4GY[_ &D?BUKW@22-
M86MH8)I)#"T8,T^V,*")/.3RQN+AL(I(QMWD EOI2BBBL^_U^"PEAMI7"RW#
M.L2?Q.40R/@#L%&23P"0,Y90="BBBBBBBBBBL]M?@6Y%CO'VAH6E$?5O+5E0
MN?0;F &<;CG;G:V-"HKMG5&,0#.%.U68HI;' +!6*@GJ0K$#G!Z5X!I7Q@U>
MX\4Q:'=^1'$K3;T@#.'5K8S1!I)0&)7Y<E%C!.[((P!]"44444445GVFOP7<
M\MI&X::!8VE0<E!)N,>>P)"DXZ@8) #*3H45P'C#^W?[4LO[.\G^S>?M6[&[
MK\V<_-]W'E>7_P M,^;\F*[^BBL^TU^"[GEM(W#30+&TJ#DH)-QCSV!(4G'4
M#!( 92?!?VD?C'K7@)HX[<6T,5QY@BD4M/./+=26(D1(EW*ZC;MDQ\V'^Z1]
M%44444445Q_Q2U^_T"RENM.2!S##)*YG>0 +& Y"I&AWDJ& R\8!VG+#(KD/
MV=?B-?>.]-N;VZ*23B[F6).(HP!'$Z1Y568*&8C<0[@==Q%<?X<^+&N2>*8M
M%U&2!456$L=NA\IC]F>=6W2@RYY7."H^7&.I/T?111111117SKX]^,>M:'KE
MCI,HMH8KBXM&/DEIW,3RF)XV>5$')#'*QJP&T!NN?HJBL_6=?@T4(URX0231
MQ1YZM)(P5$ '))/IT +'"@D:%%%%97B:2\2$_P!GI"\YR!Y[O'&O!PQ\N-V;
M#8^7Y<C/SJ<9\?\ V9OB]??$B2^DOBFV/[+Y<<:!43<)0^"<N<[ 3N9L'.,#
MBO=:*******\5_:,^)VK> +<7%FELL#R>2)&:22?<\997";$C3:4;[S2AOE)
M4#(KM="UG4-3T>TN;40RWDUI [-.S11[GA#%R(HWS\Y!V (""<,N!7G_ .S-
M\7K[XD27TE\4VQ_9?+CC0*B;A*'P3ESG8"=S-@YQ@<5[K575(YI8V%LZ)+QM
M:1&E0<C.562(GC(&&&#@\XP?G_\ X7-KW]O_ /".8L=_F8\[RKC;L\KS]VWS
M\[O+_ASC?\N_'SU] :7'-%&HN71Y>=S1HT2'DXPK22D<8!RQR<GC.!:HHHK@
M/BS_ &[_ *+_ &!Y/_'P/M'FX^YQC.[_ )9=?,V?O?N^7_%7?U%=LZHQB 9P
MIVJS%%+8X!8*Q4$]2%8@<X/2O -*^,&KW'BF+0[OR(XE:;>D 9PZM;&:(-)*
M Q*_+DHL8)W9!& /H2BBBBBBBN \8?V[_:EE_9WD_P!F\_:MV-W7YLY^;[N/
M*\O_ ):9\WY,5W]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?/?[2>MOXAO\ 3_#$
M8DV7,T4MR8\[C%YA0 8)!"A9)'W(54I&^?E->]:MJD>D0R7,[;8HHWD=L$X5
M068X ). "< $^@KRKP'\3M2^)\-Q>Z6+:W@BD:*)+A)9I)'4;]SF.2)8E*O&
M, 3$'?R0!F7X*?&U_&DL^FZA$(=2MFD\Q$R8F5'V,5.Y\%6(5@6(/#(2"0G0
M?'#P<GBS2+JW9"[K"\L(50TGFQJ70+\K'+$;#M&XJS*",UE?LX?$!_&VD12S
M9,T#&"5CD[V15*ODLS,2C*7)P2^[@#%>GU5DTN.69+DK^]2.2-6R>%D,;.,9
MP<F)#DC(QP1DY\T_:C_Y%V\_[=__ $HBH_9<_P"1=L_^WC_THEKTN/2XXIGN
M0O[UXXXV;)Y6,R,@QG P97.0,G/).!CY/^#NI/8^+=6\J,RRNU\J*,A=QNT.
M7?!$:  EF()P-J*\C(C>BZQ\;]2\#ZM#9:Y#;+9W6?+F@,N(\OM7?)-L1MG'
MFX5,*P?C[A]+^(/Q#A\&QIN'F7,\@BMK<,JO-*Q"JH+<*H+#>Y^501U8JK>=
M>+_'?BGPM =2FM+)[965Y((VF>YCB/+!GR(R5'RNZ*R@_/L* D>J^"_%\'C&
MTBO[0DQ2J2NX;6!!*LI'J&!!P2"1E21@G:KY[_;0\7G3-.AL$)!NIB6X4J8X
M=K%23R#YC1D;1R%() X;O_V>_"Z>'=#LT3!,L*SNP4(6:8>9S@G<55E3<3DA
M1T& /1:Y_2O!T>F7UUJ$9PUW';"1>?O0B10^2QZHZK@  ;,\EC7 :E\6]0\2
MWT^F>'8(7-I($N;FY9EA1L2 H(T(E;YDVAQD;@1MVE9#DZ7^T!=>&=072O$\
M,-N\F6CN87S 5+%(RRLSLJLR-\[,I7Y=\:C<X]+^(_C*?PE:O=06KW7EQO(^
M)(HD14PS%F=MWW=Q 1')*X(&0:\_^%7QFU+XCV<\UK;0B=;B54,C2QV\:;$,
M09PKM++N8[E0(-JDL8BT8?*\!_M#7S:I<:-K-N@N$W+"+:.;=)(I^Z!(3\KH
M=ZR.8D5!N<A6RLOQ'^,NN_#T0WU[9VOV*5@IB29VN(W,>X(\FT)G<&.4C=<*
M5W9*NW8?$CXQMX5L4U2TM'NK5HX9#-YD<$824X3AMTQ;+)\OE8PV2P((KC_#
MGQNUKQ;IL4VE6,=S=LK&9]ZQVT3><ZI'M>4.[F--S+O4H'C<Y5P*M_ _]HI_
M&UR^EZC +>]17/!*J[(Q#Q^7(=Z.JX)7+DA78[ N*VO%OQG9-7B\.Z:J&\?F
M268/Y,(V><1L7:TK&($@!D4,4!<_,%Q?%_QIO_AIJ,,&MK!)I]PK;+B!)(Y%
M8;=Q:-I93A2PR%R2K!E)8&.O1?B/XRG\)6KW4%J]UY<;R/B2*)$5,,Q9G;=]
MW<0$1R2N"!D&O.OAC\;=3^(=I++9V<?G?:945G9X[:&/R@\1D?#/,^\[2L2C
MC!?R0REJG@7X^ZC?:C-H-_;0+?HT@B(>>"&0IM.WYHIG ,8>5)" &4*NT;@U
M'A+]I2[\3:BVCIIT<5RC2JXEO0JAHL[U!6W8N<@C"!CC+?<#,/4/B)XJNO#,
M"W%K;I<YDCC*&;R'+2RQQ1!<Q.IRS\EF0*!G)SQT&ER32QJ;E$27G<L;M*@Y
M.,,T<1/&"<J,'(YQDVJ\J_:C_P"1=O/^W?\ ]*(JY7X":IJ4OAVVATF*'S$\
MX&6Z:6.')N)&VHL:,TOR_>8%$5B &=ED1.E^ WQM?X@":UOHA!?VS'S(QE0R
M[BN0CL9%*$;9 <A25.?GVJ1?&67Q3J\NAZ0(U-LKM/<3J[KE&\MXTB5HBQ$C
M(-[2*,!\*P"EL^R^-=YX<UH:)KJ0@3[/LL]NKA6WL43>C22,NYAMZ_(XYW1M
MY@ZOXO?%+_A"(X8;>/SKZ[D\JTB/RHSDJNYV) "@NN1D%B0 5&YUY3Q7XU\4
M>"[66]NK:QN8TC;BV:X#QGM,XD!WQ+CYU7#8.[<JJQ'M5%>5>+?C.R:O%X=T
MU4-X_,DLP?R81L\XC8NUI6,0) #(H8H"Y^8+B^+_ (TW_P --1A@UM8)-/N%
M;9<0))'(K#;N+1M+*<*6&0N258,I+ QUZ+\3_B'#\/[&2_G&[;A4C#*K2.QP
MJ G\6; )"!F"G&*X2V\=^([.#^UKZTM4L55I9+96E%^D(R<Y<B(NJ?.5.TL
M5PCG"^=?L,?\Q'_MT_\ ;BO5?&GQ;NCJ!T/0X$GODC629YF\N"%2T?)&5:3Y
M9 2$.5RN Y#(.:U+XZZG\/+N.W\36\ MYVQ'<VK.5 4 R,4<M(P!= >$( 8J
M).!7I7CSQ[)X>LC?V=N;Q!"TNY)84B$:@.7+LVX@IEE\M)-V,<9!KS#P/^T)
MJ?C6SEDL+%)[S[1,$C614CAB"1F)YFD<;F+N0H7R_-"2%=FPT?#7]I"ZN]3_
M +$UVV2VNC(R*ZG8@;:"B%79L[N=CJY#EHPJD-NKC_VR/$FIVX@M)3'%93-*
M0D4CN\AB92&EW1QA1AU*QKN ;)+,0A7Z*?Q1+HD$UWJZP6T,2AMZ3O.,<@YW
M6\)!S@*%WER< 9P#PO\ PF7B3Q)#]NTNULXK9H]\,=S([W$RD;XW'DL(H]ZE
M0$=LJP.YMN#6U\%OBX/B%!(LT9@O;9@EU"590KG< 1NY )5OE/S(05;( 9L7
M7?BWJ&M:G+H_A^"&1[?;]HNIV8VR$JQ,>(CNW;L+UW;ED4QX4N/!?VJ_$=[=
MO9V6JQQI=P+.Y>!BUO)'*8Q&R;SYBD&-T97'5=RDJP ^V:*\P^*_QI'A"YMM
M*M8Q+?W;(L8<LD,8D8QQR.54EAYG\"\E0Q++\N[$^)OQ2U;X726]Q>K;7.GR
M2".5X8Y()U8AB %>XE4_*-P/1MK(QCRK'V#2=4CU>&.Y@;=%+&DB-@C*L RG
M! (R"#@@'U%6J\U^)OQ2FT:ZM]&TN-)=2NL,@EW+!'$-Q:1R""W"/A5.[Y2>
MNU'RKSQKXB\,O;KJ-M9RQ7%W;0^=:M/MA#RJC&19!D[@V$8$*K@;L[E4XGC_
M /:4N_ UZNG7>G1^8ZHR.MZ!$RN2H;=);IM 8$$OM P2?EPQ]E^TWGV??Y4/
MVK_GGY[^3]['^M\C=]WG_5?>^7I\U97PX\577BJU2]N;=+9)HTDB43>>Y5LD
M%OW2*N5VL "QPV&"D$5Y_H_Q2UCXAR33>'8[,6,,@B$MWYP>5P-SLJQ'*J R
MX#@$@@YR61.@\&^.=6U6:\L[JTACN;2.UVCS9%AF,AE#S+)Y;D1$)E%V,RL&
M1VW9V>*_!_Q-JVJ>*+YY_)N+N.WN(65I9(8$6.XB7;&1#*VT,/E!4$Y+LV\G
M=]">-OB*GA""(SJ&O+ADC@MD<9EF; V*[JF$#,-TC*H ()7<RH> \7^._%/A
M: ZE-:63VRLKR01M,]S'$>6#/D1DJ/E=T5E!^?84!([^Q^(@U[3H]3TNWDNA
M,IV1 Q0L&&X$.9755 ==C%=YSRH=>:\Z^$'[0=Y\1Y+I(;1 8_(,*%W5%#!_
M,::?8PZJ/+5(]Y+8VE5DD2A:?M :EX9UI='U^&!4=1MEMH[ELLZYC* [WE!?
M]UA4!WYY^4@[7Q*^)^O>$H/[4^Q6R6*2*)89)2]V%,I0.3&1"FX%  IF*%@3
MN 8+Z5X \8Q^,[&#4(1A9HP2O)VL"5D3)5<[7!7. &QD<$5T%8OC3Q?!X.M)
M;^[)$42@MM&YB20JJ!ZEB ,D $Y8@9(\JM_''BS7[;^T;"RLDAD6-H8)9'DN
M'1U0APZO'%@[B<-Y;  @J3@MTOP8^.EK\3HV"+Y-U'DO 6W';G D5L+O7D G
M *MP1@HS>%?ME7-Y-]@^VQ0Q8^U;/*G>?/\ J-V=\$.W'&,;LY/3'/U+HEW?
MS.1>001IM.&BN))FW9& 5>VA &,\[B<@#'.1M5E>)M5GTR$R6MN]U+R%C1XH
M^<$@LTKH N0 2-S#.0C8->:_ /XWS?%*2\,D*0Q0?9_+4%G?YQ)OW,<!N4R,
M*N <'/6L3QQ^T==^'=3MM,>P, FFMR6D83RM"[E'VQ6S/A]P8( [D[?N$L +
M?Q0^+&N^#(EU(V4"V0F5'B9WEN@I=P'9HOW$090H',H5V4$L3M&UK_Q*O-;T
M'^V-'6%2UI+*[2N^83&/WBHODD2LI5U!8HFY5;#J2*X7]D35+^YL)G5(Y4DU
M&1II9;B19MS1PEV"^1('./FRTBEF)!Q]X^H>,?B7);W0TC28DN=0,>]U:01Q
M6\9VJ)93]YOF=3Y2?.R9;Y<INXG6/C%K'P[NH1XC@MC8S97[1:"8B-^P;S"2
M< 9*A02N60N49*[;XO?$^?X?6YNX[)[B)-ADD\V**-0S; .2\I;<5X$>W#9W
M\$5Y?8_M#ZSXATN.[TJQ%Q<(Q^ULL<AA0EV6.*-!())'V;'<H6$:D%OO?);^
M*?[2VH>#X+=_[-,#W,(9&N)$8!QM,J>5$=Y 5@ 7,39/,8VE3TOQ+^(NN:3:
MRZCI]I"MK!R1<>:]S+&?+_>K#%M\I5W,6$K!PJDND9!4]!\-_C';^,=+?5W'
MDI#YWGIEI/+\L;SR$4O^[*O\JG[VWD@US_@/XG:E\3X;B]TL6UO!%(T427"2
MS22.HW[G,<D2Q*5>,8 F(._D@#,OP4^-K^-)9]-U"(0ZE;-)YB)DQ,J/L8J=
MSX*L0K L0>&0D$A/+_VY_P#F'?\ ;W_[;U]545Q7Q)^)/_"(>1!! ]U>74A2
MWMT.S=MP9&9R"J*JD$DYZY.%#,O"^+_B!XE\ 0'4=1@T^>UC91*MN]Q'* WR
MJVZ7*XWE0<*QYZ 99>Z_X6]8_P!D?V_E_LGE[ON'S,[_ "_+V]-WF?)G.S/.
M[9\U<+;^./%FOVW]HV%E9)#(L;0P2R/)<.CJA#AU>.+!W$X;RV !!4G!;I?@
MQ\=+7XG1L$7R;J/)> MN.W.!(K87>O(!. 5;@C!1FY3XZ?M"7OP[98HK''F[
MQ%/-(A1C&X#D10NS%=K*5+/&V6Y3Y2#K?$OXBZYI-K+J.GVD*VL')%QYKW,L
M9\O]ZL,6WRE7<Q82L'"J2Z1D%3J^!OBG<?$72_MVEQ0K<^9)&\<\L@CB8 E2
M62$F3@QMM 4$,1O#+7C7[*GBC4];GU*[58[F:5K5I7GG> Y_?!=NRWF!&. /
MD" *%&.!ZK\<OC3=?#>+S(K(R(S&-9WEC6+S&0NF$1FE<<-N#"+[N QW URM
MW\?]9O[:TOM+TTW-NRQBY<)(=\NU6E2%%8R*B$,GG,KIO^49V_/TNI?%O4/$
MM]/IGAV"%S:2!+FYN6984;$@*"-")6^9-H<9&X$;=I60Y.E_M 77AG4%TKQ/
M##;O)EH[F%\P%2Q2,LK,[*K,C?.S*5^7?&HW./2_BQ_R!]0_Z\+O_P!$O7E7
M[%/_ "!Y_P#K_D_]$P5T%]\4M2\4ZA<:?X=CMBME\MS-=^:$\TL5$:+&0_&Q
M\L05)!Q@!3)J^#O&NK/J0TK5K:&,BTEF^T0M(T,Q$D2@1AP"FP2$2*Q9BVUA
MM4C=Z565XFDO$A/]GI"\YR!Y[O'&O!PQ\N-V;#8^7Y<C/SJ<9^9?V5/%&IZW
M/J5VJQW,TK6K2O/.\!S^^"[=EO,",< ?($ 4*,<"7]N?_F'?]O?_ +;UZA\4
M?'VMZ+:/J6G6T'V:)2S+/Y[73)E0'\E%01 #+L'<L(^76-U9!TO@;XKVOBG2
M_P"V,^7$D<C3J3YC1&,$R [,DX W+P&9"K;1NQ7*^ _B=J7Q/AN+W2Q;6\$4
MC11)<)+-)(ZC?N<QR1+$I5XQ@"8@[^2 ,GP?^-\WC%KG3KN%(M5M?-W1@L('
MV/LX<>;LVN0K_?ZATW E5\JE\3:M>^-(8;GR7FM_-$, ED2V17M6DP'\EF+;
M6!=S'EF 7"H%"_56ER32QJ;E$27G<L;M*@Y.,,T<1/&"<J,'(YQDVJ\E^.7Q
MINOAO%YD5D9$9C&L[RQK%YC(73"(S2N.&W!A%]W 8[@:)?'VMZSI46HZ9;0;
MOLR2OYWGAI&\K?(D$"+O(+_+&SR N0<*R,DK97PB_:!N?'MHWEVHEU!)E5XT
M9H;<1L1B9Y'#A  6&Q3+*Q0LJ;2=D.F_&_4O#NLQ:)K\-LIN/+\J:V,NSY]Z
MK\K[V;=*!'SY>T@L<J0:M_&#]H"Z^&,R1W%@DD4WF&&1+K&X(0"&4V^58!E)
M'S+\V%=L''H'Q'\577A6U>]MK=+E(8WDE4S>0X5<$E?W3JV%W,02IPN%#$@5
ME?!3XK_\+-LWO?)\C9<-%L\SS<X2-]V=B?W\8QVZ\URFC_%+6/B')--X=CLQ
M8PR"(2W?G!Y7 W.RK$<JH#+@. 2"#G)9$Z#P;XYU;59KRSNK2&.YM([7:/-D
M6&8R&4/,LGEN1$0F478S*P9';=G9XK\'_$VK:IXHOGG\FXNX[>XA96EDA@18
M[B)=L9$,K;0P^4%03DNS;R=WU?:,[(IE 5RHW*K%U#8Y 8JI8 ]"54D<X'2I
M:^0/%/B2/PUX[>ZF#LJ;0$C4R2.S6 2.-5'5F=@JC@9(R0,D=AXX_:"\0>!I
M4N-1TN.*RD8JJ^:))-P3[IFC9D4EOF ,8)4$#)4L/== \8VVN62:E&X6W>'S
M2S,H"+C+AR&*J4P0_.%(()XKS^V^(&L^-Q]IT""U2RW,(Y[QY"9P&*%DCA^>
M,*Z,/WG+ J0%.X"7X._&*;Q3-/I>J0?9M3MMS21J&\MDR '4DMC&Y?XB&!5T
M9E8A/5:JZMJD>D0R7,[;8HHWD=L$X5068X ). "< $^@KQ_PWX^\1>/8SJ&E
M16,5B\CB 71G,[*AV%V\DE1E@W'!&,?,,.W0>$_'.K>)[:Z9+2&WO(;MX!#/
M+(%0""-P[-'&WFY=\@*$5HR,/P&;QK]E3Q1J>MSZE=JL=S-*UJTKSSO <_O@
MNW9;S C' 'R! %"C' ]5^.7QINOAO%YD5D9$9C&L[RQK%YC(73"(S2N.&W!A
M%]W 8[@:Y6[^/^LW]M:7VEZ:;FW98Q<N$D.^7:K2I"BL9%1"&3SF5TW_ "C.
MWY[_ (M_:$O='U:TT@V/D?:+BV&^:1)',4C^6Q"0.RHVX':3(_"Y*?-QZ7\2
MOB#'X%M?M+H\LCR+%!#&"7EE?.R,8!QG!).#P#@,VU3PFO\ BSQ3H4#ZC+;Z
M>;>)?-DMUDF-RL0^9T\PXB+JF<L 5)!*JW"GH/"'Q0E^(>F"^T>./S]S1O'<
M.Z)%($R>8XW,@!92 -FY3RR,"H\5_94\4:GK<^I7:K'<S2M:M*\\[P'/[X+M
MV6\P(QP!\@0!0HQP)?VY_P#F'?\ ;W_[;U[7\7OB/=?#ZW-]':)<6R;!(?M'
ME2*6;:#L,+@KDJ,AMV6^YM!:H?@U\4I_B1 ;PVT<$&YT&+GSI=Z[>"@A4(,$
MGYF#< [-K*U:$?B[4)=2?3Q:0^4D<<K3_:FXCDDDC3Y/LV3*1$[;0=@Q@RC(
M)[6BO)8OC++XIU>70]($:FV5VGN)U=URC>6\:1*T18B1D&]I%& ^%8!2V?9?
M&N\\.:T-$UU(0)]GV6>W5PK;V*)O1I)&7<PV]?D<<[HV\P=A\7/BHGP]@C<1
M&XN)YEB@MT8*[L>I'#-@<#Y58[F1<#=D>=?$'Q3X@TC2;F;68+,VTUI)$PMF
MD$\+S(8XV<2,8W42,$<(Q(W;U+*I!/V*?^0//_U_R?\ HF"N*U34/[/\?M)L
M>0C "1KN=B=/"JHY &21EF*HHRSLJ@L._P#B3\9M8^&UQ!/J%M;-I\TA4B!I
MI9DPHR#)(L4>XDED78-RJRY&"]>H>+_B+9>$[(ZE<R@P%5,90AS*6&46/!PY
M8<C!QC+$A06'G^O^)_%L,#WL%G9(JKN%HSRW%W@<-\T;)$Y."X"G.W"@%^#U
M?P_^+,7CG3O[2LX9'=6V26ZE!(L@V[E#2M%&P 8,&W#*]@^4'E^@?M276I:E
M-ITECME2.2..V1_-FDNED"E#* L21!=S.Q4A51GWMPIZ#PG\<KS2[6\N/%%M
M]C-M(BQE4=1.6WCRX@[,)&!0G<KE"K!CM52YEU_Q/XMA@>]@L[)%5=PM&>6X
MN\#AOFC9(G)P7 4YVX4 OP>U^%7Q,@^(UDM];@H=Q22-N2D@ ++G ### AAU
M!&0K94<+:?%O5O'5U/#X=@MOLMM(\;7=TTC12L-H C\@_P"\V07!0HS&,LJM
MXU\0?$<^L^*]-2]C$5U;S6,,X1MT3.+DR"2,YW;&216 ;#+DJW*Y/V?17R7\
M:?$VK2>(M,M+KR51;BSF@MXY9&B+&;8&DD:%6+%E(R(R$0_*I)?=]-1:W+IU
MM+=:DL<(B5W;RI'N%$:+N+$F&)L\'Y0IX P23@>5:5\3?$/CF)K_ $6TM8[/
M:_D_:G9IIRKR*=HB=5C/R %9" &.1(RG(U?A'\>D\7SR:7?QBUU*%F1HMX9)
M&CXE,9]0P8E,L0OS*[@,5]:HKXK_ &4O&LGA_P"VP6EL]W>3?9C% K"-=L?G
M&61Y6&R-5W* 3RSLJ@<DCT71_P!I;4?#VHIIGB6TCMS(T0$D;;%17R!(2\DB
M.F[ 9E=0@5\[F&T=U\9_C)=?#)5N&LDGM7D$:R"YV.&V;L,A@.,X;!5G&%RQ
M4D"NE^%WC6?QI:)?RPQPQRJ&B"7'VAB,L&WXB15(P. S$$E7",I6HO"WB[4-
M7NY[:>TABBMY%CDE6Z:7+-"LP"(;9"<!T#%B@^;Y2V"*[6BO(/!7QBN/B==7
M,6C^3#:VNT&>>.29Y2^0A6)9(-B_(Y)9V8C9\BDL!#\./C;<W6J3>'];BCBO
MD8^4T&XPR*$\S'S,S*2GSJ20"IVL$=0&Q?VUO^0/!_U_Q_\ HF>O5?A/_P @
M?3_^O"T_]$I7S_\ L,?\Q'_MT_\ ;BOJJBOE7_FH?^?^@=7T!\1_&4_A*U>Z
M@M7NO+C>1\211(BIAF+,[;ON[B B.25P0,@UYU\,?C;J?Q#M)9;.SC\[[3*B
ML[/';0Q^4'B,CX9YGWG:5B4<8+^2&4L?#'X\W>IZM+H&L0QQ72-*$>+S51R@
M#!0D@9L,@:19"RAEV@+DC.UXQ^*5Y<:F-"T*.%[R./S;F2YWK!$FU2JX0AV8
M[TY7(7<!@Y<QFE^-=<TR_M-/U6VMBES)+_I5LTIB 2"200[9!N67<@;<3M9,
MA5)5F7G_ (Z?M"7OP[98HK''F[Q%/-(A1C&X#D10NS%=K*5+/&V6Y3Y2#[A=
MW:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %>*^&?BAK_Q%#W>C6UK;V08K&]Z9B\I
M#,"Z^3P !@,.0&R!(Y#!?*O!OB,^(_'27+QF%RTB21,RN4DBLFBE7<I*L Z,
M P^\,' S@?1_C[XEKX;DBLK:+[5J%QDPVHD2(E5!9Y&=_E10JM@G)=AM4'#%
M?/\ Q;\3?$7P[\J[U:WLYK$R;9VL_/\ ,C!X4GS6 &2>,C:2-A9"ZFO0/&/Q
M&;2-/&IV-L]Y$;?SP0\<*"(*LFYC*1(,QDL L;MD;2%R#7DOAG]I74_%UE</
MIMB)KV.9V$:AS%%;@(4+DLIEF8[U1(]K/M9@@"[6Z"7XZ7]S%86$-H(];O5+
M&&<21PPHCR*\KAMKX98F94!+!><L0HDT+SQKXB\,O;KJ-M9RQ7%W;0^=:M/M
MA#RJC&19!D[@V$8$*K@;L[E4^OT5X5XM_:$O='U:TT@V/D?:+BV&^:1)',4C
M^6Q"0.RHVX':3(_"Y*?-QVWQ>^)\_P /K<W<=D]Q$FPR2>;%%&H9M@')>4MN
M*\"/;AL[^"*YGP)\4-9\=Z;#<6-M )W64R3S&2*T5DFVJB(-\TI,?)8$1JW&
M\L&C4^ WQYE\?2S6%_"+>]MU+,J[P& <H_R."8RA**0SDL22  "![+111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111117RK_S4/\ S_T#J^I;NT2\1HI5#HZE65@&5E(P5(/!
M!'!!X(KRKP)XCM+-#8>%+03013,)9C(8;57(<M^^=999G^5 "B2*$9/G"[17
ME7[.ZNOBW5!*0SA;[<RJ44M]KBR0I9BH)Z LQ XR>M?5]?*O[#'_ #$?^W3_
M -N*^JJ*\J_:C_Y%V\_[=_\ THBH_9<_Y%VS_P"WC_THEKU6OE7X!?\ (X:M
M_P!O_P#Z61T?MS_\P[_M[_\ ;>NF^*FIR3^+M+M&N#;QK;2,CJ(0RR2B>,X,
MJ.I+^6B ,&YX0!CFO3]6^'$VKPR6T^HWC12QO&Z[;$95@589%F",@D9!!]#4
MOPO^%]M\-[9K.S:1T>9I292K-N*HA V(@QA!VSG/-=A7S!^W'I<DL-C<A?W2
M23QLV1PT@C9!C.3D1.<@8&.2,C/M7P4U2/4]%L)(6W*+2&,G!'S1J(I!R!T=
M",]#C()&#7:US_Q"U232--O+F!MLL5I<2(V <,L;,IP00<$ X((]17D'[%/_
M "!Y_P#K_D_]$P54_;:TN.73;:Y*_O4N_+5LGA9(W9QC.#DQ(<D9&.",G/H&
MK:I)J_A62YG;=++HKR.V ,LUJ68X  &22<  >@KBOV*?^0//_P!?\G_HF"N4
M_P":A_Y_Z!U=7^VM_P @>#_K_C_]$ST?$O\ Y$:/_KPTS_T*WKJOV7/^1=L_
M^WC_ -*):\E^,]L-(\9Z=-;YC>=K%I&5F!8F=H&[\ Q*$(& 1G(.3GV7Q;=Z
M-X:U2*Z:#S=8GCV0I"N^X=<[2^"RQ)A<@RR%#Y:NH<JI4>"_M?W=[>)ITM_%
M' 66YVPI(9F4X@+;Y-J*3R%VJI"E21(X<!/IKXL?\@?4/^O"[_\ 1+UY5^Q3
M_P @>?\ Z_Y/_1,%<I_S4/\ S_T#JF_:1M'^'>M67B6T4DNVV88.TLBA"I=M
MZJ9("4 "@@(77+9(]OFU2/Q?<6BV[;[=(X[YR00K*ZNMHI1@N=S[IE/)C>W7
M<H9D8=K17E7[4?\ R+MY_P!N_P#Z414?LN?\B[9_]O'_ *42UY5\ O\ D<-6
M_P"W_P#]+(Z]5OM3TOPIJ=PNEVGVC6;B/?+%#@$#:6#22.1% K,%+X(=V9'*
M.2I/C7QB:Y?Q;I+7@C5RUCA(F9U5?M;@ NZH7)(+9V( "$P=N]O4/VF/A5?>
M-8[6ZTMO])M)'94#"-SO,?SHY90K(8P1DC(R0P90K<+X3_:L>U)TSQ3:E25"
M2/Y9!VLJ#]] XZ%2SL4X(("PX-?4E%>:^+;O1O#6J1730>;K$\>R%(5WW#KG
M:7P66),+D&60H?+5U#E5*CP7]K^[O;Q-.EOXHX"RW.V%)#,RG$!;?)M12>0N
MU5(4J2)'#@)TO[1^H?VEXDT?3YD1X%DMW(9=V[SKD1R*P)*E=L0XQW;.00!]
M/U\J_L,?\Q'_ +=/_;BK?[%VJ2:O-JMS.VZ662VD=L 99C<,QP  ,DDX  ]!
M7H'[6&EQWN@3R2+EH9()(SDC:QE6(G@C/R2,,'(YSC(!&3X'U234_!#R3-N8
M:9?1@X ^6,311C@#HB 9ZG&22<FJO[%/_('G_P"O^3_T3!7'_ML6PTZYT^^A
MREP5F7S%9@P$31O'C!^4JTC$$8.3UX&)?VY_^8=_V]_^V]=K^V3JDEEHJQQM
MA9KN*.08!W*%DE Y!Q\\:G(P>,9P2#Z+:>&)[Q%EBU6Z='4,K*NGLK*1D,"+
M/!!'((X(KD$^%-O\,?[0\06LLTUX;2[D;SS&8V8_OR2L4<6,N@X! P2 !QCF
MOV)[1%TJXE"@.UZRLV!N*K%$54GJ0"S$#H"QQU-<S^W/_P P[_M[_P#;>OJJ
MBO.OBA+HNB3VVHZG$)+Q&*VBJC23R/U5$1?OD,1L+C;'(P(9&8$^2_M8ZC?:
MCI,4EU EM%]O 2,R":=ODG"LY0"*/Y1DJK39WCYUV$/[K\)_^0/I_P#UX6G_
M *)2NJKY[_:.^&>K7=[;Z]HI+36\.PHF!*H0R2;U!.) P<HT>"6X4*X9@L/P
MX_:CC\27":5K=KY-TUPD:D*6B\T2$H&C?+Q,KJ@!R^'^8F,#C;_:X\!CQ#I)
MO$!,UFV]=H9B8W*K,, X  VR%B#M$9Z L:M>"_BB_C[0HC&Y6^N&-DS*2K)-
ML)DG!"HH*P!KD*I49'E*V_%>P6EHEFBQ1*$1%"JJ@*JJ!@* .  . !P!7QU9
M1:]^SE-*5C^TZ:T@+-@F%@"@\SY23;RD,$R^59N )0BD?0OP=^+EE\3$DN;:
M,Q7$:PI.K*-P!#L@#C[Z!C(%S@@[B47<,^-? +_D<-6_[?\ _P!+(ZZ;XJ:G
M)/XNTNT:X-O&MM(R.HA#+)*)XS@RHZDOY:( P;GA &.:]/U;X<3:O#);3ZC>
M-%+&\;KML1E6!5AD68(R"1D$'T-2_"_X7VWPWMFL[-I'1YFE)E*LVXJB$#8B
M#&$';.<\UX+^PQ_S$?\ MT_]N*/C[_R.&D_]N'_I9)7JO[4?_(NWG_;O_P"E
M$5'[+G_(NV?_ &\?^E$M>JU\P?MQZI)%#8VP;]T\D\C+@<M&(U0YQD8$KC .
M#GD' Q]/U\JZ!_Q3_CZ:"U^2.?S/-'WMV^U%R_+9(S, W!&/NC"\4?MS_P#,
M._[>_P#VWKZJHHKY5_88_P"8C_VZ?^W%'Q]_Y'#2?^W#_P!+)*]5_:C_ .1=
MO/\ MW_]*(JY7X:?\B-)_P!>&I_^A7%'[%/_ "!Y_P#K_D_]$P5G_"*:;Q'K
MNNAKV2"47*J%B%MN>.%YH5RLT$O"*$7*@<L-Y)(->B^-?@@GC>%;;4+Z\EB6
M02!<6:88!E!S':J>C$8SCGITK$_:"T1-!\*36<1)2"&SB4M@L52:! 3@ 9P.
M< #/85H?LN?\B[9_]O'_ *42UY5^W/\ \P[_ +>__;>OH#XL?\@?4/\ KPN_
M_1+UY+^QK:)>:)<Q2J'1[V965@&5E,$ *D'@@C@@\$5U7@3Q':6:&P\*6@F@
MBF82S&0PVJN0Y;]\ZRRS/\J %$D4(R?.%VBO*OV=U=?%NJ"4AG"WVYE4HI;[
M7%DA2S%03T!9B!QD]:E_;G_YAW_;W_[;U]545X!HVJ+>^.;F.Y9"8;!8[8,$
M#*2L,K!. 2V))23RVPL,[1@>]7=HEXC12J'1U*LK ,K*1@J0>""."#P17RU^
MV<JZ):Z?I]JJ16IDN)/*C1$3<FS:0% Q_K7R!@$L203@CZJKY5T#_BG_ !]-
M!:_)'/YGFC[V[?:BY?ELD9F ;@C'W1A>*/VY_P#F'?\ ;W_[;U] ?%C_ ) ^
MH?\ 7A=_^B7KRK]BG_D#S_\ 7_)_Z)@KE/V&/^8C_P!NG_MQ75_MK?\ ('@_
MZ_X__1,]=KI.J2:1X5CN8&VRQ:*DB-@'#+:AE.""#@@'!!'J*XK]BG_D#S_]
M?\G_ *)@JI^VUI<<NFVUR5_>I=^6K9/"R1NSC&<')B0Y(R,<$9.?0-6U235_
M"LES.VZ6717D=L 99K4LQP  ,DDX  ]!7%?L4_\ ('G_ .O^3_T3!7%>-?#N
MO?![5+O6=-7S[.XDEEDPI>/#F20B6-6#KY?)$H(4#&6&]HZ]:^#7QYLOBA*4
M$)AO8H78JV)!Y;.H?9* #C(C+@A,G;@,%W#UJBOE7]AC_F(_]NG_ +<4?MS_
M /,._P"WO_VWKZ ^+'_('U#_ *\+O_T2]>2_L:VB7FB7,4JAT>]F5E8!E93!
M "I!X((X(/!%=5X$\1VEFAL/"EH)H(IF$LQD,-JKD.6_?.LLLS_*@!1)%",G
MSA=HKRK]G=77Q;J@E(9PM]N95**6^UQ9(4LQ4$] 68@<9/6I?^:A_P"?^@=7
MU517@'[:W_('@_Z_X_\ T3/7JOPG_P"0/I__ %X6G_HE*^?_ -AC_F(_]NG_
M +<4?'W_ )'#2?\ MP_]+)*/VY_^8=_V]_\ MO7T!\6/^0/J'_7A=_\ HEZ\
MJ_8I_P"0//\ ]?\ )_Z)@KS2RBU[]G*:4K']ITUI 6;!,+ %!YGRDFWE(8)E
M\JS< 2A%(^A?@[\7++XF))<VT9BN(UA2=64;@"'9 ''WT#&0+G!!W$HNX9\:
M^ 7_ ".&K?\ ;_\ ^ED=?55%?*O_ #4/_/\ T#J]U^->EQZGHM_',NY1:32
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M#_,3&!Q]%45\J_'W_D<-)_[</_2R2O5?VH_^1=O/^W?_ -*(J/V7/^1=L_\
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MU$DC/(J*L17Y6))7<4+ ;0R^]>"-$?0;"ULY2"\%M!$Q7)4LD:H2,@'&1QD
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MC6K>[$+C1++<4>10JW#;CN*!XSO5WC570Y C0[C'(^RH?VW- GNX+.[C0M#
MTZRN.0AD\D1Y[@$J1GH#@$@LH/:^+X[7X^Z28;(2*2JS132Q21Q)*IVB,DX$
MA(,D;&/S43#,?F\L/XUX._:#U3X01G2=7M'E,?$(D<Q.J LNT-LD$L65Q&PX
M !"LR[0ON'@6TO?B(\U_K5L;6W>VDM8+1B1)Y<I7[2\AV)("QC0)RF%!(3D2
M/X?X#\8W7[.U]<6&I0S26,LC;'"XW%!\LT0+^4=RLHE7=N7Y S938U7]I?Q1
M=>/O[.N([9XK:;SA9HPS=2EO)W.44L K$JL0!+-@O]UT%?77A#Q,?$D N3;S
MVP+,!'<(L<I XW; [%03D#=@G&<;2I.U7RK\3=4;P'XRM]5U%G-F\8\M@'<(
MI@:!U ( ^61C(ZIN(5PV"S;3;_:L\5MXLTF"2R@F>S%Q'*UTR/$@RC+& DBK
M(RL),^;M$6=JJS,Q"^R_!761J&E6:*DBB.RM%+NC1JS>4H8)O"LP& =X'EL&
M&QV(8+W5>2^+_B=+X/UMDFBGEL#IT#RO%&\RP.)YQYK[3A$,88N<%F$:X!VD
M5YK\:+BQ^.1MH= 0W%XLP62Y\J6.*&$JYVRNZKP6^9!AC\KA,,VU_I^[M$O$
M:*50Z.I5E8!E92,%2#P01P0>"*^</V<?A1)X7UG4A('$%K((X0X#AB^YHY=Z
MX3S5@;!P-P6<@[ Q5OI2O!?AK^T9;Z9IULNO^?;3>2H6:6"<QW"CI(C@2,YV
M;&D8X!9\KD'BK\"O!(_MR^UJQ@-OI<L/EVX=6B,A<PR&2-&Y$)*EE/RC#JJJ
M,,J<3X,UD?#;Q?>G4TDC%VUR(2J-+N$UPLD+ 1AF8-MVC8&(<[2 0VWMOVBO
MA=<^-HH-<TM)$N[=3^[(9+AXU<O&Z -E'4Y=4(64A\,%D01US/A;]KO4!LT^
M?37N;Y-R.$=HY&9,[LPB!RK  [P. 0Q 4?*/9?"MQ<^#["2]U9));VYF:::*
MVB:?#F,)'"BQ*<!8HD3<[%=^<RD,&/C7[)-K<^#9KJ"_L[R+[3]G$;M:S^7E
M#("K,$.W/F [FP@ 8LR\9/CI:W-_XDLM0M;.\G@M/LPE,=K.<F*YDD=5+(JO
M\I&U@=C9&&QS7I?[0=^?$6A2P6D-S)+<>7Y:"UN=_P"[GC+[E,0,? )'F;=P
M&5S1^S'>/9:5#IMS;W,%Q!YQ836\L2,&E9PRNRA#_K -I(?(8[=HW'U^O,/V
MAOA4?B'IQC@4&[A;S("2JY/1X]Q!P&7H,J"ZH68*#7"?";]HZT\/6::9KRO9
M75I'%$%:*8[T" 1MM",R-M W!@ <AE.&*IM_"#P3/K6K7GB?48# TS>7:12+
MLE6-0(_,=&W,CE$500PSF7Y=C(3Y_P#M5_:/'KV::=9WLHA6<N_V.Y1<R&,!
M1OC5B1Y9)XQ@C!)R!]*^%_%D?B)-Z1SQ$*A9)X)H&4L"=O[Q%5B,$-L+ 'O@
M@G:K*\3>(E\/PF=XYI<9 2"*2>1C@D*%C4XSC&YMJ D L,BOFK]DFUN?!LUU
M!?V=Y%]I^SB-VM9_+RAD!5F"';GS =S80 ,69>,U?C'-<Z[XBL]3M;&^DMK3
M[+O86DZE_+F:9MBNBGHVT;MN6!_APQ]5_:#OSXBT*6"TAN9);CR_+06MSO\
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MS1@%D92'BFPNV0LL8D9GSA4B493 )^C[2T2S18HE"(BA550%55 P% '  '
MX J6BOD7]G[QE'\,]3U'3]:>074TT2AQ'-,99%>0<84RL9/-#H=OSCDD$J#%
M\:=6FN?%&F7L]M-#;B2S$+,C,\J)<;V<1H"ZM\^/*(\T#;N16<(-7X_^&;S2
MKZV\6:5#,"/FF4HX9?*&%DD57WK%)"-KJ0FQ%Q+MD<J-O6OVA3\1]*O(-+M)
M!(ME*UU)-M%O#&8G,FUT8L[G!6(%4W'YV 5&%5/V0?$CZ5826TEK=%'FGN!<
M+"6M]BQQH0&SOD??&5"1J[$]!PVW%\ZY_P"$P_MO[#??8_,V[_LD^['V;[/Y
MFW9NV[OFQC?L_AW?+7:_M812^*--M[:Q@N9I3<13[4MK@XC,<R_,?+PK L 4
M8AQGE165XF^&S_%'P_9P0PS0:AI]O$HCN(98-V(Q')&K.%C.\QJRL"VW"J_E
M[V(YGP=^U3J?A=$TK4;&2YO$947<SPW#!@OEJR&)V9SD8;@N"I(+99O</A[=
M7B1W&MZQ&\4MSY2I;1H\SPVZ%O)0I'&96E+3.TG!P",K'M9%\5^#DUSH7B*\
MU.ZL;Z.VN_M6QC:3L4\R99EWJB,>B[3MW88C^'+#UK]H_P"#[_$:R7[+C[7;
MLSQ!B0'5A^\BSD*I;:I#," 5"Y569AX_X._:IU/PNB:5J-C)<WB,J+N9X;A@
MP7RU9#$[,YR,-P7!4D%LLWK>C^!;KXAV-[+K2?9Y=0CC2*'K]GBB+/;;@ C&
M42NTCAF^;Y5(3F,>-?"/XT3_  6$FD:[;3A S/%@9=26VL%#NJ-"65F5D.-V
MXC?ORM3XJ:[>ZEXET^]GM)%(6VFAMHU,EWY$<\DGSH.!,0KN4!PBE58[E8U]
M?Z!JQU>!+AHI(#(N[RY0JRJ#TW!68*2.<9R,X8!@0-"OE7]J"*3P_KVFZS+&
MYLXOLP9U /S17#RM'R1ABARH8@-S@_*V/8/&6F6_QDTN:W@5]CQH]O/)&T*F
M7!:-D\U/,VXP'=4VM'(5C=CO"^5?!7XRK\,H/["\11/9M!O:&0QR,'5I6+ A
M ^?G+;)$S&Z@C(*@OTOA?P\_Q,\0?\)!-"5T^UA2.R,B&-IFY=9MD@8E 9&=
M'^0Y\H@;ED ]ZHKY ^#.MM\!+ZYLM>B>**XVA+E5=X280Q!7:N75A*.5RR-M
M5T&6V=WXSMW_ &@9X+6S\R/1H6\V6Z9"@G?E D(D0,2OSJ6^Z"6+*=L8D^A*
M^9?'?P=,GBZTF@0I;W2M-.0JM&3&"+B-E7;A)5*)(7R':=L[\E*^FJ*RO%FG
MS:C9W$%J_ESR6\J1/N9=KLA"-N4%AAB#D<CJ.:^:OV4_B7:>%+>?2+T3)>?:
MY'$0@FE<_NU5U"Q([AD\IBX91@8QG#;<I-6FM/'"WE];36^_>RQA&N)"@M'B
M1P+<2;\[<MLWA#N4L=C&NU_:LGN/%-C!86EG>23BXCFD"V\CI&!"PV&1 T;-
MF4#]VSJ"K L"!GN_AYXZ72=&MQ-;7JRVUM#$\/V.X,I=(RN% 3:P;RSAMP5=
MR"0H6 KR3]DFUN?!LUU!?V=Y%]I^SB-VM9_+RAD!5F"';GS =S80 ,69>,_5
M55=4U-=,C::0.57&1''),_) X2)7<]>< X&2> 37RKYUS_PF']M_8;[['YFW
M?]DGW8^S?9_,V[-VW=\V,;]G\.[Y:]O^*GBI;G2+A8(+J5[JVN(HHTM;CS-S
M*8LNK1J8P"V[Y]I902@;@'@/V2#-X=M)=.O;6Z@E>Y:5&DMIEB93$@QO*;5(
M\LYWE0=RA2Q) Y2Y^T0^,?[:6SO7LMRCS%L[D'!M! 6VM&KX5SSQG )4,< ^
MBP_&P>'=2OUOX[D:?YEJT=SY$S10E[6$O')GYH\L4VH$W!Y&+@;N./U^RM?B
MOKNGZCH49=()EDO+LQR10D1/$R1Y=5W3!1@ +DJZ9;8I*9_[6UK<^,IK6"PL
M[R7[-]H$CK:S^7ES& JL4&['ED[ERA!4JS<X]5^)_AQ?B_HLD<,4T<ZXDA2>
M*2"19D7.PK(8U.58Q[\M&"Q8%BM>2_!W]HQ_!,":)J]K=-<1,B0JB%IRK\I&
MR2NC C<!'MX*%5"C:"W/PZ[>Z?XQ:_O+222:-=\MO:*;ET1[18XQV#%1(@D;
M(4MDKP5%=K^T!\+M1CNX?$VBI(MSMB\Z)!ON%<#8'VJTB.-F(Y$3*X&<.C.P
MB\,_M<:AXHQ:6.E^=>&,<I*QC#'"^8R>7\L0=AG=(  <&0?>KT7Q7:R^%?#\
MMA(D]W>7%M=!O(A>;=/<;FF;,<:HB>9,2NX(=@PH9@17*_LD&;P[:2Z=>VMU
M!*]RTJ-);3+$RF)!C>4VJ1Y9SO*@[E"EB2!U7B_XG2^#];9)HIY; Z= \KQ1
MO,L#B><>:^TX1#&&+G!9A&N =I%>:_&BXL?CD;:'0$-Q>+,%DN?*ECBAA*N=
MLKNJ\%OF088_*X3#-M?ZDHKY+^,<USKOB*SU.UL;Z2VM/LN]A:3J7\N9IFV*
MZ*>C;1NVY8'^'#'TK]H?7SX@T:2SLK:\FFN/***MI<C:$F#,S[XUV_ZH@*?G
M.Y6V[&W5+^S?JS:1H\=C=V]U!-;+.SB2VG4,IE:3*$(0YPX 0?O"0V$( )\U
M^$_VCPWXEOM1N;.]%K<M>".46=RP >=948J(]X!5<<*2"1D 9(^KZ*******
M************************************************************
M******************Y_QUX%M?'%J]E>INC;D$<.C#.V1#@X89X/(()5@5)!
MS_A_->V"?V?J2EI(5VQW0RT=Q&H4"1B69HYN0)$D/S-N>-G4-L["BO.O%^@3
M_$24V$R&+2D93.S?++=.CY$*#[\<*N@+R$*TGRB']V?,/H%I:)9HL42A$10J
MJH"JJ@8"@#@ #@ < 5+111111111111111111117BO[6'BNULM&GLI)4%S-Y
M'EQ9S(P$RN6VC)"XC;YCA<C;G<0"?LG^*[6]T:"RCE0W,/G^9%G$B@S,X;:<
M$KB1?F&5R=N=P('M5%%%%5=6U#^SH9)]CR>7&[[(UW2-M!.U5R,L<84=S@5X
MIX#^/$GQ>AN+&TM9K:X:-E,ZN&A@5QM$ID'EOYHRQCC5<LRCYT7>\?N%I:)9
MHL42A$10JJH"JJ@8"@#@ #@ < 5+111111111111111117 ?'3Q7:Z%I-VES
M*D;S6EQ'$A/SNS(4 5?O-\SKD@84'+$#)KRK]B[Q7:Q6,VGM*BW37;R+$3M=
ME,,?*@XW8\MLA<E0,L ""?I2BBBBBBBBBBBBBBO%9?VEUAUF31#87+.LACC*
M;#*[#!W>6Y15B*Y<2&0C8 Y !.WU#PEHCZ5$WG$&:6:664C)^:1RRIN(#.(T
MVQ(Q"DI&ORH %7:HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKS7XW_&;_A5T
M,,WV9[CSI&7(;RXUP,X9]KX8_P *X^8*YR-N#H>#]6/CQ[?5A%)#;)#+Y,<X
M42.\A0"<(K,$"QJRQMDLZS28"I@R]U11111111111111111111111111117D
MOQD_:!3X8W-O;RVLDJ3+N:4,$55#!2$R")' Y924 !3YOGR.P\*Q2:O,=4FC
M>$26\4<,,H'G1J"SR,P!81M(60-&"3MBC+G=^[CZJBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN \'
M_P!N_P!J7O\ :/D_V;Q]EVXW=?EQCYONY\WS/^6F/*^3-=_7FOQS\=:EX(LG
MO[&.V:*+RS(TS2ESN?R]JQHJCJRG<91QN&SH:M_ 3Q3<>*M&MKV]?S)Y/.WO
MM5<[9I$7A JCY5 X'ZT>#_[=_M2]_M'R?[-X^R[<;NORXQ\WW<^;YG_+3'E?
M)FN_HHHHHHKSKXY?%U/AG9>>%$EQ*Q2",D %L$EV&0Q1>-VWDDJN5W;AQ7CC
M_A+O"*)J$%Q'?C<?.LTM@%3<, )M_?RHK'&=RO@*S!E+[>PTFX\0W.KQR3QP
MQ:6UHA>/<KNDI0%DW#YFE$N1D?N3$,C]Y7I5%%%%%%%%%<5\7O[7^PG^P-GV
MOS$^]LW;,_-L\S]WNSC._C9NQ\^VNKTGSO)C^U;//\M/-\O=Y>_ W[=WS;=V
M=N><8SS5JBOG7Q[\8]:T/7+'291;0Q7%Q:,?)+3N8GE,3QL\J(.2&.5C5@-H
M#=<_15%%%%%%%>:_'/QUJ7@BR>_L8[9HHO+,C3-*7.Y_+VK&BJ.K*=QE'&X;
M.AJW\!/%-QXJT:VO;U_,GD\[>^U5SMFD1>$"J/E4#@?K7?U\Z_M(_&/6O 31
MQVXMH8KCS!%(I:><>6ZDL1(B1+N5U&W;)CYL/]TCZ*HHHHHHK@/A-_;O^E?V
M_P"3_P ?!^S^5C[G.<;?^673R]_[W[WF?PUW]%%%%%%%%%%9]IK\%W/+:1N&
MF@6-I4')02;C'GL"0I..H&"0 RDZ%%%%%%%%%%%%%%9^@Z_!K\0N;1Q+$S.J
MNO*DH[1M@]QN4@$<$<J2"#7(?\3W^W?^6/\ 8WV?VW[\?]]^;O\ ^V7E?]-:
M[^BBBBBBN?\ '_V[[#/_ &3L^V>6?)WXVYR,XS\N[;G9N^3?MW_+FCP!]N^P
MP?VML^V>6/.V8VYR<9Q\N[;C?M^3?NV?+BN@HK*\5^)H?"]K+?7)Q%#&SMRH
M)QT5=Q4%F.%4$C+$#O7BNF:QXE^(FG'6=-NH;7?YOD6:PQR;E21E^>:8'$IP
M0,*(SA2=FYMOI7PA\4:AXEL1<:M;?9;CS'&S#)N4'A]CDNG=<,23MWCY6 KM
M:*********SVU^!;D6.\?:&A:41]6\M65"Y]!N8 9QN.=N=K8S_'_P!N^PS_
M -D[/MGEGR=^-N<C.,_+NVYV;ODW[=_RYH\ ?;OL,']K;/MGECSMF-N<G&<?
M+NVXW[?DW[MGRXKH*******S[37X+N>6TC<-- L;2H.2@DW&//8$A2<=0,$@
M!E)T**********JZI)-%&QMD1Y>-JR.T2'D9RRQRD<9(PIR<#C.1X5\&_B]J
MGBK7KK3=0,*I;6\ZF.!"(S+%<)&9 TFZ0\,1C(7&#M!R:]_HHHHHK@/A-_;O
M^E?V_P"3_P ?!^S^5C[G.<;?^673R]_[W[WF?PUU^LZ_!HH1KEP@DFCBCSU:
M21@J( .22?3H 6.%!(YKXLZ[J6@V;W>F+;'R8Y99C<&7[D:%MJ+&!ECCJSJ!
MC&#NRO*_LO\ CV]\;Z;+<ZA+YLJW;QAMB)A1'$P&(U4=6)SC//7I7K]<!\6?
M[=_T7^P/)_X^!]H\W'W.,9W?\LNOF;/WOW?+_BKOZ****S[_ %^"PEAMI7"R
MW#.L2?Q.40R/@#L%&23P"0,Y90?.OV@/&.K>$+*2]TX6P@CC D>3S&G#2.L:
M&- HC^4L&RY8'ILPOSZWP$\4W'BK1K:]O7\R>3SM[[57.V:1%X0*H^50.!^M
M=_11117/^.O'5KX'M7O;U]L:\ #EW8YVQH,C+'' X  +,0H)'E7A+4_$_P 2
MXUO5FATJT?S&A A%Q/(I*^66$WR[=N<./++?>\LHRD6_%>N>(_AK:RW4C0ZK
M"L;,7\O[-/$Q_C9(LI) F,M@B3YB2RHA8>B_#/7SXATRTNW<2/);0M(Z[<&3
M8!+]WY00^X$#&T@C QBNEHHHHHHHHHHHHHHHHHHKS#XN^/-3T*[T^PTB."26
M]:X!\\/M41"-BV4=, *S%N&) PH)X/,^/?&OBKP192ZA<KI;11;-PC%V7.YU
MC& S*.K#.2.,_2CP%XU\5>-[*+4+9=+6*7?M$@NPXVNT9R%9AU4XP3QCZ5;\
M)>/O$6MR:AI[Q6*7UG);!23.L&V42.7.TR,^55=@_=D;B7Y78<_]EWXL:A\0
MGOWU"0,(V@,2*B(J!S,648&XCY5 WEC@=222?>J****XKXO?VO\ 83_8&S[7
MYB?>V;MF?FV>9^[W9QG?QLW8^?;75Z3YWDQ_:MGG^6GF^7N\O?@;]N[YMN[.
MW/.,9YJU145W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5%I.J1ZO#'<P-NBEC21
M&P1E6 93@@$9!!P0#ZBK5%%%%%%%5=4DFBC8VR(\O&U9':)#R,Y98Y2.,D84
MY.!QG(\*^#?Q>U3Q5KUUINH&%4MK>=3' A$9EBN$C,@:3=(>&(QD+C!V@Y->
M_P!%%%%%%%%%9^@Z_!K\0N;1Q+$S.JNO*DH[1M@]QN4@$<$<J2"#6A1117FO
MQS\=:EX(LGO[&.V:*+RS(TS2ESN?R]JQHJCJRG<91QN&SH:M_ 3Q3<>*M&MK
MV]?S)Y/.WOM5<[9I$7A JCY5 X'ZUW]%%%%%%%%%%%9^DZ_!JYE6W<2&"8Q2
M;>0L@569,]"0&&<9P<J<,"!\]_M(_%K7O DD:PM;0P322&%HP9I]L84$2><G
MEC<7#8121C;O(!+?2E%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>"^./VC[KPWJ=MILUF+5)9K<
MM+<2QL1 [E)&VPN4C(8-AC(P 7++\W%7Q_\ '3Q!X;"ZA_98BTW<F3*P:<JS
M'!81R?N"RX7#HP20[26)"UZ?X%^)Z>,],34[6%Y&/RO;H\1E5PP5DR[QIQG>
M-Q0LA#;06"UY5H'[4EUJ6I3:=)8[94CDCCMD?S9I+I9 I0R@+$D07<SL5(54
M9][<*>E\&_&:_LK2^NO$MH;46;)ADCD"R[B4"('+*YW@#>KE"'4DJHW&K;^.
M/%FOVW]HV%E9)#(L;0P2R/)<.CJA#AU>.+!W$X;RV !!4G!;H/A'\=H/B9!)
M]G01WL:L3;/)P1T1@X3)0G 9@A*$X*D%"_*7/[2EW:ZM_84FG1K<F98P6O0(
MOF 9&W&WZ%2"!C><A0F\[:]JN9[E8-T<<;7&U<QM*RQ;N-X\P0LV!S@^7EL#
M(7/'*^ _B!=^)M/&I26)02*K0PI*'G=2Q4L1,EO&HP ZG>0Z'(P<!N/^%7QX
MNO&^L3Z7/:I;+;V\I==_G2"6.9(V&\;4V_,1@*>1D.0<5T'Q;^+<GA*2#3]/
M@^U:A=;_ "HMP 0 '$CC.[;N_P!U2JR$R)L)KR_]H'Q'K.F://;:W':LERT*
M0RVC2821)5E*R+,0Q#(C%63.TIAA\P([O]G"]:R\,VDD<3S,//Q'&8P[9NI1
MP97C3C.3EAP#C)P#4^%7QXNO&^L3Z7/:I;+;V\I==_G2"6.9(V&\;4V_,1@*
M>1D.0<54^.G[0E[\.V6**QQYN\13S2(48QN Y$4+LQ7:RE2SQMEN4^4@ZWQ+
M^(NN:3:RZCI]I"MK!R1<>:]S+&?+_>K#%M\I5W,6$K!PJDND9!4]5\(?B='\
M2+$7T:>6WF/')'N+[&4Y W%$W90JV0,#=C.0:Y_2_BW-XYOI;'0O),%MM\^]
MEW2QY8.!'%$CQM)EEXDWA,*^ 08R_-7/Q]U'PYJW]A7]M \TDRK!<*\]M Z2
M >5\IBN7R7RA()57RI.$+GW#2Y)I8U-RB)+SN6-VE0<G&&:.(GC!.5&#D<XR
M;5?('[95S>3?8/ML4,6/M6SRIWGS_J-V=\$.W'&,;LY/3'/T_I^HZ@-[75M"
M%6-BH@N6FD9AC" 2V]N@SSR7 !P#P21YAI7Q^N]1\01:#)9BV&Z;S=\@EE*B
M S0D>4?+0D %AF4?-@$$9/8?%[XGS_#ZW-W'9/<1)L,DGFQ11J&;8!R7E+;B
MO CVX;._@BN9\"?%#6?'>FPW%C;0"=UE,D\QDBM%9)MJHB#?-*3'R6!$:MQO
M+!HU/@-\>9?'TLUA?PBWO;=2S*N\!@'*/\C@F,H2BD,Y+$D@  @6XOC++XIU
M>70]($:FV5VGN)U=URC>6\:1*T18B1D&]I%& ^%8!2V?9?&N\\.:T-$UU(0)
M]GV6>W5PK;V*)O1I)&7<PV]?D<<[HV\P:'QR^--U\-XO,BLC(C,8UG>6-8O,
M9"Z81&:5QPVX,(ONX#'<#43?$77-:TU+[3+2'(M(IG>?S?WK&-FEB@@CS*<,
M $:1E#Y&P.I$E:'P%^-(^)]M([QB*X@9%E12S*0RY6094;0S*X"98J%Y8Y!,
M-]\2=2\375Q9>'X(2MI)Y<UU=F58#*N0\"+&-[,."7SM&#D8:-FRM)^-]YX?
MU2/1/$,,*33[#!/;%VA;>0D:E'RXRX=2Q(PV,H$_>5H?'+XTW7PWB\R*R,B,
MQC6=Y8UB\QD+IA$9I7'#;@PB^[@,=P-=*GQ*CTS18M;O_E4VD$T@C4GYI%3"
M*"3U=PJ[C@9&Y@,FN5\-^.=<\;:8=7TY+--^\P6LBRR.P1MC!IA+"H8LK[1Y
M>W&P,XRS+J_ OXSQ_$ZU9ROEW4.P3H =F6SM="<_*VTX!.Y2"#D;7;Q_X^_\
MCAI/_;A_Z625]545Y5XM^,[)J\7AW350WC\R2S!_)A&SSB-B[6E8Q D ,BAB
M@+GY@N+XO^--_P##3488-;6"33[A6V7$"21R*PV[BT;2RG"EAD+DE6#*2P,=
M>B_$?QE/X2M7NH+5[KRXWD?$D42(J89BS.V[[NX@(CDE<$#(->=?#'XVZG\0
M[266SLX_.^TRHK.SQVT,?E!XC(^&>9]YVE8E'&"_DAE+'PQ^/-WJ>K2Z!K$,
M<5TC2A'B\U4<H P4)(&;#(&D60LH9=H"Y(STOQ;^+<GA*2#3]/@^U:A=;_*B
MW !  <2.,[MN[_=4JLA,B;":\O\ V@?$>LZ9H\]MK<=JR7+0I#+:-)A)$E64
MK(LQ#$,B,59,[2F&'S CT7]ES_D7;/\ [>/_ $HEKU6OE7]N?_F'?]O?_MO7
M8>//C9KD4!U'2-.#:<BL_P!HGR7DCX E6%9(Y43JP+!MT960A%S7:_"/XQ)\
M3+*2YMHQ'<1,RM \H(#8S&2ZH6"-TW&/((<!6VY//Z#\?I[K7!X>N[$0R[G#
M2+<>:N%A:96 \E,AE QDJ0&^8 @K6A\9_C)=?#)5N&LDGM7D$:R"YV.&V;L,
MA@.,X;!5G&%RQ4D"NEN/B9!IVD)KEV#'$UM#,R+^\8&55*QCA<DLX4$[1DY;
M:,D<5H'BSQ3KL":C%;Z>+>5?-CMVDF%RT1^9$\P9B#LF,,0%!(+*O*CIO"OQ
M"O=:TI=0%D[W3R7"_959(BA266-5=IV3&-@5R 6W$D1X^4<_\ _C?-\4I+PR
M0I#%!]G\M06=_G$F_<QP&Y3(PJX!P<]:R?CI^T)>_#MEBBL<>;O$4\TB%&,;
M@.1%"[,5VLI4L\;9;E/E(.M\2_B+KFDVLNHZ?:0K:P<D7'FO<RQGR_WJPQ;?
M*5=S%A*P<*I+I&05.UX ^-UIXGTEM9G(MHXF=9U9BXC92,+NV+O+*R$!022P
M09;BL7_A,O$GB2'[=I=K9Q6S1[X8[F1WN)E(WQN/)811[U*@([95@=S;<&MK
MX+?%P?$*"19HS!>VS!+J$JRA7.X C=R 2K?*?F0@JV0 S8M]\4M2\4ZA<:?X
M=CMBME\MS-=^:$\TL5$:+&0_&Q\L05)!Q@!3)J^#O&NK/J0TK5K:&,BTEF^T
M0M(T,Q$D2@1AP"FP2$2*Q9BVUAM4C=E7WQ2U+Q3J%QI_AV.V*V7RW,UWYH3S
M2Q41HL9#\;'RQ!4D'& %,FKX.\:ZL^I#2M6MH8R+26;[1"TC0S$21*!&' *;
M!(1(K%F+;6&U2-WI597B:2\2$_V>D+SG('GN\<:\'#'RXW9L-CY?ER,_.IQG
MYE_94\4:GK<^I7:K'<S2M:M*\\[P'/[X+MV6\P(QP!\@0!0HQP.Z^.G[0E[\
M.V6**QQYN\13S2(48QN Y$4+LQ7:RE2SQMEN4^4@VV^,FK7VH6IL].=](N9%
M1;@I)YK*6VFX(4GR8OF#H)4!D0%@R[ODM^"OC%<?$ZZN8M'\F&UM=H,\\<DS
MRE\A"L2R0;%^1R2SLQ&SY%)8"'X<?&VYNM4F\/ZW%'%?(Q\IH-QAD4)YF/F9
MF4E/G4D@%3M8(Z@-;^.7QINOAO%YD5D9$9C&L[RQK%YC(73"(S2N.&W!A%]W
M 8[@:B;XBZYK6FI?:9:0Y%I%,[S^;^]8QLTL4$$>93A@ C2,H?(V!U(DK0^
MOQI'Q/MI'>,17$#(LJ*692&7*R#*C:&97 3+%0O+'()Q-'^*6L?$.2:;P['9
MBQAD$0EN_.#RN!N=E6(Y50&7 < D$'.2R)U?PX\:ZAK-U=V6IVR6\EK';<HS
M.DID\[=,A8#]TWEC8O+*0RNQ8$+S_@KXQ7'Q.NKF+1_)AM;7:#//'),\I?(0
MK$LD&Q?D<DL[,1L^126 A^''QMN;K5)O#^MQ1Q7R,?*:#<89%">9CYF9E)3Y
MU)(!4[6".H#=-X^^),VE746DZ9!]HU">,R88LD$,7*B>5@#E0XQL7#-@@$,4
M#\3XM^+>N?#/RKG7(+.:SED\LM9M*LB,?F!(G/S917(4  D?,Z<;M#X^>.+^
MVT5K_2&C6VDAA<W&^1;C9*P4"./R@%)#H=[.&4%L('"L*O[,]_>P:':[;>-[
M=5N2&6<BX8B:8A1$\*QY+_*-TP&/F)'W:-*^/UWJ/B"+09+,6PW3>;OD$LI4
M0&:$CRCY:$@ L,RCYL @C)[_ .*OQ,@^'-DU]< N=P2.->"\A!*KG!"C"DEC
MT . S84\!KGCCQ9HD#:C-967V=&=Y+<2.;F.%-S,3)O\HG8OWD#')!\KJH[K
MX4?%>U^)%J+FV.V1<":$G+QL>QZ94X)1P & / 8,J^=>./VCKOP[J=MICV!@
M$TUN2TC">5H7<H^V*V9\/N#! '<G;]PE@!;^*'Q8UWP9$NI&R@6R$RH\3.\M
MT%+N [-%^XB#*% YE"NR@EB=H]/\ >,8_&=C!J$(PLT8)7D[6!*R)DJN=K@K
MG #8R."*Z"N ^+WQ/G^'UN;N.R>XB389)/-BBC4,VP#DO*6W%>!'MPV=_!%'
MPM^(5QXJT:'5)8?,GD\S,4&U<[9GC&WSY54?*N3N?UQS@5Y_X0_:0OO$6I7&
MGC3\206\P%ND@DD:XCD5"K3'9#'%@G+$=1\K.S)&QXM^/>J?#O4HK;6K>V^Q
MS\I) 9SY:F3:Q+NG[UHTY=$C4G<A!7.VM7]J.YO/[&O$\J'[+_H_[SSW\[_7
M1'_5>1M^]Q_K?N_-U^6HOV9;N_71;)8X(&M]TV9&N)%EV_:)-Y\L6S+D<X'F
M8; R5SQTOQ/^+<GAVXATK38/M6I7$;O'&S"*-5"N0[,Q ;E#\@920K993MW<
M?XJ^,.N_#1XYM<M;66RD94\VT=U978DXQ,Q9B$1CMVJI)7]Z#D5[!:>+(M4M
M%O[ &ZC=0R"(H&8$X./->-05YW!F4@@J1N&VO#] _:DNM2U*;3I+';*D<D<=
MLC^;-)=+(%*&4!8DB"[F=BI"JC/O;A3JZ!\:==M;6]EU/27\VTRVY"+> HN3
M(=TSN6VA&8-#YH?(&%R&:W\*OC-J7Q'LYYK6VA$ZW$JH9&ECMXTV(8@SA7:6
M7<QW*@0;5)8Q%HP^5X#_ &AKYM4N-&UFW07";EA%M'-NDD4_= D)^5T.]9',
M2*@W.0K967XC_&77?AZ(;Z]L[7[%*P4Q),[7$;F/<$>3:$SN#'*1NN%*[LE7
M;U77OB)::+IQUB1B;7R4E5E4EF63;Y8"G!!8LH&[: 3\Q4 D<+X;\<ZYXVTP
MZOIR6:;]Y@M9%ED=@C;&#3"6%0Q97VCR]N-@9QEF6U\'_C6WQ*L7DMXD^W0>
M6)H7=XH26)PZR".4A6"L0-K,K#:W&)&\@^#_ (FU;5/%%\\_DW%W';W$+*TL
MD,"+'<1+MC(AE;:&'R@J"<EV;>3N]O\ BG\4;KP#:"\-B9@JQF9EGC2%"YV%
M0S#S7(<J!^Y *MN)4@J-#X,^-9O&^E6^H7*HLLOF[A&&"#;*\8P&9CT49R3S
MGZ5Q6E_%O5OB%)(WAR"V%G%(\9N;MI,2,HC.%CB(D3AB06!#+C)1@4H^'G[0
M$EQ?'1->A2TU ;0I5PT+LXWK'PS[&*,NT;W#MD95BJ'J_B]\3Y_A];F[CLGN
M(DV&23S8HHU#-L Y+REMQ7@1[<-G?P17,^!/BAK/CO38;BQMH!.ZRF2>8R16
MBLDVU41!OFE)CY+ B-6XWE@T:GP&^/,OCZ6:POX1;WMNI9E7> P#E'^1P3&4
M)12&<EB20  0/9:RO$TEXD)_L](7G.0//=XXUX.&/EQNS8;'R_+D9^=3C/S+
M^RIXHU/6Y]2NU6.YFE:U:5YYW@.?WP7;LMY@1C@#Y @"A1C@>Z_%/XJ)X%%O
M$D1N+N[F$5O &$8=MRJ29&!5 -ZCG))(XV[F7S_Q-\3?$_@6!-1U*TLI;4*#
M,L#R)+&6VJBLSNZYWN =BRCAN0"&KUKP+XZM?'%JE[9/NC;@@\.C#&Z-QDX8
M9Y'(((925()Z"L7QIXO@\'6DM_=DB*)06VC<Q)(55 ]2Q &2 "<L0,D>=>&_
M'.N>-M,.KZ<EFF_>8+6199'8(VQ@TPEA4,65]H\O;C8&<99ET/@M\;4^(]E)
M,(B+NW4>="F,,Q#%#&SL%P^TX#,"A!#';AVY0?M'79UQ-%DL#$ TH=-PGN'S
M"98-OEL(HR?EWEF=%#$LZ*C/47Q)^-^N?#MH+J^LK;['/D>4DDKS1L(P?+>?
M8(@Q8D@*C JK $XWUZ_JGCJUT[3VU=GS:BW$RM]TLK*&0*'*_,V0%4X)8A>"
M:\U\,^/?$WBN$:E:V=G%:-AH[>:2874B  DJX C&\Y\MG50,AB"F&;R_]F'6
MTU[Q/J%Y$"$GANY5#8#!7NHG ."1G!YP2,]S7UU6?K]W/:0/):1">95RD32>
M4'(_AWE6"DC.,C!. 2H)8>0?"_\ :*N?'U^VG+8"!XE9IO-N&#(JR)&X"_9L
MEP6^ZQ49!!9:E^,'[0%U\,9DCN+!)(IO,,,B76-P0@$,IM\JP#*2/F7YL*[8
M./5?M-Y]GW^5#]J_YY^>_D_>Q_K?(W?=Y_U7WOEZ?-7-:!X]OM6TQ-1%@3+,
MNZ*WCN(F)1DW1N\DGDJ@;C(4.RAE.TG<J\U\ _C?-\4I+PR0I#%!]G\M06=_
MG$F_<QP&Y3(PJX!P<]:\J^-/B;5I/$6F6EUY*HMQ9S06\<LC1%C-L#22-"K%
MBRD9$9"(?E4DON]Z\?3W,VB:B;R..-_L5WA8I6F7;Y#8)9X82#G/&TC !SS@
M>-?LGZI>)H]Q!IT2//\ :Y6WSL\=NF880F61':1MPSY:XPH)=XRT>_NOA1\;
M;G6=1N=#UB*.&]A9]C1[DBD5<9"K*V\DK^\0CAX\MA0N6S_CI^T)>_#MEBBL
M<>;O$4\TB%&,;@.1%"[,5VLI4L\;9;E/E(/L'B;59],A,EK;O=2\A8T>*/G!
M(+-*Z +D $C<PSD(V#7C7PI_:)O?B$]T+>Q#%&MA%&)"JJKEA*\T[+MP, JJ
M1^8P)"HX5W4T?X\ZCH>M)H6O0P*96B6.>#SUCRZG9@2!C(&D*QY&P(P;)(!Q
M[U45VSJC&(!G"G:K,44MC@%@K%03U(5B!S@]*^4)?$VK7OC2&&Y\EYK?S1#
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M#E$C:"$DJI"R7#(7D&"&8;&CX)'*D#&=Q^O[2T2S18HE"(BA550%55 P% '
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M^[Y4L-LK#))#&,$,1C.Y@, XKTK]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\
MTHEKRKX!?\CAJW_;_P#^ED='[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O
M7E7[%/\ R!Y_^O\ D_\ 1,%<?\![M/@WJ][H^JL(5F5&AN)2(HW6)I-C#[R
M.CL<E\*R&,Y<X&WJ6A?\+>\30ZCI[9L=.\A9;@C,<DL4KS>7$<_/G< 6X51E
MN08_,^E**^5?VY_^8=_V]_\ MO7U57RK_P U#_S_ - ZO5?VH_\ D7;S_MW_
M /2B*C]ES_D7;/\ [>/_ $HEKRKX!?\ (X:M_P!O_P#Z61UZK?:GI?A34[A=
M+M/M&LW$>^6*' (&TL&DD<B*!68*7P0[LR.4<E2?&OC$UR_BW26O!&KEK'"1
M,SJJ_:W !=U0N206SL0 $)@[=[=W^VM_R!X/^O\ C_\ 1,]>J_"?_D#Z?_UX
M6G_HE*^7_P!EK5)-(TW7;F!MLL5I'(C8!PRQW3*<$$'! .""/45[7^R?Y/\
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MEM9@2NY$BD ..0"5P2,D YPV,'QKPA\:M9^#'EZ9KMJ[VR_+&Q/[Q5^0D1R
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M/I__ %X6G_HE*^?_ (!?\CAJW_;_ /\ I9'1^W/_ ,P[_M[_ /;>NK_;6_Y
M\'_7_'_Z)GJUXXU233/!"20MM8Z98QDX!^600Q2#D'JCD9ZC.00<&N@^%'AZ
M;4=)LI8=2N0AM(!MC6Q9%*HJM&"UHS?*P*D,Q8$$,20:MZ7\"+:RU5==DN+F
M:\&<F0P!&S$8>5B@CZ(>,8Y )SSGQ_\ ;G_YAW_;W_[;U]55\J_\U#_S_P!
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M59,N2@"'"$%#^\!*Y0 D@_9OU9M(T>.QN[>Z@FMEG9Q);3J&4RM)E"$(<X<
M(/WA(;"$ $^:_"?[1X;\2WVHW-G>BUN6O!'*+.Y8 /.LJ,5$>\ JN.%)!(R
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M$CK:S^7ES& JL4&['ED[ERA!4JS<X]E\;^*EU[1+IHH+H//;3PK"UK<"82/
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M;00%MK1J^%<\\9P"5#' /8?M812^*--M[:Q@N9I3<13[4MK@XC,<R_,?+PK
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MB0;-[X54VJTF*M_##]J"1H8])NK.YFU5,PJBX_>,@P#*TKAXVX/G,0P7#2'
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M4%GD9W^5%"JV"<EV&U0<,5\_\6_$WQ%\._*N]6M[.:Q,FV=K/S_,C!X4GS6
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MF. "3@ G !/H*\:TKXF^(?',37^BVEK'9[7\G[4[--.5>13M$3JL9^0 K(0
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M3CA@BAC,A:*:2X^50S2$@V\)& ,@*&+<\# SYKX;\?>(O'L9U#2HK&*Q>1Q
M+HSF=E0["[>22HRP;C@C&/F&';M?A;XUNO%:7+7UM]DE@NVA\DMO8!8HGR6P
M V2Y*LH"E"N,_>;M:*******************************************
M************************************************************
M************************************^5?^:A_Y_P"@=7NOQKTN/4]%
MOXYEW*+2:0#)'S1J98SP1T= <=#C!!&17FO['?\ Q,]#F@N/WD7VN:/8_P Z
M;&BB+)M;(VDNQ*]"6)(Y-=+X$\1VEFAL/"EH)H(IF$LQD,-JKD.6_?.LLLS_
M "H 4210C)\X7:*\J_9W5U\6ZH)2&<+?;F52BEOM<62%+,5!/0%F('&3UKL/
MV.]475[.]N961KR6_>29@$$A#(C*6"@84N9"HP%SOVCK7M^M^'K;7D$5Y#'.
M@8,%E19%# $!@'!&<$C/7!/K7B'[:W_('@_Z_P"/_P!$SUQ7ASQU-I5_H\6O
MQHFFBPMC9N68P"7R(]MRYVX:4'Y"' 6#>'!P/-D^M*^5?@%_R.&K?]O_ /Z6
M1UZ7^UAI<=[H$\DBY:&2"2,Y(VL95B)X(S\DC#!R.<XR 1XUXOU^=? EBN\D
M2W/E/N^8F-)+AD3+9("F),8Q@*%'R\5]-?"?_D#Z?_UX6G_HE*^?_B]_Q3_C
M73I[7Y))_LGFG[V[?*]L_#9 S" O &/O##<T?MS_ /,._P"WO_VWKZ ^+'_(
M'U#_ *\+O_T2]?+_ ,.M4DTSP1JDD+;6-V8R< _+(+6*0<@]4<C/49R"#@U[
MK\*/#TVHZ392PZE<A#:0#;&MBR*515:,%K1F^5@5(9BP((8D@U;TOX$6UEJJ
MZ[)<7,UX,Y,A@"-F(P\K%!'T0\8QR 3GG/I5?,'[0.J22^*M&MBW[I)+215P
M.&DNMKG.,G(B08)P,< 9.?I^OE7]F?\ XDGB35=-M_DM5^T8C^]_J;D1Q?,V
M6^59&'7G.6R0"#X^_P#(X:3_ -N'_I9)7U517RK_ ,U#_P _] ZOH#XL?\@?
M4/\ KPN__1+UY5^Q3_R!Y_\ K_D_]$P5RG_-0_\ /_0.K;^$4TWB/7==#7LD
M$HN54+$+;<\<+S0KE9H)>$4(N5 Y8;R20:]%\:_!!/&\*VVH7UY+$L@D"XLT
MPP#*#F.U4]&(QG'/3I7=>'M$30;:&SB)*00QQ*6P6*HH0$X &<#G  SV%:%?
M*OP"_P"1PU;_ +?_ /TLCH_;G_YAW_;W_P"V]?0'Q8_Y ^H?]>%W_P"B7KRK
M]BG_ ) \_P#U_P G_HF"N4_88_YB/_;I_P"W%=!%>RZOXUN[=KI[<I8)'"8Q
M;[R,03F(":*0-RSR'@O@'!"@BO2_%/PD/BJW>RO=0O)()-N],62YVL'7E+16
M'S*#P?TK)\5_!A8O#DN@:>SMMC8Q&0HSLPF^T!"?W:C<PV \!003G!SQ7[./
MQ<L?#^D-8:E*EK/8R3*\<K%9&!=Y"0C*&+!BR&-=S@J,@%U%3?LZ> YY]1O?
M$T@,4%ZUQ]GB<8E:.683"5@"0HPH"CG=DL,+M+\S^W/_ ,P[_M[_ /;>OJJO
ME7_FH?\ G_H'4?MS_P#,._[>_P#VWKZJKY0^']R/@YXJGTCE;*]9%BRK  O\
MUO@D.[A79H,[@"27<@K@?0OAO_B;WEQ?]8T_T6'//^J=_M,BYP4W3'RF7 W?
M9D?+*4V]57A7[9.J266BK'&V%FNXHY!@'<H624#D''SQJ<C!XQG!(/I?PG_Y
M ^G_ /7A:?\ HE*^?_B]_P 4_P"-=.GM?DDG^R>:?O;M\KVS\-D#,("\ 8^\
M,-S75_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2NJKP#]M;_ ) \'_7_
M !_^B9Z]5^$__('T_P#Z\+3_ -$I7S_\ O\ D<-6_P"W_P#]+(Z/VY_^8=_V
M]_\ MO7017LNK^-;NW:Z>W*6"1PF,6^\C$$YB FBD#<L\AX+X!P0H(KTOQ3\
M)#XJMWLKW4+R2"3;O3%DN=K!UY2T5A\R@\']*W_ 7@J'P191:?;,[11;]ID*
MESN=I#DJJCJQQ@#C'UKH*^*_V3/^*;\0365W\DYM[B )][]ZDB.ZY7*\+$YS
MG:<<$DC/VI17S!^T#JDDOBK1K8M^Z22TD5<#AI+K:YSC)R(D&"<#' &3GZ?K
MY5_9G_XDGB35=-M_DM5^T8C^]_J;D1Q?,V6^59&'7G.6R0"#X^_\CAI/_;A_
MZ625ZK^U'_R+MY_V[_\ I1%1^RY_R+MG_P!O'_I1+7E7P"_Y'#5O^W__ -+(
MZ/\ FH?^?^@=7NOQKTN/4]%OXYEW*+2:0#)'S1J98SP1T= <=#C!!&17DO[+
M5M!KGARZM]2P]HMS,K"5L1I&(HI#@DC8 Q+Y!&ULN"&YKT#P/XJ&HP1VWANT
M"Z>BLB74Q:& $;<F.,@SSD,S%RWDAW1AYVXEAY)^PQ_S$?\ MT_]N*/C[_R.
M&D_]N'_I9)7JO[4?_(NWG_;O_P"E$55?V<M+CU?PO;VTZ[HI8[N-UR1E6GF5
MAD$$9!(R"#Z&O.OV9]>?P-JUYX7N2<&:1H&9"A9XQRVW:2!)"HD!9]H"#;DO
MD^]> ?\ B8K+J1Z7D@>+/)%NJ!( ">=K@&<(0OEM.ZE=VXMU5%?)?C7P[KWP
M>U2[UG35\^SN))99,*7CPYDD(EC5@Z^7R1*"% QEAO:.O6O@U\>;+XH2E!"8
M;V*%V*MB0>6SJ'V2@ XR(RX(3)VX#!=P]:KP#]M;_D#P?]?\?_HF>O5?A/\
M\@?3_P#KPM/_ $2E?/\ \??^1PTG_MP_]+)*^@/BQ_R!]0_Z\+O_ -$O7E7[
M%/\ R!Y_^O\ D_\ 1,%<I_S4/_/_ $#J]5OM3TOPIJ=PNEVGVC6;B/?+%#@$
M#:6#22.1% K,%+X(=V9'*.2I/C7QB:Y?Q;I+7@C5RUCA(F9U5?M;@ NZH7)(
M+9V( "$P=N]O9?VH_P#D7;S_ +=__2B*C]ES_D7;/_MX_P#2B6O*O@%_R.&K
M?]O_ /Z61UU?['>J+J]G>W,K(UY+?O),P""0AD1E+!0,*7,A48"YW[1UKV_6
M_#UMKR"*\ACG0,&"RHLBA@" P#@C."1GK@GUKQ#]M;_D#P?]?\?_ *)GKT_X
M96B7FB6,4JAT?3K965@&5E," J0>""."#P17*^!/$=I9H;#PI:":"*9A+,9#
M#:JY#EOWSK++,_RH 4210C)\X7:*\J_9W5U\6ZH)2&<+?;F52BEOM<62%+,5
M!/0%F('&3UJ7X^_\CAI/_;A_Z625]545\J_ +_D<-6_[?_\ TLCKJ_VH-9:U
MO-%@,WDP-?\ F2/^[&PQO"%EW2*RC8LCGYLISE@0!7JO_"&W7_03O/\ OBP_
M^0ZXK2_A3;_!O3=2N=,EF,K6DD@:4QOM:&.5HR (U'5LD,"#@<=<G[)_D_V!
M!Y6S?YD_G;=N[?YK8WXYW>7LQNYV;>V*]/U+P];:H\<MQ#'(\+;HF=%=HVR#
MN0L"5.5!R,'('H*^</@KJDFI^,M5DF;<PCNHP< ?+'<0Q1C@#HB 9ZG&22<F
MO:OC7I<>IZ+?QS+N46DT@&2/FC4RQG@CHZ XZ'&"",BO/_V-M4DO=%:.1LK#
M=RQQC &U2L<I' &?GD8Y.3SC.  .*^ 7_(X:M_V__P#I9'6A^W#K;PVUE9@#
M9)-+*QYW;HE5% YQC$S9X)R!@CG/TK:6B6:+%$H1$4*JJ JJH& H X  X '
M%?+7P"_Y'#5O^W__ -+(ZT/C)X#USPOK3>)-%!F#K'YD: LP"K'$8GC!W2HV
MT-E.5()^0HKGI?@Y^TG:_$6>&RNX/*OAN:,@>9$66([V0GYHV*F3 .0$ROF,
M6P?=:X7XN6FBK!'=Z^L9B@F4QLX9CO/\(5,LX.,M'AE8+N=2%R/.OC]XAOM>
MT"[E>U^RVO\ HQ'GL#=.#+ 0#%'E8?F;JTC.-A4Q*7#)U7[+G_(NV?\ V\?^
ME$M>5? +_D<-6_[?_P#TLCH_;G_YAW_;W_[;U;_:/U#^TO$FCZ?,B/ LENY#
M+NW>=<B.16!)4KMB'&.[9R" /I^OE7]AC_F(_P#;I_[<5]55X!^VM_R!X/\
MK_C_ /1,]>J_"?\ Y ^G_P#7A:?^B4KY_P#C[_R.&D_]N'_I9)7T!\6/^0/J
M'_7A=_\ HEZ\J_8I_P"0//\ ]?\ )_Z)@KE/^:A_Y_Z!U>P>+;O1O#6J1730
M>;K$\>R%(5WW#KG:7P66),+D&60H?+5U#E5*CP7]K^[O;Q-.EOXHX"RW.V%)
M#,RG$!;?)M12>0NU5(4J2)'#@)[?^U'_ ,B[>?\ ;O\ ^E$5'[+G_(NV?_;Q
M_P"E$M>5? +_ )'#5O\ M_\ _2R.NK_8[U1=7L[VYE9&O);]Y)F 02$,B,I8
M*!A2YD*C 7._:.M>WZWX>MM>017D,<Z!@P65%D4, 0& <$9P2,]<$^M>(?MK
M?\@>#_K_ (__ $3/7I_PRM$O-$L8I5#H^G6RLK ,K*8$!4@\$$<$'@BN5\">
M([2S0V'A2T$T$4S"68R&&U5R'+?OG6669_E0 HDBA&3YPNT5Y5^SNKKXMU02
MD,X6^W,JE%+?:XLD*68J">@+,0.,GK4OQ]_Y'#2?^W#_ -+)*^JJRO%FA?\
M"06=Q9;MGGV\L6_&[;O0INQD9QG.,C/J*^2O#_C77OV>_P#0[^V\ZQ,AV$L?
M+R?,QY4RA@FXKO,;KNP"VQ"[,?IKX7^/[+Q[;-?V"E0TS+*&0))YBJ@^;:2&
M/E[,$,WR[5R"I4>"_L,?\Q'_ +=/_;BO9?BA+HNB3VVHZG$)+Q&*VBJC23R/
MU5$1?OD,1L+C;'(P(9&8$^2_M8ZC?:CI,4EU EM%]O 2,R":=ODG"LY0"*/Y
M1DJK39WCYUV$/T'Q+_Y$:/\ Z\-,_P#0K>NJ_9<_Y%VS_P"WC_THEK@/V6//
M\56=W.;^:*=[^225(EM.3(D9\TK);R,NY@P&,)\I"C(-=_XZ_9[@\=^7_:5[
M>2^5O\O_ (]$QOV[O]7:KG.T=<XQQWKE?VUO^0/!_P!?\?\ Z)GKU7X3_P#(
M'T__ *\+3_T2E?/_ .PQ_P Q'_MT_P#;BCX^_P#(X:3_ -N'_I9)73?%34Y)
M_%VEVC7!MXUMI&1U$(99)1/&<&5'4E_+1 &#<\( QS7I^K?#B;5X9+:?4;QH
MI8WC==MB,JP*L,BS!&02,@@^AJ7X7_"^V^&]LUG9M(Z/,TI,I5FW%40@;$08
MP@[9SGFO!?V&/^8C_P!NG_MQ1\??^1PTG_MP_P#2R2C]N?\ YAW_ &]_^V]?
M2OBS0O\ A(+.XLMVSS[>6+?C=MWH4W8R,XSG&1GU%?)7A_QKKW[/?^AW]MYU
MB9#L)8^7D^9CRIE#!-Q7>8W7=@%MB%V8_37PO\?V7CVV:_L%*AIF64,@23S%
M5!\VTD,?+V8(9OEVKD%2H["BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOE7XJV-U\.O%"^)9;=
MYK$[2SQ\[ 8%M6#DC"L"VY Q"OD*'!W;>U\=?%E?B5:OI/AK?<37/[J:;RY(
MX+>)L[VD:6/^- RJ -Q^8J=X16UO%?PMFT'PM+HVG2.\L=NV&^97D_>>=,BK
M&"?G!=%3G(8(S')8\I^S'\7;*+2H=+43/>0^=^YCA=RP:5G5@R@QJI,BJ6E:
M-5;.XJN&/%?!#5IM(\4:C)>6TR7$D=R?LZ(TKAY+B*14W* @4YXE<I%@ABZJ
MP-'BN+4/V>-6EU"VC273[R1L* T<0!?S/)VH=L<J+N6)B&786*J?G1>KT7XM
M:E\;V2PMK'R-/>0"]F,LI!B5XWDA61%BVLR90H-S,LG\"AFK0_:W,WB*TBTZ
MRM;J>5+E97:.VF:)5$3C&\)M8GS!C86 VL&*D &^?#MMX]\-PZ??Q7EO):V]
ML.;6Y\U)40PJZHJ'SE/.0F["-EO+;!6K^S=XYO\ 3K=-)U:RO(_+PL$[6]PR
ME2V!&Y*'9MSA6.(Q&,'9L!?BK:>;X+^)KK4=3A?[#>23*MP@9HU$\OG*20O+
M+L(>/AP S*' 7?VOQ!\3M\;XTTC0BYM)) UW>M$ZP(L9#>2/,16>7<4?:I4_
M=&=C2%/0/'/PDA\0:+_8J<^5;QI;N^W<KQ*!$Q8(<9QM<JH)1G QFO'_ (*_
M&5?AE!_87B*)[-H-[0R&.1@ZM*Q8$('S\Y;9(F8W4$9!4%^E\+^'G^)GB#_A
M()H2NGVL*1V1D0QM,W+K-LD#$H#(SH_R'/E$#<L@''_M;6MSXRFM8+"SO)?L
MWV@2.MK/Y>7,8"JQ0;L>63N7*$%2K-SCV7QOXJ77M$NFB@N@\]M/"L+6MP)A
M(\#84H(R<9.TR#,6[C>:\@^ _@]M1T:\\.ZG;75N]S,[QR26TZQ ^6A1MX"J
M"CPABKL@?Y5!;) Y3PK\3-7_ &?7DTW4;<SVVYO)!9DCW @L\,I1@R$,"R8R
MK$$A'+AO:OAOXFU'XH74&HW5J;*PME9X49MSSS21LBR9:-281#*V-H4%F!W2
M8(3V6O"OVJ?@_)XTM4O;*/?=VV[*KC?)$>64?*6=E8;D7(X,@4,[ &;PA^U3
M8WD CU%9(=25FC>T2&5W>5>-L8"G!9OE".596RK$@!VE^ 7@.;P]'=ZYJD7E
MWM[)),T:HSO'$29-@0*TH9F))C!=B!&I'F*17FOQCFN==\16>IVMC?26UI]E
MWL+2=2_ES-,VQ713T;:-VW+ _P .&/U)HFN1ZRADB$B@,5Q+#- V< \+,B,1
MSU QG(SD'&A7R7\0=0_X0#QHFK:@CI9R8*2!=P(^RBW9A@_P.<NOWPN"%.Y=
MWM7Q.\8"]TFZ2&VO'>XM[B&%%M9B[%D";RNW=$H9_P#EJ(V8(QC5QM+<+^R0
M9O#MI+IU[:W4$KW+2HTEM,L3*8D&-Y3:I'EG.\J#N4*6)('*7/VB'QC_ &TM
MG>O9;E'F+9W(.#:" MM:-7PKGGC. 2H8X!B^*_@S4OAYJ9\3Z&KM;SYEE39+
ME-R^9,L\;?/Y3X+DG;Y;?+B-DC)Z#0OVE]4^(VZRT;3O+G;"_:&E,L,&[/[Q
M_P!RJCY58J">6'"N?D;Z$\/:(F@VT-G$24@ACB4M@L510@)P ,X'. !GL*FU
M34UTR-II Y5<9$<<DS\D#A(E=SUYP#@9)X!-?*OP<FN="\17FIW5C?1VUW]J
MV,;2=BGF3+,N]41CT7:=N[#$?PY86OVMK6Y\936L%A9WDOV;[0)'6UG\O+F,
M!58H-V/+)W+E""I5FYQ[+XW\5+KVB731070>>VGA6%K6X$PD>!L*4$9.,G:9
M!F+=QO-<!^R09O#MI+IU[:W4$KW+2HTEM,L3*8D&-Y3:I'EG.\J#N4*6)('"
M?LO^(E^'%]>Z7J<<T=U)Y05%BDF;,0D++MA5V.5?>K*"A0%MV-N[I?V@/A=J
M,=W#XFT5)%N=L7G1(-]PK@; ^U6D1QLQ'(B97 SAT9V$7AG]KC4/%&+2QTOS
MKPQCE)6,88X7S&3R_EB#L,[I  #@R#[U>JZQH%]X=\/3003(;[[/-)),[B)/
M-E9IKEU=1$$P7D,3'8JG87( )KR7X:_'#5?#^G6UK%H4\J1PJ%EB66..13R)
M !;N"6!W,P8AV)?C=@=KX7_:3EN;V"QU739[ 7+;(9)-[!I,J%7#0QG!+ %A
MNVDKN 4EAPG[6UK<^,IK6"PL[R7[-]H$CK:S^7ES& JL4&['ED[ERA!4JS<X
M^D-$\61ZM;&[$<\8526CE@FCF!"ABHC*;G(SC]WO#,"$+&OF7SKG_A,/[;^P
MWWV/S-N_[)/NQ]F^S^9MV;MN[YL8W[/X=WRUJ_MHZ3-JUK8W\,;FWC\[S&*L
MI3S?)\O>K .F=I!W ;6PK88@'W7P+\2+?QO&D]DDQB:/<7>)HT4Y \O<^ [9
MW F+S$4H0S#*;O)?VPOAT==M(;^VB+W$,R1-L"[FCE.U1C&]R)2@15)P9'.T
MY)'M_A30O[!M8K4MO:.-0\F-ID?K)*PR?F=R78DDEF)))))U:X_XM?#]/'VG
M36+8#LNZ%CCY)5Y1L[6*@GY7*C=L9@.M>(?!7XRK\,H/["\11/9M!O:&0QR,
M'5I6+ A ^?G+;)$S&Z@C(*@OTOA?P\_Q,\0?\)!-"5T^UA2.R,B&-IFY=9MD
M@8E 9&='^0Y\H@;ED S_ -JV[E\5V<>GV%K>32I=[W9;2X\L!$D0_.T8#9+_
M "E-RD G(^7=Z7\&?$(N-/M+.2&YAGAM(D=9K>:$ QJL9P[((SDC<H#%BIR0
M"& [^O$/VP- GU?1@UNAD$%RDLFWDK&(Y59\=2 6&<9P,L<*"1H?!GXMVE_I
M-HL27+F"WBAFV6TT@1HT5"<HK!\G:0L9>0*X=D55D*>5?!R:YT+Q%>:G=6-]
M';7?VK8QM)V*>9,LR[U1&/1=IV[L,1_#EAJ_MA:-<^*)+2&QMKF=H/M'F&.W
MG9!Y@A*8<1[&SM.=I.""#@\54^,O@J^U6XB\5:!'<QW \L30M#-'=+(%"AQ'
M(#YB["L<@0,GRD_O%,A6WX9_:XU#Q1BTL=+\Z\,8Y25C&&.%\QD\OY8@[#.Z
M0  X,@^]7O\ X"\/2>'[**WN'\R?YY)GXPTLKM+,5PJ#;YCMM&T87 (S705\
MZ_&?X)WEAJ"^)- 5/.BQ++ N]7D=6RS*$(W[T)$B H7 .-[R$5T&A?M5Z=\T
M6KQS:==)C?#+'(_WLE<%(]WW=K'>B?>&W<.:ZO3O'\WC.3R=,AFCMC&K&_EC
M:)"KA2AMTE3,S$%AN8+'&0'(E4JC\)^T]\%G\4V45S8(9+FT7;MR7EDAQRNY
M@TDKJ0&4%LG,F-SL ;?A#]JFQO(!'J*R0ZDK-&]HD,KN\J\;8P%."S?*$<JR
MME6) #M:_9W^'4^DBYUC4HA'?7\S2%,<Q1LQDV8(+H6=B60LW"QAL.K >8?&
M.:YUWQ%9ZG:V-]);6GV7>PM)U+^7,TS;%=%/1MHW;<L#_#ACZK^T'?GQ%H4L
M%I#<R2W'E^6@M;G?^[GC+[E,0,? )'F;=P&5S4/[-^K-I&CQV-W;W4$ULL[.
M)+:=0RF5I,H0A#G#@!!^\)#80@ GS7X3_:/#?B6^U&YL[T6MRUX(Y19W+ !Y
MUE1BHCW@%5QPI()&0!DC/\4ZQ)HWCM[B&%[ADVDQ1X\QE^P#S"H/WF"994X+
MD! 02#7=_%'XYQ>.+1])\-B2\NKI3&Y2)U6*)BJ2,_FQ@ ,&V;N%0,6+J0N[
M/^+/PDF\+>$DL;/EH)(Y[S9NS+PWFGY47>JNRL-X&V*(%CE!75?"'XRV^IZ3
M!;:?%-<WMO:0QM;B-D&]$V#=,P\B-6V%@S/DKP%,G[NO-?V-;YM%FO[:6*;S
MFDM4*")_D*F<2>8Q 2/;DDAV5FVE4#OA2?&.:YUWQ%9ZG:V-]);6GV7>PM)U
M+^7,TS;%=%/1MHW;<L#_  X8^J_M!WY\1:%+!:0W,DMQY?EH+6YW_NYXR^Y3
M$#'P"1YFW<!E<T?LQWCV6E0Z;<V]S!<0><6$UO+$C!I6<,KLH0_ZP#:2'R&.
MW:-QXK]I7X42:MJFFWMB'CEN+A()9HP"R,I#Q387;(66,2,SYPJ1*,I@$_1]
MI:)9HL42A$10JJH"JJ@8"@#@ #@ < 5+17B'AKX[Q^'&NX=:6>*%-1O4@NVA
MF>!T$[[8O,&\EU(< !0JQQA<Y7!Y_P (^'HO%_BB/7M'A*:>D+M+.R/#'/,Z
M31LT0< L<L Y 4;D<M\S*7^CZ^=?VK;N7Q79QZ?86MY-*EWO=EM+CRP$21#\
M[1@-DO\ *4W*0"<CY=WI?P9\0BXT^TLY(;F&>&TB1UFMYH0#&JQG#L@C.2-R
M@,6*G) (8#PKXQS7.N^(K/4[6QOI+:T^R[V%I.I?RYFF;8KHIZ-M&[;E@?X<
M,?;_ (J>*EN=(N%@@NI7NK:XBBC2UN/,W,IBRZM&IC +;OGVEE!*!N > _9(
M,WAVTETZ]M;J"5[EI4:2VF6)E,2#&\IM4CRSG>5!W*%+$D#E+G[1#XQ_MI;.
M]>RW*/,6SN0<&T$!;:T:OA7//&< E0QP#G_LY^/(OA[J%_9ZPTPN;B2':QAN
M'>1PTG52GG[I/-#)N0%AG=AB 3XTZM-<^*-,O9[::&W$EF(69&9Y42XWLXC0
M%U;Y\>41YH&W<BLX0>J_M#ZX^NZ-)96UK>23W/E%$6VE;"+,'#N54JF5CR$)
M\U=R[XT.[;+^S?JS:1H\=C=V]U!-;+.SB2VG4,IE:3*$(0YPX 0?O"0V$( )
M\U^$_P!H\-^);[4;FSO1:W+7@CE%G<L 'G65&*B/> 57'"D@D9 &2,_Q7%J'
M[/&K2ZA;1I+I]Y(V% :.( OYGD[4.V.5%W+$Q#+L+%5/SHO5Z+\6M2^-[)86
MUCY&GO(!>S&64@Q*\;R0K(BQ;69,H4&YF63^!0S5H?M;F;Q%:1:=96MU/*ER
MLKM';3-$JB)QC>$VL3Y@QL+ ;6#%2 #?NDN?$OA)["UBN8+R&P@C>.6&>!V\
MH*)$0[/WGF)&RA4+9#JKA=Q%97[,?Q=LHM*ATM1,]Y#YW[F.%W+!I6=6#*#&
MJDR*I:5HU5L[BJX8\5\$-6FTCQ1J,EY;3)<21W)^SHC2N'DN(I%3<H"!3GB5
MRD6"&+JK U;^,<USKOB*SU.UL;Z2VM/LN]A:3J7\N9IFV*Z*>C;1NVY8'^'#
M'ZJTO4UU.-9HPX5LX$D<D+\$CE)51QTXR!D8(X(-&J:FNF1M-('*KC(CCDF?
MD@<)$KN>O. <#)/ )KY5^#DUSH7B*\U.ZL;Z.VN_M6QC:3L4\R99EWJB,>B[
M3MW88C^'+#UK]H_X/O\ $:R7[+C[7;LSQ!B0'5A^\BSD*I;:I#," 5"Y569A
MX_X._:IU/PNB:5J-C)<WB,J+N9X;A@P7RU9#$[,YR,-P7!4D%LLWNOPSTN[U
MQ+C4=9B$;WJHBVK ,L=L@?RXW!0$NQED,F[.0P&U,&-?G73?$>I_LSW<EG-&
M+FSG;>A+.BN%!7=&<LL;\J)5*L<*HSM*.?4/ GCW4OC-=6\CV?V;2H)%G=C)
M+F:6/S!$JN!&LBK*%<IM*JT67?)5#S_QD\&77P[UN/Q3IMMY\'S/<(HX5O+=
M9G(1045HR6\P[P)=S2<%5;I?&GQWM?'FG2V&A+)<WUU"(_)\F3]TDN$D>1CM
MC4*&V[P[*'*DY3)KT#X=>$8OA=I,5LP+&-0TS11O,[RN1O8+%'YC@$[5.W<(
MU7=PI->"_!R:YT+Q%>:G=6-]';7?VK8QM)V*>9,LR[U1&/1=IV[L,1_#EAZ?
M^U'\+G\;:<)K9"]U:L7C502SHV!*@&X#. KCAF)38HR]<A\,/VH)&ACTFZL[
MF;54S"J+C]XR# ,K2N'C;@^<Q#!<-(<#*KQ/P4UJZT+Q)J%Q/:S7,K27$,OV
M./?&DLERK9+2,@2(F-L,[# &3T)'LLOQC/A+5=1AU%)_L"36Y2Z6*66"%FM8
MM\;LI;:"Q38JJ3OD8M][-<5K]E:_%?7=/U'0HRZ03+)>79CDBA(B>)DCRZKN
MF"C  7)5TRVQ24^FJ^8/VI?.T#6-+U>;>UC#)%E5W-M>.;S9.#A SI@+\P+^
M6<X" UT'QW\?KXVT"<Z3#-<P-L:2<1R11QI'*&+CS41I?FC(;RPPC 9I&0 !
MM#]FKQ9'9:!;HT<Y$2SEW6"9URURX55VH6E)W$GR@X0*WF%#@'SKX.37.A>(
MKS4[JQOH[:[^U;&-I.Q3S)EF7>J(QZ+M.W=AB/X<L-7]L+1KGQ1):0V-M<SM
M!]H\PQV\[(/,$)3#B/8V=ISM)P00<'BI?VB/",WCF"VU[28+I;N!EC>,PS17
M*KQ(C!6P28Y&QNB#@ER=^V/(V_ O[4$GCB-+*RLW;5&CYS@62$$!IG?>9!$
M=Q7:6)(B5BQ#'S_]C36I-)DN(Q:W,J7,D"":.,&",QB1G\R1F55PL@.!ECT
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M[G4E-V3:?M%::+98-?22SN'A F@GM9@KAEP[*NV3,+-N4;CD@$,/7/\ V8?
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M2RL$1%+,S$*JJ!DL2>  .23P!46DZI'J\,=S VZ*6-)$;!&58!E." 1D$'!
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M ) \'_7_ !_^B9Z]5^$__('T_P#Z\+3_ -$I70:I>M91M)'$\S#&(XS&';)
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M%-S,3)O\HG8OWD#')!\KJH[KX4?%>U^)%J+FV.V1<":$G+QL>QZ94X)1P &
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M'5"'#J\<6#N)PWEL ""I."W2_!CXZ6OQ.C8(ODW4>2\!;<=N<"16PN]>0"<
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M5PLGS ?-MZL"5)!&=H[#5M4CTB&2YG;;%%&\CM@G"J"S' !)P 3@ GT%>5>
M_B=J7Q/AN+W2Q;6\$4C11)<)+-)(ZC?N<QR1+$I5XQ@"8@[^2 ,R_!3XVOXT
MEGTW4(A#J5LTGF(F3$RH^QBIW/@JQ"L"Q!X9"02$Y_QQ^T==^'=3MM,>P, F
MFMR6D83RM"[E'VQ6S/A]P8( [D[?N$L +?Q0^+&N^#(EU(V4"V0F5'B9WEN@
MI=P'9HOW$090H',H5V4$L3M&AK_QXFLM(AU^UM$GM'CC,O\ I#121N7,;KM:
MW(=5D 3<#EB<A-@W5M?!KXI3_$B WAMHX(-SH,7/G2[UV\%!"H08)/S,&X!V
M;65JT(_%VH2ZD^GBTA\I(XY6G^U-Q')))&GR?9LF4B)VV@[!C!E&03VM<?\
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MB'S.GF'$1=4SE@"I()56X4]!X0^*$OQ#TP7VCQQ^?N:-X[AW1(I F3S'&YD
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M.ZRF2>8R16BLDVU41!OFE)CY+ B-6XWE@T:GP&^/,OCZ6:POX1;WMNI9E7>
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M^M>(?MK?\@>#_K_C_P#1,]>J_"?_ ) ^G_\ 7A:?^B4KY_\ V&/^8C_VZ?\
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M=O/^W?\ ]*(J/V7/^1=L_P#MX_\ 2B6O*O@%_P CAJW_ &__ /I9'1_S4/\
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M&D:10S88R69G?.3R#+\^#P"!@# QH?L7:I)J\VJW,[;I99+:1VP!EF-PS'
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MK^W/_P P[_M[_P#;>OJJOE#]FJV&C>)]4L;?*6Z+=*L>YBN([I$CSDG<55B
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MV[L,1_#EAV'[6YF\16D6G65K=3RI<K*[1VTS1*HB<8WA-K$^8,;"P&U@Q4@
M^E?!;5S=:9;6[PSPRV]M!%(D\,L)W(FS*EU"N#LR-I) *[@I.*[JOC7X;^+?
M^$4\5:K=/$\D"R7PG9/F:&(W2YG*C+.JL%WA?F5"SX(4@]M\6?B(WQDC30_#
M:O.DLD9NK@HZ01J"S*CF2/<OS)O)&"=@1/,+,H]JB2W^&^GQP0Q32101A$2&
M%II7(4G)6),;G()9VV(7;+,-U?/_ .R3:W/@V:Z@O[.\B^T_9Q&[6L_EY0R
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M("K,$.W/F [FP@ 8LR\9[O\ ; T"?5]&#6Z&007*2R;>2L8CE5GQU(!89QG
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MM8,5( .)\2TN=?\ "$,$,5S#)91VGVJ*6&>%F2-&C;&4VR*&"RG!(1%#OM8
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M7:RB,J%4(!@L""/:_AOIU]X^:ZU#7K;[/'-;O:06Y:9'6!G<SEU+##/^[4N
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M2C?>:4-\I*@9%2VUUXB\6:5%=VDT=LYLH94_=QS7%Q+Y3%@VXK! CL5*8#L
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M-J=K$(I!0,Q^9L9!RK;24=-X'M7A3Q-#XHM8KZV.8IHU=>5)&>JMM+ ,IRK
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M_:]3?S/LD**AF7<I#.7;_4Q';M=_[H8[65'V^/\ [6-OJ#:3%+J$D(S?@+!
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MW+W O6EE+;BQ$L:!7+'[Q9HWSR3D9/49]_N[M+-&EE8(B*69F(554#)8D\
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M^M=5X>MH+6VACL\&W6&-82K;U\L* F&R=PVXP<G(YR:T*^5?@%_R.&K?]O\
M_P"ED=>J_M1_\B[>?]N__I1%1^RY_P B[9_]O'_I1+7E7P"_Y'#5O^W_ /\
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M,$8;HWP-[*NW:6!'?_"+P._@;2[?3I7$CQ*^YE!"[G=I"!GD@%L G!(&<+G
MZN[F,",ZJ7*J2$7:&8@9"C>RKD]!N(&>I YKYE_X0O7/^$H_X2+^S7\CS,>7
M]HM?,V>1]GW?ZW;NV_/MSC/R;\?/72_M(^'=5^(-I#8V-A)A9DF>1YK5 #Y3
M#RP!,Q)!D(8\ %/EWJP8=W\-KV]TG2X8+JQF2>UMX(O+62U?S=H$>Y&\]5'R
MJ&8.4QG:I<C)\J_9F\!:Q\.)IX[ZQ?RKGR1YB36S>64+C++YP)7$A)*Y8;<!
M&W<9_AO0=1^''BFZNWL9[F"\:?9);KO4+/,)4)9MJ*0RA7#L@4$ODJ%+=K\>
MO@M+\3K2.[B00ZA"K[8R4.]"<B)W P' Y7#-&CLZ[F5O-'">%OB7XUL=FF_V
M?YTD>Y/.GBE&[9GEIO-CA;@8#Y^?@[F9LGVOPWH][X'T\ED?4-0FD>6<HZ1A
MY67@YF=%2)51(AL'"J&6(<@>5?LS> M8^'$T\=]8OY5SY(\Q)K9O+*%QEE\X
M$KB0DE<L-N C;N.__:'TN_\ $NG2:7I]H\[3>43+YD$<:!9 Y'[R0.S?(!C:
M%PV=^05,7P#L=0\)Z6NG7UC)&]NLS*RRVTBRY<R!!B8%7)<@!L)A<F09P//_
M (;^"=9\*:_>:O)ITCV]TUU@+-:>:JR3"9#M,^TGY0I&X 9)!.,'/^"&GWWP
M?U"]L)["\N8II(DCGAB!1MC.(V)9A$JLLFYB9/W9&UOXBI\6O#&LZCXBT_5'
MLG:!9+78L'[UU2.;S"LS9$:2Y8DG<(0" )7".]=7^T1X?UCXAV<5E:Z>X*W
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M,T,D:G))C$LN68A2HV E202T>0X^BM)TN/2(8[:!=L44:1HN2<*H"J,DDG
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MJ3F*[^S[7DM[5G3S93"<[8D#X*EA@)P0O;<?H_1-,DTY"DL\EP2Q.^40A@,
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MVCYQCCJ!@\!\"_&^IZOXDO;+4+M[A;:WN8APL49,5S&@D\N/"!CD\\M@[=Q
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M@MYI6)A$SMY:^8%4LX1,[2I+))PV0 1D\5^R?XKNO%&FW%S?2O-*;^7YG.<
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M-5/VD?C'K7@)HX[<6T,5QY@BD4M/./+=26(D1(EW*ZC;MDQ\V'^Z1J_$>_\
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M*2Y9V8SG=E;B$@YR6)W%B>V#GV#XD_$R]DU!/#^A",WKPO)+/)EHK=-K;<A
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MD D6,.$*MDQN-V<9PRD;F.4+' 8"JNG^*-4^*6^?1KA+'3TD9([AX#-<3LF
MS*DNV-8"6(!YDW1X.W+*N3X.^)^H^%-9/A_Q!(DQG^>TN@(X@0=P165=H&XH
M5 ^^)?E'F*ZLO3>./B!=WFHIH&C>6+DPF6YN),.MO$?E!$88%ILLK*K?+@ID
M%'+)Q_Q!U_Q#\)8TU&:[34[7S DT;6RVY0,00X:'.,X*;G.U69?D<L-MK]H7
M6;K6?#S:C93^3:2V]L[1>5^_=9F5=C2"4JJE9%W*J$G:5+E&(JW^RY;7G]C6
M;^;#]E_TC]WY#^=_KI1_K?/V_>Y_U7W?EZ_-7L&J1S2QL+9T27C:TB-*@Y&<
MJLD1/&0,,,'!YQ@_)7V:\_X3O9YL/VK_ )Z>0_D_\>&?]5Y^[[O'^M^]\W3Y
M:^FKM=5MK9A$;6>Z+':S++:PJNW@E0UR[D/U 9 RG&5(R? /A7\</$'Q&-Y!
M:I'Y[+%Y4A4):6J[9!(Y.))'=R%\M&WC=N; C1E.AXA^.>M_#32XEUB!&U*:
MXE$3-Y9C\I!$Q=Q X!;,A10NS@;FY'[SI?B_+K7P_P!/74[;43.;=HOM,<T%
ML$D#,B?)Y42N@WGE2Y.T\2!E^;M?#GC.Y\>Z3%J.E>7#+*K$)<(TJ;D+HR9C
MDC('F+Q)@G;R8\G X_\ 9O\ C7>?$W[7]M2%/(\C9Y2NN=_F[L[Y'_N#&,=^
MM97BWXS:QX1URTT:X%G+%<R6W[Q(IHWV2R^4WRM.X5@0V.6&,$]2H] ^-GQ7
MC^&]BUQE&N7^6WB8GYVR,G"\[4!W-]T'A-RLZFN9MM/\4:9!_:ES=1RR*K2O
MIBVZ;"O),"31[I-X3A" X,@"DNN6;S#]BR.:6/4Q;.B2_P"A[6D1I4',^<JL
MD1/&0,,,'!YQ@]_\&_C7J7BK6+K2-02V7[-'/EH%E&7BF2(X,DC97YB?N@].
MG(JK\?/C-K'PNFB\L6<T%QYICW13+(NPKE6Q/M;Y77YAMW'=\B@#/JOQ8_Y
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MDD.0RJ,'>054$\5Q_A#7[[QA#')I\*:?IICQ$9$#73)A C1Q*1#"H&_RV<S
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MOJJOE#]G>T2S\6ZI%$H1$6^554!551=Q * .  . !P!4OP"_Y'#5O^W_ /\
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M^B9Z]5^$_P#R!]/_ .O"T_\ 1*5\_P#[#'_,1_[=/_;BCX!?\CAJW_;_ /\
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MCS]]PTN_[;;18RD:;<9?^YG.>_3BNZN_B#XE9&$6AA7*G:S7UNZAL<$J-I8
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M(R5& &5CD<. ZL6ZKX0?#N[MKV\U[5E"7EVVU(@P<PPJ0%0M'B-R0D8R 3A
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MJ.%!P"5&2.)_9KUJ^L-.BTN;3KF)X)&!EF AA*22-(6_>8D+ %@%1'&X)O=
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MM&(9X$1E(221$9OG\N,,'+'?(#& -PPVX0_$[PCKOB'7K'4DL=SP6]M,8DD
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MKAXR#(?+!1R6PP <,<D[55BV^-&K:U9?9X=)O8]4>%E5FA$5HLF#^\\R<X
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ML#N68*X.Q\_*A7Y1AN2-O6_'6I+H<6K6<=L938+<R^:TJHO[I96"(BL7R-P
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M-Q"K.6BC, *@#:@62>3+LW"_. Q95 !Y/E_A^?Q/\0[?^TX+N'3HI(RUM;B
M2LPW2;3*\R97(VX= RLA#B->C3?"/XX7-YJ$GA[6T"W\3,L<J*RI-L7+$@@;
M2RJ958!4=3PJ84/[?17SA^V6M[!8(_V@"T>Y1# D95F)C9P9)/,;>%:,E5"(
M,L"VYD4UZA\%[:\33;)IY87@-A;;$2!XY%_=IMW.9W5L+D'"+D\C:/E/@GP=
MFGC\6ZLMJH:1FOE#-_JXQ]K0F1AN5F QPB\NQ52R*6D3L/&OQ-U?X4:M;#5+
ME+K3KK=N(@2 1?. ^P(9)3Y:LA&XMO5BO+C>/5?B3\06\,^1:VJ>;?7DACMD
M(<Q@C&^60H"1%&&#/CYB.F!N=?/_ !U9>*?#%J^J1ZA#,8OWTUH+:)(A&N7D
M1)&S(ZJ!@9*.R D-YF ?2_AA\0X?B!8QW\ V[LJ\996:-U.&0D?@RY )0JQ4
M9Q7545X5\+?BE=_&*ZNS!,]E9VVP1K&D+3R>9NVM(TR3(,>4QVHH^_@NVS+1
M?#CXL:AI>N3>&=8D%U)N)AN41(N/)\X*Z*%&#'SQDJ^5RZD,OG_[:*WMN]J)
M[@/;R-.8X$C,2H4*89R9'\Q]LFW=A0 #M5=[9]K^)EIK-MIEW*M]!&8[:9]T
M5I)'+A$+D*[7D@0D#;NVDKG*X8 CSK]CFVO'TV1H)84@%^^]'@>21OW<&[:X
MG15RN ,HV#R=P^4>E>*?'-YK%\^B:+L2>*-7NKF5':.!7 V+& -KSE6\Q0Y$
M9"D'<=VSA?&?C/7/@[/!=ZE=#4=-E;RI,0PV\J.<L"JIU.U25RQ5L,K!"4>N
MU^-'Q%O_  KIYU/3%M9;=5B<R2/(Y99&" (D:JI!WHP?S<8W#8>#7/\ POU[
M7OB#I,$R7$=L76;?=O$DTSNLY"^7"I2)4" HS/EBP.(P,2-G_ +XQ:GXFN+O
M1M3V"^MXY"LOEJ0&20QR"01R(K;6= HC"AE5LOG#'S](]0/CA89+I)+E-X25
MX6\E5:T>41K"LP(4!RH'F9+?.Q9BV?:OB]XUUCP)IQO8ELY?*V&:1A,F=\GE
MA4@#-C&Y"6:<YPWR=*UO@)XIN/%6C6U[>OYD\GG;WVJN=LTB+P@51\J@<#]:
MX^V\=ZM\4+N>'0YH[.PM9A&UVT8N))G DSY0.863.TXW!@I1]WS^76)<?&'5
M/A/J$=CXC=+JSGW,EW'$8W4;MHRJJJ';@-)&H9U$@(=\*C>M?%+7[_0+*6ZT
MY(',,,DKF=Y  L8#D*D:'>2H8#+Q@':<L,BO,/@M\0==^)5C-(LD,3&[F4W#
MQAA$AA4I'#"I7>RNV2TS8"E?]<=P2+X8_%S5++7I?#FLN)SNE\J81QQN<()8
MR1&P14:)2V,,X9@I. <?0E%>:_%GXI3>&YK73--C2;4+R0"-7W-'&@(#2R+&
M?,VXS@@ 85V)_=E6XKQBOBOP%:C4S?0WJPQ[KBW-LJ 9VJ2IB57=5W%RQ,6%
M3<002H]%^'_Q('Q+T[[9IQ$,N[8XE1I5CD7:SJ0KQ;QM;*L&7A@2 0R#YZ^S
M7G_"=[/-A^U?\]/(?R?^/#/^J\_=]WC_ %OWOFZ?+7U?HD%S"A%Y)'(^XX:*
M)H5VX& 5>:8DYSSN P0,<9.A7"_&E;U=,N9;&X%N8[:=W;RR\I")OQ&XD01D
MA2I;:Y&[*[64&O)?V.;:\?39&@EA2 7[[T>!Y)&_=P;MKB=%7*X RC8/)W#Y
M1D_MS_\ ,._[>_\ VWKTOXN7&OV]C+J=C<);>3&TGV40Q2R% 5+>9-([)N5
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M/!VEJC%0ZV"N 2 R_97?:<=1N56P>,@'J!7TUI.J1ZO#'<P-NBEC21&P1E6
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ME[@7K2REMQ8B6- KEC]XLT;YY)R,GJ,^_P!W=I9HTLK!$12S,Q"JJ@9+$G@
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MC"7%S"3'%-+&<F&1 0@:-5#$[0<(,;J]@UOX)Z9KR"*\6>= P8++>7LBA@"
MP#SD9P2,]<$^M<I^T%;06OA2:.SP;=8;-82K;U\L30!,-D[AMQ@Y.1SDUH?L
MN?\ (NV?_;Q_Z42UY5\ O^1PU;_M_P#_ $LCH_YJ'_G_ *!U>J_M1_\ (NWG
M_;O_ .E$5<U\*;M[/P2TL3%'2RU%E92596#W!# CD$'D$<@U5_8GNT;2KB(,
M"ZWK,RY&X*T405B.H!*L >A*G'0T?ML6B-I5O*5!=;U55L#<%:*4LH/4 E5)
M'0E1GH*[6[NWO/"32RL7=]#+,S$LS,;3)8D\DD\DGDFN/_8I_P"0//\ ]?\
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MR=S?,XW-SRPR<D5ZA^U5:)/X?NF=0Q1K=D) )5O/C3<,]#M9ER.<$CH37/\
MP]NWNO [M(Q8C3M04%B2=JF=$7GL% 4#H  !P*B_8I_Y \__ %_R?^B8*Q/@
MW##XAU_7(+N6?SOM+-&$N+F$F.*:6,Y,,B A T:J&)V@X08W5[!K?P3TS7D$
M5XL\Z!@P66\O9%# $!@'G(S@D9ZX)]:Y3]H*V@M?"DT=G@VZPV:PE6WKY8F@
M"8;)W#;C!R<CG)K0_9<_Y%VS_P"WC_THEKRKX!?\CAJW_;__ .ED='_-0_\
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M."1T)JW^S+=O=>'[)I&+$+,H+$D[5GD1%Y[!0% Z   <"O)/V&/^8C_VZ?\
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MC0+('(_>2!V;Y ,;0N&SOR"IB^ =CJ'A/2UTZ^L9(WMUF9666VD67+F0(,3
MJY+D -A,+DR#.!Y_\-_!.L^%-?O-7DTZ1[>Z:ZP%FM/-59)A,AVF?:3\H4C<
M ,D@G&#G_$?X=ZS\,M6?7- #W"74CF1!%YSJ7<2R1,JJ6\IF7ATVLH^0L#M9
M]OPU/XF^*\L46JV\=GIJ3*]PCP%3/Y;Q2K$8YV>0@E0-PVI@ON+D!#H?M%_
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MW-\D9&7]?HKYK_:1\&:A'K%AKEG;/=10>0&CB#-)NBF>;!"JQ"L#@. P!!W
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M(#3>83E0F"JCJP) &X_9^L=0\+:?!I5_8R1&)IOWPEMI(MK,TH)"S>8#EBF
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M(#%5+ 'H2JDCG Z5+7D'[4O@6Z\8:2([)/,DAN%F*#[[*J2*P08^9OGR%ZD
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M+L :M^-OB!=>,;*?25T:]^U30O'B6.,6BR8Y<3LVQ@C#=&^!O95V[2P(\_\
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M23:'V,00K[3PV#@X/!Q@URGPA\+ZAX:L1;ZM<_:KCS'._+/M4GA-[@._=LL
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M*12T\X\MU)8B1$B7<KJ-NV3'S8?[I'2_%:Z\1064^I6DT=J(%:1;98XYI6B
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M3;DA=\C,VT':N=JX  KYJ_YJ'_G_ *!U=7^VM_R!X/\ K_C_ /1,]>J_"?\
MY ^G_P#7A:?^B4KY_P#@%_R.&K?]O_\ Z61T?MS_ /,._P"WO_VWH_:*U;[+
MXJTGSI-L$7V.0[FQ&F;I_,?D[5^5!N;CA1DX KZJKY5_9U_T#Q5JUK#\D ^V
M8B7Y8QLND6/Y1A?E5B%X^4$@8!-'_-0_\_\ 0.KJ_P!M;_D#P?\ 7_'_ .B9
MZZK_ )D__N _^V=<K^Q3_P @>?\ Z_Y/_1,%>_T5\J_'W_D<-)_[</\ TLDK
MU7]J/_D7;S_MW_\ 2B*C]ES_ )%VS_[>/_2B6O*O^:A_Y_Z!U=7^VM_R!X/^
MO^/_ -$SUZK\)_\ D#Z?_P!>%I_Z)2OG_P#88_YB/_;I_P"W%'_-0_\ /_0.
MKJ_VUO\ D#P?]?\ '_Z)GKT_X97:6>B6,LK!$33K9F9B%55$"$L2>  .23P!
M7->"_%\WBF,+X=MX;73HY&47$T3*CX,F_P BWB:+*[]I,CO'RSC875@/)?V=
MX3!XMU1&8N56^!=MH9B+N(%CL55R>IV@#/0 <5+\??\ D<-)_P"W#_TLDKZ
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M_ ?@W3_!\4EIIB"-!,6D02/(1(40\[V9E)38<<<$''.3\]? +_D<-6_[?_\
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MXW$5Z_JGP>T_5XV@N?M,L38W))>WSH<$$95K@@X(!&>X!K;\&Z#::!:I::<
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MW;U3Y5;=9"5MP& <R .<]7^8\\T?MS_\P[_M[_\ ;>OH#XL?\@?4/^O"[_\
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M8']XPVJ<@LV,$G!\4_;G_P"8=_V]_P#MO7U517FO[2.J2:9H%[)"VUC&D9.
M?EDE2*0<@]4<C/49R"#@U4_9<_Y%VS_[>/\ THEKRKX^_P#(X:3_ -N'_I9)
M1^T5JWV7Q5I/G2;8(OL<AW-B-,W3^8_)VK\J#<W'"C)P!7U57RK^SK_H'BK5
MK6'Y(!]LQ$ORQC9=(L?RC"_*K$+Q\H) P":Z;]C#7QJ-A=QNY>X%ZTLI;<6(
MEC0*Y8_>+-&^>2<C)ZC/O]W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5\M?MS_\
MP[_M[_\ ;>OH#XL?\@?4/^O"[_\ 1+UY5^Q3_P @>?\ Z_Y/_1,%<I_S4/\
MS_T#JZO]M;_D#P?]?\?_ *)GKU7X3_\ ('T__KPM/_1*5\__ +#'_,1_[=/_
M &XJW^R780>*K.Z^T37+72W9DDV75W#D2HNUV\J5%9F9'RQR_'S'&VO6O%'P
M3T;5$\W45DD2%7;=/>7;K&N 7;,DY"C"@L>!@<]*X7]M;_D#P?\ 7_'_ .B9
MZ]5^$_\ R!]/_P"O"T_]$I7S_P#L,?\ ,1_[=/\ VXH^ 7_(X:M_V_\ _I9'
M7:_M$? FZ\:S1:IIDNR\@C"A"WEY"%Y(S&X'RRAVP-Q"G(.Y-IW<KX)_:3U/
MPU>1Z5XG@VL\@7[0P6!E!=U\QAQ$\6[ WH44(K-F0U]/T45Y5^U'_P B[>?]
MN_\ Z414?LN?\B[9_P#;Q_Z42UY5_P U#_S_ - ZNK_;6_Y \'_7_'_Z)GKB
MOBKJRV%GX6^T2.EJ([>2;:TBX"):?/\ NR&W*K/M9?G7)VD$U]%?\*TM?^>E
MY_X'W_\ \D5#X#^'&E^!GFBTR,1/(L32KYDDC;09!&Q$CL5!.\ C )!Z[>/!
M?^:A_P"?^@=7T!\6/^0/J'_7A=_^B7KRK]BG_D#S_P#7_)_Z)@KW^BBO /VU
MO^0/!_U_Q_\ HF>O5?A/_P @?3_^O"T_]$I7S_\ L,?\Q'_MT_\ ;BCX^_\
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M<ER &PF%R9!G \_^&_@G6?"FOWFKR:=(]O=-=8"S6GFJLDPF0[3/M)^4*1N
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M7+JJ(69Y"74'Y"NTJJL0KDCT7XA:7'I&@WEM NV*+3+B-%R3A5MV51DDDX
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M1J>GW-S;)N:WELXO/QND;()4J"K'+C>5E7.&4JRA.O\  _@N[\3ZT_B34HC
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M+2*"A9'+EFB8H8"P7)]:\ :/=:-8P6]_-]HN4C DE_O')P,GEL#"[VPSXWL
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M<(F=I4EDDX;( (R>*_9/\5W7BC3;BYOI7FE-_+\SG. 8X6VJ.BJ"Q(50%&>
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M%?QP\0?$8WD%JD?GLL7E2%0EI:KMD$CDXDD=W(7RT;>-VYL"-&4[5W\4M?\
M#-C;:?J,:+J]]=O!;S-Y1C5"8@)G$)=2P:7:H"@87<RMC$FWXVT_Q-X,LI[Z
M'48[TQPN6CDM8H"B 9:9"C89T R%?*D;OE9@JGL/C/\ %+_A7]JK0Q^=>3R"
M*VA')9S_ !%0=[*. 0@R69$RN_<./US0O%VF0-?I?P2RHSRO9); Q%%W/Y4;
MA#,Y("J%(5CDCS,@,W2_ OXSQ_$ZU9ROEW4.P3H =F6SM="<_*VTX!.Y2"#D
M;7;SKXD?&G7/#FLV>F/' B336K[+<F:5XWD,30F2X6),LRM@A(]OR_O!\Q.K
M\9=>\2>#[4:PEQ $CF02VD<2O$(S(P5FFE(ED)S&C[%B^]E0N"QZNT^-J+X=
M7Q%+$6(A&Z-<)F7S/((&6;:AEZ$EF"<X+?+6)X&N]9^(FD?VI#?_ &:ZG\PP
MQ)# ;5/+<Q[6\R.68[BA);?\N_A"%PUO]F[XSR?$BUD2Z7%U;>6)'  20/NV
M. /NM\AW@#;G!7 ;8OFG_-0_\_\ 0.KZJKC_ (I:M?Z'92WNG-!FWADE=)XY
M'#J@#$*T<J;2%#8RK!CM&4&37-? 7XG7GQ*TV:[G$,4ZW$D2%$<QC$<;*S*9
M-S?,YR ZY P"#S7-:#\:=57Q*/#MZMJR!GS)$DJ,5^SM/&1OE8*2-NX88 Y
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M*UUXB@LI]2M)H[40*TBVRQQS2M$ A=I9928U= ';9$K+QM$DI(:MOX(_%O\
MX3O2SJ%WLB>*25)R/DA&P"3<"SL0HC9=Q8C#!NV#7'^&?&>M?%R>XFTJZCL-
M-@F>**40K<2SL-A!*S8VC;\_1"N\(1(067RKX@W-ZWBO38-2PTT$UC$)E4HD
MZ?:2Z3!2 %)#[752RB17"G' ^SZS];@N9D LY(XWW#+2Q-,NW!R J30D'..=
MQ& 1CG(^4/@E;7C^*M46"6%)Q]MWN\#R1M_I4>[:@G1ERV",NV!P=Q^8>Z_%
MOXG3?#'2_M<X2XNFD\I"B-%#O8.RLRF21@H53D!R688!0-E>:UN76IM"&M6V
MHE+@VPNVB,%M]G$90S&) 8GD!5" K.[[BOS8W97L/@?\4O\ A96GB\:/RY4D
M,4JC[A=55BR<D[2'! /*G*Y; 9O%/@%_R.&K?]O_ /Z61UZA\5/B)=KJ-KX=
MTMA!=72^:URZB18XE\PD(AR&<B)OO *!@ Y;?'4U:#Q%X/:W>2^CO;>6]M(I
MV:WCMY8D>=$R@1BK!]VQ\@LN5* ?,RQ?M&?$[5O %N+BS2V6!Y/)$C-))/N>
M,LKA-B1IM*-]YI0WRDJ!D5VOAJ\U#7=-L;F&>%)9+2&29I8&EWL\:-D".> )
MR22,$'(P%QS\Z_L:VUY-]O\ L4L,6/LN_P V!Y\_Z_;C9/#MQSG.[.1TQS[A
M\:/'&J^!M/-]:I:R"%8O.>0R@LS,(V"0KT&YE8%IB0-RX8@,=#X">*;CQ5HU
MM>WK^9/)YV]]JKG;-(B\(%4?*H' _6N9LO&&J?%">X71KB.RL+:8Q"Z\N.ZE
MGE7[X52_EB'#!@WWC\A!.YU3*C^)>K?#S5[?2-8<7MO>,@ANEA$$@=V6,*0N
M(R%?[RC+!75]W2.M#Q;\7KB_U^+PS8G[/GF>Y*+)(,1?:-L2ME!E!M+.K\L2
M$^0%L7XF?$O4O@[J-O)=W!O=-N5<>6T<*7"%-F]@T4<2L1N!7. P+(P4A9*W
M_P!J=;V+1[B6WN!% JQ"2-8SYL@>41LOF^8 J$.,J$RVTJ6VL5JK^S/!?KH=
MK)%) T(6YVPM%(DA;SIL SB9E4%^21 Q"\8)YK*TKXP:O<>*8M#N_(CB5IMZ
M0!G#JUL9H@TDH#$K\N2BQ@G=D$8 ]%^,_P 4O^%?VJM#'YUY/((K:$<EG/\
M$5!WLHX!"#)9D3*[]PX_7-"\7:9 U^E_!+*C/*]DEL#$47<_E1N$,SD@*H4A
M6.2/,R S=+\"_C/'\3K5G*^7=0[!.@!V9;.UT)S\K;3@$[E((.1M=O.OB1\:
M=<\.:S9Z8\<")--:OLMR9I7C>0Q-"9+A8DRS*V"$CV_+^\'S$ZOQEU[Q)X/M
M1K"7$ 2.9!+:1Q*\0C,C!6::4B60G,:/L6+[V5"X+'U#X6>-?^$WTRWU KM:
M6/YQC #JQCDVC<WR[U.W))VXSSD5U5>(6WCO5OBA=SPZ'-'9V%K,(VNVC%Q)
M,X$F?*!S"R9VG&X,%*/N^?RZQ+CXPZI\)]0CL?$;I=6<^YDNXXC&ZC=M&555
M0[<!I(U#.HD!#OA4;TOXT6UX^FWK02PI +"YWH\#R2-^[?=M<3HJY7 &4;!Y
M.X?*/)/V1+2_FTJ8V<\$:?;9,K+;R3-N\J')#)<P@#&.-I.03GG ^FJX_P"*
M6OW^@64MUIR0.889)7,[R !8P'(5(T.\E0P&7C .TY89%>(?#_XJ^)?B+I]S
M_9ZH+E;B1_M#K&D2)M1DM8058/*3NRTN0B%=[[G5E[JT^(^KP16>D/#&==FA
M>27S WV6*)'=1-*T&X9D"!0$(42-SL&U&Q?B#?\ B/X7QIJDE\FH6D<@%S"U
MO#:G:Q"*04#,?F;&0<JVTE'3>!ZK_P ++L_[+_MO=_HOV?S>J;NG^J^_M\W=
M^[V[O]9\N<UPF@0>(O'L":B+Z/38YEW16\=O'='RF^:-WDD;[Y4C(4!<!3M5
MBR@^"_Q<O=9O;G0M7C O;12?-12B2(A1"Q5L$%BP=650KJV0J #=5MO'>K?%
M"[GAT.:.SL+681M=M&+B29P),^4#F%DSM.-P8*4?=\_EUB7'QAU3X3ZA'8^(
MW2ZLY]S)=QQ&-U&[:,JJJAVX#21J&=1("'?"HWK7Q2U^_P! LI;K3D@<PPR2
MN9WD "Q@.0J1H=Y*A@,O& =IRPR*\0^'_P 5?$OQ%T^Y_L]4%RMQ(_VAUC2)
M$VHR6L(*L'E)W9:7(1"N]]SJR]5XC^,FI^$=.L;6XCA?7[J18_(9EVX,C(LK
M>6^SY\*/OHN]F*X6-D%7X@Z3XA\-:3<W%Y>I?HUI)'/;BW6(H)$*-+')$NYO
M+8[CO55:(.3L(&#]BG_D#S_]?\G_ *)@J7P9XJUCXPF>_P!-O1IUE'-Y,4?V
M>*YE<JH=I)"^ I(=<!6('W>J[W[7X;:EJPO;RQU=XY!!#:&"2-0@E1S< S,,
MDJ[&/#KPJE?D7:=S>BT44444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M45\]_L_:^)M?UZ"5RTSW)9 VYCY<,TT?4Y "AXU STP%& <?0E?*O[;6K?:H
M=-\F3=!+]HD&ULQO@0^6_!VM\KG:W/#'!P37U+:7:7B++$P='4,K*0RLI&0P
M(X((Y!'!%?+6G_\ $N^(+QP?NTDW;U3Y5;=9"5MP& <R .<]7^8\\T?MS_\
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MG_7AJ?\ Z%<4?L4_\@>?_K_D_P#1,%<?^W+:(KZ?*% =EN59L#<54PE5)ZD
MLQ Z L<=37N'Q&\>6?AVXMHOL_VO4W\S[)"BH9EW*0SEV_U,1V[7?^Z&.UE1
M]OC_ .UC;Z@VDQ2ZA)",WX"P0*Q104G*EI9/FD8*  52%<L^4;Y"ONOPG_Y
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MPO/F290[LXQ&V?1?#VMIKUM#>1 A)X8Y5#8#!74. <$C.#S@D9[FHO%FA?\
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MF/%Y^T$$95?,C&X$@@MN7C!0YX\*_9)\?WWC.34)M0G>9A]DV@D!%R)@=J*
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M9SDOC:2'$I)5@BQ$H"3ZU6+IGB^#4[NYL(B3+:K 9>,*#,&9%!/4[5R<# #
M9)W!?%?VKM7U;PU;"[M;XQ6\LT4(@BC$<@.UY#(9]QDR2F,+L&W .?F+>O\
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MS##$D,!M4\MS'M;S(Y9CN*$EM_R[^$(7#6_V;OC/)\2+61+I<75MY8D< !)
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MGVM\KK\PV[CN^10!GT_XI:_?Z!92W6G) YAADE<SO( %C <A4C0[R5# 9>,
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M+Q@':<L,BO,/@M\0==^)5C-(LD,3&[F4W#QAA$AA4I'#"I7>RNV2TS8"E?\
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M?+7[(#7^IOJ,MO/&KLULTK3Q27+.S&<[LK<0D'.2Q.XL3VP<Z'[<_P#S#O\
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M+\?,<;:]:\4?!/1M43S=1621(5=MT]Y=NL:X!=LR3D*,*"QX&!STKA?VUO\
MD#P?]?\ '_Z)GKU7X3_\@?3_ /KPM/\ T2E?+7[,MV]GI6ORQ,4=+)65E)5E
M8171# CD$'D$<@U[A^R?JD=[H$$<;9:&2>.08(VL96E Y S\DBG(R.<9R"!Z
MU<W:6HW2,%!95!8@#<S!$7GN6(4#J20!R:^6M0U;9\04\^3")MC3>WRKOLCM
M1<G W2.<*.KMP,MS]2W=HEXC12J'1U*LK ,K*1@J0>""."#P17S!^PU=NR:A
M$6)16MF5<G:&83!F Z D*H)ZD*,]!4/P"_Y'#5O^W_\ ]+(Z/VY_^8=_V]_^
MV]?0'Q8_Y ^H?]>%W_Z)>O*OV*?^0//_ -?\G_HF"O0/B-X\L_#MQ;1?9_M>
MIOYGV2%%0S+N4AG+M_J8CMVN_P#=#':RH^WQ_P#:QM]0;28I=0DA&;\!8(%8
MHH*3E2TLGS2,%  *I"N6?*-\A7TJ+P5_PF_A6#3PVUI=,M-AS@!UCCDCW':W
MR[U&[ )VYQS@UQ7[./Q"?0-(:TN[:Y?[/),(&M[>6YCF7>[,J2Q!XF82[UW;
MECP4PQ^8C;^ GPJGTZ[NO$-\IAGOFF9+;.3%'+*)?WA(!WY P,+M'WAN8JG*
M?!N&'Q#K^N07<L_G?:6:,)<7,),<4TL9R89$!"!HU4,3M!P@QNKV#6_@GIFO
M((KQ9YT#!@LMY>R*& (# /.1G!(SUP3ZUX5\8+M(?$.@65JP-E"M@UN%(==K
MW 3<'Y9@4BCP2Q&!D<DD_5]?*O[#'_,1_P"W3_VXKZJKP#]M;_D#P?\ 7_'_
M .B9Z["TNWL_"2RQ,4=-##*RDJRL+3(8$<@@\@CD&N*_8GNT;2KB(,"ZWK,R
MY&X*T405B.H!*L >A*G'0T?ML6B-I5O*5!=;U55L#<%:*4LH/4 E5)'0E1GH
M*]?^&5V]YI5C+*Q=WLK9F9B69F,2$L2>22>23R372U\J_L,?\Q'_ +=/_;BN
MF_;8M$;2K>4J"ZWJJK8&X*T4I90>H!*J2.A*C/05VMW:/9^$FBE4HZ:&596!
M5E86F"I!Y!!X(/(-<?\ L4_\@>?_ *_Y/_1,%'[:W_('@_Z_X_\ T3/7JOPG
M_P"0/I__ %X6G_HE*^?_ -AC_F(_]NG_ +<4?'W_ )'#2?\ MP_]+)*[#]L#
MP =?TY+]& >R9F(9U13')M#XW#E]RIM&X9&Y0&<JM:'B;XD7/B+13;+87C:A
M=VYMWA-M/#'&\JF-Y#)(IC$0)++ER<%0^WYV3J_@?\+?^%:Z>+-I/,E>0RRL
M/N!V55*IP#M 0 $\L<MA<A5[^OE7]N?_ )AW_;W_ .V]>M_M-7;VOA^]:-BI
M*PJ2I(.UIXT=>.Q4E2.A!(/!JI^RK=I/X?M51@Q1KA7 ()5O/D?:<=#M96P>
M<$'H17E_[;7^@3:;=0_)./M&)5^60;#"T?S##?*S$KS\I)(P2:^JJ*^5?V&/
M^8C_ -NG_MQ1^W/_ ,P[_M[_ /;>OH#XL?\ ('U#_KPN_P#T2]?+7@2[>U\#
MZFT;%2;T*2I(.UC:(Z\=BI*D=""0>#7NOP?\)66O:197$<MT0;:)6VWM]&H=
M%\N10HG55 =6 "@+@?+\N*Z"Q^$VDZ+?1ZB$/VTL5266XGED9O*92H\V5MY\
MH-Q@D*I(P%R.ZKE?B?XDT_P]8R3ZL$>VX!C=5D\QL[DC5&X9B5R >!C<2JJ6
M'%>-]0U3Q%I-]<2HEE:FPN&6%E,EZP"2G]X21%!N4)NC"RN SKOC< KS_P"Q
M3_R!Y_\ K_D_]$P5RG[#'_,1_P"W3_VXH_;G_P"8=_V]_P#MO78?MGW;P:-&
MJ,5#WL2N 2 R^7,^TXZC<JM@\9 /4"O1=)\$6.KPQW,$MXT4L:2(WV_4!E6
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M,$A5)& N1W5%?*O[#'_,1_[=/_;BNK_;6_Y \'_7_'_Z)GKU7X3_ /('T_\
MZ\+3_P!$I7S_ /L,?\Q'_MT_]N*S[[X1>(/@O<R7F@,;FU9AN10))&0,I5)8
ML L<L5WP_,%WMF(,17L'P%^/2?$Y)(I8Q#=0JA90X*NI&#(@/S@!^&4[@@9/
MG8MQY?\ \U#_ ,_] ZK=[JDE[\08HY&RL,9CC& -JFR>4C@#/SR,<G)YQG
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M%(XTB=6"_O91(S 1J.1C#;MY(*FU^SQI=_X:TZ/2]0M'@:'S2)?,@DC<-(7
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M.WEB1YT3*!&*L'W;'R"RY4H!\S+[+7'_ !2U^_T"RENM.2!S##)*YG>0 +&
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M\^4&XP2%4D8"Y'A_[<__ ##O^WO_ -MZ^@/BQ_R!]0_Z\+O_ -$O7E7[%/\
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MV4@AVG6"ZD?(R&3R_L_ED$'/FY!&PUV%%?*O_-0_\_\ 0.KJ_P!M;_D#P?\
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MF\"KXFT:694W3VG[Z,C8"%'^N!+#.WR\N5!!9D3J0 <GX/\ Q*DUOPW&MO\
M)>1XL(<*"/-"*L,@4ERRI&RRS'!PJ2L$*K@^B^-[8>'-$NH[/,0M].G6$JS;
MD$<#!,-G=D8&#G.1G.:\P_9C\-V?B#1(6\RY\R.2:.58[N\A16\QG "1S(GW
M'0DJ,$DY.[=7H%]\'-'2XBU"Y1VGADA\J6:ZN9"K"0>4H,LS _O&&U3D%FQ@
MDX/?UY5^U'_R+MY_V[_^E$5'[+G_ "+MG_V\?^E$M>5?'W_D<-)_[</_ $LD
MKU7]J/\ Y%V\_P"W?_THBKP7Q9=O!X$T]48J'O75P"0&7S+M]IQU&Y5;!XR
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M5^$__('T_P#Z\+3_ -$I7S_^PQ_S$?\ MT_]N*/C[_R.&D_]N'_I9)1^W/\
M\P[_ +>__;>OJJOE#]G>T2S\6ZI%$H1$6^554!551=Q * .  . !P!7K6A^/
M/^$BFGM_#5O"(UN";B]==MJTI,?F%%BPUS*5W9):->%8R%70MY!I=O);^/U6
M>3S9.2S[0@).GDX51G"C.%!+,% W.[98]K^VM_R!X/\ K_C_ /1,]>J_"?\
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MJ2;<G@$A2!G R1D@9(X3]FO6KZPTZ+2YM.N8G@D8&68"&$I)(TA;]YB0L 6
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MDR2KE?E(#LP&,\ <GJ>PHKR7Q?JVJ>'M;:\M+.2ZLCIT"W 0QJP99YW#)O\
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MBBBBBBBBBBBBBBBBBBBBBBBBBBOE7]K:UN?&4UK!86=Y+]F^T"1UM9_+RYC
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MW3J\BS+@R DMN9EW0IM*8"LZ^]:3JD>KPQW,#;HI8TD1L$95@&4X(!&00<$
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M52Q52>I +,0.@+''4U\B_L:R73?;X[,(K-]E+32#?'&!Y_'EJ\;NS9PH#*H
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MVK_GIY#^3][/^J\_=]WC_6_>^;I\M8GPMU:_URRBO=1:#-Q#'*B01R($5P6
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MLV 2$#,%.,5YU;Z%XN\06WVT7\%I-(L;):"V'EHI5"0[RH\J.,MN7;( PP&
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M?+E$K0_>4/MV"-&9F)!=4PZ2_$SXEZU\(K^WDO;J.\LKIGW1K;K$T:K(AD"
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MN>X8!@>H(!'(KQO]E35+72O#MY-J#(MJMW-YOF#<A4PP*5*X.[=G:%P2Q(4
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M/K7P4U2/4]%L)(6W*+2&,G!'S1J(I!R!T=",]#C()&#7837:0%5=@I=MJ D
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M2PXKQOJ&J>(M)OKB5$LK4V%PRPLIDO6 24_O"2(H-RA-T865P&==\;@%>?\
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MG_YAW_;W_P"V]>Z_%'QII_A>.%]0C\^1KA/LT"QK-.TH("M$C8^9=WWLC&0
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M-Y#)(IC$0)++ER<%0^WYV3J_@?\ "W_A6NGBS:3S)7D,LK#[@=E52J< [0$
M!/+'+87(5<G0_'G_  D4T]OX:MX1&MP3<7KKMM6E)C\PHL6&N92N[)+1KPK&
M0JZ%O(-+MY+?Q^JSR>;)R6?:$!)T\G"J,X49PH)9@H&YW;+&U^W/_P P[_M[
M_P#;>OHKXA:I)I&FWES VV6*TN)$; .&6-F4X((." <$$>HKR#]BG_D#S_\
M7_)_Z)@KE/VY_P#F'?\ ;W_[;U] ?%C_ ) ^H?\ 7A=_^B7KRK]BG_D#S_\
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MK%U#8Y 8JI8 ]"54D<X'2O*OVG_ <_C+2&2T!>6"9)UC4;FD"JZ,HY'(5RP
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M#7+.V>ZB@\@-'$&:3=%,\V"%5B%8' <!@"#N RNZ']I7PMJ'Q&LK:_MK.=!
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M(!R@!%?+5S\.->^!M\]SHB/=V<F%VA#+N!#%5EBC(?<F"1(H"\CE=[1UZ5X
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MJOS*ZC.W)\4^ 7_(X:M_V_\ _I9'75_MK?\ ('@_Z_X__1,]>J_"?_D#Z?\
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MTGQ.22*6,0W4*H64."KJ1@R(#\X ?AE.X(&3YV+<>M45\J_L,?\ ,1_[=/\
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M1P&<$]\9P">#Y5^Q/X7>RLKF_?(%Q,B(I4@%80WSAB?F!:1EX& 4(R3D#$^
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M1E@3NVJC9P<1D K7T+X+\,CPQ:16@<R%%.^1BQ:21B7EE.YG.7D9G(R<$X'
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M0^Y,$B10%Y'*[VCKTKP /$'Q%F@N-;B2SL8)!,(562*2>5"?*WJTK.JQNHD
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M&W"15V*64J&(RI&UU";RZL1'757/P'GA&^TUG4TF5E9&EG^T19# _-$50."
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M7%?\(KXIU:'[2VI0VEP\>?LJ6L4D*-CA#*YD?G +D!PK%MFY0,R_ _XR7/Q
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MIN(2&!'!!'((X(J7]ES_ )%VS_[>/_2B6O*O@%_R.&K?]O\ _P"ED='[<_\
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M;Q-%E=^TF1WCY9QL+JP'DO[.\)@\6ZHC,7*K? NVT,Q%W$"QV*JY/4[0!GH
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M'=(2I& ZN2\ZOCE9@H9E5#7S_P#MS_\ ,._[>_\ VWKZ ^+'_('U#_KPN_\
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MO_"M+7_GI>?^!]__ /)%0^ _AQI?@9YHM,C$3R+$TJ^9)(VT&01L1([%03O
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M5\H?'_Q"C>)]'E,P-JJV4RMO'DA6NF+2@YV %%4ENA51DX KZOKY5_9U_P!
M\5:M:P_) /MF(E^6,;+I%C^487Y58A>/E!(& 31\??\ D<-)_P"W#_TLDKU7
M]J/_ )%V\_[=_P#THBKE?AI_R(TG_7AJ?_H5Q1^Q3_R!Y_\ K_D_]$P5RG[<
M_P#S#O\ M[_]MZ^A?B;=O9Z5?2Q,4=+*Y964E65A$Y# CD$'D$<@UY!^Q/=H
MVE7$08%UO69ER-P5HH@K$=0"58 ]"5..AH_;8M$;2K>4J"ZWJJK8&X*T4I90
M>H!*J2.A*C/05VMW=O>>$FEE8N[Z&69F)9F8VF2Q)Y))Y)/)-<?^Q3_R!Y_^
MO^3_ -$P5PE]\(O$'P7N9+S0&-S:LPW(H$DC(&4JDL6 6.6*[X?F"[VS$&(K
MV#X"_'I/B<DD4L8ANH50LH<%74C!D0'YP _#*=P0,GSL6X]:KY5^/O\ R.&D
M_P#;A_Z625ZA^T-\$G^)\$/V>41W%NS[ ^?*99-F\,55F!&P%2 1P5(^;<OD
MNB_'_7?A;(EEXDMGEBX"R' EP!'DK*N8I]JG)!.\NWSRCI7U?:7:7B++$P='
M4,K*0RLI&0P(X((Y!'!%> ?M1Z^-&O\ 0Y)G*6Z7K2RCYBN(Y+<[RJYW%59L
M<$X) ZG/T)42W:,YB# NJJS+D;@K%@K$=0"58 ]"5..AKY:_YJ'_ )_Z!U?5
M5?*O[#'_ #$?^W3_ -N*/^:A_P"?^@=7T!\6/^0/J'_7A=_^B7KP7]G>[>S\
M):I+$Q1T:^964E65A:1$,".00>01R#7HO[)^J1WN@01QMEH9)XY!@C:QE:4#
MD#/R2*<C(YQG(('K5S=I:C=(P4%E4%B -S,$1>>Y8A0.I) ')KA?B-X\L_#M
MQ;1?9_M>IOYGV2%%0S+N4AG+M_J8CMVN_P#=#':RH^WQ_P#:QM]0;28I=0DA
M&;\!8(%8HH*3E2TLGS2,%  *I"N6?*-\A7TK_F3_ /N _P#MG7*_L4_\@>?_
M *_Y/_1,%>_T444444444444444444444444444444444444444444444444
M44444444444444444444444445\R_M'>"=9^)SVPL].D1+=9<M+-:!F:0ID!
M4G<  1CG=DDD8&,GZ \+ZW<:JF;JTDM7"IE7>"12Q!W!&AD<D*1U94)!! Z@
M;5?,'Q3\%ZYXIURUUBVTUQ%:?9]J27%JKOY4IF.=LKA,EBHP7X ;OM'L'Q)O
M;W5M+F@M;&9Y[JWGB\MI+5/*W Q[G;SV4_*Q90A?.-K%"<CB?V8_"^I^!;>3
M3]0LGC62X:59A+;N@S&JE6592X_U8P5#Y+<A0N3S5SX)UE?%/_"0QZ=(UON7
M*--:++M^S"W<X$[+D<L!NPV "5SD9^BZ???#/Q)=:B]A>7%M=QROF&(2.GGN
MLY4B-GC+)(IC8;QD?O!E2H8_:I\,:SXP^RW$5D_V>/S56-/W]TK/M+&582Z!
M3L&S8S@8R[*SJ@]%^-D6J^,]+ET^UTZ3?.T6&:>U78B.KG</-/SEDP%4LNQE
M<R!]T2V_@'8ZAX3TM=.OK&2-[=9F5EEMI%ERYD"#$P*N2Y #83"Y,@S@>?\
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MU0>R_$._U#6-,N+>WT^1I;F&:)$,ULI160)OE)EV@_,Q58S*"%7<T98A>/\
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M81\E=S?)&1E_/_BGX+USQ3KEKK%MIKB*T^S[4DN+57?RI3,<[97"9+%1@OP
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M"_ #=]H]%\>ZEJRWNG7VFV,DA6&_6XMWD@C.QC %5I=TL:DNJNH5BS!2. '
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MFT$@(N1,#M10$3.T9V@;B,G)YKZ*K%\4^+X/#(A-P3FXN8;>,*,DR2MA1Z
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MI!]GM<L93)!YD"M+, 0$)4O(JQ@ .Q4J *[#PO)XQM+JYCNTLYHFC)AD+^7
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MJ&OOX1LIKW598W$*LY:*,P J -J!9)Y,NS<+\X#%E4 'D^7^'Y_$_P 0[?\
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M+^"65&>5[)+8&(HNY_*C<(9G) 50I"L<D>9D!FZ7X%_&>/XG6K.5\NZAV"=
M#LRV=KH3GY6VG )W*00<C:[<U'XSU3XDZG>66DW0T^WT]O*D=H8[B664NRYV
MO\JH/+;&&#="0=V(^@\(76M:7JJZ=J<T=Q;&RGEBG2-89)766 ,)$!(4H),+
MLPK*P)+/D+#?>,-0\<W5Q8Z'(EM!:R>5<7DD32/YHR3' C 1ML*[9"YZ."@P
M%9^5G^(VJ_"S5(;37KA+NQO,+%<[(;=HV!4,65< *"XW[B1L*NK95XS[_7 ?
M&?XI?\*_M5:&/SKR>016T(Y+.?XBH.]E' (09+,B97?N''ZYH7B[3(&OTOX)
M949Y7LDM@8BB[G\J-PAF<D!5"D*QR1YF0&;H/@M\91\4;*1HP(;V%0LJE6>(
M.P;RY -RED)4G9N##!4MC:[>'_&VVO$\5:6L\L+SG[%L=('CC7_2I-NY#.[-
MALDX=<C@;3\Q^FEL-5V$&YM=^Y=K?9)0H7#;@5^VY))VX.X  $$-N!7YE^"5
MM>/XJU18)84G'VW>[P/)&W^E1[MJ"=&7+8(R[8'!W'YA]"^/M;U7PWITES;B
MUFFAAEEE=_-AC"Q_/A(E,K,2@*\S( V&R02HY_\ 9J^(EWX^L)[R^8,XO954
M*H143RXG"#') +'!8LV.K&C5_'&H>,M1GTC1)([>.T5?M5ZRI.RR-RD44>[:
M3\K*Y?H0X^5D7?ROC/XA:U\&IX)-3G&I6$[;7<6ZV\L3+G*KY9\O)!#*')+[
M&4>7@N?1?'WQ!N+*ZBT?2D234)HS+F82?9H8ESF20Q@M\S*8T _B(+$?*'\_
M^(-_XC^%\::I)?)J%I'(!<PM;PVIVL0BD% S'YFQD'*MM)1TW@>JQ>*IO$NG
MQWVC"&1IXPR>?(R(F5/WO*67<ROA7C!7D,-X(Y\%^%?QP\0?$8WD%JD?GLL7
ME2%0EI:KMD$CDXDD=W(7RT;>-VYL"-&4[5W\4M?\,V-MI^HQHNKWUV\%O,WE
M&-4)B F<0EU+!I=J@*!A=S*V,2;?C;3_ !-X,LI[Z'48[TQPN6CDM8H"B 9:
M9"C89T R%?*D;OE9@JGV^O&OVIUO8M'N);>X$4"K$)(UC/FR!Y1&R^;Y@"H0
MXRH3+;2I;:Q6HOV7+:\_L:S?S8?LO^D?N_(?SO\ 72C_ %OG[?O<_P"J^[\O
M7YJBMO'>K?%"[GAT.:.SL+681M=M&+B29P),^4#F%DSM.-P8*4?=\_EUB7'Q
MAU3X3ZA'8^(W2ZLY]S)=QQ&-U&[:,JJJAVX#21J&=1("'?"HWT57'_%+7[_0
M+*6ZTY(',,,DKF=Y  L8#D*D:'>2H8#+Q@':<L,BO(/A;\3_ !#\1;"8V7D"
MX-S/F>962&&,QQ>5%&$1O,?<[L"QDV*@\W/F)F+P+\:M9\,ZRFA>)-C^;)M2
M<)M)+X6$H8U"O$S#:,H&5F.]EV,@ZK]HSXG:MX MQ<6:6RP/)Y(D9I))]SQE
ME<)L2--I1OO-*&^4E0,BN?\ ^$M\7>);.RU#2HD$8CA$B2^2LURVQ3).5?:J
M0,P*H$=)&4[P K+LZ7Q'\1-1\6ZG+HF@-'"+95-U>NOG!&+IF.,#='O W K)
M@L5D4;#'N/->+?B)KOP;N(I-6E34=/GDV^8L(AF3:N2,(%C5B6)569]ZQG!C
MY(Z#XR_%75/"=G%K&F?9KBQF\LC?!.)$61 T<C,)5!5CQEEC*ED7#$DCL/@U
MXKN_%^GQZC=O PF7*K!%+&$*LZNK-+(Q<Y !PJ@$-@NI#5%'K&K2ZP]B&MOL
M:6\<[2>1)Y@$DTB)!_Q]<L4B<^:%V@CF,9 /FG[2/QCUKP$T<=N+:&*X\P12
M*6GG'ENI+$2(D2[E=1MVR8^;#_=(]ZU_7X/#T#W=VXCAC7<[MT Z=N22<  9
M+$@ $D"O%? FK>(OBI$=3BO(]-M79E@B2".Z9U5W#.YD.00?DR-H8J3Y:#!;
MS7P;J5SJ/CI'OHQ%<!I$D5=VPM'9-'O3> VQ]N],C.UAR>I^A?'WQ!N+*ZBT
M?2D234)HS+F82?9H8ESF20Q@M\S*8T _B(+$?*'\_P#B#?\ B/X7QIJDE\FH
M6D<@%S"UO#:G:Q"*04#,?F;&0<JVTE'3>![5X4\30^*+6*^MCF*:-77E21GJ
MK;2P#*<JP!.&!':N:^-*WJZ9<RV-P+<QVT[NWEEY2$3?B-Q(@C)"E2VUR-V5
MVLH->2_L<VUX^FR-!+"D OWWH\#R2-^[@W;7$Z*N5P!E&P>3N'RC$_:(F,'B
MW2W52Y5;$A%VAF(NY2%&]E7)Z#<0,]2!S7=?&[7/$/@VW&L07,/E1R1"6U2!
M3&JLQY:61S+)\Q6,E%B+ [PD>#7=VGQ@M&T5?$$N5@,(=E4%V#[O+,0R%W$2
M_(&(52?FR%YKFO[)\3^*(?MB7L.GL\>Z*T6W$N 1O0323+O64;MDFU"HVY"Y
M)%2_ ;XNR^+Q-IVI*$U*R8I, 4Q)M8HS@*>H88DVY0$J5(#A5]:KY _;*MKR
M'[!]MEAES]JV>5 \&/\ 4;L[YYMV>,8VXP>N>/I_3[;4K?>T\MM-^[;8B02V
MV7XV[G,]QA>H.$)&<C.-I\;TKXP:O<>*8M#N_(CB5IMZ0!G#JUL9H@TDH#$K
M\N2BQ@G=D$8 VOVC/B=JW@"W%Q9I;+ \GDB1FDDGW/&65PFQ(TVE&^\TH;Y2
M5 R*EMKKQ%XLTJ*[M)H[9S90RI^[CFN+B7RF+!MQ6"!'8J4P'8 AF,?,0/V:
M/C+/\1K:9+T#[1;-$&=5VJZ.I"L?F/SED<M@*H!7:.H&?\+?BE=_&*ZNS!,]
ME9VVP1K&D+3R>9NVM(TR3(,>4QVHH^_@NVS+1?#CXL:AI>N3>&=8D%U)N)AN
M41(N/)\X*Z*%&#'SQDJ^5RZD,N?^TC\8]:\!-'';BVABN/,$4BEIYQY;J2Q$
MB)$NY74;=LF/FP_W2.E^*UUXB@LI]2M)H[40*TBVRQQS2M$ A=I9928U= ';
M9$K+QM$DI(:MOX(_%O\ X3O2SJ%WLB>*25)R/DA&P"3<"SL0HC9=Q8C#!NV#
M7/\ AO7-;^*L9U"QN4TRQ,CBV'D1W4\JJ=C/)O?:F&4[0O/+ [@J.T7@3XIZ
MCI&M'PUK0$[LK-;W:1^5YBA7EW.O"8V IF,85T*'?DN,3Q[\8]:T/7+'291;
M0Q7%Q:,?)+3N8GE,3QL\J(.2&.5C5@-H#=<^E_'#XI?\*UT\WBQ^9*\@BB4_
M<#LK,&?D': A) Y8X7*Y++Q^MRZU-H0UJVU$I<&V%VT1@MOLXC*&8Q(#$\@*
MH0%9W?<5^;&[*]A\#_BE_P +*T\7C1^7*DABE4?<+JJL63DG:0X(!Y4Y7+8#
M-XI\ O\ D<-6_P"W_P#]+(Z^JJ\P^.'Q,G\*BUL+ #[;J$WDP2/_ *J([D0R
M,,,209%VC:1U9LA=C\_XVT_Q-X,LI[Z'48[TQPN6CDM8H"B 9:9"C89T R%?
M*D;OE9@JGG_VRUO8+!'^T 6CW*(8$C*LQ,;.#))YC;PK1DJH1!E@6W,BFO0/
MAQJ5SX>T2"^O)(Y+6'2HI1'% R3!4@5P"[W#(YV C[B!FP<J.*Y_X4>+]2^+
MMM<WZW9L0LSPP10Q0R*I50XDD:=':0_O%!"&(80D8+<'P$^,%WKUW=:'JN)+
MRT:;,Z *CK'*(W! "8(9AM(4!E^\%9<OY?\ &F/4(O%&F0W-TDKF2S>'$+1P
M1%KC9Q'YS,V6C#.3(&;A<J%7'T+XO\=2_#^R-Q?D74[S+%;QV\+Q&21Q^[BP
MTDYR2K$MGIPJ%L!N4U_POXLF@>YAU&!+G;E;2*WC,&1QM6:?<^64;OG&-YVY
M5/F&W\&/C!_PLK3VN(T1;R+*20E]J%]N48$!W6)^Q*L5(=1OV9;SH?&G7!XE
M3198X,*TN8H2=KA[<RQ;YIEW )E2[1HI(#XC<[4)\>?%WB+X;&&_2\CEMY)@
MK1+;1Q1*P4,J?-)+,PD"N20X*X.&7*@>@7MUK7CJV%WI4T>GPR0QRV_F1K/<
M2;E8XEY>*%#E"-@E?'S,5.8JR?V:/C+/\1K:9+T#[1;-$&=5VJZ.I"L?F/SE
MD<M@*H!7:.H$VG^*-4^*6^?1KA+'3TD9([AX#-<3LF S*DNV-8"6(!YDW1X.
MW+*N3X.^)^H^%-9/A_Q!(DQG^>TN@(X@0=P165=H&XH5 ^^)?E'F*ZLMO]HS
MXG:MX MQ<6:6RP/)Y(D9I))]SQEE<)L2--I1OO-*&^4E0,BI;:Z\1>+-*BN[
M2:.V<V4,J?NXYKBXE\IBP;<5@@1V*E,!V (9C'S$*O[/GQ@O?B797$<C1I>V
M[0CS3$6B9''#,BS1DN3')NVF-1E2HQE:\O\ @A'J$_BC44%TCW21W*23S0M*
M'"7$4?")-%L^Z-H#%44; ,8(^NK175%$I#.%&YE4HI;')"EF*@GH"S$#C)ZU
MY5^T-\;7^&$$/V>(27%PS["^?*58]F\L%96).\!0"!R6)^7:V5\7Y=:^'^GK
MJ=MJ)G-NT7VF.:"V"2!F1/D\J)70;SRI<G:>) R_-W_@OQX_C72XM3LH0'E4
MXBED,:AE<QR R)'(< JQ4[,L,9"Y./&_ 'QGU[Q)K%WIC+;-+!;SQJB@QVJR
MQS*GGNS;YRO)4*GWLJ"J?-(I\2?BCK?PCU*!KZX2[L;G)(%O'%L D'FI&%D\
MS<D9789'*G?@[BI(]5^-GQ7C^&]BUQE&N7^6WB8GYVR,G"\[4!W-]T'A-RLZ
MFN9MM/\ %&F0?VI<W4<LBJTKZ8MNFPKR3 DT>Z3>$X0@.#( I+KEF\Z_88_Y
MB/\ VZ?^W%?4MVSJC&(!G"G:K,44MC@%@K%03U(5B!S@]*^<+KXY:U:^(AI$
MT<)$?G8@MPS><7MS+;QM+(A888H&D"1HOS.X\L<0_$SQEXP^'I&IW+VLMJ6V
MM%#&SP1DJ%7>65)P&8Y!$A&_Y20&5&]@M/C!:-HJ^()<K 80[*H+L'W>68AD
M+N(E^0,0JD_-D+S7-?V3XG\40_;$O8=/9X]T5HMN)< C>@FDF7>LHW;)-J%1
MMR%R2*E^ WQ=E\7B;3M24)J5DQ28 IB3:Q1G 4]0PQ)MR@)4J0'"KPOQ3^.6
MM>$M6M;"6.%8I)+>4QVH:YG>(N8WA#2I&&9BK;0L:,,J _4GJM+O?%Z:FLLT
M-LUC+&3Y'FHJ094E4:58VF:4%0&*I)$Q8[=HP8\KX-_%[5/%6O76FZ@852VM
MYU,<"$1F6*X2,R!I-TAX8C&0N,':#DUTOQ)^)E[)J">']"$9O7A>26>3+16Z
M;6VY"!BKD[2"Z[1NC!5Q)\O*^/\ Q#XD^$H74)[J/4K+<B2HUNMNZEF)+?N5
M(484('9F&YP#&3@U[)X6\=6OB6Q35(7VVSQLY:3]WL"DB3=DX&TJ0QR5X)!*
MX)\E\,^,]:^+D]Q-I5U'8:;!,\44HA6XEG8;""5FQM&WY^B%=X0B0@LOE7Q!
MN;UO%>FP:EAIH)K&(3*I1)T^TETF"D *2'VNJEE$BN%..!]"_'/QUJ7@BR>_
ML8[9HHO+,C3-*7.Y_+VK&BJ.K*=QE'&X;.AJ7X'^-)=>T.#4=1E!<K.TLK!(
MU"I-(NX[0J* BC)P!@9/<US7AO7-;^*L9U"QN4TRQ,CBV'D1W4\JJ=C/)O?:
MF&4[0O/+ [@J.T7@3XIZCI&M'PUK0$[LK-;W:1^5YBA7EW.O"8V IF,85T*'
M?DN/;Z******************************************************
M********************^5?C[_R.&D_]N'_I9)78?MGW;P:-&J,5#WL2N 2
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M,"+'.H.,XR$E5G$:@!(Q7JOQY\30^*/"<]];',4T=JZ\J2,W$65;:6 93E6
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MPX^'4_B?7)O%=Y%):(6*VUO(,3,!#]G,DH(^0%02$ZECG=L4&3WJO /VUO\
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M2#,L VRSMA3ABQ*QQKRJ8E9=P;JOV7/^1=L_^WC_ -*):\J^ 7_(X:M_V_\
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MY@L<IMED0!L@ B5^F,%BPPW->W_LN?\ (NV?_;Q_Z42UY5\??^1PTG_MP_\
M2R2O5?VH_P#D7;S_ +=__2B*O,+:[>U^'NZ-BI*LI*D@[6ORCKQV*DJ1T()!
MX->W_!35(]3T6PDA;<HM(8R<$?-&HBD'('1T(ST.,@D8-=A-=I 55V"EVVH"
M0"S;6?:,]3M5FP.< GH#4M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?-?[2/@S4(]8L-<L[9[J*#R
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M9U"C:&&\X,;:O[3GA?4_'5O'I^GV3R+'<+*TQEMT0XC90JJTH<_ZPY+!,%>
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M2S(C;?F/VF? 6L?$>:".QL7\JV\X>8\ULOF%R@RJ^<2%Q&""V&.[!1=O/O\
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M X# $'<!E=WK6KZ8?B?IT]K=6\EK%/"HC\XKYP?[ZNT<3G:$8(0K.&9@R.B
M OY+\*O$.L_"16TC4]/N;FV3<UO+9Q>?C=(V02I4%6.7&\K*N<,I5E"=?X'\
M%W?B?6G\2:E$8$2$16-NY'G*A7F1_+("DAW_ ';[F5G8''EH6]EKQK]H_P"!
MI^(L"W%I@7MNK; 0H$J'GRBQ&00<F,D[02P. Y=?.O"WQ+\:V.S3?[/\Z2/<
MGG3Q2C=LSRTWFQPMP,!\_/P=S,V3[7X;T>]\#Z>2R/J&H32/+.4=(P\K+P<S
M.BI$JHD0V#A5#+$.0/*OV9O 6L?#B:>.^L7\JY\D>8DULWEE"XRR^<"5Q(22
MN6&W 1MW!\9/ 6L>(=>M=5L;%WBM/(&'FMH_,,-P\N5_?,0K C!90P[H,8K/
M\9Z-J'ASQ-!XC2PNIH95R\2(DDL9$1M64^0\R$[-LJY*AMVS(*L1J_M(V>K>
M/],A>TL9$@29)&C?!O22C*C"*)I $ D(8$F7<>8T5"S6_%?PWU#X@>&K:Q6
MV\UK#:,B3% \SQP-&Z85B(@0PV&0ABP*R1Q ;S:^'7Q4U'0+*+3+O2+UKNW4
M6\9CB_T9]@$<1:9FVH#@!W&],#S =IVCI?@[\*IM$FGUK5&W:G>;C(JLS1PH
MQ#"!<LV[&U1G)"A51#M!9^ _:9\!:Q\1YH([&Q?RK;SAYCS6R^87*#*KYQ(7
M$8(+88[L%%V\^U?\)5>_8_/_ +.F^U=/LWG6OWMF[=YGG;?*W?+NQYG\7E8K
MQ7]F;P%K'PXFGCOK%_*N?)'F)-;-Y90N,LOG E<2$DKEAMP$;=Q4^*?@O7/%
M.N6NL6VFN(K3[/M22XM5=_*E,QSME<)DL5&"_ #=]H]*^-^GWOC'1I+*ULYO
M/N-GR,]JOE^7-&_SG[05^95)787_ -K::S_@SIVH>&-%;3;Z$V#P0W)6[:2V
MFA7<S2"0@2D@J7)*L-A5,EQNVCS7X3WWB[P[I\<&FVD%S9[I&@EDQ&61F)W*
M'FMY-C'+H70,0V?N[0.EU#XS^)_!NR[UO3H5L1(JS- 0TBAL@$8N)0.<?> 5
MCA-RE@:^BJ\@_:E\"W7C#21'9)YDD-PLQ0??95216"#'S-\^0O4@$+EL*9?A
M)XROO[,MH6TNZ1[:&.&0.8H2WEHJ QB9XV8GY6.X1H!Y@$C.BJ_G7PL\%ZYX
M6URZUBYTUS%=_:-R1W%JSIYLHF&-TJ!\%0IR4X);MM.K^U+\.M3^(,EM'I]H
M[K;^=ND,ENB-Y@B(VAI@_&P@[E7GID<UM_&GX:77Q:TR.3[.;74+=BR1221N
M&#(OFQJ\4C)AF V.X4Y3!6-6+4>$/C1JUO +74M)O9-01FC#QPA;:1A\J.TI
M(2,%OONH:,#]XORG:O0? ;X9S^#X)KG4"&U"]F,UP5Z G)$?RG82&9V)0 98
MJ-RJK'G_  UXUU3P6UVEYIMU/9MJ-ZUO);K')*%>=V"F$%9-A.]Q*QP=R@ J
M5-0^&O"%QXR\0Q^)&M7L;:&W**LRJES.Y66(L\:G,>T-C+DDJD>W*M\G"^//
M@[JWPRU,ZUX<0RPLS,T**"4#N-T!B3!DA)(V[!E ,G:8UD/2^&;_ ,3?%7%K
MJ=NECIYD'VDA)H)I47!:W >7S L@;#.H4;0PWG!C;Z*KR7]H_P"#[_$:R7[+
MC[7;LSQ!B0'5A^\BSD*I;:I#," 5"Y569AE>$/C1JUO +74M)O9-01FC#QPA
M;:1A\J.TI(2,%OONH:,#]XORG:NU\$OAS<>"+6XO+X>;J-Y(T\ZQ[02?F981
MEEBW;F8DC8FYRNXHJM7FOQ3\%ZYXIURUUBVTUQ%:?9]J27%JKOY4IF.=LKA,
MEBHP7X ;OM'O_P#PDT_D^;]AN=_F;?)W6GF8QGS,_:?+VY^7&_?G^''-> ?"
MSP7KGA;7+K6+G37,5W]HW)'<6K.GFRB88W2H'P5"G)3@ENVT^R_%*>\U#3);
M:SLY)IKJVDCV^9;QB(R(%/F,TN"0&) CW@E<;E!#5PG[,?A?4_ MO)I^H63Q
MK)<-*LPEMW09C52K*LI<?ZL8*A\EN0H7)XKXC_#O6?AEJSZYH >X2ZD<R((O
M.=2[B62)E52WE,R\.FUE'R%@=K/M^&I_$WQ7EBBU6WCL]-297N$> J9_+>*5
M8C'.SR$$J!N&U,%]Q<@(=#]HOX"7'BB:/5]'.+Z/RPR*5B9]I^257RN)5X&6
M;E%7:04"OS_AGXG>-?$&+-+%(G,84W,]O+!MZ(929'$98$[MJHV<'$9 *U[?
M8Z=+X%TZ.WM(9+Z9%.<2(C22MNDDE=IY?E#RDEL%V4O\JL!QXW^S-X"UCX<3
M3QWUB_E7/DCS$FMF\LH7&67S@2N)"25RPVX"-NX]%^*,VJ6&HZ?=:5;&Z"0W
MRSQ[XX5*/]GVJ9) 54[U5@!\S!"!\N[''_$W7+CXN63:39Z7>1RO)$WG7D2V
MT4(5UW2!F9R6P=NU!O*,Y&<%3[5X3T+_ (1^SM[+=O\ (MXHM^-N[8@3=C)Q
MG&<9./4US7QQ\(3^,-'NK&T ,TBQE QV@E)4DVY/ )"D#.!DC) R1PG[->M7
MUAIT6ES:=<Q/!(P,LP$,)221I"W[S$A8 L J(XW!-[H')7E=+\(:I\#-4EGL
M+5[S2;J10R0*9)D7+E%"Y:3=&"PW',<BD!F5V&SI?%6E7?QNGM(7M)[32H)C
M+<?:D$4LSK@"-(U;S -C,/,#!?G?^*-0WO5<K\6/^0/J'_7A=_\ HEZ^=?V7
M_&]UX3TV5S9S75F]VX!M4\VX241Q$AXR5S$R8VN#\K*0P^=,=KHWA'4/B?K4
M.M:E ]II]IS:P2EEF=E9MLC(''EMO =B0 56- )%R]6OVG/"^I^.K>/3]/LG
MD6.X65IC+;HAQ&RA55I0Y_UAR6"8*\!@V1Z!\(3=VVGP6E]:O;2V]O#$<R0R
MH^Q=FY3%(QZ*"0RK@M@%L$UY!XV\ :I\-M:D\0Z)!]JMY\FX@4%I/G9#*N"6
M<[G_ 'BM&#L.0R"-</M>/[_4/C+ NE65G=64#S(;N>\B2$"-<NJHA9GD)=0?
MD*[2JJQ"N2/<-)TN/2(8[:!=L44:1HN2<*H"J,DDG  &22?4UX+\3?@[+JOB
M:TO(4(MKJ&1+MU5Y!A(GCD5SPL8E@9848,"#N91O +?0E?-?[3/@+6/B/-!'
M8V+^5;></,>:V7S"Y095?.)"XC!!;#'=@HNWGT_QIX4D^*.D2VEY;&UN&4&-
M9'ADV3*H965XC+\FXE"V%D*;QM7<*\:^%'B[Q'\-8QHT^DS7*K(!"R_(B>8=
MS*9D22)EW-G<6&PE@S8 "9\/A+Q!IGBEM3:T-[+&N]V3%K;-OMEC*1RRC:1'
MYFP=7<(2P!W$=M^T!\!KOQ4\.L:8 FHHL0EB1PNYE.5D24B(ET/&Y]I9%7&Q
MD"MB>&?B=XU\08LTL4B<QA3<SV\L&WHAE)D<1E@3NVJC9P<1D K7T+X+\,CP
MQ:16@<R%%.^1BQ:21B7EE.YG.7D9G(R<$X' H\;Z(^O6%U9Q$!Y[:>)2V0H9
MXV0$X!.,GG )QV->"_LT3:GX+AN-(GTVY\W[0\B2MMCM\D)$P:1\#:"@.Z+S
MF92S(C;?FJ?%/P7KGBG7+76+;37$5I]GVI)<6JN_E2F8YVRN$R6*C!?@!N^T
M>E?&_3[WQCHTEE:V<WGW&SY&>U7R_+FC?YS]H*_,JDKL+_[6TURO@;X47.N:
M!_PCFKVKVS1^8T5R'MIU#&4R(P"R%U;YV5@  8PP\Q2^!YUX9O\ Q;\'0^FP
MV9NH=Q:,^5+<Q*-S F-H64J&(W%'P1][8I9MWO7PM\/ZI<S2:MKVQ+IX_)AM
MXR?+@BR#)TD=2TC*K,<LP"J-^/D3TJOF7]H[P3K/Q.>V%GITB);K+EI9K0,S
M2%,@*D[@ ",<[LDDC QD^]:%XBN;Z%I+BRF@E2,'RS);2;VP24C9)B#@C ,G
ME Y!XYV^ ?\ "%ZY_P )1_PD7]FOY'F8\O[1:^9L\C[/N_UNW=M^?;G&?DWX
M^>NE_:1\.ZK\0;2&QL;"3"S),\CS6J 'RF'E@"9B2#(0QX *?+O5@P[OX;7M
M[I.EPP75C,D]K;P1>6LEJ_F[0(]R-YZJ/E4,P<IC.U2Y&3XI\$OA+K'AB&_T
M^^LW2+4+<0^>DMM)Y1Q)'O9//4LH$I8[3N^7 4[LC0_9NU/4/ ,4VDW>EWK.
MUR[K(D:>43L57!DE>*( >4"K!V#[L#MNST\,:SI_C!=4NK)Y%;>P-K\\.W[,
M\*#S9C"@88 ;>8RS E5PR Z'[1W@36OB2]LEMIY46RR[G-Q;%6=R@.S,BL4'
ME@JSA&8-\T:$8/K?BR]O?$&CW$7V&9+J>WEA\GS+5MK/"1OW^>%,08[<\2'K
MY0%>=? 3X>:AH6G76AZK9R117339G2:V<*LD(C<$"1F!&P;2%<$M\P4+D^?Z
M3:^)_@?/+86%N;RU9C(A6WDEB8MM429BPZ/M0*8RY Y(# JY]?\ A-H^M>([
ML:SX@2.()"R6EL(U#1^:(C)+DEG0E4VE78OEG!$:\-POQ3\%ZYXIURUUBVTU
MQ%:?9]J27%JKOY4IF.=LKA,EBHP7X ;OM&K^U3X$O?&]C:WMM;S>;!)*'MMJ
M23!9"HW_ +F20'!C7A-YVON.W:U=7K?BO4_B%I-Q!9:=-;SRV[QO]LVPI\R8
MD2,;O,=B&Q&SI'$3EF<%2AY3]E^'4?">FRP2Z=<Y-V\AW>7 Q4QQ( BSO&S-
MN&3NV1[ Q$AD41ME?"SP7KGA;7+K6+G37,5W]HW)'<6K.GFRB88W2H'P5"G)
M3@ENVT_3]>8?%&;5+#4=/NM*MC=!(;Y9X]\<*E'^S[5,D@*J=ZJP ^9@A ^7
M=CC_ (FZY<?%RR;2;/2[R.5Y(F\Z\B6VBA"NNZ0,S.2V#MVH-Y1G(S@J;7QY
M^%%UJ'AVVT^R'GR67V<D ;7D6*%XF*+\V6^;<$SD@$*6; -"WL]0\?\ AG^Q
MQ8SVTL=M'&6GV1JS6X1HU1799"9"B#+*D:!G/F,8PKR_L\>*K[1].CTB32[Q
M9X?-*R2((+<AY"X9GEVLN&DPRHDK[5+JK'*CE/@_X8UGPSXBOKFZLG>2:.X^
M>/Y+0O+-%(&$LA_U7<A1),HS^Z9E91K?M(^#-0CUBPURSMGNHH/(#1Q!FDW1
M3/-@A58A6!P' 8 @[@,KN[7XE> &^-&GX>![*5-LEJTXC\TL5.Y'6,R&.)@5
M!^82;QEXQY:B3R3P=XP\9>!D32%L#.$95C>6*2555@NU!-%(L6Q<]68A!E2P
M50J^]_#;P_?:3#/J&J_OM0N<.\49&V-$!\FUCWR"/Y2S?-E07<[G?'F'Q_\
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M8]BY3Y"?-SYDF& %2_&GXF#X<Z<]Z &E++'"C;MK2-DC.T= H9R,KN"[0P+
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MEROVD?C'K7@)HX[<6T,5QY@BD4M/./+=26(D1(EW*ZC;MDQ\V'^Z1J_$>_\
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M.S6 102>%4%@7<\(@9B#C%=+\3/&7C#X>D:G<O:RVI;:T4,;/!&2H5=Y94G
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M-R.!./F7<,D#:P((P=R+ZKXSGUC2[%I[)K::ZBCD=T-O-MEP<JL:I<,R-M!
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MAJ_E>7\FS9,NS;MQMVX&W&,8&*]0_8GNT;2KB(,"ZWK,RY&X*T405B.H!*L
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M_P!M;_D#P?\ 7_'_ .B9Z]5^$_\ R!]/_P"O"T_]$I7S_P# +_D<-6_[?_\
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MTPLKJ6<1JQ!&0 '.T&O7[OX4V5XC12M=.CJ596OKYE92,%2#<8((X(/!%6_
M?@W3_!\4EIIB"-!,6D02/(1(40\[V9E)38<<<$''.3\]? +_ )'#5O\ M_\
M_2R.OH#XG^)-/\/6,D^K!'MN 8W59/,;.Y(U1N&8E<@'@8W$JJEAQ7C?4-4\
M1:3?7$J)96IL+AEA93)>L DI_>$D10;E";HPLK@,Z[XW *\_^Q3_ ,@>?_K_
M )/_ $3!7*? +_D<-6_[?_\ TLCKZJKE?BQ_R!]0_P"O"[_]$O7E7[%/_('G
M_P"O^3_T3!787?CY+G4+FQT&VCFOPJ_:KEL1VT;*KK&LTB*TDKJ0%$:C."PW
MIL?;XI\8K2>W\6Z3]JE$LA:Q)*Q^5&!]K<!57<[ <9.YW)8L00NU%]@_:C\(
M'Q)H<Q0$O;,MPH!500@(D)W=0(F=L @D@8S]TY7PA^(CZWX>M8K9@MX6%@A5
M3B-T4XDQ)E7*6R^>02%D*F,$,P4>?_"&[3X7>*+_ $AV$=K*LC+@@QHJ(;F%
MG>3# ) 75CDC<>=P <?17P_M'%M]JG4I/=M]HE5@59&=5"1$'',<2I$3A2QC
MWLH9FKI:****************************************************
M************************************************************
M************************************************************
M******************************************************^:_P!I
MGP%K'Q'F@CL;%_*MO.'F/-;+YA<H,JOG$A<1@@MACNP47;S[UHEU)K]L1?6I
M@+J4D@E:&92"HW@&-G5D.2OS!20#E "*^6KGX<:]\#;Y[G1$>[LY,+M"&7<"
M&*K+%&0^Y,$B10%Y'*[VCKTKP /$'Q%F@N-;B2SL8)!,(562*2>5"?*WJTK.
MJQNHD ;:K$+\C@ADXK]N?_F'?]O?_MO7I>J?%_5-/C:S_LJYDU(80/'&6TYG
M) 603;@1$00Y#!2O,;LI!<6OV>_A5-X%M9);YM]]=R"2=MS.1U*HS%B'8%F9
MG'5G(RP56/FNE^$-4^!FJ2SV%J]YI-U(H9(%,DR+ERBA<M)NC!8;CF.12 S*
M[#9TOBK2KOXW3VD+VD]II4$QEN/M2"*69UP!&D:MY@&QF'F!@OSO_%&H;T7X
MO&[N=/GM+&U>YEN+>:(8DAB1-Z[-S&613T8D!5;)7!*Y!KS_ /9C\+ZGX%MY
M-/U"R>-9+AI5F$MNZ#,:J595E+C_ %8P5#Y+<A0N30_; ^'5[XI@M;FQB,PM
MVF$D: M+B7R@K*@!+ %,-CD9!QM#%?6O OC"X\3QI-+936BF/+"<JK[\@;50
M9<J,-EI!$2-A5&#DIU5?*OQ'^'>L_#+5GUS0 ]PEU(YD01><ZEW$LD3*JEO*
M9EX=-K*/D+ [6?;\-3^)OBO+%%JMO'9Z:DRO<(\!4S^6\4JQ&.=GD()4#<-J
M8+[BY 0Z'[1?P$N/%$T>KZ.<7T?EAD4K$S[3\DJOE<2KP,LW**NT@H%?G_#/
MQ.\:^(,6:6*1.8PIN9[>6#;T0RDR.(RP)W;51LX.(R 5KV^QTZ7P+IT=O:0R
M7TR*<XD1&DE;=))*[3R_*'E)+8+LI?Y58#CQO]F;P%K'PXFGCOK%_*N?)'F)
M-;-Y90N,LOG E<2$DKEAMP$;=QVO[4O@6Z\8:2([)/,DAN%F*#[[*J2*P08^
M9OGR%ZD A<MA3+\)/&5]_9EM"VEW2/;0QPR!S%"6\M%0&,3/&S$_*QW"- /,
M D9T57\Z^%G@O7/"VN76L7.FN8KO[1N2.XM6=/-E$PQNE0/@J%.2G!+=MIZ7
M]I/P[JOQ MDL+"PD(CN3(TKS6J*P571=B^<6(;>3E@A4  J23M] ^$D]Y:65
MM8WUG);O!;1QES);R1,8PL8P8Y6?+*-V"@"\KN. 6\:^*?@O7/%.N6NL6VFN
M(K3[/M22XM5=_*E,QSME<)DL5&"_ #=]H[7X^?"6?XJV,4\*O!>6_FF."4Q?
M.&*AD+1NZ!CL4H0Y7G:^,ED\ZT'XL>-KU!9K8EI65P)Y;5X6!PQ#%G:.W!4<
M+N7!( (8GGU#6_@_<7/ARXTMG22^GWSRR(BH);@S?:".J#D@1!SMPH!V@ (.
M?_9X\57VCZ='I$FEWBSP^:5DD006Y#R%PS/+M9<-)AE1)7VJ756.5'*?!_PQ
MK/AGQ%?7-U9.\DT=Q\\?R6A>6:*0,)9#_JNY"B291G]TS*RBW\0?#>H>$?%B
M:_'9S7=J^#BW5I'4?9Q;N& 4X89WJ#A7& '!W;?6OB'?ZAK&F7%O;Z?(TMS#
M-$B&:V4HK($WRDR[0?F8JL9E!"KN:,L0O'_LQ^%]3\"V\FGZA9/&LEPTJS"6
MW=!F-5*LJREQ_JQ@J'R6Y"A<GE=+\(:I\#-4EGL+5[S2;J10R0*9)D7+E%"Y
M:3=&"PW',<BD!F5V&SI?%6E7?QNGM(7M)[32H)C+<?:D$4LSK@"-(U;S -C,
M/,#!?G?^*-0WHOQ>-W<Z?/:6-J]S+<6\T0Q)#$B;UV;F,LBGHQ("JV2N"5R#
M7G_[,?A?4_ MO)I^H63QK)<-*LPEMW09C52K*LI<?ZL8*A\EN0H7)YJY\$ZR
MOBG_ (2&/3I&M]RY1IK19=OV86[G G9<CE@-V&P 2N<CL(?%>J^&-2O[EM.N
M9M/FDM7_ '?DM/')]EA1]L88M-EMB,4<HFQRI.&K*U;P_<?%K5M/U".RFL;>
MQDWR374:Q3RE'CD2%8PQ<J,?*Y.P;Y,?,NU_?Z\J_:'TN_\ $NG2:7I]H\[3
M>43+YD$<:!9 Y'[R0.S?(!C:%PV=^05)^SQI=_X:TZ/2]0M'@:'S2)?,@DC<
M-(7 _=R%U;YR,;2N%SOR0H\Z^.7P-U#3]0_X2'P]GSMQDDCC"*ZN%.Z1!@"0
M. ?,CPS.S'APY"S:%XS\8?$+=9-;)I\3X62Z,,T,D:G))C$LN68A2HV E202
MT>0X[KXX?!9/%FD)96* 36BI]E!('RHH0Q;W#-AD'&6 +JA=L FN?^#OCG6M
M/M4T>YTN=KBV5(DF=EAMF19-F6D*8 2,J%\H3M*%+ =37%?L[JZ^+=4$I#.%
MOMS*I12WVN+)"EF*@GH"S$#C)ZUTO[1O@"^;5+'7[&![I;7R?,AC W_NIQ(F
M,%G;?YA!VHVP*6.0>-#XR:QJ/CW1;E+73YX8F6 A9DS=R,+A0R)!&S,@7:',
MCG)7A8R&\Q=OX&6&J^#M*2SO;''V?S JQW$+SR%Y=^0A*PJH$C9+3;OD.$^8
M5Y_\+/!>N>%M<NM8N=-<Q7?VC<D=Q:LZ>;*)AC=*@?!4*<E."6[;3;_:9\!:
MQ\1YH([&Q?RK;SAYCS6R^87*#*KYQ(7$8(+88[L%%V\^]:)=2:_;$7UJ8"ZE
M)()6AF4@J-X!C9U9#DK\P4D Y0 BOEJY^'&O? V^>YT1'N[.3"[0AEW ABJR
MQ1D/N3!(D4!>1RN]HZ]*\ #Q!\19H+C6XDL[&"03"%5DBDGE0GRMZM*SJL;J
M) &VJQ"_(X(9.5^,_P +]3\*ZROB30(/-Z/(B*KD2']W)^Z4*S+(K98IN?<9
M')3Y6J7XEZ_KOQ.T>X"Z?)911M'NA97FN;EO-CPB(8HV1$SYCOM)8JJJ<"3'
M=_LUV>IZ-IT5A?V?V>**-F25I5,DAED:4#R57,>T-AM[!@<#;RVWU^OFOXJ^
M -4\+:^OBC3H/MD?REX5!\Q?W2VS+M!+-N4[E90VTY+IM7+]+XO\0ZC\5H#I
M>GV=U8Q2LJW5S=I]G*1=2L:"3=*6VE6 ^4 [7P)-Z>J^"_"$'@ZTBL+0$11*
M0NX[F))+,Q/J6))P  3A0!@#QK]I+X0_\)E?:9*@_P!9<?9IRK[9/*PT^5#9
M3Y$29L_>)*C#\ >_T5B^*-;N-*3-K:273E7PJ/!&H8 ;0[32(0&)ZJKD $D=
M ?G_ /9Q\$ZS\,7N1>:=(Z7"Q8:*:T+*T9? *O.@((D/.[(( P<Y'TU7G7QR
M^$2?$RR\@,([B)B\$A (#8(*,<%@C<;MO((5L-MVGPKP=XP\9>!D32%L#.$9
M5C>6*2555@NU!-%(L6Q<]68A!E2P50J^U^%?AG/K-E=_\) 1)=:@H$RIRD$8
M!\F&,,70&)F9PP!_>,26D(#MXI\.+OQ#\$'FL'TV2]MW8R+Y(9EWYV>8LD<<
MG#*@S&ZA@ K83)#'Q%\)>(-5U^RU&2T,TBK!,(8\+!"L<TD@MFN&'EE\+EW.
M 7?" KL!]%^-_P &+CXHV,-YY26^IPQL?)#K(K*3GR&EV)EAU4_ZM79UR5;S
M!Q7A;XE^-;'9IO\ 9_G21[D\Z>*4;MF>6F\V.%N!@/GY^#N9FR?=?!7A^X\'
M6+-<;[V^DD,UPT94-)*Y53M\Z2-%5$"HHS&NQ 512=M>*_"SP7KGA;7+K6+G
M37,5W]HW)'<6K.GFRB88W2H'P5"G)3@ENVT]!^U[\.+KQ5:VUS9(\SVTD@:*
M--[E9=GS@ [CM9%!"JQPQ8X"DUT&M^*]3^(6DW$%EITUO/+;O&_VS;"GS)B1
M(QN\QV(;$;.D<1.69P5*'E/V7X=1\)Z;+!+IUSDW;R'=Y<#%3'$@"+.\;,VX
M9.[9'L#$2&11&V5\+/!>N>%M<NM8N=-<Q7?VC<D=Q:LZ>;*)AC=*@?!4*<E.
M"6[;3]/UQ7Q>-W<Z?/:6-J]S+<6\T0Q)#$B;UV;F,LBGHQ("JV2N"5R#7G_[
M,?A?4_ MO)I^H63QK)<-*LPEMW09C52K*LI<?ZL8*A\EN0H7)XKX(:???!_4
M+VPGL+RYBFDB2.>&(%&V,XC8EF$2JRR;F)D_=D;6_B*GQ:\,:SJ/B+3]4>R=
MH%DM=BP?O75(YO,*S-D1I+EB2=PA ( E<([U]-6R'58-MW"%$BL'A8K*-C9&
MU\#824QO4;E!)4,Z@,WA?[,?PBN?"%S>S732;(IIK:W5@T:NNY#)<!&!&'$<
M6UE8@A6!SM4U:^._P6?QKJ^F7*H7A+>5=9)$:Q1L9@/D&]2ZF1 V=N[8N4)!
M/O5<!_PF&J?V[_9WV+_B6_9]WVK)^]C.=WW?O?N_*QYG_+7.SBN_HHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKY5_:VM;GQE-:P6%G>2
M_9OM D=;6?R\N8P%5B@W8\LG<N4(*E6;G'TKX9\1+X@A$Z1S19P"D\4D$BG
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MAYKP^=&5\Q/O#D'!'&5.-KKD;D++D9R#P!X2_P"$0L8+#S7F\F,+YC_>/).
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M#DL23DU]*>/_  E_PE]C/8>:\/G1E?,3[PY!P1QE3C:ZY&Y"RY&<@\ >$O\
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M\9WQL7!=2I7RWSS7Q3\.:M\)(AK&FZC=7,4;1K-!=N+A=K/R^6*\%MB811(
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MRI*5! =6'[N7& JEMK JI(!4MA595'K5%>-3ZG>_%#4;JQM;B2TTRR;RI98
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M)T=0RLMO RLI&0P(3!!'((X(K0\/:/I^AS2VUC##!+Y<4DJQ1+%E6,JQ$E5
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MMNH/"LC.JD1R;U(VHZOC< 5!+X5%"&N$^ 7_ ".&K?\ ;_\ ^ED=>J_M1_\
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M(&?DD4Y&1SC.00/.OVW+1[Q],BB4N[M=*JJ"S,Q-N H Y))X ')->G_M1_\
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MA;5( E@J) DDT82-/+1625TE 4!0/WBMD@8)R02#DZM%?*OP"_Y'#5O^W_\
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M,D#J14/[<_\ S#O^WO\ ]MZ^JJ^5?@%_R.&K?]O_ /Z61UZK^U'_ ,B[>?\
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M&X%%(RRC;OZMM%:&H6OB#QWIDUG<0P:=+)"T;,9!<F3* ,H1 5B1\D;R\KH
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M-*"S,Q=4<-!P-S-F122!M'EL02>*\#_!O6_">LW.M(+)Q<M<;X3/."%ED$N
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MO_AW\/T^'FG+8V>)'178LV(O-E/)9BBL5!.%!P[*@4?/MY\E_P"%,Z]_;_\
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MQTJ;XX65SXATA-.OB(]1GF0006;M*MPZ*"VY9%B*P@DNY8E80J.7=@$;*M/
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M9;8%(F!W;<@Q')#.%V^H>/O%M[>ZA%H&EMY$\EN;F:[*)*(8@Q10L;L [-(
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M,H\L;=WNOBGXI>3H3ZYIL?G_ .CK)&AYQDA6W^66_P!7DF10>-C*67!8<?\
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M.?4D1[4VB)()%1HQO>YC5F$A"[59@S$_= )&2 *]U_X5/H__ $#[/_P&A_\
MB*S]6\':1JUE=:2$C@MS,D4RQ*MN!,XA>(@A54N=\6W[P8[4(;E:^>M0^&WB
M/X%[[O2Y_M%BF7E4#Y<#RR[20,3C.,%XF9Q&I)>,5]"_!;XF#XC:<EZ0%E#-
M',B[MJR+@G&X="I5P,MM#;2Q*DUW5>2VWQ5G^(%W/IV@-&L5NH$U^X\U59A(
M%6&(%?,.X9$C-Y>%?Y6!0OX_\8M).F>+=)5Y9)G9K%FDE*EB?M;@8"*D:@
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M( ">6.6PN0J]_7S7\+?AUK?PFU"[AL[-+JQN)$"2O<QQ%55F\MV."WRK(PD
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MTZ1S&)E7#J 2K*RNAP>HW*,C()&0"I.1Y!\,[+Q-\,8#IAL([^"-LPR1W,4
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M\8?"B/7/%-EJ"A"L5N9;A "K!HFQ;2,R=69V&T/@%+=P"P4J/:JX#QA_;O\
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M'*FX[EE=<!U)60MB1G9E %<5;>'9+;QU]F6ZG+EF;[0WDO/EK(R'[T1BQSL
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M"RG:!D(O->$/#VH_%: :IJ%Y=6,4K,UK;6C_ &<I%T#2.8]TI;:&4GY0#N3
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M*@UH:7X,U3QMH\$KZA-!(UA;M D#F/,ODG$D\Y5II-Y96=5V*O(_>,!(<_\
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MQL&//^$)=3\?0QW]U)]BM9H]R6L!5YGC<(5:2X(RN1N($*Q.JNI\P.N!X_\
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MD@=2*A^/O_(X:3_VX?\ I9)7K?[35H]UX?O5C4L0L+$*"3M6>-W;CL%!8GH
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M_P!>&I_^A7%'[%/_ "!Y_P#K_D_]$P5S7[;EH]X^F11*7=VNE55!9F8FW 4
M<DD\ #DFO6O'WQ@_LJ]BT73$2XU*?/R,^R*$;"XDE(!)P!O\M<.R D$$IO\
M*OVL?#UQ8Z3%+>W3W$IOP  JPP(&2=MJ1IDG "J&E>5Q@[67>X;TK_F3_P#N
M _\ MG7*_L4_\@>?_K_D_P#1,%<I_P U#_S_ - ZNU_:^\"MX@TM;R)-TMG(
M7.-Y;RF&V7"J"#@A'8MC:B,<CD&W\+OB-_PM:WL8W.7BS+>XY_>V[1^0K85
MGF2,MPI7Y?W+PX<>9M]JHKY5^/O_ ".&D_\ ;A_Z625]55\%_#329KCPYKCI
M&[*?L&"%8@^7,9)<$#^!"&?^ZI!.!S7TK^R?JD=[H$$<;9:&2>.08(VL96E
MY S\DBG(R.<9R"!YU^VY:/>/ID42EW=KI55069F)MP% '))/  Y)KT_]J/\
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M3!7*?\U#_P _] ZC]N?_ )AW_;W_ .V]?55?*O[#'_,1_P"W3_VXKU7]J/\
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M$#-=W;^$=)\-SPO%:VT,\DC1PO'!&K[O*D=@&1,K^[1\DD C(SD@'Y_^/O\
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MOH-K<P-NBENX)$;!&5:WF93@@$9!!P0#ZBO8/A/_ ,@?3_\ KPM/_1*5\_\
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ML7AMTA2Z,JW!PJE5=8$W*S!54'?*J[CO"L 8ZY3]F_X4ZS\/9KN.XBA6*62
M><9=^Y8S+DQQH,G<&P#(T13<&V28,=5?BO\  ;4])U ZSX7=UFFD+31"14(8
MMYC,#(P5XF8 O&Q(#8P&0[4T/ OP]\3>)KF&X\1W1CM[>82"W1H@TKHT<D>\
M0+Y93>H.6+,"I"JN[>-_]H'X9ZK\28DLK7[+';QS"7?)++YK,$*@;5A*H!O?
M/S.6^4Y7D'J_ .FZKX?TZ.SN([5YK>&**(I/*L<BI\F7W6Y:,A .@D#MGA!C
M'G7P#^#.L?"Z:7S#9S07'E"3;+,LB["V&7,&UOE=OE.W<=OSJ <^_P!>8?&S
MPAJOCBTETRS6U2&1HLRRS2^854K(0(T@*J=Z@9WN"H/ +?*?!/PAJO@>TBTR
M\6U>&-I<2Q32^8%8M( 8W@"L=[$9WH I'!*_-PGQ#^#.O>+M6@UE38Q-;>1Y
M49EN)!^Z<RC>WD)NRY.<!?EP.H+'T#XM>$M2\<Z4VGQQVT<LVWS"9Y2B;)4D
M3:1;9DW!><B/:>F_K7%6/PJUS3?#[:$/LWF+)$UO/#/*KJ?M<4Q+!HEQM^=]
MZ-NP%58RW)ZK_A*O$]O_ *,VFVTDO3[4ET$M06Z.8G'G[4R X!W-M;9U%'PU
M^&-Y\,M)^QV)AGO))&DD:9WC@5V0+\NR-W95V*-IVE_F;<F0HY7X!_!G6/A=
M-+YALYH+CRA)MEF61=A;#+F#:WRNWRG;N.WYU .8OCA\#]1O-137] <+=*J;
MTW;)&=<('4N?+(,?RNC;%*H>'+D54\;^$?%'Q&TN=-0CC@=&3R;2W9%\]M\9
M+RNTTB;$3<40,"S_ #,/D3=V'P5^'.I:-IG]DZP+8V9MW011^:9SYS,TJR2!
M@@QO*_NP<YR'&W+>52_ GQ'\,KJ23PW+YD$V1]Z$.%&"HD2<",L"2%=,G 8X
MC#[:]:^%7P[U03KJOB.X$]VL)C@B41[(%?#2-\B*OG'[A9.-H(WNI 7C_B'\
M&=>\7:M!K*FQB:V\CRHS+<2#]TYE&]O(3=ER<X"_+@=06/T!I<DTL:FY1$EY
MW+&[2H.3C#-'$3Q@G*C!R.<9-JO(+O3->\.ZG?ZA8PPW-G/);D6SS&*9BEO'
M&9(B<Q)\WWR_S,L6 /N$U)O VI_$C4++4-5@2P@L)&D2%9EN)Y)-T;@EE7RU
MBRB\??\ E88PZLN5\?/@SK'Q1FB\LV<,%OYHCW2S-(V\KEFQ!M7Y47Y1NVG=
M\[ C'HOB'3=5U[2IK.6.U%U/#)"Q6>40A7B*&49MR^=YXC((V_\ +4FO*O"/
M[/VJZ9I%YH5R;5H;EC*DL<TJR)*JJ4!#6Y5D+Q1AL;65=Y!8E0-KX&6'B'PQ
M9)I-Q8PQ)'YA2YDN%8 .^[!BB,C2,&=F W1*R@*70_,<#X7_  AUWP?KEY>.
M(9EGCF7[6[A$8R2QR&3R8\N6&"3%^[0D%1,!M8ZOQ\^#.L?%&:+RS9PP6_FB
M/=+,TC;RN6;$&U?E1?E&[:=WSL",=UXMTW6]?TR2R\NR6XGADBD?SYS$%9%5
MG5?L^[)R^%+83"$M)D@<_P#L_?#/5?AM$]E=?99+>28R[XY9?-5B@4C:T(5P
M=B8^9"OS'+< >RUX!^VM_P @>#_K_C_]$SU+X(\0>(M#TJUAM;*._5K*!X+C
MSH[?8K1*4BDB8@N8SQN5E$B;<D.6-=+\$O@W)X):XOM0D2?4+N1FE=% 1079
MB$.Q6^9CN?A5R% 7Y S<5\0_@SKWB[5H-94V,36WD>5&9;B0?NG,HWMY";LN
M3G 7Y<#J"Q]ZMH'U&#9?11@NK+)$K&>(J<C;EXX]P*]04 Y(Y')\ \*_#37O
M@[=R#24&H:;,S'R&F2&12 -K$R857_A+(&$BK\RH=FSL-&^'U]XOU2'6];C2
M!+:/%M9+(+C:^6W2R-CR]V<,IC&>(\D&+#0_M _#/5?B3$EE:_98[>.82[Y)
M9?-9@A4#:L)5 -[Y^9RWRG*\@]7X!TW5?#^G1V=Q':O-;PQ11%)Y5CD5/DR^
MZW+1D(!T$@=L\(,8\Z^ ?P9UCX732^8;.:"X\H2;99ED786PRY@VM\KM\IV[
MCM^=0#D^*OP9UCQ;K$&KVILX_LOE")9)9GW^5,\J,P6!=N=P#*&.,'#GK53]
ML&2:70[<W*(DOV]-RQNTJ#]U<8PS1Q$\8)RHP<CG&3H>"/$'B+0]*M8;6RCO
MU:R@>"X\Z.WV*T2E(I(F(+F,\;E91(FW)#EC72_!+X-R>"6N+[4)$GU"[D9I
M710$4%V8A#L5OF8[GX5<A0%^0,W%?$'X6ZOI/B-/$6E0I=JV"\1=(2N(1 RD
MNZYW)DHPSM;.Y,*-_8?%CPAK?CK3Y-.1;*,3-&78S3L45&#;!B ;R616\PA
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MX<_#'4M(T:70+XVPB:WN8XYX7E=QYV[[T;QH#@NQW!QP%7;U:N:^ 7@SQ!X
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M.  ,DD^IJU17S!\4_!>N>*=<M=8MM-<16GV?:DEQ:J[^5*9CG;*X3)8J,%^
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MTLK!$12S,Q"JJ@9+$G@ #DD\ 5S_ ,./'">.;&/48D,:2M+M5B"VU)7C!..
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MS%*).5E56/EXC8#(/F-&QY4?)G.545Z5\-?%X\8Z=;7X()EA4OM#*HD'RRJ
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M6X*S1$E(R@VNR$L,5@?L<Z-+=:;)*ES-$BW[YA1;<QOB. G<9(7D&1\IVNO
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M!XR_Y$;3/^O^3_T*\KZ5\*>#-!\46L5];6%F8IHU=?\ 1[<D9ZJVU6 93E6
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M5'D 9BN'$ENQ4AHPJR;@2V,LZ*=V0!Z?HWBA/B&;!XL>6(8[V=0PD0,RO'!
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MCD($D1"*517&SAV6-\$U[+^T;JD>K^%[BY@;=%+':2(V",JT\+*<$ C((."
M?45:_9<_Y%VS_P"WC_THEKRK]AC_ )B/_;I_[<5U?[:W_('@_P"O^/\ ]$SU
MVNK:7)I'A62VG7;+%HKQNN0<,MJ589!(."",@D>AKBOV*?\ D#S_ /7_ "?^
MB8*Y3_FH?^?^@=7JO[4?_(NWG_;O_P"E$5'[+G_(NV?_ &\?^E$M>5?L,?\
M,1_[=/\ VXKJ_P!M;_D#P?\ 7_'_ .B9ZY3X^_\ (GZ3_P!N'_I')7M?A3P9
MH/BBUBOK:PLS%-&KK_H]N2,]5;:K ,IRK $X8$=JVM)\.:9X=N5CM;>""XEA
MD8&*%(V:-&B$F61!P&>/@GDX(!P<>(?$W]FV;4+J76O#EULN&DE9HQ(R'S?W
MBS^7,K?*Q?*&-L*K%P750$&A\#_CAJ-YJ+Z!KZ!;I5?8^W9(SKERC!!Y9!C^
M9'78I5!RY<&OH2BBBOE7_FH?^?\ H'5]55S^CZ=:^"H$M8_DC>XD$2 <[II7
ME,:*BCY5W,0 ,)$I9CM1F'A?[8'AF:Q:SU^S&);:14>0!F*X<26[%2&C"K)N
M!+8RSHIW9 'I^C>*$^(9L'BQY8ACO9U#"1 S*\<$!X4,1,)'W8)CDM1N169"
M.%_;6_Y \'_7_'_Z)GKT#PIX,T'Q1:Q7UM869BFC5U_T>W)&>JMM5@&4Y5@"
M<,".U;6D^'-,\.W*QVMO!!<2PR,#%"D;-&C1"3+(@X#/'P3R<$ X./GKX^_\
MCAI/_;A_Z625ZK^U'_R+MY_V[_\ I1%7*_#3_D1I/^O#4_\ T*XH_8I_Y \_
M_7_)_P"B8*ROB;^S;-J%U+K7ARZV7#22LT8D9#YO[Q9_+F5OE8OE#&V%5BX+
MJH"#0^!_QPU&\U%] U] MTJOL?;LD9URY1@@\L@Q_,CKL4J@Y<N#7T)17@O[
M9]H\^C1LBE@E[$SD D*OES)N..@W,JY/&2!U(KT7X*:I'J>BV$D+;E%I#&3@
MCYHU$4@Y Z.A&>AQD$C!KQ#XZ6CW7C'25C4L0MDQ"@D[5NI7=N.P4%B>@ )/
M KI?VUO^0/!_U_Q_^B9Z]5^$_P#R!]/_ .O"T_\ 1*5U5%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?
M/?[2>B/X>O\ 3_$\9DV6TT45R(\[A%YA<$8  #!I(WW.%8O&F/F->_VEVEXB
MRQ,'1U#*RD,K*1D,"."".01P17FO[1OP[E\=Z2UO:J7N(YHI8D#(@9@2C E\
M# C=SU!R!R>AZ_P!X.C\&6,&GPG*PQ@%N1N8DM(^"S8W.2V,D+G X K@/@=\
M$_\ A7UUJ$[*@66XVVP'SE;<9=0'8E^=X5U('S1!LN"K5Z5XFDO$A/\ 9Z0O
M.<@>>[QQKP<,?+C=FPV/E^7(S\ZG&?%?@'\&=8^%TTOF&SF@N/*$FV699%V%
ML,N8-K?*[?*=NX[?G4 Y/BK\&=8\6ZQ!J]J;./[+Y0B6269]_E3/*C,%@7;G
M< RACC!PYZUH?&WX!2_$^**[_=V^I1KL(\QY;=H][$*6\I&!&XL&$8Y)1@PV
MNO'^&?"_CK4\6=U<_9;?RPC2N;:23;PAVM$'E,NTE@Q922,F16(->ZM\/(;?
M26T6V/EQ&TDMU?:I(WH4,C!=@9B27;&W<Q)XS7DOP"\&>(/ "3Z9):P"%IFD
M2Z:8%0Q"QEA&FYY 5575&\@X#!I%+#;#\0_@SKWB[5H-94V,36WD>5&9;B0?
MNG,HWMY";LN3G 7Y<#J"Q] ^+7A+4O'.E-I\<=M'+-M\PF>4HFR5)$VD6V9-
MP7G(CVGIOZUB> /@_=PZ.WAW65@>UVOMEMY91+DRB5<J\*KE7)8-NQPJF-AN
M)\JTWX1^+_AF\EMHL@EMY&W[E:WVD@E02ES]QRH!;9D$;1O;:,>Z_"OX=W>A
MO+J&L7 NM1G549U $<<2$[8X_D0@,3O? 52V/E+*7;SKXA_!G7O%VK0:RIL8
MFMO(\J,RW$@_=.91O;R$W9<G. ORX'4%C] :7)-+&IN41)>=RQNTJ#DXPS1Q
M$\8)RHP<CG&3:HKY5_;G_P"8=_V]_P#MO7I>J:SXIMXVT^"TAEFXC74O.B2(
M@D#SVMB"P8*?F4;E#@E5=,*=KX&_")/AG9>06$EQ*P>>0  %L !%. Q1>=N[
MDDLV%W;1YU<_"'5_AMJCZGX="3VD\@,UD72'@EF91G;&%4_ZI@=Z;MNQD#E^
M@O\ P-J?Q2NK6;68$LK&TD,GV3SEN7GD&TJ7VKY/E8RN""^/,7&) R]7\8?#
M>H:XEF=)*+<07\<VZ1F2,*L4P(;9\Y5MP1E7)(8@X7)',^(=0\2>)K:;2FTZ
M"(S0R0O=FZ5K?!4J\BQ*IF 89\L')4LI?(#5H77PQO-"T(:#I1ADW6\T4DUP
M[QX\TDNRI'&^<[WV@L-GRY,G.<_]G[X9ZK\-HGLKK[+);R3&7?'++YJL4"D;
M6A"N#L3'S(5^8Y;@#FOB#\+=7TGQ&GB+2H4NU;!>(ND)7$(@927=<[DR489V
MMG<F%&_L/BQX0UOQUI\FG(ME&)FC+L9IV**C!M@Q -Y+(K>80@ 8Q^62HE;0
M^!G@[4O!%DFFWPMFBB\PQR0R2ESN??M9'B4=6;Y@PXVKLZM6A\;O 9\<Z3<6
M<8!FVAX<A2?,0[E +%0I8 Q[LC <YR,@VOA)X0/A/3+:UD!\X0QF8L59_,V*
M&4LO#! !&G)Q&B*"0HH^*OPS@^(UDUC<$H=P>.1>2D@!"MC(###$%3U!."K8
M8?/?AGX=>-O!.-.L)$%J) 1(&MY(5WX+,!,IF"@DEE5/O;BJL6RWO_PM\ R>
M%(9)+R7[1?7,GFW,^ ,M@*L:G /E(!A < 98JJ [%[6BO.OCE\(D^)EEY 81
MW$3%X)" 0&P048X+!&XW;>00K8;;M/*^$-8\6:) +"YL8[F5&:..]>ZC5-OW
M4DD09ED ZD@)(ZX!7S,L>P^#'PM_X5_:LLTGG7D\AEN9CR6<_P (8C>RCD@N
M<EF=\+OVCS3XA_!G7O%VK0:RIL8FMO(\J,RW$@_=.91O;R$W9<G. ORX'4%C
M] :7)-+&IN41)>=RQNTJ#DXPS1Q$\8)RHP<CG&3:HKQK]H'X9ZK\28DLK7[+
M';QS"7?)++YK,$*@;5A*H!O?/S.6^4Y7D'J_ .FZKX?TZ.SN([5YK>&**(I/
M*L<BI\F7W6Y:,A .@D#MGA!C'G7P#^#.L?"Z:7S#9S07'E"3;+,LB["V&7,&
MUOE=OE.W<=OSJ <\IXF_9TU?P'?'4/"DGR-E1$702(&!W(?._=R1 @;=Q+@E
M<J2GF'N_AO\ #O7-:G@OO%%P'%LS/!:@0D"4[D$DGEH(R5'S1X+,I;(9"&5L
M_P"-7A>Z\6ZS:_V'<NM_9QEI,G_1;=6RR,[ -MEE^Z8]KF6, N%C7+G_  AO
MCG_H)V?_ 'PG_P AT:)'J?Q'L=5\-:R4^VVWE!9T*JLA<F: L%0@+F-<D*&,
M;8*+(I)M? RP\0^&+)-)N+&&)(_,*7,EPK !WW8,41D:1@SLP&Z)64!2Z'YC
M@?"_X0Z[X/UR\O'$,RSQS+]K=PB,9)8Y#)Y,>7+#!)B_=H2"HF VL=7]H'X2
MZGK.I6>MZ2J3RV_E PL53!BD:9'RSH&4D[6 *L.,9R2G:^*[/7/%&GRVZP6<
M#W-NT;))/+(8@ZX<ED@VNQ5BH486-E#[Y@^U,3]G[X9ZK\-HGLKK[+);R3&7
M?'++YJL4"D;6A"N#L3'S(5^8Y;@#TOQMX73Q593V$F )H70,RAPK$?(^TD9*
MMAAR#D @@\UQ7[.WP[E\$Z6D5XI6Z=G,BLR2;%#OY<:LF1LP3(%R0'DD/!8B
MM_XJ_#.#XC636-P2AW!XY%Y*2 $*V,@,,,05/4$X*MAA\]^&?AUXV\$XTZPD
M06HD!$@:WDA7?@LP$RF8*"2654^]N*JQ;+>__"WP#)X4ADDO)?M%]<R>;<SX
M RV JQJ< ^4@&$!P!EBJH#L7S_\ :K\[6X;'1+3?Y]]=C&-WE[(Q\_F;<MM5
MI$D/RL $+'!49]E\/:(F@VT-G$24@ACB4M@L510@)P ,X'. !GL*T**\ _:!
M^$NIZSJ5GK>DJD\MOY0,+%4P8I&F1\LZ!E).U@"K#C&<DIZ>M_K-S;&5;>UB
MN&5=D+SR.L9*L2SR)#\Y#%5\I% PK$3MN 7S#X!_!G6/A=-+YALYH+CRA)ME
MF61=A;#+F#:WRNWRG;N.WYU .3XJ_!G6/%NL0:O:FSC^R^4(EDEF??Y4SRHS
M!8%VYW ,H8XP<.>M9_C/X::UI^O0>(["UCGD9?W\(N%**P0P$*\B6YPT.TJ=
MK%9-VX%0H;0^.WP^UWXDZ?$5CAB:.1'-DL@D=B5*[S.XC0,FXCRP-F-S>:YV
M*.@N?AKJ'B7PY_8UUY-O*+2TCC 9I<-#L8F1P% W% I5%<1X+!Y=P5:G[/\
MH^N^&[*/3+VUA@BAD)$S3"1V1W:1U$<1<%LEEW-)&%#*P238RM[517BO[4'P
MAN/B#:P26(WW-O(V(RZH&23:'P6P-P**1EE&W?U;:*T-0M?$'CO3)K.XA@TZ
M62%HV8R"Y,F4 90B K$CY(WEY70 @1L2KC$_9P\#:SX'L9;:Y@ACS<2R@/-N
M=R841$_=*ZQJ64$R%G8 %?).X.,K_A3.O?V__P )'FQW^9GR?-N-NSRO(V[O
M(SN\O^+&-_S;,?)7N&MSWXM@;.. W14966600HQ4Y(9(2\@#XXVQEER<H>*\
M:^ ?P9UCX732^8;.:"X\H2;99ED786PRY@VM\KM\IV[CM^=0#G5T.T\1^"WN
MGBM8;VUGO[N6*'[1Y5Q&))696W.#"(B!NV+\^Z3)P=P%OPU\/K[Q'K,?B+5H
MTM6@MS%!:QR"9QGS59I9  A_UC%0G9EW$%&#\5\5_P!G2^M-0.N>&Y-MP9#*
M\1<*_FLWS,C/\A5MS%TD(7&Y1N5A&NAX.^'?B7QBZ#Q/< 64<RR-; 6Y:9HR
MK(K^2FPPEOO*S,25QL!*NO=?$_PWJU]?6-YHQA5K>.\$GGM(L+"00JL;+%\[
M9VEP/NAD!)!V@\UXRLM>^*%J^E3V$>GPRM&99Y+E+D[$D5RJ)" =^0"-Q"D!
ME)!8$>O^'M$30;:&SB)*00QQ*6P6*HH0$X &<#G  SV%:%17;.J,8@&<*=JL
MQ12V. 6"L5!/4A6('.#TKYZ_X4SKW]O_ /"1YL=_F9\GS;C;L\KR-N[R,[O+
M_BQC?\VS'R5W?QH\(:KXYT\Z=:K:QB98C,\DTI*LK!V1 L'(W*N)&()&X>6I
M((/@OX0U7P-IXTZZ6UD$*RF%XYI069F+JCAH.!N9LR*20-H\MB"3Q7@?X-ZW
MX3UFYUI!9.+EKC?"9YP0LL@EP'%MU#!>2I!&1@$@CZ$HKC_B[X'?QSI=QIT3
MB-Y53:S E=R.L@!QR 2N"1D@'.&Q@\+^S_H^N^&[*/3+VUA@BAD)$S3"1V1W
M:1U$<1<%LEEW-)&%#*P238RMS_Q#^#.O>+M6@UE38Q-;>1Y49EN)!^Z<RC>W
MD)NRY.<!?EP.H+'T#XM>$M2\<Z4VGQQVT<LVWS"9Y2B;)4D3:1;9DW!><B/:
M>F_K6)X ^#]W#H[>'=96![7:^V6WEE$N3*)5RKPJN5<E@V['"J8V&XGRK3?A
M'XO^&;R6VBR"6WD;?N5K?:2"5!*7/W'*@%MF01M&]MHQ[K\*_AW=Z&\NH:Q<
M"ZU&=51G4 1QQ(3MCC^1" Q.]\!5+8^4LI=O1:*X_P"*OPS@^(UDUC<$H=P>
M.1>2D@!"MC(###$%3U!."K88?/?AGP7XZ\-8L;63%NL@59'DMIHU480,OF[Y
M5B"@$(%! Z1[B17O7PO^'#^&+!K74)C>37#,]R\I,BLS1I$4&_+,@1%7Y\E@
M"<*"$7RKPK\-->^#MW(-)0:AILS,?(:9(9%( VL3)A5?^$L@82*OS*AV;.PT
M;X?7WB_5(=;UN-($MH\6UDL@N-KY;=+(V/+W9PRF,9XCR08L-M?'GX7O\2-.
M-G"P29)HY8BQ*Q[AE&#81VQL=L8&=VWG&:Q?AG'XA%G;Z=<VT-DL$<<3W!E6
M>1HU1D7RHDWHLHPF6E<H#EA$X^0<I^S=\'-:\!-))<&VABN/+,L;!IYQY;L
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M\]7?P6\0MKC>(HFT]9BQVQL]R\87R?( .(E9B$ZD%06YP!\M=U_Q6'_4(_\
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M>=N^]&\: X+L=P<<!5V]6KFO@%X,\0> $GTR2U@$+3-(ETTP*AB%C+"--SR
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M HV"!EA@[03M' >$/#VH_%: :IJ%Y=6,4K,UK;6C_9RD70-(YCW2EMH92?E
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MA 7<Z,.5\>?"_5O!%D=3T[5KV6>UA9Y8YY!+%(  )&5)&V(%3>X5A*3A0IW
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M/_!1+OXJV4^I:I/=1O)-)' ()I;2*.-1D/&L957(=V7?)YN?+"G.ULY_[/\
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M"259@"3\V M<K_PJ34_$T/VG4-4O(+QX\B.V98+> L-PB*1EO-V.Q!?S SJ
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ME99/L]H6'W1Y,(^0%0 2K$[LR8;E2? 7XJ2_%/3I(YI3#>P,B22Q*FXJ>4E
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MRLI&0P(X((Y!'!%5+37X+N>6TC<-- L;2H.2@DW&//8$A2<=0,$@!E)^9?\
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M(QB940!=X+D*ZG=QM4NO.6KWK5OAWH>D0R7,]C9K%%&\CM]EB.%4%F.!&2<
M$X )]!7DOQ;UM/"_C#3+ZZ!6W-MY7F' 0,QN(R2S%5PGFHS\Y53G'(!^CZX7
MXAZ_!J^D:JMNXD,%M>12;>0L@MRS)GH2 PSC.#E3A@0/.OV*?^0//_U_R?\
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M)KT_]J/_ )%V\_[=_P#THBH_9<_Y%VS_ .WC_P!*):\J^ 7_ ".&K?\ ;_\
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M\CAJW_;_ /\ I9'75_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2OG_\
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M7V3\';M+K1K!HV# 65NI*D$;EC5'7CN&!4CJ""#R*\%_YJ'_ )_Z!U'[<_\
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M5F5MS@PB(@;MB_/NDR<'<!;\-?#Z^\1ZS'XBU:-+5H+<Q06L<@F<9\U6:60
M(?\ 6,5"=F7<048/Z_7'_%+2;_7+*6RTY8,W$,D3O/)(@17 4E5CB?<2I;&6
M4*=IPXR*X7X$_#;6/AG;RV<JV<T3R/*K+-,CAS&%VG-N05)1!D8*#<V'X6N?
M_P"%,Z]_;_\ PD>;'?YF?)\VXV[/*\C;N\C.[R_XL8W_ #;,?)75_'KX;:E\
M2K.&R@6VBVR1S.[S2G#A)$:-0+?YE^<$.2I..8Q0WP=N/%6BIHFL^2C6\<0M
MY[>21_FC5HT=DDCCZ(0K#<P?+$>6=I'E7AGP7XZ\-8L;63%NL@59'DMIHU48
M0,OF[Y5B"@$(%! Z1[B17O7PO\"W/@JP:.:8W=[(S2RO+(VUI3&B*@<J[A L
M:KN(9L MM P@\O\ ^%,Z]_;_ /PD>;'?YF?)\VXV[/*\C;N\C.[R_P"+&-_S
M;,?)70?M&?!VZ^)-G;R6^Q;RWWDQ^9^[8.@,B*QC&YMZ($+>6N"Q;&1BWJD?
MB'QGIL]O<VT-FS6EQ&RK*LTTTAC 0)UBAB9BRL7:1PO *'$HJ?LY_#'5O %N
M;>\>V6!Y/.,:K))/N>,*R%]Z1IM*+]U90WS ,!@UPL7P;\0?"S49;KPXL<]K
M,S_N&<!0G5$D661"2A8A'5RQ"DL5#LAA^+OP5\0_$#['<7&Q[A]XEB5UCM;1
M3Y6T ,S.['YVE=?,)P$4%40M[!XF^&-Q\1=+-EKCPK<^89(WM5D$<3 %4.)'
M)DX)W [00Q50&425XKX9^'7C;P3C3K"1!:B0$2!K>2%=^"S 3*9@H))953[V
MXJK%LM[_ /"WP#)X4ADDO)?M%]<R>;<SX RV JQJ< ^4@&$!P!EBJH#L7M:\
M0_:C^#]W\08+>6PP\MLTG[HD*763RP2&8A05V X. 03@Y 5NPTO5?$%]:K))
M:V<%SY94QR3R,-_(\PF*-PJ@C(B#.75QF:-D(?S_ . ?P9UCX732^8;.:"X\
MH2;99ED786PRY@VM\KM\IV[CM^=0#D^*OP9UCQ;K$&KVILX_LOE")9)9GW^5
M,\J,P6!=N=P#*&.,'#GK6U\9/@M<_$6*WNXFCM-4MV^5D=FC*[P0/.$22@KC
M>A"X5BZX^;>*MMK'BS5[+^SYK&."YDA:-KYKJ-44D$>9Y<&YU<KP"AP)"'VA
M!M'HOPP^'D/P_L8[" [MN6>0JJM(['+.0/P5<DD(%4L<9KS3P OB?P#8P6<M
ME#?*L8";+H131#);RY6F!1\;@B"+Y55,9(VFN@^&OPUNK?4[KQ#J>R.ZNHUC
M6WB;>D486+AW(&Z4>6JDK\F0S D, GE7B;]G35_ =\=0\*2?(V5$1=!(@8'<
MA\[]W)$"!MW$N"5RI*>8>[^&_P .]<UJ>"^\47 <6S,\%J!"0)3N022>6@C)
M4?-'@LRELAD(96]OK*\6:%_PD%G<66[9Y]O+%OQNV[T*;L9&<9SC(SZBO$/@
M%X,\0> $GTR2U@$+3-(ETTP*AB%C+"--SR JJNJ-Y!P&#2*6&V7X^?!G6/BC
M-%Y9LX8+?S1'NEF:1MY7+-B#:ORHORC=M.[YV!&/1?$.FZKKVE36<L=J+J>&
M2%BL\HA"O$4,HS;E\[SQ&01M_P"6I->5>$?V?M5TS2+S0KDVK0W+&5)8YI5D
M2554H"&MRK(7BC#8VLJ[R"Q*@;7P,L/$/ABR32;BQAB2/S"ES)<*P =]V#%$
M9&D8,[,!NB5E 4NA^8X'PO\ A#KO@_7+R\<0S+/',OVMW"(QDECD,GDQY<L,
M$F+]VA(*B8#:QM?$'X6ZOI/B-/$6E0I=JV"\1=(2N(1 RDNZYW)DHPSM;.Y,
M*-_O6B-<NA:\$:N6.$B9G55P  7=4+DD%L[$ !"8.W>QXAT1->MIK.4D)/#)
M$Q7 8*ZE"1D$9P>,@C/8UX+\"?"_B'X;K+IKV,,L#W#R+<&Z6) =@4DA5ED*
ML$78/+5E).\8/RU4^$.NZ9XH762(;M#O8REQ:QC,#Q",H/.D7:,!2%EW#:6;
M)<K:^,WP9U[XH_9O.-C#]GC8';+<-N=]OF-S!\J_(-J_,5YR[9&/9=+N]5$#
M?:8+7[0JQ[0EQ*(G;_EH26MBT8[J )2?NDC&X^-?\*9U[^W_ /A(\V._S,^3
MYMQMV>5Y&W=Y&=WE_P 6,;_FV8^2O9=?\*#QKI[V.IH$$RX=8I6<*0VY&5VC
MC)(*JW*8S\I#+U^:M-^$?B_X9O);:+();>1M^Y6M]I()4$I<_<<J 6V9!&T;
MVVC'NOPK^'=WH;RZAK%P+K49U5&=0!''$A.V./Y$(#$[WP%4MCY2REV\P^*_
MP&U/2=0.L^%W=9II"TT0D5"&+>8S R,%>)F +QL2 V,!D.U-#P+\/?$WB:YA
MN/$=T8[>WF$@MT:(-*Z-')'O$"^64WJ#EBS J0JKNWC5_:C^#]W\08+>6PP\
MMLTG[HD*763RP2&8A05V X. 03@Y 5O1? NHZIJ,:2:I!#;-Y>&C20S.SY W
M9 "1KP2%#3$AQEU*$/U5>(?&WX)7>LW<6N:'*(=0A7YEX3S-H;:0VW!<C]V1
M)\CIA6*JI#&O1^)/B':'2[BSCTX2J@N+K[2LN4!7S5CCB)8%N?E=RI3<C-E@
MU>GZ3X>_X1*QCL]-C1O)C1(UD?R5;!&YF:.)\,>68A#N<G.,DCQ7X>?!G7O"
M.K3ZRQL96N?/\V,2W$8_>N)3L;R'VX<#&0WRY'4AA]%5%=LZHQB 9PIVJS%%
M+8X!8*Q4$]2%8@<X/2OGK_A3.O?V_P#\)'FQW^9GR?-N-NSRO(V[O(SN\O\
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MV,&#-''"@4NO##S&"DX!!!)7NM/\,PVL+P,/-$NXS-(%=IBP"NTG 4Y4!=H
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M[O<#^\KVJBOE7Q-\!M;^']\;GPF[_9Y<DQ^9&-A (".L[!)5&\F,L&9><_,
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MO&#(BA2BB0/P#[K+?3^*K"*XTV46QN(4D5Y8?.94DCW#""5%#C<#DEUR""K
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MP*BEEL&\<W5OJ44<J3PQ11B5(WC$I@MW0GS. 2%*+@%BS!0/F->]?\*GT?\
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M7,&UOE=OE.W<=OSJ <G[0/PEU/6=2L];TE4GEM_*!A8JF#%(TR/EG0,I)VL
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M2&WU.!--T^&19)$$T=Q/*V'&49%*C"G: VT#>7(EP%7T_P"(GPQMO&FG-I;
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M _Q!I?B!M4M7CF*+N%U=L DKO L<@\N F1 "[B-<!450NX@#=Z_XE7Q NHV
MLS UB%_TUBH3+?QG:S,Z@K_J0C,0^1,2F#7HM%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%5=4O6LHVDCB>9AC$<9C#
MMD@<&5XTXSDY8< XR< _-7PL\%ZYX6URZUBYTUS%=_:-R1W%JSIYLHF&-TJ!
M\%0IR4X);MM/T_1111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111116?J7B&VTMXXKB:.-YFVQ*[JC2-D#:@8@L<L!@9.2/
M45H4444444455U#5H=.V>?(D?F2+&F]E7<[9VHN2,L<'"CD]A5JBJMQJT-M)
M'!)(BRR[O+0LH=]HR^U2<M@<G&<#DU:HHHHHHHK/T3Q#;:\AELYHYT#%2T3K
M(H8 $J2A(S@@XZX(]:T****JZ?JT.H[_ ")$D\N1HWV,K;77&Y&P3AAD94\C
MN*+C5H;:2."21%EEW>6A90[[1E]JDY; Y.,X')JU1572]6AU>-9[:1)8FSM>
M-E=#@D'#*2#@@@X[@BK5%%%%%%%%%%%%%5=+U:'5XUGMI$EB;.UXV5T."0<,
MI(.""#CN"*+?5H;F22".1&EBV^8@92Z;AE-R@Y7(Y&<9'(JU1573]6AU'?Y$
MB2>7(T;[&5MKKC<C8)PPR,J>1W%6JJZAJT.G;//D2/S)%C3>RKN=L[47)&6.
M#A1R>PJU1111156WU:&YDD@CD1I8MOF(&4NFX93<H.5R.1G&1R*+C5H;:2."
M21%EEW>6A90[[1E]JDY; Y.,X')JU111111111145W=I9HTLK!$12S,Q"JJ@
M9+$G@ #DD\ 46EVEXBRQ,'1U#*RD,K*1D,"."".01P14M%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%5=+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"
M*M444445%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %%I=I>(LL3!T=0RLI#*RD
M9# C@@CD$<$5+11111111111156XU:&VDC@DD199=WEH64.^T9?:I.6P.3C.
M!R:M4444444444444455N-6AMI(X))$667=Y:%E#OM&7VJ3EL#DXS@<FK5%%
M%%%%%%%5?[6A\[[+YB>?Y?F>5N7S-F=N_;G=MW<;L8SQG-6JJZIJT.D1M/<R
M)%$N-SR,J(,D 99B ,D@#/<@5:HHHHHHJKI^K0ZCO\B1)/+D:-]C*VUUQN1L
M$X89&5/([BK5%%%%%%%%%%%5;?5H;F22".1&EBV^8@92Z;AE-R@Y7(Y&<9'(
MHN-6AMI(X))$667=Y:%E#OM&7VJ3EL#DXS@<FK5%%%%5?[6A\[[+YB>?Y?F>
M5N7S-F=N_;G=MW<;L8SQG-6J******************JZ7JT.KQK/;2)+$V=K
MQLKH<$@X920<$$''<$5:J*[NTLT:65@B(I9F8A550,EB3P !R2> *BTO5H=7
MC6>VD26)L[7C970X)!PRD@X((..X(JU11111111111111111111111111111
M1111111111111111111111111111111111111111111111111111111117'_
M !5^)D'PYLFOK@%SN"1QKP7D()5<X(484DL>@!P&;"F;P5X2FT[==:A+Y]]+
MDNPW>3$#MS! K?<B&U<G[\K*'D)(4+U5%>5?$K49/A@W]M6^][,R*M[:@C8H
M=S_I4(9@$E\QL2*ORS%]S[6!DKTO2=4CU>&.Y@;=%+&DB-@C*L RG! (R"#@
M@'U%6J^._P!LCP39>'7L9+*". RK<*XB41JP0Q%<JN%R-[<XR1@$D 8]O_X9
M<\._\^?_ )'N?_CM8NO?LPZ?I\UG>Z1$89;:]MI'3>[K)&)HS)GS7.THH+@J
M>0"NUBRE?;Z****^._BGX-M?"OBW3([-"HEFLI9"TDDK-(UVX9RTK.Q)VC//
M7GJ37V)145W:)>(T4JAT=2K*P#*RD8*D'@@C@@\$5\=?'+P!8V7BBPLX8$CM
M[G['YL<8,:-ON&B; 0C9E% .S;SEOO$D_76B>'K;04,5G#' A8L5B18U+$ %
MB$ &< #/7 'I6A1117%?$GX0V/Q%\C[>'/V>0LNQRF0V-\;=?E;:N2,.,?*R
MY.>UJ*[MA=(T;9 92I*LR-@C!PR$,I]"I!!Y!!KY*T'08M!\?"WMP0@9V^9W
MD8L]BTCL6D9G8EV))))R:^NJ******\Z^/7@VU\1:5<R72%S;6US+$/,D55D
M6)BKE4958C'&X-@$@<,V>%_8I_Y \_\ U_R?^B8*]_HHK@/CIX8@UO2;MIPY
M\JTN)$42RHFY4+J61'59,,BD!PP!' Y.?.OV-;876B7,;9 :]F4E69&P8( <
M,A#*?0J00>00:XG0=!BT'Q\+>W!"!G;YG>1BSV+2.Q:1F=B78DDDG)KZZKQ7
M]K#PQ!>Z-/>2!S+#Y'E_O91&I,RH6\L.(BVV1EW%2V#C/ QJ_LN?\B[9_P#;
MQ_Z42UZK1111111111117BO[6'AB"]T:>\D#F6'R/+_>RB-29E0MY8<1%MLC
M+N*EL'&>!C5_9<_Y%VS_ .WC_P!*):Z#PO\ "&Q\-:A<ZM;A_M%UG?ER47<P
M>3:/]MP&.XM@C";5R*[6N ^.GAB#6])NVG#GRK2XD11+*B;E0NI9$=5DPR*0
M'# $<#DY\_\ V*?^0//_ -?\G_HF"O?ZXKXD_"&Q^(OD?;PY^SR%EV.4R&QO
MC;K\K;5R1AQCY67)SVM%%%%97B;PQ!XEA-M=!S$V=RI++#N!!4JQB="RD$@J
M25/<<"OFK]AC_F(_]NG_ +<5[KXH^$-CXEU"VU:X#_:+7&S#D(VUB\>X?[#D
ML-I7).'W+@5VM%%%%%%%%%%8OC3PA!XQM);"[!,4J@-M.U@00RL#ZA@",@@D
M88$9!/!?A"#P=:16%H"(HE(7<=S$DEF8GU+$DX  )PH P!M4444444444445
MP'P]^*\?CB^O[>U*/;6GV=4E4EO,9Q+YASP-H*!5QD'!<,RLH!\;/BO'\-[%
MKC*-<O\ +;Q,3\[9&3A>=J [F^Z#PFY6=37?T44444444444444444444445
M5U;2X]7ADMIUW12QO&ZY(RK JPR"",@D9!!]#7/_  U^&MK\.[7[%9;RAD:1
MFD;<[,V!DX"J/E55 4 8 )!))/5444445B^-/"$'C&TEL+L$Q2J VT[6!!#*
MP/J& (R""1A@1D$\%^$(/!UI%86@(BB4A=QW,2269B?4L23@  G"@# &U16?
MK^OP>'H'N[MQ'#&NYW;H!T[<DDX  R6)  )(%<_\)/'#^.=-AU&1!&9FFPBD
MD*JS2(@R>IVJ,G !.2 H.!V%%%%%%%%17=L+I&C;(#*5)5F1L$8.&0AE/H5(
M(/((-?)6@Z#%H/CX6]N"$#.WS.\C%GL6D=BTC,[$NQ))).37UU111111117
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M  ISY;(2"P8D'CQK]F'PHWC;2YS?3S- U_.9(D=XS,SP1K(9I%;S'4A@0@*
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M*4:*3CG(&=K$E05:+]JGQH^DBQT]Y3#9WLSK>2(#YHA1H@ZJ0&P"LC%@%);
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MI49AMOV:[72(//M))/[856=+YI9 [3G+;G4ET*,Q*NI1R8R02S$L?.OV&/\
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MK=W:>&1-JETPB AC665B<;(V<QKCG)W2L %&YBP7D[17FGC/XRSWFI0>'=*
MAO9ES/+.N\6X,)EVJJ,4DF"?,/F:+.U26#,4X7]K'P7'HFDQ2F2:XG:_&9IY
M#(^&2=V51\L<2YV@K$B*0B;@2H(/CCI<E[X-TV2-<K#'I\DAR!M4VYB!Y(S\
M\BC R><XP"1[_P" /&,?C.Q@U"$86:,$KR=K E9$R57.UP5S@!L9'!%6_P#A
M)(S>?V> YE%OYS,%/EJI?8@9^FYR'VJ,DB-R<8&?FKX^_P#(X:3_ -N'_I9)
M7JO[4?\ R+MY_P!N_P#Z414?LN?\B[9_]O'_ *42UZK7RK\??^1PTG_MP_\
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M=H*Q(BD(FX$J"/2O^9/_ .X#_P"V=<K^Q3_R!Y_^O^3_ -$P5RG_ #4/_/\
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M%'Q]_P"1PTG_ +</_2R2O</BA\/].^(0CTZ_R)2LDL+IQ*JHT:RE6*LH!\Q
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M-9FXFECDC5P2A>...=-K?+)Y:2 J6<%]S?+W7PC^$2>"A)=W+";4KEF>YN,
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M.KJ_VUO^0/!_U_Q_^B9ZM:Y\9X_ACX=TYPOF74UA;B!"#LRL,>YW(Q\J[AD
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M?^W3_P!N*/C[_P CAI/_ &X?^EDE>J_M1_\ (NWG_;O_ .E$5'[+G_(NV?\
MV\?^E$M>:_!CQC'X7\3:MI]X/*:\NW,3/E,L)9&C0 K_ ,M$EW(20#A0NXNM
M?35W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5Q7B:TT[XDZ=;Q7BGRK]4: $8E5
MVA>=6!&X(ZQJQR25."AW!MK?/7B_X*ZS\&/,U/0KIWME^:10/WBK\X!DC(:*
M545N7QE2Q<1HJEA]*_"SQK_PF^F6^H%=K2Q_.,8 =6,<FT;F^7>IVY).W&><
MBNJKY5\>?\6R\8V^H#Y+6]V^8?\ 40C?^YFW-RK[6"W#YQ\Q4M@X>NF^-7A
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M1J(58(D5F54%B"S'==.Q)VJ.N %& "23M?\ "N_$7_0=_P#*?;?_ !596K?
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M.@ R6;+'S7PA\#M5^'-_-)HD]K]BN67?'.DK-&HD8J%"MN<HC$ M*@<D[@"
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M;EG,XSC+8"J@PV&#$ UTO@/PG>^&+(6,MU'.8H5C@D^SF,J%!"^8!.1( -H
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MC-(VYV9L#)P%4?*JJ H P 2"22>JHK/U_7X/#T#W=VXCAC7<[MT Z=N22<
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MI;*52&<,T<IGC<(. VS8/E)+ME6WMDKN]EHHHK/U_7X/#T#W=VXCAC7<[MT
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M=Y$C4%F;/5W!9CD@9.&/!X7X7? R+QQ:)JWB0R7EU=*)$#RNJQ1,6>-4\J0
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M(8 Q&Q I93Y@D$F2[I\SJWF@M[M/&J6'VV>01M*8Y)B)F3S;,R2[$PL2'DA
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M< C&"<C/K7[4?_(NWG_;O_Z415YA;6CW7P]VQJ6(5F(4$G:M^7=N.P4%B>@
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M#QC!/"_MHZ7)J\VE6T"[I99+F-%R!EF-NJC)( R2!DD#U-=!^VM_R!X/^O\
MC_\ 1,]>J_"?_D#Z?_UX6G_HE*^?_P!AC_F(_P#;I_[<4?\ -0_\_P#0.KZ
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MH7XL?\@?4/\ KPN__1+UY5^Q3_R!Y_\ K_D_]$P5RG_-0_\ /_0.KJ_VUO\
MD#P?]?\ '_Z)GKU7X3_\@?3_ /KPM/\ T2E>%?L;>,8].6YT.Y'E70N&E1'R
MKL=@26/:5&&3RP2"=Q!/R@(QKZ*\5^)H?"]K+?7)Q%#&SMRH)QT5=Q4%F.%4
M$C+$#O7@'QRUW_A"?%.F:O<+_HOV<Q%\]/FE25L*&8[%G5\;?F^ZISG'TI7
M>.?$D>NZ/JIA#[8;>^A+,I17:.%A(4S]Y0^4+="Z,!D $^?_ +%/_('G_P"O
M^3_T3!7'_L:S'0K_ %'2KA2MP%0L/E*J8)'CD4D,<G=*,8R" 3GIGUK]J/\
MY%V\_P"W?_THBJW^S=I<FF:!91S+M8QO(!D'Y9)7EC/!/5'!QU&<$ Y%>/\
M[#'_ #$?^W3_ -N*]P^*'P_T[XA"/3K_ ")2LDL+IQ*JHT:RE6*LH!\Q RMD
M-D$#*!E^;_$'@K7OV>_],L+GSK$R#> I\O)\O/FPL6";BNP2(V[ "[T+JI^N
MO#VMIKUM#>1 A)X8Y5#8#!74. <$C.#S@D9[FM"BOE7X^_\ (X:3_P!N'_I9
M)7U565_H_A*S_P">=K:V_P#M/LBB3_@3-A5]V..YKRKX>^*[KXT>=="5[338
MKCRXXH3Y=U*5\J0F649*+CC;"48[V4N0H9_-=+TN/2O'ZPPKM1<]RQ).GEF9
MF8EF9F)9F8EF8EF)))KH)M=_X0WQS(UTN(]0MX8HGSG[RQ(C84,>9H#'@[<9
MWD[1S]*5XK\>_$D?B7PK<WD <12>24WJ49E%W&JR!3SM< .A."4920,XK5_9
M<_Y%VS_[>/\ THEKRK_FH?\ G_H'5U?[:W_('@_Z_P"/_P!$SUTL?Q,@^'/A
MJQOK@%S]BM$CC7@O(8 57."%&%)+'H <!FPIM^!?#USXUMH=2UF<N)X1(MI"
M6ALU218V"NH.^<E1\ZRL\?SN@0KR?)/V&/\ F(_]NG_MQ1_S4/\ S_T#J^JJ
M*^5?V&/^8C_VZ?\ MQ1^W/\ \P[_ +>__;>OH#XL?\@?4/\ KPN__1+UY5^Q
M3_R!Y_\ K_D_]$P5RGP"_P"1PU;_ +?_ /TLCJW^W'I<DL-C<A?W223QLV1P
MT@C9!C.3D1.<@8&.2,C/T?X>UM->MH;R($)/#'*H; 8*ZAP#@D9P><$C/<U\
MX66ER7OQ!EDC7*PQB20Y VJ;)(@>2,_/(HP,GG., D5/VY_^8=_V]_\ MO7U
M57RK_P U#_S_ - ZNK_;6_Y \'_7_'_Z)GKU7X3_ /('T_\ Z\+3_P!$I7SK
M^Q=JD>D0ZK<SMMBBCMI';!.%47#,< $G !. "?05Z5\/?%=U\:/.NA*]IIL5
MQY<<4)\NZE*^5(3+*,E%QQMA*,=[*7(4,_FNEZ7'I7C]885VHN>Y8DG3RS,S
M,2S,S$LS,2S,2S$DDU:_;G_YAW_;W_[;U]55\J_L,?\ ,1_[=/\ VXJ+X3S'
MPWXVOK:Y4A[EKP1XVL '=;M&)#< Q+GC)!(! YQ]"_%C_D#ZA_UX7?\ Z)>O
M-/V-M+DLM%:21<+-=RR1G(.Y0L<1/!./GC88.#QG&"">*_88_P"8C_VZ?^W%
M'Q]_Y'#2?^W#_P!+)*^JJ*^5?V&/^8C_ -NG_MQ75_$W]FJQ^([2ZCIDOD7+
M22J_RGR))8GDCDW+@,C&5<-(NY3M+!'9BQRO@KXZUGPSK/\ PC>NN\N^-S [
M?O"2NZ02"5B&>)E#C+;F5@J83:ZCZ4HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKQ7XY? RZ\8WEMJN
MF3I%>6^P 2_ZO".TL;C"/\P<\AE*L".FTA^Z71]7N+8A[N".Z=5!9+9GAC^5
MMQ17F#L^]A\[L4*HH\A26+<+\'_V?[KX8S/);WZ213>6)HWM<;@A)!5A<95@
M&8 _,OS99&P,'Q%_9_NO&>I1ZK]O2"6#8( EKNVB.1I8RV^X(=@6Y.T*V/N#
MI6K\4O@/'\2K>,7DB)?1\+<Q1%5*[B?+,;2N2N#P#)E7RRD!F1O-?#/[,^O/
MBUU#572Q$80Q03W$FY.%,060(BJ4R,X8#@;&&<?2NDZ7'I$,=M NV**-(T7)
M.%4!5&223@ #))/J:M5P'Q7^"=C\2(S]H79<K&5BN%SO3G< 1D!US_"W0,VP
MHS%JY30O!_BSPKN@@O;.]@&/+>\$XF'5FSY>YC\S$?-))\JKMVC*UV&A^"+V
MZG6[UBZ$Y54,=K"ABM(Y!M+,079YR'0-&TOW&RZJK%=E3XT_!:#XHP1QR2&&
M:%B8I0-X ;;YBE-RA@0H[@@@$'&Y6Y6V\">*=1LO[)OKNR$#PM%)<JLT]V4(
M(QAQ'&Q(^0L<-M);)DY/I_A;P='X1L4T^P.U8HV$;29D^8DL78!DW9<EF"E!
MR0NT8QY5_P ,[7W]K_V__:2?:_,W?\>8\O&SR_+V_:,[?+^3.=^.=V_YJZ;X
MP?"*Y^)=M%9RW4<21M'(Q6W9F:55="PS< *A#\(0S C_ %AK:\&>$=0\-6*V
M)NX96BCCC@D:U9=JJ<8=5N1O^3"J08R,98N2:XKX/_L_W7PQF>2WOTDBF\L3
M1O:XW!"2"K"XRK ,P!^9?FRR-@8\J\4Z/)K'CMX()GMY3M*3)@LC+8!U)!X9
M25 =#PZ%E)&<UZAXF^%^O_$4)::S<VMO9!@TB60F+RD,I"-YW  &2IY ;!,;
MD*5ZKXI_!^+Q?I TFWQ$85C^REBY5&B78@/.X@IE"3N(#;L,P%97@/P)KMK9
M#3-1NX(X(X5B22T5_M>P @ 22!8XRH"J&$3L5R<K)B2N?^"WP%U/X<O=JMW
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MDB7$/E>5Y=F B>6V]<![A\_.2QWELDD?=P![+HD%S"A%Y)'(^XX:*)H5VX&
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MID-C?&W7Y6VKDC#C'RLN3GM:**********BN[M+-&EE8(B*69F(554#)8D\
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MBBBBBBBBBBBBHKN[2S1I96"(BEF9B%55 R6)/  '))X KBOA)\3!\0XKJYC
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M1EW.Y8;ADA7]Y-\["1S<JI\IRQ"C=L*EW;E/VA;1/@]J-EJVB*+>699EEB4
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M9%NM76,6S92-D5_*)R22 Y$JH"" I)<."HS:MOV:[72(//M))/[856=+YI9
M[3G+;G4ET*,Q*NI1R8R02S$L?.OV&/\ F(_]NG_MQ7U51111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111111117RK^W/\
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M!=TLLES&BY RS&W51DD 9) R2!ZFO2OVH_\ D7;S_MW_ /2B*C]ES_D7;/\
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MH8V=N5!..BKN*@LQPJ@D98@=Z\5_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\
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M->7;F)GRF6$LC1H 5_Y:)+N0D@'"A=Q=:^FKN[2S1I96"(BEF9B%55 R6)/
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M$</N9CP-O)7;L)6O#]._9:U[P_)Y&GZIY5F9%9BDEQ"_(4._E)E"PQ@?O/F
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MVG]GSW5JL,;%H3'$\TGS$N4)8PJ$W\L-K.RLZK)$0C+G_P##.U]_:_\ ;_\
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M*8QD L$7R\*,O7/_ +:W_(8@_P"O"/\ ]'3UZUXN^*I^'GA:PD@8"[FLK2.
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MV3+GV#Q/X@7Q;X=DU.%WC;[!)<(89Y$*2K"YV%XF3=L?*LK?*67YER,#YJ^
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MX$(FNFN6F=I))"Q3R0GWV8* &( 7  P ,  ?8E%%<!\;/BO'\-[%KC*-<O\
M+;Q,3\[9&3A>=J [F^Z#PFY6=377Z_H,6OP/:7(+12KM=5=XR5[KNC96P>A
M.",J<@D5\M_LV:7'I'BK4K:!=L44=Y&BY)PJW42J,DDG  &22?4U]:44445X
MU^T?\<C\.H%M[3!O;A6V$E2(D''FE2<DDY$8(VDAB<A"C'PJ_9TLM&@6YU6$
M76H3*7G:XQ,%=\,R!270E6&#)\S,=Q#!6VBW\1?V>;36X)3I0%A=M"8P\&88
MI$.2T,J1X5D?/S':6X4G<J[#T'P,U)[_ $6S\V,Q/'#Y#(V=P:!FMSD$*028
M\E2,J3MYQFNZHHK@/CIX8@UO2;MIPY\JTN)$42RHFY4+J61'59,,BD!PP!'
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M6$A#+P"A]*^#GQ0N_'6A/>(HDU"%9HL$!(Y)D0/&>'  8,F_E!NW8"KBN?\
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M<2=QB8!@[*C5TO[84-QIEBEW%=W*K)<"!H%=4@V/"Y<$(BN^?+'^L=P-S
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M)A#+.TTSW$I:$A9#(9/E(6-E(0*"'QPJ@5ZA\0_C/)X:\.P:J5_TJ[MX!'L
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MWO\ *N6^6OH_XD>.$\#:?/J,B&00JN$4@%F9E1!D]!N89."0,D!B,'R#X7?
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M7!"(KOGRQ_K'<#<P  .*Z#6_#$&M^$8FG#GRM%61%$LJ)N6V5U+(CJLF&12
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M17!!C). 7&6"[MA1RLB3?&_3%^"FK66KZ6743^;Y\1DD<R[71I=\DK2D^8)
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MBB@*)1B/!#!^K^/'C&[O[VS\-:8\D%Q=,DLEPC!2D(+[@OS*Q(\MG;#(2$"
MMYA S_B#^S[9>$=)N;C1]\%U':2"20RNPFBV$3QR*=R'<F6 54Q*$*E *B_8
MUNTL]$N996"(E[,S,Q"JJB" EB3P !R2> *S_#>KZ7\58SJ'B2\A57D?R-/-
MX(HH44[4=T#1.9_OY<DAD<851M5<3PEXJMOA?XACT[2;D7.E7[1YC1UG6&61
MFC0*X?J&"[B3N,3 ,'94:OJ^BBOE#]HA7;Q;I8B(5RMCM9E+J&^URX)4,I8
M]0&4D<9'6NE_:7^%<&GZ<VLPR3?;K:2!OM#RRO(P,FW"C>(XOWDGF#RT55(V
MHJ@\=!%\=)+'PM'KLJHUTT8C578*))1(82V%"YSM:4QJ!\H*@@#<.?\ ^$&\
M-Z]#OUK4H;N^>/YYVOT_=LPRRPJ&2-8ED+-&K1D#.""/E!^RY\0Y'N+KP]+-
M]ICM-YM9P 0T4<GE$;@[97YD:(#=A2R[]H0#Z*KQK]HCXBSZ2+;1]-E$=]?S
M+&'SS%&S"/?D$NA9V 5PK<+(5PZJ15US]E+3Y(&>TDG7459Y8[MYW\UIOF9#
M(0I7&\@ED19/E!#;LDP_LO\ Q7NO%$<^F:F?]+L]HRYVSNN65@Z-\Q:-E"N_
M4[E#C?EG\U^.4-]I'B*PM(;N:X9Y+.>-;IQY F\YHD)C@2-%7Y1NV(&Y8Y)-
M>P>%O@#)H.KIK9U"::4QL+E74#SF9"IP490D0.QDB*N$V* W"[?7Z^=?C]XK
MCN]:L=#U*7R=*DC6:XP2F]MTHC21QG$6^-<_= W%V8%59.EU;]G>UT9K>;11
M);F.]M))X5FD:*>-)T8[Q)(1F,9D0\]&4*692N+^VM_R!X/^O^/_ -$SUJZ%
M\'H/'6@VD=_([R-80>20TJ0PG[.%B80I*J.R[LLSY9V+#*QE8TY_]D+XCR:C
MI]S;7K_N['RRLLC@!8F5_D)(&%3RV(+,<*P4;50"JOAO5]+^*L9U#Q)>0JKR
M/Y&GF\$44**=J.Z!HG,_W\N20R.,*HVJN)X2\56WPO\ $,>G:3<BYTJ_:/,:
M.LZPRR,T:!7#]0P7<2=QB8!@[*C5]7UG^(=;30;::\E!*00R2L%P6*HI<@9(
M&<#C) SW%> ?#'X>CXS"77-?\R6&6:46=J96$4488*6!B9#G*>7T3=L+N'+J
M5\_^(/A5_"WBO3;3S"]NLUC]E5F+O'";DXB+$ D+)O"9+$1[%+'&![5^T1\1
M9])%MH^FRB.^OYEC#YYBC9A'OR"70L[ *X5N%D*X=5(JZY^REI\D#/:23KJ*
ML\L=V\[^:TWS,AD(4KC>02R(LGR@AMV2:G[-7QBGUR"YL=8<)/8*"TDK;)3&
M-P<R!\',94!W/]Y=^&RSXOAO5]+^*L9U#Q)>0JKR/Y&GF\$44**=J.Z!HG,_
MW\N20R.,*HVJN)X2\56WPO\ $,>G:3<BYTJ_:/,:.LZPRR,T:!7#]0P7<2=Q
MB8!@[*C5TOQ^\5QW>M6.AZE+Y.E21K-<8)3>VZ41I(XSB+?&N?N@;B[,"JLG
M2ZM^SO:Z,UO-HHDMS'>VDD\*S2-%/&DZ,=XDD(S&,R(>>C*%+,I7V6JNJ637
ML;1QRO"QQB2,1EUP0>!*DB<XP<J>"<8."/DKX0Z;=:SXDU&Q:]N<16]W;^>S
M^9=")+E%"I(^0C9P2P4XRVQ59@Z'[0>@CX/ZE::II#O&T_F&5#),_F-'(DCF
M1VE+NLF]0Z$@';G)+<>M?M$?$6?21;:/ILHCOK^98P^>8HV81[\@ET+.P"N%
M;A9"N'52*NN?LI:?) SVDDZZBK/+'=O._FM-\S(9"%*XWD$LB+)\H(;=DFI^
MS5\3KGQE!<Z1JI(N;50A8NT5RR'<C[@"L@>,@*T@(;++NP_S-YK;>#K>U\=?
M88_,6(LS$K/.)=S61E=O-$GFY+DDG?DY(/!Q7UUI>F+ID:PQERJYP9)))GY)
M/+RL[GKQDG P!P *M5\ZWS2?&W7+C3W::/2=._=W$0<*)Y5E. P4AMK-&<'Y
MMJQY!C>3(X_]J+X61>!K"$Z83%927(\VW,CR+YPC?RY4\S<RDIO63#@$"/Y2
M5R/8#\0$\ ^%K6^;!==.M5A4X^>5H4"+C<I8 _,X4[MBL1TKFO!/P!M_'5C'
MJ6O2375Y=VX<2&9@L*R%Y(Q$H"JN%D!*,'C5P0J[<@XGPS\6WOPUUX^&;V0R
M64C8M9)G.Y$V$P!'95# A1$44!1*,1X(8/\ 358OC?6WT&PNKR( O!;3RJ&R
M5+)&S@'!!QD<X(..XKY_^!_P]T?XK6CZAJF;S4FF<W1:65&0DD1*%C:,!/+4
M%< @'<BD!-B>E^$M//PHL]1GU&>2:)+EYTFE=6FDC\B!44EGY?<OE*"5WLHP
MJAE%<)\+OANOQ@MQKGB%WN#-)-Y%NLLB6\*!EC^5%VLK;HB.'8,NUGW29(Y^
M'4KKX!:U!IPE>31[KR@GGO\ +&&;$CA]BQHR2,SN%&UHV7?ABK+]55%=PF=&
M16*%E(#KM+*2,!AO5ER.HW C/4$<5\JZ5Y]GXZBLYKF>Y2%IF0SOO*F6R,C[
M0H5$&XX 15  48XKU#]IR&XLM*FO[:[N8&@\DK'"ZQ(Q:58RS,J"4_+(?E$@
M3(4[<C)YKX#_  UB\8:!:C49))+;;<*MLCO##_Q\LV^3RV#RN'7Y26"*I $>
M\%VY_P#98U2YT+5[_0'E,MO;K-LW%L*T-QY>44N50/YC,X&22%YX.?J2O-?V
MA-0U2RTMSHJ.T[2*CF-2TRQ,&#-& =V[=M&5!95)88(WKQ_C'X(V1\..]W;A
M;^*R:XEG!#7!N%B:64O+\QD#2%@P)9<'Y<;4*[?[+7CJZ\8:29+U_,DAN&A#
MG[[*J1LI<Y^9OGP6ZD %LMECZ_7R7^TG87_P^NH+JUN[X:?-A71;RX)5U^\@
M=]^W>G*;BYW"0[=JA:^FM M[>^LD%L\CV\T.Y':6<RE)!N#>9(WG X;@E@R\
M ;<#'*?!SPXUO$]_)//,+B:9[<2SSR*EJ[@VX"R2N"3&JON91( Y1L$'/"_!
MWPA?>,+J^O?%5KO99%CMXYU#P1]?.$,3EDV_+$!* =^#B1B7)YKX<7;_  \\
M6S>'[%C_ &?,Q8Q.2^QOLOGAD/4$'Y,G)9,!]S*K#T7XDZ_<>*=4@\.:?.\
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ML)%EVNN1D Y)WG'K7QB^#5OJVFWE[?RS7%W%;SS1R&1DCB98PQ2*$$QI$3&
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M'7U517RK^PQ_S$?^W3_VXKJ_VUO^0/!_U_Q_^B9Z]5^$_P#R!]/_ .O"T_\
M1*5\_P#[#'_,1_[=/_;BM;QA^RU;^)-FK^'+C[,\NR>)"&2'YMCHT951)#@9
M<#:V&(51&!QJ_LW_ !*U.[NKG0M;WFZMHU9&=5WA5VHRNX/SYW(R/ABX+,9&
M!6N4_P":A_Y_Z!U1:S<C1?B DUSE$D:-8V*MAC)9B!,8'(,OR9' (.2,''T+
M\6/^0/J'_7A=_P#HEZ\%_9WM'O/"6J11*7=VOE55!9F8VD0"@#DDG@ <DUU7
M[('CR#5-+&F9"W%JTF4S\S1NYD$H&!P&<H0"V" 6QO45[+XB\30^'UC><X\V
MX@@0 KN9Y9%C4 $C.,EFQDA%8@'&*\5_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?
M3_\ KPM/_1*5U5<K\6/^0/J'_7A=_P#HEZ\J_8I_Y \__7_)_P"B8*RO&'[+
M5OXDV:OX<N/LSR[)XD(9(?FV.C1E5$D.!EP-K88A5$8'&K^S?\2M3N[JYT+6
M]YNK:-61G5=X5=J,KN#\^=R,CX8N"S&1@5KW^N5^+'_('U#_ *\+O_T2]>5?
ML4_\@>?_ *_Y/_1,%<I_S4/_ #_T#JZO]M;_ ) \'_7_ !_^B9Z\O_:,M';1
M/#\H4E%L@K-@[0S06Q52>@)"L0.I"G'0U]BZ3JD>KPQW,#;HI8TD1L$95@&4
MX(!&00<$ ^HKY?\ @%_R.&K?]O\ _P"ED='[<_\ S#O^WO\ ]MZ^I;NT2\1H
MI5#HZE65@&5E(P5(/!!'!!X(KY*^"7B1_@]JFHZ-?,6ACAFF4 $L[0IYP9%#
ME$,EOEF#'.51"P(P?J#P;HCZ-:I%,096:267;DIYLTC32A,@'8)'8)GYMN-Q
M)R3\W_MS_P#,._[>_P#VWKL/VS[1Y]&C9%+!+V)G(!(5?+F3<<=!N95R>,D#
MJ17HOP4U2/4]%L)(6W*+2&,G!'S1J(I!R!T=",]#C()&#7A7_-0_\_\ 0.H^
M/O\ R.&D_P#;A_Z625ZK^U'_ ,B[>?\ ;O\ ^E$58OP/\7P>#O"4%_=DB*)9
MRVT;F)-U(JJ!ZEB ,D $Y8@9(T/AM->?%:W35;Z=X+5Y',%I:R/#\J-+'NFF
M7;,[9/W49(_D5BI+%5\O_9WM$L_%NJ11*$1%OE55 5547<0"@#@ #@ < 5+\
M??\ D<-)_P"W#_TLDKZ ^+'_ "!]0_Z\+O\ ]$O7E7[%/_('G_Z_Y/\ T3!7
M-?M4Z1/X.U&S\2V6%(9(WP-N9$W,N\JZNXDCW1L.,(FTMA@![5\-M;3QH7UI
M ?*D5(K7=@$1*JM*=N6*N;@O')@A7$$1 (57;NJ*^5?VY_\ F'?]O?\ [;U]
M"_$VT>\TJ^BB4N[V5RJJH+,S&)P% '))/  Y)KRK]D#QY!JFEC3,A;BU:3*9
M^9HW<R"4# X#.4(!;! +8WJ*]E\1>)H?#ZQO.<>;<00( 5W,\LBQJ "1G&2S
M8R0BL0#C%>7_ !4^ NG?%.66:.0P7L++%+(B94MLBD42(=N\B)QM96! 8!BP
M0*/-? .OZY\(-6M-%U9S-97#+'$1F5,L$C3RG?8ZA'VJT9X52S",ED8R_'W_
M )'#2?\ MP_]+)*^I;N[2S1I96"(BEF9B%55 R6)/  '))X KX;^%OA:XO\
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M6K293/S-&[F02@8' 9RA +8(!;&]17LOB+Q-#X?6-YSCS;B"! "NYGED6-0
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M6=9<,0"CI\HROA_^SQJ'@S5KF]AO$,$T<B>;(K379$CH[$[ML8ERIQ(WF*2
MS0D,54^,_P"S&WB2Z74]&D2VNS(&ER7C0L/F$RM&K,DNX#.!AC\^5<,7/AY^
MSE?)=0W_ (AOGNWMI"\$0EFE16^0JY>4JP^9<E%4 E4+,1E#Z!\7OAQ=?$&W
M-C'=I;VS[#(/L_FR,5;<!O,R +D*<!=V5^_M)6H?A9\-KWP#:&P%Y'-$JR>3
MNMBC([G<,E;CYT#%B5P&); D4  <KX6_9\O?#.IS:Q;ZA'YUPTQD1K,F(B5_
M,9<?:MX ?!&&!X )(R#[?6+XHL+V]3987$=N2KAG> SL"0 K)^^C4%>3\P<$
MXR, @^5?"O\ 9\O?AF\KV6H1L)E4.DMF64E22K#;=(P(W,.N"&.02 1M?&?X
M-W7Q-5;=KU(+5)!(L8MM[EMFW+.9QG&6P%5!AL,&(!KH/!GA'4/#5BMB;N&5
MHHXXX)&M67:JG&'5;D;_ ),*I!C(QEBY)KBO@_\ L_W7PQF>2WOTDBF\L31O
M:XW!"2"K"XRK ,P!^9?FRR-@8B\%_#;Q'\/[2*SL+JRN$"G,=Q%*BPL2781O
M"=\@9W;)D ( 7:!D@=+X&^%$VC7%UJ]W,DNJ74>TNL;"WB&U,1J@=6D4,BC<
MS*[*J_<8NS<I_P ,[7W]K_V__:2?:_,W?\>8\O&SR_+V_:,[?+^3.=^.=V_Y
MJUOC?\ _^%F0PR>:D=]!&R^8(\1RY&=C#<SHN\97YG\L,_RN6S7/P?!77O$%
MG-9:YJ"3Q"W(MXD)"M*$98GGD$*2LJ-M?!W[W 9L[<-M? ;X+:A\.D"7%Z&B
M9I'>VBB0QF1@$#&9U\PC8H.T!/FQR0#OY7X@?LHRF[_M'P[<"SD+9\O+Q*A8
M,':.2(,R@Y \O;@ MA@NU!U7PG^!MWH<\>HZU>R7EU$L@A4R2R10E\J[!I#N
M<LF!]U0.<AB%9=#XS_!NZ^)JK;M>I!:I()%C%MO<MLVY9S.,XRV JH,-A@Q
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M0OR%#OY290L,8'[SY@!EE[?0'PU^'T?@6U^S([RR/(TL\TA)>65\;Y#DG&<
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MPH-F-HV\#;C Z8KQ#PE\%=<^&4TJZ'=6TMG+\WE7@E&UL\$"$'+!  7!0/\
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M@I"X+ K@R,"03X6?#:]\ VAL!>1S1*LGD[K8HR.YW#)6X^= Q8E<!B6P)%
M'*^%OV?+WPSJ<VL6^H1^=<-,9$:S)B(E?S&7'VK> 'P1A@> "2,@^WUY5^T)
M\&&^)MK&MNR)=02$QM(7"%6P)$.W.,X5@=K'*!1@,31+X"UKQ9I\EAK%Y#$7
MC*;K.-M[_* &D>0J"K'/F1QQQ[A@"15+(:OP ^$FH?#NW:VNIX3&;AY=D*LQ
M8M&D8W22!<+\N=JQAMP4^:5+(?7Z*\P^'OP:'A35]1U4D,+I@83N8R*'8R7"
ML-JI@R;=GWB%4 D$G/HNK:7'J\,EM.NZ*6-XW7)&58%6&001D$C((/H:\/\
MA'\(M?\ AP9+2"YLFLI)F?<\<TDH.W:&"*8AE@J!E,K!<94DYW1)^SQJ&F:^
MNM6MXDB_.S/=*TLP9HGC(V1>2C+R-N&B"+A0I"#=U7QG^ \/Q%M5&_%]#&%B
MN&"@OCJDNQ5!5CD_*HV,2R+@LC>8:'^RYK=\%L]5U,_8 J PQ33R@JC+MC"2
M*D:@ ?*V&"D+A#V]Z\4_#FWUW2WT8#9 ;=8H_O-LV >2WW@S;&53@M\V,,2"
M:\_^&OPPU[PE!_9?VVV2Q21C%-'$7NPIE#E ) (4W N26$Q0L0-P"E<_P/\
MLXW?AW4[G4TOS )IK@!8U$\K0NX=-TMRKX?<%+DHY.W[Y+$C;^-OP0F\:7%O
MJ>G3)!?6NW89 S(VV19(\GY@NP[V'[MMY8*W !$/COX7ZSX[TV:WOKF 3NL0
MC@A$D5HK)-N9W<[YI28^ I C5N=A8+(NW\-?A9>^ [+['%?^;LW"%9+=/(0,
MX=B41UF=LE\$S!1N'R?*,\IX+_9VOO"6H2:M#J2/<3>;YOF68*/YC;VR$N$Q
M\X##85P0!]W(.M\:_@/-\4I(C)=I#%!O\M1;L[_.(]^YC< -RF1A5P#@YZUU
M6K>$=0U?39-/GNX6EEC>)Y_LK#,;1F-OD%R )226W A.PB[US_P8^#=U\,E:
MW6]2>U>0R-&;;8X;9MRKB<XSA<AE<87"A22:UOA-X/U3PW]J_M:]^V>;<%H>
M#\J\Y/.-F[(_=+F./;\A.XUW]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<_P"/]'NM9L9[
M>PF^SW+QD1R_W3D9&1RN1E=ZY9,[U!8 5Q7PH^&VJ:7&%U^\^UB.0-#$"70$
M'<)'D=%EE8,<HKDI&55QEEC,?JM%%%%%%%%?.OQ#^#.O>+M6@UE38Q-;>1Y4
M9EN)!^Z<RC>WD)NRY.<!?EP.H+'Z TN2:6-3<HB2\[EC=I4')QAFCB)XP3E1
M@Y'.,FU11111111111111111111111111111111575))HHV-LB/+QM61VB0\
MC.66.4CC)&%.3@<9R/G_ .'GP9U[PCJT^LL;&5KGS_-C$MQ&/WKB4[&\A]N'
M QD-\N1U(8?15%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%97_
M  CRR7'VJ5WD*_ZI&V>7$2NUF0*JDLPR"SEV4,RH45W5M6BBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBHKN[2S1I96"(BEF9B%55 R6)/  '))X J+2
M]6AU>-9[:1)8FSM>-E=#@D'#*2#@@@X[@BK5%%%%5=4U:'2(VGN9$BB7&YY&
M5$&2 ,LQ &20!GN0*S]$\;V&O.8K.Z@G<*6*Q2QR,%! +$(Q.,D#/3)'K6K#
M=I.65&#%&VN 02K;5?:<=#M96P><$'H14M%%%%%%%%%%%%%%%%%9^F^(;;5'
MDBMYHY'A;;*J.KM&V2-KA22IRI&#@Y!]#6A11111116?J7B&VTMXXKB:.-YF
MVQ*[JC2-D#:@8@L<L!@9.2/45H4444444444444444444444444444444444
M445%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %%I=I>(LL3!T=0RLI#*RD9# C@
M@CD$<$5+11111111575-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"K5%%%%%
M%%%%%%%%%%%%%%%%%5=+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*M44444
M5%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %%I=I>(LL3!T=0RLI#*RD9# C@@C
MD$<$5+111111111111111111111111111111111111111573]6AU'?Y$B2>7
M(T;[&5MKKC<C8)PPR,J>1W%6J**************JZ?JT.H[_ ")$D\N1HWV,
MK;77&Y&P3AAD94\CN*M4444455U#5H=.V>?(D?F2+&F]E7<[9VHN2,L<'"CD
M]A5JBJMQJT-M)'!)(BRR[O+0LH=]HR^U2<M@<G&<#DU:HHHHHHHHHJK_ &M#
MYWV7S$\_R_,\K<OF;,[=^W.[;NXW8QGC.:M455M]6AN9)((Y$:6+;YB!E+IN
M&4W*#E<CD9QD<BK5%%%%%%%%9^B>(;;7D,MG-'.@8J6B=9%#  E24)&<$''7
M!'K6A11111111116?#XAMIYVLTFC:X1=SPAU,JK\OS% =P'S+R1CD>HK0HHH
MJK;ZM#<R201R(TL6WS$#*73<,IN4'*Y'(SC(Y%%QJT-M)'!)(BRR[O+0LH=]
MHR^U2<M@<G&<#DU:K%UOQO8:"XBO+J"!RH8+++'&Q4D@, [ XR",],@^E;58
MMMXWL+J?[''=0-<!F4PK+&9=RYWKL#;LC!R,9&#GI6A_:T/G?9?,3S_+\SRM
MR^9LSMW[<[MN[C=C&>,YJU111145W=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 46
MEVEXBRQ,'1U#*RD,K*1D,"."".01P14M%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>"^$?V;;'6IK^
M^UB$R//J-VT2EY8]L0F<*V$,9RYRP)+*4V%<9;/DOQ>^%NG>'_$FG:;:P[+6
M?[)YL>^1MV^Y>-_F9RPRH X(QU&#S7M7BO\ 9/T:]M98[*#R;DQMY4GG3D*X
MY7<':0;21AOE)VD[<-@CE?C+X"@?PI;WEU$XO+2PL8TW-*OEEF@20>7N"!CD
MJQ*[N "?E7'?_LN?\B[9_P#;Q_Z42UZK1117*_$_XAP_#^QDOYQNVX5(PRJT
MCL<*@)_%FP"0@9@IQBO%?@Q\.?\ A:[-XD\0CSVDD*VT)X@5(WZA0QRH<,@C
M?@X=G$ADW#UK6_@?I&J(%6UCMW5@T<UNJVTT;@':ZO$%.5)W -E=P!*G KE/
MV>M$N?"4NI:1>$RO'<I<"Y.[]^MPA ?#C.<PG>=S#>67)VY;V6BBBBBBBBBB
MBBBBBBL7Q?X-M?&$!M+Y#)"65B@DDC!(Y&?+92P!YP<C(!QD CYO_88_YB/_
M &Z?^W%?55%%%%%17=VEFC2RL$1%+,S$*JJ!DL2>  .23P!7%?"3XF#XAQ75
MS& (8[V2&$C=EXT2,K(=P!!8L6Q@;00IR06/SK\4_!MKX5\6Z9'9H5$LUE+(
M6DDE9I&NW#.6E9V).T9YZ\]2:^Q*********************************
M****^:_VT?#$"6,-_AS.;M(\F65D56AD+!8V<QIDQH254$D9)))S[5\)_P#D
M#Z?_ ->%I_Z)2NJHHHHHHHHKY _;3\,0:9-9W,8?S9_M/F,\LLO"F-E51([!
M%!D8A4"J,\#I7U_111111111111111111111575M+CU>&2VG7=%+&\;KDC*L
M"K#(((R"1D$'T-<_\-?AK:_#NU^Q66\H9&D9I&W.S-@9. JCY550% & "022
M3U5%%%%%?-?[:/AB!+&&_P .9S=I'DRRLBJT,A8+&SF-,F-"2J@DC))).?:O
MA/\ \@?3_P#KPM/_ $2E=511111117 ?#WXKQ^.+Z_M[4H]M:?9U2526\QG$
MOF'/ V@H%7&0<%PS*R@=_11111111111111111111111111117 ?&SXKQ_#>
MQ:XRC7+_ "V\3$_.V1DX7G:@.YON@\)N5G4UW]<5\-OA#8_#KS_L <?:) S;
MW+X"YV1KT^5=S8)RYS\S-@8[6BBBBBBBBBBBBBN ^.GAB#6])NVG#GRK2XD1
M1+*B;E0NI9$=5DPR*0'# $<#DY\__8I_Y \__7_)_P"B8*]_HHHHHKBOB3\(
M;'XB^1]O#G[/(678Y3(;&^-NORMM7)&'&/E9<G/:U%=VPND:-L@,I4E69&P1
M@X9"&4^A4@@\@@U\E:#H,6@^/A;VX(0,[?,[R,6>Q:1V+2,SL2[$DDDY-?75
M%%8OBCP39>*D\N_@CF 5U4NH+*' #;&^\A.!RI!R 0<@5\J_L;^";+Q$]])>
MP1SF);=4$JB15#F4MA6RN3L7G&0,@$ G/V)11117%?\ "H;'^U_[?P_VOR]O
MWSY>=GE^9MZ[O+^3&=F.=N_YJ[6LKQ-X8@\2PFVN@YB;.Y4EEAW @J58Q.A9
M2"05)*GN.!7S5^PQ_P Q'_MT_P#;BOJJBBBBBBN ^)7Q7C\)7%E8QE'NKR[M
MX]A)RD3R!7E('_?*9(RQ)&X(RU#\>O!MKXBTJYDND+FVMKF6(>9(JK(L3%7*
MHRJQ&.-P; ) X9L\+^Q3_P @>?\ Z_Y/_1,%>_T444444445GZ_H,6OP/:7(
M+12KM=5=XR5[KNC96P>A .",J<@D5\M_LV:7'I'BK4K:!=L44=Y&BY)PJW42
MJ,DDG  &22?4U]:445E>)O#$'B6$VUT',39W*DLL.X$%2K&)T+*02"I)4]QP
M*^:OV&/^8C_VZ?\ MQ7NOBCX0V/B74+;5K@/]HM<;,.0C;6+Q[A_L.2PVE<D
MX?<N!1\:/&,G@W2+J^@'[U(P$/'RM(ZQ*_*L#M+AL$8;&#C.:\P^"GPET[QO
MX?26^A$EQ=M<-+<GYKG?Y[J'$C;F!&P''W6.=RMN?=Q/QJLI_@YH=OH5O<22
MBZFN&DE)V 1J$W0(GS%$8N&;#\D/G*R%1ZW\0?V8-+\36J6]K&EG+%@)-'&"
M2. 5D&5,N0/O,V\-\V[EPW0:3\$;'3M1CUC,TEW';I%ODD+;BL8A\YN 3*8Q
MM8YV'EMF_P":N_HHHHKYK_;1\,0)8PW^',YNTCR99615:&0L%C9S&F3&A)50
M21DDDG/LGPRNTL]$L996"(FG6S,S$*JJ($)8D\  <DG@"JOPD^)@^(<5U<Q@
M"&.]DAA(W9>-$C*R'< 06+%L8&T$*<D%CW5%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?*OQ]_Y'#2
M?^W#_P!+)*^JJ\J_:C_Y%V\_[=__ $HBKE?@)\.X/%_AVVCU%GEMSYP2!7EA
MC %Q(Q+B*1?-8N,@M\J@*$16WO)B?LL:_/HFHW_AN1S-#;-,T3'Y0IBF\J3"
M_,0'+AL;L*0< EV-:"^+-/\ BA=77]L7T,6GV]PT$%HMXL*7 3EKB7!1I%+;
M&A*L%4J1@_,S\5XD\0Z?\&-4M[WP_=)+97'RW=K%*MRJJA0$@^83N(<M'N(*
MN&&XQLR#Z_KY@_;CU22*&QM@W[IY)Y&7 Y:,1JASC(P)7& <'/(.!CV_X.VB
M6NC6"QJ%!LK=B%  W-&KNW'<L2Q/4DDGDUV%8OBC6[;PK!/J5P HCAR[#:'9
M4W%(P6*Y)9R$4D#<^!RU>'_"[X;K\8+<:YXA=[@S23>1;K+(EO"@98_E1=K*
MVZ(CAV#+M9]TF2.?AU*Z^ 6M0:<)7DT>Z\H)Y[_+&&;$CA]BQHR2,SN%&UHV
M7?ABK+Z7^TY#<66E37]M=W,#0>25CA=8D8M*L99F5!*?ED/RB0)D*=N1D\_\
M!/AW!XO\.VT>HL\MN?."0*\L,8 N)&)<12+YK%QD%OE4!0B*V]Y//_V=["ZM
M-2U+PU'=/';KYV^6,;9LPR" M%N9DA9]XWMM=MJ@*58*ZR_M"Z''\(+^RU/1
MS)%+,TS3!IIG64QR12'>6<R,'+?O 7PP X!R3V'[84-QIEBEW%=W*K)<"!H%
M=4@V/"Y<$(BN^?+'^L=P-S   XJ;3/@.?B/I%H]_>3H/L5M]G@C93;1A;=5C
M=D9 9')+.YRI ?RE<J@<XG[-GC:\\-:G/X8U61V9<K;[B[!3$O*)N3=Y3Q .
MF2J!4&U<R5U7BW1M4\5^)8K.[A=M$BC\PJ,BWDPFX&7#8D87 4")LX50WE[2
M[-PO[0MHGP>U&RU;1%%O+,LRRQ* +=UC\KY3&N  P;Y@,#*JZ[9 7/J'[3D-
MQ9:5-?VUW<P-!Y)6.%UB1BTJQEF94$I^60_*) F0IVY&3S7P'^&L7C#0+4:C
M)));;;A5MD=X8?\ CY9M\GEL'E<.ORDL$52 (]X+MRG[-AFMM2U#PU--)):P
MK+M*R30LK07(3,?ER@Q!S(6<*<L< DC.:F@QWGA_Q0-&U6]O7M79_)+7MQ$'
M5D9H"6!0N21Y9"% 9N 2%*M] ?%K2#JL4$,<T\,\MS#%&T$TL#;2ZR7!^5@A
M(MXI67S P!&%&Y@&[#2],73(UAC+E5S@R223/R2>7E9W/7C).!@#@ 5:KY _
M8UT1M8^WQM*Z0_Z*76-GBD<_O]@\U&5T4<E@F&8[07"!TDT)[8?!CQ9;VFG9
M%G?+;J]ON;:!([0#+.9"Q613*#P<,8P0I)/H'QOL=7U_4[#3K:.0Z5*RFZ:(
ML@9=Y$\<KJP*IY/W5)42%B!O8*%Y3]I[P=;> HK36](06=W'<K$# JQH59)7
MRR!=I/R[3QAE9E<,NT#T7QU\2KK3?#']LP[%NGM+63[N45IC$K%58G[OF$J&
M+#(&X,,@\A\)?@SH?C+3H=05I);UUW370GF%PER?G=OO!0Z.<H64Y 5SO#;F
M]4^$WAF?PQIZ6EVYDE2:ZW2,<M(&N9764_,_+JP<@DD$X;D&J'QT\,0:WI-V
MTX<^5:7$B*)943<J%U+(CJLF&12 X8 C@<G/E7['/AF*_P!-DN':8.E^^ EQ
M<1QG;' PW1QR+&_)YW*=P^4Y  K$_:(5V\6Z6(B%<K8[692ZAOM<N"5#*6 /
M4!E)'&1UKI?VE_A7!I^G-K,,DWVZVD@;[0\LKR,#)MPHWB.+]Y)Y@\M%52-J
M*H/'01?'22Q\+1Z[*J-=-&(U5V"B242&$MA0N<[6E,:@?*"H( W#G_\ A!O#
M>O0[]:U*&[OGC^>=K]/W;,,LL*ADC6)9"S1JT9 S@@CY0?LN?$.1[BZ\/2S?
M:8[3>;6< $-%')Y1&X.V5^9&B W84LN_:$ ^BJ^2_P!LN&XTAK?%W<O%=>>'
M@9U6 "-XW10D:(#@N?F?>_RKEOEKL/''PIGT9T\57U^?MEHIFEC'R6[!3E+2
M$EE:)&R8<MYAD+[BFYF5JF@6&A^.8$O_ !+?P3W4R^9Y!O1%!;!N1''&LD;(
M=FP2!BQ+IDL3DMG_  )\9KX2UN7PU;W/VS3WWM:R I($;RQ.P#JVW;MWJ^T$
M&4!@J;GJWXTU:W\;>*3H>M28L8(U^SPAFB26XDCC8;V4@EL2.$^9>0JKR["3
MNK'X&1>%M0L;G2C)':QS3&>V\UWAW-;3(MP!)(3OR5C.-Q*L"-H5BW->,];D
M^*>NMX<M[AX;&WMY&O&A<))(V-C1AQY@95,B*Z,%&?-# E4QE?%[X(K\.[<Z
MUX:,UM/;[#*B22.K1!LNQ5@[-AMC.K-Y7EHQ9<CGI9O%9^)7AF35Q+);74-M
M<L?LMQ+'LEB!8AE1@"&"*P60,RH_RMD[S#^R?K%QXHT>X-]--,QNY8][RR&0
M*88>%?=O7&XD%2""<@@\UR&@ZG=Z-XU&E+=W4EH&<B*6XEE7#6;3!2'8[@K-
M\N[)P 22PR?1?VG(;BRTJ:_MKNY@:#R2L<+K$C%I5C+,RH)3\LA^42!,A3MR
M,GR_X:?!*?XG>'[=;J\,,,;2?98XUW(#Y\GFRS D&1R2RH%91&H!Y+N*ZOP7
MH;_%J66*]N))](L%CM$57*+>3(B>;/*T<S.XWA9$YP0R$$$2!SQG\%+WP+/!
M?>#D*'=BYMC.3%(!DHS+,X###.K?/E<JT85MSCJOC;\0SI<]GI$5Q':F\9S/
M<-*L3PP)@L5)!"/(-RQ.W 92!\WS)YK\1?A_X9BLI;O3M0C74H5,Z7 O1-/+
M*@+\@R\N[#.Y K"0AEX!0]!IGQYN]1\)SZNA OK=A [E!L+F2)?-"@D$^7*K
M<@+Y@/R;, GPE^#.A^,M.AU!6DEO77=-=">87"7)^=V^\%#HYRA93D!7.\-N
M;U3X3>&9_#&GI:7;F25)KK=(QRT@:YE=93\S\NK!R"203AN0:["HKN$SHR*Q
M0LI ==I921@,-ZLN1U&X$9Z@CBOD6ZAOHO&8T^*[FE=/.\F2X<2>49[(O)(J
M!!'\I;<L:HB-M5"5'S#5^-G[/TWA.%M=TR\O)+J'YIGDD9[@H0(]Z21JK#:O
MW]W'EY.Y0N&[73OVB,>&/[9.Q[R/; R.=H:XRJYX5-V4(F*)T7*!AM+#*_X0
M;PWKT._6M2AN[YX_GG:_3]VS#++"H9(UB60LT:M&0,X((^4'[+GQ#D>XNO#T
MLWVF.TWFUG !#11R>41N#ME?F1H@-V%++OVA "SF_P"%\:M>6\D[_P!CV/EH
M(8I-@N'+@[G*;Q)$3$^TAE(7RV3:Q<UB_%SP!+\$3'K7AUI(X?.5;F N\D&-
MN(]RD9*$[PQ=R5>1?+*DC'5?&;Q%+KWAU=>LKN>W/DVT@B@E01AWD6.16D1!
M*Q7S&0KO5=R E P-<_\ !_X2'XB:!:QWMU/%:!9E2"WD55<_:97:27=&=QW;
M0B?,$";PVZ0JN+\*-9O/@]KP\/7\SR6<V$A)WB+,AW0R(I5L;G)C<(0@=F+,
MWEYKM?VUO^0/!_U_Q_\ HF>N@N_B'_PK_P *VM^H1I5L+)8D=MH9VCC4#U;
MRY48)53RO+#E/^$&\-Z]#OUK4H;N^>/YYVOT_=LPRRPJ&2-8ED+-&K1D#.""
M/E!^RY\0Y'N+KP]+-]ICM-YM9P 0T4<GE$;@[97YD:(#=A2R[]H0#Z*KP70O
M#>H^,?$-W_;MN7TVV5Q;1N,VA8MMAD"%BDKF)I"S$,49MIV$(J\?XB_XM-XL
MMH-)_=6^H?9O/@ZP_O9WB.U1C;MQN3!^1BRC]V2E>E_M.0W%EI4U_;7=S T'
MDE8X76)&+2K&69E02GY9#\HD"9"G;D9/-? ?X:Q>,- M1J,DDEMMN%6V1WAA
M_P"/EFWR>6P>5PZ_*2P15( CW@NW/_LL:I<Z%J]_H#RF6WMUFV;BV%:&X\O*
M*7*H'\QF<#))"\\'.AX*TS_AH*]N=1U S?V3#(L=M:&3:C.$.7?RV!# /N/?
M,@02,D95O.OVJ_  \%/9P6K$6#+.T,#.TGE29C\_:7!8(W[M@"[?.9" N>?M
MFN%^-.G2W&F7,T-S/;F"VGE'D,B%V1/,0,Q1I  4Y\MD)!8,2#QX5^SOX*G^
M(NE7$=S=SQ6[7MPTIADQ-/))%"&\QG1OD"[LC+>:TA+!?+7?E(+G]G37(86G
MD?29V+$'=LV.0CLP",IFBPK,8QN90H^02;1H?MEPW&D-;XN[EXKKSP\#.JP
M1O&Z*$C1 <%S\S[W^5<M\M>BWOP,GEO;?Q!?ZD4NK=A+<8&+98U.XPQ$LC10
MA-Z,SE]X+.X!9@>?\ Z,/C]+<ZGJCR-I\5SY=K9J[11X5&.^5$)R^V53O63.
M[>I_=A5KG_B!97/[.M[!>:29'TR=G\RVD=FB#DY9,[<(3&%\IR6D_=MN+("&
M]E^,OQ+;P_8Q?V8R27E])'%98,;*QD(_>C<X4J%(PWS(':/<"I-97_#+NE7T
M.+_SKJ\:/$EX\TWG,V,!P"[(-O 0,& 55#;\$F7X'V^M>&H+J'Q$X,4#;H;E
MY5<LGSF5F<MNV# 93(%8!B#P J\+X;U?2_BK&=0\27D*J\C^1IYO!%%"BG:C
MN@:)S/\ ?RY)#(XPJC:JXGA+Q5;?"_Q#'IVDW(N=*OVCS&CK.L,LC-&@5P_4
M,%W$G<8F 8.RHU;?C35K?QMXI.AZU)BQ@C7[/"&:));B2.-AO92"6Q(X3YEY
M"JO+L).ZL?@9%X6U"QN=*,D=K'-,9[;S7>'<UM,BW $DA._)6,XW$JP(VA6+
M<+XTU:W\;>*3H>M28L8(U^SPAFB26XDCC8;V4@EL2.$^9>0JKR["3NK'X&1>
M%M0L;G2C)':QS3&>V\UWAW-;3(MP!)(3OR5C.-Q*L"-H5BW/^*_&MMXSU:YT
MJ^O8[33;-4615NE@>ZE<#?&S'&857?'+&K!@Q!8DX">=?$U-+^%\EOK'A6[A
M$RR"*6V2<7*2(P9RS#S6?;\H5AG&2C*4=0S>H?M"?%6?3- @O]-8Q&]:%0Y&
M)4CEA>7@@D*^% R"=N25(;:P- _9\T/4[)+K19)(I6A_<7T4TWFAL;2Y&]5R
M>5D3:A&60!#]WT_X>Z7)I&FV=M.NV6*TMXW7(.&6-589!(."",@D>AK%^-.G
M2W&F7,T-S/;F"VGE'D,B%V1/,0,Q1I  4Y\MD)!8,2#QY_\ L:W;WFE7,LK%
MW?49F9F)9F8Q0$L2>22>23R37G_QGM[O2_$NG68O9YA)-8S*+@AXEE\]HE81
M0B"/ "C(4*QRWS L375_M&_"6+2=-;6(YYVO[::)_M,DKO*5:8@(H5DCB"O*
M&3RT4+MP -Q->H? /Q--XET2SNKD[I3&R,V6);RY'B#,6))8A 6)/+$GCI4O
MQITZ6XTRYFAN9[<P6T\H\AD0NR)YB!F*-( "G/ELA(+!B0>/"OV=_!4_Q%TJ
MXCN;N>*W:]N&E,,F)IY)(H0WF,Z-\@7=D9;S6D)8+Y:[\I!<_LZ:Y#"T\CZ3
M.Q8@[MFQR$=F 1E,T6%9C&-S*%'R"3:/1?VUO^0/!_U_Q_\ HF>O1?!$T\'A
MZU>S4/<+I4!A1N%:06ZE%/S+P6P#R..XZUY_\%/AJ_BJRGN_%%L9KNXFD4-<
MJ?-6''"HK8-N/,:0J$$9Y##Y0AKG_P!F77Y]'U>_\.JY>RMFN6A#_,Z&.X6/
M@C  8-N88QN^90I+;NETRU_X7=?7;W$CMHMK)]GBAC?9'<R@!I))&BD+.JL%
M:/HI!0K@B0-0\9_!2]\"SP7W@Y"AW8N;8SDQ2 9*,RS. PPSJWSY7*M&%;<X
MZKXV_$,Z7/9Z1%<1VIO&<SW#2K$\,"8+%200CR#<L3MP&4@?-\R>:_$7X?\
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M9'*P,C.K*Q)W@EVW-PPS\[&NO_9SSJ^E6VI3/,]Q)'(CE[BYE0[)63=LEE=
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MW>C>-1I2W=U):!G(BEN)95PUFTP4AV.X*S?+NR< $DL,GI?VUO\ D#P?]?\
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M_P#Z414?LN?\B[9_]O'_ *42UY5\ O\ D<-6_P"W_P#]+(Z/VY_^8=_V]_\
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M,RIE@D:>4[['4(^U6C/"J681DLC$^$\Q\-^-KZVN5(>Y:\$>-K !W6[1B0W
M,2YXR02 0.<?0OQ8_P"0/J'_ %X7?_HEZ\*^!VER67@W4I)%PLT>H21G(.Y1
M;B(G@G'SQL,'!XSC!!/0?L4_\@>?_K_D_P#1,%<I_P U#_S_ - ZO5?VH_\
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M\Q =QCDP"\1R%.5)ZD#<,,/E8$Z$GB:%+Q-/SF=[>2? *_*B/''EAG<-S/\
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M=3(P8YZK]ES_ )%VS_[>/_2B6O*O@%_R.&K?]O\ _P"ED='[<_\ S#O^WO\
M]MZBUFY&B_$!)KG*)(T:QL5;#&2S$"8P.09?DR. 0<D8./H7XL?\@?4/^O"[
M_P#1+UY5^Q3_ ,@>?_K_ )/_ $3!7O\ 7SW\7_ [ZIXALY]%<)JJ0^?*'!2#
MR8V*+)(Z8D8N3Y)50Y:/ ;RU7+=5XS^&=_\ $F>"+5O(ATV%O-:""62:6649
M50TC0P[$VL0=OS<MSEE:,_:8M$L_#5U%$H1$6V554!551<0@* .  . !P!4O
M[+G_ "+MG_V\?^E$M>5? +_D<-6_[?\ _P!+(Z/VY_\ F'?]O?\ [;UV'[9]
MH\^C1LBE@E[$SD D*OES)N..@W,JY/&2!U(KT7X*:I'J>BV$D+;E%I#&3@CY
MHU$4@Y Z.A&>AQD$C!KPK_FH?^?^@=5OX,>,8_"_B;5M/O!Y37EVYB9\IEA+
M(T: %?\ EHDNY"2 <*%W%UKZ:N[M+-&EE8(B*69F(554#)8D\  <DG@"JGA[
M6TUZVAO(@0D\,<JAL!@KJ' ."1G!YP2,]S6A7RK^PQ_S$?\ MT_]N*ZO]M;_
M ) \'_7_ !_^B9Z]5^$__('T_P#Z\+3_ -$I7S_^PQ_S$?\ MT_]N*UO&'[+
M5OXDV:OX<N/LSR[)XD(9(?FV.C1E5$D.!EP-K88A5$8'&K^S?\2M3N[JYT+6
M]YNK:-61G5=X5=J,KN#\^=R,CX8N"S&1@5KE/^:A_P"?^@=47[2MR-&\3Z7?
M7&4MT6U9I-K%<1W3O)C .XJK D#)P1QR,_5]?*O[#'_,1_[=/_;BK?[&WC&/
M3EN=#N1Y5T+AI41\J['8$ECVE1AD\L$@G<03\H",:^BO%?B:'PO:RWUR<10Q
ML[<J"<=%7<5!9CA5!(RQ [UXK^VM_P @>#_K_C_]$SUZK\)_^0/I_P#UX6G_
M *)2O*OB;^S58_$=I=1TR7R+EI)5?Y3Y$DL3R1R;EP&1C*N&D7<IVE@CLQ8Y
M7P5\=:SX9UG_ (1O77>7?&Y@=OWA)7=()!*Q#/$RAQEMS*P5,)M=1]*5\J_'
MW_D<-)_[</\ TLDKZ ^+'_('U#_KPN__ $2]>5?L4_\ ('G_ .O^3_T3!7*?
M\U#_ ,_] ZC]N?\ YAW_ &]_^V]?17Q"TN35]-O+:!=TLMI<1HN0,LT;*HR2
M ,D@9) ]37B'[$>MI-875F =\=RLK'C;MEC5% YSG,+9X P1@GG&A^VM_P @
M>#_K_C_]$SU:^,.ER:1X+^S3KMEBM-/C=<@X99+=6&02#@@C()'H:Z#]ES_D
M7;/_ +>/_2B6O*O@%_R.&K?]O_\ Z61UV'[3/@=/$L^GI:.8]6>9EMBH"@HF
M))'>089!%]]"I9LLP2-BQ9>@\;>"-9^(,$6G7QM;>U9D-XT$DDLL@3#!8UE@
M18P77/+.1QRP5ED]*T#0(/#T"6EH@CAC7:B+T Z]^22<DDY+$DDDDFOF7X!?
M\CAJW_;_ /\ I9'1^W/_ ,P[_M[_ /;>OJJOE#]I6Y&C>)]+OKC*6Z+:LTFU
MBN([IWDQ@'<55@2!DX(XY&?J^OE7]AC_ )B/_;I_[<4?'W_D<-)_[</_ $LD
MKU7]J/\ Y%V\_P"W?_THBH_9<_Y%VS_[>/\ THEKRK]N?_F'?]O?_MO7U57R
MK_S4/_/_ $#JUOCEKO\ PA/BG3-7N%_T7[.8B^>GS2I*V%#,=BSJ^-OS?=4Y
MSCZ4K@/'/B2/7='U4PA]L-O?0EF4HKM'"PD*9^\H?*%NA=& R "?/_V*?^0/
M/_U_R?\ HF"N4_YJ'_G_ *!U=7^VM_R!X/\ K_C_ /1,]=5_S)__ ' ?_;.N
M5_8I_P"0//\ ]?\ )_Z)@KW^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBHKM79&$1"N5.UF4NH;'!*A
ME+ 'J RDCC(ZUX?XT_9VOO%NH1ZM-J2)<0^5Y7EV8")Y;;UP'N'S\Y+'>6R2
M1]W 'LNB07,*$7DD<C[CAHHFA7;@8!5YIB3G/.X#! QQD\A\7OAQ=?$&W-C'
M=I;VS[#(/L_FR,5;<!O,R +D*<!=V5^_M)6H?A9\-KWP#:&P%Y'-$JR>3NMB
MC([G<,E;CYT#%B5P&); D4  <KX6_9\O?#.IS:Q;ZA'YUPTQD1K,F(B5_,9<
M?:MX ?!&&!X )(R#4^,'[,(\37/]IZ1*+6\W!V'S+&\@8$2ADRT;]22JMO8
MX5BSL?#K]GW489XKKQ!J$ET()A+%;B:>2+S%QY<I:0J<J2WRA1VRY4LA]ZJ*
M[M$O$:*50Z.I5E8!E92,%2#P01P0>"*\*U+]FZY\-3O>>%[TV194_P!'?=)
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M89X/(()5@5)!^<-$_9<\0Z"Y@L]3$%J9B28IKF-BI(!D,2*$W[ /EWXR N_
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M$$JP*D@_.NG?LM:]X?D\C3]4\JS,BLQ22XA?D*'?RDRA88P/WGS #++V]Z\
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MW '3?$3X9:GX[M&L+B_@CB=D+^59.&8*=P4E[M\#< > #D 9P2#:^$_PVO?
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M,>TND>X)G<%&'D=<*&VY+(P?V<;LZX^M1WYB :(H^T3W#YA$4^[S%$49/S;
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MVLCQ*.K-\P8<;5V=6KTJBBBBBBBBBBBBBN/^*6DW^N64MEIRP9N(9(G>>21
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M4J@-M.U@00RL#ZA@",@@D88$9!/!?A"#P=:16%H"(HE(7<=S$DEF8GU+$DX
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M I,A/TU111111111111117"Z%\%]/T2]N]2A$@FO%=9/WCJ%#G=+Y94JZEG
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MQ%_9-TN\LI?[*A,-VJEXB))'#LH.(B)I"H#=-V5*G#$E05;WJBBBBBBBBBN
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MDDA?@@\/$R..G.",C(/!(KY5_9LTN/2/%6I6T"[8HH[R-%R3A5NHE49)).
M,DD^IKZTHHHHHHHHHHHK@/CIX8@UO2;MIPY\JTN)$42RHFY4+J61'59,,BD!
MPP!' Y.?/_V*?^0//_U_R?\ HF"O?Z***XKXD_"&Q^(OD?;PY^SR%EV.4R&Q
MOC;K\K;5R1AQCY67)SVM%%%%%%%<!\2OBO'X2N+*QC*/=7EW;Q["3E(GD"O*
M0/\ OE,D98DC<$9:[^BBBOD#]M/PQ!IDUG<QA_-G^T^8SRRR\*8V55$CL$4&
M1B%0*HSP.E?7]%%<!I?Q7CUC7)-%MBCI!:/)-("21*)8T\H=%^56)?&[YB%^
M4HP/DG[9_@VUAM(]3"'[4]S%$7,DC#R_*F;8$+%%&Y0?E4<Y/5FS[A\)_P#D
M#Z?_ ->%I_Z)2NJHHHHKSKXX^*D\+VD-Q<QR2V?VE5NTC4,6B,4NU6R5&PS>
M4'!8*X/EMN5RC8LWQ9M=;T"34=*29+>"2&.2*-/+FCB26+ST4(V%Q;,2K(PV
M*00Z,I*[7P6^)VF>-8)(])B,"6[ &$QI$%#[F# 1EDPS!NASD$D#()\P^,_Q
M+N/'&IKX2TIMBR2".ZG4JQ(V[I47YQ\J(&\Q<AW93%@ $2>J^&?@)HOA^$0)
M9PRXP2\Z+/(QP 6+2 XSC.U=J DD*,FO-/C+\(5\'+%K.DAQ!9W<=W/8J\GD
M.5D!,R*-ZQL%X;"[%B&1M"$/]%444444445E>)O#$'B6$VUT',39W*DLL.X$
M%2K&)T+*02"I)4]QP*^:OV&/^8C_ -NG_MQ7NOQ)^$-C\1?(^WAS]GD++L<I
MD-C?&W7Y6VKDC#C'RLN3GM:*************************************
M**********************************************************^9
M?B3J1\8>,M/TP.42R9)#E5(\P+]K?!!#$,B1IDGY2"0I_B^FJ\ ^#OA"^\87
M5]>^*K7>RR+';QSJ'@CZ^<(8G+)M^6("4 [\'$C$N3S7PXNW^'GBV;P_8L?[
M/F8L8G)?8WV7SPR'J"#\F3DLF ^YE5A]'^+-"_X2"SN++=L\^WEBWXW;=Z%-
MV,C.,YQD9]17B'[%_B\ZGITU@Y)-K,"O"A1'-N8*".2?,60G<. P )'"_0E?
M&'QCN3K/C2&VN<21)<Z?$J,JE?+;RI&0C'S M(Y.[/!QT  ^SZ*XKXH>-8?A
MOID]XJHK#=Y284!YI&)'R[DW9<F23!W%0[<G->:^"?@#;^.K&/4M>DFNKR[M
MPXD,S!85D+R1B)0%5<+("48/&K@A5VY!Q/AGXMO?AKKQ\,WLADLI&Q:R3.=R
M)L)@".RJ&!"B(HH"B48CP0P?0_;"AN-,L4NXKNY59+@0- KJD&QX7+@A$5WS
MY8_UCN!N8  '%=!H7P>@\=:#:1W\CO(UA!Y)#2I#"?LX6)A"DJH[+NRS/EG8
ML,K&5C3SK]DN2Y\56EQILEQ)%:V\T,H$3,DS>86)B$N[,<.8B66,([,Y(D4%
M@T6NZ8OPB\565KI!>.VN_LOFP&21HCYDDEN<C=EL#+IO+;7)(^7"T?MEPW&D
M-;XN[EXKKSP\#.JP 1O&Z*$C1 <%S\S[W^5<M\M=_P#$?]FR3Q[&]S<WLQOC
MO:*,N&LHBQ!$2KY:L%VJJ&089R/-9"24JA^RC\4;G61<:1J;R-=V[,ZF4L9=
MFX)(C;ER"DA'WV+?/M "IQS/_-0_\_\ 0.KTO]IR&XLM*FO[:[N8&@\DK'"Z
MQ(Q:58RS,J"4_+(?E$@3(4[<C)A_9]FG@\*0O9J'N%AO#"C<*T@FG**?F7@M
M@'D<=QUK*^"GPU?Q593W?BBV,UW<32*&N5/FK#CA45L&W'F-(5"",\AA\H0U
MS_[,NOSZ/J]_X=5R]E;-<M"'^9T,=PL?!&  P;<PQC=\RA26W8O[9<-QI#6^
M+NY>*Z\\/ SJL $;QNBA(T0'!<_,^]_E7+?+7HOQL^#$6L:9=WEW-)->10R3
MI(S.(H]B*SQ10JXC1&$>WYM[C=N=Y&&:J?L]_%=QX>GU#59"XLYIE,C,6E=0
MJ2JI:1_F<M)L09 /R*.>3+X%^$R_$JU35O$N^XFN?WL,/F21P6\38V+&L4G\
M:!68D[C\H8;P[--X$^'NK?#_ %HV]GE]!D5B%>42>02KN%178.I\W(^4,&1P
M7+.-RXB^+-/^*%U=?VQ?0Q:?;W#006BWBPI<!.6N)<%&D4ML:$JP52I&#\S/
MQ7B3Q#I_P8U2WO?#]TDME<?+=VL4JW*JJ% 2#YA.XART>X@JX8;C&S(/K^BO
M-?VD=4DTS0+V2%MK&-(R< _+)*D4@Y!ZHY&>HSD$'!KA?V)[1%TJXE"@.UZR
MLV!N*K%$54GJ0"S$#H"QQU-?0E?/?[;%HC:5;RE076]55; W!6BE+*#U )52
M1T)49Z"H?"VG#Q%X.^V7+S&6/3+R-=D\T4>V'STC#1Q.D3X50I+*2P&'+5G_
M +(GA"'6=*FDE:=2+V1<175S N/*A/*PRHI//4C.,#. ,3?MC>&8K#38[A&F
M+O?ID/<7$D8W1SL=L<DC1IR.-JC:/E& 2*]/^#OA"&VTZPNE:<N;*W;#75R\
M66A7/[II3%CG@;<+QM P,>(?%R&XTCQ1IEI)=W-Q$]Q83E9G78'^T-%E8XDC
MB7Y5[(#DL23DUZ_\:O%]QYEKH6F2>7>W\A#2+M+PVZ@F64 NA#8!V'N%D"$2
M!2,_7_V7]-F@=[02)J.W?'=M<3&7SQ\RRN<LN6<9<JF>24"M@BWX%\2ZIX.T
M*:Y\1*!/:+)LW2Q[I45%,0:16=2[.3&#]YCM)#,<MQ6@6&A^.8$O_$M_!/=3
M+YGD&]$4%L&Y$<<:R1LAV;!(&+$NF2Q.2V?\"?&:^$M;E\-6]S]LT]][6L@*
M2!&\L3L ZMMV[=ZOM!!E 8*FYZY_XY0WVD>(K"TANYKAGDLYXUNG'D";SFB0
MF.!(T5?E&[8@;ECDDU[!X6^ ,F@ZNFMG4)II3&PN5=0/.9D*G!1E"1 [&2(J
MX38H#<+M]?HKY5_;G_YAW_;W_P"V]>@>)OVN-$TR$R6LCW4O(6-(Y(^<$@LT
MJ( N0 2-S#.0C8-<?\ _A=J.KZM+XEUI)()"SM%&PP6:021,"KLTB)&GRHK
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MJ"H:2.3;USN7:X(!##G/C_[%FK3:O)J<]S(\LK?8]SR,SN<"<#+,23@  9[
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M" \'>%I[   Q:5<A]I9E,AA=I6!;G!D+$<# .  .!Q_[%/\ R!Y_^O\ D_\
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M ;G=B7=L99B6/)K0HHHHKY5^ 7_(X:M_V_\ _I9'7U57RK\??^1PTG_MP_\
M2R2O5?VH_P#D7;S_ +=__2B*O!?%EH\_@33V12P2]=G(!(5?,NTW''0;F5<G
MC) ZD5]5?#KQY!XZLHKZV(PZCS$!W&.3 +Q'(4Y4GJ0-PPP^5@3H2>)H4O$T
M_.9WMY)\ K\J(\<>6&=PW,_R\8.U^<K@ZM%> ?MC>!9-=T^*]@1W>TD<N%P0
M(G4>9(1C<=K(G(^ZI9F& 2O8?LU^+QXFT.V.1OMU^SN%#  Q !!\W4F+8Q()
M&2<8^Z/3ZJ_VI'YWV8-F7R_,*@$X7.T%B!A<G(4$@OM?:#L?;\O_  "_Y'#5
MO^W_ /\ 2R.C]N?_ )AW_;W_ .V]>J_M1_\ (NWG_;O_ .E$5<U\*;1[SP2T
M42EW>RU%55069F+W "@#DDG@ <DT?L@>/(-4TL:9D+<6K293/S-&[F02@8'
M9RA +8(!;&]17LOB+Q-#X?6-YSCS;B"! "NYGED6-0 2,XR6;&2$5B <8KYJ
M_;G_ .8=_P!O?_MO7U5117@'[:W_ "!X/^O^/_T3/7JOPG_Y ^G_ /7A:?\
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M9MH41 ;0=^6>3"8!#%7&<C!\O_8EU2.73;FV#?O4N_,9<'A9(T5#G&#DQ.,
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M_D<-6_[?_P#TLCH_YJ'_ )_Z!U>]?&*[2UT:_:1@H-E<*"Q &YHV1%Y[EB%
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MC& VE_=V4L196VFYB!##HP99 RGJ,@@D$J>"0?(-!L)?AXX70_$&GS6NY_\
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MD!?:1EB<%]@VU5^$.I7'@^W&FSZSI"VB[RCQS++<+O;<RKO:*,<EF5G67#$
MHZ?*,GX?^$+?P9JUS>PZY8F":.1/-DGCFNR)'1V)W.L8ERIQ(WF*2 S0D,57
M6^,'A>Q^)TR27&OV,<4/F"&-!"=H<@DLQN\LQ"J"?E7Y<JBY.>UU;Q5;ZOIL
MFGSZWIS2RQO$\^(QF-HS&WR"\ $I)+;@0G81=ZYKX1Z3IWP^BDLVUO3[FRF9
MFDA<0 DLFQL-]I888!0P97!"X 4DD^::_P#">#1[U[CP[K=E;0NO :^\J5 3
MEHMT>XNF0""QST#9*[V]0^#>E:3X)DDU"^UBVN]0GC5'E:ZC(5<)E 6D+/\
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M$,Q^8%@,$GD\'Z/\+:]X=\-6*:7#>V;6R1LA62Y@DWAB3)NRV#N+$L,!>2
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MQ)E9W3<,@*551M!#APS ^*Z=\,YO#\GD:?XDLXK,R*S%+UH7Y"AW\I'*%AC
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M&';HX.YB<[0J#C_!?@^V\):A)JT/B*Q>XF\WS?,2 H_F-O;(2[3'S@,-A7!
M'W<@V_BKX9TW6[Y=<T;6+.UU!=I.ZYB,;E0J!LAV*?NP59=KI( %*C+EK6H7
M_P#PGNR#Q!J^EI9I(KO;V5QC[1C)"R/+(&558 @+G=DGY65&7U"Y^).E6\'D
MV.H:?"555CW21/$BK@;?+2:+C:, !E XZ@8/C7@OP?;>$M0DU:'Q%8O<3>;Y
MOF) 4?S&WMD)=ICYP&&PK@@#[N0>@^,]I8_$U5MVURQ@M4D$BQCR7<MLVY9S
M=#.,M@*J##88,0#6KX=\1)H6GKI\>OZ<6CC6.*8I%O1%5E&5^V;&8?)L8C "
MG>LA8D<K\'_"]C\,9GDM]?L9(IO+$T;B$;@A)!5A=Y5@&8 _,OS99&P,'QRT
M2Q\8WEMJNF:O8Q7EOL $MS#Y>$=I8W&-_P P<\AE*L".FTA_3_"_Q.M(DWZC
MJNGO*RIE(98HX4(!+;=\KR,23@L2 55<1H=Q;BO$]WHFN^(;/5#?VI%K;/Y@
M::!HBP9OLP4EA\X9Y)"07*>7'D(71F]0_P"%L:/_ -!"S_\  F'_ .+K$\2^
M&M1\0:C8:CIU^(]/C7=+$OS+*I^;<-N4E$B$*"Q B \R/+$BO1:**S];@N9D
M LY(XWW#+2Q-,NW!R J30D'..=Q& 1CG(\:\%_L[7WA+4)-6AU)'N)O-\WS+
M,%'\QM[9"7"8^<!AL*X( ^[D'W"T5U11*0SA1N95**6QR0I9BH)Z LQ XR>M
M>'^-/V=K[Q;J$>K3:DB7$/E>5Y=F B>6V]<![A\_.2QWELDD?=P!VWQ&^'EY
MXYTXZ;+=0IYF/.D6V<[MLBR1[%-S\F-N&W&3=U&WI6?X ^#+Z!I[:-?SQWM@
M5<"-K<Q.-S!_OB9N VY@=N\,05<;5%>27/[*.L>&YG_L+4?*@DP3NEFMY."V
MU6\E65]JG[WRY);"*.ON'PK^%@\"I*\MQ)=W=PRF>XE+;G" K$H#,^ JG'))
M))YV[57NJ*BN[1+Q&BE4.CJ596 964C!4@\$$<$'@BO"M2_9NN?#4[WGA>]-
MD65/]'?=) S#*DLS&3(VL2H=)"'R5*@C;U<.F>*=3#17%SI]J"ORRV\,T\H8
M,IQMG98\$9!)W$=AD[EZ_3O"[:%:_9[*3$WRDSW >Y=V&U6DE/F1M(Q5=H.Y
M0H"A0$4)7E7@O]G:^\):A)JT.I(]Q-YOF^99@H_F-O;(2X3'S@,-A7! 'W<@
MZWQK^ \WQ2DB,EVD,4&_RU%NSO\ .(]^YC< -RF1A5P#@YZU:\<_"O5/&EC_
M &;=:C"(V\OS'2R*R2;"&&[-T5&6 8[%7D8&%RIUOA#\.+KX?6XL9+M+BV3>
M8Q]G\J12S;B-XF<%<EC@KNRWW]H"UY?\0/V493=_VCX=N!9R%L^7EXE0L&#M
M')$&90<@>7MP 6PP7:@ZKX3_  -N]#GCU'6KV2\NHED$*F262*$OE78-(=SE
MDP/NJ!SD,0K+5^*G[/E[\3'B>]U"-1"K!$BLRJ@L068[KIV).U1UP HP 22?
M5?"]A>V2;+^XCN"%0*Z0&!B0"&9_WTBDMP?E" '.!@@#:HKR7XN_!F]^):+;
MS7T<5NDS2(B6I+9P53>[7)W%58C*A 222OW=L6D_"?7=(ACMH-<VQ11I&B_8
M+<X50%49+DG  &22?4UG^+_@3K'C" VE]K9DA+*Q06<48)'(SY<JE@#S@Y&0
M#C(!'8>.OAQ=:\UJEE=I:6MK)#(+<6^]':)PT:L5FB_=+M7$:@ $9))";.JU
M339KZU: M"97C"N9(6D@;.!(#%YJDJPR ID.,C);!SY5\'_V?[KX8S/);WZ2
M13>6)HWM<;@A)!5A<95@&8 _,OS99&P,9_Q@_9A'B:Y_M/2)1:WFX.P^98WD
M# B4,F6C?J255M[ '"L6=CX=?L^ZC#/%=>(-0DNA!,)8K<33R1>8N/+E+2%3
ME26^4*.V7*ED/HOQ7^%%K\2+4VUR-LBY,,P&7C8]QTRIP Z$@, .0P5E\%T'
M]ESQ#"@LI=3$-D5=62*:Y==K!B5$16)"&8_,"P&"3R>#]%:#\.[31=.&CQJ3
M:^2\3*S$LRR;O,)88(+%F)V[0"?E"@ #RKX<?!K7?AZ)K&RO+7[%*Q82O"[7
M$;F/:72/<$SN"C#R.N%#;<ED8/[.-V=<?6H[\Q -$4?:)[A\PB*?=YBB*,GY
MM@5710P"HBHJ5M_'OX&2?$BUMUAGQ=6V0K2X"2!]@D+^6GRM\@8%%VYRNP!@
M5ZKPSI6M);C[==6QNA&%&R!FASN&9'S)&TC%5X">0BL[95P$V^?^"_V=K[PE
MJ$FK0ZDCW$WF^;YEF"C^8V]LA+A,?. PV%<$ ?=R#[K7F'P+^#0^&:7:$AC-
M<DHX9F8P*,0J^510XW.6VC!+=2  /2KNT2\1HI5#HZE65@&5E(P5(/!!'!!X
M(KYE\1?LF7VC737/AR]^SI)N!1I)H713M/EB2(.TB[@3A@I "Y+G+5ZA\(O@
M[+X0=K[4;J2]OWA6(R.[LL<>0[1)O8EAYG.XXR ,(F6W>GT5%=VB7B-%*H='
M4JRL RLI&"I!X((X(/!%>-6?P5U#P!(TGAFZ18))-TEG=AG@R0XW*Z R# *
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M>YBFAD0* BQ@0,RLH500S$N23G@"NE^%GPK3P*+B5Y3<7=W,9;B<J(P[;F8
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M*8U!8<( 37C_ (0_9<U/3X!Y.JSV D9G-M&7D"$\ ,\<T*2.$"AV" $C"Y4
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MED.?\"_A%J?P^M)+6:Y@ ,TLJK'&\H+M$L:EV<QDH"NXQHJ,2J_O@I9#G_\
M#.U]_:_]O_VDGVOS-W_'F/+QL\OR]OVC.WR_DSG?CG=O^:NF^,'PBN?B7;16
M<MU'$D;1R,5MV9FE570L,W "H0_"$,P(_P!8:ELO@W]NTL:+J\R7<"1HD+K#
MY$T>P$(V[S)%+*I"J0J_*")/,#MGQK1/V7/$.@N8+/4Q!:F8DF*:YC8J2 9#
M$BA-^P#Y=^,@+OP,U[U\-?A1:^!=/_LQ!YJ/N,YD&1*SJ%<E#E0I4!0G(V@
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M[G_X[1_PRYX=_P"?/_R/<_\ QVC_ (9<\._\^?\ Y'N?_CM'_#+GAW_GS_\
M(]S_ /':/^&7/#O_ #Y_^1[G_P".T?\ #+GAW_GS_P#(]S_\=H_X9<\._P#/
MG_Y'N?\ X[1_PRYX=_Y\_P#R/<__ !VC_AESP[_SY_\ D>Y_^.T?\,N>'?\
MGS_\CW/_ ,=H_P"&7/#O_/G_ .1[G_X[1_PRYX=_Y\__ "/<_P#QVC_AESP[
M_P ^?_D>Y_\ CM'_  RYX=_Y\_\ R/<__':/^&7/#O\ SY_^1[G_ ..T?\,N
M>'?^?/\ \CW/_P =H_X9<\._\^?_ )'N?_CM'_#+GAW_ )\__(]S_P#':/\
MAESP[_SY_P#D>Y_^.T?\,N>'?^?/_P CW/\ \=H_X9<\._\ /G_Y'N?_ ([1
M_P ,N>'?^?/_ ,CW/_QVC_AESP[_ ,^?_D>Y_P#CM'_#+GAW_GS_ /(]S_\
M':/^&7/#O_/G_P"1[G_X[1_PRYX=_P"?/_R/<_\ QVC_ (9<\._\^?\ Y'N?
M_CM'_#+GAW_GS_\ (]S_ /':/^&7/#O_ #Y_^1[G_P".T?\ #+GAW_GS_P#(
M]S_\=H_X9<\._P#/G_Y'N?\ X[1_PRYX=_Y\_P#R/<__ !VC_AESP[_SY_\
MD>Y_^.T?\,N>'?\ GS_\CW/_ ,=H_P"&7/#O_/G_ .1[G_X[575/V8-#BC8V
MU@CR\;5DNKJ)#R,Y96E(XR1A3DX'&<CRKPW^R/>V-T9[R*QN+=M_^CBXO(0N
M>5V.L3.-O0;]^5R#\Q##U_\ X9<\._\ /G_Y'N?_ ([1_P ,N>'?^?/_ ,CW
M/_QVC_AESP[_ ,^?_D>Y_P#CM'_#+GAW_GS_ /(]S_\ ':/^&7/#O_/G_P"1
M[G_X[1_PRYX=_P"?/_R/<_\ QVC_ (9<\._\^?\ Y'N?_CM'_#+GAW_GS_\
M(]S_ /':/^&7/#O_ #Y_^1[G_P".T?\ #+GAW_GS_P#(]S_\=H_X9<\._P#/
MG_Y'N?\ X[1_PRYX=_Y\_P#R/<__ !VC_AESP[_SY_\ D>Y_^.T?\,N>'?\
MGS_\CW/_ ,=H_P"&7/#O_/G_ .1[G_X[1_PRYX=_Y\__ "/<_P#QVC_AESP[
M_P ^?_D>Y_\ CM'_  RYX=_Y\_\ R/<__':\U^*7['0U":.30C#!%Y>)(Y7F
M/S DAPQ$Q.0<$?*%V@C.XX[K0/V3=#L($BN83<2JOSRM)-&7;J3MCD"J.P R
M0 ,ECECH?\,N>'?^?/\ \CW/_P =KTO2=+CTB&.V@7;%%&D:+DG"J JC)))P
M !DDGU-6J***************************************************
M*********************************************X_XJ_#.#XC636-P
M2AW!XY%Y*2 $*V,@,,,05/4$X*MAAQ6B:#XOT%#;K<Z?=(K$1RW N!,4 "KN
M\I0,X&26+MN)R[<&NFTGX>W6HW$=[K=PEPT6QX;:*/R[6&7: T@W,SS,/^6;
MR8V99E521L[^BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBHKMG5&,0#.%.U68
MHI;' +!6*@GJ0K$#G!Z5\]?\*9U[^W_^$CS8[_,SY/FW&W9Y7D;=WD9W>7_%
MC&_YMF/DKZ%M&=D4R@*Y4;E5BZAL<@,54L >A*J2.<#I4M%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%<!XF^/FB>&IC;75X@E7.Y462;:02I5C$CA6!!!4D,.XY%:
MO@KXIZ9XWW#3[A)67.4^9) !MRVR0*^WY@-V-N3C.<BNJK*\3>*[7PO";F^E
M2&(9^9SC) +;5'5F(4D*H+'' -<_X.^-&D>,I#!8W2/+V0AXG;AC\JRJA? 4
MD[<[1R<9%6_&OQ3TSP1M&H7"1,V,)\SR$'=AMD89]ORD;L;<C&<X%0Z;\7M)
MU*TDU&*ZC:WA7=*V2&09*KN0@2*6*D("N7.-@;(ST&@:_!XA@2[M'$D,B[D=
M>A'3OR"#D$'!4@@@$$5H4444445S7CCXD:?X&1)-1G$(D8J@P[LQ R<*BLV!
MQDXP"0"06&9?$GC^Q\-6HO[J=$MFV;) 2X??RNP(&+Y'S#:#\H+?=!(T- U^
M#Q# EW:.)(9%W(Z]".G?D$'((."I!! ((K0JKJFK0Z1&T]S(D42XW/(RH@R0
M!EF( R2 ,]R!7/\ _"V-'_Z"%G_X$P__ !='_"V-'_Z"%G_X$P__ !=6M+^(
M6FZO(L%M>6TLK9VI'/$[G ).%5B3@ DX[ FL^Q^+VDZC=QZ=;W4<MQ*I9%B)
ME4@!F.70-&" A."P.,<<C/84444455U35H=(C:>YD2*)<;GD9409( RS$ 9)
M &>Y KSJ[_::\/VKM&UZ"58J2L4[KD'!PR1E6'H5)!'()%=K#XVLIS L<\;F
MZ:18-C"02&-6:3:4R"%"G<>@.%)W$ [5%%%%%%%%5=4U:'2(VGN9$BB7&YY&
M5$&2 ,LQ &20!GN0*S_"OC2T\6))+8RB9(YFB9E!V[U ) ) ### AERI!X)J
M'6/']CHUU#87$Z)<W&?*C).6[#)QA<GY4W$;V!5,L"*Z"BBBBBBBBBBBHKN[
M2S1I96"(BEF9B%55 R6)/  '))X KS6[_::\/VKM&UZ"58J2L4[KD'!PR1E6
M'H5)!'()%=UX9\5VOBB$7-C*DT1Q\R'."0&VL.JL P)5@&&>0*U:Y7QK\4],
M\$;1J%PD3-C"?,\A!W8;9&&?;\I&[&W(QG.!5KP=X_L?&<9FT^=)E'W@"0ZY
M+ ;D8!TSM.-P&X#(R.:P/$WQ\T3PU,;:ZO$$JYW*BR3;2"5*L8D<*P((*DAA
MW'(K5UCXJZ7H\<,\]W"(KB0I"X<.CD'#$,FX!5/#N<(AP&89%=5111111117
M/_\ "?V/V[^R?/3[9Y>_R<G=C&<9QMW;?FV9W[/GV[>:Z"BBBBBBBBBBBBBB
MBBBBBN?\6^/['PAY7V^=(?.DV1[B>3W/ .%&1N=L(N1N89&=#6_$-MH*"6\F
MC@0L%#2NL:EB"0H+D#. 3CK@'TJ+PMXIM_%5NE[9/YD$F[8^UESM8HW#A6'S
M*1R/TK5K%\4>-K+PJGF7\\<(*NRAV 9@@!;8OWG(R.%!.2 !DBM#2=4CU>&.
MY@;=%+&DB-@C*L RG! (R"#@@'U%6J***RO$WBNU\+PFYOI4AB&?F<XR0"VU
M1U9B%)"J"QQP#7/^#OC1I'C*0P6-TCR]D(>)VX8_*LJH7P%).W.T<G&17:T4
M44444444444444444445S_\ PG]C]N_LGST^V>7O\G)W8QG&<;=VWYMF=^SY
M]NWFN@HHHHHHHHKG]'\?V.LW4UA;SH]S;X\V,$Y7L<'&&P?E?:3L8A7PQ KH
M****************S]?U^#P] ]W=N(X8UW.[= .G;DDG  &2Q( !) HT#7X/
M$,"7=HXDAD7<CKT(Z=^00<@@X*D$$ @BM"BBBBBBBBBBBBN:\7_$K3O!P)O[
MF.(A5;86S*5+;0PC7,C#.>0I P2> <=+111111111117/Z/X_L=9NIK"WG1[
MFWQYL8)RO8X.,-@_*^TG8Q"OAB!70444445S^L>/['1KJ&PN)T2YN,^5&2<M
MV&3C"Y/RIN(WL"J98$5T%%%%%%%%%%%%%%%%%%%<UXO^)6G>#@3?W,<1"JVP
MMF4J6VAA&N9&&<\A2!@D\ XZ6N?\)>/['Q?YOV"=)O)DV2;2>#V/(&5.#M=<
MHV#M8X..@HHHHHHHHHHHHHHK%\7^-+3P= ;N_E$4095W$$DL>BA5!9CU. "0
M 6/ )&K:7:7B++$P='4,K*0RLI&0P(X((Y!'!%2UQ_B_XO:3X/)2^NHXW#*I
MC!,DH)7<,QQAG4%><D <CGD9["BBBBN/\7_%[2?!Y*7UU'&X95,8)DE!*[AF
M.,,Z@KSD@#D<\C/844444444444444444444444444444444444444444444
M44444444444444444444444444444444445\R_M*?%&YU2]C\+::XC,[0QW$
MA+*=TQ 6$G;PFUE9RNXL&V< .K>Z^ _AU9>!8!;6,00;5#R8!ED(R=TC@ L<
ML2.RYPH5< >?_M%_"J#6;*;5;91#J%JOVA9T/ENPB +!F4%F(1/W9/*LJ@,J
MELV_V</C _Q&LF^U8^UV[*DI4$!U8?NY<8"J6VL"JD@%2V%5E4>?Z]K;Z]X[
MMK.X :&U4B)#DJ&-JUQYF&)7?O(PP .$3NH->P>(?@MIVO:C!K$J$7,#*V4.
MU9&3'EM( ,L4(!4@@D *^Y %'C_[(NMOXJO=5U*Z :XD:W.[DE5<S$QJ6+,$
M&Q %R1A$'\(KU#3/V=M&TZ:[F6#*WD?EO$3^Y120["-1C9EU5P<DHRCRB@&*
M[#P7;65K:11Z7Y9M%4K$8F#QX!(;# G<=V=Q))+9+$MFI==\66?A_;]MN(8-
M^=GFR)%NQC=C>1G&1G'3(]:MZ7JT.KQK/;2)+$V=KQLKH<$@X920<$$''<$5
M+=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %96B>-[#7G,5G=03N%+%8I8Y&"@@%
MB$8G&2!GIDCUK:K*E\66<4<D[7$(BAD,<KF1 D;@@%';.%8%@"IP<D#'(K0M
M+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BN/^*7A32M?AC_MB+S563]T%$S3%B#E
M4$'[ULJI9E4$;4WL,)D8MC\-]/L]#CL-5@ MU8R^22[M$\LS2)"CQL9'=3)Y
M*LAW3'@ ^9M.K\'_  7%X5MI5MHC!#-<R2QPL7+(FU(D),A+Y=8Q*5<!HS)Y
M;#*'/=5Q7QD\'2>,],ET^$X::2V!;@[5%Q$TCX++G:@+8R"V,#DBI;3X.Z-:
MHL:V%J0JA06@C=L 8&6=2S'U+$DGDDFOG#]C7PG9^(/M_P!MMX9]GV79YL:2
M[<^?NQO!QG SCK@>E>U:U\#;--3L=0L[:&.-/M,5S$D:)&\4EO*JLRY"G#'8
M0%+,)/F.U*\@TO28=(\?K!;1I%$N=J1JJ(,Z>2<*H &223CN2:^G_P#A++/[
M1]A^T0_:O^>'F)YWW=_W,[ON_-T^[STK5KG]4^(6FZ1(T%S>6T4JXW))/$CC
M(!&59@1D$$9[$&N@HHKY+@\1-^T+KPLI&QI-KYDHB5G0RJA"+(?E#;G9UX.T
MQQ%E4A\LWU5I>DPZ1&L%M&D42YVI&JH@R23A5  R22<=R37BGC;X1P^$-4L=
M>TF)(\7<$%Q"JJL(2<_9O.50R[6'F!<*""Q5RHVN7]UKG]+^(6FZO(L%M>6T
MLK9VI'/$[G ).%5B3@ DX[ FN@JK<:M#;21P22(LLN[RT+*'?:,OM4G+8')Q
MG Y-9]SXWL+6?[')=0+<%E40M+&)=S8V+L+;LG(P,9.1CK5K6_$-MH*"6\FC
M@0L%#2NL:EB"0H+D#. 3CK@'TJW:7:7B++$P='4,K*0RLI&0P(X((Y!'!%1?
MVM#YWV7S$\_R_,\K<OF;,[=^W.[;NXW8QGC.:J:?XLL]1F>U@N(9)X]V^))$
M:1=I"MN4$L,,0#D<'@\US7QJ\/6VJ:5>2W$,<CPV5VT3.BNT;>4QW(6!*G*@
MY&#D#T%>=?L4_P#('G_Z_P"3_P!$P5ZKXH\+:7<75M?WZ0_:8Y!';R2,%)=L
ME$ ) =LY:-2&*MED ;)KJJYJT^)NE7CK%%?6KN[!55;B)F9B<!0 ^22> !R3
M72U5_M:'SOLOF)Y_E^9Y6Y?,V9V[]N=VW=QNQC/&<U4T_P 66>HS/:P7$,D\
M>[?$DB-(NTA6W*"6&&(!R.#P>:U:Y_\ X6%IOG?9?MEMY_F>7Y7GQ>9OSMV;
M=V[=NXVXSGC&:Z"L76_&]AH+B*\NH('*A@LLL<;%22 P#L#C((STR#Z5JVEV
MEXBRQ,'1U#*RD,K*1D,"."".01P14M%?)<'B)OVA=>%E(V-)M?,E$2LZ&54(
M19#\H;<[.O!VF.(LJD/EF^JM+TF'2(U@MHTBB7.U(U5$&22<*H &223CN2:^
M:OC_ .&?^%27%MXAT,);EI/(FA4;87RNY1Y:@+M98V$F"OS!'4"3+U[_ . /
M&,?C.Q@U"$86:,$KR=K E9$R57.UP5S@!L9'!%>"_LBZV_BJ]U74KH!KB1K<
M[N255S,3&I8LP0;$ 7)&$0?PBN@^)/P[M/A18ZGK6DJ8KF:%8@ Q$<2RRQI(
M8@FTH<D.O)",J[ J94Z'[.OA2UUKPO#;7$2/%<?:/.4C&\^?(H8D8.X!%"MG
M<NU=I&T8U;;X&:#X4L4AO$1K>"X,_FW+@8D8JGS-\B;3A$*8"/M7<K-R?5:Y
M_5/B%IND2-!<WEM%*N-R23Q(XR 1E68$9!!&>Q!KH*S];\0VV@H);R:.!"P4
M-*ZQJ6()"@N0,X!..N ?2C1/$-MKR&6SFCG0,5+1.LBA@ 2I*$C."#CK@CUJ
M;5-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"H9O$-M!.MF\T:W#KN2$NHE9?
MF^8(3N(^5N0,<'T-:%%<K<>%M+MM3COY$A7498V2-BP$KA5^<JI/S,$X+@%P
MGREMG%=!JFK0Z1&T]S(D42XW/(RH@R0!EF( R2 ,]R!6?I?C>PU8,UM=02A6
MC5BDL;@-(VR-3M8X+-\J@\L>!DUM45%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/
M %9\_BRSM_)WW$*_:,>1F1!YN=N/+R?GSN7&W.=P]15O5-6ATB-I[F1(HEQN
M>1E1!D@#+,0!DD 9[D"JFA>++/Q!N^Q7$,^S&_RI$EVYSMSL)QG!QGK@^E6]
M4U:'2(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*S]+\;V&K!FMKJ"4*T:L4EC<!I
M&V1J=K'!9OE4'ECP,FM#5-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"JFN^+
M+/P_M^VW$,&_.SS9$BW8QNQO(SC(SCID>M:M9^M^(;;04$MY-' A8*&E=8U+
M$$A07(&< G'7 /I1HGB&VUY#+9S1SH&*EHG610P )4E"1G!!QUP1ZUH5GQ>(
M;:5)95FC*0,ZS,'4K&R#+JYSA"HY8-@J.N*-$\0VVO(9;.:.= Q4M$ZR*& !
M*DH2,X(..N"/6C6_$-MH*"6\FC@0L%#2NL:EB"0H+D#. 3CK@'TJ+2_%EGJZ
MJ]M<0RJTAC4QR(X+A#(4!4G+! 6*CG:"<8YK*^(/A;2]8C2?6$A,5O('5YF"
M(A) P6)4%6. 4;*.=H93@5PG[57AZVGT6ZO'AC:X1;=4F**957[1'\H<C<!\
MS< XY/J:F_9PU:'2/#-I/<R)%$OG[GD9409NI0,LQ &20!GN0*]5TO5H=7C6
M>VD26)L[7C970X)!PRD@X((..X(KYZ_;/\/6T&G1WB0QK</>Q*\P11*R^3-\
MI<#<1\J\$XX'H*]E^$__ "!]/_Z\+3_T2E:&M^-[#07$5Y=00.5#!998XV*D
MD!@'8'&01GID'TK5M+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BI:*^9=>UM]>\=
MVUG< -#:J1$AR5#&U:X\S#$KOWD88 '")W4&O8/$/P6T[7M1@UB5"+F!E;*'
M:LC)CRVD &6*$ J002 %?<@"CH-;\;V&@N(KRZ@@<J&"RRQQL5)(# .P.,@C
M/3(/I6K:7:7B++$P='4,K*0RLI&0P(X((Y!'!%%W=I9HTLK!$12S,Q"JJ@9+
M$G@ #DD\ 5GS^++.W\G?<0K]HQY&9$'FYVX\O)^?.Y<;<YW#U%:M%5=4U:'2
M(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*J:%XLL_$&[[%<0S[,;_*D27;G.W.PG
M&<'&>N#Z5JT45%=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %96B>-[#7G,5G=03
MN%+%8I8Y&"@@%B$8G&2!GIDCUK:K*E\66<4<D[7$(BAD,<KF1 D;@@%';.%8
M%@"IP<D#'(J6Y\0VUK!]LDFC6W*JPF9U$6UL;&WD[<'(P<X.1CK572_&]AJP
M9K:Z@E"M&K%)8W :1MD:G:QP6;Y5!Y8\#)K:KG]+^(6FZO(L%M>6TLK9VI'/
M$[G ).%5B3@ DX[ FN@KG]4^(6FZ1(T%S>6T4JXW))/$CC(!&59@1D$$9[$&
MN@KE;CPMI=MJ<=_(D*ZC+&R1L6 E<*OSE5)^9@G!< N$^4MLXKI;N[2S1I96
M"(BEF9B%55 R6)/  '))X K/U#Q99Z="EU/<0QP2;=DKR(L;;@67:Q(4Y4$C
M!Y'(XK0M+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BHM4U:'2(VGN9$BB7&YY&5$
M&2 ,LQ &20!GN0*J:%XLL_$&[[%<0S[,;_*D27;G.W.PG&<'&>N#Z5JT445R
MNC^%M+T;4)IK=(4U"XC$DH##S63=@N$S\JE_OLH =P"Y+ &NEN[M+-&EE8(B
M*69F(554#)8D\  <DG@"L_4/%EGIT*74]Q#'!)MV2O(BQMN!9=K$A3E02,'D
M<CBM"TNTO$66)@Z.H964AE92,A@1P01R"."*\J\(_&E/&6ORZ=8N'LX+*1F<
M 8DF$T2EE;)W(JMA2,!B6/SKL:O6JY_2_B%INKR+!;7EM+*V=J1SQ.YP"3A5
M8DX )..P)KH*SW\0VR&93-&#;J&G&]<Q*5+AI.?D!4%@6P"!GI1;>(;:Z@^V
M1S1M;A68S*ZF+:N=[;P=N!@Y.<#!STJ+4/%EGIT*74]Q#'!)MV2O(BQMN!9=
MK$A3E02,'D<CBM"TNTO$66)@Z.H964AE92,A@1P01R"."*BN-6AMI(X))$66
M7=Y:%E#OM&7VJ3EL#DXS@<FH=-\0VVJ/)%;S1R/"VV54=7:-LD;7"DE3E2,'
M!R#Z&JNM^-[#07$5Y=00.5#!998XV*DD!@'8'&01GID'TK5M+M+Q%EB8.CJ&
M5E(964C(8$<$$<@C@BO*M4^-*77B"TT*Q<, UQ]K( (W+!(R1!L]0PS)@9!"
MKNR)%KTK7] @\0P/:7:"2&1=KHW0CKVY!!P01@J0""" :J^"[:RM;2*/2_+-
MHJE8C$P>/ )#88$[CNSN)));)8ELUH7&K0VTD<$DB+++N\M"RAWVC+[5)RV!
MR<9P.353_A++/[1]A^T0_:O^>'F)YWW=_P!S.[[OS=/N\]*U:Q=;\;V&@N(K
MRZ@@<J&"RRQQL5)(# .P.,@C/3(/I6K:7:7B++$P='4,K*0RLI&0P(X((Y!'
M!%2T5GZWXAMM!02WDT<"%@H:5UC4L02%!<@9P"<=< ^E1:%XLL_$&[[%<0S[
M,;_*D27;G.W.PG&<'&>N#Z5JUE?\)99_9_MWVB'[+_SW\Q/)^]L^_G;][Y>O
MWN.M6]+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*AUOQ#;:"@EO)HX$+!0T
MKK&I8@D*"Y S@$XZX!]*^2_VP;2P<6-YIRP$7#7C/- (\2L&ARS/']\ABV22
M2"6[YK[$HHK/B\0VTJ2RK-&4@9UF8.I6-D&75SG"%1RP;!4=<5%H7BRS\0;O
ML5Q#/LQO\J1)=N<[<["<9P<9ZX/I1_PEEG]H^P_:(?M7_/#S$\[[N_[F=WW?
MFZ?=YZ5JUS^J?$+3=(D:"YO+:*5<;DDGB1QD C*LP(R"",]B#7055U35H=(C
M:>YD2*)<;GD9409( RS$ 9) &>Y JIKOBRS\/[?MMQ#!OSL\V1(MV,;L;R,X
MR,XZ9'K6K7*Z/X6TO1M0FFMTA34+B,22@,/-9-V"X3/RJ7^^R@!W +DL :X_
M]H;XTI\/+0Q6[C^T)E_<K@/L7.&E8$X  R$SD,^/E95?'K58NM^-[#07$5Y=
M00.5#!998XV*DD!@'8'&01GID'TK5M+M+Q%EB8.CJ&5E(964C(8$<$$<@C@B
MB[NTLT:65@B(I9F8A550,EB3P !R2> *SY_%EG;^3ON(5^T8\C,B#S<[<>7D
M_/G<N-N<[AZBLKQ1X6TNXNK:_OTA^TQR".WDD8*2[9*( 2 [9RT:D,5;+( V
M3755E?\ "66?V?[=]HA^R_\ /?S$\G[VS[^=OWOEZ_>XZU;TO5H=7C6>VD26
M)L[7C970X)!PRD@X((..X(J6[NTLT:65@B(I9F8A550,EB3P !R2> *RM$\;
MV&O.8K.Z@G<*6*Q2QR,%! +$(Q.,D#/3)'K6U116+K?C>PT%Q%>74$#E0P66
M6.-BI) 8!V!QD$9Z9!]*U;2[2\198F#HZAE92&5E(R&!'!!'((X(JIK?B&VT
M%!+>31P(6"AI76-2Q!(4%R!G )QUP#Z4:)XAMM>0RV<T<Z!BI:)UD4, "5)0
MD9P0<=<$>M:%9\7B&VE2659HRD#.LS!U*QL@RZN<X0J.6#8*CKBHM"\66?B#
M=]BN(9]F-_E2)+MSG;G83C.#C/7!]*/^$LL_M'V'[1#]J_YX>8GG?=W_ ',[
MON_-T^[STK5K*_X2RS^S_;OM$/V7_GOYB>3][9]_.W[WR]?O<=:MZ7JT.KQK
M/;2)+$V=KQLKH<$@X920<$$''<$5\G_MJ^'K;2WLI;>&.-YFNVE9$5&D;,)W
M.5 +'+$Y.3DGU-?75<KX*\+:7X:DN8-,2&.4R*]PD; NI<$H&7)*+C)C3Y4
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M_;]MN(8-^=GFR)%NQC=C>1G&1G'3(]:U:*BN[M+-&EE8(B*69F(554#)8D\
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MV\ED6>%P'B9DFAV,R-E6*[CM)&1DXQFMK_A$[/\ X3O[#]GA^R_\\/+3R?\
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ML"_\1VOC[7+N#41)<6&G-$D-O%;7<R&?/[R67R5;)1D>-5D4QNI.T'YR_/\
MQH\.0P&VU+PQ:74&H0S 8@L+F!#&5<EF5K=48AL*?[RLRN&4#;ZK\4M*C\7Z
M!+=7D4D;C3I)_)\V9 DGDB4+(JF-9"CJ,"13@C[HR17BG[-7PC@\?Z5.-0DD
M:W6YE6*!&\M4E,46ZXR/ON%*J@<%$ ?Y6WG'TUX"\%0^"+*+3[9G:*+?M,A4
MN=SM(<E54=6., <8^M=!111117RK^PQ_S$?^W3_VXKZJKY+U33_[0\?M%O=
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MR^QPR*(RADD16G;.=S&7 <,<D@J5V\;-H  Y_P"#7@:\^$EK>)J=TDMC%F6
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M4DAE91M(RP;U7PC9O\0=&@768IHY7C*SQEY;9V*[XF+B+R3MD&7,9&S# 8.
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M@\UB?LY6=YIEQ?:+<V]RVE?OFMGNHG1-GF%"A$D2Y\U'#LIV@%6.S+M7%?\
M")V?_"=_8?L\/V7_ )X>6GD_\>&_[F-OWOFZ?>YZUZ5^TYX"LK70II8HO+^S
M^3Y,<;/' A:=0S"%&$.XB5P6*;OF//2MO]F>V%UX:M8VR RW*DJS(V#<3 X9
M"&4^A4@@\@@UXK;>$HK+QU]B@:2*,LQ)61VE.^R,DO[QR\F7+-EPV\;B496"
ML-K]K3X7Z?X:TVUN+&!(&CN!#\BJN]6C9LNV-[L/*&&9B?F8G).1ZAXO^(EW
MHWA5=7C8&[:RLV+LH(WS>4KOM&%R-Y8#&W.,J5X-3]F/0(+G0UN94$DMZUPU
MT[_O&F/G2Q_.7SN&WC!XR6.,LQ/D'[//@VT7Q#J.E30QW%O"MP$$\44S9BN$
MC1LLG!VL=VW:&)R1PN/L2BO%?!'PUU-/$EYJ^J;)(!&\=HY96*J[@H$4#,>R
M/<CDA26=B"X9F/G7Q(NT\*^,[,Z8PB>X:U6[$9&&::<K(KKR 6CV,1@')67[
MY#5Z+^UAX8@O=&GO) YEA\CR_P![*(U)F5"WEAQ$6VR,NXJ6P<9X&,_]G+X=
M66N:+9W-]$+E@MRL:S 211J;A]P2,C8"67<7(,ASMW[ JKPO[,\J^$=>U73Q
M)MLX8[@LTA0<6]P$21GP,81WW$;5Y)(X&.@^"NA1_&2]NO$FJQ)(@D$%M;L3
M+%&%0%LJZ[6^5U(_A+M(_EJ=A'"?M@> X/#$]K+9@10SK-F!!MB61/*#RJH.
MQ2Z%%8*JY\L$[B>/L^BN ^.GAB#6])NVG#GRK2XD11+*B;E0NI9$=5DPR*0'
M# $<#DY\D_9$\'6VO:5,UX@G1;V0+#*JO"K>5#F0(RX+D87<V2J@A-N^3?S6
M@>'E\.^-IM,LW>&WG\P.(]B-Y;VXNFB4A1Y:[P%4Q[75  KAOFK;_:R^&NG>
M&=*MI;*VCA=+E(@R+M8H8I"0YZR',:G<^YLYY^9L]!\8?C+/H'ARR=9"+^_M
MH/WB_(P!B1YY1M3:#\P4 ;""^Y,;*[70_P!F_1;"R6QFM8Y253S)B&$KN NY
MP^\R1ABN=B.%&2,8)SY?^SSKMUX$UFX\*WLNZ%?,-N",G<,2@KM9@BO"6D*,
M2 PP"'+!N?\ VT_#$&F36=S&'\V?[3YC/+++PIC9542.P109&(5 JC/ Z5[!
M\6O@_I[Z3?S/'ONOL\D[73[7N6DB0./G93L4^6%*1A$"DJBH#QS_ .R4S>(-
M!>VN&?RX[N2-/+=X75<138#Q%'^^[$G=D@E2=O%<5^S9I<>D>*M2MH%VQ11W
MD:+DG"K=1*HR22<  9))]34/[:OAZVTM[*6WACC>9KMI61%1I&S"=SE0"QRQ
M.3DY)]37LOQ7UJS^$&ESW6GP0V\\VV*+RHDCW2D-L8[8RIV+O<!QM.TKD%JR
MOA'\#],NM+BN+Z%+JYO;=99YI0SR$S!I."S,48"3:70JS$!S\V,>?^#KF;X-
M>)SHV_;IM[)NB0AG \P,L)7#.RL)0(2S??4;W&-C+K?MH^&($L8;_#F<W:1Y
M,LK(JM#(6"QLYC3)C0DJH)(R223G0\+_ +-UEXVTJRGU&:>2X:VMV657";(O
M*'EVZH5>,(H().W>S[G+#<5KA/BYX8@\/^+M,6W#_O)+"1VDEEF=F^TLF2\K
MNWW44 9P !@5ZK^UAX8@O=&GO) YEA\CR_WLHC4F94+>6'$1;;(R[BI;!QG@
M8S_V<OAU9:YHMG<WT0N6"W*QK,!)%&IN'W!(R-@)9=Q<@R'.W?L"JO%?LN0G
MP[XAU/2H6)MT6<8;:68P7"QQL2%'(5VSC ).<<#&KXSUM_&7C&#1+X"2PMVW
M+!SL9_LAG#R#/SD,< 'Y=HV[?F?=-^VUX9A>SMM0QB=+CR,@+\R.CR88XW':
MR?+S@;GXRV1Z_P#"#1[>VTVUN8888I;BTMI)FBBCAWL8PV2(U4=6) Q@9. *
M[6N ^.GQ&_X0#2Y;I#B=_P!U!_UU<'#<JR_*H9\,-K;=N<L*J>!?@3I^BVJ)
M>V\-U=O^\N)YD6X=Y6P9"'E3=MW?=&!QRP+EF//_  X^&5Q\)+J_N6N$&BF.
M698AYC/&5VON*E6/RQAD)5RT@"%E) "\U\"] @^+DMWXAU=!</\ :3%;PR_O
M(X8U3=L XC<8F ^:/AE,GWW)'/\ QU\*/\&;VWU[0E$$<C-'-&,^47),FTJ7
MY1U!&Q JQ^6"I5BI'LOQ>TRT\9:'/=Y=XOL$T\.))HD;]UYL;,BL@?!56 D4
M[3V&37E_[(G@ZVU[2IFO$$Z+>R!8955X5;RH<R!&7!<C"[FR54$)MWR;^:T#
MP\OAWQM-IEF[PV\_F!Q'L1O+>W%TT2D*/+7> JF/:ZH %<-\U;?[67PUT[PS
MI5M+96T<+I<I$&1=K%#%(2'/60YC4[GW-G//S-G:^-VF+XD\*1ZK=EWNA:6$
M@/F2+'O=HP[^4K"'<1*XW;,@' ( &(O@7\&['QMHMI/JJF<*LZPQ[Y8TC7[1
M,7.$D&YW8_,W VK&H4%"S\?X,LY/@;XI730SR6=YY:+G!9EE;;"Y57"[DE!0
ML1G9YC*@W@5J_MS_ /,._P"WO_VWKZ5\3>&(/$L)MKH.8FSN5)98=P(*E6,3
MH64@D%22I[C@5\U?L,?\Q'_MT_\ ;BO0/!'PUU-/$EYJ^J;)(!&\=HY96*J[
M@H$4#,>R/<CDA26=B"X9F/G7Q(NT\*^,[,Z8PB>X:U6[$9&&::<K(KKR 6CV
M,1@')67[Y#5Z+^UAX8@O=&GO) YEA\CR_P![*(U)F5"WEAQ$6VR,NXJ6P<9X
M&,_]G+X=66N:+9W-]$+E@MRL:S 211J;A]P2,C8"67<7(,ASMW[ JKQ7[+D)
M\.^(=3TJ%B;=%G&&VEF,%PL<;$A1R%=LXP"3G' QVOP]L(/C+J%UK5Z!<65O
M,UM8P/\ -$ %4RS-&T:@EPRLN[)7)5AF.,BW\4/V?'NY[;4/#9@L+N!CDJIB
M1E/0XC5ER.5(*$2*Y5SM4*:GQ,\2P^*M<&@W32/I\%MYUS!##<R/+*2/+C<V
MX+A%5XY00-F[Y7RVW9B_&KPCINIV7G:+97,.H02(\!M]/N[8D[UW;B+=%.%R
MZDD,K*-I&6#>U?"S6[K6],MY]0B>*Z,>)4D78^Y&*%RNU-N_;O P  P R,$]
M57C7[3GPJ@\6:=+?!0MW:0M(DF=N8TR\D;8!W#;N*#C#XPRJSYROV5=-L->T
M'RFMHV(F>*YWQ1D2LK^=&6R#O"K(H7=RI!P, $^:^ - LO OC!K)TCDMI&=;
M9Y,;(WR)(]ADW[G26-K8$,&\P,,AP4KW_P =^";+QAJ-I#<P1RF%6N)7*AFV
M)F.&!R,$(\DKR*&.US Z[&!8KYA^VCX8@2QAO\.9S=I'DRRLBJT,A8+&SF-,
MF-"2J@DC))).?6O /AZVU[1-.BO(8YT%E:,%E19%#"!0& <$9P2,]<$^M?/7
M[&OA.S\0?;_MMO#/L^R[/-C27;GS]V-X.,X&<=<#TK5_;G_YAW_;W_[;UZA\
M8/A187.D7LDD8>Y2VEE-TRQFZ9XU\T$R;,@$KM*KM58SY<81 H&?^R-XFFUO
M10DYW?9[AX$)+%M@5)%!))^[YA5<8 15 '&3[56?K?AZVUY!%>0QSH&#!946
M10P! 8!P1G!(SUP3ZU\H?L:^$[/Q!]O^VV\,^S[+L\V-)=N?/W8W@XS@9QUP
M/2M7]N?_ )AW_;W_ .V]>H?&#X46%SI%[))&'N4MI93=,L9NF>-?-!,FS(!*
M[2J[56,^7&$0*!Q7P0^*LND^$[B\N&!-BTL4)8.^3LC,"-@DD>9*(QC:%0*.
M "U:'PXT[2;JU2^U2VFO;ZZC26>>73KR<$MEE5,P21*JJP0&+",JJ0,;0,KX
M.V=SX.U^>RL+>\&BW&YD,T4\<<;B(2;\S1*P^96A&2I8%"S.54GZ4HHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHKY%^->CR_##Q)!X@B0BTEFC=VCC3 8KLN(L$X+O&&<,VPL78@[D9A
M]:VEVEXBRQ,'1U#*RD,K*1D,"."".01P17'_ !E\=+X(TNXO-^R7RRD&-A8R
MN"L>%<X;!^=AS\BL<'&*\J_8Y^'$FB6LNIW*;7NM@AW( _E+EMX;.X+(S#@@
M9$:O\P*D<_\ \U#_ ,_] ZOJJOE7]AC_ )B/_;I_[<5ZK^U'_P B[>?]N_\
MZ415YUH>B/K/P_,49 *PSRG=D#;#>/,XX!Y*H0.V<9('([O]F7XEP^*M+AM2
MR+=6T?E-$"H8I$%5)0N]F*[60,Q 'F;@ !BNZN_',2ZA%I< $LS+(\X61,P1
MHJD,ZYWY9Y(U1<<AF?.%Y^=?A_\ $!/AMXGU.SU+$45Y<LWF'!"L9&E@9F#8
M5&CF.XD$J2N[8 Y'T_K^OP>'H'N[MQ'#&NYW;H!T[<DDX  R6)  )(%<KXWU
M)]4\/75Q+&87DTJ=VB;.Z-FMV8H<A3E2<'(!R.@Z5YU^Q3_R!Y_^O^3_ -$P
M5[_1111117RK^PQ_S$?^W3_VXKZJKY5_YJ'_ )_Z!U=7^VM_R!X/^O\ C_\
M1,]<)\:9I]&TKPWJL*AA:PP'+?=\SRK>2-2 P8@^2V<=AC()&?IKP+XZM?'%
MJE[9/NC;@@\.C#&Z-QDX89Y'(((925()-"\8QZW=7-M -R6OE*\HR4\UM_F0
M@[=I:-50OAC@R!6"D$'H*JZMI<>KPR6TZ[HI8WC=<D95@589!!&02,@@^AKY
M%_9UNY?A=X@GT34&"&91'P4,9E&)(&W-A@&1F" ?,6D563=]W[$K/UO6TTA
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MOPS-X:\&26MR-LHTR]=EPP*^8LTH5@P!# . P(X8$<]:ROV*?^0//_U_R?\
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M;!).YU9F)&%^3! ;:Y'M_BOQC'X?:"(C?/<W$<440SO8%U\V0!58[8XR9')
M4  %E+ U\Z_MS_\ ,._[>_\ VWKZJHHKY5_YJ'_G_H'5[7X^\+:7\1)FTB_3
M=/%;K/&P8)(JRF2(M&0=QVL@+AE,>3%N#' 'SIXQ\!WW[.UU#J5A</+8R7"A
MTW",MC>1#(OS*^8MVV4+\K;F"(=F[[*HKP#]M;_D#P?]?\?_ *)GKU7X3_\
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MF;:%; Q]5>%M"_L*W2 MO<;FDDQMWRNQDFDVY(7?(S-M!VKG:N  *^9?A_\
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MM5!E<9*AC:K;^7E05W[R<J2#A'[J16?^W/\ \P[_ +>__;>OH#XL?\@?4/\
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M97PJ_93LO!,ZWEQ*;N>-B8]R".)#QM;9ER74@D,6P,@A0RAJZKQG\(#XAO\
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MN!^8!OO $;7QI^"T'Q1@CCDD,,T+$Q2@;P VWS%*;E# A1W!! (.-RMJ^$/
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M00<D*<QY+$H22:Y_1OV<K?1;U]3MKV]2ZD:1I'#6V&,A+/E#;;""W."N 0"
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M2.*'S!#&EKG:'()+,;C+,0J@GY5^7*HN3GU7PS975E"([Z9+B48'F)%Y&X
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M?*ABBLE=<,'CD,0+NC*<%0R#&>IVE?2K2T2S18HE"(BA550%55 P% '  '
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M[0GQ*D^'VEO<V_\ Q\22+#"Q4,JLP9BY!(Z(C%>&&_;N4KFN:_95\!C3=/\
M[6N06O;UG=I) WF^66^498DD.1YI88W[ESN"J:]JN[1+Q&BE4.CJ596 964C
M!4@\$$<$'@BO-?A%\/W\ W>H64.1I[M;SVP.6VM()$F3>5!)!B7 W,5382=S
M,3M>,?C1I'@V007UTB2]T >5UX4_,L2N4R&!&[&X<C.#6KX.\?V/C.,S:?.D
MRC[P!(=<E@-R, Z9VG&X#<!D9'-:&M^(;;04$MY-' A8*&E=8U+$$A07(&<
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M:UO$,K8VJZR0[B2%"J940,Q) "@ECV'!KNKN[2S1I96"(BEF9B%55 R6)/
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M),&$:!V<;B^=YPQ;G<>>3537_P!H;0] G>TN;L++$VUU6.:0!NZ[HXV7(Z$
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M@"N%TOX^:)JMTMA!>(T[2&-1MD",PR,+(4$9R1A2&(<D!221GQ3]AC_F(_\
M;I_[<5[UXA\::1I]W!%=RP&]$RQ0KA9+A'F   "AGC#K@%CM4@C<<$5V%>:Z
MI^TCH&F2-#)>H67&3&DLR<@'AXD=#UYP3@Y!Y!%>@:7JT.KQK/;2)+$V=KQL
MKH<$@X920<$$''<$5S.J?%O3=->6-IBY@4M.88IKA8@"X/F-!'(L9&QLAR"
M"2,5K>$/&EIXQ@%W82B6(LR[@""&'52K ,IZ'! )!##@@GYO_;G_ .8=_P!O
M?_MO7T!\6/\ D#ZA_P!>%W_Z)>O'_P!C[5H=(T.XGN9$BB6_?<\C*B#,5N!E
MF( R2 ,]R!7L'_"V-'_Z"%G_ .!,/_Q=:NN^++/P_M^VW$,&_.SS9$BW8QNQ
MO(SC(SCID>M6]+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*M5POQ5^,5E\.
M8&DN'#S[08[=6 E<G(4XY*IE3ER,#! W-A3S_P"SW\3(O$.FVR7=W')J$C7#
M/&TJ>>3YTK?ZL'< $P0  %0# "@5V'C7XIZ9X(VC4+A(F;&$^9Y"#NPVR,,^
MWY2-V-N1C.<"CP5\4],\;[AI]PDK+G*?,D@ VY;9(%?;\P&[&W)QG.17545P
MOQ5^,5E\.8&DN'#S[08[=6 E<G(4XY*IE3ER,#! W-A3S_[/?Q,B\0Z;;)=W
M<<FH2-<,\;2IYY/G2M_JP=P 3!   5 , *!7E_\ S4/_ #_T#J]PM/CGHMY=
MKI\5Y&\[L%4+N:-F(R%$H7RB3T #9+?)][BNZKS75/VD= TR1H9+U"RXR8TE
MF3D \/$CH>O."<'(/((KT6TNTO$66)@Z.H964AE92,A@1P01R"."*EK/\0ZV
MF@VTUY*"4@ADE8+@L512Y R0,X'&2!GN*^9?V<[*;XIZI<>(-6'FF#8L"E&\
ME')+ 1Y.T>4HX4ACND$A/F89OJJO*K[X:?V%K]MJ^GKL2Y^T17RJ,J<Q-+'+
MC80F9(P)&W+N?9P2[EO0/$WBNU\+PFYOI4AB&?F<XR0"VU1U9B%)"J"QQP#7
M*^&?CYHGB686UK>(96QM5UDAW$D*%4RH@9B2 %!+'L.#7?URNG_%72]1F>W@
MNX9'CMVG<HX:-8E(5F:09C&"1D%MP'S$8YK*TOX^:)JMTMA!>(T[2&-1MD",
MPR,+(4$9R1A2&(<D!221FUXQ^-&D>#9!!?72)+W0!Y77A3\RQ*Y3(8$;L;AR
M,X-=+;>(;:Z@^V1S1M;A68S*ZF+:N=[;P=N!@Y.<#!STK%T[XJZ7J/GF*[A9
M+;RO.DW@0KYN?+_>G$9R1CY6.&^4X/%5/!WQHTCQE(8+&Z1Y>R$/$[<,?E65
M4+X"DG;G:.3C(KJ]4U:'2(VGN9$BB7&YY&5$&2 ,LQ &20!GN0*XJ?X\Z/;>
M29IWB6XQY+RV]S#&X.WY@\D2IM^8$MG: 020.:[^N5T_XJZ7J,SV\%W#(\=N
MT[E'#1K$I"LS2#,8P2,@MN ^8C'-9^B?'/1=;N396]Y&TP8J =R*S;@@5'=0
MDA+$;0C,6'*Y'-:MW\3=*LW:*6^M4=&*LK7$2LK X*D%\@@\$'D&M#3_ !99
MZC"]U!<0R01[M\J2(T:[0&;<P)484@G)X')XJ+1/&]AKSF*SNH)W"EBL4L<C
M!00"Q",3C) STR1ZUD_$728M418S91WEP5D$)FA22&(D*-\C2$;4W;-RH3*Z
M@E$?8VWH/#VB)H-M#9Q$E((8XE+8+%44("< #.!S@ 9["N*U_P#:&T/0)WM+
MF["RQ-M=5CFD ;NNZ.-ER.A .0<J<$$5V'A[Q7:^)%=[*5)DCD\MGC.Y-VQ7
MP&'RM\KKDJ2 <@G((&K17RK^PQ_S$?\ MT_]N*^@/B/X%T_Q=:O'J:)Y:QN?
M..U7A'#-(LC#Y,;02?ND##@KD5XK^Q+XFFO;6[L9#F*WDB>/)8E?-\S>HR2
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M4A69I!F,8)&06W ?,1CFI? _Q(T_QRCR:=.)A&P5QAT921D95U5L'G!Q@D$
MDJ<<UJG[2.@:9(T,EZA9<9,:2S)R >'B1T/7G!.#D'D$5Z+:7:7B++$P='4,
MK*0RLI&0P(X((Y!'!%<?XQ^-&D>#9!!?72)+W0!Y77A3\RQ*Y3(8$;L;AR,X
M-:O@[Q_8^,XS-I\Z3*/O $AUR6 W(P#IG:<;@-P&1D<UXW\5/VC;;[?9:;IU
MP-GVVU>ZN4=1"(O,4F+?T((^:1@P4*-A+;G5?=-$\0VVO(9;.:.= Q4M$ZR*
M& !*DH2,X(..N"/6N%U3]I'0-,D:&2]0LN,F-)9DY /#Q(Z'KS@G!R#R"*]
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M" QY&,<;%.1&IK6\8_ Y-<U>UURWG-O- T?FJJ ^<J-T+*R,"R$QL3O!3:N
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M_P"<Y;FOGK]AC_F(_P#;I_[<5G_&+P];:#XMTF*SAC@0M8L5B18U+&[<%B$
M&< #/7 'I7JO[2GB1Q%::)"QC?5+E(&E )V1;XUDZ.A))D4%>59-ZG&0:]0T
MOPI:Z5:KI\,2+:K&8_*QN0J<[@P;.[=D[BV2Q)+$DDUYU\.O@._@2VO[.VO9
M"EVK"$[2K6[%702#;( SX9,LHC),8Z<;3X->#D^#&F&'5;J!#+<NY<N(X@S(
MJJ@:39N.V/=T4]0 0NX^5?LU7(C\3ZI#;YCMRMTRQ;6B4!;I!'F,A=I56( *
M@H"5P,D5+^W/_P P[_M[_P#;>OH#XL?\@?4/^O"[_P#1+UY5^Q3_ ,@>?_K_
M )/_ $3!7"7^AQ?!OQ=#<.H2PNF<HVQ-D8E!1E#,J)&(Y""=ARD! ).XJ?HK
MXC6B:T+?374.+BYB:12 X$5NPN79D/WD9HTA8G"J9ESDD(W845Y5^U'_ ,B[
M>?\ ;O\ ^E$59_[/NMIH/A2&\E!*00WDK!<%BJ33N0,D#.!QD@9[BL#]E:T3
MQ8+SQ!>*)+V6]=0S -Y2B-2%B+[G0;92F-Q&Q47H.>?_ &J_"9\&SVOB+2R+
M>83&.0QA4)D;?(LF F'+#S%E+D[QM4J1NKZ4\/:VFO6T-Y$"$GACE4-@,%=0
MX!P2,X/."1GN:T*\J_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#MX_\ 2B6O(-4T
MN/5?'[03KNC;&Y<D!@-/!VM@C*G&&4Y5U)5@5)!ZK]MK2XY=-MKDK^]2[\M6
MR>%DC=G&,X.3$AR1D8X(R<GQ8\=3ZAI.C63O,9M5^RBX,/E(\D;)'Y\8+%51
MG:5<#A"-RN0A(/HMVB75HVFMHLXM&4J85.GI'@G<<!+P;3N^8%<$-\P(;FN:
M_9?\)ZOX1M9['58O+B617M\R)(?GW>:HV2.%4$*P&%^9W/.>/:J\J_:C_P"1
M=O/^W?\ ]*(JY7]BG_D#S_\ 7_)_Z)@KW^BOFO3=0A^*GB^:"[3?:Z=;SI%"
MZJT;.KI#*SHQ=3EG8@C:2$B)Y4@]K^TU\-(?%6ES705%NK:/S5E(4,4B#,\1
M;8S%=K.54$#S-I) S1^SWXD7XCZ$B:B/M+1R-#-YZHZR%"LD9(.=^$9/F8;B
MZDG)^8^2? ;0()/%NI1; (X6O&CC'RQJ4NXQ'\BX4A>"@((5E5E 9%(M_ML6
MPTZYT^^AREP5F7S%9@P$31O'C!^4JTC$$8.3UX&/</B/X4M=.T/4(8HD"&TN
M9&R-Q:18BPE=FRSR[E5C(Q+E@&+$C->:?LE:3#XET-X+Z-+B*._D\M)E65$_
M=1'Y5<$+R['C'+,>YSPO['?@ZV\2F]^V()HXFM6$3JKQ%RMP@=E93N*JS!03
MM^8L5+*C+H?M1_#2'P+):Z[I2I;L+A%9$"A!*H\R&1(]A0?ZMMX^Z2%.TDN3
MZ+\5?AQ<_&ZPTVXMYA;(RI-+$Q9UVS1HVX;<!WC&0H(4,';YDY!/VJM?LKC1
M[JT+QO=1M;L(QB26,F6/]X0,M$"C%=[;0=X3.9%#:O[/-HGB'PU:17JB="LJ
ME90)5*I<2"-2'R"%"J%'10HQC KQKX)>%+74/%6J6LL2-;I]MVPD?N<+=1JJ
MF,?(RCJJL"JL%8 ,JD:'[;%L-.N=/OH<I<%9E\Q68,!$T;QXP?E*M(Q!&#D]
M>!CL/VOOAI_;]BNIP+F>TSOP,LT+'YNB%CL;#C)"HAE8\FO0/@UXZM]>T6WO
M-Z(L5N$GSY<:QM$H63*H0D:\;U'R@1E3A0<#5^&6D_8;)96C\J6YDENI4*[7
M5[AVF,;\ LR!A$6(!(0<+PHZJN?^(7G?V;>?9=_G_9+CRO+W>9O\MMFW;\V[
M=C;CG.,<UX!^RW\;-+TBQ72KIDM9UDD;S'PL<VXL^]GP%5E4!/G(R @5B3M7
MWKP1X#@\&BX2T 2*>Y,ZQJ-JQEHXD91R>"R%@!M"AMJJ HKI:*^*_P!E+P[J
M.L_;?[-O_L6W[-YG^CQW&_/G;?\ 6$;=N#TZ[N>@KUKX@?"/Q%JUMY9U4W:;
MLR6ZQ1V#2IM8/&)8PX)8':%D'EY.Y_N@'5_9<\7Z=K.G&VTZ$V[6[#SHV/F,
MS/G;*9 J!RX0YX4J5VA0@3/(:;J$/Q4\7S07:;[73K>=(H756C9U=(96=&+J
M<L[$$;20D1/*D'M?VFOAI#XJTN:Z"HMU;1^:LI"ABD09GB+;&8KM9RJ@@>9M
M)(&:A^!'BB?XB>'FC>>1;I5GMFN#]\/MS'("K!F*I(GS$JQ922<_,;?P:\')
M\&-,,.JW4"&6Y=RY<1Q!F155 TFS<=L>[HIZ@ A=Q\J_9JN1'XGU2&WS';E;
MIEBVM$H"W2"/,9"[2JL0 5!0$K@9(K*^//@ZVL_$^FV=F@M4E6S!-NJP,K-=
M2(9%V+@.!C#8)! ]*]J\8^!M'^&=L^N6UM'%<65LRP,/-VERK11AU1AO+-(%
M9WRQ!RSC&1E?LK>%T:Q;7)L27M_-.\DNT*P7S64H,': 74N=H4$D @A%->7_
M !A\,PZ)XRL'@&W[1<6,[@!0N\W!C8@ #[WEAFSDEV8D\X'U_17SA\2];3QU
MXKL= F!^RVS&65#C;)+Y)N%# ED=-@5>5#8>5<X8&O5?BC\*+;QIISV*QQHZ
M0E;5MJKY3#:453L8HA**KA!DID#M7G7['/CJ37=/ELIW=WM)$"%L$")U/EQ@
MYW':R/P?NJ553@ +RG_-0_\ /_0.KZJHKE?BQ_R!]0_Z\+O_ -$O7E7[%/\
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MSE0"QRQ.3DY)]37T!\:O#UMJFE7DMQ#'(\-E=M$SHKM&WE,=R%@2IRH.1@Y
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M6(^[M5?-?V=[M+SQ;JDL3!T=;YE92&5E-W$0P(X((Y!'!%2_MS_\P[_M[_\
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MO#.K21D -DN&8D+*< %Q7-?LC7=SIPU'1KE@PL;D*I!9@&9I4D5=V,)NBW*
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MF/VG8'F+1F<*CI((U/E[57<@)&W+=R=J;>J^'GP<TSX?Y:PAVRM&J/*S,\C
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M0MQ,(_,^5@Q4$A3P<'!) 4#V7X>?#"Q^'\)@L(]N[:9'8EI)"HP&9C^)VKA
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M,^XJ< #"J$C.#\RDJ6#<@Y"XMZI^SEH>KR-/<V[RRMC<\ES=.YP !EFF).
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M>XN3@$EMJCS<*H+$A5 49X KJO#/AB#PU"+:U#B)<;5>66;:  H53*[E5
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MI&S>RCC 9SNP ^X$@ZL'[,^C&\FU"XC>XEFN#-ME?,:L79R B! RDGE9-X(
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M=L;9,A!P0%#'.W R16WI.J1ZO#'<P-NBEC21&P1E6 93@@$9!!P0#ZBO/_\
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MB>;RDG,,XMF?<RX$YC\DC*M\P?;@$YP":VM+^(6FZO(L%M>6TLK9VI'/$[G
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MV2=!(8FM&C#?,JOF8B0*?EWC'ROC<@+!2 S9M_&>V&D>,].FM\QO.UBTC*S
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M)1MOEJ0%Y(WL-R@E>@_;$_XF5G9:;%\UU<7Z>3'TW81XS\QPH^:5!\Q'WL]
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MI5 ;:=K @AE8'U# $9!!(PP(R">"_"$'@ZTBL+0$11*0NX[F))+,Q/J6))P
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MCY=V[!!Q@YKI:**********************JZIJT.D1M/<R)%$N-SR,J(,D
M99B ,D@#/<@5G^%?&EIXL226QE$R1S-$S*#MWJ 2 2 &&&!#+E2#P36U1117
M/^$O']CXO\W[!.DWDR;)-I/!['D#*G!VNN4;!VL<''0444444444445Q]C\7
MM)U&[CTZWNHY;B52R+$3*I #,<N@:,$!"<%@<8XY&>PJ*[NTLT:65@B(I9F8
MA550,EB3P !R2> *RO"'C2T\8P"[L)1+$69=P!!##JI5@&4]#@@$@AAP03M4
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444445P'QG^*7_"O[56AC\Z\GD$5M".2SG^(J#O
M91P"$&2S(F5W[A:T+X36=K"R7R)>SRR"6XFN(T=I90"H;:P*HJJ2L:+\L:'
MY+%O"OV&/^8C_P!NG_MQ7TKH7BRS\0;OL5Q#/LQO\J1)=N<[<["<9P<9ZX/I
M65\0_!7_  DL(>!O*OH-SVDX.UHY<8 )VMF)N%E0JRNG520I&5\&/BE_PL"U
M9IH_)O()#%<PG@JX_B"D[U4\@!QD,KIEMFX]_7'_ !BM$NM&OUD4,!97# ,
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M47=VEFC2RL$1%+,S$*JJ!DL2>  .23P!6?J'BRSTZ%+J>XAC@DV[)7D18VW
MLNUB0IRH)&#R.1Q6A:7:7B++$P='4,K*0RLI&0P(X((Y!'!%96M^-[#07$5Y
M=00.5#!998XV*DD!@'8'&01GID'TK0LM6AO\>3(CYC20;65LH^?+?@GY6VG:
MW1L'!.#5JBBOE#]N6T17T^4* [+<JS8&XJIA*J3U(!9B!T!8XZFOJJTM$LT6
M*)0B(H554!550,!0!P !P . *^:OA7K;^)_&>H2W0#&WAN8H<Y(C6*>.%2FX
MMM)4L6VX!+OP Q%>P6WP6TZUU;^W8T*W)5LA3B+>P*O+M ^^5)!YVG)8KO.Z
MNZJKJFK0Z1&T]S(D42XW/(RH@R0!EF( R2 ,]R!6?HGC>PUYS%9W4$[A2Q6*
M6.1@H(!8A&)QD@9Z9(]:VJSXO$-M*DLJS1E(&=9F#J5C9!EU<YPA4<L&P5'7
M%&B>(;;7D,MG-'.@8J6B=9%#  E24)&<$''7!'K6A17R7^T%I,,OB[34:-"L
MWV'S054B3-R\9WC'S910ISGY0!T %?6E5;?5H;F22".1&EBV^8@92Z;AE-R@
MY7(Y&<9'(JIH7BRS\0;OL5Q#/LQO\J1)=N<[<["<9P<9ZX/I4NM^(;;04$MY
M-' A8*&E=8U+$$A07(&< G'7 /I46E^++/5U5[:XAE5I#&ICD1P7"&0H"I.6
M" L5'.T$XQS65\0?"VEZQ&D^L)"8K>0.KS,$1"2!@L2H*L< HV4<[0RG KJJ
MY_Q-XLTW3LVNH7%M'YD9S%/)$NY&RIRLA&5.".F#R/6OFO2])ATCQ^L%M&D4
M2YVI&JH@SIY)PJ@ 9))..Y)KZTKG]+^(6FZO(L%M>6TLK9VI'/$[G ).%5B3
M@ DX[ FN@K*E\66<4<D[7$(BAD,<KF1 D;@@%';.%8%@"IP<D#'(K0M+M+Q%
MEB8.CJ&5E(964C(8$<$$<@C@BI:^1?C%X>MM!\6Z3%9PQP(6L6*Q(L:EC=N"
MQ" #. !GK@#TKZZHJK_:T/G?9?,3S_+\SRMR^9LSMW[<[MN[C=C&>,YJII_B
MRSU&9[6"XADGCW;XDD1I%VD*VY02PPQ .1P>#S6K7/\ _"PM-\[[+]LMO/\
M,\ORO/B\S?G;LV[MV[=QMQG/&,UT%%%%%<_JGQ"TW2)&@N;RVBE7&Y))XD<9
M (RK,",@@C/8@UMPW:3EE1@Q1MK@$$JVU7VG'0[65L'G!!Z$5+17/ZI\0M-T
MB1H+F\MHI5QN22>)'&0",JS C(((SV(-=!7S7^VUXFFLK6TL8SB*XDE>3!8%
MO*\O8IP0"N9-Q!!^94(QCGU_X@_!_3_'5JEE<Q[$BQY+1;4>(# VI\I4*5 4
MJ05P <952.KTG2X](ACMH%VQ11I&BY)PJ@*HR22<  9))]35JL76_&]AH+B*
M\NH('*A@LLL<;%22 P#L#C((STR#Z5JVEVEXBRQ,'1U#*RD,K*1D,"."".01
MP11=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %9\_BRSM_)WW$*_:,>1F1!YN=N/
M+R?GSN7&W.=P]16K16+K?C>PT%Q%>74$#E0P666.-BI) 8!V!QD$9Z9!]*T+
M+5H;_'DR(^8TD&UE;*/GRWX)^5MIVMT;!P3@U:HHKG]+^(6FZO(L%M>6TLK9
MVI'/$[G ).%5B3@ DX[ FMNTNTO$66)@Z.H964AE92,A@1P01R"."*S_ /A+
M+/[/]N^T0_9?^>_F)Y/WMGW\[?O?+U^]QUJWI>K0ZO&L]M(DL39VO&RNAP2#
MAE)!P00<=P14MW=I9HTLK!$12S,Q"JJ@9+$G@ #DD\ 5E:)XWL-><Q6=U!.X
M4L5BECD8*" 6(1B<9(&>F2/6MJN?_P"%A:;YWV7[9;>?YGE^5Y\7F;\[=FW=
MNW;N-N,YXQFMN[NTLT:65@B(I9F8A550,EB3P !R2> *\O\ A!\7O^%BWVH^
M0<V=O]E6WRFQCN$WF2'.6^9E&T'&$"Y56+9]%UOQ#;:"@EO)HX$+!0TKK&I8
M@D*"Y S@$XZX!]*BTOQ99ZNJO;7$,JM(8U,<B."X0R% 5)RP0%BHYV@G&.:U
M:*S];\0VV@H);R:.!"P4-*ZQJ6()"@N0,X!..N ?2HM"\66?B#=]BN(9]F-_
ME2)+MSG;G83C.#C/7!]*U:****Y7P5X6TOPU)<P:8D,<ID5[A(V!=2X)0,N2
M47&3&GRH 2449-=+=W:6:-+*P1$4LS,0JJH&2Q)X  Y)/ %96B>-[#7G,5G=
M03N%+%8I8Y&"@@%B$8G&2!GIDCUK0U328=7C:"YC26)L;DD570X((RK @X(!
M&>X!KY:_9WM$L_%NJ11*$1%OE55 5547<0"@#@ #@ < 5]2ZIJT.D1M/<R)%
M$N-SR,J(,D 99B ,D@#/<@5GZ)XWL-><Q6=U!.X4L5BECD8*" 6(1B<9(&>F
M2/6H?'7CJU\#VKWMZ^V-> !R[L<[8T&1ECC@<  %F(4$C%^!_B^?QCI,%_=D
M&65IRVT;5 $\BJH'H%  R22!EB3DG0N/"VEVVIQW\B0KJ,L;)&Q8"5PJ_.54
MGYF"<%P"X3Y2VSBNJKG_ /A86F^=]E^V6WG^9Y?E>?%YF_.W9MW;MV[C;C.>
M,9KH*JZAJT.G;//D2/S)%C3>RKN=L[47)&6.#A1R>PJIJ'BRSTZ9+6>XACGD
MV[(GD19&W$JNU20QRP(&!R>!S6K117/_ /"PM-\[[+]LMO/\SR_*\^+S-^=N
MS;NW;MW&W&<\8S705\R_M&ZV^H>(=(TJ4!K7SK65HSDJ[27!B(=22C (F%R,
M@.XR0V*]@^(_P6T[XAO#+?(=\+##(=C.F<F)SC)0GGC#*<[&7<V>ZHKFKOXF
MZ59NT4M]:HZ,596N(E96!P5(+Y!!X(/(-=+57^UH?.^R^8GG^7YGE;E\S9G;
MOVYW;=W&[&,\9S533_%EGJ,SVL%Q#)/'NWQ)(C2+M(5MR@EAAB <C@\'FM6L
MK_A++/[/]N^T0_9?^>_F)Y/WMGW\[?O?+U^]QUJWI>K0ZO&L]M(DL39VO&RN
MAP2#AE)!P00<=P17R?\ MJ^'K;2WLI;>&.-YFNVE9$5&D;,)W.5 +'+$Y.3D
MGU-?6MW:)>(T4JAT=2K*P#*RD8*D'@@C@@\$5S_@#0=.T"!K321&L44SK(L;
M^81+QO5V+,V\< ACN VKP !6WJFK0Z1&T]S(D42XW/(RH@R0!EF( R2 ,]R!
M530O%EGX@W?8KB&?9C?Y4B2[<YVYV$XS@XSUP?2M"[NTLT:65@B(I9F8A550
M,EB3P !R2> *Q-+^(6FZO(L%M>6TLK9VI'/$[G ).%5B3@ DX[ FO.OVJO#U
MM/HMU>/#&UPBVZI,44RJOVB/Y0Y&X#YFX!QR?4U-^SAJT.D>&;2>YD2*)?/W
M/(RH@S=2@99B ,D@#/<@5ZKI>K0ZO&L]M(DL39VO&RNAP2#AE)!P00<=P17S
MU^V?X>MH-.CO$AC6X>]B5Y@BB5E\F;Y2X&XCY5X)QP/05[+\)_\ D#Z?_P!>
M%I_Z)2M#6_&]AH+B*\NH('*A@LLL<;%22 P#L#C((STR#Z5JVEVEXBRQ,'1U
M#*RD,K*1D,"."".01P14M5=4TF'5XV@N8TEB;&Y)%5T."",JP(." 1GN :^6
MOV=[1+/Q;JD42A$1;Y550%55%W$ H X  X ' %?55W=I9HTLK!$12S,Q"JJ@
M9+$G@ #DD\ 5B:7\0M-U>18+:\MI96SM2.>)W. 2<*K$G !)QV!-=!111115
M75-6ATB-I[F1(HEQN>1E1!D@#+,0!DD 9[D"JFA>++/Q!N^Q7$,^S&_RI$EV
MYSMSL)QG!QGK@^E:M9[^(;9#,IFC!MU#3C>N8E*EPTG/R J"P+8! STJ;2]6
MAU>-9[:1)8FSM>-E=#@D'#*2#@@@X[@BK55=4U:'2(VGN9$BB7&YY&5$&2 ,
MLQ &20!GN0*AF\0VT$ZV;S1K<.NY(2ZB5E^;Y@A.XCY6Y QP?0T:WXAMM!02
MWDT<"%@H:5UC4L02%!<@9P"<=< ^E&B>(;;7D,MG-'.@8J6B=9%#  E24)&<
M$''7!'K6A7/_ /"PM-\[[+]LMO/\SR_*\^+S-^=NS;NW;MW&W&<\8S70445P
MOQJ\/6VJ:5>2W$,<CPV5VT3.BNT;>4QW(6!*G*@Y&#D#T%>=?L4_\@>?_K_D
M_P#1,%>U:[XLL_#^W[;<0P;\[/-D2+=C&[&\C.,C..F1ZU+HGB&VUY#+9S1S
MH&*EHG610P )4E"1G!!QUP1ZUYK^T-\:4^'EH8K=Q_:$R_N5P'V+G#2L"<
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M(D3:/+*^=*@CVG.5" +ALD@?,222?"M+TF'2/'ZP6T:11+G:D:JB#.GDG"J
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MY<D>A![UGF+4/VFKV.4K';Z?:LJL@E0RJ'*&7'R%R[J#L+(L7R;<[@Q;ZO\
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M. ,8 QY_^RUXOGOA=^&]6(D:U4HD3CS#Y89HIXF;YD9%8JJ@YX8@%D "\?\
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M *^,%59\VOV5=-L->T'RFMHV(F>*YWQ1D2LK^=&6R#O"K(H7=RI!P, $^:^
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M_MT_]N*Z;]L^Y%Q86EBF6N)KU6BC569G"QNC8P#D[I4 '4EN <''M_A/0O\
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M=+DO=%62-<K#=Q22'(&U2LD0/)&?GD48&3SG& 2.V^ GB:'Q!HMF\!SY5O'
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M; 1MSDMD+L:7Q;\,X-&TJ^N[@FZO_P"SKL-=S?-)DQ3$B-22L"?O& 2+:-I
M.[&3S7[%/_('G_Z_Y/\ T3!7*? +_D<-6_[?_P#TLCKTO]K#5([+0)XY&PTT
MD$<8P3N82K*1P#CY(V.3@<8SD@'BO$_AF;PUX"-K<C;*(X79<,"OF7B2A6#
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M[G5F8D87Y,$!MKD>W^*_&,?A]H(B-\]S<1Q11#.]@77S9 %5CMCC)D<D!0
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MHV.C(J@.2X0$FO2O OQI\)^![5+*RN=L:\DF&X+NQQND<^2,L<<G@  *H"@
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M[E=FR020(4V<KL"6ZA,'YAM ^8EOO$D]U=^$)KJV:U:^N@68DS+]F2;:5VE
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M3">_N[QMNX1HKP+'&&.2JJ(/H-S9<@*&8X%>@>&=#;1(1 \\UQMP \YC:3
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M;Z^2Y;?OD,D#E]_+;P]NP?)^8[@?F ;[P!&K\3O@1;?$B1)+ZXN=L>[RXXS
MJ)N"!\$P%SG8"=S-@YQ@<5%K_P #!KAM3-J%[FT681RJ\27/[Q8D_P!:D2Y
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M1_\ H'V?_@-#_P#$4?\ "I]'_P"@?9_^ T/_ ,11_P *GT?_ *!]G_X#0_\
MQ%'_  J?1_\ H'V?_@-#_P#$4?\ "I]'_P"@?9_^ T/_ ,17E7Q#_927Q=,)
M(Y[:TB3<$CM[%(^"<@NRS NV,#/"\95%W-GT#PS\&K&RA$=]:V-Q*,#S$L88
M-P  RRYD&XD$DKM7G 08YU?^%3Z/_P! ^S_\!H?_ (BC_A4^C_\ 0/L__ :'
M_P"(H_X5/H__ $#[/_P&A_\ B*/^%3Z/_P! ^S_\!H?_ (BC_A4^C_\ 0/L_
M_ :'_P"(H_X5/H__ $#[/_P&A_\ B*/^%3Z/_P! ^S_\!H?_ (BC_A4^C_\
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M%3Z/_P! ^S_\!H?_ (BC_A4^C_\ 0/L__ :'_P"(H_X5/H__ $#[/_P&A_\
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MXW/(RH@R0!EF( R2 ,]R!7G^E_M(Z!J<BPQWJ!FS@R)+"G )Y>5$0=.,D9.
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M@A26,D#DX\Q%#$#G R< G& 2.JU_7X/#T#W=VXCAC7<[MT Z=N22<  9+$@
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M;2RMG:D<\3N< DX56). "3CL":F\7^-+3P= ;N_E$4095W$$DL>BA5!9CU.
M"0 6/ )'-:!\?-$U]MEO>(SF2*-4*R1NS2OL0*KHK/\ ,>2H(0<N5'->?_M(
M_M!0^';=].TV;=?295GB93Y #8<%AG$IP5"C#IRY*D)N]JT+Q99^(-WV*XAG
MV8W^5(DNW.=N=A.,X.,]<'TK5KC_ !_XTTC0 IU:6!3$R31I(%DE#;BJ2I&
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M!NJZUJ-IK.BZ;)#=P,3,\DMJGFA=@C5O*NSN&W>C_=+(0A)4 +]'UROQ8_Y
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MQ2J'1[V965@&5E,$ *D'@@C@@\$5Q^EZ3#I'C]8+:-(HESM2-51!G3R3A5
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M));=0^]V$TA2*Y?/R%7 '65 Y5FR6^BJS];\/6VO((KR&.= P8+*BR*& (#
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M!FK7[,_CJ3QAHT<EP[R3PR/#([XRQ7#(<@Y;]VZ LWS%@2<GYCZK7RK\??\
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M\S&,!1N(4L6"@JU=U7SK^VEX.DU.Q@U",Y6TD<2+Q]V8HH?)8='15P 2=^>
MIKV#X7^.H_'&GP7L;HSM&HF"9 24*/,CPQ+##'@'.5(8$@@GQ7P?H7_"5>-K
MW4H&S!985SCK*;?[,8\,58?,LAW ,O[O'1E-9/[<_P#S#O\ M[_]MZ^JJ*^=
M?'WC.;QEXFB\,2,\5BN?/$3LCSYM3,4=EP1$0=A0=068MG9LB_;#M+;1M&MK
M.W6.$?;0R0H%C&T1S;V5%QP&<;B!C+#/+<^R_"?_ ) ^G_\ 7A:?^B4KY_\
MV&/^8C_VZ?\ MQ1\??\ D<-)_P"W#_TLDKZ*\?\ @Z/QG8SZ?,<+-&0&Y.U@
M0T;X#+G:X#8R V,'@FOG#]EZ:]N)WT*[4B'3[EYWSF1!(N^+[,<,8\><1<1X
MZ20LX#$AT^KZ*^4/C$K_  Y\66NN2$?9[ADW,RDA%6-;:X&$8NQ6-@X. "6
M ;:<_3]WK\%K;-?,X-NL)E,B_.OEA=Y<;,[AMY&W.1TS7@O[%O@Z33+&?4)#
MA;N1!&O'W82ZE\ACU=V7! (V9Y#"N?\ ^:A_Y_Z!U?55%?*O_-0_\_\ 0.KU
M7]J/_D7;S_MW_P#2B*C]ES_D7;/_ +>/_2B6O*O@%_R.&K?]O_\ Z61UE? #
MXC?\*EOKG0-8/EQM<?+(?EC24#;O)95;RI%"%7/RJ K;0K,R^]>+_C;86$!%
MA<075Y*RQ6T,<L<I>:3Y8@P60;4W8WL64 < [BH/HM17=HEXC12J'1U*LK ,
MK*1@J0>""."#P17QU\+96^!?B.33M0DQ;31[/.)>.$AL/#,000<$&,G.V-FD
M_>;58G[%M+M+Q%EB8.CJ&5E(964C(8$<$$<@C@BLK6_%"6+BVBQ+=NH9( P#
M;22/,?@F.$$'=(01D;4#R,D;?,MC<_\ "I_&<K7CHEM?><WFN, ).QD4_*QV
MXG3RRS\;07(52"/?_C7JD>F:+?R3-M4VDT8."?FD4Q1C@'J[@9Z#.20,FN5_
M95\'2>&M%C:8_-=2-<A>/E5U18QD,<Y1 _8C=M(!4UYI\ O^1PU;_M__ /2R
M.C]N?_F'?]O?_MO7T!\6/^0/J'_7A=_^B7KRK]BG_D#S_P#7_)_Z)@KC_@1=
MI!XQU178*7:_5 2 6;[4C[1GJ=JLV!S@$] :]%_:X\30Z9HDEK(?WMU)$D:@
MKGY)$E=B"0=H"8) .&9 <;LUY_\ $;Q-??!;P]I^D0'9<W$<_F2@@/%\PDDC
M3:6&[,VP2!N I90&92GK?C'PA9>!]"U!8@%+V5P)9Y"#--(R2!6ED."[M)(<
M9_B;:@ (%<?^Q3_R!Y_^O^3_ -$P5RGP"_Y'#5O^W_\ ]+(Z/VY_^8=_V]_^
MV]?4&K:7'J\,EM.NZ*6-XW7)&58%6&001D$C((/H:^1?@]I%[X:U>Z\)R9>W
MDF1Y6P641Q,LNXHKL@2XBVPR*QZ2(K$[3&WV)17/^//&,?@VT:^G'[I)( YY
M^59)DB9^%8G:'+8 RV,#&<UYA\4?V4].\3H\M@HM+K:=NSY;=F 4 /& 0HPN
M,QA2"Q=@YX,O[(WB:;6]%"3G=]GN'@0DL6V!4D4$DG[OF%5Q@!%4 <9/M5?)
M=C<_\*G\9RM>.B6U]YS>:XP D[&13\K';B=/++/QM!<A5((]_P#C7JD>F:+?
MR3-M4VDT8."?FD4Q1C@'J[@9Z#.20,FN5_95\'2>&M%C:8_-=2-<A>/E5U18
MQD,<Y1 _8C=M(!4UYI^PQ_S$?^W3_P!N*/VY_P#F'?\ ;W_[;U] ?%C_ ) ^
MH?\ 7A=_^B7KYJ^$WAF;Q+X,U*UMANE-VSJN&);RUM92JA026(0A0!RQ XZU
MVO[-W[05G<V*:=J4R03VL857E9(XY(@<( QVJ&5<*5/S, '!8E]OJ$/Q7MM8
MU"#3M,DCN2RR2W#QLLB1PJK*#N5\;S,8P%&XA2Q8*"K5X?\ MS_\P[_M[_\
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M\\6ZI+$P='6^964AE93=Q$,"."".01P14OQ]_P"1PTG_ +</_2R2OH#XL?\
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MW2,%!95!8@#<U@$1>>Y8A0.I) ')KW#X]^)H?#^BWCSG'FV\D" %=S/*IC4
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M\HP.65W/4GYF."QQ@<5Z+X0\%VG@Z 6EA$(H@S-M!))8]6+,2S'H,DD@ *.
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M]_\ MO7JNJ?LY6.H,R>?>)9M('-C'.4LOOB1E$>WY5+Y8A6&TD[-N!CT70-
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M! JA2[,%5.6(;H/AQH+Z#8QVS@J$:78C.9&CB:5VAB+%FR8XBL9PS*"N%9E
M)Z6N \3? ;1_%$QN;Z!YI3GYGN+DX!);:H\W"J"Q(50%&> *U?\ A6-E]C_L
MW$WV7IY?VFZ^[L\OR]WG;O*V\>7GR^^W/-5/!WP;TSP9(9M/B>%C]X">X*-@
M,!N1I2CXW'&X':3D8/-<UX\_9@TCQE.;MUD@E=F:1H&51(QQ\S*Z.H/&25"E
MBS,VXG-=A\//AA8_#^$P6$>W=M,CL2TDA48#,Q_$[5P@)8JHR:ZJHKNT2\1H
MI5#HZE65@&5E(P5(/!!'!!X(KR6W_9BL=,DDDT^ZOK)9-NZ.VN2B?*,#EE=S
MU)^9C@L<8'%>B^$/!=IX.@%I81"*(,S;0226/5BS$LQZ#))( "C@ #FO$WP&
MT?Q1,;F^@>:4Y^9[BY. 26VJ/-PJ@L2%4!1G@"NJ\,^&(/#4(MK4.(EQM5Y9
M9MH "A5,KN54  !00H[#DUJUPOC/X+Z?XPN?MUT)/M"PI'%(DCQM"4:1UD38
M1\X9\Y;< 57"CYMU30/@;::;.EW<S75]+"VZ!KR<SB)N[(N%7)X.6#$%59<$
M9K0\8_!O3/&<@FU")YF'W09[@(N0H.U%E")G:,[0-Q&3D\U;T+X8V6@6[65J
M)HH&Q\BW-T-N&+_(?.W1Y8DML*[\_-D5E>&?@-H_A>87-C \,HQ\R7%R,@$-
MM8>;AE)4$JP*G'(-5/B5^SWI?Q!D^T7*/'<?*&FA8([!00%8,KH>H^8KOPJK
MNVC%:'PS^"VG?#D$V2$RLNUYI#OE9=Q;;D *HZ9"*H;:I;<0#7=5E>)O#$'B
M6$VUT',39W*DLL.X$%2K&)T+*02"I)4]QP*Y7PS\!M'\+S"YL8'AE&/F2XN1
MD AMK#S<,I*@E6!4XY!H\3? ;1_%$QN;Z!YI3GYGN+DX!);:H\W"J"Q(50%&
M> *U==^&-EK]NME=":6!<_(US='=E@_SGSMTF& *[RVS'RX%'@KX7V'@C<-/
MC>)6SE/.G>,D[<MLDD9-WR@;L;L#&<9%<?IO[,FEZ7+(]N]U'!,NV6U2XD2W
MD784VOMQ*P^8M@R$9)'W25K0NOV=M&OKU]0G@\QV\C9&3M@C$*+&JK&FU2I5
M5RK[UXP  2#;\4? S3/$DRW,J.DL5O'#;M$[0^0(R[(\0CP P+Y&X,HVKA1S
MF'0/@;::;.EW<S75]+"VZ!KR<SB)N[(N%7)X.6#$%59<$9K5^)GPJLOB- +>
M^4Y1MT<B$+*AXW;20PPP&&!!!X.-RJ1-X%^&]OX-C2.)YI62/RUDGE:5U3(.
MQ0<)&O"@K&J!@B;@Q4&NJK@/$WP&T?Q1,;F^@>:4Y^9[BY. 26VJ/-PJ@L2%
M4!1G@"K5Y\'--O+5=/D29K5>D1NKLI@;-JD>=RJ[%V*<JA!*@$DD\'?!O3/!
MDAFT^)X6/W@)[@HV P&Y&E*/C<<;@=I.1@\UGW/[/NC74_VR2&1K@,K"9KJ[
M,NY<;&WF?=D8&#G(P,=*U?%7PFT_Q8D<5\DDR1JH56N+G;\H(#$"4!GPQ!D;
M+D'EC45G\'--L[5M/C29;5NL0NKL)@[]R@>=PK;VWJ,*Y(+ D BKX9^ VC^%
MYA<V,#PRC'S)<7(R 0VUAYN&4E02K J<<@T>)O@-H_BB8W-] \TIS\SW%R<
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M<("6*J,FLKQ-\!M'\43&YOH'FE.?F>XN3@$EMJCS<*H+$A5 49X K:TN'3_
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M)9-NZ.VN2B?*,#EE=SU)^9C@L<8'%=KX1^&5EX6D:YA5WNI(T26XFD>:>0*
M!EG8XS@$A JG"\850-K7] @\0P/:7:"2&1=KHW0CKVY!!P01@J0""" :\PT_
M]F*QT[?'!=7T=K)(S/:I<E;=@V T;*%#%2H"$EMY7@MGFO3] T"#P] EI:((
MX8UVHB] .O?DDG)).2Q)))))KA=4_9RT/5Y&GN;=Y96QN>2YNG<X  RS3$G
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M4#)8D\  <DG@"O/]*^/VDZUJ$6E6<IGFD:9=R*?*4QJ7.7;:&!"G:8]X.,Y
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M8JS!"DL9(')QYB*&('.!DX!., D=AJFK0Z1&T]S(D42XW/(RH@R0!EF( R2
M,]R!7*2_&C2(K62_-TGV:*X,#2 .091@[4 4F3@A@4#*5RP.T$CI= U^#Q#
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ME'DTZ<3"-@KC#HRDC(RKJK8/.#C!((!)4XYK5/VD= TR1H9+U"RXR8TEF3D
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M#G#*N1\QR #57XJ_&*R^',#27#AY]H,=NK 2N3D*<<E4RIRY&!@@;FPIY_\
M9[^)D7B'3;9+N[CDU"1KAGC:5//)\Z5O]6#N "8(  "H!@!0*\O^/O\ R.&D
M_P#;A_Z625[AK?QST71+D65Q>1K,6"D#<ZJVXH5=T4I&0P.X.RE1RV!S7=45
MS^J?$+3=(D:"YO+:*5<;DDGB1QD C*LP(R"",]B#1_PL+3?)^U?;+;R/,\OS
M?/B\O?C=LW;MN[;SMSG'.,4:7\0M-U>18+:\MI96SM2.>)W. 2<*K$G !)QV
M!-37/C>PM9_L<EU MP651"TL8EW-C8NPMNR<C QDY&.M9/C_ ,::1H 4ZM+
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M4BQ 1+A"H4,#M&W;BI=^!M3A\20:SI=@]M;R;%O!)+;J'WNPFD*17+Y^0JX
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M&0$$8()VDC*@BIX\\>ZCX$\*QM?J4U*11:[@V]E8[P)2ZRD[S"A?>&)\T@D
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M]&^"^D:)<0WMK:I%/!'LC="Z\;60E@&VNQ5B"[AG/=B0,>%?L,?\Q'_MT_\
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MX')KFKVNN6\YMYH&C\U50'SE1NA961@60F-B=X*;5P I#>2?MS_\P[_M[_\
M;>O>OC%:)=:-?K(H8"RN& 8 C<L;.C<]PP# ]00".17F'[%/_('G_P"O^3_T
M3!7'VUHEK\0ML:A069B%  W-8%W;CN6)8GJ223R:]5^)/P;N?%VLZ?J:7 6W
MM&1GB;<2&23S=R ':2^%1R=I4*I^? 4>?_MD:_9:I811PO'+<0WH5RF)&B'E
MRAXW9<^6691\C%2Y0D ^6VWW7X97;WFE6,LK%W>RMF9F)9F8Q(2Q)Y))Y)/)
M-?/7[#'_ #$?^W3_ -N*^JJY7XI^-?\ A"-,N-0"[FBC^08R"[,(X]PW+\N]
MANP0=N<<X%>?_LJ>&88M*34V&^\NY+AY9W"M*?WI0KOQO*GR@Y!)RY+=QCS7
MXRZ<OP:UZSU>Q_<VMQ@2PPA%&V,QK/&(PJIM9"I ))\W<^5(4CT_]JKP];3Z
M+=7CPQM<(MNJ3%%,JK]HC^4.1N ^9N <<GU-<U^SY\'-,\2Z%%-?P_:'G\P9
MD9B8UCGDVQQ%2K1+NR[!""[.VXD$ ?0&DZ7'I$,=M NV**-(T7).%4!5&223
M@ #))/J:M5\B_LR_&"T\(O=6&L9@NIKDNUQ*#N9R0ABE8C>A5]S;G.T%I"Q0
MCYOI#PKX.M=.NKC4[(ILOH[=F\OE&9?-;S@P8J=ZR+G: "5+DL7)KYZ_9WM$
ML_%NJ11*$1%OE55 5547<0"@#@ #@ < 4?MRVB*^GRA0'9;E6; W%5,)52>I
M +,0.@+''4UW7[9/G?V*OE;]GVN+SMN[;LVR8WXXV^9LQNXW[>^*V_ ?Q,T/
MXK60TW$:%X51[%\(5 !^6/ 4.%";E:/E %8B-L <_P#'WP#;:-X98/''+<6M
MM90)<&-1+M26).&.YE!RWRAL?,1SDY/V;OAQ8:QHMM=7D$=S(RRJ#-''($1+
MB?"(&7@;F9B3EB6P6*JBKYU#H_\ PI;Q?!!9C-K>>4BQEMS"*=_+VEF0GY)D
MW+@EBBJK/EF-=WH/B+_A+?$.H7#VL]ZFGM'!;1C[)L@<,?-E GEC^<RPY212
M6V\-C"!3X^^#;_QZD$^GZ;/#?P3*5G:6SC81@,=H:.[8Y$FUER/E.XJ1N.9?
MB7JLWC*]TCPU?#RFN(TNK]%W;&V([FW!27E2\4@/)VD1NK$J:]EU_P '6VN6
M3Z;(@6W>'R@JJH"+C"% 5*J4P"G&%(! XKG_ (-?#-_AS9&P>X-R/.=T8J8P
MBL%^0*7? W!FX(!+$XSDGP_]AC_F(_\ ;I_[<5TV@^(O^$M\0ZA</:SWJ:>T
M<%M&/LFR!PQ\V4">6/YS+#E)%);;PV,(%/C[X-O_ !ZD$^GZ;/#?P3*5G:6S
MC81@,=H:.[8Y$FUER/E.XJ1N.9?VD_B5=>'=#@@DV17U]&(YT"[@J^5_I(0Y
M91AF5 26.UB5)(WKZKX%^'%KX1T]-,C1&C\O$V4XF9E"R.ZL6SN[@D@+A!\H
M KYO_9AT1-!\3ZA9Q$E((;N)2V"Q5+J) 3@ 9P.< #/85]=5%=VB7B-%*H='
M4JRL RLI&"I!X((X(/!%?)7PCL#\(_%4FDS >3<JR0ROM5BA_>0$.T:EB2OE
M,J;5:7^\445]"_$W2X_%"Q:-(NY;F19)1DC$%O)'+(>"N=S^7#@,&'F^8 0C
M"HOC5X>MM4TJ\EN(8Y'ALKMHF=%=HV\ICN0L"5.5!R,'('H*\J_9+UM-!\/7
MEY*"4@N;B5@N"Q5+>%R!D@9P.,D#/<5;_96M$\6"\\07BB2]EO74,P#>4HC4
MA8B^YT&V4IC<1L5%Z#GG_P!JOPF?!L]KXBTLBWF$QCD,85"9&WR+)@)ARP\Q
M92Y.\;5*D;J]J\;ZVFO>'KJ\B!"3Z5/*H; 8*]NS@'!(S@\X)&>YKSK]BG_D
M#S_]?\G_ *)@K:^#?PQ?X2"_O-5O(W%Q-&3,[%!M5GVR2/(1AW:7E<L <8=R
MW'F'AO5(Y/'I>R;;!-OSL!1) ;/S&;& '5I!Y@;E9#B12P(8VOVY_P#F'?\
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MLV1?MAVEMHVC6UG;K'"/MH9(4"QC:(YM[*BXX#.-Q QEAGEN?9?A/_R!]/\
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M_P!>%W_Z)>O%?V5M"_X2#PW?66[9Y]Q=1;\;MN^VA3=C(SC.<9&?454_8_\
M$W]AR7F@7A2.X2X9TC)^=G4&.X4,"4;;Y:D!>2-[#<H)7H/VQ/\ B96=EIL7
MS75Q?IY,?3=A'C/S'"CYI4'S$?>ST!(] \6:%_PC_ANXLMV_R-(EBWXV[MEL
M4W8R<9QG&3CU->5?LK:[_P (_P"&[Z]V[_(N+J79G;NV6T+[<X.,XQG!QZ&M
M7]G/_BY2S:[JO[^Y6[9($?YH+<*D,@,,;9"-G;E^7.Q3NW%RW'VUVEU\0MT;
M!@&925((W+8%'7CN&!4CJ""#R*E_;G_YAW_;W_[;U]55\J_L,?\ ,1_[=/\
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M@N0JD$>__&O5(],T6_DF;:IM)HP<$_-(IBC' /5W ST&<D@9->*^$OA1=?\
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MF[R$2"0[B  3G&%''4GN_"'@NT\'0"TL(A%$&9MH))+'JQ9B68]!DDD !1P
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M&+ QE<LK2X;'/SYY.TKQC:UC]F?1M:O7OKF-WWQQH(0_E0($1(TV"((PPJ
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M!]H<*&   4!:MZQ^S[IFH3O>1^=;W3>6$FMY6@>%4B2$1Q!?D5=B;2"K'#,
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M,DC[I*UH77[.VC7UZ^H3P>8[>1LC)VP1B%%C55C3:I4JJY5]Z\8  )!/'GP
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MDD9-WR@;L;L#&<9%=517DMI^S1I^E(J:?/>V9V@2O;W+QM,0,*TF0RY'S$;
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M9R B! RDGE9-X( '<Y]5HK*\5^&8?%%K+8W(S%-&R-PI(ST9=P8!E.&4D'#
M'M4OA[1$T&VALXB2D$,<2EL%BJ*$!. !G YP ,]A6?XQ\!VGC*,07RN\7=!-
M-$C<J?F6)T#X*@C=G:>1C)K*\'?!O3/!DAFT^)X6/W@)[@HV P&Y&E*/C<<;
M@=I.1@\UG^/_ (#:=XTG6]D$D%VK(1<6[^7*=F=F<AER.,/MWC:H#!1BK?A#
MX.6GAR<7KO/=W:JRI<74IGE1#_ F0%4?>Y"[OG<;MK$5M>,? =IXRC$%\KO%
MW0331(W*GYEB= ^"H(W9VGD8R:RO!WP;TSP9(9M/B>%C]X">X*-@,!N1I2CX
MW'&X':3D8/-<UX9_9HT_PS.\]I/>QH[$M ER\41'S;%)B"2D)N.W+D^I.3FW
M-^SEI/\ :"ZG"LENZKCR[>0VT1.UDW?N@KH=IY\MT!Q\P.7W;7Q!^#^G^.K5
M+*YCV)%CR6BVH\0&!M3Y2H4J I4@K@ XRJD5=+^"%A9VJV4C7,Z",Q[I+F??
MY9R#$/+=%6(KA6C0*CA$+JQ12#PS\!M'\+S"YL8'AE&/F2XN1D AMK#S<,I*
M@E6!4XY!K5^(?PPL?B!"(+^/=MW&-U)62,L,%E8?@=K90D*64X%<II/[.5C:
M^6EU/>7D$.PQ6]S.9+="F C"-513A<J%.4VL05(->EZIIBZG&T,A<*V,F.22
M%^"#P\3(XZ<X(R,@\$BO/]+_ &<M#TB19[:W>*5<[7CN;I'&00<,LP(R"0<=
MB16KXQ^#>F>,Y!-J$3S,/N@SW 1<A0=J+*$3.T9V@;B,G)YKH/#/AB#PU"+:
MU#B)<;5>66;:  H53*[E5   4$*.PY-:M<!XF^ VC^*)C<WT#S2G/S/<7)P"
M2VU1YN%4%B0J@*,\ 5:O/@YIMY:KI\B3-:KTB-U=E,#9M4CSN578NQ3E4()4
M DDG@[X-Z9X,D,VGQ/"Q^\!/<%&P& W(TI1\;CC<#M)R,'FL^Y_9]T:ZG^V2
M0R-<!E83-=79EW+C8V\S[LC P<Y&!CI7H%I;"U18UR0JA069G; &!EG)9CZE
MB23R2346K:I'I$,ES.VV**-Y';!.%4%F. "3@ G !/H*\*^'W@+3/C3&^OZG
M$DLT\A00HS1B!8B41&,3(TDI7#L\G)4H$5$ !U?%?[.OA?1;66XN8?L\21L6
MF\^?*9X#*&D<%LD;5*MN;"[6S@]+\#M GMM!M;34T)<PR*\<OSGRV=]D;!L\
M>4578?NCY"!C Q;?]F*QTR2233[J^LEDV[H[:Y*)\HP.65W/4GYF."QQ@<5Z
M+X0\%VG@Z 6EA$(H@S-M!))8]6+,2S'H,DD@ *.  ,_XA_#"Q^($(@OX]VW<
M8W4E9(RPP65A^!VME"0I93@5RFD_LY6-KY:74]Y>00[#%;W,YDMT*8",(U5%
M.%RH4Y3:Q!4@UZK7BOB;]D;1=;F,Z":WW9)2!U6/)))8+(DFWKC:NU   %'.
M=77/V9]&UJ:"62-Q%;VXA2W1]D)4&1@6*@2EMTA8MO!9N6SEL^BZ!H$'AZ!+
M2T01PQKM1%Z =>_)).22<EB222235N[MA=(T;9 92I*LR-@C!PR$,I]"I!!Y
M!!KSK5/V<M#U>1I[FW>65L;GDN;IW.  ,LTQ)P  ,]@!781>#K=;:6R;S)(9
ME=9!+//,Q5UV,H>61G4%>RL #DC!)-<)X*_9RL?"6Y(Y[R6!LEK>2<BW8G:"
MS1Q+&LF57:RON1E)#*1C$VD_LY:3I5[+?PK(HF4JUNLA2VPQ5F78@4LA*\Q.
MS1$$KLVA0NAXF^ VC^*)C<WT#S2G/S/<7)P"2VU1YN%4%B0J@*,\ 5M0_#BQ
MCLFTLQE[1UVF*2268!0%"JID=F0+M!0*0$(W+AN:YKX>? &Q\#9$,ES*GF+(
M(YIB85=>C^5&(XV;(4AG5BK(C(5*@T:I^SEH>KR-/<V[RRMC<\ES=.YP !EF
MF).  !GL *Z#7?AC9:_;K970FE@7/R-<W1W98/\ .?.W288 KO+;,?+@4>"O
MA?8>"-PT^-XE;.4\Z=XR3MRVR21DW?*!NQNP,9QD5U5%<UI'P_MM+U"ZU5,F
MXNEB5RVTA5C4)M3"AE#;5+@D@E5/&!4OC3P+:^,HXX;U-Z17$4RCMN0]&!!5
ME92R,K @JQQ@X(Z"N \3? ;1_%$QN;Z!YI3GYGN+DX!);:H\W"J"Q(50%&>
M*M7GP<TV\M5T^1)FM5Z1&ZNRF!LVJ1YW*KL78IRJ$$J 223P=\&],\&2&;3X
MGA8_> GN"C8# ;D:4H^-QQN!VDY&#S65JG[.6AZO(T]S;O+*V-SR7-T[G  &
M6:8DX  &>P KT#2],73(UAC+E5S@R223/R2>7E9W/7C).!@#@ 5:KA?B9\%M
M.^(P!O4(E5=J31G9*J[@VW)!5AUP'5@NYBNTDFJF@? VTTV=+NYFNKZ6%MT#
M7DYG$3=V1<*N3P<L&(*JRX(S7HM>2^//V8-(\93F[=9()79FD:!E42,<?,RN
MCJ#QDE0I8LS-N)S78?#SX86/P_A,%A'MW;3([$M)(5& S,?Q.U<("6*J,FNJ
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHJKJEDU[&T<<KPL<8DC$9=<$'@2I(G.,'*G@G&#@CRKPW^S1;
M>&KHW]K?7R7+;]\AD@<OOY;>'MV#Y/S'<#\P#?> (]?HHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHKBOB5\+4^(,?V>YN;F.W^4M#"T2(Q4DAF+
M1.YZCY2VS*JVW<,T?#7X6I\/H_L]M<W,EO\ ,5AF:)T4L02RE8D<=#\H;9EF
M;;N.:[6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO);O\ 9GTY;EKR
MQENK!W4AA:3>2IRV\]58J"<?(I" *N%&*V]"^"=EI\D5Q<R7-[/!(SPR7<[S
MF,D*/E7Y8QRH8$J6#8.<JN._HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHKG_&/C^Q\&1B;4)TA4_=!)+M@J#M107?&X9V@[0<G
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M9.23D]3UKV7X3_\ ('T__KPM/_1*5U5?*OQ]_P"1PTG_ +</_2R2O6_VC_B
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M"-[#^)L* $"8GQWNTG\8Z6J,&*-8*X!!*M]J=]IQT.UE;!YP0>A%>M?M1_\
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M$KLS2- RJ)&./F971U!XR2H4L69FW$YKL/AY\,+'X?PF"PCV[MID=B6DD*C
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MK*02RNZL .F2 ?2J*******************JZIJT.D1M/<R)%$N-SR,J(,D
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M[A<*JD'?NW+E6SD$U%XU^*>F>"-HU"X2)FQA/F>0@[L-LC#/M^4C=C;D8SG
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M[2.@7^_9>H-D;.=Z2QY"XR%\Q%WMSPBY=NRG!KTJBBO /VUO^0/!_P!?\?\
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MDB&':1D<%D?RU4R!2 ?F*@ _*2#Q70>&?%=KXHA%S8RI-$<?,AS@D!MK#JK
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MX25ESE/F20 ;<MLD"OM^8#=C;DXSG(KH-4U:'2(VGN9$BB7&YY&5$&2 ,LQ
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M2,KN&W$1,Q+$&4CHV /1? ?Q,T/XK60TW$:%X51[%\(5 !^6/ 4.%";E:/E
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M8&VO)/BGK\%WXOTRYTYP0[62O+%PLA-P\;X=<"0>7^[8@L, Q$Y5E&A^W/\
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MP-M>2?%/7X+OQ?IESIS@AVLE>6+A9";AXWPZX$@\O]VQ!88!B)RK*-#]N?\
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M44444444444444444444444444444444444444444445\M^)H1X;\>V]S<L
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M@"I\MS& JX<>5@89N*^I?AKX0'@[3K:P  ,4*A]I9E,A^:5@6YP9"Q' P#@
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MO,C7*[MN_.#M8#5_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\
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M)>O*OV*?^0//_P!?\G_HF"N4^/O_ ".&D_\ ;A_Z625ZK^U'_P B[>?]N_\
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M$8UB?MN:_!=SV=I&X::!9VE0<E!)Y)CSV!(4G'4#!( 92?KJBOE7_FH?^?\
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MV[R$R$W!3VSH)XTB^*;WVEZ?+&UJME)%+. [,)IS)&@0$*CHJ([,P8ARR!"
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M3MRVR0,F[Y0-V-V!C.,BI?&/QC\*>+'M9;B\(>TN8YXF6"<-N0YV$M;L=C$
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MR_BDG(9V4/<W152Y!;8OG;4!P.% &  !@"M7PA\.K/P> EBLD:!641F>XDB
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MMLW,6\L#*E"!\J[0%"^@>$/!=IX.@%I81"*(,S;0226/5BS$LQZ#))( "C@
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M1NA'7MR"#@@C!4@$$$ UY+I?[(VBZ?=+=XF=5D+B"1U>#N54C9O91Q@,YW8
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MF4JUNLA2VPQ5F78@4LA*\Q.S1$$KLVA0LNJ?LY:'J\C3W-N\LK8W/)<W3N<
M 99IB3@  9[ "N@UWX8V6OVZV5T)I8%S\C7-T=V6#_.?.W288 KO+;,?+@5G
M^&?A-I/P_+W=HAM@JEI&^T3B+:JM\TBO*8V"AF(+@A?O#!YH^(EW;>*=+:"%
MH[A+UDMXF4K*NYWV-*H&0YA :8@$$")CN3:67L-)TN/2(8[:!=L44:1HN2<*
MH"J,DDG  &22?4U:HKS7X@_ #3_&UTFH2--;W28_>V[K&[%<;&8E&^9<?*PP
MV, DA5"]5+X"LI[62PDB\R";/FB1GE=R< ,TCLTC, JA6+;D"H%("KC@-/\
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MH]K,X9G60R8)4* APG(#.,G&>,GT^BBBBBBBBBBBBBBBBBBBBBBBBBBBN?\
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MH88EB9YYVBC$K&*--S%=K [G"!<CS-F15OX=?&ZQ\=S26D FBNHMY>">,I(
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MW:Z%XEBUO=Y2S+LQGS;>XM^N<8\^./=TYVYQQG&1G0N[D6J-(V2%4L0JL[8
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M<+(7)=< (0V0%);Y:+3]H?3WOUTRXBNK:61@L)GMWB64M)Y:;1S( QS@NB@
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M7]AC_F(_]NG_ +<55^"6EQZAXPU3S5W!)+V102=NY;R/:2 <-@_,H8$*X5P
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M_;L(8;68APOM_P"U'_R+MY_V[_\ I1%1^RY_R+MG_P!O'_I1+7JM> ?MK?\
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M5D"MO!95"#:-N#Y_^QW_ ,3*SO=2E^:ZN+]_.DZ;L(D@^484?-*Y^4#[V.@
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M9!FY=X7R26WCS1YV" ,X4!=H:NP_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\
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M6\^1]IQT.UE;!YP0>A%>5? B[2#QCJBNP4NU^J D LWVI'VC/4[59L#G )Z
MT?MRW:,^GQ!@75;EF7(W!6,(5B.H!*L >A*G'0U[U\5]6A;0[V<2)Y3V$^Q]
MR[&\R)A'M;.#N+ +C[Q( SD5YA^Q/=HVE7$08%UO69ER-P5HH@K$=0"58 ]"
M5..AKE+F[2U^(6Z1@H+*H+$ ;FL B+SW+$*!U)( Y-:OA+6W\7>,IX=8 Q9K
M<"QA?**K+(FR1$8_.[19EW')( =<*B;>?_;<U^"[GL[2-PTT"SM*@Y*"3R3'
MGL"0I..H&"0 RD_0OQ<U:%-'U+,B#9:7$;99?E=X?D0\\,V]-JGD[EP/F&?,
M/V)[M&TJXB# NMZS,N1N"M%$%8CJ 2K 'H2IQT->W^*_#,/BBUEL;D9BFC9&
MX4D9Z,NX, RG#*2#A@#VKYE_97T2[M=0N=-G(:WTZYDE+)C N=LEI@$@.R/&
M9#TX,:'*Y97^KZ*^>_VV+M%TJWB+ .UZK*N1N*K%*&8#J0"R@GH"PSU%>J?!
MV[2ZT:P:-@P%E;J2I!&Y8U1UX[A@5(Z@@@\BOGO]GW5H9?%VI.LB%9OMWE$,
MI$F;E)!L.?FRBEAC/R@GH":M?MS_ /,._P"WO_VWKZ@_<ZS#_!+!+'_LO&Z.
M/Q5E93[@@^E?)7PU\,S>%=:U'PM$/,@N?*#OAF(MU99&5W 79OM99(BP7_7-
M&$9!\]?7]?&OPV\:S?L_ZI/I.IJYLY9 1)AN!DK'<H@9E*LO$@7+C:!DM&4;
MV76_VC+'7$%EH4IGU"X810@12JL;,#^_<R1$;(Q\[ *Q('(V[F7J]6^(%M%J
MK:'?>6$GLHY(_,VA9&>66&2$[VPY8;-B!26'F9)X%>"_M'?"BU\#36FIZ*/)
MO)+M0EL@W[I 3(LL<9W8VOM4HJE/F0!5Z/:_;G_YAW_;W_[;U]06VK0W6SRY
M$;S8S)'M93O0;<NN#\R_.OS#(^9>>17RK^S[JT,OB[4G61"LWV[RB&4B3-RD
M@V'/S912PQGY03T!-=K^TOXTM;>ZL-+U2-_[/ED\ZXD$>2=N51$?EAACF?RP
M)1$P"-\Y4U+'Q_X*LY+>83N[6O\ Q[B4ZC.D7  V)*'1<8&,#@JI&"H([OQS
M\6!=Z#<ZMH,@G:-<*P1F*$.JR,48!@40F3YQ@ !V!0\XG[+K6MOHG]H,R>?+
M)/)>SL^7++(YS*[$D8C(;!( #%\9<L?+_P!G?7X+KQ/JE\K@6[0WTHD;Y%\L
MW43ASOQM&WD[L8'7%6_VB+M+/Q;I<LK!$1;%F9B%55%W*2Q)X  Y)/ %>]?&
M#5H;?2=11Y$5A839!901YB21Q9!/\;@JG]Y@0,GBO,/V)[M&TJXB# NMZS,N
M1N"M%$%8CJ 2K 'H2IQT-<3\+[Y/@;XAN=+OI#'9W"@12,!L/S;K>1W*I@!6
M>-V4;!(3N^5=R^J_M6ZVD&CM8@%[B\FAB@C3#.S+*DA(7.XCY0ORACN=!CYL
MUVOPW\*I\/-)@LYI !;PLTLC,-@8EI96W$)A S-@D A0-W.37@'[#5VBOJ$1
M8!V6V95R-Q53,&8#J0"R@GH"PSU%'[1%VEGXMTN65@B(MBS,Q"JJB[E)8D\
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MP4$D*"ZDXR2<=,D^M&B>"+#07,MG:P0.5*EHHHXV*D@E244'&0#CID#TK/\
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M==#"XLXV+3/*SC<DK.[,S$R(RR$$N?E+%1P  %7&UX.\ 6/@R,PZ? D*G[Q
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M^@?9_P#@-#_\165XD^ >B>))!-<V:%UC2,;&DA&U!M0;8G13A<*"1D* N<*
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M[L69FMXF9F)R6)*9))Y)/)-:NB>'K;04,5G#' A8L5B18U+$ %B$ &< #/7
M'I7%:E^SQH.HI'&]E&!$NU2A>)B, ?.T;*TAX'+ECG)SDG/8>&?"EKX7A%M8
MQ)#$,?*@QD@!=S'JS$* 68ECCDFLKQK\+-,\;[3J%NDK+C#_ #)( -V%WQE7
MV_,3MSMR<XS@T>"OA9IG@C<=/MTB9LY?YGD(.W*[Y"S[?E!VYVY&<9R:U==\
M)V?B#;]MMX9]F=GFQI+MSC=C>#C.!G'7 ]*J:7\/=-TB19[:SMHI5SM>.")'
M&00<,J@C()!QV)%5?^%3Z/\ ] ^S_P# :'_XBNEM+1+-%BB4(B*%55 554#
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MM2-51!DDG"J !DDDX[DFK5<?XX^$6E^.7274;<2O&I56W21MM)SM)C92P!Y
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MU'_R+MY_V[_^E$5<A\$_A%I?CG0+"74;<2O&MRJMNDC;:;F4[28V4L >0#D
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M_#W3=(D6>VL[:*5<[7C@B1QD$'#*H(R"0<=B157_ (5/H_\ T#[/_P !H?\
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M^JW^9MVYV_>YSC=VSCBM6N?\8^ +'QG&(=0@291]TD$.N2I.UU(=,[1G:1N
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M11111111111111111111111111111117FNJ?LY:'J\C3W-N\LK8W/)<W3N<
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M]FY$,SA4.[G_ %?F%=K97(P>U\)Z[_PD%G;WNW9Y]O%+LSNV[T#[<X&<9QG
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M!'((X(KY:_YJ'_G_ *!U?2'B_P :6G@Z W=_*(H@RKN())8]%"J"S'J< $@
ML> 2.*\0_'R'PPD$VHV5[;0W#*%E>.$JN0#\XCG=T(4YV%=Y ;"DJ0-_QY\2
MHO"MD;Y(Y+D&%I(Q CR(R@ [FE16CC3!W%V.-H8J'(Q7F'[,GQ+.LV]S+>"9
MKBYU.1\I!<RQ+NC@55\Q4D1%7&T!W&Q ,X7!KM?'7[1.C>#6>*:?S9TZPPCS
M7SO*,I/$:LI!+*[JP Z9(!]%N[M+-&EE8(B*69F(554#)8D\  <DG@"O'[[]
MJC3H4DN(;>]N+6-@K745O_H^XA?E+2/&5.7 PP!R1C(()]+\(>-+3QC +NPE
M$L19EW $$,.JE6 93T." 2"&'!!/'^.OVB=&\&L\4T_FSIUAA'FOG>492>(U
M92"65W5@!TR0">-OC]8^%/,)CN;A(9#'/);PEX87&SY'E8I'NRX&T,Q5OE8*
M< ]KX6\4V_BJW2]LG\R"3=L?:RYVL4;APK#YE(Y'Z5Y_+^T1:S22)96E]>QQ
M2&,SVMOYT!8 %@K[QG&>N,'JI*D,>P\!_$2T\=Q27%@Q>*.8Q;RI0,P1') ;
M#8&\#D Y!P",$]+7"^//C=I/@8F.\N!YP5CY* R2Y"A@I"Y"%@PV^84!SG.
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MWRMW'F9\OONQS755E>)O%=KX7A-S?2I#$,_,YQD@%MJCJS$*2%4%CC@&N?\
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M5=Q!)+'HH5068]3@ D %CP"1YHG[5&G0&$W=O>VL4ZEHYI[?;$RA0VY2CNS
MY7!16'S*3@'->P6EVEXBRQ,'1U#*RD,K*1D,"."".01P17RU_P U#_S_ - Z
MO8-4_:-T/2)&@N;AXI5QN22VND<9 (RK0@C(((SV(-=U;:Y'<P?:E$@0*S8:
M&9)<+G/[ID$N>.!MRW&T'(SE>%?B+9^*GDCLVD8Q,RR%H+B)5=2 T9:6-%#C
M<,IG=CG& :RO%_QCM/#DYLD2>[NU56>WM8C/*B'^-\$*H^[P6W?.AV[6!H^'
M'QELO'KS00"2&X@8B2"=1', #@MM#-P&^5N<JW# ;ESW5%>87?[05HSLMC;7
MM^B,5::TMS-"'!Y3>64,0,-E<J592&.:Z7X>?$^Q^($)GL)-VW:)$8%9(RPR
M%93^(W+E"0P5C@U4^(/Q>L? S)#<%Y+F7'E6T*&2=\N$&%X R3QN*[L,$W,"
M*Q?"_P"T3IVMW?\ 9TRSV=T615BNHO)9F8%@HPS!21C <J6+*$W$XKNO$WBN
MU\+PFYOI4AB&?F<XR0"VU1U9B%)"J"QQP#7'^%_CYI?B8S_96D=(&A7<(I&,
MK2*[!8HU#3.5$;EAY8("LW* L*OA#]H2R\2:@-),%U;715B$N(A&20OF;<!V
M924RPW  @=<E08?$/[26F:(R,R7,EJ\GE_;(X6-IN#LK 2,5\S&QB3$'! .T
ML00.KUOXIZ9H5K%?W-PD<$T:R1$[M[JVT@K'CS&X=20%RH.6 &:Y1?VF-&^Q
MOJ#2.L2W$L,:E/WDS1HKDQH"3M(=<,^P L ^S(S;^&O[0FE_$&3[/;.\=Q\Q
M6&90CL% )92K.AZGY0V_"LVW:,UQ7[:W_('@_P"O^/\ ]$SUZK\)_P#D#Z?_
M ->%I_Z)2L37_CE::;.]I;0W5]+"VV=;. SB)NRNV57)Y&%+$%65L$8K5^&?
MQ5LOB- ;BQ8Y1MLD;@+*AYV[@"PPP&5()!Y&=RL!E7/[06C6L_V.2:1;@LJB
M%K6[$NYL;%V&#=DY&!C)R,=:Z7QCX\M/!L8GOF=(N[B&:5%Y4?,T2.$R6 &[
M&X\#.#5OPSXG@\2PBYM2YB;&UGBEAW @,&42HA92""& *GL>#6K7RK^W/_S#
MO^WO_P!MZ^I;N[2S1I96"(BEF9B%55 R6)/  '))X KR75/VG;&RC:ZCM;Z:
MS&,74=L1;-DA>'E:/HYV'('S @9XSZ?H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!
MP5(((!!%8OBWXE6OAJ:*S;?+>3_ZFVA7?,XS@MR51%'+%I&1=JN03M..?G^/
MUCIMT;#4([FTN?W?EQR0F4R^9D+Y9M3.'Y&WK][Y1E@P'52^/+2WM9+^9GAM
MXL[VFAFMR,8Z+*B.V<@+M!W,=JY;BN0UOX^0Z1:#4WLKTV3, DXCAVLI)"2;
M&G654; *,Z*"&7NR@]_H&OP>(8$N[1Q)#(NY'7H1T[\@@Y!!P5(((!!%?,OP
M"_Y'#5O^W_\ ]+(Z^JJRO$WBNU\+PFYOI4AB&?F<XR0"VU1U9B%)"J"QQP#7
M/_#WXO6/Q!DN(]/+NMOY6Z0H41O,#$;0V'XV$'<J\],CFCQ]\6;7P9)%;.DU
MQ=39*6]LGG3E0"3)MW+A?E(SG)P< A7*Y_ASXY6FLW46GO#=6UW,S;(;B PO
ML6-Y/-Y)78=C(,$MN'W=N6&AX^^+-KX,DBMG2:XNILE+>V3SIRH!)DV[EPOR
MD9SDX. 0KE<_PY\<K36;J+3WANK:[F9MD-Q 87V+&\GF\DKL.QD&"6W#[NW+
M"9?CSH_VI=/:=TNGDCC6*2WN8GW/C8"'B7;G<,$X&"#G'-:OC7XH6'@C:=0D
M>)6QA_)G>,D[L+OCC9-WRD[<[L#.,8-:OA;Q3;^*K=+VR?S()-VQ]K+G:Q1N
M'"L/F4CD?I7'Z_\ '*TTV=[2VANKZ6%MLZV<!G$3=E=LJN3R,*6(*LK8(Q6K
M\,_BK9?$: W%BQRC;9(W 65#SMW %AA@,J02#R,[E8"AXQ^--KX;NAIZ0W-Y
M="/S'BM(O/>-?EP7&Y=N=PP.3@@D ,A:7P9\8[3Q9<_8(TGBNEA>66&>(Q21
M*K1JH<$XRPD#+M+#;RQ4X![JBBOE7X!?\CAJW_;_ /\ I9'7LO[0FB6VK:'>
M"[(41PM+&QV@B5!F( L#@LV(^,,P<H#EJY7]C_7Y]7T8K<.9!!<O%'NY*QB.
M)E3/4@%CC.<#"C"@ ;6K?M&V-KYCVL%Y>00[Q+<6T!DMT*9+J9&9%.%PQ893
M:P(8@UVO@7QU:^.+5+VR?=&W!!X=&&-T;C)PPSR.000RDJ03RM]^T3HT-U%8
M0S_:)Y;B&$"$;T!DP%<R<1E02 VQF8$XVY!P>&_VA-+\1ZF=(MG=Y?G"2A08
M)"B[F5&#$G #$,5"-M.UCE=U27]HBUFDD2RM+Z]CBD,9GM;?SH"P +!7WC.,
M]<8/525(8]AX#^(EIX[BDN+!B\4<QBWE2@9@B.2 V&P-X'(!R#@$8)YKQ%\?
MK'2[IK"WCN;VYCW>;':0F<Q[=H.XY4=6VG:6VL"K[6P#H?#/XTZ=\1@19.1*
MJ[GAD&R55W%=V 2K#IDHS!=RAMI(%:'C7XIZ9X(VC4+A(F;&$^9Y"#NPVR,,
M^WY2-V-N1C.<"N?L_C]8W]I%=P1W,TDT;R1VL4)FNBB3>2SE8RRHNX'#,ZAL
M$*2P*UJ_#'XO6/Q(C>2Q+[H]OF1R(5=-Q<)DC*'.PD;6; QG!XJKXQ^--KX;
MNAIZ0W-Y="/S'BM(O/>-?EP7&Y=N=PP.3@@D ,A:7P9\8[3Q9<_8(TGBNEA>
M66&>(Q21*K1JH<$XRPD#+M+#;RQ4X![JN/\ ''Q;TWP,Z1ZC,83(I9#Y4SJP
M!P<,D;+D<9&<@$$@!AF;0OB=9:_;M>VIFE@7'SK;71W98I\@\G=)A@0VP-LQ
M\V!65X9^/.C^*)A;6,[S2G'RI;W)P"0NYCY6%4%@"S$*,\D5M>*OB+9^%7CC
MO&D4RLJQE8+B56=B0L8:*-U+G:<)G=CG&"*\E_;6_P"0/!_U_P ?_HF>N@T'
MXL6_A#1;(M%<W!CL+0RBWA:41#[,KEI'^6),+ABI<.%96V[2&KO_  +XZM?'
M%JE[9/NC;@@\.C#&Z-QDX89Y'(((925()P/&OQNL?"MPMAB:YO&P?LUM&9I@
M"K/N(RJCY5R5SOVD-MVG=4/@#X\Z=XTG:RC,D%VK.#;W">7*=F-^,%ER.<IN
MWC:Q*A1FO1:*XJ7XK6]Q=26%C%->3P9\\0",)$> %:2:2*/<22 JLS HX(!4
MU%\./C+9>/7F@@$D-Q Q$D$ZB.8 '!;:&;@-\K<Y5N& W+GH/%_C2T\'0&[O
MY1%$&5=Q!)+'HH5068]3@ D %CP"1Y_-^TE::<5-_9ZA91,VWSKBU*1!MK,%
MRK.Q)VG "D]S@ D:'Q>^,J^";$W=K$]R[1HT3K'(UJ!(<)(\RCR]N<84/O;*
M@8#;QB?LS^,5O-)M8)?/>=VN6:1H+AHV8SS2%C.8_*)/<E\EOE^]Q7LM9^OZ
M_!X>@>[NW$<,:[G=N@'3MR23@ #)8D  D@5Y5-^U1IT 69[>]6T>;RTNS;XM
MF^9EW!B^XCY6. N_ /R;@17JN@:_!XA@2[M'$D,B[D=>A'3OR"#D$'!4@@@$
M$5PM]^T3HT-U%80S_:)Y;B&$"$;T!DP%<R<1E02 VQF8$XVY!Q4\0_M):9HC
M(S)<R6KR>7]LCA8VFX.RL!(Q7S,;&),0<$ [2Q! ]+TG5(]7ACN8&W12QI(C
M8(RK ,IP0",@@X(!]15JOF7XQ_&YKS5=/TR**>*W6]LYY7>*>.68"4;52$JL
MC("#P4)>11L4; 7]@\?:Y'K.B:C)$)% LKM<2PS0-GR&/"S(C$<]0,9R,Y!Q
MX_\ LH^+8O#FB3-(LDCF]G*0PQO-,^V"WSM1 3C)52[;45F4,R[AGV#X<?&6
MR\>O-! )(;B!B)()U$<P ."VT,W ;Y6YRK<,!N7.KXX^(EIX+1&NV.^5BL,*
M*9)I7QPB(O)).%R<*&90S#<*Y70/VA++4[U--N(+JRGE7,8NXA ').%4?.QR
MQ!"Y #$%0=Q"GK_&/C^Q\&1B;4)TA4_=!)+M@J#M107?&X9V@[0<G YK/\"_
M%6R\:6TU];,5MX)I(VDE C4A%5S(,GA-K Y?:0,[E&*Q;7]HG1KZ]33X)_,=
MO/WR ;8(Q"C2,S2/M4J55L,F]>,D@$$R_#CX\Z=\0KF:SLC)OB4L"Z;5D0-L
M+IR3C)7APC88?+PVWT6N5^(?Q/L?A_")[^3;NW"-%!:20J,E54?@-S80$J&8
M9%<?:?M,:<MRMG?175@[J"INX?)4Y;8.C,5!.?G8! %;+#%>@>+_ !E:^#X#
M=WSF.$,JEQ')( 3P,^6K%03QDX&2!G) .)X.^,FF>,Y##I\KS,/O$07 1<AB
M-SM$$3.TXW$;B,#)XK/N?V@M&M9_L<DTBW!95$+6MV)=S8V+L,&[)R,#&3D8
MZUU>M^,;?1+87MQYBPE0Q(@G=E7:7+.B1EXP%!W%U4*>&P>*Y_5OCCH^D017
M5Q="-)U#1ADE$K(=VV3RMGFA#M.'*A3Q@G(SGV?Q^L;^TBNX([F:2:-Y([6*
M$S711)O)9RL9947<#AF=0V"%)8%:U?AC\7K'XD1O)8E]T>WS(Y$*NFXN$R1E
M#G82-K-@8S@\5VM%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?*O[<__ ##O^WO_ -MZ]U^*^DPKH=[
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M:?>HD$ACG=8]P?((4*-HZ Y8#<23[5:6B6:+%$H1$4*JJ JJH& H X  X '
M%?/7[:7C&33+&#3XQA;N1S(W'W82C!,%3U=U;(((V8Y#&OH#2=+CTB&.V@7;
M%%&D:+DG"J JC)))P !DDGU-?+7PHMA\.?&-SH]OEK>=755W,JH/*%U'D$OO
M*+F($G)#%LC)4V_VM= /AF]L?$5J@WK,BR$[=ADB(D@W!=KL2JNK')^5%7*\
M9]E^)OV?QEHS0I^\6_CB6V^\I9Y-KPR8X?:F!-(,$K$CL5(4BO-/V.O'2S:7
M<6EP^U;*0OO;8D:12!G^]D='21F+= 1SCA?9? %HX@:YF4K+=3/.X8%7"MA8
M$=> KI;K%&X'&Y"26)+-\ZW-HEU\0MLBA@&5@& (W+8!T;GN& 8'J" 1R*ZO
M]MBT1M*MY2H+K>JJM@;@K12EE!Z@$JI(Z$J,]!7K7PG_ .0/I_\ UX6G_HE*
MZJBO*OVH_P#D7;S_ +=__2B*C]ES_D7;/_MX_P#2B6O)?VB+1+SQ;I<4JAT=
M;%65@&5E-W*"I!X((X(/!%>J_M56B3^'[IG4,4:W9"0"5;SXTW#/0[69<CG!
M(Z$UB?!OP='XS\'Q:?,<+-'<@-R=K"YE:-\!ESM<!L9 ;&#P36!^Q_XFFL6O
M- O#B6VD9TC)9BN',=PH8%HPJR;2 N,L[L-V21[):VB:]JCW+J"+!3!%D#<)
M9DBFF?G/'E&%$(*MEIU8%2IKS#4-:N-<\8O%!"DC:?8'RUEN)(8PTGEEYALB
ME^8I.(RI4@A0Q;*J!TOQ8\&:K\0M/DT][>RC+-&R2FZED*,K [@#9+R5W)D$
M'#'J"0?/_C9\/]1L_"=K:3XGFLID:5HN56%$F1& *HQ"(R!CMR "S9 9JZ7X
M<_M0Z7XTA%KJFRWG>,K*LH'V63(;> S$J%*CE9=OW@@,AY.A^T%HB:#X4FLX
MB2D$-G$I;!8JDT" G  S@<X &>PK0_9<_P"1=L_^WC_THEKRKX^_\CAI/_;A
M_P"EDE=W^V';3S:'N@SL2YA:?#;1Y>&49&1N'FM'QSSAL?+D=A\*M4M=3\/V
MDDC(UL+!(Y3(,1XCC\J8-O &T%&#$_*0"<E>:\D_8CT">T@O+N1"L,[0+$YX
M#F/SA)CN0"P&>A.0"2K =WIOPZT_X5ZA>^(KJ[V)<^9A9-JA2[>?*H(^:5BR
M9C50&"@KB0_,/)/C%K(U?Q;I,J)(B;K$+YJ-$S 7;Y8(X$BC.5^=5)*D@%"K
M-W?[:W_('@_Z_P"/_P!$SUZK\)_^0/I__7A:?^B4KY_^ 7_(X:M_V_\ _I9'
M6MXPUW_A*O&UEILZY@LLL@SUE-O]I$F5"L/F6,;267]WGHS"O=/'_@Z/QG8S
MZ?,<+-&0&Y.U@0T;X#+G:X#8R V,'@FO$/V)_%#WME<V#Y(MYD=&+$@+,&^0
M*1\H#1LW!P2Y. <D\_<VB77Q"VR*& 96 8 C<M@'1N>X8!@>H(!'(KJ_VV+1
M&TJWE*@NMZJJV!N"M%*64'J 2JDCH2HST%9/QGT"?5_!VG-;H9!!#8RR;>2L
M8M65GQU(!89QG RQPH)'2_#G]J'2_&D(M=4V6\[QE95E ^RR9#;P&8E0I4<K
M+M^\$!D/)]E\/:(F@VT-G$24@ACB4M@L510@)P ,X'. !GL*B\6:[_PC]G<7
MNW?Y%O++LSMW;$+[<X.,XQG!QZ&O%?V._P#B96=[J4OS75Q?OYTG3=A$D'RC
M"CYI7/R@?>QT  Q/VS_#(M4M-:A<QW$<RP;E+!L8>:-@P8;2C*V"!DE\[OE
MKUOQ9KO_  D'ANXO=NSS](EEV9W;=]L7VYP,XSC.!GT%>?\ [%/_ "!Y_P#K
M_D_]$P5[_6?XAT1->MIK.4D)/#)$Q7 8*ZE"1D$9P>,@C/8UYK\.](T_X)VR
MZ5+=&:XFF>78L;O,Q9<96"$2R! D/+'<-P8[AD*/*OV=YC/XMU1V4H66^)1M
MI92;N(E3L9ER.AVDC/0D<U+\??\ D<-)_P"W#_TLDKZ ^+'_ "!]0_Z\+O\
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M/LOA/_B8W5Y??PF1+:,C@,EMO#D@\AA<RSH2< JB%1CYWZJBOE7]AC_F(_\
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MDD!*]:\+?$J/4]%36Y/F46C32B-2/FC4^<BAR.CHRKDX.!\Q'-%G;?\ "O\
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M5L'G!!Z$5Y?\8M)_X5GXGL=:M8]ZW<C;H47=(7P(9]B*$RSI*&3+$M,6+<$
M_2'@O1'T6TBAF(,VTM,RY*M-(3).XR!@-*S,!A0 <!5  'S?\?=.D^'7B&T\
M2Q[S!+)&)BH#D%%$4D8W*$&^#[@+;BPD(*A01]"W?Q%LH-.;65E#VBPF0.I
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M?QXM?&%S;Z?H3F:629'FD\N1(X8(V5YBWF1<EU'E)@ !G!+H=N[UJO*OVF/
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M(SVY\\DMAK<Y$8C);:KMENJ\.?%WP?X=GDO+>X/VB9562:1;Z>5E7&%WS*[
M<#(! .U<YVKC/_:]\=75CI]M'8/_ *)>>8)9H_F#+M1HXQ(IVA9%9B0.752
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M:(9VEH8O.CB8='!(!YC/:_MB^!5FTNWNK=-JV4@38NQ(TBD"I]W Z.D:J%Z
MGC'*^J_!_P Z[T^.^N]GVF]Q<RF/=L_>*HB #=-L"QH1ZJ22S$NWF'[;%VBZ
M5;Q%@':]5E7(W%5BE#,!U(!903T!89ZBO5/@[=I=:-8-&P8"RMU)4@C<L:HZ
M\=PP*D=000>17SA^QWI\.MPZMI\S[?M%O$A"LHDV$3QR,H(/W?,'." 67/4
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MM&B>"+#07,MG:P0.5*EHHHXV*D@E244'&0#CID#TK:HKS75/V;M U.1II+)
MS8R(WEA3@ <)$Z(.G. ,G)/))KT#2])ATB-8+:-(HESM2-51!DDG"J !DDDX
M[DFK597A;PM;^%;=+*R3RX(]VQ-S-C<Q=N7+,?F8GD_I4K:! UR+[8/M"PM$
M).C>6S*Y0^HW*",YVG.W&YLV[NT2\1HI5#HZE65@&5E(P5(/!!'!!X(KFO\
MA4^C_P#0/L__  &A_P#B*M:A\/=-U'9Y]G;2>7&L:;X(FVHN=J+E3A1DX4<#
ML*B?X9Z88)K1;2!(9U"RHD21AP,E<[ IRI.5/53RI!YK5T#0(/#T"6EH@CAC
M7:B+T Z]^22<DDY+$DDDDFM"N?U3X>Z;J\C3W-G;2RMC<\D$3N<  99E).
M!GL *-+^'NFZ1(L]M9VT4JYVO'!$CC((.&501D$@X[$BJO\ PJ?1_P#H'V?_
M (#0_P#Q%6KCX>Z;<QQP26=LT46[RT,$11-QR^U2N%R>3C&3R:FT3P18:"YE
ML[6"!RI4M%%'&Q4D$J2B@XR <=,@>E2Z_P"%K?Q!Y/VI-_D7$<\7S,NV5,[&
M^4C.,G@Y4]P:U:JZII,.KQM!<QI+$V-R2*KH<$$95@0<$ C/< UQ7AGX!Z)X
M:F%S:V:"5<;6=I)MI!#!E$KN%8$ A@ P['DUU7B'PI:^)%1+V))DCD\Q4D&Y
M-VQDR5/RM\KM@," <$#(!''VW[/&@VT_VI;*,N69L,7>++9S^Z9C%CG@;<+Q
MM P,>@7=HEXC12J'1U*LK ,K*1@J0>""."#P17'^#O@OI'@V0SV-JB2]G)>5
MUX8?*TK.4R&(.W&X<'.!5O\ X5/H_P#T#[/_ ,!H?_B*\T^+WB2U\/W5AX?D
M'V/2[CS#<O&OD1,O.V!73 16D/\ I& I".I+JK.:]%M/AEHEXBRQ6-DZ.H96
M6W@964C(8$)@@CD$<$5YUH_A33]:U^UOM!BA6WLHYQ=3PA4MW:2(K#%&8_DD
ME7>6D*C"J5#/NVH.VU3X!Z)JMTU_/9HT[2"1CND",PP<M&'$9R1E@5(<DE@2
M3F_XA^$.D^(G@DNK6-S;*JQ#!5512"L95"JL@QPC!E ) &&;.WJGA2UU6U;3
MYHD:U:,1^5C:@48VA0N-NW VE<%2 5((!KG_  ]\%=&\/QO#;V<.R3[_ )B^
M<6&5;:6E+MMW(K!<[0P# 9YJW_PJ?1_^@?9_^ T/_P 170:II,.KQM!<QI+$
MV-R2*KH<$$95@0<$ C/< UY_I?[-V@:9(LT=DA9<X$CRS)R".4E=T/7C(.#@
MCD UZ+=VB7B-%*H='4JRL RLI&"I!X((X(/!%<U_PJ?1_P#H'V?_ (#0_P#Q
M%6M0^'NFZCL\^SMI/+C6--\$3;47.U%RIPHR<*.!V%59/A1I+J$^Q6P02+)L
M$,:HS*CHI954*^%D? 8$ G( (!&);?L\:#;3_:ELHRY9FPQ=XLMG/[IF,6.>
M!MPO&T# QZ+17*^-?A9IGC?:=0MTE9<8?YDD &["[XRK[?F)VYVY.<9P:/!7
MPLTSP1N.GVZ1,V<O\SR$';E=\A9]OR@[<[<C.,Y-:&M^"+#7G$MY:P3N%"AI
M8HY&"@DA074G&23CIDGUJI:?#+2K-UEBL;5'1@RLMO$K*P.0P(3((/((Y!KI
M:BN[1+Q&BE4.CJ596 964C!4@\$$<$'@BN%\,_ /1/#4PN;6S02KC:SM)-M(
M(8,HE=PK @$, &'8\FK\/PATF&];4Q:Q_:G;<7(+#?E6\P(245]R@[U4-G)S
MEFS-_P *GT?_ *!]G_X#0_\ Q%6KCX>Z;<QQP26=LT46[RT,$11-QR^U2N%R
M>3C&3R:-+^'NFZ1(L]M9VT4JYVO'!$CC((.&501D$@X[$BJOC7X6:9XWVG4+
M=)67&'^9) !NPN^,J^WYB=N=N3G&<&K7@[P!8^#(S#I\"0J?O$ EVP6(W.Q+
MOC<<;B=H.!@<5Y5\0?'5KJ.O)HNKOY&GQ6XFQ+^ZAN9\AD#N25>!5!(4[%:9
M"K[\*I]%N_AEHEFC2RV-DB(I9F:W@554#)8DI@ #DD\ 5POPR\*6L^N7&KZ1
M$D6G_9#;;T&R*:<2J7>%1\IB54",X"JS@E-_S-7H'C7X6:9XWVG4+=)67&'^
M9) !NPN^,J^WYB=N=N3G&<&K7@[P!8^#(S#I\"0J?O$ EVP6(W.Q+OC<<;B=
MH.!@<4>,? %CXSC$.H0),H^Z2"'7)4G:ZD.F=HSM(W 8.1Q6+8? [1["TFTZ
M*U"V]PR-*N^7<Y0ADRY?S, C( ; )/'S-GH/"_@FR\*IY=A!'""J*Q10&8("
M%WM]YR,GEB3DDDY)K:HK*T[PM;Z=<3WL2;9[GRO.?<QW>4I2/@DJ,*<?*!GO
MDUH7=HEXC12J'1U*LK ,K*1@J0>""."#P17-?\*GT?\ Z!]G_P" T/\ \16U
M<^'K:Z@^QR0QM;A540LBF+:N-B["-N!@8&,# QTKA=+_ &;M TR19H[)"RYP
M)'EF3D$<I*[H>O&0<'!'(!KT6[M$O$:*50Z.I5E8!E92,%2#P01P0>"*YK_A
M4^C_ /0/L_\ P&A_^(H\6_"S3/%L,5M>VZ/%!_JE7=%L&-NU3&4(7  V@[3A
M>/E&(=-^$.DZ;:2:=%:QK;S+ME7!+.,EEW.29&*EB4);*'&PK@8T/!W@"Q\&
M1F'3X$A4_>(!+M@L1N=B7?&XXW$[0<# XK%T3X&:+HER;VWLXUF+%@3N=5;<
M'#(CL4C(8#:452HX7 XK5N_AEI5X[2RV-J[NQ9F:WB9F8G)8DIDDGDD\DUJZ
M)X>MM!0Q6<,<"%BQ6)%C4L0 6(0 9P ,]< >E<+JG[-V@:G(TTED@9L9$;RP
MIP .$B=$'3G &3DGDDUZ!I>DPZ1&L%M&D42YVI&JH@R23A5  R22<=R36)=_
M#+2KQVEEL;5W=BS,UO$S,Q.2Q)3))/))Y)J7_A7NF^3]E^QVWD>9YGE>1%Y>
M_&W?MV[=VWC=C..,XJJWPHTG:RK96R;XY(V:.&.)]KH4<!T567*L02"#@GFL
M36_V>-!UEQ)+91J0H7$1>!<9)Y6%D4GGJ1G&!G &.[TO28=(C6"VC2*)<[4C
M5409))PJ@ 9))..Y)JU7/ZI\/=-U>1I[FSMI96QN>2")W.  ,LRDG   SV %
M%O\ #W3;:.2".SMEBEV^8@@B"/M.4W*%PV#R,YP>145I\,M*LW66*QM4=&#*
MRV\2LK Y# A,@@\@CD&B[^&6E7CM++8VKN[%F9K>)F9B<EB2F22>23R365XC
M^!FB^(A&MQ9QXA5EC$>Z *K,7*_N63(W$L <@%F(P6;-JY^$.DW-E_9C6L8M
M0RML4%#O4!1)O4A]^T8+[MS#(8D$YJZEKVB_!ZVCBD,=G"[8151F9V50"Q"*
MSN=H4-(V3G;N;)&2:[MO'-W;&W:.YM;5I)VD0K+&+@ 1P)N^9"0DDLA"_.C+
M"Y*!E$G=45GZWX>MM>017D,<Z!@P65%D4, 0& <$9P2,]<$^M95I\,M*LW66
M*QM4=&#*RV\2LK Y# A,@@\@CD&HO^%3Z/\ ] ^S_P# :'_XBK5Q\/=-N8XX
M)+.V:*+=Y:&"(HFXY?:I7"Y/)QC)Y-3:)X(L-!<RV=K! Y4J6BBCC8J2"5)1
M0<9 ..F0/2I=?\+6_B#R?M2;_(N(YXOF9=LJ9V-\I&<9/!RI[@UJU5U328=7
MC:"YC26)L;DD570X((RK @X(!&>X!KS_ $O]F[0-,D6:.R0LN<"1Y9DY!'*2
MNZ'KQD'!P1R :]%N[1+Q&BE4.CJ596 964C!4@\$$<$'@BN:_P"%3Z/_ - ^
MS_\  :'_ .(KI;2T2S18HE"(BA550%55 P% '  '  X K/T[PM;Z=<3WL2;9
M[GRO.?<QW>4I2/@DJ,*<?*!GODUJUROC7X6:9XWVG4+=)67&'^9) !NPN^,J
M^WYB=N=N3G&<&K7@[P!8^#(S#I\"0J?O$ EVP6(W.Q+OC<<;B=H.!@<5T%%>
M=:_^SSH>OSO=W-H&EE;<[+)-&"W=ML<BKD]20,DY8Y))KN]+TF'2(U@MHTBB
M7.U(U5$&22<*H &223CN2:R?&/@"Q\9QB'4($F4?=)!#KDJ3M=2'3.T9VD;@
M,'(XK*\'?!?2/!LAGL;5$E[.2\KKPP^5I6<ID,0=N-PX.<"NEUOP];:\@BO(
M8YT#!@LJ+(H8 @, X(S@D9ZX)]:RK3X9:59NLL5C:HZ,&5EMXE96!R&!"9!!
MY!'(-%W\,M*O':66QM7=V+,S6\3,S$Y+$E,DD\DGDFI;CX>Z;<QQP26=LT46
M[RT,$11-QR^U2N%R>3C&3R:YKQ]X(L-!TK49;.U@@<Z==J6BBCC8J8F)4E%!
MQD XZ9 ]*\@_9A^&^G^.=$DCU& 3"/4960Y=&4F" '#(RM@\9&<$@$@E1CZ$
M\'> +'P9&8=/@2%3]X@$NV"Q&YV)=\;CC<3M!P,#BC5/A[INKR-/<V=M+*V-
MSR01.YP !EF4DX  &>P JWH7A.S\/[OL5O#!OQO\J-(MV,[<[ ,XR<9Z9/K7
M/^,?@OI'C*03WUJCR]W!>)VX4?,T3(7P% &[.T<#&370>&?"EKX7A%M8Q)#$
M,?*@QD@!=S'JS$* 68ECCDFJFE_#W3=(D6>VL[:*5<[7C@B1QD$'#*H(R"0<
M=B14VM^"+#7G$MY:P3N%"AI8HY&"@DA074G&23CIDGUJ70O"=GX?W?8K>&#?
MC?Y4:1;L9VYV 9QDXSTR?6M6N:N_AEI5X[2RV-J[NQ9F:WB9F8G)8DIDDGDD
M\DUJZ)X>MM!0Q6<,<"%BQ6)%C4L0 6(0 9P ,]< >E<5<_L\:#<S_:FLHPX9
M6PI=(LKC'[I6$6..1MPW.X')SVMW*F@VS-%$2D$)*PPH"Q5%XCC08&<#:JC
MS@<5XK\#[G3/B?$]]J7D7>IR,YEBE5)/)C1R(TACD!V0A74EESN=SO=GX'5^
M//"_ASPW ?M=E:@RJRQQ1P1"YE8X39"J!9"Y+J 4(*DABRCYA#\/?@Y&= MM
M'UJ%)"FYW0,?E9I7D7#H00P#[6*'!^9064\]+X5^$.D^%4DCL[6-1*K+(6!E
M9D8 -&6E+L4.T93.W/.,DU%X>^"NC>'XWAM[.'9)]_S%\XL,JVTM*7;;N16"
MYVA@& SS5O\ X5/H_P#T#[/_ ,!H?_B*ZJL_6_#UMKR"*\ACG0,&"RHLBA@"
M P#@C."1GK@GUK*M/AEI5FZRQ6-JCHP966WB5E8'(8$)D$'D$<@U4\1_"'2?
M$AE>[M8Y'G96DD((E)545<2 AT&U%&$*@\Y!W-F;P5\+-,\$;CI]ND3-G+_,
M\A!VY7?(6?;\H.W.W(SC.34/B/X0Z3XD,KW=K'(\[*TDA!$I*JBKB0$.@VHH
MPA4'G(.YLS>"OA9IG@C<=/MTB9LY?YGD(.W*[Y"S[?E!VYVY&<9R:M>,? %C
MXSC$.H0),H^Z2"'7)4G:ZD.F=HSM(W 8.1Q65;_!?2+:RDTV.U1;:7;YB@N'
M?:_F)ND#>:V&Z98X'RCY>*Z71/#UMH*&*SAC@0L6*Q(L:EB "Q" #. !GK@#
MTKFO&/P7TCQE()[ZU1Y>[@O$[<*/F:)D+X"@#=G:.!C)KH/#/A2U\+PBVL8D
MAB&/E08R0 NYCU9B% +,2QQR37-:Y\#-%UT,+BSC8M,\K.-R2L[LS,3(C+(0
M2Y^4L5'   5<;7@[P!8^#(S#I\"0J?O$ EVP6(W.Q+OC<<;B=H.!@<4?\(!8
M_;O[6\A/MGE[/.P=V,8SC.W=M^7?C?L^3=MXKH*S];\/6VO((KR&.= P8+*B
MR*& (# .",X)&>N"?6L7_A4^C_\ 0/L__ :'_P"(KI;2T2S18HE"(BA550%5
M5 P% '  '  X J6N \3? /1/$LQN;JS0RMG<R-)#N))8LPB= S$DDL06/<\"
MNUTO28=(C6"VC2*)<[4C5409))PJ@ 9))..Y)KG_ /A4^C_] ^S_ / :'_XB
MM5O"EK]E;3UB1+5XY(VBC'E)M?.\ )MVYW')&#DDYSS7'ZW^SQH.LN));*-2
M%"XB+P+C)/*PLBD\]2,XP,X QW>EZ3#I$:P6T:11+G:D:JB#)).%4 #)))QW
M)-<IXQ^"^D>,I!/?6J/+W<%XG;A1\S1,A? 4 ;L[1P,9-:O@[P!8^#(S#I\"
M0J?O$ EVP6(W.Q+OC<<;B=H.!@<5-K?@BPUYQ+>6L$[A0H:6*.1@H)(4%U)Q
MDDXZ9)]:AT_X>Z;IV_R+.VC\R-HWV01+N1L;D;"C*G RIX/<55_X5/H__0/L
M_P#P&A_^(K/USX&:+KH87%G&Q:9Y6<;DE9W9F8F1&60@ES\I8J.   JXVO!W
M@"Q\&1F'3X$A4_>(!+M@L1N=B7?&XXW$[0<# XKH**RO^$6M_MG]I;/]*^S^
M1YFYO]5O\S;MSM^]SG&[MG'%2Z_H$'B&![2[020R+M=&Z$=>W((."",%2 00
M0#6A7/ZI\/=-U>1I[FSMI96QN>2")W.  ,LRDG   SV %%O\/=-MHY(([.V6
M*7;YB""((^TY3<H7#8/(SG!Y%16GPRTJS=98K&U1T8,K+;Q*RL#D,"$R"#R"
M.0:B\:_"S3/&^TZA;I*RXP_S)( -V%WQE7V_,3MSMR<XS@T>"OA9IG@C<=/M
MTB9LY?YGD(.W*[Y"S[?E!VYVY&<9R:ZJBO.K;]GC0;:?[4ME&7+,V&+O%ELY
M_=,QBQSP-N%XV@8&-76_A#I.NW8U&ZM8Y;@*%+,"58 %1N3/EN0#@%E) "X/
MRKCH-?T"#Q# ]I=H)(9%VNC=".O;D$'!!&"I (((!KD/#/P#T3PU,+FULT$J
MXVL[23;2"&#*)7<*P(!# !AV/)KNKNT2\1HI5#HZE65@&5E(P5(/!!'!!X(K
MC_!WP7TCP;(9[&U1)>SDO*Z\,/E:5G*9#$';C<.#G KM:BN[1+Q&BE4.CJ59
M6 964C!4@\$$<$'@BO.O^&;M \[[1]B3?YF_&^7R\YW8\O?Y>W/\&W9CY=N.
M*]%M+1+-%BB4(B*%55 554# 4 <  < #@"N:_P"%3Z/_ - ^S_\  :'_ .(J
MU<?#W3;F.."2SMFBBW>6A@B*)N.7VJ5PN3R<8R>34VB>"+#07,MG:P0.5*EH
MHHXV*D@E244'&0#CID#TK:KFO''PWT_QRB1ZC )A&Q9#ET921@X9&5L'C(S@
MD D$J,16WPHTFWA2V%E;&*/.Q6AC?!(56;+J26(10S$EFVC<3BK6E_#W3=(D
M6>VL[:*5<[7C@B1QD$'#*H(R"0<=B157_A4^C_\ 0/L__ :'_P"(K0UOP39:
MY;"QN8(WMU4*L94!4 4H-F,;"%)"E,%1]TBL3P=\%](\&R&>QM427LY+RNO#
M#Y6E9RF0Q!VXW#@YP*Z#7?"=GX@V_;;>&?9G9YL:2[<XW8W@XS@9QUP/2L^V
M^&6E6IW1V-JI*LI*V\0.UE*.O"="I*D=""0>#47_  J?1_\ H'V?_@-#_P#$
M5TMI:)9HL42A$10JJH"JJ@8"@#@ #@ < 5+65XF\*6OBB$VU]$DT1S\KC."0
M5W*>JL Q 92&&>"*Y7PS\ ]$\-3"YM;-!*N-K.TDVT@A@RB5W"L" 0P 8=CR
M:[^LK7_"UOX@\G[4F_R+B.>+YF7;*F=C?*1G&3P<J>X-:M9^@Z!!H$0MK1!%
M$K.RHO"@N[2-@=AN8D < <*  !576_!%AKSB6\M8)W"A0TL4<C!020H+J3C)
M)QTR3ZU#I_P]TW3M_D6=M'YD;1OL@B7<C8W(V%&5.!E3P>XJK_PJ?1_^@?9_
M^ T/_P 17544444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444445E>)O"EKXHA-M?1)-$<_*XS@D%=RGJK ,0&4AAG@BN%M/V9?#
M]JZR+9 E6# -+.ZY!R,J\A5AZA@01P017HNEZ3#I$:P6T:11+G:D:JB#)).%
M4 #)))QW)-6J**************************Y_QCX L?&<8AU"!)E'W200
MZY*D[74ATSM&=I&X#!R.*Y72_P!F[0-,D6:.R0LN<"1Y9DY!'*2NZ'KQD'!P
M1R :]%M+1+-%BB4(B*%55 554# 4 <  < #@"I:*********************
M************YKQQ\-]/\<HD>HP"81L60Y=&4D8.&1E;!XR,X) )!*C&KH&@
M0>'H$M+1!'#&NU$7H!U[\DDY))R6)))))-:%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%<_P",? =IXRC$%\KO%W0331(W*GYEB= ^"H(W9VGD8R:RO!WP;TSP9(9M
M/B>%C]X">X*-@,!N1I2CXW'&X':3D8/-=K1111111111117 >)O@'HGB68W-
MU9H96SN9&DAW$DL681.@9B226(+'N>!5_P (?"'2?!Y#V-K'&X9F$A!DE!*[
M3B20LZ@KQ@$#D\<G/8444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444455U:XDMH9)((_-E6-RD>X)O8 E4W'A<G R>
M!G)KE/A#XHU#Q+8BXU:V^RW'F.-F&3<H/#[')=.ZX8DG;O'RL!7:T44445%;
M7:70W1L& 9E)4@C<K%'7CN&!4CJ""#R*\%\3?M":GI6L6>E26*6RW%Q$"99%
MGD:*281*X\EPD;<-D%I.<=AEO?Z****XKXO>*-0\-6)N-)MOM5QYB#9AGVJ3
MR^Q"'?LN%((W;S\JD5U>DW$ES#')/'Y4K1H7CW!]C$ LFX<-@Y&1P<9%6J*B
MN[M+-&EE8(B*69F(554#)8D\  <DG@"I:******Y_P ?ZQ=:-8SW%A#]HN4C
M)CB_O'(R<#EL#+;%PSXV*0Q!H\ :Q=:S8P7%_#]GN7C!DB_NG)P<'E<C#;&R
MR9V,2P)K;6[1G,08%U569<C<%8L%8CJ 2K 'H2IQT-2T444445YAXK^*ES/J
M+:%HL4<EZD/FS2SLR6\*_(0"%&^0LK@?)@*74Y8!PN3X ^+^IS:LV@ZS9A)]
MKR+/;[S!Y8 VN0Y8[&(($F[[Y6,HK;L>RT444445P'C#QAJFF:I96=G9>=9S
M9\^?)^3G!Y'RQ[%P_P X/FY\N/# FN_HHHHHHHHHJ)KM%<1%@'9695R-Q52H
M9@.I +*">@+#/45B>/\ 6+K1K&>XL(?M%RD9,<7]XY&3@<M@9;8N&?&Q2&(-
M'@#6+K6;&"XOX?L]R\8,D7]TY.#@\KD8;8V63.QB6!-=!111142W:,YB# NJ
MJS+D;@K%@K$=0"58 ]"5..AKA?BSXPU3PW]E_LFR^V>;<!9N3\J\8'&-F[)_
M>MF./;\X.X5W]%%%%%%%%%%%%>2_'+XTW7PWB\R*R,B,QC6=Y8UB\QD+IA$9
MI7'#;@PB^[@,=P->@>"-;?7K"UO)0 \]M!*P7(4,\:N0,DG&3QDDX[FMJBBB
MN5^(_C*?PE:O=06KW7EQO(^)(HD14PS%F=MWW=Q 1')*X(&0:Y_X"_%*;XE6
M<U[/&D6V[DC1$W'"!(W7<2?F;YR"P"@XX45Z511111111145W,8$9U4N54D(
MNT,Q R%&]E7)Z#<0,]2!S7BNE?'Z[U'Q!%H,EF+8;IO-WR"64J(#-"1Y1\M"
M0 6&91\V 01D^WT444445XK:?%O5O'JSW'AJ"V:UMY'C$ETT@>X8(K8C1"GE
M]>LK ,'0DH0X67P)^T0-1TZ[O]4MI+8V++'-A697D.%*(& *OYG#1L?W89"S
MX)(RM9^+'B.TLDUR.RM38,L<I@#RR7:PD F0NNV/!'S9"L8U8%T.UR/6O 'B
MW_A+[&"_\IX?.C#>6_WAR1D'C*G&Y&P-R%6P,X'04445%#=I.65&#%&VN 02
MK;5?:<=#M96P><$'H14M>%?'3]H2]^';+%%8X\W>(IYI$*,8W <B*%V8KM92
MI9XVRW*?*0?=:****BANTG+*C!BC;7 ()5MJOM..AVLK8/."#T(KP7Q-^T)J
M>E:Q9Z5)8I;+<7$0)ED6>1HI)A$KCR7"1MPV06DYQV&6]_HHJ*:[2 JKL%+M
MM0$@%FVL^T9ZG:K-@<X!/0&O.OC9\3[WP!;M<VMEY\2QY>=I42.-F81QC9DR
MR?,06 "C!&'Y8KJ_!GQK-XWTJWU"Y5%EE\W<(PP0;97C& S,>BC.2><_2NUH
MHHHHHHHHHJKJEZUE&TD<3S,,8CC,8=LD#@RO&G&<G+#@'&3@'Q_X5?'BZ\;Z
MQ/I<]JELMO;REUW^=()8YDC8;QM3;\Q& IY&0Y!Q7M5%%%%%%%%%%%%%97B;
M59],A,EK;O=2\A8T>*/G!(+-*Z +D $C<PSD(V#7FOP#^-\WQ2DO#)"D,4'V
M?RU!9W^<2;]S' ;E,C"K@'!SUKU^HKN[2S1I96"(BEF9B%55 R6)/  '))X
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M#Y7*JP&<C%_9/UQM$T&XG2":XVW\I*0"-I,"WA)8+))'NZ8VKN<D@!3SCO\
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M6*5I%FMR<9;,@5% &Y 2N\*6_>% I-=K\4O&%UX4LI;FSMC<.D,CYW1K%&$
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ML<?)*O*-G:Q4$_*Y4;MC,!UK0\=>.K7P/:O>WK[8UX '+NQSMC09&6..!P
M68A02/-=1^/.IZ;']MFT2Y6Q\QLR&1?/6-2VZ1X-FY,*I8[R$Z#S,$,?2O O
MCJU\<6J7MD^Z-N"#PZ,,;HW&3AAGD<@@AE)4@GSKQ3^T[::%>PV!MYU,LT*M
M+<(;2)8G.UIAYP$A"G(.Y$4[6^? !)\4/C]=>!D6Y.F2-:.RHLTLT<#,[!V
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MM_V__P#I9'1^W/\ \P[_ +>__;>OH#XL?\@?4/\ KPN__1+UY5^Q3_R!Y_\
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MV\'Z:^''CK3/'GF:AIS[I3'#',K;ED0+O>-&0G P97^9<JQW .VWCPKX!?\
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M]IZ]>YN=&TX",I<:BK-YB&1=R-'&H9=RAD(G;>N06  #+SGU#^S=8_Y^[/\
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MR)"5"OU7[+G_ "+MG_V\?^E$M>5? +_D<-6_[?\ _P!+(Z/VY_\ F'?]O?\
M[;UH?M-:H-;UO2=%F4FW::%Y5WL%D$TXAP57&"JHV&SG$A V\D_2MW:)>(T4
MJAT=2K*P#*RD8*D'@@C@@\$5\M?L,?\ ,1_[=/\ VXKZJKY5_;G_ .8=_P!O
M?_MO7U57RK^PQ_S$?^W3_P!N*/C[_P CAI/_ &X?^EDE=,US<Z]XTN8X3!&]
MIIRK$\L+3X4^4[$ 31$/F=EW @;,KM.2:[KQ[\.-2\;V4NGW-Y;+%+LW&.SE
M#C:ZR#!:]8=5&<@\9^M=+\-_"#^#M/@T^28W!A5E$K J2NYBBX+/@*I" 9(
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M@;97.UR9+AB$)9I=S+")64;L1#:$KR3]AC_F(_\ ;I_[<4?'W_D<-)_[</\
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M)@-DO)\^=R+Z?7S7^VCXKM9;&'3UE1KI;M)&B!W.JB&3E@,[<^8N V"P.5!
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M7%K!(D*[8E>*-UC7 &U RD*,*!@8& /05JVEHEFBQ1*$1%"JJ@*JJ!@* .
M. !P!536_#UMKR"*\ACG0,&"RHLBA@" P#@C."1GK@GUJ;2])ATB-8+:-(HE
MSM2-51!DDG"J !DDDX[DFK5%96A>$[/P_N^Q6\,&_&_RHTBW8SMSL SC)QGI
MD^M:M%%8NM^"+#7G$MY:P3N%"AI8HY&"@DA074G&23CIDGUK:HHHHHJKJFDP
MZO&T%S&DL38W)(JNAP01E6!!P0",]P#1I>DPZ1&L%M&D42YVI&JH@R23A5
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M:"ABLX8X$+%BL2+&I8@ L0@ S@ 9ZX ]*T*S];\/6VO((KR&.= P8+*BR*&
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M!G'7 ]*U:***********Y_5/A[INKR-/<V=M+*V-SR01.YP !EF4DX  &>P
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;%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex99_006.jpg
<TEXT>
begin 644 ex99_006.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[@ .061O8F4 9       _]L 0P &! 0.
M!0X3# P3%A,0$Q$3%Q45%Q<6%!0:&AH7&!<7%QX<%Q@9&QP<)1L9'Q\?'Q\B
M'Q\?'Q\?'Q\?'Q\?'Q\?_\  "P@,Y GV 0 1 /_$ !\   $% 0$! 0$!
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MS!Y.I^'+>!MDB_Z3'*AVN/FFD)1UYZHX)4]58'&"*S_BSX+M/AGX=U#^R(A
M95C60Y,C,KR)"REI2[8V.P SA2Q9<,2:\O\ V-;:\F^W_8I88L?9=_FP//G_
M %^W&R>';CG.=V<CICGT#2_V6YK+5EUHZA^]^UFX=([=HPVYR\D8/VAB%8$H
M<[OE)!W<Y^?_ -J/_D8KS_MW_P#2>*OH#]M;_D#P?]?\?_HF>C]BG_D#S_\
M7_)_Z)@KY_\ V7/^1BL_^WC_ -)Y:[7]MK5))=2MK8M^Z2T\Q5P.&DD=7.<9
M.1$@P3@8X R<^MZ?\.K_ ,<^'K:PDNX([>:RL\;;60RJJK%(@W&[VD_* 3L
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MF*$"S:7RHLD[09(6RWS'<^ QW,!M0[!JZ/XD\6^*KB&PU2.\-C/<0QW(^R&
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M,&<7LJJ%4(J)Y<3A!CD@%C@L6;'5C6W_ ,3W^W?^6/\ 8WV?VW[\?]]^;O\
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MS+Y5^W/_ ,P[_M[_ /;>O4/BCX^UO1;1]2TZV@^S1*699_/:Z9,J _DHJ"(
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M\K@;G95B.54!EP' )!!SDLB=7\./&NH:S=7=EJ=LEO):QVW*,SI*9/.W3(6
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MM>5>+?C.R:O%X=TU4-X_,DLP?R81L\XC8NUI6,0) #(H8H"Y^8+B^+_C3?\
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M>HKR7]FK1)-4T.W:'4)XPK3JT40LV6-O.=MI\RVD<$JP?#,3A@1A2!75ZI\
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M]?55?*'[-5L-&\3ZI8V^4MT6Z58]S%<1W2)'G).XJK$ G)P3SR<R_P#-0_\
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M>E7OBA/'FF6\4.,ZG"%9582>5$R?Z62P'!12T2L5*BX:)74!B*\:_9:\:_\
M"&0ZIIM\NU[+S;EHU&Z0^4/+N1N#>6=I2,*,C)8G)'*_2'@W1'T:U2*8@RLT
MDLNW)3S9I&FE"9 .P2.P3/S;<;B3DGYO_P":A_Y_Z!U=7^VM_P @>#_K_C_]
M$SUYI^T5JDD6@Z#;!OW3VB2,N!RT=O J'.,C E<8!P<\@X&/LJOE70/^*?\
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MSRECN?:H+ $KD"O"OV2;6Y\&S74%_9WD7VG[.(W:UG\O*&0%68(=N?,!W-A
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M.6V2)F-U!&05!?I?"_AY_B9X@_X2":$KI]K"D=D9$,;3-RZS;) Q* R,Z/\
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MJN ^+/@_5/$GV7^R;W['Y5P&FX/S+Q@\9W[<']TV(Y-WSD;17?T45Y+^T?\
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M]%>-?'K> ;%;B\'VFY>0111P1O'YTKEC'&JEYBO Y)9NA*@L50\?K_A?Q9-
M]S#J,"7.W*VD5O&8,CC:LT^Y\LHW?.,;SMRJ?,-#X7?'B'Q=I,VIS)LEM(W:
MYB0JQ^1"^] 6SM< [-Y'S!EW-MW'G_ T^O\ Q,M_[6AU)+&">23R;=+6*YV(
MC&/YGDVL6+*2>H/4;0=B]W\)];U'4UNTU<1K<0WK1!8O]4$\B!T*DDL0V_?\
MQW#=@A<;5[JBO&OC-\99_#U_::'8 )<7C1!KAU\Q8DED,*LB;EW.&!;YOE 4
M AMQVY7QH\5ZM\*#;:C'>&[LS,(IK>>.!'9BKL"LD,$>!M4XXRK!21(K%1W?
MC'QU>+I(U;2HX2IM/M)^TLZE4V++C9$K;V*;ACS$"M@Y89KS_P""WQ!UWXE6
M,TBR0Q,;N93</&&$2&%2D<,*E=[*[9+3-@*5_P!<=P2I\//BUJ]IK<_AO5)$
MEE_?B"<PH#N$8EB9UBD1?*,0+E1^\W,%+CG;%K/QPUW1=<30KD62"2:-8[@P
M76QDD(V.%$V22?DP#M$@*F0*"X]E\>:I>:%ILMW \/GV]N\KEXG:-_+C9F55
M$RLFY@,$N^T<$,>:U?#,=XD(_M!X7G."?(1XXUX&5'F2.S8;/S?+D8^13G-O
M5))HHV-LB/+QM61VB0\C.66.4CC)&%.3@<9R/F_P5\<-=US5[O362!YX898H
MXHU=;;SDN$C:=Y"'D"*A=B"RAPJHH$KKFKXX^)_BKX4W*7.J>1<VDS'"QKB%
M3NW&)7V)(KA 0ADW@J2?WC*VWZ$U#6;C4[-+G2!#*TT:O$T[211[70LCD+&[
MGJIV$(2"?F4BOGOX5_'#Q!\1C>06J1^>RQ>5(5"6EJNV02.3B21W<A?+1MXW
M;FP(T93U3?%G6/ >D ZU")=6FN6AM(E,1:4%5*R,L#'<%9BI$8!)\M3M+^95
MO7-"\7:9 U^E_!+*C/*]DEL#$47<_E1N$,SD@*H4A6.2/,R S:'PQ^,5Q\4M
M/=]/\F'4(-HF2:.22 EE?85*2(RJ[+UR[1X8%'^5VYKX)?'#5_B!?RV-T+6V
M,"[I(_(N/.8+(J2(-TP5",X);)5B,1N-VWT_XLZ[J&@VGVG3!"\HDBC$4J,W
MF-+-'#& XFB"8+Y)8,#QRN"3%X^UO5?#>G27-N+6::&&665W\V&,+'\^$B4R
MLQ* KS,@#8;)!*CG_P!FKXB7?CZPGO+Y@SB]E50JA%1/+B<(,<D L<%BS8ZL
M:RH_&>J?$G4[RRTFZ&GV^GMY4CM#'<2RREV7.U_E5!Y;8PP;H2#NQ'T'A"ZU
MK2]573M3FCN+8V4\L4Z1K#)*ZRP!A(@)"E!)A=F%96!)9\A>$\>_&/6M#URQ
MTF46T,5Q<6C'R2T[F)Y3$\;/*B#DACE8U8#: W7/I?QG^*7_  K^U5H8_.O)
MY!%;0CDLY_B*@[V4< A!DLR)E=^X<?KFA>+M,@:_2_@EE1GE>R2V!B*+N?RH
MW"&9R0%4*0K')'F9 9NE^!?QGC^)UJSE?+NH=@G0 [,MG:Z$Y^5MIP"=RD$'
M(VNWG7Q(^-.N>'-9L],>.!$FFM7V6Y,TKQO(8FA,EPL299E;!"1[?E_>#YB=
M7XRZ]XD\'VHUA+B )',@EM(XE>(1F1@K--*1+(3F-'V+%][*A<%CZA\+/&O_
M  F^F6^H%=K2Q_.,8 =6,<FT;F^7>IVY).W&><BNEN[M+-&EE8(B*69F(554
M#)8D\  <DG@"O#_"_BC7?BWNO=/N$TS3UDD2$M )[B7;L&YA)^[VYW<QM\K!
MD._;O%7P9\:M0\+ZHOA_Q)L>63RQ#=1(RJ[2'* C:@923Y8=$4*Z$,&^9UU?
MVH[:\_L:\?S8?LO^C_N_(?SO]=$/];Y^W[W/^J^[\O7YJB_9EM+]M%LFCG@6
MWW39C:WD:7;]HDWCS!<JN3S@^7A<C(;'/M]?(O[:*WMN]J)[@/;R-.8X$C,2
MH4*89R9'\Q]LFW=A0 #M5=[9^I="MKR'=]MEAESC9Y4#P8Z[L[YYMV>,8VXP
M>N>/E7]C62Z;[?'9A%9OLI::0;XXP//X\M7C=V;.% 95 #,SY58Y.[T?XH:I
MX'\0)HFM3BZ@N5B\B?RHX6#/D(0D(;AI08B'Y! DRJY#;7[1GQ.U;P!;BXLT
MME@>3R1(S223[GC+*X38D:;2C?>:4-\I*@9%=UX>\7F#1(=5O"7*Z='<3%0H
M9B(!(Y ^5<GG X&>.!7G7@:?7_B9;_VM#J26,$\DGDVZ6L5SL1&,?S/)M8L6
M4D]0>HV@[%[OX3ZWJ.IK=IJXC6XAO6B"Q?ZH)Y$#H5))8AM^_P"8[ANP0N-J
M]U7QK^SE>_\ "=^*9]3G+AQ'<W"*7WXW,L*QEB,E5CE*KC;C:N, ;:^RJRO%
M?AF'Q1:RV-R,Q31LC<*2,]&7<& 93AE)!PP![5ROQG^*7_"O[56AC\Z\GD$5
MM".2SG^(J#O91P"$&2S(F5W[AQ^N:%XNTR!K]+^"65&>5[)+8&(HNY_*C<(9
MG) 50I"L<D>9D!FZ7X%_&>/XG6K.5\NZAV"= #LRV=KH3GY6VG )W*00<C:[
M<_XQ^)]]XCU8>'_#\D*,D>^[NB!*8=KJ'55;Y&8<*1\^6?:?+*,P\O\ VHK?
M5M$L(;349Q>Q27(E2Y$(MVC=(W4PNJ9C(8.'C;(;*R @@ CV6P^(,?@7P[I]
MRZ/+(]I9100Q@EY97A79&, XS@DG!X!P&;:IS]?\+^+)H'N8=1@2YVY6TBMX
MS!D<;5FGW/EE&[YQC>=N53YAT'P-^+J?$RR\\J([B)@D\8((#8!#J,E@C<[=
MW((9<MMW'T6BO&OC-\99_#U_::'8 )<7C1!KAU\Q8DED,*LB;EW.&!;YOE 4
M AMQVY7QH\5ZM\*#;:C'>&[LS,(IK>>.!'9BKL"LD,$>!M4XXRK!21(K%1W?
MC'QU>+I(U;2HX2IM/M)^TLZE4V++C9$K;V*;ACS$"M@Y89KS_P""WQ!UWXE6
M,TBR0Q,;N93</&&$2&%2D<,*E=[*[9+3-@*5_P!<=P2+X8_%S5++7I?#FLN)
MSNE\J81QQN<()8R1&P14:)2V,,X9@I. <=+\6_BO=6E[!H.AF%]0N-^]I#D0
M+L+!B/N[MN9 #N(5!^Z?S$SPG[0.GZUX;T>=+VZ&H6\[0HS?9UMWMV659$?]
MUN5D;:4;>5(8Q[3R0?1?V7/^1=L_^WC_ -*):]0NU=D81$*Y4[692ZAL<$J&
M4L >H#*2.,CK7SKH/QMU^ZUP>'KM+*&7<X:18II5PL+3*P'VE,AE QDJ0&^8
M @K78?'OX@ZQ\/81?V2VTUJ9%1U>&8R1Y VLS),%*E@1DA-I9%^8G-=?\.M?
MN?$^F17KRP-+/"'1HXV\J-F0?(RF=RY23<'PZ$XVX0@FJO@G6]5U2UEN9A:R
MDS.MJ$\VW22)9"@F9R;GB11YD>Q64KM.]@^4\Z^#?Q>U3Q5KUUINH&%4MK>=
M3' A$9EBN$C,@:3=(>&(QD+C!V@Y-<I^W/\ \P[_ +>__;>OH#XL?\@?4/\
MKPN__1+UY5^Q3_R!Y_\ K_D_]$P5[_7SK^TC\8]:\!-'';BVABN/,$4BEIYQ
MY;J2Q$B)$NY74;=LF/FP_P!TCUKXI:_?Z!92W6G) YAADE<SO( %C <A4C0[
MR5# 9>, [3EAD5YA\%OB#KOQ*L9I%DAB8W<RFX>,,(D,*E(X85*[V5VR6F;
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MO^/_ -$SUZ+X(T1->\/6MG*2$GTJ")BN P5[=4)&01G!XR",]C7SJ/"_B;X
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MNK+86?A;[1(Z6HCMY)MK2+@(EI\_[LAMRJS[67YUR=I!-?17_"M+7_GI>?\
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MN'_I9)7U57E7[4?_ "+MY_V[_P#I1%1^RY_R+MG_ -O'_I1+7E7_ #4/_/\
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M.,+D_(QX^1F&1G->-?LY_&9YM'DL20UY;-%%;>82599Y5A@+?/O*1RR!9-H
M2+8%!; /T5X>T1-!MH;.(DI!#'$I;!8JBA 3@ 9P.< #/85H444444444444
M444444444444444444444444444444444444444444444444444444444444
M445\]_&WX7:CINJ1>)M!023QK^^BQN9MJ,A<*S?.&B_=E$VN" 4!9BRW_%/C
M[4_B+8OIEAIMY;7-Q&J2R7,:PV\4;$+-AWR9."5 5 Y4EU 9=M>E^%/#2_#_
M $R*SMHWG\B-1MCV*\C%LR./.E55RS,Y!? &0N< 5X5\+/!>N>%M<NM8N=-<
MQ7?VC<D=Q:LZ>;*)AC=*@?!4*<E."6[;3]/T5\Z_'/X+S>*-=L9[7>D=S&\5
MU)&K)M1 =[/*JL-TD+F) XP=H0DJ<+ZU\7O"!\8:3=6* EY(28PI529$(DB7
M+?* 750<XX)Y'48O[.W@5O!NC00RILGES-,/GSN?[H8. 598PB,H  93U.2:
MG[0^EW_B73I-+T^T>=IO*)E\R".- L@<C]Y('9OD QM"X;._(*F+X!V.H>$]
M+73KZQDC>W69E99;:19<N9 @Q,"KDN0 V$PN3(,X'G_PW\$ZSX4U^\U>33I'
MM[IKK 6:T\U5DF$R':9]I/RA2-P R2"<8,WC;P!JGPVUJ3Q#HD'VJWGR;B!0
M6D^=D,JX)9SN?]XK1@[#D,@C7#[7C^_U#XRP+I5E9W5E \R&[GO(DA C7+JJ
M(69Y"74'Y"NTJJL0KDCM?BQH$]GHIM-&0^="UBMLB_.5,5Q 8_\ 69!"A027
MR  2YQDUE7?Q=NID:SN]$O6N'4HT02.>S8N,*K7&?+V$$"1BI"98,#M.>?\
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M!5@[!]V!VW9Z>&-9T_Q@NJ75D\BMO8&U^>';]F>%!YLQA0,, -O,99@2JX9
M>P_:1\,ZMX]M(;"TL2Q29)9)?/@$6X1,NR/>Z2.,R,"SI&?EX4ALCN_AM>WN
MDZ7#!=6,R3VMO!%Y:R6K^;M CW(WGJH^50S!RF,[5+D9/E7[,W@+6/AQ-/'?
M6+^5<^2/,2:V;RRA<99?.!*XD))7+#;@(V[@^,G@+6/$.O6NJV-B[Q6GD##S
M6T?F&&X>7*_OF(5@1@LH8=T&,5J_M$:'JWQ'LXK*RTZ9=MP)7>6:S7[J.BJ
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M***********************JZIJ:Z9&TT@<JN,B..29^2!PD2NYZ\X!P,D\
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MC;?E!WA6R65UV:O@#P=X@\)ZLT$ET;O2&5W$EPXDG!( 1 3^\W@@9_Y8E"S
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M"5 %DRJ'"Y/SJ./D93@9Q4OQ2U^_T"RENM.2!S##)*YG>0 +& Y"I&AWDJ&
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MM/\ %&F0?VI<W4<LBJTKZ8MNFPKR3 DT>Z3>$X0@.#( I+KEF\Z_88_YB/\
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M0#=(LS.\<:Y?YYFEW(JX4,6C498FO=?!>B/HMI%#,09MI:9ER5::0F2=QD#
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MXC!.8P$.>J?*>.*ZO]M;_D#P?]?\?_HF>O5?A/\ \@?3_P#KPM/_ $2E?/\
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M&>X!KR7]I>V@\)^&X['2L):F]$3*K>:,!II73<Y=@1/'SSD%2IP,BO9?A/\
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M_P"B9ZXKXJZLMA9^%OM$CI:B.WDFVM(N B6GS_NR&W*K/M9?G7)VD$U]%?\
M"M+7_GI>?^!]_P#_ "14/@/X<:7X&>:+3(Q$\BQ-*OF22-M!D$;$2.Q4$[P"
M, D'KMX["OF7]N'1'FMK*\!&R.:6)ASNW2JKJ1QC&(6SR#DC /./8/@5K::S
MH=C+&" MM'$=V =T(\ESP3P60D=\8R >!W5<U\3;M[/2KZ6)BCI97+*RDJRL
M(G(8$<@@\@CD&O(/V)[M&TJXB# NMZS,N1N"M%$%8CJ 2K 'H2IQT-'[;%HC
M:5;RE076]55; W!6BE+*#U )521T)49Z"NUN[M[SPDTLK%W?0RS,Q+,S&TR6
M)/))/))Y)KC_ -BG_D#S_P#7_)_Z)@KE/^:A_P"?^@=75_MK?\@>#_K_ (__
M $3/1\2_^1&C_P"O#3/_ $*WKJOV7/\ D7;/_MX_]*):\E^.]HD'C'2V10I=
MK!G( !9OM3IN..IVJJY/. !T J7]N?\ YAW_ &]_^V]?0'Q8_P"0/J'_ %X7
M?_HEZ\J_8I_Y \__ %_R?^B8*["[\?)<ZA<V.@VT<U^%7[5<MB.VC95=8UFD
M16DE=2 HC49P6&]-C[?%/C%:3V_BW2?M4HED+6))6/RHP/M;@*J[G8#C)W.Y
M+%B"%VHO=_MK?\@>#_K_ (__ $3/7JOPG_Y ^G_]>%I_Z)2OEK]F6[>STK7Y
M8F*.EDK*RDJRL(KHA@1R"#R".0:]P_9/U2.]T"".-LM#)/'(,$;6,K2@<@9^
M213D9'.,Y! ]:N;M+4;I&"@LJ@L0!N9@B+SW+$*!U)( Y-?.$3Q:GXXN[6[E
MF :T2. 1S7$)R(H)B@:%T(7 D<J2$+9.-Q%>OZI\'M/U>-H+G[3+$V-R27M\
MZ'!!&5:X(." 1GN :V_!N@VF@6J6FG +;Q-(JJKF0!O,;S%W,S'(DW @G(.5
MXQBMJOC5++_A!/'*M.'9)KMV1@FW/VM752,G!59)2C,#SL8@9&VOLJL_Q#K:
M:#;37DH)2"&25@N"Q5%+D#) S@<9(&>XKY5_8C\+O)<W6HG(1(5@7Y3M9G99
M&PV<941KE<$X<$XXSH?\U#_S_P! ZOJJOE7]AC_F(_\ ;I_[<5ZK^U'_ ,B[
M>?\ ;O\ ^E$5>86UV]K\/=T;%25925)!VM?E'7CL5)4CH02#P:]O^"FJ1ZGH
MMA)"VY1:0QDX(^:-1%(.0.CH1GH<9!(P:[":[2 JKL%+MM0$@%FVL^T9ZG:K
M-@<X!/0&OFKX-PP^(=?UR"[EG\[[2S1A+BYA)CBFEC.3#(@(0-&JAB=H.$&-
MU>P:W\$],UY!%>+/.@8,%EO+V10P! 8!YR,X)&>N"?6N4_:"MH+7PI-'9X-N
ML-FL)5MZ^6)H F&R=PVXP<G(YR:T/V7/^1=L_P#MX_\ 2B6O5:*^5?V>?^+=
M^([_ $"3Y4ESY6[YY&\K,D/S)\@W0.SMD#D ?*?E.?\ M(PSR)9>*86"DW.(
M#U98@!)9L 5VL&\N2<[P'4S")@P3CZ T+6T\;W4%S&"+>"VBN$!QGSKF-MH8
MJ2%>*W)W)E@PN58@;8V;$_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#MX_\ 2B6O
M*O\ FH?^?^@=75_MK?\ ('@_Z_X__1,]>J_"?_D#Z?\ ]>%I_P"B4KJJ^5?C
M[_R.&D_]N'_I9)7U+=VB7B-%*H='4JRL RLI&"I!X((X(/!%?'7[,_G6&CZ]
M=1[TQ:?NY5W+ATAN&.UACYEW*>#E<J>,BO2_V8_#=GX@T2%O,N?,CDFCE6.[
MO(45O,9P D<R)]QT)*C!).3NW5Z!??!S1TN(M0N4=IX9(?*EFNKF0JPD'E*#
M+,P/[QAM4Y!9L8).#W]%?*O[#'_,1_[=/_;BNF_;8M$;2K>4J"ZWJJK8&X*T
M4I90>H!*J2.A*C/05S/Q]_Y$_2?^W#_TCDKZ ^$__('T_P#Z\+3_ -$I7A7[
M)=A!XJL[K[1-<M=+=F239=7<.1*B[7;RI45F9D?+'+\?,<;:]:\4?!/1M43S
M=1621(5=MT]Y=NL:X!=LR3D*,*"QX&!STK*_:&^"3_$^"'[/*([BW9]@?/E,
MLFS>&*JS C8"I (X*D?-N7R71?C_ *[\+9$LO$EL\L7 60X$N (\E95S%/M4
MY()WEV^>4=*Z#XH:Q!?^+=*6:9_LDEH/+:*6506G-PB,CP,&&]O+!92 RXW'
M8*]DN_A397B-%*UTZ.I5E:^OF5E(P5(-Q@@C@@\$5;\!^#=/\'Q26FF((T$Q
M:1!(\A$A1#SO9F4E-AQQP0<<Y/SU^PQ_S$?^W3_VXH^/O_(X:3_VX?\ I9)1
M^W/_ ,P[_M[_ /;>NP_;/NW@T:-48J'O8E< D!E\N9]IQU&Y5;!XR >H%>BZ
M3X(L=7ACN8);QHI8TD1OM^H#*L RG!N 1D$'! /J*/"_POTKPE>-<VD>R\GC
MDW,TTTLCKO1I&Q+(^?G*%FQD$C)^;GQ7]B[5)-7FU6YG;=++);2.V ,LQN&8
MX  &22<  >@KH/VUO^0/!_U_Q_\ HF>O5?A/_P @?3_^O"T_]$I755\J_'W_
M )'#2?\ MP_]+)*^I;NT2\1HI5#HZE65@&5E(P5(/!!'!!X(KY:_88_YB/\
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M!!X(KY@_8:NW9-0B+$HK6S*N3M#,)@S = 2%4$]2%&>@KZDKP#]M;_D#P?\
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M5AY888E@0=K[ /-3YE/JOAGPC;_#JQ%MIT#R*F#L0Q^=*Q(#2,TCQ(6[DEE
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MCR_M%KYFSR/L^[_6[=VWY]N<9^3?CYZZ7]I'P[JOQ!M(;&QL),+,DSR/-:H
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M-9,$$%0TD<FWKG<NUP0"&'.?G7]BS5IM7DU.>YD>65OL>YY&9W.!.!EF))P
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M50R84!'[_P#:'US4_#6G2:AI]RD"P^42OD+)(Y:01D;Y'**OS@X\LME?OX)
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M!*BAQN!R2ZY!!5@:\ _9O\8:U\0WOC+>E3NLRTI579%!D!2&(KY"%U7YI"I
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MM$JRJ2V.4_:!^'UWX0T>=[>\NKNWE:%+E+N43E%$JM'+&QV%2) $90&#B3)
MV CT7]ES_D7;/_MX_P#2B6O5:^</A?//\<C<ZC<:A=6@281QVEG/Y(CC"[E=
M^"7+$D;RJY*-CY<(GH'@OPIJFGW-[:7=[/)#Y-G]DN-L9D5 T^Y#YD31/-P!
M(Y5F=2C,5)4+PGP+^).JZOKU[I6H77VB*VCN0#Y4,66BN(X@_P"[4$9!/&XC
MGO@&JO[3/CW6/AQ-!)8WS^5<^<?+>&V;RRA0X5O)!*XD  ;+#;DNV[CU_P"+
MWQ!;P-8FXA3S;F21(;:+#MOE<_*N$!)P 6QQNV[ P9@:Y7_A2%]JD/F7NL7P
MOFC^<P2B*U5\87;$B)E1QG!0O@M\A;BU\!/%>LZO'<6VO0/'/;R +,R>6)0Q
M?(&U1&VPKC?&=K*R\9^9_&O@[#/<>+=6CMF$99KX-(>61/M:99%*E6?H%W_*
MI.]@X7RWV_BEX@OO@MJUI>?;;FZLKG?YT4\@E/#J9MD86*),*Z&+;MPP*G$?
MRGZ?KS7]H3X@W7@32WNK%-TK2+'O(W+"&#?O2,$'! 5=V%WLN=WW&Y3Q-X&N
M9/#YU!KV^@U!;0W4K&XG7+^69I(3"'2.-<DHH14*87.<,&V_@7\8'\5Z-)J.
MI80VK2I-(H.&6.-9&EV*.#M;E5!!()4 $*,KPAX>U'XK0#5-0O+JQBE9FM;:
MT?[.4BZ!I',>Z4MM#*3\H!W)@2;$/ ESKGA#6CH]SY][ICJS0W<JEFC&UY!O
ME4'<=V8B)""2$9 B$(WE7QG\.R:?XKTZ-KJ>5Y6L6\V3R2Z$W+(-BK$L2@;=
MP&P@L69@VXU[_P#$.TU+0=,N)K2_.^&&:8R300RRD(@<1IY8AB4'8P)>.0_/
MD8P*YK]D_P 5W7BC3;BYOI7FE-_+\SG. 8X6VJ.BJ"Q(50%&> *J:CXBOOBG
MJUSI-A<O9Z?8[%N)H0!/)+O7,89MKQ8V2*&0,OR,6WJZJ.:^(]SJWP*EAOX+
MR>^L)I@DL-TXD8$)E5$A)8%OWC!D10I11('X!]5\>>(KO4=&.J:5.+8?8FNA
MO@$LI41B9%&9/+0D JQ*RCYLK@C)\U_9[O-6^(VG3M<7TD:&]F\R1,-<L&A3
M]U&74I;HK,&!16))(3R=N7J?#'QEJ/A3Q-+X<N[B2ZMV:7RS+)YCKF(3Q.79
M-Y/EJ%9 50,S, <<_35>(?&_QWJ,.IV&AV(DBBO&7S;B)<RE"Y25(V*,$,<?
M[QG&67*-E #NQ/V@TN?A>MKK&F7=R MPL3VTT\]S!)N21]Q$LK'HI4C/=60H
MR[FZ7XO?&F?P[H%OJMI&%FO%@";CO$1EA:7=RH#E0I R ,D,00"A+3X-W<%L
MMSIVM7LEUY(:*2683V;L5^\8V5P48$[3ERF0PWE1GT7X>^=_9MG]JW^?]DM_
M-\S=YF_RUW[MWS;MV=V><YSS6!\=-#;5-)NRL\T*QVEP[)$8U$FU"X5RT;/M
M^7!",FY696R#QY5^QSHTMUILDJ7,T2+?OF%%MS&^(X"=QDA>09'RG:Z\#C!R
M:Q/VB&=?%NEF(!G"V.U68HI;[7+@%@K%03U(5B!S@]*[#]H+0=3\-V7]M6VI
M7/GP20F2,,L5KM+XPD*)AOWCK@3-(3&"KNY SV%I\;47PZOB*6(L1"-T:X3,
MOF>00,LVU#+T)+,$YP6^6L__ (5)J?B:'[3J&J7D%X\>1';,L%O 6&X1%(RW
MF['8@OY@9U &X8#5G_L[_%&YU66YT+4W$EY8LRB4%F,J1N8G))49*MM&XX9P
MP)7<KL?;Z^2_VD]0_L[Q5IL^QY/+CLWV1KND;;=2G:JY&6.,*.YP*]?_ .%^
M_P#4)U?_ , __ME>2^ ;.3XWZ['K=S)'!%;+$\-LLT,MQB%\@%5 =4\W+LTB
M D.J)D$.ONOQI^)@^'.G/>@!I2RQPHV[:TC9(SM'0*&<C*[@NT,"P-<5;_!+
M5M;MO/O=8O8K^58V(B81V\1VINC,4+JK$88;T9 QPVT\[H?V>?C/>^)+BXT;
M5US?6WF%I0$ (201NC!,+N5F !0;67K@KN<\6^,=0\0>)8O#ZB:"Q6/S9GAW
M))*H3S WFA0T<7F@0DQE2274OE@J\U\:?$=W\%M1M+ZSN)Y[:X619+2>:6:,
M"/R]VUY7=E+;@0>2C \LC&,>B_M#ZYJ?AK3I-0T^Y2!8?*)7R%DD<M((R-\C
ME%7YP<>66ROW\$@>8>"-$\1_$G0X'@OC;"-G\MVEE,URWG2!WDE0EXT13L1,
M.6926 7RRO2^,_&NJ:U=VGA>PN/+OA;J=2NDB)5,PJ6*-M7;G<6!54^=HE61
M"6 Q/V@?A]=^$-'G>WO+J[MY6A2Y2[E$Y11*K1RQL=A4B0!&4!@XDR0-@(]%
M_9<_Y%VS_P"WC_THEKTO5M4CTB&2YG;;%%&\CM@G"J"S' !)P 3@ GT%>%>
MM-U/XRQG5KR]N;*T:246UM:.L1V@HN]I1EG^974AU!W LFQ&VG*\.?$/4_A=
MK47A_59GOK:X\D03L%$P,K%0^2[L5\TLC"1BP50R84!'ZK]J/1I?[&O+C[3-
MY?\ H_\ H^VW\G_71+U\GSNOS?ZS[W^S\M1?LRZ!--HME.MY.B;ICY"K;&+
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M>5+*1(R23.V"6 * ;=N$WH 0=QD[7PAX1U'PQJJQ27D]WIQLI_*\X[Y$E\V
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MF8A550,EB3P !R2> *^5?VS[D:S;:7?6^7MW6=EDVL%Q(L#QYR!M+*I(!P<
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MC=VX[!06)Z  D\"L_P#9/U2.]T"".-LM#)/'(,$;6,K2@<@9^213D9'.,Y!
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M($\*_:_T&72DT[[3<R74S+<AY'"(ORB#[D<2JB#<6.<,Y!"L[!$V_37Q8_Y
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M*JW*^-]'U/5-)OKK4YO)!L+AA90;0B825E$LWS22MC8'\LQ1$J5*O&QW<_\
ML4_\@>?_ *_Y/_1,%<I_S4/_ #_T#J^JJ^5?V&/^8C_VZ?\ MQ7M?Q1^,$/@
MAH;6-/M%]<R(D%L'6,MN<(&9V!"+G@$CYFX' =E\_P#C]X>OAH%W<:G=>9)_
MHQ$$"B&U0F6!2!G=-+SO.9'V'<&\I65"O5?LN?\ (NV?_;Q_Z42UY5^PQ_S$
M?^W3_P!N*/C[_P CAI/_ &X?^EDE'[<__,._[>__ &WKU7]J/_D7;S_MW_\
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M.=PW(<# /.1X+\*/@IXD^&7G?8GTY_/\O?YK7+8V;]N-D:?WSG.>W2NJ\1>
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MAWDC;@98>9&C+EL_+\V!CYV.<>5?M0?"&X^(-K!)8C?<V\C8C+J@9)-H?!;
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MNOEP)F3=M#G#%2HVL=JRGY1YIV GW"TM$LT6*)0B(H554!550,!0!P !P .
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M!&'96=GE*!_W8.]N Y($>X99PI/2_"?7;[4K9HM65%O+>18IBA!5B8(9PQ
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M (2/-CO\S/D^;<;=GE>1MW>1G=Y?\6,;_FV8^2OH6T9V13* KE1N56+J&QR
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M1XE'5F^8,.-J[.K5Z57C7[2/P?E^(R60ML[X[G8[93:D,H'FRE6*ERI1,*K
MD$C!ZCU#_A%K?['_ &;L_P!%^S^1Y>YO]5L\O;NSN^[QG.[OG/->?_LZ?"B3
MX=6,D5T$^TRW$C.R@?=4[(QOZLI"F1<A2OF$%0V[.5^U!\(;CX@VL$EB-]S;
MR-B,NJ!DDVA\%L#<"BD991MW]6VBM#4+7Q!X[TR:SN(8-.EDA:-F,@N3)E &
M4(@*Q(^2-Y>5T ($;$JXQ/V</ VL^![&6VN8(8\W$LH#S;G<F%$1/W2NL:EE
M!,A9V !7R3N#C*_X4SKW]O\ _"1YL=_F9\GS;C;L\KR-N[R,[O+_ (L8W_-L
MQ\E>X:W/?BV!LXX#=%1E999!"C%3DADA+R /CC;&67)RAXKQKX!_!G6/A=-+
MYALYH+CRA)MEF61=A;#+F#:WRNWRG;N.WYU .9?V@_A/J&LW]EK6D1B:XMF0
M-$[HJXCD,T388ID;BP?YP<%-H^\1H?$_PWKOQ)TB2 PPV3G#&V,HN))MC[A&
M9 J1Q<J&4@R;SM5FB ?,OPD\.Z[X4T>&R$%JDL:S!5EG<G<\LCJ[&&-U 7(_
M=JS&0-GS(2A5\7X!_!G6/A=-+YALYH+CRA)MEF61=A;#+F#:WRNWRG;N.WYU
M .3XJ_!G6/%NL0:O:FSC^R^4(EDEF??Y4SRHS!8%VYW ,H8XP<.>M2_M'?"/
M4?B-:6TT*1BZMVEW6ZR;E99"@RLLBPC(" D,J@@M@Y4!_1?#<>H>*+4Q:W;0
MP)+;O'+"DK2NY;Y&.4VK$NW<0JO*Q#CYT*$/X!+\"?$?PRNI)/#<OF039'WH
M0X48*B1)P(RP)(5TR<!CB,/MKUKX5?#O5!.NJ^([@3W:PF.")1'L@5\-(WR(
MJ^<?N%DXV@C>ZD!>%\=?!76?#.LOKOAO8_FR;G@+[22^6F#B1@KQ,PW'#AE9
MAL5=BN*GQ6^&WB7XBZ?%+>(@N5N %LH'C2)$VR;IY&DE8/*3M50KD(A.!N=P
MOL'P\T+6-!TTVETUF9X;=8K41B;R_P!W'M1IF8ACE@-P1%P 2"2V%M?"'^U_
ML(_M_9]K\Q_N[-VS/R[_ "_W>[.<;.-FW/S[J[6BBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBL_6[2>Z0);2B$EAN<Q^8VS!!V98*K]"K.)
M%!'S1N#BIM+TN/2HUAA7:BY[EB2269F9B69F8EF9B69B68DDFK5%%%%%%%%%
M%%%%%%%%%%<_X_\ MWV&?^R=GVSRSY._&W.1G&?EW;<[-WR;]N_Y<UY!%X?\
M1^/-*FT;6H$BDDDB/VPR0D>6LJR,#% 6W2C: @ C1ESN=67]Y[?X>T1-!MH;
M.(DI!#'$I;!8JBA 3@ 9P.< #/85H44445X5JO@;7? VJ7&J:-LOH+V2,SV\
MSA)EVECA78JH55RD9R=JN%,3A U=-#XM\2:J&CCTN"T?;E9;B\6:+(9<KLMT
MWDE<XY4#&2>BMU7@?P.GAA'9G,]U.P>YN7 $DK@8' X1%'RQQK\L:\#)))Z6
MBBBBBBBBBL6YT!]0G\RY</ C*T4(0J XP0\C%V\TJPW1@!%0G<5>18W3:HHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHKPKPW:^(_&%Q?2IJ7V2UBO[F&W4VD,I98Y&4D%E3*CA0VYB6
M#@X*\\5X_P#&'B+PEK%IHW]J^9]J\C][]DMDV>;,T7W-K;L;<_>&<XXZUZ!X
MK\'^*-)M9;BVUCSY8XV=8?L,"E]O)52HD.X@': IW-A>,Y&5\4O$.KKX<@UB
MWOO)_P! M6F184\R5Y_*1W\W/[K&_*^6BD'/S?=V=K^SAJTVKZ%:3W,CRRMY
M^YY&9W.)Y0,LQ).  !GL *]*HHHHKS#XY?'*#X9P;5Q)>R*?)ASP!R/-DP<A
M >@X+D;5P S)B>'?A!J^O1K<:YJMXEPT:CR;21+9(^6)5C&I21N1E@HP05W.
MH4C%^+6D^(/A_ITQTV\DN[4KAVE >^MTZO(LRX,@)+;F9=T*;2F K.OO6DZI
M'J\,=S VZ*6-)$;!&58!E." 1D$'! /J*M444444455U2.:6-A;.B2\;6D1I
M4'(SE5DB)XR!AA@X/.,'YU^!?C?4]7\27MEJ%V]PMM;W,0X6*,F*YC02>7'A
M QR>>6P=NX@"O5?BSX/U3Q)]E_LF]^Q^5<!IN#\R\8/&=^W!_=-B.3=\Y&T5
MW]%%%%%%%%%%%>(?$GXY3SZ@GA_P]Y<E\[.DDSG,4)"L6 YPSH 7;A@NW9LD
M<E5U;;X#SS#?=ZSJ;S,S,[13_9XLEB?EB"N$ ! P#CT &%'*W/Q,U'X,W<%C
MKLHO-/F4B*\";;A=HC5MZAF+!2<L3N=@^\.S QU[_:7:7B++$P='4,K*0RLI
M&0P(X((Y!'!%> >$?%,_QSO;U([R>TT^T:(0K:MY,LI8RA9GE9-X!52?+P!R
MF?F0L]KPUJ&N?"F*_FUN876GVT.;:1V)FED9_P!VN0'D4,6V/YN[8VSRR8U8
MUG^&/"NJ?%?2AJYU2Y@O)O.\F*%S!:($E=5C98_G;.TCS"Q< KD/L^;5B\'^
M*_$EC:?:;U+.[BNV:7:%W-%D;"_E9C=E(;$0Q%(C+YA#J:]UHHHHHHHHHHHK
MG_'^CW6LV,]O83?9[EXR(Y?[IR,C(Y7(RN]<LF=Z@L *J^%-#U#2M,BM9[E)
M;Y(U#3R1M*A.[."H>)GPOR!RRLQ =ADE:\5^!?C?4]7\27MEJ%V]PMM;W,0X
M6*,F*YC02>7'A QR>>6P=NX@"MK]J?Q/JWA.T6ZL[L10R3>1Y:0@2X>)F+&9
MG<@@QG:8UC(W?>)4&O5?AE=O>:58RRL7=[*V9F8EF9C$A+$GDDGDD\DUTM?/
M?[5VKZMX:MA=VM\8K>6:*$011B.0':\AD,^XR9)3&%V#;@'/S%O7_AE=O>:5
M8RRL7=[*V9F8EF9C$A+$GDDGDD\DUTM%%%%%%%%%%%%%%%%%%%%17:NR,(B%
M<J=K,I=0V."5#*6 /4!E)'&1UKYJTKQIJR^,8M)O+PS0QM,=J(+>(B2T,P4H
MK,6"D@+YC.1C.<DU]-4444445\]^$?%,_P <[V]2.\GM-/M&B$*VK>3+*6,H
M69Y63> 54GR\ <IGYD+/U7P;\/>(/#ES<6FJSBYL8U_T>9R&F=BQ;.<E\;20
MXE)*L$6(E 2?6J**\J_:'US4_#6G2:AI]RD"P^42OD+)(Y:01D;Y'**OS@X\
MLME?OX) /@)J5YK?AVVE\_==/YW[Z</<=+B0?,/,C9OE&T?.,<=0,'@/@7XW
MU/5_$E[9:A=O<+;6]S$.%BC)BN8T$GEQX0,<GGEL';N( KZ4HHHHHHHHHHHH
MK%U?Q?!I5U:V,A/G7;2B( 9&(HS)(Q/0 # [DEA@8W%=JBBBBBBBBBBBBL73
M/%\&IW=S81$F6U6 R\84&8,R*">IVKDX& & R3N"[5%%5=4CFEC86SHDO&UI
M$:5!R,Y59(B>,@888.#SC!^=?@7XWU/5_$E[9:A=O<+;6]S$.%BC)BN8T$GE
MQX0,<GGEL';N( KZ4HHHHHHHKRK]H?7-3\-:=)J&GW*0+#Y1*^0LDCEI!&1O
MD<HJ_.#CRRV5^_@D"W^SAJTVKZ%:3W,CRRMY^YY&9W.)Y0,LQ).  !GL *]*
MHHHHJKJVJ1Z1#)<SMMBBC>1VP3A5!9C@ DX )P 3Z"JFDZQ_PD%G'=VOR>?;
MI)$9%W;=Z!DW*KC.,C<H<9Y 8=:^</#GB75K3QC%I5]?R7*1JRG"BWB<&T>8
M9AC.PD,W4Y)P#G@ ?4E5=6MY+F&2."3RI6C<))M#[&((5]IX;!P<'@XP:Y3X
M0^%]0\-6(M]6N?M5QYCG?EGVJ3PF]P'?NV6 (W;!\J@UVM%%%> :[\8[WX@:
MHNC>&)DC2++W-X521=JD*WEJX(=06 ! S(Y&TK$"[=+:? >>U1676=3-PJ@A
MVGWP^8!PQA=3N3=R8V8Y7Y2QZUE>%/$^KZ9XA33M;D!B:RF2T>-&2*X=6C=I
M6 W 3"-&WJ2%CZ( ) 9/;Z**BNU=D81$*Y4[692ZAL<$J&4L >H#*2.,CK7S
M5I7C35E\8Q:3>7AFAC:8[406\1$EH9@I168L%) 7S&<C&<Y)KZ:HHHHHHHHH
MKBOB]<7UEI\]SI]PENT%O-*Q,(F=O+7S JEG")G:5)9).&R ",GBOV3_ !7=
M>*--N+F^E>:4W\OS.<X!CA;:HZ*H+$A5 49X KVJBBBO)?VC_C _PYLE^RX^
MUW#,D18$A%4?O)<8*L5W* K$ E@V&564\_XX^$VO:.B7VC:G=7%XK$RQ32((
M7+C#-'&^(4 ))$;9 7&Q@R*&]PTGSO)C^U;//\M/-\O=Y>_ W[=WS;=V=N><
M8SS5JBHKM79&$1"N5.UF4NH;'!*AE+ 'J RDCC(ZU\U:5XTU9?&,6DWEX9H8
MVF.U$%O$1):&8*45F+!20%\QG(QG.2:Z#]J?Q/JWA.T6ZL[L10R3>1Y:0@2X
M>)F+&9G<@@QG:8UC(W?>)4&O5?AE=O>:58RRL7=[*V9F8EF9C$A+$GDDGDD\
MDUTM%%%%%8NK^+X-*NK6QD)\Z[:41 #(Q%&9)&)Z  8'<DL,#&XKH:M;R7,,
MD<$GE2M&X23:'V,00K[3PV#@X/!Q@URGPA\+ZAX:L1;ZM<_:KCS'._+/M4GA
M-[@._=LL 1NV#Y5!KM:******Q6\7P"_&E9)N#;-<$8^41B18P2?4L3@#/"D
MMCY=VU17"_&0ZA;6$MUIUT+4V\,TS_N4F:01QEA&"[;4!P<G:QSC& "&XK]D
M3Q#<Z]I4TMY-).XO9%#2NTC!1%"0H+DG&23CIDGUKV^BBBBBBBBBBBBBO*OV
MA]<U/PUITFH:?<I L/E$KY"R2.6D$9&^1RBK\X./++97[^"0+?[.&K3:OH5I
M/<R/+*WG[GD9G<XGE RS$DX  &>P KTJBBBBBN?\,>+8_&5D+W3VPDGG")Y$
M)&4=XPY3<K%2R[@,JQ7 .TYQ\]^'/$NK6GC&+2KZ_DN4C5E.%%O$X-H\PS#&
M=A(9NIR3@'/  ^I*JZM;R7,,D<$GE2M&X23:'V,00K[3PV#@X/!Q@URGPA\+
MZAX:L1;ZM<_:KCS'._+/M4GA-[@._=LL 1NV#Y5!KM:*****************
M***********************************************************B
MMK1+4;8U"@LS$* !N9B[MQW+$L3U)))Y-?+7Q]_Y'#2?^W#_ -+)*^JJ\E_:
M8M$L_#5U%$H1$6V554!551<0@* .  . !P!7-? 2RU/6/#MM#8S)9*OG 3M$
MMS(Y^T2,2B&1411]PEPS,2V$0*CR:'[._P 8+OQ-+<Z1J^/M]JS98  NJN4D
M!$8\L%'(7*D!PPP#M9FVK[QAJ'CFZN+'0Y$MH+63RKB\DB:1_-&28X$8"-MA
M7;(7/1P4& K/RL_Q&U7X6:I#::]<)=V-YA8KG9#;M&P*ABRK@!07&_<2-A5U
M;*O&??Z*^-4O?^$[\<JLY=4ANW5%#[L?9%=E R,!6DB+LH'&]@#D[J^RJBN[
M1+Q&BE4.CJ596 964C!4@\$$<$'@BO-?B-XX3X1:9;VUHAN+@K%:VD1(9W94
M"*S*NUF P-P099F51MWAAS^N:%XNTR!K]+^"65&>5[)+8&(HNY_*C<(9G) 5
M0I"L<D>9D!FZ7X%_&>/XG6K.5\NZAV"= #LRV=KH3GY6VG )W*00<C:[>=?$
MCXTZYX<UFSTQXX$2::U?9;DS2O&\AB:$R7"Q)EF5L$)'M^7]X/F)U?CSJWB+
MPI:'5;:\C1$:-9+>*",K&KDC>99R[R$.R1Y5(PP(?RT^85T'A?Q7JWQ.T^"Z
ML7CL$DA_>3M$)Y6F5E5_*B,A18=RNNZ5FD/_ #S7 D.)\ OB]?:[?7>B:L4D
MN;3S,31H%#^7,8Y=V-HZL@CVQKE02WS=<7XD?&S6?#.LV>FSK!##+-:R,+<2
M74IB:0QO&2\:EB2K$".(/]T*Q.<R_$KQ!XQT*/\ M9?LR6T>UGM(AY[HF2Q,
MK-'EL#"2M"X  WJ%4,X]0^"WQ,'Q&TY+T@+*&:.9%W;5D7!.-PZ%2K@9;:&V
MEB5)KP_X!?\ (X:M_P!O_P#Z61UT'[2/QCUKP$T<=N+:&*X\P12*6GG'ENI+
M$2(D2[E=1MVR8^;#_=(]E^)'CA/ VGSZC(AD$*KA%(!9F9409/0;F&3@D#)
M8C!\Z\#7>L_$32/[4AO_ +-=3^888DA@-JGEN8]K>9'+,=Q0DMO^7?PA"X:7
M]GGXTS_$6RF66,&]M50,Q/EQ2EP_EL2JL4)*$/A2!]Y1@[%Y4?&G7!XE3198
MX,*TN8H2=KA[<RQ;YIEW )E2[1HI(#XC<[4)\9/&_B3X9"WU)[B":*5MDMNL
M"I;QR>6-JABYN'!(=@VY<%>0 P2O5?%OQ=MO#FD+K;*2DD,3PQ$JDCM*H9$Z
MD9P<OMW%55F ;;@\U_PBOBG5H?M+:E#:7#QY^RI:Q20HV.$,KF1^< N0'"L6
MV;E S:^ GQBF^(<=Q%>P>1>6D@690&5/F+A0%<EU8;&5U;." 0>2JU=/\4:I
M\4M\^C7"6.GI(R1W#P&:XG9,!F5)=L:P$L0#S)NCP=N65<GP=\3]1\*:R?#_
M (@D28S_ #VET!'$"#N"*RKM W%"H'WQ+\H\Q75E]UK*\6:[_P (_9W%[MW^
M1;RR[,[=VQ"^W.#C.,9P<>AKY@_8JT_^TKR_U"9W>=8XT)9MV[SG:21F)!8M
MNB'.>[9R2"/K2O&OVMM$34=!EE<D&WF@E3&,%BXAP<@Y&V5CQ@Y YQD'*_9I
MU^_\1Z'$EM+'&;6:6!FGCDN2Z@))'MVSP; JR; I+C"KC:.*\Z_8UMKR;[?]
MBEABQ]EW^; \^?\ 7[<;)X=N.<YW9R.F.?4/VF+2_70[II9X&A"VVY%MY$D+
M>=""0YN6507^8 HQ"_)DGYZ/V9;2_;1;)HYX%M]TV8VMY&EV_:)-X\P7*KD\
MX/EX7(R&QSB?M(_&/6O 31QVXMH8KCS!%(I:><>6ZDL1(B1+N5U&W;)CYL/]
MTCV#XG_$.'X?V,E_.-VW"I&&56D=CA4!/XLV 2$#,%.,5Q7_  BOBG5H?M+:
ME#:7#QY^RI:Q20HV.$,KF1^< N0'"L6V;E S:^ GQBF^(<=Q%>P>1>6D@690
M&5/F+A0%<EU8;&5U;." 0>2JU=/\4:I\4M\^C7"6.GI(R1W#P&:XG9,!F5)=
ML:P$L0#S)NCP=N65<GP=\3]1\*:R?#_B"1)C/\]I= 1Q @[@BLJ[0-Q0J!]\
M2_*/,5U9<K]I'XQZUX":..W%M#%<>8(I%+3SCRW4EB)$2)=RNHV[9,?-A_ND
M= VL>*=2U"UO((4BTR610]L_E>>D6[!EFW;664JQ=4B9MFT(ZE@V_P!JKA?C
M%K^I^'+)[[2E@D,"N\T<RN28P,LR%9$ *@$E3G</ND, K\U\!?B3J7Q*LYKV
M=K:+;))"B)#*<.$C=9&)N/F7YR"@"DXXD%<U-\9-;L->70+LV40D;]W<&"?8
MZE&:(A6N4R68"/ 8@294%B.?5/B5JU_I<4;:8T'G/-'$L4T<C^8SNHR#'*C*
M$3?(^%D.Q&;"A2:P/C1XXU7P-IYOK5+600K%YSR&4%F9A&P2%>@W,K M,2!N
M7#$!CH? 3Q3<>*M&MKV]?S)Y/.WOM5<[9I$7A JCY5 X'ZUXI\ O^1PU;_M_
M_P#2R.NK_;6_Y \'_7_'_P"B9Z]5^$__ "!]/_Z\+3_T2E=57@'[:W_('@_Z
M_P"/_P!$SUU5KXM;PMX9L[B)D%Q]@LUMT='E\V5HDV0JD;*[,_W1M/R_?(*J
M172^"TUF=(I=4>U0LI,L$4,A920=JB4W++D<;L(1G*J2,/7-7WC#4/'-U<6.
MAR);06LGE7%Y)$TC^:,DQP(P$;;"NV0N>C@H,!6?E9_B-JOPLU2&TUZX2[L;
MS"Q7.R&W:-@5#%E7 "@N-^XD;"KJV5>,^E?$GX@MX9\BUM4\V^O)#';(0YC!
M&-\LA0$B*,,&?'S$=,#<Z^?^.K+Q3X8M7U2/4(9C%^^FM!;1)$(UR\B)(V9'
M50,#)1V0$AO,P#MR?&*Y\0Z&=:TB.#*0S/,D\K$Q-$-SIMB0[R5!*[GB.#&Y
M&&*CBOA;\3_$/Q%L)C9>0+@W,^9YE9(88S'%Y4481&\Q]SNP+&38J#S<^8F8
MO OQJUGPSK*:%XDV/YLFU)PFTDOA82AC4*\3,-HR@968[V78R#Z4HKYK^*?Q
MRUKPEJUK82QPK%));RF.U#7,[Q%S&\(:5(PS,5;:%C1AE0'ZD]5IFN^)=*U$
MWNK+"FD&WEEF1#')]F58V<*2 LTDH* .5$D;;FV#ILMZ7=Z[\1XUO[2Z33+-
M\M;H;<7%S(A)4/-YI")G:'C\O(*ORS8#&I\'?BO>O?3^'=>*'4(=S),I0+,N
M X&%V_-L8.NU03'G>J,C%M#5_'&H>,M1GTC1)([>.T5?M5ZRI.RR-RD44>[:
M3\K*Y?H0X^5D7?ROC/XA:U\&IX)-3G&I6$[;7<6ZV\L3+G*KY9\O)!#*')+[
M&4>7@N?1?C/\4O\ A7]JK0Q^=>3R"*VA')9S_$5!WLHX!"#)9D3*[]PX_7-"
M\7:9 U^E_!+*C/*]DEL#$47<_E1N$,SD@*H4A6.2/,R S=+\"_C/'\3K5G*^
M7=0[!.@!V9;.UT)S\K;3@$[E((.1M=O-?BG\<M:\):M:V$L<*Q226\ICM0US
M.\1<QO"&E2,,S%6VA8T894!^I/2VWBCQ%X?U#[?K7D0Z,86>55:-A;?*?+3=
MA99)MZJIVB1'+D1CE0E3P)JWB+XJ1'4XKR/3;5V98(D@CNF=5=PSN9#D$'Y,
MC:&*D^6@P6\U\&ZE<ZCXZ1[Z,17 :1)%7=L+1V31[TW@-L?;O3(SM8<GJ?:O
MBI\1+M=1M?#NEL(+JZ7S6N742+'$OF$A$.0SD1-]X!0, '+;XZFK0>(O![6[
MR7T=[;RWMI%.S6\=O+$CSHF4",58/NV/D%ERI0#YF7V6BO&O$?Q$U'Q;J<NB
M: T<(ME4W5ZZ^<$8NF8XP-T>\#<"LF"Q611L,>X\UXM^(FN_!NXBDU:5-1T^
M>3;YBPB&9-JY(P@6-6)8E59GWK&<&/DCVJ>\N-=AAN=,GA2*2,2!I8))=ZN%
M:,@"> IP<D,"3D<+@Y^8/V-;:\F^W_8I88L?9=_FP//G_7[<;)X=N.<YW9R.
MF.?KJT5U11*0SA1N95**6QR0I9BH)Z LQ XR>M2UXAI?Q8NO'NNW&BV<AM+>
MT64R2JD;W$CQ.(64&421HF]P1\C,0G5=Y"Y[?%+4?A_X@31]3F^VVMYY7V=]
MD<<T7F2-&F[RTC5OF!5_50LB[3F,]5^U'_R+MY_V[_\ I1%1^RY_R+MG_P!O
M'_I1+7E7P"_Y'#5O^W__ -+(Z^JJBNV=48Q ,X4[59BBEL< L%8J">I"L0.<
M'I7S5JGQYUS3_$"Z3+#'((VD'V>URQE,D'F0*TLP! 0E2\BK&  [%2H KJ]%
M\7Z]X'EO;OQ,8WTZ.'?') $($A= D,8&R4@^84S*."H)D"Y9M#^R?$_BB'[8
ME[#I[/'NBM%MQ+@$;T$TDR[UE&[9)M0J-N0N211\$OC!<>+([C3[U$75;+<D
MBEU1)2I9-WR!]N'&V4HK(I*LO#A%XJZ^.6M6OB(:1-'"1'YV(+<,WG%[<RV\
M;2R(6&&*!I D:+\SN/+'$/Q,\9>,/AZ1J=R]K+:EMK10QL\$9*A5WEE2<!F.
M01(1O^4D!E1O9=+^*]K=Z,NO.=L'V<R.N>0RY5HE+^6&;S 8UZ!VQC@BO/\
MP_/XG^(=O_:<%W#IT4D9:VMQ )68;I-IE>9,KD;<.@960AQ&O1IOA'\<+F\U
M"3P]K:!;^)F6.5%94FV+EB00-I95,JL J.IX5,*'E_:,^)VK> +<7%FELL#R
M>2)&:22?<\997";$C3:4;[S2AOE)4#(KG_\ A+?%WB6SLM0TJ)!&(X1(DODK
M-<ML4R3E7VJD#,"J!'21E.\ *R[.*2/4#XX6&2Z22Y3>$E>%O)56M'E$:PK,
M"% <J!YF2WSL68MGV7XM_$B]\(16FGPF-]2U"8PQ3[#%;QDNB^849YFR/,4
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M6W>W995D1_W6Y61MI1MY4AC'M/)!ZOX'^+X/!WA*"_NR1%$LY;:-S$FZD55
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M8A%(*!F/S-C(.5;:2CIO ]J\*>)H?%%K%?6QS%-&KKRI(SU5MI8!E.58 G#
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MS8!(0,P4XQ7G5OH7B[Q!;?;1?P6DTBQLEH+8>6BE4)#O*CRHXRVY=L@## 8
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MQ"JJB" EB3P !R2> *Z_X?:_KWBV-[IGLX;8R$6SFUN"\\0)VSE&NT,:L,%
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MBBBBBBBBBBBOE7X^_P#(X:3_ -N'_I9)7U57E7[4?_(NWG_;O_Z414?LN?\
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MZO0+[X.:.EQ%J%RCM/#)#Y4LUU<R%6$@\I099F!_>,-JG(+-C!)P?%/VY_\
MF'?]O?\ [;U]5445\J_L\_\ %N_$=_H$GRI+GRMWSR-Y69(?F3Y!N@=G;('(
M ^4_*<_]I&&>1++Q3"P4FYQ >K+$ )+-@"NU@WER3G> ZF81,&"<?0&A:VGC
M>Z@N8P1;P6T5P@.,^=<QMM#%20KQ6Y.Y,L&%RK$#;&S8G[4?_(NWG_;O_P"E
M$5'[+G_(NV?_ &\?^E$M>5? +_D<-6_[?_\ TLCKJ_VUO^0/!_U_Q_\ HF>O
M5?A/_P @?3_^O"T_]$I755X!^VM_R!X/^O\ C_\ 1,]<)H_B*]\ 7FDZKJ^)
M=+?3H(8)%C++;A[=,X7<2LV5^=_F,L6\(./+C^M;2[2\198F#HZAE92&5E(R
M&!'!!'((X(KYE_9+L(/%5G=?:)KEKI;LR2;+J[AR)47:[>5*BLS,CY8Y?CYC
MC;7K7BCX)Z-JB>;J*R2)"KMNGO+MUC7 +MF2<A1A06/ P.>E>:_%N]C;QAID
M%U)(L!MMJA))HR))3<1KM,+*ZEG$:L01D !SM!KU^[^%-E>(T4K73HZE65KZ
M^964C!4@W&""."#P16!KO@W3_!^A:I::8@C06UVTB"1Y")#;9YWLS*2FPXXX
M(..<GC_V*?\ D#S_ /7_ "?^B8*X_P#;EM$5]/E"@.RW*LV!N*J82JD]2 68
M@= 6..IKZOHKY5^/O_(X:3_VX?\ I9)7K?[35V]KX?O6C8J2L*DJ2#M:>-'7
MCL5)4CH02#P:J?!_PE9:]I%E<1RW1!MHE;;>WT:AT7RY%"B=54!U8 * N!\O
MRXKH+'X3:3HM]'J(0_;2Q5)9;B>61F\IE*CS96WGR@W&"0JDC 7(\U_8PU\:
MC87<;N7N!>M+*6W%B)8T"N6/WBS1OGDG(R>HS[_=W:6:-+*P1$4LS,0JJH&2
MQ)X  Y)/ %?+7[16K?9?%6D^=)M@B^QR'<V(TS=/YC\G:ORH-S<<*,G %?55
M?*O[.O\ H'BK5K6'Y(!]LQ$ORQC9=(L?RC"_*K$+Q\H) P":/C[_ ,CAI/\
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MUY5\ O\ D<-6_P"W_P#]+(Z^JJ*^5?\ FH?^?^@=78?MGW;P:-&J,5#WL2N
M2 R^7,^TXZC<JM@\9 /4"O1=)\$6.KPQW,$MXT4L:2(WV_4!E6 93@W (R"#
M@@'U%'A?X7Z5X2O&N;2/9>3QR;F:::61UWHTC8ED?/SE"S8R"1D_-SX5_P U
M#_S_ - ZO>OC%:)=:-?K(H8"RN& 8 C<L;.C<]PP# ]00".17QM#=O!X.948
MJ'US:X!(#+]E5]IQU&Y5;!XR >H%?9/P=NTNM&L&C8,!96ZDJ01N6-4=>.X8
M%2.H((/(KP7XV_\ $N\9:7)!^[>3[%O9/E9MUQ)$VXC!.8P$.>J?*>.*ZO\
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M_P#,._[>_P#VWKZ ^+'_ "!]0_Z\+O\ ]$O7E7[%/_('G_Z_Y/\ T3!7*?\
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MI_Y \_\ U_R?^B8*Y3_FH?\ G_H'5]545\J_ +_D<-6_[?\ _P!+(Z/VY_\
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M$>JZ^B6Z0QG[-:IN7YY%PUPZ^8Q#"-FC"/DKN;Y(R,OYI\1_AWK/PRU9]<T
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MR8OAK\1-4\&Z=;6NK:7>R%856*2W2.=B@^ZLD:%&A*H44!\LY#$X8-6A\)?
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MHPP9\?,1TP-SKY_XZLO%/ABU?5(]0AF,7[Z:T%M$D0C7+R(DC9D=5 P,E'9
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MB-^&+H^\J@4 J50\BN:'QIUP>)4T66.#"M+F*$G:X>W,L6^:9=P"94NT:*2
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MX9]A?/E*L>S>6"LK$G> H! Y+$_+M;*^+\NM?#_3UU.VU$SFW:+[3'-!;!)
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M+ JJ=3M4E<L5;#*P0E'KW^TNTO$66)@Z.H964AE92,A@1P01R"."*YKXL?\
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M#D]3]"^/OB#<65U%H^E(DFH31F7,PD^S0Q+G,DAC!;YF4QH!_$06(^4/Y_\
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M(I!R!T=",]#C()&#7837:0%5=@I=MJ D LVUGVC/4[59L#G )Z U\M?MS_\
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M_"WVB1TM1';R3;6D7 1+3Y_W9#;E5GVLOSKD[2":^BO^%:6O_/2\_P# ^_\
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M-=I 55V"EVVH"0"S;6?:,]3M5FP.< GH#7RU^W/_ ,P[_M[_ /;>OH#XL?\
M('U#_KPN_P#T2]>5?L4_\@>?_K_D_P#1,%>_U\J_L,?\Q'_MT_\ ;BNF_;8M
M$;2K>4J"ZWJJK8&X*T4I90>H!*J2.A*C/05Q+WL;:QX<@NI)%@.CVBJ$DFC(
MDEBEC7:865U+.(U8@C( #G:#7T5=_"FRO$:*5KIT=2K*U]?,K*1@J0;C!!'!
M!X(JWX#\&Z?X/BDM-,01H)BTB"1Y")"B'G>S,I*;#CC@@XYR?GK]AC_F(_\
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MZ.JX)7+DA78[ N*]OKS"[\?)<ZA<V.@VT<U^%7[5<MB.VC95=8UFD16DE=2
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M5VK+87FB_:)'2U%V\DVUI%P$>W^?]V0VY59]K+\ZY.T@FO8/^%:6O_/2\_\
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M5O#]Q\6M6T_4([*:QM[&3?)-=1K%/*4>.1(5C#%RHQ\KD[!ODQ\R[7J?M&^
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M(RK&\L4DJJK!=J":*18MBYZLQ"#*E@JA5]U^'^BZAH<$^I:FIN-1N61GAA9
M(XUXBMT\V58L1[W9CN&2S?-(V&;R7X6>"]<\+:Y=:Q<Z:YBN_M&Y([BU9T\V
M43#&Z5 ^"H4Y*<$MVVGZ?KP#]KWX<77BJUMKFR1YGMI) T4:;W*R[/G !W':
MR*"%5CABQP%)KH-;\5ZG\0M)N(++3IK>>6W>-_MFV%/F3$B1C=YCL0V(V=(X
MB<LS@J4/-?LJV>H>&=.EMY[&=3]IFE)DV0DCR8PJ(LC*[.74 ;@D6"Q,NY=A
MQ/\ A"]<_P"$H_X2+^S7\CS,>7]HM?,V>1]GW?ZW;NV_/MSC/R;\?/78?M*^
M%-0\?6$%G8V<C.)HIV+26R*G[N5#$<SY+@L,[0R8Z.:RO%/PKO/'7AZ&PGLS
M;ZA80PB$M);NDA1?+=5=&=@'102K",>9Y8+,JEJS_AA\0_$FD0QZ))I3O-'F
M&*YDWQ6Z*@VH9"L9214Q]Y'!D4 +N<[FY_X2>%-=\+Z]>W8LWNM\DT+SRD64
M;>9<!C<#<C;E/EEBL2O@,,?PAOK2OF7]H[P3K/Q.>V%GITB);K+EI9K0,S2%
M,@*D[@ ",<[LDDC QD_0'A?6[C54S=6DEJX5,J[P2*6(.X(T,CDA2.K*A(((
M'4#YZTOPAJGP,U26>PM7O-)NI%#) IDF1<N44+EI-T8+#<<QR*0&978;.E\5
M:5=_&Z>TA>TGM-*@F,MQ]J012S.N (TC5O, V,P\P,%^=_XHU#=+^T/I=_XE
MTZ32]/M'G:;RB9?,@CC0+('(_>2!V;Y ,;0N&SOR"I/V>-+O_#6G1Z7J%H\#
M0^:1+YD$D;AI"X'[N0NK?.1C:5PN=^2%'JM>-2^)=4\(ZKJ,WV">YTV2:W8-
M#Y9E5Q:Q([)$<23!B$5B#M38Q'(<5BZMX?N/BUJVGZA'936-O8R;Y)KJ-8IY
M2CQR)"L88N5&/E<G8-\F/F7:]3]HWP!?-JECK]C ]TMKY/F0Q@;_ -U.)$Q@
ML[;_ #"#M1M@4L<@\:'QDUC4?'NBW*6NGSPQ,L!"S)F[D87"AD2"-F9 NT.9
M'.2O"QD-YBZOP9\$:A!HK:'JMN+>+R;F(NLZ23,)69BP1$>-1B1@"9&.Y>4P
M:\@TFU\3_ ^>6PL+<WEJS&1"MO)+$Q;:HDS%AT?:@4QER!R0&!5SZ_\ ";1]
M:\1W8UGQ D<02%DM+81J&C\T1&27)+.A*IM*NQ?+."(UX;D/VF? 6L?$>:".
MQL7\JV\X>8\ULOF%R@RJ^<2%Q&""V&.[!1=O/JOBR]O?$&CW$7V&9+J>WEA\
MGS+5MK/"1OW^>%,08[<\2'KY0%<3^S'X7U/P+;R:?J%D\:R7#2K,);=T&8U4
MJRK*7'^K&"H?);D*%R?=:^*_V4O%%UX:^VW$-L]U;?Z,)TA&^Z4GSO*>-,@.
MN<K(,AAN5Q\JL*]*\2:#J'QQOK=9[6:ST>VDW.MR&BFF;"%E,0<$9!*(XX53
M(PD+'RQTO[1_P-/Q%@6XM,"]MU;8"% E0\^46(R"#DQDG:"6!P'+KYUX6^)?
MC6QV:;_9_G21[D\Z>*4;MF>6F\V.%N!@/GY^#N9FR?:_#>CWO@?3R61]0U":
M1Y9RCI&'E9>#F9T5(E5$B&P<*H98AR!Y5^S-X"UCX<33QWUB_E7/DCS$FMF\
MLH7&67S@2N)"25RPVX"-NX[_ /:'TN_\2Z=)I>GVCSM-Y1,OF01QH%D#D?O)
M [-\@&-H7#9WY!4G[/&EW_AK3H]+U"T>!H?-(E\R"2-PTA<#]W(75OG(QM*X
M7._)"CS72_"&J? S5)9["U>\TFZD4,D"F29%RY10N6DW1@L-QS'(I 9E=ALZ
M7Q5I5W\;I[2%[2>TTJ"8RW'VI!%+,ZX C2-6\P#8S#S P7YW_BC4-;_:>^"T
MOCZ"*YL$#7D+;=N40O$W5=S 9*MAE!95 ,F,LP!S_ OQ/\2>*(TTZ33WMK@Q
MX?4)D>.) " 91"T:J\NT_*@?:7^8JL88+RG[*/AW6?"DDPDT]U@N)(E>69_L
MQC$0=B1&R&23(DPN %+#!8#<5[OPUXUU3P6UVEYIMU/9MJ-ZUO);K')*%>=V
M"F$%9-A.]Q*QP=R@ J5-0^&O"%QXR\0Q^)&M7L;:&W**LRJES.Y66(L\:G,>
MT-C+DDJD>W*M\GNM?*OP0T^^^#^H7MA/87ES%-)$D<\,0*-L9Q&Q+,(E5EDW
M,3)^[(VM_$5/BUX8UG4?$6GZH]D[0+):[%@_>NJ1S>85F;(C27+$D[A" 0!*
MX1WKU#Q[?:Q#>Z=>V%D966&_$\'FQ(/+<P>6K2N"BON5'*H6Y1U1G0%SS7Q-
MURX^+EDVDV>EWD<KR1-YUY$MM%"%==T@9F<EL';M0;RC.1G!4^U>$]"_X1^S
MM[+=O\BWBBWXV[MB!-V,G&<9QDX]37@O[2?@F]CU73]=LH)+L0-$KPQ*68&&
M4S+G;O;#[F7.PA"HR26 K:^,=_J?Q$T2:.PL)HD;:TBW(6.Y94D#8BB1W;=N
M3)\S82N!&LA<%=#]GZ6^T#18+>:PG!A6;*L8HY79[ABH1))$P K$N93$>%\L
M2!LCA?A9X+USPMKEUK%SIKF*[^T;DCN+5G3S91,,;I4#X*A3DIP2W;:?6OCE
M\(D^)EEY 81W$3%X)" 0&P048X+!&XW;>00K8;;M/A7@[QAXR\#(FD+8&<(R
MK&\L4DJJK!=J":*18MBYZLQ"#*E@JA5^@/A7X9O;!);[5W#7]TRM(JD^7#&H
M/E6ZC<5PFYR2O5G;+28WMV&J7K64;21Q/,PQB.,QAVR0.#*\:<9R<L. <9.
M?FKX6>"]<\+:Y=:Q<Z:YBN_M&Y([BU9T\V43#&Z5 ^"H4Y*<$MVVGUKXY?")
M/B99>0&$=Q$Q>"0@$!L$%&."P1N-VWD$*V&V[3X5X.\8>,O R)I"V!G",JQO
M+%)*JJP7:@FBD6+8N>K,0@RI8*H5?>_AMX.NEAGN=<*2WE[CSHQ\T,<0!$=J
M%+,A5=[EL#YF=MS2??;P_P &>'=6^ ^ISB*RGO=.N&VJ8 )7V(X*2-LC+!U1
MV4HPB5V+88JH897[8-_=Z@+&6[A%N"UX(XMPDE"AH1OD9"8P6&TB--P3',CE
MMJ?1_P :/!TGC+2+JQ@/[UXP4''S-&ZRJG+*!N*!<DX7.3G&*\U^!GB/4_#=
M@FBMI=S]JMY)!YDA6&T*M/EG,S _=\QL")92X4,N03MYKX3^"]<T'7[[419B
M1)9KR(RR.;.(DS++YJJ5GE*-M 3:KCYOOG:QK0_:9\!:Q\1YH([&Q?RK;SAY
MCS6R^87*#*KYQ(7$8(+88[L%%V\^E>.-6U+7=)FMX]-F%U<6\L)C,UIL0N@5
MG+^=\R_.VS"[F*$,L88&N4_9C\+ZGX%MY-/U"R>-9+AI5F$MNZ#,:J595E+C
M_5C!4/DMR%"Y-7]HOX"7'BB:/5]'.+Z/RPR*5B9]I^257RN)5X&6;E%7:04"
MOS_AGXG>-?$&+-+%(G,84W,]O+!MZ(929'$98$[MJHV<'$9 *UVOQ2^ G]N:
M%'I]N?-O+;]Y'*YPTLK$M<;FD+L/-9F?;N"^9LW,%6N5^&'Q#\2:1#'HDFE.
M\T>88KF3?%;HJ#:AD*QE)%3'WD<&10 NYSN;G_A)X4UWPOKU[=BS>ZWR30O/
M*191MYEP&-P-R-N4^66*Q*^ PQ_"&^M*^=?VC? %\VJ6.OV,#W2VOD^9#&!O
M_=3B1,8+.V_S"#M1M@4L<@\:'QDUC4?'NBW*6NGSPQ,L!"S)F[D87"AD2"-F
M9 NT.9'.2O"QD-YB[?P,L-5\':4EG>V./L_F!5CN(7GD+R[\A"5A50)&R6FW
M?(<)\PKS_P"%G@O7/"VN76L7.FN8KO[1N2.XM6=/-E$PQNE0/@J%.2G!+=MI
MU?VI?AUJ?Q!DMH]/M'=;?SMTADMT1O,$1&T-,'XV$'<J\],CFIOCS\*[SXHV
M4-Y#9F#48&"-"\EN2\; %@LB,RL%<Y3>T?'F'8&909? OQ/\2>*(TTZ33WMK
M@QX?4)D>.) " 91"T:J\NT_*@?:7^8JL88+RG[*/AW6?"DDPDT]U@N)(E>69
M_LQC$0=B1&R&23(DPN %+#!8#<5B\>?!W5OAEJ9UKPXAEA9F9H44$H'<;H#$
MF#)"21MV#* 9.TQK(>E\,W_B;XJXM=3MTL=/,@^TD)-!-*BX+6X#R^8%D#89
MU"C:&&\X,;=K^T/I=_XETZ32]/M'G:;RB9?,@CC0+('(_>2!V;Y ,;0N&SOR
M"I/V>-+O_#6G1Z7J%H\#0^:1+YD$D;AI"X'[N0NK?.1C:5PN=^2%'JM?+=AI
M-[\+/$]Y?FRNKRUNEF826\)D($TBS= 2I*NIC(9D)'[S&"JF']JGPQK/C#[+
M<163_9X_-58T_?W2L^TL95A+H%.P;-C.!C+LK.J#;_:[OY;[1(7FA,!.HQ[4
M9D>3;Y$W+>66126S@*[C;M)(8E%U?!'Q9O?#&E6L$^F75Q(+*!H)+2,RV\D9
MB4P[WY:-_P"&0;6P074%645J_ OX87NE7-WK>M8%_=L0(PQ?RH]V2N=[J0=J
M!%RVQ$4!N64>2^*;BZMO';R6$:2W"[2L;ML5P+ %T#?PL4W!"?E#E2WRYKT#
MXC>,]4^)EN=)TG3[RV\_ GGNT-JJ1;E!"D,=V[.' RQCW 1ON)7TK1M#;X<:
M7#96%N]V\,>T(C1Q;G(9VD8S2 (K2$DA2Y7=\JD#CR#]F;P%K'PXFGCOK%_*
MN?)'F)-;-Y90N,LOG E<2$DKEAMP$;=Q4^*?@O7/%.N6NL6VFN(K3[/M22XM
M5=_*E,QSME<)DL5&"_ #=]H]5^+?PY;XK:7]G8/:SK)YL:R>6V'4.@63RFE7
M:RL>48E<AB"04/A_@[XA^,O#")I:Z>9A&RPQM+;2;550L:J)8FCB*#;GS&)!
M!+%RN"/19/@_J.KZ#?1:@Z/JM]Y<TC*D:G,(B,-N64HA_P!5MW<(K.Q&X L]
M7]GCQ5?:/IT>D2:7>+/#YI621!!;D/(7#,\NUEPTF&5$E?:I=58Y4<I\'_#&
ML^&?$5]<W5D[R31W'SQ_):%Y9HI PED/^J[D*))E&?W3,K*-;XJ^ -4\+:^O
MBC3H/MD?REX5!\Q?W2VS+M!+-N4[E90VTY+IM7+]+XO\0ZC\5H#I>GV=U8Q2
MLJW5S=I]G*1=2L:"3=*6VE6 ^4 [7P)-Z>E:!X<B\ Z>EI8Q22I N%C5D,KE
MFR[9E>-,EF+GE1U"@<+7@OPL\%ZYX6URZUBYTUS%=_:-R1W%JSIYLHF&-TJ!
M\%0IR4X);MM,OQR^!NH:?J'_  D/A[/G;C))'&$5U<*=TB# $@< ^9'AF=F/
M#AR%FT+QGXP^(6ZR:V33XGPLET89H9(U.23&)9<LQ"E1L!*D@EH\AQ]%:3I<
M>D0QVT"[8HHTC1<DX50%49)).  ,DD^IKC_BW/>7=E<V-C9R7#SVTD8<26\<
M2F0-&<F257RJG=@(0W"[ADE?/_V;/#NJ_#^V>PO["0"2Y$BRI-:NJAE1&WKY
MP8!=@.5#E@2 H(&[WJO&OVC_ (&GXBP+<6F!>VZML!"@2H>?*+$9!!R8R3M!
M+ X#EU\Z\+?$OQK8[--_L_SI(]R>=/%*-VS/+3>;'"W P'S\_!W,S9/J&H?!
M)]9T.;3KZ437\[-.]P<[?M.!L(W*VQ%55A^15_= A53=@>7_  H\7>(_AK&-
M&GTF:Y59 (67Y$3S#N93,B21,NYL[BPV$L&;  3/A\)>(-,\4MJ;6AO98UWN
MR8M;9M]LL92.64;2(_,V#J[A"6 .XCMOV@/@-=^*GAUC3 $U%%B$L2.%W,IR
MLB2D1$NAXW/M+(JXV,@5L3PS\3O&OB#%FEBD3F,*;F>WE@V]$,I,CB,L"=VU
M4;.#B,@%:]OL=.E\"Z=';VD,E],BG.)$1I)6W222NT\ORAY22V"[*7^56 X\
M;_9F\!:Q\.)IX[ZQ?RKGR1YB36S>64+C++YP)7$A)*Y8;<!&W<2_M)^";V/5
M=/UVR@DNQ T2O#$I9@893,N=N]L/N9<["$*C))8"MKXQW^I_$31)H["PFB1M
MK2+<A8[EE20-B*)'=MVY,GS-A*X$:R%P5F^!]]J7AK0X+?\ LV=I(UG^5WA@
M9G::1T^65PRIV=G"L"4,<<JLS+S7[,W@+6/AQ-/'?6+^5<^2/,2:V;RRA<99
M?.!*XD))7+#;@(V[CZ4HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK*
M\3>(E\/PF=XYI<9 2"*2>1C@D*%C4XSC&YMJ D L,BOFK]DFUN?!LUU!?V=Y
M%]I^SB-VM9_+RAD!5F"';GS =S80 ,69>,_55%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%?*O[6UK<^,IK6"PL[R7[-]H$CK:S^7ES& JL4&['ED[ERA!4JS<
MX^E?#/B)?$$(G2.:+. 4GBD@D4X!*E9%&<9QN7<A((#'!K5HHHHHHHHHHHHH
MHHHHHHHHHHHHKY[_ &MS-XBM(M.LK6ZGE2Y65VCMIFB51$XQO";6)\P8V%@-
MK!BI !]*^"VKFZTRVMWAGAEM[:"*1)X983N1-F5+J%<'9D;22 5W!2<5VMW<
MBU1I&R0JEB%5G; &3A4!9CZ!023P 37RAYUS_P )A_;?V&^^Q^9MW_9)]V/L
MWV?S-NS=MW?-C&_9_#N^6OJ^TN1=(LBY 90P#*R-@C(RK@,I]0P!!X(!J6BB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBO*OVA]<U/PUITFH:?<I L/E$KY"R2.6D$9&^1RBK\X./++97[^"0
M+?[.&K3:OH5I/<R/+*WG[GD9G<XGE RS$DX  &>P KTJBBL75_%\&E75K8R$
M^==M*(@!D8BC,DC$]  ,#N26&!C<5VJ**Q=,\7P:G=W-A$29;58#+QA09@S(
MH)ZG:N3@8 8#).X+M445%=J[(PB(5RIVLREU#8X)4,I8 ]0&4D<9'6OFK2O&
MFK+XQBTF\O#-#&TQVH@MXB)+0S!2BLQ8*2 OF,Y&,YR37TU1111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111117BOBWXO7%_K\7AFQ
M/V?/,]R46208B^T;8E;*#*#:6=7Y8D)\@+8OQ,^)>I?!W4;>2[N#>Z;<JX\M
MHX4N$*;-[!HHXE8C<"N<!@61@I"R5ZI\4M?O] LI;K3D@<PPR2N9WD "Q@.0
MJ1H=Y*A@,O& =IRPR*\P^"WQ!UWXE6,TBR0Q,;N93</&&$2&%2D<,*E=[*[9
M+3-@*5_UQW!(OAC\7-4LM>E\.:RXG.Z7RIA''&YP@EC)$;!%1HE+8PSAF"DX
M!QTOQ;^*]U:7L&@Z&87U"XW[VD.1 NPL&(^[NVYD .XA4'[I_,3/"?M Z?K7
MAO1YTO;H:A;SM"C-]G6W>W995D1_W6Y61MI1MY4AC'M/)!]%_9<_Y%VS_P"W
MC_THEKU6O$(_&>J?$G4[RRTFZ&GV^GMY4CM#'<2RREV7.U_E5!Y;8PP;H2#N
MQ'M>&[C7=-U+^S;ZXAFA-A<207(A",\JR0+^]C5QCR_,P%0HKHP)8OG9XJD>
MH'QPL,ETDERF\)*\+>2JM:/*(UA68$* Y4#S,EOG8LQ;/NOQ;^)TWPQTO[7.
M$N+II/*0HC10[V#LK,IDD8*%4Y <EF& 4#97FM;EUJ;0AK5MJ)2X-L+MHC!;
M?9Q&4,QB0&)Y 50@*SN^XK\V-V5VOAK\1;KXK:3]HLW2SNED:&5VB\] P0$O
M&OFI_?5EW[@I!1E<88^-?L@-?ZF^HRV\\:NS6S2M/%)<L[,9SNRMQ"0<Y+$[
MBQ/;!S[WX^^(-Q9746CZ4B2:A-&9<S"3[-#$N<R2&,%OF93&@'\1!8CY0_G_
M ,0;_P 1_"^--4DODU"TCD N86MX;4[6(12"@9C\S8R#E6VDHZ;P/:O"GB:'
MQ1:Q7UL<Q31JZ\J2,]5;:6 93E6 )PP([5JU\J_\U#_S_P! ZO1?C-\99_#U
M_::'8 )<7C1!KAU\Q8DED,*LB;EW.&!;YOE 4 AMQVY7QH\5ZM\*#;:C'>&[
MLS,(IK>>.!'9BKL"LD,$>!M4XXRK!21(K%1V'Q!\<ZA%I*:SHJ0LGV<7$D5P
MK;_*9!)N4I*JAE7)923N&=K9 5\KX"_$G4OB59S7L[6T6V22%$2&4X<)&ZR,
M3<?,OSD% %)QQ(*YJ;XR:W8:\N@79LHA(W[NX,$^QU*,T1"M<IDLP$> Q DR
MH+$<^J?$K5K_ $N*-M,:#SGFCB6*:.1_,9W49!CE1E")OD?"R'8C-A0I-=7:
M*ZHHE(9PHW,JE%+8Y(4LQ4$] 68@<9/6I:**************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************\Z\3>/K:PU-+*QMA=:LT(#%=J"&'>K'SI]K-
M&G.\(%<D[?E!D0MX!^U_:7L2:<^HRQO*RW.4AC,<*$" MMWL\C$DX+$@%57$
M:'<6^FOBQ_R!]0_Z\+O_ -$O7E7[%/\ R!Y_^O\ D_\ 1,%<I_S4/_/_ $#J
MM_!75)-3\9:K),VYA'=1@X ^6.XABC' '1$ SU.,DDY->E?M1_\ (NWG_;O_
M .E$5'[+G_(NV?\ V\?^E$M>JU\M_$?X):UX/U&?7?#LI<RM+(Z#:9AYFYY5
MV,NR5-P!1>7W%0$9DWGM?@?^T4_C:Y?2]1@%O>HKG@E5=D8AX_+D.]'5<$KE
MR0KL=@7%<)_S4/\ S_T#J^@/B?XDT_P]8R3ZL$>VX!C=5D\QL[DC5&X9B5R
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M\[RS&X<X$6T(BAHG.-I**<2!RX48KH/VUO\ D#P?]?\ '_Z)GH_8I_Y \_\
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M%P0Q 3E@%!)^Z*S_ !_\5?$MSI<.N6:I9VBQQ"0%8VFD9P@,X259 L'F';$
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M+*=I*%"[QV_#WPJOOB?XA?6=1M'M['[1N*S((G=8E588S%)O+;@$\PX\LCS
MK X%>E?M0>#K_P ;V<5CI]L\K+<),9-\"1@!)4*?O)5?=\P/W=N#][.11^R_
MX.O_  19RV.H6SQ,UP\PDWP/&04B0)^[E9]WRD_=VX'WLX%<5X*^%]U\$=::
MY2":[TZ>,PB6)?-FB#LK@R11@NVWR\,RKM*D,/G(BH\:_"^Z^-VM+<O!-::=
M!&(3+*OE32A&9R8XI '7=YF%9EVA06/S@Q5]/U\Z_M;_  ED\2K;ZA9KNN%D
MCMG7(&Y99-L)R[A1B5]O R?,RQ"I7O7A[1$T&VALXB2D$,<2EL%BJ*$!. !G
M YP ,]A7S+^TC\)=8^(.I+<V-F_E1VXAW/+;+N*R2MO4>>3M(<$;@K>JBNU\
M8^&]2UCPQ'HT=C-]J%O:PG,EH$!@,#,Y;[0?E;:P3 +94[E4$$XO[,O@#5?A
MN;L7UE)B=8BA22U89B68[3F<$%BP5>",GYBJY:N$_P"%(ZY_;W]K_87\C^T_
MM.WSK7S-GVCS<8\_;NV\8W8SWQS7T!\9_A0OQ3T]8R/(NDQ)"7"$HQ7YHG*;
M\*> ^QB-RJPWA0&^>OA7?^(_@Y++;'3)[B%V5GC5974-L.&CDB$D0)W+O.')
M"!3M(X^D/#TNJS,^J:A"Z$1^7#IL$D,A +KOEDD=HXY)25ROS*L<60-TCL*^
M=/@S\$=<\$:K;ZA<V+M%%YNX1S6I<[HGC& TZCJPSDCC/TKH/VD?A+K'Q!U)
M;FQLW\J.W$.YY;9=Q625MZCSR=I#@C<%;U45[7X9\-3ZGH(TJZC>UE^P"T8O
MY4G/V<1&1?*E<%<DX!96..0N0:^:O@IX/U[X=ZHZ)ISM-+;M"'DR+6,L8Y!*
MTL8=&5=GS*K!CR@._"U]E:3;R6T,<<\GFRK&@>3:$WL  S[1PN3DX' S@5Q7
MQP^%O_"RM/-FLGERI()8F/W"ZJRA7X)VD.02.5.&PV"K>?\ PJ\6WGPYTAM-
MO--O&N[3=Y:11/-'/YKM*,2Q*\:[2^'R3@#*[GS&I^S'\!+CP(TFH:@=ES)&
MT2P@JP1-ZL69E)!8E!@*<*O4EFPE3]J7X=:G\09+:/3[1W6W\[=(9+=$;S!$
M1M#3!^-A!W*O/3(YKN_V=M%OO#FEIIVHVQ@>!GVMYD4BR*[O)D>6[%2"V"#Q
MC!!.2%]/KR7]I#PA>^++2TMM-!$XU&)Q("4$06*8^:7'*!3@Y'.<!06*@EI\
M2=6\)(MOK.GSW,@4!;FP07$<I RS,G[MH2,J.1AVWE J@"L2_P#"%Q\9-0M;
MV^M7M--L\O''.JBYN'9EWJ\1+".+,8!##++TR),QZ'[1_P #3\18%N+3 O;=
M6V A0)4//E%B,@@Y,9)V@E@<!RZ^5?!KQ9XC^'(.E/I4]S%YSA,B6,([,J\3
M%7A$.0S< *2Q??C.?H7PTFHV<<VH7ZO+<3>7MLH6C*0(I.V-6D>-'E^<M-(6
M 8@*@VH@/S+\(O@GK_@;5+?49; R)$S[E6>U#;71HR1F7!(#9 . 2,97.1]G
MUYA^T?\ #]_&VD2Q0Y,T#">)1D[V16#)@*S,2C,$ P2^WD#-6O@!X#'@O2((
M2")95$\P8,C"215)4JQ.THH6,CC)7<5!)KFOVH/!U_XWLXK'3[9Y66X28R;X
M$C "2H4_>2J^[Y@?N[<'[V<BL_X ?#2\T;2KO1=5MY(1<M.3*LENR[)(HX2H
M*2.P?AB,H5P.3G@^*M\+?$/P=U$7.G123@,P22&-I8Y8_E)62-"S*#D JV/F
M!,;$H''TKX+\3:UXW>*:>U.EVJ,7<.RRW$^"5$6UXU,*9!+LR[V&SRR 2P\D
M_:1_9NN-1N'U;24\SS,M/ H56#!<F1 ,;]V,LHS(9#D;]Y"=!\-/BIXFNX5T
M^32G:=(U5;JX,UO&  B"27S59I6W?.X1@[C.U0037NOA;1Y-'MT@GF>XE&XO
M,^ SLS%V( X506(1!PB!5!.,UJT444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444445
MY5^TNCW^C3V4$4TT\WE>6D4,LV=DT3MDQHRI\H)&XKNP=N2#7FO['NC7/A>2
M[AOK:Y@:?[/Y9DMYU0^6)B^7,>Q<;AC<1DD 9/%?3]%%%%>*_M0:?K4]K!)H
MCS!8Y&,Z6[,L[;MJQL/+&]E'S;E4_P 2L5(4LEOX*1:GKMO9R:Q',C6D<A5I
MPJR2RLTL2R$ B1?+M\IF0?O3,7()17;U^BBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBO(/VH?B/)X+TO;:OLN;F01(RN%D5<%I)%&"3@ )D8*&16#!@
MN>U^%GC7_A-],M]0*[6EC^<8P ZL8Y-HW-\N]3MR2=N,\Y%=+=J[(PB(5RIV
MLREU#8X)4,I8 ]0&4D<9'6OFK2O&FK+XQBTF\O#-#&TQVH@MXB)+0S!2BLQ8
M*2 OF,Y&,YR37HO[0^N:GX:TZ34-/N4@6'RB5\A9)'+2",C?(Y15^<''EELK
M]_!(%O\ 9PU:;5]"M)[F1Y96\_<\C,[G$\H&68DG   SV %>E5POQ;@O+2RN
M;ZQO)+=X+:20(([>2)C&&D.1)$SY91MR' 7AMIP0WG_[-GB+5?B!;/?W]_(1
M'<B-8DAM45@JH[;V\DL0V\#"E"H!(8DC;[U11117 >#_  ?JFF:I>WEY>^=9
MS8\B#!^3G(X/RQ[%RGR$^;GS),, *[^N*^+UQ?66GSW.GW"6[06\TK$PB9V\
MM?,"J6<(F=I4EDDX;( (R>*_9/\ %=UXHTVXN;Z5YI3?R_,YS@&.%MJCHJ@L
M2%4!1G@"O:J********X7XR'4+:PENM.NA:FWAFF?]RDS2".,L(P7;:@.#D[
M6.<8P 0W%?LB>(;G7M*FEO)I)W%[(H:5VD8*(H2%!<DXR2<=,D^M>WT45Q7Q
M>N+ZRT^>YT^X2W:"WFE8F$3.WEKY@52SA$SM*DLDG#9 !&3PO[+7BB]\5:5=
M7%S.9+AKV8*\N9%4F*)@ @9,(&8G8A08)"[:Y32O&FK+XQBTF\O#-#&TQVH@
MMXB)+0S!2BLQ8*2 OF,Y&,YR37TU11111111145VKLC"(A7*G:S*74-C@E0R
ME@#U 921QD=:^:M*\::LOC&+2;R\,T,;3':B"WB(DM#,%**S%@I("^8SD8SG
M)-?35%%%%8OBGQ?!X9$)N"<W%S#;QA1DF25L*/0 #+$DC@'&6PIVJ*Q?&GB^
M#P=:2W]V2(HE!;:-S$DA54#U+$ 9( )RQ R0>+],N]3@,5A<BUE++^],(G(4
M<D!695R>!D[@!G R0R^%?L@>-KWQ4^HR7\\DQ#6S*'8E5+F<ML7[J X'"@#
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M>UO,CEF.XH26W_+OX0A<-;_9N^,\GQ(M9$NEQ=6WEB1P $D#[MC@#[K?(=X
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M2(D2[E=1MVR8^;#_ '2.E^*UUXB@LI]2M)H[40*TBVRQQS2M$ A=I9928U=
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MQCC;"S7;QR# .Y1-<R@<@X^>-3D8/&,X)!^H/A/_ ,@?3_\ KPM/_1*5\_\
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MI!F6 ;99VPIPQ8E8XUY5,2LNX-U7[+G_ "+MG_V\?^E$M>5?L,?\Q'_MT_\
M;BC]N?\ YAW_ &]_^V]?55%?*O[<_P#S#O\ M[_]MZ^JJ^5?V&/^8C_VZ?\
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M\X ?AE.X(&3YV+<>7_ +_D<-6_[?_P#TLCKZJHKY5_YJ'_G_ *!U>J_M1_\
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M#(MJMW-YOF#<A4PP*5*X.[=G:%P2Q(4 D@5Z5X0U^^\80QR:?"FGZ:8\1&1
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M'4;E5L'C(!Z@5Z5\';M+K1K!HV# 65NI*D$;EC5'7CN&!4CJ""#R*\%^-O\
MQ+O&6ER0?NWD^Q;V3Y6;=<21-N(P3F,!#GJGRGCBNK_;6_Y \'_7_'_Z)GKU
M7X3_ /('T_\ Z\+3_P!$I7S_ /L,?\Q'_MT_]N*/C[_R.&D_]N'_ *624?MS
M_P#,._[>_P#VWKZJKY0_9WM$L_%NJ11*$1%OE55 5547<0"@#@ #@ < 5+_S
M4/\ S_T#J]5_:C_Y%V\_[=__ $HBJ+]F>[2S\-6LLK!$1;EF9B%55%Q,2Q)X
M  Y)/ %2^"_%\WBF,+X=MX;73HY&47$T3*CX,F_R+>)HLKOVDR.\?+.-A=6
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M09I-T4SS8(56(5@<!P& (.X#*[O>O"^O2ZXGG26TELA5"BS%!,<@D[D1G"
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M$F#)"21MV#* 9.TQK(>E\,W_ (F^*N+74[=+'3S(/M)"3032HN"UN \OF!9
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MW*"%(8[MV<.!EC'N C?<2LOQ@^"+KX9BTO3P9'LFCE"JI+3, XF(!<D$F5Y
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M1111111117RK^U=XBUGPI)"8]0=8+B25DBA3[,8Q$$4 R*YDDR),MDA2PR%
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M))M#[&((5]IX;!P<'@XP:Y3X0^%]0\-6(M]6N?M5QYCG?EGVJ3PF]P'?NV6
M(W;!\J@UMMXO@%^-*R3<&V:X(Q\HC$BQ@D^I8G &>%);'R[H?'^CW6LV,]O8
M3?9[EXR(Y?[IR,C(Y7(RN]<LF=Z@L */ &CW6C6,%O?S?:+E(P))?[QR<#)Y
M; PN]L,^-[ ,2*Z"BBBBBBBBO&OCE\6)]#N[+1=.D$5U>31!IBGF&&-Y1&K!
M&&QRS;NIX"D8!967*\0_"_Q!X5N8+C0;^>Z1F5)HKZ82JHW!BYW #9@8;8!,
MHSL+;B%]ZHHHHHHHHHKY@^)GC+6=$\1:?ILU[N@FN+*4I#%]F3#3&)HS\\DC
MJ0I+!Y"I+?=P!CZ?HHHHHHHHHHHHHHK%\,^+X/$AN!;$D6UR]O(2-H,B*A<#
M/) +;<D#)!QE<,=JBBBBBBLKQ-975["8[&9+>4Y'F/%Y^T$$95?,C&X$@@MN
M7C!0YX\*_9)\?WWC.34)M0G>9A]DV@D!%R)@=J* B9VC.T#<1DY/-?15%%%>
M(?$3XD3ZUKEOX7L9S;!U8W4Z#,P'DO)Y*%UPA,8!\Q=Q5F4C!1E8T_X?>(/"
M&K0_8;R2[TR5E\\7<HE>-5!W#)^;)R3&8@ 6PLHV+N;V^BBBBBBBBL7P;XO@
M\86J7UH289&D"%AM)"2-'NP>0"5)&<'!&0#D#FO&'@_5-3U2RO+.]\FSASY\
M&#\_.3P/EDWKA/G(\K'F1Y8D5W]%%%%%%%%?,'[5WC+6?"30K#>[(+GS0(X8
MO(=!$Z,I,N]Y"Q#@,4,:D+]S#$5]/T444444445%=J[(PB(5RIVLREU#8X)4
M,I8 ]0&4D<9'6OFK2O&FK+XQBTF\O#-#&TQVH@MXB)+0S!2BLQ8*2 OF,Y&,
MYR37TU111111111111116+X-\7P>,+5+ZT),,C2!"PVDA)&CW8/(!*DC.#@C
M(!R!M44445P'C#P?JFIZI97EG>^39PY\^#!^?G)X'RR;UPGSD>5CS(\L2*[^
MN?\ #'BV/QE9"]T]L))YPB>1"1E'>,.4W*Q4LNX#*L5P#M.<?/?ASQ+JUIXQ
MBTJ^OY+E(U93A1;Q.#:/,,PQG82&;J<DX!SP /J2BBL5O%\ OQI62;@VS7!&
M/E$8D6,$GU+$X SPI+8^7=YU^TI>:GHVG2W]A>?9XHHU5XEB4R2&618B?.9L
MQ[0V5V*&!R=W*[=7]G#5IM7T*TGN9'EE;S]SR,SN<3R@99B2<  #/8 5Z511
M117@&N_&.]^(&J+HWAB9(TBR]S>%4D7:I"MY:N"'4%@ 0,R.1M*Q NW2VGP'
MGM45EUG4S<*H(=I]\/F <,874[DW<F-F.5^4L>M97A3Q/J^F>(4T[6Y 8FLI
MDM'C1DBN'5HW:5@-P$PC1MZDA8^B "0&3V^BBBBBBBBBBBBBBBBBBBBBBBBL
MKQ-975["8[&9+>4Y'F/%Y^T$$95?,C&X$@@MN7C!0YX\*_9)\?WWC.34)M0G
M>9A]DV@D!%R)@=J* B9VC.T#<1DY/-?15%%%%%%%%%?,'[5WC+6?"30K#>[(
M+GS0(X8O(=!$Z,I,N]Y"Q#@,4,:D+]S#$5]/T44445B^#?%\'C"U2^M"3#(T
M@0L-I(21H]V#R 2I(S@X(R <@;5%%%%%%8O@WQ?!XPM4OK0DPR-($+#:2$D:
M/=@\@$J2,X.",@'(&U7%?%[POJ'B6Q-OI-S]EN/,0[\LFY0>4WH"Z=FRH).W
M8?E8FNKTFWDMH8XYY/-E6- \FT)O8 !GVCA<G)P.!G JU111111111111111
M7S!^U=XRUGPDT*PWNR"Y\T".&+R'01.C*3+O>0L0X#%#&I"_<PQ%?3]%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%>->*_'>H>)]:;P]I$PLS;P^=<7+QI,S JA6.-&RI'
M[U-Q8J2<XP%Q);L3KWAK4+&UO+J.\L[B:8/-Y*03!UMIG6$JK%=AV;PRC=N4
MJS!<!O+_ -N?_F'?]O?_ +;UZ7\7+C7[>QEU.QN$MO)C:3[*(8I9"@*EO,FD
M=DW*@9RL:8!S&&EPKG5^&_QGC\4:*^LS+AK>.8W,<8)PT2[V"[]N=R891N(&
MX*7)!-<U\*/%^I?%VVN;];LV(69X8(H8H9%4JH<22-.CM(?WB@A#$,(2,%N#
MX"?&"[UZ[NM#U7$EY:--F= %1UCE$;@@!,$,PVD* R_>"LN7X3]N?_F'?]O?
M_MO7T!\6/^0/J'_7A=_^B7KRK]BG_D#S_P#7_)_Z)@KW^OE7]N?_ )AW_;W_
M .V]=AX\U7Q=JD!U#3%CM8%5G2UVB2_9.,>8LD;QA\ N(T(8!O+.^0 5TO[/
M?QG;XFVLC7"HEU!(!(L8<(5;)C<;LXSAE(W,<H6. P%%]XPU#QS=7%CH<B6T
M%K)Y5Q>21-(_FC),<",!&VPKMD+GHX*# 5GY6?XC:K\+-4AM->N$N[&\PL5S
MLAMVC8%0Q95P H+C?N)&PJZME7C/O]<U\2/'">!M/GU&1#((57"*0"S,RH@R
M>@W,,G!(&2 Q&#YUX&N]9^(FD?VI#?\ V:ZG\PPQ)# ;5/+<Q[6\R.68[BA)
M;?\ +OX0A<-;_9N^,\GQ(M9$NEQ=6WEB1P $D#[MC@#[K?(=X VYP5P&V+Z_
M7"_%SXDGP5!&MN@FO;J98+6$LJAI&X#-EE.Q21N([LJEE#;ARFO^'O%&F0/?
MQZE'++&OFFR6S3RFQ\[P(XS,PQE4. [\ E2=PT/AU\>(?$6BR:U=IY7V;>LZ
M@KM9T56Q'N8??WJ$5B#O.S+<,W/^'Y_$_P 0[?\ M."[ATZ*2,M;6X@$K,-T
MFTRO,F5R-N'0,K(0XC7HTWPC^.%S>:A)X>UM M_$S+'*BLJ3;%RQ((&TLJF5
M6 5'4\*F%#R_M&?$[5O %N+BS2V6!Y/)$C-))/N>,LKA-B1IM*-]YI0WRDJ!
MD5+;77B+Q9I45W:31VSFRAE3]W'-<7$OE,6#;BL$".Q4I@.P!#,8^8@?LT?&
M6?XC6TR7H'VBV:(,ZKM5T=2%8_,?G+(Y; 50"NT=0,__ (6-J?Q+U.>PT"XA
MM[&UV>;>A%N'=BK85$?"E2P(! QB,N)2&5&\;_:K.HV3V=EJ;BX,2SO%=K'Y
M/FK(8PR,@&Q7C9.=C$%&C) 8G/U3\4M?O] LI;K3D@<PPR2N9WD "Q@.0J1H
M=Y*A@,O& =IRPR*XK]G[Q_J/Q"TRXNII8UN/MLBQEHMT2)LA?9L1XF8#<P!+
M[N069L8/DOP0CU"?Q1J*"Z1[I([E))YH6E#A+B*/A$FBV?=&T!BJ*-@&,$>X
M?&CQQJO@;3S?6J6L@A6+SGD,H+,S"-@D*]!N96!:8D#<N&(#&U\#_&DNO:'!
MJ.HR@N5G:65@D:A4FD7<=H5% 11DX P,GN:X_P +^*-=^+>Z]T^X33-/621(
M2T GN)=NP;F$G[O;G=S&WRL&0[]N\5?!GQJU#POJB^'_ !)L>63RQ#=1(RJ[
M2'* C:@923Y8=$4*Z$,&^9U[7XY^.M2\$63W]C';-%%Y9D:9I2YW/Y>U8T51
MU93N,HXW#9T-<U\+]>U[X@Z3!,EQ';%UFWW;Q)-,[K.0OEPJ4B5 @*,SY8L#
MB,#$C5/V=_C+J'B2[N='U@ W5LK'>JHI)24QRJY1MA(9D";% (#$DG!/O5<!
M\9_BE_PK^U5H8_.O)Y!%;0CDLY_B*@[V4< A!DLR)E=^X<?KFA>+M,@:_2_@
MEE1GE>R2V!B*+N?RHW"&9R0%4*0K')'F9 9N@^"WQE'Q1LI&C AO85"RJ59X
M@[!O+D W*60E2=FX,,%2V-KMX?\ &VVO$\5:6L\L+SG[%L=('CC7_2I-NY#.
M[-ALDX=<C@;3\Q^JM"MKR'=]MEAESC9Y4#P8Z[L[YYMV>,8VXP>N>-6O*K[Q
MAJ'CFZN+'0Y$MH+63RKB\DB:1_-&28X$8"-MA7;(7/1P4& K/RL_Q&U7X6:I
M#::]<)=V-YA8KG9#;M&P*ABRK@!07&_<2-A5U;*O&>U^.?CK4O!%D]_8QVS1
M1>69&F:4N=S^7M6-%4=64[C*.-PV=#7/_"W7-;^(6C0SK<I;2MY@:Y:".:20
MK,XRD:O'%&H50A+JS.=V$3:LDG*_!;XSZWK4U[H]TJ3:C%O,;2"..&,H?+E$
MK0_>4/MV"-&9F)!=4PZ2_$SXEZU\(K^WDO;J.\LKIGW1K;K$T:K(AD" /N)"
M,!&7E8$D[QD!CTO[1GQ.U;P!;BXLTME@>3R1(S223[GC+*X38D:;2C?>:4-\
MI*@9%9[ZUXJ\7Z=!<Z4T$*_9H'+R+BYN)/)#2E4>(PHC2,53(7<4WJXB=<V_
MV=?CA<^-GGT[5$"7MNH/"LC.JD1R;U(VHZOC< 5!+X5%"&N$^/O_ ".&D_\
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MW5K_ %RRBO=1:#-Q#'*B01R($5P6 9I)7W$J5SA5"G<,N,&NPHK@/CA\4O\
MA6NGF\6/S)7D$42G[@=E9@S\@[0$)('+'"Y7)9>/UN76IM"&M6VHE+@VPNVB
M,%M]G$90S&) 8GD!5" K.[[BOS8W97JO@U\5'^(^F&]2(+<(SQ.A8K$TJHK9
M# .RHVY>JLR9(P^T%O-1\:=<'B5-%EC@PK2YBA)VN'MS+%OFF7< F5+M&BD@
M/B-SM0GQD\;^)/AD+?4GN()HI6V2VZP*EO')Y8VJ&+FX<$AV#;EP5Y #!*]
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MZ]XDUB[TQEMFE@MYXU108[598YE3SW9M\Y7DJ%3[V5!5/FD4^)/Q1UOX1ZE
MU]<)=V-SDD"WCBV 2#S4C"R>9N2,KL,CE3OP=Q4D?2E<U\2/'">!M/GU&1#(
M(57"*0"S,RH@R>@W,,G!(&2 Q&#YUX&N]9^(FD?VI#?_ &:ZG\PPQ)# ;5/+
M<Q[6\R.68[BA);?\N_A"%PUO]F[XSR?$BUD2Z7%U;>6)'  20/NV. /NM\AW
M@#;G!7 ;8LNK^.-0\9:C/I&B21V\=HJ_:KUE2=ED;E(HH]VTGY65R_0AQ\K(
MN_E?&?Q"UKX-3P2:G.-2L)VVNXMUMY8F7.57RSY>2"&4.27V,H\O!<]_\4/B
M3/H<]MI6F)'+J-VQV"5L11QI\SRR!6#XVAMH'7:Y&678W'^.H?$O@"U?4TU%
M+]8/FDMWLXX@4.59\PG?\F0YY4!06+8&UN[T'XNVVHZ*-?E4Q0^2[LA*E@R,
MR%%)*JQ+KMCSM+DKPI.!PGA^?Q/\0[?^TX+N'3HI(RUM;B 2LPW2;3*\R97(
MVX= RLA#B->C3?"/XX7-YJ$GA[6T"W\3,L<J*RI-L7+$@@;2RJ958!4=3PJ8
M4/+^T9\3M6\ 6XN+-+98'D\D2,TDD^YXRRN$V)&FTHWWFE#?*2H&17/_ /"6
M^+O$MG9:AI42",1PB1)?)6:Y;8IDG*OM5(&8%4".DC*=X 5EV:O_  L;4_B7
MJ<]AH%Q#;V-KL\V]"+<.[%6PJ(^%*E@0"!C$9<2D,J-XW^U6=1LGL[+4W%P8
MEG>*[6/R?-60QAD9 -BO&R<[&(*-&2 Q.?IKXX?%+_A6NGF\6/S)7D$42G[@
M=E9@S\@[0$)('+'"Y7)9>/UN76IM"&M6VHE+@VPNVB,%M]G$90S&) 8GD!5"
M K.[[BOS8W97JO@U\5'^(^F&]2(+<(SQ.A8K$TJHK9# .RHVY>JLR9(P^T%O
M-1\:=<'B5-%EC@PK2YBA)VN'MS+%OFF7< F5+M&BD@/B-SM0GQD\;^)/AD+?
M4GN()HI6V2VZP*EO')Y8VJ&+FX<$AV#;EP5Y #!*]5\6_%VV\.:0NMLI*20Q
M/#$2J2.TJAD3J1G!R^W<5568!MN#S7_"*^*=6A^TMJ4-I</'G[*EK%)"C8X0
MRN9'YP"Y <*Q;9N4#)\&OCLWBRUO)-4B^S3Z?DW.%<(%_>'(0EI%91&P=#DY
M (.6VJ:7=Z[\1XUO[2Z33+-\M;H;<7%S(A)4/-YI")G:'C\O(*ORS8#&I\'?
MBO>O?3^'=>*'4(=S),I0+,N X&%V_-L8.NU03'G>J,C%O:J*************
M************************************************************
M*^=?C5\"=3N-3_X2#09?]*^0M&65'#*JQ H6 0J4'SI(0" PRX?8#X/_ +2=
MU?WL>BZ[!Y-TV%64CR"6V*R+)&^,,_)!7 9F15C .:Y_]N?_ )AW_;W_ .V]
M?0'Q8_Y ^H?]>%W_ .B7KR7]C6[2ST2YEE8(B7LS,S$*JJ(("6)/  '))X K
MK_!?B^;Q3&%\.V\-KIT<C*+B:)E1\&3?Y%O$T65W[29'>/EG&PNK >2_L[PF
M#Q;JB,Q<JM\"[;0S$7<0+'8JKD]3M &>@ XJ7]N?_F'?]O?_ +;U] ?%C_D#
MZA_UX7?_ *)>O*OV*?\ D#S_ /7_ "?^B8*]_KY5_;G_ .8=_P!O?_MO7U57
MRK^SKI/V7Q5JWDQ[8(OMD8VKB-,W2>6G VK\J':O'"G P#5O]DNP@\56=U]H
MFN6NENS))LNKN'(E1=KMY4J*S,R/ECE^/F.-M>M>*/@GHVJ)YNHK)(D*NVZ>
M\NW6-< NV9)R%&%!8\# YZ5Z+65XKU2UTJUEFU!D6U6-O-\P;D*GY2I7!W;L
M[0N"6)"@$D"N*\(:_?>,(8Y-/A33]-,>(C(@:Z9,($:.)2(85 W^6SF8'"-Y
M10\^/_L,?\Q'_MT_]N*^JJ^>_B/KXT[QII0G<B(6Q55^8J))OM,(PHS@LVQ2
M<= -QPN1]"5X!^V3JW_$G6.*3_E_BCF56_Z8R2A' /\ N.%;_9;'0UZ?\';M
M+K1K!HV# 65NI*D$;EC5'7CN&!4CJ""#R*\%^-O_ !+O&6ER0?NWD^Q;V3Y6
M;=<21-N(P3F,!#GJGRGCBNK_ &UO^0/!_P!?\?\ Z)GKU7X3_P#('T__ *\+
M3_T2E?+_ .RUJDFD:;KMS VV6*TCD1L X98[IE.""#@@'!!'J*]+_8I_Y \_
M_7_)_P"B8*Y3]N?_ )AW_;W_ .V]?0'Q8_Y ^H?]>%W_ .B7KRK]BG_D#S_]
M?\G_ *)@KE/@%_R.&K?]O_\ Z61UZK^U'_R+MY_V[_\ I1%7F%M=O:_#W=&Q
M4E64E20=K7Y1UX[%25(Z$$@\&O2OV5;M)_#]JJ,&*-<*X!!*MY\C[3CH=K*V
M#S@@]"*\O_;:_P! FTVZA^2<?:,2K\L@V&%H_F&&^5F)7GY221@DUZK^U'_R
M+MY_V[_^E$5'[+G_ "+MG_V\?^E$M>5? +_D<-6_[?\ _P!+(Z^JJ^5?VBM6
M^R^*M)\Z3;!%]CD.YL1IFZ?S'Y.U?E0;FXX49. *^JJ^5?V=?] \5:M:P_)
M/MF(E^6,;+I%C^487Y58A>/E!(& 31\??^1PTG_MP_\ 2R2OJJBOF#]DNP@\
M56=U]HFN6NENS))LNKN'(E1=KMY4J*S,R/ECE^/F.-M>M>*/@GHVJ)YNHK)(
MD*NVZ>\NW6-< NV9)R%&%!8\# YZ5G_M1_\ (NWG_;O_ .E$5'[+G_(NV?\
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MHQ4/>NK@$@,OF7;[3CJ-RJV#QD ]0*^FM)\$6.KPQW,$MXT4L:2(WV_4!E6
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MW_[;U;_:!U227Q5HUL6_=)):2*N!PTEUM<YQDY$2#!.!C@#)S]/U\J_L,?\
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M_D#ZA_UX7?\ Z)>O*OV*?^0//_U_R?\ HF"N4_YJ'_G_ *!U=7^VM_R!X/\
MK_C_ /1,]<5\5=66PL_"WVB1TM1';R3;6D7 1+3Y_P!V0VY59]K+\ZY.T@FO
MHK_A6EK_ ,]+S_P/O_\ Y(J'P'\.-+\#/-%ID8B>18FE7S))&V@R"-B)'8J"
M=X!& 2#UV\>"_P#-0_\ /_0.KJ_VUO\ D#P?]?\ '_Z)GH^)?_(C1_\ 7AIG
M_H5O75?LN?\ (NV?_;Q_Z42UZK7DO[4?A ^)-#F* E[9EN% *J"$!$A.[J!$
MSM@$$D#&?NG*^$/Q$?6_#UK%;,%O"PL$*J<1NBG$F),JY2V7SR"0LA4Q@AF"
MCS_X0W:?"[Q1?Z0[".UE61EP08T5$-S"SO)A@$@+JQR1N/.X ./HKX?VCBV^
MU3J4GNV^T2JP*LC.JA(B#CF.)4B)PI8Q[V4,S5\]?'W_ )'#2?\ MP_]+)*]
M5_:C_P"1=O/^W?\ ]*(J/V7/^1=L_P#MX_\ 2B6O*O\ FH?^?^@=75_MK?\
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ME*^7_P!EK5)-(TW7;F!MLL5I'(C8!PRQW3*<$$'! .""/45Z7^Q3_P @>?\
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MKPAK]]XPACDT^%-/TTQXB,B!KIDP@1HXE(AA4#?Y;.9@<(WE%#SX_P#L,?\
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M3I'R <[7 =>>& 8<\BHO@_X2LM>TBRN(Y;H@VT2MMO;Z-0Z+Y<BA1.JJ ZL
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M=YCL0V(V=(XB<LS@J4/-?LJV>H>&=.EMY[&=3]IFE)DV0DCR8PJ(LC*[.74
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M;\+\J[>>_HHHKG_'_A+_ (2^QGL/->'SHROF)]X<@X(XRIQM=<C<A9<C.0>
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MWRL">?OH=KY8"0>B_%#QE>R7MMH6D.(KJX4RS7#1F06\"'[^TJ4)=@4&XX!
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MRU4_;G_YAW_;W_[;U[A\:?B8/ASISWH :4LL<*-NVM(V2,[1T"AG(RNX+M#
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MJ\*\:^=IW@;3HSOC\R[.Y3N7<C-=2ID<94X1USP?E8=C7TU\';M+K1K!HV#
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MGD.YLR/@S>8_)W-\SC<W/+#)R175_MK?\@>#_K_C_P#1,]>J_"?_ ) ^G_\
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M@  815!.6(+LS-W?[:W_ "!X/^O^/_T3/7JOPG_Y ^G_ /7A:?\ HE*\5_;
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M<5%^Q/<C3KG4+&;*7!6%O+96# 1-(DF<CY2K2*"#@Y/3@X]:_:C_ .1=O/\
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M .(K/\;W,%UX>NI+/ MVTJ=H0J[%\LV[%,+@;1MQ@8&!Q@5YU^Q3_P @>?\
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M(-OX7?$;_A:UO8QN<O%F6]QS^]MVC\A6PJ!/,D9;A2OR_N7APX\S;[57RK\
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MHKFOB+X\@\"V4M]<D813Y:$[3))@E(A@,<L1U .T98_*I(M^"-;?7K"UO)0
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M45E>)O#$'B6$VUT',39W*DLL.X$%2K&)T+*02"I)4]QP*^:OV&/^8C_VZ?\
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M4444444444444444444444444444444444444444444445\J_'W_ )'#2?\
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M$2!J'C/X*7O@6>"^\'(4.[%S;&<F*0#)1F69P&&&=6^?*Y5HPK;G'7_M1_\
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M#[+^SW\2I/B#I:7-Q_Q\1R-#,P4*K,H5@X )ZHZEN%&_=M4+BO2J^5?VY_\
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M ,4^)(_#5N]U,'94V@)&IDD=F8)'&JCJS.P51P,D9(&2/%?VUO\ D#P?]?\
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M484FO?\ Q3XDC\-6[W4P=E3: D:F21V9@D<:J.K,[!5' R1D@9(\_P#VH_\
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MF-NJC)( R2!DD#U->E?M1_\ (NWG_;O_ .E$5'[+G_(NV?\ V\?^E$M>5?\
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M5S\D3RNQ!(.T!,$@'#,@.-V:^:OVY_\ F'?]O?\ [;U] ?%C_D#ZA_UX7?\
MZ)>O*OV*?^0//_U_R?\ HF"N4_YJ'_G_ *!U6_@QXQC\+^)M6T^\'E->7;F)
MGRF6$LC1H 5_Y:)+N0D@'"A=Q=:^FKN[2S1I96"(BEF9B%55 R6)/  '))X
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MH:XK]BG_ ) \_P#U_P G_HF"O?ZY7XL?\@?4/^O"[_\ 1+UY5^Q3_P @>?\
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M"G 7=E?O[25J'X6?#:]\ VAL!>1S1*LGD[K8HR.YW#)6X^= Q8E<!B6P)%
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M+SYA>3ON"A?W82.")$";4PYP?+,CL68C=A/6KOX7#Q'IS:=K<YO69BWG>7%
MR-T1HUC7"%1W)8L2P;*-L'A^G?LM:]X?D\C3]4\JS,BLQ22XA?D*'?RDRA88
MP/WGS #++V^@/AK\/H_ MK]F1WED>1I9YI"2\LKXWR').,X  R> ,EFW,>JK
MRKXS_!NZ^)JK;M>I!:I()%C%MO<MLVY9S.,XRV JH,-A@Q -1:I\'KV_T-M!
MENXY1MMHXI?(,3)'',C-N E<.1&H5  F2HWL2Q<2_P!C>*K?_1EN[&2+I]J>
M&5+H!NKB)#Y&Y,D("=K;5W]372_"KX9P?#FR6QMR7.XO)(W!>0@!FQDA1A0
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MQ-YOF^99@H_F-O;(2X3'S@,-A7! 'W<@^ZU%=J[(PB(5RIVLREU#8X)4,I8
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M,5P&"NI0D9!&<'C((SV->-?!WX.:U\/O/LEN[86,DC.KK&SW /";E#;41F0
M_.9T1E7","V3QI^SM?>+=0CU:;4D2XA\KRO+LP$3RVWK@/</GYR6.\MDDC[N
M .V^(WP\O/'.G'39;J%/,QYTBVSG=MD62/8IN?DQMPVXR;NHV]*S_ 'P9?0-
M/;1K^>.]L"K@1M;F)QN8/]\3-P&W,#MWAB"KC:HKR2Y_91UCPW,_]A:CY4$F
M"=TLUO)P6VJWDJROM4_>^7)+811U]P^%?PL'@5)7EN)+N[N&4SW$I;<X0%8E
M 9GP%4XY)))/.W:J]U7@'[:W_('@_P"O^/\ ]$SU+X(T'Q'9:5:QZ5<VKP2V
M4#HUV)3<0M)$I*(45D9%8YCWJ2H(C(94&>[^$/PAC^'<<Q,SW%U<2;YYWR"Y
M!8K\I9L8W$DDLS,Q).-JKY_X*^"&L?#K4+F31YK,6-Q(OR3"9W1 Q*X5<%F0
M,RKF4!QRV"1M/'7[/&H:UJUKK$-XDDD<D+RB=6"(8W#@0QQ_\LNN(V<-G):9
MF=G'0?%+X)WWQ%ACM;G4$6&.3S,+:#<7((Y/GCY5W,(U !"$"1I7'F'M?AQX
M5NO"MJEE<W"7*0QI'$PA\APJY #?O75L+M4$!3A<L6))KS3X@_ S4)=;3Q#H
ML\*S\&1+C=LRL8BPNQ&)5H\JP.&4Y97R1L]ET2TGMT/VJ42R%B25C\J,#  5
M5W.P'&3N=R6+$$+M1="O"O$WP O-+U0ZYX>N4AGDD+30S[S"^\EI<LNYBK-@
M^65X;+(ZE4"[=I\*[_Q3>VVH^(98&-FS-;V]JLBQ;\HPE>20^83E1\F-OR(<
MX+JW5?$7PG>^*8);.VNH[>&:$QR$VYFEPV0^&,Z( R';@H2.2&!QMY7X1?!F
M]^&B-;PWT<MN\RR.CVI#9P%?8ZW(VEE4#+!P" 0OWMWK59_B'1$UZVFLY20D
M\,D3%<!@KJ4)&01G!XR",]C7C7P=^#FM?#[S[);NV%C)(SJZQL]P#PFY0VU$
M9D /SF=$95PC MFW\8/V?[KXG3))<7Z1Q0^8(8TM<[0Y!)9C<99B%4$_*ORY
M5%R<]KJWA'4-7TV33Y[N%I98WB>?[*PS&T9C;Y!<@"4DEMP(3L(N]<U\(_@A
M/\/HI+-KN.YLIF9I(7M<$EDV-AO.888!0P97!"X 4DD^=>(OV3+[1KIKGPY>
M_9TDW HTDT+HIVGRQ)$':1=P)PP4@!<ESEJ]0^$7P=E\(.U]J-U)>W[PK$9'
M=V6./(=HDWL2P\SG<<9 &$3+;O3Z********************************
M************************************************************
M******************************JZI)-%&QMD1Y>-JR.T2'D9RRQRD<9(
MPIR<#C.1\_\ P\^#.O>$=6GUEC8RM<^?YL8EN(Q^]<2G8WD/MPX&,AOER.I#
M#Z*HHHHKR7XR> ==\0W-O<:+?"W2)?FB9GC4N&#!SL1Q*", I(-JA> =["O0
M/"_APZ.FZ:0W%RZH)KAE56<J#@!5 5$&3M1> 69CN=W=MJBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBHKN$SHR*Q0LI ==I921@,-ZLN1U&X$9Z@CBJFB:(FD(54E
MF9BTDC8,DCD %V( &<    *JA415154:%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%> ?'
MSX,ZQ\49HO+-G#!;^:(]TLS2-O*Y9L0;5^5%^4;MIW?.P(Q[5X9DO'A']H)"
MDXP#Y#O)&W RP\R-&7+9^7YL#'SL<XU:*******\U^-_@C5O%D,*:->?9621
MC(-\D6\$84^9$&<;>?DQM;=DG*+GH/ OA:XTV-)M3G^U7WE[7EVJB*"0QCC5
M50!<@;FP'D*J7X6-$ZJBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO&OV
M@?AGJOQ)B2RM?LL=O',)=\DLOFLP0J!M6$J@&]\_,Y;Y3E>0>U^%NDW^AV45
MEJ*P9MX8XD>"21PZH"H++)$FTA0N<,P8[CA!@5V%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>:_'3XSQ_#&U5POF74V\0(0=F5Q
MN=R,?*NX9 .YB0!@;G7C_ _[/Y\501WWBB:>[N)5:00/)+'%!YNUMH0;&5QC
M#*-J+]P(=BL=#Q7\"IO#UK*?"L\UI*T; V_FLT$F?OE?-+&*<@*%E##&T+\F
MXN.P^!6MIK.AV,L8("VT<1W8!W0CR7/!/!9"1WQC(!X'=444444444444444
M4445X+X1^&%[XNFO[N\U+4(8CJ-VEM'!<E%$<<SH3R7P-P**N$VA,\AACSKX
MG:;>>%=>L=(@U/46@N?LV]GNW,@\VX>)MI 51\J@C*GGKD<5ZKXK^ UU%:RM
MI^JZHUTL;&)9+O<C,.0AXCQNQM!W *2&.0"#Y?\ 'RPG/A[3]2>\NG-Q#81R
M0M+_ *.0;<RERH4%W,B!B[LQR?0*%^D/A/\ \@?3_P#KPM/_ $2E=511117S
M7_PG]Y\<M4^PZ3/-9Z9:_/-<1%XYI>=H 8 ;-V3Y:-CY0TCJS*(U[JT_9:T.
MS11%%(DR*-MPL\RS*X'$HP^P.&^883:&_AQQ7/\ AVRU#P?XF@M]1N)+NWN+
M*XAL9&*;E"&.9UE VY<+& TN"924)/58_>J*************************
M***********Y7PU\0X?$5]>V$ S]B\A7D#*59Y!(60 9^YL"MDYW[E*C;EO%
M?VR=%DM+-;U;JYVRW$4+6WF 6NT)))GRU4;FWH&W.6/8<!0OM7PG_P"0/I__
M %X6G_HE*ZJBBBBBN?\ '_A+_A+[&>P\UX?.C*^8GWAR#@CC*G&UUR-R%ER,
MY!X \)?\(A8P6'FO-Y,87S'^\>2< <X49VHN3M0*N3C)Z"BO%?VJ=%D.E3WT
M=U<Q>5&B>3'($@<2RI&_F +N?*MC!;:,<#EMVK^RY_R+MG_V\?\ I1+7JM<K
MKOQ#ATG4;/2<;I[OSFX91Y:1QN^]ARWS,NU> #ASNRF#U5%<K'\0X9M6.BQC
M=*EHUQ(X9<)\Z(D9 R=Q#[SG;A=A&[?\O544444444444445P'_"IO\ B>_V
M_P#:IO\ CW\K[/GY.FW&<_ZK^/R\?ZW]YN_AKOZRO$VAMK<)@2>:WW9!> QK
M)@@@J&DCDV]<[EVN" 0PYS\Z_L6:M-J\FISW,CRRM]CW/(S.YP)P,LQ).  !
MGL *^GZ***Y7X?\ Q#A\<+<R6P_=07<ENK[E82;$1C(NW(VDN=N"<J W&[:/
MFK]LO19-)DMY#=7,J7,D[F&20&",QB-4\N-555PLA&3ECU))+$_7]%%%%9_B
M'6TT&VFO)02D$,DK!<%BJ*7(&2!G XR0,]Q7SK\)/"47QWM+K4==:264W,D4
M*K(Z16Z^5&<PH#M!^89WAPVQ2P)W%MO3OV<=0N]+GT>_U)VB-Q$UMM#.JQQ@
MJ%=79258;2(0VR)T5E9OF!]UTG3_ .SH8X-[R>7&B;Y&W2-M &YFP,L<98]S
MDU:HHHKA?C3ITMQIES-#<SVY@MIY1Y#(A=D3S$#,4:0 %.?+9"06#$@\>?\
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M)EP(XPY *L,^6#N"YRK-7T?I=N9K552Y>7?&2ES^Y+D/DK(NR,0G (VG85(
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M")T929=[R%B' 8H8U(7[F&(KVKXO?$%O UB;B%/-N9)$AMHL.V^5S\JX0$G
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M+)YCKF(3Q.79-Y/EJ%9 50,S, <<]7\5/'=[XAU2+PSHDQ@E*LU[.(RWE1E
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MA455 46OVY_^8=_V]_\ MO7T!\6/^0/J'_7A=_\ HEZ\J_8I_P"0//\ ]?\
M)_Z)@KBO&-XWP:\6C4"NVQO>9"-[#;(5\\DE&.Y9@)BB9.THH*A\#Z*\#_\
M$S:?4FZW$A2+T^SP.Z0E2,!U<EYU?'*S!0S*J&NJHHHKY5^/O_(X:3_VX?\
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MLMW.\'G1Q2#]W--YBKYF3N(<-A0<JC$XVBOH#_A4^C_] ^S_ / :'_XBN/\
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MV?\ V\?^E$M>=?"GPY=?#_7+^/2HC>Z86V2"%HU,,@+/'%NN'02/$&*.%D.
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ME0+(RY(,A@(#^8W'T+:6B6:+%$H1$4*JJ JJH& H X  X ' %?+7_-0_\_\
M0.H_:*U;[+XJTGSI-L$7V.0[FQ&F;I_,?D[5^5!N;CA1DX KZJKY5_88_P"8
MC_VZ?^W%1?L@:;I7B&VN+.\MH)KJ.;S098HI&,3*B +O!<A74[N-JEUYRU>]
M:M\.]#TB&2YGL;-8HHWD=OLL1PJ@LQP(R3@ G !/H*[6N5^+'_('U#_KPN__
M $2]>5?L4_\ ('G_ .O^3_T3!7*?MS_\P[_M[_\ ;>OH#XL?\@?4/^O"[_\
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M/AZXL=)BEO;I[B4WX  588$#).VU(TR3@!5#2O*XP=K+O<-Z5_S)_P#W ?\
MVSKE?V*?^0//_P!?\G_HF"O?Z\J_:C_Y%V\_[=__ $HBH_9<_P"1=L_^WC_T
MHEKRK_FH?^?^@=75_MK?\@>#_K_C_P#1,]'Q+_Y$:/\ Z\-,_P#0K>CX:?\
M(C2?]>&I_P#H5Q53]EO0M'\5:0J2VEM+=6\DB3&2&%Y#N=I(VR0S%=K;5+8Y
M1@.%S7K5QX&T;0"ER;.UB*S0JCK;QAA(\BQQ8*ID'S&4 ]CR2 ,UYA^VM_R!
MX/\ K_C_ /1,]>J_"?\ Y ^G_P#7A:?^B4KY_P#^:A_Y_P"@=7T!\6/^0/J'
M_7A=_P#HEZ\O_8PM'@T:1G4J'O960D$!E\N%-PSU&Y67(XR".H-<?^PQ_P Q
M'_MT_P#;BK?QNU"SL/%^G/J2(]J;1$D$BHT8WO<QJS"0A=JLP9B?N@$C) %>
MZ_\ "I]'_P"@?9_^ T/_ ,16)XQLK+3M'U6VL(XXA%;72RI%&(E$AM1)R%50
M28W0Y&>,#.00.%_8I_Y \_\ U_R?^B8*[#5_BZ^J:G_8>BK'+<(I:YGD),%N
MJN@<;%*M,_.TJK*%<J&;B0)X5^U_H,NE)IWVFYDNIF6Y#R.$1?E$'W(XE5$&
MXL<X9R"%9V")M]%_;6_Y \'_ %_Q_P#HF>O5?A/_ ,@?3_\ KPM/_1*5\_\
M_-0_\_\ 0.J+6;D:+\0$FN<HDC1K&Q5L,9+,0)C Y!E^3(X!!R1@X^KZ^6_V
M&K1U34)2I",ULJM@[2RB8LH/0D!E)'4!AGJ*A_YJ'_G_ *!U=7^VM_R!X/\
MK_C_ /1,]>J_"?\ Y ^G_P#7A:?^B4J7XFVCWFE7T42EW>RN555!9F8Q. H
MY))X ')->-?L2ZI'+IMS;!OWJ7?F,N#PLD:*ASC!R8G& <C'(&1FW^VM_P @
M>#_K_C_]$SUV%W:/9^$FBE4HZ:&596!5E86F"I!Y!!X(/(-<?^Q3_P @>?\
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M:B"-=@ ;EO,R VQU!*%3ZKK<%SI]L(M*B@WJH2-96:*%%"D*0(HW)"D*-@V
MKG#K@5XU\ _@SK'PNFE\PV<T%QY0DVRS+(NPMAES!M;Y7;Y3MW';\Z@')\?/
M@SK'Q1FB\LV<,%OYHCW2S-(V\KEFQ!M7Y47Y1NVG=\[ C'=>+_AO+\2=,-CK
M CBG#*R26[O(BR*F!+B1(S@EF!C.[Y3Q)NPR^(>&?!?CKPUBQM9,6ZR!5D>2
MVFC51A R^;OE6(* 0@4$#I'N)%>]?"_P+<^"K!HYIC=WLC-+*\LC;6E,:(J!
MRKN$"QJNXAFP"VT#"#R__A3.O?V__P )'FQW^9GR?-N-NSRO(V[O(SN\O^+&
M-_S;,?)70?';X -\38XKJ-DAU".-$.7=H&7)9D+; WRLS%'" MR&7D%.*\,^
M%_'6IXL[JY^RV_EA&E<VTDFWA#M:(/*9=I+!BRDD9,BL0:]5\=?#61-"_L?1
M_DD3[*L+[A&5*3Q.TS,@7#?*9&91N+9*@L0#4_X2KQ/;_P"C-IMM)+T^U)=!
M+4%NCF)QY^U,@. =S;6V=16M\#_A;_PK73Q9M)YDKR&65A]P.RJI5. =H"
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MD3=W7[/_ (.U;PA91V6HFV$$<9,:1^8TX:1VD<2.6$?REBN$# ]=^%^?U6O
M/V@?A+J>LZE9ZWI*I/+;^4#"Q5,&*1ID?+.@923M8 JPXQG)*>GOHD_C2RFM
MM7ACA2XA"^2C^>Z$@DN9&14WJQ&T*C!&3>)'W )Y+\/O"_B7X2,]C!;IJ=B<
MM%B>.W,9+GIYO*Y'S/& R!B"KYW[NU\ _#6ZFU.7Q#K&P74D8CM[=&\U+:/:
M,C>P_P!;U5C'A,M(P)$F%]5K*\327B0G^STA><Y \]WCC7@X8^7&[-AL?+\N
M1GYU.,^*_ /X,ZQ\+II?,-G-!<>4)-LLRR+L+89<P;6^5V^4[=QV_.H!SVOQ
MT^#$?Q.M50-Y=U#O,#DG9EL;D<#/RMM&2!N4@$9&Y&\?\+>#O'6B[-.@F2.V
MBW(DKM;21A5SMP2DD^TX 0%<J"H(51@?0OP[\#IX+M%M%<RON=YIF $DLKG<
M\C'J23P-Q9@H52S8S7G_ ,>_@_+XUN=.N[3*O#<HDSQE(YEA9E8RK(Q!S&5)
M10&.YRRC@Y]@M+1+-%BB4(B*%55 554# 4 <  < #@"O'_V@?AGJOQ)B2RM?
MLL=O',)=\DLOFLP0J!M6$J@&]\_,Y;Y3E>0=;3_"FIQ:!/I-TD#3)ITEO"8)
M7(D/DO&@82QQA#C8"=S!B6/R# K/TG6_$_A>&.TGL(=09(T N(KP19  7$@N
M5WM*=I9G&%.X8&0:M?##X,-HL>H/JC)+/J<DAN4B+K JL9/D0G$G(E;))!&0
M!RN]O()?@3XC^&5U))X;E\R";(^]"'"C!42).!&6!)"NF3@,<1A]M>M?"KX=
MZH)UU7Q'<">[6$QP1*(]D"OAI&^1%7SC]PLG&T$;W4@+ZU11111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111117S7^TSX"UCXCS01V-B_E6WG#S'FME\PN4&57SB0N(P06PQW8*+
MMY]_\,ZK/J<(DNK=[67@-&[Q2<X!)5HG<%<D@$[6.,E%R*U:****XKXO?VO]
MA/\ 8&S[7YB?>V;MF?FV>9^[W9QG?QLW8^?;6?\ #?2-6U2*"Y\0^6L\#,8H
MH@ =VQHC-*RNR,Y1G"K'MC4.25+;!%Z+111111111111111111111165XFU6
M?3(3):V[W4O(6-'BCYP2"S2N@"Y !(W,,Y"-@UX!^S-X"UCX<33QWUB_E7/D
MCS$FMF\LH7&67S@2N)"25RPVX"-NX^E******\5ED\7C69%C%M_9K2$([A&B
M2/@A]JO'<-+@8()V%R<83:R^M:#HB:+$(8R2-SLS-@LSR.TDCG "@L[,Q"A5
M!.%55  T*******************************Y_P ?^$O^$OL9[#S7A\Z,
MKYB?>'(.".,J<;77(W(67(SD>5>#+WQ3X(A73IM/AOXH(XXX9HKF*WRJCH?,
MY; P@.Q#\I)+YW5TTVC:OX]"Q:E''8V#K^_MXYFFNY,,P\II45(TA<8+["7*
MC9N&]@OI5I:)9HL42A$10JJH"JJ@8"@#@ #@ < 5+1111111117A7[3GA?4_
M'5O'I^GV3R+'<+*TQEMT0XC90JJTH<_ZPY+!,%> P;(] ^$)N[;3X+2^M7MI
M;>WAB.9(94?8NS<IBD8]%!(95P6P"V":[6BBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBHKN8P(SJI<JI(1=H9B!D*-[*N3T&X@9ZD#FOF7_A"]<_
MX2C_ (2+^S7\CS,>7]HM?,V>1]GW?ZW;NV_/MSC/R;\?/7TU:3&=%=E*%E!*
M-M+*2,E3L9ER.AVDC/0D<U+1111111111111111111111111111117E7[0^E
MW_B73I-+T^T>=IO*)E\R".- L@<C]Y('9OD QM"X;._(*D_9XTN_\-:='I>H
M6CP-#YI$OF021N&D+@?NY"ZM\Y&-I7"YWY(4>JT444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444445ROCKXAP^$6M8Y!OEN[N&WC0,JGYW"O(<\[4!YP#\Q1
M3MW;AH>+_#)\20&V%Q/; LI,ENZQRD#G;O*,5!."=N"<8SM+ _.O[$=V]X^I
MRRL7=VM69F)9F8FX)8D\DD\DGDFOJ2BBBBBBBBBBBBBJNJ637L;1QRO"QQB2
M,1EUP0>!*DB<XP<J>"<8."/E_P#9[FF_X2K4()YYKC[/;W4"//(TLFR.ZC"@
ML?Q/&!DD@#->U_%GX3?\+"^R_P"E36WV:X$O[H_>Z<CD;95Q^[DYV9;Y6W<=
M_117 ?\ "IO^)[_;_P!JF_X]_*^SY^3IMQG/^J_C\O'^M_>;OX:[^BBBBBBB
MBBBBHKN$SHR*Q0LI ==I921@,-ZLN1U&X$9Z@CBOE72O/L_'45G-<SW*0M,R
M&=]Y4RV1D?:%"H@W' "*H "C'%?5]%%%%%%%%%%%<+\:=.EN-,N9H;F>W,%M
M/*/(9$+LB>8@9BC2  ISY;(2"P8D'CS_ /8UNWO-*N996+N^HS,S,2S,QB@)
M8D\DD\DGDFO>J********************************************X#X
M3?";_A7OVK_2IKG[3<&7]Z?N]>3R=TK9_>2<;\+\J[>>_HK*\5^)H?"]K+?7
M)Q%#&SMRH)QT5=Q4%F.%4$C+$#O1X3UW_A(+.WO=NSS[>*79G=MWH'VYP,XS
MC.!GT%:M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?'?QG\.R:?XKTZ-K
MJ>5Y6L6\V3R2Z$W+(-BK$L2@;=P&P@L69@VXU]::)IDFG(4EGDN"6)WRB$,!
M@#:/)BB7'&>03DGG& /E#]C6RN+[[?'!+Y"'[*9)5"M,,>?M5%D1XQDYW,P;
M"C:J$N)(^EMO$U[\*?$T6E374]W8WBPA!/(;B93(6C1LML"D3 [MN08CDAG"
M[?0/B_\ $2[MKVST'26"7EVVYY2H<PPJ26<+)B-R0DAP23A" NYT8<KX\^%^
MK>"+(ZGIVK7LL]K"SRQSR"6*0  2,J2-L0*F]PK"4G"A3N )]%^!_P 4O^%E
M:>+QH_+E20Q2J/N%U56+)R3M(<$ \J<KEL!F\O\ A?//\<C<ZC<:A=6@281Q
MVEG/Y(CC"[E=^"7+$D;RJY*-CY<(GI7PVT'4="O;R"^N9+JW6&T^R22#!"9N
M R,0JJTPP/,?EG&QF(R%7FO#:WOQGC.H-=7-AIYD=;:&W9(IW"'9Y\DPWL,M
MO4PX"C:I!;&YN?\ #OB^\^%FO+H6H73W=G>;7@EF9Y)XRY9(U)P<Y=-A'W.5
ME'EY=3]%5X+^U/XGU;PG:+=6=V(H9)O(\M(0)</$S%C,SN008SM,:QD;OO$J
M#45OX,U[X@:7;3QZD]FOV2W,48!\V5A N99ITEWCS'9C@;@$V,R>;N45/V;/
MC!>W]U/H6M2;KJ'(B9MF\F+Y)8BZM^\88# @,S 2,SD 5T'Q#\97WBG5QX:T
MB;[-MMVDO+E5#R1AD^5%#%/[\9WQL7!=2I7RWSS7Q3\.:M\)(AK&FZC=7,4;
M1K-!=N+A=K/R^6*\%MB811( S$2 9Q[5\-_'">.=/@U&-#&)E;*,02K*S(XR
M.HW*<' )&"0I.!\]? +_ )'#5O\ M_\ _2R.K?[5WC+6?"30K#>[(+GS0(X8
MO(=!$Z,I,N]Y"Q#@,4,:D+]S#$5[_P"/_&,?@RQGU"896&,D+R-S$A8TR%;&
MYR%S@A<Y/ ->=:!\,M1\80)?:OJ-[;W$J[Q!:2?9(H4;YDB*%"S.N[#,WS#A
M"6V;FB^$6KZ]9W5WHVIJ\B0QL;6_EB.QMNQ(PQ0A9=RL)"/,\T$.KN3RG'Z5
MXTU9?&,6DWEX9H8VF.U$%O$1):&8*45F+!20%\QG(QG.2:];^*7C6XTJ2TTS
M3U_TR_D=(Y2%9(4C"M-,59EWLJ-N1.C$'.<!'X3XB_"O4= LI=3M-7O6N[=3
M<2"27_1GV R2A857:@."40[TP/+(VG<-"R_:$:]\-2Z]'&AN8<1R19<1K*71
M >0"5Q(LFT$\'9OW L*G@#X;7'BBQ@U3^V;XW4\8FRDRFU25B6V&#!4JC?(\
M>0IVLN$!VKZ+\)H;V#3T35&+W:S70E<Y&XBYE"LN57Y"N#'@ ;-NT!<"NPKP
M70O%%_\ $'Q#=Z;=>?;V%DKX2%I("[AMD3R2H$DQ(CM(B*RJ0JG#[69L74O%
MEY\+?$T.G+<375G?^1^ZN)'D:'S97B&QW+-\K GG[Z':^6 D'2_&/QM/=ZO9
M>&XIS917*K++<HVR8C=($A1CC86:/;N&2S,HP0&22UJWPRU'PNUO+I^HWL\1
MO;3[5%<2>>[1>>@)C8(&0#),H&%>/.\X3:WLM8OC3Q?!X.M);^[)$42@MM&Y
MB20JJ!ZEB ,D $Y8@9(\:^'/@S5/B9;C5M6U"\MO/R8(+1S:JD6YB"P*G=NS
ME"<L8]I,C[@%\Z\&K=IXZ1-1(:X5I$9U4()%6R98Y=JLP4O&%<J#A2Q&%Q@>
M]>/O%M[>ZA%H&EMY$\EN;F:[*)*(8@Q10L;L [-( AS]U6R 224\_P#BKX.U
M#X7VZZUIVIWDPMI%,T-Y,T\<BNRQ@  *.K8(/.#N5T9!N[76OC?_ ,2:UU.P
MA\VXOI(H+>(G""X?<I5V;R\JKHRDC&\@8*JV]<_7_@=J.HP/(-9O3?E?E99/
ML]H6'W1Y,(^0%0 2K$[LR8;E3-^SW\7IOB3I\@E*+?6^$=MC%&W*?*F91L')
M#!D5ARI(V!E \Z'C37%\6II+W@E$;2[5V&"WQ):F7YHXV+2"/(**[DL5 \Q"
MQ<2_M)Z=J?@!8-5L]2O&W7 219)5";@FZ+;%%%'#MQ&WF!E(8D9!RQKTIO#E
M]\3;-+Q[Z:Q2>WBE@AM6 \LLC$-+*562;(=247RD&-OS$"2N:_9+^*-WXSMK
MBWOG,KVS0[96(W%'5E"'"@D@Q$EV+,Q?D\9.AX;6]^,\9U!KJYL-/,CK;0V[
M)%.X0[//DF&]AEMZF' 4;5(+8W-S_AWQ?>?"S7ET+4+I[NSO-KP2S,\D\9<L
MD:DX.<NFPC[G*RCR\NIZOXY?$VZTN:VT71FQJ5W(A#&/>L<66!D.58=5.3M?
M;&LC$*=A//\ Q!^%E]X2TFYN;;4;R[E%I(EQ%<R"6!XF0K.R*Q!C903(A#NP
MV^7\^XY/V*?^0//_ -?\G_HF"O?Z^8/VKO&6L^$FA6&]V07/F@1PQ>0Z")T9
M29=[R%B' 8H8U(7[F&(KM?C#X,U2YT^YU#^T)H;B"-YHX;=S!;(BJC21LRKY
ML[;4?:[% 6(Q'$I(J7X&_&"77M"FU/4<N]HUQYKJ$#2+&@FR%41HIV.$ Z$K
MDGDX- \)ZA\3($U._OKJS29?,@M;.1(1%&WW=\@#M,60(^6"["S *N=HQ?@[
MX_O/#FKS^%=6G^TNFYK>X8N9&R@F\MB0Q/[MB^6;Y"K(&<%,=+XO\1WOBW5C
MH.FRFVA@A62^N44F4"082WC9D*([(P<.#D<LI!B9'YKX@^"-9^'<::AH=Y?7
MKK(%FM[A_M@:,D'*KA6'S*%;8"^UR0R!6)[#QC\1[L1:=9VD)AO]448W@,+5
M51)+AV5]F]XU8[4(4,5.1P$;E/B+\*]1T"REU.TU>]:[MU-Q())?]&?8#)*%
MA5=J X)1#O3 \LC:=PT++]H1KWPU+KT<:&YAQ')%EQ&LI=$!Y )7$BR;03P=
MF_<"PJ> /AM<>*+&#5/[9OC=3QB;*3*;5)6);88,%2J-\CQY"G:RX0':NL_C
M'4/A_P"&Y;Z_'GWT,DX8ON"LS7CQ(X^53Y6&5D "@Q[0NP$$9/@#X;7'BBQ@
MU3^V;XW4\8FRDRFU25B6V&#!4JC?(\>0IVLN$!VKMP^)M3\%>');R[0W.H0-
M=;]P?:Q^U2+YN JMY*H1(  @\H#&Q<$97P[\(7?C[15O;V\O8;^Z5W$JS2PK
M& VV(K!&T<11D16/RY<.S!QN5EA_91^*]UXWM9K:].^2T\H"8G+NK[]H?U9=
MF"^<L"-PW LW%?&/QWKOAK7+.Q%UYZR26LRP0H+-')E:+R"Q>1RK[3NWNR9;
ME<*,=7JWPW\6P7$E_;ZFA9[=V:%0?+63:2L$44P:+;N5$$S%'P69@3NWQ?LN
M?$/4/B ;B6_O)'-NT?[H0VT<3+(L@!++'YA.5)P-@7 R7#%5]%\0V5[>ZI%!
M;7TT,!MY99XTCM7V8,4<*JSP,R;V,C9<ON\MU0  E>_KG_'_ (QC\&6,^H3#
M*PQDA>1N8D+&F0K8W.0N<$+G)X!KR7PI\/\ 5OB):+JFH:G=6TMQ#O@AM6$,
M,2L7:,L$8^:"K(PR5D"_([DC*U?A'\5=0T?6)/"^L,;AU9E@N,('VI%YB^9@
MG(>(!P26D5CM<MG*6OVI_$^K>$[1;JSNQ%#)-Y'EI"!+AXF8L9F=R"#&=IC6
M,C=]XE0:RK3PGXG\;6%A?VU\+5TA@\N$R2'S$$:G[1-(H?S'D8!O*=&54.&.
M\R!OH^O&OVE?B5J/@V"VBTJ,F6ZF*"4)YI5AM*1JI5E+R9(7.3A6VJ3\RY7Q
MS\(S>"M+&I:=?WL<UHT);?<S3K-EXX_G61RF=QW8"A"-RE""-NJ?'^H^+/#8
MUJTECM)5MKB60>5YY+0,W$9=PJ!O+;.]92 ^ <KN/"_!*^UWXE:;.JW[V^Z[
MG,MRRB:0[HX=L$(\Q?*5=SNQ4)L)C$1_UFW/T#Q]JWP@UQ-)UJ[-Q93-D2R,
M'.R0[(YM\C[XPKIB168JH\PJK$JYT/VKO&6L^$FA6&]V07/F@1PQ>0Z")T92
M9=[R%B' 8H8U(7[F&(KJOB/\./$?BB-[RWU![>0;VAL8OW "DC;&\T<OS2E%
M!);=&)2RHPC.^C]FSXSW'Q!M9[6ZE0ZA#ED=D4!D;[KE$=-VQ^'VA!M,8W;F
M+5PNJ>/?$%KXI72TN!=/&TGEQX%K;?O;;S,R*A9G2+=N 9G<A,*0[9KNK"PU
M;X3-?ZMJU_\ ;;$6Y9$8R*YG+IY8";)%A4LS)\C%0"K,H"@)%X4^'^K?$2T7
M5-0U.ZMI;B'?!#:L(88E8NT98(Q\T%61ADK(%^1W)&5J_"/XJZAH^L2>%]88
MW#JS+!<80/M2+S%\S!.0\0#@DM(K':Y;.4Q/VKO&6L^$FA6&]V07/F@1PQ>0
MZ")T929=[R%B' 8H8U(7[F&(KJOB/\./$?BB-[RWU![>0;VAL8OW "DC;&\T
M<OS2E%!);=&)2RHPC.^C]FSXSW'Q!M9[6ZE0ZA#ED=D4!D;[KE$=-VQ^'VA!
MM,8W;F+5PNJ>/?$%KXI72TN!=/&TGEQX%K;?O;;S,R*A9G2+=N 9G<A,*0[9
MKT7PO\,O$FC75RS:LDL$T9VO+$\SK(<'<D)=8XMI9L!79" H:(C 3G_V2?']
M]XSDU";4)WF8?9-H) 1<B8':B@(F=HSM W$9.3S6AH7BB_\ B#XAN]-NO/M[
M"R5\)"TD!=PVR)Y)4"28D1VD1%95(53A]K,V+J7BR\^%OB:'3EN)KJSO_(_=
M7$CR-#YLKQ#8[EF^5@3S]]#M?+ 2 _;1T-EL8;MIYF7[6B+ 3&(%S#(2P"QA
MV;Y."[MMW.%P&Q7HOPX9O#&B0:C<7$\T,>E12F$K;[558%D(39%&Y(52J[Y"
M"#\Q)^89.@>$]0^)D":G?WUU9I,OF06MG(D(BC;[N^0!VF+($?+!=A9@%7.T
M8OP=\?WGAS5Y_"NK3_:73<UO<,7,C903>6Q(8G]VQ?+-\A5D#."F/?Z*****
M************************************************************
M************************************************************
M************************************************************
M*****************************^5?C[_R.&D_]N'_ *625]55\J_L,?\
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M?,O_ #4/_/\ T#JM_&[4+.P\7Z<^I(CVIM$202*C1C>]S&K,)"%VJS!F)^Z
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M55,9(VFN@^&OPUNK?4[KQ#J>R.ZNHUC6WB;>D486+AW(&Z4>6JDK\F0S D,
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M6:4(A+E@BAF1,GQCX/U?XQ+#9ZE:)IUG%<++*WVA+F>3".H6/RUV+C<0Q?\
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M(1MK>:6M)<KT0*?,*8;'K_PD^(,WCRS^VSVKVF9,(CEFWIL1UE4F./*G<0"
M0<<$]NUHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK
MSKXP3:\P@@\/K&#(S":=]F80&CV, [8((W[L)(<#Y0&QGQ72? 9/B"\LK&0Q
MZM;VRW"W[%662>3YIRT&QHT20780!03$(E8;RS ^]?"2]U>ZL_\ B?1)%=+)
MM&PH=Z!$Q(WENZABV[(&T<<*!BO"OB7I>MZMI=YJ/B=42&'8;:RB,842N! L
MYD0R/M3S2XC+G>^0VQ  W5^!=+UOP^U@^CJDFBW,<4C6\AC+VBS.LTH$A,4D
MN [>6Q+G&0R$A6;TKXMWNKVMG_Q(8DENFDVG>4&Q"CYD7S'12P;;@'<.>5(S
M7@NK> R/$%G97TADU:XMFN&OU*JL<\?S0%8-BQND8M"A# &42LQV%5 ]J^#\
MVO*)X/$"QDQLHAG39F8%I-[$(V  -FW*1G!^8%LXX7QUI>M^(&OWUA4CT6VC
MED6WC,8>[6%VFB!D!EDBR$7S&!0XP%0$LR\I\--+UO2=+L]1\,*CPS;S<V4I
MC*F5 8&G$CF-]K^4',8<;'P%WH2%^BO'M[?65E+)I4237@V>7'(0$;+J'R2\
M?1"Q'S#D#KT/S+X]\&2O/I2^)LW5]J$WD,R.D(MXON)&HBCV.XDN1*S$%<QB
M,90EF]K^&B^(K"]GM=8,=Q9JK-#=JL<;NV8PB;(V&T;=Q(*$A@0)&7;G/\;:
M%K_B_49-/#):Z*8RLDRB)YID>-!)'AS(RMN+JK!4"KECO(4-Y)\(]-U"XT^3
M5?"B""47K1SV;LDR3QJWFQ8DF"LA1)_*8!E\Q5WAEDX;Z:^VWW]F^;Y2?VA]
MDW>3D>7]H\O/EYWXV^9\N=_3^+O7S+\7--U"WT^/5?%:">4WJQP6:,D*01LW
MFRYDA#,Y=(/*4%F\M6WEFDX7UOP3H6O^$-1CT\LEUHHC"QS,(DFA1(W$<>$,
M;,VX(K,5<,N&&PE@NA\2U\17][!:Z.8[>S95::[98Y'1LR!TV2,=PV[2 $!+
M8!D5=V/%/ 7@R5)]57PSFUOM/F\A6=TF%Q%]QXV$L>Q',EL958 +F0QG" ,O
MTUX"O;Z]LHI-5B2&\._S(XR"BX=@F"'DZH%)^8\D].@^=?B7I>MZMI=YJ/B=
M42&'8;:RB,842N! LYD0R/M3S2XC+G>^0VQ  W5^!=+UOP^U@^CJDFBW,<4C
M6\AC+VBS.LTH$A,4DN [>6Q+G&0R$A6;NOC!-KS""#P^L8,C,)IWV9A :/8P
M#M@@C?NPDAP/E ;&?%=)\!D^(+RRL9#'JUO;+<+?L599)Y/FG+0;&C1)!=A
M%!,0B5AO+,#[U\)+W5[JS_XGT2172R;1L*'>@1,2-Y;NH8MNR!M''"@8KM:*
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M****************************************************Y^R\!65E
M?2ZK'%B\FC$<DFYSN4! !M+%!_JUY"@\=>3GH*RO%/A:W\56[V5ZGF02;=Z;
MF7.U@Z\H58?,H/!_2K>DZ7'I$,=M NV**-(T7).%4!5&223@ #))/J:M5S][
MX"LKV^BU62+-Y#&8XY-SC:I#@C:&"'_6-R5)YZ\#'055U;2X]7ADMIUW12QO
M&ZY(RK JPR"",@D9!!]#53PMX6M_"MNEE9)Y<$>[8FYFQN8NW+EF/S,3R?TK
M5KG_ !)X"LO$LUO<W<6^6TD\R!MSKL;*-G"L W**<,"..G)ST%%<_P""O 5E
MX(A:VT^+RHFD,A7<[Y8A5)S(S'HH&,XXZ=:Z"N?\:^ K+QO"MMJ$7FQ+() N
MYTPP#*#F-E/1B,9QSTZ5T%%<_P"&_ 5EX:FN+FTBV2W<GF3MN=M[9=LX9B%Y
M=CA0!STX&.@K*\4^%K?Q5;O97J>9!)MWIN9<[6#KRA5A\R@\']*MZ3I<>D0Q
MVT"[8HHTC1<DX50%49)).  ,DD^IJU7/V7@*RLKZ758XL7DT8CDDW.=R@( -
MI8H/]6O(4'CKR<]!11111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111117S+^T-^TW/X<N3
MINCO'O1?WT^/,9)-W,2AAY>0!AR0_+%?D=#6A\-/V8(-6A74?$3375Y/&K,D
MDDJ[ 0FP,<K*954;6RP5<E-IVAS-\4OA5>^ [*6[\-7<\$,<,GFVC2EXEB(#
M2/#YF3&X(9R<[SN8QNI 1_6OA/\ \@?3_P#KPM/_ $2E=511117QKX0^)4GQ
M:\401WG[S3S)<>5:R*#"%2"?RV:,ET,O.68[CN)"D*% T/!OP(\2:-8ZIIP8
M1Q2P@1()EVRR"5"S)CE \*.C;_+WAT5Q@$IZ+^RM\,M3\"PW2ZDOEK+)$8XO
M,63!4-ODPC,@W949SN.SY@ %)]UHHHHHHHHK@/C9\5X_AO8M<91KE_EMXF)^
M=LC)PO.U =S?=!X3<K.IKJO%FGS:C9W$%J_ESR6\J1/N9=KLA"-N4%AAB#D<
MCJ.:\ _9:^#VK^![RXGU!/)@>W";/-1][[U*MMC9E^50PRV"-^%R"V/I2BBB
MBBBO)?V@?CD/AI BVWER7LK#;&Y8A8^=TK!2#C(VJ"RY))&X(PKR7X2?#*Z^
M-O\ Q-_$5Q-+;I)MAB'[M7*[/,( 4(D1V[&\H!G<,2RLF6]5U3]G:#28VD\.
MS3:?=##+LFE:"5E(*"9'+[E'S 8X&]BRN/E,/[+]W=W5I?-J3%KL:K.LQ8@G
M>L4",OR_+@8V@+\H  7Y0*]EHHHK/U_7X/#T#W=VXCAC7<[MT Z=N22<  9+
M$@ $D"N?^$GCA_'.FPZC(@C,S38122%59I$09/4[5&3@ G) 4' \%_X4=KO_
M  E/]J?\N_V_S?M'G#_4[MWE8W>;_JOW.W;M_ASY?S5W?[5GQ5G\$V45O9L8
MY[MG7S .4C0#S-IR"KDNH4@' W$%6"FO'Q\)]0\9Z+I>IZ5&'O1->//*'2*Y
M=S<,8Y3(Y4N5*'DON!8;01DC5^*'P(\2>(=4BNU82OY-F/M"S+&L4B(BR, =
MCJ!*'E'EIT;*C>2H^NJ****YKXB^/(/ ME+?7)&$4^6A.TR28)2(8#'+$=0#
MM&6/RJ2+?@C6WUZPM;R4 //;02L%R%#/&KD#))QD\9)..YK:HHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHK*\6:[_ ,(_9W%[MW^1;RR[,[=VQ"^W.#C.,9P<>AK\YO!%
ML/$>JVL=YF47%[ LQ9FW.))5#Y;.[)R<G.<G.<U^EU%>-?'GXF#X1:9#;:>
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M7^VCX8@2QAO\.9S=I'DRRLBJT,A8+&SF-,F-"2J@DC))).?:OA/_ ,@?3_\
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M LV8L85+HN39^<<;&!4>9R I  ^4 +Q7N&J?LGZ!>QM'' \+'&)(YI2ZX(/
ME:1.<8.5/!.,'!'%?!WQGJ'A'7Y_#.IW+WBMN,4K%G8,(A,IW.VY5,6=R?.%
MD VG!9F^E*****XK_A4-C_:_]OX?[7Y>W[Y\O.SR_,V]=WE_)C.S'.W?\U=K
M11111111165XK\30^%[66^N3B*&-G;E03CHJ[BH+,<*H)&6('>OG#X<:"_[0
MMW-J^M _8;=C%;VJN1'N(W,"RLKY52C,V%,C%<$(GEU[?JGP4T74XVADL+8*
MV,F.)87X(/#Q!''3G!&1D'@D5POPG\*W/@/7;VRN))+E+RVCN(KJ5F:0K"_E
M>4Y889U$HR0V H0[1O"K[?111117BO[6'AB"]T:>\D#F6'R/+_>RB-29E0MY
M8<1%MLC+N*EL'&>!C5_9<_Y%VS_[>/\ THEKU6BBBBN ^'OQ7C\<7U_;VI1[
M:T^SJDJDMYC.)?,.>!M!0*N,@X+AF5E [^BBBBBBN ^.GAB#6])NVG#GRK2X
MD11+*B;E0NI9$=5DPR*0'# $<#DY\_\ V*?^0//_ -?\G_HF"O>KNT2\1HI5
M#HZE65@&5E(P5(/!!'!!X(KXZ^.7@"QLO%%A9PP)';W/V/S8XP8T;?<-$V A
M&S** =FWG+?>))]U_P"&7/#O_/G_ .1[G_X[6?8_L[6GA;5K'4]*0QI&TR3Q
M;RZ[6@F"R@R.7SO*H5&X$," NUBW3?&SXKQ_#>Q:XRC7+_+;Q,3\[9&3A>=J
M [F^Z#PFY6=372^+_!MKXP@-I?(9(2RL4$DD8)'(SY;*6 /.#D9 .,@$?-_[
M#'_,1_[=/_;BOJJN5^)7PUM?B):_8KW>$$BR*T;;75ER,C(93\K,I# C!) !
M (Z#2=+CTB&.V@7;%%&D:+DG"J JC)))P !DDGU-6J*******^:_'.N_\)IX
MPM=$NUWV-O\ ,86.8Y)?LSSB1E &<95=K%EPK=I'4]U>_LX62ZM;ZO8L;,PL
M&DAA4(DA487&,",$?+* ")%R,*Q9F]:KY;\>>-KWXT:L= T6<1V,:L9YT8XD
M3 25CC:70%_+6-25D)WLQ0AH_9?#/P$T7P_"($LX9<8)>=%GD8X +%I <9QG
M:NU 22%&37G7QH^%A\$VIU70C)&(+F*YFLUDE-F^R0.TGDKW#",G!1%BC) 4
MJ*]%^.GAB#6])NVG#GRK2XD11+*B;E0NI9$=5DPR*0'# $<#DY\__8I_Y \_
M_7_)_P"B8*]_HHHHHHKR7XP_"H?$/4=-CG4FTA6\DG(++D?N D>X X+-U&5)
M17*L& KA?CW\!-&\*Z-<WME;>7/'Y.Q_-G;&Z:-&X>1E/RL1R/UH^ GP$T;Q
M5HUM>WMMYD\GG;W\V=<[9I$7A)%4?*H' _6NZ^#WPJ'P\U'4HX%(M)ELY("2
MS8'[\/'N(&2K=!EB$9"S%B:]:HHHHJ*[MA=(T;9 92I*LR-@C!PR$,I]"I!!
MY!!KY%\+>%K?PKX[2RLD\N"/=L3<S8W6!=N7+,?F8GD_I7U_1117B'[57@FR
MFT>ZOS!']J1K=A,%"RY\V.+EAAF&QB,,2.AQE5(/V5?!-E#H]K?B"/[4[7#&
M8J&ESYLD7#'+*-B@84@=3C+,3[?1111116+XH\$V7BI/+OX(Y@%=5+J"RAP
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MCE-+FN_"_B=='U>]OI+220K ?M=TH82 _9RQ3:S_ #$1MLV*)<DML1@WT?\
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MMRY.XMRJ[:]Z^)NG!-,:&)YDD_=0V[K/,CK+*RV\#O(KAW4/(K/N+Y +%78
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MP8J?EV @N6W-BNP^"-U'XAT.WFWSL9X2)6DFF:4R*/)E97,C.@+H2FQEVYW
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MF>O5?A/_ ,@?3_\ KPM/_1*5U5?*OQ]_Y'#2?^W#_P!+)*]5_:C_ .1=O/\
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M<@8&.2,C.K^V+X.DEM[?6K4[);.0!W7"R!79?+??N#?)* % R09"PVX8GN_
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MK&0*K!6;JT@1L?8E>5?M,>!9/&&C21VZ/)/#(DT:)C+%<JXP1EOW;N0J_,6
M R?E/-?L<>+QJNDM8DC?:3,  &!\N4F1&)/RDE_,'&,!1D=V]ZKE?B7_ *=8
MW%A%\US=6ETD,8ZL?)89)Z*H+*I=BJ!F12P9U!\:_8CUM)K"ZLP#OCN5E8\;
M=LL:HH'.<YA;/ &",$\XT/VUO^0/!_U_Q_\ HF>NUU;2Y-(\*R6TZ[98M%>-
MUR#AEM2K#()!P01D$CT-<5^Q3_R!Y_\ K_D_]$P5RG_-0_\ /_0.J+X,7(TC
MQGJ,-QF-YVOEC5E8%B9UG7MP#$I<$X!&,$Y&?6OVH_\ D7;S_MW_ /2B*C]E
MS_D7;/\ [>/_ $HEKRK]AC_F(_\ ;I_[<4?'W_D<-)_[</\ TLDK6^.6N_\
M"$^*=,U>X7_1?LYB+YZ?-*DK84,QV+.KXV_-]U3G./I2LK0/$D>N^<80^V&X
MDA+,I17:/ D*9^\H?*%NA=& R "?FK]AC_F(_P#;I_[<5]55Y5\8/C.WA*XM
MM*L51]0NY(@GFAQ!&KR>6'<KACE@0 IR,%CT57Y7X_> _P"S= N[B[N)KRZ_
MT8^9*V(U;S8(R8H$VPQ<;L$*9,.ZF1@QSU7[+G_(NV?_ &\?^E$M>5?L,?\
M,1_[=/\ VXH^/O\ R.&D_P#;A_Z625%K-R-%^("37.421HUC8JV&,EF($Q@<
M@R_)D< @Y(P<?0OQ8_Y ^H?]>%W_ .B7KRK]BG_D#S_]?\G_ *)@KW^OE7X^
M_P#(X:3_ -N'_I9)7U57/ZQJ-KX15[A^'N;B,!0?GFG9$ACC0.P7<RQJH&54
M %W*@.U?.O[<_P#S#O\ M[_]MZ^JJ^5?V&/^8C_VZ?\ MQ1\??\ D<-)_P"W
M#_TLDKJ_VUO^0/!_U_Q_^B9ZM>.-+DU/P0D<*[F&F6,A&0/EC$,LAY(Z(A..
MIQ@ G KJ_P!G7QC'XHT6V:,8:WC6VD7DX:)54')5<[DVOQD#=MR2#7:ZCXDC
ML;B"S(=I;CS2NU2RJL:AGD=NBJ"R(">2[J #R1XK\3?V:K'XCM+J.F2^1<M)
M*K_*?(DEB>2.3<N R,95PTB[E.TL$=F+'*^"OCK6?#.L_P#"-ZZ[R[XW,#M^
M\)*[I!()6(9XF4.,MN96"IA-KJ/I2OE#Q3,?#/CV&YN%.RX:$1[=I)$MO]D5
ML;N )<@YP< D \9^KZ^8/V'-+DBAOKDK^Z>2"-6R.6C$C.,9R,"5#DC!SP3@
MXJ?\U#_S_P! ZOJJJNK:7'J\,EM.NZ*6-XW7)&58%6&001D$C((/H:^/_P!F
MS5)/AOKT^C7S;/.S"> J-*AW0OND"MM92PCP/G,B?*<@C[*KY5_;G_YAW_;W
M_P"V]?0'Q8_Y ^H?]>%W_P"B7KRK]BG_ ) \_P#U_P G_HF"N4_YJ'_G_H'5
MU?[:W_('@_Z_X_\ T3/7/_''2Y+WP;ILD:Y6&/3Y)#D#:IMS$#R1GYY%&!D\
MYQ@$CW_P!XQC\9V,&H0C"S1@E>3M8$K(F2JYVN"N< -C(X(K*^(6H?VQ#>:-
M;H[W4FF7#C"XC&\-%$K.Q"AG;=M&>B.6V@#/DO[$>MI-875F =\=RLK'C;ME
MC5% YSG,+9X P1@GG&A^VM_R!X/^O^/_ -$SUZ_\/=+DTC3;.VG7;+%:6\;K
MD'#+&JL,@D'!!&02/0UQ7[4?_(NWG_;O_P"E$5'[+G_(NV?_ &\?^E$M>JU\
MJ_L,?\Q'_MT_]N*]5^,'QG;PE<6VE6*H^H7<D03S0X@C5Y/+#N5PQRP( 4Y&
M"QZ*K\K\?O ?]FZ!=W%W<37EU_HQ\R5L1JWFP1DQ0)MABXW8(4R8=U,C!CGG
M],TN34_A\8X5W,(Y9",@?+'>M+(>2.B(3CJ<8 )P*]5_9U\8Q^*-%MFC&&MX
MUMI%Y.&B55!R57.Y-K\9 W;<D@UVNH^)([&X@LR':6X\TKM4LJK&H9Y';HJ@
MLB GDNZ@ \D?*OBOPW'XF\<RV4Y=8YHV1C&Q1P#IW8C]0<JPRK!E)!Z7X1>+
MY?A#J+>%-3)>*293:7 #XS+C:NULX1FX.S(2;>"6!+K]-445Y5^U'_R+MY_V
M[_\ I1%1^RY_R+MG_P!O'_I1+7E7Q]_Y'#2?^W#_ -+)*]5_:C_Y%V\_[=__
M $HBKPKQ-I<E[X#L9(URL-V\DAR!M4S7,0/)&?GD48&3SG& 2/JKP!XQC\9V
M,&H0C"S1@E>3M8$K(F2JYVN"N< -C(X(JW_PDD9O/[/ <RBW\YF"GRU4OL0,
M_3<Y#[5&21&Y.,#.K117RK^PQ_S$?^W3_P!N*^JJ\U^.GQGC^&-JKA?,NIMX
M@0@[,KC<[D8^5=PR =S$@# W.N5XW\!S/I-]=:M</<W/V"X;RU9DLHV5)741
MPKM#[2PVR3>9)E$<%&  \_\ V;-+DU?PKJ5M NZ662\C1<@99K6)5&20!DD#
M)('J:ZK]C[QC'J^D?80,2V<C!AR<K*[RH_W0!DEUP"3\F3C<!7L&O^)(]#\D
M2!V:>XCAC5%+L6;))..BJBL[L< (K'DX!^9?VB+877BW2XVR RV*DJS(V#=R
M@X9"&4^A4@@\@@U+H6J-^S=JC6%TSRZ5>8DCEPY:(@E22 -C,.!,$&YD\MP
M<1'ZJKY5^ 7_ ".&K?\ ;_\ ^ED='[<__,._[>__ &WJ+]J.8^'?$.F:K,I-
MNBP'*[2S&"X:210"PY"NN,X!)QG@X^KZ^8/V?M+DE\5:S<A?W227<;-D<-)=
M;D&,Y.1$YR!@8Y(R,Z'[9?A=Q!:ZQ;966VFV,Z*0X5OFC<R*05"2+A<\;I>"
M"?F[K2[V'XS1*Y.+5;0JXC=6*W-S;E9$#8'S002E3E61FG.5#PD#Q#]G[6WM
M4NO"=R DTUZJE.3E "-01G4LH'D0&-"GS;Y 5;'SI]B5\J_ +_D<-6_[?_\
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MKL02#M 3!(!PS(#C=FM6OE7]N?\ YAW_ &]_^V]?55?*OP"_Y'#5O^W_ /\
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M\WS+,%'\QM[9"7"8^<!AL*X( ^[D'W"T5U11*0SA1N95**6QR0I9BH)Z LQ
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M);WZ213>6)HWM<;@A)!5A<95@&8 _,OS99&P,'Q%_9_NO&>I1ZK]O2"6#8(
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M62/8IN?DQMPVXR;NHV]*S_ 'P9?0-/;1K^>.]L"K@1M;F)QN8/\ ?$S<!MS
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M5JBBBBBBBBBBBBBBBBBBBBBBBBBJNJ:M#I$;3W,B11+C<\C*B#) &68@#)(
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MG:\;*Z'!(.&4D'!!!QW!%6J***********BN[M+-&EE8(B*69F(554#)8D\
M <DG@"HM+U:'5XUGMI$EB;.UXV5T."0<,I(.""#CN"*M4444455U35H=(C:>
MYD2*)<;GD9409( RS$ 9) &>Y JU156XU:&VDC@DD199=WEH64.^T9?:I.6P
M.3C.!R:M445BVWC>PNI_L<=U UP&93"LL9EW+G>NP-NR,'(QD8.>E;5%%5=/
MU:'4=_D2))Y<C1OL96VNN-R-@G##(RIY'<47&K0VTD<$DB+++N\M"RAWVC+[
M5)RV!R<9P.35JBBBBBBBBBL_6_$-MH*"6\FC@0L%#2NL:EB"0H+D#. 3CK@'
MTK0HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHKYE_;(\$V5A817T,$<=PUZ%>1%",XDCE=]^W&\E
MD!RV2#G!&YL^J_ [P39:+IEE<6T$:3264+22A1YK&1%D?+GYR"_."<#
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M>Y? 7.R->GRKN;!.7.?F9L#%7XE?%>/PE<65C&4>ZO+NWCV$G*1/(%>4@?\
M?*9(RQ)&X(RUW]%%5=4TF'5XV@N8TEB;&Y)%5T."",JP(." 1GN :^/_ /A
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M'))"_!!X>)D<=.<$9&0>"17RK^S9I<>D>*M2MH%VQ11WD:+DG"K=1*HR22<
M 9))]37UI1111117 :7\5X]8UR31;8HZ06CR32 DD2B6-/*'1?E5B7QN^8A?
ME*,#Q_[67@VUO])FU&5"UQ;K$L3>9)M0//&KX0-Y>2#@DKD@#GY5QM?LN?\
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M./YV'S.1D,')WAAD-RP;M?AIJ=U\2]!MY[BXD@FE619);<1QNP5Y(>KI($)
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MQC,B'GHRA2S*5YK]L*&XTRQ2[BN[E5DN! T"NJ0;'A<N"$17?/EC_6.X&Y@
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M")\(3\H)7<0J&O1?VI-#N=.L6U;3[JYMY(I(_.5+F=(V1BL0VQABH8,5/R[
M07+;FQ78?!&ZC\0Z';S;YV,\)$K233-*9%'DRLKF1G0%T)38R[<[@%8FK?P?
MT@P6GVPS3RB[8SQB::6;RX7)>WB'F,VTB)EW\L2^[+NH3'A_P"_Y'#5O^W__
M -+(Z[#Q7XUMO&>K7.E7U['::;9JBR*MTL#W4K@;XV8XS"J[XY8U8,&(+$G
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M3_\ KPM/_1*5\_\ [#'_ #$?^W3_ -N*/C[_ ,CAI/\ VX?^EDE1:S<C1?B
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M@A3)AW4R,&.>J_9<_P"1=L_^WC_THEKRK]AC_F(_]NG_ +<4?'W_ )'#2?\
MMP_]+)*BUFY&B_$!)KG*)(T:QL5;#&2S$"8P.09?DR. 0<D8./H7XL?\@?4/
M^O"[_P#1+UY5^Q3_ ,@>?_K_ )/_ $3!7O\ 17RK_P U#_S_ - ZNK_;6_Y
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MW_[;UM_M<ZD^@W.CZB(S(EM<R.W55+!H)%0M@A2PC;'!. 2 <&O?] U^#Q#
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M /\ 2R.O5?VH_P#D7;S_ +=__2B*C]ES_D7;/_MX_P#2B6O*OC[_ ,CAI/\
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MAI&AAV)M8@[?FY;G+*T?-?MB:3Y6API;QXBANX>$7"1H(I8UX4850651T&2
M.H%>M?#KQY!XZLHKZV(PZCS$!W&.3 +Q'(4Y4GJ0-PPP^5@3H2>)H4O$T_.9
MWMY)\ K\J(\<>6&=PW,_R\8.U^<K@ZM%?*OP"_Y'#5O^W_\ ]+(Z]5_:C_Y%
MV\_[=_\ THBH_9<_Y%VS_P"WC_THEKRKX!?\CAJW_;__ .ED==WX9^)$_P 9
M+NZM=.G-KIMNJJ\R#%Y,9!(HV%U984X+9V^:-JX*ER(_-/C%H,6B^+=)CA!P
M6L69F=Y9&;[6XW,\C,[G: H+$D*JJ,*H T/VY_\ F'?]O?\ [;U]5445\J_
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MCY3-U^63$;,7&YL[CP'^S-?>$]2N+VTO4M('D98TB07$AMVDW^63<+M1@JH
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MVU\'?O<!FSMPVU\!O@MJ'PZ0)<7H:)FD=[:*)#&9& 0,9G7S"-B@[0$^;')
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M(_UAK:\&>$=0\-6*V)NX96BCCC@D:U9=JJ<8=5N1O^3"J08R,98N2:XKX/\
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M\_(0H*A& &268YKS7PE\%=<^&4TJZ'=6TMG+\WE7@E&UL\$"$'+!  7!0/\
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M9P !D\ 9+-N8^=>"_AMXC^']I%9V%U97"!3F.XBE186)+L(WA.^0,[MDR $
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MN#=W+2-$J3-(LH5"79I&+;C@D84?P_15I"8$5&8N54 NVT,Q P6.Q57)ZG:
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M!>0@!FQDA1A0 HZ #)9LL;?Q*\(#QCIUS8$ F6%@FXLJB0?-$Q*\X$@4G@Y
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MXW))/$CC(!&59@1D$$9[$&N@JK<:M#;21P22(LLN[RT+*'?:,OM4G+8')QG
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MRDCH2*^M*S];\/6VO((KR&.= P8+*BR*& (# .",X)&>N"?6OF7]AC_F(_\
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M-@S 8!;,C$MC<V?F)P,?0'QT\*6NNZ3=O<Q)(\-I<21.1\Z,J%P5;[R_,BY
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M&"X4JI*G=\H<!3O96]%U7X/Z3XE%IJ&E1VR/;W<$T<MOY:1.J3)YR,8E*O\
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MPF2 61CAL$.<%9(U(VOB?^SYI_BBQDM[*WMK:YX:*5(ECPRGHQC"DJPRISN
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MVOC[7+N#41)<6&G-$D-O%;7<R&?/[R67R5;)1D>-5D4QNI.T'YR_/_&CPY#
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MF)&%^3! ;:Y'M_BOQC'X?:"(C?/<W$<440SO8%U\V0!58[8XR9') 4  %E+
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MKR2-[!!&&@%K*'<;H]T9.]PK,NTK\X#9'U?=W:6:-+*P1$4LS,0JJH&2Q)X
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M&1I8&9@V%1HYCN)!*DKNV .1]/Z_K\'AZ![N[<1PQKN=VZ =.W)).  ,EB0
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MX0\+#PS +<33W!W,QDN)6FE)/N>  , !0!QG&XL3JW<)G1D5BA92 Z[2RDC
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M&8#+QL>XZ94X ="0& '(8*R^0>&?V);6RF$E]=O<1#!\M(_(W$$'#-YDAVD
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M2W/F=JY7P_\ L[0^&;2YL;*\NEBNH94>.0PRQ;GB:+?M$2,"-P)V.A;:H8D
M"BT^#>I: BV^E:S/#;JH 2>"&\8$#: KN$VH%"@(!@$$C[U=A\/OAK:^!8W2
MVWO)+(9)IY6WSRL23EWP,XR<  #DG&YF8Y7PF^$W_"O?M7^E37/VFX,O[T_=
MZ\GD[I6S^\DXWX7Y5V\]_111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111111111111117A
M7C3]G:^\6ZA'JTVI(EQ#Y7E>79@(GEMO7 >X?/SDL=Y;))'W< >UZ7'-%&HN
M71Y>=S1HT2'DXPK22D<8!RQR<GC.!:HHHHHHHHHHHHHK@/B]\.+KX@VYL8[M
M+>V?89!]G\V1BK;@-YF0!<A3@+NROW]I*T?"'X<77P^MQ8R7:7%LF\QC[/Y4
MBEFW$;Q,X*Y+'!7=EOO[0%KOZ***********************************
M********************************************************XKXO
M?#;_ (6+8FP\][?,B/N4;E.T_==<KO7G(&1APK<[<&+X5?"P>!8%CEN)+N95
M*"64MA(^,11(S.(DPJ[@I^8J"3A45.ZHHJ*[5V1A$0KE3M9E+J&QP2H92P!Z
M@,I(XR.M>'_\,[7W]K_V_P#VDGVOS-W_ !YCR\;/+\O;]HSM\OY,YWXYW;_F
MKW"T5U11*0SA1N95**6QR0I9BH)Z LQ XR>M2T4444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444445RO_  MC1_\ H(6?_@3#_P#%T?\ "V-'_P"@
MA9_^!,/_ ,74MI\3=*O'6**^M7=V"JJW$3,S$X"@!\DD\ #DFNEHHHHHHKFM
M9^)6G:-.EG/<QBXDFCB6$-OEWR8V HFYE!R/F8!>1DC(STM%%%%%%%%%%<_J
MGQ"TW2)&@N;RVBE7&Y))XD<9 (RK,",@@C/8@UMVEVEXBRQ,'1U#*RD,K*1D
M,"."".01P146J:M#I$;3W,B11+C<\C*B#) &68@#)( SW(%<_P#\+8T?_H(6
M?_@3#_\ %UU5%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<5XQ^-&D>#9!!?7
M2)+W0!Y77A3\RQ*Y3(8$;L;AR,X-&D_&K1M76-X+R%C+(D:)NQ,6:01J/*($
MHRQ')4#;\Y.WYJ["[NTLT:65@B(I9F8A550,EB3P !R2> *RO"'C2T\8P"[L
M)1+$69=P!!##JI5@&4]#@@$@AAP03M444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444445\H?MRVB*^GRA0'9
M;E6; W%5,)52>I +,0.@+''4U]"_\*GT?_H'V?\ X#0__$5S7B?X*:9J,UO)
M8PP6]W9W-K<8B5(LQ^<"P=8U^8,L;^62!\ZX#!=^?2KN[2S1I96"(BEF9B%5
M5 R6)/  '))X K/U#Q99Z="EU/<0QP2;=DKR(L;;@67:Q(4Y4$C!Y'(XJWI>
MK0ZO&L]M(DL39VO&RNAP2#AE)!P00<=P1530O%EGX@W?8KB&?9C?Y4B2[<YV
MYV$XS@XSUP?2M"[NTLT:65@B(I9F8A550,EB3P !R2> *S]0\66>G0I=3W$,
M<$FW9*\B+&VX%EVL2%.5!(P>1R.*T+2[2\198F#HZAE92&5E(R&!'!!'((X(
MKY*^,7AZVT'Q;I,5G#' A:Q8K$BQJ6-VX+$( ,X &>N /2OKJN?_ .%A:;YW
MV7[9;>?YGE^5Y\7F;\[=FW=NW;N-N,YXQFN@HHHK%UOQO8:"XBO+J"!RH8++
M+'&Q4D@, [ XR",],@^E:MI=I>(LL3!T=0RLI#*RD9# C@@CD$<$5%JFK0Z1
M&T]S(D42XW/(RH@R0!EF( R2 ,]R!530O%EGX@W?8KB&?9C?Y4B2[<YVYV$X
MS@XSUP?2M6N ^.GA2UUW2;M[F))'AM+B2)R/G1E0N"K?>7YD7(!PP&&!&17S
M_P#LZ_%>3X=2+I6M%XK6YCBFM7<CRHQ*"P;/:*3<,D-MC<'<JDR,OU_7D'PT
MTF&W\1ZXZ1HK#[!@A5!'F0F27! _C<!G_O, 3D\UZ?K?B&VT%!+>31P(6"AI
M76-2Q!(4%R!G )QUP#Z5%H7BRS\0;OL5Q#/LQO\ *D27;G.W.PG&<'&>N#Z5
MH7=VEFC2RL$1%+,S$*JJ!DL2>  .23P!6?J'BRSTZ%+J>XAC@DV[)7D18VW
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M(;;04$MY-' A8*&E=8U+$$A07(&< G'7 /I1HGB&VUY#+9S1SH&*EHG610P
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MG<ZLS$C"_)@@-M<CV_Q7XQC\/M!$1OGN;B.**(9WL"Z^;( JL=L<9,CD@*
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M2(SP-'(%.0K*8/J-RX< L%89-'C7]GBV\8WBZA=7=X)TP(C&\$?EA7:1%4K
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M111111111165XLT+_A(+.XLMVSS[>6+?C=MWH4W8R,XSG&1GU%>?_P#"B?\
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M8H_X8IT?_GO>?]_(?_C%'_#%.C_\][S_ +^0_P#QBC_ABG1_^>]Y_P!_(?\
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M_/>\_P"_D/\ \8H_X8IT?_GO>?\ ?R'_ .,4?\,4Z/\ \][S_OY#_P#&*/\
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MZ/\ \][S_OY#_P#&*/\ ABG1_P#GO>?]_(?_ (Q1_P ,4Z/_ ,][S_OY#_\
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M0_\ QBC_ (8IT?\ Y[WG_?R'_P",4?\ #%.C_P#/>\_[^0__ !BC_ABG1_\
MGO>?]_(?_C%'_#%.C_\ />\_[^0__&*/^&*='_Y[WG_?R'_XQ1_PQ3H__/>\
M_P"_D/\ \8H_X8IT?_GO>?\ ?R'_ .,4?\,4Z/\ \][S_OY#_P#&*/\ ABG1
M_P#GO>?]_(?_ (Q1_P ,4Z/_ ,][S_OY#_\ &*/^&*='_P">]Y_W\A_^,4?\
M,4Z/_P ][S_OY#_\8H_X8IT?_GO>?]_(?_C%'_#%.C_\][S_ +^0_P#QBC_A
MBG1_^>]Y_P!_(?\ XQ1_PQ3H_P#SWO/^_D/_ ,8H_P"&*='_ .>]Y_W\A_\
MC%'_  Q3H_\ SWO/^_D/_P 8H_X8IT?_ )[WG_?R'_XQ1_PQ3H__ #WO/^_D
M/_QBC_ABG1_^>]Y_W\A_^,4?\,4Z/_SWO/\ OY#_ /&*/^&*='_Y[WG_ '\A
M_P#C%'_#%.C_ //>\_[^0_\ QBC_ (8IT?\ Y[WG_?R'_P",4?\ #%.C_P#/
M>\_[^0__ !BC_ABG1_\ GO>?]_(?_C%'_#%.C_\ />\_[^0__&*/^&*='_Y[
MWG_?R'_XQ1_PQ3H__/>\_P"_D/\ \8H_X8IT?_GO>?\ ?R'_ .,4?\,4Z/\
M\][S_OY#_P#&*/\ ABG1_P#GO>?]_(?_ (Q1_P ,4Z/_ ,][S_OY#_\ &*[#
MX7_L]6'PWN6O+.2=W>%HB)6C9=I9')&R-#G*#OC&>*]/HHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKR7QQ^T;;^!G2/4;*]A,BED.VV=6 .#
MADN67(XR,Y () ##,O\ POW_ *A.K_\ @'_]LJWX%_:)T;QDR10S^5._2&8>
M4^=X15!YC9F)!54=F(/3(('I5%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?*O[<_\ S#O^WO\ ]MZ^
MJJ\%_:O^%L&L:=)J<,0%W RN[I'F22/Y8W#E2,A5P^Y@VQ8R!M4L:U?V7/BB
M_C;3C#<N7NK5@DC,26=&R8G)V@9P&0\LQ*;V.7KIH/C-;ZGYS:;;W-]%;Y$D
MMND9CW#=F-#++$96  .(@X(9,$[@*O\ PS^*ME\1H#<6+'*-MDC<!94/.W<
M6&& RI!(/(SN5@/%?C'\;FO-5T_3(HIXK=;VSGE=XIXY9@)1M5(2JR,@(/!0
MEY%&Q1L!?Z%T_P 3P7L+W.7CBCW;VGBEMMH4!F8B=(SM .=V-O!YX./-=4_:
M=L;*-KJ.UOIK,8Q=1VQ%LV2%X>5H^CG8<@?,"!GC/I^@:_!XA@2[M'$D,B[D
M=>A'3OR"#D$'!4@@@$$5S7A?XO6/B74+G2;<O]HM<[\H0C;6"2;3_L.0IW!<
MDY3<N37:T444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444445\J_MS_\ ,._[>_\ VWKZJKC_ (Q7:6NC7[2,%!LKA06(
M W-&R(O/<L0H'4D@#DU\]_L=^&?[;L]6@F#K!<1Q0%U&.J3B0*Q!7<JR ]\;
ME)&",^M?#O2-/^"=LNE2W1FN)IGEV+&[S,67&5@A$L@0)#RQW#<&.X9"CRK]
MG>8S^+=4=E*%EOB4;:64F[B)4[&9<CH=I(ST)'-2_'W_ )'#2?\ MP_]+)*[
M7]J'5FG;3-(";TO+^/S%,KQ(ZH\:^2Y16;:S2@EADH4#!6.,>BW<^JWB-%+9
M63HZE65KR5E92,%2#88((X(/!%<A^SG\*=0^&T-Q;7TL+Q22))$L19MK8*RD
MEHT/($8 R1\IX&3GU6WTF&VDDGCC199=OF.%4.^T83<P&6P.!G.!P*M44444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M445\H?MRW:,^GQ!@75;EF7(W!6,(5B.H!*L >A*G'0U]"_\ "V-'_P"@A9_^
M!,/_ ,77@OQ3^)5S\:7&A>'8S):LT?VBY9&6/KO4$LN8T4IDD@/(R[4! Q)Z
M+K.@2?!GPU-'I/[RX@CW&0Q@LS.ZB68JO]Q"2N[<%1%#EE4YJ?LNM:V^B?V@
MS)Y\LD\E[.SY<LLCG,KL21B,AL$@ ,7QERQ\O_9WU^"Z\3ZI?*X%NT-]*)&^
M1?+-U$X<[\;1MY.[&!UQ5O\ :(NTL_%NERRL$1%L69F(5547<I+$G@ #DD\
M5U?[7?AF?5((+ZQ<F;3V:21(S^]CCDP5N.&#J%>#@@'^)L@1L:O^!?VN-*U.
MU1]3D^S70XD01S2(2,?.A1'PI[!CN4Y!W !V[OX9^.W\=/<7L((T\,D5L64J
MTC1E_.G * A&+*BC<QS&V0C%EK:T?Q_8ZS=36%O.CW-OCS8P3E>QP<8;!^5]
MI.QB%?#$"N@HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHKE?^%3Z/\ ] ^S_P# :'_XBC_A4^C_ /0/L_\ P&A_
M^(KI;2T2S18HE"(BA550%55 P% '  '  X HN[1+Q&BE4.CJ596 964C!4@\
M$$<$'@BN%\,_ /1/#4PN;6S02KC:SM)-M((8,HE=PK @$, &'8\FK\/PATF&
M];4Q:Q_:G;<7(+#?E6\P(245]R@[U4-G)SEFS;\<?#?3_'*)'J, F$;%D.71
ME)&#AD96P>,C."0"02HQH>&?"EKX7A%M8Q)#$,?*@QD@!=S'JS$* 68ECCDF
MN/N?V>-!N9_M3648<,K84ND65QC]TK"+''(VX;G<#DY] M+1+-%BB4(B*%55
M 554# 4 <  < #@"L31_ %CHUU-?V\")<W&/-D .6[G SA<GYGV@;V 9\L :
MZ"BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO@#]J/_
M )&*\_[=_P#TGBKRJBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBOU4HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
*HHHHHHHHHHK_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>gctk-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaGFObP9z5Z8qekhvWB+bWnaXy0nRb02mymhlrVWYYoN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:GCTK="http://glucotrack.com/20241231" elementFormDefault="qualified" targetNamespace="http://glucotrack.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://glucotrack.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss" id="StatementsOfOperationsAndComprehensiveLoss">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity" id="StatementsOfChangesInStockholdersDeficitEquity">
          <link:definition>00000005 - Statement - Consolidated Statements of Changes in Stockholders' (Deficit) Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/General" id="General">
          <link:definition>999014 - Disclosure - GENERAL</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/LoansFromStockholders" id="LoansFromStockholders">
          <link:definition>999016 - Disclosure - LOANS FROM STOCKHOLDERS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SignificantTransactions" id="SignificantTransactions">
          <link:definition>999017 - Disclosure - SIGNIFICANT TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilities" id="CommitmentsAndContingentLiabilities">
          <link:definition>999018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/LeaseAgreement" id="LeaseAgreement">
          <link:definition>999019 - Disclosure - LEASE AGREEMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNet" id="FinanceIncomeExpensesNet">
          <link:definition>999020 - Disclosure - FINANCE (INCOME) EXPENSES, NET</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection" id="CommonStockAndWarrantsWith-downRoundProtection">
          <link:definition>999021 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpenses" id="ResearchAndDevelopmentExpenses">
          <link:definition>999022 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpenses" id="GeneralAndAdministrativeExpenses">
          <link:definition>999023 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/IncomeTax" id="IncomeTax">
          <link:definition>999024 - Disclosure - INCOME TAX</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/RelatedParties" id="RelatedParties">
          <link:definition>999025 - Disclosure - RELATED PARTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SegmentReporting" id="SegmentReporting">
          <link:definition>999026 - Disclosure - SEGMENT REPORTING</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>999027 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SignificantTransactionsTables" id="SignificantTransactionsTables">
          <link:definition>999030 - Disclosure - SIGNIFICANT TRANSACTIONS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/LeaseAgreementTables" id="LeaseAgreementTables">
          <link:definition>999031 - Disclosure - LEASE AGREEMENT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNetTables" id="FinanceIncomeExpensesNetTables">
          <link:definition>999032 - Disclosure - FINANCE (INCOME) EXPENSES, NET (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables" id="CommonStockAndWarrantsWith-downRoundProtectionTables">
          <link:definition>999033 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables" id="ResearchAndDevelopmentExpensesTables">
          <link:definition>999034 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables" id="GeneralAndAdministrativeExpensesTables">
          <link:definition>999035 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/IncomeTaxTables" id="IncomeTaxTables">
          <link:definition>999036 - Disclosure - INCOME TAX (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/GeneralDetailsNarrative" id="GeneralDetailsNarrative">
          <link:definition>999037 - Disclosure - GENERAL (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails" id="ScheduleOfOfficialExchangeRateDetails">
          <link:definition>999038 - Disclosure - SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" id="ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails">
          <link:definition>999039 - Disclosure - SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" id="ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails">
          <link:definition>999040 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" id="ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails">
          <link:definition>999041 - Disclosure - SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" id="ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails">
          <link:definition>999042 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
          <link:definition>999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative" id="LoansFromStockholdersDetailsNarrative">
          <link:definition>999045 - Disclosure - LOANS FROM STOCKHOLDERS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" id="ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails">
          <link:definition>999046 - Disclosure - SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails" id="ScheduleOfReconciliationOfFairValueOfWarrantsDetails">
          <link:definition>999047 - Disclosure - SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SignificantTransactionsDetailsNarrative" id="SignificantTransactionsDetailsNarrative">
          <link:definition>999048 - Disclosure - SIGNIFICANT TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" id="CommitmentsAndContingentLiabilitiesDetailsNarrative">
          <link:definition>999049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails" id="ScheduleOfOperatingLeaseDetails">
          <link:definition>999050 - Disclosure - SCHEDULE OF OPERATING LEASE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" id="ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails">
          <link:definition>999051 - Disclosure - SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" id="ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails">
          <link:definition>999052 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/LeaseAgreementDetailsNarrative" id="LeaseAgreementDetailsNarrative">
          <link:definition>999053 - Disclosure - LEASE AGREEMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails" id="ScheduleOfFinanceExpensesDetails">
          <link:definition>999054 - Disclosure - SCHEDULE OF FINANCE EXPENSES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" id="ScheduleOfShareOptionActivityForEmployeesAndMembersDetails">
          <link:definition>999055 - Disclosure - SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails" id="ScheduleOfAssumptionsUsedToValueOptionsDetails">
          <link:definition>999056 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails" id="ScheduleOfWarrantsActivityDetails">
          <link:definition>999057 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" id="ScheduleOfTotalCompensationCostEquityBasedAwardsDetails">
          <link:definition>999058 - Disclosure - SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" id="CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative">
          <link:definition>999059 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" id="ScheduleOfResearchAndDevelopmentExpensesDetails">
          <link:definition>999060 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" id="ScheduleOfGeneralAndAdministrativeExpensesDetails">
          <link:definition>999061 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails" id="ScheduleOfIncomeTaxLossForYearDetails">
          <link:definition>999062 - Disclosure - SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails" id="ScheduleOfDeferredTaxAssetsDetails">
          <link:definition>999063 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/IncomeTaxDetailsNarrative" id="IncomeTaxDetailsNarrative">
          <link:definition>999064 - Disclosure - INCOME TAX (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/RelatedPartiesDetailsNarrative" id="RelatedPartiesDetailsNarrative">
          <link:definition>999065 - Disclosure - RELATED PARTIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://glucotrack.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>999066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
    <element id="GCTK_ReceiptsOnAccountOfSharesMember" name="ReceiptsOnAccountOfSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FurnitureAndOfficeEquipmentMember" name="FurnitureAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_PrefundedWarrantsMember" name="PrefundedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_PerformanceMilestoneMember" name="PerformanceMilestoneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FourSeparateLendersMember" name="FourSeparateLendersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ExchangeAgreementMember" name="ExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_UnsecuredPromissoryNotesMember" name="UnsecuredPromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeriesACommonWarrantMember" name="SeriesACommonWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeriesBCommonWarrantMember" name="SeriesBCommonWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ConvertiblePromissoryNotesMember" name="ConvertiblePromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_WarrantsAgreementMember" name="WarrantsAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FirstWarrantMember" name="FirstWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SecondWarrantMember" name="SecondWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ThirdWarrantMember" name="ThirdWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JuneThirtyNotesMember" name="JuneThirtyNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeriesAWarrantsMember" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeriesBWarrantsMember" name="SeriesBWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JuneTwentySevenNotesMember" name="JuneTwentySevenNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_AugustTwentyThreeWarrantMember" name="AugustTwentyThreeWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_AugustTwentyThreeWarrantOneMember" name="AugustTwentyThreeWarrantOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_AugustTwentyThreeWarrantTwoMember" name="AugustTwentyThreeWarrantTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_AugustTwentyThreeWarrantThreeMember" name="AugustTwentyThreeWarrantThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JulyEighteenNotesMember" name="JulyEighteenNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JulyTwentySevenNotesMember" name="JulyTwentySevenNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeptemberFiveWarrantsMember" name="SeptemberFiveWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeptemberFiveWarrantsOneMember" name="SeptemberFiveWarrantsOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeptemberFiveWarrantsTwoMember" name="SeptemberFiveWarrantsTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeptemberFiveWarrantsThirdMember" name="SeptemberFiveWarrantsThirdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeriesAWarrantMember" name="SeriesAWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeriesBWarrantMember" name="SeriesBWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JuneTwentySevenWarrantsMember" name="JuneTwentySevenWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JulyMember" name="JulyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JulyWarrantsMember" name="JulyWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JulyThirtyMember" name="JulyThirtyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_JulyEighteenMember" name="JulyEighteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_IsraeliInnovationAuthorityMember" name="IsraeliInnovationAuthorityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_IntellectualPropertyPurchaseAgreementMember" name="IntellectualPropertyPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_TrueupSharesMember" name="TrueupSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_LessThanOneYearMember" name="LessThanOneYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_BetweenOneYearToTwoYearsMember" name="BetweenOneYearToTwoYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_MoreThanTwoYearsMember" name="MoreThanTwoYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DrindaBenjaminMember" name="DrindaBenjaminMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_MarkTapsakMember" name="MarkTapsakMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SalariesAndRelatedMember" name="SalariesAndRelatedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ProfessionalFeesMember" name="ProfessionalFeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DepreciationMember" name="DepreciationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_TapsakEnterprisesLLCAgreementMember" name="TapsakEnterprisesLLCAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SalesAgreementMember" name="SalesAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ReceiptsOnAccountOfShares" name="ReceiptsOnAccountOfShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_GainLossOnEquityIssuance" name="GainLossOnEquityIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FinanceExpenseIncomeNet" name="FinanceExpenseIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering" name="StockIssuedDuringPeriodValueUnderwrittenPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" name="StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" name="AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" name="StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" name="StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" name="StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" name="StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" name="StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" name="StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" name="StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" name="StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" name="StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_EquityIssuanceCosts" name="EquityIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" name="IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders" name="LinkageDifferenceOnPrincipalOfLoansFromStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering" name="NetProceedsReceivedFromUnderwrittenPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering" name="ProceedsReceivedFromUnderwrittenPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DeemedDividendUponTriggerOfDownRoundProtection" name="DeemedDividendUponTriggerOfDownRoundProtection" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SettlementOfLiabilitiesWithEquity" name="SettlementOfLiabilitiesWithEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_NonCashDerivativeLiability" name="NonCashDerivativeLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_NoInsiderTradingFlag" name="NoInsiderTradingFlag" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DisclosureSignificantTransactionsAbstract" name="DisclosureSignificantTransactionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SignificantTransactionsTextBlock" name="SignificantTransactionsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DisclosureLeaseAgreementAbstract" name="DisclosureLeaseAgreementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract" name="DisclosureGeneralAndAdministrativeExpensesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_GeneralAndAdministrativeExpensesTextBlock" name="GeneralAndAdministrativeExpensesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FunctionalCurrencyPolicyTextBlock" name="FunctionalCurrencyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock" name="ModificationOfEquityClassifiedContractsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ConvertiblePromissoryNotesPolicyTextBlock" name="ConvertiblePromissoryNotesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" name="AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_RoyaltyBearingGrantsPolicyTextBlock" name="RoyaltyBearingGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock" name="WarrantsWithDownRoundProtectionPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" name="NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock" name="ScheduleOfPropertyRatesOfDepreciationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" name="ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" name="ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" name="ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" name="ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" name="ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances" name="ProceedsFromPublicOfferingsAndDebtIssuances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" name="DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_QuarterlyPaymentsEqualsToSalesPercentage" name="QuarterlyPaymentsEqualsToSalesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition" name="ProceedsFromAllocatedWarrantsAtInitialRecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DiscountAmortizationAndInterestExpenses" name="DiscountAmortizationAndInterestExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_PartialConversionNotesAndAccruedInterest" name="PartialConversionNotesAndAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_LockUpPeriodDescription" name="LockUpPeriodDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_EmbeddedConversionFeaturePercentage" name="EmbeddedConversionFeaturePercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FairValueOfWarrantRelatedDerivatives" name="FairValueOfWarrantRelatedDerivatives" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FairValueOfWarrantRelatedDerivativesValue" name="FairValueOfWarrantRelatedDerivativesValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ClassOfWarrantOrRightReasonForCashRaised" name="ClassOfWarrantOrRightReasonForCashRaised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_RoyaltyPercentage" name="RoyaltyPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_AggregateSalesPriceOfUnitsPercentage" name="AggregateSalesPriceOfUnitsPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_MarketabilityDiscountRate" name="MarketabilityDiscountRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DiscountAmortizationAndInterestExpensesOne" name="DiscountAmortizationAndInterestExpensesOne" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DiscountAmortizationAndInterestExpensesTwo" name="DiscountAmortizationAndInterestExpensesTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_FinanceIncomeNet" name="FinanceIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_WarrantsOriginalExercisePrice" name="WarrantsOriginalExercisePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_PublicOfferingPrice" name="PublicOfferingPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DeferredTaxAssetsTaxVacationAccrual" name="DeferredTaxAssetsTaxVacationAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_DeferredTaxAssetValuationAllowance" name="DeferredTaxAssetValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ComputersMember" name="ComputersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones" name="EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_SeptemberFiveWarrantsThreeMember" name="SeptemberFiveWarrantsThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>18
<FILENAME>gctk-20241231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://glucotrack.com/role/Cover" xlink:href="gctk-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/BalanceSheets" xlink:href="gctk-20241231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/BalanceSheetsParenthetical" xlink:href="gctk-20241231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="gctk-20241231.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity" xlink:href="gctk-20241231.xsd#StatementsOfChangesInStockholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfCashFlows" xlink:href="gctk-20241231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/General" xlink:href="gctk-20241231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LoansFromStockholders" xlink:href="gctk-20241231.xsd#LoansFromStockholders" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactions" xlink:href="gctk-20241231.xsd#SignificantTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilities" xlink:href="gctk-20241231.xsd#CommitmentsAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreement" xlink:href="gctk-20241231.xsd#LeaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNet" xlink:href="gctk-20241231.xsd#FinanceIncomeExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtection" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpenses" xlink:href="gctk-20241231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpenses" xlink:href="gctk-20241231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTax" xlink:href="gctk-20241231.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/RelatedParties" xlink:href="gctk-20241231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SegmentReporting" xlink:href="gctk-20241231.xsd#SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SubsequentEvents" xlink:href="gctk-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactionsTables" xlink:href="gctk-20241231.xsd#SignificantTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreementTables" xlink:href="gctk-20241231.xsd#LeaseAgreementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNetTables" xlink:href="gctk-20241231.xsd#FinanceIncomeExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="gctk-20241231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables" xlink:href="gctk-20241231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTaxTables" xlink:href="gctk-20241231.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralDetailsNarrative" xlink:href="gctk-20241231.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails" xlink:href="gctk-20241231.xsd#ScheduleOfOfficialExchangeRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:href="gctk-20241231.xsd#ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative" xlink:href="gctk-20241231.xsd#LoansFromStockholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactionsDetailsNarrative" xlink:href="gctk-20241231.xsd#SignificantTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:href="gctk-20241231.xsd#CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails" xlink:href="gctk-20241231.xsd#ScheduleOfOperatingLeaseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:href="gctk-20241231.xsd#ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:href="gctk-20241231.xsd#ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreementDetailsNarrative" xlink:href="gctk-20241231.xsd#LeaseAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfFinanceExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:href="gctk-20241231.xsd#ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails" xlink:href="gctk-20241231.xsd#ScheduleOfWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails" xlink:href="gctk-20241231.xsd#ScheduleOfIncomeTaxLossForYearDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTaxDetailsNarrative" xlink:href="gctk-20241231.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/RelatedPartiesDetailsNarrative" xlink:href="gctk-20241231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SubsequentEventsDetailsNarrative" xlink:href="gctk-20241231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaapRestrictedCashNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapRestrictedCashNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ReceiptsOnAccountOfShares" xlink:label="loc_GCTKReceiptsOnAccountOfShares" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_GCTKReceiptsOnAccountOfShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GainLossOnEquityIssuance" xlink:label="loc_GCTKGainLossOnEquityIssuance" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_GCTKGainLossOnEquityIssuance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FinanceExpenseIncomeNet" xlink:label="loc_GCTKFinanceExpenseIncomeNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_GCTKFinanceExpenseIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; (Deficit) Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EquityIssuanceCosts" xlink:label="loc_GCTKEquityIssuanceCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCTKEquityIssuanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:label="loc_GCTKIssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCTKIssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GainLossOnEquityIssuance" xlink:label="loc_GCTKGainLossOnEquityIssuance" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCTKGainLossOnEquityIssuance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_GCTKLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCTKLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering" xlink:label="loc_GCTKNetProceedsReceivedFromUnderwrittenPublicOffering" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_GCTKNetProceedsReceivedFromUnderwrittenPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsReceivedFromUnderwrittenPublicOffering" xlink:label="loc_GCTKProceedsReceivedFromUnderwrittenPublicOffering" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_GCTKProceedsReceivedFromUnderwrittenPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000012 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000013 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/General" xlink:title="999014 - Disclosure - GENERAL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LoansFromStockholders" xlink:title="999016 - Disclosure - LOANS FROM STOCKHOLDERS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactions" xlink:title="999017 - Disclosure - SIGNIFICANT TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommitmentsAndContingentLiabilities" xlink:title="999018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreement" xlink:title="999019 - Disclosure - LEASE AGREEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/FinanceIncomeExpensesNet" xlink:title="999020 - Disclosure - FINANCE (INCOME) EXPENSES, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection" xlink:title="999021 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ResearchAndDevelopmentExpenses" xlink:title="999022 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralAndAdministrativeExpenses" xlink:title="999023 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTax" xlink:title="999024 - Disclosure - INCOME TAX" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/RelatedParties" xlink:title="999025 - Disclosure - RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SegmentReporting" xlink:title="999026 - Disclosure - SEGMENT REPORTING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SubsequentEvents" xlink:title="999027 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactionsTables" xlink:title="999030 - Disclosure - SIGNIFICANT TRANSACTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreementTables" xlink:title="999031 - Disclosure - LEASE AGREEMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/FinanceIncomeExpensesNetTables" xlink:title="999032 - Disclosure - FINANCE (INCOME) EXPENSES, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:title="999033 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="999034 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables" xlink:title="999035 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTaxTables" xlink:title="999036 - Disclosure - INCOME TAX (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralDetailsNarrative" xlink:title="999037 - Disclosure - GENERAL (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails" xlink:title="999038 - Disclosure - SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:title="999039 - Disclosure - SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:title="999040 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:title="999041 - Disclosure - SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:label="loc_GCTKDeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_GCTKDeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:title="999042 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative" xlink:title="999045 - Disclosure - LOANS FROM STOCKHOLDERS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:title="999046 - Disclosure - SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:title="999047 - Disclosure - SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactionsDetailsNarrative" xlink:title="999048 - Disclosure - SIGNIFICANT TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:title="999049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails" xlink:title="999050 - Disclosure - SCHEDULE OF OPERATING LEASE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:title="999051 - Disclosure - SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:title="999052 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreementDetailsNarrative" xlink:title="999053 - Disclosure - LEASE AGREEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails" xlink:title="999054 - Disclosure - SCHEDULE OF FINANCE EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FinanceIncomeNet" xlink:label="loc_GCTKFinanceIncomeNet" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpensesOne" xlink:label="loc_GCTKDiscountAmortizationAndInterestExpensesOne" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GCTKFinanceIncomeNet" xlink:to="loc_GCTKDiscountAmortizationAndInterestExpensesOne" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GCTKFinanceIncomeNet" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpensesTwo" xlink:label="loc_GCTKDiscountAmortizationAndInterestExpensesTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GCTKFinanceIncomeNet" xlink:to="loc_GCTKDiscountAmortizationAndInterestExpensesTwo" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDeposits" xlink:label="loc_us-gaapInterestExpenseDeposits" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GCTKFinanceIncomeNet" xlink:to="loc_us-gaapInterestExpenseDeposits" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GCTKFinanceIncomeNet" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:title="999055 - Disclosure - SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:title="999056 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails" xlink:title="999057 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:title="999058 - Disclosure - SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:title="999059 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:title="999060 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:title="999061 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInvestmentExpense" xlink:label="loc_us-gaapInvestmentIncomeInvestmentExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapInvestmentIncomeInvestmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails" xlink:title="999062 - Disclosure - SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="999063 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeferredTaxAssetsTaxVacationAccrual" xlink:label="loc_GCTKDeferredTaxAssetsTaxVacationAccrual" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_GCTKDeferredTaxAssetsTaxVacationAccrual" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeferredTaxAssetValuationAllowance" xlink:label="loc_GCTKDeferredTaxAssetValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_GCTKDeferredTaxAssetValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTaxDetailsNarrative" xlink:title="999064 - Disclosure - INCOME TAX (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/RelatedPartiesDetailsNarrative" xlink:title="999065 - Disclosure - RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SubsequentEventsDetailsNarrative" xlink:title="999066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>19
<FILENAME>gctk-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://glucotrack.com/role/Cover" xlink:href="gctk-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/BalanceSheets" xlink:href="gctk-20241231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/BalanceSheetsParenthetical" xlink:href="gctk-20241231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="gctk-20241231.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity" xlink:href="gctk-20241231.xsd#StatementsOfChangesInStockholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfCashFlows" xlink:href="gctk-20241231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/General" xlink:href="gctk-20241231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LoansFromStockholders" xlink:href="gctk-20241231.xsd#LoansFromStockholders" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactions" xlink:href="gctk-20241231.xsd#SignificantTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilities" xlink:href="gctk-20241231.xsd#CommitmentsAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreement" xlink:href="gctk-20241231.xsd#LeaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNet" xlink:href="gctk-20241231.xsd#FinanceIncomeExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtection" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpenses" xlink:href="gctk-20241231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpenses" xlink:href="gctk-20241231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTax" xlink:href="gctk-20241231.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/RelatedParties" xlink:href="gctk-20241231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SegmentReporting" xlink:href="gctk-20241231.xsd#SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SubsequentEvents" xlink:href="gctk-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactionsTables" xlink:href="gctk-20241231.xsd#SignificantTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreementTables" xlink:href="gctk-20241231.xsd#LeaseAgreementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNetTables" xlink:href="gctk-20241231.xsd#FinanceIncomeExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="gctk-20241231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables" xlink:href="gctk-20241231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTaxTables" xlink:href="gctk-20241231.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralDetailsNarrative" xlink:href="gctk-20241231.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails" xlink:href="gctk-20241231.xsd#ScheduleOfOfficialExchangeRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:href="gctk-20241231.xsd#ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative" xlink:href="gctk-20241231.xsd#LoansFromStockholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactionsDetailsNarrative" xlink:href="gctk-20241231.xsd#SignificantTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:href="gctk-20241231.xsd#CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails" xlink:href="gctk-20241231.xsd#ScheduleOfOperatingLeaseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:href="gctk-20241231.xsd#ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:href="gctk-20241231.xsd#ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreementDetailsNarrative" xlink:href="gctk-20241231.xsd#LeaseAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfFinanceExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:href="gctk-20241231.xsd#ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails" xlink:href="gctk-20241231.xsd#ScheduleOfWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails" xlink:href="gctk-20241231.xsd#ScheduleOfIncomeTaxLossForYearDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTaxDetailsNarrative" xlink:href="gctk-20241231.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/RelatedPartiesDetailsNarrative" xlink:href="gctk-20241231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SubsequentEventsDetailsNarrative" xlink:href="gctk-20241231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; (Deficit) Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ReceiptsOnAccountOfSharesMember" xlink:label="loc_GCTKReceiptsOnAccountOfSharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKReceiptsOnAccountOfSharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering" xlink:label="loc_GCTKStockIssuedDuringPeriodValueUnderwrittenPublicOffering_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueUnderwrittenPublicOffering_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesUnderwrittenPublicOffering_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesUnderwrittenPublicOffering_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" xlink:label="loc_GCTKAdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKAdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_GCTKStockToBeIssuedDuringPeriodValueRestrictedStockAwardGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockToBeIssuedDuringPeriodValueRestrictedStockAwardGross_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" xlink:label="loc_GCTKStockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" xlink:label="loc_GCTKStockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" xlink:label="loc_GCTKStockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" xlink:label="loc_GCTKStockIssuedDuringPeriodValueSettlementOfFinancialLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueSettlementOfFinancialLiabilities_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_70" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000012 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000013 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/General" xlink:title="999014 - Disclosure - GENERAL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LoansFromStockholders" xlink:title="999016 - Disclosure - LOANS FROM STOCKHOLDERS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactions" xlink:title="999017 - Disclosure - SIGNIFICANT TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommitmentsAndContingentLiabilities" xlink:title="999018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreement" xlink:title="999019 - Disclosure - LEASE AGREEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/FinanceIncomeExpensesNet" xlink:title="999020 - Disclosure - FINANCE (INCOME) EXPENSES, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection" xlink:title="999021 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ResearchAndDevelopmentExpenses" xlink:title="999022 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralAndAdministrativeExpenses" xlink:title="999023 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTax" xlink:title="999024 - Disclosure - INCOME TAX" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/RelatedParties" xlink:title="999025 - Disclosure - RELATED PARTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SegmentReporting" xlink:title="999026 - Disclosure - SEGMENT REPORTING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SubsequentEvents" xlink:title="999027 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactionsTables" xlink:title="999030 - Disclosure - SIGNIFICANT TRANSACTIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenWarrantsMember" xlink:label="loc_GCTKJuneTwentySevenWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneTwentySevenWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" xlink:label="loc_GCTKScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" xlink:label="loc_GCTKScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreementTables" xlink:title="999031 - Disclosure - LEASE AGREEMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/FinanceIncomeExpensesNetTables" xlink:title="999032 - Disclosure - FINANCE (INCOME) EXPENSES, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:title="999033 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="999034 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables" xlink:title="999035 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTaxTables" xlink:title="999036 - Disclosure - INCOME TAX (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralDetailsNarrative" xlink:title="999037 - Disclosure - GENERAL (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsFromPublicOfferingsAndDebtIssuances" xlink:label="loc_GCTKProceedsFromPublicOfferingsAndDebtIssuances_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_GCTKProceedsFromPublicOfferingsAndDebtIssuances_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails" xlink:title="999038 - Disclosure - SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:title="999039 - Disclosure - SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:title="999040 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FurnitureAndOfficeEquipmentMember" xlink:label="loc_GCTKFurnitureAndOfficeEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_GCTKFurnitureAndOfficeEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:title="999041 - Disclosure - SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPrefundedWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PerformanceMilestoneMember" xlink:label="loc_GCTKPerformanceMilestoneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPerformanceMilestoneMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:label="loc_GCTKDeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKDeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:title="999042 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative" xlink:title="999045 - Disclosure - LOANS FROM STOCKHOLDERS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FourSeparateLendersMember" xlink:label="loc_GCTKFourSeparateLendersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_GCTKFourSeparateLendersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL" xlink:label="loc_countryIL_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_QuarterlyPaymentsEqualsToSalesPercentage" xlink:label="loc_GCTKQuarterlyPaymentsEqualsToSalesPercentage_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_GCTKQuarterlyPaymentsEqualsToSalesPercentage_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:title="999046 - Disclosure - SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenWarrantsMember" xlink:label="loc_GCTKJuneTwentySevenWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneTwentySevenWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition" xlink:label="loc_GCTKProceedsFromAllocatedWarrantsAtInitialRecognition_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKProceedsFromAllocatedWarrantsAtInitialRecognition_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpenses" xlink:label="loc_GCTKDiscountAmortizationAndInterestExpenses_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKDiscountAmortizationAndInterestExpenses_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PartialConversionNotesAndAccruedInterest" xlink:label="loc_GCTKPartialConversionNotesAndAccruedInterest_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKPartialConversionNotesAndAccruedInterest_40" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:title="999047 - Disclosure - SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantMember" xlink:label="loc_GCTKSeriesAWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesAWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantMember" xlink:label="loc_GCTKSeriesBWarrantMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBWarrantMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyMember" xlink:label="loc_GCTKJulyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyWarrantsMember" xlink:label="loc_GCTKJulyWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyWarrantsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyThirtyMember" xlink:label="loc_GCTKJulyThirtyMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyThirtyMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyEighteenMember" xlink:label="loc_GCTKJulyEighteenMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyEighteenMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent_180" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactionsDetailsNarrative" xlink:title="999048 - Disclosure - SIGNIFICANT TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPrefundedWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesACommonWarrantMember" xlink:label="loc_GCTKSeriesACommonWarrantMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeriesACommonWarrantMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBCommonWarrantMember" xlink:label="loc_GCTKSeriesBCommonWarrantMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeriesBCommonWarrantMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FirstWarrantMember" xlink:label="loc_GCTKFirstWarrantMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKFirstWarrantMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SecondWarrantMember" xlink:label="loc_GCTKSecondWarrantMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSecondWarrantMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ThirdWarrantMember" xlink:label="loc_GCTKThirdWarrantMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKThirdWarrantMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneThirtyNotesMember" xlink:label="loc_GCTKJuneThirtyNotesMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneThirtyNotesMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenNotesMember" xlink:label="loc_GCTKJuneTwentySevenNotesMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneTwentySevenNotesMember_390" xlink:type="arc" order="391" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantOneMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantOneMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantOneMember_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantTwoMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantTwoMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantTwoMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantThreeMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantThreeMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantThreeMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyEighteenNotesMember" xlink:label="loc_GCTKJulyEighteenNotesMember_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJulyEighteenNotesMember_500" xlink:type="arc" order="501" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyTwentySevenNotesMember" xlink:label="loc_GCTKJulyTwentySevenNotesMember_510" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJulyTwentySevenNotesMember_510" xlink:type="arc" order="511" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsMember" xlink:label="loc_GCTKSeptemberFiveWarrantsMember_530" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsMember_530" xlink:type="arc" order="531" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsOneMember" xlink:label="loc_GCTKSeptemberFiveWarrantsOneMember_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsOneMember_550" xlink:type="arc" order="551" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsTwoMember" xlink:label="loc_GCTKSeptemberFiveWarrantsTwoMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsTwoMember_560" xlink:type="arc" order="561" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsThirdMember" xlink:label="loc_GCTKSeptemberFiveWarrantsThirdMember_570" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsThirdMember_570" xlink:type="arc" order="571" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ExchangeAgreementMember" xlink:label="loc_GCTKExchangeAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKExchangeAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsAgreementMember" xlink:label="loc_GCTKWarrantsAgreementMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKWarrantsAgreementMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_650" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_650" xlink:type="arc" order="651" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_UnsecuredPromissoryNotesMember" xlink:label="loc_GCTKUnsecuredPromissoryNotesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_GCTKUnsecuredPromissoryNotesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ConvertiblePromissoryNotesMember" xlink:label="loc_GCTKConvertiblePromissoryNotesMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKConvertiblePromissoryNotesMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantsMember" xlink:label="loc_GCTKSeriesAWarrantsMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesAWarrantsMember_340" xlink:type="arc" order="342" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantsMember" xlink:label="loc_GCTKSeriesBWarrantsMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBWarrantsMember_350" xlink:type="arc" order="352" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesACommonWarrantMember" xlink:label="loc_GCTKSeriesACommonWarrantMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesACommonWarrantMember_620" xlink:type="arc" order="621" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBCommonWarrantMember" xlink:label="loc_GCTKSeriesBCommonWarrantMember_630" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBCommonWarrantMember_630" xlink:type="arc" order="631" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKPrefundedWarrantsMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantMember" xlink:label="loc_GCTKSeriesAWarrantMember_660" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesAWarrantMember_660" xlink:type="arc" order="661" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantMember" xlink:label="loc_GCTKSeriesBWarrantMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBWarrantMember_680" xlink:type="arc" order="681" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_730" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_730" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LockUpPeriodDescription" xlink:label="loc_GCTKLockUpPeriodDescription_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKLockUpPeriodDescription_730" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_730" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_730" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_730" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_730" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_730" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_730" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_730" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtDescription" xlink:label="loc_us-gaapShortTermDebtDescription_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermDebtDescription_730" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_730" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_730" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_730" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_730" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_730" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_730" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_730" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_730" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_730" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense_730" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_730" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_730" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscriptions_730" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_730" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementLoss" xlink:label="loc_us-gaapLitigationSettlementLoss_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLitigationSettlementLoss_730" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_730" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EmbeddedConversionFeaturePercentage" xlink:label="loc_GCTKEmbeddedConversionFeaturePercentage_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKEmbeddedConversionFeaturePercentage_730" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_730" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_730" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:label="loc_us-gaapDerivativeLiabilityFairValueOfCollateral_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilityFairValueOfCollateral_730" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_730" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FairValueOfWarrantRelatedDerivatives" xlink:label="loc_GCTKFairValueOfWarrantRelatedDerivatives_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKFairValueOfWarrantRelatedDerivatives_730" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FairValueOfWarrantRelatedDerivativesValue" xlink:label="loc_GCTKFairValueOfWarrantRelatedDerivativesValue_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKFairValueOfWarrantRelatedDerivativesValue_730" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement_730" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_730" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="loc_us-gaapEquityFairValueDisclosure_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityFairValueDisclosure_730" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_730" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaapDebtInstrumentMeasurementInput_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMeasurementInput_730" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EquityIssuanceCosts" xlink:label="loc_GCTKEquityIssuanceCosts_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKEquityIssuanceCosts_730" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ClassOfWarrantOrRightReasonForCashRaised" xlink:label="loc_GCTKClassOfWarrantOrRightReasonForCashRaised_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKClassOfWarrantOrRightReasonForCashRaised_730" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GainLossOnEquityIssuance" xlink:label="loc_GCTKGainLossOnEquityIssuance_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKGainLossOnEquityIssuance_730" xlink:type="arc" order="41" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:title="999049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingenciesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:label="loc_us-gaapLegalEntityTypeOfCounterpartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="loc_us-gaapLegalEntityTypeOfCounterpartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:label="loc_us-gaapLegalEntityTypeOfCounterpartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="loc_us-gaapLegalEntityTypeOfCounterpartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IsraeliInnovationAuthorityMember" xlink:label="loc_GCTKIsraeliInnovationAuthorityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLegalEntityTypeOfCounterpartyDomain" xlink:to="loc_GCTKIsraeliInnovationAuthorityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IsraeliInnovationAuthorityMember" xlink:label="loc_GCTKIsraeliInnovationAuthorityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_GCTKIsraeliInnovationAuthorityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IntellectualPropertyPurchaseAgreementMember" xlink:label="loc_GCTKIntellectualPropertyPurchaseAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKIntellectualPropertyPurchaseAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_TrueupSharesMember" xlink:label="loc_GCTKTrueupSharesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKTrueupSharesMember_80" xlink:type="arc" order="84" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_RoyaltyPercentage" xlink:label="loc_GCTKRoyaltyPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_GCTKRoyaltyPercentage_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AggregateSalesPriceOfUnitsPercentage" xlink:label="loc_GCTKAggregateSalesPriceOfUnitsPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_GCTKAggregateSalesPriceOfUnitsPercentage_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesRestrictedStock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesRestrictedStock_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapShareBasedCompensation_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarketabilityDiscountRate" xlink:label="loc_GCTKMarketabilityDiscountRate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_GCTKMarketabilityDiscountRate_150" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails" xlink:title="999050 - Disclosure - SCHEDULE OF OPERATING LEASE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:title="999051 - Disclosure - SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaapLesseeLeaseDescriptionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaapLesseeLeaseDescriptionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeLeaseDescriptionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="loc_us-gaapLeaseContractualTermAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapLeaseContractualTermAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaapLeaseContractualTermDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLeaseContractualTermAxis" xlink:to="loc_us-gaapLeaseContractualTermDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaapLeaseContractualTermDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLeaseContractualTermAxis" xlink:to="loc_us-gaapLeaseContractualTermDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LessThanOneYearMember" xlink:label="loc_GCTKLessThanOneYearMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseContractualTermDomain" xlink:to="loc_GCTKLessThanOneYearMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_BetweenOneYearToTwoYearsMember" xlink:label="loc_GCTKBetweenOneYearToTwoYearsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseContractualTermDomain" xlink:to="loc_GCTKBetweenOneYearToTwoYearsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MoreThanTwoYearsMember" xlink:label="loc_GCTKMoreThanTwoYearsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseContractualTermDomain" xlink:to="loc_GCTKMoreThanTwoYearsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:title="999052 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreementDetailsNarrative" xlink:title="999053 - Disclosure - LEASE AGREEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAgreementsMember" xlink:label="loc_us-gaapLeaseAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_us-gaapLeaseAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSecurityDeposit_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails" xlink:title="999054 - Disclosure - SCHEDULE OF FINANCE EXPENSES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:title="999055 - Disclosure - SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:title="999056 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails" xlink:title="999057 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:title="999058 - Disclosure - SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaapLongTermPurchaseCommitmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaapLongTermPurchaseCommitmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementMember" xlink:label="loc_us-gaapResearchAndDevelopmentArrangementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="loc_us-gaapResearchAndDevelopmentArrangementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:title="999059 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPrefundedWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DrindaBenjaminMember" xlink:label="loc_GCTKDrindaBenjaminMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GCTKDrindaBenjaminMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarkTapsakMember" xlink:label="loc_GCTKMarkTapsakMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GCTKMarkTapsakMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability" xlink:label="loc_us-gaapDescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOfficersCompensation_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualMaximumContractualTerm1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualMaximumContractualTerm1_190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsOriginalExercisePrice" xlink:label="loc_GCTKWarrantsOriginalExercisePrice_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GCTKWarrantsOriginalExercisePrice_190" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PublicOfferingPrice" xlink:label="loc_GCTKPublicOfferingPrice_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GCTKPublicOfferingPrice_190" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_190" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:title="999060 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SalariesAndRelatedMember" xlink:label="loc_GCTKSalariesAndRelatedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_GCTKSalariesAndRelatedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProfessionalFeesMember" xlink:label="loc_GCTKProfessionalFeesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_GCTKProfessionalFeesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DepreciationMember" xlink:label="loc_GCTKDepreciationMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_GCTKDepreciationMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenseMember" xlink:label="loc_us-gaapOtherExpenseMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapOtherExpenseMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:title="999061 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLaborAndRelatedExpense_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInvestmentExpense" xlink:label="loc_us-gaapInvestmentIncomeInvestmentExpense_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeInvestmentExpense_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails" xlink:title="999062 - Disclosure - SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="999063 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTaxDetailsNarrative" xlink:title="999064 - Disclosure - INCOME TAX (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/RelatedPartiesDetailsNarrative" xlink:title="999065 - Disclosure - RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarkTapsakMember" xlink:label="loc_GCTKMarkTapsakMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_GCTKMarkTapsakMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_TapsakEnterprisesLLCAgreementMember" xlink:label="loc_GCTKTapsakEnterprisesLLCAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKTapsakEnterprisesLLCAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SubsequentEventsDetailsNarrative" xlink:title="999066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SalesAgreementMember" xlink:label="loc_GCTKSalesAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKSalesAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SecuritiesPurchaseAgreementMember" xlink:label="loc_GCTKSecuritiesPurchaseAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKSecuritiesPurchaseAgreementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantsMember" xlink:label="loc_GCTKSeriesBWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeriesBWarrantsMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_130" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>gctk-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ReceiptsOnAccountOfSharesMember" xlink:label="GCTK_ReceiptsOnAccountOfSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ReceiptsOnAccountOfSharesMember" xlink:to="GCTK_ReceiptsOnAccountOfSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ReceiptsOnAccountOfSharesMember_lbl" xml:lang="en-US">Receipts on Account of Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IsraelTaxAuthorityMember" xlink:to="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FurnitureAndOfficeEquipmentMember" xlink:label="GCTK_FurnitureAndOfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FurnitureAndOfficeEquipmentMember" xlink:to="GCTK_FurnitureAndOfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FurnitureAndOfficeEquipmentMember_lbl" xml:lang="en-US">Furniture and Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="GCTK_PrefundedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PrefundedWarrantsMember" xlink:to="GCTK_PrefundedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_PrefundedWarrantsMember_lbl" xml:lang="en-US">Prefunded Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PerformanceMilestoneMember" xlink:label="GCTK_PerformanceMilestoneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PerformanceMilestoneMember" xlink:to="GCTK_PerformanceMilestoneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_PerformanceMilestoneMember_lbl" xml:lang="en-US">Performance Milestone [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Lender Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FourSeparateLendersMember" xlink:label="GCTK_FourSeparateLendersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FourSeparateLendersMember" xlink:to="GCTK_FourSeparateLendersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FourSeparateLendersMember_lbl" xml:lang="en-US">Four Separate Lenders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL" xlink:label="country_IL" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl" xml:lang="en-US">ISRAEL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ExchangeAgreementMember" xlink:label="GCTK_ExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ExchangeAgreementMember" xlink:to="GCTK_ExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ExchangeAgreementMember_lbl" xml:lang="en-US">Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_UnsecuredPromissoryNotesMember" xlink:label="GCTK_UnsecuredPromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_UnsecuredPromissoryNotesMember" xlink:to="GCTK_UnsecuredPromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_UnsecuredPromissoryNotesMember_lbl" xml:lang="en-US">Unsecured Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesACommonWarrantMember" xlink:label="GCTK_SeriesACommonWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesACommonWarrantMember" xlink:to="GCTK_SeriesACommonWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeriesACommonWarrantMember_lbl" xml:lang="en-US">Series A Common Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBCommonWarrantMember" xlink:label="GCTK_SeriesBCommonWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesBCommonWarrantMember" xlink:to="GCTK_SeriesBCommonWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeriesBCommonWarrantMember_lbl" xml:lang="en-US">Series B Common Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ConvertiblePromissoryNotesMember" xlink:label="GCTK_ConvertiblePromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ConvertiblePromissoryNotesMember" xlink:to="GCTK_ConvertiblePromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ConvertiblePromissoryNotesMember_lbl" xml:lang="en-US">Convertible Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsAgreementMember" xlink:label="GCTK_WarrantsAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_WarrantsAgreementMember" xlink:to="GCTK_WarrantsAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_WarrantsAgreementMember_lbl" xml:lang="en-US">Warrants Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FirstWarrantMember" xlink:label="GCTK_FirstWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FirstWarrantMember" xlink:to="GCTK_FirstWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FirstWarrantMember_lbl" xml:lang="en-US">First Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SecondWarrantMember" xlink:label="GCTK_SecondWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SecondWarrantMember" xlink:to="GCTK_SecondWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SecondWarrantMember_lbl" xml:lang="en-US">Second Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ThirdWarrantMember" xlink:label="GCTK_ThirdWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ThirdWarrantMember" xlink:to="GCTK_ThirdWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ThirdWarrantMember_lbl" xml:lang="en-US">Third Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneThirtyNotesMember" xlink:label="GCTK_JuneThirtyNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JuneThirtyNotesMember" xlink:to="GCTK_JuneThirtyNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JuneThirtyNotesMember_lbl" xml:lang="en-US">June 30 Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantsMember" xlink:label="GCTK_SeriesAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesAWarrantsMember" xlink:to="GCTK_SeriesAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantsMember" xlink:label="GCTK_SeriesBWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesBWarrantsMember" xlink:to="GCTK_SeriesBWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeriesBWarrantsMember_lbl" xml:lang="en-US">Series B Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenNotesMember" xlink:label="GCTK_JuneTwentySevenNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JuneTwentySevenNotesMember" xlink:to="GCTK_JuneTwentySevenNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JuneTwentySevenNotesMember_lbl" xml:lang="en-US">June 27 Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantMember" xlink:label="GCTK_AugustTwentyThreeWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantMember" xlink:to="GCTK_AugustTwentyThreeWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_AugustTwentyThreeWarrantMember_lbl" xml:lang="en-US">August 23 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantOneMember" xlink:label="GCTK_AugustTwentyThreeWarrantOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantOneMember" xlink:to="GCTK_AugustTwentyThreeWarrantOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_AugustTwentyThreeWarrantOneMember_lbl" xml:lang="en-US">August 23 Warrant One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantTwoMember" xlink:label="GCTK_AugustTwentyThreeWarrantTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantTwoMember" xlink:to="GCTK_AugustTwentyThreeWarrantTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_AugustTwentyThreeWarrantTwoMember_lbl" xml:lang="en-US">August Twenty Three Warrant Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantThreeMember" xlink:label="GCTK_AugustTwentyThreeWarrantThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantThreeMember" xlink:to="GCTK_AugustTwentyThreeWarrantThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_AugustTwentyThreeWarrantThreeMember_lbl" xml:lang="en-US">August 23 Warrant Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyEighteenNotesMember" xlink:label="GCTK_JulyEighteenNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyEighteenNotesMember" xlink:to="GCTK_JulyEighteenNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JulyEighteenNotesMember_lbl" xml:lang="en-US">July 18 Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyTwentySevenNotesMember" xlink:label="GCTK_JulyTwentySevenNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyTwentySevenNotesMember" xlink:to="GCTK_JulyTwentySevenNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JulyTwentySevenNotesMember_lbl" xml:lang="en-US">July 27 Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsMember" xlink:label="GCTK_SeptemberFiveWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsMember" xlink:to="GCTK_SeptemberFiveWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeptemberFiveWarrantsMember_lbl" xml:lang="en-US">September Five Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsOneMember" xlink:label="GCTK_SeptemberFiveWarrantsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsOneMember" xlink:to="GCTK_SeptemberFiveWarrantsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeptemberFiveWarrantsOneMember_lbl" xml:lang="en-US">September 5 Warrants One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsTwoMember" xlink:label="GCTK_SeptemberFiveWarrantsTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsTwoMember" xlink:to="GCTK_SeptemberFiveWarrantsTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeptemberFiveWarrantsTwoMember_lbl" xml:lang="en-US">September Five Warrants Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsThirdMember" xlink:label="GCTK_SeptemberFiveWarrantsThirdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsThirdMember" xlink:to="GCTK_SeptemberFiveWarrantsThirdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeptemberFiveWarrantsThirdMember_lbl" xml:lang="en-US">September Five Warrants Third [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantMember" xlink:label="GCTK_SeriesAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesAWarrantMember" xlink:to="GCTK_SeriesAWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeriesAWarrantMember_lbl" xml:lang="en-US">Series A Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantMember" xlink:label="GCTK_SeriesBWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesBWarrantMember" xlink:to="GCTK_SeriesBWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SeriesBWarrantMember_lbl" xml:lang="en-US">Series B Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenWarrantsMember" xlink:label="GCTK_JuneTwentySevenWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JuneTwentySevenWarrantsMember" xlink:to="GCTK_JuneTwentySevenWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JuneTwentySevenWarrantsMember_lbl" xml:lang="en-US">June 27 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyMember" xlink:label="GCTK_JulyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyMember" xlink:to="GCTK_JulyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JulyMember_lbl" xml:lang="en-US">July [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyWarrantsMember" xlink:label="GCTK_JulyWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyWarrantsMember" xlink:to="GCTK_JulyWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JulyWarrantsMember_lbl" xml:lang="en-US">July Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyThirtyMember" xlink:label="GCTK_JulyThirtyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyThirtyMember" xlink:to="GCTK_JulyThirtyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JulyThirtyMember_lbl" xml:lang="en-US">July 30 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyEighteenMember" xlink:label="GCTK_JulyEighteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyEighteenMember" xlink:to="GCTK_JulyEighteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_JulyEighteenMember_lbl" xml:lang="en-US">July 18 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_lbl" xml:lang="en-US">Legal Entity of Counterparty, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IsraeliInnovationAuthorityMember" xlink:label="GCTK_IsraeliInnovationAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_IsraeliInnovationAuthorityMember" xlink:to="GCTK_IsraeliInnovationAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_IsraeliInnovationAuthorityMember_lbl" xml:lang="en-US">Israeli Innovation Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IntellectualPropertyPurchaseAgreementMember" xlink:label="GCTK_IntellectualPropertyPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_IntellectualPropertyPurchaseAgreementMember" xlink:to="GCTK_IntellectualPropertyPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_IntellectualPropertyPurchaseAgreementMember_lbl" xml:lang="en-US">Intellectual Property Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_TrueupSharesMember" xlink:label="GCTK_TrueupSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_TrueupSharesMember" xlink:to="GCTK_TrueupSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_TrueupSharesMember_lbl" xml:lang="en-US">Trueup Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAgreementsMember" xlink:label="us-gaap_LeaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAgreementsMember" xlink:to="us-gaap_LeaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAgreementsMember_lbl" xml:lang="en-US">Lease Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LessThanOneYearMember" xlink:label="GCTK_LessThanOneYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_LessThanOneYearMember" xlink:to="GCTK_LessThanOneYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_LessThanOneYearMember_lbl" xml:lang="en-US">Less Than One Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_BetweenOneYearToTwoYearsMember" xlink:label="GCTK_BetweenOneYearToTwoYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_BetweenOneYearToTwoYearsMember" xlink:to="GCTK_BetweenOneYearToTwoYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_BetweenOneYearToTwoYearsMember_lbl" xml:lang="en-US">Between 1 - 2 Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MoreThanTwoYearsMember" xlink:label="GCTK_MoreThanTwoYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_MoreThanTwoYearsMember" xlink:to="GCTK_MoreThanTwoYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_MoreThanTwoYearsMember_lbl" xml:lang="en-US">More Than 2 Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DrindaBenjaminMember" xlink:label="GCTK_DrindaBenjaminMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DrindaBenjaminMember" xlink:to="GCTK_DrindaBenjaminMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DrindaBenjaminMember_lbl" xml:lang="en-US">Drinda Benjamin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarkTapsakMember" xlink:label="GCTK_MarkTapsakMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_MarkTapsakMember" xlink:to="GCTK_MarkTapsakMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_MarkTapsakMember_lbl" xml:lang="en-US">Mark Tapsak [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementMember" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementMember" xlink:to="us-gaap_ResearchAndDevelopmentArrangementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember_lbl" xml:lang="en-US">Research and Development Arrangement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SalariesAndRelatedMember" xlink:label="GCTK_SalariesAndRelatedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SalariesAndRelatedMember" xlink:to="GCTK_SalariesAndRelatedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SalariesAndRelatedMember_lbl" xml:lang="en-US">Salaries and Related [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProfessionalFeesMember" xlink:label="GCTK_ProfessionalFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProfessionalFeesMember" xlink:to="GCTK_ProfessionalFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ProfessionalFeesMember_lbl" xml:lang="en-US">Professional Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DepreciationMember" xlink:label="GCTK_DepreciationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DepreciationMember" xlink:to="GCTK_DepreciationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DepreciationMember_lbl" xml:lang="en-US">Depreciation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenseMember" xlink:label="us-gaap_OtherExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenseMember" xlink:to="us-gaap_OtherExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenseMember_lbl" xml:lang="en-US">Other Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_TapsakEnterprisesLLCAgreementMember" xlink:label="GCTK_TapsakEnterprisesLLCAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_TapsakEnterprisesLLCAgreementMember" xlink:to="GCTK_TapsakEnterprisesLLCAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_TapsakEnterprisesLLCAgreementMember_lbl" xml:lang="en-US">Tapsak Enterprises LLC Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SalesAgreementMember" xlink:label="GCTK_SalesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SalesAgreementMember" xlink:to="GCTK_SalesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SalesAgreementMember_lbl" xml:lang="en-US">Sales Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SecuritiesPurchaseAgreementMember" xlink:label="GCTK_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SecuritiesPurchaseAgreementMember" xlink:to="GCTK_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingParValuePerShare" xlink:label="dei_EntityListingParValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingParValuePerShare" xlink:to="dei_EntityListingParValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingParValuePerShare_lbl" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorOpinionTextBlock_lbl" xml:lang="en-US">Auditor Opinion [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents (Note 2D)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use asset, net (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xml:lang="en-US">Restricted cash (Note 2D)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability, current (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Convertible promissory notes (Note 4E)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Non-Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Derivative financial liabilities (Note 4F, 4G and Note 4J)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability, non-current (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Loans from stockholders (Note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingent liabilities (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; (Deficit) Equity (Note 8)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock of $0.001 par value (&#8220;Common Stock&#8221;): 100,000,000 shares authorized as of December 31, 2024 and 2023; 802,609 and 208,914 shares issued and outstanding as of December 31, 2024 and 2023, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ReceiptsOnAccountOfShares" xlink:label="GCTK_ReceiptsOnAccountOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ReceiptsOnAccountOfShares" xlink:to="GCTK_ReceiptsOnAccountOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ReceiptsOnAccountOfShares_lbl" xml:lang="en-US">Receipts on account of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; (deficit) equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses (Note 9)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingExpense" xlink:label="us-gaap_MarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingExpense" xlink:to="us-gaap_MarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingExpense_lbl" xml:lang="en-US">Marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses (Note 10)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other (income) expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GainLossOnEquityIssuance" xlink:label="GCTK_GainLossOnEquityIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_GainLossOnEquityIssuance" xlink:to="GCTK_GainLossOnEquityIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="GCTK_GainLossOnEquityIssuance_lbl" xml:lang="en-US">Loss on equity issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement_lbl" xml:lang="en-US">Loss on settlement of liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FinanceExpenseIncomeNet" xlink:label="GCTK_FinanceExpenseIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FinanceExpenseIncomeNet" xlink:to="GCTK_FinanceExpenseIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="GCTK_FinanceExpenseIncomeNet_lbl" xml:lang="en-US">Finance expense (income), net (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Loss for the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive loss:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss for the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of Common Stock outstanding used in computing basic net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of Common Stock outstanding used in computing diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Loss for the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering" xlink:label="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering" xlink:to="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering_lbl" xml:lang="en-US">Net proceeds received from underwritten U.S. public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" xlink:label="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" xlink:to="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering_lbl" xml:lang="en-US">Net proceeds received from underwritten U.S. public offering, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" xlink:label="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" xlink:to="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted_lbl" xml:lang="en-US">Deemed dividend resulted from trigger of down round protection feature of certain warrants granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Issuance of restricted shares as compensation to directors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Issuance of restricted shares as compensation to directors, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Restricted shares to be issued as compensation towards directors</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" xlink:label="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" xlink:to="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone_lbl" xml:lang="en-US">Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B)</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" xlink:label="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" xlink:to="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone_lbl" xml:lang="en-US">Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of Common Stock upon private placement transaction (Note 4C)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of Common Stock upon private placement transaction (Note 4C), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" xlink:label="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" xlink:to="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares_lbl" xml:lang="en-US">Exercise of prefunded warrants into shares</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" xlink:label="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" xlink:to="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares_lbl" xml:lang="en-US">Exercise of prefunded warrants into shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" xlink:label="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" xlink:to="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions_lbl" xml:lang="en-US">Issuance of detachable warrants through private placement transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" xlink:label="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" xlink:to="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions_lbl" xml:lang="en-US">Issuance of detachable warrants through private placement transactions, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Exchange of warrants into shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Exchange of warrants into shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" xlink:label="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" xlink:to="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities_lbl" xml:lang="en-US">Issuance of shares and warrants as settlement of financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" xlink:label="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" xlink:to="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities_lbl" xml:lang="en-US">Issuance of shares and warrants as settlement of financial liabilities, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Issuance of detachable warrants through private placement transactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile loss for the year to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EquityIssuanceCosts" xlink:label="GCTK_EquityIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_EquityIssuanceCosts" xlink:to="GCTK_EquityIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_EquityIssuanceCosts_lbl" xml:lang="en-US">Equity issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:label="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:to="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors_lbl" xml:lang="en-US">Issuance of restricted shares as compensation to directors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Shares issued to CEO for achieving of IP Agreement milestones</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Discount amortization and interest expenses related to promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders_lbl" xml:lang="en-US">Linkage difference on principal of loans from stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Decrease (increase) in other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Increase in accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Increase (decrease) in other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investment activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investment activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Issuance of promissory notes and detachable warrants through private placement Transaction (Note 4E)</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering" xlink:label="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering" xlink:to="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering_lbl" xml:lang="en-US">Net proceeds received from underwritten U.S. public offering (Note 4J)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Issuance of convertible promissory notes - related parties (Note 4G)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Issuance of convertible promissory notes and bifurcated conversion feature through private placement transaction (Note 4F)</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsReceivedFromUnderwrittenPublicOffering" xlink:label="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering" xlink:to="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering_lbl" xml:lang="en-US">Net proceeds received from underwritten U.S. public offering (Note 4C)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash, cash equivalents, and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidAbstract" xlink:label="us-gaap_InterestPaidAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidAbstract" xlink:to="us-gaap_InterestPaidAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidAbstract_lbl" xml:lang="en-US">(a) Net cash (received) paid during the year for:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">(b) Non-cash investment and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeemedDividendUponTriggerOfDownRoundProtection" xlink:label="GCTK_DeemedDividendUponTriggerOfDownRoundProtection" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeemedDividendUponTriggerOfDownRoundProtection" xlink:to="GCTK_DeemedDividendUponTriggerOfDownRoundProtection_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DeemedDividendUponTriggerOfDownRoundProtection_lbl" xml:lang="en-US">Deemed dividend upon trigger of down round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Recognition of right for use asset against a lease liability (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SettlementOfLiabilitiesWithEquity" xlink:label="GCTK_SettlementOfLiabilitiesWithEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SettlementOfLiabilitiesWithEquity" xlink:to="GCTK_SettlementOfLiabilitiesWithEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SettlementOfLiabilitiesWithEquity_lbl" xml:lang="en-US">Settlement of liabilities with equity (Note 4H and 4I)</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NonCashDerivativeLiability" xlink:label="GCTK_NonCashDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NonCashDerivativeLiability" xlink:to="GCTK_NonCashDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_NonCashDerivativeLiability_lbl" xml:lang="en-US">Derivative liability (Note 4G)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Conversion of debt into equity (Note 4F and 4G)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NoInsiderTradingFlag" xlink:label="GCTK_NoInsiderTradingFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NoInsiderTradingFlag" xlink:to="GCTK_NoInsiderTradingFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_NoInsiderTradingFlag_lbl" xml:lang="en-US">No insider trading flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="cyd_MaterialCybersecurityIncidentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentAbstract" xlink:to="cyd_MaterialCybersecurityIncidentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentAbstract_lbl" xml:lang="en-US">Material Cybersecurity Incident [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Nature [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Scope [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Timing [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">LOANS FROM STOCKHOLDERS</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureSignificantTransactionsAbstract" xlink:label="GCTK_DisclosureSignificantTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DisclosureSignificantTransactionsAbstract" xlink:to="GCTK_DisclosureSignificantTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DisclosureSignificantTransactionsAbstract_lbl" xml:lang="en-US">Significant Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SignificantTransactionsTextBlock" xlink:label="GCTK_SignificantTransactionsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SignificantTransactionsTextBlock" xlink:to="GCTK_SignificantTransactionsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SignificantTransactionsTextBlock_lbl" xml:lang="en-US">SIGNIFICANT TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureLeaseAgreementAbstract" xlink:label="GCTK_DisclosureLeaseAgreementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DisclosureLeaseAgreementAbstract" xlink:to="GCTK_DisclosureLeaseAgreementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DisclosureLeaseAgreementAbstract_lbl" xml:lang="en-US">Lease Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASE AGREEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="us-gaap_InvestmentsAllOtherInvestmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract_lbl" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl" xml:lang="en-US">FINANCE (INCOME) EXPENSES, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl" xml:lang="en-US">Research and Development [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xml:lang="en-US">RESEARCH AND DEVELOPMENT EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract_lbl" xml:lang="en-US">General And Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GeneralAndAdministrativeExpensesTextBlock" xlink:label="GCTK_GeneralAndAdministrativeExpensesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_GeneralAndAdministrativeExpensesTextBlock" xlink:to="GCTK_GeneralAndAdministrativeExpensesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_GeneralAndAdministrativeExpensesTextBlock_lbl" xml:lang="en-US">GENERAL AND ADMINISTRATIVE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT REPORTING</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates in the preparation of financial statements</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FunctionalCurrencyPolicyTextBlock" xlink:label="GCTK_FunctionalCurrencyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FunctionalCurrencyPolicyTextBlock" xlink:to="GCTK_FunctionalCurrencyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FunctionalCurrencyPolicyTextBlock_lbl" xml:lang="en-US">Functional currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock" xlink:label="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock" xlink:to="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock_lbl" xml:lang="en-US">Modification of equity-classified contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ConvertiblePromissoryNotesPolicyTextBlock" xlink:label="GCTK_ConvertiblePromissoryNotesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ConvertiblePromissoryNotesPolicyTextBlock" xlink:to="GCTK_ConvertiblePromissoryNotesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ConvertiblePromissoryNotesPolicyTextBlock_lbl" xml:lang="en-US">Convertible Promissory Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:label="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:to="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_lbl" xml:lang="en-US">Allocation of proceeds and related issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_RoyaltyBearingGrantsPolicyTextBlock" xlink:label="GCTK_RoyaltyBearingGrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_RoyaltyBearingGrantsPolicyTextBlock" xlink:to="GCTK_RoyaltyBearingGrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_RoyaltyBearingGrantsPolicyTextBlock_lbl" xml:lang="en-US">Royalty-bearing grants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of credit risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock" xlink:label="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock" xlink:to="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock_lbl" xml:lang="en-US">Warrants with down-round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently adopted accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:to="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently issued accounting pronouncements, not yet adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock" xlink:label="us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock" xlink:to="us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OFFICIAL EXCHANGE RATE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock" xlink:label="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock" xlink:to="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" xlink:label="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" xlink:to="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" xlink:label="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" xlink:to="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OPERATING LEASE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" xlink:label="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" xlink:to="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FINANCE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xml:lang="en-US">SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">SCHEDULE OF WARRANTS ACTIVITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:label="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:to="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:label="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:to="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INCOME TAX LOSS FOR THE YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsFromPublicOfferingsAndDebtIssuances" xlink:label="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances" xlink:to="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances_lbl" xml:lang="en-US">Proceeds from public offerings and debt issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:label="us-gaap_ForeignCurrencyExchangeRateRemeasurement1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:to="us-gaap_ForeignCurrencyExchangeRateRemeasurement1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyExchangeRateRemeasurement1_lbl" xml:lang="en-US">Official exchange rate of NIS 1 to US dollar</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xml:lang="en-US">Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property and equipment rates of depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:label="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:to="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_lbl" xml:lang="en-US">Deemed dividend related to trigger of down round protection feature (see Note 8C3 below)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic net loss per common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted net loss per common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="srt_PlatformOperatorCryptoAssetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetTable" xlink:to="srt_PlatformOperatorCryptoAssetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetTable_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="srt_PlatformOperatorCryptoAssetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetLineItems" xlink:to="srt_PlatformOperatorCryptoAssetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetLineItems_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Balance &#8211; November 14, 2024 &#8211; Warrant issuance date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value adjustments &#8211; Derivative financial liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_3_lbl" xml:lang="en-US">Balance &#8211; December 31, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_4_lbl" xml:lang="en-US">Warrant derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">FDIC insurance limit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Cumulative research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US">Total loan amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Repayment of loan</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_QuarterlyPaymentsEqualsToSalesPercentage" xlink:label="GCTK_QuarterlyPaymentsEqualsToSalesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_QuarterlyPaymentsEqualsToSalesPercentage" xlink:to="GCTK_QuarterlyPaymentsEqualsToSalesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_QuarterlyPaymentsEqualsToSalesPercentage_lbl" xml:lang="en-US">Sales percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xml:lang="en-US">Total proceeds received</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition" xlink:label="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition" xlink:to="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition_lbl" xml:lang="en-US">Total proceeds allocated to June 27 Warrants at initial recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpenses" xlink:label="GCTK_DiscountAmortizationAndInterestExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DiscountAmortizationAndInterestExpenses" xlink:to="GCTK_DiscountAmortizationAndInterestExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DiscountAmortizationAndInterestExpenses_lbl" xml:lang="en-US">Discount amortization and interest expenses related to June 27 Notes (Note 7 below)</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PartialConversionNotesAndAccruedInterest" xlink:label="GCTK_PartialConversionNotesAndAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PartialConversionNotesAndAccruedInterest" xlink:to="GCTK_PartialConversionNotesAndAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_PartialConversionNotesAndAccruedInterest_lbl" xml:lang="en-US">Partial conversion June 27 Notes and accrued Interest (Note 4H and Note 4I below)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xml:lang="en-US">Balance December</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Derivative Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_2_lbl" xml:lang="en-US">Derivative Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_5_lbl" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Pre-funded warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Shares of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LockUpPeriodDescription" xlink:label="GCTK_LockUpPeriodDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_LockUpPeriodDescription" xlink:to="GCTK_LockUpPeriodDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_LockUpPeriodDescription_lbl" xml:lang="en-US">Lock-up period conditions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Gross proceeds from public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt instrument face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to purchase shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtDescription" xlink:label="us-gaap_ShortTermDebtDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtDescription" xlink:to="us-gaap_ShortTermDebtDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtDescription_lbl" xml:lang="en-US">Notes payable description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants and rights outstanding term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Debt discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt instrument interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock issued during period shares issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="us-gaap_CommonStockSharesSubscriptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscriptions" xlink:to="us-gaap_CommonStockSharesSubscriptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesSubscriptions_lbl" xml:lang="en-US">Fair value of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeLiabilities_3_lbl" xml:lang="en-US">Derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementLoss" xlink:label="us-gaap_LitigationSettlementLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementLoss" xlink:to="us-gaap_LitigationSettlementLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LitigationSettlementLoss_lbl" xml:lang="en-US">Settlement of debt loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Expected term years</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EmbeddedConversionFeaturePercentage" xlink:label="GCTK_EmbeddedConversionFeaturePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_EmbeddedConversionFeaturePercentage" xlink:to="GCTK_EmbeddedConversionFeaturePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_EmbeddedConversionFeaturePercentage_lbl" xml:lang="en-US">Embedded conversion feature percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US">Fair value of embedded derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_4_lbl" xml:lang="en-US">Fair value issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:to="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl" xml:lang="en-US">Fair value of the derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xml:lang="en-US">Conversion amount</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FairValueOfWarrantRelatedDerivatives" xlink:label="GCTK_FairValueOfWarrantRelatedDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FairValueOfWarrantRelatedDerivatives" xlink:to="GCTK_FairValueOfWarrantRelatedDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FairValueOfWarrantRelatedDerivatives_lbl" xml:lang="en-US">Fair value of the warrant related derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FairValueOfWarrantRelatedDerivativesValue" xlink:label="GCTK_FairValueOfWarrantRelatedDerivativesValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FairValueOfWarrantRelatedDerivativesValue" xlink:to="GCTK_FairValueOfWarrantRelatedDerivativesValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FairValueOfWarrantRelatedDerivativesValue_lbl" xml:lang="en-US">Fair value of the warrant related derivatives book value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement_2_lbl" xml:lang="en-US">Loss on settlement debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xml:lang="en-US">Warrants exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="us-gaap_EquityFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityFairValueDisclosure" xlink:to="us-gaap_EquityFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityFairValueDisclosure_lbl" xml:lang="en-US">Equity fair value disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xml:lang="en-US">volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ClassOfWarrantOrRightReasonForCashRaised" xlink:label="GCTK_ClassOfWarrantOrRightReasonForCashRaised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ClassOfWarrantOrRightReasonForCashRaised" xlink:to="GCTK_ClassOfWarrantOrRightReasonForCashRaised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ClassOfWarrantOrRightReasonForCashRaised_lbl" xml:lang="en-US">Fair value cash raised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US">Loss Contingencies [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US">Contingent consideration liability</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_RoyaltyPercentage" xlink:label="GCTK_RoyaltyPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_RoyaltyPercentage" xlink:to="GCTK_RoyaltyPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_RoyaltyPercentage_lbl" xml:lang="en-US">Royalty percentage maximum</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Number of common shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AggregateSalesPriceOfUnitsPercentage" xlink:label="GCTK_AggregateSalesPriceOfUnitsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AggregateSalesPriceOfUnitsPercentage" xlink:to="GCTK_AggregateSalesPriceOfUnitsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_AggregateSalesPriceOfUnitsPercentage_lbl" xml:lang="en-US">Commission as a percentage of aggregate sales price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="us-gaap_WeightedAverageNumberOfSharesRestrictedStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock_lbl" xml:lang="en-US">Restricted shares to the seller</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarketabilityDiscountRate" xlink:label="GCTK_MarketabilityDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_MarketabilityDiscountRate" xlink:to="GCTK_MarketabilityDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_MarketabilityDiscountRate_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DisclosureLeaseAgreementAbstract" xlink:to="GCTK_DisclosureLeaseAgreementAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GCTK_DisclosureLeaseAgreementAbstract_2_lbl" xml:lang="en-US">Schedule Of Operating Lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Operating right-of-use asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Current operating lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Non-Current operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DisclosureLeaseAgreementAbstract" xlink:to="GCTK_DisclosureLeaseAgreementAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="GCTK_DisclosureLeaseAgreementAbstract_3_lbl" xml:lang="en-US">Schedule Of Weighted Average Remaining Lease Terms And Discount Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Lease term (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Monthly rental fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lessee term of contract</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpensesOne" xlink:label="GCTK_DiscountAmortizationAndInterestExpensesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DiscountAmortizationAndInterestExpensesOne" xlink:to="GCTK_DiscountAmortizationAndInterestExpensesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DiscountAmortizationAndInterestExpensesOne_lbl" xml:lang="en-US">Discount amortization and interest expenses related to June 27 Notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest expenses related to July 18 Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpensesTwo" xlink:label="GCTK_DiscountAmortizationAndInterestExpensesTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DiscountAmortizationAndInterestExpensesTwo" xlink:to="GCTK_DiscountAmortizationAndInterestExpensesTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DiscountAmortizationAndInterestExpensesTwo_lbl" xml:lang="en-US">Interest expense and debt discount amortization related to July 30 Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDeposits" xlink:label="us-gaap_InterestExpenseDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDeposits" xlink:to="us-gaap_InterestExpenseDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDeposits_lbl" xml:lang="en-US">Interest on bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Exchange rate differentials, bank commissions and miscellaneous</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FinanceIncomeNet" xlink:label="GCTK_FinanceIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FinanceIncomeNet" xlink:to="GCTK_FinanceIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="GCTK_FinanceIncomeNet_lbl" xml:lang="en-US">Finance (income) expenses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number outstanding beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of share options outstanding, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted average remaining contractual life, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value outstanding, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Number of share options outstanding, forfeited or expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, forfeited or expired</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted average remaining contractual life, Forfeited or expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value outstanding, forfeited or expired</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_lbl" xml:lang="en-US">Number of share options outstanding, cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number outstanding ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number exercisable, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price exercisable, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:to="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_lbl" xml:lang="en-US">Weighted average remaining contractual life, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value outstanding exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield (%)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of share warrants outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average exercise price outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of share warrants outstanding, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted average remaining contractual life, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_lbl" xml:lang="en-US">Number of share warrants outstanding, cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_lbl" xml:lang="en-US">Number of share options outstanding, forfeited or expired</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, forfeited or expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number of share warrants outstanding, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted average exercise price outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2_lbl" xml:lang="en-US">Intrinsic value outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Number of share options exercisable, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price exercisable, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_lbl" xml:lang="en-US">Weighted average remaining contractual life, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="us-gaap_LongTermPurchaseCommitmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_LongTermPurchaseCommitmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentTable_lbl" xml:lang="en-US">Long-Term Purchase Commitment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="us-gaap_LongTermPurchaseCommitmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentLineItems_lbl" xml:lang="en-US">Long-Term Purchase Commitment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Total compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Exercises in period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability" xlink:label="us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability" xlink:to="us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability_lbl" xml:lang="en-US">Plan description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Share based options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficersCompensation" xlink:label="us-gaap_OfficersCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="us-gaap_OfficersCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficersCompensation_lbl" xml:lang="en-US">Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Grant date period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Exercise price of options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Stock based compensation income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_lbl" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Maximum Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsOriginalExercisePrice" xlink:label="GCTK_WarrantsOriginalExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_WarrantsOriginalExercisePrice" xlink:to="GCTK_WarrantsOriginalExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_WarrantsOriginalExercisePrice_lbl" xml:lang="en-US">Warrants original exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PublicOfferingPrice" xlink:label="GCTK_PublicOfferingPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PublicOfferingPrice" xlink:to="GCTK_PublicOfferingPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_PublicOfferingPrice_lbl" xml:lang="en-US">Public offering price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_3_lbl" xml:lang="en-US">Total Research and Development Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Salaries and related expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees (including directors&#8217; fees)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInvestmentExpense" xlink:label="us-gaap_InvestmentIncomeInvestmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="us-gaap_InvestmentIncomeInvestmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInvestmentExpense_lbl" xml:lang="en-US">Insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Total general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic" xlink:to="us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic_lbl" xml:lang="en-US">Domestic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlementsForeign" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlementsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxSettlementsForeign" xlink:to="us-gaap_IncomeTaxReconciliationTaxSettlementsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlementsForeign_lbl" xml:lang="en-US">Foreign entity (Integrity Israel)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:to="us-gaap_IncomeTaxReconciliationTaxSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlements_lbl" xml:lang="en-US">&#160;Total loss for the year</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeferredTaxAssetsTaxVacationAccrual" xlink:label="GCTK_DeferredTaxAssetsTaxVacationAccrual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeferredTaxAssetsTaxVacationAccrual" xlink:to="GCTK_DeferredTaxAssetsTaxVacationAccrual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DeferredTaxAssetsTaxVacationAccrual_lbl" xml:lang="en-US">Vacation accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Research and development credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating losses carry forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax asset before deferred tax liabilities and valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeferredTaxAssetValuationAllowance" xlink:label="GCTK_DeferredTaxAssetValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeferredTaxAssetValuationAllowance" xlink:to="GCTK_DeferredTaxAssetValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="GCTK_DeferredTaxAssetValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Offering price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Common stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NoInsiderTradingFlag" xlink:to="GCTK_NoInsiderTradingFlag_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_NoInsiderTradingFlag_doc" xml:lang="en-US">No insider trading flag.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ReceiptsOnAccountOfShares" xlink:to="GCTK_ReceiptsOnAccountOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ReceiptsOnAccountOfShares_doc" xml:lang="en-US">Receipts on account of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FinanceIncomeNet" xlink:to="GCTK_FinanceIncomeNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FinanceIncomeNet_doc" xml:lang="en-US">Finance income net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_GainLossOnEquityIssuance" xlink:to="GCTK_GainLossOnEquityIssuance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_GainLossOnEquityIssuance_doc" xml:lang="en-US">Gain loss on equity issuance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ReceiptsOnAccountOfSharesMember" xlink:to="GCTK_ReceiptsOnAccountOfSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ReceiptsOnAccountOfSharesMember_doc" xml:lang="en-US">Receipts on Account of Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" xlink:to="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted_doc" xml:lang="en-US">Adjustments to additional paid in capital deemed dividend resulted from trigger of down round protection feature of certain warrants granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross_doc" xml:lang="en-US">Stock to be issued during period value restricted stock award gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" xlink:to="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares_doc" xml:lang="en-US">Exercise of prefunded warrants into shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" xlink:to="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares_doc" xml:lang="en-US">Exercise of prefunded warrants into shares ,shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" xlink:to="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions_doc" xml:lang="en-US">Stock issued during period value detachable warrants through private placement transactions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" xlink:to="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions_doc" xml:lang="en-US">Stock issued during period shares detachable warrants through private placement transactions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" xlink:to="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone_doc" xml:lang="en-US">Stock issued during period value restricted stock payment for achievement of milestone.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" xlink:to="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone_doc" xml:lang="en-US">Stock issued during period shares restricted stock payment for achievement of milestone.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" xlink:to="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities_doc" xml:lang="en-US">Stock issued during period value settlement of financial liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" xlink:to="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities_doc" xml:lang="en-US">Stock issued during period shares settlement of financial liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering" xlink:to="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering_doc" xml:lang="en-US">Stock issued during period value underwritten public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" xlink:to="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering_doc" xml:lang="en-US">Stock issued during period shares underwritten public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:to="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors_doc" xml:lang="en-US">Issuance of restricted shares as compensation to the board of directors.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders_doc" xml:lang="en-US">Linkage difference on principal of loans from stockholders .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering" xlink:to="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ProceedsReceivedFromUnderwrittenPublicOffering_doc" xml:lang="en-US">Proceeds received from underwritten public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeemedDividendUponTriggerOfDownRoundProtection" xlink:to="GCTK_DeemedDividendUponTriggerOfDownRoundProtection_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DeemedDividendUponTriggerOfDownRoundProtection_doc" xml:lang="en-US">Deemed dividend upon trigger of down round protection.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering" xlink:to="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering_doc" xml:lang="en-US">Net proceeds received from underwritten public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SettlementOfLiabilitiesWithEquity" xlink:to="GCTK_SettlementOfLiabilitiesWithEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SettlementOfLiabilitiesWithEquity_doc" xml:lang="en-US">Settlement of liabilities with equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NonCashDerivativeLiability" xlink:to="GCTK_NonCashDerivativeLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_NonCashDerivativeLiability_doc" xml:lang="en-US">Non cash derivative liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances" xlink:to="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ProceedsFromPublicOfferingsAndDebtIssuances_doc" xml:lang="en-US">Proceeds from public offerings and debt issuances.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_EquityIssuanceCosts" xlink:to="GCTK_EquityIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_EquityIssuanceCosts_doc" xml:lang="en-US">Equity issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FourSeparateLendersMember" xlink:to="GCTK_FourSeparateLendersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FourSeparateLendersMember_doc" xml:lang="en-US">Four Separate Lenders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_QuarterlyPaymentsEqualsToSalesPercentage" xlink:to="GCTK_QuarterlyPaymentsEqualsToSalesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_QuarterlyPaymentsEqualsToSalesPercentage_doc" xml:lang="en-US">Quarterly payments equals to sales, percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FunctionalCurrencyPolicyTextBlock" xlink:to="GCTK_FunctionalCurrencyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FunctionalCurrencyPolicyTextBlock_doc" xml:lang="en-US">Functional Currency [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SignificantTransactionsTextBlock" xlink:to="GCTK_SignificantTransactionsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SignificantTransactionsTextBlock_doc" xml:lang="en-US">Significant Transactions [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PrefundedWarrantsMember" xlink:to="GCTK_PrefundedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_PrefundedWarrantsMember_doc" xml:lang="en-US">Prefunded Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_LockUpPeriodDescription" xlink:to="GCTK_LockUpPeriodDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_LockUpPeriodDescription_doc" xml:lang="en-US">Lock up period description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ExchangeAgreementMember" xlink:to="GCTK_ExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ExchangeAgreementMember_doc" xml:lang="en-US">Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_IsraeliInnovationAuthorityMember" xlink:to="GCTK_IsraeliInnovationAuthorityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_IsraeliInnovationAuthorityMember_doc" xml:lang="en-US">Israeli Innovation Authority [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_RoyaltyPercentage" xlink:to="GCTK_RoyaltyPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_RoyaltyPercentage_doc" xml:lang="en-US">Royalty percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_UnsecuredPromissoryNotesMember" xlink:to="GCTK_UnsecuredPromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_UnsecuredPromissoryNotesMember_doc" xml:lang="en-US">Unsecured Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_IntellectualPropertyPurchaseAgreementMember" xlink:to="GCTK_IntellectualPropertyPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_IntellectualPropertyPurchaseAgreementMember_doc" xml:lang="en-US">Intellectual Property Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AggregateSalesPriceOfUnitsPercentage" xlink:to="GCTK_AggregateSalesPriceOfUnitsPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_AggregateSalesPriceOfUnitsPercentage_doc" xml:lang="en-US">Aggregate sales price of units percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_TrueupSharesMember" xlink:to="GCTK_TrueupSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_TrueupSharesMember_doc" xml:lang="en-US">Trueup Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JuneTwentySevenWarrantsMember" xlink:to="GCTK_JuneTwentySevenWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JuneTwentySevenWarrantsMember_doc" xml:lang="en-US">June 27 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" xlink:to="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_doc" xml:lang="en-US">Schedule Of Reconciliation Of Carrying Amount Of Notes [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_MarketabilityDiscountRate" xlink:to="GCTK_MarketabilityDiscountRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_MarketabilityDiscountRate_doc" xml:lang="en-US">Marketability discount rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition" xlink:to="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition_doc" xml:lang="en-US">Proceeds from allocated warrants at initial recognition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DiscountAmortizationAndInterestExpenses" xlink:to="GCTK_DiscountAmortizationAndInterestExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DiscountAmortizationAndInterestExpenses_doc" xml:lang="en-US">Discount amortization and interest expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PartialConversionNotesAndAccruedInterest" xlink:to="GCTK_PartialConversionNotesAndAccruedInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_PartialConversionNotesAndAccruedInterest_doc" xml:lang="en-US">Partial conversion notes and accrued interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock" xlink:to="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock_doc" xml:lang="en-US">Schedule Of Property Rates Of Depreciation [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ComputersMember" xlink:label="GCTK_ComputersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ComputersMember" xlink:to="GCTK_ComputersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ComputersMember_doc" xml:lang="en-US">Computers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FurnitureAndOfficeEquipmentMember" xlink:to="GCTK_FurnitureAndOfficeEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FurnitureAndOfficeEquipmentMember_doc" xml:lang="en-US">Furniture and Office Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JuneTwentySevenNotesMember" xlink:to="GCTK_JuneTwentySevenNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JuneTwentySevenNotesMember_doc" xml:lang="en-US">June Twenty Seven Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock" xlink:to="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock_doc" xml:lang="en-US">Modification Of Equity Classified Contracts [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ConvertiblePromissoryNotesPolicyTextBlock" xlink:to="GCTK_ConvertiblePromissoryNotesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ConvertiblePromissoryNotesPolicyTextBlock_doc" xml:lang="en-US">Convertible Promissory Notes [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:to="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_doc" xml:lang="en-US">Allocation Of Proceeds And Related Issuance Costs [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_RoyaltyBearingGrantsPolicyTextBlock" xlink:to="GCTK_RoyaltyBearingGrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_RoyaltyBearingGrantsPolicyTextBlock_doc" xml:lang="en-US">Royalty Bearing Grants [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" xlink:to="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_doc" xml:lang="en-US">Schedule Of Weighted Average Remaining Lease Terms And Discount Rate [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DiscountAmortizationAndInterestExpensesOne" xlink:to="GCTK_DiscountAmortizationAndInterestExpensesOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DiscountAmortizationAndInterestExpensesOne_doc" xml:lang="en-US">Discount amortization and interest expenses one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesACommonWarrantMember" xlink:to="GCTK_SeriesACommonWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeriesACommonWarrantMember_doc" xml:lang="en-US">Series A Common Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DiscountAmortizationAndInterestExpensesTwo" xlink:to="GCTK_DiscountAmortizationAndInterestExpensesTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DiscountAmortizationAndInterestExpensesTwo_doc" xml:lang="en-US">Discount amortization and interest expenses two.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesBCommonWarrantMember" xlink:to="GCTK_SeriesBCommonWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeriesBCommonWarrantMember_doc" xml:lang="en-US">Series B Common Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:to="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_doc" xml:lang="en-US">Deemed dividend related to trigger of down round protection feature.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ConvertiblePromissoryNotesMember" xlink:to="GCTK_ConvertiblePromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ConvertiblePromissoryNotesMember_doc" xml:lang="en-US">Convertible Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_WarrantsAgreementMember" xlink:to="GCTK_WarrantsAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_WarrantsAgreementMember_doc" xml:lang="en-US">Warrants Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PerformanceMilestoneMember" xlink:to="GCTK_PerformanceMilestoneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_PerformanceMilestoneMember_doc" xml:lang="en-US">Performance Milestone [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FirstWarrantMember" xlink:to="GCTK_FirstWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FirstWarrantMember_doc" xml:lang="en-US">First Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SecondWarrantMember" xlink:to="GCTK_SecondWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SecondWarrantMember_doc" xml:lang="en-US">Second Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ThirdWarrantMember" xlink:to="GCTK_ThirdWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ThirdWarrantMember_doc" xml:lang="en-US">Third Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_EmbeddedConversionFeaturePercentage" xlink:to="GCTK_EmbeddedConversionFeaturePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_EmbeddedConversionFeaturePercentage_doc" xml:lang="en-US">Embedded conversion feature percentage.</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones" xlink:label="GCTK_EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones" xlink:to="GCTK_EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones_doc" xml:lang="en-US">Earnings per share diluted including warrants and performance milestones.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:to="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_doc" xml:lang="en-US">New accounting pronouncements, not yet adopted [policy text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock" xlink:to="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock_doc" xml:lang="en-US">Warrants With Down Round Protection [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantMember" xlink:to="GCTK_AugustTwentyThreeWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_AugustTwentyThreeWarrantMember_doc" xml:lang="en-US">August Twenty Three Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantOneMember" xlink:to="GCTK_AugustTwentyThreeWarrantOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_AugustTwentyThreeWarrantOneMember_doc" xml:lang="en-US">August 23 Warrant One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantTwoMember" xlink:to="GCTK_AugustTwentyThreeWarrantTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_AugustTwentyThreeWarrantTwoMember_doc" xml:lang="en-US">August Twenty Three Warrant Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_AugustTwentyThreeWarrantThreeMember" xlink:to="GCTK_AugustTwentyThreeWarrantThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_AugustTwentyThreeWarrantThreeMember_doc" xml:lang="en-US">August Twenty Three Warrant Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyEighteenNotesMember" xlink:to="GCTK_JulyEighteenNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JulyEighteenNotesMember_doc" xml:lang="en-US">July Eighteen Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsMember" xlink:to="GCTK_SeptemberFiveWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeptemberFiveWarrantsMember_doc" xml:lang="en-US">September Five Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsOneMember" xlink:to="GCTK_SeptemberFiveWarrantsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeptemberFiveWarrantsOneMember_doc" xml:lang="en-US">September Five Warrants One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsTwoMember" xlink:to="GCTK_SeptemberFiveWarrantsTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeptemberFiveWarrantsTwoMember_doc" xml:lang="en-US">September Five Warrants Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsThreeMember" xlink:label="GCTK_SeptemberFiveWarrantsThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsThreeMember" xlink:to="GCTK_SeptemberFiveWarrantsThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeptemberFiveWarrantsThreeMember_doc" xml:lang="en-US">September Five Warrants Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_MarkTapsakMember" xlink:to="GCTK_MarkTapsakMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_MarkTapsakMember_doc" xml:lang="en-US">Mark Tapsak [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:to="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_doc" xml:lang="en-US">Schedule Of Research And Development Expenses [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_GeneralAndAdministrativeExpensesTextBlock" xlink:to="GCTK_GeneralAndAdministrativeExpensesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_GeneralAndAdministrativeExpensesTextBlock_doc" xml:lang="en-US">General and Administrative Expenses [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:to="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_doc" xml:lang="en-US">Schedule Of General And Administrative Expenses [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeferredTaxAssetsTaxVacationAccrual" xlink:to="GCTK_DeferredTaxAssetsTaxVacationAccrual_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DeferredTaxAssetsTaxVacationAccrual_doc" xml:lang="en-US">Deferred tax assets tax vacation accrual.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeferredTaxAssetValuationAllowance" xlink:to="GCTK_DeferredTaxAssetValuationAllowance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DeferredTaxAssetValuationAllowance_doc" xml:lang="en-US">Valuation allowance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_TapsakEnterprisesLLCAgreementMember" xlink:to="GCTK_TapsakEnterprisesLLCAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_TapsakEnterprisesLLCAgreementMember_doc" xml:lang="en-US">Tapsak Enterprises LLC Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SalesAgreementMember" xlink:to="GCTK_SalesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SalesAgreementMember_doc" xml:lang="en-US">Sales Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SecuritiesPurchaseAgreementMember" xlink:to="GCTK_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesBWarrantsMember" xlink:to="GCTK_SeriesBWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeriesBWarrantsMember_doc" xml:lang="en-US">Series B Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_doc" xml:lang="en-US">Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_doc" xml:lang="en-US">Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award equity instruments other than options exerciable in period intrinsic value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options cancelled in period gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Sharebased compensation shares authorized under stock option plans exercise price range outstanding other than options weighted average remaining contractual term.</link:label>
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_doc" xml:lang="en-US">Sharebased compensation arrangement by share based payment award non option equity instruments exercised weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options cancelled in period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments cancelled weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_doc" xml:lang="en-US">Sharebased compensation shares authorized under stock option plans exercise price range outstanding other than options weighted average remaining contractual term 2.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesAWarrantMember" xlink:to="GCTK_SeriesAWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeriesAWarrantMember_doc" xml:lang="en-US">Series A Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesBWarrantMember" xlink:to="GCTK_SeriesBWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeriesBWarrantMember_doc" xml:lang="en-US">Series B Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JuneThirtyNotesMember" xlink:to="GCTK_JuneThirtyNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JuneThirtyNotesMember_doc" xml:lang="en-US">June Thirty Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeriesAWarrantsMember" xlink:to="GCTK_SeriesAWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeriesAWarrantsMember_doc" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyTwentySevenNotesMember" xlink:to="GCTK_JulyTwentySevenNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JulyTwentySevenNotesMember_doc" xml:lang="en-US">July Twenty Seven Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" xlink:to="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_doc" xml:lang="en-US">Schedule Of Reconciliation Of The Fair Value Warrants [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyEighteenMember" xlink:to="GCTK_JulyEighteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JulyEighteenMember_doc" xml:lang="en-US">July 18 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ClassOfWarrantOrRightReasonForCashRaised" xlink:to="GCTK_ClassOfWarrantOrRightReasonForCashRaised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ClassOfWarrantOrRightReasonForCashRaised_doc" xml:lang="en-US">Class of warrant or right reason for cash raised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FairValueOfWarrantRelatedDerivatives" xlink:to="GCTK_FairValueOfWarrantRelatedDerivatives_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FairValueOfWarrantRelatedDerivatives_doc" xml:lang="en-US">Fair value of warrant related derivatives.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FairValueOfWarrantRelatedDerivativesValue" xlink:to="GCTK_FairValueOfWarrantRelatedDerivativesValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FairValueOfWarrantRelatedDerivativesValue_doc" xml:lang="en-US">Fair value of warrant related derivatives value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:to="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award options exercisable weighted average fairvalue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_doc" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercisable Weighted Average Exercise Price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SeptemberFiveWarrantsThirdMember" xlink:to="GCTK_SeptemberFiveWarrantsThirdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SeptemberFiveWarrantsThirdMember_doc" xml:lang="en-US">September Five Warrants Third [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SalariesAndRelatedMember" xlink:to="GCTK_SalariesAndRelatedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_SalariesAndRelatedMember_doc" xml:lang="en-US">Salaries and Related [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ProfessionalFeesMember" xlink:to="GCTK_ProfessionalFeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ProfessionalFeesMember_doc" xml:lang="en-US">Professional Fees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DepreciationMember" xlink:to="GCTK_DepreciationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DepreciationMember_doc" xml:lang="en-US">Depreciation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_BetweenOneYearToTwoYearsMember" xlink:to="GCTK_BetweenOneYearToTwoYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_BetweenOneYearToTwoYearsMember_doc" xml:lang="en-US">Between 1 - 2 Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_LessThanOneYearMember" xlink:to="GCTK_LessThanOneYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_LessThanOneYearMember_doc" xml:lang="en-US">Less Than One Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_MoreThanTwoYearsMember" xlink:to="GCTK_MoreThanTwoYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_MoreThanTwoYearsMember_doc" xml:lang="en-US">More Than 2 Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DrindaBenjaminMember" xlink:to="GCTK_DrindaBenjaminMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_DrindaBenjaminMember_doc" xml:lang="en-US">Drinda Benjamin [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_WarrantsOriginalExercisePrice" xlink:to="GCTK_WarrantsOriginalExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_WarrantsOriginalExercisePrice_doc" xml:lang="en-US">Warrants original exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_PublicOfferingPrice" xlink:to="GCTK_PublicOfferingPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_PublicOfferingPrice_doc" xml:lang="en-US">Public offering price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments forfeited weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyThirtyMember" xlink:to="GCTK_JulyThirtyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JulyThirtyMember_doc" xml:lang="en-US">July Thirty [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyWarrantsMember" xlink:to="GCTK_JulyWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JulyWarrantsMember_doc" xml:lang="en-US">July Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_JulyMember" xlink:to="GCTK_JulyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_JulyMember_doc" xml:lang="en-US">July [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FinanceExpenseIncomeNet" xlink:to="GCTK_FinanceExpenseIncomeNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="GCTK_FinanceExpenseIncomeNet_doc" xml:lang="en-US">Finance expense income net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_GainLossOnEquityIssuance" xlink:to="GCTK_GainLossOnEquityIssuance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_GainLossOnEquityIssuance_3_lbl" xml:lang="en-US">GainLossOnEquityIssuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FinanceExpenseIncomeNet" xlink:to="GCTK_FinanceExpenseIncomeNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FinanceExpenseIncomeNet_3_lbl" xml:lang="en-US">FinanceExpenseIncomeNet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_2_lbl" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:to="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors_3_lbl" xml:lang="en-US">IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_2_lbl" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:to="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_3_lbl" xml:lang="en-US">DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Other Research and Development Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_FinanceIncomeNet" xlink:to="GCTK_FinanceIncomeNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_FinanceIncomeNet_3_lbl" xml:lang="en-US">FinanceIncomeNet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_3_lbl" xml:lang="en-US">SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_3_lbl" xml:lang="en-US">SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:to="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" xlink:to="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_3_lbl" xml:lang="en-US">SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GCTK_DeferredTaxAssetValuationAllowance" xlink:to="GCTK_DeferredTaxAssetValuationAllowance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GCTK_DeferredTaxAssetValuationAllowance_3_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>21
<FILENAME>gctk-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://glucotrack.com/role/Cover" xlink:href="gctk-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/BalanceSheets" xlink:href="gctk-20241231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/BalanceSheetsParenthetical" xlink:href="gctk-20241231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="gctk-20241231.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity" xlink:href="gctk-20241231.xsd#StatementsOfChangesInStockholdersDeficitEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/StatementsOfCashFlows" xlink:href="gctk-20241231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/General" xlink:href="gctk-20241231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LoansFromStockholders" xlink:href="gctk-20241231.xsd#LoansFromStockholders" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactions" xlink:href="gctk-20241231.xsd#SignificantTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilities" xlink:href="gctk-20241231.xsd#CommitmentsAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreement" xlink:href="gctk-20241231.xsd#LeaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNet" xlink:href="gctk-20241231.xsd#FinanceIncomeExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtection" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpenses" xlink:href="gctk-20241231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpenses" xlink:href="gctk-20241231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTax" xlink:href="gctk-20241231.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/RelatedParties" xlink:href="gctk-20241231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SegmentReporting" xlink:href="gctk-20241231.xsd#SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SubsequentEvents" xlink:href="gctk-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactionsTables" xlink:href="gctk-20241231.xsd#SignificantTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreementTables" xlink:href="gctk-20241231.xsd#LeaseAgreementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/FinanceIncomeExpensesNetTables" xlink:href="gctk-20241231.xsd#FinanceIncomeExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="gctk-20241231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables" xlink:href="gctk-20241231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTaxTables" xlink:href="gctk-20241231.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/GeneralDetailsNarrative" xlink:href="gctk-20241231.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails" xlink:href="gctk-20241231.xsd#ScheduleOfOfficialExchangeRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:href="gctk-20241231.xsd#ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="gctk-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative" xlink:href="gctk-20241231.xsd#LoansFromStockholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SignificantTransactionsDetailsNarrative" xlink:href="gctk-20241231.xsd#SignificantTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:href="gctk-20241231.xsd#CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails" xlink:href="gctk-20241231.xsd#ScheduleOfOperatingLeaseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:href="gctk-20241231.xsd#ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:href="gctk-20241231.xsd#ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/LeaseAgreementDetailsNarrative" xlink:href="gctk-20241231.xsd#LeaseAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfFinanceExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:href="gctk-20241231.xsd#ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails" xlink:href="gctk-20241231.xsd#ScheduleOfWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:href="gctk-20241231.xsd#CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:href="gctk-20241231.xsd#ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails" xlink:href="gctk-20241231.xsd#ScheduleOfIncomeTaxLossForYearDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="gctk-20241231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/IncomeTaxDetailsNarrative" xlink:href="gctk-20241231.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/RelatedPartiesDetailsNarrative" xlink:href="gctk-20241231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://glucotrack.com/role/SubsequentEventsDetailsNarrative" xlink:href="gctk-20241231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingParValuePerShare" xlink:label="loc_deiEntityListingParValuePerShare" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityListingParValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="loc_deiAuditorOpinionTextBlock" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorOpinionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaapRestrictedCashNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRestrictedCashNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ReceiptsOnAccountOfShares" xlink:label="loc_GCTKReceiptsOnAccountOfShares" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_GCTKReceiptsOnAccountOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GainLossOnEquityIssuance" xlink:label="loc_GCTKGainLossOnEquityIssuance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_GCTKGainLossOnEquityIssuance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FinanceExpenseIncomeNet" xlink:label="loc_GCTKFinanceExpenseIncomeNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_GCTKFinanceExpenseIncomeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; (Deficit) Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ReceiptsOnAccountOfSharesMember" xlink:label="loc_GCTKReceiptsOnAccountOfSharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_GCTKReceiptsOnAccountOfSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering" xlink:label="loc_GCTKStockIssuedDuringPeriodValueUnderwrittenPublicOffering" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueUnderwrittenPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesUnderwrittenPublicOffering" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesUnderwrittenPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" xlink:label="loc_GCTKAdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKAdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_GCTKStockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockToBeIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" xlink:label="loc_GCTKStockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" xlink:label="loc_GCTKStockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" xlink:label="loc_GCTKStockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" xlink:label="loc_GCTKStockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodValueSettlementOfFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" xlink:label="loc_GCTKStockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKStockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EquityIssuanceCosts" xlink:label="loc_GCTKEquityIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_GCTKEquityIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:label="loc_GCTKIssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_GCTKIssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GainLossOnEquityIssuance" xlink:label="loc_GCTKGainLossOnEquityIssuance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_GCTKGainLossOnEquityIssuance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_GCTKLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_GCTKLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering" xlink:label="loc_GCTKNetProceedsReceivedFromUnderwrittenPublicOffering" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_GCTKNetProceedsReceivedFromUnderwrittenPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsReceivedFromUnderwrittenPublicOffering" xlink:label="loc_GCTKProceedsReceivedFromUnderwrittenPublicOffering" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_GCTKProceedsReceivedFromUnderwrittenPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidAbstract" xlink:label="loc_us-gaapInterestPaidAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInterestPaidAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeemedDividendUponTriggerOfDownRoundProtection" xlink:label="loc_GCTKDeemedDividendUponTriggerOfDownRoundProtection" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_GCTKDeemedDividendUponTriggerOfDownRoundProtection" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SettlementOfLiabilitiesWithEquity" xlink:label="loc_GCTKSettlementOfLiabilitiesWithEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_GCTKSettlementOfLiabilitiesWithEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NonCashDerivativeLiability" xlink:label="loc_GCTKNonCashDerivativeLiability" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_GCTKNonCashDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NoInsiderTradingFlag" xlink:label="loc_GCTKNoInsiderTradingFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_GCTKNoInsiderTradingFlag" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000012 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="loc_cydCybersecurityRiskRoleOfManagementTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskRoleOfManagementTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000013 - Disclosure - Material Cybersecurity Incident Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="loc_cydMaterialCybersecurityIncidentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentNatureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentNatureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentScopeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentScopeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentTimingTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentTimingTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/General" xlink:title="999014 - Disclosure - GENERAL">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LoansFromStockholders" xlink:title="999016 - Disclosure - LOANS FROM STOCKHOLDERS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactions" xlink:title="999017 - Disclosure - SIGNIFICANT TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureSignificantTransactionsAbstract" xlink:label="loc_GCTKDisclosureSignificantTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SignificantTransactionsTextBlock" xlink:label="loc_GCTKSignificantTransactionsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureSignificantTransactionsAbstract" xlink:to="loc_GCTKSignificantTransactionsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommitmentsAndContingentLiabilities" xlink:title="999018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreement" xlink:title="999019 - Disclosure - LEASE AGREEMENT">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureLeaseAgreementAbstract" xlink:label="loc_GCTKDisclosureLeaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/FinanceIncomeExpensesNet" xlink:title="999020 - Disclosure - FINANCE (INCOME) EXPENSES, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaapFinancialInstrumentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_us-gaapFinancialInstrumentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection" xlink:title="999021 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ResearchAndDevelopmentExpenses" xlink:title="999022 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralAndAdministrativeExpenses" xlink:title="999023 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="loc_GCTKDisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GeneralAndAdministrativeExpensesTextBlock" xlink:label="loc_GCTKGeneralAndAdministrativeExpensesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_GCTKGeneralAndAdministrativeExpensesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTax" xlink:title="999024 - Disclosure - INCOME TAX">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/RelatedParties" xlink:title="999025 - Disclosure - RELATED PARTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SegmentReporting" xlink:title="999026 - Disclosure - SEGMENT REPORTING">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SubsequentEvents" xlink:title="999027 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FunctionalCurrencyPolicyTextBlock" xlink:label="loc_GCTKFunctionalCurrencyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKFunctionalCurrencyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock" xlink:label="loc_GCTKModificationOfEquityClassifiedContractsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKModificationOfEquityClassifiedContractsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ConvertiblePromissoryNotesPolicyTextBlock" xlink:label="loc_GCTKConvertiblePromissoryNotesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKConvertiblePromissoryNotesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:label="loc_GCTKAllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKAllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_RoyaltyBearingGrantsPolicyTextBlock" xlink:label="loc_GCTKRoyaltyBearingGrantsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKRoyaltyBearingGrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock" xlink:label="loc_GCTKWarrantsWithDownRoundProtectionPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKWarrantsWithDownRoundProtectionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="loc_GCTKNewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKNewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock" xlink:label="loc_us-gaapScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock" xlink:label="loc_GCTKScheduleOfPropertyRatesOfDepreciationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GCTKScheduleOfPropertyRatesOfDepreciationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactionsTables" xlink:title="999030 - Disclosure - SIGNIFICANT TRANSACTIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureSignificantTransactionsAbstract" xlink:label="loc_GCTKDisclosureSignificantTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureSignificantTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenWarrantsMember" xlink:label="loc_GCTKJuneTwentySevenWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneTwentySevenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" xlink:label="loc_GCTKScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" xlink:label="loc_GCTKScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreementTables" xlink:title="999031 - Disclosure - LEASE AGREEMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureLeaseAgreementAbstract" xlink:label="loc_GCTKDisclosureLeaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" xlink:label="loc_GCTKScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_GCTKScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/FinanceIncomeExpensesNetTables" xlink:title="999032 - Disclosure - FINANCE (INCOME) EXPENSES, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:label="loc_srtScheduleOfCondensedFinancialStatementsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_srtScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables" xlink:title="999033 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaapDisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapDisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaapScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="999034 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:label="loc_GCTKScheduleOfResearchAndDevelopmentExpensesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_GCTKScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables" xlink:title="999035 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="loc_GCTKDisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:label="loc_GCTKScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_GCTKScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTaxTables" xlink:title="999036 - Disclosure - INCOME TAX (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/GeneralDetailsNarrative" xlink:title="999037 - Disclosure - GENERAL (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsFromPublicOfferingsAndDebtIssuances" xlink:label="loc_GCTKProceedsFromPublicOfferingsAndDebtIssuances" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_GCTKProceedsFromPublicOfferingsAndDebtIssuances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails" xlink:title="999038 - Disclosure - SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateRemeasurement1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyExchangeRateRemeasurement1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails" xlink:title="999039 - Disclosure - SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails" xlink:title="999040 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FurnitureAndOfficeEquipmentMember" xlink:label="loc_GCTKFurnitureAndOfficeEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_GCTKFurnitureAndOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails" xlink:title="999041 - Disclosure - SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPrefundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PerformanceMilestoneMember" xlink:label="loc_GCTKPerformanceMilestoneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPerformanceMilestoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:label="loc_GCTKDeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKDeemedDividendRelatedToTriggerOfDownRoundProtectionFeature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:title="999042 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_srtPlatformOperatorCryptoAssetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative" xlink:title="999045 - Disclosure - LOANS FROM STOCKHOLDERS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FourSeparateLendersMember" xlink:label="loc_GCTKFourSeparateLendersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_GCTKFourSeparateLendersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_srtStatementGeographicalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL" xlink:label="loc_countryIL" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_QuarterlyPaymentsEqualsToSalesPercentage" xlink:label="loc_GCTKQuarterlyPaymentsEqualsToSalesPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_GCTKQuarterlyPaymentsEqualsToSalesPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails" xlink:title="999046 - Disclosure - SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureSignificantTransactionsAbstract" xlink:label="loc_GCTKDisclosureSignificantTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureSignificantTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenWarrantsMember" xlink:label="loc_GCTKJuneTwentySevenWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneTwentySevenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition" xlink:label="loc_GCTKProceedsFromAllocatedWarrantsAtInitialRecognition" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKProceedsFromAllocatedWarrantsAtInitialRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpenses" xlink:label="loc_GCTKDiscountAmortizationAndInterestExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKDiscountAmortizationAndInterestExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PartialConversionNotesAndAccruedInterest" xlink:label="loc_GCTKPartialConversionNotesAndAccruedInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKPartialConversionNotesAndAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails" xlink:title="999047 - Disclosure - SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureSignificantTransactionsAbstract" xlink:label="loc_GCTKDisclosureSignificantTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureSignificantTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantMember" xlink:label="loc_GCTKSeriesAWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesAWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantMember" xlink:label="loc_GCTKSeriesBWarrantMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyMember" xlink:label="loc_GCTKJulyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyWarrantsMember" xlink:label="loc_GCTKJulyWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyThirtyMember" xlink:label="loc_GCTKJulyThirtyMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyThirtyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyEighteenMember" xlink:label="loc_GCTKJulyEighteenMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKJulyEighteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SignificantTransactionsDetailsNarrative" xlink:title="999048 - Disclosure - SIGNIFICANT TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureSignificantTransactionsAbstract" xlink:label="loc_GCTKDisclosureSignificantTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureSignificantTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPrefundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesACommonWarrantMember" xlink:label="loc_GCTKSeriesACommonWarrantMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeriesACommonWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBCommonWarrantMember" xlink:label="loc_GCTKSeriesBCommonWarrantMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeriesBCommonWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FirstWarrantMember" xlink:label="loc_GCTKFirstWarrantMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKFirstWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SecondWarrantMember" xlink:label="loc_GCTKSecondWarrantMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSecondWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ThirdWarrantMember" xlink:label="loc_GCTKThirdWarrantMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKThirdWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneThirtyNotesMember" xlink:label="loc_GCTKJuneThirtyNotesMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneThirtyNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JuneTwentySevenNotesMember" xlink:label="loc_GCTKJuneTwentySevenNotesMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJuneTwentySevenNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantOneMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantOneMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantTwoMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantTwoMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AugustTwentyThreeWarrantThreeMember" xlink:label="loc_GCTKAugustTwentyThreeWarrantThreeMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKAugustTwentyThreeWarrantThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyEighteenNotesMember" xlink:label="loc_GCTKJulyEighteenNotesMember" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJulyEighteenNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_JulyTwentySevenNotesMember" xlink:label="loc_GCTKJulyTwentySevenNotesMember" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKJulyTwentySevenNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsMember" xlink:label="loc_GCTKSeptemberFiveWarrantsMember" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsOneMember" xlink:label="loc_GCTKSeptemberFiveWarrantsOneMember" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsTwoMember" xlink:label="loc_GCTKSeptemberFiveWarrantsTwoMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeptemberFiveWarrantsThirdMember" xlink:label="loc_GCTKSeptemberFiveWarrantsThirdMember" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeptemberFiveWarrantsThirdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ExchangeAgreementMember" xlink:label="loc_GCTKExchangeAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsAgreementMember" xlink:label="loc_GCTKWarrantsAgreementMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKWarrantsAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="660" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_UnsecuredPromissoryNotesMember" xlink:label="loc_GCTKUnsecuredPromissoryNotesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_GCTKUnsecuredPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ConvertiblePromissoryNotesMember" xlink:label="loc_GCTKConvertiblePromissoryNotesMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_GCTKConvertiblePromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantsMember" xlink:label="loc_GCTKSeriesAWarrantsMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantsMember" xlink:label="loc_GCTKSeriesBWarrantsMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesACommonWarrantMember" xlink:label="loc_GCTKSeriesACommonWarrantMember_2" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesACommonWarrantMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBCommonWarrantMember" xlink:label="loc_GCTKSeriesBCommonWarrantMember_2" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBCommonWarrantMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember_2" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKPrefundedWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesAWarrantMember" xlink:label="loc_GCTKSeriesAWarrantMember" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesAWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantMember" xlink:label="loc_GCTKSeriesBWarrantMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKSeriesBWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LockUpPeriodDescription" xlink:label="loc_GCTKLockUpPeriodDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKLockUpPeriodDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtDescription" xlink:label="loc_us-gaapShortTermDebtDescription" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermDebtDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscriptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementLoss" xlink:label="loc_us-gaapLitigationSettlementLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLitigationSettlementLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EmbeddedConversionFeaturePercentage" xlink:label="loc_GCTKEmbeddedConversionFeaturePercentage" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKEmbeddedConversionFeaturePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:label="loc_us-gaapDerivativeLiabilityFairValueOfCollateral" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilityFairValueOfCollateral" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FairValueOfWarrantRelatedDerivatives" xlink:label="loc_GCTKFairValueOfWarrantRelatedDerivatives" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKFairValueOfWarrantRelatedDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FairValueOfWarrantRelatedDerivativesValue" xlink:label="loc_GCTKFairValueOfWarrantRelatedDerivativesValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKFairValueOfWarrantRelatedDerivativesValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="loc_us-gaapEquityFairValueDisclosure" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaapDebtInstrumentMeasurementInput" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_EquityIssuanceCosts" xlink:label="loc_GCTKEquityIssuanceCosts" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKEquityIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ClassOfWarrantOrRightReasonForCashRaised" xlink:label="loc_GCTKClassOfWarrantOrRightReasonForCashRaised" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKClassOfWarrantOrRightReasonForCashRaised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_GainLossOnEquityIssuance" xlink:label="loc_GCTKGainLossOnEquityIssuance" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GCTKGainLossOnEquityIssuance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" xlink:title="999049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLossContingenciesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapLossContingenciesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:label="loc_us-gaapLegalEntityTypeOfCounterpartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="loc_us-gaapLegalEntityTypeOfCounterpartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IsraeliInnovationAuthorityMember" xlink:label="loc_GCTKIsraeliInnovationAuthorityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLegalEntityTypeOfCounterpartyDomain" xlink:to="loc_GCTKIsraeliInnovationAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IsraeliInnovationAuthorityMember" xlink:label="loc_GCTKIsraeliInnovationAuthorityMember_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_GCTKIsraeliInnovationAuthorityMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_IntellectualPropertyPurchaseAgreementMember" xlink:label="loc_GCTKIntellectualPropertyPurchaseAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKIntellectualPropertyPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_TrueupSharesMember" xlink:label="loc_GCTKTrueupSharesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GCTKTrueupSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_RoyaltyPercentage" xlink:label="loc_GCTKRoyaltyPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_GCTKRoyaltyPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_AggregateSalesPriceOfUnitsPercentage" xlink:label="loc_GCTKAggregateSalesPriceOfUnitsPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_GCTKAggregateSalesPriceOfUnitsPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesRestrictedStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarketabilityDiscountRate" xlink:label="loc_GCTKMarketabilityDiscountRate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_GCTKMarketabilityDiscountRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails" xlink:title="999050 - Disclosure - SCHEDULE OF OPERATING LEASE (Details)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureLeaseAgreementAbstract" xlink:label="loc_GCTKDisclosureLeaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails" xlink:title="999051 - Disclosure - SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureLeaseAgreementAbstract" xlink:label="loc_GCTKDisclosureLeaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaapLesseeLeaseDescriptionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapLesseeLeaseDescriptionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaapLesseeLeaseDescriptionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapLesseeLeaseDescriptionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="loc_us-gaapLeaseContractualTermAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapLeaseContractualTermAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaapLeaseContractualTermDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseContractualTermAxis" xlink:to="loc_us-gaapLeaseContractualTermDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_LessThanOneYearMember" xlink:label="loc_GCTKLessThanOneYearMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseContractualTermDomain" xlink:to="loc_GCTKLessThanOneYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_BetweenOneYearToTwoYearsMember" xlink:label="loc_GCTKBetweenOneYearToTwoYearsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseContractualTermDomain" xlink:to="loc_GCTKBetweenOneYearToTwoYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MoreThanTwoYearsMember" xlink:label="loc_GCTKMoreThanTwoYearsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseContractualTermDomain" xlink:to="loc_GCTKMoreThanTwoYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails" xlink:title="999052 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureLeaseAgreementAbstract" xlink:label="loc_GCTKDisclosureLeaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/LeaseAgreementDetailsNarrative" xlink:title="999053 - Disclosure - LEASE AGREEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureLeaseAgreementAbstract" xlink:label="loc_GCTKDisclosureLeaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureLeaseAgreementAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAgreementsMember" xlink:label="loc_us-gaapLeaseAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_us-gaapLeaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails" xlink:title="999054 - Disclosure - SCHEDULE OF FINANCE EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpensesOne" xlink:label="loc_GCTKDiscountAmortizationAndInterestExpensesOne" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_GCTKDiscountAmortizationAndInterestExpensesOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DiscountAmortizationAndInterestExpensesTwo" xlink:label="loc_GCTKDiscountAmortizationAndInterestExpensesTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_GCTKDiscountAmortizationAndInterestExpensesTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDeposits" xlink:label="loc_us-gaapInterestExpenseDeposits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_us-gaapInterestExpenseDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_FinanceIncomeNet" xlink:label="loc_GCTKFinanceIncomeNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsAllOtherInvestmentsAbstract" xlink:to="loc_GCTKFinanceIncomeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails" xlink:title="999055 - Disclosure - SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:label="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" xlink:label="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="loc_GCTKSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails" xlink:title="999056 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails" xlink:title="999057 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" xlink:label="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" xlink:label="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" xlink:label="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_GCTKShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails" xlink:title="999058 - Disclosure - SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaapLongTermPurchaseCommitmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapLongTermPurchaseCommitmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaapLongTermPurchaseCommitmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapLongTermPurchaseCommitmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementMember" xlink:label="loc_us-gaapResearchAndDevelopmentArrangementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="loc_us-gaapResearchAndDevelopmentArrangementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative" xlink:title="999059 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PrefundedWarrantsMember" xlink:label="loc_GCTKPrefundedWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKPrefundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DrindaBenjaminMember" xlink:label="loc_GCTKDrindaBenjaminMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GCTKDrindaBenjaminMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarkTapsakMember" xlink:label="loc_GCTKMarkTapsakMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_GCTKMarkTapsakMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability" xlink:label="loc_us-gaapDescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualMaximumContractualTerm1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_WarrantsOriginalExercisePrice" xlink:label="loc_GCTKWarrantsOriginalExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GCTKWarrantsOriginalExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_PublicOfferingPrice" xlink:label="loc_GCTKPublicOfferingPrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GCTKPublicOfferingPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:title="999060 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SalariesAndRelatedMember" xlink:label="loc_GCTKSalariesAndRelatedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_GCTKSalariesAndRelatedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_ProfessionalFeesMember" xlink:label="loc_GCTKProfessionalFeesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_GCTKProfessionalFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DepreciationMember" xlink:label="loc_GCTKDepreciationMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_GCTKDepreciationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenseMember" xlink:label="loc_us-gaapOtherExpenseMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapOtherExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:title="999061 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="loc_GCTKDisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GCTKDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInvestmentExpense" xlink:label="loc_us-gaapInvestmentIncomeInvestmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeInvestmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails" xlink:title="999062 - Disclosure - SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxSettlementsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxSettlementsDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlementsForeign" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxSettlementsForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxSettlementsForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxSettlements" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxSettlements" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="999063 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeferredTaxAssetsTaxVacationAccrual" xlink:label="loc_GCTKDeferredTaxAssetsTaxVacationAccrual" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_GCTKDeferredTaxAssetsTaxVacationAccrual" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_DeferredTaxAssetValuationAllowance" xlink:label="loc_GCTKDeferredTaxAssetValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_GCTKDeferredTaxAssetValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/IncomeTaxDetailsNarrative" xlink:title="999064 - Disclosure - INCOME TAX (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/RelatedPartiesDetailsNarrative" xlink:title="999065 - Disclosure - RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_MarkTapsakMember" xlink:label="loc_GCTKMarkTapsakMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_GCTKMarkTapsakMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_TapsakEnterprisesLLCAgreementMember" xlink:label="loc_GCTKTapsakEnterprisesLLCAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKTapsakEnterprisesLLCAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/SubsequentEventsDetailsNarrative" xlink:title="999066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SalesAgreementMember" xlink:label="loc_GCTKSalesAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKSalesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SecuritiesPurchaseAgreementMember" xlink:label="loc_GCTKSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_GCTKSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gctk-20241231.xsd#GCTK_SeriesBWarrantsMember" xlink:label="loc_GCTKSeriesBWarrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GCTKSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GLUCOTRACK,
INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001506983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0668934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">301
                                            Route 17 North<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rutherford<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">842-7715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GCTK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,585,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text">We
have audited the accompanying consolidated balance sheets of Glucotrack Inc. a Delaware corporation (the &#8220;Company&#8221;) as
of December 31, 2024, and 2023, the related consolidated statements of operations and comprehensive loss, changes in
stockholders&#8217; equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes
(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023, and
the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with
accounting principles generally accepted in the United States of America<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">FAHN KANNE & CO. GRANT THORNTON ISRAEL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel-Aviv,
    Israel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents (Note 2D)</a></td>
<td class="nump">$ 5,617<span></span>
</td>
<td class="nump">$ 4,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,768<span></span>
</td>
<td class="nump">4,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net (Note 6)</a></td>
<td class="nump">59<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (Note 2D)</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">5,932<span></span>
</td>
<td class="nump">4,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current (Note 6)</a></td>
<td class="nump">26<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory notes (Note 4E)</a></td>
<td class="nump">5<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative financial liabilities (Note 4F, 4G and Note 4J)</a></td>
<td class="nump">17,421<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, non-current (Note 6)</a></td>
<td class="nump">33<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Loans from stockholders (Note 3)</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">18,932<span></span>
</td>
<td class="nump">1,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities (Note 5)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (Deficit) Equity (Note 8)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock of $0.001 par value (&#8220;Common Stock&#8221;): 100,000,000 shares authorized as of December 31, 2024 and 2023; 802,609 and 208,914 shares issued and outstanding as of December 31, 2024 and 2023, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">119,229<span></span>
</td>
<td class="nump">112,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ReceiptsOnAccountOfShares', window );">Receipts on account of shares</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(132,450)<span></span>
</td>
<td class="num">(109,853)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; (deficit) equity</a></td>
<td class="num">(13,000)<span></span>
</td>
<td class="nump">3,197<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; (DEFICIT) EQUITY</a></td>
<td class="nump">$ 5,932<span></span>
</td>
<td class="nump">$ 4,905<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ReceiptsOnAccountOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receipts on account of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ReceiptsOnAccountOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">791,609<span></span>
</td>
<td class="nump">208,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">791,609<span></span>
</td>
<td class="nump">208,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses (Note 9)</a></td>
<td class="nump">$ 9,499<span></span>
</td>
<td class="nump">$ 4,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Marketing expenses</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses (Note 10)</a></td>
<td class="nump">4,655<span></span>
</td>
<td class="nump">2,278<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">14,547<span></span>
</td>
<td class="nump">7,104<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="nump">14,547<span></span>
</td>
<td class="nump">7,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivative liability</a></td>
<td class="nump">798<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_GainLossOnEquityIssuance', window );">Loss on equity issuance</a></td>
<td class="nump">1,925<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Loss on settlement of liabilities</a></td>
<td class="nump">4,758<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_FinanceExpenseIncomeNet', window );">Finance expense (income), net (Note 7)</a></td>
<td class="nump">583<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the year</a></td>
<td class="nump">22,597<span></span>
</td>
<td class="nump">7,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss for the year</a></td>
<td class="nump">$ 22,573<span></span>
</td>
<td class="nump">$ 7,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per share</a></td>
<td class="nump">$ 68.44<span></span>
</td>
<td class="nump">$ 34.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per share</a></td>
<td class="nump">$ 68.44<span></span>
</td>
<td class="nump">$ 34.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Common Stock outstanding used in computing basic net loss per share</a></td>
<td class="nump">330,171<span></span>
</td>
<td class="nump">207,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Common Stock outstanding used in computing diluted net loss per share</a></td>
<td class="nump">330,171<span></span>
</td>
<td class="nump">207,603<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_FinanceExpenseIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance expense income net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_FinanceExpenseIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_GainLossOnEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on equity issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_GainLossOnEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)<br></strong></div></th>
<th class="th" colspan="2"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Receipts on Account of Shares [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 103,110,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="num">$ (101,901,000)<span></span>
</td>
<td class="nump">$ 1,230,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">154,999<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,097,000)<span></span>
</td>
<td class="num">(7,097,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering', window );">Net proceeds received from underwritten U.S. public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,730,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,730,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering', window );">Net proceeds received from underwritten U.S. public offering, shares</a></td>
<td class="nump">53,765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted', window );">Deemed dividend resulted from trigger of down round protection feature of certain warrants granted</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">855,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(855,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">281,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">281,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted shares as compensation to directors</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">54,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted shares as compensation to directors, shares</a></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">112,986,000<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="num">(109,853,000)<span></span>
</td>
<td class="nump">3,197,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">208,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(22,597,000)<span></span>
</td>
<td class="num">(22,597,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">173,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">173,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted shares as compensation to directors</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">126,000<span></span>
</td>
<td class="num">(48,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">78,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted shares as compensation to directors, shares</a></td>
<td class="nump">4,343<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted shares to be issued as compensation towards directors</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">228,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">228,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone', window );">Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">192,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">192,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone', window );">Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B), shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of Common Stock upon private placement transaction (Note 4C)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of Common Stock upon private placement transaction (Note 4C), shares</a></td>
<td class="nump">3,968<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares', window );">Exercise of prefunded warrants into shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares', window );">Exercise of prefunded warrants into shares, shares</a></td>
<td class="nump">19,765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares</a></td>
<td class="nump">121,867<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions', window );">Issuance of detachable warrants through private placement transactions</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions', window );">Issuance of detachable warrants through private placement transactions, shares</a></td>
<td class="nump">237,845<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Exchange of warrants into shares</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Exchange of warrants into shares, shares</a></td>
<td class="nump">35,932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities', window );">Issuance of shares and warrants as settlement of financial liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,618,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,618,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities', window );">Issuance of shares and warrants as settlement of financial liabilities, shares</a></td>
<td class="nump">156,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of detachable warrants through private placement transactions</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,635,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,635,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 119,229,000<span></span>
</td>
<td class="nump">$ 228,000<span></span>
</td>
<td class="num">$ (8,000)<span></span>
</td>
<td class="num">$ (132,450,000)<span></span>
</td>
<td class="num">$ (13,000,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2024</a></td>
<td class="nump">791,609<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Less than 1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital deemed dividend resulted from trigger of down round protection feature of certain warrants granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares detachable warrants through private placement transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of prefunded warrants into shares ,shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares restricted stock payment for achievement of milestone.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares settlement of financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares underwritten public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value detachable warrants through private placement transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of prefunded warrants into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value restricted stock payment for achievement of milestone.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value settlement of financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value underwritten public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock to be issued during period value restricted stock award gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the year</a></td>
<td class="num">$ (22,597)<span></span>
</td>
<td class="num">$ (7,097)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile loss for the year to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_EquityIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="nump">1,217<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors', window );">Issuance of restricted shares as compensation to directors</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Shares issued to CEO for achieving of IP Agreement milestones</a></td>
<td class="nump">192<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Loss on settlement of liabilities</a></td>
<td class="nump">4,758<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_GainLossOnEquityIssuance', window );">Loss on equity issuance</a></td>
<td class="nump">1,925<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivative liability</a></td>
<td class="nump">798<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Discount amortization and interest expenses related to promissory notes</a></td>
<td class="nump">628<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders', window );">Linkage difference on principal of loans from stockholders</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">225<span></span>
</td>
<td class="num">(309)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase in accounts payable</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Increase (decrease) in other current liabilities</a></td>
<td class="num">(421)<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(12,490)<span></span>
</td>
<td class="num">(6,558)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investment activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(104)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investment activities</a></td>
<td class="num">(104)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Issuance of promissory notes and detachable warrants through private placement Transaction (Note 4E)</a></td>
<td class="nump">100<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering', window );">Net proceeds received from underwritten U.S. public offering (Note 4J)</a></td>
<td class="nump">8,783<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Issuance of convertible promissory notes - related parties (Note 4G)</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of convertible promissory notes and bifurcated conversion feature through private placement transaction (Note 4F)</a></td>
<td class="nump">360<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ProceedsReceivedFromUnderwrittenPublicOffering', window );">Net proceeds received from underwritten U.S. public offering (Note 4C)</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">8,730<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">13,743<span></span>
</td>
<td class="nump">8,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">1,125<span></span>
</td>
<td class="nump">2,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at beginning of the year</a></td>
<td class="nump">4,502<span></span>
</td>
<td class="nump">2,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at end of the year</a></td>
<td class="nump">5,627<span></span>
</td>
<td class="nump">4,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidAbstract', window );"><strong>(a) Net cash (received) paid during the year for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="num">(62)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>(b) Non-cash investment and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DeemedDividendUponTriggerOfDownRoundProtection', window );">Deemed dividend upon trigger of down round protection</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Recognition of right for use asset against a lease liability (Note 6)</a></td>
<td class="nump">79<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SettlementOfLiabilitiesWithEquity', window );">Settlement of liabilities with equity (Note 4H and 4I)</a></td>
<td class="nump">1,743<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_NonCashDerivativeLiability', window );">Derivative liability (Note 4G)</a></td>
<td class="nump">35<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of debt into equity (Note 4F and 4G)</a></td>
<td class="nump">$ 2,284<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DeemedDividendUponTriggerOfDownRoundProtection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deemed dividend upon trigger of down round protection.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DeemedDividendUponTriggerOfDownRoundProtection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_EquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_EquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_GainLossOnEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on equity issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_GainLossOnEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of restricted shares as compensation to the board of directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Linkage difference on principal of loans from stockholders .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds received from underwritten public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_NonCashDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_NonCashDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ProceedsReceivedFromUnderwrittenPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from underwritten public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ProceedsReceivedFromUnderwrittenPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SettlementOfLiabilitiesWithEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement of liabilities with equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SettlementOfLiabilitiesWithEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (22,597)<span></span>
</td>
<td class="num">$ (7,097)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_NoInsiderTradingFlag', window );">No insider trading flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_NoInsiderTradingFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>No insider trading flag.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_NoInsiderTradingFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risk
Management and Strategy</i></b></span>&#160;<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information
systems and protect the confidentiality, integrity, and availability of our data. The Company considers its primary cybersecurity risks
to be theft of intellectual property, theft of other business data, fraud or extortion, lack of access to its information systems, harm
to employees, harm to business partners, violation of privacy laws, potential reputational risk, and litigation or other legal risk if
a cybersecurity incident were to occur. It is difficult to assign a monetary materiality assessment to these risks or to the impact if
the Company were to sustain a breach of its systems. The Company&#8217;s approach to cybersecurity is based on the premise that any cybersecurity
incident could result in material harm to the Company. We have a cybersecurity and risk management processes in place to oversee risks
associated with cybersecurity and respond to emerging threats in a timely and effective manner. We monitor our systems to assess cybersecurity risks and threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Managing
Material Risks &amp; Integrated Overall Risk Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zr85dhfOxlq">We
have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zB6t3xTQfVR9">integrated</span> cybersecurity risk management into our broader risk management framework. This integration ensures that cybersecurity
considerations are an integral part of our decision-making process. We conduct annual risk assessments and quarterly vulnerability scans
of risks posed by cybersecurity threats in conjunction with our insurance renewal cycles. As a result of these assessments, we have implemented
technical, administrative, and, where appropriate, physical controls and practices to proactively monitor our systems and user accounts
including, but not limited to, deploying solutions to constantly monitor users accessing systems, implementation of two factor authentication
for logins, and improved rules for password maintenance</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Like
many companies, we make use of cloud-based solutions provided by several large service providers for critical information technology
infrastructure such as email and file storage. We do not maintain stand-alone servers for our email, file storage or other business applications.
In the normal course of our relationships with the providers of these services, we regularly monitor their message boards and other formal
and informal communications channels for signs of breaches of their systems. We also survey available public information for indications
that they have suffered a breach of their systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Engage
Third Parties on Risk Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has been designated with oversight responsibility for cybersecurity risks and our Chief Financial Officer is responsible
for managing our efforts in this area. Neither the Chief Financial Officer nor any member of the Audit Committee has relevant expertise
in cybersecurity. Recognizing the complexity and evolving nature of cybersecurity threats, the Company has retained an <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zj75rM3MZCdh">third-party technical
expert </span>to support its information technology systems including addressing cybersecurity risks. This relationship enables us to leverage
specialized knowledge and insights, to ensure our cybersecurity strategies and processes are aligned with industry best practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Oversee
Third Party Risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240101__20241231_zrtDYO8CHBgh">We
utilize various third-party software applications in the functioning of our core business. We conduct assessments of all third-party
providers and maintain ongoing reviews to ensure compliance with our cybersecurity standards. Our assessment of risks associated with
the use of third-party providers is part of our overall cybersecurity framework</span>. In addition, some of our business partners also
maintain data related to our trials and ongoing product development on servers they maintain. We require these partners to comply with
all HIPAA standards for maintaining security of their systems where this data resides.</span></p>

&#160;<i>&#160;</i><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
from Cybersecurity Threats</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face risk from cybersecurity threats that could have a material adverse effect on our business, financial condition, results of operations,
cash flows or reputation. For more information about the cybersecurity risks we face, see the risk factor entitled &#8220;<i>Security
threats to our information technology infrastructure could expose us to liability and damage our reputation and business</i>.&#8221;
in <i>Item 1A., Risk Factors</i>. </span></p>

&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">We
have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zB6t3xTQfVR9">integrated</span> cybersecurity risk management into our broader risk management framework. This integration ensures that cybersecurity
considerations are an integral part of our decision-making process. We conduct annual risk assessments and quarterly vulnerability scans
of risks posed by cybersecurity threats in conjunction with our insurance renewal cycles. As a result of these assessments, we have implemented
technical, administrative, and, where appropriate, physical controls and practices to proactively monitor our systems and user accounts
including, but not limited to, deploying solutions to constantly monitor users accessing systems, implementation of two factor authentication
for logins, and improved rules for password maintenance<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governance</i></b></span>&#160;<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes the
significance of these threats to our operational integrity and stockholder confidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk
Management Personnel</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
utilize an out-sourced information technology (IT) network and cybersecurity compliance service provider, Windstar Technologies,
Inc. (&#8220;Windstar&#8221;) Windstar, under the supervision of our Chief Financial Officer, is responsible for developing and
implementing our information security program. Windstar provides managed IT network and cloud services, network, cyber and web
security services, cyber risk audits and compliance and penetration testing assessments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
of Directors Oversight</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240101__20241231_zE5Z9F8KMYXf">Our Board is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes
the significance of these threats to our operational integrity and stockholder confidence</span>. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20240101__20241231_zwJfGL7z4pGj">The
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zNn16VnzcPwj">Audit Committee</span> is central to the Board&#8217;s oversight of cybersecurity risks and bears the primary responsibility for this domain</span>. </span></p>

&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our Board is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes
the significance of these threats to our operational integrity and stockholder confidence<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Management&#8217;s
Role Managing Risk and Reporting to the Board</i></span>&#160;<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not currently have an employee who has significant and demonstrated professional IT management experience.
Presently, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20240101__20241231_zJ4QFgMhK2m7">our Chief Financial Officer with assistance from our third-party IT services provider, Windstar,
are primarily responsible for informing the Audit Committee regarding cybersecurity risks. They provide briefings to the Audit Committee
on a regular basis, with a minimum frequency of once per year</span>. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to scheduled meetings, the Audit Committee and the Chief Financial Officer maintain an ongoing
dialogue regarding emerging or potential cybersecurity risks. Together, they receive updates on any significant developments in the
cybersecurity domain, ensuring the Board&#8217;s oversight is proactive and responsive. This involvement ensures that cybersecurity
considerations are integrated into the Company&#8217;s broader strategic objectives and helps in identify areas for improvement,
ensuring the alignment of cybersecurity efforts with the overall risk management framework.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zQJf2UDLuSg6">not</span> experienced any previous cybersecurity incidents that have materially affected or are reasonably likely to materially
affect our business strategy, results of operations, or financial condition.&#160;</span></p>

&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">The
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zNn16VnzcPwj">Audit Committee</span> is central to the Board&#8217;s oversight of cybersecurity risks and bears the primary responsibility for this domain<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">our Chief Financial Officer with assistance from our third-party IT services provider, Windstar,
are primarily responsible for informing the Audit Committee regarding cybersecurity risks. They provide briefings to the Audit Committee
on a regular basis, with a minimum frequency of once per year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z0lfR6pHfO5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; <span id="xdx_822_zKts6pKaDwxb">GENERAL</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was incorporated on May 18, 2010 under the laws of the State of Delaware. The Company is currently developing an implantable
CBGM, the Glucotrack CBGM, for persons with Type 1 diabetes and insulin-dependent Type 2 diabetes.</span></p>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Glucotrack CBGM is being developed for use by Type 1 diabetes patients as
                                            well as insulin-dependent Type 2 patients. Implant longevity is key to the success of such
                                            a device. The Company has continued to evolve its sensor chemistry following the successful
                                            in-vitro feasibility study demonstrating that a minimum two-year implant life is highly probable
                                            with the current sensor design. Recently the Company announced that a 3-year longevity is
                                            feasible leveraging both in-vitro and in-silico test results. The Company has also completed
                                            multiple animal studies with initial prototype systems which demonstrated a simple implant
                                            procedure with good safety and functionality. The results of both were presented in poster
                                            form at the 2024 American Diabetes Association annual conference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
to the above progress on the Glucotrack CBGM, the Company has also successfully demonstrated continuous glucose sensing in the epidural
space. This latter approach is of importance for patients with diabetes already contemplating spinal cord stimulation therapy for their
condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
regulatory submission has been made for a first in human study outside of the United States. This will be an acute study intended to
demonstrate device performance and safety. All preparatory clinical activities and applicable regulatory approvals are complete. In parallel,
the Company is also preparing for a long-term clinical trial outside the United States that is expected to begin in the second quarter
of 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The
Company believes its technology, if successful, has the potential to be more accurate, more convenient and have a longer duration than
other implantable glucose monitors that are either in the market or currently under development.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
    and capital resources</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            date, the Company has not yet commercialized the Glucotrack CBGM Product. Further development
                                            and commercialization efforts are expected to require substantial additional expenditure.
                                            Therefore, the Company is dependent upon external sources for financing its operations. As
                                            of December 31, 2024, the Company has incurred an accumulated deficit of $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20241231_zGL5wqlPBts4" title="Accumulated deficit">132,450</span>. In addition,
                                            the Company has generated operating losses and negative cash flow from operations since inception.
                                            As of December 31, 2024, the balance of cash and cash equivalents amounted to $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20241231_z7xelKLAfS54" title="Cash and cash equivalents">5,617</span>.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended December 31, 2024, the Company raised approximately $<span id="xdx_903_ecustom--ProceedsFromPublicOfferingsAndDebtIssuances_pn6n6_c20240101__20241231_zkKyt77U0Hz5" title="Proceeds from public offerings and debt issuances">15</span> million through public offerings and debt issuances which
    were subsequently converted to equity. In addition, subsequent to the balance sheet date, the Company raised $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20250101__20250328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zE8QizcG9CTf" title="Proceeds from sale of common stock">6.3</span> million through the
    sale of shares of Common Stock. See Note 4 and 14. The Company plans to finance its operations through the sale of equity
    securities (and/or debt securities). There can be no assurance that the Company will succeed in obtaining the necessary financing
    or generating sufficient revenue from sale of its Glucotrack CBGM Product in order to continue its operations as a going concern.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    has considered the significance of such conditions in relation to the Company&#8217;s ability to meet its current obligations and
    to achieve its business targets and determined that these conditions raise substantial doubt about the Company&#8217;s ability to
    continue as a going concern.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zpPV7MwXNhhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 - <span id="xdx_823_zBoHat5hP5yc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America
(US GAAP).</span></p>

<p id="xdx_84E_eus-gaap--UseOfEstimates_zjDx5ZhV6Yt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zEznVgam0Iz4">Use
    of estimates in the preparation of financial statements</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions
    that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of
    the financial statements, and the reported amounts of expenses during the reported periods. Actual results could differ from those
    estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to evaluation of going
    concern, the classification of financial instruments as equity or liability, share based compensation and the determination of the fair value of derivative
    liabilities.</span></td></tr>
  </table>
<p id="xdx_84D_ecustom--FunctionalCurrencyPolicyTextBlock_zcMGwwBuz3Z3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zsfOrdVScWMf">Functional
    currency</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    functional currency of the Company is the US dollar, which is the currency of the primary economic environment in which it operates.
    In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to foreign currency
    are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions
    included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses
    arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.
    The functional currency of the Israeli subsidiary is the New Israeli Shekel (&#8220;NIS&#8221;) and its financial statements are
    included in consolidation, based on translation into US dollars. Accordingly, assets and liabilities were translated from NIS to
    US dollars using year-end exchange rates, and expense items were translated at average exchange rates during the year. Gains or losses
    resulting from translation adjustments are reflected in stockholders&#8217; equity, under &#8220;accumulated other comprehensive
    income&#8221;.</span></td></tr>
  </table>
<p id="xdx_899_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zZ9rfSF7hGXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B8_zTTl2xrLE2B8" style="display: none">SCHEDULE OF OFFICIAL EXCHANGE RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Official exchange rate of NIS
    1 to US dollar</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20241231_z3HXiJacJyz9" title="Official exchange rate of NIS 1 to US dollar">0.274</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231_zvIwJW1INYW9" title="Official exchange rate of NIS 1 to US dollar">0.272</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Increase (Decrease) of the official exchange
    rate of NIS 1 to US dollar during the year:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20241231_z2itxYshtO72" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:">0.74</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_di_uPure_c20231231_z76cwanQoTr2" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:">(8.86</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  </table>

<p id="xdx_8A9_zoMrBAn5EBze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zid9BrgUl8zf" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_ze3PW2OpjFOe">Principles
    of consolidation</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
    have been eliminated in consolidation.</span></td></tr>
  </table>
<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zvmJcRej0eh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zTEQrxYW2h43">Cash
    and cash equivalents and restricted cash</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company considers all short-term investments, which are highly liquid investments with original
                                            maturities of three months or less at the date of purchase, to be cash equivalents.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash is invested in certificates of deposit, which are used to secure Integrity Israel&#8217;s obligations in respect of its credit
    card.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    presentation of statement of cash flows purposes, restricted cash balances are included with cash and cash equivalents, when reconciling
    the reported period total amounts.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s cash is held with financial institutions in the United States and Israel. Management believes that the financial
    institutions that hold the Company&#8217;s cash are financially sound and, accordingly, minimal credit risk exists with respect to
    these investments. Account balances held in the Unites States may, at times, exceed the Federal Deposit Insurance Corporation (FDIC)
    insurance limit. As of December 31, 2024 and 2023, the Company had $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20241231_zEPeadpMAweg" title="FDIC insurance limit">4,968</span> and $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20231231_zvIRQSvWJPFf" title="FDIC insurance limit">3,942</span>, respectively, in excess of the FDIC insurance
    limit.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p id="xdx_898_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zouO1GTW9Lbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zJV2l25V0qPi" style="display: none">SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20241231_z3WoxWo2yNN3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20231231_zfkg4c0VGFR9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzao3_z4E5ARni6Iuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,617</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,492</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCash_iI_pn3n3_maCCERCzao3_zOrcs6hmU6U4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Restricted cash</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzao3_zvgHrUD5n5v" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total cash, cash equivalents,
    and restricted cash shown in the statement of cash flows</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,627</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,502</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zTJK59TQNx7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWgRKuvXVJP8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zpuB5HHvNqCk">Property
    and equipment, net</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over
    the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated
    depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected
    in the statements of operations and comprehensive loss.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rates
    of depreciation:</span></td></tr>
  </table>
<p id="xdx_89B_ecustom--ScheduleOfPropertyRatesOfDepreciationTableTextBlock_zw0g56Tqghwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zFW86EHUW8dj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Computers and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zVRpfYDp41N7" title="Property and equipment rates of depreciation">3</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and office equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zOYuSeCsE90d" title="Property and equipment rates of depreciation">7</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaKkwjrOhRdg" title="Property and equipment rates of depreciation">15</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zTJTnyrhRK9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zOIbb9kzGgK1" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_ziWv8giK7N0f">Impairment
    of long-lived assets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Group&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;,
    whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
    of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows
    expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by
    the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment
    losses related to long lived assets.</span></td></tr>
</table>

<p id="xdx_84D_ecustom--ModificationOfEquityClassifiedContractsPolicyTextBlock_ziZE3MIk5rr" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z56evVdHSr88">Modification
    of equity-classified contracts</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    modification or exchange of equity-classified contracts, such as warrants that were classified as equity before the modification or
    exchange and remained eligible for equity classification after the modification, was accounted for in a similar manner to a
    modification of stock-based compensation. Accordingly, the incremental fair value from the modification or exchange (the change in
    the fair value of the instrument before and after the modification or exchange), due to the characteristics of the modification, was recognized as a reduction of retained earnings (or an increase of
    accumulated deficit) as a deemed dividend. Modifications or exchanges that result in a decrease in the fair value of an
    equity-classified share-based payment awards are not recognized. In addition, the amount of the deemed dividend is also recognized
    as an adjustment to earnings available to common shareholders for purposes of calculating earnings per share.</span></td></tr>
  </table>
<p id="xdx_84A_ecustom--ConvertiblePromissoryNotesPolicyTextBlock_zrN5WIV4goI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zPLmBcF6oOKe">Convertible
    Promissory Notes</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition of convertible promissory notes and similar instruments, the Company considers the provisions of ASC 815-40,
    &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;) in order to determine whether
    the conversion features embedded within the convertible instrument should be separated from the host instrument.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            it is determined that an embedded derivative required to be bifurcated (such as embedded
                                            conversion feature that does not qualify for equity classification), the Company recognizes
                                            the embedded derivative bifurcated as a separate derivative liability upon initial recognition
                                            and on subsequent periods at fair value. The remaining consideration amount received or allocated
                                            to the entire convertible instrument is allocated to the host debt instrument. The difference
                                            between the face value of the host and the allocated amount represents a discount which is
                                            amortized as finance expense to profit or loss using the effective interest method over the
                                            term of the note until its stated maturity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    it is determined that the embedded conversion feature qualifies for equity classification (such when the embedded conversion option,
    if it were freestanding, is not qualified as a derivative in accordance with the provisions of ASC 815-10, &#8220;Derivatives and
    Hedging&#8221; since its terms did not require or permit net settlement or when the embedded conversion option is indexed to the
    entity&#8217;s own stock), the conversion option is not bifurcated. When bifurcation is not required, the Company considers whether
    the debt instrument involves a significant premium (i.e. when the proceeds received or allocated upon issuance exceed the principal
    amount that will be paid at maturity). When it is determined that a substantial premium exists, the entire premium is allocated to
    paid-in capital and when it is determined, otherwise no additional accounting is required and the convertible promissory note is
    accounted for at amortized cost using the effective interest method over the term of the note until its stated maturity.</span></p></td></tr>
</table>

<p id="xdx_847_ecustom--AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_z5sd7NFjOR4a" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zx0GcQuIiITa">Allocation
    of proceeds and related issuance costs</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            multiple instruments are issued in a single transaction (package issuance), the total gross
                                            proceeds from the transaction are allocated among the individual freestanding instruments
                                            identified. The allocation occurs after identifying all freestanding instruments and the
                                            subsequent measurement basis for those instruments.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    instruments that are required to be subsequently measured at fair value (such as derivative liabilities) are measured at fair value
    and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at
    fair value (such as liabilities measured at amortized cost, common shares and warrants eligible for equity classification), based
    on the relative fair value basis for such instruments.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    costs allocated to financial instruments that are required to be subsequently measured at fair value are immediately expensed.
    Issuance costs allocated to shares and warrants classified as equity components and are recorded as a reduction of additional
    paid-in capital. Issuance costs allocated to financial liabilities measured at amortized cost are recorded as a discount and
    accreted over the contractual term of the financial instrument using the effective interest method.</span></p></td></tr>
</table>

<p id="xdx_840_eus-gaap--DerivativesPolicyTextBlock_zzaf9EzAzAJ8" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>J.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zwRtdmypMikh">Warrants</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
                                            classified warrants</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    warrants that were determined to be freestanding financial instruments that are legally detachable and separately exercisable, do
    not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary
    Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company&#8217;s own shares, were classified
    as equity instruments. As such warrants were issued together with financial instruments that are not subsequently measured at fair
    value, the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair
    value basis. Direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
                                            classified as derivative liabilities</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition of Series A Warrants and Series B Warrants that were issued in November 2024 as part of an equity issuance and
    debt conversions, management considered the provisions of ASC 815-40, Derivatives and Hedging &#8212; Contracts in Entity&#8217;s
    Own Equity and determined that the settlement amount of Series A Warrants and Series B Warrants might not be based on an exchange
    of a fixed number of shares for a fixed amount of consideration and thus such Warrants are not eligible to be considered as indexed
    to the Company&#8217;s own shares. Accordingly, the Series A Warrants and Series B Warrants were accounted for as warrant derivative
    liability at fair value and the changes in fair values are carried to profit or loss. In accordance with ASC 210-10-20, the warrant
    derivative liability is presented as a noncurrent liability since its settlement will require the issuance of shares and not the
    use of any resources that are properly classified as current assets.</span></p></td></tr>
  </table>
<p id="xdx_840_eus-gaap--LesseeLeasesPolicyTextBlock_zAFnE1nB1bz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>K.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zSqGXDVPbGRf">Leases</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company applies ASC Topic 842, &#8220;Leases&#8221; (&#8220;ASC 842&#8221;) under which the
                                            Company determines if an arrangement is a lease at inception.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases
    are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following
    criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option
    to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful
    life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset,
    or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end
    of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company&#8217;s
    lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be
    classified as operating leases.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of Use (&#8220;ROU&#8221;) assets and liabilities are recognized on the commencement date based on the present value of remaining
    lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the
    time of commencement. As most of the Company&#8217;s leases do not provide an implicit rate, the Company uses its Incremental Borrowing
    Rate (&#8220;IBR&#8221;) based on the information available on the commencement date in determining the present value of lease payments.
    The Company&#8217;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
    and in economic environments where the leased asset is located. The ROU asset also includes any lease payments made prior to commencement
    and is recorded net of any lease incentives received. Moreover, the ROU asset may also include initial direct costs, which are incremental
    costs of a lease that would not have been incurred if the lease had not been obtained. The Company uses the long-lived assets impairment
    guidance in ASC 360-10, &#8220;Property, Plant, and Equipment - Overall&#8221;, to determine whether a ROU asset is impaired, and
    if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option
    to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain
    that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company
    will not exercise the option.</span></p></td></tr>
</table>

<p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8Ckl0y83uBd" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>L.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_znRym6lSYEtf">Income
    tax</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are
    determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial
    accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the
    enacted tax rates expected to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets
    are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial
    statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements.
    According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting
    policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not
    recognize such items in its fiscal 2024 and 2023 financial statements and did not recognize any liability with respect to unrecognized
    tax position in its balance sheet.</span></td></tr>
  </table>
<p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zaqMHPXIf17k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zKvC4MV0qI9f">Research
    and development expenses</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development expenses are charged to operations and comprehensive loss, as incurred.</span></td></tr>
  </table>
<p id="xdx_846_ecustom--RoyaltyBearingGrantsPolicyTextBlock_z8mdfwVJt0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWOO3CIF9uye">Royalty-bearing
    grants</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalty-bearing
    grants from the Israeli Innovation Authority (IIA) to fund approved research and development projects are recognized at the time
    Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs. To date,
    the cumulative research and development grants received by Integrity Israel from IIA amounted to $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zxQ1tqmmUSfh" title="Cumulative research and development">93</span>. See also Note 5A below.</span></td></tr>
  </table>
<p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_z9o48b788pJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>O.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zHt8cvBHACei">Basic
    and diluted loss per share</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share for the year ended December 31, 2024 is computed by dividing the loss for the period applicable for Common Stockholders
and the holders of the pre-funded warrants divided by the weighted average number of shares of Common Stock outstanding and shares of
Common Stock to be issued upon the exercise of prefunded warrants during the period. Basic loss per share for December 31, 2023 is computed
by dividing the loss for the period applicable (after considering the effect of deemed dividend related to trigger of down round protection
feature) for Common Stockholders and the holders of the pre-funded warrants divided by the weighted average number of shares of Common
Stock outstanding and shares of Common Stock to be issued upon achievement of first performance milestone <span style="background-color: white">(see
Note </span>5B <span style="background-color: white">below) and upon </span>exercise of pre-funded warrants (see Note 8B below) during
the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing, diluted loss per share, basic earnings per share are adjusted to reflect the potential dilution that could occur upon the
exercise of options or warrants issued or granted using the &#8220;treasury stock method&#8221;, and using the if-converted method for
other financial instruments such as convertible liabilities and other share settled derivative liabilities, if the effect of each of
such financial instruments is dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing diluted loss per share, the average stock price for the period is used in determining the number of Common Stock assumed to
be purchased from the proceeds to be received from the exercise of stock options or stock warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
that will be issued upon exercise of all stock options and stock warrants, have been excluded from the calculation of the diluted net
loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result
of the exercise or conversion of these instruments was anti-dilutive</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zBj6J9PKDyHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zcK24H5JdCR2" style="display: none">SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240101__20241231_z6Ym4uflSN3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20230101__20231231_z5zzqKUWHrA7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In thousands
    of US dollars</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(except
    share data)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_iN_pn3n3_di_maNILATzfsR_zmwax6xVGU0l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,097</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_iN_pn3n3_di_maNILATzfsR_zpbcLJeGQ6R8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Deemed
    dividend related to trigger of down round protection feature (see Note 8C3 below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">855</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iNT_pn3n3_di_mtNILATzfsR_z3nyCkEPqS75" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable
    to common stockholders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    used in computing basic and diluted net loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zUwaJqH5hLqc" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj6bGPKWH3na" title="Ordinary shares used in computing diluted net loss per common stock">330,171</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQoV8c1SBjS1" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_ztuK22onwYV6" title="Ordinary shares used in computing diluted net loss per common stock">193,131</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    to be issued upon exercise of pre-funded warrants (see Note 8B1 below)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zXDAwwEkUIN2" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zskmRws7TrWj" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0661"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zX4Xg66JJtuk" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zjBrCIsx5YDh" title="Ordinary shares used in computing diluted net loss per common stock">13,971</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Shares
    of Common Stock to be issued upon achievement of first performance milestone (see Note 5B below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_z4WPaA8G3I53" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zS2qa5cwJH8b" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0669"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></span></span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zbbEBgBnhxD7" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zXNs6HF7bgu" title="Ordinary shares used in computing diluted net loss per common stock">501</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zKqCY5joreQ7" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zxOBS8n14FZ" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share">330,171</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zmHxTTLjbWWc" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zpCU3cJC3yI7" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share">207,603</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss
    per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zeDTjIp7toZ1" title="Basic net loss per common stock"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zOWA1Kng7Vz7" title="Diluted net loss per common stock">68.44</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zwlwpLprfKLb" title="Basic net loss per common stock"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_z4hc6XluP3Na" title="Diluted net loss per common stock">34.18</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zG6bWZc6ZMle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Note 14 regarding a significant issuance of shares as part of the exercise of the Series B Warrants subsequent to the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLF7bBtd6dQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>P.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zbIkTHzb4Xl4">Stock-based
    compensation</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair
    values in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments including grants of stock
    options are recognized in the consolidated statement of operations and comprehensive loss as an operating expense based on the fair
    value of the award at the date of grant. The fair value of stock options granted is estimated using the Black-Scholes option-pricing
    model. The Company has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the
    requisite service period or over the implicit service period when a performance condition affects the vesting, and it is considered
    probable that the performance condition will be achieved. Share-based payments to non-employees are accounted for in accordance with
    ASC 718.</span></td></tr>
  </table>
<p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zw3K0lUr9aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zUIeoiC4EIgl">Fair
    value of financial instruments</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
    Topic 825-10, &#8220;Financial Instruments&#8221; defines financial instruments and requires disclosure of the fair value of financial
    instruments held by the Company. The Company considers the carrying amount of cash and cash equivalents, restricted cash, accounts
    receivable, other current assets, accounts payable and other current liabilities balances, to approximate their fair values due to
    the short-term maturities of such financial instruments. ASC Topic 825-10, establishes the following fair value hierarchy, which
    prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair
    value hierarchy gives the highest priority to Level 1 inputs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 - Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 - Unobservable inputs are used when little or no market data is available. Level 3 inputs are considered as the lowest priority
    under the fair value hierarchy.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    fair value of the financial instruments included in the working capital of the Company (cash and cash equivalents, accounts payable
    and other current assets and liabilities) approximates their carrying value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not estimate the fair value of the loans received from stockholders since their repayment schedule has not yet been determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjxuB5pAO6r8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no Level 3 assets or liabilities for the year ended December 31, 2023. The following table presents changes in Level 3 assets and
liabilities measured at fair value for the year ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_z5O5I8YYPGZi" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20241114__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGGSdi8tCfHi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zYHWiGgSwBAc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; November 14, 2024
    &#8211; Warrant issuance date</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,626</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FairValueAdjustmentOfWarrants_z7jXuJroSoDi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value adjustments &#8211; Derivative financial liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">795</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_z7DlHWtDQvw4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A9_za73EkdSN8C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zFilp6g8Nc6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the Company&#8217;s assets and liabilities which are measured at fair value on a recurring basis by level
within the fair value hierarchy:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zGEafnPJxhX3" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair
    Value Measurements as of December 31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    I</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    II</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    III</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Liability:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant derivative
    liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWoUjctiPq35" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8XKvtuCOA69" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsrWFm7aZ6Qg" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_zfoypcLOJi29" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_z5lTH7oIToS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zzdcZwraGoa8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zNHFGJM5Nsc4">Segment
    reporting</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation
    by the chief operating decision maker, or (&#8220;CODM&#8221;). The Company has identified its Chief Executive Officer, Paul V. Goode, as the CODM who is responsible for making decisions regarding resource allocation and assessing performance. The Company views
    its operations and manages its business as one operating segment. The Company&#8217;s long-lived assets consist primarily of property
    and equipment, net, which are all held in the United States.</span></td></tr>
  </table>
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z2FGCZ6IAGlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_z1EHr4i96mI3">Concentrations
    of credit risk</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents,
    and restricted cash. Cash and cash equivalents and restricted cash are deposited with a major bank in the United States. Management
    believes that such financial institutions are financially sound, accordingly, minimal credit risk exists with respect to these financial
    instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts,
    option contracts or other foreign hedging arrangements.</span></td></tr>
  </table>
<p id="xdx_841_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zAlGHH2E7KW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>T.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z5Yi9ZOFIsFf">Contingencies</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
    has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
    information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></td></tr>
  </table>
<p id="xdx_847_ecustom--WarrantsWithDownRoundProtectionPolicyTextBlock_zn4f45ay0S6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zqEHhM9QsPOi">Warrants
    with down-round protection</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company disregards the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining
    liability or equity classification in accordance with the provisions of ASU 2017-11, &#8220;Earnings Per Share&#8221; (ASU 2017-11).
    Based on its evaluation, management has determined that such warrants with down-round protection feature are eligible for equity
    classification.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordantly,
upon the occurrence of an event that triggers a down round protection feature (i.e., when the exercise price of the warrants is adjusted
downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available
to common shareholders for purposes of basic earnings per share calculation. See also Note 2P above.</span></p>

<p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ziEK3LmjD6qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>V.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zqfiCRG2Y698">Recently
    adopted accounting pronouncements</span> </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU
    2023-07&#8221;). This standard requires a public entity to disclose significant segment expenses and other segment items on an interim
    and annual basis. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker.
    ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after
    December 15, 2024, with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all
    prior periods presented in the financial statements. The Company adopted ASU 2023-07 for the fiscal year ended December 31, 2024
    and interim financial statements thereafter, on a retrospective basis for all prior periods presented in the financial statements.
    The adoption of ASU 2023-07 did not change the way that the Company identifies its reportable segments and, as a result, did not
    have a material impact on the Company&#8217;s financial position or results of operations. See (Note 13) - Segment Reporting for
    further information.</span></td></tr>
  </table>
<p id="xdx_846_ecustom--NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_zHjYSoLTljei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>W.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zXFMCpsDTK0f">Recently
    issued accounting pronouncements, not yet adopted</span> </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    November 2024, the FASB issued ASU 2024-03, &#8220;Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation
    Disclosures&#8221; to require more detailed information about specified categories of expenses (purchases of inventory, employee
    compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the income
    statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and for interim periods within fiscal years
    beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial
    statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented
    in the financial statements. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial
    statements and related disclosures. The adoption of this pronouncement is not expected to have a material impact on the Company&#8217;s
    consolidated financial statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures related to improvements
    to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for
    the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning
    after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</span></td></tr>
  </table>

<p id="xdx_85A_zh2CGAkErrJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS FROM STOCKHOLDERS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LOANS FROM STOCKHOLDERS</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_z5f1aSH53Oy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3</b> &#8211; <b><span id="xdx_827_zOfH3zoHyk4h">LOANS FROM STOCKHOLDERS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the years 2003-2004, Integrity Israel received loans from stockholders (four separate lenders) in a total amount of approximately
    $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfLongTermDebt_pn3n3_c20030101__20041231__us-gaap--LineOfCreditFacilityAxis__custom--FourSeparateLendersMember__srt--StatementGeographicalAxis__country--IL_zr9dQFodh7xe" title="Total loan amount">400</span>. However, following the repayment of the entire balance to certain lender in 2015, the remaining balance as of December 31,
    2024 is approximately $<span id="xdx_903_eus-gaap--RepaymentsOfLongTermDebt_pn3n3_c20240101__20241231__us-gaap--LineOfCreditFacilityAxis__custom--FourSeparateLendersMember__srt--StatementGeographicalAxis__country--IL_zsZWIq7gVNub" title="Repayment of loan">203</span>. The loans are indexed to the Israeli consumer price index from their origination date and bear no interest.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company will be required to pay the loans, in quarterly installments, commencing on the first quarter following the first fiscal
    year in which the Company reports net profit in its annual report. At such time, the Company will be required to make quarterly payments
    equal to <span id="xdx_90E_ecustom--QuarterlyPaymentsEqualsToSalesPercentage_pid_dp_uPure_c20240101__20241231_zfmt4Ik4MBL3" title="Sales percent">10</span>% of its total sales for each quarter until the loans have been repaid in full. Notwithstanding the repayment mechanism,
    the Company will not be required to repay the loans during any period in which such payment would cause a deficit in the Company&#8217;s
    working capital.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, the Company does not expect to make any material repayments during the following 12-month period, if any, and
    accordingly the entire remaining balance of the loans from stockholders have been presented as non-current liability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DisclosureSignificantTransactionsAbstract', window );"><strong>Significant Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SignificantTransactionsTextBlock', window );">SIGNIFICANT TRANSACTIONS</a></td>
<td class="text"><p id="xdx_80B_ecustom--SignificantTransactionsTextBlock_zlR8CmcYuYhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8211; <span id="xdx_82A_zdHYqqQx9lwg">SIGNIFICANT TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    of pre-funded warrants</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 3, 2024, <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240103__20240103__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGN0l6NFO3O1" title="Pre-funded warrants">19,765</span> pre-funded warrants granted through underwritten public offering in April 2023 have been fully exercised
    into the same number of shares of Common Stock of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange
    Agreement</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 13, 2024, the Company entered into an Exchange Agreement with certain warrant holders (the &#8220;Holders&#8221;), pursuant
    to which the Company and the Holders agreed to exchange (the &#8220;Exchange&#8221;) warrants with down round protection feature
    exercisable to common shares (the &#8220;Warrants&#8221;) owned by the Holders for shares of Common Stock to be issued by the Company.
    On February 15, 2024, <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20240215_z6TLVGLUwzbc" title="Shares of Common Stock">35,932 </span>shares of Common Stock have been issued in exchange for <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20240215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNBITjKu9TU5" title="Shares of Common Stock">43,820</span> Warrants (the &#8220;Shares&#8221;).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            was also agreed that the Holders will not, during the period (&#8220;Lock-Up Period&#8221;)
                                            (i) offer, pledge, announce the intention to sell, contract to sell, sell any option or contract
                                            to purchase, purchase any option or contract to sell, grant any option, right or warrant
                                            to purchase, or otherwise transfer or dispose of, directly or indirectly, any Shares, (ii)
                                            enter into any swap or other agreement that transfers, in whole or in part, any of the economic
                                            consequences of ownership of the Shares of, whether any such transaction described in clause
                                            (i) or (ii) above is to be settled by delivery of Shares or such other securities, in cash
                                            or otherwise, (iii) make any demand for or exercise any right with respect to, the registration
                                            of any Shares or any security convertible into or exercisable or exchangeable for shares
                                            of common stock, or (iv) publicly announce an intention to effect any transaction specific
                                            in clause (i), (ii) or (iii) above, provided that the Holder, during the Lock-Up Period,
                                            may <span id="xdx_900_ecustom--LockUpPeriodDescription_c20240213__20240213__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zTyrs3D4LGHg" title="Lock-up period conditions">(a) sell or contract to sell Shares at a price higher than $0.5 per Share on any trading
                                            day up to 10% of the daily volume of Shares or (b) sell or contract to sell Shares at a price
                                            higher than $0.8 per Share on any trading day with no volume limitation.</span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Lock-Up Period shall expire at the earliest of (i) 365 days after the date hereof or (ii) until the Shares traded above $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20240213__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zBrTVdgo8hKl" title="Share price">100.00</span> per
    Share for five consecutive trading days.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounted for the Exchange of the aforesaid warrants with shares in a similar manner of a modification of shares-based payment as a deemed dividend which was calculated at the closing
    date by the management using the assistance of external appraiser as the excess of fair value of the shares to be issued after taking
    into consideration a discount for lack of marketability at a rate of 16.81% over the Lock-Up Period over the fair value of the original
    equity instrument (i.e. warrants which included down round protection feature). However, since the fair value of the shares was estimated
    as less than the fair value of the replaced equity instrument, deemed dividend was not recorded.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
    Placement Agreement</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 22, 2024, the Company entered into a private placement agreement under which the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240422__20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbdezgYJDnM6" title="Number of shares issued">3,968</span> shares of its common
    stock at a price of $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrwSVH7pwn68" title="Common stock share price">126</span> per share for aggregate gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20240422__20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzEu8KMDeaXe" title="Aggregate gross proceeds offering">500</span> (the &#8220;Offering&#8221;). The Offering included participation
    of certain members of the Company&#8217;s executive management, Board of Directors and existing shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adoption
    of 2024 Equity Incentive Plan and Reverse Share Split</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            April 26, 2024, the Company held its Annual Meeting of Shareholders (the &#8220;Annual Meeting&#8221;)
                                            under which the Company&#8217;s stockholders approved, inter alia, the following proposals:
                                            (i) adoption of the Company&#8217;s 2024 Equity Incentive Plan and (ii) an amendment to Article
                                            IV of the Company&#8217;s Certificate of Incorporation, to effect a reverse stock split of
                                            the Company&#8217;s Common Stock at a ratio of between one-for-five and one-for-thirty, with
                                            such ratio to be determined at the sole discretion of the Board of Directors. Following the
                                            Annual Meeting, on April 30, 2024, the Company&#8217;s Board of Directors approved a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240430__20240430_zCGY9Uuxwkea" title="Reverse stock split">one-for-five</span>
                                            reverse stock split of the Company&#8217;s issued and outstanding shares of common stock.
                                            On May 17, 2024, the Company filed a Certificate of Amendment to the Company&#8217;s Certificate
                                            of Incorporation with the Secretary of State of the State of Delaware which effected the
                                            reverse stock split.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 3, 2025, subsequent to the balance sheet date on December 31, 2024, the Company approved to effect an additional reverse
    stock split of twenty-for-one (20 to 1). The reverse split did not impact the total number of authorized shares of common stock or
    the par value per share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    accounting purposes, all shares, options and warrants to purchase shares of common stock and loss per share amounts have been adjusted
    to give retroactive effect to both of the reverse splits for all periods presented in these consolidated financial statements. Any
    fractional shares resulting from the reverse splits were rounded up to the nearest whole share.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    and Warrant Purchase Agreements</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            June 27, 2024, the Company entered into note and warrant purchase agreements (the &#8220;Purchase
                                            Agreement&#8221;) with certain investors (the &#8220;June 27 Investors&#8221;), providing
                                            for the private placement of unsecured promissory notes in the aggregate principal amount
                                            of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240627__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNotesMember_zRv9SM97kIZb" title="Aggregate principal amount">100</span> (the &#8220;June 27 Notes&#8221; and each a &#8220;June 27 Note&#8221;) and warrants
                                            to purchase up to an aggregate of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240627_ztkGGeX4DbRc" title="Aggregate of shares">15,000</span> shares of the Company&#8217;s Common Stock (the
                                            &#8220;June 27 Warrants&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShortTermDebtDescription_c20240627__20240627_zieJexGNEwv9" title="Notes payable description">The
    June 27 Notes bear simple interest at a rate of 3% per annum and are due and payable in cash on the earlier of: (a) 12 months from
    the date of the June 27 Note; or (b) the date the Company raises third-party equity capital in an amount equal to or in excess of
    $1,000 (the &#8220;Maturity Date&#8221;). The Company may prepay the June 27 Notes at any time prior to the Maturity Date without
    penalty. If an event of default occurs, the then-outstanding principal amount of the June 27 Notes plus any unpaid accrued interest
    will accelerate and become immediately payable in cash.</span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of June 27 Warrants has a fixed exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240627_ztRn2iQS7MY9" title="Warrants exercise price">99</span> per share. The June 27 Warrants are immediately exercisable and have a <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240627_zbTJcsbZj1Fi" title="Warrants term">5</span>-year
    term.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition, the management allocated the gross cash proceeds received based on the relative fair value of the June 27 Notes
    and the detachable June 27 Warrants in total amount of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240627__20240627_zmtZee7eSgq2" title="Proceeds from notes">15</span> and $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240627__20240627_z9moFUDsLI2h" title="Fair value of warrants">85</span>, respectively. The fair value of the June 27 Note was determined
    based on a rating model using a debt discount rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240627_zfFYEaz45n3" title="Debt discount rate">28.65</span>% which represented the Company&#8217;s applicable rate of risk. The fair
    value of the June 27 Warrants was determined by using Black-Scholes pricing model taking into account, inter alia, expected stock
    price volatility of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20240627__20240627_zu3fi8rRqQJ2" title="Price volatility">245</span>% and risk-free interest rate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20240627__20240627_zNbNEZZm8Gz9" title="Risk free interest rate">4.52</span>%. The amount allocated to June 27 Warrants was classified as a component
    of equity (as their terms permit the holders to receive a fixed number of shares of common stock upon exercise for a fixed exercise
    price).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    June 27 Notes were accounted for as a financial liability measured at amortized cost. In subsequent periods, the Company recognized
    a discount and interest expense over the economic life of the June 27 Notes based on the effective interest rate method.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tabular presentation reflects the reconciliation of the carrying amount of the June 27 Notes during the period of years ended
December 31, 2024:</span></p>

<p id="xdx_890_ecustom--ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zxSka9mHzdi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zID20Ar4xsO6" style="display: none">SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zQzBG2rGhi89" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended<br/> December 31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--WarrantsAndRightsOutstanding_iS_pn3n3_zBqCZcYjxCba" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_zNAWB0oWRiXf" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total proceeds received</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromAllocatedWarrantsAtInitialRecognition_pn3n3_zl0W3dNDg9Md" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total proceeds allocated to June 27 Warrants
    at initial recognition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--DiscountAmortizationAndInterestExpenses_pn3n3_zjUlikiL6W5f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount amortization and interest expenses
    related to June 27 Notes (Note 7 below)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--PartialConversionNotesAndAccruedInterest_pn3n3_zblcEzG7AGM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Partial conversion June
    27 Notes and accrued Interest (Note 4H and Note 4I below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(26</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstanding_iE_pn3n3_z7iEpCvk4pL" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance December</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AE_ztXZHekuZg23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period commencing the issuance date through December 31, 2024, none of the June 27 Warrants have been exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
    Promissory Notes</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            July 18, 2024, the Company entered into a series of convertible promissory notes with three
                                            directors, and one member of the Company&#8217;s executive management (the &#8220;July 18
                                            Investors&#8221;), providing for the private placement of unsecured convertible promissory
                                            notes in the aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zGIEAjUhfCd4" title="Debt instrument face amount">360</span> (the &#8220;July 18 Notes&#8221; and each
                                            a &#8220;July 18 Note&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    July 18 Notes bore simple interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zmxR4IGaVL76" title="Debt instrument interest rate">8</span>% per annum. Upon initial date, the management measured the fair value of the embedded
    conversion feature which is accounted for as embedded derivative liability. The difference between the total gross cash proceeds
    received and the fair value of the embedded conversion feature is allocated to the host component of the July 18 Notes that are measured
    at amortized cost under which in subsequent periods the Company recognizes a discount expense over the economic life of the July
    18 Notes based on the effective interest rate method. However, the fair value of the embedded derivative liability related to the
    conversion feature was determined by the management at an insignificant amount since upon closing of a Qualified Financing, the loan
    will convert based on market conditions (i.e. conversion price will be equal to the fair value of the share upon conversion) and
    thus all proceeds received of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_pn3n3_c20240718__20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z352712MHZhd" title="Conversion price">360</span> were allocated to the July 18 Notes.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 5, 2024, the Company and one of July 18 noteholders entered into a conversion agreement, under which the Company agreed
    to convert his portion of the outstanding principal nominal amount plus any accrued but unpaid interest pursuant to the July 18 Note,
    totaling $<span id="xdx_904_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFGdte93rCyg" title="Interest expense">101</span> into <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240905__20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z7AIvJgbwjh6" title="Stock issued during period shares issued for services">4,955</span> shares of Common Stock at a conversion price of $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjyKAXhkdBSd" title="Conversion price per share">20.4</span> per share. Please see note 4I.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In
    November 2024, the Company and the remaining July 18 noteholders entered into a conversion agreement under which the Company agreed
    to convert their portion of the outstanding principal nominal amount plus any accrued but unpaid interest pursuant to the July 18
    Note, totaling $<span id="xdx_90E_eus-gaap--InterestExpense_pn3n3_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO1wVwsBdW87" title="Interest expense">305</span>
    to Common Stock and warrants at a conversion price of $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZ6V3R04nNxe" title="Conversion price per share">31.2</span>
    per share. The July 18 noteholders received <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOm3FLVIkE5d" title="Stock issued during period shares issued for services">9,760</span>
    shares of Common Stock, <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesACommonWarrantMember_zrF4T0nv00Dl" title="Stock issued during period shares issued for services">9,760</span>
    Series A Warrants and <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesBCommonWarrantMember_zE7t1kVmD8r9" title="Stock issued during period shares issued for services">9,760</span>
    Series B Warrants. The fair value of the shares of Common Stock received was $<span id="xdx_905_eus-gaap--CommonStockSharesSubscriptions_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpW3GebmbFoi" title="Fair value of common stock">60</span>.
    The Series A and Series B Warrants are treated as derivative liabilities and at grant date were valued at $<span id="xdx_909_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesACommonWarrantMember_zbghkfmRsmCh" title="Derivative financial liabilities">43</span>
    and $<span id="xdx_907_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesBCommonWarrantMember_z6A3HYYa6s56" title="Derivative financial liabilities">279</span>,
    respectively. As a result, the Company recorded a loss on the settlement of debt in the amount of $<span id="xdx_902_eus-gaap--LitigationSettlementLoss_pn3n3_c20241101__20241130_z5O0Y6dxo2c4" title="Settlement of debt loss">79</span>
    in the Statement of Operations. Please see Note 4J for the terms and valuation methodology of the Series A and Series B
    Warrants.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
    Promissory Note and Warrant Agreements</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    July 30, 2024, the Company entered into a convertible promissory note and three warrant agreements (the &#8220;July 30 Warrants&#8221;)
    with an existing investor (the &#8220;July 30 Holder&#8221;), providing for the private placement of a secured convertible promissory
    note in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240730__us-gaap--ShortTermDebtTypeAxis__custom--ConvertiblePromissoryNotesMember__us-gaap--TypeOfArrangementAxis__custom--WarrantsAgreementMember_ztUekVUIZXOf" title="Debt instrument face amount">4,000</span> (the &#8220;July 30 Note&#8221;). The July 30 Note bore simple interest at a rate
    of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240730__us-gaap--ShortTermDebtTypeAxis__custom--ConvertiblePromissoryNotesMember__us-gaap--TypeOfArrangementAxis__custom--WarrantsAgreementMember_zW3TEMO4BSmh" title="Debt instrument interest rate">8</span>% per annum and is due and payable in cash on earlier of: (i) 12 months anniversary of July 30 Note, or (ii) closing date of
    a Sale Transaction (defined below) (the &#8220;Maturity Date&#8221;). The July 30 Note is secured by a first-priority security interest
    on all Company&#8217;s assets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
July 30 Warrant becomes exercisable 12 months after its issuance and has term of <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20240730__20240730_z24iw094gAl8">10</span> years. The July 30 Warrants are exercisable for cash
only and have no price-based antidilution. The first July 30 Warrant is for <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_z4Q0Cs9LY69h">106,667</span> shares at $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zWwO0eENRtW6" title="Exercise price">37.50</span> per share. The second July 30 Warrant
is for <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zU1Ku3QGllpl">76,191</span> shares at $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_z3Ugdsmakn4" title="Exercise price">52.50</span> per share. The third July 30 Warrant is for <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_z1kbIallstY3">59,259</span> shares at $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zgZYmHg1fRp1" title="Exercise price">67.50</span> per share. Management has determined
that the warrants are eligible to be classified as a component of equity as their terms permit the holders to receive a fixed number
of shares of common stock upon exercise for a fixed exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the initial date, the Company has issued four freestanding instruments that include (i) a financial instrument that is considered as
&#8220;host&#8221; which comprised of July 30 Note and two embedded derivative financial instruments (i.e. an embedded conversion feature
and an embedded redemption feature to receive cash equals to <span id="xdx_90F_ecustom--EmbeddedConversionFeaturePercentage_iI_pid_dp_c20240730_zIsEmfYfef7g" title="Embedded conversion feature percentage">200</span>% of July 30 Note balance upon the occurrence of a Sale Transaction)
and (ii) three series of detachable warrants. At the initial date, the Company is required to estimate the fair value of the freestanding
instruments and allocate the total gross proceeds received between them based on that relative fair value identified. The fair value
of the embedded derivative financial instruments (i.e. the conversion right and the redemption right) should be bifurcated from the host
instrument and remeasured on recurring basis at each reporting period under marked to market approach, the July 30 Note was accounted
for at amortized cost whereby discount and interest expenses are recorded over the economic life of the July 30 Note based on the effective
interest rate method and the July 30 Warrants are classified into equity without any further subsequent measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            initial recognition, the management by using the assistance of an external appraiser allocated
                                            the gross cash proceeds received based on the relative fair value of the July 30 Note and
                                            the detachable July 30 Warrants in total amount of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240730__20240730_zqSo9tsVZMv" title="Proceeds from notes">1,450</span> and $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240730__20240730_zdMQ41uT4G04" title="Fair value of warrants">2,550</span>, respectively. The fair
                                            value of the convertible note was determined by using hybrid method that includes conversion
                                            scenario and liquidation scenario taking into account, inter alia, a debt discount rate of
                                            <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240730_zwJGQesNW7Je" title="Debt discount rate">28.65</span>%. The fair value of the July 30 Warrants was determined by using Black-Scholes pricing
                                            model taking into account, inter alia, expected stock price volatility of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240730__20240730_zqVH78shgyHi" title="Volatility">122.8</span>% and risk-free
                                            interest rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240730__20240730_zmgCmHyq9079" title="Risk- free interest rate">4.78</span>%. The amount allocated to July 30 Warrants was classified as a component
                                            of equity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
    it was determined that the embedded conversion feature and embedded redemption feature are required to be bifurcated from the host
    loan instrument. The fair value of the bifurcated derivatives was determined by the management using the assistance of an external
    appraiser in a total amount of $<span id="xdx_903_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_c20240730_zWIAD82R0aM3" title="Fair value of embedded derivative liability">35</span> upon initial recognition and in subsequent periods as derivative liability at fair value through
    profit and loss. The remaining amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240730_z7woT8PnKIq4">1,415</span> was allocated to the host loan instrument which in subsequent periods was accounted
    for using the effective interest method over the term of the loan, until its stated maturity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 24, 2024, the Company held a special meeting of its stockholders under which shares of common stock issuable by the Company
upon conversion of the July 30 Note and exercise of the July 30 Warrants was approved. The July 30 Holder has not elected to trigger
the exercise of the July 30 Warrants into shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 12, 2024, the Company and the July 30 Holder entered into an agreement for the settlement of the July 30 Note plus any accrued
but unpaid interest totaling $<span id="xdx_902_eus-gaap--InterestExpense_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zX0cijeriv81" title="Unpaid interest">4,093</span> to Common Stock and warrants at a conversion price of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zsV6MmZsmKD5" title="Conversion price">31.0</span> per share. The July 30 Holder received
<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zsTiE8jZpGi" title="Shares issued">132,036</span> shares of Common Stock, <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zM5mUwXLFugi" title="Shares issued">132,036</span> Series A Warrants and <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zTeq0VCiAZ6f" title="Shares issued">132,036</span> Series B Warrants. The fair value of the shares of Common Stock
received was $<span id="xdx_908_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zQjXYDtMfBma" title="Fair value">813</span>. The Series A and Series B Warrants are treated as derivative liabilities and at grant date were valued at $<span id="xdx_905_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zJ36WYzAnv99" title="Derivative liabilities">609</span> and
$<span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zIQyIiV0gD68" title="Derivative liabilities">3,768</span>, respectively. As of the settlement date, the carrying amount of the July 30 Note under the effective interest method was $<span id="xdx_90D_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zJmXQPChHK3c" title="Fair value of the derivative liability">1,978</span>
and the fair value of the derivative liability relating to the conversion feature was $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zcNAy2fNwUEe" title="Conversion amount">37</span>. Upon settlement, the total fair value of
the warrant related derivatives of $<span id="xdx_908_ecustom--FairValueOfWarrantRelatedDerivatives_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zVrWQQeFlpF2" title="Fair value of the warrant related derivatives">4,377</span> and the equity received of $<span id="xdx_900_ecustom--FairValueOfWarrantRelatedDerivativesValue_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zeVJKt7GYZu9" title="Fair value of the warrant related derivatives book value">813</span> exceeded the net book value of the July 30 Note of $<span id="xdx_90F_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zIfR0Di3BRqd" title="Fair value of the derivative liability">1,978</span> and
the value of the debt conversion derivative that was settled of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zxci8mtEqcGc" title="Conversion amount">37</span>. As a result, the Company recorded a loss on  extinguishment of debt
in the amount of $<span id="xdx_900_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20241112__20241112_zCYwIZucXBB" title="Loss on settlement debt">3,175</span> in the Statement of Operations. Please see Note 4J for the terms and valuation methodology of the Series A and
Series B Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
    23 Conversion</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 23, 2024 (the &#8220;Commitment Date&#8221;), the Company and two of June 27 Investors entered into conversion agreement,
    under which the Company agreed to convert the principal nominal amount plus any accrued but unpaid interest pursuant to each of June
    27 Notes, with a face value of $<span id="xdx_90F_eus-gaap--InterestExpense_pn3n3_c20240823__20240823__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zbMIAdMndhwg" title="Interest expense">20</span> each (the &#8220;Debt&#8221;), held by the Investors to Common Stock at a conversion price of
    $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zySWPQaJNg5h" title="Conversion price">20.4</span> per share. On October 15, 2024, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241015__20241015_zkNOk5IwPrRg" title="Stock issued during period shares issued for services">985</span> shares of common stock for each of the two of the June 27 Investors
    in respect of each respective Debt converted.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            satisfaction of the Debt, the Company also issued to each of the two June 27 Investors three
                                            warrants (each an &#8220;August 23 Warrant&#8221;). Each August 23 Warrant becomes exercisable
                                            on <span id="xdx_906_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20240823__20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantMember_z17UjLLG5V18" title="Warrants exercisable">August 16, 2025</span> and has term of <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantMember_zox6rZrPFCMa" title="Warrants and rights outstanding term">10 years</span>. The August 23 Warrants are exercisable for cash
                                            only and have no price-based antidilution. The first August 23 Warrant is for <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantOneMember_zBTOw9onf0lc" title="Class of warrant or right number of securities called by warrants or rights">535</span> shares
                                            of Common Stock and is exercisable at $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantOneMember_zl5Zo0nipCH5" title="Exercise price">37.5</span> per share. The second August 23 Warrant is for
                                            <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantTwoMember_zFSd0H8KkNk4" title="Class of warrant or right number of securities called by warrants or rights">382</span> shares of Common Stock, exercisable at $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantTwoMember_zVpQ5VfNf7Fg" title="Exercise price">52.5</span> per share. The third August 23 Warrant is
                                            for <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantThreeMember_zmqSh3JPAbhg" title="Class of warrant or right number of securities called by warrants or rights">297</span> shares of Common Stock, exercisable at $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantThreeMember_zJiZ1aa04Xi2" title="Exercise price">67.5</span> per share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    above transaction was accounted for as a settlement of financial liabilities under which the instruments issued or to be issued to
    the June 27 Investors (i.e. shares of common stock and August 23 Warrants) are eligible for equity classification and thus both have
    been recorded as part of equity based on the total fair value of $<span id="xdx_904_eus-gaap--EquityFairValueDisclosure_iI_pn3n3_c20240823_z09wiISPCquk" title="Equity fair value disclosure">238</span> at the Commitment Date. The difference between the fair value
    of these equity instruments and the carrying amount of each of the respective Debt at the Commitment Date amounted to $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240823_zVWWZ50izxml" title="Debt instrument face amount">11</span> was charged
    immediately to the finance expenses (see also Note 7 below). Due to the above settlement, the Company recorded a loss on the settlement
    on the amount of $<span id="xdx_90E_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20240823__20240823_zABvb7YnA8A3" title="Loss on settlement debt">216</span>.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the period commencing the issuance date through December 31, 2024, none of the August 23 Warrants have been exercised.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
    5 Conversion</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            September 5, 2024 (the &#8220;Commitment Date&#8221;), the Company and one of June 27 Investors
                                            and July 18 Investors entered into a conversion agreement, under which the Company agreed
                                            to convert outstanding board fees amounted $<span id="xdx_90F_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_z9pzxzE6iHB9" title="Interest expense">113</span> and the principal nominal amount plus any
                                            accrued but unpaid interest pursuant to June 27 Note and July 18 Note, totaling $<span id="xdx_909_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--JulyEighteenNotesMember_zEH9y3uBrvh4" title="Interest expense">146</span> (referring
                                            together as a &#8220;Debt&#8221;), held by the Investor to Common Stock at a conversion price
                                            of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--JulyTwentySevenNotesMember_zO03f1MMbfPa" title="Conversion price">20.4</span> per share. On October 15, 2024, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241015__20241015__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zKAXvRUgXwKc" title="Stock issued during period shares issued for services">12,712</span> shares of common stock
                                            for the June 27 Investor in respect of the Debt converted.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    satisfaction of the Debt, the Company also issued to June 27 Investor and July 18 Investor three warrants (each an &#8220;September
    5 Warrant&#8221;). Each September 5 Warrant becomes exercisable on <span id="xdx_904_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsMember_zrJHLMPfYbN1" title="Warrants exercisable">August 16, 2025</span> and has term of <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsMember_zYMEHkoOBh22" title="Warrants and rights outstanding term">10 years</span>. The September 5 Warrants
    are exercisable for cash only and have no price-based antidilution. The first September 5 Warrant is for <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsOneMember_zzRItV2Z0FV1" title="Class of warrant or right number of securities called by warrants or rights">6,915</span> shares of Common Stock
    and is exercisable at $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsOneMember_zNOlSfhqkr7" title="Exercise price">37.5</span> per share. The second September 5 Warrant is for <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsTwoMember_zuiLyxiXgVBc" title="Class of warrant or right number of securities called by warrants or rights">4,940</span> shares of Common Stock, exercisable at $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsTwoMember_zCw1Ee4GHrzg" title="Exercise price">52.5</span> per
    share. The third September 5 Warrant is for <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsThirdMember_zxa637LkjBKi" title="Class of warrant or right number of securities called by warrants or rights">3,842</span> shares of Common Stock, exercisable at $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsThirdMember_zCZWpWrxNCj6" title="Exercise price">67.5</span> per share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    above transaction was accounted for as settlements of financial liabilities under which the instruments issued or to be issued to
    the July 18 Investor (i.e. shares of common stock and September 5 Warrants) are eligible for equity classification and thus both
    have been recorded as part of equity based on the total fair value of $<span id="xdx_901_eus-gaap--EquityFairValueDisclosure_iI_pn3n3_c20240905_zOmw3OhEbMwa" title="Equity fair value disclosure">1,505</span> at the Commitment Date. The carrying amount of the Debt
    at the Commitment Date amounted to $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240905_zRgoLrr0GsIl" title="Debt instrument face amount">227</span> and the difference was recorded as loss on settlement of debt in the Statement of Operations
    in the amount of $<span id="xdx_905_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20240905__20240905_zGqVLk76fea9" title="Loss on settlement debt">1,278</span> (see also Note 7 below).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the period commencing the issuance date through December 31, 2024, none of the September 5 Warrants have been exercised.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>November
    12 Issuance</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 12, 2024, the Company completed a public offering (the &#8220;Offering&#8221;) under
                                            which the Company received gross proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20241112__20241112_zWMSviPQXNsj" title="Gross proceeds from public offering">10,000</span> in exchange for issuance of an aggregate
                                            of (i) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSJlQiH5QPG5" title="Shares issued">121,867</span> shares (the &#8220;Shares&#8221;) of its Common Stock, (ii) <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zBmn4GDkNb6e" title="Warrants to purchase shares">237,845</span> pre-funded
                                            warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to an aggregate of <span id="xdx_905_eus-gaap--SharesIssued_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zRv3svNccvHe" title="Shares issued">237,845</span>
                                            shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;) in lieu of Shares, (iii)
                                            Series A Warrants (the &#8220;Series A Warrants&#8221;) to purchase up to <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonWarrantMember_zm5NzMxZQNA7" title="Warrants to purchase shares">359,712</span> shares
                                            of Common Stock (the &#8220;Series A Warrant Shares&#8221;) and (iv) Series B Warrants (the
                                            &#8220;Series B Warrants&#8221; and, together with the Series A Warrants, the &#8220;Common
                                            Warrants&#8221;) to purchase up to <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBCommonWarrantMember_zdTkdbD1EI43" title="Warrants to purchase shares">359,712</span> shares of Common Stock (&#8220;the &#8220;Series
                                            B Warrant Shares&#8221; together with the Series A Warrant Shares, the &#8220;Warrant Shares&#8221;).
                                            Each Share or Pre-Funded Warrant, as applicable, was sold together with one Series A Warrant
                                            to purchase one share of Common Stock and one Series B Warrant to purchase one Common Share.
                                            The public offering price for each Share and accompanying Common Warrants was $<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_zKl7wgiBIuCc" title="Shares issued, per share">27.80</span>, and
                                            the public offering price for each Pre-Funded Warrant and accompanying Common Warrants was
                                            $<span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1EMHM1vM2we" title="Shares issued, per share">27.78</span> (the &#8220;Offering Price&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Pre-Funded Warrants have an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zZvYu8Vi9P68" title="Warrant, exercise price">0.02</span> per share, are exercisable immediately and expire when exercised in full. Each
    Series A Common Warrant will have an exercise price per share of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonWarrantMember_zKpeGoJL24Pi" title="Warrant, exercise price">36.2</span> and will be exercisable beginning on the date on which Stockholder
    Approval (as defined below) is received and deemed effective (the &#8220;Initial Exercise Date&#8221; or the &#8220;Stockholder Approval
    Date&#8221;). The Series A Warrants will expire on the five-year anniversary of the Initial Exercise Date. The Series B Warrants
    will have an exercise price per share of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBCommonWarrantMember_zjlVZPq8QtB8" title="Warrant, exercise price">36.2</span> and will be exercisable beginning on the Initial Exercise Date. The Series B Warrants
    will expire on the two and one-half year anniversary of the Initial Exercise Date. The issuance of Common Warrant Shares upon exercise
    of the Common Warrants is subject to stockholder approval under applicable rules and regulations of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
    (&#8220;Stockholder Approval&#8221; and the date on which Stockholder Approval is received and deemed effective, the &#8220;Stockholder
    Approval Date&#8221;).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    exercise price of Series A Warrants and Series B Warrants is subject to certain adjustments. If at the time of exercise there is
    no effective registration statement registering, or the prospectus is not available for the issuance of the Series A Warrants Shares
    and Series B Warrant Shares to the holders, then the Series A Warrants and Series B Warrants may also be exercised, in whole or in
    part, at such time by means of a &#8220;cashless exercise&#8221;. In addition, the holders are entitled to an option to require the
    Company to purchase the Series A Warrants and Series B Warrants for cash in an amount equal to their Black-Scholes Option Pricing
    Model value, in the event that certain fundamental transactions (which some of them are not considered solely within the control
    of the Company) as defined in the Series B Warrants agreement, occur. Additionally, holders of Series B Warrants may also effect
    an &#8220;alternative cashless exercise&#8221; at any time while the Series B Warrants are outstanding following the Initial Exercise
    Date. Under the alternate cashless exercise option, the holder of the Series B Warrant has the right to receive an aggregate number
    of shares equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cashless exercise
    of the Series B Warrant and (ii) 3.0. The Company analyzed the terms of the warrants in accordance with Accounting Standards Codification
    No. 480, <i>Distinguishing Liabilities from Equity</i> (&#8220;ASC 480&#8221;) and determined that the Series A and Series B Warrants
    are not eligible for equity classification and thus would be classified as derivative liabilities and recorded at fair value, with
    changes in fair value recorded through profit or loss. The Company used the Monte Carlo Simulation method for determining the fair
    value of the warrants. The Series A Warrant assumptions used in the Monte Carlo simulations are an expected term of <span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z9949G0KyME5" title="Expected term years">5</span> years, exercise
    price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zapUGoyJRTH2" title="Exercise price">36.2</span>, comparable company volatility of <span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zfbhkTyUAOkj" title="Volatility rate">96.3</span>%, risk-free interest rate of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zdUvutBgIIG1" title="Interest rate">4.32</span>% and share price of $<span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zG3cqmPoSnke" title="Share price">6.17</span>. The Series B Warrant
    assumptions used in the Monte Carlo simulations are an expected term of <span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z5PN0aZYYAta" title="Expected term years">2.5</span> years, exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdp6iUyw1Rkd" title="exercise price">36.2</span>, company historical volatility
    of <span id="xdx_903_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zTOC484c1zv6" title="volatility">378.6</span>%, risk-free interest rate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zH1czuAkJ01d" title="Risk free interest rate">4.30</span>% and share price of $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zFDs7PjQaQr4" title="Share price">6.17</span>.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition, the management allocated the gross cash proceeds to the detachable instruments included in the issuance, firstly
    to Series A Warrants and Series B Warrants which were classified as financial instruments that are required to be subsequently measured
    at fair value. The fair value at the issuance date of the Series A and Series B Warrants received was $<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zuLbq51y5WQ7" title="Fair value issuance">1,659</span> and <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zFrPrcpYpKd6" title="Fair value issuance">10,266</span>, respectively.
    Accordingly, there were no remaining proceeds to allocate to the equity instruments (the Shares and the Pre-Funded Warrants). Issuance
    costs in the amount of $<span id="xdx_903_ecustom--EquityIssuanceCosts_pn3n3_c20240101__20241231_zw0w21SCrWjg" title="Equity issuance costs">1,217</span> were recorded as expenses in the Statement of Operations.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition, as the total fair value of the derivative liabilities amounting to $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241231_zmNPvMQPCwh7" title="Fair value issuance">11,925</span> exceeded the $<span id="xdx_90B_ecustom--ClassOfWarrantOrRightReasonForCashRaised_pn3n3_c20240101__20241231_z0mpSHsOPeug" title="Fair value cash raised">10,000</span> of cash raised in the issuance,
    the Company recorded an immediate loss from the issuance of equity in the amount of $<span id="xdx_901_ecustom--GainLossOnEquityIssuance_iN_pn3n3_di_c20240101__20241231_z4w4LImdwUVb" title="Loss on equity issuance">1,925</span> in the Statement of Operations.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Note 14 regarding a significant issuance of shares as a settlement of Series B Warrants subsequent to the balance sheet date.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tabular presentation reflects the reconciliation of the fair value of the Warrants during the period from their issuance through
December 31, 2024:</span></p>

<p id="xdx_894_ecustom--ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_zHPTjgCmnKH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zrEEX7hZhYze" style="display: none">SCHEDULE OF RECONCILIATION OF THE
FAIR VALUE OF THE WARRANTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Common Warrants</b></td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    A Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    B Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">July issuance</td>
    <td>&#160;</td>
    <td>$</td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zothQHk05qo5" style="text-align: right">34</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zyjzotPs6cZk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Settlement of July warrants</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_98D_eus-gaap--DerivativeLiabilities_iNI_di_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zM5WrZeLqBHa" style="text-align: right">(37</td>
    <td>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zSEgNfU2s6Q6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">November issuance</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 12%">-</td>
    <td style="width: 1%">&#160;</td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zAHJKYckqqI" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,659</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z2SDXoaKDPl4" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,266</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231_zEoAAEQdhnG6" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,925</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Settlement of July 30 Convertible Promissory
    Note</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zKji4VH4AQU9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">609</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_z8ojZdUDHMI1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,768</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zdfnem8pASHg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,377</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Settlement of July 18 Convertible Promissory
    Note</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_z4eCCdZQksGh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zYXCzt00Le54" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">279</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zVSbUt2Vord9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zm6qh7wfSiLg" style="border-bottom: Black 1pt solid; text-align: right">3</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zIrMNUIrn8Mi" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">230</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zyr94jq70tQ2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">565</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231_zrbSjxmjjQ8e" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">798</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2024</span></td>
    <td>&#160;</td>
    <td><b>$</b></td>
    <td style="text-align: right"><b>-</b></td>
    <td>&#160;</td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z2TXbwpfsUo9" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,544</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdqXFV0gyFfi" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,877</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_znRu6gwQIiKe" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DisclosureSignificantTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DisclosureSignificantTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SignificantTransactionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Transactions [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SignificantTransactionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zEHqyKYrVkde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_822_zi4zQGR3fTw">COMMITMENTS AND CONTINGENT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    2004, the Israeli Innovation Authority (IIA) provided Integrity Israel with a grant of approximately $<span id="xdx_908_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember_zetCAtf0Hq11">93</span> (NIS <span id="xdx_902_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_uIsrael_c20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember_zuBzhv6IbkT1" title="Contingent consideration liability">420,000</span>), for develop
    a non-invasive blood glucose monitor (the &#8220;Development Plan&#8221;). Integrity Israel is required to pay royalties to IIA at
    a rate ranging between <span id="xdx_90B_ecustom--RoyaltyPercentage_pid_dp_uPure_c20040303__20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember__srt--RangeAxis__srt--MinimumMember_z5RtbXBJvz0l" title="Royalty percentage minimum">3</span>-<span id="xdx_903_ecustom--RoyaltyPercentage_pid_dp_uPure_c20040303__20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember__srt--RangeAxis__srt--MaximumMember_z10Fcv8efBy9" title="Royalty percentage maximum">5</span>% of the proceeds from sale of the Company&#8217;s products arising from the Development Plan up to an
    amount equal to $<span id="xdx_90A_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20040304__dei--LegalEntityAxis__custom--IsraeliInnovationAuthorityMember_zwWDitPsIrN5" title="Business combination contingent consideration liability">93</span>, plus interest at LIBOR from the grant date. Until December 31,2023 the Liability was subject to LIBOR interest
    rate and commencing January 1,2024 the interest rate was replaced with Term SOFR (Secured Overnight Financing Rate). As of December
    31, 2024, the remaining contingent liability with respect to royalty payment on future sales equals approximately $<span id="xdx_90A_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20241231__dei--LegalEntityAxis__custom--IsraeliInnovationAuthorityMember_zu37c9wZAwJ7" title="Contingent consideration liability">93</span>, excluding
    interest. Such contingent obligation has no expiration date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 7, 2022 (&#8220;the Closing Date&#8221;), the Company entered into Intellectual Property Purchase Agreement (the &#8220;Agreement&#8221;)
    with Paul Goode, which is the Company&#8217;s Chief Executive Officer (the &#8220;Seller&#8221;), under which it was agreed that
    on and subject to the terms and conditions of the Agreement, at the Closing Date, Seller sold and assigned to the Company, all of
    Seller&#8217;s right, title and interest in and to the following assets, properties and rights (collectively, the &#8220;Purchased
    Assets&#8221;): (i) all rights, title, interests in all current and future intellectual property, including, but not limited to patents,
    trademarks, trade secrets, industry know-how and other IP rights relating to an implantable continuous glucose sensor (collectively,
    the &#8220;Conveyed Intellectual Property&#8221;); and (ii) all the goodwill relating to the Purchased Assets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            consideration for the sale of the Purchased Assets to the Company, at the Closing Date, the
                                            Company paid to Seller cash in the amount of one dollar and obligated to issue up to <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221007__20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWZfCLCqLA46" title="Number of common shares issued">10,000</span>
                                            shares of Common Stock to be issued based upon specified performance milestones as set forth
                                            in the Agreement (the &#8220;Purchase Price&#8221;). In addition, if upon the final issuance,
                                            the aggregate <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221007__20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zXURTxGcQiSh" title="Number of common shares issued">10,000</span> shares represent less than <span id="xdx_905_ecustom--AggregateSalesPriceOfUnitsPercentage_iI_pid_dp_uPure_c20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zBos30nfLKbc" title="Commission as a percentage of aggregate sales price">1.5</span>% of the then outstanding Common Stock
                                            of the Company, the final issuance will include such number of additional shares so that
                                            the total aggregate issuance equals <span id="xdx_900_ecustom--AggregateSalesPriceOfUnitsPercentage_iI_pid_dp_uPure_c20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__custom--TrueupSharesMember_zgC4d7NKwUel" title="Commission as a percentage of aggregate sales price">1.5</span>% of the outstanding shares (the &#8220;True-Up Shares&#8221;).
                                            All shares of Common Stock of the Company that will be issued under the agreement shall be
                                            (i) restricted over a limited period as defined in the Agreement and (ii) subject to the
                                            lockup provisions.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    the Company acquires net assets that do not constitute a business, as defined under ASU 2017-01 Business Combinations (Topic 805)
    Clarifying the Definition of a Business (such when there is no substantive process in the acquired entity) the transaction is accounted
    for as asset acquisition and no goodwill is recognized. The acquired In-Process Research and Development intangible asset (&#8220;IPR&amp;D&#8221;)
    to be used in research and development projects which have been determined not to have alternative future use at the acquisition
    date, is expensed immediately.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the Closing Date, it was determined that the asset acquisition represents the purchase of IPR&amp;D with no alternative future use.
    However, the achievement of each of the performance milestones is considered as a contingent event outside the Company&#8217;s control
    and thus the contingent consideration which is equal to the fair value of the Purchase Price as measured at the Closing Date will
    be recognized when and if it becomes probable that each target will be achieved within the reasonable period. Such additional contingent
    consideration will be recognized in subsequent periods if and when the contingency (the achievement of targets) is resolved.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            June 2023, the Company achieved the first performance milestone out of the five performance
                                            milestones outlined in the Agreement executed between the Company and the Seller as of the
                                            Closing Date. As a result, upon the date of the fulfilment of the first performance milestone
                                            the Company was committed to issue <span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20230601__20230630_zQKMDIv4s1Lc" title="Restricted shares to the seller">1,000</span> restricted shares to the Seller. Accordingly, the
                                            Company recorded an amount of $<span id="xdx_90C_eus-gaap--OtherResearchAndDevelopmentExpense_pn3n3_c20230601__20230630_zEyozOrEvXIj" title="Research and development expenses">131</span> as research and development expenses with a similar amount
                                            as an increase to additional paid-in capital. The first performance milestone shares were
                                            issued on February 6, 2024.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    May 2024, the Company achieved the second performance milestone out of the five performance milestones outlined in the Agreement
    executed between the Company and the Seller as of the Closing Date. As result, the Company is committed to issue <span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20240501__20240531_zJpI6oGbMYud" title="Restricted shares">1,500</span> restricted
    shares to the Seller. Accordingly, the Company recorded stock-based compensation expenses amounted to $<span id="xdx_907_eus-gaap--ShareBasedCompensation_pn3n3_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv06VEqaR4y1" title="Stock based compensation">192</span> which represents the quoted
    price of its Common Stock at the Closing Date, after taking into consideration a discount for lack of marketability in a rate of
    <span id="xdx_906_ecustom--MarketabilityDiscountRate_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgbT2MZMgaSd" title="Discount rate">30</span>% over the applicable restriction period. The second performance milestone shares were issued on November 20, 2024, excluding <span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20241120__20241120_zSrsCQwxDCA" title="Restricted shares to the seller">11,000</span>
    shares that were issued erroneously and were returned to the Company subsequent to the balance sheet date.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, the achievement of all other remaining performance milestones was not considered probable and thus no stock-based
    compensation expenses were recorded with respect to thereof.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASE AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DisclosureLeaseAgreementAbstract', window );"><strong>Lease Agreement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASE AGREEMENT</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--LesseeOperatingLeasesTextBlock_zjFUoUFgp7m3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 - <span id="xdx_827_zzfNFJgSREwl">LEASE AGREEMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 19, 2024, the Company entered into Lease Agreement (the &#8220;Agreement&#8221;) with Tapsak Enterprises LLC dba Virginia
    Analytical (the &#8220;Landlord&#8221;) under which it was agreed that the Company will lease from the Landlord a premises located
    in Front Royal, Virginia area for a monthly rental fee of $<span id="xdx_904_eus-gaap--OperatingLeasePayments_pn2n3_c20240219__20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_zqmazfV95FSj" title="Monthly rental fee">2.5</span> over a period of <span id="xdx_905_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_z4OzQoSgRKne" title="Lessee term of contract">3</span>-years commencing March 1, 2024 through February
    28, 2027 (the &#8220;Initial Lease Period&#8221;). Security deposit of $<span id="xdx_908_eus-gaap--SecurityDeposit_iI_pn2n3_c20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_zTcwS2iSUG91" title="Security deposit">2.5</span> which represents payment of one month is held by the
    Landlord which will be return to the Company at the end of the Initial Lease Period.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, the Company has an option to renew the Initial Lease Period for another two additional
                                            periods of 3-years each following the Initial Lease Period (the &#8220;Option Term&#8221;),
                                            following advanced notice as defined in the Agreement. The monthly rental fee over the Option
                                            Term shall be the fair market rate determined as what is a comparable cost for similar property
                                            in Front Royal, Virginia area.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with the provision of ASC 842, Leases, at the commencement date of the Agreement, the Company recognized the right to
    use asset equals to lease liability in total amount of $<span id="xdx_90D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20240219_zSON18amzYVk" title="Lease liability">79</span>. The lease liability was measured at the present value of the future lease
    payments, which are discounted based on an estimate of the incremental interest rate that the Company would be required to pay to
    borrow a similar amount for a similar period in order to obtain a similar amount on the initial recognition date of the lease.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    part of the leasing period, the Company considered only the Initial Lease Period as the realization of the option to extend the period
    was not considered as reasonably certain.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zCv0w4IN9TN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zx0Wt3ZQECd7" style="display: none">SCHEDULE OF OPERATING LEASE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20241231_zROtWDANxNda" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zmiQMgLk0ir7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    right-of-use asset</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_zVXHdFK7wvl8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Current operating lease
    liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zM0gd3dxYT48" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-Current operating
    lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_z0sRuQFxj291" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zOhVyechJiM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity
analysis of the Company&#8217;s lease liability:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_zhxN2Bz7Sp2f" style="display: none">SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20241231_zhk6aBE1hwgl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--LessThanOneYearMember_zQvMjhyypqvl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less than one year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--BetweenOneYearToTwoYearsMember_zZ34HneL7Pj3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Between 1-2 years</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">30</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--MoreThanTwoYearsMember_zG16V3qeFvE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">More than 2 years</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_zz2zcZcRKCyd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease
    payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">65</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3n3_zpgSXldQotae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: imputed interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zVtdeuD5xcGb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_z6zNMXmlhw13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Additional
information on lease</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_z3IoBd8a5rOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the weighted average remaining lease terms and discount rate for the lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zXoNDsXyxAM7" style="display: none">SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease term (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zhDMnhG3g924" title="Lease term (years)">2.17</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20241231_z46dRs2l8mE8" title="Weighted average discount rate">9.03</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p id="xdx_8A5_zQb0mj22NE15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DisclosureLeaseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DisclosureLeaseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE (INCOME) EXPENSES, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCE (INCOME) EXPENSES, NET</a></td>
<td class="text"><p id="xdx_809_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zNWEnU769FUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_829_zaihkd8GrwPj">FINANCE (INCOME) EXPENSES, NET</span></b></span></p>

<p id="xdx_893_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zRY8tApv7TFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zhhyHkGx7s26" style="display: none">SCHEDULE OF FINANCE EXPENSES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20241231_zoPRSF7kunhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zUwuhKxaWOI" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Unaudited</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--DiscountAmortizationAndInterestExpensesOne_pn3n3_msFINztjv_zPDUlIGixaS8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount amortization and interest
    expenses related to June 27 Notes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--InterestExpense_pn3n3_msFINztjv_zvmQStutmMhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expenses related to July 18 Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--DiscountAmortizationAndInterestExpensesTwo_pn3n3_msFINztjv_zQdB24YN1PN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense and debt discount amortization
    related to July 30 Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">563</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpenseDeposits_pn3n3_msFINztjv_zTdn9coQ6hs8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest on bank deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(62</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OtherExpenses_pn3n3_msFINztjv_zQZspfc7BTNg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate differentials,
    bank commissions and miscellaneous</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--FinanceIncomeNet_iNT_pn3n3_di_mtFINztjv_zWdZHG9yDxmj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance (income) expenses,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">583</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p id="xdx_8A8_zZjKSS2PwPY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zS2na9NIF4ci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8211; <span id="xdx_829_zkPT3d3hLrQh">COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    of the rights attached to the Common Stock</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    share of Common Stock entitles the holder to one vote, either in person or by proxy, on each matter submitted to the approval of
    the Company&#8217;s stockholders. The holders of Common Stock are not permitted to vote their shares cumulatively. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
    Issuances</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>1.
                                            2023 Equity Issuances</i></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 13, 2023, the Company completed an underwritten public offering under which the Company received gross proceeds of approximately
    $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20230413__20230413_zxsMl0N5OWo8" title="Gross proceeds">10</span> million for issuance of (i) <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230413__20230413__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9pc7SVGJm8b" title="Common stock shares">53,765</span> shares of common stock and (ii) <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230413__20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zrEzQVIriFxg" title="Common stock shares">19,765</span> pre-funded warrants at a price to the public of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_z9NeeBducPe4" title="Share price">136</span>
    per share. The pre-funded warrants are exercisable for the same number of shares of common stock and may be exercised at any time
    until exercised in full at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zjwIA9gadBMe" title="Exercise price">0.001</span>.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            satisfaction of customary closing conditions, the closing date of the above underwritten
                                            public offering was April 17, 2023 (the &#8220;Closing Date&#8221;). The Company received
                                            substantially all the pre-funded warrant&#8217;s proceeds upfront (without any conditions)
                                            as part of the pre-funded warrant&#8217;s purchase price and in return the Company is obligated
                                            to issue fixed number of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230417__20230417__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGgK4SiizlB7" title="Common stock shares">19,765</span> shares of Common Stock to the holders. Thus, pre-funded warrants
                                            were accounted for and were classified as additional paid-in capital as part of the Company&#8217;s
                                            stockholders&#8217; equity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    incremental and direct issuance costs amounted to $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230413__20230413_zEO8wFS4Gj74">1,270</span> thousand. These expenses were deducted from additional paid-in capital as
    they were allocated to shares of Common Stock and pre-funded warrants.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 3, 2024, the above pre-funded warrants have been fully exercised to <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240103__20240103__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zykf73pA6Cxe" title="Exercises in period">19,765</span> shares of Common Stock of the Company.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
    2024 Equity Issuances</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Notes 4H, 4I and 4J relating to the issuances of shares during 2024.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
    Subsequent event issuances</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Note 14 regarding a significant issuance of shares as a settlement of Series B Warrants subsequent to the balance sheet date.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock-based
    compensation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 11, 2010, the Company&#8217;s Board of Directors approved and adopted the 2010 Share Incentive Plan (the &#8220;Plan&#8221;),
    pursuant to which the Company&#8217;s Board of Directors may award share options to purchase the Company&#8217;s Common Stock as
    well as restricted shares, Restricted Stock Units (the &#8220;RSU&#8221;) and other share-based awards to designated participants.
    Subject to the terms and conditions of the Plan, <span id="xdx_90E_eus-gaap--DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability_c20100110__20100111_zAojIuIoyRRl" title="Plan description">the Company&#8217;s Board of Directors has full authority in its discretion, from
    time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the respective award
    agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of shares to be
    covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and the nature
    and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
    or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election
    as to the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and
    to take actions, as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions
    of the Plan and to amend from time to time the terms of the Plan</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
    of equity awards to employees </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    August 2023, the Company granted Ms. Drinda Benjamin, the Vice President, Marketing of the Company, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230801__20230831__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zc28hDhlxYLd" title="Share based options">2,220</span> options estimated at fair
    value of $<span id="xdx_904_eus-gaap--OfficersCompensation_pn3n3_c20230801__20230831__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYpuTgAko2y1" title="Compensation">51</span>, to purchase the same number of Common Stock, with an exercise price per share equals to the greater of (A) $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230831__srt--TitleOfIndividualAxis__custom--MarkTapsakMember_zE1Yjk4iukvf" title="Share price">136</span> per
    share or (B) the closing price of a share of Common Stock on the grant date, as reported by Bloomberg L.P., which shall vest in equal
    monthly installments over a period of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pid_dtY_c20230801__20230831__srt--TitleOfIndividualAxis__custom--MarkTapsakMember_zzHal6xMW2Ud" title="Grant date period">3</span>-years following the grant date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 14, 2024, the Board of Directors approved the cancellation of all outstanding stock options previously granted to employees,
    directors, and officers of the Company. Concurrently, the Board authorized the issuance of new stock options to the relevant parties.
    The new stock options were issued in replacement with exercise price $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20240614__20240614__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z9ff6GRShmb" title="Exercise price of options">245</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During
    the years ended December 31, 2024 and 2023, the Company recorded stock-based compensation expenses of $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20241231__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember_zyX7Tu2BKz3h" title="Stock based compensation income">173</span>
    and $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember_zqHZIqHqIbol" title="Stock based compensation income">281</span>,
    respectively.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following table presents the Company&#8217;s stock options (excluding RSU) activity for employees and members of the Board of Directors
    of the Company under the Plan, for the years ended December 31, 2024 and 2023:</span></td></tr>
  </table>
<p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zUnlVWsVFWIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z4lrO17mV4sf" style="display: none">SCHEDULE
OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            Options</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            Price</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>life</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>value</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231_zaAzo52k2B6i" style="width: 12%; text-align: right" title="Number outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">8,046</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_znEjOLrl6XJ4" style="width: 12%; text-align: right" title="Weighted average exercise price outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif">152</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z4WJGfWup6U9" title="Weighted average remaining contractual life, Outstanding">2.1</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20230101__20231231_zCUbl0Mjflgk" style="width: 12%; text-align: right" title="Intrinsic value outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231_zfU8A4GVfRV3" style="text-align: right" title="Number of share options outstanding, granted"><span style="font-family: Times New Roman, Times, Serif">2,221</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zZcDHiPYBGgl" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z2iQAj7uehRc" title="Weighted average remaining contractual life, Granted">9.7</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20230101__20231231_z604wfjuE9x8" style="text-align: right" title="Intrinsic value outstanding, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1154">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231_z5ztECF9ku5d" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif">(269</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zlMwPp17oRUe" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif">1290</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zkJDZf9fcDE5" title="Weighted average remaining contractual life, Forfeited or expired">1.7</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20230101__20231231_zz1ROjgS7evc" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20241231_zUPtgFfsZwUe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">9,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20241231_zrFV1luqjgE8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zOLtT6oPq8za" title="Weighted average remaining contractual life, Outstanding">8.0</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zkOXzBCL2CK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20241231_zdoCwT2epni9" style="text-align: right" title="Number of share options outstanding, granted"><span style="font-family: Times New Roman, Times, Serif">6,438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_z1VtIh8cpZr9" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">49.72</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20240101__20241231_zUsBUuVQFV1l" title="Weighted average remaining contractual life, Granted">9.37</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20240101__20241231_zjL9Ynrz5evl" style="text-align: right" title="Intrinsic value outstanding, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_pid_c20240101__20241231_zeiu4L5S6Jcb" style="text-align: right" title="Number of share options outstanding, cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></span></td><td style="text-align: left">&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240101__20241231_zshCKLI4meTl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_zQob9IMwjH9f" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20240101__20241231_zz2eaNDWu22k" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20241231_zWBSV3HSyHG5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">16,436</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zy9RbIAzzlF" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">49.72</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zssR7b6JLeE3" title="Weighted average remaining contractual life, Outstanding">9.37</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zGRFWdgoD0d2" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20241231_zQXojA8mW6ra" style="border-bottom: Black 2.5pt double; text-align: right" title="Number exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">11,249</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_fKg_____zefzLVfuQ09d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">*49.11</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_dtY_c20240101__20241231_z6OgQHJ6l88b" title="Weighted average remaining contractual life, Exercisable">9.41</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zMpdZmEQYNBd" style="border-bottom: Black 2.5pt double; text-align: center" title="Intrinsic value outstanding exercisable, Ending balance"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0E_zSs6eOY0FQQ4" style="width: 15pt; text-align: right">*</td><td id="xdx_F14_zB5eie8s33dc" style="text-align: justify">After modification of exercise price</td>
</tr></table>

<p id="xdx_8A7_zqkTIkOoi42a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of
    the Company&#8217;s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied
    by the number of in-the-money share options) that would have been received by the share option holders had all share options holders
    exercised their share options on December 31 of each of the reported period. This amount is impacted by the changes in the fair market
    value of the Company&#8217;s Ordinary Share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the years ended December 31, 2024 and 2023, stock options have not been exercised into Common Stock. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following table presents the assumptions used to estimate the fair values of the share options granted in the reported periods presented:</span></td></tr>
  </table>
<p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zjPjM1faXsEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zgQjCPA7XeD8" style="display: none">SCHEDULE
OF ASSUMPTIONS USED TO VALUE OPTIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 78%; margin-left: 1.5in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240101__20241231_zoco2NDkmdqg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zbXCx5X3LeV2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Volatility (%)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_z7KiyVdc2EG2" title="Volatility, minimum">207</span>-<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_z3bFWhyk5vWb" title="Volatility, maximum">288</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231_z3XREW8cGXZ5" title="Volatility">220</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate (%)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zWBEKiGF8mKe" title="Risk-free interest rate, minimum">3.51</span>-<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zq7vmfW03l74" title="Risk-free interest rate, maximum">4.64</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231_ztCnsGkLlJ26" title="Risk-free interest rate">4.7</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_zZ6L68M33u1e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yield (%)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231_z2u6oAWG6Yg4" title="Expected life (years)">3</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zdZdM8Yc69Id" title="Expected life (years)">3</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercise price ($)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MinimumMember_zKNewAmVrF39" title="Exercise price, minimum">41</span>-<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MaximumMember_zryWBW8KOAwa" title="Exercise price, maximum">58</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231_zqzEfhJPHuyj" title="Exercise price">140</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price ($)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharePrice_iI_pid_c20241231_zhHl6wdu3URi" title="Share price">49.0</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zItWZe8rqN88" title="Share price">30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_zKazbGoLV2A9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G<b>.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, there was $<span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_c20241231_zrr03num4jtj">298</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    unrecognized compensation expense related to unvested stock options. The Company recognizes compensation expense on an accelerated
    vesting basis over the requisite service periods, which results in a weighted average period of approximately <span id="xdx_90B_eus-gaap--DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_dtY_c20240101__20241231_zBI5tkr03Bt1">1.9 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years
    over which the unrecognized compensation expense is expected to be recognized.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
    of equity awards to non-employees</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    closing of underwritten U.S. public offering in 2023 as noted in Note 8B above, a down round protection feature of certain
    previously granted warrants, was triggered through the reduction of their original exercise prices from a price in a range of $<span id="xdx_908_ecustom--WarrantsOriginalExercisePrice_iI_pn3n3_c20230413__srt--RangeAxis__srt--MinimumMember_zFv73y5L1WMi" title="Warrants original exercise price">335</span>
    -$<span id="xdx_903_ecustom--WarrantsOriginalExercisePrice_iI_pn3n3_c20230413__srt--RangeAxis__srt--MaximumMember_zdRobEy8doxg" title="Warrants original exercise price">7,020</span>
    to a price of $<span id="xdx_902_ecustom--PublicOfferingPrice_iI_pid_c20230413_zOPLne8Rwys5" title="Public offering price">136</span>
    which represented the public offering price. Such reduction was accounted for in accordance with the provisions of ASU 2017-11 as a
    deemed dividend estimated at a total amount of $<span id="xdx_902_eus-gaap--AdditionalPaidInCapital_iI_pn3n3_c20230413_zej7ZbxDNmS4" title="Additional paid in capital">855</span>
    thousand which was recorded as part of the additional paid-in capital versus increase of accumulated deficit. Regarding the effect
    of the loss per share, see also Note 2O above.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following table presents the Company&#8217;s warrants activity for the years ended December 31, 2024 and 2023:</span></td></tr>
  </table>
<p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zz3x9OT8Q3Z6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z3KtLYkDtfp5" style="display: none">SCHEDULE
OF WARRANTS ACTIVITY</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            Warrants</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            Price</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>life</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>value</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20240101__20241231_zCnVzou8sMsc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1248">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20240101__20241231_zKLzb6IWIJN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1250">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iS_pid_c20240101__20241231_zRqnnYeSaLk3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20240101__20241231_zPl8gX257xNf" style="width: 12%; text-align: right" title="Number of share warrants outstanding, granted"><span style="font-family: Times New Roman, Times, Serif">1,278,259</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20240101__20241231_zeKl98MZJFah" style="width: 12%; text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">39.66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z9dXKfNYeT23" title="Weighted average remaining contractual life, Granted">9.31</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_pid_c20240101__20241231_zFRqZ3odyWHg" style="text-align: right" title="Number of share warrants outstanding, cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_pid_c20240101__20241231_zTR5NRmxVzJd" style="text-align: right" title="Weighted average exercise price, cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20240101__20241231_z3nkyB9LmqOg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_pid_c20240101__20241231_zSMIyESEGBji" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20240101__20241231_zUS7LlIrOzhi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">1,278,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20240101__20241231_zUI9uG1tRdr4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">39.66</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_z4aCRMu8GOId" title="Weighted average remaining contractual life, Outstanding">9.31</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iE_pid_c20240101__20241231_zQPsNMwjNva3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240101__20241231_zMGsGRoioc61" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share options exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">1,278,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zZaQRERu0qdj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">39.66</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_dtY_c20240101__20241231_zOH7Lo6Ps39h" title="Weighted average remaining contractual life, Exercisable">9.31</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zjv2ltqCtgdl" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zArscaMVYNKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    total compensation cost related to all of the Company&#8217;s equity-based awards recognized during the years ended December 31,
    2024 and 2023 was comprised as follows:</span></td></tr>
  </table>
<p id="xdx_89D_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zN9EaBRuUQl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zwXR2MIxMf8c" style="display: none">SCHEDULE
OF TOTAL COMPENSATION COST EQUITY BASED AWARDS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240101__20241231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_zwVM0JAAKlac" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20231231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_z8tnmwU7QbD8" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zcDJHAAIkttl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">307</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">176</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zyyS2nvu4MK2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">364</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zxSSOebnpZq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total compensation cost
    </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">335</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AA_zsyo2Y6jrSLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH AND DEVELOPMENT EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">RESEARCH AND DEVELOPMENT EXPENSES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_z5GT5QD7l5Wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_827_zbEbjiwqGhQa">RESEARCH AND DEVELOPMENT EXPENSES</span></b></span></p>

<p id="xdx_89D_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_zeYCwsmQlvV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_z3tS403mB4J" style="display: none">SCHEDULE
OF RESEARCH AND DEVELOPMENT EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240101__20241231_zieA5Qcf5x0k" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20231231_zaCiAlzk1Fma" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Research and
    Development</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--SalariesAndRelatedMember_zBPzX7Rqwqkf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Salaries and related expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,881</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">930</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--ProfessionalFeesMember_ze9rs3UF3WU2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,363</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,709</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--DepreciationMember_zSD4xvmiNPy2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--OtherExpenseMember_zSfuba1NFXS9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">241</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_zYw3VtnrXsgj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Research and Development
    Expense</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,499</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,704</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AE_zqXIUkkgAa02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract', window );"><strong>General And Administrative Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_GeneralAndAdministrativeExpensesTextBlock', window );">GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
<td class="text"><p id="xdx_805_ecustom--GeneralAndAdministrativeExpensesTextBlock_zznxPwI2bId6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_824_zjBGTRGWPtph">GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></p>

<p id="xdx_89A_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_z2CXkyoEzpk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zFHyXYGZvPRg" style="display: none">SCHEDULE
OF GENERAL AND ADMINISTRATIVE EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240101__20241231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM8UdbFpODS" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zT9wmhaz4rAe" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">General and
    Administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LaborAndRelatedExpense_pn3n3_maGAAEzQ9k_zCpat4NjDHgk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Salaries and related expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">476</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">340</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ProfessionalFees_pn3n3_maGAAEzQ9k_zi4SxpoWDAhl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees (including directors&#8217;
    fees)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepreciationAndAmortization_pn3n3_maGAAEzQ9k_zrUjIai7EGw1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentIncomeInvestmentExpense_pn3n3_maGAAEzQ9k_zIIKtdrgapB7" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Insurance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">313</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherGeneralAndAdministrativeExpense_pn3n3_maGAAEzQ9k_zWX9v32IOFne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">120</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzQ9k_zw6DDv0l8y45" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total general and administrative
    expenses</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,655</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,278</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AB_zH0EAE74M6el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_GeneralAndAdministrativeExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General and Administrative Expenses [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_GeneralAndAdministrativeExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAX</a></td>
<td class="text"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zOjE6R0Asjge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211; <span id="xdx_821_znES89XFp9D7">INCOME TAX</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Measurement
    of results for tax purposes under the Israeli Income Tax (Inflationary Adjustments) Law, 1985 (the &#8220;Inflationary Adjustment
    Law&#8221;)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
    January 1, 2008, the results of operations of Integrity Israel for tax purposes have been measured on a nominal basis.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
    assessments</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    federal, state and local income tax purposes the Company remains open for examination by the tax authorities for the tax years from
    2019 through 2022 under the general statute of limitations. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding,
    pursuant and subject to the provisions of article 145 of the Income Tax Ordinance, Integrity Israel&#8217;s tax returns that were
    filed with the tax authority up to and including 2018 are considered final.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
    for the years ended December 31, 2024 and 2023 consists of the following:</b></span></td></tr>
  </table>
<p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z6iMj2VfIwxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B3_zLn2HZGvSjL" style="display: none">SCHEDULE
OF INCOME TAX LOSS FOR THE YEAR</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 55%; margin-left: 1in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20241231_z9llL1qhyTj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20230101__20231231_zN8DzbJCIRRb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationTaxSettlementsDomestic_z721b59wgzy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Domestic</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,502</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,945</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationTaxSettlementsForeign_zZbKhuq8YfDa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign entity (Integrity
    Israel)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">152</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationTaxSettlements_zX2ikabwNa2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="display: none; font-size: 10pt">Total
    loss for the year</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,097</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_z0Oj0ARLpWv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
    Operating Losses (NOL) carryforward </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, the Company had cumulative Net Operating Losses (NOL) carry forward for US federal purposes of approximately
    $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20241231_zr1c7rgsOgr4" title="Operating loss carryforwards">31.6</span> million to offset against future taxable income for an indefinite period of time. Integrity Israel has cumulative NOL carry
    forward for Israeli income tax purposes of approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zjHIp1RnvlI4" title="Operating loss carryforwards">38.5</span> million to offset against future taxable income for an indefinite
    period of time.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31, 2024 and 2023, the main reconciling item is the recognition of valuation allowance in respect of deferred
    taxes relating to accumulated net operating losses carried forward and other permanent and temporary differences due to the uncertainty
    of the realization of such deferred taxes.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    taxes result principally from temporary differences in the recognition of certain revenue and expense items for financial and income
    tax reporting purposes. Significant components of the Company&#8217;s future tax assets are as follows:</span></td></tr>
  </table>
<p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z3M5qgJqhpPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zoi4M9xEydMj" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20241231_zd3wTWWq6y94" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_z7RHaI1h04Bk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Composition
    of deferred tax assets:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsTaxVacationAccrual_iI_pn3n3_maDTAGzT7c_zf71lr31RLTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vacation accrual</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">208</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pn3n3_maDTAGzT7c_z4haGyC1HmA5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development credits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzT7c_zYDnguFiRVFb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net operating losses carry
    forwards</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,981</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,368</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzT7c_maDTANzC5T_ztVwDgQk3JP6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset
    before deferred tax liabilities and valuation allowance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,465</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,467</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--DeferredTaxAssetValuationAllowance_iNI_pn3n3_di_msDTANzC5T_zeoDvg2oPx4d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,465</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13,467</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzC5T_zsCEpPYzmoXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_zHIxdSaaxFkh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ziFcjqHPMZQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_82E_zMsUzROzqZq6">RELATED PARTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information regarding the intellectual property purchase agreement from the company&#8217;s CEO - See Note 5B above.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information regarding loans received from certain Stockholders - See Note 3 above.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tapsak
                                            Enterprises LLC, dba Virginia Analytical</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 25, 2022, the Company entered into agreement with Tapsak Enterprises LLC dba Virginia Analytical, which fully owned by Mark
    Tapsak, who serves as the Vice President of Sensor Science of the Company, under which, Tapsak Enterprises LLC dba Virginia Analytical,
    is providing laboratory space, equipment and materials to support the Company sensor development activities. During the years ended
    December 31, 2024 and 2023, a total amount of $<span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkTapsakMember__us-gaap--TypeOfArrangementAxis__custom--TapsakEnterprisesLLCAgreementMember_zvSz1aPhauI4" title="Research and development expense">25</span> and $<span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkTapsakMember__us-gaap--TypeOfArrangementAxis__custom--TapsakEnterprisesLLCAgreementMember_zD5w8oGf5CY" title="Research and development expense">162</span> were recorded as part of the Company&#8217;s research and development
    expenses, respectively.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information regarding execution of lease agreement with Tapsak Enterprises LLC dba Virginia Analytical, see Note 6.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regarding
    the issuances of notes, shares, warrants and settlement of notes, ee Note 4 above.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_z1aHqmXzeOPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 &#8211; <span id="xdx_826_z9kq90wzW5mi">SEGMENT REPORTING</span>:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
280, &#8220;Segment Reporting&#8221; establishes standards for reporting information about operating segments on a basis consistent with
the Company&#8217;s internal organization structure as well as information about services categories, business segments and major customers
in financial statements. The Company has only one reportable segment, the Glucotrack CBGM Product Segment, as all their research and
development activities are related the development of the Glucotrack CBGM Product. Since the Company operates in one operating segment,
all required financial segment information can be found in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adheres to the provisions of ASC 280, Segment Reporting, which establishes standards for the way public business enterprises
report information about operating segments in annual financial statements and requires that those enterprises report selected information
about operating segments in financial statements issued to shareholders. As the Company is currently involved in the development of one
product, the Platform, the Company has determined that it operates in a single reportable segment. The Company&#8217;s Chief Operating
Decision Maker (CODM), its Chief Executive Officer (CEO), reviews the consolidated results of operations when making decisions about
allocating resources and assessing the performance of the Company as a whole and, hence, the Company has only one reportable segment.
The Company&#8217;s assets are located in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zjINXV4Rhkzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14</b> &#8211; <b><span id="xdx_820_z2cIP0TmiaDf">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">2025 Reverse Stock
Split and Increase in Authorized Common Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Company filed with the Delaware
Secretary of State a Certificate of Amendment to its Certificate of Incorporation which became effective at 4:30 p.m. on February 3, 2025,
to implement a <span id="xdx_907_eus-gaap--StockholdersEquityReverseStockSplit_c20250203__20250203__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znlyfRrYAsRf" title="Reverse stock split">reverse stock split at a ratio of 1-for-20</span> (the &#8220;2025 Reverse Stock Split&#8221;) of the shares of its Common Stock.
The 2025 Reverse Stock Split was approved by the Company&#8217;s stockholders at the special meeting of stockholders held on January 3,
2025 (the &#8220;Special Meeting&#8221;). All shares and per share numbers in the consolidated financial statements have been retroactively adjusted and are
reflected on a post-reverse share split basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On
January 3, 2025, the Company filed an amendment to the Company&#8217;s Certificate of Incorporation, as to increase the Company&#8217;s
authorized shares of Common Stock from <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250103__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhi3msvb42Gf">100,000,000</span> to <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250103__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4p1Qx4rViik">250,000,000</span>. On February 3, 2025, the stockholders approved at the Special Meeting
the increase in the Company&#8217;s authorized shares of Common Stock from <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250203__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcWCRmZ1hj19">100,000,000</span>
to <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250203__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z54fTH6c6nP3">250,000,000</span>,
as well as the full issuance of shares of Common Stock issuable by the Company upon the exercise of Series A Warrants and Series B Warrants
(see below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">ATM Sales Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On December 17, 2024, the Company entered
into an ATM sales agreement (the &#8220;Sales Agreement&#8221;) with Dawson James Securities, Inc. (&#8220;Dawson James&#8221;), pursuant
to which the Company have agreed to issue and sell shares of Common Stock, having an aggregate offering price of up to $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn4n6_c20241217__20241217__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_z1Q7vBemxfE6" title="Offering price">8.23</span> million, from time
to time, through an &#8220;at-the-market&#8221; equity offering program under which Dawson James will act as sales agent (the &#8220;Agent&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On March 21, 2025, the Company sold <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250321__20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z770A3VPDTXg" title="Common stock, shares">12,377,967</span>
shares of Common Stock at an average offering price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_c20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWJe4YJK2nHd" title="Share price">0.304</span> per share pursuant to the Sales Agreement. for net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20250321__20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5ft65ZIrhHl" title="Net proceeds">3.6</span>
million, after deducting fees owed to the Agent from such sale. The shares of Common Stock were offered by the Company pursuant
to a prospectus supplement dated December 17, 2024, and accompanying prospectus dated October 3, 2024, which forms a part of the Company&#8217;s
registration statement on Form S-3 (Registration No. 333-282297), which was declared effective by the Securities and Exchange Commission,
on October 3, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Registered Direct Offering</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On February 4, 2025, the Company
entered into a securities purchase agreement with certain institutional investors, relating to the registered direct offering and sale
of an aggregate of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zj5kwefqLKr6" title="Common stock, shares">2,638,042</span> shares of Common Stock at an offering price of $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVQ4b0x48d8h" title="Share price">1.15</span> per share. The net proceeds to the Company from the
offering were approximately $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYErQYbglKCk" title="Net proceeds">2.7</span> million, after deducting fees owed to placement agent and other offering expenses. The February 2025
offering closed on February 5, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The shares of Common Stock from
the February 2025 registered direct offering was offered by the Company pursuant to a prospectus supplement dated February 4, 2025, and
accompanying prospectus dated October 3, 2024, which forms a part of the Company&#8217;s registration statement on Form S-3 (Registration
No. 333-282297), which was declared effective by the Securities and Exchange Commission, on October 3, 2024. Dawson James acted as the
placement agent for the offerings pursuant to a placement agency agreement, dated February 4, 2025, by and between the Company and Dawson
James.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Warrant Exchange</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Beginning
on January 6, 2025, through March 15, 2025, the Company received exchange notices from certain holders of the Series B Warrants, with
respect to an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBWarrantsMember_zTkYqUcZU36j">359,612</span>
of the Series B Warrants, requiring the delivery of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhyLm0xBnLU7">9,721,782</span>
shares of Common Stock according to the alternative cashless exercise, as applicable to the Series B Warrants under the November
2024 offering. The remaining <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBWarrantsMember_zSSPMilZUlUe">100</span>
Series B Warrants are exchangeable for an aggregate of approximately <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zORxgWiXwBD4">1,940</span>
shares of Common Stock (subject to adjustment in the event of any stock dividend and split, reverse stock split, recapitalization,
reorganization or similar transaction).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline">Appointment of Peter C. Wulff as Chief Financial
Officer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">In connection with Mr.
Cardwell&#8217;s resignation, on January 28, 2025, the Board appointed Peter C. Wulff as Chief Financial Officer of the Company.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates in the preparation of financial statements</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--UseOfEstimates_zjDx5ZhV6Yt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zEznVgam0Iz4">Use
    of estimates in the preparation of financial statements</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions
    that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of
    the financial statements, and the reported amounts of expenses during the reported periods. Actual results could differ from those
    estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to evaluation of going
    concern, the classification of financial instruments as equity or liability, share based compensation and the determination of the fair value of derivative
    liabilities.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_FunctionalCurrencyPolicyTextBlock', window );">Functional currency</a></td>
<td class="text"><p id="xdx_84D_ecustom--FunctionalCurrencyPolicyTextBlock_zcMGwwBuz3Z3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zsfOrdVScWMf">Functional
    currency</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    functional currency of the Company is the US dollar, which is the currency of the primary economic environment in which it operates.
    In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to foreign currency
    are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions
    included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses
    arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.
    The functional currency of the Israeli subsidiary is the New Israeli Shekel (&#8220;NIS&#8221;) and its financial statements are
    included in consolidation, based on translation into US dollars. Accordingly, assets and liabilities were translated from NIS to
    US dollars using year-end exchange rates, and expense items were translated at average exchange rates during the year. Gains or losses
    resulting from translation adjustments are reflected in stockholders&#8217; equity, under &#8220;accumulated other comprehensive
    income&#8221;.</span></td></tr>
  </table>
<p id="xdx_899_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zZ9rfSF7hGXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B8_zTTl2xrLE2B8" style="display: none">SCHEDULE OF OFFICIAL EXCHANGE RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Official exchange rate of NIS
    1 to US dollar</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20241231_z3HXiJacJyz9" title="Official exchange rate of NIS 1 to US dollar">0.274</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231_zvIwJW1INYW9" title="Official exchange rate of NIS 1 to US dollar">0.272</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Increase (Decrease) of the official exchange
    rate of NIS 1 to US dollar during the year:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20241231_z2itxYshtO72" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:">0.74</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_di_uPure_c20231231_z76cwanQoTr2" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:">(8.86</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  </table>

<p id="xdx_8A9_zoMrBAn5EBze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zid9BrgUl8zf" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_ze3PW2OpjFOe">Principles
    of consolidation</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
    have been eliminated in consolidation.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and cash equivalents and restricted cash</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zvmJcRej0eh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zTEQrxYW2h43">Cash
    and cash equivalents and restricted cash</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company considers all short-term investments, which are highly liquid investments with original
                                            maturities of three months or less at the date of purchase, to be cash equivalents.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash is invested in certificates of deposit, which are used to secure Integrity Israel&#8217;s obligations in respect of its credit
    card.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    presentation of statement of cash flows purposes, restricted cash balances are included with cash and cash equivalents, when reconciling
    the reported period total amounts.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s cash is held with financial institutions in the United States and Israel. Management believes that the financial
    institutions that hold the Company&#8217;s cash are financially sound and, accordingly, minimal credit risk exists with respect to
    these investments. Account balances held in the Unites States may, at times, exceed the Federal Deposit Insurance Corporation (FDIC)
    insurance limit. As of December 31, 2024 and 2023, the Company had $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20241231_zEPeadpMAweg" title="FDIC insurance limit">4,968</span> and $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20231231_zvIRQSvWJPFf" title="FDIC insurance limit">3,942</span>, respectively, in excess of the FDIC insurance
    limit.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p id="xdx_898_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zouO1GTW9Lbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zJV2l25V0qPi" style="display: none">SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20241231_z3WoxWo2yNN3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20231231_zfkg4c0VGFR9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzao3_z4E5ARni6Iuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,617</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,492</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCash_iI_pn3n3_maCCERCzao3_zOrcs6hmU6U4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Restricted cash</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzao3_zvgHrUD5n5v" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total cash, cash equivalents,
    and restricted cash shown in the statement of cash flows</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,627</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,502</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zTJK59TQNx7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment, net</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWgRKuvXVJP8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zpuB5HHvNqCk">Property
    and equipment, net</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over
    the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated
    depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected
    in the statements of operations and comprehensive loss.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rates
    of depreciation:</span></td></tr>
  </table>
<p id="xdx_89B_ecustom--ScheduleOfPropertyRatesOfDepreciationTableTextBlock_zw0g56Tqghwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zFW86EHUW8dj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Computers and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zVRpfYDp41N7" title="Property and equipment rates of depreciation">3</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and office equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zOYuSeCsE90d" title="Property and equipment rates of depreciation">7</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaKkwjrOhRdg" title="Property and equipment rates of depreciation">15</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zTJTnyrhRK9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zOIbb9kzGgK1" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_ziWv8giK7N0f">Impairment
    of long-lived assets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Group&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;,
    whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
    of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows
    expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by
    the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment
    losses related to long lived assets.</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock', window );">Modification of equity-classified contracts</a></td>
<td class="text"><p id="xdx_84D_ecustom--ModificationOfEquityClassifiedContractsPolicyTextBlock_ziZE3MIk5rr" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z56evVdHSr88">Modification
    of equity-classified contracts</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    modification or exchange of equity-classified contracts, such as warrants that were classified as equity before the modification or
    exchange and remained eligible for equity classification after the modification, was accounted for in a similar manner to a
    modification of stock-based compensation. Accordingly, the incremental fair value from the modification or exchange (the change in
    the fair value of the instrument before and after the modification or exchange), due to the characteristics of the modification, was recognized as a reduction of retained earnings (or an increase of
    accumulated deficit) as a deemed dividend. Modifications or exchanges that result in a decrease in the fair value of an
    equity-classified share-based payment awards are not recognized. In addition, the amount of the deemed dividend is also recognized
    as an adjustment to earnings available to common shareholders for purposes of calculating earnings per share.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ConvertiblePromissoryNotesPolicyTextBlock', window );">Convertible Promissory Notes</a></td>
<td class="text"><p id="xdx_84A_ecustom--ConvertiblePromissoryNotesPolicyTextBlock_zrN5WIV4goI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zPLmBcF6oOKe">Convertible
    Promissory Notes</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition of convertible promissory notes and similar instruments, the Company considers the provisions of ASC 815-40,
    &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;) in order to determine whether
    the conversion features embedded within the convertible instrument should be separated from the host instrument.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            it is determined that an embedded derivative required to be bifurcated (such as embedded
                                            conversion feature that does not qualify for equity classification), the Company recognizes
                                            the embedded derivative bifurcated as a separate derivative liability upon initial recognition
                                            and on subsequent periods at fair value. The remaining consideration amount received or allocated
                                            to the entire convertible instrument is allocated to the host debt instrument. The difference
                                            between the face value of the host and the allocated amount represents a discount which is
                                            amortized as finance expense to profit or loss using the effective interest method over the
                                            term of the note until its stated maturity.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    it is determined that the embedded conversion feature qualifies for equity classification (such when the embedded conversion option,
    if it were freestanding, is not qualified as a derivative in accordance with the provisions of ASC 815-10, &#8220;Derivatives and
    Hedging&#8221; since its terms did not require or permit net settlement or when the embedded conversion option is indexed to the
    entity&#8217;s own stock), the conversion option is not bifurcated. When bifurcation is not required, the Company considers whether
    the debt instrument involves a significant premium (i.e. when the proceeds received or allocated upon issuance exceed the principal
    amount that will be paid at maturity). When it is determined that a substantial premium exists, the entire premium is allocated to
    paid-in capital and when it is determined, otherwise no additional accounting is required and the convertible promissory note is
    accounted for at amortized cost using the effective interest method over the term of the note until its stated maturity.</span></p></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock', window );">Allocation of proceeds and related issuance costs</a></td>
<td class="text"><p id="xdx_847_ecustom--AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_z5sd7NFjOR4a" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zx0GcQuIiITa">Allocation
    of proceeds and related issuance costs</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            multiple instruments are issued in a single transaction (package issuance), the total gross
                                            proceeds from the transaction are allocated among the individual freestanding instruments
                                            identified. The allocation occurs after identifying all freestanding instruments and the
                                            subsequent measurement basis for those instruments.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    instruments that are required to be subsequently measured at fair value (such as derivative liabilities) are measured at fair value
    and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at
    fair value (such as liabilities measured at amortized cost, common shares and warrants eligible for equity classification), based
    on the relative fair value basis for such instruments.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    costs allocated to financial instruments that are required to be subsequently measured at fair value are immediately expensed.
    Issuance costs allocated to shares and warrants classified as equity components and are recorded as a reduction of additional
    paid-in capital. Issuance costs allocated to financial liabilities measured at amortized cost are recorded as a discount and
    accreted over the contractual term of the financial instrument using the effective interest method.</span></p></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_840_eus-gaap--DerivativesPolicyTextBlock_zzaf9EzAzAJ8" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>J.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zwRtdmypMikh">Warrants</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
                                            classified warrants</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    warrants that were determined to be freestanding financial instruments that are legally detachable and separately exercisable, do
    not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary
    Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company&#8217;s own shares, were classified
    as equity instruments. As such warrants were issued together with financial instruments that are not subsequently measured at fair
    value, the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair
    value basis. Direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
                                            classified as derivative liabilities</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    initial recognition of Series A Warrants and Series B Warrants that were issued in November 2024 as part of an equity issuance and
    debt conversions, management considered the provisions of ASC 815-40, Derivatives and Hedging &#8212; Contracts in Entity&#8217;s
    Own Equity and determined that the settlement amount of Series A Warrants and Series B Warrants might not be based on an exchange
    of a fixed number of shares for a fixed amount of consideration and thus such Warrants are not eligible to be considered as indexed
    to the Company&#8217;s own shares. Accordingly, the Series A Warrants and Series B Warrants were accounted for as warrant derivative
    liability at fair value and the changes in fair values are carried to profit or loss. In accordance with ASC 210-10-20, the warrant
    derivative liability is presented as a noncurrent liability since its settlement will require the issuance of shares and not the
    use of any resources that are properly classified as current assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_840_eus-gaap--LesseeLeasesPolicyTextBlock_zAFnE1nB1bz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>K.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zSqGXDVPbGRf">Leases</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company applies ASC Topic 842, &#8220;Leases&#8221; (&#8220;ASC 842&#8221;) under which the
                                            Company determines if an arrangement is a lease at inception.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases
    are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following
    criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option
    to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful
    life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset,
    or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end
    of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company&#8217;s
    lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be
    classified as operating leases.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of Use (&#8220;ROU&#8221;) assets and liabilities are recognized on the commencement date based on the present value of remaining
    lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the
    time of commencement. As most of the Company&#8217;s leases do not provide an implicit rate, the Company uses its Incremental Borrowing
    Rate (&#8220;IBR&#8221;) based on the information available on the commencement date in determining the present value of lease payments.
    The Company&#8217;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
    and in economic environments where the leased asset is located. The ROU asset also includes any lease payments made prior to commencement
    and is recorded net of any lease incentives received. Moreover, the ROU asset may also include initial direct costs, which are incremental
    costs of a lease that would not have been incurred if the lease had not been obtained. The Company uses the long-lived assets impairment
    guidance in ASC 360-10, &#8220;Property, Plant, and Equipment - Overall&#8221;, to determine whether a ROU asset is impaired, and
    if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option
    to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain
    that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company
    will not exercise the option.</span></p></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income tax</a></td>
<td class="text"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8Ckl0y83uBd" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>L.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_znRym6lSYEtf">Income
    tax</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are
    determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial
    accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the
    enacted tax rates expected to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets
    are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial
    statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements.
    According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting
    policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not
    recognize such items in its fiscal 2024 and 2023 financial statements and did not recognize any liability with respect to unrecognized
    tax position in its balance sheet.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development expenses</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zaqMHPXIf17k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zKvC4MV0qI9f">Research
    and development expenses</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development expenses are charged to operations and comprehensive loss, as incurred.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_RoyaltyBearingGrantsPolicyTextBlock', window );">Royalty-bearing grants</a></td>
<td class="text"><p id="xdx_846_ecustom--RoyaltyBearingGrantsPolicyTextBlock_z8mdfwVJt0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWOO3CIF9uye">Royalty-bearing
    grants</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalty-bearing
    grants from the Israeli Innovation Authority (IIA) to fund approved research and development projects are recognized at the time
    Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs. To date,
    the cumulative research and development grants received by Integrity Israel from IIA amounted to $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zxQ1tqmmUSfh" title="Cumulative research and development">93</span>. See also Note 5A below.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and diluted loss per share</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_z9o48b788pJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>O.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zHt8cvBHACei">Basic
    and diluted loss per share</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share for the year ended December 31, 2024 is computed by dividing the loss for the period applicable for Common Stockholders
and the holders of the pre-funded warrants divided by the weighted average number of shares of Common Stock outstanding and shares of
Common Stock to be issued upon the exercise of prefunded warrants during the period. Basic loss per share for December 31, 2023 is computed
by dividing the loss for the period applicable (after considering the effect of deemed dividend related to trigger of down round protection
feature) for Common Stockholders and the holders of the pre-funded warrants divided by the weighted average number of shares of Common
Stock outstanding and shares of Common Stock to be issued upon achievement of first performance milestone <span style="background-color: white">(see
Note </span>5B <span style="background-color: white">below) and upon </span>exercise of pre-funded warrants (see Note 8B below) during
the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing, diluted loss per share, basic earnings per share are adjusted to reflect the potential dilution that could occur upon the
exercise of options or warrants issued or granted using the &#8220;treasury stock method&#8221;, and using the if-converted method for
other financial instruments such as convertible liabilities and other share settled derivative liabilities, if the effect of each of
such financial instruments is dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing diluted loss per share, the average stock price for the period is used in determining the number of Common Stock assumed to
be purchased from the proceeds to be received from the exercise of stock options or stock warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
that will be issued upon exercise of all stock options and stock warrants, have been excluded from the calculation of the diluted net
loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result
of the exercise or conversion of these instruments was anti-dilutive</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zBj6J9PKDyHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zcK24H5JdCR2" style="display: none">SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240101__20241231_z6Ym4uflSN3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20230101__20231231_z5zzqKUWHrA7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In thousands
    of US dollars</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(except
    share data)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_iN_pn3n3_di_maNILATzfsR_zmwax6xVGU0l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,097</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_iN_pn3n3_di_maNILATzfsR_zpbcLJeGQ6R8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Deemed
    dividend related to trigger of down round protection feature (see Note 8C3 below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">855</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iNT_pn3n3_di_mtNILATzfsR_z3nyCkEPqS75" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable
    to common stockholders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    used in computing basic and diluted net loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zUwaJqH5hLqc" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj6bGPKWH3na" title="Ordinary shares used in computing diluted net loss per common stock">330,171</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQoV8c1SBjS1" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_ztuK22onwYV6" title="Ordinary shares used in computing diluted net loss per common stock">193,131</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    to be issued upon exercise of pre-funded warrants (see Note 8B1 below)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zXDAwwEkUIN2" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zskmRws7TrWj" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0661"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zX4Xg66JJtuk" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zjBrCIsx5YDh" title="Ordinary shares used in computing diluted net loss per common stock">13,971</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Shares
    of Common Stock to be issued upon achievement of first performance milestone (see Note 5B below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_z4WPaA8G3I53" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zS2qa5cwJH8b" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0669"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></span></span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zbbEBgBnhxD7" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zXNs6HF7bgu" title="Ordinary shares used in computing diluted net loss per common stock">501</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zKqCY5joreQ7" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zxOBS8n14FZ" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share">330,171</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zmHxTTLjbWWc" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zpCU3cJC3yI7" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share">207,603</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss
    per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zeDTjIp7toZ1" title="Basic net loss per common stock"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zOWA1Kng7Vz7" title="Diluted net loss per common stock">68.44</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zwlwpLprfKLb" title="Basic net loss per common stock"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_z4hc6XluP3Na" title="Diluted net loss per common stock">34.18</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zG6bWZc6ZMle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Note 14 regarding a significant issuance of shares as part of the exercise of the Series B Warrants subsequent to the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based compensation</a></td>
<td class="text"><p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLF7bBtd6dQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>P.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zbIkTHzb4Xl4">Stock-based
    compensation</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair
    values in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments including grants of stock
    options are recognized in the consolidated statement of operations and comprehensive loss as an operating expense based on the fair
    value of the award at the date of grant. The fair value of stock options granted is estimated using the Black-Scholes option-pricing
    model. The Company has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the
    requisite service period or over the implicit service period when a performance condition affects the vesting, and it is considered
    probable that the performance condition will be achieved. Share-based payments to non-employees are accounted for in accordance with
    ASC 718.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zw3K0lUr9aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zUIeoiC4EIgl">Fair
    value of financial instruments</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
    Topic 825-10, &#8220;Financial Instruments&#8221; defines financial instruments and requires disclosure of the fair value of financial
    instruments held by the Company. The Company considers the carrying amount of cash and cash equivalents, restricted cash, accounts
    receivable, other current assets, accounts payable and other current liabilities balances, to approximate their fair values due to
    the short-term maturities of such financial instruments. ASC Topic 825-10, establishes the following fair value hierarchy, which
    prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair
    value hierarchy gives the highest priority to Level 1 inputs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 - Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 - Unobservable inputs are used when little or no market data is available. Level 3 inputs are considered as the lowest priority
    under the fair value hierarchy.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    fair value of the financial instruments included in the working capital of the Company (cash and cash equivalents, accounts payable
    and other current assets and liabilities) approximates their carrying value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not estimate the fair value of the loans received from stockholders since their repayment schedule has not yet been determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjxuB5pAO6r8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no Level 3 assets or liabilities for the year ended December 31, 2023. The following table presents changes in Level 3 assets and
liabilities measured at fair value for the year ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_z5O5I8YYPGZi" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20241114__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGGSdi8tCfHi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zYHWiGgSwBAc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; November 14, 2024
    &#8211; Warrant issuance date</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,626</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FairValueAdjustmentOfWarrants_z7jXuJroSoDi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value adjustments &#8211; Derivative financial liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">795</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_z7DlHWtDQvw4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A9_za73EkdSN8C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zFilp6g8Nc6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the Company&#8217;s assets and liabilities which are measured at fair value on a recurring basis by level
within the fair value hierarchy:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zGEafnPJxhX3" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair
    Value Measurements as of December 31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    I</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    II</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    III</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Liability:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant derivative
    liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWoUjctiPq35" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8XKvtuCOA69" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsrWFm7aZ6Qg" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_zfoypcLOJi29" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_z5lTH7oIToS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment reporting</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zzdcZwraGoa8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zNHFGJM5Nsc4">Segment
    reporting</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation
    by the chief operating decision maker, or (&#8220;CODM&#8221;). The Company has identified its Chief Executive Officer, Paul V. Goode, as the CODM who is responsible for making decisions regarding resource allocation and assessing performance. The Company views
    its operations and manages its business as one operating segment. The Company&#8217;s long-lived assets consist primarily of property
    and equipment, net, which are all held in the United States.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of credit risk</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z2FGCZ6IAGlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_z1EHr4i96mI3">Concentrations
    of credit risk</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents,
    and restricted cash. Cash and cash equivalents and restricted cash are deposited with a major bank in the United States. Management
    believes that such financial institutions are financially sound, accordingly, minimal credit risk exists with respect to these financial
    instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts,
    option contracts or other foreign hedging arrangements.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><p id="xdx_841_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zAlGHH2E7KW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>T.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z5Yi9ZOFIsFf">Contingencies</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
    has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
    information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock', window );">Warrants with down-round protection</a></td>
<td class="text"><p id="xdx_847_ecustom--WarrantsWithDownRoundProtectionPolicyTextBlock_zn4f45ay0S6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zqEHhM9QsPOi">Warrants
    with down-round protection</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company disregards the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining
    liability or equity classification in accordance with the provisions of ASU 2017-11, &#8220;Earnings Per Share&#8221; (ASU 2017-11).
    Based on its evaluation, management has determined that such warrants with down-round protection feature are eligible for equity
    classification.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordantly,
upon the occurrence of an event that triggers a down round protection feature (i.e., when the exercise price of the warrants is adjusted
downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available
to common shareholders for purposes of basic earnings per share calculation. See also Note 2P above.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently adopted accounting pronouncements</a></td>
<td class="text"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ziEK3LmjD6qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>V.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zqfiCRG2Y698">Recently
    adopted accounting pronouncements</span> </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU
    2023-07&#8221;). This standard requires a public entity to disclose significant segment expenses and other segment items on an interim
    and annual basis. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker.
    ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after
    December 15, 2024, with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all
    prior periods presented in the financial statements. The Company adopted ASU 2023-07 for the fiscal year ended December 31, 2024
    and interim financial statements thereafter, on a retrospective basis for all prior periods presented in the financial statements.
    The adoption of ASU 2023-07 did not change the way that the Company identifies its reportable segments and, as a result, did not
    have a material impact on the Company&#8217;s financial position or results of operations. See (Note 13) - Segment Reporting for
    further information.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock', window );">Recently issued accounting pronouncements, not yet adopted</a></td>
<td class="text"><p id="xdx_846_ecustom--NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_zHjYSoLTljei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>W.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zXFMCpsDTK0f">Recently
    issued accounting pronouncements, not yet adopted</span> </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    November 2024, the FASB issued ASU 2024-03, &#8220;Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation
    Disclosures&#8221; to require more detailed information about specified categories of expenses (purchases of inventory, employee
    compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the income
    statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and for interim periods within fiscal years
    beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial
    statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented
    in the financial statements. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial
    statements and related disclosures. The adoption of this pronouncement is not expected to have a material impact on the Company&#8217;s
    consolidated financial statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures related to improvements
    to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for
    the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning
    after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocation Of Proceeds And Related Issuance Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ConvertiblePromissoryNotesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Promissory Notes [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ConvertiblePromissoryNotesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_FunctionalCurrencyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Functional Currency [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_FunctionalCurrencyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Modification Of Equity Classified Contracts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>New accounting pronouncements, not yet adopted [policy text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_RoyaltyBearingGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Bearing Grants [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_RoyaltyBearingGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants With Down Round Protection [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477850/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock', window );">SCHEDULE OF OFFICIAL EXCHANGE RATE</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zZ9rfSF7hGXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B8_zTTl2xrLE2B8" style="display: none">SCHEDULE OF OFFICIAL EXCHANGE RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Official exchange rate of NIS
    1 to US dollar</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20241231_z3HXiJacJyz9" title="Official exchange rate of NIS 1 to US dollar">0.274</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231_zvIwJW1INYW9" title="Official exchange rate of NIS 1 to US dollar">0.272</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Increase (Decrease) of the official exchange
    rate of NIS 1 to US dollar during the year:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20241231_z2itxYshtO72" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:">0.74</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_di_uPure_c20231231_z76cwanQoTr2" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:">(8.86</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zouO1GTW9Lbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zJV2l25V0qPi" style="display: none">SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20241231_z3WoxWo2yNN3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20231231_zfkg4c0VGFR9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzao3_z4E5ARni6Iuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,617</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,492</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCash_iI_pn3n3_maCCERCzao3_zOrcs6hmU6U4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Restricted cash</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzao3_zvgHrUD5n5v" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total cash, cash equivalents,
    and restricted cash shown in the statement of cash flows</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,627</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,502</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock', window );">SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfPropertyRatesOfDepreciationTableTextBlock_zw0g56Tqghwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zFW86EHUW8dj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Computers and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zVRpfYDp41N7" title="Property and equipment rates of depreciation">3</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and office equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zOYuSeCsE90d" title="Property and equipment rates of depreciation">7</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaKkwjrOhRdg" title="Property and equipment rates of depreciation">15</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zBj6J9PKDyHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zcK24H5JdCR2" style="display: none">SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240101__20241231_z6Ym4uflSN3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20230101__20231231_z5zzqKUWHrA7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In thousands
    of US dollars</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(except
    share data)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_iN_pn3n3_di_maNILATzfsR_zmwax6xVGU0l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,097</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_iN_pn3n3_di_maNILATzfsR_zpbcLJeGQ6R8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Deemed
    dividend related to trigger of down round protection feature (see Note 8C3 below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">855</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iNT_pn3n3_di_mtNILATzfsR_z3nyCkEPqS75" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable
    to common stockholders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    used in computing basic and diluted net loss per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zUwaJqH5hLqc" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj6bGPKWH3na" title="Ordinary shares used in computing diluted net loss per common stock">330,171</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQoV8c1SBjS1" title="Shares of Common Stock used in computing basic net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_ztuK22onwYV6" title="Ordinary shares used in computing diluted net loss per common stock">193,131</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Shares of Common Stock
    to be issued upon exercise of pre-funded warrants (see Note 8B1 below)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zXDAwwEkUIN2" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zskmRws7TrWj" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0661"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zX4Xg66JJtuk" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zjBrCIsx5YDh" title="Ordinary shares used in computing diluted net loss per common stock">13,971</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Shares
    of Common Stock to be issued upon achievement of first performance milestone (see Note 5B below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_z4WPaA8G3I53" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zS2qa5cwJH8b" title="Ordinary shares used in computing diluted net loss per common stock"><span style="-sec-ix-hidden: xdx2ixbrl0669"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></span></span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zbbEBgBnhxD7" title="Ordinary shares used in computing diluted net loss per common stock"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zXNs6HF7bgu" title="Ordinary shares used in computing diluted net loss per common stock">501</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zKqCY5joreQ7" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zxOBS8n14FZ" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share">330,171</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zmHxTTLjbWWc" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zpCU3cJC3yI7" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share">207,603</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss
    per common stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zeDTjIp7toZ1" title="Basic net loss per common stock"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zOWA1Kng7Vz7" title="Diluted net loss per common stock">68.44</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zwlwpLprfKLb" title="Basic net loss per common stock"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_z4hc6XluP3Na" title="Diluted net loss per common stock">34.18</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</a></td>
<td class="text"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjxuB5pAO6r8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no Level 3 assets or liabilities for the year ended December 31, 2023. The following table presents changes in Level 3 assets and
liabilities measured at fair value for the year ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_z5O5I8YYPGZi" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20241114__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGGSdi8tCfHi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zYHWiGgSwBAc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; November 14, 2024
    &#8211; Warrant issuance date</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,626</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FairValueAdjustmentOfWarrants_z7jXuJroSoDi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value adjustments &#8211; Derivative financial liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">795</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_z7DlHWtDQvw4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance &#8211; December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zFilp6g8Nc6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the Company&#8217;s assets and liabilities which are measured at fair value on a recurring basis by level
within the fair value hierarchy:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zGEafnPJxhX3" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair
    Value Measurements as of December 31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    I</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    II</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level
    III</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Liability:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant derivative
    liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWoUjctiPq35" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8XKvtuCOA69" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsrWFm7aZ6Qg" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_zfoypcLOJi29" style="width: 12%; text-align: right" title="Warrant derivative liability"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Property Rates Of Depreciation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the U.S. dollar denominated balances, balances reported for financial reporting purposes and the differences between the two balances by each relevant line item on the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479424/830-30-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock', window );">SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS</a></td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_zHPTjgCmnKH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zrEEX7hZhYze" style="display: none">SCHEDULE OF RECONCILIATION OF THE
FAIR VALUE OF THE WARRANTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Common Warrants</b></td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    A Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    B Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">July issuance</td>
    <td>&#160;</td>
    <td>$</td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zothQHk05qo5" style="text-align: right">34</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zyjzotPs6cZk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Settlement of July warrants</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_98D_eus-gaap--DerivativeLiabilities_iNI_di_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zM5WrZeLqBHa" style="text-align: right">(37</td>
    <td>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zSEgNfU2s6Q6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">November issuance</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 12%">-</td>
    <td style="width: 1%">&#160;</td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zAHJKYckqqI" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,659</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z2SDXoaKDPl4" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,266</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231_zEoAAEQdhnG6" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,925</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Settlement of July 30 Convertible Promissory
    Note</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zKji4VH4AQU9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">609</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_z8ojZdUDHMI1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,768</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zdfnem8pASHg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,377</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Settlement of July 18 Convertible Promissory
    Note</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-</td>
    <td>&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_z4eCCdZQksGh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zYXCzt00Le54" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">279</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zVSbUt2Vord9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zm6qh7wfSiLg" style="border-bottom: Black 1pt solid; text-align: right">3</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zIrMNUIrn8Mi" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">230</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zyr94jq70tQ2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">565</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231_zrbSjxmjjQ8e" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">798</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2024</span></td>
    <td>&#160;</td>
    <td><b>$</b></td>
    <td style="text-align: right"><b>-</b></td>
    <td>&#160;</td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z2TXbwpfsUo9" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,544</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdqXFV0gyFfi" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,877</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_znRu6gwQIiKe" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,421</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenWarrantsMember', window );">June 27 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock', window );">SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES</a></td>
<td class="text"><p id="xdx_890_ecustom--ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zxSka9mHzdi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zID20Ar4xsO6" style="display: none">SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zQzBG2rGhi89" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended<br/> December 31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--WarrantsAndRightsOutstanding_iS_pn3n3_zBqCZcYjxCba" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_zNAWB0oWRiXf" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total proceeds received</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromAllocatedWarrantsAtInitialRecognition_pn3n3_zl0W3dNDg9Md" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total proceeds allocated to June 27 Warrants
    at initial recognition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--DiscountAmortizationAndInterestExpenses_pn3n3_zjUlikiL6W5f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount amortization and interest expenses
    related to June 27 Notes (Note 7 below)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--PartialConversionNotesAndAccruedInterest_pn3n3_zblcEzG7AGM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Partial conversion June
    27 Notes and accrued Interest (Note 4H and Note 4I below)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(26</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstanding_iE_pn3n3_z7iEpCvk4pL" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance December</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Reconciliation Of Carrying Amount Of Notes [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Reconciliation Of The Fair Value Warrants [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASE AGREEMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DisclosureLeaseAgreementAbstract', window );"><strong>Lease Agreement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">SCHEDULE OF OPERATING LEASE</a></td>
<td class="text"><p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zCv0w4IN9TN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zx0Wt3ZQECd7" style="display: none">SCHEDULE OF OPERATING LEASE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20241231_zROtWDANxNda" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zmiQMgLk0ir7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    right-of-use asset</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_zVXHdFK7wvl8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Current operating lease
    liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zM0gd3dxYT48" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-Current operating
    lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zOhVyechJiM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity
analysis of the Company&#8217;s lease liability:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B6_zhxN2Bz7Sp2f" style="display: none">SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20241231_zhk6aBE1hwgl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--LessThanOneYearMember_zQvMjhyypqvl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less than one year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--BetweenOneYearToTwoYearsMember_zZ34HneL7Pj3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Between 1-2 years</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">30</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--MoreThanTwoYearsMember_zG16V3qeFvE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">More than 2 years</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_zz2zcZcRKCyd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease
    payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">65</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3n3_zpgSXldQotae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: imputed interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zVtdeuD5xcGb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock', window );">SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE</a></td>
<td class="text"><p id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_z3IoBd8a5rOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the weighted average remaining lease terms and discount rate for the lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zXoNDsXyxAM7" style="display: none">SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease term (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zhDMnhG3g924" title="Lease term (years)">2.17</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20241231_z46dRs2l8mE8" title="Weighted average discount rate">9.03</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DisclosureLeaseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DisclosureLeaseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Weighted Average Remaining Lease Terms And Discount Rate [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE (INCOME) EXPENSES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock', window );">SCHEDULE OF FINANCE EXPENSES</a></td>
<td class="text"><p id="xdx_893_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zRY8tApv7TFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zhhyHkGx7s26" style="display: none">SCHEDULE OF FINANCE EXPENSES</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20241231_zoPRSF7kunhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zUwuhKxaWOI" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Unaudited</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--DiscountAmortizationAndInterestExpensesOne_pn3n3_msFINztjv_zPDUlIGixaS8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount amortization and interest
    expenses related to June 27 Notes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--InterestExpense_pn3n3_msFINztjv_zvmQStutmMhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expenses related to July 18 Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--DiscountAmortizationAndInterestExpensesTwo_pn3n3_msFINztjv_zQdB24YN1PN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense and debt discount amortization
    related to July 30 Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">563</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpenseDeposits_pn3n3_msFINztjv_zTdn9coQ6hs8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest on bank deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(62</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OtherExpenses_pn3n3_msFINztjv_zQZspfc7BTNg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate differentials,
    bank commissions and miscellaneous</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--FinanceIncomeNet_iNT_pn3n3_di_mtFINztjv_zWdZHG9yDxmj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance (income) expenses,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">583</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedFinancialStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zUnlVWsVFWIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z4lrO17mV4sf" style="display: none">SCHEDULE
OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            Options</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            Price</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>life</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>value</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231_zaAzo52k2B6i" style="width: 12%; text-align: right" title="Number outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">8,046</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_znEjOLrl6XJ4" style="width: 12%; text-align: right" title="Weighted average exercise price outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif">152</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z4WJGfWup6U9" title="Weighted average remaining contractual life, Outstanding">2.1</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20230101__20231231_zCUbl0Mjflgk" style="width: 12%; text-align: right" title="Intrinsic value outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231_zfU8A4GVfRV3" style="text-align: right" title="Number of share options outstanding, granted"><span style="font-family: Times New Roman, Times, Serif">2,221</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zZcDHiPYBGgl" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z2iQAj7uehRc" title="Weighted average remaining contractual life, Granted">9.7</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20230101__20231231_z604wfjuE9x8" style="text-align: right" title="Intrinsic value outstanding, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1154">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231_z5ztECF9ku5d" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif">(269</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zlMwPp17oRUe" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif">1290</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zkJDZf9fcDE5" title="Weighted average remaining contractual life, Forfeited or expired">1.7</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20230101__20231231_zz1ROjgS7evc" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20241231_zUPtgFfsZwUe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">9,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20241231_zrFV1luqjgE8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zOLtT6oPq8za" title="Weighted average remaining contractual life, Outstanding">8.0</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zkOXzBCL2CK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20241231_zdoCwT2epni9" style="text-align: right" title="Number of share options outstanding, granted"><span style="font-family: Times New Roman, Times, Serif">6,438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_z1VtIh8cpZr9" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">49.72</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20240101__20241231_zUsBUuVQFV1l" title="Weighted average remaining contractual life, Granted">9.37</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20240101__20241231_zjL9Ynrz5evl" style="text-align: right" title="Intrinsic value outstanding, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_pid_c20240101__20241231_zeiu4L5S6Jcb" style="text-align: right" title="Number of share options outstanding, cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></span></td><td style="text-align: left">&#160;</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240101__20241231_zshCKLI4meTl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_zQob9IMwjH9f" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20240101__20241231_zz2eaNDWu22k" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20241231_zWBSV3HSyHG5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">16,436</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zy9RbIAzzlF" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">49.72</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zssR7b6JLeE3" title="Weighted average remaining contractual life, Outstanding">9.37</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zGRFWdgoD0d2" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20241231_zQXojA8mW6ra" style="border-bottom: Black 2.5pt double; text-align: right" title="Number exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">11,249</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_fKg_____zefzLVfuQ09d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">*49.11</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_dtY_c20240101__20241231_z6OgQHJ6l88b" title="Weighted average remaining contractual life, Exercisable">9.41</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zMpdZmEQYNBd" style="border-bottom: Black 2.5pt double; text-align: center" title="Intrinsic value outstanding exercisable, Ending balance"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0E_zSs6eOY0FQQ4" style="width: 15pt; text-align: right">*</td><td id="xdx_F14_zB5eie8s33dc" style="text-align: justify">After modification of exercise price</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zjPjM1faXsEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B2_zgQjCPA7XeD8" style="display: none">SCHEDULE
OF ASSUMPTIONS USED TO VALUE OPTIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 78%; margin-left: 1.5in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240101__20241231_zoco2NDkmdqg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20230101__20231231_zbXCx5X3LeV2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Volatility (%)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_z7KiyVdc2EG2" title="Volatility, minimum">207</span>-<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_z3bFWhyk5vWb" title="Volatility, maximum">288</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231_z3XREW8cGXZ5" title="Volatility">220</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate (%)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zWBEKiGF8mKe" title="Risk-free interest rate, minimum">3.51</span>-<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zq7vmfW03l74" title="Risk-free interest rate, maximum">4.64</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231_ztCnsGkLlJ26" title="Risk-free interest rate">4.7</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_zZ6L68M33u1e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yield (%)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231_z2u6oAWG6Yg4" title="Expected life (years)">3</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zdZdM8Yc69Id" title="Expected life (years)">3</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercise price ($)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MinimumMember_zKNewAmVrF39" title="Exercise price, minimum">41</span>-<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MaximumMember_zryWBW8KOAwa" title="Exercise price, maximum">58</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231_zqzEfhJPHuyj" title="Exercise price">140</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price ($)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharePrice_iI_pid_c20241231_zhHl6wdu3URi" title="Share price">49.0</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zItWZe8rqN88" title="Share price">30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">SCHEDULE OF WARRANTS ACTIVITY</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zz3x9OT8Q3Z6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z3KtLYkDtfp5" style="display: none">SCHEDULE
OF WARRANTS ACTIVITY</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
                                            Warrants</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            Price</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>life</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>value</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20240101__20241231_zCnVzou8sMsc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1248">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20240101__20241231_zKLzb6IWIJN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1250">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iS_pid_c20240101__20241231_zRqnnYeSaLk3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20240101__20241231_zPl8gX257xNf" style="width: 12%; text-align: right" title="Number of share warrants outstanding, granted"><span style="font-family: Times New Roman, Times, Serif">1,278,259</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20240101__20241231_zeKl98MZJFah" style="width: 12%; text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">39.66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z9dXKfNYeT23" title="Weighted average remaining contractual life, Granted">9.31</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_pid_c20240101__20241231_zFRqZ3odyWHg" style="text-align: right" title="Number of share warrants outstanding, cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_pid_c20240101__20241231_zTR5NRmxVzJd" style="text-align: right" title="Weighted average exercise price, cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited or expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20240101__20241231_z3nkyB9LmqOg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_pid_c20240101__20241231_zSMIyESEGBji" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20240101__20241231_zUS7LlIrOzhi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">1,278,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20240101__20241231_zUI9uG1tRdr4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">39.66</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_z4aCRMu8GOId" title="Weighted average remaining contractual life, Outstanding">9.31</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iE_pid_c20240101__20241231_zQPsNMwjNva3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240101__20241231_zMGsGRoioc61" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share options exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">1,278,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zZaQRERu0qdj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"><span style="font-family: Times New Roman, Times, Serif">39.66</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_dtY_c20240101__20241231_zOH7Lo6Ps39h" title="Weighted average remaining contractual life, Exercisable">9.31</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zjv2ltqCtgdl" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zN9EaBRuUQl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zwXR2MIxMf8c" style="display: none">SCHEDULE
OF TOTAL COMPENSATION COST EQUITY BASED AWARDS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240101__20241231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_zwVM0JAAKlac" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20231231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_z8tnmwU7QbD8" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zcDJHAAIkttl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">307</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">176</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zyyS2nvu4MK2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">364</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zxSSOebnpZq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total compensation cost
    </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">335</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH AND DEVELOPMENT EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock', window );">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_zeYCwsmQlvV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_z3tS403mB4J" style="display: none">SCHEDULE
OF RESEARCH AND DEVELOPMENT EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240101__20241231_zieA5Qcf5x0k" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20231231_zaCiAlzk1Fma" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Research and
    Development</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--SalariesAndRelatedMember_zBPzX7Rqwqkf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Salaries and related expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,881</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">930</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--ProfessionalFeesMember_ze9rs3UF3WU2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,363</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,709</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--DepreciationMember_zSD4xvmiNPy2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--OtherExpenseMember_zSfuba1NFXS9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">241</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_zYw3VtnrXsgj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Research and Development
    Expense</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,499</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,704</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Research And Development Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract', window );"><strong>General And Administrative Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock', window );">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_z2CXkyoEzpk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zFHyXYGZvPRg" style="display: none">SCHEDULE
OF GENERAL AND ADMINISTRATIVE EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240101__20241231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM8UdbFpODS" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zT9wmhaz4rAe" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    thousands of US dollars</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">General and
    Administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LaborAndRelatedExpense_pn3n3_maGAAEzQ9k_zCpat4NjDHgk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Salaries and related expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">476</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">340</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ProfessionalFees_pn3n3_maGAAEzQ9k_zi4SxpoWDAhl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees (including directors&#8217;
    fees)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepreciationAndAmortization_pn3n3_maGAAEzQ9k_zrUjIai7EGw1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentIncomeInvestmentExpense_pn3n3_maGAAEzQ9k_zIIKtdrgapB7" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Insurance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">313</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherGeneralAndAdministrativeExpense_pn3n3_maGAAEzQ9k_zWX9v32IOFne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">120</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzQ9k_zw6DDv0l8y45" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total general and administrative
    expenses</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,655</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,278</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of General And Administrative Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">SCHEDULE OF INCOME TAX LOSS FOR THE YEAR</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z6iMj2VfIwxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B3_zLn2HZGvSjL" style="display: none">SCHEDULE
OF INCOME TAX LOSS FOR THE YEAR</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 55%; margin-left: 1in">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240101__20241231_z9llL1qhyTj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20230101__20231231_zN8DzbJCIRRb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationTaxSettlementsDomestic_z721b59wgzy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Domestic</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,502</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,945</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationTaxSettlementsForeign_zZbKhuq8YfDa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign entity (Integrity
    Israel)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">152</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationTaxSettlements_zX2ikabwNa2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="display: none; font-size: 10pt">Total
    loss for the year</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,597</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,097</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z3M5qgJqhpPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zoi4M9xEydMj" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20241231_zd3wTWWq6y94" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_z7RHaI1h04Bk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Composition
    of deferred tax assets:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--DeferredTaxAssetsTaxVacationAccrual_iI_pn3n3_maDTAGzT7c_zf71lr31RLTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vacation accrual</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">208</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pn3n3_maDTAGzT7c_z4haGyC1HmA5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development credits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzT7c_zYDnguFiRVFb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net operating losses carry
    forwards</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,981</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,368</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzT7c_maDTANzC5T_ztVwDgQk3JP6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset
    before deferred tax liabilities and valuation allowance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,465</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,467</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--DeferredTaxAssetValuationAllowance_iNI_pn3n3_di_msDTANzC5T_zeoDvg2oPx4d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,465</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13,467</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzC5T_zsCEpPYzmoXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 13, 2023</div></th>
<th class="th"><div>Mar. 28, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,450<span></span>
</td>
<td class="nump">$ 109,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,617<span></span>
</td>
<td class="nump">$ 4,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ProceedsFromPublicOfferingsAndDebtIssuances', window );">Proceeds from public offerings and debt issuances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ProceedsFromPublicOfferingsAndDebtIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from public offerings and debt issuances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ProceedsFromPublicOfferingsAndDebtIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1', window );">Official exchange rate of NIS 1 to US dollar</a></td>
<td class="nump">0.274<span></span>
</td>
<td class="nump">0.272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:</a></td>
<td class="nump">0.74<span></span>
</td>
<td class="nump">8.86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479424/830-30-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateRemeasurement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479424/830-30-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 5,617<span></span>
</td>
<td class="nump">$ 4,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</a></td>
<td class="nump">$ 5,627<span></span>
</td>
<td class="nump">$ 4,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment rates of depreciation</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=GCTK_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment rates of depreciation</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=GCTK_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment rates of depreciation</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=GCTK_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=GCTK_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 22,597<span></span>
</td>
<td class="nump">$ 7,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature', window );">Deemed dividend related to trigger of down round protection feature (see Note 8C3 below)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 22,597<span></span>
</td>
<td class="nump">$ 7,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Common Stock outstanding used in computing basic net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">330,171<span></span>
</td>
<td class="nump">207,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Common Stock outstanding used in computing diluted net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">330,171<span></span>
</td>
<td class="nump">207,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 68.44<span></span>
</td>
<td class="nump">$ 34.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 68.44<span></span>
</td>
<td class="nump">$ 34.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Common Stock outstanding used in computing basic net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">330,171<span></span>
</td>
<td class="nump">193,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Common Stock outstanding used in computing diluted net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">330,171<span></span>
</td>
<td class="nump">193,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember', window );">Prefunded Warrants [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Common Stock outstanding used in computing basic net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Common Stock outstanding used in computing diluted net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_PerformanceMilestoneMember', window );">Performance Milestone [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Common Stock outstanding used in computing basic net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Common Stock outstanding used in computing diluted net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">After modification of exercise price</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deemed dividend related to trigger of down round protection feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_PerformanceMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_PerformanceMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 30, 2024</div></th>
<th class="th"><div>Jun. 27, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Balance &#8211; November 14, 2024 &#8211; Warrant issuance date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustments &#8211; Derivative financial liability</a></td>
<td class="nump">$ 2,550<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Balance &#8211; December 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,421<span></span>
</td>
<td class="nump">17,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Balance &#8211; November 14, 2024 &#8211; Warrant issuance date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustments &#8211; Derivative financial liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Balance &#8211; December 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,421<span></span>
</td>
<td class="nump">$ 17,421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section FF<br> -Paragraph Question 2<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.FF.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476188/405-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 13, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant derivative liability</a></td>
<td class="nump">$ 17,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant derivative liability</a></td>
<td class="nump">17,421<span></span>
</td>
<td class="nump">$ 16,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant derivative liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant derivative liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant derivative liability</a></td>
<td class="nump">$ 17,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">FDIC insurance limit</a></td>
<td class="nump">$ 4,968<span></span>
</td>
<td class="nump">$ 3,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Cumulative research and development</a></td>
<td class="nump">9,499<span></span>
</td>
<td class="nump">$ 4,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Cumulative research and development</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS FROM STOCKHOLDERS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2004</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_QuarterlyPaymentsEqualsToSalesPercentage', window );">Sales percent</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=GCTK_FourSeparateLendersMember', window );">Four Separate Lenders [Member] | ISRAEL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Total loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of loan</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_QuarterlyPaymentsEqualsToSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Quarterly payments equals to sales, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_QuarterlyPaymentsEqualsToSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=GCTK_FourSeparateLendersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=GCTK_FourSeparateLendersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Total proceeds received</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Balance December</a></td>
<td class="nump">11,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenWarrantsMember', window );">June 27 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Opening balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Total proceeds received</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition', window );">Total proceeds allocated to June 27 Warrants at initial recognition</a></td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DiscountAmortizationAndInterestExpenses', window );">Discount amortization and interest expenses related to June 27 Notes (Note 7 below)</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_PartialConversionNotesAndAccruedInterest', window );">Partial conversion June 27 Notes and accrued Interest (Note 4H and Note 4I below)</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Balance December</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DiscountAmortizationAndInterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount amortization and interest expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DiscountAmortizationAndInterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_PartialConversionNotesAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partial conversion notes and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_PartialConversionNotesAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from allocated warrants at initial recognition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 30, 2024</div></th>
<th class="th"><div>Jun. 27, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 12, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="nump">$ 2,550<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyMember', window );">July [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyWarrantsMember', window );">July Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyThirtyMember', window );">July 30 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyEighteenMember', window );">July 18 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | July [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | July Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember', window );">Series A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
<td class="nump">$ 1,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember', window );">Series A Warrant [Member] | July 30 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember', window );">Series A Warrant [Member] | July 18 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember', window );">Series B Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,266<span></span>
</td>
<td class="nump">$ 10,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember', window );">Series B Warrant [Member] | July 30 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,768)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember', window );">Series B Warrant [Member] | July 18 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=GCTK_JulyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=GCTK_JulyWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=GCTK_JulyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=GCTK_JulyEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=GCTK_JulyEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT TRANSACTIONS (Details Narrative)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 12, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 15, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 05, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 23, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 18, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th">
<div>Apr. 22, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 13, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 03, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 17, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 13, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 15, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares of Common Stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">791,609<span></span>
</td>
<td class="nump">208,914<span></span>
</td>
<td class="nump">35,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.0<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds from public offering</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one-for-five<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 1,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtDescription', window );">Notes payable description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
    June 27 Notes bear simple interest at a rate of 3% per annum and are due and payable in cash on the earlier of: (a) 12 months from
    the date of the June 27 Note; or (b) the date the Company raises third-party equity capital in an amount equal to or in excess of
    $1,000 (the &#8220;Maturity Date&#8221;). The Company may prepay the June 27 Notes at any time prior to the Maturity Date without
    penalty. If an event of default occurs, the then-outstanding principal amount of the June 27 Notes plus any unpaid accrued interest
    will accelerate and become immediately payable in cash.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementLoss', window );">Settlement of debt loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Expected term years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_EmbeddedConversionFeaturePercentage', window );">Embedded conversion feature percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of embedded derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,284<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Loss on settlement debt</a></td>
<td class="nump">$ 3,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,758)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityFairValueDisclosure', window );">Equity fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,505<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_EquityIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ClassOfWarrantOrRightReasonForCashRaised', window );">Fair value cash raised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_GainLossOnEquityIssuance', window );">Loss on equity issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,925<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesACommonWarrantMember', window );">Series A Common Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="nump">359,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="nump">$ 36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBCommonWarrantMember', window );">Series B Common Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="nump">359,712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="nump">$ 36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_PrefundedWarrantsMember', window );">Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">27.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember', window );">Series A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">6.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="nump">$ 36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Expected term years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value issuance</a></td>
<td class="nump">$ 1,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">volatility</a></td>
<td class="nump">96.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember', window );">Series B Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">$ 6.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="nump">$ 36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Expected term years</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value issuance</a></td>
<td class="nump">$ 10,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">volatility</a></td>
<td class="nump">378.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=GCTK_UnsecuredPromissoryNotesMember', window );">Unsecured Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds from public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">$ 27.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=GCTK_ExchangeAgreementMember', window );">Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_LockUpPeriodDescription', window );">Lock-up period conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(a) sell or contract to sell Shares at a price higher than $0.5 per Share on any trading
                                            day up to 10% of the daily volume of Shares or (b) sell or contract to sell Shares at a price
                                            higher than $0.8 per Share on any trading day with no volume limitation.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=GCTK_WarrantsAgreementMember', window );">Warrants Agreement [Member] | Convertible Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember', window );">Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Pre-funded warrants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,765<span></span>
</td>
<td class="nump">19,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="nump">237,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued | shares</a></td>
<td class="nump">237,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares of Common Stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="nump">121,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,760,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Fair value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeriesACommonWarrantMember', window );">Series A Common Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeriesBCommonWarrantMember', window );">Series B Common Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_FirstWarrantMember', window );">First Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_SecondWarrantMember', window );">Second Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_ThirdWarrantMember', window );">Third Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneThirtyNotesMember', window );">June 30 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="nump">132,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 4,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="nump">$ 31.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueOfCollateral', window );">Fair value of the derivative liability</a></td>
<td class="nump">$ 1,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion amount</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_FairValueOfWarrantRelatedDerivatives', window );">Fair value of the warrant related derivatives</a></td>
<td class="nump">4,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_FairValueOfWarrantRelatedDerivativesValue', window );">Fair value of the warrant related derivatives book value</a></td>
<td class="nump">$ 813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneThirtyNotesMember', window );">June 30 Notes [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="nump">132,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value issuance</a></td>
<td class="nump">$ 813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneThirtyNotesMember', window );">June 30 Notes [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="nump">132,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 3,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenNotesMember', window );">June 27 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantMember', window );">August 23 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 16,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantOneMember', window );">August 23 Warrant One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantTwoMember', window );">August Twenty Three Warrant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantThreeMember', window );">August 23 Warrant Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JulyEighteenNotesMember', window );">July 18 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_JulyTwentySevenNotesMember', window );">July 27 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsMember', window );">September Five Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 16,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsOneMember', window );">September 5 Warrants One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsTwoMember', window );">September Five Warrants Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsThirdMember', window );">September Five Warrants Third [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ClassOfWarrantOrRightReasonForCashRaised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right reason for cash raised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ClassOfWarrantOrRightReasonForCashRaised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_EmbeddedConversionFeaturePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Embedded conversion feature percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_EmbeddedConversionFeaturePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_EquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_EquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_FairValueOfWarrantRelatedDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrant related derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_FairValueOfWarrantRelatedDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_FairValueOfWarrantRelatedDerivativesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrant related derivatives value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_FairValueOfWarrantRelatedDerivativesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_GainLossOnEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on equity issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_GainLossOnEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_LockUpPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lock up period description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_LockUpPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the warrants or rights are exercisable, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscriptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481142/505-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscriptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueOfCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of securities pledged as collateral against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueOfCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the entity's equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from litigation settlement for amount awarded to other party. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of borrowing classified as short-term upon issuance. Includes, but is not limited to, description of underlying arrangement, repayment terms, interest rate, collateral provided, restriction on use of asset and activity, and compliance with debt covenant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesACommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesACommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesBCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=GCTK_UnsecuredPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=GCTK_UnsecuredPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GCTK_ExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GCTK_ExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GCTK_WarrantsAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GCTK_WarrantsAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=GCTK_ConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=GCTK_ConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeriesACommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SeriesACommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeriesBCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SeriesBCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_FirstWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_FirstWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SecondWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SecondWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_ThirdWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_ThirdWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneThirtyNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_JuneThirtyNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_JuneTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_AugustTwentyThreeWarrantThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_JulyEighteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_JulyEighteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_JulyTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_JulyTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsThirdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SeptemberFiveWarrantsThirdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 20, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 12, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 13, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 07, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 04, 2004 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 04, 2004 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Restricted shares to the seller | shares</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and development expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,867<span></span>
</td>
<td class="nump">53,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_MarketabilityDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=GCTK_IntellectualPropertyPurchaseAgreementMember', window );">Intellectual Property Purchase Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=GCTK_IsraeliInnovationAuthorityMember', window );">Israeli Innovation Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Intellectual Property Purchase Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_AggregateSalesPriceOfUnitsPercentage', window );">Commission as a percentage of aggregate sales price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Intellectual Property Purchase Agreement [Member] | Common Stock [Member] | Trueup Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_AggregateSalesPriceOfUnitsPercentage', window );">Commission as a percentage of aggregate sales price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=GCTK_IsraeliInnovationAuthorityMember', window );">Israeli Innovation Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 420,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=GCTK_IsraeliInnovationAuthorityMember', window );">Israeli Innovation Authority [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_RoyaltyPercentage', window );">Royalty percentage maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=GCTK_IsraeliInnovationAuthorityMember', window );">Israeli Innovation Authority [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_RoyaltyPercentage', window );">Royalty percentage maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_AggregateSalesPriceOfUnitsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate sales price of units percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_AggregateSalesPriceOfUnitsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_MarketabilityDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketability discount rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_MarketabilityDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_RoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_RoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GCTK_IntellectualPropertyPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GCTK_IntellectualPropertyPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=GCTK_IsraeliInnovationAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=GCTK_IsraeliInnovationAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GCTK_TrueupSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GCTK_TrueupSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=GCTK_IsraeliInnovationAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=GCTK_IsraeliInnovationAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OPERATING LEASE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DisclosureLeaseAgreementAbstract', window );"><strong>Lease Agreement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use asset</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">26<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-Current operating lease liability</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DisclosureLeaseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DisclosureLeaseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 19, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total operating lease payments</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=GCTK_LessThanOneYearMember', window );">Less Than One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total operating lease payments</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=GCTK_BetweenOneYearToTwoYearsMember', window );">Between 1 - 2 Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total operating lease payments</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=GCTK_MoreThanTwoYearsMember', window );">More Than 2 Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total operating lease payments</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=GCTK_LessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=GCTK_LessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=GCTK_BetweenOneYearToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=GCTK_BetweenOneYearToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=GCTK_MoreThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=GCTK_MoreThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DisclosureLeaseAgreementAbstract', window );"><strong>Lease Agreement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Lease term (years)</a></td>
<td class="text">2 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">9.03%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DisclosureLeaseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DisclosureLeaseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASE AGREEMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 19, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">$ 79,000<span></span>
</td>
<td class="nump">$ 59,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_LeaseAgreementsMember', window );">Lease Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Monthly rental fee</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee term of contract</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_LeaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_LeaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF FINANCE EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DiscountAmortizationAndInterestExpensesOne', window );">Discount amortization and interest expenses related to June 27 Notes</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expenses related to July 18 Notes</a></td>
<td class="nump">44<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DiscountAmortizationAndInterestExpensesTwo', window );">Interest expense and debt discount amortization related to July 30 Notes</a></td>
<td class="nump">563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDeposits', window );">Interest on bank deposits</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Exchange rate differentials, bank commissions and miscellaneous</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_FinanceIncomeNet', window );">Finance (income) expenses, net</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DiscountAmortizationAndInterestExpensesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount amortization and interest expenses one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DiscountAmortizationAndInterestExpensesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DiscountAmortizationAndInterestExpensesTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount amortization and interest expenses two.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DiscountAmortizationAndInterestExpensesTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_FinanceIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance income net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_FinanceIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number outstanding beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,998<span></span>
</td>
<td class="nump">8,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstanding, beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, Outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9 years 4 months 13 days<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic value outstanding, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of share options outstanding, granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,438<span></span>
</td>
<td class="nump">2,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 49.72<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm', window );">Weighted average remaining contractual life, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9 years 4 months 13 days<span></span>
</td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue', window );">Intrinsic value outstanding, granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of share options outstanding, forfeited or expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited or expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, Forfeited or expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue', window );">Intrinsic value outstanding, forfeited or expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross', window );">Number of share options outstanding, cancelled</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number outstanding ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,436<span></span>
</td>
<td class="nump">9,998<span></span>
</td>
<td class="nump">8,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstanding, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 49.72<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number exercisable, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price exercisable, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 49.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue', window );">Weighted average remaining contractual life, Exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9 years 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue', window );">Intrinsic value outstanding exercisable, Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">After modification of exercise price</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award equity instruments other than options exerciable in period intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options cancelled in period gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award options exercisable weighted average fairvalue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of award forfeited under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 30, 2024</div></th>
<th class="th"><div>Jun. 27, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">122.80%<span></span>
</td>
<td class="nump">245.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.64%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="nump">4.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.0<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF WARRANTS ACTIVITY (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of share warrants outstanding, beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price outstanding, beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue', window );">Intrinsic value outstanding, beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of share warrants outstanding, granted</a></td>
<td class="nump">1,278,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice', window );">Weighted average exercise price, granted</a></td>
<td class="nump">$ 39.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm', window );">Weighted average remaining contractual life, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 3 months 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod', window );">Number of share warrants outstanding, cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice', window );">Weighted average exercise price, cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations', window );">Number of share options outstanding, forfeited or expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited or expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of share warrants outstanding, ending balance</a></td>
<td class="nump">1,278,259<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price outstanding, ending balance</a></td>
<td class="nump">$ 39.66<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, Outstanding</a></td>
<td class="text">9 years 3 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue', window );">Intrinsic value outstanding, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of share options exercisable, ending balance</a></td>
<td class="nump">1,278,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price exercisable, ending balance</a></td>
<td class="nump">$ 39.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3', window );">Weighted average remaining contractual life, Exercisable</a></td>
<td class="text">9 years 3 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue', window );">Intrinsic value outstanding exercisable, Ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options cancelled in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award equity instruments other than options exerciable in period intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments cancelled weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments forfeited weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercisable Weighted Average Exercise Price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation shares authorized under stock option plans exercise price range outstanding other than options weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation shares authorized under stock option plans exercise price range outstanding other than options weighted average remaining contractual term 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were either cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details) - Research and Development Arrangement [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-Term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation cost</a></td>
<td class="nump">$ 671<span></span>
</td>
<td class="nump">$ 335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-Term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation cost</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-Term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation cost</a></td>
<td class="nump">$ 364<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2024</div></th>
<th class="th"><div>Jun. 14, 2024</div></th>
<th class="th"><div>Jan. 03, 2024</div></th>
<th class="th"><div>Apr. 17, 2023</div></th>
<th class="th"><div>Apr. 13, 2023</div></th>
<th class="th"><div>Jan. 11, 2010</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 27, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability', window );">Plan description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company&#8217;s Board of Directors has full authority in its discretion, from
    time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the respective award
    agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of shares to be
    covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and the nature
    and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
    or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election
    as to the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and
    to take actions, as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions
    of the Plan and to amend from time to time the terms of the Plan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,438<span></span>
</td>
<td class="nump">2,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1', window );">Deferred Compensation Arrangement with Individual, Maximum Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_PublicOfferingPrice', window );">Public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">855,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_WarrantsOriginalExercisePrice', window );">Warrants original exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">335,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_WarrantsOriginalExercisePrice', window );">Warrants original exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=GCTK_DrindaBenjaminMember', window );">Drinda Benjamin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173,000<span></span>
</td>
<td class="nump">$ 281,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=GCTK_DrindaBenjaminMember', window );">Drinda Benjamin [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=GCTK_MarkTapsakMember', window );">Mark Tapsak [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Grant date period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercise price of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares</a></td>
<td class="nump">121,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember', window );">Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,765<span></span>
</td>
<td class="nump">19,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercises in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_PublicOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_PublicOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_WarrantsOriginalExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants original exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_WarrantsOriginalExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum term of the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482943/710-10-55-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of nature and effect of change affecting comparability of defined contribution plan. Includes, but is not limited to, change in rate of employer contributions, business combination, or divestiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=GCTK_DrindaBenjaminMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=GCTK_DrindaBenjaminMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=GCTK_MarkTapsakMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=GCTK_MarkTapsakMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expense</a></td>
<td class="nump">$ 9,499<span></span>
</td>
<td class="nump">$ 4,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=GCTK_SalariesAndRelatedMember', window );">Salaries and Related [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expense</a></td>
<td class="nump">1,881<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=GCTK_ProfessionalFeesMember', window );">Professional Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expense</a></td>
<td class="nump">7,363<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=GCTK_DepreciationMember', window );">Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember', window );">Other Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expense</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=GCTK_SalariesAndRelatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=GCTK_SalariesAndRelatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=GCTK_ProfessionalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=GCTK_ProfessionalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=GCTK_DepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=GCTK_DepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total general and administrative expenses</a></td>
<td class="nump">$ 4,655<span></span>
</td>
<td class="nump">$ 2,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and related expenses</a></td>
<td class="nump">476<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees (including directors&#8217; fees)</a></td>
<td class="nump">3,724<span></span>
</td>
<td class="nump">1,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Insurance</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total general and administrative expenses</a></td>
<td class="nump">$ 4,655<span></span>
</td>
<td class="nump">$ 2,278<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic', window );">Domestic</a></td>
<td class="nump">$ 22,502<span></span>
</td>
<td class="nump">$ 6,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlementsForeign', window );">Foreign entity (Integrity Israel)</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlements', window );">&#160;Total loss for the year</a></td>
<td class="nump">$ 22,597<span></span>
</td>
<td class="nump">$ 7,097<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlementsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlementsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DeferredTaxAssetsTaxVacationAccrual', window );">Vacation accrual</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credits</a></td>
<td class="nump">3,276<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses carry forwards</a></td>
<td class="nump">16,981<span></span>
</td>
<td class="nump">12,368<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax asset before deferred tax liabilities and valuation allowance</a></td>
<td class="nump">20,465<span></span>
</td>
<td class="nump">13,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GCTK_DeferredTaxAssetValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(20,465)<span></span>
</td>
<td class="num">(13,467)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DeferredTaxAssetValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DeferredTaxAssetValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GCTK_DeferredTaxAssetsTaxVacationAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets tax vacation accrual.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GCTK_DeferredTaxAssetsTaxVacationAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GCTK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAX (Details Narrative)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 31.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 38.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses (Note 9)</a></td>
<td class="nump">$ 9,499<span></span>
</td>
<td class="nump">$ 4,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=GCTK_MarkTapsakMember', window );">Mark Tapsak [Member] | Tapsak Enterprises LLC Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses (Note 9)</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=GCTK_MarkTapsakMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=GCTK_MarkTapsakMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GCTK_TapsakEnterprisesLLCAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GCTK_TapsakEnterprisesLLCAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2025</div></th>
<th class="th"><div>Feb. 04, 2025</div></th>
<th class="th"><div>Feb. 03, 2025</div></th>
<th class="th"><div>Dec. 17, 2024</div></th>
<th class="th"><div>Nov. 12, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 13, 2023</div></th>
<th class="th"><div>Mar. 15, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 03, 2025</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one-for-five<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=GCTK_SalesAgreementMember', window );">Sales Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">reverse stock split at a ratio of 1-for-20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,721,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Sales Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock, shares</a></td>
<td class="nump">12,377,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price</a></td>
<td class="nump">$ 0.304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds</a></td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,638,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GCTK_SalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GCTK_SalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=GCTK_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=GCTK_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=GCTK_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=GCTK_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>86
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (.*?UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( (.*?UH>2N>I\0   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DE%+PS 0Q[^*Y+V]M&4*H<N+8T\*@@/%MY#<
MMF#3A.2DW;<WK5NGZ ?P,7?__.YW<*T.0ON(3]$'C&0QW8RNZY/08<V.1$$
M)'U$IU*9$WUN[GUTBO(S'B H_:X."#7GM^"0E%&D8 (682$RV1HM=$1%/I[Q
M1B_X\!&[&68T8(<.>TI0E14P.4T,I[%KX0J88(31I:\"FH4X5__$SAU@Y^28
M[)(:AJ$<FCF7=ZC@]?'A>5ZWL'TBU6O,OY(5= JX9I?)+\W]9K=ELN;UJN!-
MT52[NA(U%WSU-KG^\+L*.V_LWOXSX[MOQA=!V<*ONY"?4$L#!!0    ( (.*
M?UJ97)PC$ 8  )PG   3    >&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^
M[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZ
MFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *
MI4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>
M+&A T%116F]?(+3E'S/X%<M4C66C 1-702:YB+3R^6S%_-K>/F7/Z3H=,H%N
M,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8
MSG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CV
MVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI
M)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN
M.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(
M@?5'@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\
M+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E,L_O^0KK3CQG'U:6L%W/S^2>C'(C
MN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6
MH8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V
M5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\'1,2S90+!D&&ER0F$JDY?DU($_XK
MI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:P4:O&W6':-(\>OX%^9PU"AR1&QT"
M9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:<K46@;9QJ81@6A+&T7A.TK01_%FL
M-9,^8,CLS9%USM:1#A&27C="/F+.BY 1OQZ&.$J:[:)Q6 3]GE[#2<'H@LMF
M_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >CFED)O816:I^JAS0^J!XR"@7QN1X^
MY7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_+GW/I>^Y]#VATK<W(WUGP=.+6]Y&
M;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?P.S]:#Z>\>WZV22$KYI9+2,6D$N!
MLT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T
M/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL<QP3A[+##MG/)(=MG>@'37[]EUV
MY".E,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1
MT?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q
M+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW
M&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07
MIDJB\QE3ON<K2<15.+]%,[82EQB\X^;'<4Y3N!)VM@\",KF[.:EZ93%GIO+?
M+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_IN
MDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY
M*17.K3XY?T4L@X9.7M(E$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)
MP3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+PWING2TG_]M>U#VT%SU&\Z.9X!ZS
MAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT
M>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,
M>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*
M/-S^[PVPPL2.X>V+OP%02P,$%     @ @XI_6H+)=;[;"0  =3H  !@   !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6RUFV]OVCH;QM_W4UB<:=HD*/E#"]O:
M2C2T&V<;[0&V:<_TO'"#*=&2.,=.2OOMSVTG$#(YADCF3#H-D/N*_8OMW)<=
M7ZPI^\U7A*3H.0IC?ME:I6GROMOE_HI$F)_2A,3PRY*R"*?PD3UV><((7LB@
M*.PZEG7>C7 0MZXNY'?W[.J"9FD8Q.2>(9Y%$68OUR2DZ\N6W=I\,0T>5ZGX
MHGMUD>!',B/IM^2>P:?N5F411"3F 8T1(\O+UM!^/^KU1( \XWM UGSG&(FJ
M/%#Z6WP8+RY;EB@1"8F?"@D,?YZ(1\)0*$$Y_BU$6]MKBL#=XXWZK:P\5.8!
M<^+1\$>P2%>7K4$++<@29V$ZI>M/I*C0F=#S:<CE_]$Z/_?,;2$_XRF-BF H
M013$^5_\7(#8"1A8-0%.$>#\$6#W:@+<(L ]-*!7!$C4W;PJDL,(I_CJ@M$U
M8N)L4!,'$J:,ANH'L;COLY3!KP'$I5<>?2(,=="WV0B]>?46O4)=Q%>8$8Z"
M&'V+@Y2WX4LX_AJ$(=PI?M%-X;HBNNL7U[C.K^'47,-VT%<:IRN.;N(%650%
MNE#@;:F=3:FO':WBB/BGR+7;R+&<GJ) GC[\*V;;\#-%^$@?_G<6GR)GH+IZ
MI3;N]AZX4L_5WH-?PP>>,N@'_U<1SA5Z:@4Q.+SG"?;)90MZ/R?LB;2N7O]E
MGUL?5'1,BHT,B57(];;D>CKUJQ'U,QB$4C1_28@*FS[<MCJ?57RT44WY&!*K
M\#G;\CG35G (<!82T&V('U6 ]/%+''(55T\;UI20(;$*H?,MH?/#6M PCC,<
MHBE)*$M5I/0Z*<N4H+1134$9$JN ZF]!]0_L:@S#4U\^M.MAZ;5JFY4VK"DM
M0V(56H,MK<%AM.X)"^A"//@0/)^58]0>I<VCKO99IXUO"LV06 7:NRVT=X=!
MNPVX#WVQ8'<+7RNS#KW:[4\5+&U,4UB&Q"JP;*O,W*Q&N'X2S.IA[1&K:USZ
ML*; 3*E5B>WDNK:VDE[&V)_ =#USCURG8SL=UU9BTT8VQF9(K8K-*;$YVGK>
MQ&F0O@"UD*!)%CT0IH2E%[$LN]-SW+ZZE6EC&^,RI%;%56;SMC;EW>":DL=
M)/30WB8X4K<OO=#'+]^\N_ETZ'UNGXPGWJF2G-%<WI1:E5R9S=OZ?+P@YT$?
M9= _Q^ 6G]%G\J)DIY>RH+V=6>?O!JZ2FM$,WY1:E5J9X]OZ)+V@-L?/:+P
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M*;4JK#+I=P]:=[C/'L+ 1[<AQ>J!WV0*[QE5&Q5J9U)-O"+[=#4X/;_H/JG
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MNF.^96_[[79/Y5#N).R6I^<;,K]B,;'#44B6$&J=]L'#LGR/8_XAI8G<]?=
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M73VM<>BYC</Q"^4IJVKUR (FZN!'UOXRSPHYZ3BD >4H0H'&4* ("A1#@1(
MD"Z2UHWTW&[DZ2)QCB.FMX9#\UR0NRYG#R20M B4%H/2$BB:KI'6X/3<!N?N
M-/299ZP@_'5S^T$]$ZFM<$[K:4?):/\X64'K9>_F T1?U,;Y@)*@#%(HT!@*
M%$&!8BA0 @#2)=5:K-[I%BNDI)R#E,T_Q:/!<'^4 CV^"$J+0&DQ*"V!HNF2
M:DU>[W23-Z-"[KGK>YJV4YF8\7(YG;F7S7;A0)U4A *-H4 1%"B& B4 (%U
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M.:]?SBC)*%<)Y/>3LA2;-ZJ [8/(;O\&4$L#!!0    ( (.*?UH?SQL77@@
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MX/<Y![/5#_H%V\MKD_\!4$L#!!0    ( (.*?UI%UM:850(  *L%   8
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M0L7QS41/+R\^W;V?O-=_3&]_Y^?CR_?\Q^2O=],OXT^3R]M9H-6G)6"LVC8
M"('H+:6*H T_!,,O]C$QP/\J>3T\HWV<OAVIFXYD_*2'Q_0_=4N,C%\FN[*@
M>A0=JK/'LM>K"X22 !@Q *^.1VHRT-<U>GWM$TV*JVQP7*)+TZKAOL<Z\&.!
M,Q80Z] ("@L#>PMJ"40V9^6-;.(^H0@NTF(A+[('PJ#7*>:YCC!_H-<&* %V
M&YP+$G@;1.$(L]P6P$L/QMDB]H(&^@_4%6G)GW&EVK0YI@% '9,+\)@W%*"B
MAH)OEXGU9E/&9UT_(3P<\E"XYC>EPDV)7[(& #,;.1HK>@":-Y<VP$(L<:1I
M2!;(.J#])*4%0],B_X>=C$',+<*< Z2Z=&YB]YW9+W1SR-T:J!%8%A1JQ3;#
M[>-=)$W7-U?7DYO;OY&@H(Q<?P812<C[F>$+[R?7-Q/PC&ZG5Y?J;P8E ^5T
MVY)QC3CE1'W8UJ!/T ;A$W)O3/#"F1Z^4A\&>@IRGM?X%0)75.7J"(F;"57)
MDG^LJ^W&J<N==X0:#[EY1 P"M7,W:5\*"*.YD]<^_+/,GNCK J,:A'=B 14/
M,5%HB4#90S3QP)BOPRAFD=? *D 8TJIYF9&1]H;!,9<0'"7&<BIH6EU6:$[(
MTJ%'#<$6.@/R@:)XY7,O[#V0ZD98.5P"C0T.Y1;Y?0Y\17R ,5>04'H&!DYM
M0&Q$% /3DS?$P5;/D")1& Z0[F$(.&O6\HI.$H&F$J<Y0;0NF!O)!#(92V!
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MMP!:BTGSV5GD4%!@FO#)!=<<9\'Y05=$M442E[XW1\@ 89V(.PY=(O^1+N5
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M[R(:KT#R2FMWV'@'_4L[_P]02P,$%     @ @XI_6M6EBN2L%   EST  !D
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M5$1D10014JQEH+(".<?R(M=I'*HLEZ=$C&3S>B_>ZVO\J?_BS)';,LM+/"U
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MEZG$S&AX =XOM7;-#2MHO^Z<_1=02P,$%     @ @XI_6I]4=8%S!0   0P
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MX?'IB0^J<L-J8N3:.=!"&O(S-\SI!X+*)M#Z4M(GK">V0/-+&OX&4$L#!!0
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M9_E4#DPJ]SL;=45/6\.'I41%;\[-\\2ZMF!G_'H5[@V'#]=2@X?T,.Q?TOV
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M$6F6R(2/$$7-7CNBAW[SL-OC%J-S)"?$CJO?VU(I*BKWX; '82\2]]K)5-!
M>^H2KM7'.SR @V;[\$", KA%)R:50H@YYH;Z:N]V<KT/L31F3<XK:1(QM#P!
M7E#4?-;#2YG0F925+%\2$<6&]V)#'=PC_#J%6CM/^N"F*JC)'A4=KYBNQ4=*
M'/2A,PAZ8AP "^[_[V*%E55&348[&JN4<2F'&2A;CXU8+W+E-4?)'V1:5@*4
MO-_<O>"];<$J( LZW]%0?PGJ2@)L,*V*Y9Z,:RH(5$Y,Z"T3:<4$<Z PV;+
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M;?:/2_J=@H8-Z/NYUF[SP@FVOWS._@502P,$%     @ @XI_6@B(EH3! P
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M7Z9YG"_2.)-5#8\!-]55UU;Z%QL/)*PG_N1ZXG:M1.LY'+HH\@H0G<!S2>=
M7 ,>0LF3UH_ %_5:WLWDQ_'X*\B#?S0IH!58(0?A@<_+NH!/WY4'9)PG,JY
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MNPR;=&A+*Z\P"]T>V%=5=%4Y>!5;E,^KO0*'@0E\&.XUAU#HGE L=_A1DQ7
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M4$:==R.P.6Q-72Y&(*F]%RX:8LOK(ZY@Y&I?KA;<,TXCR\]L[(!/F 0\:>7
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MWR?\P7%OCL;@.EDI]>(F\V(<QDX0"LRM8V#T>L49"N&(2,:7AC-L2SK@\?C
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MD6L'=9XS)O<;':"=^-$O4$L#!!0    ( (.*?UI%#'!?V0(  #D&   9
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MQ\FW%-(?T_1NEL[@[)'/)=I/_<A11U\795OTRQJ=O8/>9'"KE2LLI"K'_"U
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M*$M%DNOXTD&M?DXE/&Z_T'_3P<M@UIC#BI9_DUP4"VMJH1PVN"G%(SW\ 5U
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MB?JY(-<):GW%F'P9Z/Y5_Z[<?U!+ P04    " "#BG]:I&0M\*H"  !J"0
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M965T-#,N>&ULK9=M;R(W$,>_RFA[JA*IEWV  $D!B0#7<+I Q$-/5=479G<
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MT@2*IL>N=!#'7.Y#8XSCA=J?DJ:=971:E6,AU.J@:/JM ,KJV)@+>FB,\2T
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MQ,6R&S=2K)3F=C3R9#SOSF?1"AFJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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M:F*C?RJSW;N*:UWIHOM.HG;I7LJ@?2>=/3*#Y4R6LUC.9CF'Y5R6\UC.9[F
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M=\<OZ.]L\;J8)R)QQ,M/1:;R@7/I0(8+LB[5 ]^^Q[J@KL%+>2GM%;9UK.=
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M!EAU@+5MP* .&&P;<% ''&P;<%@''+X)V%A+PSI@^+:$@PT!1W7 T9L <U/
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M:UZ5'E4#?=2D4Z%MR]X( >:9?"J -Z\?R]D]]0X4U6H[5ND;&28%.E/1CJ&
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M5+P<$B['=0_CZK-\*S(28-M2AU4@7Z'E?_Q0]2I?#B5])K ="=Q2 O<4NI)
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M?9+DSU?* 9Z2].MZ\2;_ U!+ P04    " "#BG]:[ GJ"&@#  "J%@  #0
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M_NQJF#=@8'D@T]/F&E]MO$)VUP&VIKLJ!!LI7HG82/&Y!L0^;\"((OMJ8WF
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MPP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ @XI_6IE<G",0!@
MG"<  !,              ( !XP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " "#BG]:@LEUOML)  !U.@  &               @($D"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ @XI_6FQX+O S!@
ME1D  !@              ("!-1(  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( (.*?UJ_+OU\B (  "4'   8              " @9X8
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "#BG]:@_49
MROD$  "B$@  &               @(%<&P  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ @XI_6C9_O-:'"0  E$P  !@
M ("!BR   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( (.*
M?UH?SQL77@@  ,@F   8              " @4@J  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " "#BG]:1=;6F%4"  "K!0  &
M        @('<,@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ @XI_6D[K+^D+ @  KP0  !@              ("!9S4  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( (.*?UH\I3,X$0(  -T$   8
M              " @:@W  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " "#BG]:IQ3*[T8+  #L(P  &0              @('O.0  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( (.*?UK>$^8E5@<
M !X0   9              " @6Q%  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ @XI_6A$5^UK%)   2'(  !D              ("!
M^4P  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "#BG]:
M4,&*%WX#  !U!P  &0              @('U<0  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( (.*?UK5I8KDK!0  )<]   9
M      " @:IU  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ @XI_6O_H6-^0!P  Z1$  !D              ("!C8H  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "#BG]:GU1U@7,%   !#
M&0              @(%4D@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( (.*?UKT%B"9_ (  )X&   9              " @?Z7  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ @XI_6E&:U2C6
M#   C2   !D              ("!,9L  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " "#BG]:OBO[!;@"   9!@  &0
M@($^J   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( (.*
M?UHN-KF9VP(  %@&   9              " @2VK  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ @XI_6JV+._/[!0  !0T  !D
M         ("!/ZX  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " "#BG]:"(B6A,$#  "!"   &0              @(%QM   >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( (.*?UK?=D,3B00  ,(*
M   9              " @6FX  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ @XI_6NS,Z6*=!0  #0T  !D              ("!*;T
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "#BG]::[)N
MFCTF  "2?@  &0              @(']P@  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( (.*?UHY0@#UT@8   X2   9
M  " @7'I  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
M@XI_6A]N==;; P  !0D  !D              ("!>O   'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " "#BG]:_@[[(ID#  #O"   &0
M            @(&,]   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( (.*?UH^$ZO1_0(  'T&   9              " @5SX  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ @XI_6B2YR#/0!
ML P  !D              ("!D/L  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " "#BG]:6PH;;+4"  #]!0  &0              @(&7
M  $ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( (.*?UI%
M#'!?V0(  #D&   9              " @8,# 0!X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ @XI_6L5D&&)= P  G <  !D
M     ("!DP8! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (.*?UJGG\P6Q@0   $6   9              "
M@6<6 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ @XI_
M6JFA:U/F P  O!(  !D              ("!9!L! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " "#BG]:4(<BE= #   9%P  &0
M        @(&!'P$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( (.*?UI>J<FT#0,  %8)   9              " @8@C 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ @XI_6@ZUSB+O @  D0D
M !D              ("!S"8! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " "#BG]:M[NL;9@#   S#   &0              @('R*0$
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( (.*?UI_7M>O
M9@<  %Y.   9              " @<$M 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ @XI_6CJQ*:7"*P  @3H# !D
M ("!7C4! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "#
MBG]:_$@)TW$)  "6>@  &0              @(%780$ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( (.*?UH)F6YG:P(  ,,&   9
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M970U,2YX;6Q02P$"% ,4    " "#BG]:7"FV0U\%  "^'0  &0
M    @(%=>@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M (.*?UI-+PH7. 0  "88   9              " @?-_ 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ @XI_6IQL#K)!!   *!<  !D
M             ("!8H0! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    " "#BG]:?IZRZ$4#  !J"P  &0              @(':B $ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( (.*?UH?<9PP0 T
M /R.   9              " @5:, 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ @XI_6M_Z7X8P P  > L  !D              ("!
MS9D! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "#BG]:
M'RJ&V$X#  "\"0  &0              @($TG0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( (.*?UKYJ\"SRP(  !L'   9
M      " @;F@ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ @XI_6OEE;!L% P  T @  !D              ("!NZ,! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " "#BG]:$^:N#$\"   8!@
M&0              @('WI@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+
M 0(4 Q0    ( (.*?UKTRZ]:X@(  )P(   9              " @7VI 0!X
M;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ @XI_6B:02EH#
M"@  0HP  !D              ("!EJP! 'AL+W=O<FMS:&5E=',O<VAE970V
M,RYX;6Q02P$"% ,4    " "#BG]:[ GJ"&@#  "J%@  #0
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:+GAM;%!+!08     1P!' &@3  !VQ0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>205</ContextCount>
  <ElementCount>349</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Stockholders' (Deficit) Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' (Deficit) Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>999014 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/General</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>999016 - Disclosure - LOANS FROM STOCKHOLDERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/LoansFromStockholders</Role>
      <ShortName>LOANS FROM STOCKHOLDERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>999017 - Disclosure - SIGNIFICANT TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SignificantTransactions</Role>
      <ShortName>SIGNIFICANT TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>999018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/CommitmentsAndContingentLiabilities</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>999019 - Disclosure - LEASE AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/LeaseAgreement</Role>
      <ShortName>LEASE AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>999020 - Disclosure - FINANCE (INCOME) EXPENSES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/FinanceIncomeExpensesNet</Role>
      <ShortName>FINANCE (INCOME) EXPENSES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>999021 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection</Role>
      <ShortName>COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>999022 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ResearchAndDevelopmentExpenses</Role>
      <ShortName>RESEARCH AND DEVELOPMENT EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>999023 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/GeneralAndAdministrativeExpenses</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>999024 - Disclosure - INCOME TAX</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/IncomeTax</Role>
      <ShortName>INCOME TAX</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>999025 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/RelatedParties</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>999026 - Disclosure - SEGMENT REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SegmentReporting</Role>
      <ShortName>SEGMENT REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>999027 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>999030 - Disclosure - SIGNIFICANT TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SignificantTransactionsTables</Role>
      <ShortName>SIGNIFICANT TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/SignificantTransactions</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>999031 - Disclosure - LEASE AGREEMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/LeaseAgreementTables</Role>
      <ShortName>LEASE AGREEMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/LeaseAgreement</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>999032 - Disclosure - FINANCE (INCOME) EXPENSES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/FinanceIncomeExpensesNetTables</Role>
      <ShortName>FINANCE (INCOME) EXPENSES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/FinanceIncomeExpensesNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>999033 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables</Role>
      <ShortName>COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>999034 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables</Role>
      <ShortName>RESEARCH AND DEVELOPMENT EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/ResearchAndDevelopmentExpenses</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>999035 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/GeneralAndAdministrativeExpenses</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>999036 - Disclosure - INCOME TAX (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/IncomeTaxTables</Role>
      <ShortName>INCOME TAX (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://glucotrack.com/role/IncomeTax</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>999037 - Disclosure - GENERAL (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/GeneralDetailsNarrative</Role>
      <ShortName>GENERAL (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>999038 - Disclosure - SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails</Role>
      <ShortName>SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>999039 - Disclosure - SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails</Role>
      <ShortName>SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>999040 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>999041 - Disclosure - SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails</Role>
      <ShortName>SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>999042 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails</Role>
      <ShortName>SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>999045 - Disclosure - LOANS FROM STOCKHOLDERS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative</Role>
      <ShortName>LOANS FROM STOCKHOLDERS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/LoansFromStockholders</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>999046 - Disclosure - SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails</Role>
      <ShortName>SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>999047 - Disclosure - SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails</Role>
      <ShortName>SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>999048 - Disclosure - SIGNIFICANT TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SignificantTransactionsDetailsNarrative</Role>
      <ShortName>SIGNIFICANT TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/SignificantTransactionsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>999049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/CommitmentsAndContingentLiabilities</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>999050 - Disclosure - SCHEDULE OF OPERATING LEASE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails</Role>
      <ShortName>SCHEDULE OF OPERATING LEASE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>999051 - Disclosure - SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails</Role>
      <ShortName>SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>999052 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails</Role>
      <ShortName>SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>999053 - Disclosure - LEASE AGREEMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/LeaseAgreementDetailsNarrative</Role>
      <ShortName>LEASE AGREEMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/LeaseAgreementTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>999054 - Disclosure - SCHEDULE OF FINANCE EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails</Role>
      <ShortName>SCHEDULE OF FINANCE EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>999055 - Disclosure - SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails</Role>
      <ShortName>SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>999056 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails</Role>
      <ShortName>SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>999057 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails</Role>
      <ShortName>SCHEDULE OF WARRANTS ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>999058 - Disclosure - SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails</Role>
      <ShortName>SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>999059 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative</Role>
      <ShortName>COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>999060 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails</Role>
      <ShortName>SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>999061 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails</Role>
      <ShortName>SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>999062 - Disclosure - SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails</Role>
      <ShortName>SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>999063 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>999064 - Disclosure - INCOME TAX (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/IncomeTaxDetailsNarrative</Role>
      <ShortName>INCOME TAX (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/IncomeTaxTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>999065 - Disclosure - RELATED PARTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/RelatedPartiesDetailsNarrative</Role>
      <ShortName>RELATED PARTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/RelatedParties</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>999066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://glucotrack.com/role/SubsequentEvents</ParentRole>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="form10-k.htm">form10-k.htm</File>
    <File>gctk-20241231.xsd</File>
    <File>gctk-20241231_cal.xml</File>
    <File>gctk-20241231_def.xml</File>
    <File>gctk-20241231_lab.xml</File>
    <File>gctk-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="639">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="12">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>92
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form10-k.htm": {
   "nsprefix": "GCTK",
   "nsuri": "http://glucotrack.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    },
    "schema": {
     "local": [
      "gctk-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "gctk-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "gctk-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gctk-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gctk-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 276,
   "keyCustom": 73,
   "axisStandard": 22,
   "axisCustom": 0,
   "memberStandard": 25,
   "memberCustom": 49,
   "hidden": {
    "total": 152,
    "http://glucotrack.com/20241231": 47,
    "http://fasb.org/us-gaap/2024": 102,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 205,
   "entityCount": 1,
   "segmentCount": 81,
   "elementCount": 641,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 639,
    "http://xbrl.sec.gov/dei/2024": 41,
    "http://xbrl.sec.gov/cyd/2024": 12,
    "http://xbrl.sec.gov/ecd/2024": 1,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://glucotrack.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://glucotrack.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OtherAssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://glucotrack.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:MarketingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity",
     "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' (Deficit) Equity",
     "shortName": "Consolidated Statements of Changes in Stockholders' (Deficit) Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://glucotrack.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:NoInsiderTradingFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:NoInsiderTradingFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://glucotrack.com/role/General",
     "longName": "999014 - Disclosure - GENERAL",
     "shortName": "GENERAL",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://glucotrack.com/role/LoansFromStockholders",
     "longName": "999016 - Disclosure - LOANS FROM STOCKHOLDERS",
     "shortName": "LOANS FROM STOCKHOLDERS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://glucotrack.com/role/SignificantTransactions",
     "longName": "999017 - Disclosure - SIGNIFICANT TRANSACTIONS",
     "shortName": "SIGNIFICANT TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:SignificantTransactionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:SignificantTransactionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://glucotrack.com/role/CommitmentsAndContingentLiabilities",
     "longName": "999018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://glucotrack.com/role/LeaseAgreement",
     "longName": "999019 - Disclosure - LEASE AGREEMENT",
     "shortName": "LEASE AGREEMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://glucotrack.com/role/FinanceIncomeExpensesNet",
     "longName": "999020 - Disclosure - FINANCE (INCOME) EXPENSES, NET",
     "shortName": "FINANCE (INCOME) EXPENSES, NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection",
     "longName": "999021 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION",
     "shortName": "COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://glucotrack.com/role/ResearchAndDevelopmentExpenses",
     "longName": "999022 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES",
     "shortName": "RESEARCH AND DEVELOPMENT EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://glucotrack.com/role/GeneralAndAdministrativeExpenses",
     "longName": "999023 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES",
     "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:GeneralAndAdministrativeExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:GeneralAndAdministrativeExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://glucotrack.com/role/IncomeTax",
     "longName": "999024 - Disclosure - INCOME TAX",
     "shortName": "INCOME TAX",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://glucotrack.com/role/RelatedParties",
     "longName": "999025 - Disclosure - RELATED PARTIES",
     "shortName": "RELATED PARTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://glucotrack.com/role/SegmentReporting",
     "longName": "999026 - Disclosure - SEGMENT REPORTING",
     "shortName": "SEGMENT REPORTING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://glucotrack.com/role/SubsequentEvents",
     "longName": "999027 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "999028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "999029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "GCTK:FunctionalCurrencyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "GCTK:FunctionalCurrencyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://glucotrack.com/role/SignificantTransactionsTables",
     "longName": "999030 - Disclosure - SIGNIFICANT TRANSACTIONS (Tables)",
     "shortName": "SIGNIFICANT TRANSACTIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://glucotrack.com/role/LeaseAgreementTables",
     "longName": "999031 - Disclosure - LEASE AGREEMENT (Tables)",
     "shortName": "LEASE AGREEMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://glucotrack.com/role/FinanceIncomeExpensesNetTables",
     "longName": "999032 - Disclosure - FINANCE (INCOME) EXPENSES, NET (Tables)",
     "shortName": "FINANCE (INCOME) EXPENSES, NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables",
     "longName": "999033 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)",
     "shortName": "COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables",
     "longName": "999034 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)",
     "shortName": "RESEARCH AND DEVELOPMENT EXPENSES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables",
     "longName": "999035 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)",
     "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "GCTK:GeneralAndAdministrativeExpensesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "GCTK:GeneralAndAdministrativeExpensesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://glucotrack.com/role/IncomeTaxTables",
     "longName": "999036 - Disclosure - INCOME TAX (Tables)",
     "shortName": "INCOME TAX (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://glucotrack.com/role/GeneralDetailsNarrative",
     "longName": "999037 - Disclosure - GENERAL (Details Narrative)",
     "shortName": "GENERAL (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:ProceedsFromPublicOfferingsAndDebtIssuances",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails",
     "longName": "999038 - Disclosure - SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)",
     "shortName": "SCHEDULE OF OFFICIAL EXCHANGE RATE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ForeignCurrencyExchangeRateRemeasurement1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock",
       "GCTK:FunctionalCurrencyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ForeignCurrencyExchangeRateRemeasurement1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock",
       "GCTK:FunctionalCurrencyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails",
     "longName": "999039 - Disclosure - SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)",
     "shortName": "SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:RestrictedCash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails",
     "longName": "999040 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31_us-gaap_ComputerEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfPropertyRatesOfDepreciationTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_us-gaap_ComputerEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfPropertyRatesOfDepreciationTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
     "longName": "999041 - Disclosure - SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)",
     "shortName": "SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "GCTK:DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
     "longName": "999042 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)",
     "shortName": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2024-07-302024-07-30",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-11-142024-12-31_us-gaap_FairValueInputsLevel3Member",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
     "longName": "999043 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)",
     "shortName": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:DerivativeLiabilitiesNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member",
      "name": "us-gaap:DerivativeLiabilitiesNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashFDICInsuredAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashFDICInsuredAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative",
     "longName": "999045 - Disclosure - LOANS FROM STOCKHOLDERS (Details Narrative)",
     "shortName": "LOANS FROM STOCKHOLDERS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:QuarterlyPaymentsEqualsToSalesPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:QuarterlyPaymentsEqualsToSalesPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
     "longName": "999046 - Disclosure - SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)",
     "shortName": "SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ProceedsFromIssuanceOfWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember",
      "name": "us-gaap:ProceedsFromIssuanceOfWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock",
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
     "longName": "999047 - Disclosure - SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)",
     "shortName": "SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_us-gaap_CommonStockMember28421750",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock",
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
     "longName": "999048 - Disclosure - SIGNIFICANT TRANSACTIONS (Details Narrative)",
     "shortName": "SIGNIFICANT TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-15",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
     "longName": "999049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2024-11-202024-11-20",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-11-202024-11-20",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails",
     "longName": "999050 - Disclosure - SCHEDULE OF OPERATING LEASE (Details)",
     "shortName": "SCHEDULE OF OPERATING LEASE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R48": {
     "role": "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails",
     "longName": "999051 - Disclosure - SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)",
     "shortName": "SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails",
     "longName": "999052 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)",
     "shortName": "SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://glucotrack.com/role/LeaseAgreementDetailsNarrative",
     "longName": "999053 - Disclosure - LEASE AGREEMENT (Details Narrative)",
     "shortName": "LEASE AGREEMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-19",
      "name": "us-gaap:OperatingLeaseLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-02-192024-02-19_us-gaap_LeaseAgreementsMember",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-2",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails",
     "longName": "999054 - Disclosure - SCHEDULE OF FINANCE EXPENSES (Details)",
     "shortName": "SCHEDULE OF FINANCE EXPENSES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:DiscountAmortizationAndInterestExpensesOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "GCTK:DiscountAmortizationAndInterestExpensesOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails",
     "longName": "999055 - Disclosure - SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)",
     "shortName": "SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
     "longName": "999056 - Disclosure - SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)",
     "shortName": "SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails",
     "longName": "999057 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)",
     "shortName": "SCHEDULE OF WARRANTS ACTIVITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails",
     "longName": "999058 - Disclosure - SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)",
     "shortName": "SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
     "longName": "999059 - Disclosure - COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)",
     "shortName": "COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2023-04-132023-04-13",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-132023-04-13",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
     "longName": "999060 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)",
     "shortName": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_custom_SalariesAndRelatedMember",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
     "longName": "999061 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)",
     "shortName": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "GCTK:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
       "GCTK:GeneralAndAdministrativeExpensesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails",
     "longName": "999062 - Disclosure - SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)",
     "shortName": "SCHEDULE OF INCOME TAX LOSS FOR THE YEAR (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails",
     "longName": "999063 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "GCTK:DeferredTaxAssetsTaxVacationAccrual",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "GCTK:DeferredTaxAssetsTaxVacationAccrual",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://glucotrack.com/role/IncomeTaxDetailsNarrative",
     "longName": "999064 - Disclosure - INCOME TAX (Details Narrative)",
     "shortName": "INCOME TAX (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://glucotrack.com/role/RelatedPartiesDetailsNarrative",
     "longName": "999065 - Disclosure - RELATED PARTIES (Details Narrative)",
     "shortName": "RELATED PARTIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://glucotrack.com/role/SubsequentEventsDetailsNarrative",
     "longName": "999066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2024-04-302024-04-30",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "GCTK:SignificantTransactionsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-12-172024-12-17_custom_SalesAgreementMember",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity of Counterparty, Type [Axis]",
        "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r76"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r687"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r167",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r77",
      "r154",
      "r493",
      "r512",
      "r513"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r167",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r11",
      "r19",
      "r388",
      "r391",
      "r438",
      "r508",
      "r509",
      "r829",
      "r830",
      "r831",
      "r841",
      "r842",
      "r843",
      "r844"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r687",
      "r946"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r841",
      "r842",
      "r843",
      "r844",
      "r884",
      "r949"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "GCTK_AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deemed dividend resulted from trigger of down round protection feature of certain warrants granted",
        "documentation": "Adjustments to additional paid in capital deemed dividend resulted from trigger of down round protection feature of certain warrants granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of detachable warrants through private placement transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r36",
      "r95"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile loss for the year to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_AggregateSalesPriceOfUnitsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "AggregateSalesPriceOfUnitsPercentage",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commission as a percentage of aggregate sales price",
        "documentation": "Aggregate sales price of units percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r748",
      "r762",
      "r788"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r765",
      "r791"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r783"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r741",
      "r752",
      "r766",
      "r783",
      "r792",
      "r796",
      "r804"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total compensation cost",
        "verboseLabel": "Stock based compensation income",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r347"
     ]
    },
    "GCTK_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation of proceeds and related issuance costs",
        "documentation": "Allocation Of Proceeds And Related Issuance Costs [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount amortization and interest expenses related to promissory notes",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r670",
      "r671",
      "r835",
      "r896"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative",
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r113",
      "r150",
      "r180",
      "r210",
      "r218",
      "r231",
      "r234",
      "r244",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r383",
      "r385",
      "r410",
      "r489",
      "r570",
      "r659",
      "r660",
      "r687",
      "r708",
      "r872",
      "r873",
      "r903"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r156",
      "r180",
      "r244",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r383",
      "r385",
      "r410",
      "r687",
      "r872",
      "r873",
      "r903"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r720",
      "r722",
      "r744"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r720",
      "r722",
      "r744"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r720",
      "r722",
      "r744"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "GCTK_AugustTwentyThreeWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "AugustTwentyThreeWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "August 23 Warrant [Member]",
        "documentation": "August Twenty Three Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_AugustTwentyThreeWarrantOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "AugustTwentyThreeWarrantOneMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "August 23 Warrant One [Member]",
        "documentation": "August 23 Warrant One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_AugustTwentyThreeWarrantThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "AugustTwentyThreeWarrantThreeMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "August 23 Warrant Three [Member]",
        "documentation": "August Twenty Three Warrant Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_AugustTwentyThreeWarrantTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "AugustTwentyThreeWarrantTwoMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "August Twenty Three Warrant Two [Member]",
        "documentation": "August Twenty Three Warrant Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "GCTK_BetweenOneYearToTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "BetweenOneYearToTwoYearsMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Between 1 - 2 Years [Member]",
        "documentation": "Between 1 - 2 Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "documentation": "Leader of board of directors."
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r101",
      "r379",
      "r400",
      "r401",
      "r402"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets",
      "http://glucotrack.com/role/GeneralDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents (Note 2D)",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r149",
      "r648"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents and restricted cash",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r104"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the statement of cash flows",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r84",
      "r177"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of the year",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of the year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r84",
      "r177"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r84"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FDIC insurance limit",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r151",
      "r152",
      "r153",
      "r180",
      "r201",
      "r202",
      "r205",
      "r207",
      "r212",
      "r213",
      "r244",
      "r261",
      "r263",
      "r264",
      "r265",
      "r268",
      "r269",
      "r288",
      "r289",
      "r291",
      "r294",
      "r300",
      "r410",
      "r519",
      "r520",
      "r521",
      "r522",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r558",
      "r579",
      "r601",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r823",
      "r837",
      "r845"
     ]
    },
    "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercisable",
        "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "exercise price",
        "verboseLabel": "Exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase shares",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "GCTK_ClassOfWarrantOrRightReasonForCashRaised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ClassOfWarrantOrRightReasonForCashRaised",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value cash raised",
        "documentation": "Class of warrant or right reason for cash raised."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingent liabilities (Note 5)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r108",
      "r491",
      "r557"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENT LIABILITIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r252",
      "r253",
      "r632",
      "r861",
      "r866"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r633"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r698",
      "r699",
      "r700",
      "r702",
      "r703",
      "r704",
      "r705",
      "r841",
      "r842",
      "r844",
      "r884",
      "r944",
      "r949"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheetsParenthetical",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "verboseLabel": "Common stock share price",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheetsParenthetical",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "verboseLabel": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r558"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheetsParenthetical",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "verboseLabel": "Shares of Common Stock",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r69",
      "r558",
      "r576",
      "r949",
      "r950"
     ]
    },
    "us-gaap_CommonStockSharesSubscriptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesSubscriptions",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of common stock",
        "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r69"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock of $0.001 par value (\u201cCommon Stock\u201d): 100,000,000 shares authorized as of December 31, 2024 and 2023; 802,609 and 208,914 shares issued and outstanding as of December 31, 2024 and 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r492",
      "r687"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Comprehensive loss for the year",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r162",
      "r164",
      "r170",
      "r486",
      "r501",
      "r502"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations of credit risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r117"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r650"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible promissory notes (Note 4E)",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayableMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Payable [Member]",
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r106"
     ]
    },
    "GCTK_ConvertiblePromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ConvertiblePromissoryNotesMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Notes [Member]",
        "documentation": "Convertible Promissory Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ConvertiblePromissoryNotesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ConvertiblePromissoryNotesPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Notes",
        "documentation": "Convertible Promissory Notes [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r730",
      "r814"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r730",
      "r814"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r816"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r816"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r725",
      "r809"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r726",
      "r810"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r726",
      "r810"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r724",
      "r808"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r727",
      "r811"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r729",
      "r813"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r729",
      "r813"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r730",
      "r814"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r733",
      "r817"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r731",
      "r815"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r728",
      "r812"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of debt into equity (Note 4F and 4G)",
        "verboseLabel": "Conversion amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r27"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r59",
      "r60",
      "r106",
      "r107",
      "r183",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r685",
      "r838",
      "r862",
      "r863",
      "r864",
      "r895",
      "r897"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Conversion price",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r272"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument face amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r421",
      "r422",
      "r668",
      "r669",
      "r685"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt discount rate",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r286",
      "r421",
      "r422",
      "r685"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r271"
     ]
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMeasurementInput",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "volatility",
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r183",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r685",
      "r838",
      "r862",
      "r863",
      "r864",
      "r895",
      "r897"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term years",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deemed dividend related to trigger of down round protection feature (see Note 8C3 below)",
        "documentation": "Deemed dividend related to trigger of down round protection feature.",
        "label": "DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_DeemedDividendUponTriggerOfDownRoundProtection": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DeemedDividendUponTriggerOfDownRoundProtection",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deemed dividend upon trigger of down round protection",
        "documentation": "Deemed dividend upon trigger of down round protection."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualMaximumContractualTerm1",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Compensation Arrangement with Individual, Maximum Contractual Term",
        "documentation": "Maximum term of the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r39"
     ]
    },
    "GCTK_DeferredTaxAssetValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DeferredTaxAssetValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "documentation": "Valuation allowance.",
        "label": "Valuation allowance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset before deferred tax liabilities and valuation allowance",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses carry forwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development credits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "GCTK_DeferredTaxAssetsTaxVacationAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DeferredTaxAssetsTaxVacationAccrual",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vacation accrual",
        "documentation": "Deferred tax assets tax vacation accrual."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r34"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r34"
     ]
    },
    "GCTK_DepreciationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DepreciationMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation [Member]",
        "documentation": "Depreciation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      },
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of derivative liability",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Derivative Liability",
        "label": "Derivative Liability",
        "verboseLabel": "Derivative liabilities",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r158",
      "r398",
      "r399",
      "r406",
      "r409",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r571",
      "r573",
      "r574",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r649",
      "r887",
      "r888",
      "r889",
      "r945"
     ]
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets",
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative financial liabilities (Note 4F, 4G and Note 4J)",
        "periodStartLabel": "Balance \u2013 November 14, 2024 \u2013 Warrant issuance date",
        "periodEndLabel": "Balance \u2013 December 31, 2024",
        "verboseLabel": "Warrant derivative liability",
        "terseLabel": "Derivative Liability, Noncurrent",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_DerivativeLiabilityFairValueOfCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilityFairValueOfCollateral",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of the derivative liability",
        "documentation": "Fair value of securities pledged as collateral against derivative liabilities."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r48",
      "r49",
      "r50",
      "r51",
      "r182",
      "r197"
     ]
    },
    "us-gaap_DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan description",
        "documentation": "Description of nature and effect of change affecting comparability of defined contribution plan. Includes, but is not limited to, change in rate of employer contributions, business combination, or divestiture."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "GCTK_DisclosureGeneralAndAdministrativeExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DisclosureGeneralAndAdministrativeExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General And Administrative Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_DisclosureLeaseAgreementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DisclosureLeaseAgreementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreement",
        "verboseLabel": "Schedule Of Operating Lease",
        "terseLabel": "Schedule Of Weighted Average Remaining Lease Terms And Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r42"
     ]
    },
    "GCTK_DisclosureSignificantTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DisclosureSignificantTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_DiscountAmortizationAndInterestExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DiscountAmortizationAndInterestExpenses",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount amortization and interest expenses related to June 27 Notes (Note 7 below)",
        "documentation": "Discount amortization and interest expenses."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_DiscountAmortizationAndInterestExpensesOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DiscountAmortizationAndInterestExpensesOne",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails": {
       "parentTag": "GCTK_FinanceIncomeNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount amortization and interest expenses related to June 27 Notes",
        "documentation": "Discount amortization and interest expenses one."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_DiscountAmortizationAndInterestExpensesTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DiscountAmortizationAndInterestExpensesTwo",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails": {
       "parentTag": "GCTK_FinanceIncomeNet",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense and debt discount amortization related to July 30 Notes",
        "documentation": "Discount amortization and interest expenses two."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r722",
      "r744"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r722",
      "r744",
      "r784"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "GCTK_DrindaBenjaminMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "DrindaBenjaminMember",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Drinda Benjamin [Member]",
        "documentation": "Drinda Benjamin [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per share",
        "verboseLabel": "Basic net loss per common stock",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r198",
      "r201",
      "r205",
      "r206",
      "r207",
      "r209",
      "r377",
      "r381",
      "r395",
      "r396",
      "r487",
      "r503",
      "r651"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per share",
        "verboseLabel": "Diluted net loss per common stock",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r201",
      "r205",
      "r206",
      "r207",
      "r209",
      "r377",
      "r381",
      "r395",
      "r396",
      "r487",
      "r503",
      "r651"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted loss per share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r208"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "GCTK_EmbeddedConversionFeaturePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "EmbeddedConversionFeaturePercentage",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Embedded conversion feature percentage",
        "documentation": "Embedded conversion feature percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of embedded derivative liability",
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r887",
      "r888",
      "r889"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsTables",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r145",
      "r166",
      "r167",
      "r168",
      "r184",
      "r185",
      "r186",
      "r188",
      "r193",
      "r195",
      "r197",
      "r211",
      "r245",
      "r246",
      "r247",
      "r302",
      "r368",
      "r369",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r381",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r394",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r423",
      "r425",
      "r438",
      "r500",
      "r508",
      "r509",
      "r510",
      "r528",
      "r601"
     ]
    },
    "us-gaap_EquityFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity fair value disclosure",
        "documentation": "Fair value of the entity's equity."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r886",
      "r890"
     ]
    },
    "GCTK_EquityIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "EquityIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity issuance costs",
        "documentation": "Equity issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r748",
      "r762",
      "r788"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r734",
      "r745",
      "r759",
      "r785"
     ]
    },
    "GCTK_ExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ExchangeAgreementMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange Agreement [Member]",
        "documentation": "Exchange Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value adjustments \u2013 Derivative financial liability",
        "verboseLabel": "Fair Value Adjustment of Warrants",
        "terseLabel": "Fair value of warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r399",
      "r406",
      "r679"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r399",
      "r406",
      "r679"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE",
        "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r885",
      "r886",
      "r891"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r397",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r408",
      "r448",
      "r449",
      "r450",
      "r668",
      "r669",
      "r674",
      "r675",
      "r676",
      "r679",
      "r681"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r402",
      "r679",
      "r888",
      "r892"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r304",
      "r309",
      "r399",
      "r406",
      "r448",
      "r674",
      "r675",
      "r676",
      "r679"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r304",
      "r309",
      "r399",
      "r400",
      "r406",
      "r449",
      "r668",
      "r669",
      "r674",
      "r675",
      "r676",
      "r679"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r399",
      "r400",
      "r401",
      "r402",
      "r406",
      "r450",
      "r668",
      "r669",
      "r674",
      "r675",
      "r676",
      "r679",
      "r681"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r402",
      "r679",
      "r888",
      "r892"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r397",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r408",
      "r448",
      "r449",
      "r450",
      "r668",
      "r669",
      "r674",
      "r675",
      "r676",
      "r679",
      "r681"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r892"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of financial instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "GCTK_FairValueOfWarrantRelatedDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FairValueOfWarrantRelatedDerivatives",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of the warrant related derivatives",
        "documentation": "Fair value of warrant related derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_FairValueOfWarrantRelatedDerivativesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FairValueOfWarrantRelatedDerivativesValue",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of the warrant related derivatives book value",
        "documentation": "Fair value of warrant related derivatives value."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_FinanceExpenseIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FinanceExpenseIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Finance expense (income), net (Note 7)",
        "documentation": "Finance expense income net.",
        "label": "FinanceExpenseIncomeNet"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_FinanceIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FinanceIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Finance (income) expenses, net",
        "documentation": "Finance income net.",
        "label": "FinanceIncomeNet"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/FinanceIncomeExpensesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCE (INCOME) EXPENSES, NET",
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_FirstWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FirstWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Warrant [Member]",
        "documentation": "First Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyExchangeRateRemeasurement1",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Official exchange rate of NIS 1 to US dollar",
        "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_ForeignCurrencyExchangeRateTranslation1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyExchangeRateTranslation1",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfOfficialExchangeRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:",
        "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r419"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r766",
      "r792"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r766",
      "r792"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r766",
      "r792"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r766",
      "r792"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r766",
      "r792"
     ]
    },
    "GCTK_FourSeparateLendersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FourSeparateLendersMember",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Separate Lenders [Member]",
        "documentation": "Four Separate Lenders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_FunctionalCurrencyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FunctionalCurrencyPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional currency",
        "documentation": "Functional Currency [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_FurnitureAndOfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "FurnitureAndOfficeEquipmentMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Office Equipment [Member]",
        "documentation": "Furniture and Office Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_GainLossOnEquityIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "GainLossOnEquityIssuance",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      },
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/StatementsOfCashFlows",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on equity issuance",
        "documentation": "Gain loss on equity issuance.",
        "label": "GainLossOnEquityIssuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossRelatedToLitigationSettlement",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 5.0
      },
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/StatementsOfCashFlows",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on settlement of liabilities",
        "label": "Loss on settlement debt",
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r867"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      },
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative expenses (Note 10)",
        "totalLabel": "Total general and administrative expenses",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r581"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "GCTK_GeneralAndAdministrativeExpensesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "GeneralAndAdministrativeExpensesTextBlock",
     "presentation": [
      "http://glucotrack.com/role/GeneralAndAdministrativeExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL AND ADMINISTRATIVE EXPENSES",
        "documentation": "General and Administrative Expenses [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "IL",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r720",
      "r722",
      "r744"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of long-lived assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r90"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r250",
      "r251",
      "r403",
      "r404",
      "r407",
      "r505",
      "r507",
      "r586",
      "r646",
      "r680",
      "r916"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r251",
      "r403",
      "r404",
      "r407",
      "r505",
      "r507",
      "r586",
      "r646",
      "r680",
      "r916"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxDetailsNarrative",
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r881"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxDetailsNarrative",
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r881"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/IncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAX",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r352",
      "r355",
      "r357",
      "r358",
      "r359",
      "r361",
      "r365",
      "r370",
      "r371",
      "r372",
      "r373",
      "r524",
      "r678"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r353",
      "r354",
      "r361",
      "r362",
      "r364",
      "r367",
      "r518"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxSettlements",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total loss for the year",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r879"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlementsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxSettlementsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r879"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlementsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxSettlementsForeign",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfIncomeTaxLossForYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign entity (Integrity Israel)",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r879"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in other current assets",
        "label": "Increase (Decrease) in Other Current Assets",
        "documentation": "Amount of increase (decrease) in current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in other current liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r766",
      "r783",
      "r792",
      "r796",
      "r804"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r723",
      "r807"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r723",
      "r807"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r723",
      "r807"
     ]
    },
    "GCTK_IntellectualPropertyPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "IntellectualPropertyPurchaseAgreementMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intellectual Property Purchase Agreement [Member]",
        "documentation": "Intellectual Property Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails": {
       "parentTag": "GCTK_FinanceIncomeNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "verboseLabel": "Interest expenses related to July 18 Notes",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r218",
      "r219",
      "r220",
      "r234",
      "r420",
      "r659",
      "r660"
     ]
    },
    "us-gaap_InterestExpenseDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDeposits",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails": {
       "parentTag": "GCTK_FinanceIncomeNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest on bank deposits",
        "documentation": "Aggregate amount of interest expense on all deposits."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_InterestPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(a) Net cash (received) paid during the year for:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r175",
      "r176"
     ]
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInvestmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance",
        "documentation": "Amount of expenses related to the generation of investment income."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r706",
      "r914"
     ]
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IsraelTaxAuthorityMember",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxDetailsNarrative",
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel Tax Authority [Member]",
        "documentation": "Designated tax department of the government of Israel."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_IsraeliInnovationAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "IsraeliInnovationAuthorityMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israeli Innovation Authority [Member]",
        "documentation": "Israeli Innovation Authority [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of restricted shares as compensation to directors",
        "documentation": "Issuance of restricted shares as compensation to the board of directors.",
        "label": "IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to CEO for achieving of IP Agreement milestones",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "GCTK_JulyEighteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JulyEighteenMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 18 [Member]",
        "documentation": "July 18 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JulyEighteenNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JulyEighteenNotesMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 18 Notes [Member]",
        "documentation": "July Eighteen Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JulyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JulyMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July [Member]",
        "documentation": "July [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JulyThirtyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JulyThirtyMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 30 [Member]",
        "documentation": "July Thirty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JulyTwentySevenNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JulyTwentySevenNotesMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 27 Notes [Member]",
        "documentation": "July Twenty Seven Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JulyWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JulyWarrantsMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July Warrants [Member]",
        "documentation": "July Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JuneThirtyNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JuneThirtyNotesMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "June 30 Notes [Member]",
        "documentation": "June Thirty Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JuneTwentySevenNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JuneTwentySevenNotesMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "June 27 Notes [Member]",
        "documentation": "June Twenty Seven Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_JuneTwentySevenWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "JuneTwentySevenWarrantsMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
      "http://glucotrack.com/role/SignificantTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "June 27 Warrants [Member]",
        "documentation": "June 27 Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and related expenses",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "us-gaap_LeaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseAgreementsMember",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements [Member]",
        "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860"
     ]
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r824"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r824"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OPERATING LEASE",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalEntityTypeOfCounterpartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalEntityTypeOfCounterpartyDomain",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of the other party participating in a financial transaction."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_LessThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "LessThanOneYearMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less Than One Year [Member]",
        "documentation": "Less Than One Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r437"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r437"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total operating lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee term of contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASE AGREEMENT",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r59",
      "r60",
      "r61",
      "r64",
      "r65",
      "r66",
      "r67",
      "r180",
      "r244",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r384",
      "r385",
      "r386",
      "r410",
      "r556",
      "r652",
      "r708",
      "r872",
      "r903",
      "r904"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 (DEFICIT) EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r109",
      "r495",
      "r687",
      "r839",
      "r852",
      "r893"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 (DEFICIT) EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r148",
      "r180",
      "r244",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r384",
      "r385",
      "r386",
      "r410",
      "r687",
      "r872",
      "r903",
      "r904"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r63",
      "r838",
      "r870",
      "r871"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r63",
      "r838",
      "r870"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r838",
      "r870"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r63",
      "r260",
      "r838",
      "r870"
     ]
    },
    "GCTK_LinkageDifferenceOnPrincipalOfLoansFromStockholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "LinkageDifferenceOnPrincipalOfLoansFromStockholders",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Linkage difference on principal of loans from stockholders",
        "documentation": "Linkage difference on principal of loans from stockholders ."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationSettlementLoss",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement of debt loss",
        "documentation": "Amount of loss from litigation settlement for amount awarded to other party. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_LockUpPeriodDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "LockUpPeriodDescription",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lock-up period conditions",
        "documentation": "Lock up period description."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOANS FROM STOCKHOLDERS",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Category of Item Purchased [Axis]",
        "documentation": "Information by category of items purchased under a long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermPurchaseCommitmentLineItems",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Purchase Commitment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermPurchaseCommitmentTable",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Purchase Commitment [Table]",
        "documentation": "Disclosure of information about long-term purchase arrangement. Includes, but is not limited to, term of arrangement with supplier, minimum quantity required, milestone, period covered by arrangement, and committed amount. Excludes short-term purchase arrangement and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r259",
      "r348",
      "r666",
      "r868",
      "r869"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r259",
      "r348",
      "r666",
      "r868",
      "r869"
     ]
    },
    "GCTK_MarkTapsakMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "MarkTapsakMember",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark Tapsak [Member]",
        "documentation": "Mark Tapsak [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_MarketabilityDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "MarketabilityDiscountRate",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate",
        "documentation": "Marketability discount rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketing expenses",
        "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r755",
      "r756"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r755",
      "r757"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r755",
      "r758"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r755",
      "r758"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r755",
      "r758"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r755",
      "r758"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r125",
      "r127",
      "r128",
      "r130",
      "r143",
      "r144",
      "r255",
      "r256",
      "r257",
      "r258",
      "r311",
      "r348",
      "r402",
      "r453",
      "r504",
      "r506",
      "r514",
      "r548",
      "r549",
      "r609",
      "r611",
      "r613",
      "r614",
      "r623",
      "r643",
      "r644",
      "r665",
      "r672",
      "r677",
      "r681",
      "r682",
      "r683",
      "r684",
      "r696",
      "r874",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r125",
      "r127",
      "r128",
      "r130",
      "r143",
      "r144",
      "r255",
      "r256",
      "r257",
      "r258",
      "r311",
      "r348",
      "r402",
      "r453",
      "r504",
      "r506",
      "r514",
      "r548",
      "r549",
      "r609",
      "r611",
      "r613",
      "r614",
      "r623",
      "r643",
      "r644",
      "r665",
      "r672",
      "r677",
      "r681",
      "r682",
      "r683",
      "r696",
      "r874",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "GCTK_ModificationOfEquityClassifiedContractsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ModificationOfEquityClassifiedContractsPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Modification of equity-classified contracts",
        "documentation": "Modification Of Equity Classified Contracts [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_MoreThanTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "MoreThanTwoYearsMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "More Than 2 Years [Member]",
        "documentation": "More Than 2 Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investment activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investment activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85",
      "r86"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/StatementsOfCashFlows",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Loss for the year",
        "label": "Loss for the year",
        "verboseLabel": "Net Income (Loss)",
        "negatedLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r86",
      "r110",
      "r146",
      "r160",
      "r163",
      "r168",
      "r180",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r203",
      "r244",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r377",
      "r381",
      "r396",
      "r410",
      "r499",
      "r578",
      "r599",
      "r600",
      "r706",
      "r872"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net loss attributable to common stockholders",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r189",
      "r190",
      "r191",
      "r192",
      "r198",
      "r199",
      "r204",
      "r207",
      "r381"
     ]
    },
    "GCTK_NetProceedsReceivedFromUnderwrittenPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "NetProceedsReceivedFromUnderwrittenPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds received from underwritten U.S. public offering (Note 4J)",
        "documentation": "Net proceeds received from underwritten public offering."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently issued accounting pronouncements, not yet adopted",
        "documentation": "New accounting pronouncements, not yet adopted [policy text block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently adopted accounting pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_NoInsiderTradingFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "NoInsiderTradingFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No insider trading flag",
        "documentation": "No insider trading flag."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_NonCashDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "NonCashDerivativeLiability",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liability (Note 4G)",
        "documentation": "Non cash derivative liability."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(b) Non-cash investment and financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficersCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OfficersCompensation",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation",
        "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r653",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfMaturityAnalysisOfLeaseLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of lease liabilities",
        "verboseLabel": "Lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets",
      "http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability, current (Note 6)",
        "verboseLabel": "Current operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets",
      "http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability, non-current (Note 6)",
        "verboseLabel": "Non-Current operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly rental fee",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r431"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets",
      "http://glucotrack.com/role/ScheduleOfOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use asset, net (Note 6)",
        "verboseLabel": "Operating right-of-use asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r686"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease term (years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r686"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxDetailsNarrative",
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxDetailsNarrative",
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r102",
      "r515",
      "r516"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current assets",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r687"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r500"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r16",
      "r161",
      "r164",
      "r169",
      "r193",
      "r411",
      "r412",
      "r417",
      "r485",
      "r500",
      "r829",
      "r830"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenseMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expense [Member]",
        "documentation": "Primary financial statement caption encompassing other expense."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails": {
       "parentTag": "GCTK_FinanceIncomeNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfFinanceExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange rate differentials, bank commissions and miscellaneous",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80"
     ]
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r948"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r687"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from stockholders (Note 3)",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other (income) expense",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development expenses",
        "label": "Other Research and Development Expense",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r764",
      "r790"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r742",
      "r753",
      "r767",
      "r793"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r742",
      "r753",
      "r767",
      "r793"
     ]
    },
    "GCTK_PartialConversionNotesAndAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "PartialConversionNotesAndAccruedInterest",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partial conversion June 27 Notes and accrued Interest (Note 4H and Note 4I below)",
        "documentation": "Partial conversion notes and accrued interest."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "GCTK_PerformanceMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "PerformanceMilestoneMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Milestone [Member]",
        "documentation": "Performance Milestone [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_PlatformOperatorCryptoAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "PlatformOperatorCryptoAssetLineItems",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r249"
     ]
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "PlatformOperatorCryptoAssetTable",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Table]",
        "documentation": "Disclosure of information about crypto-asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r249"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "GCTK_PrefundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "PrefundedWarrantsMember",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prefunded Warrants [Member]",
        "documentation": "Prefunded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ProceedsFromAllocatedWarrantsAtInitialRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ProceedsFromAllocatedWarrantsAtInitialRecognition",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total proceeds allocated to June 27 Warrants at initial recognition",
        "documentation": "Proceeds from allocated warrants at initial recognition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of convertible promissory notes and bifurcated conversion feature through private placement transaction (Note 4F)",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds from public offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/GeneralDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of common stock",
        "verboseLabel": "Gross proceeds",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from notes",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total loan amount",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r519"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of promissory notes and detachable warrants through private placement Transaction (Note 4E)",
        "verboseLabel": "Total proceeds received",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r519"
     ]
    },
    "GCTK_ProceedsFromPublicOfferingsAndDebtIssuances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ProceedsFromPublicOfferingsAndDebtIssuances",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/GeneralDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from public offerings and debt issuances",
        "documentation": "Proceeds from public offerings and debt issuances."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of convertible promissory notes - related parties (Note 4G)",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "GCTK_ProceedsReceivedFromUnderwrittenPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ProceedsReceivedFromUnderwrittenPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds received from underwritten U.S. public offering (Note 4C)",
        "documentation": "Proceeds received from underwritten public offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees (including directors\u2019 fees)",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r706",
      "r947",
      "r948"
     ]
    },
    "GCTK_ProfessionalFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ProfessionalFeesMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Fees [Member]",
        "documentation": "Professional Fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r436"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r436",
      "r488",
      "r498",
      "r687"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r118",
      "r121",
      "r497"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r436"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment rates of depreciation",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_PublicOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "PublicOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public offering price",
        "documentation": "Public offering price."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "GCTK_QuarterlyPaymentsEqualsToSalesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "QuarterlyPaymentsEqualsToSalesPercentage",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales percent",
        "documentation": "Quarterly payments equals to sales, percentage."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r125",
      "r127",
      "r128",
      "r130",
      "r143",
      "r144",
      "r255",
      "r256",
      "r257",
      "r258",
      "r303",
      "r311",
      "r338",
      "r339",
      "r340",
      "r348",
      "r402",
      "r451",
      "r452",
      "r453",
      "r504",
      "r506",
      "r514",
      "r548",
      "r549",
      "r609",
      "r611",
      "r613",
      "r614",
      "r623",
      "r643",
      "r644",
      "r665",
      "r672",
      "r677",
      "r681",
      "r682",
      "r683",
      "r684",
      "r696",
      "r700",
      "r865",
      "r874",
      "r888",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r125",
      "r127",
      "r128",
      "r130",
      "r143",
      "r144",
      "r255",
      "r256",
      "r257",
      "r258",
      "r303",
      "r311",
      "r338",
      "r339",
      "r340",
      "r348",
      "r402",
      "r451",
      "r452",
      "r453",
      "r504",
      "r506",
      "r514",
      "r548",
      "r549",
      "r609",
      "r611",
      "r613",
      "r614",
      "r623",
      "r643",
      "r644",
      "r665",
      "r672",
      "r677",
      "r681",
      "r682",
      "r683",
      "r684",
      "r696",
      "r700",
      "r865",
      "r874",
      "r888",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ]
    },
    "GCTK_ReceiptsOnAccountOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ReceiptsOnAccountOfShares",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receipts on account of shares",
        "documentation": "Receipts on account of shares."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ReceiptsOnAccountOfSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ReceiptsOnAccountOfSharesMember",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receipts on Account of Shares [Member]",
        "documentation": "Receipts on Account of Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r734",
      "r745",
      "r759",
      "r785"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r310",
      "r442",
      "r443",
      "r490",
      "r496",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r575",
      "r577",
      "r608"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r582",
      "r583",
      "r586"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r310",
      "r442",
      "r443",
      "r490",
      "r496",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r575",
      "r577",
      "r608",
      "r902"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTIES",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r443",
      "r444",
      "r525",
      "r526",
      "r527",
      "r584",
      "r585",
      "r586",
      "r605",
      "r607"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of loan",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r522"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentArrangementMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Arrangement [Member]",
        "documentation": "Contractual obligation to provide funding of research and development costs over periods that initially exceed one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses (Note 9)",
        "verboseLabel": "Cumulative research and development",
        "terseLabel": "Total Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r646",
      "r659",
      "r911"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfTotalCompensationCostEquityBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/ResearchAndDevelopmentExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RESEARCH AND DEVELOPMENT EXPENSES",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r645"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r746",
      "r760",
      "r786"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r736",
      "r747",
      "r761",
      "r787"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r743",
      "r754",
      "r768",
      "r794"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfRestrictCashBalancesAreIncludedWithCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r826",
      "r836",
      "r912",
      "r913"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted cash (Note 2D)",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r827",
      "r836"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets",
      "http://glucotrack.com/role/GeneralDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r95",
      "r494",
      "r511",
      "r513",
      "r523",
      "r559",
      "r687"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r184",
      "r185",
      "r186",
      "r188",
      "r193",
      "r195",
      "r197",
      "r245",
      "r246",
      "r247",
      "r368",
      "r369",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r381",
      "r387",
      "r389",
      "r390",
      "r392",
      "r394",
      "r423",
      "r425",
      "r508",
      "r510",
      "r528",
      "r949"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognition of right for use asset against a lease liability (Note 6)",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r686"
     ]
    },
    "GCTK_RoyaltyBearingGrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "RoyaltyBearingGrantsPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty-bearing grants",
        "documentation": "Royalty Bearing Grants [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_RoyaltyPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "RoyaltyPercentage",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty percentage maximum",
        "documentation": "Royalty percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "GCTK_SalariesAndRelatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SalariesAndRelatedMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and Related [Member]",
        "documentation": "Salaries and Related [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering price",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share price",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SalesAgreementMember",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Agreement [Member]",
        "documentation": "Sales Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/FinanceIncomeExpensesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF FINANCE EXPENSES",
        "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r840"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DEFERRED TAX ASSETS",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OFFICIAL EXCHANGE RATE",
        "documentation": "Tabular disclosure of the U.S. dollar denominated balances, balances reported for financial reporting purposes and the differences between the two balances by each relevant line item on the financial statements."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF INCOME TAX LOSS FOR THE YEAR",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r678",
      "r878"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r886"
     ]
    },
    "GCTK_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/GeneralAndAdministrativeExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES",
        "documentation": "Schedule Of General And Administrative Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfPropertyAndEquipmentRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r436"
     ]
    },
    "GCTK_ScheduleOfPropertyRatesOfDepreciationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ScheduleOfPropertyRatesOfDepreciationTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION",
        "documentation": "Schedule Of Property Rates Of Depreciation [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES",
        "documentation": "Schedule Of Reconciliation Of Carrying Amount Of Notes [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF RECONCILIATION OF THE FAIR VALUE OF THE WARRANTS",
        "documentation": "Schedule Of Reconciliation Of The Fair Value Warrants [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r582",
      "r583",
      "r586"
     ]
    },
    "GCTK_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/ResearchAndDevelopmentExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES",
        "documentation": "Schedule Of Research And Development Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF WARRANTS ACTIVITY",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "GCTK_ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE",
        "documentation": "Schedule Of Weighted Average Remaining Lease Terms And Discount Rate [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SecondWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SecondWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Warrant [Member]",
        "documentation": "Second Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security deposit",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r126",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r240",
      "r241",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r542",
      "r544",
      "r546",
      "r610",
      "r612",
      "r615",
      "r624",
      "r631",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r647",
      "r673",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r700",
      "r875",
      "r915",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT REPORTING",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r210",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r222",
      "r223",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r239",
      "r242",
      "r654",
      "r657",
      "r658",
      "r659",
      "r661",
      "r663",
      "r664"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment reporting",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r237",
      "r240",
      "r655",
      "r656",
      "r662"
     ]
    },
    "GCTK_SeptemberFiveWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeptemberFiveWarrantsMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Five Warrants [Member]",
        "documentation": "September Five Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeptemberFiveWarrantsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeptemberFiveWarrantsOneMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 5 Warrants One [Member]",
        "documentation": "September Five Warrants One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeptemberFiveWarrantsThirdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeptemberFiveWarrantsThirdMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Five Warrants Third [Member]",
        "documentation": "September Five Warrants Third [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeptemberFiveWarrantsTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeptemberFiveWarrantsTwoMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Five Warrants Two [Member]",
        "documentation": "September Five Warrants Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeriesACommonWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeriesACommonWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Common Warrant [Member]",
        "documentation": "Series A Common Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeriesAWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeriesAWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Warrant [Member]",
        "documentation": "Series A Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeriesAWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeriesAWarrantsMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Warrants [Member]",
        "documentation": "Series A Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeriesBCommonWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeriesBCommonWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Common Warrant [Member]",
        "documentation": "Series B Common Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeriesBWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeriesBWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Warrant [Member]",
        "documentation": "Series B Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SeriesBWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SeriesBWarrantsMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Warrants [Member]",
        "documentation": "Series B Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SettlementOfLiabilitiesWithEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SettlementOfLiabilitiesWithEquity",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement of liabilities with equity (Note 4H and 4I)",
        "documentation": "Settlement of liabilities with equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://glucotrack.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Stock based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share warrants outstanding, cancelled",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options cancelled in period."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails",
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrinsic value outstanding exercisable, Ending balance",
        "documentation": "Sharebased compensation arrangement by sharebased payment award equity instruments other than options exerciable in period intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrinsic value outstanding, forfeited or expired",
        "documentation": "Per share or unit weighted-average intrinsic value of award forfeited under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share warrants outstanding, granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrinsic value outstanding, granted",
        "documentation": "Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Intrinsic value outstanding, beginning balance",
        "periodEndLabel": "Intrinsic value outstanding, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value",
        "documentation": "Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of share warrants outstanding, beginning balance",
        "periodEndLabel": "Number of share warrants outstanding, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price outstanding, beginning balance",
        "periodEndLabel": "Weighted average exercise price outstanding, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield (%)",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate",
        "verboseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, cancelled",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments cancelled weighted average exercise price."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average exercise price, forfeited or expired",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments forfeited weighted average exercise price.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of share options outstanding, forfeited or expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations",
        "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98"
     ]
    },
    "GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average exercise price, granted",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options outstanding, cancelled",
        "documentation": "Share based compensation arrangement by share based payment award options cancelled in period gross."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number exercisable, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average exercise price exercisable, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price of options",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of share options outstanding, forfeited or expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options outstanding, granted",
        "verboseLabel": "Share based options",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Intrinsic value outstanding, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number outstanding beginning balance",
        "periodEndLabel": "Number outstanding ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price outstanding, beginning balance",
        "periodEndLabel": "Weighted average exercise price outstanding, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of share options exercisable, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "GCTK_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average exercise price exercisable, ending balance",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercisable Weighted Average Exercise Price.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, forfeited or expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r316",
      "r335",
      "r336",
      "r337",
      "r338",
      "r341",
      "r343",
      "r344",
      "r345",
      "r346"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life (years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "GCTK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue": {
     "xbrltype": "durationItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life, Exercisable",
        "documentation": "Sharebased compensation arrangement by sharebased payment award options exercisable weighted average fairvalue."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant date period",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3": {
     "xbrltype": "durationItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining contractual life, Exercisable",
        "documentation": "Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term.",
        "label": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life, Granted",
        "documentation": "Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life, Forfeited or expired",
        "documentation": "Sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average remaining contractual term."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfShareOptionActivityForEmployeesAndMembersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life, Outstanding",
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining contractual life, Granted",
        "documentation": "Sharebased compensation shares authorized under stock option plans exercise price range outstanding other than options weighted average remaining contractual term.",
        "label": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining contractual life, Outstanding",
        "documentation": "Sharebased compensation shares authorized under stock option plans exercise price range outstanding other than options weighted average remaining contractual term 2.",
        "label": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssued",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share price",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtDescription",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable description",
        "documentation": "Description of borrowing classified as short-term upon issuance. Includes, but is not limited to, description of underlying arrangement, repayment terms, interest rate, collateral provided, restriction on use of asset and activity, and compliance with debt covenant."
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r862",
      "r863",
      "r864"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r862",
      "r863",
      "r864"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r178"
     ]
    },
    "GCTK_SignificantTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "SignificantTransactionsTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT TRANSACTIONS",
        "documentation": "Significant Transactions [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r151",
      "r152",
      "r153",
      "r180",
      "r201",
      "r202",
      "r205",
      "r207",
      "r212",
      "r213",
      "r244",
      "r261",
      "r263",
      "r264",
      "r265",
      "r268",
      "r269",
      "r288",
      "r289",
      "r291",
      "r294",
      "r300",
      "r410",
      "r519",
      "r520",
      "r521",
      "r522",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r558",
      "r579",
      "r601",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r823",
      "r837",
      "r845"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsTables",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r69",
      "r73",
      "r74",
      "r145",
      "r166",
      "r167",
      "r168",
      "r184",
      "r185",
      "r186",
      "r188",
      "r193",
      "r195",
      "r197",
      "r211",
      "r245",
      "r246",
      "r247",
      "r302",
      "r368",
      "r369",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r381",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r394",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r423",
      "r425",
      "r438",
      "r500",
      "r508",
      "r509",
      "r510",
      "r528",
      "r601"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://glucotrack.com/role/LoansFromStockholdersDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r126",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r240",
      "r241",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r542",
      "r544",
      "r546",
      "r610",
      "r612",
      "r615",
      "r624",
      "r631",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r647",
      "r673",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r700",
      "r875",
      "r915",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsTables",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r211",
      "r425",
      "r454",
      "r517",
      "r539",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r577",
      "r580",
      "r581",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601",
      "r701"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/ScheduleOfAssumptionsUsedToValueOptionsDetails",
      "http://glucotrack.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsTables",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r211",
      "r243",
      "r425",
      "r454",
      "r517",
      "r539",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r577",
      "r580",
      "r581",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601",
      "r701"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r738",
      "r749",
      "r763",
      "r789"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange of warrants into shares, shares",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r38",
      "r69",
      "r73",
      "r95",
      "r280"
     ]
    },
    "GCTK_StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of detachable warrants through private placement transactions, shares",
        "documentation": "Stock issued during period shares detachable warrants through private placement transactions."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of prefunded warrants into shares, shares",
        "documentation": "Exercise of prefunded warrants into shares ,shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued during period shares issued for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares",
        "verboseLabel": "Shares issued",
        "terseLabel": "Number of common shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r68",
      "r69",
      "r95",
      "r519",
      "r601",
      "r626"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Stock upon private placement transaction (Note 4C), shares",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of restricted shares as compensation to directors, shares",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r68",
      "r69",
      "r95"
     ]
    },
    "GCTK_StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B), shares",
        "documentation": "Stock issued during period shares restricted stock payment for achievement of milestone."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares and warrants as settlement of financial liabilities, shares",
        "documentation": "Stock issued during period shares settlement of financial liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-funded warrants",
        "verboseLabel": "Exercises in period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r68",
      "r69",
      "r95",
      "r322"
     ]
    },
    "GCTK_StockIssuedDuringPeriodSharesUnderwrittenPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesUnderwrittenPublicOffering",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds received from underwritten U.S. public offering, shares",
        "documentation": "Stock issued during period shares underwritten public offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange of warrants into shares",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r69",
      "r73",
      "r74",
      "r95"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion price",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r69",
      "r73",
      "r74",
      "r95"
     ]
    },
    "GCTK_StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of detachable warrants through private placement transactions",
        "documentation": "Stock issued during period value detachable warrants through private placement transactions."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of prefunded warrants into shares",
        "documentation": "Exercise of prefunded warrants into shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Ordinary Shares upon completion of public offering, net of offering expenses",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r68",
      "r69",
      "r95",
      "r528",
      "r601",
      "r626",
      "r707"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Stock upon private placement transaction (Note 4C)",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of restricted shares as compensation to directors",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r95"
     ]
    },
    "GCTK_StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B)",
        "documentation": "Stock issued during period value restricted stock payment for achievement of milestone."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares and warrants as settlement of financial liabilities",
        "documentation": "Stock issued during period value settlement of financial liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r68",
      "r69",
      "r95"
     ]
    },
    "GCTK_StockIssuedDuringPeriodValueUnderwrittenPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockIssuedDuringPeriodValueUnderwrittenPublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds received from underwritten U.S. public offering",
        "documentation": "Stock issued during period value underwritten public offering."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares to be issued as compensation towards directors",
        "documentation": "Stock to be issued during period value restricted stock award gross."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://glucotrack.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets",
      "http://glucotrack.com/role/StatementsOfChangesInStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 (deficit) equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r73",
      "r74",
      "r88",
      "r560",
      "r576",
      "r602",
      "r603",
      "r687",
      "r708",
      "r839",
      "r852",
      "r893",
      "r949"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://glucotrack.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 (Deficit) Equity (Note 8)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtection"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r179",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r302",
      "r393",
      "r604",
      "r606",
      "r630"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse stock split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://glucotrack.com/role/GeneralDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r446"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://glucotrack.com/role/GeneralDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r446"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://glucotrack.com/role/GeneralDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r446"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://glucotrack.com/role/GeneralDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r446"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://glucotrack.com/role/GeneralDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r446"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r447"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://glucotrack.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of cash flow activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "GCTK_TapsakEnterprisesLLCAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "TapsakEnterprisesLLCAgreementMember",
     "presentation": [
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tapsak Enterprises LLC Agreement [Member]",
        "documentation": "Tapsak Enterprises LLC Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_ThirdWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "ThirdWarrantMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Warrant [Member]",
        "documentation": "Third Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r851",
      "r901"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "GCTK_TrueupSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "TrueupSharesMember",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trueup Shares [Member]",
        "documentation": "Trueup Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative",
      "http://glucotrack.com/role/LeaseAgreementDetailsNarrative",
      "http://glucotrack.com/role/RelatedPartiesDetailsNarrative",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative",
      "http://glucotrack.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "GCTK_UnsecuredPromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "UnsecuredPromissoryNotesMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Promissory Notes [Member]",
        "documentation": "Unsecured Promissory Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of estimates in the preparation of financial statements",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r115",
      "r116",
      "r119",
      "r120"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r698",
      "r699",
      "r702",
      "r703",
      "r704",
      "r705"
     ]
    },
    "GCTK_WarrantsAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "WarrantsAgreementMember",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Agreement [Member]",
        "documentation": "Warrants Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfReconciliationOfCarryingAmountOfJune27NotesDetails",
      "http://glucotrack.com/role/ScheduleOfReconciliationOfFairValueOfWarrantsDetails",
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Opening balance",
        "periodEndLabel": "Balance December",
        "label": "Warrants and Rights Outstanding",
        "verboseLabel": "Fair value issuance",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://glucotrack.com/role/SignificantTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and rights outstanding term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ]
    },
    "GCTK_WarrantsOriginalExercisePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "WarrantsOriginalExercisePrice",
     "crdr": "debit",
     "presentation": [
      "http://glucotrack.com/role/CommonStockAndWarrantsWith-downRoundProtectionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants original exercise price",
        "documentation": "Warrants original exercise price."
       }
      }
     },
     "auth_ref": []
    },
    "GCTK_WarrantsWithDownRoundProtectionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://glucotrack.com/20241231",
     "localname": "WarrantsWithDownRoundProtectionPolicyTextBlock",
     "presentation": [
      "http://glucotrack.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants with down-round protection",
        "documentation": "Warrants With Down Round Protection [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of Common Stock outstanding used in computing diluted net loss per share",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r207"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://glucotrack.com/role/ScheduleOfAntidilutiveNetLossAndWeightedAverageDetails",
      "http://glucotrack.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of Common Stock outstanding used in computing basic net loss per share",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r207"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "presentation": [
      "http://glucotrack.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares to the seller",
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-13"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482943/710-10-55-7"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "70",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479424/830-30-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "FF",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.FF.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479424/830-30-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>93
<FILENAME>0001641172-25-001861-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-001861-xbrl.zip
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MW(^.;SL#Z-O>U>LQ]\C#\P#FS^M4L/#NF* _45B0&PHL3==T!O$Z@82NXD3
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M9 (/32P\:R'DEDLQC%,^')UAGL]&B^)"[%7L]P_-IU]#LV"!C  7@MX*'A5
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M%&^/WY(C7WO_75J\^:%<NJY9M7X-++.OS [-UFE#V]O[>>QM6.62,1A/;',
M>WH_N[ES3I=+9XWW,#X'^]($RYCVC"O3JH[_&)F?P>C;:N2XT3A^2U[X*:O%
MGTDLF;?,;S+N4B6\43ME_$5T'?)RR0DYIXYD(8<;)A<@%Q0,SA/BPY1&H9"
M(^>A"'!-]3<(/;CP$R>4 N%I,.1.#0[5F@/?_9J$G7X81(0O#T1Z=:3AIB*5
MN:1$ $4571A0AP8S*J#5U)!(QR=:N41B\)B/@RL0%G42P21#C0AWP;QU%H3/
M*> . 8MC!1C_U$R72 H+*BB"V\22X5]#&6HP(8D/%V'H4@WZ"T8]E(O[2/:-
MPMCSF$-%N81BE)1<%0W9)Y2;-(@2$2>$2Y A-#] 7@@.8K1?)RT#6S.LW*PJ
MEG*1%A$SPFE<'=_Z= F&(]6(BB4-QTFZ+%C"%Q[>H"WFM/W_X.'#,6<;O9$)
M?7,TLB9&?WAU\;'2J*37$V,P**Z?;(\;YLJ%FMIX]XARZH"CV].GB_^FR.(0
MO["M#*-*?ES2[<$/P'VW2XLW:RMKVX,=P#O;+3Q[03-,>0KR$M]?@H,!Z:M\
ML,H1@GY-F* !\C56D52$7+-U2(X ,T_S]- ]6D7?.J.LLDD>@LVSUHD&F(1(
MD.:HCLHYFR;"?]/43HJ8KTZ+=<C\B/>VI.0*O@GE=D>DX]WP_%FXS3C6QH"D
MA,4J+ GC6/]85M,*XA,FD/F1H+'BN*:&B>]C4L=^B&&-QH$(21]KZ2J/<<(=
M=1\%NBP5K8HGSDK\+$3"B(ITSSA#L5WL5 C@';6F*-PXGX5NC!+1S0APMMP
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MTEW>LN:B0)>EHE61QU6)G]$[C*A(SXPS%.LU6=$71]2>HL' ]2QT8Y2([D>
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M-ELUL4[Y?1>8XV]U1IQ@#1R(];??F@77-6 #207$$S99(_N<Z+C2SL^D&5=
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MT$.'P@N7'>&13!I\:?*AE(5WP)9.B7-);@/A#"+> TD-0E \==(\YJ,X"@:
MTX(Y7G9NV4/Y?%"Z=3"':3R//79+EYHE3FE&KMDM7?_/89NN>0+*D+NG+ K
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M!@8>/"Y8]LH#DIMY_-NCX_>'Q8,]*!]IIY"VIAWEXTM[4-ZYMC 29"C#C'C
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M<*@J7+DE 69NS'+,VYBS2YPGD>I0ZH4*/[)-7H1$D!&0&W@FCP\%C[R6K:=
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MHJX7;";AX+T-E^LOVF$"'D3^.Y]WX*GU#S:JQ$WF>]W@O>UP3$3;^/0Q'K#
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M.P__^7[Y3SFSR!WUC0YAX]/^=G-S;P^+HE_5B4IVP/3?_[G?;.Q]B*V$^WR
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M=3E*U@RU^\(U:_,(2G:LR<$_+"(2,4O[J?-Y/(R@(PCP\/"@/@GM-!:!0YB
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M,6SD?C!!;HZ*0&[4C'$0\F(U,'']MKH^6Q!X_B?Y;V-P[W*C6_1:S7/7<WN
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M*<4:"8XED;7<%)@*X36R4E-X=WBO1+0V'U%9Y"^KJ[Z")^E;JFRB1@!#=A'
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MEV^6?4^(\$5\!";WWZP_^"#_]%Q<11$^T*"07V[4FR8-6S]+]D473Y*U+V(
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M23;@42EF!' ]T;_*%TR:-:6UT-,PM(;L?$?>RGE')$MC^]7L?"MW*BEZ# B
M32.*6^PLJ;/\-E7H_"5S'3(OPT)/"O%A43!F?(!L(.#[%/E7QLE\LL+VJZRP
M.6:%[5=98:^"S4I%21H_4*,T;Z?'^YF</?U*UD$ND"#:;<"F8B3!-AIN%,EF
M\S#6YT)I]&/NW]$)GZ7"6W':QY07M%)DEUJR"T_M+VA!RG,U5:^CSC)ETM"U
M%O/:]/ER<JTUGSJ)U/U),G"-'L/>1#*IVM)3KMD<B^Q@[GT1[Y9!+!'0P/@
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M>J4[U!%8Y'FHFBORZ65+Z?Q9FV><\'GF7,9;'I-7IMRW\XZE[6**/(1IF\#
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MSF>0/S=>>DS%;;ATCE>%%T-A#CF=S$+C^&(\)T-BH1U>X%)X=YG,8).5*R:
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M$62 S<UT=<@Y"RB883P\#%&&@HJ&4H?0V*<\J6<C8+\7;OY _!LTAK>,TNA
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M5)2"?_HJFMA?/?$9GS&_I[FHMR!S Y>Y<<DK4,!$;/_^ZM?O7_[==&R!/EB
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M*_HVNZ*?S5W1?_X*F&OA<RW\<P[+)Y(0!GMOZNU.4A$!C?[J]5^U8U#ZKPV
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MU\&!OHH1?[\HXF]FU;H/SRQ4<*]6"03*&T<;JU'#FTH!^4I7D8LD7[,C@ZE
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M)!QN.0KV>I:G-"'.$?IO4():1.+FO@M Q5\F]!!F&_^L8W$Y*2%K'@[YZ0A
M&)='-3X=8DC$6IQ77E6HD@4Q/OOLH6Y3>=?5T)W/9Z/3>.;;KM? 'A)X1 _:
M$>A$8]%:7-F?P&(BJE#Y:NC]CDV3QM!S<06Y:O++"_*H)3@]Z C><)  6DK&
MUVUW==,E,:;O/>YV5,SO#L.=+ HK]G8R:%E_,(IM]!F0'1ABNY. !/48TPG
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M:0<6,B8$E21=:W:LQYKO.GZ48:!ZQ!V6E'XQ#)-J'@^6'04C61 GUGV[R>
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M\,_]0?JV__:_Q^/I1AF$>RL:A(W;]>P'%XO?6!J"Z:&J+'N*-Y#C>H[AE5H
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M3>$%EV[3DDRRGU!+@D6@]\P[!K6XB"83='@F=-42T*R]_H#1@Z@PQ*P+S9H
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MJ@6(^@*&88*L^BHJ#-QSP*FK^;;ZP6JK& :CS^<IQC+1:YVDWZ$C(I>WG'7
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M]UXF".X&/WE%@/Y)RAY%^467A."<E3NU92T/P%JPZ$CT]KV6N:P#!:&G :O
M>OO+> MB.+A9/*B#@MC&_D":PV16956#>2?Q!?;X()V5ZJ-THW:*SM68%=S7
M@HH<\;7P ^QZCVB#^'+=8TI8)@,#Q,@Q(B^8@75"OW^N7!"L!2=FFH)#4U7E
MI#MPDG2JR@FS*IUVEXRH2S>'J=W-:OG'@_"/:"&Z!RW_6 L*(OX1+0PL49-N
MDG$TCPJ/8XJ38&RF=LL='D(#?A,/N?)-*DG \ /1R$_Z>ZW_<GU6@5HP(VSU
MK/%ZF6CEL"9WRD3(Y$!X6DU22ZF6U_I7R(TBS'BYIL02\< H$8%X+1#B("6'
M2(%:.$&6$70P3-&GAM;89JZR@G<)]6NDM%0D^.<](,/]/7K6YTP0]J^(T*R5
MUEC7V9U5&U "&&YGM^.FQ;R'W\AYS@ 2 XMJQF6AU8VM7V[0W_$.-6UQPPXO
M,T:LBTKMK?C&O:WNJ;MUGMZZTCX/#OU^M^.[NRG,;E(J!F;^K;2IC_VV;0;/
M.(JR!".<&9B6V20H-4,8RR&W-W"O/'ZAN,RQ/6;CF?6;S&=TJCK7&'E2C1EQ
MLS=%V.QB"U,KC/B5.#J\R#-LSKK O-?XAMH7F"26P X(E5%#.0\6BE UYAW0
M,A%JG6# 4/=5+>E9S:V_ST.SWAV3L%>Q#";!5#,>[@(+V3D%?WL89!2/S$%&
M1P5N,P_-/?KJ\U8@I8/^8)EW4 '!NY- V)3^_LZ@Q+S.L%L')]4N?4W_8)D3
MTJ^]8-"KOP#.)4RO&+]WN"]6'7^O80%U'ELA%^R!2&98Z+)JS,(UD.I(. X7
MMT=IFE#-))U_IK.XFLC,GEG#6/ R LW?\P^[MW%N&N2B^57L$_8/=QT;37SU
MV5WQCKY_L+LJ?8C:^3UV%KD9C'[U[+/#-OOL+K//#MOLLTV\P'?APNEW6A?.
M6E"0=N$H(+ E"0OJ$3:E.-$ =0[]L=$WREX<^(:CPRNY< 17&ESOPJEY<)H]
MPKLF!TVI630C04L8)ER*.H^DL1NUG9<J'[$,SZ<Y"OL1@6L<_.T%27X$:9AI
M36=<2(5'OB"FCXA'K"ESKGN01B'5;'SG;04OE(D@HPLIMKJ]%]B]$J'ZXCA$
M:T,5N+E[30A-6\,7)4!@XYG&_3H-X+5GL/L96SBEQ?)YH:JHMW6( ,:DY&U3
M\3=B_-)W^ ^S$VC%1Y&USK-,MJ'X!V&6S[N=G8YX&T81VJ(?" 3/1E&1],!4
MI0 %T.ACYZB;E@UFX=P;,VXJOK13OH;H+/^@@VPV+<RMB*Q_;<M4J8J>0^A"
M!\'01XC+Y"81VB:$W0ARQ&M#+8NLPE2&\75>4-"$58<%-9DA,@PY ;:>9VH:
M"JP1&+J&7:]"[M20V2UBD/MZ;(5@BF6!UX=9K@IX,ZP"9L>_:N)RNMWUMMY@
M"]AWR8[7[_>W1>^@UQT<O%!>1ZJ8LGM\-*(JOG)<<"M\X75[7?]@;[^<$U&&
M<BV5I])C=OY;(8S1Z^^#83G UJ_;DX*PDPP,@A.=])JCD_K75;-4F-PID"H%
M%5#Q$R7B@%>^X5=JL5R:',RN/SCT][L]6WZE%J>?Y^K&K?"B]NA+47F4Q0V?
MMV?.FUVC*.G).4:S9)"7$7<)6CA%HE9Y #GUO+>_<] QC3&:1Q9FY/IB5W_-
M_D%IWPQ3)7S$MLIXK5:!=9&-03]U9K9AY<B(0]" C#KZOHD3-4C..CMRE%FA
ME5GKFZ.*S"_A#'X+CZ#*>=CWNW!?X&ZBC]GVI@%.D"'#5[ C4QF7:IP=#9;I
MEZ(;1B%C#A:(J[3B,?6E*BGSI>66=,)7,#G;_[.F,N+7=%$<KW4U*F(K-6L,
MI%S&6?T2V7<QQ*4C7&^T6.*B-#*"5J)/QE?]PSF)C,,Y3C%JM]_S._V]I1X]
M_7V)0US-!YM^(I8MSO?8&XX:='.PJ%\&_]84@FY3%UT*8;_1Z42'JC5^%V!<
M-($_Y<M C@D9RJ@CO3:#98U642KZ;N9?2^Y".8';\$ WC8*NLQ/.4H$JE_>H
M1\DRSAQFH'Z=-3&QLLJR.B/3IKN3:-'9]7</=QF7P+ ;L3R$#1>HUUEV;=Y$
M">@&#'$,?$2W^U&OK2Q+XYN[NA>H.WLZZ"!J[(._O9I?E)ZI,8CVSCU$0OO9
M6X&.DLQ:3*UI_*"FL>E9TEV:>@HO@W,#Q0#/+6@TA"MG6K:"7P67&4$+X>2L
MX>=C&>R.I_N@\U."GFHV0IG1F.8C)E.%HJ]TXS.$QUBF<<"O%#:'RV=*AA+F
MKJ$A*)X?[/3ZWHR]/;YJZ![."%(=_TM) M30&H93"PCR;=B1;>Z7H UPU375
M>4]RG@:S4OY-:7\(@#X8Y8B:J7>\NMM'Y\X>[WA'M-B&YC-QH@ZM&A[&OG,$
M@C,+QK*6>E$YS =BE \"($-M;+'3K&IDR^TXT-4B0%?K[^_[AR6'1"W9"X@+
M!"5&LNJD];RS S+6*=FX9N,K.-(P+8'W$)^RA__):3 4@WKIEGQ4C**^O[?;
M)U^\%TRPG<P8\1=)@9](7,^EK2IS"UBH$PC> ,1.):)D,*'[8WB/E;\^1A'M
MUCDC#AGZ^D@6<"6/T7E;N;T>1:2[#J.J)84:)VN]6J3DH28$M3 O%.98:%.^
M4QD%.??>Y:"<)8@Q$81U+I,$QB@8=?NM>%+]O?Z!WUF:XJ.89P/3[.YT![64
MI68T7+)<:(A:]7/9FXU<$E$1\R(#IC;74(]LX]=WMN;)='[.OWD_RA.2O02;
M2/W)T6:*)2<[JD9@>?!9CI-+U?JMJ9@NF\IH<KV#O>]M?72?T8[V'DB%P_T7
MOE"J$AE>HRC _;#^>[4SIZ^/?1S3SKT!]5_O!3&#BE..6\CER;FD%&7;S90D
MJ!95;!N[F)AZF,Q*L9(*!-H/H0"*1D&DHM:64LH'6WI\M+#T[B\]WB'G4@YE
M?HDZ4:647[AS8_(KR=DRXHL]6C-!QHDOB^*>O]_96T$4NTHQPS'25INQY1?L
MIZWGU7Q:NJ#< 445G%\^:&W@M5C%RGESNYTV;^X.\^9V.VW>W"9>X%O6(Y4'
M4=PC!E"K"2]9S$M0@^(8 T$.>/6>!6MC)PUK)-U&$#=C/1L8%.X<F;$HUPJR
MZ?LS4?D+%6A4AD'&F!@JADW)!!C!W^.(Y)(1N.6>;N: _?4(\)F=X;VNO[^T
M@H+E?RJQW1]N!O# ^@M4/0FO,G#[BKK3+&LJW7+J?UEGW\J*X9]ZM:9%A/;Q
M(R(RYQ)BM@K] -&1@1(865JUR6SLG0F'PE&S\*^ PS&I3-+S(%9_8S:>:F#A
MY3;G[C:S!)!/;P)'7+(.QFIS9WU5CX8/:4*V1^"=P*T94<!HN6L@\S64E0$N
M\LMA:OWU1XGPX/0^L^+AG:[ZUMR*-Z,/*NG1S6.\"6/_D:4]251+:(&U8>25
M'<.5B)*YRA(%\U2W#,?VNW 2]).&IBQ8H016.VI2SBN, 5F%<,&A9<!V1)3)
MRREAL,=@=H5P1MP"[:/$ABW,7HHX*,9ASM 0:A+._+US8%>9LC/UC,H&GZ^
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MK+:DK1_+N8P)46:&$\=2EB2M(,DD&2+C9",P-X"5A=H-R15V>9A'L($HM'K
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M-3;)T!^Y>>I+CX>R26Y ZN+!^F8'GJ$/VF?+?CFLY*6Q3JRWM8I16B_VJ<.
M])00=B?03II)VXW%[;CV<DI,/B1UADTTDC/' 7!,;;J4+[+5>(_%I>6RWNI<
M#$!D E$G.Q3^CJ]%X8B =VY*? G\5*(\DR5)1O2;V/,.@*]$7^V_L4;D,DLP
MA>V33Y :Y&K$]K53&.\BB3.!)WW*Z,_ A-HOVPQ[UNM%<!\3M1]KMS-VLM0Q
M5!!?*\E* J@U?<;^52Y@PCK=X4%7^SNLHK_#E3>],@MYO]&!:&#V.ES'-1TB
M4+R0]>I;JK'"N2^M&UFL& G)Q87DK@E>,XM!GDI,,?+5Z0U#6:M!0]F_[C)K
MBA.>1#"M1P\BX$WV0"'F$*+6^QYU L!J55)IJ,>(\*,(R)[/IJ?I3B>HJ^HT
MW FN]D?5D.?\LR6?_<DF9P)!"BB<3S-UG5Q$D1^*WE5*-TU!R_&O]/GDA,!#
M6'/ :F$0KO.3AR/A"F"%&"E78/26>;"%]BU-A]#@'JL>BIE(7Y\D9C8CM!HP
M>5O,1IX&,UE//Z/M,AP7F-A3WPOX!KZ'^[V+RF[%'=P8CJ7!#4=QDDCXDY&H
MTT?H9;X0/IO"-2RS @$O^E2)+%')S-#9#2S@_+.=SH&930E>+DVM0JR!C"U^
M< @L-)\U:9\P#+;."I#G4\"I@+1=[K43YQFCDWD*,-I45J5;W@ADB$G4,^1&
M[167,"$?O0'J7\?X6_9[T\ 'WNZE)O2FU;B',A2SU-' A$N-[Q@J'9N1_61/
MC/XX-2]C4<)UZB1E;$1R0]D[S@D>T/,2G^!:YK7OEOAV^"O17X D_?+*T=.@
MS6V1#P^J"U>Z2!FML. J)3&>=ZT>U4@\& ,35ZJ$J40FH?++R+MF&7=-8)G0
M=3*5GY9]V40:33\IJ)B*Q!#I* O".EYD)8;,).Q]99DRH2C2DI'<(*OK %:_
M79CKH5M>*.\.#$LX"8:&:0DO%6X3'.3.*'T.Z@DK:B))VJKSCL:[P,>C+VWC
M-QR,?W^66=*V:N)GG$*AN9%L0Z2:HLE6HE$LN^FQ3V%5T6R9N6[#^>((2$/2
MQCYWFZ.,!JVF@"&<8*>/QFXNQ"N1?590Y)"]HJF::C_$W Z#KSZWHM?/"TAA
M9RFG>[-Z\G*NWY:1VV83TP]+B>FO6_9'HA4#F6#'6)_)S=9G_\W[]N6D_>:+
M/X)7Q].#@P_Q.?=X^)RX&,5X%[I77[SAYR\C9$3M3KOSY0O^J]/M=;[\N_/'
M^-V_CK]]?G\=O.)>DS^_^A CK%- S(_'L,<PR"M[%+IIRJ^<3:+LRZ=?PW__
ML_OM>M3[:_ZOR]/L_&V8C[KAUW_]S_G57[_]/OG7KV'^K_GKUZ/H]\EPZH7#
MO__*O=_>G\+\@V\_1G'T :,3P8AX%FS8)W_\\ZMW23S%^1VT._"_64S_[G0/
M>IU7W'XY^_E5\"W[<1C'H>\"K\O]5[03V!.S#?]SU'UE1^X4%O+KV>=__%BW
M'URB ZJ&.0M)&3L&^1PX0I5!'I48Y%DA'?N3BOJ]BQ,?\^E_!^F>>H'T*:'\
MOF#7/>*(SCB>MJOR>2ZT\"'.+'<V"X,1!H)>-A-8G*)ZN$M1W62*ZN$N1?7A
M4U2W"46!K])FA>&Q$H87IY\^6^?GYX^&A_$ B]^FTWT07>>DJ.MTVJCK8)B,
MFL]7TC!3D2XD0"[L7]%YP%U8G_.F;>&U^(D"B%<) F.C.(N3'S%.F?GK]\Z:
MB(5:^U77A%NT56[*UOEG'V3''E(9?K1;\7BKJ]5P/Q?2EE@=I%9?Z!R>6,5R
M/7E]J;N9NK2QR=X00=R?SL)X[F-%G[CFK:U9;R$@J[5?4]LM:\,K3[F@##<J
MS:]0P3,TX^7'+^O0O!6OA,*H->?;3(255]0[_+Z.%OA^GPBFAZIV@7>!.EV>
MV0IO1@(\P..!5T3Q3>+.U'2ZW^OSK'G)VI=__/VR6E1Q1TZOGNF&#+IWW)&+
M. TJKG)I=JV++,BTK++TY&JXUVWWG6[OV.D.!OM5NEGVE<WK9%Y_X>:A_5<+
M%+W8\S=V^@N/?/F15SE&7M[@:+O7=-O\&ZJE''1 II3[Y@C8,99B#WU1_V;=
M8V.W$SOXV&<M^^\\'(^W^RCO<CT/!]N]IN6N9Z58[_FRRS_R(+7?NZ%[_0R9
MY6%ON]=TV_R?*1-\FP21?499)=M]/G<2T$^< S[6G7LXEO<F:<'/AC M8/3I
M: *6YW8?V5VNX<GA=J]I6Z_AAEG?:>0E\,M_8&UZ&&_W$=WEVAT]<?/D^7._
MTS#T(_N-&_T[N-KNL[J3QG>RW6O:UONW8;;W>SR)D..%;I3-HV=H:3QKK4]D
M9#QH).&!JKCJ([$41"PX$AW[8O*&*OP[G9^:('\<2SFQ2CXL&5C<QGC,.J:S
M[*OK4W-0(:==I@+8U$^NN3%N73% $U!I&F!(_T-\S=4)W7:WT[)_\^TI=G_E
M7G7AW!C[+_B5]CEBB=9%$B,$D_W&O_;#>$8%N6YF?TS 0DBSQ+5?!_$4P3X)
M70&FAID$J7MC>_H'"IIIBF5G(M*%\3MW!+L<$!@F8F=RO2T6CTSF,^#0?H10
M1RV80X %);%^JT/M92T$-1$%;[_GL!#X^\16^R;7!69UB@6D!8S,)";,T<Q^
M&WGQ)4S"!-:\]"-\8W4W/OVG.YW]],81&_[9'TTB$!57<PW]BE?\7*(0U!]+
MR\:<9YAM^U"U+J&E3/R%9_')3WVL)F8R,O87EO'>S]Q1GO@$L#46P_>-X>%=
M[\L[ V^1U(CCOXW@$OH^U;C D.?361ZFOOUF'KG38)0:!X')L8XQW@V,)$*M
MA5&MZJAO_&]P>[EM="IW6CY#*PFBX+WOM8R#5#V4$<WJ]26\^9(1V8'[>%CZ
M#$=):_Z D6)THL1A$+D,]V#_&074\CR;MRPUIB(=($>\9]ABZAM6)E+NG0#1
MP HE+$:&NXR'00((*W]"K$1/8393W S:3(3SP%CTZQ@NMDTH\H\7<-X",5'P
MZ)=$1!7US4*(,TS+3DJ)29?^*/&QA=/C28O'V\P&.85DQ]MZJV"P&C9<"(;?
MW2C']EA89]^RB^-2.5F_387XJ1BO1"*ZV,R H@<JGYJ8 00*!'_@BJ]LT*]O
M@$*!@("<J)39QU(V#Q:<S D2GX"(>4U%*>6F3=<'R0W$$/!AHE;)KQS@PZ,6
M8A"9K[,2R45C VL/I,XH%[!X\"V\;H39<!*NA] :B,,86]9#XO\]CWS&BM'<
M$;D42!1$!ELP+ZO [747@>KR8)C?_<C]RPV!SVB9H]<W@2EGV&$=(;[5]V7V
MI7KJT4).\RO8=)0[ \23.)TE($5A(=WR12C.44O0"JXT'L.U"YN0IZ)J4T[
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MJ3OU+DQJMZ)<$MI]69>\L;+KDIMH\6 5=<F<-!%^1/&$"*<J- %DP/!!XL]
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M-\M!^7-%#]S+ -U<LJ[^AMS!TEOT.XZCG);XXWWX3QI?9N1:Q@^L/0P BY[
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M<'GQ:1]IM,A2M+:-B1.$Q,&,RROY\+&]M9^@H2=3+82ASUVE*;G'YJY!',D
ML^;7G':]?K,Y!^S]6TML-&WFF_QK1>L526*7H]:;5C%-;)$?^Y0-<TK]AI/!
M)F\8DW'G-@:!.!2D#=2/0W?J6C,*I(C^W>5+IDA,L:?8S!P4"8/R$C.A38(K
M3'2TZ?I)!1GIF,#T1Q-D?8HT) 6 #FZ*O;(BD.9!9BK/= .FG%PAB+:J2(,1
M[<N4%NW)5^R1[-6BWJZ5_IT2+O7;8GW35J41;%G2\^)\_/>@<M(.KJ:,&SE:
M&*6B$?Y?3)CP(AM5="M@.G4HZ,SJG>XK&2?!%7F&E)T+U.9.D0"!X78Y;!6Z
ME !+/6.)*-#")?$U<6?2=U'V"(QS;@TD/!#D@"!_E5(URAV$(P0P1@?<59B/
MXM2WIJ K9-Q!UHS'YT/1+E:T$2$G(6K': * @AXGH7<3>+Y@U*B61=1$A&QM
M9*/H% BHF9 [ E4[U=XIN OYV,6N1A1,9/<DAL MDD3O_&$B$^6D.W%"D/>9
M;(Q);)7D4U^"YJOCT8>KLZ>KOL$SL2"PF\)X" L[)<\H:1E*U3L=C]T@,3UH
M>/8$?>9_@[,PWDK.3:F=&'Z*0OBXJO)JWX9.7"U.UJ(PMSP8QY@X[OQ_\VZ+
M>*LR&(GQUV2LOW:!$2,VB%;=.5CNQ9Q5;W@O%:QM UT=5\#.K%M)D/:J)G^Z
M,45&W3N<IG$_73X9Z>,)IMK'8YD^GGK1]$"(O5L1NUHAQ'N\"_%N,L1[O OQ
M;B^9E-4NHZAWJY2N[0[Q H<7>V:H6>QJMY@-IX7T/NYYTSFI#>FB?W[UW$S;
MF$1=K9I5J8]RC*#3KZ+5[5F<1ZGH7JN_524E.+T_>K^Y20*3-K/X=&+]%:L5
MRLU(0WG^&'UNAH^1FT.Z>*T<=G%]USFRAT$8XK*PBR-[&41$T%!%T! FUYAP
MPHK92#U"_%PHL)T3Q]R8IE(QQUI]*T"M^*-7LPFZKF_B>MPL3M5Y24]W^[!4
M^\!/R%+!/WIULX95&;XUK6"Q@] '6QS]E<8^&,<!)NU4Z1/8F %4GDPW=TQU
MI0,^@.T ?P/I\>_B:+H1,>O!2J&A%%NX<M?^)!B%?.38SIU=&@F'(XO9M@7?
M!(46KQ+7HU;)AI/".O7\<#8)RGZ*D*HEM2\#]3KSF<O1)([):_"'>Z/C>473
M';G#/^/DJPC<O783DXAJPG6A?R5V<*24UBM-G(8&5Z.>V4NI9\_ FEV1I9<J
M^K=*Z&QY_T]A6,B=JX@>VQ0]E_XL4R7-VJP7/[9$GA!Y@+N%9"%UJ<6]U>85
M&?,B*T?PF6$0%RJ7F,=7/)Q%2]BL*@-.',+3"?JF?T/#_V",\!+"8RP]J.1B
M/SG6A0Z>3)GF3!F9 BSS9&3N"#YAIIX,YTCM[D16(;/1+5O365S\?2K,-))*
MWC6FX,"DA[I*33G:Y=05[^"&4[<L7R4:42M=;+ :X'I33CM)L]1R"6)#,UX=
M)\0&@?"08*_ H-'!B>U6P:H/?>)0JG@/?\1^4= S0ADW1$<%.D@8QH,4;9J4
MV$$*$N*'8@LM3\0)B)&_85=G9=TIW%Y,F$&)R9Y>G<%<O"*ISRI S5W6M0BJ
MJ M+*81;Q7)ED]I\BA>5G.K84Y7Z!P81MH*F6R-.G@K$R 'L"+I@3[?*[3GU
MKH,4;6S^5O@.B-GS':2K.M;N'"W0K/+L*26E3JJ1]_EBXB93=S37GO4SC"U3
M:1W0>Y9S&HGA\-X#:0Q:1QY=N8[]X5_<A;'HCO^8N5>QM?<&]!Z8J7X*Y2M'
M57 6^NU^SNZV2UE2:E2#OW&_QEFU%MS>>P>\*H:QW^R7&4AM=HOIT9A0+M0(
M4^H3LR@_,/SXNG:&TY28*+DP\JL_MX<RM4?U]38DK8O5G#D9V3*A#>ZFI42M
MD*Z/S<D?#J5^>Z37@_5K.*,8*&IC%K'(2Q&Y[1SNN?M2[S,[E>Y:-6S%FC?<
MOJOV&L"'><*.>O-&4/+(2:_O )L"12'!)*0\T<T0'*NA=P(PNY3,L4ELQS>1
M4139:7\O[7H,[<:X*"R_ \DY#H!=*6E^^?8,^&&0Z6:TI(/!:,))S-Y@^@+]
MXSQKDBGZ&?S<?(MFH6(.N*R,)*]8_\MNY/:LU_L:LY&L%'29<&[G,\P70I=*
M  ,0&<18=2]N&EZ4FP2]29A)(0+TK'=IK13N+*A9H#=C#:ZX4(HVV/"OD(=C
MWX#:YU/VD44Y6$97:+0T2BVA^9!T7^@B_37U+@'U"KT9FN3H^J,JAD]X 69A
M96*Q5E9LG)*X4>H*C8+V"-.98<>&;AJD/\+?[^)D:O>07"ET!_JR@7?->648
M=<30?QP5J['-9"4D=T]%\:SN,3TR^*GV#2($3F&VVC=T5!"PZ0WVXC?(?!KK
MM*"^?O*O8^KP:'].L *E??Q#N_,#EB3;>_@3U/6Z[9^,7]!S]''GI_V:R<)6
M]MJW3=;8#IQJ:O=Y&TR7M&K137,O51&<,=OCVF9")>%2#.EUY>WBN#/#6QS+
M.5%J)#Q*<[-NT(&'MX4GN">_I7=B#&+*.42$26&DLP-9%&9+XQ3RVWG^O&AQ
M(OVF,]O_R3+WH9R2?*>MD#5%?0,IH+05\E%Q3+ $ZVY;49[PO7=#/P+;0:AZ
MC'7E<8M:3F^SXQEM AA>4::OXA0L^#K"@:_4ZGZR;W\#<0Z9YTF%YC!&0N^2
M-[VSXN#%@RR.#28NA?&0&($'8VX"F*AX()JR.L?W>B&_(A47QS5>8\O7*$29
MPL99*[^J=$DOR8M@G\K;^C=O)+-S\>7KRI>E^5CW6/HBHH%S2'.Z0ISU>7YA
M7\BC.453GE$@Q'LM01Z2>&K(HR!D@#R,6=V7,B2_M'"U9I7FG7B$%,,B2M7M
MW<HP[2+#+%%J\X26N>OV'>ZZ\49K39=]F7<U;[>UKMM>-Z&E;YT%M\Z<[KVO
M76$CRH[\QJ,&%HJ!FQMCB64-8<%^+W[-"N=K+7>^B]^W#HYF+77I5F$MY3DO
M<]!6Y: %^5<.FCQJ)=UO 6&O>-K6JN]:/TDC_-XM+]V$)*N;F;7*L==NUMV(
MW#A[DBU6OV+TW$?_%,-CBGU)V,#_+<P C"A2V<1UZ3I629MW% K=B:R35SA]
M\H/R2_K+Z;V-%P2WP:K=ADU)M,:-M]9S_3&+<JGWU=]\:_TW?S6.9Y[(/6]\
MP1OVK)U#6^<,>\ X@><3T'(VD?!1JFS\+(X0R6H7&=B*-6^8!,XCJIQ+/,K@
M48[X8N-D"@-X+&&!+6*[>/BYB$HC6XR%(N(1W_?Y4IF_HY_TVX>V3FK'H2\/
M_D'%2Y8LOIA0:<:9&*CN=HK/3#]<\7'IA9-^-I<*AE.9.6?X4;5[%G/_%?*#
MF9S/16?P=S K0,''$KI=?UG!MC6_-)!;%?)MPNDAA'0!DTDL&4"!_^+N4Q9"
M ,>*=9DJWKN'B= ^ 2^$<Z[\4ML <A!K+'D8L0_LDD9!XM8_*/>+ZGVM<8X5
M:'#G=%E,X2PPC>S:A3FA2!<),6+8<P%!J]Z<BJB3\)+?^$,0F[X\%Q@IC$=4
M.N)F-O"DFYN;%A6G8,K,U]8HGB(+:EF?C>(<K,F./#I,3 !-QW,9-U+Q=W'M
MN-1--_UVX0-O*M)#<+M!VE)<G^+^3MU:X=[.8JHQM:AXVR0*3+*$H<2:<#AX
M6GB6X0(S_(^ 1,&'2>8>'_R#*X7)F>;;Y5%W<:AG+5L$S'T2CWPO3T!I1$7S
MT@S2P.7XY%/UJ]'TA'.A@3'M)/)6K'G#E/$9LZ<M2H6CW.DH5EG**MXM!.Y,
M727D/LQ6151[;LL[-77G5!?.ERH2=XG@C62&Y".613W->[+9E137L*APZV17
MN+7)PJV37>'6,R?D;1%RHO@,@9DL#5)_KE5#)?N#7P32Z(O:GF+EV]8L??.J
M@+2,E7G#R=EL)V-%%ADW%42OC]66!Q887",LL6.+W(R#41IRICNPH%N24LD+
M;E#J(%:%AN.7Z6EA]QLT7BGW'"P[PXF9^MK\QND(PQ$W<.;3+BJC-248K$AZ
M'7P[R3$=7:8NOCVCZ3!42NJY_VO_P6A ]B=\CFS9!7/2H(06PYV)F;BT92-%
M@-JF9VA48WHT#HZ*AJR<*VRI\'0<[7G[>X/]O2#8K_H\=G;>\^96Q*;/(RRM
M3*S/B<L-BT#E&LUW?/QE\W&;1PV\GU]]\[Y].6D/OOC^R#LX$-?E<^+110G\
M%!T%IUX\RWSO7>A>??&&G[^,,%#4[K0[7[[@OSK=7N?+O\=ODIO3:# ;MP>@
MEH=NFO+@LTF4??GT:_CO?W:_78]Z?\W_=7F:G;\-\U$W_/JO_SF_^NNWWR?_
M^C7,_S5__=_#[K?9/[MA.)J_G@RG_WWUYV^_7_^S^]=7[W]^#T<WIU_P\+[]
M&,71!P22H48+$6[;)W_\\RN$;\'Y'+0[\+]93/_N= ]ZG5<"E?#G5\&W[,=A
M'(>^&V5)[K^B/7CGCK(V_,]1[Y4=@?K]\RO8C!]OW8M7OY  Q$)G>A+#841D
M,R*R@G=8#&87Z5!Z/>$BFJN2EU(8TV!@3X(AE=45G:M<+#3,YUR^!U9W&,H
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MX*W$?\TL_;K>?$$J8%/+98OCX)OOZ<JA2KUMXH\):594:JFA-;+!UR ,L9#
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M):D<](RPX9EQ"/4FBU'[@Z$]XH?L7HVP-B.'Y2GC'6E+*2-\[2FQ44B(BH
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M&R6SF-):@&/D(XI,N>,Q%AMA,*'!EX>4,'6_!=-\*HD8"?%K$)F)"0D#?%
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M_Y%Y+1KBM/6FU3 "/[0'=J9 4V;K /8.K$>,EH).),C6ALLK"S@^F1J2]H7
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M-;WM)YL'$$J[0/O3(;#^X.3HA(324KEJDKXN$O_@74Z1A%7E4^^^E*9:S\H
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MKC(Q>9S%]\8HM5F8^'$R3T4O9DI302?M%PQK M\VQX*YQ&<>9<RE0%3*JH6
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M@;TQGGF$Q7\GEU2R1(#< N2;  (R7\(H=0<24LIA4:L9WM_:L*32\Q'1KDM
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MF:"BFBF\4GE"?% 3 1LN@YE'/2*341X1-H[Q?U=> 7<1G'M3;U_-+30A"L\
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M=M*/R#$%_0=KM"M7GDO2GH'B*^M_:53&YP(TX0+DZ 60K]K"S>-U>_PUSR[
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M$ Y/EK*-JD9GN"G#J(PA"0UK!//?$_G)_%NU)I)F2DB4)X)RPME_,/X].85
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M@[T19A W;FIZ51S+Z(%$D3O#:UG!G]-4U)]/O]:&ZNSG3^%22'PJPI3N%J!
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M EL&>2^%1(]9HR"*H?FZB'K>(V^C]06'RJU-,?/AD\ASQ-#2\%@,JSMVL#0
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M_>B&1_:,1K3\I6"*>@A%DTQ&PA$I=NDPB<+PH*8CJ.F0&#Q=@PX%"](ZAF^
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M*RU8;<UN!<J+%*TZ= D:,">;UC6%N^?\NR1P-:A$"(9T9BQ,J66 "IH?DA*
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M*OVIL*;"NDDBMWR!W0XH7"+<TZHU588XOEZG8YP=O6L3_V!&_LF&) NY);X
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MHK_MBWG?:,_NFKIM'!<;S;[Y_M/IW(75XT)+%)>0VM323^7VS<GM'EGZQ%A
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MW*&#V@XB_ 82F7^'-FE/H)I?;$Q'XA?]BW&ST\-(#R,]C'_K86Q]]A]-*K,
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MJUP1HF\&Q&[B<X0_2!__>(B$'*E\;AU9@)\DS[ D,*X43$Q_*((43YPP#;A
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M2 I51:PYQQT8(_Y4<>UF! (_$HTU?7Y:BEQY;M<Q.@SAP(3ZJM6YU<'-I C
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M(A*C2I.V]>@9VZZ>8/H:,3SH:((>"SNK? _8_&H<2.U0-/ P!1,=, 5M"MI
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M62P*V'3M5P:A8 B1HG5*Q*H<VIINLMY[:.GO>'X#O),@4A&,&#69E7E-OMG
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M/_\!GD[+L65\$4PPDPO5L<4D<&*+[,&$=MF8KJ>[SKO0NO_94%\LZ_':#<<
MK^\]E5669&C8UIC;5<[&4JF03N&UE@WNPAK1B).&U/]FV2GX5C@H=1DJ"%O&
MD5/ OPA?EX:SER;&8O(@?W)F Z\YC\\.11"')'FM&0/H?!?OA9O\?>O:;NG7
M<:;Z;I3=:VTBY!@^8]'G!4 ]2+%9]DJ&S:1*A94-BIS,@#YJL0)\N0(V0]U!
MH2^"SWVGMQ1>7&\B8TM! V!CO#?-[F(LY:XO7QN] EI,L]-DJ*[!! +3ZXPS
MW$>4T#6J,6 K;D3)K9?=8I4(9(NI4FY)7$A!IQ2(-?MK.S ,[^?TBJQEN3DL
M='->@#Z!7YULR2^#TRD[G(GVV\2A]GM6?6_T^^\W:$U6X@ T/A38+ =E!0I$
M:_#N&TU>@06,A_5@824*2(=5Z%\(XQ&^1JP\-09)/OFAXL)?ER#BKKK_!>&J
M\0YRDM[X-^RB0H_:6-MJ^)=OS.\^?M\W*L4C87?!N_&@^WHI-U8Z1+X<HM)E
MHY;(RS#-B^P0O_DBO'\U$?;"C;"1X'"_\L*+W/"NE%U"2,9=N6:NFM^GUH2C
M2%N.9IZL050QYT!N1% 7O@3%=U_YWF6F5L]ECXJ@_';C(:@-#9!HE+5(+0:B
M+1!-))R[\">P$.AN"1D' /[$>A8)(EJ9! M BL6BV$N1(M[)!)N/X)--T6'G
MLLA[8(9(D1?FJ"T'+.2$Q50*DT\?=\>K[//T/FX^1;*%(@$"Z0)>?P2=MF8-
M=:+G!;! O@OQ*,"WC'=:] 9'M>!-8+T:(4G/VE#&!NJ"/\3B="A<U/5JWU\7
M3-E)5:'40@+M!DHA6\JQF70VXR'NS1/'V.)9*="UD"*3NB.AXVHL\-$1PZ!$
M)#"6SHL/B3YZ3Q5X@5-F'<P47>AC]UAH-:T9.;6[F[O,^QT[#; >XL<8T]M@
M0>%&CGP,->;%LV5I##[>1H: ;?'4X\T(./:,!C/?T,<NI^D'G)U\8$W%7-[U
M8?-,X)@M]M_OO_32HU!N%1;F4J4\F]ME)G!T(S^_GI'O)-7T63I8.;,X3VJA
MW-+9H138,/J8"/@KTY$S.06L]H$NBK0BF^"5I;2X6376:D0Q",$L,'Q1;:6K
M,1946\_@_C%!U_+W6S;7$@X6T\*:V/G-JUJRA;-@9 ,L(EC0<V-:#V$V*(&,
M,+)Y21H5)$"3,!.YD1'6D(T@564R4>1W3F2^8'601P-!@IH/DB@'M3!6) I>
MQT,O+XR[6 C15L=.T63$<ABK-,#1CHPQVE:8IHD-@_5^ HRS@YE9S^QU09$]
M&^1C['" 83F%VF@,I21 -QFL3IB98;YPN1:_<%=*KT]:%P=!6OZF]XOX^+OU
M5KK7+@Z7B8<UMO/K%?/$3UKKX98;>6$<IV$WGHXX<<"L@<C.4*1'4!C*L8Y%
MOG7-CJ;G"R8 IGE5[[U (QELM*H.2N5,3D'K(6RKFU%T$1EM%M!0%VGB,[P
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MY07_:\U-<[?U,3]]>.PMM*1%;AFT]%Z#(%CS'M=3"E7,_/!GB[)H&14E$N=
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M@ATEA?5/(RSM#^$6;18+#-]0<+Q6A4TWI>UIT\O3SRLWWW_\ZK^^O=5/O"?
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MQ*N1[T0" QQFX!G#6 %&F_R.E^4L#Y<Q71ZC(8\P7R(N58\6:SF.W [)2$!
M%C*V$DD"(N"]PZ<T,1P%1V/S+_J6C@O^)RS<+">BB8)<G^11J8R$31_.<#T
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M/-*PH@!:!_P%WH+_<L&8LIFXE8P[-PBXQXED(76$D$;\:,%1K[W[D0_6)WN
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M3CUC+K&ZSW/,!9)>\-LD^L5'2(%N8;5#@"!NBKDC6A2H;NZDE$7;*N.M/;T
MTZ[J\)57()0W)$K'Q<S^BI'S5P'&8F3T$,:CUB5JC)"*?4>B<PF_BZ87EK+X
M)U713D^[8%@U!W5L![X+O,Z)[EPENE=SJT:BDIWQ1-X-A4Z>^G3;N"6V+3%M
ML35K)CKUV=+H<B1^_+KE/=6NU*PU-+M05:_QGE90KF3)[(2,?\)G9V1"^9Z.
M6?2^] P\-FANHV0I-L6RP7F6INF"P2'-(XB5")H^P7A+S5]:Q]H<8(L7*:KS
MG%V9JP>#6K\F>G=8>9796<:9=&]!O7*.@\].]X04ZPV_\K2%#ZQT32TXM#Q%
MU$Y_5HJ!TA*? FBK9AO4' R-:>X-%<1I=)TOE:^+R'45O> ^-&(!Z^UB%8"S
M>F/4,K]>7G."_OH^V$EUO1,=O-!X+CELGO5:9?5P/<[FC0KSY>*KJXK**F/G
M AH\RI)QG^!*A5R1%/5G3F1%HYZ "U&686-#YO:L=98R7"=X-5'$JA26IH)$
MD8- @E?61B*XM50-?X/XC1AP*T"W!L*'_>I[+KWHTEO-]7L!7+^I:^!* ?WS
M"4%Y.N(K^/W<$+71F!,DXKR3-#A*#'07&^ LP4)>^[4^LUO$R?D-)Q8^[I[8
M!][18L<\96^J[Y(&[(&,:!'S')@&PWS_X75EAC@/2F;3"QW:=W_B)^?9 $_'
M*4"LXJV(HCPUO7@V>GX.1XBQ/'41XDO[A]$G&"/Z'-@U&]7UEY.Z_NW6]1>2
MNOZ#)Y>M[ROQ?R3^#PKDQ;^]\^/Q79I1?%V"7&1G#=:RD#U1*$GH2;2"(J#]
MR;;<-RJ>35MTHJ!W0=95<>:*^)F.41K!Y\TWI6CTV[#,O%4^^ >IKRLP^E.<
M.8$U8JAS T)G K6$3\0-D6&W*$A$[Z!+D.@H,N+G4-N_^ BI-B3UZ4;A^P0+
M2YJ)3:PECZFTU,#>U)5AE8F9W@Q2S%K'2A56M(4^$?D.@SV7+F1R1@T;^6F9
M#DO^1HZT.;!NOSKB!*Q,2E8#L\&@<-WNC,:]@+Y2<.P[\NN$.8R@DK?":29G
M_P1[?UZ^=8_RO-Y0-[?1SN8"*]\^AWJ;A L2<>D/9'4'XI+FZUCS)*@]B4AA
M\27J$Z)FLADJ_(CD60P'8$X B,13B6 D8SG3V^UJ=C_7JK-=2<4L5_?G>L9(
M61?OSAC^AUR&W<C9.I_]+'9U]N+'/#NR_6)$QOGLB,XI7<6[PVUGV<1,>X[<
M,H^JA^V&=: OG_4<.$+3RNM9N,KJ)E>9M:XRN^E5OMW\KK_=O-5[LG@ 5[DP
M.S+"5<;A]F9+P7YO<I=V)IL(=>*),$V$Z><3II='97MB(XO YO#L$AS&MJ)*
MH@2!PY\LB^P+=5W!L^W.PU>2\/<.R3>0SV>GW9 ^P(3U6,;DHGGKS-8SQ3Y-
M5+33I,TTP7 JQ#_+=?>X)ZUF2PN)S=8\U.9@I8VE!AE9 ?-8R\X83<QO>IX_
M2.+CD_IX]51'QS.UU:4JE"XNGN<Y46EFBN/'G#JPMN$:*G]RWJG>U"X?;FM_
M-:^8SDVE76.:+9C.RE2JW?ICO?N+N6JVF=I=Z[;YJU;KD.&N=[6[BUJ[8^'7
M+EV=,1^7_Z%XV*V_H L1:@A_!N&"$EY!YQ5?U#OO+\%.IR06!E\2^7A/-^($
M]LRVYJ_C,X-/__>$]09[ N-+_L=P/$C<.V^0#(I([0#E@6?H\A'UKX Z;^#>
MD39L..H\N]XUGB8DL2,$,:/^1XWE1LK"4>_!](Q'(E:2\I20:D*J1[,)[A.0
MJF*F1AWU+OIV7M=1[T,4!@D+_$-8H!4H/FJ,)8G]^T;9Q5XA82UD']",?>[-
M;/9Y^R$3XL'Y&'Q 2JYJ-U?UG^26CN"6OI XPM?DKH[@K@Z)HM:7LHE =>!4
M(C"3JTBN(KF*Y"H.YBK"2K9O3 \K $-%UB4>8K:R\@^C#'M?V'0NQ69+*3:?
M_[HH_8Q ;K;P]P90.XH;H3(64D@\&2!LP($:KV<W>?OJ/"0S6OVW;SU<O)AB
MI466JC'6-CA.F,96GX6.HR[<G4(YYRIS.<^^LA<%P4J$;!A%[8ZKZJ&A()$N
M<$8[_!/O@;&>$U, R3<XLNW6/"P<DF]M.FNF#3D3A7*;C>HII=*YP KT )S?
M"3;^ 616W Z9>:JT7=/=EQ*?5'MIWBIBX>?WG$5\YF*,$97QUD4YJ#+UF<ER
MV:%&(-:P!49+&D;DV81<][:Q^!&8/&A7)%RL[)5!$:%BE4<^0%JK8S <)+>J
M+OQL [H[<-G [M#],\S>&:S%,%C*,')/WZ\'3_JD\% .9AA6*)1QA!,9",FE
M& =089IEL%9A@D5=H9IBY'+AFF+L_&AAHEHFH%5&0M2[D,'9[<A@3^WN,JE;
M?>B)Z;N7@3A\M8C(>MSL\+5G*>M\$,CL5/@X'0D\C_#B^!Q9X:.GB)C."B?G
MIP>"OIL8GT\C04.VQ;D^7->T/-YS%MNDHB.U$I>W/O10S."A5,E=/P[:C]D%
M(]';F-Q%.4:W@A._PSIL331"LT-WZ9Y'$*[7L,S9JC"P-,]+Z=O&Q$]"194H
M5!18;..+)DL-P4#J^MV_O!%:ORZNAV)8*_"@*2N^,UN'XO+KN6><%A];2D@N
M/F5VF\8;IF6SSOLP# Q'VT,/E;/"?>6EJ*-1N[^>Z6:H-F',-A\2"66VY:WA
M+M?5[H\#L=E.SLMGQ6@F6T*6H21A/@Y]DDXEKTNJINB$^S=A[%)WQ$F^[-[;
M8RE(*!;2N>G@1:^5/TKAC+2M"L20YE@^M](<.UP;;'4 T M[W.'=*SJA!SJ:
M*] 11E 6++E=I>)ZMQXEC?N(@AA7UDPD%69VP9&3%2QR?18:M)NOX$^F^;E6
MJUZ57_4\'\TR'/C<]5I)\YO2]I?MVI$K3W@M'3=LTY< J[)0#JO@^F8QQ(CL
M$;(W_Q3Z7@A(;&)K.=!O,R-5O)NV)IFBW'Y X8W4@R'R+5NT$4]Y+9*/H?,]
M6PX<>[%KNC^,>JU#(?Y]4(3'DLX<FB6="3:E7[]?_AZ4!_W+6GX]4]I/T=RF
M75U('Z!=G<$<(:IAG;"%_>@$M9U8ZBXQ%LY,GV?:S9=AIXC>^^',],-1"4+:
M] 5VI4V_!ZJ(,=@:M OV++\1@:W.],V&/,]-(5F3U,EK&5[6>R+:*;7'XI<+
MDPWL[8T[?VAIPZN!^GOJT/(C90-'/,C#C@&'2Q+V5=<+FXVH*Z?*Y=!!*%]R
MV9]8_M.HM;3?I.(%&E:N'C.B_O8RK)7B3BK^K-0=.=?8G^;7\\HY3?3U#?2$
MZ/=LIV^1##RF^NKI?OO+6%XP$)JW6K<@M]Y*<VXG&<MKF^@+[7\/Y&A/SDMG
MZ<VL](0W'*X#/XX,YP45X+7Y<WY1O66K/XJ;9CCOA=>MMLJ+Z<A6^4ZH8#L!
M^"0?>GM>L1#YT OTQ<O5:9=%$TDH)_G0(;KN.P5M<;V*/%-#+J1RV20]<X\E
M.5O(B%Z@K\RC5A^5^I/?RI(RMR0C.CS-K>>-<EJFN?)9,70=;$)W^TV++A]:
M,->R#Q<]SNK%@_YX#SZKK:=%^]))*.NP6#C  "XD1F>3S.B#K;2+)S-Z@6)>
M;LN_)&6>1^_B\61&%TM'G!D=6W5JE4Y]_JSVF%?L;&!N6"<5TB)#@IZ[S7<*
MW_N]:!99WWS17LFCM-J=L7B/YG5\ AS:PM&?)A(PN8?D'O9\#TE!TN=/3F3W
M6)"TH BHH^J/VWINC+KBD18DA=89#C(Q,:&(N!VJZY;P+)#&O=PKU^^F+S?E
MP3&6\(0EB]4UN E9?/+BEB!=)[GX(RAIW&+YP@)+G+.(:UP^Z2P;LA7<\;'#
MU1WBDO*%]<H7<DG^T];3,GS*%VK!Y/QTT7G,WG1F-]?Y9>4+R*AB^$.RFY?4
M+OA&BTN;]:S+0(I&Z [G2:[B9Z35Y<4+2RAX5F[WZI7Y7+Q:KW;A#R/MR(4+
MO@1?WKQE7J3TD(3F_]C:A87F17O/HF"#<U-4M5WL%;[?HEIV)[4+Z^>GE-F#
MK5Z(GJ.2L(>]J@1;&I(2H7SANGWUQ _ERS3/AK/*#T3JAS3)R]$]E =?N[ C
MH]Q@31R^N\0HCT35<?84<-Q""*/\_J?\4BF-GPH*YS7*D;W0P1#Q5E7WA9.+
MH*1OUO,ODTFQN;7;_B4B^&BM<@?*K6N5#WX,G^'?' WFMX\#_3Y=YD.;YP=(
MX_]O9T0>DWV^>>\_;)]G0@^22*C_C[7/KU95CBR202\R&5QQ@D*M@$#3N] <
MWM]\+XBE4F\]T]OQ]JV:WFPZ3&^_6$\-;.I<Q"%F"4GO5:!78\B,7QG_IJ@#
MF!.UI.1NPO\>U^Y_-2[X, :W6Z;78I'I?;PCK Z[KX 7U(G(X>/'>(Z,Z=FA
M;L3XKBK,T3],)KV :\'6.3Z41>M\=S2Q*QO_OQI<WOE??_T[,5<><\I0D$XU
M>?(/D_[&&+^:T*7MY2;P&'F>@=()8Q__>X(9(?R.W]8W?P^U= &V;8ZI2Z=A
MZ&&P"P*O$3#&_2\GR5VE:\_SCEI S5_IJ_O[W,+$OH6S-B3I_UN@WJM,[GE^
MD4<"*JG9+-_W+12QA\ECKCR094V2-43EA/$+D179$^9C+/Z#*06?#Y).'SHG
MYY4!1GQF+//" &^4Z*/RP*-%$V9O+FLP/'*7CHOTRH.)M8-2I?@\?WOMUE^;
MLI!CN1,G,E'Z6$5.],KP[>&O6O\-N(@U\=6'9CT([$$\)Z)Y$3'R!AWX]XTQ
M>%=?%D5NHF)PS)]./ ZR\.O[X/&BNRPZN(*TQ?/V$:OA(=PR:G1'B,#&#8<*
M&G) ;!Z!)4@,%I ,Q1>N)[^#PCC!UA#(3OHG6</ZHO>Y+_ G3(P#I" LT)@>
MTJ8(T<5XA$4TSPRP*F:*Q0$! _X(\IR39O_S?TMLIOA-99H*1D=.F3'4"&-D
MNH;(J5@$<C-"Y5Q_!/\/GW.3B8@Q!*#%<,H*:+H3(L89+';)5[S)N6-=U 3\
M%.()$+T9^99DI;L#SQVATS&6GC-W[OM7_$U.8Z:R+O+,""O4>)MXCPKJ(^$=
MO]A8ROD,,Y)%3!4J_CJ&2!0]R?3&7PD@)IP$:GQ4GK1[R>FU]1Z#9^]G3'<D
MJ PWEG5)8_!/ C[DOF:#V!^!XJ2:UTVN!G.K5Z014,Q;"G%#9TLEI2TH-^2:
M"8/<)8,\8_.'RR,-(-.Q UG[MW>.T;EW?A2\_%+'#'AH\5&PL55P%6(B7PCO
M$%X(W?U2^-4R-BDL_@-,#*M'E)'9' BS=QD('S-!AD2ZSYC=T'FB'27$OQ?B
MOSHJXC<5N0%&(GD*G@2*PRY-C5-5?6P0ND[T"IE!&)0Q*'Z6V">R7C6%O5OI
M,)I@F&J"1\M0S=<A_I_EW&$]3R)2^]P$3$9%1Q[W87XA<Z<_0KPNHN; WP_D
M2-=1P:]#_4?V 74!TBZ&ZD+$7SQQ&8)E5W)'K"]ZGK^T7NXR ^ZG6AONQ,*T
M=G7!/L^']R_55J7X$UV6K)>[W$<GYYWJ3>WRX;;V5_.*J70Z#W>M;KW9Z# /
MG=HETVTRCY7;AQK3I)]NYOJ)S*U#.%'"'V4@@[:83K'TM^6& 2<3\$K"A=P,
MW.-_\T\'B:,QRE)'&5EH2ISA\$Z1C[O,>PE7QR<'G_[O"7MBX5NNG'GV\Z+*
M?9EM7+Z.^;=AZ)(@G[VM](I&V5J$C!A2]K, S[8B H=WJ95GO_[5O9_5C_S/
M["UZ9 _I4L..3MG%I1(9N3)KS%^?VPFN[1ZQ"FO5!%J(L1T39$.\\XNI],Y_
M@;%&#B#L/V+8N=33R3ES3%LV;=)(N\YF/%O>-9*&3N_\8^3YX7#S1$0?QST=
MG-3=)SGOZM[C3'?:^D:2<]E+(S##K"WD_M[@$!YED=,$4=!FS)>_@P:3&V]B
M-WG1:B^BZ<#\>W<I6N8K<W_'F6$8F(ACIQSFXDAVMI+C'/ZIVL<$0:30OM<V
MIZ$[01+&^I@V$9L\ZRU=0?Y94<4?PNR1[[.U:[L,R5XKQ8SI2ENK&8B\I[6:
MP[/I8I3L8A53+"10L8Y$8SA"D(_%H 3C4^^=IW=\Y]Q'R#O/]JZ>1K/7_/M3
MS__.Z4J'<.<&).O=>3FF.R\MF<6QE,W$R]G^3KCU=O+!8VF$'AZI%RETP2&7
M_=FN/97ZUS]_YWTH]  (TY<B?<;2.>DQDXF)'MDE R3W1H];*"R-$=:VH+Z>
M#A1$,LB0@E2-42"LN*@#)BV%(ZIV"Y,JXZ(\N+,K?&5UX\:B*79/%[4?PO55
M:?S#GG(=@ 7[T?*6;&\]>9_)QL-?LF?YP"JR!24OEBK&T,<36L5[*[Z/!T_I
MK A3D5;>_A[TO27;6_/V\_'<?NZLD(LH7K:HXR7<>$^JFQ]^AE#<M*JD7K_>
MBM_9PBJZVSNYK:7#Q61'Y\X"[>A=$YE#<;/BY-MCZZ8Z?2F\"SR2^$6\FO\N
MW!9*=]FLGK$+S;8Y4&"#DS1WP<P$)/*)-AE7^QPV4][S**GDZM:].G:=,4>'
M$H78OB5J,D!2PLY\(7GP"=>(IO4L>);7J<5?)IV@K5TFN'$!JQ?DRM-UX=?0
MMBY\[W6[70G8D T!XS@,;!8F0RB/B4:N=DLC"Y8 _YN_*_WJ%\IU?G,:\='*
MPU%([H^ED.W$XC?NZF=VC/KRGT3H;>AXC:7;GS]:NWJ&U8E]IMN=IJA0)&3^
MK"K:Z2GI'UOY$%3C=\.->4<R*)_G/_ >*^-'Y2I;=K "3Y7S7N+L(3MUP:Z>
M79ORL)GUVO:Y>G>%=[ENS>&^^;U3!Z9Y[\KLZ>*I]*.)7QA\[WN)M4>Z=^>F
M//>^><^V?-38>J)7?5*/:RCJ,Y2KMWEM,/K>NM%G+P&4=6 $Y>M,S6X^DB"3
MBQH+/URM*[8)Y.1P$CUK30)?$*\N@K1%X'QT(Q:FO)Y]: L6$3J./A0%1FL2
MRF;9.)J$'A;))!BY"B/+*S'2$ MU[>DW*BEO#9CN%#M&^O/PW,88F3TL?%SL
MGK>LZ5H)FS?<O'<MWSZRE?(Q-UTC;0_01U_4>73^[_\Y/66N(*CU#]/BAN@;
M7NE-AU99_S!E#![1 /!BS.FI07*\\!ZVB,?5*1"J:!9[!4)[P"AU\ZNKX6E;
MDT6C.D(70@/7_!&1EAYY>AQ>G3H/TCS";TQW-L$05!2N)_2_,0U,A?28&S(<
M*%MT/O5?\S'XDXVB)G[^^U]\\CYWH"#N];2',&WBM2?D"IWG7O Y=WH@GEZ1
MQL=V7TCG"YU@ OP41 <>_77DK7:V#7S2T"=IZ$.!O#ZJACX56@[N-YLE!;UW
ML,HQY53F/\OJ@"[1 "D*XKO<![8ED:;B'\S/P+,NJ<AEFTK\!9+00-!4?^.U
M*JL:48JDK)1U*NJ*DLYBO23WHKVL4H&V 5,$]3YL#M]IUDHNRKJUJI-SMASH
M4K*:HL6&!T9G3%U24%\>2C!N#._6WC^,3X9#8Q0D<AKMZ:1+[TB%GUV]W: '
MI-6\D;&64_V7PS_B'7!]S",1))/1WIBP+FU3K0HJ(V/^9/2!>M,%%1O7C(J4
M=["*C890*68Z$OHC_ 55%S727I)CIMX.]$9_3HSKW&2BR!^D(94X8[RX?>&#
MVP'.E2=!&]4E'K*'=$XT/(R>L6I+XL\7];SVBI'Z0LML-\*<+7CC9W%L[.0\
M<U;V:M6,1^>/#45G5O,*@A#TQ@$M5B,M1B)DABPQXO:0C9?\CAJ))@T&]ZZ/
M_('*"-9%LL>CC&!HKZ'SGZF2(#)$@>' 7:T"X6(V<XK&$U&>(:1ZMY4T ?X<
M9/IGF@V5LZ,@T8>)+!'@^J*L@HJ&R52'N;131= T)#$/9YTS9J+W1*S"R-"6
M';Z$]3'P.\(42)B)0!I[-F#F0NF"-GM/87V-EZ<20P(I#-;.-$35^@'B-%TA
M3<'[&-\X@;Y^HJ!W0=95K+Z9S4(QEX"?0!G$[]$483C$Y@MT-<>+#D>&!LGK
M?7-J VUW+N,O"A(G>OJUJ\P *UT8+!I^(1HET8[@R05SJ&2/C'DRP&@:ZRZ&
M RVS)IO.9;+A4B^NWHO96?XV\W1GQRC,-P5M(<A&(J./EH(9X#9.8Z4SNRJ'
M(ALVEK[,]LEF\T&V#[G^TX4;R,9_ ^XD"+XM]VJS$B]_# _B!H*S&7)AP['+
M;J"82@>7)]/NW[)%'7XDP=H7TB+LH&EP@\6@![F$>;-U*Z%2>SI3[5KQEH>1
MK#Y5GW<M.TO/R:T=EL.F4+:P]+A,"]7J74P8DI=3D@V>,1V=?-=D5L#0L(T,
M4Q5@H(6L$'Z$/U!X&..$I9)&^1MFG._80B:#&P9,I?. ^6ZF>)K) .OE"!S&
M5 S>K'@Q.S-C.UG#%TK';!@3' +NU;*.*U@[ 0 YL<4)?%VJ<A,!/^Y'8W/T
M4OS=^[ALC#MVKK7]/#/!"\"N^G2)5?Z=@#='N.JP\:YE1%+*+V=3V@B+*.B!
M3R\?KA$,3P6:Y>.?)YRB60-%W$=Q:A\%Z%FJ#DZ-OH(XE5 ;OGM]K%-/#(\&
M0E_0SI@V&G(*&>]%QH]@E.I;JC2992*K*CA!:+/M%*,B_%I1E:DH9IM4%/O;
MPWO7#P]3(3Q,J';M:T@09:=071R'J1!J5H!WR(^IQ#/ 3=_!^@=I%W[0R(X'
M N06_*J./OW@%3<&+=%QD,!G;:VO#>YI-:CW?]6_]W^T-9_G\^Q'N=DMW6=_
M%XXFI\$[,*#R/,_^T&Y_O5YJ@TD^S," ITJ[76ET.TREVJT_UKN_O'DH.XD)
MQWP@_MOVL"A_M]*.!Q;0G(EH_4Y=!Q7<&';3TSVXYN/A6^;Z'\/Q(''OO*%'
M[L0M#W;4?'P[.R;!Y$@;-GGYOAN0)S2Q&PPQYX8?-9H;0\^/>@^F^RT2M;;H
MO-^$5!-2/9)-<)^ 5!4TY@0)(_I1[Z)O9],<]3Z@!T#" O\,%E@WQV\?-<:2
MT9/[1MGH(T$.PT3V>?LATUS(P_KOOB?$?/8#7A_<_X3G],DM[>V6_!N@)7=U
MB'=U2!2UW5%#WAVQ9_F-+KJI:ZK&223(SJE^93-AIXYM"LGJT*0OFI'7,KRL
M]T2T@P$85MI(*98A,C3D59=43='A0[4))4K=$2<9DZ\;LE&30EW-ST+'+O;W
M%E]4I<>YK)?4.[5O):30Q^!>Z4!R*QPIVQ>?8GH(ZZT2+5 1(0%G.6D'G_FN
M6GGF2BM;>?KBY^Y&I/SIY%':+7F8KBS#<4NR[B\Y#5E-8992SH_;>:]0?ZI_
M;]BI7$_>:BMW)N21$U!^=2_<A(#V0$#[P9K3! 4.!P7VQD,M7]AJAME^DZ1?
MJ,/=OF8MAFD]SA!WU+$S2/8P&>06>H@;22[9PB9SZJYIT4K 47V^27@VE59V
M0J7D?-6ZU"(UW\&4V1)+PY]LOOC1&$0T HRRHQ/O:;)Q#_G;3ON_B">XWBRC
M_'I-I:RF@"FV")9].;BOU"[FXX69[?@I235GE_"LC6=87%*$6D X@P5Z3!%W
ML58@W:(?8KET]_O[%3<*:X+LFV1)>=)^SG%-ZMV\&W*V?%8(+(M*J'?[(V=C
M1VWRH%T-5O"PB(6._!03*KHVDA5HM_$ Q<(DC9VB<PNKM^Z^LZ0.T^%H]0HF
M#Z*WS6003W>2X(D&9?[GCT'C%^JRV6#>8>68,(X\#3+O(,48%!>F9<NZ P_R
MI9,%MG$X9WMR7C[+9J)-24BH^_"I.\BQL;,M'MJPBRK8WJ*X8*@==:=;6\%C
M8U#P5AH2UAFNML:NVF^_LS(_>[H91K3&^N9+3OR.<5=>D,*^1Z9]&LRL;M7T
ML%!R/>.CV\XWVN./Q_EW/KSQ<2 8NMI/EV#H:@&\"Z&;W,.?< \[&'(9=[;3
ME:P,D "\3E:@KZ*@!#JR=Y9F%3*U:H<2;*'9?[PBS+@$'0Q "5K:"@I95'T6
M&G0.L^ OO++2Z^RB?#M^:P;K6$8K5[>*-?"Y]K52WW<FZW*18U*9?<9K_R#B
M2&]5O;,8U'KJ7>>N/JMU:M<7+T)X]>[XJ*.04,=!4<<><"5L(DMR\<G%'Z("
M?(@)X+DD.VM[^G#T!/!:L)Q_Z!1OQ;K2G(^$B-Y&1!%@W[E9>\H,\9QQ^+$8
MA?7&K*Z=#I+D8^Z5XMF#RVE?Q@SJ9?TZH[5Y9<V<]H0GA+N%\.RBN/E8V4CY
M)PF[^&,R^+UI+!<'F\;"!D\/RG'5]IU>NF[6EX2AEN6Q.* +D\NR_OBA(GO(
MV2SL.NDL";/XDZP);ZW'$D7BOJ4V[J8OC7<N9*W'@2@.(=V&Q>A.]6,M]-@^
MC?WQ!+T?7(]^$0EC3_ @P8,$#Q(\2/#@6+2:W0='#..,M)U/@B-1S)E8BF(-
MH^616"PT*8B,O.W*\)'C<D+$1NZNU>NV+,C]0F9EEA"R5SX8:V8[;M"()QS!
MU;E>J5T2&3E.<O=6S:V%BQY?A0/[EJ8]+:/ZW]Q]N];6TV_\2^@@R-%0_V;U
MMVL>=P06L%YP-(EV'!,+.(QH1WE+T0X'343SP&>#@QS-F^*M7&BIV?*20O]E
M00X'4-L-<I32VPMRK'^R26SC2%C#CJLR*48!0IEEF9X81Z"2\/+.BMI;51OR
M8I@ AUM!J!V&@A RV%$Z\*Y6YES#OQ;HVS%*L%)]GE<4M<_=/?YJ_'@]FC&
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M2-P^?-2 =\)A*9**-3 <K&1NZ%&.@K,MREZ@8 -!K%.1!A+HK\\P#64!C]F
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M0B@S0^:#+\90GE!JAO"W($L%4AF8^B5RMQH_(%6C >J296G\(0W60"$#"^
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M]IZWH)?64$A"8N5!694@Q=2O+I>,+D&R8M.$.;@+9PZ3=859(T@K@VK!XZX
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M\.7BXN7EY:WG/X,7'_T(WEK^F@^@$8)P&^RAO7M]%_^+IO_F.MZ/+^2_1Q!
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M+_:D2'F![SHV60)2/%^* <2()JBZOI5!SR6UX_Y1B7:F@G$)@D=:)KX-SE<
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M-J3<PN)G1(OB*WC]:63^_4\=6M#9A('FQ9& N&ZLR+\D$QCCA[:*U?RO($#
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MS,DOI9Y;:Y542HY),,(>.Z0VA:C4N,V"B9S5"B*L:_)GY D$82J1>U0U>0K
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MND<"3L-H59D+P7$;8>3D><X8J];)4\>";)3 0]SPCFL&?O59P1^RJ<5Y*MG
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M4G8O.0X' ;&+X*2N3Z%^J%3V&-0*IZ).@4$<V<C/D\PS3* >LJP2H344BK,
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M^=.<3,#9)LTGO.$+V$M)N.XN>'=]LWAPE#-<Q'6,_K/,IM-E ,Z>JAYDX!'
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MO >%+.F',$J\_W#"^1F=E(>%1SNH5<A3*IY03$OU9+OU[F?N!L;MJCQ:8AR
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M=QB[CZ[G$?G/O1TC_)O_#U!+ P04    " "$BG]:;;,HN&.-    ^0< %0
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M2* /&"=4#,?+X,MHGS^F),H/;']'XX=T"BY99 ;>I)):&@R?C!"[I"H4$-5
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M=3]^*>.W7[\/ON@_=_MW9Y];!JO^W,T?87QN"2+A<Q<REPX+[NF/>Y;$]$M
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M;Q;KU[7,1284@JY7LPP%)J12WHE@A*9<OG)56Z)<.K&E@2#H>KG*B@9OX=)
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M(1-F/$R67^)SGV817W:[:*1Q3:(D#-[BY'^";:39 I/+.?,3.IBUEY )>2>
M"9EPNP$7194LG(G+Z'- 0M.>5EO&Z::4#%YK5ZDIX)T6.E3"@4\F ZK>_!QG
M.8E6.0YY!:</291G\\4'[4*(0<<E5ZS@-[FC50##)1N476X==<IB7%P+O:!Z
MV;<7#U0#\FD9[++@DR9$%63<!:<*>,>PM"/@G0DZ5$(H2L50(><W"'V;4O<V
M6U]'!*]HB]GX,8C(-I '(S8*KL)2.^!5?*J7]DX=:XC"!)<IL72#6@U5>G""
ME]LTV;!ENVHGB=7#CW*V-/SV, YRO$G)@4;H.:XE0MVB[-#6G*[9GF9R:TEW
M6%/>.7T>_$+URE*#<9[IU-N3(:#P#--7_3A*PFO\A.-TQZ]4.]X*:PK4[+0=
MAVQ]3.H$;S:J8-C:#Z\DH./:? VAH=^Z%!B,7YXFJW2+Z_JQM^PA+$5)[7NU
M&D[/39JAMTY2JL7!,,^,43AX5<ER9\C54:5VA=X&5'@%:=8JZ5B3+SN<9/J[
MTJPT_;M#J2EF5]A2 T-&>ZS6+K!4AN/^WN$$DR"F)H[";91$="[.+V>WX:2E
MKDM6]C*GR4LK13#,[(.VR\U2EU.SK7UV=JH.+U.GS$]6)^$<Q]1]ZTI>*&7=
M'6(VP#T>9%8(>J>-#3K);>I<G/.D5+@T,>Y)NL991D?N(+[!NKQ'E:0S4NBA
MUI20B\$@A!:;>$'Z41@QZ4MSX1KO"%Y%/([3; I*I-QM"2HA'C<$!1$8WUZ)
M2[SJ_"@()VJ9Y8^8V(0H,D&7\8@::#/X$*6\L\0(K4L4+@@OOBU'KGM^>(T$
M21:L&)6SMX?F+YK9?I\&W,Z_^AK6GH;9:H-A8F_(XJ2L"&)80'.7)J3\3Z;&
MXIR+)KD4NUP3?AB21!G.;F_'%B>*K-3<G?>P-^)X ,2LXYUA/8$*"5/%#F9#
M%5%==R>%:*2.;>ZGE<NYG$8I83:G4((0#'YHD$FF3MCAA;0+O-J3B/FP'F<5
M+91<7EQJ9T#S&E.]!A#.6,*47'%:ZEWRX&'/H\_C] F3T4/&#Z%TK)7\[NK8
MLQ16=>BY]:-W3J@0B?>=4QD:CY12KC_T=;K:,Z*Q=#^)!>V?77UF&:CJ*S=_
M _&1)8"$>74IPI,J'7_@$7UPR!Y^$P<;"?S.[ZX^L116]8U;/X+XR#)$0MYL
M)8.8D*_/?(VS%8EV;+:DLZ,EYORC2T *W[XA XL"(C U$QJRGAS['&_*/9\T
MJ;?/-6Y,(>_:]6MA=\<"J3 (TM@@5(X63254:WGBT2A)]D$\Q[N4Z.C3%G/-
M&AG(+EF:,J X(@&FI$8ABPIA3XSXKWU <DSB@Y$4@J1K7BB@=JG1$0/%#CDV
M)4%J<;\<X6NW_%RAD22BJ//IA@*L,/7HR('BB0*<>DI2R_MERN(1Q_$XW>Z"
MQ.Q09,*NV:(&W.6+* F*,4IX2LYP#52JP*'-Y(E%YS1,LC2V(>^3/ )L'7]J
M8; 4ZB*T9!%70TS/$Y/N,8G2D(;9Q,0A0=(U>Q10N[SIB(%BC!R;DBN%..+R
M_DDR24(KBM1R?@C2@2FG1RD$D!QM9"9J3%CRM3]BW$39*H@++#?T;[)JL1I9
MUP11PNV21! $1105.B59"H6*,US%*V%841X[NC0D_9!%@"JG2BT&D"A=;"::
M\)IK/D@RWA/20JT><=2BSC9E#6#K_5F%' BB&, )N[:%>(LHGD:@":^5?1/%
M^&XO20"1B[CBA@I<Q8GN[R"XH #5Y4 AAI@<*@2]?/EJER#)[X*MS$/(Q=PR
M0 ZRS8*V#" F2($IV'"414S8"R/&F!6/C:=)B+_\'1^4=@ER;CFA@-DF14<(
M$"ODR!2T*(41ET94W LQ[DFT#<AA$:T,0X4HZ)8:*J!M;G2E )%# 4W!CE(:
M+:9CGR/),O@R#2E1HW54'*DWL$0I[Y8L!MAMSBB$ 5%'CU#!(*J$VEH^B<0J
M,Y!=VDAWX'=#D<,X#=41BD'++:FL3&A32ZL"B& V.!4T:ZE>%3DI*"6H; "Q
M%KPP;A2&]$5EY?_<1@E^I;1?*NN671JX;4Y)! $Q28U.P9]2\JKZ!V(ZK+P]
M$-*\[F'J:_^D>6U+FM>@2?-Z"&F6GU,@I'G3P]0W_DGSQI8T;T"3YLT@TM /
M[]77C-DEFV29?I8E9RLEO5!&A"HES%$,'ET$;":RC/E5I@0Q%9\TX8'5C-R3
M]"E*5NJ0627NA3 *T%+6=&3A44<.T,2?.B"N]+SZFB(H-W:22LR/EVF#E+N8
M0@8>2=K C,ZED/9)B?LTRX/X_XMVVHFX7-@+/:2 I21I2<*CB@R>B3"%#J)*
M/B;6)5W9AH;T*%GG=W='@"6PCD> &S^"(($,D7@$N%@]*81<?V;&48(#A4=H
M_^SL(TM U=^X\1N,3RP"$KXP[]=4QD='9@5RX_O'-%$G"(@BSBXR5X"K;S+O
M_ [BBRM "1<XICS7C,EY6HW_DN,DD[OOQF_.1O8NG'H@KWX \76[:(1ANOK=
M\=?\A40Y?3*[36"?E+L\LKQ!A9RKKZR%67UQJ1"(KZ]#UF5"*8O:PHYIL4CC
M:!7E4;)Y3R>?) ID5LF$7!%"#;!B@R@!@@I*6$()GUH059*.27!/^"TCF'X(
M?@@0)R$FL_5:.MKKA%V1P@RX(H=:$@1)C/#$XKKXY:JA@0H5Q'7\TF::97M,
M>I%'HN*)0DKP"B()\A#II )I)%6AZ)-;95VSPZO7#_R669F#%42<C4D*</6(
MU/D=!#<4H.1W^J9K].KUBX=O4:7E^//?I4L2A'1(7!RV#VFLJ#XEE7)% @W$
MB@<2$1!44./JLN$N1:4H*F1]5*=J@968T_G=%0&DL*I/W_H1Q$>7(1(Z?^M;
M>W+YDR^K1W;YE^) @ES,M>N7@>RZ_Z8," IH@"GJBAY0)>OC0,)QR-J8@X"-
MMR!@8P@"-A"#@(UM$+#Q%@14CRU*A%"_-'N(HTV@*$ZHE79-"@WD+C\DHJ"H
MHL:G]!FU"CKJN*YHR4N<39-U2K;\^3?T'Q(K%7+.:EKJ8-9%+65"(#BB0R:4
MM2R*SC6$$9-VS8M]&.4X+,#<1$F0K*(@KLLCRE;$S2K.V&()OB:.01X&A^Q
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M)0 [@7%# @1'E+!487'SK@ _M?/V#W&TNHG30+W*TI)Q7#%/A-<IEG<4 ,0
M$96J1!X71%S2R_=_&R2?R'Z7KP[W)%UAS+*LLMI;F=;?++7=<J:726TV6:D"
MXED?O H&'IM C3:N&B.6S\4\EC3.JKFEJT^+QX"^P-D^S]@(2H&I5\&U2HZW
M%RP,Z&PR:#0 4<\"IFK#@6LBKGJ%"F74T/8T/\N.50!Q^/8PQVM,V+F#)?Z2
MOZ4/^J2985CHNIZ]69O3G<P9%4&0L"]:U50O0\T&T /+$2N;0+^R1A!OQ?7]
MY=/5FO!$DI2,\AS3KL&3F.2G#73"KFAG!ESQ3"T)@EA&>%TF3<<W<U1JH(:*
MCP,)QWM!J&?>YA-"4C).Z?"]TM#'1LG]W2PF \1K6E0:(&AE#5-S>8N02(9X
M,^C8#OJ5M>3:617C^FV4L7#Q/B ?@WB/[S'A0[LR@%#*NPW0#+#;L9E"& 3#
M;! J(K)2Z0I1-<3UV%)Y$9KY2(--R4U$ME/9 GGG=Z<)KEU8K6S6ZD<07) A
MDN:I4N_!A-#TVL]WGNVBA/HM78RME'3\[550.RSHBD'B@P*;BAFEN,\XN(2B
M.''7^M4Q'63GZQH_0?KLFM-TU:?V<(:N?#2K)J4X."5(./[$76B=SUS]#.E3
M=S"I/G<E=M9/O@ZR!XYVG[W<!,&N^.XXSK/J+T<"E'_XK0YE9^LZOKU/B^WZ
MT0.[<6K577WNI^J",D.,85SJH^>=9 / "L?PZGE+NFY,9RIM]&NE?]Y19@@O
M1UF&\ZQ<^38042'KDGE:N$VJ207!<$N'3G559:'CG3#C('L<)2'[G\D_]]%3
M$+/%Q5$^#@@YT+D5GU4IS+;4=4FH7N8T"6:E"(9P?= *!*1**$A"M&+_P$=U
M].(NS3%Z??VM=U;RY)-6KU*\")F@2[ZI@3;))4J!89(2FCP?:%5ZKP"&][*A
MB$=V&(GACQ-YF@?QK>V8IJIJP1J!QHG9#K,+T9+-+0XR/(\VCS3D^Y!A;I"J
M%^AUG'H4&_@MYZ)3@.-G+% *+J?203%30H1IO4S7+_?T/SC;KE""\W+<^G?_
MP]8]22GD_'!/S<CI^,S&YAV;.-PIF:=7<4D\&_!-WNGDP=#. J18N[%0X3$2
MKN0YT[P3;([IW")BQP98%'='/ZIVZ%.+NR26"7235"I9,(0R .R2Z2A>A-MP
M0NQB?-<._CZ")764!#$\4L5%L^7H%HT6B\ERX?U#WT;!0Q1'>80SZ@!Y]MIC
M&H>89,P9Y@?#*I&]NDNR]#6J22=;73 ^IR=@X=Z+Z>CM]':ZG$X6:'1WC1;+
MV?CO/\]NKR?SQ;_]X<^O7_WIK^C%]>1F.IXNOT63__HP7?X#$FOM5C-U"IZ8
M:;&NJ9:&R+Y^*YP-1>]T*@_&9??!(7B(L6'%0"'L=#34 FZ-CE)),/31PA/V
M^4IAM"NDO?.F/6VM&'TP+$H:E/PM)Z@,4*\G=#7 \,H*IFE%(:[4KNI5+#"+
M">,T>:+ST(AV P;)SG69E)SNQ5@9T-J$T6J H9X53/%6P5H)[>A[BK(L)0>4
ML 9*TOTX\<\ZOLPO#OFZW0.9M/,]&#5D82-&% 7#+#T^_99,#"C<LB:0;^[8
MT<8S8XR+$=:,:6_8 &7,<5'-?LHGT_'$(S5\!:5$!3#^R :E>,-)\A+B%/ :
MD^@I8+7^I%8IWH!1RR7++$UH\LR@ H9I=CB%0T:U%EK7>7D-MU8%5C=7Z,=W
M?$.G^.^_ 0BTY/,7(R$M] #,+_6D-"J!H:4MTAX3S83Z1W"3S6[@:::A1L%G
M\&\@GE(:#N-,$,5KK8,D0^RMH*RQ-5!RZXU_;C6,,8<9WL(V0Y &-N#71OJ0
M(GQ6/B/*>>T"EKJ:\C)UF [92EIH-=RN9!FAMY>QE.)@W(P9H[B 56L4Z<.5
M3BZ)N/[HW^WTWNF&LK?=;S?[&>Q?]]ZQ;BH<=ZCQFMWJ_2TJFBB)]F?_1&M4
M%-*>EA#$7+LP&<BNWVK*@"&0 IC,0U4%FMA1K?_[A^]^^.$5V@4$/?'B "\8
MF5[_\->F(/_3J[]^^Q-Z]<,/5S\4_Q]E176G8)\_IB3Z%PY1D+$FK_$*L\J7
MZ,VK*\28P%TA_<>;OZ(___#ZZM]_^$OYES]?_>75CU4[$;OT)N2_I,>"4<8V
MKQ!5WF%^04%\WCJ+@S;1PY ?> OB^R *I\DXV$4TRFA\'=4>L(6BT\UU:T-:
M&^U&+3 =QAJJL %?*])N$X4OHP2M"MU3V;=9Y9\XI5Z]?O.*T^K=>/GWW^:4
M_-$NSV9)N?<_6Q>5U3J6F81=T,<.,*.,7M([3:S@B:FLA3RBGC,H-)CW*CR<
M?]^T6NVW^Y@50^,S:%:;EN!'G&34=[)2:5M\FV;9':9F+H,OZF25?JTX3@D:
M8F(G5ZA/$]Z)>AIN2791U0I*B[W39CLHX@UYI_(<YT&4X' 2D(35-&W +F-@
MQ5NR472;^&]K2/L(@$D+#"VMH>J8&!:2WFDGSM*LIW.^Y\=V\V)82WA*?/*5
MO$PV)0ZK*3'F#7BGD"E1W;R:J5"#=+3 L% LU8%%/4NT\E,MS_(T06/B<Q^0
M&>$574)=O<=>FIX6<DRF*-9V5&I@AE5[K(H5H*PHT5TO_$#B7S''&M4+2^9W
M(&IXXIL*NH)G77&(_%)@U/-*6!R$QR]^R[8UMRIIK[QJ0]9RJA"%RZ<6/BLN
M%0O$\'BDOK;"3L4KHQ175MC(P^66^;H**<'2"]U3,81EQ8)-757/L"VKE';)
M+0/D)JT4HF 8I<<GW!+ I1NEVP$5.YSC#-.7R"JA7>,G'*>\4L?DRPXGF2J>
M-^@XKHMAAM\ICJ%6 ,,O&Y22,AE<A^]\AD<MA NU*JWD+_YW^]\'Y!-FB2]Z
MGHEB+JFE MED4U<&#($4P+J<J<5JDGCGQCN<8!+$E/FC<!LE$7.4;.]>3Q6C
MEDOF6)K0)))!!0RO['!V:59J<<\4M/2ZSNG5#_Z]4YUW7AJE2JV4R'DY-="%
M*3TE4 G!6D55P9.OWZ?U@0 PWJHVX+B!:C*U*>F%+R)4*6..8FXX\Y>",PG>
ML)7*I35U!)R:<R14R#]EV*[Y79JD;0/TXYM)R?EQ$:,!PI$1I88/>FF998-6
M?H[\19'^\&WEH+R3[7BX[UT0):R3S)+CW]0E-2WT_!S:-)@A/[:I4()&/%O
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MBD0$C:Q3HNC@ME@B$X3C?#3HNL2@HIC*LFC[*.Z#*9,O9,6S]%5&-02<<D(
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MMWV*'!8)+@,+W0UF4I@*#RDR0ITY8D@D49%(PR)<XR)@;L)+DLC [".!C7
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MX>T]S<KIV#9G;Q0RTZ5I.T/GOSMH[N,Z*RBZ$ZUI^!".(G2=$V378+I%A]I
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MACT"!RTB#0U"-/P!P0 :D2P^_D#SISOQ)_%S^9/X/W MQ2__#U!+ P04
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M)="1JNS4&*HG&.:4?<_UQ,*KA5'=K2GJV.*_]A.Q-HFM0 B)_33TW0<_\!.
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MFP:LHPC%62P87/'^/T,_).]5HBAM#KXCPA. @DU+8/]@!OL'..PHYU MFY;
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M.\GA%5=A7\FE!>P.KF[9DOC4,HBJL&2)_(0C_8P]N;#*VH)KOE@@&3FOZ&(
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M1X21/G=?E+<E9@-!1=EB-(?I1*J&%;J,IR1Q_9 L^BX->59MAH\>6?**YJH
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MDRTEXV674&X/?W$I==EG/O'_+8T6X 0ATH.=-P!3(W2!H>_BJJ7P$"U#1$4
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M_J1TM,'Z8P?\-;/3% "YZGJ>F65ZXM(Q%1@M1 U3QK3@&+1+R3M#@]?1I6X
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MHNKS<!7 +.6E'2>_#E7W18OJ>1.T$'$]JF6\7._5R?$4E;$2>4*\QPY:GZ.
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MXK^Z8(52. 5_C&*ZIA*QUTZI!$)I,;@JY4KK57*O2H;EQ75Q0+%=49LRNC*
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MZD>*=*PICNUBO:PPT-LYWF!B5@7Y[6!OVRGR[6!OG4C>#O9O!_O76!+>#O^
M&6N6F/7,ZHSHR9NAM>=E[:_%D%?SBRZ.O,M#+HAB2^S) I:!C$ET]+/>$#Y_
MUQ%-_/]H@NJ5G;"3D<$R ;!^U7& @_")Q.(-B'1-/_VL7?( 7;%=JV Q@V%
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M?H(85KE]B,GO6T[=DPC.!CA/?BX$5=[?S/K_NA<U1C^S_[7(?9+G3^\VD?=
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M"?O-_P]02P$"% ,4    " "$BG]:03ZHGWT"  !L#0  "@
M@ $     97@R,2TQ+FAT;5!+ 0(4 Q0    ( (2*?UH*JV(>/00  #<A   *
M              "  :4"  !E>#(S+3$N:'1M4$L! A0#%     @ A(I_6A_3
M43ZR!P  JC    H              ( !"@<  &5X,S$M,2YH=&U02P$"% ,4
M    " "$BG]:E0]UD,X'  " ,   "@              @ 'D#@  97@S,2TR
M+FAT;5!+ 0(4 Q0    ( (2*?UHQQ]^WPP0  #X?   *              "
M =H6  !E>#,R+3$N:'1M4$L! A0#%     @ A(I_6EI$XIW'!   3R(   H
M             ( !Q1L  &5X,S(M,BYH=&U02P$"% ,4    " "$BG]:M'HE
MJ947  #8W   "0              @ &T(   97@T+3$N:'1M4$L! A0#%
M  @ A(I_6G6"-@4Z @  P!,   H              ( !<#@  &5X.3DM,2YH
M=&U02P$"% ,4    " "$BG]:+KZ&,40E P 5HQX #               @ '2
M.@  9F]R;3$P+6LN:'1M4$L! A0#%     @ A(I_6LNDQ $5%@  O?   !$
M             ( !0& # &=C=&LM,C R-#$R,S$N>'-D4$L! A0#%     @
MA(I_6EE!*KC-%0  L.\  !4              ( !A'8# &=C=&LM,C R-#$R
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( (2*?UH6Q#?I53<  "!5 P 5
M      "  82, P!G8W1K+3(P,C0Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "$
MBG]:;;,HN&.-    ^0< %0              @ $,Q , 9V-T:RTR,#(T,3(S
M,5]L86(N>&UL4$L! A0#%     @ A(I_6L39+DS47P  G/T% !4
M     ( !HE$$ &=C=&LM,C R-#$R,S%?<')E+GAM;%!+!08     #@ . $0#
(  "IL00    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:GCTK="http://glucotrack.com/20241231"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="gctk-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-06-28</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReceiptsOnAccountOfSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReceiptsOnAccountOfSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ReceiptsOnAccountOfSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ReceiptsOnAccountOfSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-03-28_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-28</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_IsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">GCTK:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">GCTK:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_PerformanceMilestoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PerformanceMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PerformanceMilestoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PerformanceMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-13_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-13</instant>
        </period>
    </context>
    <context id="From2024-11-142024-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2003-01-012004-12-31_custom_FourSeparateLendersMember_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">GCTK:FourSeparateLendersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2003-01-01</startDate>
            <endDate>2004-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_FourSeparateLendersMember_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">GCTK:FourSeparateLendersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-032024-01-03_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-03</startDate>
            <endDate>2024-01-03</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-02-15</instant>
        </period>
    </context>
    <context id="AsOf2024-02-15_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-15</instant>
        </period>
    </context>
    <context id="From2024-02-132024-02-13_custom_ExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-13_custom_ExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-13</instant>
        </period>
    </context>
    <context id="From2024-04-222024-04-22_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-22</startDate>
            <endDate>2024-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-22_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-22</instant>
        </period>
    </context>
    <context id="From2024-04-302024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-27_custom_UnsecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">GCTK:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-27</instant>
        </period>
    </context>
    <context id="AsOf2024-06-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-06-27</instant>
        </period>
    </context>
    <context id="From2024-06-272024-06-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-06-27</startDate>
            <endDate>2024-06-27</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-18_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-18</instant>
        </period>
    </context>
    <context id="From2024-07-182024-07-18_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-18</startDate>
            <endDate>2024-07-18</endDate>
        </period>
    </context>
    <context id="From2024-09-052024-09-05_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-05_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-05</instant>
        </period>
    </context>
    <context id="From2024-11-012024-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="From2024-11-012024-11-30_custom_SeriesACommonWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesACommonWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-30_custom_SeriesBCommonWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesBCommonWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_SeriesACommonWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesACommonWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_SeriesBCommonWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesBCommonWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="From2024-11-012024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-30_custom_ConvertiblePromissoryNotesMember_custom_WarrantsAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:WarrantsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-30</instant>
        </period>
    </context>
    <context id="From2024-07-302024-07-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-07-30</startDate>
            <endDate>2024-07-30</endDate>
        </period>
    </context>
    <context id="From2024-07-302024-07-30_custom_FirstWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:FirstWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-30</startDate>
            <endDate>2024-07-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-30_custom_FirstWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:FirstWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-30</instant>
        </period>
    </context>
    <context id="From2024-07-302024-07-30_custom_SecondWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SecondWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-30</startDate>
            <endDate>2024-07-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-30_custom_SecondWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SecondWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-30</instant>
        </period>
    </context>
    <context id="From2024-07-302024-07-30_custom_ThirdWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ThirdWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-30</startDate>
            <endDate>2024-07-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-30_custom_ThirdWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:ThirdWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-30</instant>
        </period>
    </context>
    <context id="AsOf2024-07-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-07-30</instant>
        </period>
    </context>
    <context id="From2024-11-122024-11-12_custom_JuneThirtyNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_JuneThirtyNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneThirtyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="From2024-11-122024-11-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="From2024-08-232024-08-23_custom_JuneTwentySevenNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-23</startDate>
            <endDate>2024-08-23</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-23_custom_JuneTwentySevenNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-23</instant>
        </period>
    </context>
    <context id="From2024-10-152024-10-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-10-15</startDate>
            <endDate>2024-10-15</endDate>
        </period>
    </context>
    <context id="From2024-08-232024-08-23_custom_AugustTwentyThreeWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-23</startDate>
            <endDate>2024-08-23</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-23</instant>
        </period>
    </context>
    <context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-23</instant>
        </period>
    </context>
    <context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-23</instant>
        </period>
    </context>
    <context id="AsOf2024-08-23_custom_AugustTwentyThreeWarrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:AugustTwentyThreeWarrantThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-23</instant>
        </period>
    </context>
    <context id="AsOf2024-08-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-08-23</instant>
        </period>
    </context>
    <context id="From2024-08-232024-08-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-08-23</startDate>
            <endDate>2024-08-23</endDate>
        </period>
    </context>
    <context id="From2024-09-052024-09-05_custom_JuneTwentySevenNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="From2024-09-052024-09-05_custom_JulyEighteenNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JulyEighteenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-05_custom_JulyTwentySevenNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JulyTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-05</instant>
        </period>
    </context>
    <context id="From2024-10-152024-10-15_custom_JuneTwentySevenNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-15</startDate>
            <endDate>2024-10-15</endDate>
        </period>
    </context>
    <context id="From2024-09-052024-09-05_custom_SeptemberFiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-05</instant>
        </period>
    </context>
    <context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-05</instant>
        </period>
    </context>
    <context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-05</instant>
        </period>
    </context>
    <context id="AsOf2024-09-05_custom_SeptemberFiveWarrantsThirdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeptemberFiveWarrantsThirdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-05</instant>
        </period>
    </context>
    <context id="AsOf2024-09-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-09-05</instant>
        </period>
    </context>
    <context id="From2024-09-052024-09-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="From2024-11-122024-11-12_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_SeriesACommonWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesACommonWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_SeriesBCommonWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBCommonWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_PrefundedWarrantsMember28421031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="AsOf2024-11-12_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="From2024-11-122024-11-12_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="From2024-11-122024-11-12_custom_SeriesBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-12_custom_SeriesBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_JuneTwentySevenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_JuneTwentySevenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:JuneTwentySevenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_JulyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_JulyWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_JulyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyEighteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyEighteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyEighteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyEighteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_JulyEighteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">GCTK:JulyEighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember28421750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2004-03-04</instant>
        </period>
    </context>
    <context id="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-03-03</startDate>
            <endDate>2004-03-04</endDate>
        </period>
    </context>
    <context id="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-03-03</startDate>
            <endDate>2004-03-04</endDate>
        </period>
    </context>
    <context id="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember28422109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2004-03-04</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_IsraeliInnovationAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">GCTK:IsraeliInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-07</startDate>
            <endDate>2022-10-07</endDate>
        </period>
    </context>
    <context id="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-07</startDate>
            <endDate>2022-10-07</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember_custom_TrueupSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GCTK:TrueupSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:IntellectualPropertyPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="From2023-06-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-11-202024-11-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2024-11-20</startDate>
            <endDate>2024-11-20</endDate>
        </period>
    </context>
    <context id="From2024-02-192024-02-19_us-gaap_LeaseAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-19</startDate>
            <endDate>2024-02-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-19_us-gaap_LeaseAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-19</instant>
        </period>
    </context>
    <context id="AsOf2024-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2024-02-19</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LessThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">GCTK:LessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BetweenOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">GCTK:BetweenOneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_MoreThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">GCTK:MoreThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2023-04-132023-04-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2023-04-13</startDate>
            <endDate>2023-04-13</endDate>
        </period>
    </context>
    <context id="From2023-04-132023-04-13_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-13</startDate>
            <endDate>2023-04-13</endDate>
        </period>
    </context>
    <context id="From2023-04-132023-04-13_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-13</startDate>
            <endDate>2023-04-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-13_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-13</instant>
        </period>
    </context>
    <context id="From2023-04-172023-04-17_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-17</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="From2010-01-102010-01-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2010-01-10</startDate>
            <endDate>2010-01-11</endDate>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_custom_DrindaBenjaminMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:DrindaBenjaminMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-31_custom_MarkTapsakMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_custom_MarkTapsakMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2024-06-142024-06-14_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-14</startDate>
            <endDate>2024-06-14</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DrindaBenjaminMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:DrindaBenjaminMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DrindaBenjaminMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">GCTK:DrindaBenjaminMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-13_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-13</instant>
        </period>
    </context>
    <context id="AsOf2023-04-13_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-13</instant>
        </period>
    </context>
    <context id="AsOf2023-04-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <instant>2023-04-13</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SalariesAndRelatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:SalariesAndRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SalariesAndRelatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:SalariesAndRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ProfessionalFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:ProfessionalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ProfessionalFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:ProfessionalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:DepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">GCTK:DepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_OtherExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_OtherExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_IsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:TapsakEnterprisesLLCAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">GCTK:MarkTapsakMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:TapsakEnterprisesLLCAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-02-032025-02-03_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-03</startDate>
            <endDate>2025-02-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-03_srt_MinimumMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="AsOf2025-01-03_srt_MaximumMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="AsOf2025-02-03_srt_MinimumMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-03</instant>
        </period>
    </context>
    <context id="AsOf2025-02-03_srt_MaximumMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-03</instant>
        </period>
    </context>
    <context id="From2024-12-172024-12-17_custom_SalesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-17</startDate>
            <endDate>2024-12-17</endDate>
        </period>
    </context>
    <context id="From2025-03-212025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-21</startDate>
            <endDate>2025-03-21</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-21</instant>
        </period>
    </context>
    <context id="From2025-02-042025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-04</startDate>
            <endDate>2025-02-04</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">GCTK:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-04</instant>
        </period>
    </context>
    <context id="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GCTK:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-06</startDate>
            <endDate>2025-03-15</endDate>
        </period>
    </context>
    <context id="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-06</startDate>
            <endDate>2025-03-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Israel">
        <measure>iso4217:ILS</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000004">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-01-01to2024-12-31" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000006">0001506983</dei:EntityCentralIndexKey>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0113"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0128"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0165"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0201"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0204"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:GainLossOnEquityIssuance
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0207"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0210"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0243"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0252"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0259"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0260"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0263"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
      contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0277"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0292"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0298"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0323"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0332"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0340"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0347"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0380"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueDetachableWarrantsThroughPrivatePlacementTransactions
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0419"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:EquityIssuanceCosts
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:GainLossOnEquityIssuance
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:NetProceedsReceivedFromUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0518"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:DeemedDividendUponTriggerOfDownRoundProtection
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0554"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:SettlementOfLiabilitiesWithEquity
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:NonCashDerivativeLiability
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-12-31_custom_PrefundedWarrantsMember"
      id="xdx2ixbrl0661"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-12-31_custom_PrefundedWarrantsMember"
      id="xdx2ixbrl0663"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-12-31_custom_PerformanceMilestoneMember"
      id="xdx2ixbrl0669"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-12-31_custom_PerformanceMilestoneMember"
      id="xdx2ixbrl0671"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0707"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-12-31_custom_JuneTwentySevenWarrantsMember"
      id="xdx2ixbrl0777"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_custom_JulyMember"
      id="xdx2ixbrl0992"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_custom_JulyWarrantsMember"
      id="xdx2ixbrl0994"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:DiscountAmortizationAndInterestExpensesOne
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1088"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1091"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1154"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1162"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1170"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1178"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1180"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1182"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1184"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1186"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1194"
      unitRef="USD"
      xsi:nil="true"/>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1202"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1219"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1220"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1248"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1250"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1252"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1260"
      unitRef="Shares"
      xsi:nil="true"/>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1262"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1264"
      unitRef="Shares"
      xsi:nil="true"/>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1266"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1274"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl1282"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1371"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="Fact000013">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2024-01-01to2024-12-31" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-01-01to2024-12-31" id="Fact000015">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-01-01to2024-12-31" id="Fact000016">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2024-01-01to2024-12-31" id="Fact000017">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2024-01-01to2024-12-31" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-01-01to2024-12-31" id="Fact000019">001-42374</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="Fact000020">GLUCOTRACK, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-12-31" id="Fact000021">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-01to2024-12-31" id="Fact000022">98-0668934</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-12-31" id="Fact000023">301                                             Route 17 North</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-12-31" id="Fact000024">Suite 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-12-31" id="Fact000025">Rutherford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-12-31" id="Fact000026">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-12-31" id="Fact000027">07070</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-12-31" id="Fact000028">(201)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-12-31" id="Fact000029">842-7715</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2024-01-01to2024-12-31" id="Fact000030">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-01-01to2024-12-31" id="Fact000031">GCTK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-01-01to2024-12-31" id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2024-01-01to2024-12-31" id="Fact000033">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2024-01-01to2024-12-31" id="Fact000034">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2024-01-01to2024-12-31" id="Fact000035">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-01-01to2024-12-31" id="Fact000036">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-12-31" id="Fact000037">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-12-31" id="Fact000038">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-12-31" id="Fact000039">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2024-01-01to2024-12-31" id="Fact000040">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2024-01-01to2024-12-31" id="Fact000041">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2024-01-01to2024-12-31" id="Fact000042">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2024-06-28"
      decimals="-5"
      id="Fact000043"
      unitRef="USD">8600000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000044"
      unitRef="Shares">25585853</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityListingParValuePerShare
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000045"
      unitRef="USDPShares">0.001</dei:EntityListingParValuePerShare>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000046">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000053">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risk
Management and Strategy&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information
systems and protect the confidentiality, integrity, and availability of our data. The Company considers its primary cybersecurity risks
to be theft of intellectual property, theft of other business data, fraud or extortion, lack of access to its information systems, harm
to employees, harm to business partners, violation of privacy laws, potential reputational risk, and litigation or other legal risk if
a cybersecurity incident were to occur. It is difficult to assign a monetary materiality assessment to these risks or to the impact if
the Company were to sustain a breach of its systems. The Company&#x2019;s approach to cybersecurity is based on the premise that any cybersecurity
incident could result in material harm to the Company. We have a cybersecurity and risk management processes in place to oversee risks
associated with cybersecurity and respond to emerging threats in a timely and effective manner. We monitor our systems to assess cybersecurity risks and threats.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Managing
Material Risks &amp;amp; Integrated Overall Risk Management&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240101__20241231_zr85dhfOxlq"&gt;We
have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zB6t3xTQfVR9"&gt;integrated&lt;/span&gt; cybersecurity risk management into our broader risk management framework. This integration ensures that cybersecurity
considerations are an integral part of our decision-making process. We conduct annual risk assessments and quarterly vulnerability scans
of risks posed by cybersecurity threats in conjunction with our insurance renewal cycles. As a result of these assessments, we have implemented
technical, administrative, and, where appropriate, physical controls and practices to proactively monitor our systems and user accounts
including, but not limited to, deploying solutions to constantly monitor users accessing systems, implementation of two factor authentication
for logins, and improved rules for password maintenance&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Like
many companies, we make use of cloud-based solutions provided by several large service providers for critical information technology
infrastructure such as email and file storage. We do not maintain stand-alone servers for our email, file storage or other business applications.
In the normal course of our relationships with the providers of these services, we regularly monitor their message boards and other formal
and informal communications channels for signs of breaches of their systems. We also survey available public information for indications
that they have suffered a breach of their systems.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Engage
Third Parties on Risk Management&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Audit Committee has been designated with oversight responsibility for cybersecurity risks and our Chief Financial Officer is responsible
for managing our efforts in this area. Neither the Chief Financial Officer nor any member of the Audit Committee has relevant expertise
in cybersecurity. Recognizing the complexity and evolving nature of cybersecurity threats, the Company has retained an &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240101__20241231_zj75rM3MZCdh"&gt;third-party technical
expert &lt;/span&gt;to support its information technology systems including addressing cybersecurity risks. This relationship enables us to leverage
specialized knowledge and insights, to ensure our cybersecurity strategies and processes are aligned with industry best practices.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Oversee
Third Party Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240101__20241231_zrtDYO8CHBgh"&gt;We
utilize various third-party software applications in the functioning of our core business. We conduct assessments of all third-party
providers and maintain ongoing reviews to ensure compliance with our cybersecurity standards. Our assessment of risks associated with
the use of third-party providers is part of our overall cybersecurity framework&lt;/span&gt;. In addition, some of our business partners also
maintain data related to our trials and ongoing product development on servers they maintain. We require these partners to comply with
all HIPAA standards for maintaining security of their systems where this data resides.&lt;/span&gt;&lt;/p&gt;

&#160;&lt;i&gt;&#160;&lt;/i&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Risks
from Cybersecurity Threats&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
face risk from cybersecurity threats that could have a material adverse effect on our business, financial condition, results of operations,
cash flows or reputation. For more information about the cybersecurity risks we face, see the risk factor entitled &#x201c;&lt;i&gt;Security
threats to our information technology infrastructure could expose us to liability and damage our reputation and business&lt;/i&gt;.&#x201d;
in &lt;i&gt;Item 1A., Risk Factors&lt;/i&gt;. &lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000054">We
have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240101__20241231_zB6t3xTQfVR9"&gt;integrated&lt;/span&gt; cybersecurity risk management into our broader risk management framework. This integration ensures that cybersecurity
considerations are an integral part of our decision-making process. We conduct annual risk assessments and quarterly vulnerability scans
of risks posed by cybersecurity threats in conjunction with our insurance renewal cycles. As a result of these assessments, we have implemented
technical, administrative, and, where appropriate, physical controls and practices to proactively monitor our systems and user accounts
including, but not limited to, deploying solutions to constantly monitor users accessing systems, implementation of two factor authentication
for logins, and improved rules for password maintenance</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000055">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000056">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="From2024-01-01to2024-12-31" id="Fact000057">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000061">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Governance&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board of Directors is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes the
significance of these threats to our operational integrity and stockholder confidence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Risk
Management Personnel&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
utilize an out-sourced information technology (IT) network and cybersecurity compliance service provider, Windstar Technologies,
Inc. (&#x201c;Windstar&#x201d;) Windstar, under the supervision of our Chief Financial Officer, is responsible for developing and
implementing our information security program. Windstar provides managed IT network and cloud services, network, cyber and web
security services, cyber risk audits and compliance and penetration testing assessments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Board
of Directors Oversight&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240101__20241231_zE5Z9F8KMYXf"&gt;Our Board is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes
the significance of these threats to our operational integrity and stockholder confidence&lt;/span&gt;. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20240101__20241231_zwJfGL7z4pGj"&gt;The
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zNn16VnzcPwj"&gt;Audit Committee&lt;/span&gt; is central to the Board&#x2019;s oversight of cybersecurity risks and bears the primary responsibility for this domain&lt;/span&gt;. &lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000062">Our Board is aware of the critical nature of managing risks associated with cybersecurity threats, and recognizes
the significance of these threats to our operational integrity and stockholder confidence</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000063">The
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240101__20241231_zNn16VnzcPwj"&gt;Audit Committee&lt;/span&gt; is central to the Board&#x2019;s oversight of cybersecurity risks and bears the primary responsibility for this domain</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="From2024-01-01to2024-12-31" id="Fact000064">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000068">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Management&#x2019;s
Role Managing Risk and Reporting to the Board&lt;/i&gt;&lt;/span&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We do not currently have an employee who has significant and demonstrated professional IT management experience.
Presently, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20240101__20241231_zJ4QFgMhK2m7"&gt;our Chief Financial Officer with assistance from our third-party IT services provider, Windstar,
are primarily responsible for informing the Audit Committee regarding cybersecurity risks. They provide briefings to the Audit Committee
on a regular basis, with a minimum frequency of once per year&lt;/span&gt;. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to scheduled meetings, the Audit Committee and the Chief Financial Officer maintain an ongoing
dialogue regarding emerging or potential cybersecurity risks. Together, they receive updates on any significant developments in the
cybersecurity domain, ensuring the Board&#x2019;s oversight is proactive and responsive. This involvement ensures that cybersecurity
considerations are integrated into the Company&#x2019;s broader strategic objectives and helps in identify areas for improvement,
ensuring the alignment of cybersecurity efforts with the overall risk management framework.]&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
date, we have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240101__20241231_zQJf2UDLuSg6"&gt;not&lt;/span&gt; experienced any previous cybersecurity incidents that have materially affected or are reasonably likely to materially
affect our business strategy, results of operations, or financial condition.&#160;&lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000069">our Chief Financial Officer with assistance from our third-party IT services provider, Windstar,
are primarily responsible for informing the Audit Committee regarding cybersecurity risks. They provide briefings to the Audit Committee
on a regular basis, with a minimum frequency of once per year</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2024-01-01to2024-12-31" id="Fact000070">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <GCTK:NoInsiderTradingFlag contextRef="From2024-01-01to2024-12-31" id="Fact000072">true</GCTK:NoInsiderTradingFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000073">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId contextRef="From2024-01-01to2024-12-31" id="Fact000074">1375</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000075">We
have audited the accompanying consolidated balance sheets of Glucotrack Inc. a Delaware corporation (the &#x201c;Company&#x201d;) as
of December 31, 2024, and 2023, the related consolidated statements of operations and comprehensive loss, changes in
stockholders&#x2019; equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes
(collectively referred to as the &#x201c;consolidated financial statements&#x201d;). In our opinion, the consolidated financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023, and
the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with
accounting principles generally accepted in the United States of America</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="From2024-01-01to2024-12-31" id="Fact000076">FAHN KANNE &amp; CO. GRANT THORNTON ISRAEL</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2024-01-01to2024-12-31" id="Fact000077">Tel-Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000082"
      unitRef="USD">5617000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000083"
      unitRef="USD">4492000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000085"
      unitRef="USD">151000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000086"
      unitRef="USD">376000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000088"
      unitRef="USD">5768000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000089"
      unitRef="USD">4868000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000091"
      unitRef="USD">59000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000094"
      unitRef="USD">95000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000095"
      unitRef="USD">27000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000097"
      unitRef="USD">10000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000098"
      unitRef="USD">10000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000100"
      unitRef="USD">5932000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000101"
      unitRef="USD">4905000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000109"
      unitRef="USD">992000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000110"
      unitRef="USD">839000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000112"
      unitRef="USD">26000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000115"
      unitRef="USD">5000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000118"
      unitRef="USD">252000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000119"
      unitRef="USD">673000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000121"
      unitRef="USD">1275000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000122"
      unitRef="USD">1512000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000127"
      unitRef="USD">17421000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000130"
      unitRef="USD">33000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000133"
      unitRef="USD">203000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000134"
      unitRef="USD">196000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000136"
      unitRef="USD">18932000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000137"
      unitRef="USD">1708000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000145"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000147"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000152"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000154"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">791609</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000158"
      unitRef="Shares">791609</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000160"
      unitRef="Shares">208914</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000162"
      unitRef="Shares">208914</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000149"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000164"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000167"
      unitRef="USD">119229000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000168"
      unitRef="USD">112986000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <GCTK:ReceiptsOnAccountOfShares
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000170"
      unitRef="USD">228000</GCTK:ReceiptsOnAccountOfShares>
    <GCTK:ReceiptsOnAccountOfShares
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000171"
      unitRef="USD">48000</GCTK:ReceiptsOnAccountOfShares>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000173"
      unitRef="USD">-8000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000174"
      unitRef="USD">16000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000176"
      unitRef="USD">-132450000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000177"
      unitRef="USD">-109853000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000179"
      unitRef="USD">-13000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000180"
      unitRef="USD">3197000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000182"
      unitRef="USD">5932000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000183"
      unitRef="USD">4905000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000185"
      unitRef="USD">9499000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000186"
      unitRef="USD">4704000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:MarketingExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000188"
      unitRef="USD">393000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000189"
      unitRef="USD">122000</us-gaap:MarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000191"
      unitRef="USD">4655000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000192"
      unitRef="USD">2278000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000194"
      unitRef="USD">14547000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000195"
      unitRef="USD">7104000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000197"
      unitRef="USD">-14547000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000198"
      unitRef="USD">-7104000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000200"
      unitRef="USD">14000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000203"
      unitRef="USD">-798000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <GCTK:GainLossOnEquityIssuance
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000206"
      unitRef="USD">-1925000</GCTK:GainLossOnEquityIssuance>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000209"
      unitRef="USD">-4758000</us-gaap:GainLossRelatedToLitigationSettlement>
    <GCTK:FinanceExpenseIncomeNet
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000212"
      unitRef="USD">-583000</GCTK:FinanceExpenseIncomeNet>
    <GCTK:FinanceExpenseIncomeNet
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000213"
      unitRef="USD">7000</GCTK:FinanceExpenseIncomeNet>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000215"
      unitRef="USD">-22597000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000216"
      unitRef="USD">-7097000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000221"
      unitRef="USD">24000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000222"
      unitRef="USD">-1000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000224"
      unitRef="USD">-22573000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000225"
      unitRef="USD">-7098000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000227"
      unitRef="USDPShares">68.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000229"
      unitRef="USDPShares">68.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000231"
      unitRef="USDPShares">34.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000233"
      unitRef="USDPShares">34.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000235"
      unitRef="Shares">330171</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000237"
      unitRef="Shares">330171</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000239"
      unitRef="Shares">207603</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000241"
      unitRef="Shares">207603</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000250"
      unitRef="Shares">154999</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000244"
      unitRef="USD">103110000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000245"
      unitRef="USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000246"
      unitRef="USD">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000247"
      unitRef="USD">-101901000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000248"
      unitRef="USD">1230000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000256"
      unitRef="USD">-7097000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000257"
      unitRef="USD">-7097000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000262"
      unitRef="USD">-1000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000264"
      unitRef="USD">-1000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <GCTK:StockIssuedDuringPeriodSharesUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000273"
      unitRef="Shares">53765</GCTK:StockIssuedDuringPeriodSharesUnderwrittenPublicOffering>
    <GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">8730000</GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering>
    <GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000271"
      unitRef="USD">8730000</GCTK:StockIssuedDuringPeriodValueUnderwrittenPublicOffering>
    <GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000276"
      unitRef="USD">855000</GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted>
    <GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000279"
      unitRef="USD">-855000</GCTK:AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000283"
      unitRef="USD">281000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000287"
      unitRef="USD">281000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000296"
      unitRef="Shares">150</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000290"
      unitRef="USD">10000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2023-01-012023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000291"
      unitRef="USD">44000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">54000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000305"
      unitRef="Shares">208914</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000299"
      unitRef="USD">112986000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000300"
      unitRef="USD">48000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000301"
      unitRef="USD">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000302"
      unitRef="USD">-109853000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000303"
      unitRef="USD">3197000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000314"
      unitRef="Shares">208914</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000308"
      unitRef="USD">112986000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000309"
      unitRef="USD">48000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000310"
      unitRef="USD">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000311"
      unitRef="USD">-109853000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000312"
      unitRef="USD">3197000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000320"
      unitRef="USD">-22597000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000321"
      unitRef="USD">-22597000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2024-01-012024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000326"
      unitRef="USD">-24000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000328"
      unitRef="USD">-24000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000331"
      unitRef="USD">173000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000335"
      unitRef="USD">173000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000344"
      unitRef="Shares">4343</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000338"
      unitRef="USD">126000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000339"
      unitRef="USD">-48000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000342"
      unitRef="USD">78000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000348"
      unitRef="USD">228000</GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross>
    <GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000351"
      unitRef="USD">228000</GCTK:StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross>
    <GCTK:StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000360"
      unitRef="Shares">2500</GCTK:StockIssuedDuringPeriodSharesRestrictedStockPaymentForAchievementOfMilestone>
    <GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000354"
      unitRef="USD">192000</GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone>
    <GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000358"
      unitRef="USD">192000</GCTK:StockIssuedDuringPeriodValueRestrictedStockPaymentForAchievementOfMilestone>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000369"
      unitRef="Shares">3968</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000363"
      unitRef="USD">500000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000367"
      unitRef="USD">500000</us-gaap:StockIssuedDuringPeriodValueOther>
    <GCTK:StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000378"
      unitRef="USD">19765</GCTK:StockIssuedDuringPeriodSharesExerciseofPrefundedWarrantsIntoShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000387"
      unitRef="Shares">121867</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <GCTK:StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000396"
      unitRef="Shares">237845</GCTK:StockIssuedDuringPeriodSharesDetachableWarrantsThroughPrivatePlacementTransactions>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000405"
      unitRef="Shares">35932</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000398"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000399"
      unitRef="USD">-1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <GCTK:StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000414"
      unitRef="Shares">156475</GCTK:StockIssuedDuringPeriodSharesSettlementOfFinancialLiabilities>
    <GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000408"
      unitRef="USD">2618000</GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities>
    <GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000412"
      unitRef="USD">2618000</GCTK:StockIssuedDuringPeriodValueSettlementOfFinancialLiabilities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000417"
      unitRef="USD">2635000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000421"
      unitRef="USD">2635000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000430"
      unitRef="Shares">791609</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000423"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000424"
      unitRef="USD">119229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000425"
      unitRef="USD">228000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000426"
      unitRef="USD">-8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000427"
      unitRef="USD">-132450000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000428"
      unitRef="USD">-13000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000439"
      unitRef="Shares">791609</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000432"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000433"
      unitRef="USD">119229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_ReceiptsOnAccountOfSharesMember"
      decimals="-3"
      id="Fact000434"
      unitRef="USD">228000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000435"
      unitRef="USD">-8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000436"
      unitRef="USD">-132450000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000437"
      unitRef="USD">-13000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000445"
      unitRef="USD">-22597000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000446"
      unitRef="USD">-7097000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000451"
      unitRef="USD">36000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000452"
      unitRef="USD">13000</us-gaap:Depreciation>
    <GCTK:EquityIssuanceCosts
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000454"
      unitRef="USD">1217000</GCTK:EquityIssuanceCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000457"
      unitRef="USD">173000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000458"
      unitRef="USD">281000</us-gaap:ShareBasedCompensation>
    <GCTK:IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000460"
      unitRef="USD">306000</GCTK:IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors>
    <GCTK:IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000461"
      unitRef="USD">54000</GCTK:IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000463"
      unitRef="USD">192000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000466"
      unitRef="USD">-4758000</us-gaap:GainLossRelatedToLitigationSettlement>
    <GCTK:GainLossOnEquityIssuance
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000469"
      unitRef="USD">-1925000</GCTK:GainLossOnEquityIssuance>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000472"
      unitRef="USD">-798000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000475"
      unitRef="USD">628000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <GCTK:LinkageDifferenceOnPrincipalOfLoansFromStockholders
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000478"
      unitRef="USD">7000</GCTK:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <GCTK:LinkageDifferenceOnPrincipalOfLoansFromStockholders
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000479"
      unitRef="USD">1000</GCTK:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000484"
      unitRef="USD">-225000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000485"
      unitRef="USD">309000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000487"
      unitRef="USD">263000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000488"
      unitRef="USD">167000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000490"
      unitRef="USD">-421000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000491"
      unitRef="USD">332000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000493"
      unitRef="USD">-12490000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000494"
      unitRef="USD">-6558000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000499"
      unitRef="USD">104000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000502"
      unitRef="USD">-104000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000508"
      unitRef="USD">100000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <GCTK:NetProceedsReceivedFromUnderwrittenPublicOffering
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000511"
      unitRef="USD">8783000</GCTK:NetProceedsReceivedFromUnderwrittenPublicOffering>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000514"
      unitRef="USD">4000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000517"
      unitRef="USD">360000</us-gaap:ProceedsFromConvertibleDebt>
    <GCTK:ProceedsReceivedFromUnderwrittenPublicOffering
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000520"
      unitRef="USD">500000</GCTK:ProceedsReceivedFromUnderwrittenPublicOffering>
    <GCTK:ProceedsReceivedFromUnderwrittenPublicOffering
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000521"
      unitRef="USD">8730000</GCTK:ProceedsReceivedFromUnderwrittenPublicOffering>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000523"
      unitRef="USD">13743000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000524"
      unitRef="USD">8730000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000526"
      unitRef="USD">-24000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000527"
      unitRef="USD">-1000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000529"
      unitRef="USD">1125000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000530"
      unitRef="USD">2171000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000532"
      unitRef="USD">4502000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000533"
      unitRef="USD">2331000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000535"
      unitRef="USD">5627000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000536"
      unitRef="USD">4502000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000544"
      unitRef="USD">62000</us-gaap:InterestPaidNet>
    <GCTK:DeemedDividendUponTriggerOfDownRoundProtection
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000551"
      unitRef="USD">855000</GCTK:DeemedDividendUponTriggerOfDownRoundProtection>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000553"
      unitRef="USD">79000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <GCTK:SettlementOfLiabilitiesWithEquity
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000556"
      unitRef="USD">1743000</GCTK:SettlementOfLiabilitiesWithEquity>
    <GCTK:NonCashDerivativeLiability
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000559"
      unitRef="USD">35000</GCTK:NonCashDerivativeLiability>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000562"
      unitRef="USD">2284000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000565">&lt;p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z0lfR6pHfO5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; &lt;span id="xdx_822_zKts6pKaDwxb"&gt;GENERAL&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company was incorporated on May 18, 2010 under the laws of the State of Delaware. The Company is currently developing an implantable
CBGM, the Glucotrack CBGM, for persons with Type 1 diabetes and insulin-dependent Type 2 diabetes.&lt;/span&gt;&lt;/p&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Glucotrack CBGM is being developed for use by Type 1 diabetes patients as
                                            well as insulin-dependent Type 2 patients. Implant longevity is key to the success of such
                                            a device. The Company has continued to evolve its sensor chemistry following the successful
                                            in-vitro feasibility study demonstrating that a minimum two-year implant life is highly probable
                                            with the current sensor design. Recently the Company announced that a 3-year longevity is
                                            feasible leveraging both in-vitro and in-silico test results. The Company has also completed
                                            multiple animal studies with initial prototype systems which demonstrated a simple implant
                                            procedure with good safety and functionality. The results of both were presented in poster
                                            form at the 2024 American Diabetes Association annual conference.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further
to the above progress on the Glucotrack CBGM, the Company has also successfully demonstrated continuous glucose sensing in the epidural
space. This latter approach is of importance for patients with diabetes already contemplating spinal cord stimulation therapy for their
condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
regulatory submission has been made for a first in human study outside of the United States. This will be an acute study intended to
demonstrate device performance and safety. All preparatory clinical activities and applicable regulatory approvals are complete. In parallel,
the Company is also preparing for a long-term clinical trial outside the United States that is expected to begin in the second quarter
of 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The
Company believes its technology, if successful, has the potential to be more accurate, more convenient and have a longer duration than
other implantable glucose monitors that are either in the market or currently under development.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liquidity
    and capital resources&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
                                            date, the Company has not yet commercialized the Glucotrack CBGM Product. Further development
                                            and commercialization efforts are expected to require substantial additional expenditure.
                                            Therefore, the Company is dependent upon external sources for financing its operations. As
                                            of December 31, 2024, the Company has incurred an accumulated deficit of $&lt;span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20241231_zGL5wqlPBts4" title="Accumulated deficit"&gt;132,450&lt;/span&gt;. In addition,
                                            the Company has generated operating losses and negative cash flow from operations since inception.
                                            As of December 31, 2024, the balance of cash and cash equivalents amounted to $&lt;span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20241231_z7xelKLAfS54" title="Cash and cash equivalents"&gt;5,617&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
    the year ended December 31, 2024, the Company raised approximately $&lt;span id="xdx_903_ecustom--ProceedsFromPublicOfferingsAndDebtIssuances_pn6n6_c20240101__20241231_zkKyt77U0Hz5" title="Proceeds from public offerings and debt issuances"&gt;15&lt;/span&gt; million through public offerings and debt issuances which
    were subsequently converted to equity. In addition, subsequent to the balance sheet date, the Company raised $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20250101__20250328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zE8QizcG9CTf" title="Proceeds from sale of common stock"&gt;6.3&lt;/span&gt; million through the
    sale of shares of Common Stock. See Note 4 and 14. The Company plans to finance its operations through the sale of equity
    securities (and/or debt securities). There can be no assurance that the Company will succeed in obtaining the necessary financing
    or generating sufficient revenue from sale of its Glucotrack CBGM Product in order to continue its operations as a going concern.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
    has considered the significance of such conditions in relation to the Company&#x2019;s ability to meet its current obligations and
    to achieve its business targets and determined that these conditions raise substantial doubt about the Company&#x2019;s ability to
    continue as a going concern.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000567"
      unitRef="USD">-132450000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000569"
      unitRef="USD">5617000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <GCTK:ProceedsFromPublicOfferingsAndDebtIssuances
      contextRef="From2024-01-01to2024-12-31"
      decimals="-6"
      id="Fact000571"
      unitRef="USD">15000000</GCTK:ProceedsFromPublicOfferingsAndDebtIssuances>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-01-012025-03-28_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact000573"
      unitRef="USD">6300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000575">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zpPV7MwXNhhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 - &lt;span id="xdx_823_zBoHat5hP5yc"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America
(US GAAP).&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--UseOfEstimates_zjDx5ZhV6Yt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zEznVgam0Iz4"&gt;Use
    of estimates in the preparation of financial statements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions
    that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of
    the financial statements, and the reported amounts of expenses during the reported periods. Actual results could differ from those
    estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to evaluation of going
    concern, the classification of financial instruments as equity or liability, share based compensation and the determination of the fair value of derivative
    liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_84D_ecustom--FunctionalCurrencyPolicyTextBlock_zcMGwwBuz3Z3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zsfOrdVScWMf"&gt;Functional
    currency&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    functional currency of the Company is the US dollar, which is the currency of the primary economic environment in which it operates.
    In accordance with ASC 830, &#x201c;Foreign Currency Matters&#x201d; (ASC 830), balances denominated in or linked to foreign currency
    are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions
    included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses
    arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.
    The functional currency of the Israeli subsidiary is the New Israeli Shekel (&#x201c;NIS&#x201d;) and its financial statements are
    included in consolidation, based on translation into US dollars. Accordingly, assets and liabilities were translated from NIS to
    US dollars using year-end exchange rates, and expense items were translated at average exchange rates during the year. Gains or losses
    resulting from translation adjustments are reflected in stockholders&#x2019; equity, under &#x201c;accumulated other comprehensive
    income&#x201d;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_899_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zZ9rfSF7hGXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zTTl2xrLE2B8" style="display: none"&gt;SCHEDULE OF OFFICIAL EXCHANGE RATE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Official exchange rate of NIS
    1 to US dollar&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20241231_z3HXiJacJyz9" title="Official exchange rate of NIS 1 to US dollar"&gt;0.274&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231_zvIwJW1INYW9" title="Official exchange rate of NIS 1 to US dollar"&gt;0.272&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase (Decrease) of the official exchange
    rate of NIS 1 to US dollar during the year:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20241231_z2itxYshtO72" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:"&gt;0.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_di_uPure_c20231231_z76cwanQoTr2" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:"&gt;(8.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zoMrBAn5EBze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zid9BrgUl8zf" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;C.
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_ze3PW2OpjFOe"&gt;Principles
    of consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
    have been eliminated in consolidation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zvmJcRej0eh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zTEQrxYW2h43"&gt;Cash
    and cash equivalents and restricted cash&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company considers all short-term investments, which are highly liquid investments with original
                                            maturities of three months or less at the date of purchase, to be cash equivalents.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    cash is invested in certificates of deposit, which are used to secure Integrity Israel&#x2019;s obligations in respect of its credit
    card.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    presentation of statement of cash flows purposes, restricted cash balances are included with cash and cash equivalents, when reconciling
    the reported period total amounts.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company&#x2019;s cash is held with financial institutions in the United States and Israel. Management believes that the financial
    institutions that hold the Company&#x2019;s cash are financially sound and, accordingly, minimal credit risk exists with respect to
    these investments. Account balances held in the Unites States may, at times, exceed the Federal Deposit Insurance Corporation (FDIC)
    insurance limit. As of December 31, 2024 and 2023, the Company had $&lt;span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20241231_zEPeadpMAweg" title="FDIC insurance limit"&gt;4,968&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20231231_zvIRQSvWJPFf" title="FDIC insurance limit"&gt;3,942&lt;/span&gt;, respectively, in excess of the FDIC insurance
    limit.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_898_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zouO1GTW9Lbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zJV2l25V0qPi" style="display: none"&gt;SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231_z3WoxWo2yNN3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zfkg4c0VGFR9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzao3_z4E5ARni6Iuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,617&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,492&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RestrictedCash_iI_pn3n3_maCCERCzao3_zOrcs6hmU6U4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzao3_zvgHrUD5n5v" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total cash, cash equivalents,
    and restricted cash shown in the statement of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,502&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zTJK59TQNx7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWgRKuvXVJP8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zpuB5HHvNqCk"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
    and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over
    the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated
    depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected
    in the statements of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rates
    of depreciation:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_89B_ecustom--ScheduleOfPropertyRatesOfDepreciationTableTextBlock_zw0g56Tqghwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zFW86EHUW8dj" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 16%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zVRpfYDp41N7" title="Property and equipment rates of depreciation"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zOYuSeCsE90d" title="Property and equipment rates of depreciation"&gt;7&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaKkwjrOhRdg" title="Property and equipment rates of depreciation"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zTJTnyrhRK9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zOIbb9kzGgK1" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_ziWv8giK7N0f"&gt;Impairment
    of long-lived assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Group&#x2019;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d;,
    whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
    of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows
    expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by
    the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment
    losses related to long lived assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_84D_ecustom--ModificationOfEquityClassifiedContractsPolicyTextBlock_ziZE3MIk5rr" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_z56evVdHSr88"&gt;Modification
    of equity-classified contracts&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    modification or exchange of equity-classified contracts, such as warrants that were classified as equity before the modification or
    exchange and remained eligible for equity classification after the modification, was accounted for in a similar manner to a
    modification of stock-based compensation. Accordingly, the incremental fair value from the modification or exchange (the change in
    the fair value of the instrument before and after the modification or exchange), due to the characteristics of the modification, was recognized as a reduction of retained earnings (or an increase of
    accumulated deficit) as a deemed dividend. Modifications or exchanges that result in a decrease in the fair value of an
    equity-classified share-based payment awards are not recognized. In addition, the amount of the deemed dividend is also recognized
    as an adjustment to earnings available to common shareholders for purposes of calculating earnings per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_84A_ecustom--ConvertiblePromissoryNotesPolicyTextBlock_zrN5WIV4goI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;H.
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zPLmBcF6oOKe"&gt;Convertible
    Promissory Notes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
    initial recognition of convertible promissory notes and similar instruments, the Company considers the provisions of ASC 815-40,
    &#x201c;Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASC 815-40&#x201d;) in order to determine whether
    the conversion features embedded within the convertible instrument should be separated from the host instrument.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
                                            it is determined that an embedded derivative required to be bifurcated (such as embedded
                                            conversion feature that does not qualify for equity classification), the Company recognizes
                                            the embedded derivative bifurcated as a separate derivative liability upon initial recognition
                                            and on subsequent periods at fair value. The remaining consideration amount received or allocated
                                            to the entire convertible instrument is allocated to the host debt instrument. The difference
                                            between the face value of the host and the allocated amount represents a discount which is
                                            amortized as finance expense to profit or loss using the effective interest method over the
                                            term of the note until its stated maturity.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
    it is determined that the embedded conversion feature qualifies for equity classification (such when the embedded conversion option,
    if it were freestanding, is not qualified as a derivative in accordance with the provisions of ASC 815-10, &#x201c;Derivatives and
    Hedging&#x201d; since its terms did not require or permit net settlement or when the embedded conversion option is indexed to the
    entity&#x2019;s own stock), the conversion option is not bifurcated. When bifurcation is not required, the Company considers whether
    the debt instrument involves a significant premium (i.e. when the proceeds received or allocated upon issuance exceed the principal
    amount that will be paid at maturity). When it is determined that a substantial premium exists, the entire premium is allocated to
    paid-in capital and when it is determined, otherwise no additional accounting is required and the convertible promissory note is
    accounted for at amortized cost using the effective interest method over the term of the note until its stated maturity.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_847_ecustom--AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_z5sd7NFjOR4a" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zx0GcQuIiITa"&gt;Allocation
    of proceeds and related issuance costs&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
                                            multiple instruments are issued in a single transaction (package issuance), the total gross
                                            proceeds from the transaction are allocated among the individual freestanding instruments
                                            identified. The allocation occurs after identifying all freestanding instruments and the
                                            subsequent measurement basis for those instruments.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    instruments that are required to be subsequently measured at fair value (such as derivative liabilities) are measured at fair value
    and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at
    fair value (such as liabilities measured at amortized cost, common shares and warrants eligible for equity classification), based
    on the relative fair value basis for such instruments.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issuance
    costs allocated to financial instruments that are required to be subsequently measured at fair value are immediately expensed.
    Issuance costs allocated to shares and warrants classified as equity components and are recorded as a reduction of additional
    paid-in capital. Issuance costs allocated to financial liabilities measured at amortized cost are recorded as a discount and
    accreted over the contractual term of the financial instrument using the effective interest method.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_840_eus-gaap--DerivativesPolicyTextBlock_zzaf9EzAzAJ8" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zwRtdmypMikh"&gt;Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Equity
                                            classified warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
    warrants that were determined to be freestanding financial instruments that are legally detachable and separately exercisable, do
    not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary
    Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company&#x2019;s own shares, were classified
    as equity instruments. As such warrants were issued together with financial instruments that are not subsequently measured at fair
    value, the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair
    value basis. Direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants
                                            classified as derivative liabilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
    initial recognition of Series A Warrants and Series B Warrants that were issued in November 2024 as part of an equity issuance and
    debt conversions, management considered the provisions of ASC 815-40, Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s
    Own Equity and determined that the settlement amount of Series A Warrants and Series B Warrants might not be based on an exchange
    of a fixed number of shares for a fixed amount of consideration and thus such Warrants are not eligible to be considered as indexed
    to the Company&#x2019;s own shares. Accordingly, the Series A Warrants and Series B Warrants were accounted for as warrant derivative
    liability at fair value and the changes in fair values are carried to profit or loss. In accordance with ASC 210-10-20, the warrant
    derivative liability is presented as a noncurrent liability since its settlement will require the issuance of shares and not the
    use of any resources that are properly classified as current assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_840_eus-gaap--LesseeLeasesPolicyTextBlock_zAFnE1nB1bz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zSqGXDVPbGRf"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company applies ASC Topic 842, &#x201c;Leases&#x201d; (&#x201c;ASC 842&#x201d;) under which the
                                            Company determines if an arrangement is a lease at inception.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leases
    are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following
    criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option
    to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful
    life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset,
    or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end
    of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company&#x2019;s
    lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be
    classified as operating leases.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right
    of Use (&#x201c;ROU&#x201d;) assets and liabilities are recognized on the commencement date based on the present value of remaining
    lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the
    time of commencement. As most of the Company&#x2019;s leases do not provide an implicit rate, the Company uses its Incremental Borrowing
    Rate (&#x201c;IBR&#x201d;) based on the information available on the commencement date in determining the present value of lease payments.
    The Company&#x2019;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
    and in economic environments where the leased asset is located. The ROU asset also includes any lease payments made prior to commencement
    and is recorded net of any lease incentives received. Moreover, the ROU asset may also include initial direct costs, which are incremental
    costs of a lease that would not have been incurred if the lease had not been obtained. The Company uses the long-lived assets impairment
    guidance in ASC 360-10, &#x201c;Property, Plant, and Equipment - Overall&#x201d;, to determine whether a ROU asset is impaired, and
    if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option
    to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain
    that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company
    will not exercise the option.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8Ckl0y83uBd" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_znRym6lSYEtf"&gt;Income
    tax&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. Accordingly, deferred income taxes are
    determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial
    accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the
    enacted tax rates expected to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets
    are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial
    statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise&#x2019;s financial statements.
    According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#x2019;s accounting
    policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not
    recognize such items in its fiscal 2024 and 2023 financial statements and did not recognize any liability with respect to unrecognized
    tax position in its balance sheet.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zaqMHPXIf17k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zKvC4MV0qI9f"&gt;Research
    and development expenses&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
    and development expenses are charged to operations and comprehensive loss, as incurred.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_846_ecustom--RoyaltyBearingGrantsPolicyTextBlock_z8mdfwVJt0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;N.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zWOO3CIF9uye"&gt;Royalty-bearing
    grants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Royalty-bearing
    grants from the Israeli Innovation Authority (IIA) to fund approved research and development projects are recognized at the time
    Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs. To date,
    the cumulative research and development grants received by Integrity Israel from IIA amounted to $&lt;span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zxQ1tqmmUSfh" title="Cumulative research and development"&gt;93&lt;/span&gt;. See also Note 5A below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_z9o48b788pJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;O.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zHt8cvBHACei"&gt;Basic
    and diluted loss per share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share for the year ended December 31, 2024 is computed by dividing the loss for the period applicable for Common Stockholders
and the holders of the pre-funded warrants divided by the weighted average number of shares of Common Stock outstanding and shares of
Common Stock to be issued upon the exercise of prefunded warrants during the period. Basic loss per share for December 31, 2023 is computed
by dividing the loss for the period applicable (after considering the effect of deemed dividend related to trigger of down round protection
feature) for Common Stockholders and the holders of the pre-funded warrants divided by the weighted average number of shares of Common
Stock outstanding and shares of Common Stock to be issued upon achievement of first performance milestone &lt;span style="background-color: white"&gt;(see
Note &lt;/span&gt;5B &lt;span style="background-color: white"&gt;below) and upon &lt;/span&gt;exercise of pre-funded warrants (see Note 8B below) during
the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
computing, diluted loss per share, basic earnings per share are adjusted to reflect the potential dilution that could occur upon the
exercise of options or warrants issued or granted using the &#x201c;treasury stock method&#x201d;, and using the if-converted method for
other financial instruments such as convertible liabilities and other share settled derivative liabilities, if the effect of each of
such financial instruments is dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
computing diluted loss per share, the average stock price for the period is used in determining the number of Common Stock assumed to
be purchased from the proceeds to be received from the exercise of stock options or stock warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares
that will be issued upon exercise of all stock options and stock warrants, have been excluded from the calculation of the diluted net
loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result
of the exercise or conversion of these instruments was anti-dilutive&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zBj6J9PKDyHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zcK24H5JdCR2" style="display: none"&gt;SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240101__20241231_z6Ym4uflSN3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230101__20231231_z5zzqKUWHrA7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In thousands
    of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(except
    share data)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_iN_pn3n3_di_maNILATzfsR_zmwax6xVGU0l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,097&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_iN_pn3n3_di_maNILATzfsR_zpbcLJeGQ6R8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deemed
    dividend related to trigger of down round protection feature (see Note 8C3 below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0647"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iNT_pn3n3_di_mtNILATzfsR_z3nyCkEPqS75" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss attributable
    to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,952&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares of Common Stock
    used in computing basic and diluted net loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zUwaJqH5hLqc" title="Shares of Common Stock used in computing basic net loss per common stock"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj6bGPKWH3na" title="Ordinary shares used in computing diluted net loss per common stock"&gt;330,171&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQoV8c1SBjS1" title="Shares of Common Stock used in computing basic net loss per common stock"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_ztuK22onwYV6" title="Ordinary shares used in computing diluted net loss per common stock"&gt;193,131&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares of Common Stock
    to be issued upon exercise of pre-funded warrants (see Note 8B1 below)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zXDAwwEkUIN2" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zskmRws7TrWj" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0661"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zX4Xg66JJtuk" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zjBrCIsx5YDh" title="Ordinary shares used in computing diluted net loss per common stock"&gt;13,971&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares
    of Common Stock to be issued upon achievement of first performance milestone (see Note 5B below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_z4WPaA8G3I53" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zS2qa5cwJH8b" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0669"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0671"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zbbEBgBnhxD7" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zXNs6HF7bgu" title="Ordinary shares used in computing diluted net loss per common stock"&gt;501&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zKqCY5joreQ7" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zxOBS8n14FZ" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"&gt;330,171&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zmHxTTLjbWWc" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zpCU3cJC3yI7" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"&gt;207,603&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net loss
    per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zeDTjIp7toZ1" title="Basic net loss per common stock"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zOWA1Kng7Vz7" title="Diluted net loss per common stock"&gt;68.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zwlwpLprfKLb" title="Basic net loss per common stock"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_z4hc6XluP3Na" title="Diluted net loss per common stock"&gt;34.18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zG6bWZc6ZMle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;See
Note 14 regarding a significant issuance of shares as part of the exercise of the Series B Warrants subsequent to the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLF7bBtd6dQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;P.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zbIkTHzb4Xl4"&gt;Stock-based
    compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair
    values in accordance with ASC 718, &#x201c;Compensation-Stock Compensation&#x201d;. Share-based payments including grants of stock
    options are recognized in the consolidated statement of operations and comprehensive loss as an operating expense based on the fair
    value of the award at the date of grant. The fair value of stock options granted is estimated using the Black-Scholes option-pricing
    model. The Company has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the
    requisite service period or over the implicit service period when a performance condition affects the vesting, and it is considered
    probable that the performance condition will be achieved. Share-based payments to non-employees are accounted for in accordance with
    ASC 718.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zw3K0lUr9aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zUIeoiC4EIgl"&gt;Fair
    value of financial instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
    Topic 825-10, &#x201c;Financial Instruments&#x201d; defines financial instruments and requires disclosure of the fair value of financial
    instruments held by the Company. The Company considers the carrying amount of cash and cash equivalents, restricted cash, accounts
    receivable, other current assets, accounts payable and other current liabilities balances, to approximate their fair values due to
    the short-term maturities of such financial instruments. ASC Topic 825-10, establishes the following fair value hierarchy, which
    prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair
    value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2 - Observable prices that are based on inputs not quoted on active markets but corroborated by market data.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3 - Unobservable inputs are used when little or no market data is available. Level 3 inputs are considered as the lowest priority
    under the fair value hierarchy.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    fair value of the financial instruments included in the working capital of the Company (cash and cash equivalents, accounts payable
    and other current assets and liabilities) approximates their carrying value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company did not estimate the fair value of the loans received from stockholders since their repayment schedule has not yet been determined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjxuB5pAO6r8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no Level 3 assets or liabilities for the year ended December 31, 2023. The following table presents changes in Level 3 assets and
liabilities measured at fair value for the year ended December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_z5O5I8YYPGZi" style="display: none"&gt;SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20241114__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGGSdi8tCfHi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zYHWiGgSwBAc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance &#x2013; November 14, 2024
    &#x2013; Warrant issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FairValueAdjustmentOfWarrants_z7jXuJroSoDi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value adjustments &#x2013; Derivative financial liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;795&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_z7DlHWtDQvw4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_za73EkdSN8C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zFilp6g8Nc6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the Company&#x2019;s assets and liabilities which are measured at fair value on a recurring basis by level
within the fair value hierarchy:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zGEafnPJxhX3" style="display: none"&gt;SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    Value Measurements as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    I&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    II&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    III&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant derivative
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWoUjctiPq35" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8XKvtuCOA69" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsrWFm7aZ6Qg" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_zfoypcLOJi29" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z5lTH7oIToS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zzdcZwraGoa8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;R.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zNHFGJM5Nsc4"&gt;Segment
    reporting&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
    segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation
    by the chief operating decision maker, or (&#x201c;CODM&#x201d;). The Company has identified its Chief Executive Officer, Paul V. Goode, as the CODM who is responsible for making decisions regarding resource allocation and assessing performance. The Company views
    its operations and manages its business as one operating segment. The Company&#x2019;s long-lived assets consist primarily of property
    and equipment, net, which are all held in the United States.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z2FGCZ6IAGlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;S.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_z1EHr4i96mI3"&gt;Concentrations
    of credit risk&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents,
    and restricted cash. Cash and cash equivalents and restricted cash are deposited with a major bank in the United States. Management
    believes that such financial institutions are financially sound, accordingly, minimal credit risk exists with respect to these financial
    instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts,
    option contracts or other foreign hedging arrangements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_841_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zAlGHH2E7KW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;T.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_z5Yi9ZOFIsFf"&gt;Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
    has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
    information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_847_ecustom--WarrantsWithDownRoundProtectionPolicyTextBlock_zn4f45ay0S6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zqEHhM9QsPOi"&gt;Warrants
    with down-round protection&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company disregards the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining
    liability or equity classification in accordance with the provisions of ASU 2017-11, &#x201c;Earnings Per Share&#x201d; (ASU 2017-11).
    Based on its evaluation, management has determined that such warrants with down-round protection feature are eligible for equity
    classification.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordantly,
upon the occurrence of an event that triggers a down round protection feature (i.e., when the exercise price of the warrants is adjusted
downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available
to common shareholders for purposes of basic earnings per share calculation. See also Note 2P above.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ziEK3LmjD6qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;V.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zqfiCRG2Y698"&gt;Recently
    adopted accounting pronouncements&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU
    2023-07&#x201d;). This standard requires a public entity to disclose significant segment expenses and other segment items on an interim
    and annual basis. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker.
    ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after
    December 15, 2024, with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all
    prior periods presented in the financial statements. The Company adopted ASU 2023-07 for the fiscal year ended December 31, 2024
    and interim financial statements thereafter, on a retrospective basis for all prior periods presented in the financial statements.
    The adoption of ASU 2023-07 did not change the way that the Company identifies its reportable segments and, as a result, did not
    have a material impact on the Company&#x2019;s financial position or results of operations. See (Note 13) - Segment Reporting for
    further information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_846_ecustom--NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_zHjYSoLTljei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;W.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zXFMCpsDTK0f"&gt;Recently
    issued accounting pronouncements, not yet adopted&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation
    Disclosures&#x201d; to require more detailed information about specified categories of expenses (purchases of inventory, employee
    compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the income
    statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and for interim periods within fiscal years
    beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial
    statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented
    in the financial statements. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial
    statements and related disclosures. The adoption of this pronouncement is not expected to have a material impact on the Company&#x2019;s
    consolidated financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures related to improvements
    to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for
    the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning
    after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_85A_zh2CGAkErrJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-01-01to2024-12-31" id="Fact000577">&lt;p id="xdx_84E_eus-gaap--UseOfEstimates_zjDx5ZhV6Yt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zEznVgam0Iz4"&gt;Use
    of estimates in the preparation of financial statements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions
    that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of
    the financial statements, and the reported amounts of expenses during the reported periods. Actual results could differ from those
    estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to evaluation of going
    concern, the classification of financial instruments as equity or liability, share based compensation and the determination of the fair value of derivative
    liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:UseOfEstimates>
    <GCTK:FunctionalCurrencyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000579">&lt;p id="xdx_84D_ecustom--FunctionalCurrencyPolicyTextBlock_zcMGwwBuz3Z3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zsfOrdVScWMf"&gt;Functional
    currency&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    functional currency of the Company is the US dollar, which is the currency of the primary economic environment in which it operates.
    In accordance with ASC 830, &#x201c;Foreign Currency Matters&#x201d; (ASC 830), balances denominated in or linked to foreign currency
    are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions
    included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses
    arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.
    The functional currency of the Israeli subsidiary is the New Israeli Shekel (&#x201c;NIS&#x201d;) and its financial statements are
    included in consolidation, based on translation into US dollars. Accordingly, assets and liabilities were translated from NIS to
    US dollars using year-end exchange rates, and expense items were translated at average exchange rates during the year. Gains or losses
    resulting from translation adjustments are reflected in stockholders&#x2019; equity, under &#x201c;accumulated other comprehensive
    income&#x201d;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_899_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zZ9rfSF7hGXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zTTl2xrLE2B8" style="display: none"&gt;SCHEDULE OF OFFICIAL EXCHANGE RATE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Official exchange rate of NIS
    1 to US dollar&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20241231_z3HXiJacJyz9" title="Official exchange rate of NIS 1 to US dollar"&gt;0.274&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231_zvIwJW1INYW9" title="Official exchange rate of NIS 1 to US dollar"&gt;0.272&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase (Decrease) of the official exchange
    rate of NIS 1 to US dollar during the year:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20241231_z2itxYshtO72" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:"&gt;0.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_di_uPure_c20231231_z76cwanQoTr2" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:"&gt;(8.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zoMrBAn5EBze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GCTK:FunctionalCurrencyPolicyTextBlock>
    <us-gaap:ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000581">&lt;p id="xdx_899_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zZ9rfSF7hGXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zTTl2xrLE2B8" style="display: none"&gt;SCHEDULE OF OFFICIAL EXCHANGE RATE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Official exchange rate of NIS
    1 to US dollar&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20241231_z3HXiJacJyz9" title="Official exchange rate of NIS 1 to US dollar"&gt;0.274&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231_zvIwJW1INYW9" title="Official exchange rate of NIS 1 to US dollar"&gt;0.272&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase (Decrease) of the official exchange
    rate of NIS 1 to US dollar during the year:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20241231_z2itxYshtO72" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:"&gt;0.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_di_uPure_c20231231_z76cwanQoTr2" title="Increase (Decrease) of the official exchange rate of NIS 1 to US dollar during the year:"&gt;(8.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock>
    <us-gaap:ForeignCurrencyExchangeRateRemeasurement1
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000583"
      unitRef="Pure">0.274</us-gaap:ForeignCurrencyExchangeRateRemeasurement1>
    <us-gaap:ForeignCurrencyExchangeRateRemeasurement1
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000585"
      unitRef="Pure">0.272</us-gaap:ForeignCurrencyExchangeRateRemeasurement1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000587"
      unitRef="Pure">0.74</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000589"
      unitRef="Pure">8.86</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000591">&lt;p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zid9BrgUl8zf" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;C.
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_ze3PW2OpjFOe"&gt;Principles
    of consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
    have been eliminated in consolidation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2024-01-01to2024-12-31" id="Fact000593">&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zvmJcRej0eh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zTEQrxYW2h43"&gt;Cash
    and cash equivalents and restricted cash&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company considers all short-term investments, which are highly liquid investments with original
                                            maturities of three months or less at the date of purchase, to be cash equivalents.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    cash is invested in certificates of deposit, which are used to secure Integrity Israel&#x2019;s obligations in respect of its credit
    card.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    presentation of statement of cash flows purposes, restricted cash balances are included with cash and cash equivalents, when reconciling
    the reported period total amounts.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company&#x2019;s cash is held with financial institutions in the United States and Israel. Management believes that the financial
    institutions that hold the Company&#x2019;s cash are financially sound and, accordingly, minimal credit risk exists with respect to
    these investments. Account balances held in the Unites States may, at times, exceed the Federal Deposit Insurance Corporation (FDIC)
    insurance limit. As of December 31, 2024 and 2023, the Company had $&lt;span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20241231_zEPeadpMAweg" title="FDIC insurance limit"&gt;4,968&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20231231_zvIRQSvWJPFf" title="FDIC insurance limit"&gt;3,942&lt;/span&gt;, respectively, in excess of the FDIC insurance
    limit.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_898_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zouO1GTW9Lbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zJV2l25V0qPi" style="display: none"&gt;SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231_z3WoxWo2yNN3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zfkg4c0VGFR9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzao3_z4E5ARni6Iuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,617&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,492&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RestrictedCash_iI_pn3n3_maCCERCzao3_zOrcs6hmU6U4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzao3_zvgHrUD5n5v" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total cash, cash equivalents,
    and restricted cash shown in the statement of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,502&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zTJK59TQNx7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000595"
      unitRef="USD">4968000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000597"
      unitRef="USD">3942000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000599">&lt;p id="xdx_898_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zouO1GTW9Lbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zJV2l25V0qPi" style="display: none"&gt;SCHEDULE OF RESTRICT CASH BALANCES ARE INCLUDED WITH CASH AND CASH EQUIVALENTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20241231_z3WoxWo2yNN3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zfkg4c0VGFR9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maCCERCzao3_z4E5ARni6Iuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,617&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,492&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RestrictedCash_iI_pn3n3_maCCERCzao3_zOrcs6hmU6U4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCERCzao3_zvgHrUD5n5v" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total cash, cash equivalents,
    and restricted cash shown in the statement of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,502&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000601"
      unitRef="USD">5617000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000602"
      unitRef="USD">4492000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000604"
      unitRef="USD">10000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000605"
      unitRef="USD">10000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000607"
      unitRef="USD">5627000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000608"
      unitRef="USD">4502000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000610">&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWgRKuvXVJP8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zpuB5HHvNqCk"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
    and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over
    the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated
    depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected
    in the statements of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rates
    of depreciation:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_89B_ecustom--ScheduleOfPropertyRatesOfDepreciationTableTextBlock_zw0g56Tqghwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zFW86EHUW8dj" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 16%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zVRpfYDp41N7" title="Property and equipment rates of depreciation"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zOYuSeCsE90d" title="Property and equipment rates of depreciation"&gt;7&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaKkwjrOhRdg" title="Property and equipment rates of depreciation"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zTJTnyrhRK9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <GCTK:ScheduleOfPropertyRatesOfDepreciationTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000612">&lt;p id="xdx_89B_ecustom--ScheduleOfPropertyRatesOfDepreciationTableTextBlock_zw0g56Tqghwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zFW86EHUW8dj" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT, RATES OF DEPRECIATION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 16%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zVRpfYDp41N7" title="Property and equipment rates of depreciation"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zOYuSeCsE90d" title="Property and equipment rates of depreciation"&gt;7&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaKkwjrOhRdg" title="Property and equipment rates of depreciation"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</GCTK:ScheduleOfPropertyRatesOfDepreciationTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_us-gaap_ComputerEquipmentMember"
      id="Fact000614">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MinimumMember"
      id="Fact000616">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-12-31_custom_FurnitureAndOfficeEquipmentMember_srt_MaximumMember"
      id="Fact000618">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000620">&lt;p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zOIbb9kzGgK1" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_ziWv8giK7N0f"&gt;Impairment
    of long-lived assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Group&#x2019;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d;,
    whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
    of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows
    expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by
    the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment
    losses related to long lived assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <GCTK:ModificationOfEquityClassifiedContractsPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000622">&lt;p id="xdx_84D_ecustom--ModificationOfEquityClassifiedContractsPolicyTextBlock_ziZE3MIk5rr" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_z56evVdHSr88"&gt;Modification
    of equity-classified contracts&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    modification or exchange of equity-classified contracts, such as warrants that were classified as equity before the modification or
    exchange and remained eligible for equity classification after the modification, was accounted for in a similar manner to a
    modification of stock-based compensation. Accordingly, the incremental fair value from the modification or exchange (the change in
    the fair value of the instrument before and after the modification or exchange), due to the characteristics of the modification, was recognized as a reduction of retained earnings (or an increase of
    accumulated deficit) as a deemed dividend. Modifications or exchanges that result in a decrease in the fair value of an
    equity-classified share-based payment awards are not recognized. In addition, the amount of the deemed dividend is also recognized
    as an adjustment to earnings available to common shareholders for purposes of calculating earnings per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</GCTK:ModificationOfEquityClassifiedContractsPolicyTextBlock>
    <GCTK:ConvertiblePromissoryNotesPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000624">&lt;p id="xdx_84A_ecustom--ConvertiblePromissoryNotesPolicyTextBlock_zrN5WIV4goI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;H.
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zPLmBcF6oOKe"&gt;Convertible
    Promissory Notes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
    initial recognition of convertible promissory notes and similar instruments, the Company considers the provisions of ASC 815-40,
    &#x201c;Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASC 815-40&#x201d;) in order to determine whether
    the conversion features embedded within the convertible instrument should be separated from the host instrument.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
                                            it is determined that an embedded derivative required to be bifurcated (such as embedded
                                            conversion feature that does not qualify for equity classification), the Company recognizes
                                            the embedded derivative bifurcated as a separate derivative liability upon initial recognition
                                            and on subsequent periods at fair value. The remaining consideration amount received or allocated
                                            to the entire convertible instrument is allocated to the host debt instrument. The difference
                                            between the face value of the host and the allocated amount represents a discount which is
                                            amortized as finance expense to profit or loss using the effective interest method over the
                                            term of the note until its stated maturity.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
    it is determined that the embedded conversion feature qualifies for equity classification (such when the embedded conversion option,
    if it were freestanding, is not qualified as a derivative in accordance with the provisions of ASC 815-10, &#x201c;Derivatives and
    Hedging&#x201d; since its terms did not require or permit net settlement or when the embedded conversion option is indexed to the
    entity&#x2019;s own stock), the conversion option is not bifurcated. When bifurcation is not required, the Company considers whether
    the debt instrument involves a significant premium (i.e. when the proceeds received or allocated upon issuance exceed the principal
    amount that will be paid at maturity). When it is determined that a substantial premium exists, the entire premium is allocated to
    paid-in capital and when it is determined, otherwise no additional accounting is required and the convertible promissory note is
    accounted for at amortized cost using the effective interest method over the term of the note until its stated maturity.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</GCTK:ConvertiblePromissoryNotesPolicyTextBlock>
    <GCTK:AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000626">&lt;p id="xdx_847_ecustom--AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_z5sd7NFjOR4a" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zx0GcQuIiITa"&gt;Allocation
    of proceeds and related issuance costs&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
                                            multiple instruments are issued in a single transaction (package issuance), the total gross
                                            proceeds from the transaction are allocated among the individual freestanding instruments
                                            identified. The allocation occurs after identifying all freestanding instruments and the
                                            subsequent measurement basis for those instruments.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    instruments that are required to be subsequently measured at fair value (such as derivative liabilities) are measured at fair value
    and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at
    fair value (such as liabilities measured at amortized cost, common shares and warrants eligible for equity classification), based
    on the relative fair value basis for such instruments.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issuance
    costs allocated to financial instruments that are required to be subsequently measured at fair value are immediately expensed.
    Issuance costs allocated to shares and warrants classified as equity components and are recorded as a reduction of additional
    paid-in capital. Issuance costs allocated to financial liabilities measured at amortized cost are recorded as a discount and
    accreted over the contractual term of the financial instrument using the effective interest method.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</GCTK:AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000628">&lt;p id="xdx_840_eus-gaap--DerivativesPolicyTextBlock_zzaf9EzAzAJ8" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zwRtdmypMikh"&gt;Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Equity
                                            classified warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
    warrants that were determined to be freestanding financial instruments that are legally detachable and separately exercisable, do
    not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary
    Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company&#x2019;s own shares, were classified
    as equity instruments. As such warrants were issued together with financial instruments that are not subsequently measured at fair
    value, the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair
    value basis. Direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants
                                            classified as derivative liabilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
    initial recognition of Series A Warrants and Series B Warrants that were issued in November 2024 as part of an equity issuance and
    debt conversions, management considered the provisions of ASC 815-40, Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s
    Own Equity and determined that the settlement amount of Series A Warrants and Series B Warrants might not be based on an exchange
    of a fixed number of shares for a fixed amount of consideration and thus such Warrants are not eligible to be considered as indexed
    to the Company&#x2019;s own shares. Accordingly, the Series A Warrants and Series B Warrants were accounted for as warrant derivative
    liability at fair value and the changes in fair values are carried to profit or loss. In accordance with ASC 210-10-20, the warrant
    derivative liability is presented as a noncurrent liability since its settlement will require the issuance of shares and not the
    use of any resources that are properly classified as current assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000630">&lt;p id="xdx_840_eus-gaap--LesseeLeasesPolicyTextBlock_zAFnE1nB1bz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zSqGXDVPbGRf"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company applies ASC Topic 842, &#x201c;Leases&#x201d; (&#x201c;ASC 842&#x201d;) under which the
                                            Company determines if an arrangement is a lease at inception.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leases
    are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following
    criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option
    to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful
    life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset,
    or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end
    of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company&#x2019;s
    lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be
    classified as operating leases.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right
    of Use (&#x201c;ROU&#x201d;) assets and liabilities are recognized on the commencement date based on the present value of remaining
    lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the
    time of commencement. As most of the Company&#x2019;s leases do not provide an implicit rate, the Company uses its Incremental Borrowing
    Rate (&#x201c;IBR&#x201d;) based on the information available on the commencement date in determining the present value of lease payments.
    The Company&#x2019;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
    and in economic environments where the leased asset is located. The ROU asset also includes any lease payments made prior to commencement
    and is recorded net of any lease incentives received. Moreover, the ROU asset may also include initial direct costs, which are incremental
    costs of a lease that would not have been incurred if the lease had not been obtained. The Company uses the long-lived assets impairment
    guidance in ASC 360-10, &#x201c;Property, Plant, and Equipment - Overall&#x201d;, to determine whether a ROU asset is impaired, and
    if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option
    to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain
    that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company
    will not exercise the option.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000632">&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8Ckl0y83uBd" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_znRym6lSYEtf"&gt;Income
    tax&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. Accordingly, deferred income taxes are
    determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial
    accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the
    enacted tax rates expected to be in effect when these differences reverse. Valuation allowances in respect of deferred tax assets
    are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial
    statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise&#x2019;s financial statements.
    According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#x2019;s accounting
    policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not
    recognize such items in its fiscal 2024 and 2023 financial statements and did not recognize any liability with respect to unrecognized
    tax position in its balance sheet.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2024-01-01to2024-12-31" id="Fact000634">&lt;p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zaqMHPXIf17k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zKvC4MV0qI9f"&gt;Research
    and development expenses&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
    and development expenses are charged to operations and comprehensive loss, as incurred.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <GCTK:RoyaltyBearingGrantsPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000636">&lt;p id="xdx_846_ecustom--RoyaltyBearingGrantsPolicyTextBlock_z8mdfwVJt0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;N.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zWOO3CIF9uye"&gt;Royalty-bearing
    grants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Royalty-bearing
    grants from the Israeli Innovation Authority (IIA) to fund approved research and development projects are recognized at the time
    Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs. To date,
    the cumulative research and development grants received by Integrity Israel from IIA amounted to $&lt;span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zxQ1tqmmUSfh" title="Cumulative research and development"&gt;93&lt;/span&gt;. See also Note 5A below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</GCTK:RoyaltyBearingGrantsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_us-gaap_IsraelTaxAuthorityMember"
      decimals="-3"
      id="Fact000638"
      unitRef="USD">93000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000640">&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_z9o48b788pJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;O.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zHt8cvBHACei"&gt;Basic
    and diluted loss per share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share for the year ended December 31, 2024 is computed by dividing the loss for the period applicable for Common Stockholders
and the holders of the pre-funded warrants divided by the weighted average number of shares of Common Stock outstanding and shares of
Common Stock to be issued upon the exercise of prefunded warrants during the period. Basic loss per share for December 31, 2023 is computed
by dividing the loss for the period applicable (after considering the effect of deemed dividend related to trigger of down round protection
feature) for Common Stockholders and the holders of the pre-funded warrants divided by the weighted average number of shares of Common
Stock outstanding and shares of Common Stock to be issued upon achievement of first performance milestone &lt;span style="background-color: white"&gt;(see
Note &lt;/span&gt;5B &lt;span style="background-color: white"&gt;below) and upon &lt;/span&gt;exercise of pre-funded warrants (see Note 8B below) during
the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
computing, diluted loss per share, basic earnings per share are adjusted to reflect the potential dilution that could occur upon the
exercise of options or warrants issued or granted using the &#x201c;treasury stock method&#x201d;, and using the if-converted method for
other financial instruments such as convertible liabilities and other share settled derivative liabilities, if the effect of each of
such financial instruments is dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
computing diluted loss per share, the average stock price for the period is used in determining the number of Common Stock assumed to
be purchased from the proceeds to be received from the exercise of stock options or stock warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares
that will be issued upon exercise of all stock options and stock warrants, have been excluded from the calculation of the diluted net
loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result
of the exercise or conversion of these instruments was anti-dilutive&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zBj6J9PKDyHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zcK24H5JdCR2" style="display: none"&gt;SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240101__20241231_z6Ym4uflSN3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230101__20231231_z5zzqKUWHrA7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In thousands
    of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(except
    share data)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_iN_pn3n3_di_maNILATzfsR_zmwax6xVGU0l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,097&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_iN_pn3n3_di_maNILATzfsR_zpbcLJeGQ6R8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deemed
    dividend related to trigger of down round protection feature (see Note 8C3 below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0647"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iNT_pn3n3_di_mtNILATzfsR_z3nyCkEPqS75" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss attributable
    to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,952&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares of Common Stock
    used in computing basic and diluted net loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zUwaJqH5hLqc" title="Shares of Common Stock used in computing basic net loss per common stock"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj6bGPKWH3na" title="Ordinary shares used in computing diluted net loss per common stock"&gt;330,171&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQoV8c1SBjS1" title="Shares of Common Stock used in computing basic net loss per common stock"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_ztuK22onwYV6" title="Ordinary shares used in computing diluted net loss per common stock"&gt;193,131&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares of Common Stock
    to be issued upon exercise of pre-funded warrants (see Note 8B1 below)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zXDAwwEkUIN2" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zskmRws7TrWj" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0661"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zX4Xg66JJtuk" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zjBrCIsx5YDh" title="Ordinary shares used in computing diluted net loss per common stock"&gt;13,971&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares
    of Common Stock to be issued upon achievement of first performance milestone (see Note 5B below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_z4WPaA8G3I53" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zS2qa5cwJH8b" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0669"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0671"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zbbEBgBnhxD7" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zXNs6HF7bgu" title="Ordinary shares used in computing diluted net loss per common stock"&gt;501&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zKqCY5joreQ7" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zxOBS8n14FZ" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"&gt;330,171&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zmHxTTLjbWWc" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zpCU3cJC3yI7" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"&gt;207,603&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net loss
    per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zeDTjIp7toZ1" title="Basic net loss per common stock"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zOWA1Kng7Vz7" title="Diluted net loss per common stock"&gt;68.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zwlwpLprfKLb" title="Basic net loss per common stock"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_z4hc6XluP3Na" title="Diluted net loss per common stock"&gt;34.18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zG6bWZc6ZMle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;See
Note 14 regarding a significant issuance of shares as part of the exercise of the Series B Warrants subsequent to the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000642">&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zBj6J9PKDyHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zcK24H5JdCR2" style="display: none"&gt;SCHEDULE OF ANTIDILUTIVE NET LOSS AND WEIGHTED AVERAGE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240101__20241231_z6Ym4uflSN3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230101__20231231_z5zzqKUWHrA7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In thousands
    of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(except
    share data)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_iN_pn3n3_di_maNILATzfsR_zmwax6xVGU0l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,097&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature_iN_pn3n3_di_maNILATzfsR_zpbcLJeGQ6R8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deemed
    dividend related to trigger of down round protection feature (see Note 8C3 below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0647"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iNT_pn3n3_di_mtNILATzfsR_z3nyCkEPqS75" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss attributable
    to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,952&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares of Common Stock
    used in computing basic and diluted net loss per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zUwaJqH5hLqc" title="Shares of Common Stock used in computing basic net loss per common stock"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj6bGPKWH3na" title="Ordinary shares used in computing diluted net loss per common stock"&gt;330,171&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQoV8c1SBjS1" title="Shares of Common Stock used in computing basic net loss per common stock"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_ztuK22onwYV6" title="Ordinary shares used in computing diluted net loss per common stock"&gt;193,131&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares of Common Stock
    to be issued upon exercise of pre-funded warrants (see Note 8B1 below)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zXDAwwEkUIN2" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zskmRws7TrWj" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0661"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zX4Xg66JJtuk" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_fKCop_zjBrCIsx5YDh" title="Ordinary shares used in computing diluted net loss per common stock"&gt;13,971&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares
    of Common Stock to be issued upon achievement of first performance milestone (see Note 5B below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_z4WPaA8G3I53" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zS2qa5cwJH8b" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0669"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0671"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zbbEBgBnhxD7" title="Ordinary shares used in computing diluted net loss per common stock"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceMilestoneMember_fKCop_zXNs6HF7bgu" title="Ordinary shares used in computing diluted net loss per common stock"&gt;501&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average number
    of Common Stock outstanding used in computing basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20241231_zKqCY5joreQ7" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20241231_zxOBS8n14FZ" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"&gt;330,171&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zmHxTTLjbWWc" title="Weighted average number of Common Stock outstanding used in computing basic net loss per share"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zpCU3cJC3yI7" title="Weighted average number of Common Stock outstanding used in computing diluted net loss per share"&gt;207,603&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net loss
    per common stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20241231_zeDTjIp7toZ1" title="Basic net loss per common stock"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20241231_zOWA1Kng7Vz7" title="Diluted net loss per common stock"&gt;68.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zwlwpLprfKLb" title="Basic net loss per common stock"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_z4hc6XluP3Na" title="Diluted net loss per common stock"&gt;34.18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000644"
      unitRef="USD">-22597000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000645"
      unitRef="USD">-7097000</us-gaap:NetIncomeLoss>
    <GCTK:DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000648"
      unitRef="USD">-855000</GCTK:DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000650"
      unitRef="USD">-22597000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000651"
      unitRef="USD">-7952000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000653"
      unitRef="Shares">330171</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000655"
      unitRef="Shares">330171</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000657"
      unitRef="Shares">193131</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000659"
      unitRef="Shares">193131</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact000665"
      unitRef="Shares">13971</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact000667"
      unitRef="Shares">13971</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31_custom_PerformanceMilestoneMember"
      decimals="INF"
      id="Fact000673"
      unitRef="Shares">501</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31_custom_PerformanceMilestoneMember"
      decimals="INF"
      id="Fact000675"
      unitRef="Shares">501</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000677"
      unitRef="Shares">330171</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000679"
      unitRef="Shares">330171</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000681"
      unitRef="Shares">207603</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000683"
      unitRef="Shares">207603</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000685"
      unitRef="USDPShares">68.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000687"
      unitRef="USDPShares">68.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000689"
      unitRef="USDPShares">34.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000691"
      unitRef="USDPShares">34.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2024-01-01to2024-12-31" id="Fact000693">&lt;p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLF7bBtd6dQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;P.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zbIkTHzb4Xl4"&gt;Stock-based
    compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair
    values in accordance with ASC 718, &#x201c;Compensation-Stock Compensation&#x201d;. Share-based payments including grants of stock
    options are recognized in the consolidated statement of operations and comprehensive loss as an operating expense based on the fair
    value of the award at the date of grant. The fair value of stock options granted is estimated using the Black-Scholes option-pricing
    model. The Company has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the
    requisite service period or over the implicit service period when a performance condition affects the vesting, and it is considered
    probable that the performance condition will be achieved. Share-based payments to non-employees are accounted for in accordance with
    ASC 718.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-01-01to2024-12-31" id="Fact000695">&lt;p id="xdx_84F_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zw3K0lUr9aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zUIeoiC4EIgl"&gt;Fair
    value of financial instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
    Topic 825-10, &#x201c;Financial Instruments&#x201d; defines financial instruments and requires disclosure of the fair value of financial
    instruments held by the Company. The Company considers the carrying amount of cash and cash equivalents, restricted cash, accounts
    receivable, other current assets, accounts payable and other current liabilities balances, to approximate their fair values due to
    the short-term maturities of such financial instruments. ASC Topic 825-10, establishes the following fair value hierarchy, which
    prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair
    value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2 - Observable prices that are based on inputs not quoted on active markets but corroborated by market data.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3 - Unobservable inputs are used when little or no market data is available. Level 3 inputs are considered as the lowest priority
    under the fair value hierarchy.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    fair value of the financial instruments included in the working capital of the Company (cash and cash equivalents, accounts payable
    and other current assets and liabilities) approximates their carrying value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company did not estimate the fair value of the loans received from stockholders since their repayment schedule has not yet been determined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjxuB5pAO6r8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no Level 3 assets or liabilities for the year ended December 31, 2023. The following table presents changes in Level 3 assets and
liabilities measured at fair value for the year ended December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_z5O5I8YYPGZi" style="display: none"&gt;SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20241114__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGGSdi8tCfHi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zYHWiGgSwBAc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance &#x2013; November 14, 2024
    &#x2013; Warrant issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FairValueAdjustmentOfWarrants_z7jXuJroSoDi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value adjustments &#x2013; Derivative financial liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;795&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_z7DlHWtDQvw4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_za73EkdSN8C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zFilp6g8Nc6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the Company&#x2019;s assets and liabilities which are measured at fair value on a recurring basis by level
within the fair value hierarchy:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zGEafnPJxhX3" style="display: none"&gt;SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    Value Measurements as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    I&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    II&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    III&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant derivative
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWoUjctiPq35" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8XKvtuCOA69" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsrWFm7aZ6Qg" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_zfoypcLOJi29" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z5lTH7oIToS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000697">&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjxuB5pAO6r8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no Level 3 assets or liabilities for the year ended December 31, 2023. The following table presents changes in Level 3 assets and
liabilities measured at fair value for the year ended December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_z5O5I8YYPGZi" style="display: none"&gt;SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20241114__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGGSdi8tCfHi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zYHWiGgSwBAc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance &#x2013; November 14, 2024
    &#x2013; Warrant issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FairValueAdjustmentOfWarrants_z7jXuJroSoDi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value adjustments &#x2013; Derivative financial liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;795&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_z7DlHWtDQvw4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-11-13_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000699"
      unitRef="USD">16626000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-11-142024-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000701"
      unitRef="USD">795000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000703"
      unitRef="USD">17421000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000705">&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zFilp6g8Nc6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the Company&#x2019;s assets and liabilities which are measured at fair value on a recurring basis by level
within the fair value hierarchy:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zGEafnPJxhX3" style="display: none"&gt;SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    Value Measurements as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    I&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    II&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    III&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant derivative
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWoUjctiPq35" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8XKvtuCOA69" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsrWFm7aZ6Qg" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_zfoypcLOJi29" style="width: 12%; text-align: right" title="Warrant derivative liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000711"
      unitRef="USD">17421000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000713"
      unitRef="USD">17421000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000715">&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zzdcZwraGoa8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;R.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zNHFGJM5Nsc4"&gt;Segment
    reporting&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
    segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation
    by the chief operating decision maker, or (&#x201c;CODM&#x201d;). The Company has identified its Chief Executive Officer, Paul V. Goode, as the CODM who is responsible for making decisions regarding resource allocation and assessing performance. The Company views
    its operations and manages its business as one operating segment. The Company&#x2019;s long-lived assets consist primarily of property
    and equipment, net, which are all held in the United States.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2024-01-01to2024-12-31" id="Fact000717">&lt;p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z2FGCZ6IAGlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;S.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_z1EHr4i96mI3"&gt;Concentrations
    of credit risk&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents,
    and restricted cash. Cash and cash equivalents and restricted cash are deposited with a major bank in the United States. Management
    believes that such financial institutions are financially sound, accordingly, minimal credit risk exists with respect to these financial
    instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts,
    option contracts or other foreign hedging arrangements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000719">&lt;p id="xdx_841_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zAlGHH2E7KW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;T.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_z5Yi9ZOFIsFf"&gt;Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
    has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
    information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <GCTK:WarrantsWithDownRoundProtectionPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000721">&lt;p id="xdx_847_ecustom--WarrantsWithDownRoundProtectionPolicyTextBlock_zn4f45ay0S6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zqEHhM9QsPOi"&gt;Warrants
    with down-round protection&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company disregards the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining
    liability or equity classification in accordance with the provisions of ASU 2017-11, &#x201c;Earnings Per Share&#x201d; (ASU 2017-11).
    Based on its evaluation, management has determined that such warrants with down-round protection feature are eligible for equity
    classification.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordantly,
upon the occurrence of an event that triggers a down round protection feature (i.e., when the exercise price of the warrants is adjusted
downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available
to common shareholders for purposes of basic earnings per share calculation. See also Note 2P above.&lt;/span&gt;&lt;/p&gt;

</GCTK:WarrantsWithDownRoundProtectionPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000723">&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ziEK3LmjD6qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;V.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zqfiCRG2Y698"&gt;Recently
    adopted accounting pronouncements&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU
    2023-07&#x201d;). This standard requires a public entity to disclose significant segment expenses and other segment items on an interim
    and annual basis. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker.
    ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after
    December 15, 2024, with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all
    prior periods presented in the financial statements. The Company adopted ASU 2023-07 for the fiscal year ended December 31, 2024
    and interim financial statements thereafter, on a retrospective basis for all prior periods presented in the financial statements.
    The adoption of ASU 2023-07 did not change the way that the Company identifies its reportable segments and, as a result, did not
    have a material impact on the Company&#x2019;s financial position or results of operations. See (Note 13) - Segment Reporting for
    further information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <GCTK:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000725">&lt;p id="xdx_846_ecustom--NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_zHjYSoLTljei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;W.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zXFMCpsDTK0f"&gt;Recently
    issued accounting pronouncements, not yet adopted&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation
    Disclosures&#x201d; to require more detailed information about specified categories of expenses (purchases of inventory, employee
    compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the income
    statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and for interim periods within fiscal years
    beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial
    statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented
    in the financial statements. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial
    statements and related disclosures. The adoption of this pronouncement is not expected to have a material impact on the Company&#x2019;s
    consolidated financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures related to improvements
    to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for
    the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning
    after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</GCTK:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock>
    <us-gaap:LongTermDebtTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000727">&lt;p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_z5f1aSH53Oy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3&lt;/b&gt; &#x2013; &lt;b&gt;&lt;span id="xdx_827_zOfH3zoHyk4h"&gt;LOANS FROM STOCKHOLDERS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
    the years 2003-2004, Integrity Israel received loans from stockholders (four separate lenders) in a total amount of approximately
    $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfLongTermDebt_pn3n3_c20030101__20041231__us-gaap--LineOfCreditFacilityAxis__custom--FourSeparateLendersMember__srt--StatementGeographicalAxis__country--IL_zr9dQFodh7xe" title="Total loan amount"&gt;400&lt;/span&gt;. However, following the repayment of the entire balance to certain lender in 2015, the remaining balance as of December 31,
    2024 is approximately $&lt;span id="xdx_903_eus-gaap--RepaymentsOfLongTermDebt_pn3n3_c20240101__20241231__us-gaap--LineOfCreditFacilityAxis__custom--FourSeparateLendersMember__srt--StatementGeographicalAxis__country--IL_zsZWIq7gVNub" title="Repayment of loan"&gt;203&lt;/span&gt;. The loans are indexed to the Israeli consumer price index from their origination date and bear no interest.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company will be required to pay the loans, in quarterly installments, commencing on the first quarter following the first fiscal
    year in which the Company reports net profit in its annual report. At such time, the Company will be required to make quarterly payments
    equal to &lt;span id="xdx_90E_ecustom--QuarterlyPaymentsEqualsToSalesPercentage_pid_dp_uPure_c20240101__20241231_zfmt4Ik4MBL3" title="Sales percent"&gt;10&lt;/span&gt;% of its total sales for each quarter until the loans have been repaid in full. Notwithstanding the repayment mechanism,
    the Company will not be required to repay the loans during any period in which such payment would cause a deficit in the Company&#x2019;s
    working capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 31, 2024, the Company does not expect to make any material repayments during the following 12-month period, if any, and
    accordingly the entire remaining balance of the loans from stockholders have been presented as non-current liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2003-01-012004-12-31_custom_FourSeparateLendersMember_country_IL"
      decimals="-3"
      id="Fact000729"
      unitRef="USD">400000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2024-01-012024-12-31_custom_FourSeparateLendersMember_country_IL"
      decimals="-3"
      id="Fact000731"
      unitRef="USD">203000</us-gaap:RepaymentsOfLongTermDebt>
    <GCTK:QuarterlyPaymentsEqualsToSalesPercentage
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000733"
      unitRef="Pure">0.10</GCTK:QuarterlyPaymentsEqualsToSalesPercentage>
    <GCTK:SignificantTransactionsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000735">&lt;p id="xdx_80B_ecustom--SignificantTransactionsTextBlock_zlR8CmcYuYhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 &#x2013; &lt;span id="xdx_82A_zdHYqqQx9lwg"&gt;SIGNIFICANT TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
    of pre-funded warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    January 3, 2024, &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240103__20240103__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGN0l6NFO3O1" title="Pre-funded warrants"&gt;19,765&lt;/span&gt; pre-funded warrants granted through underwritten public offering in April 2023 have been fully exercised
    into the same number of shares of Common Stock of the Company. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exchange
    Agreement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    February 13, 2024, the Company entered into an Exchange Agreement with certain warrant holders (the &#x201c;Holders&#x201d;), pursuant
    to which the Company and the Holders agreed to exchange (the &#x201c;Exchange&#x201d;) warrants with down round protection feature
    exercisable to common shares (the &#x201c;Warrants&#x201d;) owned by the Holders for shares of Common Stock to be issued by the Company.
    On February 15, 2024, &lt;span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20240215_z6TLVGLUwzbc" title="Shares of Common Stock"&gt;35,932 &lt;/span&gt;shares of Common Stock have been issued in exchange for &lt;span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20240215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNBITjKu9TU5" title="Shares of Common Stock"&gt;43,820&lt;/span&gt; Warrants (the &#x201c;Shares&#x201d;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;It
                                            was also agreed that the Holders will not, during the period (&#x201c;Lock-Up Period&#x201d;)
                                            (i) offer, pledge, announce the intention to sell, contract to sell, sell any option or contract
                                            to purchase, purchase any option or contract to sell, grant any option, right or warrant
                                            to purchase, or otherwise transfer or dispose of, directly or indirectly, any Shares, (ii)
                                            enter into any swap or other agreement that transfers, in whole or in part, any of the economic
                                            consequences of ownership of the Shares of, whether any such transaction described in clause
                                            (i) or (ii) above is to be settled by delivery of Shares or such other securities, in cash
                                            or otherwise, (iii) make any demand for or exercise any right with respect to, the registration
                                            of any Shares or any security convertible into or exercisable or exchangeable for shares
                                            of common stock, or (iv) publicly announce an intention to effect any transaction specific
                                            in clause (i), (ii) or (iii) above, provided that the Holder, during the Lock-Up Period,
                                            may &lt;span id="xdx_900_ecustom--LockUpPeriodDescription_c20240213__20240213__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zTyrs3D4LGHg" title="Lock-up period conditions"&gt;(a) sell or contract to sell Shares at a price higher than $0.5 per Share on any trading
                                            day up to 10% of the daily volume of Shares or (b) sell or contract to sell Shares at a price
                                            higher than $0.8 per Share on any trading day with no volume limitation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Lock-Up Period shall expire at the earliest of (i) 365 days after the date hereof or (ii) until the Shares traded above $&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20240213__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zBrTVdgo8hKl" title="Share price"&gt;100.00&lt;/span&gt; per
    Share for five consecutive trading days.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company accounted for the Exchange of the aforesaid warrants with shares in a similar manner of a modification of shares-based payment as a deemed dividend which was calculated at the closing
    date by the management using the assistance of external appraiser as the excess of fair value of the shares to be issued after taking
    into consideration a discount for lack of marketability at a rate of 16.81% over the Lock-Up Period over the fair value of the original
    equity instrument (i.e. warrants which included down round protection feature). However, since the fair value of the shares was estimated
    as less than the fair value of the replaced equity instrument, deemed dividend was not recorded.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Private
    Placement Agreement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    April 22, 2024, the Company entered into a private placement agreement under which the Company issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240422__20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbdezgYJDnM6" title="Number of shares issued"&gt;3,968&lt;/span&gt; shares of its common
    stock at a price of $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrwSVH7pwn68" title="Common stock share price"&gt;126&lt;/span&gt; per share for aggregate gross proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20240422__20240422__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzEu8KMDeaXe" title="Aggregate gross proceeds offering"&gt;500&lt;/span&gt; (the &#x201c;Offering&#x201d;). The Offering included participation
    of certain members of the Company&#x2019;s executive management, Board of Directors and existing shareholders.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adoption
    of 2024 Equity Incentive Plan and Reverse Share Split&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            April 26, 2024, the Company held its Annual Meeting of Shareholders (the &#x201c;Annual Meeting&#x201d;)
                                            under which the Company&#x2019;s stockholders approved, inter alia, the following proposals:
                                            (i) adoption of the Company&#x2019;s 2024 Equity Incentive Plan and (ii) an amendment to Article
                                            IV of the Company&#x2019;s Certificate of Incorporation, to effect a reverse stock split of
                                            the Company&#x2019;s Common Stock at a ratio of between one-for-five and one-for-thirty, with
                                            such ratio to be determined at the sole discretion of the Board of Directors. Following the
                                            Annual Meeting, on April 30, 2024, the Company&#x2019;s Board of Directors approved a &lt;span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240430__20240430_zCGY9Uuxwkea" title="Reverse stock split"&gt;one-for-five&lt;/span&gt;
                                            reverse stock split of the Company&#x2019;s issued and outstanding shares of common stock.
                                            On May 17, 2024, the Company filed a Certificate of Amendment to the Company&#x2019;s Certificate
                                            of Incorporation with the Secretary of State of the State of Delaware which effected the
                                            reverse stock split.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    February 3, 2025, subsequent to the balance sheet date on December 31, 2024, the Company approved to effect an additional reverse
    stock split of twenty-for-one (20 to 1). The reverse split did not impact the total number of authorized shares of common stock or
    the par value per share.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    accounting purposes, all shares, options and warrants to purchase shares of common stock and loss per share amounts have been adjusted
    to give retroactive effect to both of the reverse splits for all periods presented in these consolidated financial statements. Any
    fractional shares resulting from the reverse splits were rounded up to the nearest whole share.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
    and Warrant Purchase Agreements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            June 27, 2024, the Company entered into note and warrant purchase agreements (the &#x201c;Purchase
                                            Agreement&#x201d;) with certain investors (the &#x201c;June 27 Investors&#x201d;), providing
                                            for the private placement of unsecured promissory notes in the aggregate principal amount
                                            of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240627__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNotesMember_zRv9SM97kIZb" title="Aggregate principal amount"&gt;100&lt;/span&gt; (the &#x201c;June 27 Notes&#x201d; and each a &#x201c;June 27 Note&#x201d;) and warrants
                                            to purchase up to an aggregate of &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240627_ztkGGeX4DbRc" title="Aggregate of shares"&gt;15,000&lt;/span&gt; shares of the Company&#x2019;s Common Stock (the
                                            &#x201c;June 27 Warrants&#x201d;).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShortTermDebtDescription_c20240627__20240627_zieJexGNEwv9" title="Notes payable description"&gt;The
    June 27 Notes bear simple interest at a rate of 3% per annum and are due and payable in cash on the earlier of: (a) 12 months from
    the date of the June 27 Note; or (b) the date the Company raises third-party equity capital in an amount equal to or in excess of
    $1,000 (the &#x201c;Maturity Date&#x201d;). The Company may prepay the June 27 Notes at any time prior to the Maturity Date without
    penalty. If an event of default occurs, the then-outstanding principal amount of the June 27 Notes plus any unpaid accrued interest
    will accelerate and become immediately payable in cash.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
    of June 27 Warrants has a fixed exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240627_ztRn2iQS7MY9" title="Warrants exercise price"&gt;99&lt;/span&gt; per share. The June 27 Warrants are immediately exercisable and have a &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240627_zbTJcsbZj1Fi" title="Warrants term"&gt;5&lt;/span&gt;-year
    term.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
    initial recognition, the management allocated the gross cash proceeds received based on the relative fair value of the June 27 Notes
    and the detachable June 27 Warrants in total amount of $&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240627__20240627_zmtZee7eSgq2" title="Proceeds from notes"&gt;15&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240627__20240627_z9moFUDsLI2h" title="Fair value of warrants"&gt;85&lt;/span&gt;, respectively. The fair value of the June 27 Note was determined
    based on a rating model using a debt discount rate of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240627_zfFYEaz45n3" title="Debt discount rate"&gt;28.65&lt;/span&gt;% which represented the Company&#x2019;s applicable rate of risk. The fair
    value of the June 27 Warrants was determined by using Black-Scholes pricing model taking into account, inter alia, expected stock
    price volatility of &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20240627__20240627_zu3fi8rRqQJ2" title="Price volatility"&gt;245&lt;/span&gt;% and risk-free interest rate of &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20240627__20240627_zNbNEZZm8Gz9" title="Risk free interest rate"&gt;4.52&lt;/span&gt;%. The amount allocated to June 27 Warrants was classified as a component
    of equity (as their terms permit the holders to receive a fixed number of shares of common stock upon exercise for a fixed exercise
    price).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    June 27 Notes were accounted for as a financial liability measured at amortized cost. In subsequent periods, the Company recognized
    a discount and interest expense over the economic life of the June 27 Notes based on the effective interest rate method.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tabular presentation reflects the reconciliation of the carrying amount of the June 27 Notes during the period of years ended
December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zxSka9mHzdi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zID20Ar4xsO6" style="display: none"&gt;SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zQzBG2rGhi89" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended&lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WarrantsAndRightsOutstanding_iS_pn3n3_zBqCZcYjxCba" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_zNAWB0oWRiXf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total proceeds received&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProceedsFromAllocatedWarrantsAtInitialRecognition_pn3n3_zl0W3dNDg9Md" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total proceeds allocated to June 27 Warrants
    at initial recognition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DiscountAmortizationAndInterestExpenses_pn3n3_zjUlikiL6W5f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount amortization and interest expenses
    related to June 27 Notes (Note 7 below)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--PartialConversionNotesAndAccruedInterest_pn3n3_zblcEzG7AGM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Partial conversion June
    27 Notes and accrued Interest (Note 4H and Note 4I below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstanding_iE_pn3n3_z7iEpCvk4pL" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance December&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_ztXZHekuZg23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period commencing the issuance date through December 31, 2024, none of the June 27 Warrants have been exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Convertible
    Promissory Notes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            July 18, 2024, the Company entered into a series of convertible promissory notes with three
                                            directors, and one member of the Company&#x2019;s executive management (the &#x201c;July 18
                                            Investors&#x201d;), providing for the private placement of unsecured convertible promissory
                                            notes in the aggregate principal amount of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zGIEAjUhfCd4" title="Debt instrument face amount"&gt;360&lt;/span&gt; (the &#x201c;July 18 Notes&#x201d; and each
                                            a &#x201c;July 18 Note&#x201d;).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    July 18 Notes bore simple interest at a rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zmxR4IGaVL76" title="Debt instrument interest rate"&gt;8&lt;/span&gt;% per annum. Upon initial date, the management measured the fair value of the embedded
    conversion feature which is accounted for as embedded derivative liability. The difference between the total gross cash proceeds
    received and the fair value of the embedded conversion feature is allocated to the host component of the July 18 Notes that are measured
    at amortized cost under which in subsequent periods the Company recognizes a discount expense over the economic life of the July
    18 Notes based on the effective interest rate method. However, the fair value of the embedded derivative liability related to the
    conversion feature was determined by the management at an insignificant amount since upon closing of a Qualified Financing, the loan
    will convert based on market conditions (i.e. conversion price will be equal to the fair value of the share upon conversion) and
    thus all proceeds received of $&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_pn3n3_c20240718__20240718__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z352712MHZhd" title="Conversion price"&gt;360&lt;/span&gt; were allocated to the July 18 Notes.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    September 5, 2024, the Company and one of July 18 noteholders entered into a conversion agreement, under which the Company agreed
    to convert his portion of the outstanding principal nominal amount plus any accrued but unpaid interest pursuant to the July 18 Note,
    totaling $&lt;span id="xdx_904_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFGdte93rCyg" title="Interest expense"&gt;101&lt;/span&gt; into &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240905__20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z7AIvJgbwjh6" title="Stock issued during period shares issued for services"&gt;4,955&lt;/span&gt; shares of Common Stock at a conversion price of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240905__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjyKAXhkdBSd" title="Conversion price per share"&gt;20.4&lt;/span&gt; per share. Please see note 4I.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;In
    November 2024, the Company and the remaining July 18 noteholders entered into a conversion agreement under which the Company agreed
    to convert their portion of the outstanding principal nominal amount plus any accrued but unpaid interest pursuant to the July 18
    Note, totaling $&lt;span id="xdx_90E_eus-gaap--InterestExpense_pn3n3_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO1wVwsBdW87" title="Interest expense"&gt;305&lt;/span&gt;
    to Common Stock and warrants at a conversion price of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZ6V3R04nNxe" title="Conversion price per share"&gt;31.2&lt;/span&gt;
    per share. The July 18 noteholders received &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOm3FLVIkE5d" title="Stock issued during period shares issued for services"&gt;9,760&lt;/span&gt;
    shares of Common Stock, &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesACommonWarrantMember_zrF4T0nv00Dl" title="Stock issued during period shares issued for services"&gt;9,760&lt;/span&gt;
    Series A Warrants and &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241101__20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesBCommonWarrantMember_zE7t1kVmD8r9" title="Stock issued during period shares issued for services"&gt;9,760&lt;/span&gt;
    Series B Warrants. The fair value of the shares of Common Stock received was $&lt;span id="xdx_905_eus-gaap--CommonStockSharesSubscriptions_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpW3GebmbFoi" title="Fair value of common stock"&gt;60&lt;/span&gt;.
    The Series A and Series B Warrants are treated as derivative liabilities and at grant date were valued at $&lt;span id="xdx_909_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesACommonWarrantMember_zbghkfmRsmCh" title="Derivative financial liabilities"&gt;43&lt;/span&gt;
    and $&lt;span id="xdx_907_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241130__us-gaap--StatementEquityComponentsAxis__custom--SeriesBCommonWarrantMember_z6A3HYYa6s56" title="Derivative financial liabilities"&gt;279&lt;/span&gt;,
    respectively. As a result, the Company recorded a loss on the settlement of debt in the amount of $&lt;span id="xdx_902_eus-gaap--LitigationSettlementLoss_pn3n3_c20241101__20241130_z5O0Y6dxo2c4" title="Settlement of debt loss"&gt;79&lt;/span&gt;
    in the Statement of Operations. Please see Note 4J for the terms and valuation methodology of the Series A and Series B
    Warrants.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Convertible
    Promissory Note and Warrant Agreements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    July 30, 2024, the Company entered into a convertible promissory note and three warrant agreements (the &#x201c;July 30 Warrants&#x201d;)
    with an existing investor (the &#x201c;July 30 Holder&#x201d;), providing for the private placement of a secured convertible promissory
    note in the aggregate principal amount of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240730__us-gaap--ShortTermDebtTypeAxis__custom--ConvertiblePromissoryNotesMember__us-gaap--TypeOfArrangementAxis__custom--WarrantsAgreementMember_ztUekVUIZXOf" title="Debt instrument face amount"&gt;4,000&lt;/span&gt; (the &#x201c;July 30 Note&#x201d;). The July 30 Note bore simple interest at a rate
    of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240730__us-gaap--ShortTermDebtTypeAxis__custom--ConvertiblePromissoryNotesMember__us-gaap--TypeOfArrangementAxis__custom--WarrantsAgreementMember_zW3TEMO4BSmh" title="Debt instrument interest rate"&gt;8&lt;/span&gt;% per annum and is due and payable in cash on earlier of: (i) 12 months anniversary of July 30 Note, or (ii) closing date of
    a Sale Transaction (defined below) (the &#x201c;Maturity Date&#x201d;). The July 30 Note is secured by a first-priority security interest
    on all Company&#x2019;s assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
July 30 Warrant becomes exercisable 12 months after its issuance and has term of &lt;span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20240730__20240730_z24iw094gAl8"&gt;10&lt;/span&gt; years. The July 30 Warrants are exercisable for cash
only and have no price-based antidilution. The first July 30 Warrant is for &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_z4Q0Cs9LY69h"&gt;106,667&lt;/span&gt; shares at $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zWwO0eENRtW6" title="Exercise price"&gt;37.50&lt;/span&gt; per share. The second July 30 Warrant
is for &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zU1Ku3QGllpl"&gt;76,191&lt;/span&gt; shares at $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_z3Ugdsmakn4" title="Exercise price"&gt;52.50&lt;/span&gt; per share. The third July 30 Warrant is for &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240730__20240730__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_z1kbIallstY3"&gt;59,259&lt;/span&gt; shares at $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240730__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zgZYmHg1fRp1" title="Exercise price"&gt;67.50&lt;/span&gt; per share. Management has determined
that the warrants are eligible to be classified as a component of equity as their terms permit the holders to receive a fixed number
of shares of common stock upon exercise for a fixed exercise price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the initial date, the Company has issued four freestanding instruments that include (i) a financial instrument that is considered as
&#x201c;host&#x201d; which comprised of July 30 Note and two embedded derivative financial instruments (i.e. an embedded conversion feature
and an embedded redemption feature to receive cash equals to &lt;span id="xdx_90F_ecustom--EmbeddedConversionFeaturePercentage_iI_pid_dp_c20240730_zIsEmfYfef7g" title="Embedded conversion feature percentage"&gt;200&lt;/span&gt;% of July 30 Note balance upon the occurrence of a Sale Transaction)
and (ii) three series of detachable warrants. At the initial date, the Company is required to estimate the fair value of the freestanding
instruments and allocate the total gross proceeds received between them based on that relative fair value identified. The fair value
of the embedded derivative financial instruments (i.e. the conversion right and the redemption right) should be bifurcated from the host
instrument and remeasured on recurring basis at each reporting period under marked to market approach, the July 30 Note was accounted
for at amortized cost whereby discount and interest expenses are recorded over the economic life of the July 30 Note based on the effective
interest rate method and the July 30 Warrants are classified into equity without any further subsequent measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
                                            initial recognition, the management by using the assistance of an external appraiser allocated
                                            the gross cash proceeds received based on the relative fair value of the July 30 Note and
                                            the detachable July 30 Warrants in total amount of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240730__20240730_zqSo9tsVZMv" title="Proceeds from notes"&gt;1,450&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240730__20240730_zdMQ41uT4G04" title="Fair value of warrants"&gt;2,550&lt;/span&gt;, respectively. The fair
                                            value of the convertible note was determined by using hybrid method that includes conversion
                                            scenario and liquidation scenario taking into account, inter alia, a debt discount rate of
                                            &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240730_zwJGQesNW7Je" title="Debt discount rate"&gt;28.65&lt;/span&gt;%. The fair value of the July 30 Warrants was determined by using Black-Scholes pricing
                                            model taking into account, inter alia, expected stock price volatility of &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240730__20240730_zqVH78shgyHi" title="Volatility"&gt;122.8&lt;/span&gt;% and risk-free
                                            interest rate of &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240730__20240730_zmgCmHyq9079" title="Risk- free interest rate"&gt;4.78&lt;/span&gt;%. The amount allocated to July 30 Warrants was classified as a component
                                            of equity.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furthermore,
    it was determined that the embedded conversion feature and embedded redemption feature are required to be bifurcated from the host
    loan instrument. The fair value of the bifurcated derivatives was determined by the management using the assistance of an external
    appraiser in a total amount of $&lt;span id="xdx_903_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_c20240730_zWIAD82R0aM3" title="Fair value of embedded derivative liability"&gt;35&lt;/span&gt; upon initial recognition and in subsequent periods as derivative liability at fair value through
    profit and loss. The remaining amount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240730_z7woT8PnKIq4"&gt;1,415&lt;/span&gt; was allocated to the host loan instrument which in subsequent periods was accounted
    for using the effective interest method over the term of the loan, until its stated maturity.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 24, 2024, the Company held a special meeting of its stockholders under which shares of common stock issuable by the Company
upon conversion of the July 30 Note and exercise of the July 30 Warrants was approved. The July 30 Holder has not elected to trigger
the exercise of the July 30 Warrants into shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 12, 2024, the Company and the July 30 Holder entered into an agreement for the settlement of the July 30 Note plus any accrued
but unpaid interest totaling $&lt;span id="xdx_902_eus-gaap--InterestExpense_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zX0cijeriv81" title="Unpaid interest"&gt;4,093&lt;/span&gt; to Common Stock and warrants at a conversion price of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zsV6MmZsmKD5" title="Conversion price"&gt;31.0&lt;/span&gt; per share. The July 30 Holder received
&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zsTiE8jZpGi" title="Shares issued"&gt;132,036&lt;/span&gt; shares of Common Stock, &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zM5mUwXLFugi" title="Shares issued"&gt;132,036&lt;/span&gt; Series A Warrants and &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zTeq0VCiAZ6f" title="Shares issued"&gt;132,036&lt;/span&gt; Series B Warrants. The fair value of the shares of Common Stock
received was $&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zQjXYDtMfBma" title="Fair value"&gt;813&lt;/span&gt;. The Series A and Series B Warrants are treated as derivative liabilities and at grant date were valued at $&lt;span id="xdx_905_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zJ36WYzAnv99" title="Derivative liabilities"&gt;609&lt;/span&gt; and
$&lt;span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zIQyIiV0gD68" title="Derivative liabilities"&gt;3,768&lt;/span&gt;, respectively. As of the settlement date, the carrying amount of the July 30 Note under the effective interest method was $&lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zJmXQPChHK3c" title="Fair value of the derivative liability"&gt;1,978&lt;/span&gt;
and the fair value of the derivative liability relating to the conversion feature was $&lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zcNAy2fNwUEe" title="Conversion amount"&gt;37&lt;/span&gt;. Upon settlement, the total fair value of
the warrant related derivatives of $&lt;span id="xdx_908_ecustom--FairValueOfWarrantRelatedDerivatives_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zVrWQQeFlpF2" title="Fair value of the warrant related derivatives"&gt;4,377&lt;/span&gt; and the equity received of $&lt;span id="xdx_900_ecustom--FairValueOfWarrantRelatedDerivativesValue_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zeVJKt7GYZu9" title="Fair value of the warrant related derivatives book value"&gt;813&lt;/span&gt; exceeded the net book value of the July 30 Note of $&lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_pn3n3_c20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zIfR0Di3BRqd" title="Fair value of the derivative liability"&gt;1,978&lt;/span&gt; and
the value of the debt conversion derivative that was settled of $&lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn3n3_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__custom--JuneThirtyNotesMember_zxci8mtEqcGc" title="Conversion amount"&gt;37&lt;/span&gt;. As a result, the Company recorded a loss on  extinguishment of debt
in the amount of $&lt;span id="xdx_900_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20241112__20241112_zCYwIZucXBB" title="Loss on settlement debt"&gt;3,175&lt;/span&gt; in the Statement of Operations. Please see Note 4J for the terms and valuation methodology of the Series A and
Series B Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
    23 Conversion&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    August 23, 2024 (the &#x201c;Commitment Date&#x201d;), the Company and two of June 27 Investors entered into conversion agreement,
    under which the Company agreed to convert the principal nominal amount plus any accrued but unpaid interest pursuant to each of June
    27 Notes, with a face value of $&lt;span id="xdx_90F_eus-gaap--InterestExpense_pn3n3_c20240823__20240823__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zbMIAdMndhwg" title="Interest expense"&gt;20&lt;/span&gt; each (the &#x201c;Debt&#x201d;), held by the Investors to Common Stock at a conversion price of
    $&lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zySWPQaJNg5h" title="Conversion price"&gt;20.4&lt;/span&gt; per share. On October 15, 2024, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241015__20241015_zkNOk5IwPrRg" title="Stock issued during period shares issued for services"&gt;985&lt;/span&gt; shares of common stock for each of the two of the June 27 Investors
    in respect of each respective Debt converted.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            satisfaction of the Debt, the Company also issued to each of the two June 27 Investors three
                                            warrants (each an &#x201c;August 23 Warrant&#x201d;). Each August 23 Warrant becomes exercisable
                                            on &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20240823__20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantMember_z17UjLLG5V18" title="Warrants exercisable"&gt;August 16, 2025&lt;/span&gt; and has term of &lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantMember_zox6rZrPFCMa" title="Warrants and rights outstanding term"&gt;10 years&lt;/span&gt;. The August 23 Warrants are exercisable for cash
                                            only and have no price-based antidilution. The first August 23 Warrant is for &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantOneMember_zBTOw9onf0lc" title="Class of warrant or right number of securities called by warrants or rights"&gt;535&lt;/span&gt; shares
                                            of Common Stock and is exercisable at $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantOneMember_zl5Zo0nipCH5" title="Exercise price"&gt;37.5&lt;/span&gt; per share. The second August 23 Warrant is for
                                            &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantTwoMember_zFSd0H8KkNk4" title="Class of warrant or right number of securities called by warrants or rights"&gt;382&lt;/span&gt; shares of Common Stock, exercisable at $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantTwoMember_zVpQ5VfNf7Fg" title="Exercise price"&gt;52.5&lt;/span&gt; per share. The third August 23 Warrant is
                                            for &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantThreeMember_zmqSh3JPAbhg" title="Class of warrant or right number of securities called by warrants or rights"&gt;297&lt;/span&gt; shares of Common Stock, exercisable at $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240823__us-gaap--StatementEquityComponentsAxis__custom--AugustTwentyThreeWarrantThreeMember_zJiZ1aa04Xi2" title="Exercise price"&gt;67.5&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    above transaction was accounted for as a settlement of financial liabilities under which the instruments issued or to be issued to
    the June 27 Investors (i.e. shares of common stock and August 23 Warrants) are eligible for equity classification and thus both have
    been recorded as part of equity based on the total fair value of $&lt;span id="xdx_904_eus-gaap--EquityFairValueDisclosure_iI_pn3n3_c20240823_z09wiISPCquk" title="Equity fair value disclosure"&gt;238&lt;/span&gt; at the Commitment Date. The difference between the fair value
    of these equity instruments and the carrying amount of each of the respective Debt at the Commitment Date amounted to $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240823_zVWWZ50izxml" title="Debt instrument face amount"&gt;11&lt;/span&gt; was charged
    immediately to the finance expenses (see also Note 7 below). Due to the above settlement, the Company recorded a loss on the settlement
    on the amount of $&lt;span id="xdx_90E_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20240823__20240823_zABvb7YnA8A3" title="Loss on settlement debt"&gt;216&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
    the period commencing the issuance date through December 31, 2024, none of the August 23 Warrants have been exercised.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
    5 Conversion&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            September 5, 2024 (the &#x201c;Commitment Date&#x201d;), the Company and one of June 27 Investors
                                            and July 18 Investors entered into a conversion agreement, under which the Company agreed
                                            to convert outstanding board fees amounted $&lt;span id="xdx_90F_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_z9pzxzE6iHB9" title="Interest expense"&gt;113&lt;/span&gt; and the principal nominal amount plus any
                                            accrued but unpaid interest pursuant to June 27 Note and July 18 Note, totaling $&lt;span id="xdx_909_eus-gaap--InterestExpense_pn3n3_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--JulyEighteenNotesMember_zEH9y3uBrvh4" title="Interest expense"&gt;146&lt;/span&gt; (referring
                                            together as a &#x201c;Debt&#x201d;), held by the Investor to Common Stock at a conversion price
                                            of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--JulyTwentySevenNotesMember_zO03f1MMbfPa" title="Conversion price"&gt;20.4&lt;/span&gt; per share. On October 15, 2024, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20241015__20241015__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenNotesMember_zKAXvRUgXwKc" title="Stock issued during period shares issued for services"&gt;12,712&lt;/span&gt; shares of common stock
                                            for the June 27 Investor in respect of the Debt converted.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    satisfaction of the Debt, the Company also issued to June 27 Investor and July 18 Investor three warrants (each an &#x201c;September
    5 Warrant&#x201d;). Each September 5 Warrant becomes exercisable on &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20240905__20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsMember_zrJHLMPfYbN1" title="Warrants exercisable"&gt;August 16, 2025&lt;/span&gt; and has term of &lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsMember_zYMEHkoOBh22" title="Warrants and rights outstanding term"&gt;10 years&lt;/span&gt;. The September 5 Warrants
    are exercisable for cash only and have no price-based antidilution. The first September 5 Warrant is for &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsOneMember_zzRItV2Z0FV1" title="Class of warrant or right number of securities called by warrants or rights"&gt;6,915&lt;/span&gt; shares of Common Stock
    and is exercisable at $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsOneMember_zNOlSfhqkr7" title="Exercise price"&gt;37.5&lt;/span&gt; per share. The second September 5 Warrant is for &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsTwoMember_zuiLyxiXgVBc" title="Class of warrant or right number of securities called by warrants or rights"&gt;4,940&lt;/span&gt; shares of Common Stock, exercisable at $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsTwoMember_zCw1Ee4GHrzg" title="Exercise price"&gt;52.5&lt;/span&gt; per
    share. The third September 5 Warrant is for &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsThirdMember_zxa637LkjBKi" title="Class of warrant or right number of securities called by warrants or rights"&gt;3,842&lt;/span&gt; shares of Common Stock, exercisable at $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240905__us-gaap--StatementEquityComponentsAxis__custom--SeptemberFiveWarrantsThirdMember_zCZWpWrxNCj6" title="Exercise price"&gt;67.5&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    above transaction was accounted for as settlements of financial liabilities under which the instruments issued or to be issued to
    the July 18 Investor (i.e. shares of common stock and September 5 Warrants) are eligible for equity classification and thus both
    have been recorded as part of equity based on the total fair value of $&lt;span id="xdx_901_eus-gaap--EquityFairValueDisclosure_iI_pn3n3_c20240905_zOmw3OhEbMwa" title="Equity fair value disclosure"&gt;1,505&lt;/span&gt; at the Commitment Date. The carrying amount of the Debt
    at the Commitment Date amounted to $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240905_zRgoLrr0GsIl" title="Debt instrument face amount"&gt;227&lt;/span&gt; and the difference was recorded as loss on settlement of debt in the Statement of Operations
    in the amount of $&lt;span id="xdx_905_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_c20240905__20240905_zGqVLk76fea9" title="Loss on settlement debt"&gt;1,278&lt;/span&gt; (see also Note 7 below).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
    the period commencing the issuance date through December 31, 2024, none of the September 5 Warrants have been exercised.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;November
    12 Issuance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            November 12, 2024, the Company completed a public offering (the &#x201c;Offering&#x201d;) under
                                            which the Company received gross proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20241112__20241112_zWMSviPQXNsj" title="Gross proceeds from public offering"&gt;10,000&lt;/span&gt; in exchange for issuance of an aggregate
                                            of (i) &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20241112__20241112__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSJlQiH5QPG5" title="Shares issued"&gt;121,867&lt;/span&gt; shares (the &#x201c;Shares&#x201d;) of its Common Stock, (ii) &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zBmn4GDkNb6e" title="Warrants to purchase shares"&gt;237,845&lt;/span&gt; pre-funded
                                            warrants (the &#x201c;Pre-Funded Warrants&#x201d;) to purchase up to an aggregate of &lt;span id="xdx_905_eus-gaap--SharesIssued_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zRv3svNccvHe" title="Shares issued"&gt;237,845&lt;/span&gt;
                                            shares of Common Stock (the &#x201c;Pre-Funded Warrant Shares&#x201d;) in lieu of Shares, (iii)
                                            Series A Warrants (the &#x201c;Series A Warrants&#x201d;) to purchase up to &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonWarrantMember_zm5NzMxZQNA7" title="Warrants to purchase shares"&gt;359,712&lt;/span&gt; shares
                                            of Common Stock (the &#x201c;Series A Warrant Shares&#x201d;) and (iv) Series B Warrants (the
                                            &#x201c;Series B Warrants&#x201d; and, together with the Series A Warrants, the &#x201c;Common
                                            Warrants&#x201d;) to purchase up to &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBCommonWarrantMember_zdTkdbD1EI43" title="Warrants to purchase shares"&gt;359,712&lt;/span&gt; shares of Common Stock (&#x201c;the &#x201c;Series
                                            B Warrant Shares&#x201d; together with the Series A Warrant Shares, the &#x201c;Warrant Shares&#x201d;).
                                            Each Share or Pre-Funded Warrant, as applicable, was sold together with one Series A Warrant
                                            to purchase one share of Common Stock and one Series B Warrant to purchase one Common Share.
                                            The public offering price for each Share and accompanying Common Warrants was $&lt;span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_zKl7wgiBIuCc" title="Shares issued, per share"&gt;27.80&lt;/span&gt;, and
                                            the public offering price for each Pre-Funded Warrant and accompanying Common Warrants was
                                            $&lt;span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1EMHM1vM2we" title="Shares issued, per share"&gt;27.78&lt;/span&gt; (the &#x201c;Offering Price&#x201d;).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Pre-Funded Warrants have an exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zZvYu8Vi9P68" title="Warrant, exercise price"&gt;0.02&lt;/span&gt; per share, are exercisable immediately and expire when exercised in full. Each
    Series A Common Warrant will have an exercise price per share of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonWarrantMember_zKpeGoJL24Pi" title="Warrant, exercise price"&gt;36.2&lt;/span&gt; and will be exercisable beginning on the date on which Stockholder
    Approval (as defined below) is received and deemed effective (the &#x201c;Initial Exercise Date&#x201d; or the &#x201c;Stockholder Approval
    Date&#x201d;). The Series A Warrants will expire on the five-year anniversary of the Initial Exercise Date. The Series B Warrants
    will have an exercise price per share of $&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBCommonWarrantMember_zjlVZPq8QtB8" title="Warrant, exercise price"&gt;36.2&lt;/span&gt; and will be exercisable beginning on the Initial Exercise Date. The Series B Warrants
    will expire on the two and one-half year anniversary of the Initial Exercise Date. The issuance of Common Warrant Shares upon exercise
    of the Common Warrants is subject to stockholder approval under applicable rules and regulations of The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;)
    (&#x201c;Stockholder Approval&#x201d; and the date on which Stockholder Approval is received and deemed effective, the &#x201c;Stockholder
    Approval Date&#x201d;).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    exercise price of Series A Warrants and Series B Warrants is subject to certain adjustments. If at the time of exercise there is
    no effective registration statement registering, or the prospectus is not available for the issuance of the Series A Warrants Shares
    and Series B Warrant Shares to the holders, then the Series A Warrants and Series B Warrants may also be exercised, in whole or in
    part, at such time by means of a &#x201c;cashless exercise&#x201d;. In addition, the holders are entitled to an option to require the
    Company to purchase the Series A Warrants and Series B Warrants for cash in an amount equal to their Black-Scholes Option Pricing
    Model value, in the event that certain fundamental transactions (which some of them are not considered solely within the control
    of the Company) as defined in the Series B Warrants agreement, occur. Additionally, holders of Series B Warrants may also effect
    an &#x201c;alternative cashless exercise&#x201d; at any time while the Series B Warrants are outstanding following the Initial Exercise
    Date. Under the alternate cashless exercise option, the holder of the Series B Warrant has the right to receive an aggregate number
    of shares equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cashless exercise
    of the Series B Warrant and (ii) 3.0. The Company analyzed the terms of the warrants in accordance with Accounting Standards Codification
    No. 480, &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt; (&#x201c;ASC 480&#x201d;) and determined that the Series A and Series B Warrants
    are not eligible for equity classification and thus would be classified as derivative liabilities and recorded at fair value, with
    changes in fair value recorded through profit or loss. The Company used the Monte Carlo Simulation method for determining the fair
    value of the warrants. The Series A Warrant assumptions used in the Monte Carlo simulations are an expected term of &lt;span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z9949G0KyME5" title="Expected term years"&gt;5&lt;/span&gt; years, exercise
    price of $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zapUGoyJRTH2" title="Exercise price"&gt;36.2&lt;/span&gt;, comparable company volatility of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zfbhkTyUAOkj" title="Volatility rate"&gt;96.3&lt;/span&gt;%, risk-free interest rate of &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zdUvutBgIIG1" title="Interest rate"&gt;4.32&lt;/span&gt;% and share price of $&lt;span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zG3cqmPoSnke" title="Share price"&gt;6.17&lt;/span&gt;. The Series B Warrant
    assumptions used in the Monte Carlo simulations are an expected term of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z5PN0aZYYAta" title="Expected term years"&gt;2.5&lt;/span&gt; years, exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdp6iUyw1Rkd" title="exercise price"&gt;36.2&lt;/span&gt;, company historical volatility
    of &lt;span id="xdx_903_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zTOC484c1zv6" title="volatility"&gt;378.6&lt;/span&gt;%, risk-free interest rate of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20241112__20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zH1czuAkJ01d" title="Risk free interest rate"&gt;4.30&lt;/span&gt;% and share price of $&lt;span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zFDs7PjQaQr4" title="Share price"&gt;6.17&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
    initial recognition, the management allocated the gross cash proceeds to the detachable instruments included in the issuance, firstly
    to Series A Warrants and Series B Warrants which were classified as financial instruments that are required to be subsequently measured
    at fair value. The fair value at the issuance date of the Series A and Series B Warrants received was $&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zuLbq51y5WQ7" title="Fair value issuance"&gt;1,659&lt;/span&gt; and &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241112__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zFrPrcpYpKd6" title="Fair value issuance"&gt;10,266&lt;/span&gt;, respectively.
    Accordingly, there were no remaining proceeds to allocate to the equity instruments (the Shares and the Pre-Funded Warrants). Issuance
    costs in the amount of $&lt;span id="xdx_903_ecustom--EquityIssuanceCosts_pn3n3_c20240101__20241231_zw0w21SCrWjg" title="Equity issuance costs"&gt;1,217&lt;/span&gt; were recorded as expenses in the Statement of Operations.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    addition, as the total fair value of the derivative liabilities amounting to $&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20241231_zmNPvMQPCwh7" title="Fair value issuance"&gt;11,925&lt;/span&gt; exceeded the $&lt;span id="xdx_90B_ecustom--ClassOfWarrantOrRightReasonForCashRaised_pn3n3_c20240101__20241231_z0mpSHsOPeug" title="Fair value cash raised"&gt;10,000&lt;/span&gt; of cash raised in the issuance,
    the Company recorded an immediate loss from the issuance of equity in the amount of $&lt;span id="xdx_901_ecustom--GainLossOnEquityIssuance_iN_pn3n3_di_c20240101__20241231_z4w4LImdwUVb" title="Loss on equity issuance"&gt;1,925&lt;/span&gt; in the Statement of Operations.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;See
    Note 14 regarding a significant issuance of shares as a settlement of Series B Warrants subsequent to the balance sheet date.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tabular presentation reflects the reconciliation of the fair value of the Warrants during the period from their issuance through
December 31, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_zHPTjgCmnKH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B1_zrEEX7hZhYze" style="display: none"&gt;SCHEDULE OF RECONCILIATION OF THE
FAIR VALUE OF THE WARRANTS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Common Warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series
    A Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series
    B Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;July issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zothQHk05qo5" style="text-align: right"&gt;34&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zyjzotPs6cZk" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Settlement of July warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iNI_di_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zM5WrZeLqBHa" style="text-align: right"&gt;(37&lt;/td&gt;
    &lt;td&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zSEgNfU2s6Q6" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;November issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;-&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zAHJKYckqqI" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,659&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z2SDXoaKDPl4" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231_zEoAAEQdhnG6" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,925&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Settlement of July 30 Convertible Promissory
    Note&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zKji4VH4AQU9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_z8ojZdUDHMI1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,768&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zdfnem8pASHg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,377&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Settlement of July 18 Convertible Promissory
    Note&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_z4eCCdZQksGh" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zYXCzt00Le54" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;279&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zVSbUt2Vord9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zm6qh7wfSiLg" style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zIrMNUIrn8Mi" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zyr94jq70tQ2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;565&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231_zrbSjxmjjQ8e" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;798&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z2TXbwpfsUo9" style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,544&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdqXFV0gyFfi" style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,877&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_znRu6gwQIiKe" style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</GCTK:SignificantTransactionsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-01-032024-01-03_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact000737"
      unitRef="Shares">19765</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-02-15"
      decimals="INF"
      id="Fact000739"
      unitRef="Shares">35932</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-02-15_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000741"
      unitRef="Shares">43820</us-gaap:CommonStockSharesIssued>
    <GCTK:LockUpPeriodDescription
      contextRef="From2024-02-132024-02-13_custom_ExchangeAgreementMember"
      id="Fact000743">(a) sell or contract to sell Shares at a price higher than $0.5 per Share on any trading
                                            day up to 10% of the daily volume of Shares or (b) sell or contract to sell Shares at a price
                                            higher than $0.8 per Share on any trading day with no volume limitation.</GCTK:LockUpPeriodDescription>
    <us-gaap:SharePrice
      contextRef="AsOf2024-02-13_custom_ExchangeAgreementMember"
      decimals="INF"
      id="Fact000745"
      unitRef="USDPShares">100.00</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-04-222024-04-22_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000747"
      unitRef="Shares">3968</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-04-22_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000749"
      unitRef="USDPShares">126</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-04-222024-04-22_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact000751"
      unitRef="USD">500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2024-04-302024-04-30" id="Fact000753">one-for-five</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-06-27_custom_UnsecuredPromissoryNotesMember"
      decimals="-3"
      id="Fact000755"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-06-27"
      decimals="INF"
      id="Fact000757"
      unitRef="Shares">15000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShortTermDebtDescription contextRef="From2024-06-272024-06-27" id="Fact000759">The
    June 27 Notes bear simple interest at a rate of 3% per annum and are due and payable in cash on the earlier of: (a) 12 months from
    the date of the June 27 Note; or (b) the date the Company raises third-party equity capital in an amount equal to or in excess of
    $1,000 (the &#x201c;Maturity Date&#x201d;). The Company may prepay the June 27 Notes at any time prior to the Maturity Date without
    penalty. If an event of default occurs, the then-outstanding principal amount of the June 27 Notes plus any unpaid accrued interest
    will accelerate and become immediately payable in cash.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-27"
      decimals="INF"
      id="Fact000761"
      unitRef="USDPShares">99</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2024-06-27" id="Fact000763">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-06-272024-06-27"
      decimals="-3"
      id="Fact000765"
      unitRef="USD">15000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-06-272024-06-27"
      decimals="-3"
      id="Fact000767"
      unitRef="USD">85000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-06-27"
      decimals="INF"
      id="Fact000769"
      unitRef="Pure">0.2865</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-06-272024-06-27"
      decimals="INF"
      id="Fact000771"
      unitRef="Pure">2.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-06-272024-06-27"
      decimals="INF"
      id="Fact000773"
      unitRef="Pure">0.0452</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <GCTK:ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock
      contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember"
      id="Fact000775">&lt;p id="xdx_890_ecustom--ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zxSka9mHzdi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zID20Ar4xsO6" style="display: none"&gt;SCHEDULE OF RECONCILIATION OF THE CARRYING AMOUNT OF JUNE 27 NOTES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--JuneTwentySevenWarrantsMember_zQzBG2rGhi89" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended&lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WarrantsAndRightsOutstanding_iS_pn3n3_zBqCZcYjxCba" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_zNAWB0oWRiXf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total proceeds received&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProceedsFromAllocatedWarrantsAtInitialRecognition_pn3n3_zl0W3dNDg9Md" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total proceeds allocated to June 27 Warrants
    at initial recognition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DiscountAmortizationAndInterestExpenses_pn3n3_zjUlikiL6W5f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount amortization and interest expenses
    related to June 27 Notes (Note 7 below)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--PartialConversionNotesAndAccruedInterest_pn3n3_zblcEzG7AGM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Partial conversion June
    27 Notes and accrued Interest (Note 4H and Note 4I below)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstanding_iE_pn3n3_z7iEpCvk4pL" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance December&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</GCTK:ScheduleOfReconciliationOfCarryingAmountOfNotesTableTextBlock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember"
      decimals="-3"
      id="Fact000779"
      unitRef="USD">100000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <GCTK:ProceedsFromAllocatedWarrantsAtInitialRecognition
      contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember"
      decimals="-3"
      id="Fact000781"
      unitRef="USD">-85000</GCTK:ProceedsFromAllocatedWarrantsAtInitialRecognition>
    <GCTK:DiscountAmortizationAndInterestExpenses
      contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember"
      decimals="-3"
      id="Fact000783"
      unitRef="USD">16000</GCTK:DiscountAmortizationAndInterestExpenses>
    <GCTK:PartialConversionNotesAndAccruedInterest
      contextRef="From2024-01-012024-12-31_custom_JuneTwentySevenWarrantsMember"
      decimals="-3"
      id="Fact000785"
      unitRef="USD">-26000</GCTK:PartialConversionNotesAndAccruedInterest>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_custom_JuneTwentySevenWarrantsMember"
      decimals="-3"
      id="Fact000787"
      unitRef="USD">5000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-07-18_us-gaap_ConvertibleNotesPayableMember"
      decimals="-3"
      id="Fact000789"
      unitRef="USD">360000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-07-18_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact000791"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2024-07-182024-07-18_us-gaap_ConvertibleNotesPayableMember"
      decimals="-3"
      id="Fact000793"
      unitRef="USD">360000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:InterestExpense
      contextRef="From2024-09-052024-09-05_us-gaap_ConvertibleNotesPayableMember"
      decimals="-3"
      id="Fact000795"
      unitRef="USD">101000</us-gaap:InterestExpense>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-09-052024-09-05_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact000797"
      unitRef="Shares">4955</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-09-05_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact000799"
      unitRef="USDPShares">20.4</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:InterestExpense
      contextRef="From2024-11-012024-11-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000801"
      unitRef="USD">305000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-11-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000803"
      unitRef="USDPShares">31.2</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-11-012024-11-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000805"
      unitRef="Shares">9760000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-11-012024-11-30_custom_SeriesACommonWarrantMember"
      decimals="INF"
      id="Fact000807"
      unitRef="Shares">9760</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-11-012024-11-30_custom_SeriesBCommonWarrantMember"
      decimals="INF"
      id="Fact000809"
      unitRef="Shares">9760</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="AsOf2024-11-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000811"
      unitRef="USD">60000</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-11-30_custom_SeriesACommonWarrantMember"
      decimals="-3"
      id="Fact000813"
      unitRef="USD">43000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-11-30_custom_SeriesBCommonWarrantMember"
      decimals="-3"
      id="Fact000815"
      unitRef="USD">279000</us-gaap:DerivativeLiabilities>
    <us-gaap:LitigationSettlementLoss
      contextRef="From2024-11-012024-11-30"
      decimals="-3"
      id="Fact000817"
      unitRef="USD">79000</us-gaap:LitigationSettlementLoss>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-07-30_custom_ConvertiblePromissoryNotesMember_custom_WarrantsAgreementMember"
      decimals="-3"
      id="Fact000819"
      unitRef="USD">4000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-07-30_custom_ConvertiblePromissoryNotesMember_custom_WarrantsAgreementMember"
      decimals="INF"
      id="Fact000821"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="From2024-07-302024-07-30" id="Fact000822">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-302024-07-30_custom_FirstWarrantMember"
      decimals="INF"
      id="Fact000823"
      unitRef="Shares">106667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-07-30_custom_FirstWarrantMember"
      decimals="INF"
      id="Fact000825"
      unitRef="USDPShares">37.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-302024-07-30_custom_SecondWarrantMember"
      decimals="INF"
      id="Fact000826"
      unitRef="Shares">76191</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-07-30_custom_SecondWarrantMember"
      decimals="INF"
      id="Fact000828"
      unitRef="USDPShares">52.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-302024-07-30_custom_ThirdWarrantMember"
      decimals="INF"
      id="Fact000829"
      unitRef="Shares">59259</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-07-30_custom_ThirdWarrantMember"
      decimals="INF"
      id="Fact000831"
      unitRef="USDPShares">67.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <GCTK:EmbeddedConversionFeaturePercentage
      contextRef="AsOf2024-07-30"
      decimals="INF"
      id="Fact000833"
      unitRef="Pure">2</GCTK:EmbeddedConversionFeaturePercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-07-302024-07-30"
      decimals="-3"
      id="Fact000835"
      unitRef="USD">1450000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-302024-07-30"
      decimals="-3"
      id="Fact000837"
      unitRef="USD">2550000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-07-30"
      decimals="INF"
      id="Fact000839"
      unitRef="Pure">0.2865</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-302024-07-30"
      decimals="INF"
      id="Fact000841"
      unitRef="Pure">1.228</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-07-302024-07-30"
      decimals="INF"
      id="Fact000843"
      unitRef="Pure">0.0478</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2024-07-30"
      decimals="-3"
      id="Fact000845"
      unitRef="USD">35000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-07-30"
      decimals="-3"
      id="Fact000846"
      unitRef="USD">1415000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestExpense
      contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember"
      decimals="-3"
      id="Fact000848"
      unitRef="USD">4093000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember"
      decimals="INF"
      id="Fact000850"
      unitRef="USDPShares">31.0</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember"
      decimals="INF"
      id="Fact000852"
      unitRef="Shares">132036</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact000854"
      unitRef="Shares">132036</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact000856"
      unitRef="Shares">132036</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      id="Fact000858"
      unitRef="USD">813000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      id="Fact000860"
      unitRef="USD">609000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      id="Fact000862"
      unitRef="USD">3768000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember"
      decimals="-3"
      id="Fact000864"
      unitRef="USD">1978000</us-gaap:DerivativeLiabilityFairValueOfCollateral>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember"
      decimals="-3"
      id="Fact000866"
      unitRef="USD">37000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <GCTK:FairValueOfWarrantRelatedDerivatives
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember"
      decimals="-3"
      id="Fact000868"
      unitRef="USD">4377000</GCTK:FairValueOfWarrantRelatedDerivatives>
    <GCTK:FairValueOfWarrantRelatedDerivativesValue
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember"
      decimals="-3"
      id="Fact000870"
      unitRef="USD">813000</GCTK:FairValueOfWarrantRelatedDerivativesValue>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral
      contextRef="AsOf2024-11-12_custom_JuneThirtyNotesMember"
      decimals="-3"
      id="Fact000872"
      unitRef="USD">1978000</us-gaap:DerivativeLiabilityFairValueOfCollateral>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-11-122024-11-12_custom_JuneThirtyNotesMember"
      decimals="-3"
      id="Fact000874"
      unitRef="USD">37000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2024-11-122024-11-12"
      decimals="-3"
      id="Fact000876"
      unitRef="USD">3175000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:InterestExpense
      contextRef="From2024-08-232024-08-23_custom_JuneTwentySevenNotesMember"
      decimals="-3"
      id="Fact000878"
      unitRef="USD">20000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-08-23_custom_JuneTwentySevenNotesMember"
      decimals="INF"
      id="Fact000880"
      unitRef="USDPShares">20.4</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-10-152024-10-15"
      decimals="INF"
      id="Fact000882"
      unitRef="Shares">985</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="From2024-08-232024-08-23_custom_AugustTwentyThreeWarrantMember"
      id="Fact000884">2025-08-16</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantMember"
      id="Fact000886">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantOneMember"
      decimals="INF"
      id="Fact000888"
      unitRef="Shares">535</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantOneMember"
      decimals="INF"
      id="Fact000890"
      unitRef="USDPShares">37.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantTwoMember"
      decimals="INF"
      id="Fact000892"
      unitRef="Shares">382</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantTwoMember"
      decimals="INF"
      id="Fact000894"
      unitRef="USDPShares">52.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantThreeMember"
      decimals="INF"
      id="Fact000896"
      unitRef="Shares">297</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-08-23_custom_AugustTwentyThreeWarrantThreeMember"
      decimals="INF"
      id="Fact000898"
      unitRef="USDPShares">67.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:EquityFairValueDisclosure
      contextRef="AsOf2024-08-23"
      decimals="-3"
      id="Fact000900"
      unitRef="USD">238000</us-gaap:EquityFairValueDisclosure>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-08-23"
      decimals="-3"
      id="Fact000902"
      unitRef="USD">11000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2024-08-232024-08-23"
      decimals="-3"
      id="Fact000904"
      unitRef="USD">216000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:InterestExpense
      contextRef="From2024-09-052024-09-05_custom_JuneTwentySevenNotesMember"
      decimals="-3"
      id="Fact000906"
      unitRef="USD">113000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-09-052024-09-05_custom_JulyEighteenNotesMember"
      decimals="-3"
      id="Fact000908"
      unitRef="USD">146000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-09-05_custom_JulyTwentySevenNotesMember"
      decimals="INF"
      id="Fact000910"
      unitRef="USDPShares">20.4</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-10-152024-10-15_custom_JuneTwentySevenNotesMember"
      decimals="INF"
      id="Fact000912"
      unitRef="Shares">12712</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="From2024-09-052024-09-05_custom_SeptemberFiveWarrantsMember"
      id="Fact000914">2025-08-16</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsMember"
      id="Fact000916">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsOneMember"
      decimals="INF"
      id="Fact000918"
      unitRef="Shares">6915</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsOneMember"
      decimals="INF"
      id="Fact000920"
      unitRef="USDPShares">37.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsTwoMember"
      decimals="INF"
      id="Fact000922"
      unitRef="Shares">4940</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsTwoMember"
      decimals="INF"
      id="Fact000924"
      unitRef="USDPShares">52.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsThirdMember"
      decimals="INF"
      id="Fact000926"
      unitRef="Shares">3842</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-05_custom_SeptemberFiveWarrantsThirdMember"
      decimals="INF"
      id="Fact000928"
      unitRef="USDPShares">67.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:EquityFairValueDisclosure
      contextRef="AsOf2024-09-05"
      decimals="-3"
      id="Fact000930"
      unitRef="USD">1505000</us-gaap:EquityFairValueDisclosure>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-09-05"
      decimals="-3"
      id="Fact000932"
      unitRef="USD">227000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2024-09-052024-09-05"
      decimals="-3"
      id="Fact000934"
      unitRef="USD">1278000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-11-122024-11-12"
      decimals="-3"
      id="Fact000936"
      unitRef="USD">10000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-122024-11-12_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000938"
      unitRef="Shares">121867</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact000940"
      unitRef="Shares">237845</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact000942"
      unitRef="Shares">237845</us-gaap:SharesIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-11-12_custom_SeriesACommonWarrantMember"
      decimals="INF"
      id="Fact000944"
      unitRef="Shares">359712</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-11-12_custom_SeriesBCommonWarrantMember"
      decimals="-3"
      id="Fact000946"
      unitRef="Shares">359712000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember28421031"
      decimals="INF"
      id="Fact000948"
      unitRef="USDPShares">27.80</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-12_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000950"
      unitRef="USDPShares">27.78</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-11-12_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact000952"
      unitRef="USDPShares">0.02</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-11-12_custom_SeriesACommonWarrantMember"
      decimals="INF"
      id="Fact000954"
      unitRef="USDPShares">36.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-11-12_custom_SeriesBCommonWarrantMember"
      decimals="INF"
      id="Fact000956"
      unitRef="USDPShares">36.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2024-11-122024-11-12_custom_SeriesAWarrantMember"
      id="Fact000958">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember"
      decimals="INF"
      id="Fact000960"
      unitRef="USDPShares">36.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember"
      decimals="INF"
      id="Fact000962"
      unitRef="Pure">96.3</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-11-122024-11-12_custom_SeriesAWarrantMember"
      decimals="INF"
      id="Fact000964"
      unitRef="Pure">0.0432</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember"
      decimals="INF"
      id="Fact000966"
      unitRef="USDPShares">6.17</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2024-11-122024-11-12_custom_SeriesBWarrantMember"
      id="Fact000968">P2Y6M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember"
      decimals="INF"
      id="Fact000970"
      unitRef="USDPShares">36.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember"
      decimals="INF"
      id="Fact000972"
      unitRef="Pure">378.6</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-11-122024-11-12_custom_SeriesBWarrantMember"
      decimals="INF"
      id="Fact000974"
      unitRef="Pure">0.0430</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember"
      decimals="INF"
      id="Fact000976"
      unitRef="USDPShares">6.17</us-gaap:SharePrice>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-11-12_custom_SeriesAWarrantMember"
      decimals="-3"
      id="Fact000978"
      unitRef="USD">1659000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-11-12_custom_SeriesBWarrantMember"
      decimals="-3"
      id="Fact000980"
      unitRef="USD">10266000</us-gaap:WarrantsAndRightsOutstanding>
    <GCTK:EquityIssuanceCosts
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000982"
      unitRef="USD">1217000</GCTK:EquityIssuanceCosts>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000984"
      unitRef="USD">11925000</us-gaap:WarrantsAndRightsOutstanding>
    <GCTK:ClassOfWarrantOrRightReasonForCashRaised
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000986"
      unitRef="USD">10000000</GCTK:ClassOfWarrantOrRightReasonForCashRaised>
    <GCTK:GainLossOnEquityIssuance
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact000988"
      unitRef="USD">-1925000</GCTK:GainLossOnEquityIssuance>
    <GCTK:ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000990">&lt;p id="xdx_894_ecustom--ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock_zHPTjgCmnKH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B1_zrEEX7hZhYze" style="display: none"&gt;SCHEDULE OF RECONCILIATION OF THE
FAIR VALUE OF THE WARRANTS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Common Warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series
    A Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Series
    B Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;July issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zothQHk05qo5" style="text-align: right"&gt;34&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyMember_zyjzotPs6cZk" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Settlement of July warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iNI_di_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zM5WrZeLqBHa" style="text-align: right"&gt;(37&lt;/td&gt;
    &lt;td&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyWarrantsMember_zSEgNfU2s6Q6" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;November issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;-&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zAHJKYckqqI" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,659&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_z2SDXoaKDPl4" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231_zEoAAEQdhnG6" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,925&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Settlement of July 30 Convertible Promissory
    Note&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zKji4VH4AQU9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_z8ojZdUDHMI1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,768&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyThirtyMember_zdfnem8pASHg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,377&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Settlement of July 18 Convertible Promissory
    Note&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_z4eCCdZQksGh" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zYXCzt00Le54" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;279&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_c20241231__us-gaap--ShortTermDebtTypeAxis__custom--JulyEighteenMember_zVSbUt2Vord9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zm6qh7wfSiLg" style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_zIrMNUIrn8Mi" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zyr94jq70tQ2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;565&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20241231_zrbSjxmjjQ8e" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;798&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantMember_z2TXbwpfsUo9" style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,544&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zdqXFV0gyFfi" style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,877&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20241231_znRu6gwQIiKe" style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,421&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</GCTK:ScheduleOfReconciliationOfTheFairValueWarrantsTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyMember"
      decimals="-3"
      id="Fact000991"
      unitRef="USD">34000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember_custom_JulyWarrantsMember"
      decimals="-3"
      id="Fact000993"
      unitRef="USD">37000</us-gaap:DerivativeLiabilities>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember"
      decimals="-3"
      id="Fact000995"
      unitRef="USD">1659000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember"
      decimals="-3"
      id="Fact000996"
      unitRef="USD">10266000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000997"
      unitRef="USD">11925000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyThirtyMember"
      decimals="-3"
      id="Fact000998"
      unitRef="USD">609000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyThirtyMember"
      decimals="-3"
      id="Fact000999"
      unitRef="USD">3768000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_custom_JulyThirtyMember"
      decimals="-3"
      id="Fact001000"
      unitRef="USD">4377000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember_custom_JulyEighteenMember"
      decimals="-3"
      id="Fact001001"
      unitRef="USD">45000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember_custom_JulyEighteenMember"
      decimals="-3"
      id="Fact001002"
      unitRef="USD">279000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31_custom_JulyEighteenMember"
      decimals="-3"
      id="Fact001003"
      unitRef="USD">324000</us-gaap:DerivativeLiabilities>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember28421750"
      decimals="-3"
      id="Fact001004"
      unitRef="USD">3000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-12-31_custom_SeriesAWarrantMember"
      decimals="-3"
      id="Fact001005"
      unitRef="USD">230000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-12-31_custom_SeriesBWarrantMember"
      decimals="-3"
      id="Fact001006"
      unitRef="USD">565000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001007"
      unitRef="USD">798000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31_custom_SeriesAWarrantMember"
      decimals="-3"
      id="Fact001008"
      unitRef="USD">2544000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31_custom_SeriesBWarrantMember"
      decimals="-3"
      id="Fact001009"
      unitRef="USD">14877000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001010"
      unitRef="USD">17421000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001012">&lt;p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zEHqyKYrVkde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 - &lt;span id="xdx_822_zi4zQGR3fTw"&gt;COMMITMENTS AND CONTINGENT LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    2004, the Israeli Innovation Authority (IIA) provided Integrity Israel with a grant of approximately $&lt;span id="xdx_908_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember_zetCAtf0Hq11"&gt;93&lt;/span&gt; (NIS &lt;span id="xdx_902_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_uIsrael_c20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember_zuBzhv6IbkT1" title="Contingent consideration liability"&gt;420,000&lt;/span&gt;), for develop
    a non-invasive blood glucose monitor (the &#x201c;Development Plan&#x201d;). Integrity Israel is required to pay royalties to IIA at
    a rate ranging between &lt;span id="xdx_90B_ecustom--RoyaltyPercentage_pid_dp_uPure_c20040303__20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember__srt--RangeAxis__srt--MinimumMember_z5RtbXBJvz0l" title="Royalty percentage minimum"&gt;3&lt;/span&gt;-&lt;span id="xdx_903_ecustom--RoyaltyPercentage_pid_dp_uPure_c20040303__20040304__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--IsraeliInnovationAuthorityMember__srt--RangeAxis__srt--MaximumMember_z10Fcv8efBy9" title="Royalty percentage maximum"&gt;5&lt;/span&gt;% of the proceeds from sale of the Company&#x2019;s products arising from the Development Plan up to an
    amount equal to $&lt;span id="xdx_90A_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20040304__dei--LegalEntityAxis__custom--IsraeliInnovationAuthorityMember_zwWDitPsIrN5" title="Business combination contingent consideration liability"&gt;93&lt;/span&gt;, plus interest at LIBOR from the grant date. Until December 31,2023 the Liability was subject to LIBOR interest
    rate and commencing January 1,2024 the interest rate was replaced with Term SOFR (Secured Overnight Financing Rate). As of December
    31, 2024, the remaining contingent liability with respect to royalty payment on future sales equals approximately $&lt;span id="xdx_90A_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_c20241231__dei--LegalEntityAxis__custom--IsraeliInnovationAuthorityMember_zu37c9wZAwJ7" title="Contingent consideration liability"&gt;93&lt;/span&gt;, excluding
    interest. Such contingent obligation has no expiration date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    October 7, 2022 (&#x201c;the Closing Date&#x201d;), the Company entered into Intellectual Property Purchase Agreement (the &#x201c;Agreement&#x201d;)
    with Paul Goode, which is the Company&#x2019;s Chief Executive Officer (the &#x201c;Seller&#x201d;), under which it was agreed that
    on and subject to the terms and conditions of the Agreement, at the Closing Date, Seller sold and assigned to the Company, all of
    Seller&#x2019;s right, title and interest in and to the following assets, properties and rights (collectively, the &#x201c;Purchased
    Assets&#x201d;): (i) all rights, title, interests in all current and future intellectual property, including, but not limited to patents,
    trademarks, trade secrets, industry know-how and other IP rights relating to an implantable continuous glucose sensor (collectively,
    the &#x201c;Conveyed Intellectual Property&#x201d;); and (ii) all the goodwill relating to the Purchased Assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            consideration for the sale of the Purchased Assets to the Company, at the Closing Date, the
                                            Company paid to Seller cash in the amount of one dollar and obligated to issue up to &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221007__20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWZfCLCqLA46" title="Number of common shares issued"&gt;10,000&lt;/span&gt;
                                            shares of Common Stock to be issued based upon specified performance milestones as set forth
                                            in the Agreement (the &#x201c;Purchase Price&#x201d;). In addition, if upon the final issuance,
                                            the aggregate &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221007__20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zXURTxGcQiSh" title="Number of common shares issued"&gt;10,000&lt;/span&gt; shares represent less than &lt;span id="xdx_905_ecustom--AggregateSalesPriceOfUnitsPercentage_iI_pid_dp_uPure_c20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zBos30nfLKbc" title="Commission as a percentage of aggregate sales price"&gt;1.5&lt;/span&gt;% of the then outstanding Common Stock
                                            of the Company, the final issuance will include such number of additional shares so that
                                            the total aggregate issuance equals &lt;span id="xdx_900_ecustom--AggregateSalesPriceOfUnitsPercentage_iI_pid_dp_uPure_c20221007__us-gaap--TypeOfArrangementAxis__custom--IntellectualPropertyPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__custom--TrueupSharesMember_zgC4d7NKwUel" title="Commission as a percentage of aggregate sales price"&gt;1.5&lt;/span&gt;% of the outstanding shares (the &#x201c;True-Up Shares&#x201d;).
                                            All shares of Common Stock of the Company that will be issued under the agreement shall be
                                            (i) restricted over a limited period as defined in the Agreement and (ii) subject to the
                                            lockup provisions.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
    the Company acquires net assets that do not constitute a business, as defined under ASU 2017-01 Business Combinations (Topic 805)
    Clarifying the Definition of a Business (such when there is no substantive process in the acquired entity) the transaction is accounted
    for as asset acquisition and no goodwill is recognized. The acquired In-Process Research and Development intangible asset (&#x201c;IPR&amp;amp;D&#x201d;)
    to be used in research and development projects which have been determined not to have alternative future use at the acquisition
    date, is expensed immediately.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    the Closing Date, it was determined that the asset acquisition represents the purchase of IPR&amp;amp;D with no alternative future use.
    However, the achievement of each of the performance milestones is considered as a contingent event outside the Company&#x2019;s control
    and thus the contingent consideration which is equal to the fair value of the Purchase Price as measured at the Closing Date will
    be recognized when and if it becomes probable that each target will be achieved within the reasonable period. Such additional contingent
    consideration will be recognized in subsequent periods if and when the contingency (the achievement of targets) is resolved.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            June 2023, the Company achieved the first performance milestone out of the five performance
                                            milestones outlined in the Agreement executed between the Company and the Seller as of the
                                            Closing Date. As a result, upon the date of the fulfilment of the first performance milestone
                                            the Company was committed to issue &lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20230601__20230630_zQKMDIv4s1Lc" title="Restricted shares to the seller"&gt;1,000&lt;/span&gt; restricted shares to the Seller. Accordingly, the
                                            Company recorded an amount of $&lt;span id="xdx_90C_eus-gaap--OtherResearchAndDevelopmentExpense_pn3n3_c20230601__20230630_zEyozOrEvXIj" title="Research and development expenses"&gt;131&lt;/span&gt; as research and development expenses with a similar amount
                                            as an increase to additional paid-in capital. The first performance milestone shares were
                                            issued on February 6, 2024.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    May 2024, the Company achieved the second performance milestone out of the five performance milestones outlined in the Agreement
    executed between the Company and the Seller as of the Closing Date. As result, the Company is committed to issue &lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20240501__20240531_zJpI6oGbMYud" title="Restricted shares"&gt;1,500&lt;/span&gt; restricted
    shares to the Seller. Accordingly, the Company recorded stock-based compensation expenses amounted to $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensation_pn3n3_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv06VEqaR4y1" title="Stock based compensation"&gt;192&lt;/span&gt; which represents the quoted
    price of its Common Stock at the Closing Date, after taking into consideration a discount for lack of marketability in a rate of
    &lt;span id="xdx_906_ecustom--MarketabilityDiscountRate_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgbT2MZMgaSd" title="Discount rate"&gt;30&lt;/span&gt;% over the applicable restriction period. The second performance milestone shares were issued on November 20, 2024, excluding &lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_c20241120__20241120_zSrsCQwxDCA" title="Restricted shares to the seller"&gt;11,000&lt;/span&gt;
    shares that were issued erroneously and were returned to the Company subsequent to the balance sheet date.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 31, 2024, the achievement of all other remaining performance milestones was not considered probable and thus no stock-based
    compensation expenses were recorded with respect to thereof.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember"
      decimals="-3"
      id="Fact001013"
      unitRef="USD">93000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember"
      decimals="0"
      id="Fact001015"
      unitRef="Israel">420000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <GCTK:RoyaltyPercentage
      contextRef="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001017"
      unitRef="Pure">0.03</GCTK:RoyaltyPercentage>
    <GCTK:RoyaltyPercentage
      contextRef="From2004-03-032004-03-04_custom_IsraeliInnovationAuthorityMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001019"
      unitRef="Pure">0.05</GCTK:RoyaltyPercentage>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2004-03-04_custom_IsraeliInnovationAuthorityMember28422109"
      decimals="-3"
      id="Fact001021"
      unitRef="USD">93000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2024-12-31_custom_IsraeliInnovationAuthorityMember"
      decimals="-3"
      id="Fact001023"
      unitRef="USD">93000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001025"
      unitRef="Shares">10000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-10-072022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001027"
      unitRef="Shares">10000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <GCTK:AggregateSalesPriceOfUnitsPercentage
      contextRef="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001029"
      unitRef="Pure">0.015</GCTK:AggregateSalesPriceOfUnitsPercentage>
    <GCTK:AggregateSalesPriceOfUnitsPercentage
      contextRef="AsOf2022-10-07_custom_IntellectualPropertyPurchaseAgreementMember_us-gaap_CommonStockMember_srt_MinimumMember_custom_TrueupSharesMember"
      decimals="INF"
      id="Fact001031"
      unitRef="Pure">0.015</GCTK:AggregateSalesPriceOfUnitsPercentage>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="From2023-06-012023-06-30"
      decimals="INF"
      id="Fact001033"
      unitRef="Shares">1000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2023-06-012023-06-30"
      decimals="-3"
      id="Fact001035"
      unitRef="USD">131000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="From2024-05-012024-05-31"
      decimals="INF"
      id="Fact001037"
      unitRef="Shares">1500</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001039"
      unitRef="USD">192000</us-gaap:ShareBasedCompensation>
    <GCTK:MarketabilityDiscountRate
      contextRef="From2024-01-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001041"
      unitRef="Pure">0.30</GCTK:MarketabilityDiscountRate>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="From2024-11-202024-11-20"
      decimals="INF"
      id="Fact001043"
      unitRef="Shares">11000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001045">&lt;p id="xdx_80A_eus-gaap--LesseeOperatingLeasesTextBlock_zjFUoUFgp7m3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 - &lt;span id="xdx_827_zzfNFJgSREwl"&gt;LEASE AGREEMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    February 19, 2024, the Company entered into Lease Agreement (the &#x201c;Agreement&#x201d;) with Tapsak Enterprises LLC dba Virginia
    Analytical (the &#x201c;Landlord&#x201d;) under which it was agreed that the Company will lease from the Landlord a premises located
    in Front Royal, Virginia area for a monthly rental fee of $&lt;span id="xdx_904_eus-gaap--OperatingLeasePayments_pn2n3_c20240219__20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_zqmazfV95FSj" title="Monthly rental fee"&gt;2.5&lt;/span&gt; over a period of &lt;span id="xdx_905_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_z4OzQoSgRKne" title="Lessee term of contract"&gt;3&lt;/span&gt;-years commencing March 1, 2024 through February
    28, 2027 (the &#x201c;Initial Lease Period&#x201d;). Security deposit of $&lt;span id="xdx_908_eus-gaap--SecurityDeposit_iI_pn2n3_c20240219__us-gaap--TypeOfArrangementAxis__us-gaap--LeaseAgreementsMember_zTcwS2iSUG91" title="Security deposit"&gt;2.5&lt;/span&gt; which represents payment of one month is held by the
    Landlord which will be return to the Company at the end of the Initial Lease Period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            addition, the Company has an option to renew the Initial Lease Period for another two additional
                                            periods of 3-years each following the Initial Lease Period (the &#x201c;Option Term&#x201d;),
                                            following advanced notice as defined in the Agreement. The monthly rental fee over the Option
                                            Term shall be the fair market rate determined as what is a comparable cost for similar property
                                            in Front Royal, Virginia area.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    accordance with the provision of ASC 842, Leases, at the commencement date of the Agreement, the Company recognized the right to
    use asset equals to lease liability in total amount of $&lt;span id="xdx_90D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20240219_zSON18amzYVk" title="Lease liability"&gt;79&lt;/span&gt;. The lease liability was measured at the present value of the future lease
    payments, which are discounted based on an estimate of the incremental interest rate that the Company would be required to pay to
    borrow a similar amount for a similar period in order to obtain a similar amount on the initial recognition date of the lease.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    part of the leasing period, the Company considered only the Initial Lease Period as the realization of the option to extend the period
    was not considered as reasonably certain.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zCv0w4IN9TN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
lease:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zx0Wt3ZQECd7" style="display: none"&gt;SCHEDULE OF OPERATING LEASE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20241231_zROtWDANxNda" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zmiQMgLk0ir7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_zVXHdFK7wvl8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current operating lease
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zM0gd3dxYT48" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-Current operating
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_z0sRuQFxj291" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zOhVyechJiM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturity
analysis of the Company&#x2019;s lease liability:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zhxN2Bz7Sp2f" style="display: none"&gt;SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20241231_zhk6aBE1hwgl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--LessThanOneYearMember_zQvMjhyypqvl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--BetweenOneYearToTwoYearsMember_zZ34HneL7Pj3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Between 1-2 years&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--MoreThanTwoYearsMember_zG16V3qeFvE9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;More than 2 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_zz2zcZcRKCyd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total operating lease
    payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3n3_zpgSXldQotae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zVtdeuD5xcGb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z6zNMXmlhw13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Additional
information on lease&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_z3IoBd8a5rOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of the weighted average remaining lease terms and discount rate for the lease:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zXoNDsXyxAM7" style="display: none"&gt;SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zhDMnhG3g924" title="Lease term (years)"&gt;2.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20241231_z46dRs2l8mE8" title="Weighted average discount rate"&gt;9.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zQb0mj22NE15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-02-192024-02-19_us-gaap_LeaseAgreementsMember"
      decimals="-2"
      id="Fact001047"
      unitRef="USD">2500</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="AsOf2024-02-19_us-gaap_LeaseAgreementsMember"
      id="Fact001049">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-02-19_us-gaap_LeaseAgreementsMember"
      decimals="-2"
      id="Fact001051"
      unitRef="USD">2500</us-gaap:SecurityDeposit>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-02-19"
      decimals="-3"
      id="Fact001053"
      unitRef="USD">79000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001055">&lt;p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zCv0w4IN9TN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
lease:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zx0Wt3ZQECd7" style="display: none"&gt;SCHEDULE OF OPERATING LEASE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20241231_zROtWDANxNda" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zmiQMgLk0ir7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_zVXHdFK7wvl8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current operating lease
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zM0gd3dxYT48" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-Current operating
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001057"
      unitRef="USD">59000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001059"
      unitRef="USD">26000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001061"
      unitRef="USD">33000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001063">&lt;p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zOhVyechJiM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturity
analysis of the Company&#x2019;s lease liability:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zhxN2Bz7Sp2f" style="display: none"&gt;SCHEDULE OF MATURITY ANALYSIS OF LEASE LIABILITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20241231_zhk6aBE1hwgl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--LessThanOneYearMember_zQvMjhyypqvl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--BetweenOneYearToTwoYearsMember_zZ34HneL7Pj3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Between 1-2 years&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_hus-gaap--LeaseContractualTermAxis__custom--MoreThanTwoYearsMember_zG16V3qeFvE9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;More than 2 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_zz2zcZcRKCyd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total operating lease
    payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3n3_zpgSXldQotae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zVtdeuD5xcGb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-12-31_custom_LessThanOneYearMember"
      decimals="-3"
      id="Fact001065"
      unitRef="USD">30000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-12-31_custom_BetweenOneYearToTwoYearsMember"
      decimals="-3"
      id="Fact001067"
      unitRef="USD">30000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-12-31_custom_MoreThanTwoYearsMember"
      decimals="-3"
      id="Fact001069"
      unitRef="USD">5000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001071"
      unitRef="USD">65000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001073"
      unitRef="USD">6000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001075"
      unitRef="USD">59000</us-gaap:OperatingLeaseLiability>
    <GCTK:ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001077">&lt;p id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock_z3IoBd8a5rOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of the weighted average remaining lease terms and discount rate for the lease:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zXoNDsXyxAM7" style="display: none"&gt;SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERMS AND DISCOUNT RATE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zhDMnhG3g924" title="Lease term (years)"&gt;2.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20241231_z46dRs2l8mE8" title="Weighted average discount rate"&gt;9.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</GCTK:ScheduleOfWeightedAverageRemainingLeaseTermsAndDiscountRateTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-12-31" id="Fact001079">P2Y2M1D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001081"
      unitRef="Pure">0.0903</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001083">&lt;p id="xdx_809_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zNWEnU769FUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - &lt;span id="xdx_829_zaihkd8GrwPj"&gt;FINANCE (INCOME) EXPENSES, NET&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zRY8tApv7TFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zhhyHkGx7s26" style="display: none"&gt;SCHEDULE OF FINANCE EXPENSES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20241231_zoPRSF7kunhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20231231_zUwuhKxaWOI" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DiscountAmortizationAndInterestExpensesOne_pn3n3_msFINztjv_zPDUlIGixaS8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount amortization and interest
    expenses related to June 27 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1088"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InterestExpense_pn3n3_msFINztjv_zvmQStutmMhh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses related to July 18 Notes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DiscountAmortizationAndInterestExpensesTwo_pn3n3_msFINztjv_zQdB24YN1PN6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense and debt discount amortization
    related to July 30 Notes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;563&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--InterestExpenseDeposits_pn3n3_msFINztjv_zTdn9coQ6hs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest on bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(62&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OtherExpenses_pn3n3_msFINztjv_zQZspfc7BTNg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate differentials,
    bank commissions and miscellaneous&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FinanceIncomeNet_iNT_pn3n3_di_mtFINztjv_zWdZHG9yDxmj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Finance (income) expenses,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zZjKSS2PwPY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <srt:ScheduleOfCondensedFinancialStatementsTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001085">&lt;p id="xdx_893_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zRY8tApv7TFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zhhyHkGx7s26" style="display: none"&gt;SCHEDULE OF FINANCE EXPENSES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20241231_zoPRSF7kunhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20231231_zUwuhKxaWOI" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DiscountAmortizationAndInterestExpensesOne_pn3n3_msFINztjv_zPDUlIGixaS8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount amortization and interest
    expenses related to June 27 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1088"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InterestExpense_pn3n3_msFINztjv_zvmQStutmMhh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses related to July 18 Notes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DiscountAmortizationAndInterestExpensesTwo_pn3n3_msFINztjv_zQdB24YN1PN6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense and debt discount amortization
    related to July 30 Notes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;563&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--InterestExpenseDeposits_pn3n3_msFINztjv_zTdn9coQ6hs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest on bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(62&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OtherExpenses_pn3n3_msFINztjv_zQZspfc7BTNg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate differentials,
    bank commissions and miscellaneous&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FinanceIncomeNet_iNT_pn3n3_di_mtFINztjv_zWdZHG9yDxmj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Finance (income) expenses,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</srt:ScheduleOfCondensedFinancialStatementsTableTextBlock>
    <GCTK:DiscountAmortizationAndInterestExpensesOne
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001087"
      unitRef="USD">21000</GCTK:DiscountAmortizationAndInterestExpensesOne>
    <us-gaap:InterestExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001090"
      unitRef="USD">44000</us-gaap:InterestExpense>
    <GCTK:DiscountAmortizationAndInterestExpensesTwo
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001093"
      unitRef="USD">563000</GCTK:DiscountAmortizationAndInterestExpensesTwo>
    <us-gaap:InterestExpenseDeposits
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001096"
      unitRef="USD">-62000</us-gaap:InterestExpenseDeposits>
    <us-gaap:InterestExpenseDeposits
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001097"
      unitRef="USD">-17000</us-gaap:InterestExpenseDeposits>
    <us-gaap:OtherExpenses
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001099"
      unitRef="USD">17000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001100"
      unitRef="USD">10000</us-gaap:OtherExpenses>
    <GCTK:FinanceIncomeNet
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001102"
      unitRef="USD">-583000</GCTK:FinanceIncomeNet>
    <GCTK:FinanceIncomeNet
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001103"
      unitRef="USD">7000</GCTK:FinanceIncomeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001105">&lt;p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zS2na9NIF4ci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2013; &lt;span id="xdx_829_zkPT3d3hLrQh"&gt;COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Description
    of the rights attached to the Common Stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
    share of Common Stock entitles the holder to one vote, either in person or by proxy, on each matter submitted to the approval of
    the Company&#x2019;s stockholders. The holders of Common Stock are not permitted to vote their shares cumulatively. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity
    Issuances&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;1.
                                            2023 Equity Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    April 13, 2023, the Company completed an underwritten public offering under which the Company received gross proceeds of approximately
    $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20230413__20230413_zxsMl0N5OWo8" title="Gross proceeds"&gt;10&lt;/span&gt; million for issuance of (i) &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230413__20230413__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9pc7SVGJm8b" title="Common stock shares"&gt;53,765&lt;/span&gt; shares of common stock and (ii) &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230413__20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zrEzQVIriFxg" title="Common stock shares"&gt;19,765&lt;/span&gt; pre-funded warrants at a price to the public of $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_z9NeeBducPe4" title="Share price"&gt;136&lt;/span&gt;
    per share. The pre-funded warrants are exercisable for the same number of shares of common stock and may be exercised at any time
    until exercised in full at an exercise price of $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230413__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zjwIA9gadBMe" title="Exercise price"&gt;0.001&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
                                            satisfaction of customary closing conditions, the closing date of the above underwritten
                                            public offering was April 17, 2023 (the &#x201c;Closing Date&#x201d;). The Company received
                                            substantially all the pre-funded warrant&#x2019;s proceeds upfront (without any conditions)
                                            as part of the pre-funded warrant&#x2019;s purchase price and in return the Company is obligated
                                            to issue fixed number of &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230417__20230417__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGgK4SiizlB7" title="Common stock shares"&gt;19,765&lt;/span&gt; shares of Common Stock to the holders. Thus, pre-funded warrants
                                            were accounted for and were classified as additional paid-in capital as part of the Company&#x2019;s
                                            stockholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    incremental and direct issuance costs amounted to $&lt;span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230413__20230413_zEO8wFS4Gj74"&gt;1,270&lt;/span&gt; thousand. These expenses were deducted from additional paid-in capital as
    they were allocated to shares of Common Stock and pre-funded warrants.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    January 3, 2024, the above pre-funded warrants have been fully exercised to &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240103__20240103__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zykf73pA6Cxe" title="Exercises in period"&gt;19,765&lt;/span&gt; shares of Common Stock of the Company.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.
    2024 Equity Issuances&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;See
    Notes 4H, 4I and 4J relating to the issuances of shares during 2024.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.
    Subsequent event issuances&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;See
    Note 14 regarding a significant issuance of shares as a settlement of Series B Warrants subsequent to the balance sheet date.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock-based
    compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    January 11, 2010, the Company&#x2019;s Board of Directors approved and adopted the 2010 Share Incentive Plan (the &#x201c;Plan&#x201d;),
    pursuant to which the Company&#x2019;s Board of Directors may award share options to purchase the Company&#x2019;s Common Stock as
    well as restricted shares, Restricted Stock Units (the &#x201c;RSU&#x201d;) and other share-based awards to designated participants.
    Subject to the terms and conditions of the Plan, &lt;span id="xdx_90E_eus-gaap--DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability_c20100110__20100111_zAojIuIoyRRl" title="Plan description"&gt;the Company&#x2019;s Board of Directors has full authority in its discretion, from
    time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the respective award
    agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of shares to be
    covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and the nature
    and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
    or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election
    as to the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and
    to take actions, as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions
    of the Plan and to amend from time to time the terms of the Plan&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Grant
    of equity awards to employees &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    August 2023, the Company granted Ms. Drinda Benjamin, the Vice President, Marketing of the Company, &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230801__20230831__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zc28hDhlxYLd" title="Share based options"&gt;2,220&lt;/span&gt; options estimated at fair
    value of $&lt;span id="xdx_904_eus-gaap--OfficersCompensation_pn3n3_c20230801__20230831__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYpuTgAko2y1" title="Compensation"&gt;51&lt;/span&gt;, to purchase the same number of Common Stock, with an exercise price per share equals to the greater of (A) $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230831__srt--TitleOfIndividualAxis__custom--MarkTapsakMember_zE1Yjk4iukvf" title="Share price"&gt;136&lt;/span&gt; per
    share or (B) the closing price of a share of Common Stock on the grant date, as reported by Bloomberg L.P., which shall vest in equal
    monthly installments over a period of &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pid_dtY_c20230801__20230831__srt--TitleOfIndividualAxis__custom--MarkTapsakMember_zzHal6xMW2Ud" title="Grant date period"&gt;3&lt;/span&gt;-years following the grant date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 14, 2024, the Board of Directors approved the cancellation of all outstanding stock options previously granted to employees,
    directors, and officers of the Company. Concurrently, the Board authorized the issuance of new stock options to the relevant parties.
    The new stock options were issued in replacement with exercise price $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20240614__20240614__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z9ff6GRShmb" title="Exercise price of options"&gt;245&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;During
    the years ended December 31, 2024 and 2023, the Company recorded stock-based compensation expenses of $&lt;span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20241231__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember_zyX7Tu2BKz3h" title="Stock based compensation income"&gt;173&lt;/span&gt;
    and $&lt;span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--DrindaBenjaminMember_zqHZIqHqIbol" title="Stock based compensation income"&gt;281&lt;/span&gt;,
    respectively.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;D&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    following table presents the Company&#x2019;s stock options (excluding RSU) activity for employees and members of the Board of Directors
    of the Company under the Plan, for the years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zUnlVWsVFWIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_z4lrO17mV4sf" style="display: none"&gt;SCHEDULE
OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
                                            Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
                                            Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;life&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231_zaAzo52k2B6i" style="width: 12%; text-align: right" title="Number outstanding beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,046&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_znEjOLrl6XJ4" style="width: 12%; text-align: right" title="Weighted average exercise price outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z4WJGfWup6U9" title="Weighted average remaining contractual life, Outstanding"&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20230101__20231231_zCUbl0Mjflgk" style="width: 12%; text-align: right" title="Intrinsic value outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1146"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231_zfU8A4GVfRV3" style="text-align: right" title="Number of share options outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,221&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zZcDHiPYBGgl" style="text-align: right" title="Weighted average exercise price, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z2iQAj7uehRc" title="Weighted average remaining contractual life, Granted"&gt;9.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20230101__20231231_z604wfjuE9x8" style="text-align: right" title="Intrinsic value outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1154"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231_z5ztECF9ku5d" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(269&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zlMwPp17oRUe" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1290&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zkJDZf9fcDE5" title="Weighted average remaining contractual life, Forfeited or expired"&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20230101__20231231_zz1ROjgS7evc" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20241231_zUPtgFfsZwUe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20241231_zrFV1luqjgE8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zOLtT6oPq8za" title="Weighted average remaining contractual life, Outstanding"&gt;8.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zkOXzBCL2CK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1170"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20241231_zdoCwT2epni9" style="text-align: right" title="Number of share options outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,438&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_z1VtIh8cpZr9" style="text-align: right" title="Weighted average exercise price, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49.72&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20240101__20241231_zUsBUuVQFV1l" title="Weighted average remaining contractual life, Granted"&gt;9.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20240101__20241231_zjL9Ynrz5evl" style="text-align: right" title="Intrinsic value outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1178"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_pid_c20240101__20241231_zeiu4L5S6Jcb" style="text-align: right" title="Number of share options outstanding, cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240101__20241231_zshCKLI4meTl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1182"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_zQob9IMwjH9f" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1184"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20240101__20241231_zz2eaNDWu22k" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20241231_zWBSV3HSyHG5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,436&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zy9RbIAzzlF" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49.72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zssR7b6JLeE3" title="Weighted average remaining contractual life, Outstanding"&gt;9.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zGRFWdgoD0d2" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20241231_zQXojA8mW6ra" style="border-bottom: Black 2.5pt double; text-align: right" title="Number exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,249&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_fKg_____zefzLVfuQ09d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*49.11&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_dtY_c20240101__20241231_z6OgQHJ6l88b" title="Weighted average remaining contractual life, Exercisable"&gt;9.41&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zMpdZmEQYNBd" style="border-bottom: Black 2.5pt double; text-align: center" title="Intrinsic value outstanding exercisable, Ending balance"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1202"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0E_zSs6eOY0FQQ4" style="width: 15pt; text-align: right"&gt;*&lt;/td&gt;&lt;td id="xdx_F14_zB5eie8s33dc" style="text-align: justify"&gt;After modification of exercise price&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A7_zqkTIkOoi42a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of
    the Company&#x2019;s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied
    by the number of in-the-money share options) that would have been received by the share option holders had all share options holders
    exercised their share options on December 31 of each of the reported period. This amount is impacted by the changes in the fair market
    value of the Company&#x2019;s Ordinary Share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;E&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
    the years ended December 31, 2024 and 2023, stock options have not been exercised into Common Stock. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;F&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    following table presents the assumptions used to estimate the fair values of the share options granted in the reported periods presented:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zjPjM1faXsEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B2_zgQjCPA7XeD8" style="display: none"&gt;SCHEDULE
OF ASSUMPTIONS USED TO VALUE OPTIONS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 78%; margin-left: 1.5in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240101__20241231_zoco2NDkmdqg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20231231_zbXCx5X3LeV2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_z7KiyVdc2EG2" title="Volatility, minimum"&gt;207&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_z3bFWhyk5vWb" title="Volatility, maximum"&gt;288&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231_z3XREW8cGXZ5" title="Volatility"&gt;220&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zWBEKiGF8mKe" title="Risk-free interest rate, minimum"&gt;3.51&lt;/span&gt;-&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zq7vmfW03l74" title="Risk-free interest rate, maximum"&gt;4.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231_ztCnsGkLlJ26" title="Risk-free interest rate"&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_zZ6L68M33u1e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1220"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231_z2u6oAWG6Yg4" title="Expected life (years)"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zdZdM8Yc69Id" title="Expected life (years)"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price ($)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MinimumMember_zKNewAmVrF39" title="Exercise price, minimum"&gt;41&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MaximumMember_zryWBW8KOAwa" title="Exercise price, maximum"&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231_zqzEfhJPHuyj" title="Exercise price"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price ($)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharePrice_iI_pid_c20241231_zhHl6wdu3URi" title="Share price"&gt;49.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zItWZe8rqN88" title="Share price"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zKazbGoLV2A9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;G&lt;b&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 31, 2024, there was $&lt;span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_c20241231_zrr03num4jtj"&gt;298&lt;/span&gt; &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
    unrecognized compensation expense related to unvested stock options. The Company recognizes compensation expense on an accelerated
    vesting basis over the requisite service periods, which results in a weighted average period of approximately &lt;span id="xdx_90B_eus-gaap--DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_dtY_c20240101__20241231_zBI5tkr03Bt1"&gt;1.9 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years
    over which the unrecognized compensation expense is expected to be recognized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Grant
    of equity awards to non-employees&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
    closing of underwritten U.S. public offering in 2023 as noted in Note 8B above, a down round protection feature of certain
    previously granted warrants, was triggered through the reduction of their original exercise prices from a price in a range of $&lt;span id="xdx_908_ecustom--WarrantsOriginalExercisePrice_iI_pn3n3_c20230413__srt--RangeAxis__srt--MinimumMember_zFv73y5L1WMi" title="Warrants original exercise price"&gt;335&lt;/span&gt;
    -$&lt;span id="xdx_903_ecustom--WarrantsOriginalExercisePrice_iI_pn3n3_c20230413__srt--RangeAxis__srt--MaximumMember_zdRobEy8doxg" title="Warrants original exercise price"&gt;7,020&lt;/span&gt;
    to a price of $&lt;span id="xdx_902_ecustom--PublicOfferingPrice_iI_pid_c20230413_zOPLne8Rwys5" title="Public offering price"&gt;136&lt;/span&gt;
    which represented the public offering price. Such reduction was accounted for in accordance with the provisions of ASU 2017-11 as a
    deemed dividend estimated at a total amount of $&lt;span id="xdx_902_eus-gaap--AdditionalPaidInCapital_iI_pn3n3_c20230413_zej7ZbxDNmS4" title="Additional paid in capital"&gt;855&lt;/span&gt;
    thousand which was recorded as part of the additional paid-in capital versus increase of accumulated deficit. Regarding the effect
    of the loss per share, see also Note 2O above.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    following table presents the Company&#x2019;s warrants activity for the years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zz3x9OT8Q3Z6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_z3KtLYkDtfp5" style="display: none"&gt;SCHEDULE
OF WARRANTS ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
                                            Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
                                            Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;life&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20240101__20241231_zCnVzou8sMsc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1248"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20240101__20241231_zKLzb6IWIJN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1250"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iS_pid_c20240101__20241231_zRqnnYeSaLk3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1252"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20240101__20241231_zPl8gX257xNf" style="width: 12%; text-align: right" title="Number of share warrants outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,278,259&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20240101__20241231_zeKl98MZJFah" style="width: 12%; text-align: right" title="Weighted average exercise price, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z9dXKfNYeT23" title="Weighted average remaining contractual life, Granted"&gt;9.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_pid_c20240101__20241231_zFRqZ3odyWHg" style="text-align: right" title="Number of share warrants outstanding, cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1260"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_pid_c20240101__20241231_zTR5NRmxVzJd" style="text-align: right" title="Weighted average exercise price, cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20240101__20241231_z3nkyB9LmqOg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_pid_c20240101__20241231_zSMIyESEGBji" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20240101__20241231_zUS7LlIrOzhi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,278,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20240101__20241231_zUI9uG1tRdr4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_z4aCRMu8GOId" title="Weighted average remaining contractual life, Outstanding"&gt;9.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iE_pid_c20240101__20241231_zQPsNMwjNva3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240101__20241231_zMGsGRoioc61" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share options exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,278,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zZaQRERu0qdj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_dtY_c20240101__20241231_zOH7Lo6Ps39h" title="Weighted average remaining contractual life, Exercisable"&gt;9.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zjv2ltqCtgdl" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zArscaMVYNKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    total compensation cost related to all of the Company&#x2019;s equity-based awards recognized during the years ended December 31,
    2024 and 2023 was comprised as follows:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_89D_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zN9EaBRuUQl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B7_zwXR2MIxMf8c" style="display: none"&gt;SCHEDULE
OF TOTAL COMPENSATION COST EQUITY BASED AWARDS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20241231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_zwVM0JAAKlac" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20231231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_z8tnmwU7QbD8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zcDJHAAIkttl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;307&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;176&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zyyS2nvu4MK2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;364&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;159&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zxSSOebnpZq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total compensation cost
    &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;335&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zsyo2Y6jrSLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-04-132023-04-13"
      decimals="-6"
      id="Fact001107"
      unitRef="USD">10000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-04-132023-04-13_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001109"
      unitRef="Shares">53765</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-04-132023-04-13_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001111"
      unitRef="Shares">19765</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-04-13_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001113"
      unitRef="USDPShares">136</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-04-13_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001115"
      unitRef="USDPShares">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-04-172023-04-17_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001117"
      unitRef="Shares">19765</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-04-132023-04-13"
      decimals="-3"
      id="Fact001118"
      unitRef="USD">1270000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-01-032024-01-03_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001120"
      unitRef="Shares">19765</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability contextRef="From2010-01-102010-01-11" id="Fact001122">the Company&#x2019;s Board of Directors has full authority in its discretion, from
    time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the respective award
    agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of shares to be
    covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and the nature
    and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
    or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election
    as to the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and
    to take actions, as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions
    of the Plan and to amend from time to time the terms of the Plan</us-gaap:DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-08-012023-08-31_custom_DrindaBenjaminMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact001124"
      unitRef="Shares">2220</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:OfficersCompensation
      contextRef="From2023-08-012023-08-31_custom_DrindaBenjaminMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact001126"
      unitRef="USD">51000</us-gaap:OfficersCompensation>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-08-31_custom_MarkTapsakMember"
      decimals="INF"
      id="Fact001128"
      unitRef="USDPShares">136</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-08-012023-08-31_custom_MarkTapsakMember"
      id="Fact001130">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2024-06-142024-06-14_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001132"
      unitRef="USD">245000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31_custom_DrindaBenjaminMember"
      decimals="-3"
      id="Fact001134"
      unitRef="USD">173000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_custom_DrindaBenjaminMember"
      decimals="-3"
      id="Fact001136"
      unitRef="USD">281000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001138">&lt;p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zUnlVWsVFWIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_z4lrO17mV4sf" style="display: none"&gt;SCHEDULE
OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
                                            Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
                                            Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;life&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231_zaAzo52k2B6i" style="width: 12%; text-align: right" title="Number outstanding beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,046&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_znEjOLrl6XJ4" style="width: 12%; text-align: right" title="Weighted average exercise price outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z4WJGfWup6U9" title="Weighted average remaining contractual life, Outstanding"&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20230101__20231231_zCUbl0Mjflgk" style="width: 12%; text-align: right" title="Intrinsic value outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1146"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231_zfU8A4GVfRV3" style="text-align: right" title="Number of share options outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,221&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zZcDHiPYBGgl" style="text-align: right" title="Weighted average exercise price, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z2iQAj7uehRc" title="Weighted average remaining contractual life, Granted"&gt;9.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20230101__20231231_z604wfjuE9x8" style="text-align: right" title="Intrinsic value outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1154"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231_z5ztECF9ku5d" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(269&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zlMwPp17oRUe" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1290&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zkJDZf9fcDE5" title="Weighted average remaining contractual life, Forfeited or expired"&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20230101__20231231_zz1ROjgS7evc" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20241231_zUPtgFfsZwUe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20241231_zrFV1luqjgE8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zOLtT6oPq8za" title="Weighted average remaining contractual life, Outstanding"&gt;8.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zkOXzBCL2CK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1170"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20241231_zdoCwT2epni9" style="text-align: right" title="Number of share options outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,438&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_z1VtIh8cpZr9" style="text-align: right" title="Weighted average exercise price, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49.72&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_dtY_c20240101__20241231_zUsBUuVQFV1l" title="Weighted average remaining contractual life, Granted"&gt;9.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20240101__20241231_zjL9Ynrz5evl" style="text-align: right" title="Intrinsic value outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1178"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodGross_pid_c20240101__20241231_zeiu4L5S6Jcb" style="text-align: right" title="Number of share options outstanding, cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240101__20241231_zshCKLI4meTl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1182"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20241231_zQob9IMwjH9f" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1184"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue_pid_c20240101__20241231_zz2eaNDWu22k" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20241231_zWBSV3HSyHG5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number outstanding ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,436&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zy9RbIAzzlF" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49.72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zssR7b6JLeE3" title="Weighted average remaining contractual life, Outstanding"&gt;9.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240101__20241231_zGRFWdgoD0d2" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20241231_zQXojA8mW6ra" style="border-bottom: Black 2.5pt double; text-align: right" title="Number exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,249&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_fKg_____zefzLVfuQ09d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*49.11&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue_dtY_c20240101__20241231_z6OgQHJ6l88b" title="Weighted average remaining contractual life, Exercisable"&gt;9.41&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zMpdZmEQYNBd" style="border-bottom: Black 2.5pt double; text-align: center" title="Intrinsic value outstanding exercisable, Ending balance"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1202"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0E_zSs6eOY0FQQ4" style="width: 15pt; text-align: right"&gt;*&lt;/td&gt;&lt;td id="xdx_F14_zB5eie8s33dc" style="text-align: justify"&gt;After modification of exercise price&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001140"
      unitRef="Shares">8046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001142"
      unitRef="USDPShares">152</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-012022-12-31" id="Fact001144">P2Y1M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001148"
      unitRef="Shares">2221</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001150"
      unitRef="USDPShares">28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="From2023-01-012023-12-31" id="Fact001152">P9Y8M12D</GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001156"
      unitRef="Shares">269</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001158"
      unitRef="USDPShares">1290</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1 contextRef="From2023-01-012023-12-31" id="Fact001160">P1Y8M12D</GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001164"
      unitRef="Shares">9998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001166"
      unitRef="USDPShares">90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2023-01-012023-12-31" id="Fact001168">P8Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001172"
      unitRef="Shares">6438</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001174"
      unitRef="USDPShares">49.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="From2024-01-01to2024-12-31" id="Fact001176">P9Y4M13D</GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001188"
      unitRef="Shares">16436</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001190"
      unitRef="USDPShares">49.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2024-01-01to2024-12-31" id="Fact001192">P9Y4M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001196"
      unitRef="Shares">11249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001198"
      unitRef="USDPShares">49.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <GCTK:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue contextRef="From2024-01-01to2024-12-31" id="Fact001200">P9Y4M28D</GCTK:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001205">&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zjPjM1faXsEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B2_zgQjCPA7XeD8" style="display: none"&gt;SCHEDULE
OF ASSUMPTIONS USED TO VALUE OPTIONS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 78%; margin-left: 1.5in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240101__20241231_zoco2NDkmdqg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20231231_zbXCx5X3LeV2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20241231_z7KiyVdc2EG2" title="Volatility, minimum"&gt;207&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20241231_z3bFWhyk5vWb" title="Volatility, maximum"&gt;288&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231_z3XREW8cGXZ5" title="Volatility"&gt;220&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20241231_zWBEKiGF8mKe" title="Risk-free interest rate, minimum"&gt;3.51&lt;/span&gt;-&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20241231_zq7vmfW03l74" title="Risk-free interest rate, maximum"&gt;4.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231_ztCnsGkLlJ26" title="Risk-free interest rate"&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_zZ6L68M33u1e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1220"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231_z2u6oAWG6Yg4" title="Expected life (years)"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zdZdM8Yc69Id" title="Expected life (years)"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price ($)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MinimumMember_zKNewAmVrF39" title="Exercise price, minimum"&gt;41&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20241231__srt--RangeAxis__srt--MaximumMember_zryWBW8KOAwa" title="Exercise price, maximum"&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231_zqzEfhJPHuyj" title="Exercise price"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price ($)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharePrice_iI_pid_c20241231_zhHl6wdu3URi" title="Share price"&gt;49.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zItWZe8rqN88" title="Share price"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001207"
      unitRef="Pure">2.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001209"
      unitRef="Pure">2.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001211"
      unitRef="Pure">2.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001213"
      unitRef="Pure">0.0351</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001215"
      unitRef="Pure">0.0464</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001217"
      unitRef="Pure">0.047</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2024-01-01to2024-12-31" id="Fact001222">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2023-01-012023-12-31" id="Fact001224">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001226"
      unitRef="USDPShares">41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001228"
      unitRef="USDPShares">58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001230"
      unitRef="USDPShares">140</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001232"
      unitRef="USDPShares">49.0</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001234"
      unitRef="USDPShares">30</us-gaap:SharePrice>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001235"
      unitRef="USD">298000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm1 contextRef="From2024-01-01to2024-12-31" id="Fact001236">P1Y10M24D</us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm1>
    <GCTK:WarrantsOriginalExercisePrice
      contextRef="AsOf2023-04-13_srt_MinimumMember"
      decimals="-3"
      id="Fact001238"
      unitRef="USD">335000</GCTK:WarrantsOriginalExercisePrice>
    <GCTK:WarrantsOriginalExercisePrice
      contextRef="AsOf2023-04-13_srt_MaximumMember"
      decimals="-3"
      id="Fact001240"
      unitRef="USD">7020000</GCTK:WarrantsOriginalExercisePrice>
    <GCTK:PublicOfferingPrice
      contextRef="AsOf2023-04-13"
      decimals="INF"
      id="Fact001242"
      unitRef="USD">136</GCTK:PublicOfferingPrice>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-04-13"
      decimals="-3"
      id="Fact001244"
      unitRef="USD">855000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001246">&lt;p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zz3x9OT8Q3Z6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_z3KtLYkDtfp5" style="display: none"&gt;SCHEDULE
OF WARRANTS ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
                                            Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
                                            Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;life&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20240101__20241231_zCnVzou8sMsc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1248"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20240101__20241231_zKLzb6IWIJN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1250"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iS_pid_c20240101__20241231_zRqnnYeSaLk3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1252"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20240101__20241231_zPl8gX257xNf" style="width: 12%; text-align: right" title="Number of share warrants outstanding, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,278,259&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20240101__20241231_zeKl98MZJFah" style="width: 12%; text-align: right" title="Weighted average exercise price, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z9dXKfNYeT23" title="Weighted average remaining contractual life, Granted"&gt;9.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_pid_c20240101__20241231_zFRqZ3odyWHg" style="text-align: right" title="Number of share warrants outstanding, cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1260"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice_pid_c20240101__20241231_zTR5NRmxVzJd" style="text-align: right" title="Weighted average exercise price, cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20240101__20241231_z3nkyB9LmqOg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share options outstanding, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageExercisePrice_pid_c20240101__20241231_zSMIyESEGBji" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited or expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20240101__20241231_zUS7LlIrOzhi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share warrants outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,278,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20240101__20241231_zUI9uG1tRdr4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_z4aCRMu8GOId" title="Weighted average remaining contractual life, Outstanding"&gt;9.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iE_pid_c20240101__20241231_zQPsNMwjNva3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240101__20241231_zMGsGRoioc61" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of share options exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,278,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20241231_zZaQRERu0qdj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price exercisable, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39.66&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3_dtY_c20240101__20241231_zOH7Lo6Ps39h" title="Weighted average remaining contractual life, Exercisable"&gt;9.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExerciableInPeriodIntrinsicValue_pid_c20240101__20241231_zjv2ltqCtgdl" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic value outstanding exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001254"
      unitRef="Shares">1278259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact001256"
      unitRef="USDPShares">39.66</GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice>
    <GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm contextRef="From2023-01-012023-12-31" id="Fact001258">P9Y3M21D</GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001268"
      unitRef="Shares">1278259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001270"
      unitRef="USDPShares">39.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2024-01-01to2024-12-31" id="Fact001272">P9Y3M21D</GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOtherThanOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001276"
      unitRef="Shares">1278259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001278"
      unitRef="USDPShares">39.66</GCTK:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice>
    <GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3 contextRef="From2024-01-01to2024-12-31" id="Fact001280">P9Y3M21D</GCTK:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm3>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001284">&lt;p id="xdx_89D_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zN9EaBRuUQl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B7_zwXR2MIxMf8c" style="display: none"&gt;SCHEDULE
OF TOTAL COMPENSATION COST EQUITY BASED AWARDS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20241231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_zwVM0JAAKlac" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20231231__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_z8tnmwU7QbD8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zcDJHAAIkttl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;307&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;176&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zyyS2nvu4MK2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;364&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;159&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zxSSOebnpZq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total compensation cost
    &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;335&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact001286"
      unitRef="USD">307000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact001287"
      unitRef="USD">176000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001289"
      unitRef="USD">364000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001290"
      unitRef="USD">159000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-12-31_us-gaap_ResearchAndDevelopmentArrangementMember"
      decimals="-3"
      id="Fact001292"
      unitRef="USD">671000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentArrangementMember"
      decimals="-3"
      id="Fact001293"
      unitRef="USD">335000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001295">&lt;p id="xdx_80A_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_z5GT5QD7l5Wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2013; &lt;span id="xdx_827_zbEbjiwqGhQa"&gt;RESEARCH AND DEVELOPMENT EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_zeYCwsmQlvV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B0_z3tS403mB4J" style="display: none"&gt;SCHEDULE
OF RESEARCH AND DEVELOPMENT EXPENSES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240101__20241231_zieA5Qcf5x0k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230101__20231231_zaCiAlzk1Fma" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and
    Development&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--SalariesAndRelatedMember_zBPzX7Rqwqkf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,881&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;930&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--ProfessionalFeesMember_ze9rs3UF3WU2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,363&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,709&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--DepreciationMember_zSD4xvmiNPy2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--OtherExpenseMember_zSfuba1NFXS9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_zYw3VtnrXsgj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Research and Development
    Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,499&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,704&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zqXIUkkgAa02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <GCTK:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001297">&lt;p id="xdx_89D_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_zeYCwsmQlvV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B0_z3tS403mB4J" style="display: none"&gt;SCHEDULE
OF RESEARCH AND DEVELOPMENT EXPENSES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240101__20241231_zieA5Qcf5x0k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230101__20231231_zaCiAlzk1Fma" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and
    Development&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--SalariesAndRelatedMember_zBPzX7Rqwqkf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,881&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;930&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--ProfessionalFeesMember_ze9rs3UF3WU2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,363&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,709&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__custom--DepreciationMember_zSD4xvmiNPy2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--OtherExpenseMember_zSfuba1NFXS9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_zYw3VtnrXsgj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Research and Development
    Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,499&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,704&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</GCTK:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_custom_SalariesAndRelatedMember"
      decimals="-3"
      id="Fact001299"
      unitRef="USD">1881000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_SalariesAndRelatedMember"
      decimals="-3"
      id="Fact001300"
      unitRef="USD">930000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_custom_ProfessionalFeesMember"
      decimals="-3"
      id="Fact001302"
      unitRef="USD">7363000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_ProfessionalFeesMember"
      decimals="-3"
      id="Fact001303"
      unitRef="USD">3709000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_custom_DepreciationMember"
      decimals="-3"
      id="Fact001305"
      unitRef="USD">14000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_DepreciationMember"
      decimals="-3"
      id="Fact001306"
      unitRef="USD">10000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_us-gaap_OtherExpenseMember"
      decimals="-3"
      id="Fact001308"
      unitRef="USD">241000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_us-gaap_OtherExpenseMember"
      decimals="-3"
      id="Fact001309"
      unitRef="USD">55000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001311"
      unitRef="USD">9499000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001312"
      unitRef="USD">4704000</us-gaap:ResearchAndDevelopmentExpense>
    <GCTK:GeneralAndAdministrativeExpensesTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001314">&lt;p id="xdx_805_ecustom--GeneralAndAdministrativeExpensesTextBlock_zznxPwI2bId6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_824_zjBGTRGWPtph"&gt;GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_z2CXkyoEzpk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zFHyXYGZvPRg" style="display: none"&gt;SCHEDULE
OF GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20241231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM8UdbFpODS" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zT9wmhaz4rAe" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and
    Administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LaborAndRelatedExpense_pn3n3_maGAAEzQ9k_zCpat4NjDHgk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;476&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;340&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProfessionalFees_pn3n3_maGAAEzQ9k_zi4SxpoWDAhl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees (including directors&#x2019;
    fees)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,724&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,527&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DepreciationAndAmortization_pn3n3_maGAAEzQ9k_zrUjIai7EGw1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InvestmentIncomeInvestmentExpense_pn3n3_maGAAEzQ9k_zIIKtdrgapB7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherGeneralAndAdministrativeExpense_pn3n3_maGAAEzQ9k_zWX9v32IOFne" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzQ9k_zw6DDv0l8y45" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total general and administrative
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,655&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,278&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zH0EAE74M6el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</GCTK:GeneralAndAdministrativeExpensesTextBlock>
    <GCTK:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001316">&lt;p id="xdx_89A_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_z2CXkyoEzpk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zFHyXYGZvPRg" style="display: none"&gt;SCHEDULE
OF GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20241231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zM8UdbFpODS" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zT9wmhaz4rAe" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    thousands of US dollars&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and
    Administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LaborAndRelatedExpense_pn3n3_maGAAEzQ9k_zCpat4NjDHgk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;476&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;340&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProfessionalFees_pn3n3_maGAAEzQ9k_zi4SxpoWDAhl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees (including directors&#x2019;
    fees)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,724&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,527&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DepreciationAndAmortization_pn3n3_maGAAEzQ9k_zrUjIai7EGw1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InvestmentIncomeInvestmentExpense_pn3n3_maGAAEzQ9k_zIIKtdrgapB7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherGeneralAndAdministrativeExpense_pn3n3_maGAAEzQ9k_zWX9v32IOFne" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzQ9k_zw6DDv0l8y45" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total general and administrative
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,655&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,278&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</GCTK:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001318"
      unitRef="USD">476000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001319"
      unitRef="USD">340000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001321"
      unitRef="USD">3724000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001322"
      unitRef="USD">1527000</us-gaap:ProfessionalFees>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001324"
      unitRef="USD">22000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001325"
      unitRef="USD">3000</us-gaap:DepreciationAndAmortization>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001327"
      unitRef="USD">313000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001328"
      unitRef="USD">336000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001330"
      unitRef="USD">120000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001331"
      unitRef="USD">72000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001333"
      unitRef="USD">4655000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001334"
      unitRef="USD">2278000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001336">&lt;p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zOjE6R0Asjge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2013; &lt;span id="xdx_821_znES89XFp9D7"&gt;INCOME TAX&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Measurement
    of results for tax purposes under the Israeli Income Tax (Inflationary Adjustments) Law, 1985 (the &#x201c;Inflationary Adjustment
    Law&#x201d;)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
    January 1, 2008, the results of operations of Integrity Israel for tax purposes have been measured on a nominal basis.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Tax
    assessments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    federal, state and local income tax purposes the Company remains open for examination by the tax authorities for the tax years from
    2019 through 2022 under the general statute of limitations. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding,
    pursuant and subject to the provisions of article 145 of the Income Tax Ordinance, Integrity Israel&#x2019;s tax returns that were
    filed with the tax authority up to and including 2018 are considered final.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss
    for the years ended December 31, 2024 and 2023 consists of the following:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z6iMj2VfIwxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B3_zLn2HZGvSjL" style="display: none"&gt;SCHEDULE
OF INCOME TAX LOSS FOR THE YEAR&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 55%; margin-left: 1in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20241231_z9llL1qhyTj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230101__20231231_zN8DzbJCIRRb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationTaxSettlementsDomestic_z721b59wgzy3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,502&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,945&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationTaxSettlementsForeign_zZbKhuq8YfDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign entity (Integrity
    Israel)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationTaxSettlements_zX2ikabwNa2i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="display: none; font-size: 10pt"&gt;Total
    loss for the year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,097&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z0Oj0ARLpWv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net
    Operating Losses (NOL) carryforward &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 31, 2024, the Company had cumulative Net Operating Losses (NOL) carry forward for US federal purposes of approximately
    $&lt;span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20241231_zr1c7rgsOgr4" title="Operating loss carryforwards"&gt;31.6&lt;/span&gt; million to offset against future taxable income for an indefinite period of time. Integrity Israel has cumulative NOL carry
    forward for Israeli income tax purposes of approximately $&lt;span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20241231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zjHIp1RnvlI4" title="Operating loss carryforwards"&gt;38.5&lt;/span&gt; million to offset against future taxable income for an indefinite
    period of time.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31, 2024 and 2023, the main reconciling item is the recognition of valuation allowance in respect of deferred
    taxes relating to accumulated net operating losses carried forward and other permanent and temporary differences due to the uncertainty
    of the realization of such deferred taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    taxes result principally from temporary differences in the recognition of certain revenue and expense items for financial and income
    tax reporting purposes. Significant components of the Company&#x2019;s future tax assets are as follows:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z3M5qgJqhpPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zoi4M9xEydMj" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20241231_zd3wTWWq6y94" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231_z7RHaI1h04Bk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Composition
    of deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredTaxAssetsTaxVacationAccrual_iI_pn3n3_maDTAGzT7c_zf71lr31RLTh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vacation accrual&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pn3n3_maDTAGzT7c_z4haGyC1HmA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,276&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,033&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzT7c_zYDnguFiRVFb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating losses carry
    forwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,981&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,368&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzT7c_maDTANzC5T_ztVwDgQk3JP6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deferred tax asset
    before deferred tax liabilities and valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,465&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,467&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredTaxAssetValuationAllowance_iNI_pn3n3_di_msDTANzC5T_zeoDvg2oPx4d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,465&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(13,467&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzC5T_zsCEpPYzmoXe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zHIxdSaaxFkh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001338">&lt;p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z6iMj2VfIwxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B3_zLn2HZGvSjL" style="display: none"&gt;SCHEDULE
OF INCOME TAX LOSS FOR THE YEAR&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 55%; margin-left: 1in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20241231_z9llL1qhyTj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230101__20231231_zN8DzbJCIRRb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationTaxSettlementsDomestic_z721b59wgzy3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,502&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,945&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationTaxSettlementsForeign_zZbKhuq8YfDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign entity (Integrity
    Israel)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationTaxSettlements_zX2ikabwNa2i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="display: none; font-size: 10pt"&gt;Total
    loss for the year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,597&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,097&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001340"
      unitRef="USD">22502000</us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic>
    <us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001341"
      unitRef="USD">6945000</us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic>
    <us-gaap:IncomeTaxReconciliationTaxSettlementsForeign
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001343"
      unitRef="USD">95000</us-gaap:IncomeTaxReconciliationTaxSettlementsForeign>
    <us-gaap:IncomeTaxReconciliationTaxSettlementsForeign
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001344"
      unitRef="USD">152000</us-gaap:IncomeTaxReconciliationTaxSettlementsForeign>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="From2024-01-01to2024-12-31"
      decimals="-3"
      id="Fact001346"
      unitRef="USD">22597000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001347"
      unitRef="USD">7097000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="Fact001349"
      unitRef="USD">31600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-12-31_us-gaap_IsraelTaxAuthorityMember"
      decimals="-5"
      id="Fact001351"
      unitRef="USD">38500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001353">&lt;p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z3M5qgJqhpPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zoi4M9xEydMj" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20241231_zd3wTWWq6y94" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231_z7RHaI1h04Bk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Composition
    of deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredTaxAssetsTaxVacationAccrual_iI_pn3n3_maDTAGzT7c_zf71lr31RLTh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vacation accrual&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pn3n3_maDTAGzT7c_z4haGyC1HmA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,276&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,033&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzT7c_zYDnguFiRVFb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating losses carry
    forwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,981&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,368&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzT7c_maDTANzC5T_ztVwDgQk3JP6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deferred tax asset
    before deferred tax liabilities and valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,465&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,467&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredTaxAssetValuationAllowance_iNI_pn3n3_di_msDTANzC5T_zeoDvg2oPx4d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,465&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(13,467&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzC5T_zsCEpPYzmoXe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <GCTK:DeferredTaxAssetsTaxVacationAccrual
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001355"
      unitRef="USD">208000</GCTK:DeferredTaxAssetsTaxVacationAccrual>
    <GCTK:DeferredTaxAssetsTaxVacationAccrual
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001356"
      unitRef="USD">66000</GCTK:DeferredTaxAssetsTaxVacationAccrual>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001358"
      unitRef="USD">3276000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001359"
      unitRef="USD">1033000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001361"
      unitRef="USD">16981000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001362"
      unitRef="USD">12368000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001364"
      unitRef="USD">20465000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001365"
      unitRef="USD">13467000</us-gaap:DeferredTaxAssetsGross>
    <GCTK:DeferredTaxAssetValuationAllowance
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001367"
      unitRef="USD">20465000</GCTK:DeferredTaxAssetValuationAllowance>
    <GCTK:DeferredTaxAssetValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001368"
      unitRef="USD">13467000</GCTK:DeferredTaxAssetValuationAllowance>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001373">&lt;p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ziFcjqHPMZQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 &#x2013; &lt;span id="xdx_82E_zMsUzROzqZq6"&gt;RELATED PARTIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    more information regarding the intellectual property purchase agreement from the company&#x2019;s CEO - See Note 5B above.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    more information regarding loans received from certain Stockholders - See Note 3 above.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Tapsak
                                            Enterprises LLC, dba Virginia Analytical&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    October 25, 2022, the Company entered into agreement with Tapsak Enterprises LLC dba Virginia Analytical, which fully owned by Mark
    Tapsak, who serves as the Vice President of Sensor Science of the Company, under which, Tapsak Enterprises LLC dba Virginia Analytical,
    is providing laboratory space, equipment and materials to support the Company sensor development activities. During the years ended
    December 31, 2024 and 2023, a total amount of $&lt;span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkTapsakMember__us-gaap--TypeOfArrangementAxis__custom--TapsakEnterprisesLLCAgreementMember_zvSz1aPhauI4" title="Research and development expense"&gt;25&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkTapsakMember__us-gaap--TypeOfArrangementAxis__custom--TapsakEnterprisesLLCAgreementMember_zD5w8oGf5CY" title="Research and development expense"&gt;162&lt;/span&gt; were recorded as part of the Company&#x2019;s research and development
    expenses, respectively.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    more information regarding execution of lease agreement with Tapsak Enterprises LLC dba Virginia Analytical, see Note 6.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Regarding
    the issuances of notes, shares, warrants and settlement of notes, ee Note 4 above.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember"
      decimals="-3"
      id="Fact001375"
      unitRef="USD">25000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_MarkTapsakMember_custom_TapsakEnterprisesLLCAgreementMember"
      decimals="-3"
      id="Fact001377"
      unitRef="USD">162000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001379">&lt;p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_z1aHqmXzeOPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13 &#x2013; &lt;span id="xdx_826_z9kq90wzW5mi"&gt;SEGMENT REPORTING&lt;/span&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
280, &#x201c;Segment Reporting&#x201d; establishes standards for reporting information about operating segments on a basis consistent with
the Company&#x2019;s internal organization structure as well as information about services categories, business segments and major customers
in financial statements. The Company has only one reportable segment, the Glucotrack CBGM Product Segment, as all their research and
development activities are related the development of the Glucotrack CBGM Product. Since the Company operates in one operating segment,
all required financial segment information can be found in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adheres to the provisions of ASC 280, Segment Reporting, which establishes standards for the way public business enterprises
report information about operating segments in annual financial statements and requires that those enterprises report selected information
about operating segments in financial statements issued to shareholders. As the Company is currently involved in the development of one
product, the Platform, the Company has determined that it operates in a single reportable segment. The Company&#x2019;s Chief Operating
Decision Maker (CODM), its Chief Executive Officer (CEO), reviews the consolidated results of operations when making decisions about
allocating resources and assessing the performance of the Company as a whole and, hence, the Company has only one reportable segment.
The Company&#x2019;s assets are located in the United States of America.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact001381">&lt;p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zjINXV4Rhkzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14&lt;/b&gt; &#x2013; &lt;b&gt;&lt;span id="xdx_820_z2cIP0TmiaDf"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;2025 Reverse Stock
Split and Increase in Authorized Common Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;The Company filed with the Delaware
Secretary of State a Certificate of Amendment to its Certificate of Incorporation which became effective at 4:30 p.m. on February 3, 2025,
to implement a &lt;span id="xdx_907_eus-gaap--StockholdersEquityReverseStockSplit_c20250203__20250203__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znlyfRrYAsRf" title="Reverse stock split"&gt;reverse stock split at a ratio of 1-for-20&lt;/span&gt; (the &#x201c;2025 Reverse Stock Split&#x201d;) of the shares of its Common Stock.
The 2025 Reverse Stock Split was approved by the Company&#x2019;s stockholders at the special meeting of stockholders held on January 3,
2025 (the &#x201c;Special Meeting&#x201d;). All shares and per share numbers in the consolidated financial statements have been retroactively adjusted and are
reflected on a post-reverse share split basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;On
January 3, 2025, the Company filed an amendment to the Company&#x2019;s Certificate of Incorporation, as to increase the Company&#x2019;s
authorized shares of Common Stock from &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250103__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhi3msvb42Gf"&gt;100,000,000&lt;/span&gt; to &lt;span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250103__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4p1Qx4rViik"&gt;250,000,000&lt;/span&gt;. On February 3, 2025, the stockholders approved at the Special Meeting
the increase in the Company&#x2019;s authorized shares of Common Stock from &lt;span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250203__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcWCRmZ1hj19"&gt;100,000,000&lt;/span&gt;
to &lt;span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250203__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z54fTH6c6nP3"&gt;250,000,000&lt;/span&gt;,
as well as the full issuance of shares of Common Stock issuable by the Company upon the exercise of Series A Warrants and Series B Warrants
(see below).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;ATM Sales Agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;On December 17, 2024, the Company entered
into an ATM sales agreement (the &#x201c;Sales Agreement&#x201d;) with Dawson James Securities, Inc. (&#x201c;Dawson James&#x201d;), pursuant
to which the Company have agreed to issue and sell shares of Common Stock, having an aggregate offering price of up to $&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn4n6_c20241217__20241217__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_z1Q7vBemxfE6" title="Offering price"&gt;8.23&lt;/span&gt; million, from time
to time, through an &#x201c;at-the-market&#x201d; equity offering program under which Dawson James will act as sales agent (the &#x201c;Agent&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;On March 21, 2025, the Company sold &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250321__20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z770A3VPDTXg" title="Common stock, shares"&gt;12,377,967&lt;/span&gt;
shares of Common Stock at an average offering price of $&lt;span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_c20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWJe4YJK2nHd" title="Share price"&gt;0.304&lt;/span&gt; per share pursuant to the Sales Agreement. for net proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20250321__20250321__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5ft65ZIrhHl" title="Net proceeds"&gt;3.6&lt;/span&gt;
million, after deducting fees owed to the Agent from such sale. The shares of Common Stock were offered by the Company pursuant
to a prospectus supplement dated December 17, 2024, and accompanying prospectus dated October 3, 2024, which forms a part of the Company&#x2019;s
registration statement on Form S-3 (Registration No. 333-282297), which was declared effective by the Securities and Exchange Commission,
on October 3, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Registered Direct Offering&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;On February 4, 2025, the Company
entered into a securities purchase agreement with certain institutional investors, relating to the registered direct offering and sale
of an aggregate of &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zj5kwefqLKr6" title="Common stock, shares"&gt;2,638,042&lt;/span&gt; shares of Common Stock at an offering price of $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVQ4b0x48d8h" title="Share price"&gt;1.15&lt;/span&gt; per share. The net proceeds to the Company from the
offering were approximately $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYErQYbglKCk" title="Net proceeds"&gt;2.7&lt;/span&gt; million, after deducting fees owed to placement agent and other offering expenses. The February 2025
offering closed on February 5, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;The shares of Common Stock from
the February 2025 registered direct offering was offered by the Company pursuant to a prospectus supplement dated February 4, 2025, and
accompanying prospectus dated October 3, 2024, which forms a part of the Company&#x2019;s registration statement on Form S-3 (Registration
No. 333-282297), which was declared effective by the Securities and Exchange Commission, on October 3, 2024. Dawson James acted as the
placement agent for the offerings pursuant to a placement agency agreement, dated February 4, 2025, by and between the Company and Dawson
James.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Warrant Exchange&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;Beginning
on January 6, 2025, through March 15, 2025, the Company received exchange notices from certain holders of the Series B Warrants, with
respect to an aggregate of &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBWarrantsMember_zTkYqUcZU36j"&gt;359,612&lt;/span&gt;
of the Series B Warrants, requiring the delivery of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhyLm0xBnLU7"&gt;9,721,782&lt;/span&gt;
shares of Common Stock according to the alternative cashless exercise, as applicable to the Series B Warrants under the November
2024 offering. The remaining &lt;span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBWarrantsMember_zSSPMilZUlUe"&gt;100&lt;/span&gt;
Series B Warrants are exchangeable for an aggregate of approximately &lt;span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_pid_c20250106__20250315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zORxgWiXwBD4"&gt;1,940&lt;/span&gt;
shares of Common Stock (subject to adjustment in the event of any stock dividend and split, reverse stock split, recapitalization,
reorganization or similar transaction).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Appointment of Peter C. Wulff as Chief Financial
Officer&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;In connection with Mr.
Cardwell&#x2019;s resignation, on January 28, 2025, the Board appointed Peter C. Wulff as Chief Financial Officer of the Company.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="From2025-02-032025-02-03_us-gaap_SubsequentEventMember"
      id="Fact001383">reverse stock split at a ratio of 1-for-20</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-01-03_srt_MinimumMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001384"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-01-03_srt_MaximumMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001385"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-02-03_srt_MinimumMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001386"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-02-03_srt_MaximumMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001387"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-12-172024-12-17_custom_SalesAgreementMember"
      decimals="-4"
      id="Fact001389"
      unitRef="USD">8230000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-212025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001391"
      unitRef="Shares">12377967</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001393"
      unitRef="USDPShares">0.304</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2025-03-212025-03-21_custom_SalesAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact001395"
      unitRef="USD">3600000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-02-042025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001397"
      unitRef="Shares">2638042</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001399"
      unitRef="USDPShares">1.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2025-02-042025-02-04_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact001401"
      unitRef="USD">2700000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact001402"
      unitRef="Shares">359612</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001403"
      unitRef="Shares">9721782</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact001404"
      unitRef="Shares">100</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-062025-03-15_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001405"
      unitRef="Shares">1940</us-gaap:ConversionOfStockSharesConverted1>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#xdx2ixbrl0289"
          xlink:label="xdx2ixbrl0289"
          xlink:type="locator"/>
        <link:footnote id="Footnote000440" xlink:label="Footnote000440" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Less than 1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0289"
          xlink:to="Footnote000440"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000653"
          xlink:label="Fact000653"
          xlink:type="locator"/>
        <link:footnote id="Footnote001203" xlink:label="Footnote001203" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">After modification of exercise price</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000653"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000655"
          xlink:label="Fact000655"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000655"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000657"
          xlink:label="Fact000657"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000657"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000659"
          xlink:label="Fact000659"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000659"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0661"
          xlink:label="xdx2ixbrl0661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0661"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0663"
          xlink:label="xdx2ixbrl0663"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0663"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000665"
          xlink:label="Fact000665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000665"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000667"
          xlink:label="Fact000667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000667"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0669"
          xlink:label="xdx2ixbrl0669"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0669"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0671"
          xlink:label="xdx2ixbrl0671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0671"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000673"
          xlink:label="Fact000673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000673"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000675"
          xlink:label="Fact000675"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000675"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001198"
          xlink:label="Fact001198"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001198"
          xlink:to="Footnote001203"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
